Citrus Sinensis ID: 014210
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 429 | 2.2.26 [Sep-21-2011] | |||||||
| Q9SCS2 | 601 | CDPK-related kinase 5 OS= | yes | no | 0.946 | 0.675 | 0.794 | 0.0 | |
| P53681 | 602 | CDPK-related protein kina | N/A | no | 0.932 | 0.664 | 0.762 | 0.0 | |
| Q9LET1 | 577 | CDPK-related kinase 7 OS= | no | no | 0.888 | 0.660 | 0.714 | 1e-164 | |
| Q10KY3 | 600 | Calcium/calmodulin-depend | yes | no | 0.799 | 0.571 | 0.801 | 1e-163 | |
| O80673 | 576 | CDPK-related kinase 1 OS= | no | no | 0.885 | 0.659 | 0.710 | 1e-163 | |
| Q9LJL9 | 599 | CDPK-related kinase 2 OS= | no | no | 0.906 | 0.649 | 0.671 | 1e-158 | |
| Q9FX86 | 606 | CDPK-related kinase 8 OS= | no | no | 0.911 | 0.645 | 0.653 | 1e-155 | |
| Q9ZUZ2 | 595 | CDPK-related kinase 3 OS= | no | no | 0.927 | 0.668 | 0.622 | 1e-136 | |
| Q9FIM9 | 594 | CDPK-related kinase 4 OS= | no | no | 0.785 | 0.567 | 0.667 | 1e-128 | |
| Q9SG12 | 594 | CDPK-related kinase 6 OS= | no | no | 0.785 | 0.567 | 0.676 | 1e-123 |
| >sp|Q9SCS2|CAMK5_ARATH CDPK-related kinase 5 OS=Arabidopsis thaliana GN=CRK5 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 671 bits (1732), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 336/423 (79%), Positives = 365/423 (86%), Gaps = 17/423 (4%)
Query: 1 MGLCNSKPSSNSSSPKSDLIRNKNTPVPANGTPIPAPSPLNAESQSNNNRTNVKGNDDAV 60
MGLC SKP+S++S D +N+P+PA+ + P+ S +N E Q N
Sbjct: 1 MGLCTSKPNSSNS----DQTPARNSPLPASESVKPSSSSVNGEDQCVTTTNN-------- 48
Query: 61 IEGKKSPFFPFYSPSPAHYFFSKKS---SPARSSANSTPNRFFKRPFPPPSPAKHIKAVL 117
EGKKSPFFPFYSPSPAHYFFSKK+ SPA +S NSTP RFFKRPFPPPSPAKHI+AVL
Sbjct: 49 -EGKKSPFFPFYSPSPAHYFFSKKTPARSPATNSTNSTPKRFFKRPFPPPSPAKHIRAVL 107
Query: 118 ARRHGSVKPNEAAIPEGSEPEPAA-GLNKSFGFSKHFANKYELGEEVGRGHFGYTCAAKF 176
ARRHGSVKPN +AIPEGSE E GL+KSFGFSK FA+KYELG+EVGRGHFGYTCAAKF
Sbjct: 108 ARRHGSVKPNSSAIPEGSEAEGGGVGLDKSFGFSKSFASKYELGDEVGRGHFGYTCAAKF 167
Query: 177 KKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYV 236
KKG+ KGQQVAVKVIPK KMTTAIAIEDVRREVKILRAL+GHNNL F+DAYED DNVY+
Sbjct: 168 KKGDNKGQQVAVKVIPKAKMTTAIAIEDVRREVKILRALSGHNNLPHFYDAYEDHDNVYI 227
Query: 237 VMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTK 296
VMELCEGGELLDRILSRGGKYTE+DAK VMIQILNVVAFCHLQGVVHRDLKPENFLFT+K
Sbjct: 228 VMELCEGGELLDRILSRGGKYTEEDAKTVMIQILNVVAFCHLQGVVHRDLKPENFLFTSK 287
Query: 297 DENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRSYSTEADVWSIGVIAYILLC 356
++ S LKAIDFGLSD+VRPDERLNDIVGSAYYVAPEVLHRSYSTEAD+WS+GVI YILLC
Sbjct: 288 EDTSQLKAIDFGLSDYVRPDERLNDIVGSAYYVAPEVLHRSYSTEADIWSVGVIVYILLC 347
Query: 357 GSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSE 416
GSRPFWARTESGIFRAVLKADPSFD+ PWP LSSEARDFVKRLLNKDPRKRLTAAQALS
Sbjct: 348 GSRPFWARTESGIFRAVLKADPSFDDPPWPLLSSEARDFVKRLLNKDPRKRLTAAQALSH 407
Query: 417 LLI 419
I
Sbjct: 408 PWI 410
|
May play a role in signal transduction pathways that involve calcium as a second messenger. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|P53681|CRK_DAUCA CDPK-related protein kinase OS=Daucus carota GN=CRK PE=2 SV=1 | Back alignment and function description |
|---|
Score = 643 bits (1659), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 327/429 (76%), Positives = 354/429 (82%), Gaps = 29/429 (6%)
Query: 1 MGLCNSKPSSNSSSPKSDLIRNKNTPVPANGTPIPA------PSPLNAESQSNNNRTNVK 54
MG+C SKPS P+ DL N +T +P N T +P P + +Q NN
Sbjct: 1 MGICVSKPS-----PEPDL-HNHHTSIPVNDTSLPPQDNSIPPKDIAIPAQDNNKPP--- 51
Query: 55 GNDDAVIEGKKSPFFPFYSPSPAHYFFSKKS----SPARSSANSTPNRFFKRPFPPPSPA 110
GKKSPF PFYSPSPAH+ FSKKS SPA S+NSTP R F PFPPPSPA
Sbjct: 52 --------GKKSPFLPFYSPSPAHFLFSKKSPAVGSPAAGSSNSTPKRLF--PFPPPSPA 101
Query: 111 KHIKAVLARRHGSVKPNEAAIPEGSEPEPAAGLNKSFGFSKHFANKYELGEEVGRGHFGY 170
KHIKA ARRHGSVKPNEAAIPE +E + AGL+KSFGFSK F +K+E+GEEVGRGHFGY
Sbjct: 102 KHIKAAWARRHGSVKPNEAAIPENNEVDGGAGLDKSFGFSKKFGSKFEVGEEVGRGHFGY 161
Query: 171 TCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED 230
TC AKFKKGE KGQ VAVKVIPK KMTTAIAIEDVRREVKILRALTGHNNLV+F+DA+ED
Sbjct: 162 TCRAKFKKGEFKGQDVAVKVIPKAKMTTAIAIEDVRREVKILRALTGHNNLVQFYDAFED 221
Query: 231 TDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPEN 290
NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPEN
Sbjct: 222 HTNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPEN 281
Query: 291 FLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRSYSTEADVWSIGVI 350
FLF +KDE+S LKAIDFGLSD+V+PDERLNDIVGSAYYVAPEVLHRSYSTEADVWSIGVI
Sbjct: 282 FLFKSKDEDSQLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHRSYSTEADVWSIGVI 341
Query: 351 AYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTA 410
+YILLCGSRPFWARTESGIFRAVLKA+ SFDE PWPS+SSEA+DFVKRLLNKDPRKR+TA
Sbjct: 342 SYILLCGSRPFWARTESGIFRAVLKANLSFDEPPWPSVSSEAKDFVKRLLNKDPRKRMTA 401
Query: 411 AQALSELLI 419
AQAL I
Sbjct: 402 AQALCHSWI 410
|
Daucus carota (taxid: 4039) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LET1|CAMK7_ARATH CDPK-related kinase 7 OS=Arabidopsis thaliana GN=CRK7 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 579 bits (1492), Expect = e-164, Method: Compositional matrix adjust.
Identities = 296/414 (71%), Positives = 327/414 (78%), Gaps = 33/414 (7%)
Query: 1 MGLCNSKPSSNSSSPKSDLIRNKNTPVPANGTPIPAPSPLNAESQSNNNRTNVKGNDDAV 60
MGLC+ KP S KN P+ P S A
Sbjct: 1 MGLCHGKPIEQQS---------KNLPISNEIEETPKNSSQKA------------------ 33
Query: 61 IEGKKSPFFPFYSPSPAHYFFSKKSSPARSSANSTPNRFFKRPFPPPSPAKHIKAVLARR 120
KS FPFYSPSP F + + SS +STP R FKRPFPPPSPAKHI+A+LARR
Sbjct: 34 ----KSSGFPFYSPSPLPSLFKTSPAVSSSSVSSTPLRIFKRPFPPPSPAKHIRALLARR 89
Query: 121 HGSVKPNEAAIPEGSEPEPAAGLNKSFGFSKHFANKYELGEEVGRGHFGYTCAAKFKKGE 180
HGSVKPNEA+IPEGSE E GL+K FGFSK FA+ YE+ EVGRGHFGYTC+AK KKG
Sbjct: 90 HGSVKPNEASIPEGSECE--VGLDKKFGFSKQFASHYEIDGEVGRGHFGYTCSAKGKKGS 147
Query: 181 LKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMEL 240
LKGQ VAVKVIPK KMTTAIAIEDVRREVKILRALTGH NLV+F+DA+ED +NVY+VMEL
Sbjct: 148 LKGQDVAVKVIPKSKMTTAIAIEDVRREVKILRALTGHKNLVQFYDAFEDDENVYIVMEL 207
Query: 241 CEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENS 300
C+GGELLD+IL RGGKY+E DAK VMIQIL+VVA+CHLQGVVHRDLKPENFLFTTKDE+S
Sbjct: 208 CQGGELLDKILQRGGKYSEVDAKKVMIQILSVVAYCHLQGVVHRDLKPENFLFTTKDESS 267
Query: 301 VLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRSYSTEADVWSIGVIAYILLCGSRP 360
LKAIDFGLSD+VRPDERLNDIVGSAYYVAPEVLHR+Y TEAD+WSIGVIAYILLCGSRP
Sbjct: 268 PLKAIDFGLSDYVRPDERLNDIVGSAYYVAPEVLHRTYGTEADMWSIGVIAYILLCGSRP 327
Query: 361 FWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQAL 414
FWAR+ESGIFRAVLKA+P+F+EAPWPSLS +A DFVKRLLNKD RKRLTAAQAL
Sbjct: 328 FWARSESGIFRAVLKAEPNFEEAPWPSLSPDAVDFVKRLLNKDYRKRLTAAQAL 381
|
May play a role in signal transduction pathways that involve calcium as a second messenger. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q10KY3|CAMK1_ORYSJ Calcium/calmodulin-dependent serine/threonine-protein kinase 1 OS=Oryza sativa subsp. japonica GN=CAMK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 575 bits (1483), Expect = e-163, Method: Compositional matrix adjust.
Identities = 278/347 (80%), Positives = 307/347 (88%), Gaps = 4/347 (1%)
Query: 69 FPFYSPSPAHYFFSKKSSPARSSANSTPNRF-FKRPFPPPSPAKHIKAVLARRHGSVKPN 127
FPFY PSP S K SPA SS STP R FKRPFPPPSPAKHI+A+LARRHGSVKPN
Sbjct: 61 FPFYLPSPLPAS-SYKGSPANSSVASTPARGGFKRPFPPPSPAKHIRALLARRHGSVKPN 119
Query: 128 EAAIPEGSEPEPAAGLNKSFGFSKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVA 187
EA+IPE EP L+K FGFS+HFA KYELG EVGRGHFGYTCAA KKGELKG VA
Sbjct: 120 EASIPESGEP--GVALDKGFGFSRHFAAKYELGREVGRGHFGYTCAATCKKGELKGDDVA 177
Query: 188 VKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELL 247
VKVIPK KMTTAIAIEDVRREV+IL +L GH+NLV+F+DAYED +NVY+VMELC+GGELL
Sbjct: 178 VKVIPKAKMTTAIAIEDVRREVRILSSLAGHSNLVQFYDAYEDEENVYIVMELCKGGELL 237
Query: 248 DRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDF 307
DRIL+RGGKY+E+DAK VM QIL+V +FCHLQGVVHRDLKPENFLF++KDENS +K IDF
Sbjct: 238 DRILARGGKYSEEDAKVVMRQILSVASFCHLQGVVHRDLKPENFLFSSKDENSAMKVIDF 297
Query: 308 GLSDFVRPDERLNDIVGSAYYVAPEVLHRSYSTEADVWSIGVIAYILLCGSRPFWARTES 367
GLSDFV+PDERLNDIVGSAYYVAPEVLHRSY TEAD+WSIGVI YILLCGSRPFWARTES
Sbjct: 298 GLSDFVKPDERLNDIVGSAYYVAPEVLHRSYGTEADMWSIGVIVYILLCGSRPFWARTES 357
Query: 368 GIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQAL 414
GIFRAVLKADPSF+EAPWP+LS+EA+DFV+RLLNKD RKR+TAAQAL
Sbjct: 358 GIFRAVLKADPSFEEAPWPTLSAEAKDFVRRLLNKDYRKRMTAAQAL 404
|
Possesses kinase activity in vitro. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 EC: 7 |
| >sp|O80673|CAMK1_ARATH CDPK-related kinase 1 OS=Arabidopsis thaliana GN=CRK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 574 bits (1479), Expect = e-163, Method: Compositional matrix adjust.
Identities = 294/414 (71%), Positives = 327/414 (78%), Gaps = 34/414 (8%)
Query: 1 MGLCNSKPSSNSSSPKSDLIRNKNTPVPANGTPIPAPSPLNAESQSNNNRTNVKGNDDAV 60
MG+C+ KP S KS + + P N P PA
Sbjct: 1 MGICHGKPVEQQS--KSLPVSGETNEAPTNSQP-PA------------------------ 33
Query: 61 IEGKKSPFFPFYSPSPAHYFFSKKSSPARSSANSTPNRFFKRPFPPPSPAKHIKAVLARR 120
KS FPFYSPSP F K S SS +STP R FKRPFPPPSPAKHI+A LARR
Sbjct: 34 ----KSSGFPFYSPSPVPSLF-KSSPSVSSSVSSTPLRIFKRPFPPPSPAKHIRAFLARR 88
Query: 121 HGSVKPNEAAIPEGSEPEPAAGLNKSFGFSKHFANKYELGEEVGRGHFGYTCAAKFKKGE 180
+GSVKPNE +IPEG E E GL+KSFGFSK FA+ YE+ EVGRGHFGYTC+AK KKG
Sbjct: 89 YGSVKPNEVSIPEGKECE--IGLDKSFGFSKQFASHYEIDGEVGRGHFGYTCSAKGKKGS 146
Query: 181 LKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMEL 240
LKGQ+VAVKVIPK KMTTAIAIEDV REVK+LRALTGH NLV+F+DA+ED +NVY+VMEL
Sbjct: 147 LKGQEVAVKVIPKSKMTTAIAIEDVSREVKMLRALTGHKNLVQFYDAFEDDENVYIVMEL 206
Query: 241 CEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENS 300
C+GGELLD+IL RGGKY+EDDAK VM+QIL+VVA+CHLQGVVHRDLKPENFLF+TKDE S
Sbjct: 207 CKGGELLDKILQRGGKYSEDDAKKVMVQILSVVAYCHLQGVVHRDLKPENFLFSTKDETS 266
Query: 301 VLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRSYSTEADVWSIGVIAYILLCGSRP 360
LKAIDFGLSD+V+PDERLNDIVGSAYYVAPEVLHR+Y TEAD+WSIGVIAYILLCGSRP
Sbjct: 267 PLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHRTYGTEADMWSIGVIAYILLCGSRP 326
Query: 361 FWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQAL 414
FWARTESGIFRAVLKA+P+F+EAPWPSLS EA DFVKRLLNKD RKRLTAAQAL
Sbjct: 327 FWARTESGIFRAVLKAEPNFEEAPWPSLSPEAVDFVKRLLNKDYRKRLTAAQAL 380
|
May play a role in signal transduction pathways that involve calcium as a second messenger (By similarity). Serine/threonine kinase that phosphorylates histone H3. Confers thermotolerance; involved in the heat-shock-mediated calmodulin-dependent signal transduction leading to the activation of heat-shock transcription factors (HSFs); phosphorylates HSFA1A. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LJL9|CAMK2_ARATH CDPK-related kinase 2 OS=Arabidopsis thaliana GN=CRK2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 559 bits (1441), Expect = e-158, Method: Compositional matrix adjust.
Identities = 286/426 (67%), Positives = 328/426 (76%), Gaps = 37/426 (8%)
Query: 1 MGLCNSKPSS----NSSSPKSDLIRNKNTPVPANGTPIPAPSPLNAESQSNNNRTNVKGN 56
MG C SKPSS N +PK +++N ++ PA+ P SP+ +
Sbjct: 1 MGGCTSKPSSSVKPNPYAPKDAVLQNDDS-TPAH----PGKSPVRSSPAV---------- 45
Query: 57 DDAVIEGKKSPFFPFYSPSPAHYFFSKKSSPA---RSSANSTPNRFFKRPFPPPSPAKHI 113
K SPFFPFY+PSPA + +K S STP R R F PPSPA+HI
Sbjct: 46 -------KASPFFPFYTPSPARHRRNKSRDGGGGESKSVTSTPLRQLARAFHPPSPARHI 98
Query: 114 KAVLARRHGSVKPNEAAIPEGSEPEPA-----AGLNKSFGFSKHFANKYELGEEVGRGHF 168
+ VL RR + EAA+P + + GL+K FGFSK ++ ELGEE+GRGHF
Sbjct: 99 RDVLRRRK---EKKEAALPAARQQKEEEEREEVGLDKRFGFSKELQSRIELGEEIGRGHF 155
Query: 169 GYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAY 228
GYTC+AKFKKGELK Q+VAVKVIPK KMT+AI+IEDVRREVKILRAL+GH NLV+F+DA+
Sbjct: 156 GYTCSAKFKKGELKDQEVAVKVIPKSKMTSAISIEDVRREVKILRALSGHQNLVQFYDAF 215
Query: 229 EDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKP 288
ED NVY+VMELC GGELLDRIL+RGGKY+EDDAKAV+IQILNVVAFCHLQGVVHRDLKP
Sbjct: 216 EDNANVYIVMELCGGGELLDRILARGGKYSEDDAKAVLIQILNVVAFCHLQGVVHRDLKP 275
Query: 289 ENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRSYSTEADVWSIG 348
ENFL+T+K+ENS+LK IDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRSY+TEADVWSIG
Sbjct: 276 ENFLYTSKEENSMLKVIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRSYTTEADVWSIG 335
Query: 349 VIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRL 408
VIAYILLCGSRPFWARTESGIFRAVLKADPSFDE PWPSLS EA+DFVKRLL KDPRKR+
Sbjct: 336 VIAYILLCGSRPFWARTESGIFRAVLKADPSFDEPPWPSLSFEAKDFVKRLLYKDPRKRM 395
Query: 409 TAAQAL 414
TA+QAL
Sbjct: 396 TASQAL 401
|
May play a role in signal transduction pathways that involve calcium as a second messenger. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FX86|CAMK8_ARATH CDPK-related kinase 8 OS=Arabidopsis thaliana GN=CRK8 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 550 bits (1416), Expect = e-155, Method: Compositional matrix adjust.
Identities = 281/430 (65%), Positives = 324/430 (75%), Gaps = 39/430 (9%)
Query: 1 MGLCNSKPSSNSS-----SPKSDLIRNKN-TPVPANGTPIPAPSPLNAESQSNNNRTNVK 54
MG C SKPS++S +P +D + + P +PIP PS
Sbjct: 1 MGGCTSKPSTSSGRPNPFAPGNDYPQIDDFAPDHPGKSPIPTPS---------------- 44
Query: 55 GNDDAVIEGKKSPFFPFYSPSPAHYFFSKKSSPA----RSSANSTPNRFFKRPFPPPSPA 110
K SPFFPFY+PSPA + +K S STP R +R F PPSPA
Sbjct: 45 -------AAKASPFFPFYTPSPARHRRNKSRDVGGGGESKSLTSTPLRQLRRAFHPPSPA 97
Query: 111 KHIKAVLARRHGSVKPNEAAIPEGSEPEP------AAGLNKSFGFSKHFANKYELGEEVG 164
KHI+A L RR G + + + + + P GL+K FGFSK F ++ ELGEE+G
Sbjct: 98 KHIRAALRRRKGKKEAALSGVTQLTTEVPQREEEEEVGLDKRFGFSKEFHSRVELGEEIG 157
Query: 165 RGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKF 224
RGHFGYTC+AKFKKGELKGQ VAVK+IPK KMTTAIAIEDVRREVKIL+AL+GH NLV+F
Sbjct: 158 RGHFGYTCSAKFKKGELKGQVVAVKIIPKSKMTTAIAIEDVRREVKILQALSGHKNLVQF 217
Query: 225 FDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHR 284
+DA+ED NVY+ MELCEGGELLDRIL+RGGKY+E+DAK V+IQILNVVAFCH QGVVHR
Sbjct: 218 YDAFEDNANVYIAMELCEGGELLDRILARGGKYSENDAKPVIIQILNVVAFCHFQGVVHR 277
Query: 285 DLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRSYSTEADV 344
DLKPENFL+T+K+ENS LKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRSY+TEADV
Sbjct: 278 DLKPENFLYTSKEENSQLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRSYTTEADV 337
Query: 345 WSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDP 404
WSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDE PWP LSS+A+DFVKRLL KDP
Sbjct: 338 WSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEPPWPFLSSDAKDFVKRLLFKDP 397
Query: 405 RKRLTAAQAL 414
R+R++A+QAL
Sbjct: 398 RRRMSASQAL 407
|
May play a role in signal transduction pathways that involve calcium as a second messenger. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZUZ2|CAMK3_ARATH CDPK-related kinase 3 OS=Arabidopsis thaliana GN=CRK3 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 486 bits (1250), Expect = e-136, Method: Compositional matrix adjust.
Identities = 260/418 (62%), Positives = 306/418 (73%), Gaps = 20/418 (4%)
Query: 1 MGLCNSKPSSNSSSPKSDLIRNKNT-PVPANGTPIPAPSPLNAESQSNN--NRTNVKGND 57
MG C K N S + N T V +G I +P+N N +N
Sbjct: 1 MGQCYGK--VNQSKQNGEEEANTTTYVVSGDGNQIQPLTPVNYGRAKNTPARSSNPSPWP 58
Query: 58 DAVIEGKKSPFFPFYSPSPAHYFFSKKSSPARSSANSTPNRFFKRPFPPPSPAKHIKAVL 117
G SP SPSPA STP RFF+RPFPPPSPAKHIKA L
Sbjct: 59 SPFPHGSASPLPSGVSPSPAR--------------TSTPRRFFRRPFPPPSPAKHIKASL 104
Query: 118 ARRHGSVKPNEAAIPEGSEPEPAAGLNKSFGFSKHFANKYELGEEVGRGHFGYTCAAKFK 177
+R G VKP E IPE EP L+KSFG+ K+F KYELG+EVGRGHFG+TC+ + K
Sbjct: 105 IKRLG-VKPKEGPIPEERGTEPEQSLDKSFGYGKNFGAKYELGKEVGRGHFGHTCSGRGK 163
Query: 178 KGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVV 237
KG++K +AVK+I K KMTTAIAIEDVRREVK+L++L+GH L+K++DA ED +NVY+V
Sbjct: 164 KGDIKDHPIAVKIISKAKMTTAIAIEDVRREVKLLKSLSGHKYLIKYYDACEDANNVYIV 223
Query: 238 MELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKD 297
MELC+GGELLDRIL+RGGKY EDDAKA+++QIL VV+FCHLQGVVHRDLKPENFLFT+
Sbjct: 224 MELCDGGELLDRILARGGKYPEDDAKAIVVQILTVVSFCHLQGVVHRDLKPENFLFTSSR 283
Query: 298 ENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRSYSTEADVWSIGVIAYILLCG 357
E+S LK IDFGLSDF+RPDERLNDIVGSAYYVAPEVLHRSYS EAD+WSIGVI YILLCG
Sbjct: 284 EDSDLKLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLHRSYSLEADIWSIGVITYILLCG 343
Query: 358 SRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALS 415
SRPFWARTESGIFR VL+ +P++D+ PWPS SSE +DFVKRLLNKD RKR++A QAL+
Sbjct: 344 SRPFWARTESGIFRTVLRTEPNYDDVPWPSCSSEGKDFVKRLLNKDYRKRMSAVQALT 401
|
May play a role in signal transduction pathways that involve calcium as a second messenger (By similarity). Serine/threonine kinase that phosphorylates histone H3 an GLN1-1. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FIM9|CAMK4_ARATH CDPK-related kinase 4 OS=Arabidopsis thaliana GN=CRK4 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 458 bits (1178), Expect = e-128, Method: Compositional matrix adjust.
Identities = 237/355 (66%), Positives = 285/355 (80%), Gaps = 18/355 (5%)
Query: 70 PFYSPSPAHYFFSKKSSPARSSANSTPNRFFKRPFPPPSPAKHIKAVLARRHGSV-KPNE 128
PF SP PA SPAR TP R FK PFPPPSPAK I A L RR G+ +P +
Sbjct: 56 PFQSPLPA----GVAPSPAR-----TPGRKFKWPFPPPSPAKPIMAALRRRRGAPPQPRD 106
Query: 129 AAIPEGSEPEPAAG--------LNKSFGFSKHFANKYELGEEVGRGHFGYTCAAKFKKGE 180
IPE SE G L+K+FGF K+F KYELG+EVGRGHFG+TC AK KKG+
Sbjct: 107 EPIPEDSEDVVDHGGDSGGGERLDKNFGFGKNFEGKYELGKEVGRGHFGHTCWAKAKKGK 166
Query: 181 LKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMEL 240
+K Q VAVK+I K KMT+ ++IEDVRREVK+L+AL+GH ++VKF+D YED DNV+VVMEL
Sbjct: 167 MKNQTVAVKIISKAKMTSTLSIEDVRREVKLLKALSGHRHMVKFYDVYEDADNVFVVMEL 226
Query: 241 CEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENS 300
CEGGELLDRIL+RGG+Y E DAK +++QIL+ AF HLQGVVHRDLKPENFLFT+++E++
Sbjct: 227 CEGGELLDRILARGGRYPEVDAKRILVQILSATAFFHLQGVVHRDLKPENFLFTSRNEDA 286
Query: 301 VLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRSYSTEADVWSIGVIAYILLCGSRP 360
+LK IDFGLSDF+R D+RLND+VGSAYYVAPEVLHRSYSTEAD+WSIGVI+YILLCGSRP
Sbjct: 287 ILKVIDFGLSDFIRYDQRLNDVVGSAYYVAPEVLHRSYSTEADMWSIGVISYILLCGSRP 346
Query: 361 FWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALS 415
F+ RTES IFR VL+A+P+F++ PWPS+S A+DFVKRLLNKD RKR+TAAQAL+
Sbjct: 347 FYGRTESAIFRCVLRANPNFEDMPWPSISPTAKDFVKRLLNKDHRKRMTAAQALA 401
|
May play a role in signal transduction pathways that involve calcium as a second messenger. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SG12|CAMK6_ARATH CDPK-related kinase 6 OS=Arabidopsis thaliana GN=CRK6 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 442 bits (1136), Expect = e-123, Method: Compositional matrix adjust.
Identities = 238/352 (67%), Positives = 287/352 (81%), Gaps = 15/352 (4%)
Query: 70 PFYSPSPAHYFFSKKSSPARSSANSTPNRFFKRPFPPPSPAKHIKAVLARRHGSV-KPNE 128
PF SP PA SPAR TP R FK PFPPPSPAK I A L RR G+ P +
Sbjct: 58 PFQSPLPA----GVAPSPAR-----TPGRKFKWPFPPPSPAKPIMAALRRRRGTAPHPRD 108
Query: 129 AAIPEGSEPEPAAG-----LNKSFGFSKHFANKYELGEEVGRGHFGYTCAAKFKKGELKG 183
IPE SE + G L+K+FGF+K+F KYELG EVGRGHFG+TC AK KKG++KG
Sbjct: 109 GPIPEDSEAGGSGGGIGERLDKNFGFAKNFEGKYELGREVGRGHFGHTCWAKAKKGKIKG 168
Query: 184 QQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEG 243
Q VAVK+I K KMT+A++IEDVRREVK+L+AL+GH+++VKF+D +ED+DNV+VVMELCEG
Sbjct: 169 QTVAVKIISKSKMTSALSIEDVRREVKLLKALSGHSHMVKFYDVFEDSDNVFVVMELCEG 228
Query: 244 GELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLK 303
GELLD IL+RGG+Y E +AK +++QIL+ AF HLQGVVHRDLKPENFLFT+K+E++VLK
Sbjct: 229 GELLDSILARGGRYPEAEAKRILVQILSATAFFHLQGVVHRDLKPENFLFTSKNEDAVLK 288
Query: 304 AIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRSYSTEADVWSIGVIAYILLCGSRPFWA 363
IDFGLSD+ R D+RLND+VGSAYYVAPEVLHRSYSTEAD+WSIGVI+YILLCGSRPF+
Sbjct: 289 VIDFGLSDYARFDQRLNDVVGSAYYVAPEVLHRSYSTEADIWSIGVISYILLCGSRPFYG 348
Query: 364 RTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALS 415
RTES IFR VL+A+P+FD+ PWPS+S A+DFVKRLLNKD RKR+TAAQAL+
Sbjct: 349 RTESAIFRCVLRANPNFDDLPWPSISPIAKDFVKRLLNKDHRKRMTAAQALA 400
|
May play a role in signal transduction pathways that involve calcium as a second messenger. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 429 | ||||||
| 224081597 | 607 | CPK related kinase 5 [Populus trichocarp | 0.944 | 0.667 | 0.817 | 0.0 | |
| 224096786 | 606 | CPK related protein kinase 7 [Populus tr | 0.941 | 0.666 | 0.812 | 0.0 | |
| 297816306 | 597 | hypothetical protein ARALYDRAFT_485401 [ | 0.937 | 0.673 | 0.799 | 0.0 | |
| 16904214 | 601 | calcium/calmodulin-dependent protein kin | 0.946 | 0.675 | 0.794 | 0.0 | |
| 15229785 | 601 | CDPK-related kinase [Arabidopsis thalian | 0.946 | 0.675 | 0.794 | 0.0 | |
| 16904226 | 602 | calcium/calmodulin-dependent protein kin | 0.934 | 0.666 | 0.787 | 0.0 | |
| 73761697 | 617 | CDPK-related protein kinase [Gossypium h | 0.965 | 0.670 | 0.819 | 0.0 | |
| 449460636 | 621 | PREDICTED: CDPK-related protein kinase-l | 0.948 | 0.655 | 0.769 | 0.0 | |
| 334185866 | 632 | CDPK-related kinase [Arabidopsis thalian | 0.937 | 0.636 | 0.744 | 0.0 | |
| 1706130 | 602 | RecName: Full=CDPK-related protein kinas | 0.932 | 0.664 | 0.762 | 0.0 |
| >gi|224081597|ref|XP_002306462.1| CPK related kinase 5 [Populus trichocarpa] gi|222855911|gb|EEE93458.1| CPK related kinase 5 [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 690 bits (1780), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 344/421 (81%), Positives = 363/421 (86%), Gaps = 16/421 (3%)
Query: 1 MGLCNSKPSSNSSSPKSDLIRNKNTPVPANGTPIPAPSPLNAESQSNNNRTNVKGNDDAV 60
MG+C SKPS NS+ I+ K+ +P N T P P A + N+T V+
Sbjct: 1 MGICTSKPSPNSTLFSPVAIQAKDNSIPTNDTA--KPDPATASLNDHTNKTTVE------ 52
Query: 61 IEGKKSPFFPFYSPSPAHYFFSKKSSPARS------SANSTPNRFFKRPFPPPSPAKHIK 114
KKSP FPFYSPSPAH FFSKKSSPARS SANSTP RFFKRPFPPPSPAKHI+
Sbjct: 53 -PVKKSPLFPFYSPSPAHRFFSKKSSPARSPARNAASANSTPKRFFKRPFPPPSPAKHIR 111
Query: 115 AVLARRHGSVKPNEAAIPEGSEPEPAAGLNKSFGFSKHFANKYELGEEVGRGHFGYTCAA 174
AVLARRHGSVKPNEAAIPEGSE GL+KSFGFSKHF NKYELG+EVGRGHFGYTC A
Sbjct: 112 AVLARRHGSVKPNEAAIPEGSE-TGGEGLDKSFGFSKHFGNKYELGDEVGRGHFGYTCQA 170
Query: 175 KFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234
KFKKGELKGQQVAVKVIPK KMTTAIAIEDVRREVKILRALTGHNNLV F+DAYED DNV
Sbjct: 171 KFKKGELKGQQVAVKVIPKAKMTTAIAIEDVRREVKILRALTGHNNLVHFYDAYEDHDNV 230
Query: 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFT 294
Y+VMELCEGGELLDRIL+RGGKY+EDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFT
Sbjct: 231 YIVMELCEGGELLDRILARGGKYSEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFT 290
Query: 295 TKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRSYSTEADVWSIGVIAYIL 354
+KDENS LKAIDFGLSDFV+PDERLNDIVGSAYYVAPEVLHRSY TEADVWSIGVIAYIL
Sbjct: 291 SKDENSQLKAIDFGLSDFVKPDERLNDIVGSAYYVAPEVLHRSYGTEADVWSIGVIAYIL 350
Query: 355 LCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQAL 414
LCGSRPFWARTESGIFRAVLKADPSFDE PWPSLS EA+DFVK+LLNKDPRKRLTAAQAL
Sbjct: 351 LCGSRPFWARTESGIFRAVLKADPSFDETPWPSLSPEAKDFVKQLLNKDPRKRLTAAQAL 410
Query: 415 S 415
S
Sbjct: 411 S 411
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224096786|ref|XP_002310736.1| CPK related protein kinase 7 [Populus trichocarpa] gi|222853639|gb|EEE91186.1| CPK related protein kinase 7 [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 682 bits (1760), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 342/421 (81%), Positives = 360/421 (85%), Gaps = 17/421 (4%)
Query: 1 MGLCNSKPSSNSSSPKSDLIRNKNTPVPANGTPIPAPSPLNAESQSNNNRTNVKGNDDAV 60
MG+C SKPS NS+ I+ + +P TP P P N Q NN T ++
Sbjct: 1 MGICTSKPSPNSTLSSPIAIQANDNSIPTKDTPRPDPRTPNVNDQ--NNSTGLES----- 53
Query: 61 IEGKKSPFFPFYSPSPAHYFFSKKSSPARS------SANSTPNRFFKRPFPPPSPAKHIK 114
KKSPF F+SPSPAHYFFSKKSSPARS SANSTP R FKRPFPPPSPAKHI+
Sbjct: 54 --VKKSPF-NFFSPSPAHYFFSKKSSPARSPARNAASANSTPKRLFKRPFPPPSPAKHIR 110
Query: 115 AVLARRHGSVKPNEAAIPEGSEPEPAAGLNKSFGFSKHFANKYELGEEVGRGHFGYTCAA 174
AVLARRHGSVKPNEA IPEG E E AAGL KSFGFSKHF NKYELG+EVGRGHFGYTC A
Sbjct: 111 AVLARRHGSVKPNEATIPEGGEAE-AAGLVKSFGFSKHFGNKYELGDEVGRGHFGYTCQA 169
Query: 175 KFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234
KFKKGELKGQQVAVKVIPK KMTTAIAIEDVRREV ILRAL GHNNLV+F+DAYED DNV
Sbjct: 170 KFKKGELKGQQVAVKVIPKAKMTTAIAIEDVRREVNILRALNGHNNLVQFYDAYEDHDNV 229
Query: 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFT 294
Y+VMELCEGGELLDRIL+RGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFT
Sbjct: 230 YIVMELCEGGELLDRILARGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFT 289
Query: 295 TKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRSYSTEADVWSIGVIAYIL 354
+KDE+S LKAIDFGLSDFV+PDERLNDIVGSAYYVAPEVLHRSY TEADVWSIGVIAYIL
Sbjct: 290 SKDEDSQLKAIDFGLSDFVKPDERLNDIVGSAYYVAPEVLHRSYGTEADVWSIGVIAYIL 349
Query: 355 LCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQAL 414
LCGSRPFWARTESGIFRAVLKADPSFDE PWPSLS EA+DFVKRLLNKDPRKRLTAAQAL
Sbjct: 350 LCGSRPFWARTESGIFRAVLKADPSFDETPWPSLSPEAKDFVKRLLNKDPRKRLTAAQAL 409
Query: 415 S 415
S
Sbjct: 410 S 410
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297816306|ref|XP_002876036.1| hypothetical protein ARALYDRAFT_485401 [Arabidopsis lyrata subsp. lyrata] gi|297321874|gb|EFH52295.1| hypothetical protein ARALYDRAFT_485401 [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 675 bits (1742), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 338/423 (79%), Positives = 364/423 (86%), Gaps = 21/423 (4%)
Query: 1 MGLCNSKPSSNSSSPKSDLIRNKNTPVPANGTPIPAPSPLNAESQSNNNRTNVKGNDDAV 60
MGLC SKP+S P SD I +N+P+PA+ + P S SN ++ N
Sbjct: 1 MGLCTSKPNS----PNSDQIPARNSPLPASESVKP--------SSSNEDQCVTTNN---- 44
Query: 61 IEGKKSPFFPFYSPSPAHYFFSKKS---SPARSSANSTPNRFFKRPFPPPSPAKHIKAVL 117
EGKKSPFFPFYSPSPAHYFFSKK+ SPA +S NSTP RFFKRPFPPPSPAKHI+AVL
Sbjct: 45 -EGKKSPFFPFYSPSPAHYFFSKKTPARSPATNSTNSTPKRFFKRPFPPPSPAKHIRAVL 103
Query: 118 ARRHGSVKPNEAAIPEGSEPEPAA-GLNKSFGFSKHFANKYELGEEVGRGHFGYTCAAKF 176
ARRHGSVKPN AAIPEGSE E GL+KSFGFSK FA+KYELG+EVGRGHFGYTCAAKF
Sbjct: 104 ARRHGSVKPNSAAIPEGSEAEGGGVGLDKSFGFSKSFASKYELGDEVGRGHFGYTCAAKF 163
Query: 177 KKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYV 236
KKG+ KGQQVAVKVIPK KMTTAIAIEDVRREVKILRAL+GHNNL F+DAYED DNVY+
Sbjct: 164 KKGDNKGQQVAVKVIPKAKMTTAIAIEDVRREVKILRALSGHNNLPHFYDAYEDHDNVYI 223
Query: 237 VMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTK 296
VMELCEGGELLDRILSRGGKYTE+DAK VMIQILNVVAFCHLQGVVHRDLKPENFLFT+K
Sbjct: 224 VMELCEGGELLDRILSRGGKYTEEDAKTVMIQILNVVAFCHLQGVVHRDLKPENFLFTSK 283
Query: 297 DENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRSYSTEADVWSIGVIAYILLC 356
++ S LKAIDFGLSD+VRPDERLNDIVGSAYYVAPEVLHRSYSTEAD+WS+GVI YILLC
Sbjct: 284 EDTSQLKAIDFGLSDYVRPDERLNDIVGSAYYVAPEVLHRSYSTEADIWSVGVIVYILLC 343
Query: 357 GSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSE 416
GSRPFWARTESGIFRAVLKADPSFD+ PWP LSSEARDFVKRLLNKDPRKRLTAAQALS
Sbjct: 344 GSRPFWARTESGIFRAVLKADPSFDDPPWPLLSSEARDFVKRLLNKDPRKRLTAAQALSH 403
Query: 417 LLI 419
I
Sbjct: 404 PWI 406
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|16904214|gb|AAL30814.1|AF435446_1 calcium/calmodulin-dependent protein kinase CaMK1 [Arabidopsis thaliana] gi|2154715|emb|CAA70572.1| CDPK-related protein kinase [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 672 bits (1733), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 336/423 (79%), Positives = 365/423 (86%), Gaps = 17/423 (4%)
Query: 1 MGLCNSKPSSNSSSPKSDLIRNKNTPVPANGTPIPAPSPLNAESQSNNNRTNVKGNDDAV 60
MGLC SKP+S++S D +N+P+PA+ + P+ S +N E Q N
Sbjct: 1 MGLCTSKPNSSNS----DQTPARNSPLPASESVKPSSSSVNGEDQCVTTTNN-------- 48
Query: 61 IEGKKSPFFPFYSPSPAHYFFSKKS---SPARSSANSTPNRFFKRPFPPPSPAKHIKAVL 117
EGKKSPFFPFYSPSPAHYFFSKK+ SPA +S NSTP RFFKRPFPPPSPAKHI+AVL
Sbjct: 49 -EGKKSPFFPFYSPSPAHYFFSKKTPARSPATNSTNSTPKRFFKRPFPPPSPAKHIRAVL 107
Query: 118 ARRHGSVKPNEAAIPEGSEPEPAA-GLNKSFGFSKHFANKYELGEEVGRGHFGYTCAAKF 176
ARRHGSVKPN +AIPEGSE E GL+KSFGFSK FA+KYELG+EVGRGHFGYTCAAKF
Sbjct: 108 ARRHGSVKPNSSAIPEGSEAEGGGVGLDKSFGFSKSFASKYELGDEVGRGHFGYTCAAKF 167
Query: 177 KKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYV 236
KKG+ KGQQVAVKVIPK KMTTAIAIEDVRREVKILRAL+GHNNL F+DAYED DNVY+
Sbjct: 168 KKGDNKGQQVAVKVIPKAKMTTAIAIEDVRREVKILRALSGHNNLPHFYDAYEDHDNVYI 227
Query: 237 VMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTK 296
VMELCEGGELLDRILSRGGKYTE+DAK VMIQILNVVAFCHLQGVVHRDLKPENFLFT+K
Sbjct: 228 VMELCEGGELLDRILSRGGKYTEEDAKTVMIQILNVVAFCHLQGVVHRDLKPENFLFTSK 287
Query: 297 DENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRSYSTEADVWSIGVIAYILLC 356
++ S LKAIDFGLSD+VRPDERLNDIVGSAYYVAPEVLHRSYSTEAD+WS+GVI YILLC
Sbjct: 288 EDTSQLKAIDFGLSDYVRPDERLNDIVGSAYYVAPEVLHRSYSTEADIWSVGVIVYILLC 347
Query: 357 GSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSE 416
GSRPFWARTESGIFRAVLKADPSFD+ PWP LSSEARDFVKRLLNKDPRKRLTAAQALS
Sbjct: 348 GSRPFWARTESGIFRAVLKADPSFDDPPWPLLSSEARDFVKRLLNKDPRKRLTAAQALSH 407
Query: 417 LLI 419
I
Sbjct: 408 PWI 410
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15229785|ref|NP_190622.1| CDPK-related kinase [Arabidopsis thaliana] gi|75337058|sp|Q9SCS2.1|CAMK5_ARATH RecName: Full=CDPK-related kinase 5; Short=AtCRK5; AltName: Full=Calcium/calmodulin-dependent protein kinase 1 gi|6561993|emb|CAB62482.1| CDPK-related protein kinase [Arabidopsis thaliana] gi|332645155|gb|AEE78676.1| CDPK-related kinase [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 671 bits (1732), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 336/423 (79%), Positives = 365/423 (86%), Gaps = 17/423 (4%)
Query: 1 MGLCNSKPSSNSSSPKSDLIRNKNTPVPANGTPIPAPSPLNAESQSNNNRTNVKGNDDAV 60
MGLC SKP+S++S D +N+P+PA+ + P+ S +N E Q N
Sbjct: 1 MGLCTSKPNSSNS----DQTPARNSPLPASESVKPSSSSVNGEDQCVTTTNN-------- 48
Query: 61 IEGKKSPFFPFYSPSPAHYFFSKKS---SPARSSANSTPNRFFKRPFPPPSPAKHIKAVL 117
EGKKSPFFPFYSPSPAHYFFSKK+ SPA +S NSTP RFFKRPFPPPSPAKHI+AVL
Sbjct: 49 -EGKKSPFFPFYSPSPAHYFFSKKTPARSPATNSTNSTPKRFFKRPFPPPSPAKHIRAVL 107
Query: 118 ARRHGSVKPNEAAIPEGSEPEPAA-GLNKSFGFSKHFANKYELGEEVGRGHFGYTCAAKF 176
ARRHGSVKPN +AIPEGSE E GL+KSFGFSK FA+KYELG+EVGRGHFGYTCAAKF
Sbjct: 108 ARRHGSVKPNSSAIPEGSEAEGGGVGLDKSFGFSKSFASKYELGDEVGRGHFGYTCAAKF 167
Query: 177 KKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYV 236
KKG+ KGQQVAVKVIPK KMTTAIAIEDVRREVKILRAL+GHNNL F+DAYED DNVY+
Sbjct: 168 KKGDNKGQQVAVKVIPKAKMTTAIAIEDVRREVKILRALSGHNNLPHFYDAYEDHDNVYI 227
Query: 237 VMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTK 296
VMELCEGGELLDRILSRGGKYTE+DAK VMIQILNVVAFCHLQGVVHRDLKPENFLFT+K
Sbjct: 228 VMELCEGGELLDRILSRGGKYTEEDAKTVMIQILNVVAFCHLQGVVHRDLKPENFLFTSK 287
Query: 297 DENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRSYSTEADVWSIGVIAYILLC 356
++ S LKAIDFGLSD+VRPDERLNDIVGSAYYVAPEVLHRSYSTEAD+WS+GVI YILLC
Sbjct: 288 EDTSQLKAIDFGLSDYVRPDERLNDIVGSAYYVAPEVLHRSYSTEADIWSVGVIVYILLC 347
Query: 357 GSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSE 416
GSRPFWARTESGIFRAVLKADPSFD+ PWP LSSEARDFVKRLLNKDPRKRLTAAQALS
Sbjct: 348 GSRPFWARTESGIFRAVLKADPSFDDPPWPLLSSEARDFVKRLLNKDPRKRLTAAQALSH 407
Query: 417 LLI 419
I
Sbjct: 408 PWI 410
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|16904226|gb|AAL30820.1|AF435452_1 calcium/calmodulin-dependent protein kinase CaMK3 [Nicotiana tabacum] | Back alignment and taxonomy information |
|---|
Score = 671 bits (1730), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 329/418 (78%), Positives = 362/418 (86%), Gaps = 17/418 (4%)
Query: 1 MGLCNSKPSSNSSSPKSDLIRNKNTPVPANGTPIPAPSPLNAESQSNNNRTNVKGNDDAV 60
MG C SKPS+ S + V +G P S + + N+++T ND+
Sbjct: 1 MGACTSKPSNFSVD---------DITVAGDGAIFPVKSGPSNDDDVNSHQTK---NDEPS 48
Query: 61 IEGKKSPFFPFYSPSPAHYFFSKKSSPARSSANSTPNRFFKRPFPPPSPAKHIKAVLARR 120
+ GKKSPFFPFYSPSPAHY FSKKS +S+NSTP RFFKRPFPPPSPAKHI+++LARR
Sbjct: 49 V-GKKSPFFPFYSPSPAHYLFSKKSPATNASSNSTPMRFFKRPFPPPSPAKHIRSLLARR 107
Query: 121 HGSVKPNEAAIPEGSEPE----PAAGLNKSFGFSKHFANKYELGEEVGRGHFGYTCAAKF 176
HG+VKPNE+AIPEG+E E AGL+KSFGFSK+F NKYE+GEEVGRGHFGYTC AKF
Sbjct: 108 HGTVKPNESAIPEGNESEVGDGGGAGLDKSFGFSKNFVNKYEMGEEVGRGHFGYTCKAKF 167
Query: 177 KKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYV 236
KKGE+KGQ+VAVKVIPK KMTTAIAIEDVRREVKILRALTGHNNLVKF+DAYED +NVY+
Sbjct: 168 KKGEVKGQEVAVKVIPKSKMTTAIAIEDVRREVKILRALTGHNNLVKFYDAYEDPNNVYI 227
Query: 237 VMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTK 296
VMELCEGGELLDRILSRGGKYTEDDAK+VMIQIL VVAFCHLQGVVHRDLKPENFLFT+K
Sbjct: 228 VMELCEGGELLDRILSRGGKYTEDDAKSVMIQILKVVAFCHLQGVVHRDLKPENFLFTSK 287
Query: 297 DENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRSYSTEADVWSIGVIAYILLC 356
DEN+ LKAIDFGLSDFV+PDERLNDIVGSAYYVAPEVLHRSYSTEADVWSIGVIAYILLC
Sbjct: 288 DENAQLKAIDFGLSDFVKPDERLNDIVGSAYYVAPEVLHRSYSTEADVWSIGVIAYILLC 347
Query: 357 GSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQAL 414
GSRPFWARTESGIFRAVLKADPSFDE PWP+LSSEA+DFVKRLLNKDPRKR+TAAQAL
Sbjct: 348 GSRPFWARTESGIFRAVLKADPSFDEQPWPTLSSEAKDFVKRLLNKDPRKRMTAAQAL 405
|
Source: Nicotiana tabacum Species: Nicotiana tabacum Genus: Nicotiana Family: Solanaceae Order: Solanales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|73761697|gb|AAZ83348.1| CDPK-related protein kinase [Gossypium hirsutum] | Back alignment and taxonomy information |
|---|
Score = 667 bits (1720), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 346/422 (81%), Positives = 369/422 (87%), Gaps = 8/422 (1%)
Query: 1 MGLCNSKPSSNSSSPKSDLIRNKNTPV---PANGTPIPAPSPLNAESQSNNNRTNVKGND 57
MGLC SKPS N S + I +N + P + + P P +N++ K +
Sbjct: 1 MGLCTSKPSPNPSDSTNASINTRNNDIYRKPNSVSASPLPDGVNSKEDQGKQGEEEKESS 60
Query: 58 DAVIEGKKSPFFPFYSPSPAHYFFSKKSSPARSSANSTPNRFFKRPFPPPSPAKHIKAVL 117
+ EGKKSPFFPFYSPSPAHY FSKKS PARSS NSTP RFF+RPFPPPSPAKHI+AVL
Sbjct: 61 NPNNEGKKSPFFPFYSPSPAHYLFSKKS-PARSSTNSTPKRFFRRPFPPPSPAKHIRAVL 119
Query: 118 ARRHGSVKPNEAAIPEGSEPEPAA----GLNKSFGFSKHFANKYELGEEVGRGHFGYTCA 173
ARRHGSVKPNEAAIPEGS+ E A GL+KSFGFSKHF +KYELG+EVGRGHFGYTC
Sbjct: 120 ARRHGSVKPNEAAIPEGSDAEAAGATGTGLDKSFGFSKHFGSKYELGDEVGRGHFGYTCT 179
Query: 174 AKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233
AKFKKGELKGQQVAVKVIPK KMTTAIAIEDVRREVKILRAL+GH+NLV+F+DAYED DN
Sbjct: 180 AKFKKGELKGQQVAVKVIPKAKMTTAIAIEDVRREVKILRALSGHSNLVQFYDAYEDHDN 239
Query: 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLF 293
VY+VMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLF
Sbjct: 240 VYIVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLF 299
Query: 294 TTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRSYSTEADVWSIGVIAYI 353
T+KDENS LKAIDFGLSDFV+PDERLNDIVGSAYYVAPEVLHRSYSTEADVWSIGVIAYI
Sbjct: 300 TSKDENSQLKAIDFGLSDFVKPDERLNDIVGSAYYVAPEVLHRSYSTEADVWSIGVIAYI 359
Query: 354 LLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQA 413
LLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQA
Sbjct: 360 LLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQA 419
Query: 414 LS 415
LS
Sbjct: 420 LS 421
|
Source: Gossypium hirsutum Species: Gossypium hirsutum Genus: Gossypium Family: Malvaceae Order: Malvales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449460636|ref|XP_004148051.1| PREDICTED: CDPK-related protein kinase-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 664 bits (1714), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 333/433 (76%), Positives = 360/433 (83%), Gaps = 26/433 (6%)
Query: 1 MGLCNSKPSSNSSSPKSDLIRNK----------NTPVPANGTPIPAPSPL-----NAESQ 45
MGLCNSKPS P SDL K N+ P + T + SPL N
Sbjct: 1 MGLCNSKPS-----PNSDLFAEKSGSRTPNEGSNSTQPNSVTAMGGASPLPPSSENGRDG 55
Query: 46 SNNNRTNVKGNDDAVIEGKKSPFFPFYSPSPAHYFFSKKS---SPARSSANSTPNRFFKR 102
NR N D V KKSPFFPFYSPSPAHY FSKKS SPA +SANSTP RFF++
Sbjct: 56 RAGNRRNESHEMDNV---KKSPFFPFYSPSPAHYLFSKKSPARSPANASANSTPKRFFRK 112
Query: 103 PFPPPSPAKHIKAVLARRHGSVKPNEAAIPEGSEPEPAAGLNKSFGFSKHFANKYELGEE 162
PFPPPSPAKHI+AVLARRHGSVKPNE +IPEG+E E GL+K+FGFSKH +KYELGEE
Sbjct: 113 PFPPPSPAKHIRAVLARRHGSVKPNEVSIPEGTEAEGVTGLDKNFGFSKHLGSKYELGEE 172
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLV 222
VGRGHFGYTCAAKFKKGELKGQQVAVK+IPK KMTTAIAIEDVRREVKIL++L+GH NLV
Sbjct: 173 VGRGHFGYTCAAKFKKGELKGQQVAVKIIPKSKMTTAIAIEDVRREVKILKSLSGHKNLV 232
Query: 223 KFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVV 282
F+DAYED DNVY+VMELCEGGELLDRILSRGGKYTE+DA+AVM QIL VVAFCHLQGVV
Sbjct: 233 NFYDAYEDHDNVYIVMELCEGGELLDRILSRGGKYTEEDARAVMTQILYVVAFCHLQGVV 292
Query: 283 HRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRSYSTEA 342
HRDLKPENFLFT++DENS LKAIDFGLSDF +PDERLNDIVGSAYYVAPEVLHRSYSTEA
Sbjct: 293 HRDLKPENFLFTSRDENSPLKAIDFGLSDFAKPDERLNDIVGSAYYVAPEVLHRSYSTEA 352
Query: 343 DVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNK 402
DVWSIGVIAYILLCGSRPFWARTESGIF+AVLKADP FDE PWPSLSSEA+DFVKRLL K
Sbjct: 353 DVWSIGVIAYILLCGSRPFWARTESGIFKAVLKADPIFDEPPWPSLSSEAKDFVKRLLVK 412
Query: 403 DPRKRLTAAQALS 415
DPRKR++AAQALS
Sbjct: 413 DPRKRMSAAQALS 425
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|334185866|ref|NP_001190048.1| CDPK-related kinase [Arabidopsis thaliana] gi|332645156|gb|AEE78677.1| CDPK-related kinase [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 656 bits (1692), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 335/450 (74%), Positives = 364/450 (80%), Gaps = 48/450 (10%)
Query: 1 MGLCNSKPSSNSSSPKSDLIRNKNTPVPANGTPIPAPSPLNAESQSNNNRTNVKGNDDAV 60
MGLC SKP+S++S D +N+P+PA+ + P+ S +N E Q N
Sbjct: 1 MGLCTSKPNSSNS----DQTPARNSPLPASESVKPSSSSVNGEDQCVTTTNN-------- 48
Query: 61 IEGKKSPFFPFYSPSPAHYFFSKKS---SPARSSANSTPNRFFKRPFPPPSPAKHIKAVL 117
EGKKSPFFPFYSPSPAHYFFSKK+ SPA +S NSTP RFFKRPFPPPSPAKHI+AVL
Sbjct: 49 -EGKKSPFFPFYSPSPAHYFFSKKTPARSPATNSTNSTPKRFFKRPFPPPSPAKHIRAVL 107
Query: 118 ARRHGSVKPNEAAIPEGSEPEPAA-GLNKSFGFSKHFANKYELGEEVGRGHFGYTCAAKF 176
ARRHGSVKPN +AIPEGSE E GL+KSFGFSK FA+KYELG+EVGRGHFGYTCAAKF
Sbjct: 108 ARRHGSVKPNSSAIPEGSEAEGGGVGLDKSFGFSKSFASKYELGDEVGRGHFGYTCAAKF 167
Query: 177 KKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYV 236
KKG+ KGQQVAVKVIPK KMTTAIAIEDVRREVKILRAL+GHNNL F+DAYED DNVY+
Sbjct: 168 KKGDNKGQQVAVKVIPKAKMTTAIAIEDVRREVKILRALSGHNNLPHFYDAYEDHDNVYI 227
Query: 237 VMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTK 296
VMELCEGGELLDRILSRGGKYTE+DAK VMIQILNVVAFCHLQGVVHRDLKPENFLFT+K
Sbjct: 228 VMELCEGGELLDRILSRGGKYTEEDAKTVMIQILNVVAFCHLQGVVHRDLKPENFLFTSK 287
Query: 297 DENSVLKAIDFGLSDFVRP-------------------------------DERLNDIVGS 325
++ S LKAIDFGLSD+VRP DERLNDIVGS
Sbjct: 288 EDTSQLKAIDFGLSDYVRPGKALRLYAICKLRFQNLETSICLYALTIAFADERLNDIVGS 347
Query: 326 AYYVAPEVLHRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPW 385
AYYVAPEVLHRSYSTEAD+WS+GVI YILLCGSRPFWARTESGIFRAVLKADPSFD+ PW
Sbjct: 348 AYYVAPEVLHRSYSTEADIWSVGVIVYILLCGSRPFWARTESGIFRAVLKADPSFDDPPW 407
Query: 386 PSLSSEARDFVKRLLNKDPRKRLTAAQALS 415
P LSSEARDFVKRLLNKDPRKRLTAAQALS
Sbjct: 408 PLLSSEARDFVKRLLNKDPRKRLTAAQALS 437
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|1706130|sp|P53681.1|CRK_DAUCA RecName: Full=CDPK-related protein kinase; AltName: Full=PK421 gi|1103386|emb|CAA58750.1| CDPK-related protein kinase [Daucus carota] | Back alignment and taxonomy information |
|---|
Score = 643 bits (1659), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 327/429 (76%), Positives = 354/429 (82%), Gaps = 29/429 (6%)
Query: 1 MGLCNSKPSSNSSSPKSDLIRNKNTPVPANGTPIPA------PSPLNAESQSNNNRTNVK 54
MG+C SKPS P+ DL N +T +P N T +P P + +Q NN
Sbjct: 1 MGICVSKPS-----PEPDL-HNHHTSIPVNDTSLPPQDNSIPPKDIAIPAQDNNKPP--- 51
Query: 55 GNDDAVIEGKKSPFFPFYSPSPAHYFFSKKS----SPARSSANSTPNRFFKRPFPPPSPA 110
GKKSPF PFYSPSPAH+ FSKKS SPA S+NSTP R F PFPPPSPA
Sbjct: 52 --------GKKSPFLPFYSPSPAHFLFSKKSPAVGSPAAGSSNSTPKRLF--PFPPPSPA 101
Query: 111 KHIKAVLARRHGSVKPNEAAIPEGSEPEPAAGLNKSFGFSKHFANKYELGEEVGRGHFGY 170
KHIKA ARRHGSVKPNEAAIPE +E + AGL+KSFGFSK F +K+E+GEEVGRGHFGY
Sbjct: 102 KHIKAAWARRHGSVKPNEAAIPENNEVDGGAGLDKSFGFSKKFGSKFEVGEEVGRGHFGY 161
Query: 171 TCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED 230
TC AKFKKGE KGQ VAVKVIPK KMTTAIAIEDVRREVKILRALTGHNNLV+F+DA+ED
Sbjct: 162 TCRAKFKKGEFKGQDVAVKVIPKAKMTTAIAIEDVRREVKILRALTGHNNLVQFYDAFED 221
Query: 231 TDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPEN 290
NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPEN
Sbjct: 222 HTNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPEN 281
Query: 291 FLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRSYSTEADVWSIGVI 350
FLF +KDE+S LKAIDFGLSD+V+PDERLNDIVGSAYYVAPEVLHRSYSTEADVWSIGVI
Sbjct: 282 FLFKSKDEDSQLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHRSYSTEADVWSIGVI 341
Query: 351 AYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTA 410
+YILLCGSRPFWARTESGIFRAVLKA+ SFDE PWPS+SSEA+DFVKRLLNKDPRKR+TA
Sbjct: 342 SYILLCGSRPFWARTESGIFRAVLKANLSFDEPPWPSVSSEAKDFVKRLLNKDPRKRMTA 401
Query: 411 AQALSELLI 419
AQAL I
Sbjct: 402 AQALCHSWI 410
|
Source: Daucus carota Species: Daucus carota Genus: Daucus Family: Apiaceae Order: Apiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 429 | ||||||
| TAIR|locus:2103655 | 577 | AT3G56760 [Arabidopsis thalian | 0.766 | 0.570 | 0.792 | 1.2e-138 | |
| TAIR|locus:2063197 | 576 | CRK1 "AT2G41140" [Arabidopsis | 0.766 | 0.571 | 0.783 | 1.3e-137 | |
| TAIR|locus:2094053 | 599 | AT3G19100 [Arabidopsis thalian | 0.703 | 0.504 | 0.793 | 2.5e-129 | |
| TAIR|locus:2012232 | 606 | AT1G49580 [Arabidopsis thalian | 0.708 | 0.501 | 0.782 | 2.2e-128 | |
| TAIR|locus:2062764 | 595 | CRK3 "AT2G46700" [Arabidopsis | 0.710 | 0.512 | 0.728 | 1.9e-123 | |
| TAIR|locus:2082931 | 594 | AT3G49370 [Arabidopsis thalian | 0.713 | 0.515 | 0.692 | 2e-117 | |
| TAIR|locus:2152876 | 594 | AT5G24430 [Arabidopsis thalian | 0.713 | 0.515 | 0.682 | 2.9e-116 | |
| TAIR|locus:2827826 | 571 | CPK16 "AT2G17890" [Arabidopsis | 0.631 | 0.474 | 0.621 | 7.5e-89 | |
| TAIR|locus:2156947 | 523 | CPK28 "calcium-dependent prote | 0.643 | 0.527 | 0.597 | 1.3e-84 | |
| TAIR|locus:505006616 | 535 | CPK7 "calmodulin-domain protei | 0.606 | 0.485 | 0.564 | 5.7e-75 |
| TAIR|locus:2103655 AT3G56760 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1339 (476.4 bits), Expect = 1.2e-138, Sum P(2) = 1.2e-138
Identities = 264/333 (79%), Positives = 292/333 (87%)
Query: 84 KSSPA--RSSANSTXXXXXXXXXXXXXXAKHIKAVLARRHGSVKPNEAAIPEGSEPEPAA 141
K+SPA SS +ST AKHI+A+LARRHGSVKPNEA+IPEGSE E
Sbjct: 51 KTSPAVSSSSVSSTPLRIFKRPFPPPSPAKHIRALLARRHGSVKPNEASIPEGSECE--V 108
Query: 142 GLNKSFGFSKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIA 201
GL+K FGFSK FA+ YE+ EVGRGHFGYTC+AK KKG LKGQ VAVKVIPK KMTTAIA
Sbjct: 109 GLDKKFGFSKQFASHYEIDGEVGRGHFGYTCSAKGKKGSLKGQDVAVKVIPKSKMTTAIA 168
Query: 202 IEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDD 261
IEDVRREVKILRALTGH NLV+F+DA+ED +NVY+VMELC+GGELLD+IL RGGKY+E D
Sbjct: 169 IEDVRREVKILRALTGHKNLVQFYDAFEDDENVYIVMELCQGGELLDKILQRGGKYSEVD 228
Query: 262 AKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLND 321
AK VMIQIL+VVA+CHLQGVVHRDLKPENFLFTTKDE+S LKAIDFGLSD+VRPDERLND
Sbjct: 229 AKKVMIQILSVVAYCHLQGVVHRDLKPENFLFTTKDESSPLKAIDFGLSDYVRPDERLND 288
Query: 322 IVGSAYYVAPEVLHRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFD 381
IVGSAYYVAPEVLHR+Y TEAD+WSIGVIAYILLCGSRPFWAR+ESGIFRAVLKA+P+F+
Sbjct: 289 IVGSAYYVAPEVLHRTYGTEADMWSIGVIAYILLCGSRPFWARSESGIFRAVLKAEPNFE 348
Query: 382 EAPWPSLSSEARDFVKRLLNKDPRKRLTAAQAL 414
EAPWPSLS +A DFVKRLLNKD RKRLTAAQAL
Sbjct: 349 EAPWPSLSPDAVDFVKRLLNKDYRKRLTAAQAL 381
|
|
| TAIR|locus:2063197 CRK1 "AT2G41140" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1327 (472.2 bits), Expect = 1.3e-137, Sum P(2) = 1.3e-137
Identities = 260/332 (78%), Positives = 290/332 (87%)
Query: 84 KSSPA-RSSANSTXXXXXXXXXXXXXXAKHIKAVLARRHGSVKPNEAAIPEGSEPEPAAG 142
KSSP+ SS +ST AKHI+A LARR+GSVKPNE +IPEG E E G
Sbjct: 51 KSSPSVSSSVSSTPLRIFKRPFPPPSPAKHIRAFLARRYGSVKPNEVSIPEGKECE--IG 108
Query: 143 LNKSFGFSKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAI 202
L+KSFGFSK FA+ YE+ EVGRGHFGYTC+AK KKG LKGQ+VAVKVIPK KMTTAIAI
Sbjct: 109 LDKSFGFSKQFASHYEIDGEVGRGHFGYTCSAKGKKGSLKGQEVAVKVIPKSKMTTAIAI 168
Query: 203 EDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDA 262
EDV REVK+LRALTGH NLV+F+DA+ED +NVY+VMELC+GGELLD+IL RGGKY+EDDA
Sbjct: 169 EDVSREVKMLRALTGHKNLVQFYDAFEDDENVYIVMELCKGGELLDKILQRGGKYSEDDA 228
Query: 263 KAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDI 322
K VM+QIL+VVA+CHLQGVVHRDLKPENFLF+TKDE S LKAIDFGLSD+V+PDERLNDI
Sbjct: 229 KKVMVQILSVVAYCHLQGVVHRDLKPENFLFSTKDETSPLKAIDFGLSDYVKPDERLNDI 288
Query: 323 VGSAYYVAPEVLHRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDE 382
VGSAYYVAPEVLHR+Y TEAD+WSIGVIAYILLCGSRPFWARTESGIFRAVLKA+P+F+E
Sbjct: 289 VGSAYYVAPEVLHRTYGTEADMWSIGVIAYILLCGSRPFWARTESGIFRAVLKAEPNFEE 348
Query: 383 APWPSLSSEARDFVKRLLNKDPRKRLTAAQAL 414
APWPSLS EA DFVKRLLNKD RKRLTAAQAL
Sbjct: 349 APWPSLSPEAVDFVKRLLNKDYRKRLTAAQAL 380
|
|
| TAIR|locus:2094053 AT3G19100 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1269 (451.8 bits), Expect = 2.5e-129, P = 2.5e-129
Identities = 246/310 (79%), Positives = 274/310 (88%)
Query: 110 AKHIKAVLARRHGSVKPNEAAIPEG-----SEPEPAAGLNKSFGFSKHFANKYELGEEVG 164
A+HI+ VL RR + EAA+P E GL+K FGFSK ++ ELGEE+G
Sbjct: 95 ARHIRDVLRRRK---EKKEAALPAARQQKEEEEREEVGLDKRFGFSKELQSRIELGEEIG 151
Query: 165 RGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKF 224
RGHFGYTC+AKFKKGELK Q+VAVKVIPK KMT+AI+IEDVRREVKILRAL+GH NLV+F
Sbjct: 152 RGHFGYTCSAKFKKGELKDQEVAVKVIPKSKMTSAISIEDVRREVKILRALSGHQNLVQF 211
Query: 225 FDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHR 284
+DA+ED NVY+VMELC GGELLDRIL+RGGKY+EDDAKAV+IQILNVVAFCHLQGVVHR
Sbjct: 212 YDAFEDNANVYIVMELCGGGELLDRILARGGKYSEDDAKAVLIQILNVVAFCHLQGVVHR 271
Query: 285 DLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRSYSTEADV 344
DLKPENFL+T+K+ENS+LK IDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRSY+TEADV
Sbjct: 272 DLKPENFLYTSKEENSMLKVIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRSYTTEADV 331
Query: 345 WSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDP 404
WSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDE PWPSLS EA+DFVKRLL KDP
Sbjct: 332 WSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEPPWPSLSFEAKDFVKRLLYKDP 391
Query: 405 RKRLTAAQAL 414
RKR+TA+QAL
Sbjct: 392 RKRMTASQAL 401
|
|
| TAIR|locus:2012232 AT1G49580 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1260 (448.6 bits), Expect = 2.2e-128, P = 2.2e-128
Identities = 244/312 (78%), Positives = 273/312 (87%)
Query: 110 AKHIKAVLARRHGS-------VKPNEAAIPEGSEPEPAAGLNKSFGFSKHFANKYELGEE 162
AKHI+A L RR G V +P+ E E GL+K FGFSK F ++ ELGEE
Sbjct: 97 AKHIRAALRRRKGKKEAALSGVTQLTTEVPQREEEEEV-GLDKRFGFSKEFHSRVELGEE 155
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLV 222
+GRGHFGYTC+AKFKKGELKGQ VAVK+IPK KMTTAIAIEDVRREVKIL+AL+GH NLV
Sbjct: 156 IGRGHFGYTCSAKFKKGELKGQVVAVKIIPKSKMTTAIAIEDVRREVKILQALSGHKNLV 215
Query: 223 KFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVV 282
+F+DA+ED NVY+ MELCEGGELLDRIL+RGGKY+E+DAK V+IQILNVVAFCH QGVV
Sbjct: 216 QFYDAFEDNANVYIAMELCEGGELLDRILARGGKYSENDAKPVIIQILNVVAFCHFQGVV 275
Query: 283 HRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRSYSTEA 342
HRDLKPENFL+T+K+ENS LKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRSY+TEA
Sbjct: 276 HRDLKPENFLYTSKEENSQLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRSYTTEA 335
Query: 343 DVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNK 402
DVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDE PWP LSS+A+DFVKRLL K
Sbjct: 336 DVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEPPWPFLSSDAKDFVKRLLFK 395
Query: 403 DPRKRLTAAQAL 414
DPR+R++A+QAL
Sbjct: 396 DPRRRMSASQAL 407
|
|
| TAIR|locus:2062764 CRK3 "AT2G46700" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1196 (426.1 bits), Expect = 1.9e-123, Sum P(2) = 1.9e-123
Identities = 223/306 (72%), Positives = 263/306 (85%)
Query: 110 AKHIKAVLARRHGSVKPNEAAIPEGSEPEPAAGLNKSFGFSKHFANKYELGEEVGRGHFG 169
AKHIKA L +R G VKP E IPE EP L+KSFG+ K+F KYELG+EVGRGHFG
Sbjct: 97 AKHIKASLIKRLG-VKPKEGPIPEERGTEPEQSLDKSFGYGKNFGAKYELGKEVGRGHFG 155
Query: 170 YTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYE 229
+TC+ + KKG++K +AVK+I K KMTTAIAIEDVRREVK+L++L+GH L+K++DA E
Sbjct: 156 HTCSGRGKKGDIKDHPIAVKIISKAKMTTAIAIEDVRREVKLLKSLSGHKYLIKYYDACE 215
Query: 230 DTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPE 289
D +NVY+VMELC+GGELLDRIL+RGGKY EDDAKA+++QIL VV+FCHLQGVVHRDLKPE
Sbjct: 216 DANNVYIVMELCDGGELLDRILARGGKYPEDDAKAIVVQILTVVSFCHLQGVVHRDLKPE 275
Query: 290 NFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRSYSTEADVWSIGV 349
NFLFT+ E+S LK IDFGLSDF+RPDERLNDIVGSAYYVAPEVLHRSYS EAD+WSIGV
Sbjct: 276 NFLFTSSREDSDLKLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLHRSYSLEADIWSIGV 335
Query: 350 IAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLT 409
I YILLCGSRPFWARTESGIFR VL+ +P++D+ PWPS SSE +DFVKRLLNKD RKR++
Sbjct: 336 ITYILLCGSRPFWARTESGIFRTVLRTEPNYDDVPWPSCSSEGKDFVKRLLNKDYRKRMS 395
Query: 410 AAQALS 415
A QAL+
Sbjct: 396 AVQALT 401
|
|
| TAIR|locus:2082931 AT3G49370 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1138 (405.7 bits), Expect = 2.0e-117, Sum P(2) = 2.0e-117
Identities = 216/312 (69%), Positives = 265/312 (84%)
Query: 110 AKHIKAVLARRHGSVK-PNEAAIPEGSEPEPAAG-----LNKSFGFSKHFANKYELGEEV 163
AK I A L RR G+ P + IPE SE + G L+K+FGF+K+F KYELG EV
Sbjct: 89 AKPIMAALRRRRGTAPHPRDGPIPEDSEAGGSGGGIGERLDKNFGFAKNFEGKYELGREV 148
Query: 164 GRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVK 223
GRGHFG+TC AK KKG++KGQ VAVK+I K KMT+A++IEDVRREVK+L+AL+GH+++VK
Sbjct: 149 GRGHFGHTCWAKAKKGKIKGQTVAVKIISKSKMTSALSIEDVRREVKLLKALSGHSHMVK 208
Query: 224 FFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVH 283
F+D +ED+DNV+VVMELCEGGELLD IL+RGG+Y E +AK +++QIL+ AF HLQGVVH
Sbjct: 209 FYDVFEDSDNVFVVMELCEGGELLDSILARGGRYPEAEAKRILVQILSATAFFHLQGVVH 268
Query: 284 RDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRSYSTEAD 343
RDLKPENFLFT+K+E++VLK IDFGLSD+ R D+RLND+VGSAYYVAPEVLHRSYSTEAD
Sbjct: 269 RDLKPENFLFTSKNEDAVLKVIDFGLSDYARFDQRLNDVVGSAYYVAPEVLHRSYSTEAD 328
Query: 344 VWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKD 403
+WSIGVI+YILLCGSRPF+ RTES IFR VL+A+P+FD+ PWPS+S A+DFVKRLLNKD
Sbjct: 329 IWSIGVISYILLCGSRPFYGRTESAIFRCVLRANPNFDDLPWPSISPIAKDFVKRLLNKD 388
Query: 404 PRKRLTAAQALS 415
RKR+TAAQAL+
Sbjct: 389 HRKRMTAAQALA 400
|
|
| TAIR|locus:2152876 AT5G24430 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1127 (401.8 bits), Expect = 2.9e-116, Sum P(2) = 2.9e-116
Identities = 215/315 (68%), Positives = 264/315 (83%)
Query: 110 AKHIKAVLARRHGSV-KPNEAAIPEGSEP------EPAAG--LNKSFGFSKHFANKYELG 160
AK I A L RR G+ +P + IPE SE + G L+K+FGF K+F KYELG
Sbjct: 87 AKPIMAALRRRRGAPPQPRDEPIPEDSEDVVDHGGDSGGGERLDKNFGFGKNFEGKYELG 146
Query: 161 EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNN 220
+EVGRGHFG+TC AK KKG++K Q VAVK+I K KMT+ ++IEDVRREVK+L+AL+GH +
Sbjct: 147 KEVGRGHFGHTCWAKAKKGKMKNQTVAVKIISKAKMTSTLSIEDVRREVKLLKALSGHRH 206
Query: 221 LVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQG 280
+VKF+D YED DNV+VVMELCEGGELLDRIL+RGG+Y E DAK +++QIL+ AF HLQG
Sbjct: 207 MVKFYDVYEDADNVFVVMELCEGGELLDRILARGGRYPEVDAKRILVQILSATAFFHLQG 266
Query: 281 VVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRSYST 340
VVHRDLKPENFLFT+++E+++LK IDFGLSDF+R D+RLND+VGSAYYVAPEVLHRSYST
Sbjct: 267 VVHRDLKPENFLFTSRNEDAILKVIDFGLSDFIRYDQRLNDVVGSAYYVAPEVLHRSYST 326
Query: 341 EADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLL 400
EAD+WSIGVI+YILLCGSRPF+ RTES IFR VL+A+P+F++ PWPS+S A+DFVKRLL
Sbjct: 327 EADMWSIGVISYILLCGSRPFYGRTESAIFRCVLRANPNFEDMPWPSISPTAKDFVKRLL 386
Query: 401 NKDPRKRLTAAQALS 415
NKD RKR+TAAQAL+
Sbjct: 387 NKDHRKRMTAAQALA 401
|
|
| TAIR|locus:2827826 CPK16 "AT2G17890" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 887 (317.3 bits), Expect = 7.5e-89, P = 7.5e-89
Identities = 171/275 (62%), Positives = 215/275 (78%)
Query: 142 GLNKSFGFSKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIA 201
G FG++K F ++Y +G+ +G G FGYT A KK G +VAVK I K KMT IA
Sbjct: 93 GKRVDFGYAKDFDHRYTIGKLLGHGQFGYTYVATDKK---TGDRVAVKKIDKAKMTIPIA 149
Query: 202 IEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSR-GGKYTED 260
+EDV+REVKIL+ALTGH N+V+F++A+ED ++VY+VMELCEGGELLDRIL+R +Y+E
Sbjct: 150 VEDVKREVKILQALTGHENVVRFYNAFEDKNSVYIVMELCEGGELLDRILARKDSRYSER 209
Query: 261 DAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLN 320
DA V+ Q+L V A CHL+G+VHRD+KPENFLF + +E+S LKA DFGLSDF++P ++ +
Sbjct: 210 DAAVVVRQMLKVAAECHLRGLVHRDMKPENFLFKSTEEDSPLKATDFGLSDFIKPGKKFH 269
Query: 321 DIVGSAYYVAPEVLHRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSF 380
DIVGSAYYVAPEVL R E+DVWSIGVI+YILLCG RPFW +TE GIF+ VLK P F
Sbjct: 270 DIVGSAYYVAPEVLKRRSGPESDVWSIGVISYILLCGRRPFWDKTEDGIFKEVLKNKPDF 329
Query: 381 DEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALS 415
PWP++S+ A+DFVK+LL KDPR RLTAAQALS
Sbjct: 330 RRKPWPTISNSAKDFVKKLLVKDPRARLTAAQALS 364
|
|
| TAIR|locus:2156947 CPK28 "calcium-dependent protein kinase 28" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 847 (303.2 bits), Expect = 1.3e-84, P = 1.3e-84
Identities = 169/283 (59%), Positives = 206/283 (72%)
Query: 134 GSEPEPAAGLNKSFGFSKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPK 193
GS P G FG+SK F + Y +G+ +G G FGYT A + G +VAVK + K
Sbjct: 42 GSIP---CGKRTDFGYSKDFHDHYTIGKLLGHGQFGYTYVAIHRPN---GDRVAVKRLDK 95
Query: 194 HKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSR 253
KM IA+EDV+REV+IL AL+GH N+V+F +A+ED D VY+VMELCEGGELLDRILS+
Sbjct: 96 SKMVLPIAVEDVKREVQILIALSGHENVVQFHNAFEDDDYVYIVMELCEGGELLDRILSK 155
Query: 254 -GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312
G +Y+E DA V+ Q+L V CHL G+VHRD+KPENFLF + +S LKA DFGLSDF
Sbjct: 156 KGNRYSEKDAAVVVRQMLKVAGECHLHGLVHRDMKPENFLFKSAQLDSPLKATDFGLSDF 215
Query: 313 VRPDERLNDIVGSAYYVAPEVLHRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRA 372
++P +R +DIVGSAYYVAPEVL R E+DVWSIGVI YILLCG RPFW RTE GIF+
Sbjct: 216 IKPGKRFHDIVGSAYYVAPEVLKRRSGPESDVWSIGVITYILLCGRRPFWDRTEDGIFKE 275
Query: 373 VLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALS 415
VL+ P F PW ++S A+DFVK+LL KDPR RLTAAQALS
Sbjct: 276 VLRNKPDFSRKPWATISDSAKDFVKKLLVKDPRARLTAAQALS 318
|
|
| TAIR|locus:505006616 CPK7 "calmodulin-domain protein kinase 7" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 756 (271.2 bits), Expect = 5.7e-75, P = 5.7e-75
Identities = 149/264 (56%), Positives = 186/264 (70%)
Query: 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRAL 215
+Y+LG EVGRG FG T K+ G++ A K I K K+ TA+ IEDVRREV+I++ +
Sbjct: 58 QYDLGREVGRGEFGITYLCTDKE---TGEKYACKSISKKKLRTAVDIEDVRREVEIMKHM 114
Query: 216 TGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAF 275
H N+V D++ED D V++VMELCEGGEL DRI++RG YTE A AVM I+ VV
Sbjct: 115 PKHPNVVSLKDSFEDDDAVHIVMELCEGGELFDRIVARG-HYTERAAAAVMKTIVEVVQI 173
Query: 276 CHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLH 335
CH QGV+HRDLKPENFLF K E S LKAIDFGLS F +P E+ N+IVGS YY+APEVL
Sbjct: 174 CHKQGVMHRDLKPENFLFANKKETSALKAIDFGLSVFFKPGEQFNEIVGSPYYMAPEVLR 233
Query: 336 RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDF 395
R+Y E DVWS GVI YILLCG PFWA TE G+ +A++++ F PWP +S A+D
Sbjct: 234 RNYGPEIDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPRVSDSAKDL 293
Query: 396 VKRLLNKDPRKRLTAAQALSELLI 419
V+++L DP+KRLTAAQ L I
Sbjct: 294 VRKMLEPDPKKRLTAAQVLEHTWI 317
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q9SCS2 | CAMK5_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.7943 | 0.9463 | 0.6755 | yes | no |
| P53681 | CRK_DAUCA | 2, ., 7, ., 1, 1, ., 1 | 0.7622 | 0.9324 | 0.6644 | N/A | no |
| Q10KY3 | CAMK1_ORYSJ | 2, ., 7, ., 1, 1, ., 1, 7 | 0.8011 | 0.7995 | 0.5716 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.946 |
| 3rd Layer | 2.7.11 | 0.963 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | CRK5 | CPK related kinase 5 (607 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
 | grail3.0049009101 | elongation factor 1-alpha; This protein promotes the GTP-dependent binding of aminoacyl-tRNA to [...] (450 aa) | • | 0.510 | |||||||
 | grail3.0049008501 | RecName- Full=Elongation factor 1-alpha;; This protein promotes the GTP-dependent binding of am [...] (449 aa) | • | 0.510 | |||||||
 | grail3.0028013201 | RecName- Full=Elongation factor 1-alpha;; This protein promotes the GTP-dependent binding of am [...] (447 aa) | • | 0.510 | |||||||
 | grail3.0022037901 | elongation factor 1-alpha; This protein promotes the GTP-dependent binding of aminoacyl-tRNA to [...] (449 aa) | • | 0.510 | |||||||
 | grail3.0022037501 | RecName- Full=Elongation factor 1-alpha;; This protein promotes the GTP-dependent binding of am [...] (449 aa) | • | 0.510 | |||||||
 | eugene3.00102124 | RecName- Full=Elongation factor 1-alpha;; This protein promotes the GTP-dependent binding of am [...] (450 aa) | • | 0.510 | |||||||
 | estExt_Genewise1_v1.C_LG_VIII1205 | RecName- Full=Elongation factor 1-alpha;; This protein promotes the GTP-dependent binding of am [...] (450 aa) | • | 0.510 | |||||||
 | eugene3.00770028 | hypothetical protein (487 aa) | • | 0.423 | |||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 429 | |||
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-100 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 9e-88 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-63 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-62 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-61 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-56 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 6e-54 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-52 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-51 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 3e-51 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-50 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 6e-50 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-46 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 3e-46 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-44 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 3e-44 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 6e-43 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 8e-43 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-41 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 7e-41 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 3e-40 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 5e-40 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 9e-40 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 1e-39 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-39 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-38 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-37 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 3e-37 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 4e-37 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 7e-37 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 4e-36 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-35 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-35 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 5e-35 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 5e-35 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 6e-35 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 7e-35 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-34 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 1e-34 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-34 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-34 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 7e-34 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-33 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 3e-33 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 3e-33 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 5e-33 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 3e-32 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 4e-32 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-31 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-31 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-31 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 3e-31 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-30 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-30 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-30 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-30 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 3e-30 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 8e-30 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-29 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-29 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-29 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 3e-29 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 3e-29 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 6e-29 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 6e-29 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 7e-29 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 8e-29 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 9e-29 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-28 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-28 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 2e-28 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-28 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 4e-28 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 4e-28 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 5e-28 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 7e-28 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 8e-28 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 1e-27 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-27 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-27 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 4e-27 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 9e-27 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 9e-27 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-26 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 4e-26 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 4e-26 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 4e-26 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 5e-26 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 5e-26 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 5e-26 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 6e-26 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 6e-26 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 9e-26 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-25 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-25 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-25 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-25 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-25 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 3e-25 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 4e-25 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 5e-25 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 8e-25 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 8e-25 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 1e-24 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 2e-24 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-24 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-24 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 3e-24 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 4e-24 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 7e-24 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 9e-24 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-23 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-23 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-23 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-23 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 1e-23 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-23 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-23 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-23 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-23 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 3e-23 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 3e-23 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 5e-23 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 5e-23 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 6e-23 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 7e-23 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 8e-23 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-22 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-22 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-22 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-22 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-22 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-22 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-22 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-22 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 3e-22 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 3e-22 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 3e-22 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 3e-22 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 4e-22 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 5e-22 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 6e-22 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 8e-22 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-21 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-21 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-21 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-21 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-21 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-21 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 3e-21 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 3e-21 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 4e-21 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 5e-21 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 5e-21 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-20 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-20 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-20 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-20 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-20 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-20 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-20 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 3e-20 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 3e-20 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 4e-20 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 4e-20 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 4e-20 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 4e-20 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 4e-20 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 6e-20 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 6e-20 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 8e-20 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 9e-20 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 1e-19 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 1e-19 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 1e-19 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-19 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-19 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-19 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-19 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 3e-19 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-18 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-18 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-18 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-18 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-18 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 3e-18 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 3e-18 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 4e-18 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 6e-18 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 7e-18 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 7e-18 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 1e-17 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-17 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 3e-17 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 3e-17 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 4e-17 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 6e-17 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 9e-17 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-16 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-16 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-16 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-16 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-16 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-16 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 3e-16 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 5e-16 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 9e-16 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-15 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-15 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 3e-15 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 4e-15 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 5e-15 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 9e-15 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 4e-14 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 5e-14 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 5e-14 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 6e-14 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-13 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-13 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 2e-13 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-13 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 3e-13 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 3e-13 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 4e-13 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 4e-13 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 5e-13 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 5e-13 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 5e-13 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 5e-13 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 9e-13 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-12 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-12 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-12 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-12 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 3e-12 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 5e-12 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 6e-12 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 6e-12 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 9e-12 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-11 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-11 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 3e-11 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 3e-11 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 3e-11 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 4e-11 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 5e-11 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 6e-11 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 6e-11 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-10 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-10 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-10 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-10 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-10 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-10 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-10 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 4e-10 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 5e-10 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 1e-09 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-09 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-09 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 5e-09 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 6e-09 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 6e-09 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 6e-09 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 8e-09 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 1e-08 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 1e-08 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-08 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 4e-08 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 8e-08 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 8e-08 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 1e-07 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 1e-07 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-07 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 3e-07 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 4e-07 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 5e-07 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 5e-07 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 8e-07 | |
| PRK14879 | 211 | PRK14879, PRK14879, serine/threonine protein kinas | 2e-06 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 2e-06 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 2e-06 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 2e-06 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 3e-06 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 3e-06 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 4e-06 | |
| COG3642 | 204 | COG3642, COG3642, Mn2+-dependent serine/threonine | 5e-06 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 7e-06 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 8e-06 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 9e-06 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 9e-06 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 4e-05 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 4e-05 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 7e-05 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 8e-05 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-04 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 1e-04 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 1e-04 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-04 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-04 | |
| TIGR03724 | 199 | TIGR03724, arch_bud32, Kae1-associated kinase Bud3 | 2e-04 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 2e-04 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 4e-04 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 5e-04 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 0.001 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 0.002 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 0.004 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 299 bits (768), Expect = e-100
Identities = 114/260 (43%), Positives = 162/260 (62%), Gaps = 13/260 (5%)
Query: 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALT 216
YE+ E++G G FG A+ KK G+ VA+KVI K K+ E + RE+KIL+ L
Sbjct: 1 YEILEKLGEGSFGKVYLARDKK---TGKLVAIKVIKKKKIKKDR--ERILREIKILKKL- 54
Query: 217 GHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFC 276
H N+V+ +D +ED D +Y+VME CEGG+L D + RG + +ED+A+ + QIL+ + +
Sbjct: 55 KHPNIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRG-RLSEDEARFYLRQILSALEYL 113
Query: 277 HLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVL-H 335
H +G+VHRDLKPEN L DE+ +K DFGL+ + P E+L VG+ Y+APEVL
Sbjct: 114 HSKGIVHRDLKPENILL---DEDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLG 170
Query: 336 RSYSTEADVWSIGVIAYILLCGSRPFWARTE-SGIFRAVLKADPSFDEAPWPSLSSEARD 394
+ Y D+WS+GVI Y LL G PF + +F+ + K P F P +S EA+D
Sbjct: 171 KGYGKAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPP-PEWDISPEAKD 229
Query: 395 FVKRLLNKDPRKRLTAAQAL 414
+++LL KDP KRLTA +AL
Sbjct: 230 LIRKLLVKDPEKRLTAEEAL 249
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 267 bits (684), Expect = 9e-88
Identities = 118/264 (44%), Positives = 156/264 (59%), Gaps = 15/264 (5%)
Query: 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALT 216
YEL ++G G FG AK K G+ VAVK++ K + RRE++ILR L
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGT---GKIVAVKILKKRSEKSKKDQTA-RREIRILRRL- 55
Query: 217 GHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFC 276
H N+V+ DA+ED D++Y+VME CEGG+L D LSRGG +ED+AK + +QIL + +
Sbjct: 56 SHPNIVRLIDAFEDKDHLYLVMEYCEGGDLFD-YLSRGGPLSEDEAKKIALQILRGLEYL 114
Query: 277 HLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDERLNDIVGSAYYVAPEVL- 334
H G++HRDLKPEN L DEN V+K DFGL+ ++ L VG+ +Y+APEVL
Sbjct: 115 HSNGIIHRDLKPENILL---DENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLL 171
Query: 335 -HRSYSTEADVWSIGVIAYILLCGSRPFWARTESG---IFRAVLKADPSFDEAPWPSLSS 390
Y + DVWS+GVI Y LL G PF + R +L FDE W S S
Sbjct: 172 GGNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSE 231
Query: 391 EARDFVKRLLNKDPRKRLTAAQAL 414
EA+D +K+ LNKDP KR TA + L
Sbjct: 232 EAKDLIKKCLNKDPSKRPTAEEIL 255
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 203 bits (518), Expect = 2e-63
Identities = 92/258 (35%), Positives = 140/258 (54%), Gaps = 46/258 (17%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLV 222
+G G FG A+ KK G++VA+K+I K ++ + E++ RE++IL+ L H N+V
Sbjct: 1 LGEGGFGTVYLARDKK---TGKKVAIKIIKKEDSSSLL--EELLREIEILKKLN-HPNIV 54
Query: 223 KFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVV 282
K + +ED +++Y+VME CEGG L D + GK +ED+ +++QIL + + H G++
Sbjct: 55 KLYGVFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGII 114
Query: 283 HRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDER-LNDIVGSAYYVAPEVLH--RSYS 339
HRDLKPEN L +N +K DFGLS + D+ L IVG+ Y+APEVL YS
Sbjct: 115 HRDLKPENILLD--SDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYS 172
Query: 340 TEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRL 399
++D+WS+GVI Y L E +D ++++
Sbjct: 173 EKSDIWSLGVILYEL-----------------------------------PELKDLIRKM 197
Query: 400 LNKDPRKRLTAAQALSEL 417
L KDP KR +A + L L
Sbjct: 198 LQKDPEKRPSAKEILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 201 bits (514), Expect = 2e-62
Identities = 89/253 (35%), Positives = 132/253 (52%), Gaps = 14/253 (5%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLV 222
+G+G FG + K G+ A+KV+ K K+ +E E IL + H +V
Sbjct: 1 LGKGSFGKVLLVRKKD---TGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRIN-HPFIV 56
Query: 223 KFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVV 282
K A++ + +Y+V+E GGEL LS+ G+++E+ A+ +I+ + + H G++
Sbjct: 57 KLHYAFQTEEKLYLVLEYAPGGELFSH-LSKEGRFSEERARFYAAEIVLALEYLHSLGII 115
Query: 283 HRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDERLNDIVGSAYYVAPEVLHRS-YST 340
+RDLKPEN L D + +K DFGL+ + R N G+ Y+APEVL Y
Sbjct: 116 YRDLKPENILL---DADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGK 172
Query: 341 EADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLL 400
D WS+GV+ Y +L G PF+A I+ +LK F E LS EARD + LL
Sbjct: 173 AVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPE----FLSPEARDLISGLL 228
Query: 401 NKDPRKRLTAAQA 413
KDP KRL + A
Sbjct: 229 QKDPTKRLGSGGA 241
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 199 bits (509), Expect = 2e-61
Identities = 82/270 (30%), Positives = 141/270 (52%), Gaps = 18/270 (6%)
Query: 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRAL 215
KYE+ +++G+G FG ++ G+ +K I M+ ED EVKIL+ L
Sbjct: 1 KYEIIKQIGKGSFG--KVYLVRRKS-DGKLYVLKEIDLSNMS-EKEREDALNEVKILKKL 56
Query: 216 TGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSR---GGKYTEDDAKAVMIQILNV 272
H N++K+++++E+ + +VME +GG+L +I + G + E+ +Q+
Sbjct: 57 N-HPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLA 115
Query: 273 VAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERL-NDIVGSAYYVAP 331
+ + H + ++HRD+KP+N T+ ++K DFG+S + L +VG+ YY++P
Sbjct: 116 LKYLHSRKILHRDIKPQNIFLTSNG---LVKLGDFGISKVLSSTVDLAKTVVGTPYYLSP 172
Query: 332 EVL-HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPS-LS 389
E+ ++ Y+ ++D+WS+G + Y L PF + +LK P PS S
Sbjct: 173 ELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQY----PPIPSQYS 228
Query: 390 SEARDFVKRLLNKDPRKRLTAAQALSELLI 419
SE R+ V LL KDP +R + AQ L I
Sbjct: 229 SELRNLVSSLLQKDPEERPSIAQILQSPFI 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 186 bits (474), Expect = 2e-56
Identities = 91/263 (34%), Positives = 142/263 (53%), Gaps = 16/263 (6%)
Query: 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRAL 215
+E+ E++G+G FG A+ K+ G++VA+KVI E + E++IL+
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKR---TGKEVAIKVIKLESKE---KKEKIINEIQILKKC 54
Query: 216 TGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAF 275
H N+VK++ +Y D +++VME C GG L D + S TE V ++L + +
Sbjct: 55 K-HPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEY 113
Query: 276 CHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLH 335
H G++HRD+K N L T+ E +K IDFGLS + + N +VG+ Y++APEV++
Sbjct: 114 LHSNGIIHRDIKAANILLTSDGE---VKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVIN 170
Query: 336 R-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLK-ADPSFDEAPWPSLSS-EA 392
Y +AD+WS+G+ A L G P+ +E +A+ K A P S E
Sbjct: 171 GKPYDYKADIWSLGITAIELAEGKPPY---SELPPMKALFKIATNGPPGLRNPEKWSDEF 227
Query: 393 RDFVKRLLNKDPRKRLTAAQALS 415
+DF+K+ L K+P KR TA Q L
Sbjct: 228 KDFLKKCLQKNPEKRPTAEQLLK 250
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 180 bits (458), Expect = 6e-54
Identities = 86/269 (31%), Positives = 137/269 (50%), Gaps = 24/269 (8%)
Query: 156 KYELGEEVGRGHFG--YTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILR 213
++ GE +GRG FG Y K G+ +AVK + + +E + RE++IL
Sbjct: 1 EWTRGELLGRGSFGSVYLALDK-----DTGELMAVKSVELSGDSEE-ELEALEREIRILS 54
Query: 214 ALTGHNNLVKFFDAY--EDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILN 271
+L H N+V+++ + E+ + + + +E GG L +L + GK E + QIL
Sbjct: 55 SLQ-HPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSS-LLKKFGKLPEPVIRKYTRQILE 112
Query: 272 VVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS---DFVRPDERLNDIVGSAYY 328
+A+ H G+VHRD+K N L D + V+K DFG + + E + G+ Y+
Sbjct: 113 GLAYLHSNGIVHRDIKGANILV---DSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYW 169
Query: 329 VAPEVLHRS-YSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPW-P 386
+APEV+ Y AD+WS+G + G P W+ + + A L S E P P
Sbjct: 170 MAPEVIRGEEYGRAADIWSLGCTVIEMATGKPP-WSELGNPM--AALYKIGSSGEPPEIP 226
Query: 387 S-LSSEARDFVKRLLNKDPRKRLTAAQAL 414
LS EA+DF+++ L +DP+KR TA + L
Sbjct: 227 EHLSEEAKDFLRKCLRRDPKKRPTADELL 255
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 176 bits (449), Expect = 2e-52
Identities = 83/285 (29%), Positives = 144/285 (50%), Gaps = 33/285 (11%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRA 214
+ ++ G+ +G G F AK K+ ++ A+K++ K ++ ++ V+ E ++L
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKET---NKEYAIKILDKRQLIKEKKVKYVKIEKEVLTR 57
Query: 215 LTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVA 274
L GH ++K + ++D +N+Y V+E GELL I G E + +IL +
Sbjct: 58 LNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSL-DEKCTRFYAAEILLALE 116
Query: 275 FCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDE----------------- 317
+ H +G++HRDLKPEN L D++ +K DFG + + P+
Sbjct: 117 YLHSKGIIHRDLKPENILL---DKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIE 173
Query: 318 ----RLNDIVGSAYYVAPEVLHRSYSTEA-DVWSIGVIAYILLCGSRPFWARTESGIFRA 372
R VG+A YV+PE+L+ + ++ D+W++G I Y +L G PF E F+
Sbjct: 174 KNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQK 233
Query: 373 VLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSEL 417
+LK + SF P+ +A+D +++LL DP+ RL + EL
Sbjct: 234 ILKLEYSFP----PNFPPDAKDLIEKLLVLDPQDRLGVNEGYDEL 274
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 177 bits (448), Expect = 2e-51
Identities = 91/286 (31%), Positives = 150/286 (52%), Gaps = 30/286 (10%)
Query: 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRAL 215
Y + ++G G FG A+ +K VA+KV+ K + + +E RE++IL +L
Sbjct: 1 SYRILRKLGEGSFGEVYLARDRK------LVALKVLAKKLESKSKEVERFLREIQILASL 54
Query: 216 TGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRI--LSRGGKYTEDDAKAVMIQILNVV 273
N+VK +D ++D ++Y+VME +GG L D + + R G +E +A ++ QIL+ +
Sbjct: 55 NHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSAL 114
Query: 274 AFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR-------PDERLNDIVGSA 326
+ H +G++HRD+KPEN L + V+K IDFGL+ + + VG+
Sbjct: 115 EYLHSKGIIHRDIKPENILLD--RDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTP 172
Query: 327 YYVAPEVLH----RSYSTEADVWSIGVIAYILLCGSRPF----WARTESGIFRAVLKADP 378
Y+APEVL S+ +D+WS+G+ Y LL G PF + S + +L+
Sbjct: 173 GYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPT 232
Query: 379 SFDEAPW-----PSLSSEARDFVKRLLNKDPRKRLTAAQALSELLI 419
+P +S A D +K+LL KDP+ RL+++ LS L+
Sbjct: 233 PSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLL 278
|
Length = 384 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 172 bits (439), Expect = 3e-51
Identities = 92/266 (34%), Positives = 145/266 (54%), Gaps = 22/266 (8%)
Query: 156 KYELGEEVGRGHFGYTCAAKFKKG--ELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILR 213
Y+LG+ +GRG FG KG G VA+K I K+ A++ + +E+ +L+
Sbjct: 1 NYQLGDLIGRGAFG-----VVYKGLNLETGDFVAIKQISLEKIKEE-ALKSIMQEIDLLK 54
Query: 214 ALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVV 273
L H N+VK+ + E +D++Y+++E E G L +I+ + G + E + Q+L +
Sbjct: 55 NLK-HPNIVKYIGSIETSDSLYIILEYAENGSLR-QIIKKFGPFPESLVAVYVYQVLQGL 112
Query: 274 AFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDER-LNDIVGSAYYVAPE 332
A+ H QGV+HRD+K N L TTKD V+K DFG++ + + +VG+ Y++APE
Sbjct: 113 AYLHEQGVIHRDIKAANIL-TTKDG--VVKLADFGVATKLNDVSKDDASVVGTPYWMAPE 169
Query: 333 VLHRS-YSTEADVWSIGVIAYILLCGSRPFWARTE-SGIFRAVLKADPSFDEAPWPS-LS 389
V+ S ST +D+WS+G LL G+ P++ + +FR V D P P +S
Sbjct: 170 VIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIV-----QDDHPPLPEGIS 224
Query: 390 SEARDFVKRLLNKDPRKRLTAAQALS 415
E +DF+ + KDP R TA Q L
Sbjct: 225 PELKDFLMQCFQKDPNLRPTAKQLLK 250
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 171 bits (435), Expect = 2e-50
Identities = 89/258 (34%), Positives = 126/258 (48%), Gaps = 20/258 (7%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLV 222
+ +G +G AK KK G A+KVI K M ++ V E IL +V
Sbjct: 1 ISKGAYGRVFLAK-KK--STGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQ-SPYVV 56
Query: 223 KFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVV 282
K + +++ N+Y+VME GG+L +L G ED A+ + +I+ + + H G++
Sbjct: 57 KLYYSFQGKKNLYLVMEYLPGGDLA-SLLENVGSLDEDVARIYIAEIVLALEYLHSNGII 115
Query: 283 HRDLKPENFLFTTKDENSVLKAIDFGLSDF---------VRPDERLNDIVGSAYYVAPEV 333
HRDLKP+N L D N LK DFGLS ++ IVG+ Y+APEV
Sbjct: 116 HRDLKPDNILI---DSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEV 172
Query: 334 -LHRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEA 392
L + +S D WS+G I Y L G PF T IF+ +L + E +S EA
Sbjct: 173 ILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPED--VEVSDEA 230
Query: 393 RDFVKRLLNKDPRKRLTA 410
D + +LL DP KRL A
Sbjct: 231 IDLISKLLVPDPEKRLGA 248
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 169 bits (430), Expect = 6e-50
Identities = 84/257 (32%), Positives = 137/257 (53%), Gaps = 18/257 (7%)
Query: 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALT 216
+EL +G+G FG C + + + A+K + K K ++ +V E +IL+ L
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRD---TKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELN 58
Query: 217 GHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRI-LSRGGKYTEDDAKAVMIQILNVVAF 275
H LV + +++D +N+Y+V++L GG+L R LS+ K++E+ K + +I+ + +
Sbjct: 59 -HPFLVNLWYSFQDEENMYLVVDLLLGGDL--RYHLSQKVKFSEEQVKFWICEIVLALEY 115
Query: 276 CHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVL- 334
H +G++HRD+KP+N L DE + DF ++ V PD G+ Y+APEVL
Sbjct: 116 LHSKGIIHRDIKPDNILL---DEQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLC 172
Query: 335 HRSYSTEADVWSIGVIAYILLCGSRPFWART---ESGIFRAVLKADPSFDEAPWPSLSSE 391
+ YS D WS+GV AY L G RP+ + I AD + + S+E
Sbjct: 173 RQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLY----PATWSTE 228
Query: 392 ARDFVKRLLNKDPRKRL 408
A D + +LL +DP+KRL
Sbjct: 229 AIDAINKLLERDPQKRL 245
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 161 bits (410), Expect = 1e-46
Identities = 80/256 (31%), Positives = 131/256 (51%), Gaps = 21/256 (8%)
Query: 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALT 216
+E + +G G FG + K G+ A+K++ K K+ +E V E +IL+++
Sbjct: 3 FEFIKTLGTGSFGRVMLVRHKG---SGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIR 59
Query: 217 GHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFC 276
H LV + +++D N+Y+VME GGEL L + G++ E A+ Q++ + +
Sbjct: 60 -HPFLVNLYGSFQDDSNLYLVMEYVPGGELFSH-LRKSGRFPEPVARFYAAQVVLALEYL 117
Query: 277 HLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEV-LH 335
H +V+RDLKPEN L D + +K DFG + V R + G+ Y+APE+ L
Sbjct: 118 HSLDIVYRDLKPENLLL---DSDGYIKITDFGFAKRV--KGRTYTLCGTPEYLAPEIILS 172
Query: 336 RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKAD---PSFDEAPWPSLSSEA 392
+ Y D W++G++ Y +L G PF+ I+ +L+ PSF S +A
Sbjct: 173 KGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPSF-------FSPDA 225
Query: 393 RDFVKRLLNKDPRKRL 408
+D ++ LL D KRL
Sbjct: 226 KDLIRNLLQVDLTKRL 241
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 160 bits (408), Expect = 3e-46
Identities = 97/296 (32%), Positives = 145/296 (48%), Gaps = 56/296 (18%)
Query: 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVR--REVKILRA 214
Y++ +++G G FG A+ K+ G+ VA+K + K K + E+ REVK LR
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKE---TGELVAIKKM-KKKFYS---WEECMNLREVKSLRK 53
Query: 215 LTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKY-TEDDAKAVMIQILNVV 273
L H N+VK + + + D +Y V E EG L + R GK +E ++++ QIL +
Sbjct: 54 LNEHPNIVKLKEVFRENDELYFVFEYMEG-NLYQLMKDRKGKPFSESVIRSIIYQILQGL 112
Query: 274 AFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEV 333
A H G HRDLKPEN L + + V+K DFGL+ +R D V + +Y APE+
Sbjct: 113 AHIHKHGFFHRDLKPENLLVSGPE---VVKIADFGLAREIRSRPPYTDYVSTRWYRAPEI 169
Query: 334 L--HRSYSTEADVWSIGVIA---YILLCGSRP-FWARTESG-IFR--AVLKADPSFDEAP 384
L SYS+ D+W++G I Y L RP F +E +++ +VL + +
Sbjct: 170 LLRSTSYSSPVDIWALGCIMAELYTL----RPLFPGSSEIDQLYKICSVLG---TPTKQD 222
Query: 385 W--------------------------PSLSSEARDFVKRLLNKDPRKRLTAAQAL 414
W P+ S EA D +K +L DP+KR TA+QAL
Sbjct: 223 WPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQAL 278
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 155 bits (395), Expect = 2e-44
Identities = 90/293 (30%), Positives = 139/293 (47%), Gaps = 51/293 (17%)
Query: 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMT-----TAIAIEDVRREVKI 211
YE E++G G +G A+ KK G+ VA+K I TA+ RE+ +
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKK---TGEIVALKKIRLDNEEEGIPSTAL------REISL 51
Query: 212 LRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRIL-SRGGKYTEDDAKAVMIQIL 270
L+ L H N+VK D +Y+V E C+ L + L R G + + K++M Q+L
Sbjct: 52 LKELK-HPNIVKLLDVIHTERKLYLVFEYCD--MDLKKYLDKRPGPLSPNLIKSIMYQLL 108
Query: 271 NVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDERLNDIVGSAYYV 329
+A+CH ++HRDLKP+N L + + VLK DFGL+ F P V + +Y
Sbjct: 109 RGLAYCHSHRILHRDLKPQNILI---NRDGVLKLADFGLARAFGIPLRTYTHEVVTLWYR 165
Query: 330 APEVL--HRSYSTEADVWSIGVIAYILLCGSRPFWARTESG----IFRAVL-----KADP 378
APE+L + YST D+WS+G I ++ G F +E IF+ +L ++ P
Sbjct: 166 APEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQ-ILGTPTEESWP 224
Query: 379 SFDEAPW-----------------PSLSSEARDFVKRLLNKDPRKRLTAAQAL 414
+ P P L E D + ++L +P KR++A +AL
Sbjct: 225 GVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEAL 277
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 156 bits (397), Expect = 3e-44
Identities = 96/305 (31%), Positives = 147/305 (48%), Gaps = 62/305 (20%)
Query: 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDV----R--REV 209
+YEL + +G G +G C+A K+ G++VA+K I +D+ R RE+
Sbjct: 1 RYELLKPIGSGAYGVVCSAVDKR---TGRKVAIKKISN-------VFDDLIDAKRILREI 50
Query: 210 KILRALTGHNNLVKFFD-----AYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKA 264
K+LR L H N++ D + ED ++VY+V EL E L +++ T+D +
Sbjct: 51 KLLRHL-RHENIIGLLDILRPPSPEDFNDVYIVTELMETD--LHKVIKSPQPLTDDHIQY 107
Query: 265 VMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDER----LN 320
+ QIL + + H V+HRDLKP N L + N LK DFGL+ V PDE L
Sbjct: 108 FLYQILRGLKYLHSANVIHRDLKPSNILV---NSNCDLKICDFGLARGVDPDEDEKGFLT 164
Query: 321 DIVGSAYYVAPEVL--HRSYSTEADVWSIGVIAYILLCGSRPFWA--------------- 363
+ V + +Y APE+L Y+ D+WS+G I LL +P +
Sbjct: 165 EYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELL-TRKPLFPGRDYIDQLNLIVEVL 223
Query: 364 --RTESGI-------FRAVLKADPSFDEAPW----PSLSSEARDFVKRLLNKDPRKRLTA 410
+E + R LK+ P + P P S EA D ++++L DP+KR+TA
Sbjct: 224 GTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITA 283
Query: 411 AQALS 415
+AL+
Sbjct: 284 DEALA 288
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 151 bits (383), Expect = 6e-43
Identities = 76/252 (30%), Positives = 131/252 (51%), Gaps = 19/252 (7%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQV--AVKVIPKHKMTTAIAIEDVRREVKILRALTGHNN 220
+G G FG + + ++K + A+K + K + E + E +IL H
Sbjct: 1 LGVGGFG-----RVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEIL-EECNHPF 54
Query: 221 LVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQG 280
+VK + ++D +Y++ME C GGEL IL G + E A+ + ++ + H +G
Sbjct: 55 IVKLYRTFKDKKYIYMLMEYCLGGELWT-ILRDRGLFDEYTARFYIACVVLAFEYLHNRG 113
Query: 281 VVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEV-LHRSYS 339
+++RDLKPEN L D N +K +DFG + ++ ++ G+ YVAPE+ L++ Y
Sbjct: 114 IIYRDLKPENLLL---DSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKGYD 170
Query: 340 TEADVWSIGVIAYILLCGSRPFWARTES--GIFRAVLKADPSFDEAPWPS-LSSEARDFV 396
D WS+G++ Y LL G PF E I+ +LK + + +P+ + A+D +
Sbjct: 171 FSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGN---GKLEFPNYIDKAAKDLI 227
Query: 397 KRLLNKDPRKRL 408
K+LL ++P +RL
Sbjct: 228 KQLLRRNPEERL 239
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 150 bits (382), Expect = 8e-43
Identities = 86/275 (31%), Positives = 134/275 (48%), Gaps = 32/275 (11%)
Query: 156 KYELGEEVGRGHFG--YTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILR 213
+++ G ++G G FG YT GEL +AVK I I+++ E+K+L
Sbjct: 1 RWQRGNKIGGGTFGKVYTAV-NLDTGEL----MAVKEIRIQDNDPKT-IKEIADEMKVLE 54
Query: 214 ALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDA--KAVMIQILN 271
L H NLVK++ + VY+ ME C GG L + L G+ D+ + +Q+L
Sbjct: 55 LLK-HPNLVKYYGVEVHREKVYIFMEYCSGGTLEE--LLEHGR-ILDEHVIRVYTLQLLE 110
Query: 272 VVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV-----RPDERLNDIVGSA 326
+A+ H G+VHRD+KP N D N V+K DFG + + E + + G+
Sbjct: 111 GLAYLHSHGIVHRDIKPANIFL---DHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTP 167
Query: 327 YYVAPEVLHRSYSTE----ADVWSIGVIAYILLCGSRPFWARTESG---IFRAVLKADPS 379
Y+APEV+ AD+WS+G + + G RP W+ ++ +F P
Sbjct: 168 AYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRP-WSELDNEFQIMFHVGAGHKPP 226
Query: 380 FDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQAL 414
++ LS E +DF+ R L DP+KR TA++ L
Sbjct: 227 IPDS--LQLSPEGKDFLDRCLESDPKKRPTASELL 259
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 147 bits (373), Expect = 1e-41
Identities = 81/251 (32%), Positives = 121/251 (48%), Gaps = 11/251 (4%)
Query: 161 EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNN 220
+ + +G FG AK + G A+KV+ K M + +V+ E I+
Sbjct: 2 KPISKGAFGSVYLAKKR---STGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPY 58
Query: 221 LVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQG 280
+ K + +++ D +Y+VME GG+ I + GG ED AK + +++ V H +G
Sbjct: 59 VAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGG-LPEDWAKQYIAEVVLGVEDLHQRG 117
Query: 281 VVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRSYST 340
++HRD+KPEN L D+ LK DFGLS R VG+ Y+APE +
Sbjct: 118 IIHRDIKPENLLI---DQTGHLKLTDFGLS---RNGLENKKFVGTPDYLAPETILGVGDD 171
Query: 341 EA-DVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRL 399
+ D WS+G + + L G PF A T +F +L ++ E S EA D + RL
Sbjct: 172 KMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRL 231
Query: 400 LNKDPRKRLTA 410
L DP KRL A
Sbjct: 232 LCMDPAKRLGA 242
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 146 bits (371), Expect = 7e-41
Identities = 78/272 (28%), Positives = 127/272 (46%), Gaps = 30/272 (11%)
Query: 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIP--KHKMTTAIAIEDVRREVKI 211
Y+ E++G G G A + G++VA+K + K I E+ I
Sbjct: 18 RELYKNLEKIGEGASGEVYKATDRA---TGKEVAIKKMRLRKQNKELII------NEILI 68
Query: 212 LRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILN 271
++ H N+V ++D+Y D ++VVME +GG L D I + E V ++L
Sbjct: 69 MKDCK-HPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQ 127
Query: 272 VVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFG----LSDFVRPDERLNDIVGSAY 327
+ + H Q V+HRD+K +N L + +K DFG L+ + + N +VG+ Y
Sbjct: 128 GLEYLHSQNVIHRDIKSDNILLSKDGS---VKLADFGFAAQLT---KEKSKRNSVVGTPY 181
Query: 328 YVAPEVLHRS-YSTEADVWSIGVIAYILLCGSRPFWARTESG---IFRAVLKADPSFDEA 383
++APEV+ R Y + D+WS+G++ + G P+ E +F K P
Sbjct: 182 WMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYL--REPPLRALFLITTKGIPPLKNP 239
Query: 384 PWPSLSSEARDFVKRLLNKDPRKRLTAAQALS 415
S E +DF+ + L KDP KR +A + L
Sbjct: 240 --EKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 144 bits (366), Expect = 3e-40
Identities = 92/290 (31%), Positives = 132/290 (45%), Gaps = 44/290 (15%)
Query: 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVR--REVKILRA 214
Y+ ++G G +G A+ K L G+ VA+K K K+ RE+K+L+
Sbjct: 1 YQKLGKIGEGTYGVVYKARDK---LTGEIVAIK---KIKLRFESEGIPKTALREIKLLKE 54
Query: 215 LTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVA 274
L H N++K D + ++Y+V E + +L I R E K+ + Q+L +A
Sbjct: 55 LN-HPNIIKLLDVFRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLA 112
Query: 275 FCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDER-LNDIVGSAYYVAPEV 333
FCH G++HRDLKPEN L T VLK DFGL+ R V + +Y APE+
Sbjct: 113 FCHSHGILHRDLKPENLLINT---EGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPEL 169
Query: 334 LHRS--YSTEADVWSIGVIAYILLCGSRPFWARTE-----SGIF---------------- 370
L YST D+WS+G I LL RP + IF
Sbjct: 170 LLGDKGYSTPVDIWSVGCIFAELLSR-RPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTS 228
Query: 371 --RAVLKADPSFDEAPW----PSLSSEARDFVKRLLNKDPRKRLTAAQAL 414
R + P P P+ S +A D + ++L+ DP KR+TA QAL
Sbjct: 229 LARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQAL 278
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 144 bits (366), Expect = 5e-40
Identities = 90/300 (30%), Positives = 136/300 (45%), Gaps = 59/300 (19%)
Query: 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMT--------TAIAIEDVRR 207
+YE G+++G G + A+ K+ G+ VA+K I + TA+ R
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKE---TGRIVAIKKIKLGERKEAKDGINFTAL------R 51
Query: 208 EVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGG-ELL--DRILSRGGKYTEDDAKA 264
E+K+L+ L H N++ D + N+ +V E E E + D+ + T D K+
Sbjct: 52 EIKLLQELK-HPNIIGLLDVFGHKSNINLVFEFMETDLEKVIKDKSIV----LTPADIKS 106
Query: 265 VMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDERLNDIV 323
M+ L + + H ++HRDLKP N L + VLK DFGL+ F P+ ++ V
Sbjct: 107 YMLMTLRGLEYLHSNWILHRDLKPNNLLI---ASDGVLKLADFGLARSFGSPNRKMTHQV 163
Query: 324 GSAYYVAPEVLH--RSYSTEADVWSIGVI-AYILLCGSRPFWARTE-----SGIFRA--- 372
+ +Y APE+L R Y D+WS+G I A +LL PF IF A
Sbjct: 164 VTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLL--RVPFLPGDSDIDQLGKIFEALGT 221
Query: 373 -------VLKADPS---FDEAPWPSL-------SSEARDFVKRLLNKDPRKRLTAAQALS 415
+ + P F P L S +A D ++RLL +P KR+TA QAL
Sbjct: 222 PTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE 281
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 143 bits (363), Expect = 9e-40
Identities = 91/290 (31%), Positives = 136/290 (46%), Gaps = 39/290 (13%)
Query: 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRAL 215
+Y++ +G G G AK ++ G+ VA+K + ++ I RE+K L+A
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRE---TGETVALKKVALRRLEGGIP-NQALREIKALQAC 56
Query: 216 TGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAF 275
H +VK D + +VME +L + + E K+ M +L VA+
Sbjct: 57 -QHPYVVKLLDVFPHGSGFVLVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAY 114
Query: 276 CHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD-FVRPDERL-NDIVGSAYYVAPEV 333
H G++HRDLKP N L + VLK DFGL+ F + RL + V + +Y APE+
Sbjct: 115 MHANGIMHRDLKPANLLI---SADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPEL 171
Query: 334 LH--RSYSTEADVWSIGVIAYILLCGSRPFWARTE----SGIFRAV----------LKAD 377
L+ R Y D+W++G I LL GS F + + +FR + L +
Sbjct: 172 LYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSL 231
Query: 378 P-----SFDEA---PW----PSLSSEARDFVKRLLNKDPRKRLTAAQALS 415
P +F E+ P P S EA D +K LL DP KRL+AA+AL
Sbjct: 232 PDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR 281
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 143 bits (363), Expect = 1e-39
Identities = 97/300 (32%), Positives = 139/300 (46%), Gaps = 55/300 (18%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVR----REVK 210
NKYE+ VG G +G + K G+ VA+K K + EDV+ REVK
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKA---TGEIVAIK-----KFKESEDDEDVKKTALREVK 52
Query: 211 ILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGG--ELLDRILSRGGKYTEDDAKAVMIQ 268
+LR L H N+V +A+ +Y+V E E ELL+ S GG D ++ + Q
Sbjct: 53 VLRQLR-HENIVNLKEAFRRKGRLYLVFEYVERTLLELLEA--SPGG-LPPDAVRSYIWQ 108
Query: 269 ILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV--RPDERLNDIVGSA 326
+L +A+CH ++HRD+KPEN L E+ VLK DFG + + RP L D V +
Sbjct: 109 LLQAIAYCHSHNIIHRDIKPENILV---SESGVLKLCDFGFARALRARPASPLTDYVATR 165
Query: 327 YYVAPEVL--HRSYSTEADVWSIGVIAYILLCGSRPFWARTES-----GIFRA------- 372
+Y APE+L +Y DVW+IG I LL G P + I +
Sbjct: 166 WYRAPELLVGDTNYGKPVDVWAIGCIMAELLDG-EPLFPGDSDIDQLYLIQKCLGPLPPS 224
Query: 373 ---VLKADPSFDEAPWPS--------------LSSEARDFVKRLLNKDPRKRLTAAQALS 415
+ ++P F +P +SS A DF+K L DP++RLT + L
Sbjct: 225 HQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 141 bits (358), Expect = 2e-39
Identities = 78/264 (29%), Positives = 126/264 (47%), Gaps = 18/264 (6%)
Query: 158 ELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIP-KHKMTTAIAIEDVRREVKILRALT 216
E + +G+G G + K G+ A+K I + + RE+K LR+
Sbjct: 4 ERVKVLGQGSSGVVYKVRHKP---TGKIYALKKIHVDGDEEF---RKQLLRELKTLRS-C 56
Query: 217 GHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFC 276
+VK + A+ + +V+E +GG L +L + GK E + QIL + +
Sbjct: 57 ESPYVVKCYGAFYKEGEISIVLEYMDGGSL-ADLLKKVGKIPEPVLAYIARQILKGLDYL 115
Query: 277 HLQ-GVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP-DERLNDIVGSAYYVAPEVL 334
H + ++HRD+KP N L +K E +K DFG+S + ++ N VG+ Y++PE +
Sbjct: 116 HTKRHIIHRDIKPSNLLINSKGE---VKIADFGISKVLENTLDQCNTFVGTVTYMSPERI 172
Query: 335 H-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPS--LSSE 391
SYS AD+WS+G+ G PF + F +++A P+ S E
Sbjct: 173 QGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFF-ELMQAICDGPPPSLPAEEFSPE 231
Query: 392 ARDFVKRLLNKDPRKRLTAAQALS 415
RDF+ L KDP+KR +AA+ L
Sbjct: 232 FRDFISACLQKDPKKRPSAAELLQ 255
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 139 bits (352), Expect = 2e-38
Identities = 96/287 (33%), Positives = 139/287 (48%), Gaps = 45/287 (15%)
Query: 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRAL 215
YE+ E +G+G FG + K G+ + K I MT + V EV ILR L
Sbjct: 1 DYEVLETIGKGSFGTVRKVRRKS---DGKILVWKEIDYGNMTEKEKQQLVS-EVNILREL 56
Query: 216 TGHNNLVKFFDAYEDTDN--VYVVMELCEGGELLDRILSR----GGKYTEDDAKAVMIQI 269
H N+V+++D D N +Y+VME CEGG+L +++ + E+ ++ Q+
Sbjct: 57 K-HPNIVRYYDRIIDRSNQTLYIVMEYCEGGDL-AQLIQKCKKERKYIEEEFIWRILTQL 114
Query: 270 LNVVAFCHLQG-----VVHRDLKPEN-FLFTTKDENSVLKAIDFGLSDFVRPDERL-NDI 322
L + CH + V+HRDLKP N FL D N+ +K DFGL+ + D
Sbjct: 115 LLALYECHNRSDPGNTVLHRDLKPANIFL----DANNNVKLGDFGLAKILGHDSSFAKTY 170
Query: 323 VGSAYYVAPEVL-HRSYSTEADVWSIGVIAYILLCGSRPFWART--------ESGIFRAV 373
VG+ YY++PE L H SY ++D+WS+G + Y L S PF AR + G FR
Sbjct: 171 VGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFR-- 228
Query: 374 LKADPSFDEAPWPSL-SSEARDFVKRLLNKDPRKRLTAAQALSELLI 419
P SSE + +K +LN DP KR + + L LI
Sbjct: 229 ----------RIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI 265
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 138 bits (350), Expect = 2e-37
Identities = 89/261 (34%), Positives = 130/261 (49%), Gaps = 20/261 (7%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRA 214
+++ +VG+G +G AK K G+ VA+K + K + + V E IL
Sbjct: 1 KDFQILTQVGQGGYGQVFLAKKKD---TGEIVALKRMKKSLLFKLNEVRHVLTERDIL-T 56
Query: 215 LTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVA 274
T LVK A++D + +Y+ ME GG+ +L+ G +ED A+ M ++ V
Sbjct: 57 TTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDF-RTLLNNLGVLSEDHARFYMAEMFEAVD 115
Query: 275 FCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDERLNDIVGSAYYVAPEV 333
H G +HRDLKPENFL D + +K DFGLS V N +VGS Y+APEV
Sbjct: 116 ALHELGYIHRDLKPENFLI---DASGHIKLTDFGLSKGIV---TYANSVVGSPDYMAPEV 169
Query: 334 LH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLK-----ADPSFDEAPWPS 387
L + Y D WS+G + Y LCG PF T + + + P +D+ P +
Sbjct: 170 LRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDD-PRFN 228
Query: 388 LSSEARDFVKRLLNKDPRKRL 408
LS EA D + +L+N DP +R
Sbjct: 229 LSDEAWDLITKLIN-DPSRRF 248
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 3e-37
Identities = 81/272 (29%), Positives = 129/272 (47%), Gaps = 22/272 (8%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRA 214
+ YEL E +G G AA ++VA+K I K T++ +++R+EV+ + +
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLP---NNEKVAIKRIDLEKCQTSV--DELRKEVQAM-S 54
Query: 215 LTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLD---RILSRGGKYTEDDAKAVMIQILN 271
H N+VK++ ++ D +++VM GG LLD RGG E V+ ++L
Sbjct: 55 QCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGG-LDEAIIATVLKEVLK 113
Query: 272 VVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV-----RPDERLNDIVGSA 326
+ + H G +HRD+K N L E+ +K DFG+S + R + VG+
Sbjct: 114 GLEYLHSNGQIHRDIKAGNILL---GEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTP 170
Query: 327 YYVAPEVLH--RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSF--DE 382
++APEV+ Y +AD+WS G+ A L G+ P+ + L+ DP
Sbjct: 171 CWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETG 230
Query: 383 APWPSLSSEARDFVKRLLNKDPRKRLTAAQAL 414
A + S R + L KDP KR TA + L
Sbjct: 231 ADYKKYSKSFRKMISLCLQKDPSKRPTAEELL 262
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 4e-37
Identities = 85/266 (31%), Positives = 132/266 (49%), Gaps = 20/266 (7%)
Query: 156 KYELGEEVGRGHFG--YTCAAKFKKGELKGQQVAVKVIP--KHKMTTAIAIEDVRREVKI 211
++ GE +G G FG Y G+ AVK + T A++ + +E+ +
Sbjct: 1 RWRKGELLGSGSFGSVYE-GLNLDDGDF----FAVKEVSLADDGQTGQEAVKQLEQEIAL 55
Query: 212 LRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILN 271
L L H N+V++ + DN+Y+ +EL GG L ++L + G + E + QIL
Sbjct: 56 LSKLQ-HPNIVQYLGTEREEDNLYIFLELVPGGSLA-KLLKKYGSFPEPVIRLYTRQILL 113
Query: 272 VVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAP 331
+ + H + VHRD+K N L D N V+K DFG++ V GS Y++AP
Sbjct: 114 GLEYLHDRNTVHRDIKGANILV---DTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAP 170
Query: 332 EVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWP-SL 388
EV+ + Y AD+WS+G + + +P W++ E AV K S + P P L
Sbjct: 171 EVIAQQGGYGLAADIWSLGCTV-LEMATGKPPWSQLEG--VAAVFKIGRSKELPPIPDHL 227
Query: 389 SSEARDFVKRLLNKDPRKRLTAAQAL 414
S EA+DF+ + L +DP R TAA+ L
Sbjct: 228 SDEAKDFILKCLQRDPSLRPTAAELL 253
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 7e-37
Identities = 83/284 (29%), Positives = 136/284 (47%), Gaps = 39/284 (13%)
Query: 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILR 213
+EL E +G G +G A+ KK GQ VA+K++ E+++ E ILR
Sbjct: 5 TGIFELVEVIGEGTYGKVYKARHKK---TGQLVAIKIMD----IIEDEEEEIKEEYNILR 57
Query: 214 ALTGHNNLVKFFDAY------EDTDNVYVVMELCEGG---ELLDRILSRGGKYTEDDAKA 264
+ H N+ F+ A+ + D +++VMELC GG +L+ + +G + E+
Sbjct: 58 KYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAY 117
Query: 265 VMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDERLNDIV 323
++ + L +A+ H V+HRD+K +N L T +N+ +K +DFG+S R N +
Sbjct: 118 ILRETLRGLAYLHENKVIHRDIKGQNILLT---KNAEVKLVDFGVSAQLDSTLGRRNTFI 174
Query: 324 GSAYYVAPEVLH------RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKAD 377
G+ Y++APEV+ SY +DVWS+G+ A L G P + RA+ K
Sbjct: 175 GTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPL---CDMHPMRALFKIP 231
Query: 378 PSFDEAPWPSLSSEAR------DFVKRLLNKDPRKRLTAAQALS 415
+ P P+L S DF+ L K+ +R + L
Sbjct: 232 RN----PPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 133 bits (338), Expect = 4e-36
Identities = 87/300 (29%), Positives = 129/300 (43%), Gaps = 60/300 (20%)
Query: 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMT-----TAIAIEDVRREVKI 211
YE ++G G +G A+ KK G+ VA+K I TAI RE+K+
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKK---TGELVALKKIRMENEKEGFPITAI------REIKL 51
Query: 212 LRALTGHNNLVKFFDAY--EDTDNVYVVMELCE----GGELLDRILSRGGKYTEDDAKAV 265
L+ L H N+V+ + + ++Y+V E + G LLD S K+TE K
Sbjct: 52 LQKLR-HPNIVRLKEIVTSKGKGSIYMVFEYMDHDLTG--LLD---SPEVKFTESQIKCY 105
Query: 266 MIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV--RPDERLNDIV 323
M Q+L + + H G++HRD+K N L + + VLK DFGL+ R + V
Sbjct: 106 MKQLLEGLQYLHSNGILHRDIKGSNILI---NNDGVLKLADFGLARPYTKRNSADYTNRV 162
Query: 324 GSAYYVAPEVL--HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFD 381
+ +Y PE+L Y E D+WS+G I L G F TE + + S
Sbjct: 163 ITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPT 222
Query: 382 EAPWPSL---------------------------SSEARDFVKRLLNKDPRKRLTAAQAL 414
+ WP + A D + +LL DP+KR++A QAL
Sbjct: 223 DENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQAL 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 131 bits (332), Expect = 1e-35
Identities = 79/274 (28%), Positives = 124/274 (45%), Gaps = 32/274 (11%)
Query: 158 ELGEEVGRGHFGYTCAAKFK-KGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALT 216
LG+++G G FG K K KG K +VAVK + + IE+ RE +I+R L
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDAS--EQQIEEFLREARIMRKL- 58
Query: 217 GHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFC 276
H N+VK + + +Y+VME EGG+LL + K + D + +QI + +
Sbjct: 59 DHPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYL 118
Query: 277 HLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYV------- 329
+ +HRDL N L EN V+K DFGLS + D+ YY
Sbjct: 119 ESKNFIHRDLAARNCLV---GENLVVKISDFGLSRDLYDDD---------YYRKRGGKLP 166
Query: 330 ----APEVL-HRSYSTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAVLKADPSFDEA 383
APE L +++++DVWS GV+ + I G +P+ + + +
Sbjct: 167 IRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNG--YRLPQ 224
Query: 384 PWPSLSSEARDFVKRLLNKDPRKRLTAAQALSEL 417
P P+ E D + + +DP R T ++ + L
Sbjct: 225 P-PNCPPELYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 132 bits (333), Expect = 2e-35
Identities = 89/283 (31%), Positives = 144/283 (50%), Gaps = 27/283 (9%)
Query: 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTT-AIAIEDVRREVKILRAL 215
+EL +G G +G + G G+ A+KV+ K + A E R E ++L A+
Sbjct: 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAV 61
Query: 216 TGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAF 275
LV A++ ++++++ GGEL + R +TE + + + +I V+A
Sbjct: 62 RRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQRE-HFTESEVRVYIAEI--VLAL 118
Query: 276 CHLQ--GVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDE--RLNDIVGSAYYVAP 331
HL G+++RD+K EN L D + DFGLS +E R G+ Y+AP
Sbjct: 119 DHLHQLGIIYRDIKLENILL---DSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAP 175
Query: 332 EVLHR---SYSTEADVWSIGVIAYILLCGSRPFWA----RTESGIFRAVLKADPSFDEAP 384
EV+ + D WS+GV+ + LL G+ PF ++S I R +LK+ P F
Sbjct: 176 EVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFP--- 232
Query: 385 WPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLICYQSYLFF 427
++S+EARDF+++LL KDP+KRL A A E+ +++ FF
Sbjct: 233 -KTMSAEARDFIQKLLEKDPKKRLGANGA-DEI----KNHPFF 269
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 130 bits (328), Expect = 5e-35
Identities = 84/273 (30%), Positives = 128/273 (46%), Gaps = 30/273 (10%)
Query: 156 KYELGEEVGRGHFGYTCAAK-FKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRA 214
YEL + +G G +G A+ GEL VA+KVI K+ E +++E+ +L+
Sbjct: 4 DYELIQRIGSGTYGDVYKARDIATGEL----VAIKVI---KLEPGDDFEIIQQEISMLKE 56
Query: 215 LTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVA 274
H N+V +F +Y D +++VME C GG L D G +E V + L +A
Sbjct: 57 CR-HPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLA 115
Query: 275 FCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDERLNDIVGSAYYVAPEV 333
+ H G +HRD+K N L T E+ +K DFG+S + +G+ Y++APEV
Sbjct: 116 YLHETGKIHRDIKGANILLT---EDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEV 172
Query: 334 L----HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAP----- 384
Y + D+W++G+ A L P + + RA+ S P
Sbjct: 173 AAVERKGGYDGKCDIWALGITAIELAELQPPMF---DLHPMRALFLISKSNFPPPKLKDK 229
Query: 385 --WPSLSSEARDFVKRLLNKDPRKRLTAAQALS 415
W S DF+K+ L KDP+KR TA + L
Sbjct: 230 EKW---SPVFHDFIKKCLTKDPKKRPTATKLLQ 259
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 5e-35
Identities = 79/267 (29%), Positives = 140/267 (52%), Gaps = 29/267 (10%)
Query: 161 EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRAL--TGH 218
E +GRG +G A K G+ VA+K+I + T + D++REV +L L +
Sbjct: 7 ELIGRGAYG---AVYRGKHVPTGRVVALKII--NLDTPDDDVSDIQREVALLSQLRQSQP 61
Query: 219 NNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHL 278
N+ K++ +Y ++++ME EGG + R L + G E ++ ++L + + H
Sbjct: 62 PNITKYYGSYLKGPRLWIIMEYAEGGSV--RTLMKAGPIAEKYISVIIREVLVALKYIHK 119
Query: 279 QGVVHRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDERLNDIVGSAYYVAPEVLH-- 335
GV+HRD+K N L T +K DFG++ + + + VG+ Y++APEV+
Sbjct: 120 VGVIHRDIKAANILVTNTGN---VKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEG 176
Query: 336 RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVL----KADPSFDEAPWPSLSSE 391
+ Y T+AD+WS+G+ Y + G+ P+ ++ FRA++ P ++ + S
Sbjct: 177 KYYDTKADIWSLGITIYEMATGNPPY---SDVDAFRAMMLIPKSKPPRLEDNGY---SKL 230
Query: 392 ARDFVKRLLNKDPRKRLTAAQALSELL 418
R+FV L+++P++RL+A ELL
Sbjct: 231 LREFVAACLDEEPKERLSA----EELL 253
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 6e-35
Identities = 89/294 (30%), Positives = 137/294 (46%), Gaps = 50/294 (17%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRA 214
+ +E+ + +GRG FG + K GQ A+KV+ K M I VR E IL
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKD---TGQVYAMKVLRKSDMIKRNQIAHVRAERDIL-- 55
Query: 215 LTGHNN--LVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAK---AVMIQI 269
++ +VK + +++D +++Y+VME GG+L+ +L R + E+ A+ A ++
Sbjct: 56 -ADADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLM-NLLIRKDVFPEETARFYIAELVLA 113
Query: 270 LNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS--------DFVRPDERLND 321
L+ V H G +HRD+KP+N L D + +K DFGL ++ N
Sbjct: 114 LDSV---HKLGFIHRDIKPDNILI---DADGHIKLADFGLCKKMNKAKDREYYLNDSHNL 167
Query: 322 ----------------------IVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGS 358
VG+ Y+APEVL Y E D WS+GVI Y +L G
Sbjct: 168 LFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGF 227
Query: 359 RPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQ 412
PF++ T + ++ S P P +S EA D + RLL DP RL + +
Sbjct: 228 PPFYSDTLQETYNKIINWKESLRFPPDPPVSPEAIDLICRLL-CDPEDRLGSFE 280
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 129 bits (327), Expect = 7e-35
Identities = 77/276 (27%), Positives = 122/276 (44%), Gaps = 35/276 (12%)
Query: 158 ELGEEVGRGHFG--YTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRAL 215
LG+++G G FG Y K K K +VAVK + + I E+ RE +I+R L
Sbjct: 2 TLGKKLGEGAFGEVYKGTLKGKGDG-KEVEVAVKTLKEDASEQQI--EEFLREARIMRKL 58
Query: 216 TGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKY-TEDDAKAVMIQILNVVA 274
H N+VK + + + +VME GG+LLD + K + D + +QI +
Sbjct: 59 -DHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGME 117
Query: 275 FCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYV----- 329
+ + +HRDL N L EN V+K DFGLS + D+ YY
Sbjct: 118 YLESKNFIHRDLAARNCLV---GENLVVKISDFGLSRDLYDDD---------YYKVKGGK 165
Query: 330 ------APEVL-HRSYSTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAVLKADPSFD 381
APE L +++++DVWS GV+ + I G P+ + + + + K
Sbjct: 166 LPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKGY--RL 223
Query: 382 EAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSEL 417
P P+ E + + +DP R T ++ + L
Sbjct: 224 PKP-PNCPPELYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 1e-34
Identities = 85/276 (30%), Positives = 136/276 (49%), Gaps = 39/276 (14%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRA 214
+ L E +G+G FG A K+ Q VA+KVI + I ED+++E++ L
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKR---TNQVVAIKVIDLEEAEDEI--EDIQQEIQFLSQ 55
Query: 215 LTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVA 274
+ K++ ++ ++++ME C GG LD L + GK E ++ ++L +
Sbjct: 56 CRS-PYITKYYGSFLKGSKLWIIMEYCGGGSCLD--LLKPGKLDETYIAFILREVLLGLE 112
Query: 275 FCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDERLNDIVGSAYYVAPEV 333
+ H +G +HRD+K N L + E +K DFG+S + N VG+ +++APEV
Sbjct: 113 YLHEEGKIHRDIKAANILLS---EEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEV 169
Query: 334 LHRS-YSTEADVWSIGVIAYILLCGSRPFWARTESGI--FRAVL---KADPSFDEAPWPS 387
+ +S Y +AD+WS+G+ A L G P S + R + K +P PS
Sbjct: 170 IKQSGYDEKADIWSLGITAIELAKGEPPL-----SDLHPMRVLFLIPKNNP-------PS 217
Query: 388 L-----SSEARDFVKRLLNKDPRKRLTAAQALSELL 418
L S +DFV LNKDP++R +A ELL
Sbjct: 218 LEGNKFSKPFKDFVSLCLNKDPKERPSA----KELL 249
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 1e-34
Identities = 85/264 (32%), Positives = 135/264 (51%), Gaps = 33/264 (12%)
Query: 162 EVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRR---------EVKIL 212
++G G G C A K G+QVAVK KM D+R+ EV I+
Sbjct: 26 KIGEGSTGIVCIATDKS---TGRQVAVK-----KM-------DLRKQQRRELLFNEVVIM 70
Query: 213 RALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNV 272
R H N+V+ + +Y D ++VVME EGG L D I++ + E+ V + +L
Sbjct: 71 RDYQ-HPNIVEMYSSYLVGDELWVVMEFLEGGALTD-IVTHT-RMNEEQIATVCLAVLKA 127
Query: 273 VAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPD-ERLNDIVGSAYYVAP 331
++F H QGV+HRD+K ++ L T+ + +K DFG V + R +VG+ Y++AP
Sbjct: 128 LSFLHAQGVIHRDIKSDSILLTS---DGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAP 184
Query: 332 EVLHRS-YSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSS 390
EV+ R Y TE D+WS+G++ ++ G P++ + + P + +S
Sbjct: 185 EVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNL-HKVSP 243
Query: 391 EARDFVKRLLNKDPRKRLTAAQAL 414
R F+ R+L +DP +R TAA+ L
Sbjct: 244 RLRSFLDRMLVRDPAQRATAAELL 267
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 130 bits (328), Expect = 2e-34
Identities = 76/249 (30%), Positives = 126/249 (50%), Gaps = 15/249 (6%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLV 222
+G+G FG A+ K + AVKV+ K + +E E ++L H L
Sbjct: 3 LGKGSFGKVLLAELKG---TDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLT 59
Query: 223 KFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVV 282
+ ++ D ++ VME GG+L+ I R G++ E A+ +I+ + F H +G++
Sbjct: 60 QLHSCFQTKDRLFFVMEYVNGGDLMFHIQ-RSGRFDEPRARFYAAEIVLGLQFLHERGII 118
Query: 283 HRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDERLNDIVGSAYYVAPEVL-HRSYST 340
+RDLK +N L D +K DFG+ + + + G+ Y+APE+L ++ Y
Sbjct: 119 YRDLKLDNVLL---DSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQPYGP 175
Query: 341 EADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWP-SLSSEARDFVKRL 399
D W++GV+ Y +L G PF E +F+++L+ DE +P LS EA+ +K
Sbjct: 176 AVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILE-----DEVRYPRWLSKEAKSILKSF 230
Query: 400 LNKDPRKRL 408
L K+P KRL
Sbjct: 231 LTKNPEKRL 239
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 2e-34
Identities = 79/273 (28%), Positives = 139/273 (50%), Gaps = 39/273 (14%)
Query: 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALT 216
+++ E++G G +G A K+ GQ VA+KV+P + + +++ +E+ IL+
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKET---GQVVAIKVVP---VEEDL--QEIIKEISILKQ-C 55
Query: 217 GHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFC 276
+VK++ +Y ++++VME C G + D + TE++ A++ Q L + +
Sbjct: 56 DSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYL 115
Query: 277 HLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLND-------IVGSAYYV 329
H +HRD+K N L +E K DFG+S +L D ++G+ +++
Sbjct: 116 HSNKKIHRDIKAGNILL---NEEGQAKLADFGVS------GQLTDTMAKRNTVIGTPFWM 166
Query: 330 APEVLHRS-YSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVL----KADPSFDEAP 384
APEV+ Y+ +AD+WS+G+ A I + +P ++ RA+ K P+ + P
Sbjct: 167 APEVIQEIGYNNKADIWSLGITA-IEMAEGKPPYSDIHP--MRAIFMIPNKPPPTLSD-P 222
Query: 385 --WPSLSSEARDFVKRLLNKDPRKRLTAAQALS 415
W S E DFVK+ L KDP +R +A Q L
Sbjct: 223 EKW---SPEFNDFVKKCLVKDPEERPSAIQLLQ 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 7e-34
Identities = 87/298 (29%), Positives = 139/298 (46%), Gaps = 45/298 (15%)
Query: 151 KHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVK 210
KHF + + +G+G G + K G+ A+KV+ K +M ++ V E +
Sbjct: 1 KHF----KKIKLLGKGDVGRVFLVRLKG---TGKLFALKVLDKKEMIKRNKVKRVLTEQE 53
Query: 211 ILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKY-TEDDAKAVMIQI 269
IL L H L + +++ + +VM+ C GGEL + + GK +E+ A+ ++
Sbjct: 54 ILATLD-HPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEV 112
Query: 270 LNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS------------------- 310
L + + HL G+V+RDLKPEN L E+ + DF LS
Sbjct: 113 LLALEYLHLLGIVYRDLKPENILLH---ESGHIMLSDFDLSKQSDVEPPPVSKALRKGSR 169
Query: 311 ---------DFVR--PDERLNDIVGSAYYVAPEVLHRSYSTEA-DVWSIGVIAYILLCGS 358
+ P R N VG+ Y+APEV+ A D W++G++ Y +L G+
Sbjct: 170 RSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGT 229
Query: 359 RPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSE 416
PF F +LK + +F P +SS ARD +++LL KDP KRL + + +E
Sbjct: 230 TPFKGSNRDETFSNILKKEVTF--PGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAE 285
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 126 bits (317), Expect = 2e-33
Identities = 74/266 (27%), Positives = 140/266 (52%), Gaps = 14/266 (5%)
Query: 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALT 216
Y +G+G FG A +++ E V K + +++ D E+ IL +L
Sbjct: 2 YIPIRVLGKGAFGE--ATLYRRTE-DDSLVVWKEVNLTRLSEKER-RDALNEIVIL-SLL 56
Query: 217 GHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGK-YTEDDAKAVMIQILNVVAF 275
H N++ +++ + D + + + ME GG L D+I+ + G+ + E+ + QI++ V++
Sbjct: 57 QHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSY 116
Query: 276 CHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLND-IVGSAYYVAPEVL 334
H G++HRD+K N +F TK ++K DFG+S + + + + +VG+ YY++PE+
Sbjct: 117 IHKAGILHRDIKTLN-IFLTKA--GLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELC 173
Query: 335 H-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEAR 393
Y+ ++D+W++G + Y LL R F A + +++ + + + + SSE
Sbjct: 174 QGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVY---SSELI 230
Query: 394 DFVKRLLNKDPRKRLTAAQALSELLI 419
V LL +DP KR TA + L + L+
Sbjct: 231 SLVHSLLQQDPEKRPTADEVLDQPLL 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 127 bits (320), Expect = 3e-33
Identities = 80/253 (31%), Positives = 126/253 (49%), Gaps = 15/253 (5%)
Query: 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALT 216
+E+GE +G G FG AK K G+ A+K + K ++ ++ V +E IL L+
Sbjct: 20 FEMGETLGTGSFGRVRIAKHKG---TGEYYAIKCLKKREILKMKQVQHVAQEKSILMELS 76
Query: 217 GHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFC 276
H +V +++D + VY ++E GGEL L + G++ D AK +++ +
Sbjct: 77 -HPFIVNMMCSFQDENRVYFLLEFVVGGELFTH-LRKAGRFPNDVAKFYHAELVLAFEYL 134
Query: 277 HLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLH- 335
H + +++RDLKPEN L D +K DFG + V +R + G+ Y+APEV+
Sbjct: 135 HSKDIIYRDLKPENLLL---DNKGHVKVTDFGFAKKVP--DRTFTLCGTPEYLAPEVIQS 189
Query: 336 RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDF 395
+ + D W++GV+ Y + G PF+ T I+ +L F W ARD
Sbjct: 190 KGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPN--W--FDGRARDL 245
Query: 396 VKRLLNKDPRKRL 408
VK LL D KRL
Sbjct: 246 VKGLLQTDHTKRL 258
|
Length = 329 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 3e-33
Identities = 88/302 (29%), Positives = 135/302 (44%), Gaps = 50/302 (16%)
Query: 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKI 211
++Y+ E +G G +G C+A + G++VA+K IP H + RE+KI
Sbjct: 2 DVGSRYKPIENIGSGAYGVVCSAIDTR---SGKKVAIKKIP-HAFDVPTLAKRTLRELKI 57
Query: 212 LRALTGHNNLVKFFDAY----EDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMI 267
LR H+N++ D D +VYVVM+L E L I+ TE+ + +
Sbjct: 58 LRHFK-HDNIIAIRDILRPPGADFKDVYVVMDLMESD--LHHIIHSDQPLTEEHIRYFLY 114
Query: 268 QILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV--RPDER---LNDI 322
Q+L + + H V+HRDLKP N L +E+ L+ DFG++ + P E + +
Sbjct: 115 QLLRGLKYIHSANVIHRDLKPSNLLV---NEDCELRIGDFGMARGLSSSPTEHKYFMTEY 171
Query: 323 VGSAYYVAPE---VLHRSYSTEADVWSIG-----------------------VIAYILLC 356
V + +Y APE L Y+T D+WS+G +I +L
Sbjct: 172 VATRWYRAPELLLSLPE-YTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGS 230
Query: 357 GSRPFWARTESGIFRAVLKADPSFDEAPW----PSLSSEARDFVKRLLNKDPRKRLTAAQ 412
S R S R ++ P PW P S EA D + ++L DP +R+T Q
Sbjct: 231 PSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQ 290
Query: 413 AL 414
AL
Sbjct: 291 AL 292
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 126 bits (317), Expect = 5e-33
Identities = 77/249 (30%), Positives = 126/249 (50%), Gaps = 15/249 (6%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLV 222
+G+G FG A+ K+ G+ AVKV+ K + +E E +IL H L
Sbjct: 3 LGKGSFGKVMLARLKE---SGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLT 59
Query: 223 KFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVV 282
+ + ++ D ++ VME GG+L+ I + ++ E A+ +I + + F H +G++
Sbjct: 60 QLYCCFQTPDRLFFVMEFVNGGDLMFHI-QKSRRFDEARARFYAAEITSALMFLHDKGII 118
Query: 283 HRDLKPENFLFTTKDENSVLKAIDFGL-SDFVRPDERLNDIVGSAYYVAPEVLHRS-YST 340
+RDLK +N L D K DFG+ + + + + G+ Y+APE+L Y
Sbjct: 119 YRDLKLDNVLL---DHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYGP 175
Query: 341 EADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPS-LSSEARDFVKRL 399
D W++GV+ Y +LCG PF A E +F A+L DE +P+ LS +A D +K
Sbjct: 176 SVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILN-----DEVVYPTWLSQDAVDILKAF 230
Query: 400 LNKDPRKRL 408
+ K+P RL
Sbjct: 231 MTKNPTMRL 239
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 3e-32
Identities = 71/261 (27%), Positives = 125/261 (47%), Gaps = 14/261 (5%)
Query: 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALT 216
+E+ ++G+G FG K + A+K I KM E + E ++L L
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKA---DKRVYAMKQIDLSKMNRREREEAID-EARVLAKLD 57
Query: 217 GHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILS-RGGKYTEDDAKAVMIQILNVVAF 275
+ ++++++++ D + +VME E G+L + RG ED IQIL +A
Sbjct: 58 -SSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAH 116
Query: 276 CHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERL-NDIVGSAYYVAPEVL 334
H + ++HRD+K N LF +N +K D G++ + + N IVG+ YY++PE+
Sbjct: 117 LHSKKILHRDIKSLN-LFLDAYDN--VKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELC 173
Query: 335 H-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEAR 393
+ Y+ ++DVW++GV+ Y G PF A + + +++ F S +
Sbjct: 174 EDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRG--VFPPVSQM-YSQQLA 230
Query: 394 DFVKRLLNKDPRKRLTAAQAL 414
+ + L KD R+R Q L
Sbjct: 231 QLIDQCLTKDYRQRPDTFQLL 251
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 122 bits (309), Expect = 4e-32
Identities = 82/267 (30%), Positives = 131/267 (49%), Gaps = 22/267 (8%)
Query: 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALT 216
+E+ E+G G FG A+ K+ G A K+I ++ + +ED E+ IL +
Sbjct: 7 WEIIGELGDGAFGKVYKAQHKE---TGLFAAAKII---QIESEEELEDFMVEIDIL-SEC 59
Query: 217 GHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFC 276
H N+V ++AY + +++++E C+GG L +L TE + V Q+L + F
Sbjct: 60 KHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFL 119
Query: 277 HLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDERLNDIVGSAYYVAPEVL- 334
H V+HRDLK N L T + +K DFG+S ++ + +G+ Y++APEV+
Sbjct: 120 HSHKVIHRDLKAGNILLTLDGD---VKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVA 176
Query: 335 -----HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAP--WPS 387
Y +AD+WS+G+ L P + +LK++P + P W
Sbjct: 177 CETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKW-- 234
Query: 388 LSSEARDFVKRLLNKDPRKRLTAAQAL 414
SS DF+K L KDP R TAA+ L
Sbjct: 235 -SSSFNDFLKSCLVKDPDDRPTAAELL 260
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 1e-31
Identities = 71/263 (26%), Positives = 129/263 (49%), Gaps = 19/263 (7%)
Query: 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKH-------KMTTAIAIEDVRREV 209
Y + E +G G FG C K +K +A+K I H K +I D+ EV
Sbjct: 2 YAVLEHLGSGAFG--CVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEV 59
Query: 210 KILRALTGHNNLVKFFDAYEDTDNVYVVMELCEG---GELLDRILSRGGKYTEDDAKAVM 266
I++ H N+V+++ + + D +Y+VM+L EG GE + + + ++TE+ +
Sbjct: 60 TIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIF 119
Query: 267 IQILNVVAFCHLQG-VVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGS 325
+Q++ + + H + +VHRDL P N + D+ ++ DFGL+ +P+ +L +VG+
Sbjct: 120 VQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTI---TDFGLAKQKQPESKLTSVVGT 176
Query: 326 AYYVAPEVL-HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAP 384
Y PE++ + Y +ADVW+ G I Y + PF++ + +++A ++ P
Sbjct: 177 ILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEA--VYEPLP 234
Query: 385 WPSLSSEARDFVKRLLNKDPRKR 407
S + D + L D R
Sbjct: 235 EGMYSEDVTDVITSCLTPDAEAR 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 1e-31
Identities = 92/300 (30%), Positives = 142/300 (47%), Gaps = 45/300 (15%)
Query: 147 FGFSKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVR 206
FG N+Y + VG G FG C+A+ +L GQ VA+K I K T +A +
Sbjct: 2 FGTVFEITNRYVDLQPVGMGAFGLVCSAR---DQLTGQNVAIKKIMKPFSTPVLA-KRTY 57
Query: 207 REVKILRALTGHNNLVKFFDAY-EDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAV 265
RE+K+L+ L H N++ D + +++Y V EL G L R+L+ + +
Sbjct: 58 RELKLLKHLR-HENIISLSDIFISPLEDIYFVTELL--GTDLHRLLT-SRPLEKQFIQYF 113
Query: 266 MIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP-DERLNDIVG 324
+ QIL + + H GVVHRDLKP N L +EN LK DFGL+ R D ++ V
Sbjct: 114 LYQILRGLKYVHSAGVVHRDLKPSNILI---NENCDLKICDFGLA---RIQDPQMTGYVS 167
Query: 325 SAYYVAPEVL--HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVL-------- 374
+ YY APE++ + Y E D+WS G I +L G F + F +
Sbjct: 168 TRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPD 227
Query: 375 ---------------KADPSFDEAP----WPSLSSEARDFVKRLLNKDPRKRLTAAQALS 415
++ P + P + + A D ++++L DP+KR++AA+AL+
Sbjct: 228 DVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALA 287
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 120 bits (304), Expect = 2e-31
Identities = 69/225 (30%), Positives = 104/225 (46%), Gaps = 40/225 (17%)
Query: 158 ELGEEVGRGHFGYTCAAKFKKGELKG------QQVAVKVIPKHKMTTAIAIEDVRREVKI 211
ELG+++G G FG + KG LKG +VAVK + + + E+ E I
Sbjct: 2 ELGKKLGEGAFG-----EVYKGTLKGDGEGTETKVAVKTLKEG--ASEEEREEFLEEASI 54
Query: 212 LRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILN 271
++ L H N+V+ + +Y+V E GG+LLD + G K T D + +QI
Sbjct: 55 MKKL-SHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAK 113
Query: 272 VVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYV-- 329
+ + + VHRDL N L EN V+K DFGLS + D+ YY
Sbjct: 114 GMEYLESKNFVHRDLAARNCLV---TENLVVKISDFGLSRDIYEDD---------YYRKR 161
Query: 330 ----------APEVL-HRSYSTEADVWSIGVIAY-ILLCGSRPFW 362
APE L +++++DVWS GV+ + I G +P+
Sbjct: 162 GGGKLPIKWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYP 206
|
Length = 258 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 3e-31
Identities = 81/261 (31%), Positives = 141/261 (54%), Gaps = 27/261 (10%)
Query: 162 EVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNL 221
++G G G C A+ K G+QVAVK++ K E + EV I+R H N+
Sbjct: 28 KIGEGSTGIVCIAREKH---SGRQVAVKMMDLRKQQRR---ELLFNEVVIMRDYQ-HQNV 80
Query: 222 VKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGV 281
V+ + +Y + ++V+ME +GG L D I+S+ + E+ V +L + + H QGV
Sbjct: 81 VEMYKSYLVGEELWVLMEFLQGGALTD-IVSQT-RLNEEQIATVCESVLQALCYLHSQGV 138
Query: 282 VHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPD-ERLNDIVGSAYYVAPEVLHRS-YS 339
+HRD+K ++ L T + +K DFG + D + +VG+ Y++APEV+ R+ Y
Sbjct: 139 IHRDIKSDSILLTL---DGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYG 195
Query: 340 TEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSL------SSEAR 393
TE D+WS+G++ ++ G P+++ + ++A ++P P L S R
Sbjct: 196 TEVDIWSLGIMVIEMVDGEPPYFSDSP-------VQAMKRLRDSPPPKLKNAHKISPVLR 248
Query: 394 DFVKRLLNKDPRKRLTAAQAL 414
DF++R+L ++P++R TA + L
Sbjct: 249 DFLERMLTREPQERATAQELL 269
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 1e-30
Identities = 84/301 (27%), Positives = 142/301 (47%), Gaps = 53/301 (17%)
Query: 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPK---HKMTTAIAIEDVRREVKILR 213
YEL +E+G+G +G C+A+ + + + VA+K I K+ A+ RE+K+LR
Sbjct: 2 YELIKELGQGAYGIVCSARNAETS-EEETVAIKKITNVFSKKILAKRAL----RELKLLR 56
Query: 214 ALTGHNNLVKFFDA----YEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQI 269
GH N+ +D + + +Y+ EL E L +I+ G T+ ++ + QI
Sbjct: 57 HFRGHKNITCLYDMDIVFPGNFNELYLYEELMEAD--LHQIIRSGQPLTDAHFQSFIYQI 114
Query: 270 LNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS-----DFVRPDERLNDIVG 324
L + + H V+HRDLKP N L E LK DFGL+ + + + V
Sbjct: 115 LCGLKYIHSANVLHRDLKPGNLLVNADCE---LKICDFGLARGFSENPGENAGFMTEYVA 171
Query: 325 SAYYVAPEVL--HRSYSTEADVWSIGVIAYILLCGSRPFW-------------------- 362
+ +Y APE++ +SY+ DVWS+G I LL G +P +
Sbjct: 172 TRWYRAPEIMLSFQSYTKAIDVWSVGCILAELL-GRKPVFKGKDYVDQLNQILQVLGTPD 230
Query: 363 ----ARTESGIFRAVLKADPSFDEAPWPSL----SSEARDFVKRLLNKDPRKRLTAAQAL 414
+R S + +++ P+ + P+ S+ + A D +++LL DP KR++ +AL
Sbjct: 231 EETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEAL 290
Query: 415 S 415
Sbjct: 291 E 291
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 2e-30
Identities = 76/272 (27%), Positives = 130/272 (47%), Gaps = 24/272 (8%)
Query: 156 KYELGEEVGRGHFG--YTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRR----EV 209
KYE VGRG FG + C + + + V +K IP +MT +D R E
Sbjct: 1 KYEKIRVVGRGAFGIVHLC-----RRKADQKLVIIKQIPVEQMT-----KDERLAAQNEC 50
Query: 210 KILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKY-TEDDAKAVMIQ 268
++L+ L+ H N++++++ + + + +VME GG L + I R ED +Q
Sbjct: 51 QVLKLLS-HPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQ 109
Query: 269 ILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYY 328
IL + H + ++HRDLK +N L V+K DFG+S + + +VG+ Y
Sbjct: 110 ILLALHHVHTKLILHRDLKTQNILLDKH--KMVVKIGDFGISKILSSKSKAYTVVGTPCY 167
Query: 329 VAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPS 387
++PE+ + Y+ ++D+W++G + Y L R F A + VLK
Sbjct: 168 ISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPAL---VLKIMSGTFAPISDR 224
Query: 388 LSSEARDFVKRLLNKDPRKRLTAAQALSELLI 419
S + R + +LN DP KR +Q +++ +
Sbjct: 225 YSPDLRQLILSMLNLDPSKRPQLSQIMAQPIC 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 2e-30
Identities = 87/266 (32%), Positives = 135/266 (50%), Gaps = 21/266 (7%)
Query: 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVI--PKHKMTTAIAIEDVRREVKILR 213
+Y + VG G FG A + Q+ A+K I PK ++ A+ED R+E +L
Sbjct: 1 QYNVLRVVGEGSFG---RALLVQHVNSDQKYAMKEIRLPK----SSSAVEDSRKEA-VLL 52
Query: 214 ALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRI-LSRGGKYTEDDAKAVMIQILNV 272
A H N+V F +++E ++Y+VME C+GG+L+ +I L RG + ED +Q+
Sbjct: 53 AKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLG 112
Query: 273 VAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV-RPDERLNDIVGSAYYVAP 331
V H + V+HRD+K +N T +N +K DFG + + P VG+ YYV P
Sbjct: 113 VQHIHEKRVLHRDIKSKNIFLT---QNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPP 169
Query: 332 EVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPS-LS 389
E+ Y+ ++D+WS+G I Y L PF A + + V + P PS S
Sbjct: 170 EIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYK----PLPSHYS 225
Query: 390 SEARDFVKRLLNKDPRKRLTAAQALS 415
E R +K++ ++PR R +A LS
Sbjct: 226 YELRSLIKQMFKRNPRSRPSATTILS 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 2e-30
Identities = 70/279 (25%), Positives = 119/279 (42%), Gaps = 40/279 (14%)
Query: 161 EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNN 220
+++G G FG K K + K +VAVK + + + +D +E ++++ L GH N
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKED--ASEEERKDFLKEARVMKKL-GHPN 57
Query: 221 LVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAV--------MIQILNV 272
+V+ + + +Y+V+E EGG+LLD + + + + IQI
Sbjct: 58 VVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKG 117
Query: 273 VAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYV--- 329
+ + + VHRDL N L E+ V+K DFGLS V D+ YY
Sbjct: 118 MEYLASKKFVHRDLAARNCLVG---EDLVVKISDFGLSRDVYDDD---------YYRKKT 165
Query: 330 ---------APEVL-HRSYSTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAVLKADP 378
APE L +++++DVWS GV+ + I G+ P+ + + + K
Sbjct: 166 GGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKG-- 223
Query: 379 SFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSEL 417
P E + + DP R T ++ + L
Sbjct: 224 YRLPKP-EYCPDELYELMLSCWQLDPEDRPTFSELVERL 261
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 3e-30
Identities = 74/270 (27%), Positives = 134/270 (49%), Gaps = 21/270 (7%)
Query: 160 GEEVGRGHFGYT-CAAKFKKGEL---KGQQVAVKVIPKHKMTTAIAIEDVRREVKILRAL 215
GE +G+G +G A GE+ K ++ + +H ++ +R E++ L+ L
Sbjct: 6 GELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDL 65
Query: 216 TGHNNLVKFFDAYEDTDNVY-VVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVA 274
H N+V++ +E T+ + +E GG + L G++ E + Q+L +A
Sbjct: 66 D-HLNIVQYL-GFETTEEYLSIFLEYVPGGSI-GSCLRTYGRFEEQLVRFFTEQVLEGLA 122
Query: 275 FCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGL---SDFVRPDERLNDIVGSAYYVAP 331
+ H +G++HRDLK +N L D + + K DFG+ SD + +++ + GS +++AP
Sbjct: 123 YLHSKGILHRDLKADNLLV---DADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAP 179
Query: 332 EVLH---RSYSTEADVWSIGVIAYILLCGSRPFWARTES--GIFR-AVLKADPSFDEAPW 385
EV+H + YS + D+WS+G + + G RP W+ E+ +F+ ++ P
Sbjct: 180 EVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP-WSDEEAIAAMFKLGNKRSAPPIPPDVS 238
Query: 386 PSLSSEARDFVKRLLNKDPRKRLTAAQALS 415
+LS A DF+ +P R TA + L
Sbjct: 239 MNLSPVALDFLNACFTINPDNRPTARELLQ 268
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 8e-30
Identities = 77/267 (28%), Positives = 140/267 (52%), Gaps = 14/267 (5%)
Query: 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRAL 215
KY +++G G FG K K+ G+Q +K I KM+ E+ R+EV +L +
Sbjct: 1 KYVKVKKIGEGSFGKAILVKSKE---DGKQYVIKEINISKMSPK-EREESRKEVAVLSNM 56
Query: 216 TGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILS-RGGKYTEDDAKAVMIQILNVVA 274
H N+V++ +++E+ N+Y+VM+ CEGG+L +I + RG + ED +QI +
Sbjct: 57 K-HPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALK 115
Query: 275 FCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERL-NDIVGSAYYVAPEV 333
H + ++HRD+K +N +F TKD +K DFG++ + L +G+ YY++PE+
Sbjct: 116 HVHDRKILHRDIKSQN-IFLTKD--GTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEI 172
Query: 334 L-HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEA 392
+R Y+ ++D+W++G + Y + F A + +++ S+ S +
Sbjct: 173 CENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRG--SYPPVS-SHYSYDL 229
Query: 393 RDFVKRLLNKDPRKRLTAAQALSELLI 419
R+ V +L ++PR R + L + I
Sbjct: 230 RNLVSQLFKRNPRDRPSVNSILEKNFI 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (291), Expect = 2e-29
Identities = 87/294 (29%), Positives = 134/294 (45%), Gaps = 46/294 (15%)
Query: 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALT 216
YE E+G G +G A+ G+ VA+K + I + +R E+ +L+ L
Sbjct: 1 YEELAEIGEGAYGTVYKARDLN---TGRFVALKKVRVPLSEEGIPLSTLR-EIALLKQLE 56
Query: 217 --GHNNLVKFFD--AYEDTDN---VYVVMELCEGGELLDRILSRGGK--YTEDDAKAVMI 267
H N+V+ D TD + +V E + + L LS+ K + K +M
Sbjct: 57 SFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVD--QDLATYLSKCPKPGLPPETIKDLMR 114
Query: 268 QILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAY 327
Q+L V F H +VHRDLKP+N L T+ + +K DFGL+ + L +V + +
Sbjct: 115 QLLRGVDFLHSHRIVHRDLKPQNILVTSDGQ---VKIADFGLARIYSFEMALTSVVVTLW 171
Query: 328 YVAPEVLHRS-YSTEADVWSIGVIAYILLCGSRP-FWARTESG----IFR---------- 371
Y APEVL +S Y+T D+WS+G I L RP F +E+ IF
Sbjct: 172 YRAPEVLLQSSYATPVDMWSVGCIFAELF-RRRPLFRGTSEADQLDKIFDVIGLPSEEEW 230
Query: 372 ---AVLKADPSFD-------EAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALS 415
L SF ++ P + E D +K++L +P KR++A +AL
Sbjct: 231 PRNVSLPRS-SFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 2e-29
Identities = 84/268 (31%), Positives = 130/268 (48%), Gaps = 15/268 (5%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKM-TTAIAIEDVRREVKILRALTGHNNL 221
+G+G +G + G G+ A+KV+ K + + E IL A+ H +
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVK-HPFI 62
Query: 222 VKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGV 281
V A++ +Y+++E GGEL L R G + ED A + +I + H QG+
Sbjct: 63 VDLIYAFQTGGKLYLILEYLSGGELFMH-LEREGIFMEDTACFYLSEISLALEHLHQQGI 121
Query: 282 VHRDLKPENFLFTTKDENSVLKAIDFGL-SDFVRPDERLNDIVGSAYYVAPEVLHRSYST 340
++RDLKPEN L D +K DFGL + + + G+ Y+APE+L RS
Sbjct: 122 IYRDLKPENILL---DAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMRSGHG 178
Query: 341 EA-DVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRL 399
+A D WS+G + Y +L G+ PF A +LK + P L+ EARD +K+L
Sbjct: 179 KAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLP----PYLTPEARDLLKKL 234
Query: 400 LNKDPRKRLTAAQALSELLICYQSYLFF 427
L ++P RL A + + QS+ FF
Sbjct: 235 LKRNPSSRLGAGPGDAAEV---QSHPFF 259
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 2e-29
Identities = 89/288 (30%), Positives = 142/288 (49%), Gaps = 40/288 (13%)
Query: 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVI-PKHKMTTAIAIEDVRREVKIL 212
++ +E+ E +G+G +G KK G + AVK++ P H + E++ E IL
Sbjct: 17 SDTWEIIETIGKGTYGKVFKVLNKK---NGSKAAVKILDPIHDID-----EEIEAEYNIL 68
Query: 213 RALTGHNNLVKFFDAY-----EDTDNVYVVMELCEGGELLDRI---LSRGGKYTEDDAKA 264
+AL+ H N+VKF+ Y ++ D +++V+ELC GG + D + L RG + E
Sbjct: 69 KALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAY 128
Query: 265 VMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDERLNDIV 323
++ + L + H+ +HRD+K N L TT+ +K +DFG+S R N V
Sbjct: 129 ILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGG---VKLVDFGVSAQLTSTRLRRNTSV 185
Query: 324 GSAYYVAPEV------LHRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKAD 377
G+ +++APEV L +Y DVWS+G+ A L G P + RA+ K
Sbjct: 186 GTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPL---ADLHPMRALFK-- 240
Query: 378 PSFDEAPWPSL------SSEARDFVKRLLNKDPRKRLTAAQALSELLI 419
P P+L S+E DF+++ L KD KR T + L + I
Sbjct: 241 --IPRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 3e-29
Identities = 84/302 (27%), Positives = 144/302 (47%), Gaps = 60/302 (19%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMT----TAIAIEDVRREVK 210
++Y+ VG G +G C+A K G++VA+K K++ +AI + RE++
Sbjct: 15 DRYQNLSPVGSGAYGQVCSAFDTKT---GRKVAIK-----KLSRPFQSAIHAKRTYRELR 66
Query: 211 ILRALTGHNNLVKFFDAY------EDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKA 264
+L+ + H N++ D + ED +VY+V L G L+ I+ + K ++D +
Sbjct: 67 LLKHMD-HENVIGLLDVFTPASSLEDFQDVYLVTHLM--GADLNNIV-KCQKLSDDHIQF 122
Query: 265 VMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP-DERLNDIV 323
++ QIL + + H G++HRDLKP N +E+ LK +DFGL+ R D+ + V
Sbjct: 123 LVYQILRGLKYIHSAGIIHRDLKPSNIAV---NEDCELKILDFGLA---RHTDDEMTGYV 176
Query: 324 GSAYYVAPEVLH--RSYSTEADVWSIGVIAYILLCG-----------------------S 358
+ +Y APE++ Y+ D+WS+G I LL G
Sbjct: 177 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPD 236
Query: 359 RPFWARTESGIFRAVLKADP-----SFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQA 413
+ S R +++ P F E + + A D ++++L DP KR+TAA+A
Sbjct: 237 EELLQKISSESARNYIQSLPQMPKKDFKEV-FSGANPLAIDLLEKMLVLDPDKRITAAEA 295
Query: 414 LS 415
L+
Sbjct: 296 LA 297
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 3e-29
Identities = 69/254 (27%), Positives = 125/254 (49%), Gaps = 17/254 (6%)
Query: 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALT 216
E + VG G FG + + E A+KV+ ++ + V E ++L+ ++
Sbjct: 3 LERIKTVGTGTFGRVHLVRDRISE---HYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVS 59
Query: 217 GHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFC 276
H +++ F D +Y++ME GGEL + + G +++ +I+ + +
Sbjct: 60 -HPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSG-RFSNSTGLFYASEIVCALEYL 117
Query: 277 HLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHR 336
H + +V+RDLKPEN L D+ +K DFG + +R +R + G+ Y+APEV+
Sbjct: 118 HSKEIVYRDLKPENILL---DKEGHIKLTDFGFAKKLR--DRTWTLCGTPEYLAPEVIQS 172
Query: 337 S-YSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWP-SLSSEARD 394
++ D W++G++ Y +L G PF+ GI+ +L + +P L A+D
Sbjct: 173 KGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAG-----KLEFPRHLDLYAKD 227
Query: 395 FVKRLLNKDPRKRL 408
+K+LL D +RL
Sbjct: 228 LIKKLLVVDRTRRL 241
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 6e-29
Identities = 73/273 (26%), Positives = 135/273 (49%), Gaps = 26/273 (9%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRA 214
+++ +++G+G F A L G+ VA+K + +M A A +D +E+ +L+
Sbjct: 2 GNFKIEKKIGKGQFSVVYKAICL---LDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQ 58
Query: 215 LTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAV--------M 266
L H N++K+ ++ + + + +V+EL + G+L SR K+ + + +
Sbjct: 59 LD-HPNVIKYLASFIENNELNIVLELADAGDL-----SRMIKHFKKQKRLIPERTIWKYF 112
Query: 267 IQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDE-RLNDIVGS 325
+Q+ + + H + ++HRD+KP N T V+K D GL F + +VG+
Sbjct: 113 VQLCSALEHMHSKRIMHRDIKPANVFITA---TGVVKLGDLGLGRFFSSKTTAAHSLVGT 169
Query: 326 AYYVAPEVLHRS-YSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAP 384
YY++PE +H + Y+ ++D+WS+G + Y + PF+ + ++ K D P
Sbjct: 170 PYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN--LYSLCKKIEKCDYPP 227
Query: 385 WPS--LSSEARDFVKRLLNKDPRKRLTAAQALS 415
P+ S E RD V R +N DP KR + L
Sbjct: 228 LPADHYSEELRDLVSRCINPDPEKRPDISYVLQ 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 6e-29
Identities = 78/263 (29%), Positives = 135/263 (51%), Gaps = 20/263 (7%)
Query: 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMT-TAIAIEDVRREVKILRAL 215
+EL + +G G +G + G G+ A+KV+ K + A E R E ++L +
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 61
Query: 216 TGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAF 275
LV A++ ++++++ GGEL + R ++ E + + +I+ +
Sbjct: 62 RQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRE-RFKEQEVQIYSGEIVLALEH 120
Query: 276 CHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPD-ERLNDIVGSAYYVAPEV 333
H G+++RD+K EN L D N + DFGLS +F + ER G+ Y+AP++
Sbjct: 121 LHKLGIIYRDIKLENILL---DSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDI 177
Query: 334 LH---RSYSTEADVWSIGVIAYILLCGSRPFWA----RTESGIFRAVLKADPSFDEAPWP 386
+ + D WS+GV+ Y LL G+ PF +++ I R +LK++P P+P
Sbjct: 178 VRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEP-----PYP 232
Query: 387 S-LSSEARDFVKRLLNKDPRKRL 408
+S+ A+D ++RLL KDP+KRL
Sbjct: 233 QEMSALAKDIIQRLLMKDPKKRL 255
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 7e-29
Identities = 82/257 (31%), Positives = 130/257 (50%), Gaps = 24/257 (9%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRR---EVKILRALTGHN 219
+G+G FG + G GQ A+KV+ K + + D R E IL A H
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKK----ATLKVRDRVRTKMERDIL-AEVNHP 58
Query: 220 NLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQ 279
+VK A++ +Y++++ GG+L R LS+ +TE+D K + ++ + H
Sbjct: 59 FIVKLHYAFQTEGKLYLILDFLRGGDLFTR-LSKEVMFTEEDVKFYLAELALALDHLHSL 117
Query: 280 GVVHRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDERLNDIVGSAYYVAPEVLHR-S 337
G+++RDLKPEN L DE +K DFGLS + + +++ G+ Y+APEV++R
Sbjct: 118 GIIYRDLKPENILL---DEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRG 174
Query: 338 YSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKAD---PSFDEAPWPSLSSEARD 394
++ AD WS GV+ + +L GS PF + +LKA P F LS EA+
Sbjct: 175 HTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQF-------LSPEAQS 227
Query: 395 FVKRLLNKDPRKRLTAA 411
++ L ++P RL A
Sbjct: 228 LLRALFKRNPANRLGAG 244
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 8e-29
Identities = 78/254 (30%), Positives = 127/254 (50%), Gaps = 18/254 (7%)
Query: 164 GRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRAL--TGHNNL 221
GRGHFG A++KK G+ A+K + K + +E + E +I H L
Sbjct: 8 GRGHFGKVLLAEYKK---TGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFL 64
Query: 222 VKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGV 281
V F ++ D+V VME GG+L+ I + ++E A ++ + + H +
Sbjct: 65 VNLFACFQTEDHVCFVMEYAAGGDLMMHIHT--DVFSEPRAVFYAACVVLGLQYLHENKI 122
Query: 282 VHRDLKPENFLFTTKDENSVLKAIDFGL-SDFVRPDERLNDIVGSAYYVAPEVL-HRSYS 339
V+RDLK +N L T+ +K DFGL + + +R + G+ ++APEVL SY+
Sbjct: 123 VYRDLKLDNLLLDTE---GFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTETSYT 179
Query: 340 TEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWP-SLSSEARDFVKR 398
D W +GV+ Y +L G PF E +F +++ DE +P LS EA ++R
Sbjct: 180 RAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVN-----DEVRYPRFLSREAISIMRR 234
Query: 399 LLNKDPRKRLTAAQ 412
LL ++P +RL + +
Sbjct: 235 LLRRNPERRLGSGE 248
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 9e-29
Identities = 85/301 (28%), Positives = 133/301 (44%), Gaps = 63/301 (20%)
Query: 156 KYELGEEVGRGHFG--YTCAAKFKKGELKGQQVAVK---------VIPKHKMTTAIAIED 204
KYE ++G G +G + C + GQ VA+K VI K IA+
Sbjct: 2 KYEKLSKIGEGSYGVVFKC-----RNRETGQIVAIKKFVESEDDPVIKK------IAL-- 48
Query: 205 VRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKA 264
RE+++L+ L H NLV + + +++V E C+ +L+ + E K
Sbjct: 49 --REIRMLKQLK-HPNLVNLIEVFRRKRKLHLVFEYCDH-TVLNELEKNPRGVPEHLIKK 104
Query: 265 VMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV-RPDERLNDIV 323
++ Q L V FCH +HRD+KPEN L T + +K DFG + + P + D V
Sbjct: 105 IIWQTLQAVNFCHKHNCIHRDVKPENILIT---KQGQIKLCDFGFARILTGPGDDYTDYV 161
Query: 324 GSAYYVAPEVL--HRSYSTEADVWSIGVIAYILLCGSRPFWA------------RT---- 365
+ +Y APE+L Y DVW+IG + LL G +P W +T
Sbjct: 162 ATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTG-QPLWPGKSDVDQLYLIRKTLGDL 220
Query: 366 ---------ESGIFRAVLKADPSFD---EAPWPSLSSEARDFVKRLLNKDPRKRLTAAQA 413
+ F+ + +P E+ +P++SS A F+K L DP +RL+ +
Sbjct: 221 IPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEEL 280
Query: 414 L 414
L
Sbjct: 281 L 281
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 1e-28
Identities = 87/302 (28%), Positives = 135/302 (44%), Gaps = 60/302 (19%)
Query: 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVI-PKHKMTTAIAIEDVR--REVKILR 213
Y+ +G G +G C+A K G +VA+K I P T R RE+KILR
Sbjct: 7 YQNLSYIGEGAYGMVCSATHK---PTGVKVAIKKISPFEHQTFCQ-----RTLREIKILR 58
Query: 214 ALTGHNNLVKFFD-----AYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQ 268
H N++ D ++E ++VY+V EL E L +++ + + D + + Q
Sbjct: 59 RFK-HENIIGILDIIRPPSFESFNDVYIVQELMETD--LYKLI-KTQHLSNDHIQYFLYQ 114
Query: 269 ILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDER----LNDIVG 324
IL + + H V+HRDLKP N L T N LK DFGL+ P+ L + V
Sbjct: 115 ILRGLKYIHSANVLHRDLKPSNLLLNT---NCDLKICDFGLARIADPEHDHTGFLTEYVA 171
Query: 325 SAYYVAPEVL--HRSYSTEADVWSIGVI-AYILLCGSRPFW------------------- 362
+ +Y APE++ + Y+ D+WS+G I A +L RP +
Sbjct: 172 TRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSN--RPLFPGKDYLHQLNLILGVLGTP 229
Query: 363 -----ARTESGIFRAVLKADPSFDEAPWPSL----SSEARDFVKRLLNKDPRKRLTAAQA 413
S R +K+ P + PW L +A D + ++L +P KR+T +A
Sbjct: 230 SQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEA 289
Query: 414 LS 415
L+
Sbjct: 290 LA 291
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 1e-28
Identities = 78/250 (31%), Positives = 126/250 (50%), Gaps = 18/250 (7%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRAL--TGHNN 220
+G+G FG + K G+ A+K++ K + IA ++V + R L T H
Sbjct: 3 LGKGTFGKVILVREKAT---GKYYAMKILKKEVI---IAKDEVAHTLTESRVLQNTRHPF 56
Query: 221 LVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQG 280
L +++ D + VME GGEL LSR ++ED A+ +I++ + + H
Sbjct: 57 LTALKYSFQTHDRLCFVMEYANGGELFFH-LSRERVFSEDRARFYGAEIVSALGYLHSCD 115
Query: 281 VVHRDLKPENFLFTTKDENSVLKAIDFGL-SDFVRPDERLNDIVGSAYYVAPEVLHRS-Y 338
VV+RDLK EN + D++ +K DFGL + + + G+ Y+APEVL + Y
Sbjct: 116 VVYRDLKLENLML---DKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY 172
Query: 339 STEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKR 398
D W +GV+ Y ++CG PF+ + +F +L + F +LS EA+ +
Sbjct: 173 GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR----TLSPEAKSLLAG 228
Query: 399 LLNKDPRKRL 408
LL KDP++RL
Sbjct: 229 LLKKDPKQRL 238
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 2e-28
Identities = 79/268 (29%), Positives = 133/268 (49%), Gaps = 22/268 (8%)
Query: 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRAL 215
+Y L + +G+G FG K KK + + +K IP ++ ++ +E ++L L
Sbjct: 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQ-ANQEAQLLSKL 59
Query: 216 TGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILS---RGGKYTEDDAKAVMIQILNV 272
H +VKF ++ + D ++ E CEG +L ++ G +E+ IQ+L
Sbjct: 60 D-HPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLG 118
Query: 273 VAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERL-NDIVGSAYYVAP 331
V + H + ++HRDLK +N +N++LK DFG+S + L G+ YY++P
Sbjct: 119 VHYMHQRRILHRDLKAKNIFL----KNNLLKIGDFGVSRLLMGSCDLATTFTGTPYYMSP 174
Query: 332 EVL-HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSL-- 388
E L H+ Y +++D+WS+G I Y + C + F VL+ E P PSL
Sbjct: 175 EALKHQGYDSKSDIWSLGCILYEMCCLAHAFEG---QNFLSVVLR----IVEGPTPSLPE 227
Query: 389 --SSEARDFVKRLLNKDPRKRLTAAQAL 414
S + ++ +LNKDP R +AA+ L
Sbjct: 228 TYSRQLNSIMQSMLNKDPSLRPSAAEIL 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 2e-28
Identities = 79/256 (30%), Positives = 129/256 (50%), Gaps = 19/256 (7%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLV 222
VGRGHFG + + + G A+KV+ K + + E IL +++ +
Sbjct: 9 VGRGHFG---EVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDIL-SISNSPWIP 64
Query: 223 KFFDAYEDTDNVYVVMELCEGGELLDRILSR-GGKYTEDDAKAVMIQILNVVAFCHLQGV 281
+ A++D DN+Y+VME GG+LL +L+R ++ ED A+ + +++ + H G
Sbjct: 65 QLQYAFQDKDNLYLVMEYQPGGDLLS-LLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGY 123
Query: 282 VHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDI--VGSAYYVAPEVLHR--- 336
VHRD+KPEN L D +K DFG + + ++ +N VG+ Y+APEVL
Sbjct: 124 VHRDIKPENVLI---DRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNG 180
Query: 337 ----SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEA 392
+Y E D WS+GVIAY ++ G PF T + + ++ P +SS+
Sbjct: 181 DGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSDF 240
Query: 393 RDFVKRLLNKDPRKRL 408
D ++ LL ++RL
Sbjct: 241 LDLIQSLLC-GQKERL 255
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 4e-28
Identities = 83/295 (28%), Positives = 128/295 (43%), Gaps = 49/295 (16%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVI---PKHKMTTAIAIEDVRREVKI 211
KYE VG G +G K K+ GQ VA+K KM IA+ RE+++
Sbjct: 1 EKYENLGLVGEGSYGMVMKCKHKE---TGQIVAIKKFLESEDDKMVKKIAM----REIRM 53
Query: 212 LRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILN 271
L+ L H NLV + + +Y+V E + +LD + E + + QIL
Sbjct: 54 LKQLR-HENLVNLIEVFRRKKRLYLVFEFVDH-TVLDDLEKYPNGLDESRVRKYLFQILR 111
Query: 272 VVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR-PDERLNDIVGSAYYVA 330
+ FCH ++HRD+KPEN L + ++ V+K DFG + + P E D V + +Y A
Sbjct: 112 GIEFCHSHNIIHRDIKPENILVS---QSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRA 168
Query: 331 PEVL--HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGI----------------FRA 372
PE+L Y D+W++G + +L G F +S I +
Sbjct: 169 PELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLF--PGDSDIDQLYHIIKCLGNLIPRHQE 226
Query: 373 VLKADPSFD-------------EAPWPSLSSEARDFVKRLLNKDPRKRLTAAQAL 414
+ + +P F E +P LS D K+ L DP R +++Q L
Sbjct: 227 IFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLL 281
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 4e-28
Identities = 73/273 (26%), Positives = 124/273 (45%), Gaps = 45/273 (16%)
Query: 162 EVGRGHFGYTCAAKFKKGELKGQQVAVKVIP---KHKMTTAIAIEDVRREVKILRALTGH 218
E+G G+ G + G+ +AVK I + I RE+ IL
Sbjct: 8 ELGAGNSGVVSKVLHRP---TGKIMAVKTIRLEINEAIQKQIL-----RELDILHKCN-S 58
Query: 219 NNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYT-EDDAKAVMIQILNVVAFCH 277
+V F+ A+ + ++ + ME +GG L D+IL E + + +L + + H
Sbjct: 59 PYIVGFYGAFYNNGDISICMEYMDGGSL-DKILKEVQGRIPERILGKIAVAVLKGLTYLH 117
Query: 278 LQ-GVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDI----VGSAYYVAPE 332
+ ++HRD+KP N L ++ + +K DFG+S + +N + VG++ Y+APE
Sbjct: 118 EKHKIIHRDVKPSNILVNSRGQ---IKLCDFGVSG-----QLVNSLAKTFVGTSSYMAPE 169
Query: 333 VLH-RSYSTEADVWSIGVIAYILLCGSRPF--WARTESGIF---RAVLKADPSFDEAPWP 386
+ YS ++D+WS+G+ L G P+ GIF + ++ P P
Sbjct: 170 RIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPP-------P 222
Query: 387 SL-----SSEARDFVKRLLNKDPRKRLTAAQAL 414
L S + +DFV L KDPR+R + + L
Sbjct: 223 RLPSGKFSPDFQDFVNLCLIKDPRERPSYKELL 255
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 112 bits (280), Expect = 5e-28
Identities = 79/256 (30%), Positives = 131/256 (51%), Gaps = 17/256 (6%)
Query: 162 EVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNL 221
++G G G C A K G+QVAVK + K E + EV I+R H N+
Sbjct: 29 KIGEGSTGIVCIATEKH---TGKQVAVKKMDLRKQQRR---ELLFNEVVIMRDYH-HENV 81
Query: 222 VKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGV 281
V +++Y D ++VVME EGG L D + + E+ V + +L +++ H QGV
Sbjct: 82 VDMYNSYLVGDELWVVMEFLEGGALTDIVTHT--RMNEEQIATVCLSVLRALSYLHNQGV 139
Query: 282 VHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPD-ERLNDIVGSAYYVAPEVLHR-SYS 339
+HRD+K ++ L T+ + +K DFG V + + +VG+ Y++APEV+ R Y
Sbjct: 140 IHRDIKSDSILLTS---DGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYG 196
Query: 340 TEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKA-DPSFDEAPWPSLSSEARDFVKR 398
TE D+WS+G++ ++ G P++ R + P ++ +SS R F+
Sbjct: 197 TEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDS--HKVSSVLRGFLDL 254
Query: 399 LLNKDPRKRLTAAQAL 414
+L ++P +R TA + L
Sbjct: 255 MLVREPSQRATAQELL 270
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 7e-28
Identities = 79/250 (31%), Positives = 126/250 (50%), Gaps = 18/250 (7%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRAL--TGHNN 220
+G+G FG + K G+ A+K++ K + IA ++V V R L T H
Sbjct: 3 LGKGTFGKVILVREKA---TGRYYAMKILRKEVI---IAKDEVAHTVTESRVLQNTRHPF 56
Query: 221 LVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQG 280
L A++ D + VME GGEL LSR +TE+ A+ +I++ + + H +
Sbjct: 57 LTALKYAFQTHDRLCFVMEYANGGELFFH-LSRERVFTEERARFYGAEIVSALEYLHSRD 115
Query: 281 VVHRDLKPENFLFTTKDENSVLKAIDFGL-SDFVRPDERLNDIVGSAYYVAPEVLH-RSY 338
VV+RD+K EN + D++ +K DFGL + + + G+ Y+APEVL Y
Sbjct: 116 VVYRDIKLENLML---DKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY 172
Query: 339 STEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKR 398
D W +GV+ Y ++CG PF+ + +F +L + F +LS EA+ +
Sbjct: 173 GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR----TLSPEAKSLLAG 228
Query: 399 LLNKDPRKRL 408
LL KDP++RL
Sbjct: 229 LLKKDPKQRL 238
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 8e-28
Identities = 80/260 (30%), Positives = 128/260 (49%), Gaps = 15/260 (5%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILR--ALTGHNN 220
+G+G FG + K + A+KV+ K ++ + E IL L
Sbjct: 1 IGKGTFGQVYQVRKKD---TRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPF 57
Query: 221 LVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQG 280
+V +++ ++Y+V + GGEL L + G+++ED AK + +++ + H
Sbjct: 58 IVGLKFSFQTDSDLYLVTDYMSGGELFWH-LQKEGRFSEDRAKFYIAELVLALEHLHKYD 116
Query: 281 VVHRDLKPENFLFTTKDENSVLKAIDFGLSDF-VRPDERLNDIVGSAYYVAPEVL--HRS 337
+V+RDLKPEN L D + DFGLS + ++ N G+ Y+APEVL +
Sbjct: 117 IVYRDLKPENILL---DATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKG 173
Query: 338 YSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVK 397
Y+ D WS+GV+ + + CG PF+A ++R + F P LS E R FVK
Sbjct: 174 YTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRF---PKNVLSDEGRQFVK 230
Query: 398 RLLNKDPRKRLTAAQALSEL 417
LLN++P+ RL A + EL
Sbjct: 231 GLLNRNPQHRLGAHRDAVEL 250
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 1e-27
Identities = 73/248 (29%), Positives = 124/248 (50%), Gaps = 13/248 (5%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLV 222
+G+G FG A+ K Q A+K + K + +E E ++L H L
Sbjct: 3 LGKGSFGKVFLAELKG---TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLT 59
Query: 223 KFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVV 282
+ ++ +N++ VME GG+L+ I S K+ A +I+ + F H +G+V
Sbjct: 60 HLYCTFQTKENLFFVMEYLNGGDLMFHIQS-CHKFDLPRATFYAAEIICGLQFLHSKGIV 118
Query: 283 HRDLKPENFLFTTKDENSVLKAIDFGL-SDFVRPDERLNDIVGSAYYVAPEVL-HRSYST 340
+RDLK +N L D + +K DFG+ + + D + G+ Y+APE+L + Y+T
Sbjct: 119 YRDLKLDNILL---DTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYNT 175
Query: 341 EADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLL 400
D WS GV+ Y +L G PF E +F+++ +P + W L+ EA+D + +L
Sbjct: 176 SVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPR--W--LTREAKDILVKLF 231
Query: 401 NKDPRKRL 408
++P +RL
Sbjct: 232 VREPERRL 239
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 2e-27
Identities = 79/261 (30%), Positives = 134/261 (51%), Gaps = 25/261 (9%)
Query: 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRAL 215
+YE+ +++G G FG K + + +K I KM E ++EV IL A
Sbjct: 1 RYEIIKKIGEGSFG---KIYLAKAKSDSEHCVIKEIDLTKMPVK-EKEASKKEV-ILLAK 55
Query: 216 TGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRI-LSRGGKYTEDDAKAVMIQILNVVA 274
H N+V FF ++++ +++VME C+GG+L+ RI RG ++ED + +QI +
Sbjct: 56 MKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLK 115
Query: 275 FCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLND-------IVGSAY 327
H + ++HRD+K +N +F +K+ V K DFG++ +LND VG+ Y
Sbjct: 116 HIHDRKILHRDIKSQN-IFLSKN-GMVAKLGDFGIA------RQLNDSMELAYTCVGTPY 167
Query: 328 YVAPEVL-HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWP 386
Y++PE+ +R Y+ + D+WS+G + Y L PF + + + VLK + P
Sbjct: 168 YLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPF---EGNNLHQLVLKICQGYFAPISP 224
Query: 387 SLSSEARDFVKRLLNKDPRKR 407
+ S + R + +L PR R
Sbjct: 225 NFSRDLRSLISQLFKVSPRDR 245
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 2e-27
Identities = 81/287 (28%), Positives = 129/287 (44%), Gaps = 46/287 (16%)
Query: 161 EEVGRGHFGYTCAAKFK-KGELKGQQVAVKVI--PKHKMTTAIAIEDVRREVKILRALTG 217
E++G G T A +K + G+ VA+K I + T + AI RE+ +++ L
Sbjct: 6 EKLGEG----TYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAI----REISLMKELK- 56
Query: 218 HNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRG--GKYTEDDAKAVMIQILNVVAF 275
H N+V+ D + + +V E + +L + + G G + K+ Q+L +AF
Sbjct: 57 HENIVRLHDVIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAF 115
Query: 276 CHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDERLNDIVGSAYYVAPEVL 334
CH V+HRDLKP+N L + E LK DFGL+ F P ++ V + +Y AP+VL
Sbjct: 116 CHENRVLHRDLKPQNLLINKRGE---LKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVL 172
Query: 335 --HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSS-- 390
R+YST D+WS+G I ++ G F + + + E+ WP +S
Sbjct: 173 LGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLP 232
Query: 391 -----------------------EARDFVKRLLNKDPRKRLTAAQAL 414
D + RLL +P R++A AL
Sbjct: 233 EYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDAL 279
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 4e-27
Identities = 79/284 (27%), Positives = 134/284 (47%), Gaps = 51/284 (17%)
Query: 155 NKYELGEEVGRGHFG--YTCAAKFKKGELKGQQVAVKVIP--KHKMTTAIAIEDVRREVK 210
+ G+ +G+G FG Y C G+++AVK +P T + + E++
Sbjct: 2 TNWRRGKLLGQGAFGRVYLCY-----DVDTGRELAVKQVPFDPDSPETKKEVNALECEIQ 56
Query: 211 ILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRG-------GKYTEDDAK 263
+L+ L H +V+++ D + + + ME GG + D++ + G KYT
Sbjct: 57 LLKNLQ-HERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTR---- 111
Query: 264 AVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDI- 322
QIL V + H +VHRD+K N L +D +K DFG S +RL I
Sbjct: 112 ----QILEGVEYLHSNMIVHRDIKGANIL---RDSAGNVKLGDFGAS------KRLQTIC 158
Query: 323 ---------VGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTE--SGIF 370
G+ Y+++PEV+ Y +ADVWS+G +L +P WA E + IF
Sbjct: 159 SSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLT-EKPPWAEFEAMAAIF 217
Query: 371 RAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQAL 414
+ + P+ + P +S +AR+F++R ++ +KR +A + L
Sbjct: 218 K--IATQPTNPQLP-SHVSPDARNFLRRTFVENAKKRPSAEELL 258
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 9e-27
Identities = 83/261 (31%), Positives = 130/261 (49%), Gaps = 27/261 (10%)
Query: 162 EVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNL 221
++G G G C A K G+ VAVK + K E + EV I+R H N+
Sbjct: 27 KIGEGSTGIVCIATVKS---SGKLVAVKKMDLRKQQRR---ELLFNEVVIMRDYQ-HENV 79
Query: 222 VKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGV 281
V+ +++Y D ++VVME EGG L D + + E+ AV + +L ++ H QGV
Sbjct: 80 VEMYNSYLVGDELWVVMEFLEGGALTDIVTHT--RMNEEQIAAVCLAVLKALSVLHAQGV 137
Query: 282 VHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPD-ERLNDIVGSAYYVAPEVLHR-SYS 339
+HRD+K ++ L T + +K DFG V + R +VG+ Y++APE++ R Y
Sbjct: 138 IHRDIKSDSILLT---HDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYG 194
Query: 340 TEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSL------SSEAR 393
E D+WS+G++ ++ G P++ LKA + P L S +
Sbjct: 195 PEVDIWSLGIMVIEMVDGEPPYFNEPP-------LKAMKMIRDNLPPKLKNLHKVSPSLK 247
Query: 394 DFVKRLLNKDPRKRLTAAQAL 414
F+ RLL +DP +R TAA+ L
Sbjct: 248 GFLDRLLVRDPAQRATAAELL 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 108 bits (270), Expect = 9e-27
Identities = 84/274 (30%), Positives = 130/274 (47%), Gaps = 18/274 (6%)
Query: 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALT 216
+E+ E+G G FG A+ K+ G A KVI + +ED E+ IL A
Sbjct: 7 WEIIGELGDGAFGKVYKAQNKE---TGVLAAAKVI---DTKSEEELEDYMVEIDIL-ASC 59
Query: 217 GHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFC 276
H N+VK DA+ +N+++++E C GG + +L TE + V Q L + +
Sbjct: 60 DHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYL 119
Query: 277 HLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDERLNDIVGSAYYVAPEVL- 334
H ++HRDLK N LFT + +K DFG+S R +R + +G+ Y++APEV+
Sbjct: 120 HENKIIHRDLKAGNILFTLDGD---IKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVM 176
Query: 335 -----HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLS 389
R Y +ADVWS+G+ + P + + K++P P S
Sbjct: 177 CETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQP-SRWS 235
Query: 390 SEARDFVKRLLNKDPRKRLTAAQALSELLICYQS 423
SE +DF+K+ L K+ R T Q L + S
Sbjct: 236 SEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVNS 269
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 2e-26
Identities = 78/264 (29%), Positives = 132/264 (50%), Gaps = 17/264 (6%)
Query: 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTT-AIAIEDVRREVKILRAL 215
+EL + +G G +G + G G+ A+KV+ K + A +E R E +L +
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHV 61
Query: 216 TGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAF 275
LV A++ ++++++ GGE+ + R ++ED+ + +I+ +
Sbjct: 62 RQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRD-NFSEDEVRFYSGEIILALEH 120
Query: 276 CHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPD-ERLNDIVGSAYYVAPEV 333
H G+V+RD+K EN L D + DFGLS +F+ + ER G+ Y+APE+
Sbjct: 121 LHKLGIVYRDIKLENILL---DSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEI 177
Query: 334 LH--RSYSTEADVWSIGVIAYILLCGSRPFWAR----TESGIFRAVLKADPSFDEAPWPS 387
+ + D WS+G++ + LL G+ PF T+S + R +LK DP F
Sbjct: 178 IRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFP----SF 233
Query: 388 LSSEARDFVKRLLNKDPRKRLTAA 411
+ EA+D + +LL KDP+KRL A
Sbjct: 234 IGPEAQDLLHKLLRKDPKKRLGAG 257
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 4e-26
Identities = 74/248 (29%), Positives = 122/248 (49%), Gaps = 14/248 (5%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLV 222
+G+G FG + K G+ A+K++ K + + E ++L+ T H L
Sbjct: 3 LGKGTFGKVILVREKA---SGKYYAMKILKKEVIIAKDEVAHTLTESRVLKN-TRHPFLT 58
Query: 223 KFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVV 282
+++ D + VME GGEL LSR ++ED + +I++ + + H +V
Sbjct: 59 SLKYSFQTKDRLCFVMEYVNGGELFFH-LSRERVFSEDRTRFYGAEIVSALDYLHSGKIV 117
Query: 283 HRDLKPENFLFTTKDENSVLKAIDFGL-SDFVRPDERLNDIVGSAYYVAPEVLH-RSYST 340
+RDLK EN + D++ +K DFGL + + + G+ Y+APEVL Y
Sbjct: 118 YRDLKLENLML---DKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDYGR 174
Query: 341 EADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLL 400
D W +GV+ Y ++CG PF+ + +F +L D F +LS++A+ + LL
Sbjct: 175 AVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPR----TLSADAKSLLSGLL 230
Query: 401 NKDPRKRL 408
KDP KRL
Sbjct: 231 IKDPNKRL 238
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 4e-26
Identities = 77/261 (29%), Positives = 123/261 (47%), Gaps = 21/261 (8%)
Query: 163 VGRGHFGYTCAAKFKKGELKG--QQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNN 220
+G+G FG K ELKG + A+KV+ K + ++ E +IL H
Sbjct: 3 LGKGSFG-----KVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPF 57
Query: 221 LVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQG 280
L ++ D ++ VME GG+L+ +I R K+ E ++ ++ + F H G
Sbjct: 58 LTALHCCFQTKDRLFFVMEYVNGGDLMFQI-QRSRKFDEPRSRFYAAEVTLALMFLHRHG 116
Query: 281 VVHRDLKPENFLFTTKDENSVLKAIDFGL-SDFVRPDERLNDIVGSAYYVAPEVLHR-SY 338
V++RDLK +N L D K DFG+ + + G+ Y+APE+L Y
Sbjct: 117 VIYRDLKLDNILL---DAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEY 173
Query: 339 STEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPS-LSSEARDFVK 397
D W++GV+ Y ++ G PF A E +F ++L D+ +P LS EA +K
Sbjct: 174 GPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILH-----DDVLYPVWLSKEAVSILK 228
Query: 398 RLLNKDPRKRL--TAAQALSE 416
+ K+P KRL A+Q +
Sbjct: 229 AFMTKNPNKRLGCVASQGGED 249
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 4e-26
Identities = 74/248 (29%), Positives = 126/248 (50%), Gaps = 13/248 (5%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLV 222
+G+G FG A+ K + A+K + K + +E E ++L H L
Sbjct: 3 LGKGSFGKVMLAELKG---TNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLT 59
Query: 223 KFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVV 282
F ++ ++++ VME GG+L+ I S G ++ E A+ +I+ + F H +G++
Sbjct: 60 HLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSG-RFDEARARFYAAEIICGLQFLHKKGII 118
Query: 283 HRDLKPENFLFTTKDENSVLKAIDFGLSDF-VRPDERLNDIVGSAYYVAPEVLH-RSYST 340
+RDLK +N L D++ +K DFG+ + + + + G+ Y+APE+L + Y+
Sbjct: 119 YRDLKLDNVLL---DKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYNE 175
Query: 341 EADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLL 400
D WS GV+ Y +L G PF E +F ++L P F W +S EA+D + +L
Sbjct: 176 SVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPR--W--ISKEAKDCLSKLF 231
Query: 401 NKDPRKRL 408
+DP KRL
Sbjct: 232 ERDPTKRL 239
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 5e-26
Identities = 93/306 (30%), Positives = 133/306 (43%), Gaps = 74/306 (24%)
Query: 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVI---------PKHKMTTAIAIEDVRR 207
Y+ E++G G +G A+ K G+ VA+K I P +TAI R
Sbjct: 1 YQKVEKIGEGTYGVVYKARDKLT---GEIVALKKIRLETEDEGVP----STAI------R 47
Query: 208 EVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKY---------T 258
E+ +L+ L H N+V+ D + +Y+V E LD L KY
Sbjct: 48 EISLLKELN-HPNIVRLLDVVHSENKLYLVFEF------LDLDLK---KYMDSSPLTGLD 97
Query: 259 EDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD-FVRPDE 317
K+ + Q+L +A+CH V+HRDLKP+N L D LK DFGL+ F P
Sbjct: 98 PPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLI---DREGALKLADFGLARAFGVPVR 154
Query: 318 RLNDIVGSAYYVAPEVL--HRSYSTEADVWSIGVIAYILLCGSRP-FWARTESG----IF 370
V + +Y APE+L R YST D+WSIG I + + RP F +E IF
Sbjct: 155 TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCI-FAEMVNRRPLFPGDSEIDQLFRIF 213
Query: 371 RAVLKAD--------------PSF-------DEAPWPSLSSEARDFVKRLLNKDPRKRLT 409
R + D P+F P+L + D + ++L DP KR++
Sbjct: 214 RTLGTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRIS 273
Query: 410 AAQALS 415
A AL
Sbjct: 274 AKAALQ 279
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 5e-26
Identities = 79/273 (28%), Positives = 130/273 (47%), Gaps = 35/273 (12%)
Query: 160 GEEVGRGHFGYTCAAKFKKGELKGQQVAVKVI---PKHKMTTAIAIEDVRREVKILRALT 216
GE +G+G +G +G+L +AVK + + + E ++ EV +L++L
Sbjct: 5 GEVLGKGAYGTVYCGLTNQGQL----IAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLK 60
Query: 217 GHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFC 276
H N+V++ D + + + ME GG + IL+R G E QIL+ VA+
Sbjct: 61 -HVNIVQYLGTCLDDNTISIFMEFVPGGSI-SSILNRFGPLPEPVFCKYTKQILDGVAYL 118
Query: 277 HLQGVVHRDLKPENFLFTTKDENSVLKAIDFG-------LSDFVRPDERLNDIVGSAYYV 329
H VVHRD+K N + N ++K IDFG + L + G+ Y++
Sbjct: 119 HNNCVVHRDIKGNNVMLMP---NGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWM 175
Query: 330 APEVLHRS-YSTEADVWSIGVIAYILLCGSRPFWARTE--SGIF-----RAVLKADPSFD 381
APEV++ S Y ++D+WSIG + + G +P A + + +F R ++ P
Sbjct: 176 APEVINESGYGRKSDIWSIGCTVFEMATG-KPPLASMDRLAAMFYIGAHRGLM---PRLP 231
Query: 382 EAPWPSLSSEARDFVKRLLNKDPRKRLTAAQAL 414
+ S S+ A DFV L +D +R +A Q L
Sbjct: 232 D----SFSAAAIDFVTSCLTRDQHERPSALQLL 260
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 5e-26
Identities = 79/265 (29%), Positives = 127/265 (47%), Gaps = 18/265 (6%)
Query: 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALT 216
+E+ E+G G FG AK K+ G A KVI + + +ED E++IL A
Sbjct: 14 WEIIGELGDGAFGKVYKAKNKE---TGALAAAKVI---ETKSEEELEDYMVEIEIL-ATC 66
Query: 217 GHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFC 276
H +VK A+ +++++E C GG + +L TE + + Q+L + +
Sbjct: 67 NHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYL 126
Query: 277 HLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDERLNDIVGSAYYVAPEVL- 334
H ++HRDLK N L T + +K DFG+S V+ +R + +G+ Y++APEV+
Sbjct: 127 HSMKIIHRDLKAGNVLLTLDGD---IKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVM 183
Query: 335 -----HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLS 389
Y +AD+WS+G+ + P + + K++P P S
Sbjct: 184 CETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQP-SKWS 242
Query: 390 SEARDFVKRLLNKDPRKRLTAAQAL 414
E RDF+K L+K P R +AAQ L
Sbjct: 243 MEFRDFLKTALDKHPETRPSAAQLL 267
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 107 bits (267), Expect = 6e-26
Identities = 77/267 (28%), Positives = 128/267 (47%), Gaps = 17/267 (6%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLV 222
+G+G FG A+ K E + AVKV+ K + + + E +L H LV
Sbjct: 3 IGKGSFGKVLLARHKAEE---KFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLV 59
Query: 223 KFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVV 282
+++ D +Y V++ GGEL L R + E A+ +I + + + H +V
Sbjct: 60 GLHFSFQTADKLYFVLDYINGGELFYH-LQRERCFLEPRARFYAAEIASALGYLHSLNIV 118
Query: 283 HRDLKPENFLFTTKDENSVLKAIDFGL-SDFVRPDERLNDIVGSAYYVAPEVLHRS-YST 340
+RDLKPEN L D + DFGL + + + + G+ Y+APEVLH+ Y
Sbjct: 119 YRDLKPENILL---DSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDR 175
Query: 341 EADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLL 400
D W +G + Y +L G PF++R + ++ +L P++++ AR ++ LL
Sbjct: 176 TVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLK----PNITNSARHLLEGLL 231
Query: 401 NKDPRKRLTAAQALSELLICYQSYLFF 427
KD KRL A E+ ++++FF
Sbjct: 232 QKDRTKRLGAKDDFMEI----KNHIFF 254
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 6e-26
Identities = 80/257 (31%), Positives = 120/257 (46%), Gaps = 41/257 (15%)
Query: 184 QQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNN--LVKFFDAYEDTDNVYVVMELC 241
Q+ A+K I K + I+ V E IL T N +V F ++E ++ +VME
Sbjct: 27 QRFAMKKINKQNLILRNQIQQVFVERDIL---TFAENPFVVSMFCSFETKRHLCMVMEYV 83
Query: 242 EGGE---LLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDE 298
EGG+ LL I G D A+ + + + + H G+VHRDLKP+N L T+
Sbjct: 84 EGGDCATLLKNI----GALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGH 139
Query: 299 NSVLKAIDFGLSD-------------FVRPDERL---NDIVGSAYYVAPEV-LHRSYSTE 341
+K DFGLS + D R + G+ Y+APEV L + Y
Sbjct: 140 ---IKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKP 196
Query: 342 ADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWP----SLSSEARDFVK 397
D W++G+I Y L G PF+ T +F V+ D+ WP +L ++A+D +
Sbjct: 197 VDWWAMGIILYEFLVGCVPFFGDTPEELFGQVIS-----DDIEWPEGDEALPADAQDLIS 251
Query: 398 RLLNKDPRKRLTAAQAL 414
RLL ++P +RL A
Sbjct: 252 RLLRQNPLERLGTGGAF 268
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 9e-26
Identities = 87/290 (30%), Positives = 130/290 (44%), Gaps = 50/290 (17%)
Query: 161 EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMT-----TAIAIEDVRREVKILRAL 215
E++G G +G A+ K G+ VA+K I T TAI RE+ +L+ L
Sbjct: 6 EKIGEGTYGVVYKARNKL---TGEVVALKKIRLDTETEGVPSTAI------REISLLKEL 56
Query: 216 TGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRIL--SRGGKYTEDDAKAVMIQILNVV 273
H N+VK D + +Y+V E + L + + S K+ + Q+L +
Sbjct: 57 N-HPNIVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASPLSGIPLPLIKSYLFQLLQGL 113
Query: 274 AFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD-FVRPDERLNDIVGSAYYVAPE 332
AFCH V+HRDLKP+N L + +K DFGL+ F P V + +Y APE
Sbjct: 114 AFCHSHRVLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPE 170
Query: 333 VL--HRSYSTEADVWSIGVIAYILLCGSRPFWARTESG----IFRAVLKAD----PSFDE 382
+L + YST D+WS+G I ++ F +E IFR + D P
Sbjct: 171 ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 230
Query: 383 AP--------W---------PSLSSEARDFVKRLLNKDPRKRLTAAQALS 415
P W P L + RD + ++L+ DP KR++A AL+
Sbjct: 231 LPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 1e-25
Identities = 88/314 (28%), Positives = 129/314 (41%), Gaps = 72/314 (22%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRA 214
+KYE ++G+G FG A+ KK Q VA+K + I +R E+KIL+
Sbjct: 12 SKYEKLAKIGQGTFGEVFKARHKK---TKQIVALKKVLMENEKEGFPITALR-EIKILQL 67
Query: 215 LTGHNNLVKF----------FDAYEDTDNVYVVMELCEGGELLDRILSRGG-KYTEDDAK 263
L H N+V ++ Y+ + Y+V E CE L +LS K+T + K
Sbjct: 68 LK-HENVVNLIEICRTKATPYNRYKGS--FYLVFEFCEHD--LAGLLSNKNVKFTLSEIK 122
Query: 264 AVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDE----R 318
VM +LN + + H ++HRD+K N L T ++ +LK DFGL+ F R
Sbjct: 123 KVMKMLLNGLYYIHRNKILHRDMKAANILIT---KDGILKLADFGLARAFSLSKNSKPNR 179
Query: 319 LNDIVGSAYYVAPEVL--HRSYSTEADVWSIGVIA---------------------YILL 355
+ V + +Y PE+L R Y D+W G I L
Sbjct: 180 YTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQL 239
Query: 356 CGS-----------RPFWARTE--SGIFRAVLKADPSFDEAPWPSLSS-EARDFVKRLLN 401
CGS + + E G R V E P + A D + +LL
Sbjct: 240 CGSITPEVWPGVDKLELFKKMELPQGQKRKV-------KERLKPYVKDPHALDLIDKLLV 292
Query: 402 KDPRKRLTAAQALS 415
DP KR+ A AL+
Sbjct: 293 LDPAKRIDADTALN 306
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 82/293 (27%), Positives = 134/293 (45%), Gaps = 61/293 (20%)
Query: 183 GQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT----------- 231
++VAVK I +T +++ RE+KI+R L H+N+VK ++ +
Sbjct: 30 DKRVAVKKI---VLTDPQSVKHALREIKIIRRLD-HDNIVKVYEVLGPSGSDLTEDVGSL 85
Query: 232 ---DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKP 288
++VY+V E E L +L +G +E+ A+ M Q+L + + H V+HRDLKP
Sbjct: 86 TELNSVYIVQEYMETD--LANVLEQG-PLSEEHARLFMYQLLRGLKYIHSANVLHRDLKP 142
Query: 289 ENFLFTTKDENSVLKAIDFGLSDFVRPDER----LNDIVGSAYYVAPEVL--HRSYSTEA 342
N T E+ VLK DFGL+ V P L++ + + +Y +P +L +Y+
Sbjct: 143 ANVFINT--EDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAI 200
Query: 343 DVWSIGVIAYILLCGSRPFWARTESGIFRAVLKA---------------DPSF-DEAPW- 385
D+W+ G I +L G F E + +L++ PSF
Sbjct: 201 DMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGE 260
Query: 386 ---------PSLSSEARDFVKRLLNKDPRKRLTAAQALSELLICYQSYLFFYS 429
P ++ EA DF++++L +P RLTA +AL Y+ YS
Sbjct: 261 PRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM------HPYMSCYS 307
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 88/310 (28%), Positives = 136/310 (43%), Gaps = 63/310 (20%)
Query: 151 KHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVR---- 206
KH KYE+ +++G+G +G A ++ + VA+K I A +
Sbjct: 3 KHILRKYEILQKLGKGAYGIVWKAIDRR---TKEVVALKKIFD-------AFRNATDAQR 52
Query: 207 --REVKILRALTGHNNLVKFFD---AYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDD 261
RE+ L+ L H N+VK + A D D +Y+V E E L ++ R +
Sbjct: 53 TFREIMFLQELGDHPNIVKLLNVIKAENDKD-IYLVFEYMETD--LHAVI-RANILEDVH 108
Query: 262 AKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDER--- 318
+ +M Q+L + + H V+HRDLKP N L + + +K DFGL+ + E
Sbjct: 109 KRYIMYQLLKALKYIHSGNVIHRDLKPSNILL---NSDCRVKLADFGLARSLSELEENPE 165
Query: 319 ---LNDIVGSAYYVAPEVL--HRSYSTEADVWSIGVIAYILLCGSRPFWART-------- 365
L D V + +Y APE+L Y+ D+WS+G I +L G +P + T
Sbjct: 166 NPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLG-KPLFPGTSTLNQLEK 224
Query: 366 ----------------ESGIFRAVLKADPSFDEAP----WPSLSSEARDFVKRLLNKDPR 405
+S +L + PS P P S +A D +K+LL +P
Sbjct: 225 IIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPN 284
Query: 406 KRLTAAQALS 415
KRLTA +AL
Sbjct: 285 KRLTAEEALE 294
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 1e-25
Identities = 75/249 (30%), Positives = 125/249 (50%), Gaps = 15/249 (6%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLV 222
+G+G FG K K G+ A+K++ K + + E ++L+ + H L
Sbjct: 3 LGKGTFGKVILVKEKA---TGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN-SRHPFLT 58
Query: 223 KFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQ-GV 281
+++ D + VME GGEL LSR ++ED A+ +I++ + + H + V
Sbjct: 59 ALKYSFQTHDRLCFVMEYANGGELFFH-LSRERVFSEDRARFYGAEIVSALDYLHSEKNV 117
Query: 282 VHRDLKPENFLFTTKDENSVLKAIDFGL-SDFVRPDERLNDIVGSAYYVAPEVLH-RSYS 339
V+RDLK EN + D++ +K DFGL + ++ + G+ Y+APEVL Y
Sbjct: 118 VYRDLKLENLML---DKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYG 174
Query: 340 TEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRL 399
D W +GV+ Y ++CG PF+ + +F +L + F +LS EA+ + L
Sbjct: 175 RAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR----TLSPEAKSLLSGL 230
Query: 400 LNKDPRKRL 408
L KDP++RL
Sbjct: 231 LKKDPKQRL 239
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 2e-25
Identities = 85/288 (29%), Positives = 130/288 (45%), Gaps = 38/288 (13%)
Query: 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRAL 215
KYE E++G G +G AK ++ + VA+K + + +R E+ +L+ L
Sbjct: 1 KYEKLEKIGEGTYGTVFKAKNRE---THEIVALKRVRLDDDDEGVPSSALR-EICLLKEL 56
Query: 216 TGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAF 275
H N+V+ +D + +V E C+ +L S G + K+ M Q+L +AF
Sbjct: 57 K-HKNIVRLYDVLHSDKKLTLVFEYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAF 114
Query: 276 CHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDERLNDIVGSAYYVAPEVL 334
CH V+HRDLKP+N L N LK DFGL+ F P + V + +Y P+VL
Sbjct: 115 CHSHNVLHRDLKPQNLLINK---NGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVL 171
Query: 335 --HRSYSTEADVWSIGVIAYILLCGSRPFWARTE-----SGIFRAV-------------- 373
+ YST D+WS G I L RP + + IFR +
Sbjct: 172 FGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKL 231
Query: 374 --LKADPSFD-----EAPWPSLSSEARDFVKRLLNKDPRKRLTAAQAL 414
K P + P L+S RD ++ LL +P +R++A +AL
Sbjct: 232 PDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEAL 279
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 3e-25
Identities = 80/273 (29%), Positives = 133/273 (48%), Gaps = 31/273 (11%)
Query: 160 GEEVGRGHFGYT-CAAKFKKGELKG-QQVAVKVIP-KHKMTTAIAIEDVRREVKILRALT 216
G +G G FG GEL +QV + + K ++ + RE+ +L+ L
Sbjct: 5 GALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQ 64
Query: 217 GHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFC 276
H N+V++ + D D++ + +E GG + +L+ G + E + + QIL + +
Sbjct: 65 -HENIVQYLGSSLDADHLNIFLEYVPGGSV-AALLNNYGAFEETLVRNFVRQILKGLNYL 122
Query: 277 HLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV------------RPDERLNDIVG 324
H +G++HRD+K N L D +K DFG+S + RP + G
Sbjct: 123 HNRGIIHRDIKGANILV---DNKGGIKISDFGISKKLEANSLSTKTNGARP-----SLQG 174
Query: 325 SAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTE-SGIFRAVLKADPSFDE 382
S +++APEV+ + SY+ +AD+WS+G + +L G PF T+ IF+ A P
Sbjct: 175 SVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEIPS 234
Query: 383 APWPSLSSEARDFVKRLLNKDPRKRLTAAQALS 415
++SSEA DF+++ D KR TAA+ L
Sbjct: 235 ----NISSEAIDFLEKTFEIDHNKRPTAAELLK 263
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 4e-25
Identities = 81/264 (30%), Positives = 131/264 (49%), Gaps = 21/264 (7%)
Query: 156 KYELGEEVGRGHFG--YTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILR 213
KY E++G+G G YT E+ +Q+ ++ PK ++ + E+ ++R
Sbjct: 20 KYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKEL--------IINEILVMR 71
Query: 214 ALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVV 273
H N+V + D+Y D ++VVME GG L D + E AV + L +
Sbjct: 72 ENK-HPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQAL 128
Query: 274 AFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDER-LNDIVGSAYYVAPE 332
F H V+HRD+K +N L + SV K DFG + P++ + +VG+ Y++APE
Sbjct: 129 EFLHSNQVIHRDIKSDNILLGM--DGSV-KLTDFGFCAQITPEQSKRSTMVGTPYWMAPE 185
Query: 333 VLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWP-SLSS 390
V+ R +Y + D+WS+G++A ++ G P+ E+ + L A E P LS+
Sbjct: 186 VVTRKAYGPKVDIWSLGIMAIEMVEGEPPYL--NENPLRALYLIATNGTPELQNPEKLSA 243
Query: 391 EARDFVKRLLNKDPRKRLTAAQAL 414
RDF+ R L D KR +A + L
Sbjct: 244 IFRDFLNRCLEMDVEKRGSAKELL 267
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 5e-25
Identities = 85/286 (29%), Positives = 131/286 (45%), Gaps = 50/286 (17%)
Query: 166 GHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFF 225
G +G A+ KK G+ VA+K + K I +R E+ IL L H N+V
Sbjct: 16 GTYGVVYRARDKK---TGEIVALKKLKMEKEKEGFPITSLR-EINILLKL-QHPNIVTVK 70
Query: 226 DAY--EDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVH 283
+ + D +Y+VME E +L + + + + + K +M+Q+L+ VA H ++H
Sbjct: 71 EVVVGSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILH 129
Query: 284 RDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDERLNDIVGSAYYVAPEVL--HRSYST 340
RDLK N L + +LK DFGL+ ++ P + +V + +Y APE+L + YST
Sbjct: 130 RDLKTSNLLLNNR---GILKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLLGAKEYST 186
Query: 341 EADVWSIGVIAYILLCGSRPFWARTE----SGIFRAVLKADPSFDEAPWP---------- 386
D+WS+G I LL F ++E + IF+ + P+ E WP
Sbjct: 187 AIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLL--GTPT--EKIWPGFSELPGAKK 242
Query: 387 ------------------SLSSEARDFVKRLLNKDPRKRLTAAQAL 414
SLS D + RLL DP KR++A AL
Sbjct: 243 KTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDAL 288
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 8e-25
Identities = 67/231 (29%), Positives = 113/231 (48%), Gaps = 35/231 (15%)
Query: 207 REVKILRALTGHNNLVKFFDAY--EDTDNVYVVMELCEGGEL---LDRILSRGGKYTEDD 261
RE++I ++ +VK++ A+ E + ++ + ME CEGG L ++ RGG+ E
Sbjct: 48 RELEINKS-CKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKV 106
Query: 262 AKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLND 321
+ +L +++ H + ++HRD+KP N L T K + +K DFG+S E +N
Sbjct: 107 LGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQ---VKLCDFGVS-----GELVNS 158
Query: 322 I----VGSAYYVAPE-VLHRSYSTEADVWSIGVIAYILLCGSRPFWARTE---------- 366
+ G+++Y+APE + + YS +DVWS+G+ + PF E
Sbjct: 159 LAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLS 218
Query: 367 --SGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALS 415
+ LK +P + W S E +DF+K+ L KDP +R T L
Sbjct: 219 YIVNMPNPELKDEPG-NGIKW---SEEFKDFIKQCLEKDPTRRPTPWDMLE 265
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 8e-25
Identities = 73/250 (29%), Positives = 120/250 (48%), Gaps = 17/250 (6%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQ--VAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNN 220
+G+G FG K E KG A+K++ K + +E E ++L
Sbjct: 8 LGKGSFG-----KVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPF 62
Query: 221 LVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQG 280
L + ++ D +Y VME GG+L+ I + GK+ E A +I + F H +G
Sbjct: 63 LTQLHSCFQTMDRLYFVMEYVNGGDLMYHI-QQVGKFKEPHAVFYAAEIAIGLFFLHSKG 121
Query: 281 VVHRDLKPENFLFTTKDENSVLKAIDFGL-SDFVRPDERLNDIVGSAYYVAPE-VLHRSY 338
+++RDLK +N + D +K DFG+ + + + G+ Y+APE + ++ Y
Sbjct: 122 IIYRDLKLDNVML---DAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQPY 178
Query: 339 STEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKR 398
D W+ GV+ Y +L G PF E +F+++++ + S+ + SLS EA K
Sbjct: 179 GKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPK----SLSKEAVSICKG 234
Query: 399 LLNKDPRKRL 408
LL K P KRL
Sbjct: 235 LLTKHPAKRL 244
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 1e-24
Identities = 93/303 (30%), Positives = 139/303 (45%), Gaps = 65/303 (21%)
Query: 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVI---------PKHKMTTAIAIEDVR 206
Y E++G G +G + KK GQ VA+K I P +TAI
Sbjct: 1 DYTKIEKIGEGTYGVVYKGRNKK---TGQIVAMKKIRLESEEEGVP----STAI------ 47
Query: 207 REVKILRALTGHNNLVKFFDAYEDTDNVYVVMEL--CEGGELLDRILSRGGKYTEDD-AK 263
RE+ +L+ L H N+V D +Y++ E + + LD + G+Y + + K
Sbjct: 48 REISLLKELQ-HPNIVCLQDVLMQESRLYLIFEFLSMDLKKYLDSL--PKGQYMDAELVK 104
Query: 264 AVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDERLNDI 322
+ + QIL + FCH + V+HRDLKP+N L D V+K DFGL+ F P
Sbjct: 105 SYLYQILQGILFCHSRRVLHRDLKPQNLLI---DNKGVIKLADFGLARAFGIPVRVYTHE 161
Query: 323 VGSAYYVAPEVLHRS--YSTEADVWSIGVIAYILLCGSRP-FWARTESG----IFRAVLK 375
V + +Y APEVL S YST D+WSIG I + + +P F +E IFR +
Sbjct: 162 VVTLWYRAPEVLLGSPRYSTPVDIWSIGTI-FAEMATKKPLFHGDSEIDQLFRIFRIL-- 218
Query: 376 ADPSFDEAP--------------W---------PSLSSEARDFVKRLLNKDPRKRLTAAQ 412
P+ D P W +L + D ++++L DP KR++A +
Sbjct: 219 GTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKK 278
Query: 413 ALS 415
AL+
Sbjct: 279 ALN 281
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 2e-24
Identities = 75/254 (29%), Positives = 124/254 (48%), Gaps = 18/254 (7%)
Query: 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALT 216
+E+ + +GRG FG K K GQ A+K++ K +M R E +L +
Sbjct: 3 FEILKVIGRGAFGEVAVVKMKN---TGQVYAMKILNKWEMLKRAETACFREERDVL--VN 57
Query: 217 GHNNLV-KFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAF 275
G + A++D +N+Y+VM+ GG+LL + + ED A+ + +++ +
Sbjct: 58 GDRRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDS 117
Query: 276 CHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDE--RLNDIVGSAYYVAPEV 333
H G VHRD+KP+N L D+N ++ DFG + D + N VG+ Y++PE+
Sbjct: 118 VHQLGYVHRDIKPDNVLL---DKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEI 174
Query: 334 LHR------SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPW-P 386
L Y E D WS+GV Y +L G PF+A + + ++ F P
Sbjct: 175 LQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVT 234
Query: 387 SLSSEARDFVKRLL 400
+S EA+D ++RL+
Sbjct: 235 DVSEEAKDLIRRLI 248
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 2e-24
Identities = 86/305 (28%), Positives = 131/305 (42%), Gaps = 61/305 (20%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIED------VRRE 208
+ YE E++G G +G A+ K G+ VA+K T + +++ RE
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKN---TGKLVALK-------KTRLEMDEEGIPPTALRE 50
Query: 209 VKILRALTGHNNLVKFFDAYEDTDN------VYVVMELCEGGELLDRILSRGGKYT---- 258
+ +L+ L+ +V+ D E + +Y+V E + +L + S G
Sbjct: 51 ISLLQMLSESIYIVRLLDV-EHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLP 108
Query: 259 EDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDE 317
K+ M Q+L VA CH GV+HRDLKP+N L + +LK D GL F P +
Sbjct: 109 AKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLL--VDKQKGLLKIADLGLGRAFSIPVK 166
Query: 318 RLNDIVGSAYYVAPEVL--HRSYSTEADVWSIGVIAYILLCGSRPFWARTES----GIFR 371
+ + +Y APEVL YST D+WS+G I + F +E IF+
Sbjct: 167 SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFK 226
Query: 372 AVLKADPSFDEAP-------W---------------PSLSSEARDFVKRLLNKDPRKRLT 409
L P+ P W P LS E D ++++L DP KR++
Sbjct: 227 --LLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRIS 284
Query: 410 AAQAL 414
A AL
Sbjct: 285 AKAAL 289
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 2e-24
Identities = 73/246 (29%), Positives = 120/246 (48%), Gaps = 14/246 (5%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLV 222
+G G FG A +K + VA+K K K+ ++ V E KIL + H V
Sbjct: 38 LGTGSFGRVILATYKNEDFP--PVAIKRFEKSKIIKQKQVDHVFSERKILNYIN-HPFCV 94
Query: 223 KFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVV 282
+ +++D +Y+V+E GGE L R ++ D QI+ + + +V
Sbjct: 95 NLYGSFKDESYLYLVLEFVIGGEFFT-FLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIV 153
Query: 283 HRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVL-HRSYSTE 341
+RDLKPEN L D++ +K DFG + V D R + G+ Y+APE+L + +
Sbjct: 154 YRDLKPENLLL---DKDGFIKMTDFGFAKVV--DTRTYTLCGTPEYIAPEILLNVGHGKA 208
Query: 342 ADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLN 401
AD W++G+ Y +L G PF+A I++ +L+ F + L + + +K+LL+
Sbjct: 209 ADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKF----LDNNCKHLMKKLLS 264
Query: 402 KDPRKR 407
D KR
Sbjct: 265 HDLTKR 270
|
Length = 340 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 3e-24
Identities = 83/262 (31%), Positives = 130/262 (49%), Gaps = 17/262 (6%)
Query: 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRAL 215
KY E++G+G G A GQ+VA+K I K E + E+ +++ L
Sbjct: 20 KYTRYEKIGQGASGTVFTAI---DVATGQEVAIKQINLQKQPKK---ELIINEILVMKEL 73
Query: 216 TGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAF 275
+ N+V F D++ D ++VVME GG L D + E AV + L + F
Sbjct: 74 K-NPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETC--MDEAQIAAVCRECLQALEF 130
Query: 276 CHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDE-RLNDIVGSAYYVAPEVL 334
H V+HRD+K +N L + SV K DFG + P++ + + +VG+ Y++APEV+
Sbjct: 131 LHANQVIHRDIKSDNVLLGM--DGSV-KLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV 187
Query: 335 HR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPS-LSSEA 392
R +Y + D+WS+G++A ++ G P+ E+ + L A E P LS
Sbjct: 188 TRKAYGPKVDIWSLGIMAIEMVEGEPPYL--NENPLRALYLIATNGTPELQNPEKLSPIF 245
Query: 393 RDFVKRLLNKDPRKRLTAAQAL 414
RDF+ R L D KR +A + L
Sbjct: 246 RDFLNRCLEMDVEKRGSAKELL 267
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 4e-24
Identities = 73/249 (29%), Positives = 127/249 (51%), Gaps = 15/249 (6%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNN-L 221
+G+G FG A+ K KG+ AVK + K + +E E ++L AL N L
Sbjct: 3 LGKGSFGKVLLAELKG---KGEYFAVKALKKDVVLIDDDVECTMVEKRVL-ALAWENPFL 58
Query: 222 VKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGV 281
+ ++ ++++ VME GG+L+ I +G ++ A +I+ + F H +G+
Sbjct: 59 THLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKG-RFDLYRATFYAAEIVCGLQFLHSKGI 117
Query: 282 VHRDLKPENFLFTTKDENSVLKAIDFGL-SDFVRPDERLNDIVGSAYYVAPEVLH-RSYS 339
++RDLK +N + D + +K DFG+ + V D R + G+ Y+APE+L Y+
Sbjct: 118 IYRDLKLDNVML---DRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKYT 174
Query: 340 TEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRL 399
D WS GV+ Y +L G PF E +F ++ P + W ++ E++D +++L
Sbjct: 175 FSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPR--W--ITKESKDILEKL 230
Query: 400 LNKDPRKRL 408
+DP +RL
Sbjct: 231 FERDPTRRL 239
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 7e-24
Identities = 83/292 (28%), Positives = 125/292 (42%), Gaps = 56/292 (19%)
Query: 163 VGRGHFGYTC-AAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNL 221
+G G FG C K L A+K + K + V+ E IL A + +
Sbjct: 9 IGIGAFGEVCLVRKVDTNAL----YAMKTLRKADVLMRNQAAHVKAERDIL-AEADNEWV 63
Query: 222 VKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGV 281
VK + +++D DN+Y VM+ GG+++ +L R G + ED A+ + ++ + H G
Sbjct: 64 VKLYYSFQDKDNLYFVMDYIPGGDMMS-LLIRLGIFEEDLARFYIAELTCAIESVHKMGF 122
Query: 282 VHRDLKPENFLFTTKDENSVLKAIDFGL--------------------SDFVRPDERLND 321
+HRD+KP+N L D + +K DFGL D + P E ++
Sbjct: 123 IHRDIKPDNILI---DRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSE 179
Query: 322 I------------------------VGSAYYVAPEVLHRS-YSTEADVWSIGVIAYILLC 356
I VG+ Y+APEVL R+ Y+ D WS+GVI Y +L
Sbjct: 180 IDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLV 239
Query: 357 GSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRL 408
G PF A T + V+ + + LS EA D + RL RL
Sbjct: 240 GQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRL 290
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 9e-24
Identities = 78/275 (28%), Positives = 123/275 (44%), Gaps = 26/275 (9%)
Query: 149 FSKHFANK-YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRR 207
FSK K + E+G G FG A F + + VA+K + + +D+ +
Sbjct: 8 FSKDDPEKLFTDLREIGHGSFG---AVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIK 64
Query: 208 EVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEG--GELLDRILSRGGKYTEDDAKAV 265
EV+ L+ L H N +++ Y ++VME C G ++L+ + + E + A+
Sbjct: 65 EVRFLQQLR-HPNTIEYKGCYLREHTAWLVMEYCLGSASDILE-VHKKP--LQEVEIAAI 120
Query: 266 MIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGS 325
L +A+ H +HRD+K N L T E +K DFG + V P N VG+
Sbjct: 121 CHGALQGLAYLHSHERIHRDIKAGNILLT---EPGTVKLADFGSASLVSP---ANSFVGT 174
Query: 326 AYYVAPEVL----HRSYSTEADVWSIGVIAYILLCGSRP--FWARTESGIFRAVLKADPS 379
Y++APEV+ Y + DVWS+G I I L +P F S ++ P+
Sbjct: 175 PYWMAPEVILAMDEGQYDGKVDVWSLG-ITCIELAERKPPLFNMNAMSALYHIAQNDSPT 233
Query: 380 FDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQAL 414
W S R+FV L K P+ R ++ + L
Sbjct: 234 LSSNDW---SDYFRNFVDSCLQKIPQDRPSSEELL 265
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 69/255 (27%), Positives = 124/255 (48%), Gaps = 20/255 (7%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLV 222
+GRG + + KK + Q A+KV+ K + I+ V+ E + + + LV
Sbjct: 3 IGRGSYAKVLLVRLKKND---QIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLV 59
Query: 223 KFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVV 282
++ T +++V+E GG+L+ + R K E+ A+ +I + F H +G++
Sbjct: 60 GLHSCFQTTSRLFLVIEYVNGGDLMFH-MQRQRKLPEEHARFYAAEICIALNFLHERGII 118
Query: 283 HRDLKPENFLFTTKDENSVLKAIDFGL-SDFVRPDERLNDIVGSAYYVAPEVLH-RSYST 340
+RDLK +N L D + +K D+G+ + + P + + G+ Y+APE+L Y
Sbjct: 119 YRDLKLDNVLL---DADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGF 175
Query: 341 EADVWSIGVIAYILLCGSRPF-------WARTESGIFRAVLKADPSFDEAPWPSLSSEAR 393
D W++GV+ + ++ G PF TE +F+ +L+ LS +A
Sbjct: 176 SVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPR----FLSVKAS 231
Query: 394 DFVKRLLNKDPRKRL 408
+K LNKDP++RL
Sbjct: 232 HVLKGFLNKDPKERL 246
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 99.7 bits (248), Expect = 1e-23
Identities = 79/281 (28%), Positives = 130/281 (46%), Gaps = 28/281 (9%)
Query: 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILR 213
A +EL E VG G +G + K GQ A+KV+ T E+++ E+ +L+
Sbjct: 15 AGIFELVEVVGNGTYGQVYKGRHVK---TGQLAAIKVMD----VTEDEEEEIKLEINMLK 67
Query: 214 ALTGHNNLVKFFDAY------EDTDNVYVVMELCEGGELLDRIL-SRGGKYTEDDAKAVM 266
+ H N+ ++ A+ D +++VME C G + D + ++G ED +
Sbjct: 68 KYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYIC 127
Query: 267 IQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDERLNDIVGS 325
+IL +A H V+HRD+K +N L T EN+ +K +DFG+S R R N +G+
Sbjct: 128 REILRGLAHLHAHKVIHRDIKGQNVLLT---ENAEVKLVDFGVSAQLDRTVGRRNTFIGT 184
Query: 326 AYYVAPEVL------HRSYSTEADVWSIGVIAYILLCGSRPFW-ARTESGIFRAVLKADP 378
Y++APEV+ +Y +D+WS+G+ A + G+ P +F P
Sbjct: 185 PYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPP 244
Query: 379 SFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLI 419
W S + DF++ L K+ R + Q L I
Sbjct: 245 KLKSKKW---SKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 99.8 bits (248), Expect = 1e-23
Identities = 78/264 (29%), Positives = 132/264 (50%), Gaps = 21/264 (7%)
Query: 156 KYELGEEVGRGHFG--YTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILR 213
KY E++G+G G YT E+ +Q+ ++ PK ++ + E+ ++R
Sbjct: 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL--------IINEILVMR 72
Query: 214 ALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVV 273
+ N+V + D+Y D ++VVME GG L D + E AV + L +
Sbjct: 73 E-NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC--MDEGQIAAVCRECLQAL 129
Query: 274 AFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDE-RLNDIVGSAYYVAPE 332
F H V+HRD+K +N L + +K DFG + P++ + + +VG+ Y++APE
Sbjct: 130 EFLHSNQVIHRDIKSDNILLGM---DGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPE 186
Query: 333 VLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPS-LSS 390
V+ R +Y + D+WS+G++A ++ G P+ E+ + L A E P LS+
Sbjct: 187 VVTRKAYGPKVDIWSLGIMAIEMIEGEPPYL--NENPLRALYLIATNGTPELQNPEKLSA 244
Query: 391 EARDFVKRLLNKDPRKRLTAAQAL 414
RDF+ R L+ D KR +A + L
Sbjct: 245 IFRDFLNRCLDMDVEKRGSAKELL 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 99.5 bits (248), Expect = 1e-23
Identities = 88/300 (29%), Positives = 137/300 (45%), Gaps = 59/300 (19%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKM-----TTAIAIEDVRREV 209
++YE E++G G +G A+ + + + +A+K I + +TAI RE+
Sbjct: 2 DQYEKVEKIGEGTYGVVYKARDR---VTNETIALKKIRLEQEDEGVPSTAI------REI 52
Query: 210 KILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDA------K 263
+L+ + H N+V+ D +Y+V E LD L + + D A K
Sbjct: 53 SLLKEMQ-HGNIVRLQDVVHSEKRLYLVFEY------LDLDLKKHMDSSPDFAKNPRLIK 105
Query: 264 AVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD-FVRPDERLNDI 322
+ QIL +A+CH V+HRDLKP+N L + + LK DFGL+ F P
Sbjct: 106 TYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRR--TNALKLADFGLARAFGIPVRTFTHE 163
Query: 323 VGSAYYVAPEVL--HRSYSTEADVWSIGVIAYILLCGSRP-FWARTE----SGIFRAV-- 373
V + +Y APE+L R YST D+WS+G I + + +P F +E IFR +
Sbjct: 164 VVTLWYRAPEILLGSRHYSTPVDIWSVGCI-FAEMVNQKPLFPGDSEIDELFKIFRILGT 222
Query: 374 --------LKADPSFDEA--PW---------PSLSSEARDFVKRLLNKDPRKRLTAAQAL 414
+ + P + A W P+L D + ++L DP KR+TA AL
Sbjct: 223 PNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAAL 282
|
Length = 294 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 84/289 (29%), Positives = 135/289 (46%), Gaps = 55/289 (19%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLV 222
+GRG FG + K G A+K + K +M + VR E IL A + +V
Sbjct: 9 IGRGAFGEVRLVQKKD---TGHIYAMKKLRKSEMLEKEQVAHVRAERDIL-AEADNPWVV 64
Query: 223 KFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVV 282
K + +++D + +Y++ME GG+++ +L + +TE++ + + + + + H G +
Sbjct: 65 KLYYSFQDENYLYLIMEYLPGGDMMT-LLMKKDTFTEEETRFYIAETILAIDSIHKLGYI 123
Query: 283 HRDLKPENFLFTTKDENSVLKAIDFGL---------SDFVR------PDERLNDI----- 322
HRD+KP+N L D +K DFGL ++F R P L+ I
Sbjct: 124 HRDIKPDNLLL---DAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMS 180
Query: 323 -------------------VGSAYYVAPEVLHRS-YSTEADVWSIGVIAYILLCGSRPFW 362
VG+ Y+APEV ++ Y+ E D WS+GVI Y +L G PF
Sbjct: 181 SKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFC 240
Query: 363 ARTESGIFRAVL--KADPSF-DEAPWPSLSSEARDFVKRLLNKDPRKRL 408
+ +R ++ K F DE P LS EA+D +KRL + +RL
Sbjct: 241 SDNPQETYRKIINWKETLQFPDEVP---LSPEAKDLIKRLCC-EAERRL 285
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 99.0 bits (246), Expect = 2e-23
Identities = 80/266 (30%), Positives = 136/266 (51%), Gaps = 26/266 (9%)
Query: 161 EEVGRGHFGYTCAAKFKKGELKGQQV-AVKVIPKHKMTTAIAIEDVRREVKILRALTGHN 219
E +G+G FG FK + + QQV A+K+I + I ED+++E+ +L +
Sbjct: 10 ERIGKGSFGEV----FKGIDNRTQQVVAIKIIDLEEAEDEI--EDIQQEITVL-SQCDSP 62
Query: 220 NLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQ 279
+ K++ +Y ++++ME GG LD L R G + E ++ +IL + + H +
Sbjct: 63 YVTKYYGSYLKGTKLWIIMEYLGGGSALD--LLRAGPFDEFQIATMLKEILKGLDYLHSE 120
Query: 280 GVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDE-RLNDIVGSAYYVAPEVLHRS- 337
+HRD+K N L + E +K DFG++ + + + N VG+ +++APEV+ +S
Sbjct: 121 KKIHRDIKAANVLLS---EQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSA 177
Query: 338 YSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSE----AR 393
Y ++AD+WS+G+ A L G P ++ R VL P P+L+ E +
Sbjct: 178 YDSKADIWSLGITAIELAKGEPP---NSDMHPMR-VLFLIPKN---NPPTLTGEFSKPFK 230
Query: 394 DFVKRLLNKDPRKRLTAAQALSELLI 419
+F+ LNKDP R TA + L I
Sbjct: 231 EFIDACLNKDPSFRPTAKELLKHKFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 99.0 bits (246), Expect = 2e-23
Identities = 77/281 (27%), Positives = 133/281 (47%), Gaps = 28/281 (9%)
Query: 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILR 213
A +EL E VG G +G + K GQ A+KV+ T E++++E+ +L+
Sbjct: 5 AGIFELVELVGNGTYGQVYKGRHVK---TGQLAAIKVMD----VTGDEEEEIKQEINMLK 57
Query: 214 ALTGHNNLVKFFDAYEDT------DNVYVVMELCEGGELLDRIL-SRGGKYTEDDAKAVM 266
+ H N+ ++ A+ D +++VME C G + D I ++G E+ +
Sbjct: 58 KYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYIC 117
Query: 267 IQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDERLNDIVGS 325
+IL ++ H V+HRD+K +N L T EN+ +K +DFG+S R R N +G+
Sbjct: 118 REILRGLSHLHQHKVIHRDIKGQNVLLT---ENAEVKLVDFGVSAQLDRTVGRRNTFIGT 174
Query: 326 AYYVAPEVL------HRSYSTEADVWSIGVIAYILLCGSRPFW-ARTESGIFRAVLKADP 378
Y++APEV+ +Y ++D+WS+G+ A + G+ P +F P
Sbjct: 175 PYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAP 234
Query: 379 SFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLI 419
W S + + F++ L K+ +R T Q + I
Sbjct: 235 RLKSKKW---SKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 102 bits (254), Expect = 2e-23
Identities = 79/230 (34%), Positives = 117/230 (50%), Gaps = 18/230 (7%)
Query: 206 RREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGK---YTEDDA 262
R E+ L A H +VK FD ++ D + ++ME GG+L +I R + + E +
Sbjct: 113 RSELHCLAACD-HFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEV 171
Query: 263 KAVMIQILNVVAFCHLQGVVHRDLKPEN-FLFTTKDENSVLKAIDFGLS----DFVRPDE 317
+ QI+ + H + ++HRDLK N FL T ++K DFG S D V D
Sbjct: 172 GLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPT----GIIKLGDFGFSKQYSDSVSLDV 227
Query: 318 RLNDIVGSAYYVAPEVLHRS-YSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKA 376
+ G+ YY+APE+ R YS +AD+WS+GVI Y LL RPF ++ I + VL
Sbjct: 228 A-SSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYG 286
Query: 377 DPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLICYQSYLF 426
+D P P +SS + + LL+K+P R T Q L + Y + LF
Sbjct: 287 K--YDPFPCP-VSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKYVANLF 333
|
Length = 478 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 98.4 bits (245), Expect = 2e-23
Identities = 80/281 (28%), Positives = 129/281 (45%), Gaps = 39/281 (13%)
Query: 156 KYELGEE-----VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVK 210
+YE E +G+G +G AA+ ++ ++A+K IP+ ++ + E+
Sbjct: 4 EYEYDENGERVVLGKGTYGIVYAARDLSTQV---RIAIKEIPERDSRY---VQPLHEEIA 57
Query: 211 ILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGG--KYTEDDAKAVMIQ 268
+ L H N+V++ + + + ME GG L + S+ G K E Q
Sbjct: 58 LHSYLK-HRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQ 116
Query: 269 ILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDI------ 322
IL + + H +VHRD+K +N L T + V+K DFG S +RL I
Sbjct: 117 ILEGLKYLHDNQIVHRDIKGDNVLVNTY--SGVVKISDFGTS------KRLAGINPCTET 168
Query: 323 -VGSAYYVAPEVLH---RSYSTEADVWSIGVIAYILLCGSRPFW--ARTESGIFR-AVLK 375
G+ Y+APEV+ R Y AD+WS+G + G PF ++ +F+ + K
Sbjct: 169 FTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFK 228
Query: 376 ADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSE 416
P E SLS+EA++F+ R DP KR +A L +
Sbjct: 229 IHPEIPE----SLSAEAKNFILRCFEPDPDKRASAHDLLQD 265
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 99.0 bits (247), Expect = 3e-23
Identities = 78/285 (27%), Positives = 128/285 (44%), Gaps = 44/285 (15%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLV 222
+G G +G A+ G+ VA+K + I I +R E+ +L L H N+V
Sbjct: 15 IGEGTYGIVYRARDTT---SGEIVALKKVRMDNERDGIPISSLR-EITLLLNLR-HPNIV 69
Query: 223 KFFD--AYEDTDNVYVVMELCEG--GELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHL 278
+ + + D++++VME CE LLD + + ++E K +M+Q+L + + H
Sbjct: 70 ELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPT---PFSESQVKCLMLQLLRGLQYLHE 126
Query: 279 QGVVHRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDERLNDIVGSAYYVAPEVL--H 335
++HRDLK N L T K LK DFGL+ + P + + V + +Y APE+L
Sbjct: 127 NFIIHRDLKVSNLLLTDK---GCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGC 183
Query: 336 RSYSTEADVWSIGVIAYILLCGSRPFWARTE-------------------------SGIF 370
+Y+T D+W++G I LL ++E +
Sbjct: 184 TTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVG 243
Query: 371 RAVLKADP-SFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQAL 414
+ L P + + +P LS + LL DP+KR TA +AL
Sbjct: 244 KFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEAL 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 3e-23
Identities = 85/299 (28%), Positives = 140/299 (46%), Gaps = 47/299 (15%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIP----KHKMTTAIAIE-DVRREV 209
N+YE+ +++G G FG K K+ + + K I K + + + IE +V RE+
Sbjct: 13 NEYEVIKKIGNGRFGEVFLVKHKRTQ---EFFCWKAISYRGLKEREKSQLVIEVNVMREL 69
Query: 210 KILRALTGHNNLVKFFDAYEDTDN--VYVVMELCEGGEL---LDRILSRGGKYTEDDAKA 264
K H N+V++ D + + N +Y++ME C+ G+L + + GK E
Sbjct: 70 K-------HKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVD 122
Query: 265 VMIQILNVVAFCHL-------QGVVHRDLKPENFLFTTK--------------DENSVLK 303
+ Q+L+ +A+CH + V+HRDLKP+N +T + + K
Sbjct: 123 ITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAK 182
Query: 304 AIDFGLSDFVRPDERLNDIVGSAYYVAPEVL---HRSYSTEADVWSIGVIAYILLCGSRP 360
DFGLS + + + VG+ YY +PE+L +SY ++D+W++G I Y L G P
Sbjct: 183 IGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTP 242
Query: 361 FWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLI 419
F + LK P + P S E +K LLN ++R +A Q L +I
Sbjct: 243 FHKANNFSQLISELKRGP---DLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQII 298
|
Length = 1021 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 5e-23
Identities = 71/263 (26%), Positives = 131/263 (49%), Gaps = 26/263 (9%)
Query: 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALT 216
+++ +++GRG F A L + VA+K + +M A A +D +E+ +L+ L
Sbjct: 4 FQIEKKIGRGQFSEVYRATC---LLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLN 60
Query: 217 GHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAV--------MIQ 268
H N++K+ D++ + + + +V+EL + G+L I KY + + + +Q
Sbjct: 61 -HPNVIKYLDSFIEDNELNIVLELADAGDLSQMI-----KYFKKQKRLIPERTVWKYFVQ 114
Query: 269 ILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDER-LNDIVGSAY 327
+ + V H + V+HRD+KP N T V+K D GL F + +VG+ Y
Sbjct: 115 LCSAVEHMHSRRVMHRDIKPANVFITA---TGVVKLGDLGLGRFFSSKTTAAHSLVGTPY 171
Query: 328 YVAPEVLHRS-YSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWP 386
Y++PE +H + Y+ ++D+WS+G + Y + PF+ + +F K + D P P
Sbjct: 172 YMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYG-DKMNLFSLCQKIEQC-DYPPLP 229
Query: 387 S--LSSEARDFVKRLLNKDPRKR 407
+ S + R+ V + DP +R
Sbjct: 230 TEHYSEKLRELVSMCIYPDPDQR 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 5e-23
Identities = 72/259 (27%), Positives = 126/259 (48%), Gaps = 18/259 (6%)
Query: 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALT 216
+ + +++GRG F A L G VA+K + + A A D +E+ +L+ L
Sbjct: 4 FRIEKKIGRGQFSEVYRATCL---LDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN 60
Query: 217 GHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYT----EDDAKAVMIQILNV 272
H N++K++ ++ + + + +V+EL + G+L R++ K E +Q+ +
Sbjct: 61 -HPNVIKYYASFIEDNELNIVLELADAGDL-SRMIKHFKKQKRLIPEKTVWKYFVQLCSA 118
Query: 273 VAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDER-LNDIVGSAYYVAP 331
+ H + V+HRD+KP N T V+K D GL F + +VG+ YY++P
Sbjct: 119 LEHMHSRRVMHRDIKPANVFITA---TGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSP 175
Query: 332 EVLHRS-YSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPS--L 388
E +H + Y+ ++D+WS+G + Y + PF+ + ++ K D P PS
Sbjct: 176 ERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN--LYSLCKKIEQCDYPPLPSDHY 233
Query: 389 SSEARDFVKRLLNKDPRKR 407
S E R V +N DP KR
Sbjct: 234 SEELRQLVNMCINPDPEKR 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 98.5 bits (245), Expect = 6e-23
Identities = 77/267 (28%), Positives = 124/267 (46%), Gaps = 17/267 (6%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLV 222
+G+G FG AK K G AVKV+ K + + E +L H LV
Sbjct: 3 IGKGSFGKVLLAKRKS---DGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLV 59
Query: 223 KFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVV 282
+++ + +Y V++ GGEL L R + E A+ ++ + + + H ++
Sbjct: 60 GLHYSFQTAEKLYFVLDYVNGGELFFH-LQRERCFLEPRARFYAAEVASAIGYLHSLNII 118
Query: 283 HRDLKPENFLFTTKDENSVLKAIDFGL-SDFVRPDERLNDIVGSAYYVAPEVLHRS-YST 340
+RDLKPEN L D + DFGL + V P+E + G+ Y+APEVL + Y
Sbjct: 119 YRDLKPENILL---DSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYDR 175
Query: 341 EADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLL 400
D W +G + Y +L G PF++R S ++ +L + A D + LL
Sbjct: 176 TVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLP----GGKTVAACDLLVGLL 231
Query: 401 NKDPRKRLTAAQALSELLICYQSYLFF 427
+KD R+RL A E+ ++++FF
Sbjct: 232 HKDQRRRLGAKADFLEI----KNHVFF 254
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 7e-23
Identities = 69/244 (28%), Positives = 109/244 (44%), Gaps = 14/244 (5%)
Query: 183 GQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN-VYVVMELC 241
G +VA+K++ RRE + L H N+V D+ E ++ V E
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLY-HPNIVALLDSGEAPPGLLFAVFEYV 61
Query: 242 EGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSV 301
G L + L+ G + +M+Q+L+ +A H QG+VHRDLKP+N + +
Sbjct: 62 PGRTLREV-LAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPH 120
Query: 302 LKAIDFG----LSDFVRPDE----RLNDIVGSAYYVAPEVLHRSYST-EADVWSIGVIAY 352
K +DFG L D R +++G+ Y APE L T +D+++ G+I
Sbjct: 121 AKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFL 180
Query: 353 ILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQ 412
L G R + + I L PW + +++ LNKDPR+R +A
Sbjct: 181 ECLTGQRVVQGASVAEILYQQLSPVD-VSLPPWIA-GHPLGQVLRKALNKDPRQRAASAP 238
Query: 413 ALSE 416
AL+E
Sbjct: 239 ALAE 242
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 98.9 bits (246), Expect = 8e-23
Identities = 88/296 (29%), Positives = 131/296 (44%), Gaps = 60/296 (20%)
Query: 163 VGRGHFGYTC-AAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNL 221
+G G FG C A K L A+K + K + + V+ E IL A + +
Sbjct: 9 LGIGAFGEVCLARKVDTKAL----YAMKTLRKKDVLLRNQVAHVKAERDIL-AEADNEWV 63
Query: 222 VKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGV 281
V+ + +++D DN+Y VM+ GG+++ +L R G + ED A+ + ++ V H G
Sbjct: 64 VRLYYSFQDKDNLYFVMDYIPGGDMMS-LLIRMGIFPEDLARFYIAELTCAVESVHKMGF 122
Query: 282 VHRDLKPENFLFTTKDENSVLKAIDFGL---------------SDFVRPD---------- 316
+HRD+KP+N L D + +K DFGL D VR D
Sbjct: 123 IHRDIKPDNILI---DRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGD 179
Query: 317 -------ERL----------------NDIVGSAYYVAPEVLHRS-YSTEADVWSIGVIAY 352
+RL + +VG+ Y+APEVL R+ Y+ D WS+GVI Y
Sbjct: 180 PANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY 239
Query: 353 ILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRL 408
+L G PF A+T V+ S P LS EA D + +L + P RL
Sbjct: 240 EMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRL 294
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 96.7 bits (240), Expect = 1e-22
Identities = 75/262 (28%), Positives = 134/262 (51%), Gaps = 18/262 (6%)
Query: 161 EEVGRGHFGYTCAAKFKKGELKGQQV-AVKVIPKHKMTTAIAIEDVRREVKILRALTGHN 219
E++G+G FG FK + + Q+V A+K+I + I ED+++E+ +L +
Sbjct: 10 EKIGKGSFGEV----FKGIDNRTQKVVAIKIIDLEEAEDEI--EDIQQEITVL-SQCDSP 62
Query: 220 NLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQ 279
+ K++ +Y ++++ME GG LD L G E ++ +IL + + H +
Sbjct: 63 YVTKYYGSYLKDTKLWIIMEYLGGGSALD--LLEPGPLDETQIATILREILKGLDYLHSE 120
Query: 280 GVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDE-RLNDIVGSAYYVAPEVLHRS- 337
+HRD+K N L + E+ +K DFG++ + + + N VG+ +++APEV+ +S
Sbjct: 121 KKIHRDIKAANVLLS---EHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSA 177
Query: 338 YSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVK 397
Y ++AD+WS+G+ A L G P + + K +P E + S ++FV+
Sbjct: 178 YDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNY---SKPLKEFVE 234
Query: 398 RLLNKDPRKRLTAAQALSELLI 419
LNK+P R TA + L I
Sbjct: 235 ACLNKEPSFRPTAKELLKHKFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 2e-22
Identities = 67/236 (28%), Positives = 115/236 (48%), Gaps = 13/236 (5%)
Query: 183 GQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCE 242
Q A+K + M+ ED E++IL ++ H N++ + +A+ D + + +VME
Sbjct: 25 NQFYALKEVDLGSMSQK-EREDAVNEIRILASVN-HPNIISYKEAFLDGNKLCIVMEYAP 82
Query: 243 GGELLDRILSRGGK---YTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDEN 299
G+L I R K E + + IQ+L + H Q ++HRDLK N L N
Sbjct: 83 FGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLV---AN 139
Query: 300 SVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGS 358
++K D G+S V +G+ +Y+APEV R YS ++D+WS+G + Y + +
Sbjct: 140 DLVKIGDLGISK-VLKKNMAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFA 198
Query: 359 RPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQAL 414
PF AR+ + V + + P P S + ++F++ +L P+ R + L
Sbjct: 199 PPFEARSMQDLRYKVQRG--KYPPIP-PIYSQDLQNFIRSMLQVKPKLRPNCDKIL 251
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 96.6 bits (240), Expect = 2e-22
Identities = 74/248 (29%), Positives = 117/248 (47%), Gaps = 9/248 (3%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLV 222
+G+G FG CA + + G+ A K + K ++ E +IL + +V
Sbjct: 8 LGKGGFGEVCACQVRA---TGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF-VV 63
Query: 223 KFFDAYEDTDNVYVVMELCEGGELLDRILSRGGK-YTEDDAKAVMIQILNVVAFCHLQGV 281
AYE D + +V+ + GG+L I + G + E+ A +IL + H +
Sbjct: 64 NLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENT 123
Query: 282 VHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVL-HRSYST 340
V+RDLKPEN L D+ ++ D GL+ + E + VG+ Y+APEVL ++ Y+
Sbjct: 124 VYRDLKPENILL---DDYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNNQRYTL 180
Query: 341 EADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLL 400
D W +G + Y ++ G PF R E V + +E S EA+ K LL
Sbjct: 181 SPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICKMLL 240
Query: 401 NKDPRKRL 408
KDP++RL
Sbjct: 241 TKDPKQRL 248
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 96.3 bits (239), Expect = 2e-22
Identities = 74/262 (28%), Positives = 132/262 (50%), Gaps = 18/262 (6%)
Query: 161 EEVGRGHFGYTCAAKFKKGELKGQQV-AVKVIPKHKMTTAIAIEDVRREVKILRALTGHN 219
E +G+G FG +K + + ++V A+K+I + I ED+++E+ +L +
Sbjct: 10 ERIGKGSFGEV----YKGIDNRTKEVVAIKIIDLEEAEDEI--EDIQQEITVL-SQCDSP 62
Query: 220 NLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQ 279
+ +++ +Y ++++ME GG LD L + G E ++ +IL + + H +
Sbjct: 63 YITRYYGSYLKGTKLWIIMEYLGGGSALD--LLKPGPLEETYIATILREILKGLDYLHSE 120
Query: 280 GVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDE-RLNDIVGSAYYVAPEVLHRS- 337
+HRD+K N L + E +K DFG++ + + + N VG+ +++APEV+ +S
Sbjct: 121 RKIHRDIKAANVLLS---EQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSA 177
Query: 338 YSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVK 397
Y +AD+WS+G+ A L G P + + K P E + S ++FV+
Sbjct: 178 YDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQY---SKPFKEFVE 234
Query: 398 RLLNKDPRKRLTAAQALSELLI 419
LNKDPR R TA + L I
Sbjct: 235 ACLNKDPRFRPTAKELLKHKFI 256
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 97.1 bits (241), Expect = 2e-22
Identities = 71/254 (27%), Positives = 122/254 (48%), Gaps = 18/254 (7%)
Query: 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALT 216
+E+ + +GRG FG K K + + A+K++ K +M R E +L +
Sbjct: 3 FEILKVIGRGAFGEVAVVKLKNAD---KVFAMKILNKWEMLKRAETACFREERDVL--VN 57
Query: 217 GHNNLVKFFD-AYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAF 275
G N + A++D +N+Y+VM+ GG+LL + + ED A+ + +++ +
Sbjct: 58 GDNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDS 117
Query: 276 CHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLND--IVGSAYYVAPEV 333
H VHRD+KP+N L D N ++ DFG + D + VG+ Y++PE+
Sbjct: 118 VHQLHYVHRDIKPDNILM---DMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEI 174
Query: 334 LHR------SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFD-EAPWP 386
L Y E D WS+GV Y +L G PF+A + + ++ F A
Sbjct: 175 LQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVT 234
Query: 387 SLSSEARDFVKRLL 400
+S +A+D ++RL+
Sbjct: 235 DVSEDAKDLIRRLI 248
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 2e-22
Identities = 61/222 (27%), Positives = 107/222 (48%), Gaps = 20/222 (9%)
Query: 159 LGEEVGRGHFGYTCAAKFKKGELKGQ-QVAVKVIPKHKMTTAIAIEDVRREVKILRALTG 217
+E+G G FG G+ +G+ VA+K+I + M+ +D E K++ L+
Sbjct: 8 FLKELGSGQFGVV-----HLGKWRGKIDVAIKMIREGAMSE----DDFIEEAKVMMKLS- 57
Query: 218 HNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCH 277
H NLV+ + +++V E G LL+ + R GK + + + + +
Sbjct: 58 HPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLE 117
Query: 278 LQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYV---APEVL 334
G +HRDL N L E++V+K DFGL+ +V D+ + G+ + V PEV
Sbjct: 118 SNGFIHRDLAARNCLV---GEDNVVKVSDFGLARYVLDDQYTSS-QGTKFPVKWAPPEVF 173
Query: 335 HRS-YSTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAVL 374
S +S+++DVWS GV+ + + G P+ + S + +V
Sbjct: 174 DYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVS 215
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 96.6 bits (241), Expect = 2e-22
Identities = 92/326 (28%), Positives = 134/326 (41%), Gaps = 97/326 (29%)
Query: 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKM-----TTAIAIEDVRREVKI 211
YE+ ++G G FG A+ K G+ VA+K I H TA+ RE+KI
Sbjct: 10 YEILGKLGEGTFGEVYKARQIK---TGRVVALKKILMHNEKDGFPITAL------REIKI 60
Query: 212 LRALTGHNNLVKFFD-AYEDTDN-------VYVVM-----ELCEGGELLD--RILSRGGK 256
L+ L H N+V D A E D VY+V +L LL+ + K
Sbjct: 61 LKKLK-HPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSG---LLENPSV-----K 111
Query: 257 YTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP- 315
TE K M+Q+L + + H ++HRD+K N L D +LK DFGL+ RP
Sbjct: 112 LTESQIKCYMLQLLEGINYLHENHILHRDIKAANILI---DNQGILKIADFGLA---RPY 165
Query: 316 --------------DERLNDIVGSAYYVAPEVL--HRSYSTEADVWSIGVIAYILLCGSR 359
+ ++V + +Y PE+L R Y+T D+W IG + + R
Sbjct: 166 DGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTR-R 224
Query: 360 P-FWARTE----SGIFRAVLKADPSFDEAPWP--------------------------SL 388
P +++ IF+ P+ E WP L
Sbjct: 225 PILQGKSDIDQLHLIFKLC--GTPT--EETWPGWRSLPGCEGVHSFTNYPRTLEERFGKL 280
Query: 389 SSEARDFVKRLLNKDPRKRLTAAQAL 414
E D + +LL+ DP KRLTA+ AL
Sbjct: 281 GPEGLDLLSKLLSLDPYKRLTASDAL 306
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 96.2 bits (239), Expect = 2e-22
Identities = 81/284 (28%), Positives = 125/284 (44%), Gaps = 32/284 (11%)
Query: 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVI-PKHKMTTAIAIEDVRREVKIL 212
+ +E+ E +G+G +G KK G AVK++ P + E++ E IL
Sbjct: 21 TDTWEIIETIGKGTYGKVYKVTNKK---DGSLAAVKILDPISDVD-----EEIEAEYNIL 72
Query: 213 RALTGHNNLVKFFDAYEDTDN-----VYVVMELCEGG---ELLDRILSRGGKYTEDDAKA 264
++L H N+VKF+ + D +++V+ELC GG EL+ +L G + E
Sbjct: 73 QSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISY 132
Query: 265 VMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDERLNDIV 323
++ L + H ++HRD+K N L TT E V K +DFG+S R N V
Sbjct: 133 ILYGALLGLQHLHNNRIIHRDVKGNNILLTT--EGGV-KLVDFGVSAQLTSTRLRRNTSV 189
Query: 324 GSAYYVAPEVL------HRSYSTEADVWSIGVIAYILLCGSRP-FWARTESGIFRAVLKA 376
G+ +++APEV+ SY DVWS+G+ A L G P F +F+
Sbjct: 190 GTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNP 249
Query: 377 DPSF-DEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLI 419
P+ W F+ + L KD R + L I
Sbjct: 250 PPTLLHPEKW---CRSFNHFISQCLIKDFEARPSVTHLLEHPFI 290
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 3e-22
Identities = 76/249 (30%), Positives = 119/249 (47%), Gaps = 11/249 (4%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLV 222
+G+G FG CA + K G+ A K + K ++ + E KIL +V
Sbjct: 1 LGKGGFGEVCACQVKA---TGKMYACKKLDKKRLKKRKGEQMALNEKKIL-EKVSSRFIV 56
Query: 223 KFFDAYEDTDNVYVVMELCEGGELLDRILSRGGK-YTEDDAKAVMIQILNVVAFCHLQGV 281
A+E D++ +VM L GG+L I + G + E A QI+ + H + +
Sbjct: 57 SLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRI 116
Query: 282 VHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRS-YST 340
V+RDLKPEN L D++ ++ D GL+ ++ +++ G+ Y+APEVL Y
Sbjct: 117 VYRDLKPENVLL---DDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEVYDF 173
Query: 341 EADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWP-SLSSEARDFVKRL 399
D +++G Y ++ G PF R E + + LK +P S EA+D + L
Sbjct: 174 SVDWFALGCTLYEMIAGRSPFRQRKEK-VEKEELKRRTLEMAVEYPDKFSPEAKDLCEAL 232
Query: 400 LNKDPRKRL 408
L KDP KRL
Sbjct: 233 LQKDPEKRL 241
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 96.6 bits (240), Expect = 3e-22
Identities = 78/269 (28%), Positives = 124/269 (46%), Gaps = 17/269 (6%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLV 222
+G+G FG AK K L G+ AVKV+ K + + + E +L H LV
Sbjct: 3 IGKGSFGKVLLAKRK---LDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLV 59
Query: 223 KFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVV 282
+++ T+ +Y V++ GGEL L R + E A+ +I + + + H +V
Sbjct: 60 GLHYSFQTTEKLYFVLDFVNGGELFFH-LQRERSFPEPRARFYAAEIASALGYLHSINIV 118
Query: 283 HRDLKPENFLFTTKDENSVLKAIDFGL-SDFVRPDERLNDIVGSAYYVAPEVLHRS-YST 340
+RDLKPEN L D + DFGL + + + G+ Y+APEV+ + Y
Sbjct: 119 YRDLKPENILL---DSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDN 175
Query: 341 EADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLL 400
D W +G + Y +L G PF+ R + ++ +L P S A ++ LL
Sbjct: 176 TVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLR----PGASLTAWSILEELL 231
Query: 401 NKDPRKRLTAAQALSELLICYQSYLFFYS 429
KD ++RL A + E+ Q + FF S
Sbjct: 232 EKDRQRRLGAKEDFLEI----QEHPFFES 256
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 96.7 bits (240), Expect = 3e-22
Identities = 70/257 (27%), Positives = 123/257 (47%), Gaps = 22/257 (8%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLV 222
+GRG + + KK E + A+KV+ K + I+ V+ E + + H LV
Sbjct: 3 IGRGSYAKVLLVRLKKTE---RIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLV 59
Query: 223 KFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVV 282
++ ++ V+E GG+L+ + R K E+ A+ +I + + H +G++
Sbjct: 60 GLHSCFQTESRLFFVIEYVNGGDLMFH-MQRQRKLPEEHARFYSAEISLALNYLHERGII 118
Query: 283 HRDLKPENFLFTTKDENSVLKAIDFGL-SDFVRPDERLNDIVGSAYYVAPEVLH-RSYST 340
+RDLK +N L D +K D+G+ + +RP + + G+ Y+APE+L Y
Sbjct: 119 YRDLKLDNVLL---DSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGF 175
Query: 341 EADVWSIGVIAYILLCGSRPF---------WARTESGIFRAVLKADPSFDEAPWPSLSSE 391
D W++GV+ + ++ G PF TE +F+ +L+ SLS +
Sbjct: 176 SVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR----SLSVK 231
Query: 392 ARDFVKRLLNKDPRKRL 408
A +K LNKDP++RL
Sbjct: 232 AASVLKSFLNKDPKERL 248
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 95.9 bits (238), Expect = 3e-22
Identities = 77/264 (29%), Positives = 131/264 (49%), Gaps = 21/264 (7%)
Query: 156 KYELGEEVGRGHFG--YTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILR 213
KY E++G+G G YT E+ +Q+ ++ PK ++ + E+ ++R
Sbjct: 20 KYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKEL--------IINEILVMR 71
Query: 214 ALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVV 273
+ N+V + D+Y D ++VVME GG L D + E AV + L +
Sbjct: 72 E-NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC--MDEGQIAAVCRECLQAL 128
Query: 274 AFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDE-RLNDIVGSAYYVAPE 332
F H V+HRD+K +N L + +K DFG + P++ + + +VG+ Y++APE
Sbjct: 129 DFLHSNQVIHRDIKSDNILLGM---DGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPE 185
Query: 333 VLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPS-LSS 390
V+ R +Y + D+WS+G++A ++ G P+ E+ + L A E P LS+
Sbjct: 186 VVTRKAYGPKVDIWSLGIMAIEMVEGEPPYL--NENPLRALYLIATNGTPELQNPERLSA 243
Query: 391 EARDFVKRLLNKDPRKRLTAAQAL 414
RDF+ R L D +R +A + L
Sbjct: 244 VFRDFLNRCLEMDVDRRGSAKELL 267
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.8 bits (239), Expect = 4e-22
Identities = 92/320 (28%), Positives = 135/320 (42%), Gaps = 70/320 (21%)
Query: 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVI--PKHKMT----TAIAIEDVRREV 209
KYE+ +GRG +G AK K G+ G++ A+K K + T +A RE+
Sbjct: 1 KYEIEGCIGRGTYGRVYKAKRKNGK-DGKEYAIKKFKGDKEQYTGISQSAC------REI 53
Query: 210 KILRALTGHNNLVKFFDAY-EDTD-NVYVVMELCEGGELLDRI----LSRGGKYTEDDAK 263
+LR L H N+V + + E D +VY++ + E +L I ++ K
Sbjct: 54 ALLRELK-HENVVSLVEVFLEHADKSVYLLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVK 111
Query: 264 AVMIQILNVVAFCHLQGVVHRDLKPENFLFT-TKDENSVLKAIDFGLSDFV----RPDER 318
+++ QILN V + H V+HRDLKP N L E V+K D GL+ +P
Sbjct: 112 SLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLAD 171
Query: 319 LNDIVGSAYYVAPEVL--HRSYSTEADVWSIGVIAYILLCGSRPFWARTES--------- 367
L+ +V + +Y APE+L R Y+ D+W+IG I LL F R
Sbjct: 172 LDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQR 231
Query: 368 ----GIFR-------------------AVLKADPSFDEAPWPSL----------SSEARD 394
IF L D P SL S+ D
Sbjct: 232 DQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFD 291
Query: 395 FVKRLLNKDPRKRLTAAQAL 414
+++LL DP KR+TA +AL
Sbjct: 292 LLRKLLEYDPTKRITAEEAL 311
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 95.8 bits (238), Expect = 5e-22
Identities = 73/257 (28%), Positives = 122/257 (47%), Gaps = 23/257 (8%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLV 222
+G+G FG A+ K + A+K++ K + +E E ++L L
Sbjct: 8 LGKGSFGKVMLAERKG---TDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLT 64
Query: 223 KFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVV 282
+ ++ D +Y VME GG+L+ I + GK+ E A +I + F H +G++
Sbjct: 65 QLHSCFQTVDRLYFVMEYVNGGDLMYHI-QQVGKFKEPQAVFYAAEISVGLFFLHRRGII 123
Query: 283 HRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIV------GSAYYVAPEVL-H 335
+RDLK +N + D +K DFG+ E + D V G+ Y+APE++ +
Sbjct: 124 YRDLKLDNVML---DSEGHIKIADFGMCK-----EHMVDGVTTRTFCGTPDYIAPEIIAY 175
Query: 336 RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDF 395
+ Y D W+ GV+ Y +L G PF E +F+++++ + S+ + SLS EA
Sbjct: 176 QPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPK----SLSKEAVSI 231
Query: 396 VKRLLNKDPRKRLTAAQ 412
K L+ K P KRL
Sbjct: 232 CKGLMTKHPSKRLGCGP 248
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 6e-22
Identities = 73/263 (27%), Positives = 125/263 (47%), Gaps = 24/263 (9%)
Query: 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALT 216
+E+ + +GRG FG K K E + A+K++ K +M R E +L +
Sbjct: 3 FEIIKVIGRGAFGEVAVVKMKHTE---RIYAMKILNKWEMLKRAETACFREERNVL--VN 57
Query: 217 GHNNLVKFFD-AYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAF 275
G + A++D + +Y+VM+ GG+LL + + ED A+ + +++ +
Sbjct: 58 GDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHS 117
Query: 276 CHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLND--IVGSAYYVAPEV 333
H VHRD+KP+N L D N ++ DFG + D + VG+ Y++PE+
Sbjct: 118 IHQLHYVHRDIKPDNVLL---DMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEI 174
Query: 334 LHR------SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPS 387
L Y E D WS+GV Y +L G PF+A + + ++ + F +PS
Sbjct: 175 LQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQ---FPS 231
Query: 388 ----LSSEARDFVKRLLNKDPRK 406
+S EA+D ++RL+ R+
Sbjct: 232 HITDVSEEAKDLIQRLICSRERR 254
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.0 bits (236), Expect = 8e-22
Identities = 68/248 (27%), Positives = 120/248 (48%), Gaps = 14/248 (5%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLV 222
+G+G FG + K+ + A+K I K + + + E +L A +V
Sbjct: 1 IGKGSFGKVMQVR-KRDTQR--IYALKTIRKAHIVSRSEVTHTLAERTVL-AQVNCPFIV 56
Query: 223 KFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVV 282
+++ + +Y+V+ GGEL L R G++ A+ ++L + H V+
Sbjct: 57 PLKFSFQSPEKLYLVLAFINGGELFHH-LQREGRFDLSRARFYTAELLCALENLHKFNVI 115
Query: 283 HRDLKPENFLFTTKDENSVLKAIDFGLSDF-VRPDERLNDIVGSAYYVAPEVLH-RSYST 340
+RDLKPEN L D + DFGL ++ D++ N G+ Y+APE+L Y+
Sbjct: 116 YRDLKPENILL---DYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTK 172
Query: 341 EADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLL 400
D W++GV+ Y +L G PF+ + ++R +L+ F + +A+D + LL
Sbjct: 173 AVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPD----GFDRDAKDLLIGLL 228
Query: 401 NKDPRKRL 408
++DP +RL
Sbjct: 229 SRDPTRRL 236
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 94.5 bits (235), Expect = 1e-21
Identities = 78/269 (28%), Positives = 127/269 (47%), Gaps = 17/269 (6%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLV 222
+G+G FG AK K G+ AVKV+ K + + + E +L H LV
Sbjct: 3 IGKGSFGKVLLAKHK---ADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLV 59
Query: 223 KFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVV 282
+++ D +Y V++ GGEL L R + E A+ +I + + + H ++
Sbjct: 60 GLHYSFQTADKLYFVLDYVNGGELFFH-LQRERSFPEPRARFYAAEIASALGYLHSLNII 118
Query: 283 HRDLKPENFLFTTKDENSVLKAIDFGL-SDFVRPDERLNDIVGSAYYVAPEVLHRS-YST 340
+RDLKPEN L D + DFGL + + + + G+ Y+APEVL + Y
Sbjct: 119 YRDLKPENILL---DSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYDR 175
Query: 341 EADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLL 400
D W +G + Y +L G PF++R + ++ +L P++S AR ++ LL
Sbjct: 176 TVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLK----PNISVSARHLLEGLL 231
Query: 401 NKDPRKRLTAAQALSELLICYQSYLFFYS 429
KD KRL A E+ ++++FF S
Sbjct: 232 QKDRTKRLGAKDDFLEI----KNHVFFSS 256
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 2e-21
Identities = 86/296 (29%), Positives = 132/296 (44%), Gaps = 49/296 (16%)
Query: 158 ELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTG 217
E +G G FG + + G++VA+K +P + ++ + V RE+K+L
Sbjct: 3 EPDRPIGYGAFGVVWSVTDPR---DGKRVALKKMP-NVFQNLVSCKRVFRELKMLCFFK- 57
Query: 218 HNNLVKFFDAYEDTD-----NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNV 272
H+N++ D + +YVV EL + L +I+ + D K + QIL
Sbjct: 58 HDNVLSALDILQPPHIDPFEEIYVVTELMQSD--LHKIIVSPQPLSSDHVKVFLYQILRG 115
Query: 273 VAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDI--VGSAYYVA 330
+ + H G++HRD+KP N L + N VLK DFGL+ PDE + V + YY A
Sbjct: 116 LKYLHSAGILHRDIKPGNLLVNS---NCVLKICDFGLARVEEPDESKHMTQEVVTQYYRA 172
Query: 331 PEVL--HRSYSTEADVWSIGVIAYILLCGSRPFWART----------------------- 365
PE+L R Y++ D+WS+G I LL F A++
Sbjct: 173 PEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSA 232
Query: 366 ----ESGIFRAVLKADPSFDEAPWPS--LSSEARDFVKRLLNKDPRKRLTAAQALS 415
+ I R K PS S + EA + R+L DP KR++AA AL+
Sbjct: 233 CEGARAHILRGPHKP-PSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALA 287
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 93.0 bits (231), Expect = 2e-21
Identities = 66/267 (24%), Positives = 118/267 (44%), Gaps = 21/267 (7%)
Query: 160 GEEVGRGHFGYTC--AAKFKKGELKGQQVAVKVIPKHKMTTA---IAIEDVRREVKILRA 214
G+++G G F +C A K G L +AVK + + T++ +E +R+E++++
Sbjct: 5 GQQLGTGAFS-SCYQARDVKTGTL----MAVKQVTYVRNTSSEQEEVVEALRKEIRLMAR 59
Query: 215 LTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVA 274
L H ++++ A + + + +E GG + +LS+ G + E Q+L ++
Sbjct: 60 LN-HPHIIRMLGATCEDSHFNLFVEWMAGGSV-SHLLSKYGAFKEAVIINYTEQLLRGLS 117
Query: 275 FCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGL-----SDFVRPDERLNDIVGSAYYV 329
+ H ++HRD+K N L + + L+ DFG + E ++G+ ++
Sbjct: 118 YLHENQIIHRDVKGANLLIDSTGQR--LRIADFGAAARLAAKGTGAGEFQGQLLGTIAFM 175
Query: 330 APEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPS- 387
APEVL Y DVWS+G + + P+ A S + K + P
Sbjct: 176 APEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEH 235
Query: 388 LSSEARDFVKRLLNKDPRKRLTAAQAL 414
LS RD R L P R + + L
Sbjct: 236 LSPGLRDVTLRCLELQPEDRPPSRELL 262
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 2e-21
Identities = 82/273 (30%), Positives = 131/273 (47%), Gaps = 35/273 (12%)
Query: 157 YELGEEVGRGHFGYTCAAK-FKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRAL 215
+EL + +G G +G A+ GEL A+KVI K+ V++E+ +++
Sbjct: 11 FELIQRIGSGTYGDVYKARNVNTGEL----AAIKVI---KLEPGEDFAVVQQEIIMMKDC 63
Query: 216 TGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAF 275
H+N+V +F +Y D +++ ME C GG L D I G +E V + L + +
Sbjct: 64 K-HSNIVAYFGSYLRRDKLWICMEFCGGGSLQD-IYHVTGPLSESQIAYVSRETLQGLYY 121
Query: 276 CHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPD-ERLNDIVGSAYYVAPEV- 333
H +G +HRD+K N L T +N +K DFG+S + + +G+ Y++APEV
Sbjct: 122 LHSKGKMHRDIKGANILLT---DNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVA 178
Query: 334 -LHRS--YSTEADVWSIGVIAYIL---------LCGSRPFWARTESGIFRAVLKADPSFD 381
+ R Y+ D+W++G+ A L L R + T+S LK D
Sbjct: 179 AVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLK-----D 233
Query: 382 EAPWPSLSSEARDFVKRLLNKDPRKRLTAAQAL 414
+ W S+ FVK L K+P+KR TA + L
Sbjct: 234 KMKW---SNSFHHFVKMALTKNPKKRPTAEKLL 263
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 2e-21
Identities = 80/300 (26%), Positives = 124/300 (41%), Gaps = 49/300 (16%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRA 214
+K+++ ++G G +G A+ K G+ VA+K + I +R E+KILR
Sbjct: 7 DKFDIIGQIGEGTYGQVYKARDK---DTGELVALKKVRLDNEKEGFPITAIR-EIKILRQ 62
Query: 215 LTGHNNLVKF----------FDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKA 264
L H N+V D +D Y+V E + +L+ + S ++ED K+
Sbjct: 63 LN-HRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKS 120
Query: 265 VMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDER--LNDI 322
M Q+L + +CH + +HRD+K N L K + +K DFGL+ +E +
Sbjct: 121 FMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQ---IKLADFGLARLYNSEESRPYTNK 177
Query: 323 VGSAYYVAPEVL--HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSF 380
V + +Y PE+L Y DVWS G I L F A E + + S
Sbjct: 178 VITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSP 237
Query: 381 DEAPWPS--------------------------LSSEARDFVKRLLNKDPRKRLTAAQAL 414
A WP + + A D + +L DP KR TA +AL
Sbjct: 238 CPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEAL 297
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 2e-21
Identities = 82/277 (29%), Positives = 132/277 (47%), Gaps = 35/277 (12%)
Query: 157 YELGEEVGRGHFGYTCAA-KFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRAL 215
YEL + VG G +G A GEL AVK+I K+ +++E+ +++
Sbjct: 11 YELIQRVGSGTYGDVYKARNLHTGEL----AAVKII---KLEPGDDFSLIQQEIFMVKEC 63
Query: 216 TGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAF 275
H N+V +F +Y + +++ ME C GG L D I G +E V + L +A+
Sbjct: 64 K-HCNIVAYFGSYLSREKLWICMEYCGGGSLQD-IYHVTGPLSELQIAYVCRETLQGLAY 121
Query: 276 CHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPD-ERLNDIVGSAYYVAPEVL 334
H +G +HRD+K N L T +N +K DFG++ + + +G+ Y++APEV
Sbjct: 122 LHSKGKMHRDIKGANILLT---DNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVA 178
Query: 335 ----HRSYSTEADVWSIGVIAYIL---------LCGSRPFWARTESGIFRAVLKADPSFD 381
+ Y+ D+W++G+ A L L R + ++S LK D
Sbjct: 179 AVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLK-----D 233
Query: 382 EAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELL 418
+ W SS +FVK L K+P+KR TA + L+ L
Sbjct: 234 KTKW---SSTFHNFVKISLTKNPKKRPTAERLLTHLF 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 92.3 bits (229), Expect = 3e-21
Identities = 73/268 (27%), Positives = 130/268 (48%), Gaps = 29/268 (10%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIED--VRREVKILRALTGHNN 220
VG+G +G + + G+Q VI K + A E +E ++L L H N
Sbjct: 8 VGKGSYGEVSLVRHRT---DGKQY---VIKKLNLRNASRRERKAAEQEAQLLSQLK-HPN 60
Query: 221 LVKFFDAYEDTDN-VYVVMELCEGGELLDRILSRGGK-YTEDDAKAVMIQILNVVAFCHL 278
+V + +++E D +Y+VM CEGG+L ++ + GK E+ +QI + + H
Sbjct: 61 IVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHE 120
Query: 279 QGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLND----IVGSAYYVAPEVL 334
+ ++HRDLK +N T +++K D G++ R E D ++G+ YY++PE+
Sbjct: 121 KHILHRDLKTQNVFLT---RTNIIKVGDLGIA---RVLENQCDMASTLIGTPYYMSPELF 174
Query: 335 -HRSYSTEADVWSIGVIAYILLCGSRPFWAR-TESGIFRAVLKADPSFDEAPWPS-LSSE 391
++ Y+ ++DVW++G Y + F A+ S ++R + P P P S E
Sbjct: 175 SNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLP-----PMPKDYSPE 229
Query: 392 ARDFVKRLLNKDPRKRLTAAQALSELLI 419
+ + +L+K P KR + L + I
Sbjct: 230 LGELIATMLSKRPEKRPSVKSILRQPYI 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 3e-21
Identities = 73/254 (28%), Positives = 128/254 (50%), Gaps = 25/254 (9%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNN-L 221
+G+G FG A+ K + + A+K++ K + +E E ++L AL+G L
Sbjct: 8 LGKGSFGKVMLAERKGTD---ELYAIKILKKDVVIQDDDVECTMVEKRVL-ALSGKPPFL 63
Query: 222 VKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGV 281
+ ++ D +Y VME GG+L+ +I + G++ E A +I + F H +G+
Sbjct: 64 TQLHSCFQTMDRLYFVMEYVNGGDLMYQI-QQVGRFKEPHAVFYAAEIAIGLFFLHSKGI 122
Query: 282 VHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIV------GSAYYVAPEVL- 334
++RDLK +N + D +K DFG+ E + D V G+ Y+APE++
Sbjct: 123 IYRDLKLDNVML---DSEGHIKIADFGMCK-----ENMWDGVTTKTFCGTPDYIAPEIIA 174
Query: 335 HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARD 394
++ Y D W+ GV+ Y +L G PF E +F+++++ + ++ + S+S EA
Sbjct: 175 YQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPK----SMSKEAVA 230
Query: 395 FVKRLLNKDPRKRL 408
K L+ K P KRL
Sbjct: 231 ICKGLMTKHPGKRL 244
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 91.7 bits (228), Expect = 4e-21
Identities = 59/197 (29%), Positives = 89/197 (45%), Gaps = 21/197 (10%)
Query: 158 ELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTG 217
+LG +G+G FG G+ +GQ+VAVK + K T A A E ++ L
Sbjct: 9 KLGATIGKGEFG-----DVMLGDYRGQKVAVKCL-KDDSTAAQAFLA---EASVMTTLR- 58
Query: 218 HNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKY-TEDDAKAVMIQILNVVAFC 276
H NLV+ + +Y+V E G L+D + SRG T + + + +
Sbjct: 59 HPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYL 118
Query: 277 HLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGS--AYYVAPEVL 334
+ VHRDL N L E+ V K DFGL+ + G + APE L
Sbjct: 119 EEKNFVHRDLAARNVLV---SEDLVAKVSDFGLAK----EASQGQDSGKLPVKWTAPEAL 171
Query: 335 -HRSYSTEADVWSIGVI 350
+ +ST++DVWS G++
Sbjct: 172 REKKFSTKSDVWSFGIL 188
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 93.0 bits (231), Expect = 5e-21
Identities = 71/257 (27%), Positives = 122/257 (47%), Gaps = 22/257 (8%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLV 222
+GRG + + KK + A+KVI K + I+ V+ E + + H LV
Sbjct: 3 IGRGSYAKVLLVELKKTR---RIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLV 59
Query: 223 KFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVV 282
++ ++ V+E GG+L+ + R K E+ A+ +I + F H +G++
Sbjct: 60 GLHSCFQTESRLFFVIEFVSGGDLMFH-MQRQRKLPEEHARFYSAEISLALNFLHERGII 118
Query: 283 HRDLKPENFLFTTKDENSVLKAIDFGL-SDFVRPDERLNDIVGSAYYVAPEVLH-RSYST 340
+RDLK +N L D +K D+G+ + +RP + + G+ Y+APE+L Y
Sbjct: 119 YRDLKLDNVLL---DAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGF 175
Query: 341 EADVWSIGVIAYILLCGSRPF---------WARTESGIFRAVLKADPSFDEAPWPSLSSE 391
D W++GV+ + ++ G PF TE +F+ +L+ SLS +
Sbjct: 176 SVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPR----SLSVK 231
Query: 392 ARDFVKRLLNKDPRKRL 408
A +K LNKDP++RL
Sbjct: 232 ASSVLKGFLNKDPKERL 248
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 5e-21
Identities = 70/253 (27%), Positives = 116/253 (45%), Gaps = 32/253 (12%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKIL---RALTGHN 219
+GRG FG + + + Q A+K++ K +M R + R + H
Sbjct: 51 IGRGAFG---EVQLVRHKSSKQVYAMKLLSKFEMIK-------RSDSAFFWEERDIMAHA 100
Query: 220 N---LVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFC 276
N +V+ A++D +Y+VME GG+L++ L E A+ +++ +
Sbjct: 101 NSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVN--LMSNYDIPEKWARFYTAEVVLALDAI 158
Query: 277 HLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDE----RLNDIVGSAYYVAPE 332
H G +HRD+KP+N L D++ LK DFG ++ D R + VG+ Y++PE
Sbjct: 159 HSMGFIHRDVKPDNMLL---DKSGHLKLADFGTC--MKMDANGMVRCDTAVGTPDYISPE 213
Query: 333 VL-----HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPS 387
VL Y E D WS+GV Y +L G PF+A + G + ++ S
Sbjct: 214 VLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIE 273
Query: 388 LSSEARDFVKRLL 400
+S +A+D + L
Sbjct: 274 ISKQAKDLICAFL 286
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 1e-20
Identities = 83/299 (27%), Positives = 136/299 (45%), Gaps = 56/299 (18%)
Query: 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRAL 215
+Y+ VG G +G CAA K L+ VAVK + + + I + RE+++L+ +
Sbjct: 18 RYQNLSPVGSGAYGSVCAAFDTKTGLR---VAVKKLSR-PFQSIIHAKRTYRELRLLKHM 73
Query: 216 TGHNNLVKFFDAY------EDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQI 269
H N++ D + E+ ++VY+V L G L+ I+ + K T+D + ++ QI
Sbjct: 74 K-HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIV-KCQKLTDDHVQFLIYQI 129
Query: 270 LNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYV 329
L + + H ++HRDLKP N +E+ LK +DFGL+ D+ + V + +Y
Sbjct: 130 LRGLKYIHSADIIHRDLKPSNL---AVNEDCELKILDFGLARHT--DDEMTGYVATRWYR 184
Query: 330 APEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPS 387
APE++ Y+ D+WS+G I LL G F + +L+ P
Sbjct: 185 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR----LVGTPGAE 240
Query: 388 L-----SSEAR--------------------------DFVKRLLNKDPRKRLTAAQALS 415
L S AR D ++++L D KR+TAAQAL+
Sbjct: 241 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 299
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 92.0 bits (229), Expect = 1e-20
Identities = 84/307 (27%), Positives = 135/307 (43%), Gaps = 71/307 (23%)
Query: 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVR------REV 209
KY + +GRG +G C+AK ++VA+K I A ++ RE+
Sbjct: 6 KYVPIKPIGRGAYGIVCSAK---NSETNEKVAIKKIAN-------AFDNRIDAKRTLREI 55
Query: 210 KILRALTGHNNLVKFFD--------AYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDD 261
K+LR L H N++ D A+ D VY+V EL + L +I+ ++D
Sbjct: 56 KLLRHLD-HENVIAIKDIMPPPHREAFND---VYIVYELMDTD--LHQIIRSSQTLSDDH 109
Query: 262 AKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP----DE 317
+ + Q+L + + H V+HRDLKP N L + N LK DFGL+ R +
Sbjct: 110 CQYFLYQLLRGLKYIHSANVLHRDLKPSNLLL---NANCDLKICDFGLA---RTTSEKGD 163
Query: 318 RLNDIVGSAYYVAPEVLHRS--YSTEADVWSIGVIAYILLCGSRPFWARTE--------- 366
+ + V + +Y APE+L Y+T DVWS+G I LL G +P + +
Sbjct: 164 FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELL-GRKPLFPGKDYVHQLKLIT 222
Query: 367 ---------------SGIFRAVLKADPSFDEAP----WPSLSSEARDFVKRLLNKDPRKR 407
+ R +++ P +P + A D ++++L DP KR
Sbjct: 223 ELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKR 282
Query: 408 LTAAQAL 414
+T +AL
Sbjct: 283 ITVEEAL 289
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.7 bits (225), Expect = 1e-20
Identities = 73/252 (28%), Positives = 116/252 (46%), Gaps = 17/252 (6%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLV 222
+G+G FG CA + + G+ A K + K ++ E +IL + +V
Sbjct: 8 LGKGGFGEVCACQVR---ATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF-VV 63
Query: 223 KFFDAYEDTDNVYVVMELCEGGELLDRILSRG-GKYTEDDAKAVMIQILNVVAFCHLQGV 281
AYE D + +V+ L GG+L I + G + E+ A +I + H + +
Sbjct: 64 SLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERI 123
Query: 282 VHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVL-HRSYST 340
V+RDLKPEN L D+ ++ D GL+ + E + VG+ Y+APEV+ + Y+
Sbjct: 124 VYRDLKPENILL---DDYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAPEVVKNERYTF 180
Query: 341 EADVWSIGVIAYILLCGSRPFWARTE----SGIFRAVLKADPSFDEAPWPSLSSEARDFV 396
D W +G + Y ++ G PF R E + R V + + E S AR
Sbjct: 181 SPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSE----KFSEAARSIC 236
Query: 397 KRLLNKDPRKRL 408
++LL KDP RL
Sbjct: 237 RQLLTKDPGFRL 248
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 2e-20
Identities = 74/255 (29%), Positives = 125/255 (49%), Gaps = 23/255 (9%)
Query: 157 YELGEEVGRGHFG--YTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRA 214
+ LG+ +G+G FG Y C EL +QV P+ T+ + + E+++L+
Sbjct: 4 WRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFD--PESPETSK-EVNALECEIQLLKN 60
Query: 215 LTGHNNLVKFFDAYEDT--DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNV 272
L H +V+++ D + + ME GG + D++ S G TE+ + QIL
Sbjct: 61 LL-HERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGA-LTENVTRKYTRQILEG 118
Query: 273 VAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR----PDERLNDIVGSAYY 328
V++ H +VHRD+K N L +D +K DFG S ++ + + G+ Y+
Sbjct: 119 VSYLHSNMIVHRDIKGANIL---RDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYW 175
Query: 329 VAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTE--SGIFRAVLKADPSFDEAPW 385
++PEV+ Y +AD+WS+G +L +P WA E + IF+ + P+ P
Sbjct: 176 MSPEVISGEGYGRKADIWSVGCTVVEMLT-EKPPWAEFEAMAAIFK--IATQPTNPVLP- 231
Query: 386 PSLSSEARDFVKRLL 400
P +S RDF+KR+
Sbjct: 232 PHVSDHCRDFLKRIF 246
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 2e-20
Identities = 68/253 (26%), Positives = 109/253 (43%), Gaps = 55/253 (21%)
Query: 207 REVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVM 266
RE+KI+ + H N++ D Y + D + +VM++ L +++ R + TE K ++
Sbjct: 69 RELKIMNEIK-HENIMGLVDVYVEGDFINLVMDIMASD--LKKVVDRKIRLTESQVKCIL 125
Query: 267 IQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS---------------D 311
+QILN + H +HRDL P N +K + K DFGL+ +
Sbjct: 126 LQILNGLNVLHKWYFMHRDLSPANIFINSK---GICKIADFGLARRYGYPPYSDTLSKDE 182
Query: 312 FVRPDERLNDIVGSAYYVAPEVLHRS--YSTEADVWSIGVIAYILLCGSRPFWARTE--- 366
++ E + V + +Y APE+L + Y D+WS+G I LL G F E
Sbjct: 183 TMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQ 242
Query: 367 -SGIFRAVLKADPSFDEAPWPSL------------------------SSEARDFVKRLLN 401
IF L P+ E WP S +A D ++ LL
Sbjct: 243 LGRIFE--LLGTPN--EDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLK 298
Query: 402 KDPRKRLTAAQAL 414
+P +R++A +AL
Sbjct: 299 LNPLERISAKEAL 311
|
Length = 335 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 89.6 bits (222), Expect = 2e-20
Identities = 63/214 (29%), Positives = 110/214 (51%), Gaps = 18/214 (8%)
Query: 159 LGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGH 218
L +E+G G FG + L+ ++VA+K I + M+ ED E +++ L+ H
Sbjct: 8 LVQEIGSGQFGLV----WLGYWLEKRKVAIKTIREGAMSE----EDFIEEAQVMMKLS-H 58
Query: 219 NNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHL 278
LV+ + + + +V E E G L D + ++ GK++++ + + + +A+
Sbjct: 59 PKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLES 118
Query: 279 QGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYV---APEVLH 335
V+HRDL N L EN V+K DFG++ FV D++ G+ + V +PEV
Sbjct: 119 SNVIHRDLAARNCLVG---ENQVVKVSDFGMTRFVL-DDQYTSSTGTKFPVKWSSPEVFS 174
Query: 336 RS-YSTEADVWSIGVIAYILLC-GSRPFWARTES 367
S YS+++DVWS GV+ + + G P+ R+ S
Sbjct: 175 FSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS 208
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 90.5 bits (225), Expect = 2e-20
Identities = 82/276 (29%), Positives = 120/276 (43%), Gaps = 49/276 (17%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVK-ILR 213
N E E+G G G +FKK G +AVK + + + E K IL
Sbjct: 15 NDLENLGEIGSGTCGQVYKMRFKK---TGHVMAVKQMRR---------TGNKEENKRILM 62
Query: 214 AL----TGHN--NLVKFFDAYEDTDNVYVVMELCEGGELLDRILSR-GGKYTEDDAKAVM 266
L H+ +VK + + +V++ MEL LD++L R G ED +
Sbjct: 63 DLDVVLKSHDCPYIVKCYGYFITDSDVFICMELM--STCLDKLLKRIQGPIPEDILGKMT 120
Query: 267 IQILNVVAFCHL---QGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIV 323
+ I+ A +L GV+HRD+KP N L D + +K DFG+S + +
Sbjct: 121 VAIVK--ALHYLKEKHGVIHRDVKPSNILL---DASGNVKLCDFGISGRLVDSKAKTRSA 175
Query: 324 GSAYYVAPEVL-----HRSYSTEADVWSIGVIAYILLCGSRPF-WARTESGIFRAVLKAD 377
G A Y+APE + + Y ADVWS+G+ L G P+ +TE + +L+ +
Sbjct: 176 GCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEE 235
Query: 378 PSFDEAPWPSL------SSEARDFVKRLLNKDPRKR 407
P PSL S + FV L KD RKR
Sbjct: 236 P-------PSLPPNEGFSPDFCSFVDLCLTKDHRKR 264
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 91.1 bits (226), Expect = 3e-20
Identities = 81/297 (27%), Positives = 138/297 (46%), Gaps = 53/297 (17%)
Query: 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRAL 215
+Y ++VG G +G C+A K+ G++VA+K + + + I + RE+ +L+ +
Sbjct: 16 RYTSLKQVGSGAYGSVCSAIDKR---TGEKVAIKKLSR-PFQSEIFAKRAYRELTLLKHM 71
Query: 216 TGHNNLVKFFD------AYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQI 269
H N++ D + ++ + Y+VM + L +I G +ED + ++ Q+
Sbjct: 72 Q-HENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTD--LQKI--MGHPLSEDKVQYLVYQM 126
Query: 270 LNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYV 329
L + + H G++HRDLKP N +E+ LK +DFGL+ D + V + +Y
Sbjct: 127 LCGLKYIHSAGIIHRDLKPGNL---AVNEDCELKILDFGLAR--HADAEMTGYVVTRWYR 181
Query: 330 APEV----LHRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKAD----PSF- 380
APEV +H Y+ D+WS+G I +L G F + +LK P F
Sbjct: 182 APEVILNWMH--YNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFV 239
Query: 381 ----DEAP------------------WPSLSSEARDFVKRLLNKDPRKRLTAAQALS 415
D+A +P S +A D ++++L D KRLTA +AL
Sbjct: 240 QKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALE 296
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 3e-20
Identities = 88/308 (28%), Positives = 135/308 (43%), Gaps = 35/308 (11%)
Query: 126 PNEAAIPEGSEPEPAAGLNKSFGFSKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQ 185
+A I P K +K A KY + +G G G AK G+
Sbjct: 4 SGDAMIGRVCRTFPDT-FAKDEATAKEQAKKYWISRVLGSGATGTVLCAKRVS---DGEP 59
Query: 186 VAVKVIPKHKMTTAIAIEDVRREVKIL------RALTGHNNLVKFFDAYEDTDN------ 233
AVKV+ M+ A + EV L + H + A +D N
Sbjct: 60 FAVKVVDMEGMSEA-DKNRAQAEVCCLLNCDFFSIVKCHEDF-----AKKDPRNPENVLM 113
Query: 234 VYVVMELCEGGELLDRILSR---GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPEN 290
+ +V++ G+L I SR + E +A + IQ+L V H + ++HRD+K N
Sbjct: 114 IALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSAN 173
Query: 291 FLFTTKDENSVLKAIDFGLSDFVR---PDERLNDIVGSAYYVAPEVLHRS-YSTEADVWS 346
L + N ++K DFG S D+ G+ YYVAPE+ R YS +AD++S
Sbjct: 174 ILLCS---NGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFS 230
Query: 347 IGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRK 406
+GV+ Y LL RPF + L +D P PS+S E ++ V LL+ DP++
Sbjct: 231 LGVLLYELLTLKRPFDGENMEEVMHKTLAG--RYDPLP-PSISPEMQEIVTALLSSDPKR 287
Query: 407 RLTAAQAL 414
R ++++ L
Sbjct: 288 RPSSSKLL 295
|
Length = 496 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.7 bits (223), Expect = 4e-20
Identities = 85/305 (27%), Positives = 135/305 (44%), Gaps = 70/305 (22%)
Query: 157 YELGEEVGRGHFGYTCAAKFK-KGELKGQQVAVKVI--------PKHKMTTAIAIEDVRR 207
Y+ +++G G + A +K + +L GQ VA+K I P TAI R
Sbjct: 7 YKKLDKLGEG----SYATVYKGRSKLTGQLVALKEIRLEHEEGAP----FTAI------R 52
Query: 208 EVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMI 267
E +L+ L H N+V D + +V E + +L + GG + + + +
Sbjct: 53 EASLLKDLK-HANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLF 110
Query: 268 QILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR----PDERLNDIV 323
Q+L +A+CH + V+HRDLKP+N L + + E LK DFGL+ R P + ++ V
Sbjct: 111 QLLRGLAYCHQRRVLHRDLKPQNLLISERGE---LKLADFGLA---RAKSVPSKTYSNEV 164
Query: 324 GSAYYVAPEVLHRS--YSTEADVWSIGVIAYILLCGSRPFWARTESG-----IFRAVLKA 376
+ +Y P+VL S YST D+W +G I Y + G F T+ IFR VL
Sbjct: 165 VTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFR-VL-G 222
Query: 377 DPSFDEAP------------------------WPSLS--SEARDFVKRLLNKDPRKRLTA 410
P+ + P P L + + L +P+KR++A
Sbjct: 223 TPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISA 282
Query: 411 AQALS 415
A+A+
Sbjct: 283 AEAMK 287
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 4e-20
Identities = 72/248 (29%), Positives = 115/248 (46%), Gaps = 9/248 (3%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLV 222
+G+G FG CA + + G+ A K + K ++ E +IL + +V
Sbjct: 8 LGKGGFGEVCACQVRA---TGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF-VV 63
Query: 223 KFFDAYEDTDNVYVVMELCEGGELLDRILSRG-GKYTEDDAKAVMIQILNVVAFCHLQGV 281
AYE D + +V+ L GG+L I G + E A +I + H + +
Sbjct: 64 SLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERI 123
Query: 282 VHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVL-HRSYST 340
V+RDLKPEN L D++ ++ D GL+ V + + VG+ Y+APEV+ + Y+
Sbjct: 124 VYRDLKPENILL---DDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTF 180
Query: 341 EADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLL 400
D W++G + Y ++ G PF R + V + E S +AR K LL
Sbjct: 181 SPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLCKMLL 240
Query: 401 NKDPRKRL 408
KDP++RL
Sbjct: 241 CKDPKERL 248
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 90.7 bits (225), Expect = 4e-20
Identities = 94/348 (27%), Positives = 153/348 (43%), Gaps = 49/348 (14%)
Query: 85 SSPARSSANSTPNRFFKRP---FPPPSPAKHIKAVLARRHGSVKPNEAAIPEGSEPEPAA 141
++ ++T +R +RP P P + L S + ++ S P+A
Sbjct: 10 VPLPSTARHTTKSRPRRRPDLTLPLPQRDPSLAVPLPLPPPSSSSSSSSSSSASGSAPSA 69
Query: 142 GLNKSFGFSKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVI-PKHKMTTAI 200
+ S + E +G G G + G+ A+KVI H+ T
Sbjct: 70 AKSLS---------ELERVNRIGSGAGGTVYKVIHRP---TGRLYALKVIYGNHEDTVRR 117
Query: 201 AIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTED 260
I RE++ILR + H N+VK D ++ + V++E +GG L ++ + D
Sbjct: 118 QIC---REIEILRDVN-HPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQ-FLAD 172
Query: 261 DAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV-RPDERL 319
A+ QIL+ +A+ H + +VHRD+KP N L + +K DFG+S + + +
Sbjct: 173 VAR----QILSGIAYLHRRHIVHRDIKPSNLLINSAKN---VKIADFGVSRILAQTMDPC 225
Query: 320 NDIVGSAYYVAPEVL-----HRSYSTEA-DVWSIGVIAYILLCGSRPF-------WARTE 366
N VG+ Y++PE + H +Y A D+WS+GV G PF WA
Sbjct: 226 NSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWA--- 282
Query: 367 SGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQAL 414
+ A+ + P EAP + S E R F+ L ++P KR +A Q L
Sbjct: 283 -SLMCAICMSQPP--EAP-ATASREFRHFISCCLQREPAKRWSAMQLL 326
|
Length = 353 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 4e-20
Identities = 76/259 (29%), Positives = 113/259 (43%), Gaps = 21/259 (8%)
Query: 162 EVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNL 221
E+G G FG A F + VAVK + T +D+ +EVK L+ L H N
Sbjct: 28 EIGHGSFG---AVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLK-HPNT 83
Query: 222 VKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGV 281
+++ Y ++VME C G D + E + A+ L +A+ H +
Sbjct: 84 IEYKGCYLKEHTAWLVMEYCLGSAS-DLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNM 142
Query: 282 VHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVL----HRS 337
+HRD+K N L T E +K DFG + P N VG+ Y++APEV+
Sbjct: 143 IHRDIKAGNILLT---EPGQVKLADFGSASKSSP---ANSFVGTPYWMAPEVILAMDEGQ 196
Query: 338 YSTEADVWSIGVIAYILLCGSRP--FWARTESGIFRAVLKADPSFDEAPWPSLSSEARDF 395
Y + DVWS+G I I L +P F S ++ P+ W + R F
Sbjct: 197 YDGKVDVWSLG-ITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEW---TDSFRGF 252
Query: 396 VKRLLNKDPRKRLTAAQAL 414
V L K P++R +A+ L
Sbjct: 253 VDYCLQKIPQERPASAELL 271
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 4e-20
Identities = 64/233 (27%), Positives = 102/233 (43%), Gaps = 44/233 (18%)
Query: 159 LGEEVGRGHFGYTCAAKFKKGELKGQ--QVAVKVIPKHKMTTAIAIEDVRREVKILRALT 216
L E+G G FG + E + VAVK + + + A +D RE ++L
Sbjct: 9 LKRELGEGAFGKVFLGECYHLEPENDKELVAVKTL--KETASNDARKDFEREAELLTNF- 65
Query: 217 GHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRG-------------GKYTEDDAK 263
H N+VKF+ + D +V E E G+L + S G G+ T
Sbjct: 66 QHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLL 125
Query: 264 AVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIV 323
+ +QI + + + Q VHRDL N L + V+K DFG+S D+
Sbjct: 126 QIAVQIASGMVYLASQHFVHRDLATRNCLVGY---DLVVKIGDFGMS---------RDVY 173
Query: 324 GSAYY------------VAPE-VLHRSYSTEADVWSIGVIAY-ILLCGSRPFW 362
+ YY + PE +++R ++TE+DVWS GV+ + I G +P++
Sbjct: 174 TTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWY 226
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 6e-20
Identities = 75/281 (26%), Positives = 125/281 (44%), Gaps = 45/281 (16%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRA 214
+ +E + +GRG FG + + + G A+K++ K M + +R E IL
Sbjct: 1 DDFESLKVIGRGAFG---EVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVE 57
Query: 215 LTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVA 274
G +VK F +++D N+Y++ME GG+++ +L + +E+ + + + + +
Sbjct: 58 ADG-AWVVKMFYSFQDKRNLYLIMEFLPGGDMMT-LLMKKDTLSEEATQFYIAETVLAID 115
Query: 275 FCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGL---------------------SDFV 313
H G +HRD+KP+N L K +K DFGL SDF
Sbjct: 116 AIHQLGFIHRDIKPDNLLLDAKGH---VKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFS 172
Query: 314 -------RPDERLN--------DIVGSAYYVAPEVLHRS-YSTEADVWSIGVIAYILLCG 357
R E VG+ Y+APEV ++ Y+ D WS+GVI Y +L G
Sbjct: 173 FQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232
Query: 358 SRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKR 398
PF + T +R V+ + P +S +A+D + R
Sbjct: 233 YPPFCSETPQETYRKVMNWKETLVFPPEVPISEKAKDLILR 273
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 6e-20
Identities = 71/252 (28%), Positives = 121/252 (48%), Gaps = 20/252 (7%)
Query: 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILR 213
A Y++ + +GRG FG + K + + A+K++ K +M E I+
Sbjct: 42 AEDYDVVKVIGRGAFGEVQLVRHKSSQ---KVYAMKLLSKFEMIKRSDSAFFWEERDIM- 97
Query: 214 ALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVV 273
A +V+ F A++D +Y+VME GG+L++ L E AK +++ +
Sbjct: 98 AFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVN--LMSNYDVPEKWAKFYTAEVVLAL 155
Query: 274 AFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDE----RLNDIVGSAYYV 329
H G++HRD+KP+N L D++ LK DFG ++ DE R + VG+ Y+
Sbjct: 156 DAIHSMGLIHRDVKPDNMLL---DKHGHLKLADFGTC--MKMDETGMVRCDTAVGTPDYI 210
Query: 330 APEVLHRS-----YSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAP 384
+PEVL Y E D WS+GV + +L G PF+A + G + ++ S +
Sbjct: 211 SPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPE 270
Query: 385 WPSLSSEARDFV 396
+S A++ +
Sbjct: 271 DVEISKHAKNLI 282
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 89.0 bits (220), Expect = 8e-20
Identities = 73/267 (27%), Positives = 117/267 (43%), Gaps = 21/267 (7%)
Query: 162 EVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNL 221
E+G G FG A F + + VA+K + + +D+ +EV+ L+ L H N
Sbjct: 22 EIGHGSFG---AVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR-HPNT 77
Query: 222 VKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGV 281
+++ Y ++VME C G D + E + AV L +A+ H +
Sbjct: 78 IQYRGCYLREHTAWLVMEYCLGSAS-DLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNM 136
Query: 282 VHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVL----HRS 337
+HRD+K N L + E ++K DFG + + P N VG+ Y++APEV+
Sbjct: 137 IHRDVKAGNILLS---EPGLVKLGDFGSASIMAP---ANXFVGTPYWMAPEVILAMDEGQ 190
Query: 338 YSTEADVWSIGVIAYILLCGSRP--FWARTESGIFRAVLKADPSFDEAPWPSLSSEARDF 395
Y + DVWS+G+ I L +P F S ++ P+ W S R+F
Sbjct: 191 YDGKVDVWSLGITC-IELAERKPPLFNMNAMSALYHIAQNESPALQSGHW---SEYFRNF 246
Query: 396 VKRLLNKDPRKRLTAAQALSELLICYQ 422
V L K P+ R T+ L + +
Sbjct: 247 VDSCLQKIPQDRPTSEVLLKHRFVLRE 273
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 9e-20
Identities = 70/250 (28%), Positives = 118/250 (47%), Gaps = 16/250 (6%)
Query: 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILR 213
A YE+ + +GRG FG + + + + A+K++ K +M E I+
Sbjct: 42 AEDYEVVKVIGRGAFG---EVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIM- 97
Query: 214 ALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVV 273
A +V+ F A++D +Y+VME GG+L++ L E A+ +++ +
Sbjct: 98 AFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVN--LMSNYDVPEKWARFYTAEVVLAL 155
Query: 274 AFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDE--RLNDIVGSAYYVAP 331
H G +HRD+KP+N L D++ LK DFG + + R + VG+ Y++P
Sbjct: 156 DAIHSMGFIHRDVKPDNMLL---DKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISP 212
Query: 332 EVLHRS-----YSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWP 386
EVL Y E D WS+GV Y +L G PF+A + G + ++ S
Sbjct: 213 EVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDN 272
Query: 387 SLSSEARDFV 396
+S EA++ +
Sbjct: 273 DISKEAKNLI 282
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 1e-19
Identities = 81/301 (26%), Positives = 133/301 (44%), Gaps = 51/301 (16%)
Query: 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRAL 215
+Y++ E +G+G +G C+A G++VA+K I + A + RE+K+LR L
Sbjct: 1 RYKIQEVIGKGSYGVVCSAI---DTHTGEKVAIKKINDVFEHVSDATR-ILREIKLLRLL 56
Query: 216 TGHNNLVKFFD-----AYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQIL 270
H ++V+ + + ++YVV EL E L +++ T + + + Q+L
Sbjct: 57 R-HPDIVEIKHIMLPPSRREFKDIYVVFELMESD--LHQVIKANDDLTPEHHQFFLYQLL 113
Query: 271 NVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDER----LNDIVGSA 326
+ + H V HRDLKP+N L + + LK DFGL+ D D V +
Sbjct: 114 RALKYIHTANVFHRDLKPKNIL---ANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 170
Query: 327 YYVAPEV---LHRSYSTEADVWSIGVIAYILLCGSRPFW--------------------- 362
+Y APE+ Y+ D+WSIG I +L G +P +
Sbjct: 171 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTG-KPLFPGKNVVHQLDLITDLLGTPSP 229
Query: 363 ---ARTESGIFRAVL----KADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALS 415
+R + R L K P +P+ A ++RLL DP+ R TA +AL+
Sbjct: 230 ETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA 289
Query: 416 E 416
+
Sbjct: 290 D 290
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 1e-19
Identities = 78/287 (27%), Positives = 123/287 (42%), Gaps = 59/287 (20%)
Query: 163 VGRGHFGYTC-AAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNL 221
+G G FG C A K L A+K + K + + V+ E IL A + +
Sbjct: 9 LGIGAFGEVCLACKVDTHAL----YAMKTLRKKDVLNRNQVAHVKAERDIL-AEADNEWV 63
Query: 222 VKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGV 281
VK + +++D DN+Y VM+ GG+++ +L R + E A+ + ++ + H G
Sbjct: 64 VKLYYSFQDKDNLYFVMDYIPGGDMMS-LLIRMEVFPEVLARFYIAELTLAIESVHKMGF 122
Query: 282 VHRDLKPENFLFTTKDENSVLKAIDFGL--------------------SDFVRPDERLND 321
+HRD+KP+N L D + +K DFGL D + P + +D
Sbjct: 123 IHRDIKPDNILI---DLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDD 179
Query: 322 I----------------------------VGSAYYVAPEVLHRS-YSTEADVWSIGVIAY 352
+ VG+ Y+APEVL R Y+ D WS+GVI +
Sbjct: 180 VSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILF 239
Query: 353 ILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRL 399
+L G PF A T + V+ + + P LS EA D + +L
Sbjct: 240 EMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKL 286
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 1e-19
Identities = 73/274 (26%), Positives = 122/274 (44%), Gaps = 45/274 (16%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLV 222
+GRG FG + + + G A+K++ K M + +R E IL +V
Sbjct: 9 IGRGAFG---EVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDIL-VEADSLWVV 64
Query: 223 KFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVV 282
K F +++D N+Y++ME GG+++ +L + TE++ + + + + + H G +
Sbjct: 65 KMFYSFQDKLNLYLIMEFLPGGDMMT-LLMKKDTLTEEETQFYIAETVLAIDSIHQLGFI 123
Query: 283 HRDLKPENFLFTTKDENSVLKAIDFGL---------------------SDFV-------- 313
HRD+KP+N L +K +K DFGL SDF
Sbjct: 124 HRDIKPDNLLLDSKGH---VKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKR 180
Query: 314 ------RPDERLN-DIVGSAYYVAPEV-LHRSYSTEADVWSIGVIAYILLCGSRPFWART 365
R +L VG+ Y+APEV + Y+ D WS+GVI Y +L G PF + T
Sbjct: 181 KAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSET 240
Query: 366 ESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRL 399
++ V+ + P +S +A+D + R
Sbjct: 241 PQETYKKVMNWKETLIFPPEVPISEKAKDLILRF 274
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 1e-19
Identities = 62/222 (27%), Positives = 107/222 (48%), Gaps = 17/222 (7%)
Query: 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALT 216
+ L ++G G+FG +K +VA+K++ K + +D ++EV+ L+ L
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNR----VRVAIKIL---KSDDLLKQQDFQKEVQALKRLR 60
Query: 217 GHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMI--QILNVVA 274
H +L+ F + VY++ EL E G LL + S G+ A + + Q+ +A
Sbjct: 61 -HKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQ-VLPVASLIDMACQVAEGMA 118
Query: 275 FCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAY-YVAPEV 333
+ Q +HRDL N L E+ V K DFGL+ ++ D L+ Y + APE
Sbjct: 119 YLEEQNSIHRDLAARNILV---GEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEA 175
Query: 334 L-HRSYSTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAV 373
H ++ST++DVWS G++ Y + G P+ ++ +
Sbjct: 176 ASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQI 217
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 88.6 bits (219), Expect = 1e-19
Identities = 74/264 (28%), Positives = 116/264 (43%), Gaps = 21/264 (7%)
Query: 162 EVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNL 221
E+G G FG A F + + VA+K + + +D+ +EVK L+ + H N
Sbjct: 32 EIGHGSFG---AVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIK-HPNS 87
Query: 222 VKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGV 281
+++ Y ++VME C G D + E + A+ L +A+ H +
Sbjct: 88 IEYKGCYLREHTAWLVMEYCLGSAS-DLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNM 146
Query: 282 VHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVL----HRS 337
+HRD+K N L T E +K DFG + P N VG+ Y++APEV+
Sbjct: 147 IHRDIKAGNILLT---EPGQVKLADFGSASIASP---ANSFVGTPYWMAPEVILAMDEGQ 200
Query: 338 YSTEADVWSIGVIAYILLCGSRP--FWARTESGIFRAVLKADPSFDEAPWPSLSSEARDF 395
Y + DVWS+G I I L +P F S ++ P+ W S R+F
Sbjct: 201 YDGKVDVWSLG-ITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEW---SDYFRNF 256
Query: 396 VKRLLNKDPRKRLTAAQALSELLI 419
V L K P+ R T+ + L + +
Sbjct: 257 VDSCLQKIPQDRPTSEELLKHMFV 280
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 2e-19
Identities = 66/214 (30%), Positives = 105/214 (49%), Gaps = 34/214 (15%)
Query: 221 LVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQG 280
+V F+ A+ VY+ ME + G L D++ + GG TE + V+ +I V ++G
Sbjct: 61 IVDFYGAFFIEGAVYMCMEYMDAGSL-DKLYA-GGVATEGIPEDVLRRITYAV----VKG 114
Query: 281 ---------VVHRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDERLNDIVGSAYYVA 330
++HRD+KP N L + +K DFG+S + V + N +G Y+A
Sbjct: 115 LKFLKEEHNIIHRDVKPTNVLVNGNGQ---VKLCDFGVSGNLVASLAKTN--IGCQSYMA 169
Query: 331 PEVLHR-------SYSTEADVWSIGVIAYILLCGSRPFWARTESGIF---RAVLKADPSF 380
PE + +Y+ ++DVWS+G+ + G P+ T + IF A++ DP
Sbjct: 170 PERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPP- 228
Query: 381 DEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQAL 414
P S +A+DFV + LNK P +R T AQ L
Sbjct: 229 -TLP-SGYSDDAQDFVAKCLNKIPNRRPTYAQLL 260
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 2e-19
Identities = 77/295 (26%), Positives = 138/295 (46%), Gaps = 48/295 (16%)
Query: 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRAL 215
+Y ++VG G +G C+A ++ G +VA+K + + + A + RE+++L+ +
Sbjct: 16 RYRDLKQVGSGAYGTVCSALDRR---TGAKVAIKKLYRPFQSELFA-KRAYRELRLLKHM 71
Query: 216 TGHNNLVKFFDAY------EDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQI 269
H N++ D + + + Y+VM G L +++ + K +ED + ++ Q+
Sbjct: 72 K-HENVIGLLDVFTPDLSLDRFHDFYLVMPFM--GTDLGKLM-KHEKLSEDRIQFLVYQM 127
Query: 270 LNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYV 329
L + + H G++HRDLKP N +E+ LK +DFGL+ + D + V + +Y
Sbjct: 128 LKGLKYIHAAGIIHRDLKPGNLAV---NEDCELKILDFGLAR--QTDSEMTGYVVTRWYR 182
Query: 330 APEVLHR--SYSTEADVWSIGVIAYILLCG-----------------------SRPFWAR 364
APEV+ Y+ D+WS+G I +L G S+ F +
Sbjct: 183 APEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQK 242
Query: 365 TESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNK----DPRKRLTAAQALS 415
+S + +K P F + + SL A +L K D R+TAA+AL+
Sbjct: 243 LQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 3e-19
Identities = 67/248 (27%), Positives = 113/248 (45%), Gaps = 9/248 (3%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLV 222
+G+G FG CA + + G+ A K + K ++ E +IL + +V
Sbjct: 8 LGKGGFGEVCACQVRA---TGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNS-RFVV 63
Query: 223 KFFDAYEDTDNVYVVMELCEGGELLDRILSRGGK-YTEDDAKAVMIQILNVVAFCHLQGV 281
AYE D + +V+ + GG+L I + G + E A ++ + + +
Sbjct: 64 SLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERI 123
Query: 282 VHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVL-HRSYST 340
V+RDLKPEN L D+ ++ D GL+ + E + VG+ Y+APEV+ + Y+
Sbjct: 124 VYRDLKPENILL---DDRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINNEKYTF 180
Query: 341 EADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLL 400
D W +G + Y ++ G PF R E V + E S +A+ + LL
Sbjct: 181 SPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICRMLL 240
Query: 401 NKDPRKRL 408
K+P++RL
Sbjct: 241 TKNPKERL 248
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 1e-18
Identities = 75/266 (28%), Positives = 125/266 (46%), Gaps = 22/266 (8%)
Query: 160 GEEVGRGHFG--YTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTG 217
G+ +G+G FG Y C EL +QV P+ T+ + + E+++L+ L
Sbjct: 7 GKLLGQGAFGRVYLCYDVDTGRELAAKQVQFD--PESPETSK-EVSALECEIQLLKNLQ- 62
Query: 218 HNNLVKFFDAYED--TDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAF 275
H +V+++ D + + ME GG + D++ + G TE + QIL +++
Sbjct: 63 HERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGA-LTESVTRKYTRQILEGMSY 121
Query: 276 CHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR----PDERLNDIVGSAYYVAP 331
H +VHRD+K N L +D +K DFG S ++ + + G+ Y+++P
Sbjct: 122 LHSNMIVHRDIKGANIL---RDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSP 178
Query: 332 EVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSS 390
EV+ Y +ADVWS+G +L +P WA E+ A+ K PS S
Sbjct: 179 EVISGEGYGRKADVWSLGCTVVEMLT-EKPPWAEYEA--MAAIFKIATQPTNPQLPSHIS 235
Query: 391 E-ARDFVKRLLNKDPRKRLTAAQALS 415
E ARDF+ + + R R +A + L
Sbjct: 236 EHARDFLGCIF-VEARHRPSAEELLR 260
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 1e-18
Identities = 85/296 (28%), Positives = 126/296 (42%), Gaps = 50/296 (16%)
Query: 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRAL 215
+YE E+G G +G A+ G VA+K + + + VR EV +L+ L
Sbjct: 1 QYEPVAEIGVGAYGTVYKARDPH---SGHFVALKSVRVQTNEDGLPLSTVR-EVALLKRL 56
Query: 216 TG--HNNLVKFFD--AYEDTD---NVYVVMELCEGG--ELLDRILSRGGKYTEDDAKAVM 266
H N+V+ D A TD V +V E + LD++ G + K +M
Sbjct: 57 EAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPG--LPAETIKDLM 114
Query: 267 IQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSA 326
Q L + F H +VHRDLKPEN L T+ + +K DFGL+ L +V +
Sbjct: 115 RQFLRGLDFLHANCIVHRDLKPENILVTSGGQ---VKLADFGLARIYSCQMALTPVVVTL 171
Query: 327 YYVAPEVLHRS-YSTEADVWSIGVI------AYILLCGSRPFWARTESGIFRAVLKADPS 379
+Y APEVL +S Y+T D+WS+G I L CG+ A IF + P
Sbjct: 172 WYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSE--ADQLGKIFDLI--GLPP 227
Query: 380 FDEAPW---------------------PSLSSEARDFVKRLLNKDPRKRLTAAQAL 414
D+ P P + + +L +P KR++A +AL
Sbjct: 228 EDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRAL 283
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 85.1 bits (211), Expect = 1e-18
Identities = 60/211 (28%), Positives = 93/211 (44%), Gaps = 20/211 (9%)
Query: 162 EVGRGHFG--YTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHN 219
++G GHFG C G+QVAVK H D RE++ILR L H
Sbjct: 11 QLGEGHFGKVELCRYDPLGDN-TGEQVAVKS-LNHSGEEQ-HRSDFEREIEILRTLD-HE 66
Query: 220 NLVKFFDAYEDT--DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVM--IQILNVVAF 275
N+VK+ E ++ ++ME G L R + + + + ++ QI + +
Sbjct: 67 NIVKYKGVCEKPGGRSLRLIMEYLPSGSL--RDYLQRHRDQINLKRLLLFSSQICKGMDY 124
Query: 276 CHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDE---RLNDIVGS-AYYVAP 331
Q +HRDL N L + ++K DFGL+ + D+ + + S ++ AP
Sbjct: 125 LGSQRYIHRDLAARNILV---ESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAP 181
Query: 332 EVLH-RSYSTEADVWSIGVIAYILLCGSRPF 361
E L +S+ +DVWS GV Y L P
Sbjct: 182 ECLRTSKFSSASDVWSFGVTLYELFTYGDPS 212
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 2e-18
Identities = 71/243 (29%), Positives = 111/243 (45%), Gaps = 53/243 (21%)
Query: 201 AIEDVRREVKILRAL-TGHN----NLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGG 255
A VR++ ILR L H +V F+ A+ + +N+ + ME + G L DRI +GG
Sbjct: 42 AKSSVRKQ--ILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSL-DRIYKKGG 98
Query: 256 KYTEDDAKAVMIQILNVVAFCHLQG---------VVHRDLKPENFLFTTKDENSVLKAID 306
+ IL +A ++G ++HRD+KP N L ++ + +K D
Sbjct: 99 PIPVE--------ILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQ---IKLCD 147
Query: 307 FGLSDFVRPDERLNDI----VGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPF 361
FG+S E +N I VG++ Y++PE + Y+ ++DVWS+G+ L G PF
Sbjct: 148 FGVSG-----ELINSIADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPF 202
Query: 362 WARTES--------GIF----RAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLT 409
GI + V + P + +P + RDFV L KDP +R T
Sbjct: 203 AFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFP---EDLRDFVDACLLKDPTERPT 259
Query: 410 AAQ 412
Q
Sbjct: 260 PQQ 262
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 2e-18
Identities = 73/263 (27%), Positives = 130/263 (49%), Gaps = 27/263 (10%)
Query: 157 YELGEEVGRGHFG--YTCAAKFKKGELKGQQVAVKVIP--KHKMTTAIAIEDVRREVKIL 212
+ LG+ +GRG FG Y C G+++AVK +P T+ + + E+++L
Sbjct: 4 WRLGKLLGRGAFGEVYLCY-----DADTGRELAVKQVPFDPDSQETSKEVNALECEIQLL 58
Query: 213 RALTGHNNLVKFFDAYEDTDN--VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQIL 270
+ L H+ +V+++ D + + + +E GG + D+ L G TE+ + QIL
Sbjct: 59 KNLR-HDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQ-LKAYGALTENVTRRYTRQIL 116
Query: 271 NVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR----PDERLNDIVGSA 326
V++ H +VHRD+K N L +D +K DFG S ++ + + G+
Sbjct: 117 QGVSYLHSNMIVHRDIKGANIL---RDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTP 173
Query: 327 YYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTE--SGIFRAVLKADPSFDEA 383
Y+++PEV+ Y +ADVWS+ +L +P WA E + IF+ + P+
Sbjct: 174 YWMSPEVISGEGYGRKADVWSVACTVVEMLT-EKPPWAEYEAMAAIFK--IATQPTKPML 230
Query: 384 PWPSLSSEARDFVKRLLNKDPRK 406
P +S RDF+K++ ++ R+
Sbjct: 231 P-DGVSDACRDFLKQIFVEEKRR 252
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 3e-18
Identities = 74/292 (25%), Positives = 126/292 (43%), Gaps = 40/292 (13%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRA 214
NK+E+ VG G +G + K+ + + VA+K + + E RE+K+LR
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETK---EIVAIKKFKDSEENEEVK-ETTLRELKMLRT 56
Query: 215 LTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVA 274
L N+V+ +A+ +Y+V E E +L+ + + ++ + Q++ +
Sbjct: 57 LK-QENIVELKEAFRRRGKLYLVFEYVEK-NMLELLEEMPNGVPPEKVRSYIYQLIKAIH 114
Query: 275 FCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP--DERLNDIVGSAYYVAPE 332
+CH +VHRD+KPEN L + D VLK DFG + + + + V + +Y +PE
Sbjct: 115 WCHKNDIVHRDIKPENLLISHND---VLKLCDFGFARNLSEGSNANYTEYVATRWYRSPE 171
Query: 333 VLHRS-YSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLK--------------AD 377
+L + Y D+WS+G I L G F +E + K ++
Sbjct: 172 LLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSN 231
Query: 378 PSFDEAPWPS--------------LSSEARDFVKRLLNKDPRKRLTAAQALS 415
P F +P+ LS D +K LL +P R Q L+
Sbjct: 232 PRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 3e-18
Identities = 63/207 (30%), Positives = 102/207 (49%), Gaps = 20/207 (9%)
Query: 161 EEVGRGHFGYTCAAKFKKGELKGQ-QVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHN 219
+E+G G FG K G+ +GQ VA+K+I + M+ IE E K++ L+ H
Sbjct: 10 KELGTGQFGVV-----KYGKWRGQYDVAIKMIKEGSMSEDEFIE----EAKVMMKLS-HE 59
Query: 220 NLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQ 279
LV+ + +Y+V E G LL+ + G ++ + + +A+ +
Sbjct: 60 KLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESK 119
Query: 280 GVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYV---APEVLHR 336
+HRDL N L D+ +K DFGLS +V DE + VGS + V PEVL
Sbjct: 120 QFIHRDLAARNCLV---DDQGCVKVSDFGLSRYVLDDEYTSS-VGSKFPVRWSPPEVLLY 175
Query: 337 S-YSTEADVWSIGVIAY-ILLCGSRPF 361
S +S+++DVW+ GV+ + + G P+
Sbjct: 176 SKFSSKSDVWAFGVLMWEVYSLGKMPY 202
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 4e-18
Identities = 62/223 (27%), Positives = 107/223 (47%), Gaps = 20/223 (8%)
Query: 161 EEVGRGHFGYTCAAKFKKGELKGQ-QVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHN 219
+E+G G FG G+ + Q +VA+K I + M+ ED E K++ L+ H
Sbjct: 10 KELGSGQFGVV-----HLGKWRAQIKVAIKAINEGAMSE----EDFIEEAKVMMKLS-HP 59
Query: 220 NLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQ 279
LV+ + +Y+V E E G LL+ + R GK ++D ++ + + +
Sbjct: 60 KLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERN 119
Query: 280 GVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYV---APEVLHR 336
+HRDL N L + V+K DFG++ +V DE + G+ + V PEV +
Sbjct: 120 SFIHRDLAARNCLVS---STGVVKVSDFGMTRYVLDDEYTSS-SGAKFPVKWSPPEVFNF 175
Query: 337 S-YSTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAVLKAD 377
S YS+++DVWS GV+ + + G PF ++ + + +
Sbjct: 176 SKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGF 218
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 6e-18
Identities = 75/298 (25%), Positives = 137/298 (45%), Gaps = 54/298 (18%)
Query: 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRAL 215
+Y+ VG G +G C+A + Q+VAVK + + + I RE+++L+ +
Sbjct: 16 RYQNLTPVGSGAYGSVCSAYDTRLR---QKVAVKKLSR-PFQSLIHARRTYRELRLLKHM 71
Query: 216 TGHNNLVKFFDAY------EDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQI 269
H N++ D + E+ + VY+V L G L+ I+ + K +++ + ++ Q+
Sbjct: 72 K-HENVIGLLDVFTPATSIENFNEVYLVTNLM--GADLNNIV-KCQKLSDEHVQFLIYQL 127
Query: 270 LNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYV 329
L + + H G++HRDLKP N +E+ L+ +DFGL+ + D+ + V + +Y
Sbjct: 128 LRGLKYIHSAGIIHRDLKPSNV---AVNEDCELRILDFGLAR--QADDEMTGYVATRWYR 182
Query: 330 APEVLHR--SYSTEADVWSIGVIAYILLCG-----------------------SRPFWAR 364
APE++ Y+ D+WS+G I LL G S +
Sbjct: 183 APEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKK 242
Query: 365 TESGIFRAVLKADPSFDEAPWPSLSSEAR-------DFVKRLLNKDPRKRLTAAQALS 415
S R +++ P P L R D ++++L D KR++A++AL+
Sbjct: 243 ISSEHARKYIQSLPHM---PQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA 297
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 7e-18
Identities = 73/295 (24%), Positives = 125/295 (42%), Gaps = 58/295 (19%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLV 222
+G+G FG + + + G+ A+K + K +M + V+ E +L A + +V
Sbjct: 9 IGKGAFG---EVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVL-AESDSPWVV 64
Query: 223 KFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVV 282
+ +++D +Y++ME GG+L+ +L + ++ED + M + + + H G +
Sbjct: 65 SLYYSFQDAQYLYLIMEFLPGGDLMT-MLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFI 123
Query: 283 HRDLKPENFLFTTKDENSVLKAIDFGLSD----------FVRP----------DERLNDI 322
HRD+KP+N L D +K DFGLS + + D R +
Sbjct: 124 HRDIKPDNILI---DRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVA 180
Query: 323 VGS---------------------AY-------YVAPEV-LHRSYSTEADVWSIGVIAYI 353
V S AY Y+APE+ L + Y E D WS+G I +
Sbjct: 181 VDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFE 240
Query: 354 LLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRL 408
L G PF + +R ++ + LS EA D ++RL+ + RL
Sbjct: 241 CLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRL 294
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 7e-18
Identities = 74/257 (28%), Positives = 128/257 (49%), Gaps = 27/257 (10%)
Query: 163 VGRGHFG--YTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNN 220
+GRG FG Y C +K + G+ A+K + K ++ E + +I+ +L +
Sbjct: 2 IGRGGFGEVYGC----RKAD-TGKMYAMKCLDKKRIKMKQG-ETLALNERIMLSLVSTGD 55
Query: 221 ---LVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCH 277
+V A+ D + +++L GG+L LS+ G ++E + + +I+ + H
Sbjct: 56 CPFIVCMSYAFHTPDKLSFILDLMNGGDL-HYHLSQHGVFSEAEMRFYAAEIILGLEHMH 114
Query: 278 LQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDERLNDIVGSAYYVAPEVLHR 336
+ VV+RDLKP N L DE+ ++ D GL+ DF + ++ + VG+ Y+APEVL +
Sbjct: 115 NRFVVYRDLKPANILL---DEHGHVRISDLGLACDFSK--KKPHASVGTHGYMAPEVLQK 169
Query: 337 --SYSTEADVWSIGVIAYILLCGSRPF---WARTESGIFRAVLKADPSFDEAPWPSLSSE 391
+Y + AD +S+G + + LL G PF + + I R L + S S E
Sbjct: 170 GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPD----SFSPE 225
Query: 392 ARDFVKRLLNKDPRKRL 408
R ++ LL +D +RL
Sbjct: 226 LRSLLEGLLQRDVNRRL 242
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 1e-17
Identities = 85/269 (31%), Positives = 126/269 (46%), Gaps = 35/269 (13%)
Query: 171 TCAAKFK-KGELKGQQVAVKVIP-KHKM---TTAIAIEDVRREVKILRALTGHNNLVKFF 225
T A FK + +L VA+K I +H+ TAI REV +L+ L H N+V
Sbjct: 17 TYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAI------REVSLLKNLK-HANIVTLH 69
Query: 226 DAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRD 285
D + +V E + +L + + G + + K M Q+L +++CH + ++HRD
Sbjct: 70 DIIHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRD 128
Query: 286 LKPENFLFTTKDENSVLKAIDFGLSDFVR-PDERLNDIVGSAYYVAPEVLHRS--YSTEA 342
LKP+N L K E LK DFGL+ P + ++ V + +Y P+VL S YST
Sbjct: 129 LKPQNLLINEKGE---LKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPI 185
Query: 343 DVWSIGVIAYILLCGSRPFWARTESG----IFRAVLKADPSFDEAPWPSLSS--EARDF- 395
D+W +G I Y + G F T IFR L P+ E WP ++S E R +
Sbjct: 186 DMWGVGCILYEMATGRPMFPGSTVKEELHLIFR--LLGTPT--EETWPGITSNEEFRSYL 241
Query: 396 -----VKRLLNKDPRKRLTAAQALSELLI 419
+ L+N PR LS LL+
Sbjct: 242 FPQYRAQPLINHAPRLDTDGIDLLSSLLL 270
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 81.6 bits (202), Expect = 2e-17
Identities = 56/199 (28%), Positives = 90/199 (45%), Gaps = 18/199 (9%)
Query: 159 LGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGH 218
L ++G G FG + +VAVK + M+ E +E +I++ L H
Sbjct: 10 LERKLGAGQFGEVWMGTW----NGTTKVAVKTLKPGTMSP----EAFLQEAQIMKKLR-H 60
Query: 219 NNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMI-QILNVVAFCH 277
+ LV+ + + + +Y+V E G LLD + S GK M QI +A+
Sbjct: 61 DKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE 120
Query: 278 LQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAY---YVAPE-V 333
+ +HRDL N L EN V K DFGL+ + DE G+ + + APE
Sbjct: 121 SRNYIHRDLAARNILV---GENLVCKIADFGLARLIEDDE-YTAREGAKFPIKWTAPEAA 176
Query: 334 LHRSYSTEADVWSIGVIAY 352
+ ++ ++DVWS G++
Sbjct: 177 NYGRFTIKSDVWSFGILLT 195
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 3e-17
Identities = 68/273 (24%), Positives = 112/273 (41%), Gaps = 32/273 (11%)
Query: 161 EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNN 220
+++G G FG ++ K VAVK + K++ + +D +E I+ +L H N
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIM--DDFLKEAAIMHSLD-HEN 57
Query: 221 LVKFFDAYEDTDNVYVVMELCEGGELLDRI-LSRGGKYTEDDAKAVMIQILNVVAFCHLQ 279
L++ + T + +V EL G LLDR+ G + +QI N + + +
Sbjct: 58 LIRLYGVVL-THPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESK 116
Query: 280 GVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYV---------- 329
+HRDL N L + D+ +K DFGL L +YV
Sbjct: 117 RFIHRDLAARNILLASDDK---VKIGDFGLM------RALPQ--NEDHYVMEEHLKVPFA 165
Query: 330 --APEVL-HRSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPW 385
APE L R++S +DVW GV + + G P+ + S I + + K E P
Sbjct: 166 WCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERL-ERP- 223
Query: 386 PSLSSEARDFVKRLLNKDPRKRLTAAQALSELL 418
+ + + + + +P R T A L
Sbjct: 224 EACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 3e-17
Identities = 80/281 (28%), Positives = 125/281 (44%), Gaps = 30/281 (10%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIED--VRREVKIL 212
N G+ +G G FG A L +KV K TA + E + E+KI+
Sbjct: 35 NNLSFGKTLGAGAFGKVVEATAYG--LSKSDAVMKVAVKMLKPTAHSSEREALMSELKIM 92
Query: 213 RALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKY-TEDDAKAVMIQILN 271
L H N+V A + V+ E C G+LL+ + + + T +D + Q+
Sbjct: 93 SHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAK 152
Query: 272 VVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIV-GSAY--- 327
+AF + +HRDL N L T ++K DFGL+ + D N +V G+A
Sbjct: 153 GMAFLASKNCIHRDLAARNVLLT---HGKIVKICDFGLARDIMNDS--NYVVKGNARLPV 207
Query: 328 -YVAPE-VLHRSYSTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAVLK-----ADPS 379
++APE + + Y+ E+DVWS G++ + I GS P+ F ++K A P
Sbjct: 208 KWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQPE 267
Query: 380 FDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLIC 420
AP +E D +K + DP KR T Q + +L+
Sbjct: 268 H--AP-----AEIYDIMKTCWDADPLKRPTFKQ-IVQLIGK 300
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 4e-17
Identities = 66/228 (28%), Positives = 102/228 (44%), Gaps = 26/228 (11%)
Query: 207 REVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSR-----GGKYTEDD 261
REV +L+ L H N+V D ++ +V E LD+ L + G +
Sbjct: 53 REVSLLKDLK-HANIVTLHDIIHTEKSLTLVFEY------LDKDLKQYLDDCGNSINMHN 105
Query: 262 AKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR-PDERLN 320
K + Q+L + +CH + V+HRDLKP+N L + E LK DFGL+ P + +
Sbjct: 106 VKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGE---LKLADFGLARAKSIPTKTYS 162
Query: 321 DIVGSAYYVAPEVLHRS--YSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADP 378
+ V + +Y P++L S YST+ D+W +G I Y + G F T + +
Sbjct: 163 NEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILG 222
Query: 379 SFDEAPWPSLSSE--------ARDFVKRLLNKDPRKRLTAAQALSELL 418
+ E WP + S + L N PR A+ LS+LL
Sbjct: 223 TPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLL 270
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 6e-17
Identities = 66/252 (26%), Positives = 113/252 (44%), Gaps = 16/252 (6%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLV 222
+G+G FG CA + K G+ A K + K ++ + E +IL + +V
Sbjct: 1 LGKGGFGEVCAVQVKN---TGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPF-IV 56
Query: 223 KFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTE-DDAKAVMIQILNVVAFCHLQGV 281
A+E ++ +VM L GG+L I + G + E + QI + H +
Sbjct: 57 NLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDI 116
Query: 282 VHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVL-HRSYST 340
V+RD+KPEN L D+ + D GL+ ++ + + G+ Y+APE+L YS
Sbjct: 117 VYRDMKPENVLL---DDQGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEILKEEPYSY 173
Query: 341 EADVWSIGVIAYILLCGSRPFWARTE----SGIFRAVLKADPSFDEAPWPSLSSEARDFV 396
D +++G Y ++ G PF E + R L+ + F+ + + E++D
Sbjct: 174 PVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQ---NFTEESKDIC 230
Query: 397 KRLLNKDPRKRL 408
+ L K P RL
Sbjct: 231 RLFLAKKPEDRL 242
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 9e-17
Identities = 84/310 (27%), Positives = 137/310 (44%), Gaps = 66/310 (21%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVI--PKHKMTTAIAIEDVRREVKIL 212
+Y+ + +G G G CAA + GQ VA+K + P +T A + RE+ ++
Sbjct: 16 KRYQNLKPIGSGAQGIVCAAY---DTVTGQNVAIKKLSRPFQNVTHA---KRAYRELVLM 69
Query: 213 RALTGHNNLVKFFDAY------EDTDNVYVVMELCEGG--ELLDRILSRGGKYTEDDAKA 264
+ L H N++ + + E+ +VY+VMEL + +++ L +
Sbjct: 70 K-LVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLD------HERMSY 122
Query: 265 VMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVG 324
++ Q+L + H G++HRDLKP N + + + LK +DFGL+ + V
Sbjct: 123 LLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYVV 179
Query: 325 SAYYVAPEV-LHRSYSTEADVWSIGVIAYILLCGSRPF--------WAR------TESGI 369
+ YY APEV L Y D+WS+G I ++ G+ F W + T S
Sbjct: 180 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDE 239
Query: 370 FRAVLK-------------ADPSFDEA------PWPSLS------SEARDFVKRLLNKDP 404
F + L+ A SF+E P S S S+ARD + ++L DP
Sbjct: 240 FMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDP 299
Query: 405 RKRLTAAQAL 414
KR++ AL
Sbjct: 300 EKRISVDDAL 309
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 1e-16
Identities = 83/306 (27%), Positives = 136/306 (44%), Gaps = 61/306 (19%)
Query: 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVI--PKHKMTTAIAIEDVRREVKILR 213
+Y+ + +G G G CAA + G VAVK + P T A + RE+ +L+
Sbjct: 22 RYQQLKPIGSGAQGIVCAAF---DTVLGINVAVKKLSRPFQNQTHA---KRAYRELVLLK 75
Query: 214 ALTGHNNLVKFFDAY------EDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMI 267
+ H N++ + + E+ +VY+VMEL + L +++ + + ++
Sbjct: 76 CVN-HKNIISLLNVFTPQKSLEEFQDVYLVMELMDAN--LCQVIHM--ELDHERMSYLLY 130
Query: 268 QILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAY 327
Q+L + H G++HRDLKP N + + + LK +DFGL+ + + V + Y
Sbjct: 131 QMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTACTNFMMTPYVVTRY 187
Query: 328 YVAPEV-LHRSYSTEADVWSIGVIAYILLCGSRPF--------WAR------TESGIFRA 372
Y APEV L Y D+WS+G I L+ GS F W + T S F
Sbjct: 188 YRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMN 247
Query: 373 VLKA-----------------DPSFDEAPWPSLS-------SEARDFVKRLLNKDPRKRL 408
L+ + F + +PS S S+ARD + ++L DP KR+
Sbjct: 248 RLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRI 307
Query: 409 TAAQAL 414
+ +AL
Sbjct: 308 SVDEAL 313
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 1e-16
Identities = 70/207 (33%), Positives = 103/207 (49%), Gaps = 22/207 (10%)
Query: 156 KYELGEEVGRGHFGYTCAAKFKKGELK--GQQVAVKVIPKHKMTTAIAIEDVRREVKILR 213
+YE E+G G +G FK +LK G+ VA+K + + + +R EV +LR
Sbjct: 2 QYECVAEIGEGAYGKV----FKARDLKNGGRFVALKRVRVQTGEEGMPLSTIR-EVAVLR 56
Query: 214 ALTG--HNNLVKFFD--AYEDTD---NVYVVMELCEGG--ELLDRILSRGGKYTEDDAKA 264
L H N+V+ FD TD + +V E + LD++ G + K
Sbjct: 57 HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPG--VPTETIKD 114
Query: 265 VMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVG 324
+M Q+L + F H VVHRDLKP+N L T+ + +K DFGL+ L +V
Sbjct: 115 MMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQ---IKLADFGLARIYSFQMALTSVVV 171
Query: 325 SAYYVAPEV-LHRSYSTEADVWSIGVI 350
+ +Y APEV L SY+T D+WS+G I
Sbjct: 172 TLWYRAPEVLLQSSYATPVDLWSVGCI 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 2e-16
Identities = 60/192 (31%), Positives = 93/192 (48%), Gaps = 18/192 (9%)
Query: 207 REVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSR-----GGKYTEDD 261
REV +L+ L H N+V D ++ +V E LD+ L + G + +
Sbjct: 53 REVSLLKDLK-HANIVTLHDIVHTDKSLTLVFEY------LDKDLKQYMDDCGNIMSMHN 105
Query: 262 AKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR-PDERLN 320
K + QIL +A+CH + V+HRDLKP+N L + E LK DFGL+ P + +
Sbjct: 106 VKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGE---LKLADFGLARAKSVPTKTYS 162
Query: 321 DIVGSAYYVAPEVLHRS--YSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADP 378
+ V + +Y P+VL S YST+ D+W +G I + + G F T + +
Sbjct: 163 NEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLG 222
Query: 379 SFDEAPWPSLSS 390
+ E WP +SS
Sbjct: 223 TPTEETWPGISS 234
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 79.0 bits (194), Expect = 2e-16
Identities = 83/298 (27%), Positives = 130/298 (43%), Gaps = 50/298 (16%)
Query: 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVI--PKHKMTTAIAIEDVRREVKI 211
A+ YE E++G G + K K + G+ VA+KVI + + T AI RE +
Sbjct: 4 ADSYEKLEKLGEGSYATVYKGKSK---VNGKLVALKVIRLQEEEGTPFTAI----REASL 56
Query: 212 LRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILN 271
L+ L H N+V D + + +V E +L + G ++ K + Q+L
Sbjct: 57 LKGLK-HANIVLLHDIIHTKETLTLVFEYVHT-DLCQYMDKHPGGLHPENVKLFLFQLLR 114
Query: 272 VVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR-PDERLNDIVGSAYYVA 330
+++ H + ++HRDLKP+N L + E LK DFGL+ P ++ V + +Y
Sbjct: 115 GLSYIHQRYILHRDLKPQNLLISDTGE---LKLADFGLARAKSVPSHTYSNEVVTLWYRP 171
Query: 331 PEVLHRS--YSTEADVWSIGVIAYILLCGSRPFWARTE-----SGIFRAVLKADPSFDEA 383
P+VL S YST D+W +G I ++ G F + IF ++ P+ D
Sbjct: 172 PDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIF--LVLGTPNEDTW 229
Query: 384 P------------------------WPSLS--SEARDFVKRLLNKDPRKRLTAAQALS 415
P W LS + A D +LL P+ RL+A ALS
Sbjct: 230 PGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 2e-16
Identities = 69/251 (27%), Positives = 109/251 (43%), Gaps = 54/251 (21%)
Query: 161 EEVGRGHFGYTCAAKFKKGELKGQ-QVAVKVIPKHKMTTAIAIEDVRR----EVKILRAL 215
E++G+G+FG KG LKG +VAVK + T D++R E +IL+
Sbjct: 1 EKIGKGNFG-----DVYKGVLKGNTEVAVKTC---RSTL---PPDLKRKFLQEAEILKQY 49
Query: 216 TGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAF 275
H N+VK +Y+VMEL GG LL + + + T + + + +
Sbjct: 50 D-HPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEY 108
Query: 276 CHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAY------YV 329
+ +HRDL N L EN+VLK DFG+S R +E V +
Sbjct: 109 LESKNCIHRDLAARNCLV---GENNVLKISDFGMS---REEEGGIYTVSDGLKQIPIKWT 162
Query: 330 APEVLHRS-YSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSL 388
APE L+ Y++E+DVWS G++ + F S + P+P +
Sbjct: 163 APEALNYGRYTSESDVWSYGILLW---------------ETF--------SLGDTPYPGM 199
Query: 389 S-SEARDFVKR 398
S + R+ ++
Sbjct: 200 SNQQTRERIES 210
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 78.5 bits (194), Expect = 2e-16
Identities = 80/281 (28%), Positives = 124/281 (44%), Gaps = 52/281 (18%)
Query: 177 KKGE------LK------GQQVAVKVIPKHKMTTAIAIEDVR--REVKILRALTGHNNLV 222
K GE LK G+ A+K + KH ++E V RE++ LR L+ H N++
Sbjct: 6 KIGEGTFSEVLKAQSRKTGKYYAIKCMKKH----FKSLEQVNNLREIQALRRLSPHPNIL 61
Query: 223 KFFDAYED--TDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQG 280
+ + D T + +V EL + L + I R E K+ M Q+L + H G
Sbjct: 62 RLIEVLFDRKTGRLALVFELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNG 120
Query: 281 VVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRS--Y 338
+ HRD+KPEN L KD+ +LK DFG + + + + +Y APE L Y
Sbjct: 121 IFHRDIKPENILI--KDD--ILKLADFGSCRGIYSKPPYTEYISTRWYRAPECLLTDGYY 176
Query: 339 STEADVWSIGVIAYILLCGSRPFWARTE----SGI--------------FRAVLKADPSF 380
+ D+W++G + + +L F E + I FR + +F
Sbjct: 177 GPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNF 236
Query: 381 -----DEAPW--PSLSSEARDFVKRLLNKDPRKRLTAAQAL 414
P+ S+E D +K+LL DP +R+TA QAL
Sbjct: 237 PSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQAL 277
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 3e-16
Identities = 66/215 (30%), Positives = 102/215 (47%), Gaps = 17/215 (7%)
Query: 149 FSKHFANKYELGEEVGRGHFGYTCAAKFK-KGELKGQQVAVKVIPKHKMTTAIAIEDVRR 207
F K F + ++G GHFG ++ +G+ G+QVAVK + IA D+++
Sbjct: 1 FEKRFLKRIR---DLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIA--DLKK 55
Query: 208 EVKILRALTGHNNLVKFFD-AYEDTDN-VYVVMELCEGGELLDRILSRGGKYTEDDAKAV 265
E++ILR L H N+VK+ ED N + ++ME G L + + K
Sbjct: 56 EIEILRNLY-HENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKY 114
Query: 266 MIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERL----ND 321
+QI + + + VHRDL N L + E+ V K DFGL+ + D+ +D
Sbjct: 115 AVQICKGMDYLGSRQYVHRDLAARNVL--VESEHQV-KIGDFGLTKAIETDKEYYTVKDD 171
Query: 322 IVGSAYYVAPEVL-HRSYSTEADVWSIGVIAYILL 355
+ ++ APE L + +DVWS GV Y LL
Sbjct: 172 LDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELL 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 5e-16
Identities = 74/257 (28%), Positives = 129/257 (50%), Gaps = 27/257 (10%)
Query: 163 VGRGHFG--YTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNN 220
+GRG FG Y C +K + G+ A+K + K ++ E + +I+ +L +
Sbjct: 2 IGRGGFGEVYGC----RKAD-TGKMYAMKCLDKKRIKMKQG-ETLALNERIMLSLVSTGD 55
Query: 221 ---LVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCH 277
+V A+ D + +++L GG+L LS+ G ++E + + +I+ + H
Sbjct: 56 CPFIVCMTYAFHTPDKLCFILDLMNGGDL-HYHLSQHGVFSEKEMRFYATEIILGLEHMH 114
Query: 278 LQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDERLNDIVGSAYYVAPEVLHR 336
+ VV+RDLKP N L DE+ ++ D GL+ DF + ++ + VG+ Y+APEVL +
Sbjct: 115 NRFVVYRDLKPANILL---DEHGHVRISDLGLACDFSK--KKPHASVGTHGYMAPEVLQK 169
Query: 337 --SYSTEADVWSIGVIAYILLCGSRPFW---ARTESGIFRAVLKADPSFDEAPWPSLSSE 391
+Y + AD +S+G + + LL G PF + + I R L + + S S E
Sbjct: 170 GTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPD----SFSPE 225
Query: 392 ARDFVKRLLNKDPRKRL 408
+ ++ LL +D KRL
Sbjct: 226 LKSLLEGLLQRDVSKRL 242
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 9e-16
Identities = 80/306 (26%), Positives = 128/306 (41%), Gaps = 58/306 (18%)
Query: 147 FGFSKHFANKYELGEEVGRGHFGYTCAAKFKK-GELKGQQVAVKVIPKHKMTTAIAIE-D 204
FG + + N +LGE + A +K + GQ VA+KVI M T +
Sbjct: 1 FGAATSYLNLEKLGEG--------SYATVYKGISRINGQLVALKVI---SMKTEEGVPFT 49
Query: 205 VRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKA 264
RE +L+ L H N+V D + + V E +L ++ G + +
Sbjct: 50 AIREASLLKGLK-HANIVLLHDIIHTKETLTFVFEYMHT-DLAQYMIQHPGGLHPYNVRL 107
Query: 265 VMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR-PDERLNDIV 323
M Q+L +A+ H Q ++HRDLKP+N L + E LK DFGL+ P + + V
Sbjct: 108 FMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGE---LKLADFGLARAKSIPSQTYSSEV 164
Query: 324 GSAYYVAPEVLHRS--YSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLK-----A 376
+ +Y P+VL + YS+ D+W G I +I + +P + S +F + K
Sbjct: 165 VTLWYRPPDVLLGATDYSSALDIWGAGCI-FIEMLQGQPAFPGV-SDVFEQLEKIWTVLG 222
Query: 377 DPSFDEAPWPSLSS----------------------------EARDFVKRLLNKDPRKRL 408
P+ E WP +S +A D ++L P+ R+
Sbjct: 223 VPT--EDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRI 280
Query: 409 TAAQAL 414
+A AL
Sbjct: 281 SAQDAL 286
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 2e-15
Identities = 68/252 (26%), Positives = 114/252 (45%), Gaps = 14/252 (5%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLV 222
+G+G FG A + + G+ A K + K ++ E E +IL A +V
Sbjct: 1 LGKGGFGEVSACQMRA---TGKLYACKKLNKKRLKKRKGYEGAMVEKRIL-AKVHSRFIV 56
Query: 223 KFFDAYEDTDNVYVVMELCEGGELLDRILS---RGGKYTEDDAKAVMIQILNVVAFCHLQ 279
A++ ++ +VM + GG+L I + + E A QI++ + H +
Sbjct: 57 SLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR 116
Query: 280 GVVHRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDERLNDIVGSAYYVAPEVLH-RS 337
+++RDLKPEN L D + ++ D GL+ + + G+ ++APE+L
Sbjct: 117 RIIYRDLKPENVLL---DNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEE 173
Query: 338 YSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWP-SLSSEARDFV 396
Y D +++GV Y ++ PF AR E + LK D +P S ++ F
Sbjct: 174 YDFSVDYFALGVTLYEMIAARGPFRARGEK-VENKELKQRILNDSVTYPDKFSPASKSFC 232
Query: 397 KRLLNKDPRKRL 408
+ LL KDP KRL
Sbjct: 233 EALLAKDPEKRL 244
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 2e-15
Identities = 76/277 (27%), Positives = 118/277 (42%), Gaps = 50/277 (18%)
Query: 163 VGRGHFG--YTCAAKFKKGELKG-QQVAVKVIPKHKMTTAIAIEDVRREVKILRALTG-- 217
+G G FG Y A G G +VAVK + K A + ++E L
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKG------ATDQEKKEFLKEAHLMSNF 56
Query: 218 -HNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAV----MIQI-LN 271
H N+VK + Y++MEL EGG+LL + R + + ++ I L+
Sbjct: 57 NHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYL--RDARVERFGPPLLTLKELLDICLD 114
Query: 272 VVAFCH-LQGV--VHRDLKPENFLFTTKDENS--VLKAIDFGLSDFVRPDERLNDIVGSA 326
V C L+ + +HRDL N L + K ++ V+K DFGL+ DI S
Sbjct: 115 VAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA---------RDIYKSD 165
Query: 327 YY------------VAPEVLHRS-YSTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRA 372
YY +APE L ++T++DVWS GV+ + IL G +P+ A + +
Sbjct: 166 YYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQH 225
Query: 373 VLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLT 409
V A + P + + + +DP +R T
Sbjct: 226 V-TAGGRL-QKP-ENCPDKIYQLMTNCWAQDPSERPT 259
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 74.9 bits (185), Expect = 3e-15
Identities = 59/234 (25%), Positives = 103/234 (44%), Gaps = 28/234 (11%)
Query: 184 QQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEG 243
Q++ V+ I K K AI E + + + + N +K + + ++M+ +
Sbjct: 41 QKLFVQKIIKAKNFNAI-------EPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKD 93
Query: 244 GELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLK 303
G+L D +L + GK +E + K ++ Q++ + H ++H D+K EN L+ + L
Sbjct: 94 GDLFD-LLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYL- 151
Query: 304 AIDFGLSDFVRPDERLNDIVG--SAY-----YVAPE-VLHRSYSTEADVWSIGVIAYILL 355
D+GL I+G S Y Y +PE + +Y D W++GV+ Y LL
Sbjct: 152 -CDYGLC----------KIIGTPSCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELL 200
Query: 356 CGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLT 409
G PF + + L ++S A DFV+ +L + RLT
Sbjct: 201 TGKHPFKEDEDEELDLESLLKRQQKKLPFIKNVSKNANDFVQSMLKYNINYRLT 254
|
Length = 267 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 4e-15
Identities = 60/230 (26%), Positives = 100/230 (43%), Gaps = 35/230 (15%)
Query: 161 EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNN 220
+ +G G FG C + K K VA+K + ++ D E I+ H N
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTL--KAGSSDKQRLDFLTEASIMGQFD-HPN 66
Query: 221 LVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQG 280
+++ + V ++ E E G L D+ L E+D K + Q++ + L+G
Sbjct: 67 IIRLEGVVTKSRPVMIITEYMENGSL-DKFLR------ENDGKFTVGQLVGM-----LRG 114
Query: 281 V------------VHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVG---S 325
+ VHRDL N L + N V K DFGLS + E G
Sbjct: 115 IASGMKYLSEMNYVHRDLAARNILV---NSNLVCKVSDFGLSRRLEDSEATYTTKGGKIP 171
Query: 326 AYYVAPEVL-HRSYSTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAV 373
+ APE + +R +++ +DVWS G++ + ++ G RP+W + + +AV
Sbjct: 172 IRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAV 221
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 5e-15
Identities = 53/202 (26%), Positives = 88/202 (43%), Gaps = 29/202 (14%)
Query: 161 EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNN 220
+E+G G+FG + K +VAVK + + + ++ RE ++ L H
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGK--KEFLREASVMAQLD-HPC 57
Query: 221 LVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQG 280
+V+ + + + +VMEL G LL + R + D K + Q+ +A+ +
Sbjct: 58 IVRLIGVCK-GEPLMLVMELAPLGPLLKYLKKRR-EIPVSDLKELAHQVAMGMAYLESKH 115
Query: 281 VVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYY------------ 328
VHRDL N L + + K DFG+S + GS YY
Sbjct: 116 FVHRDLAARNVLLVNRHQ---AKISDFGMSRALGA--------GSDYYRATTAGRWPLKW 164
Query: 329 VAPEVLH-RSYSTEADVWSIGV 349
APE ++ +S+++DVWS GV
Sbjct: 165 YAPECINYGKFSSKSDVWSYGV 186
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 9e-15
Identities = 74/258 (28%), Positives = 116/258 (44%), Gaps = 55/258 (21%)
Query: 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRAL 215
K LGE +G G FG GE GQ+VAVK I K +T +E+ K+
Sbjct: 7 KLTLGEIIGEGEFGAVLQ-----GEYTGQKVAVKNI-KCDVTAQAFLEETAVMTKL---- 56
Query: 216 TGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNV--- 272
H NLV+ + +Y+VMEL G L++ + +RG A +IQ+L
Sbjct: 57 -HHKNLVRLLGVILH-NGLYIVMELMSKGNLVNFLRTRG------RALVSVIQLLQFSLD 108
Query: 273 ----VAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYY 328
+ + + +VHRDL N L + E+ V K DFGL+ +++ +
Sbjct: 109 VAEGMEYLESKKLVHRDLAARNILVS---EDGVAKVSDFGLARVGS--MGVDNSKLPVKW 163
Query: 329 VAPEVL-HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPS 387
APE L H+ +S+++DVWS GV+ W +F S+ AP+P
Sbjct: 164 TAPEALKHKKFSSKSDVWSYGVL----------LWE-----VF--------SYGRAPYPK 200
Query: 388 LS-SEARDFVKRLLNKDP 404
+S E ++ V++ +P
Sbjct: 201 MSLKEVKECVEKGYRMEP 218
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 4e-14
Identities = 56/198 (28%), Positives = 92/198 (46%), Gaps = 19/198 (9%)
Query: 158 ELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTG 217
+L + +G+G FG G+ +G +VAVK I K+ T + E ++ L
Sbjct: 9 KLLQTIGKGEFG-----DVMLGDYRGNKVAVKCI-KNDATAQAFLA----EASVMTQLR- 57
Query: 218 HNNLVKFFDA-YEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAK-AVMIQILNVVAF 275
H+NLV+ E+ +Y+V E G L+D + SRG D + + + +
Sbjct: 58 HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEY 117
Query: 276 CHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVL- 334
VHRDL N L + E++V K DFGL+ + + + APE L
Sbjct: 118 LEANNFVHRDLAARNVLVS---EDNVAKVSDFGLTKEASSTQDTGKL--PVKWTAPEALR 172
Query: 335 HRSYSTEADVWSIGVIAY 352
+ +ST++DVWS G++ +
Sbjct: 173 EKKFSTKSDVWSFGILLW 190
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 5e-14
Identities = 75/306 (24%), Positives = 131/306 (42%), Gaps = 61/306 (19%)
Query: 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVI--PKHKMTTAIAIEDVRREVKILR 213
+Y+ + +G G G CAA + + VA+K + P T A + RE+ +++
Sbjct: 18 RYQNLKPIGSGAQGIVCAAY---DAVLDRNVAIKKLSRPFQNQTHA---KRAYRELVLMK 71
Query: 214 ALTGHNNLVKFFDAY------EDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMI 267
+ H N++ + + E+ +VY+VMEL + L +++ + + ++
Sbjct: 72 CVN-HKNIISLLNVFTPQKSLEEFQDVYLVMELMDAN--LCQVIQM--ELDHERMSYLLY 126
Query: 268 QILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAY 327
Q+L + H G++HRDLKP N + + + LK +DFGL+ + V + Y
Sbjct: 127 QMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYVVTRY 183
Query: 328 YVAPEV-LHRSYSTEADVWSIGVIA------YILLCGSR----------------PFWAR 364
Y APEV L Y D+WS+G I IL G P + +
Sbjct: 184 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK 243
Query: 365 TESGIFRAVLKADPSFDEAPWPSL----------------SSEARDFVKRLLNKDPRKRL 408
R ++ P + +P L +S+ARD + ++L DP KR+
Sbjct: 244 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRI 303
Query: 409 TAAQAL 414
+ +AL
Sbjct: 304 SVDEAL 309
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 5e-14
Identities = 71/258 (27%), Positives = 119/258 (46%), Gaps = 22/258 (8%)
Query: 158 ELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTG 217
LG +G G FG + E + VAVK K+ + ++ E +E I+R
Sbjct: 9 TLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTC-KNCTSPSVR-EKFLQEAYIMRQFD- 65
Query: 218 HNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVM--IQILNVVAF 275
H ++VK + + V++VMEL GEL R + KY+ D A ++ Q+ +A+
Sbjct: 66 HPHIVKLIGVITE-NPVWIVMELAPLGEL--RSYLQVNKYSLDLASLILYSYQLSTALAY 122
Query: 276 CHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGS--AYYVAPEV 333
+ VHRD+ N L ++ D +K DFGLS ++ + G ++APE
Sbjct: 123 LESKRFVHRDIAARNVLVSSPD---CVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPES 179
Query: 334 LH-RSYSTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAVLKAD--PSFDEAPWPSLS 389
++ R +++ +DVW GV + IL+ G +PF + + + + P P P+L
Sbjct: 180 INFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMPPNCP-PTLY 238
Query: 390 SEARDFVKRLLNKDPRKR 407
S + + DP KR
Sbjct: 239 S----LMTKCWAYDPSKR 252
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 71.2 bits (175), Expect = 6e-14
Identities = 67/295 (22%), Positives = 113/295 (38%), Gaps = 55/295 (18%)
Query: 155 NKYELGEEVGRGHFGYT---CAAKFKKGELKGQQVAVK-VIPKHKMTTAIAIEDVRREVK 210
K L E+G+G FG A KGE + + VA+K V M I E
Sbjct: 6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETR-VAIKTVNENASMRERIEF---LNEAS 61
Query: 211 ILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSR---------GGKYTEDD 261
+++ H+ +V+ VVMEL G+L + SR G T
Sbjct: 62 VMKEFNCHH-VVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQK 120
Query: 262 AKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLND 321
+ +I + +A+ + VHRDL N + E+ +K DFG++ D
Sbjct: 121 FIQMAAEIADGMAYLAAKKFVHRDLAARNCMVA---EDLTVKIGDFGMT---------RD 168
Query: 322 IVGSAYY------------VAPEVLHRS-YSTEADVWSIGVIAY-ILLCGSRPFWARTES 367
I + YY +APE L ++T++DVWS GV+ + + +P+ +
Sbjct: 169 IYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNE 228
Query: 368 GIFRAVLKAD----PSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELL 418
+ + V+ P + ++ +P+ R T + +S L
Sbjct: 229 EVLKFVIDGGHLDLPENCPDKL-------LELMRMCWQYNPKMRPTFLEIVSSLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 2e-13
Identities = 84/320 (26%), Positives = 137/320 (42%), Gaps = 67/320 (20%)
Query: 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRAL 215
+YE G +VGRG +G+ AK K G+ + A+K I ++ + RE+ +LR L
Sbjct: 3 EYE-GCKVGRGTYGHVYKAKRKDGK-DDRDYALKQIEGTGISMSAC-----REIALLREL 55
Query: 216 TGHN--NLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDA-------KAVM 266
N +L K F ++ D V+++ + E R K + K+++
Sbjct: 56 KHPNVISLQKVFLSHADR-KVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLL 114
Query: 267 IQILNVVAFCHLQGVVHRDLKPENFLFTTKD-ENSVLKAIDFGLSDF----VRPDERLND 321
QIL+ + + H V+HRDLKP N L + E +K D G + ++P L+
Sbjct: 115 YQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDP 174
Query: 322 IVGSAYYVAPEVL--HRSYSTEADVWSIGVIAYILLCGSRPFWARTE------------- 366
+V + +Y APE+L R Y+ D+W+IG I LL F R E
Sbjct: 175 VVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQL 234
Query: 367 SGIFRAV-LKADPSFDE-APWPSLSSEARDF----------------------------V 396
IF + AD +++ P S+ +DF +
Sbjct: 235 DRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLL 294
Query: 397 KRLLNKDPRKRLTAAQALSE 416
++LL DP KR+T+ QA+ +
Sbjct: 295 QKLLTMDPIKRITSEQAMQD 314
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 2e-13
Identities = 75/306 (24%), Positives = 131/306 (42%), Gaps = 61/306 (19%)
Query: 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVI--PKHKMTTAIAIEDVRREVKILR 213
+Y+ + +G G G CAA E + VA+K + P T A + RE+ +++
Sbjct: 25 RYQNLKPIGSGAQGIVCAAYDAILE---RNVAIKKLSRPFQNQTHA---KRAYRELVLMK 78
Query: 214 ALTGHNNLVKFFDAY------EDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMI 267
+ H N++ + + E+ +VY+VMEL + L +++ + + ++
Sbjct: 79 CVN-HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQM--ELDHERMSYLLY 133
Query: 268 QILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAY 327
Q+L + H G++HRDLKP N + + + LK +DFGL+ + V + Y
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYVVTRY 190
Query: 328 YVAPEV-LHRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVL------------ 374
Y APEV L Y D+WS+G I ++ G F + V+
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMK 250
Query: 375 KADPS-------------------FDEAPWPSLS-------SEARDFVKRLLNKDPRKRL 408
K P+ F + +P+ S S+ARD + ++L D KR+
Sbjct: 251 KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRI 310
Query: 409 TAAQAL 414
+ +AL
Sbjct: 311 SVDEAL 316
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 2e-13
Identities = 84/321 (26%), Positives = 139/321 (43%), Gaps = 69/321 (21%)
Query: 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRAL 215
+YE G +VGRG +G+ AK K G+ ++ A+K I ++ + RE+ +LR L
Sbjct: 3 EYE-GCKVGRGTYGHVYKAKRKDGK-DEKEYALKQIEGTGISMSAC-----REIALLREL 55
Query: 216 TGHNNLV---KFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDD-------AKAV 265
H N++ K F ++ D V+++ + E R K + K++
Sbjct: 56 K-HPNVIALQKVFLSHSDR-KVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSL 113
Query: 266 MIQILNVVAFCHLQGVVHRDLKPENFLFTTKD-ENSVLKAIDFGLSDF----VRPDERLN 320
+ QIL+ + + H V+HRDLKP N L + E +K D G + ++P L+
Sbjct: 114 LYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLD 173
Query: 321 DIVGSAYYVAPEVL--HRSYSTEADVWSIGVIAYILLCGSRPFWARTE------------ 366
+V + +Y APE+L R Y+ D+W+IG I LL F R E
Sbjct: 174 PVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQ 233
Query: 367 -SGIFRAV-LKADPSFDE----APWPSLSSEARD-------------------------F 395
IF + AD +++ +P+L + R
Sbjct: 234 LDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLL 293
Query: 396 VKRLLNKDPRKRLTAAQALSE 416
+++LL DP KR+T+ QAL +
Sbjct: 294 LQKLLTMDPTKRITSEQALQD 314
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 2e-13
Identities = 69/262 (26%), Positives = 115/262 (43%), Gaps = 37/262 (14%)
Query: 161 EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNN 220
E +GRG+FG + G L+ V V + +E +IL+ + H N
Sbjct: 1 ERIGRGNFGEVFS-----GRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYS-HPN 54
Query: 221 LVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQG 280
+V+ +Y+VMEL +GG+ L + + G + + ++ + + +
Sbjct: 55 IVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH 114
Query: 281 VVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAY---------YVAP 331
+HRDL N L T E +VLK DFG+S R +E D V ++ + AP
Sbjct: 115 CIHRDLAARNCLVT---EKNVLKISDFGMS---REEE---DGVYASTGGMKQIPVKWTAP 165
Query: 332 EVL-HRSYSTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLS 389
E L + YS+E+DVWS G++ + G+ P+ + A+ + P P L
Sbjct: 166 EALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQG----VRLPCPELC 221
Query: 390 SEARDFVKRLLNK----DPRKR 407
+A V RL+ + DP +R
Sbjct: 222 PDA---VYRLMERCWEYDPGQR 240
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 3e-13
Identities = 62/231 (26%), Positives = 104/231 (45%), Gaps = 29/231 (12%)
Query: 155 NKYELGEEVGRGHFGYTCAAKF----KKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVK 210
+K LG+ +G G FG A+ K + VAVK++ T + D+ E++
Sbjct: 15 DKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDD--ATEKDLSDLVSEME 72
Query: 211 ILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSR---GGKYTED------- 260
+++ + H N++ A +YV++E G L + + +R G +Y+ D
Sbjct: 73 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDE 132
Query: 261 -----DAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP 315
D + Q+ + + Q +HRDL N L T EN+V+K DFGL+ V
Sbjct: 133 QMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADFGLARDVNN 189
Query: 316 DERLNDIVGS---AYYVAPEVL-HRSYSTEADVWSIGVIAY-ILLCGSRPF 361
+ ++APE L R Y+ ++DVWS GV+ + I G P+
Sbjct: 190 IDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 240
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 3e-13
Identities = 65/260 (25%), Positives = 117/260 (45%), Gaps = 26/260 (10%)
Query: 158 ELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTG 217
+L +++G G FG + +VAVK + M+ +E E +++ L
Sbjct: 9 KLVKKLGAGQFGEVWMGYYNNS----TKVAVKTLKPGTMSVQAFLE----EANLMKTLQ- 59
Query: 218 HNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILS-RGGKYTEDDAKAVMIQILNVVAFC 276
H+ LV+ + + +Y++ E G LLD + S GGK QI +A+
Sbjct: 60 HDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYI 119
Query: 277 HLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAY---YVAPEV 333
+ +HRDL+ N L + E+ + K DFGL+ + +E G+ + + APE
Sbjct: 120 ERKNYIHRDLRAANVLVS---ESLMCKIADFGLARVIEDNE-YTAREGAKFPIKWTAPEA 175
Query: 334 LHR-SYSTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAVLKA--DPSFDEAPWPSLS 389
++ S++ ++DVWS G++ Y I+ G P+ + S + A+ + P + P
Sbjct: 176 INFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENCP----- 230
Query: 390 SEARDFVKRLLNKDPRKRLT 409
E D +K + +R T
Sbjct: 231 DELYDIMKTCWKEKAEERPT 250
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 4e-13
Identities = 61/198 (30%), Positives = 94/198 (47%), Gaps = 19/198 (9%)
Query: 161 EEVGRGHFGYTCAAKFKKGELKGQQ-VAVKVIPKHKMTTAIAIEDVRREVKILRALTGHN 219
E +G+G+FG + KG LK + VAVK K + + I+ + E +IL+ H
Sbjct: 1 ELLGKGNFG-----EVFKGTLKDKTPVAVKTC-KEDLPQELKIKFLS-EARILKQYD-HP 52
Query: 220 NLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQ 279
N+VK +Y+VMEL GG+ L + + + + +A+ +
Sbjct: 53 NIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESK 112
Query: 280 GVVHRDLKPENFLFTTKDENSVLKAIDFGLS----DFVRPDERLNDIVGSAYYVAPEVL- 334
+HRDL N L EN+VLK DFG+S D + L I + APE L
Sbjct: 113 NCIHRDLAARNCLV---GENNVLKISDFGMSRQEDDGIYSSSGLKQI--PIKWTAPEALN 167
Query: 335 HRSYSTEADVWSIGVIAY 352
+ YS+E+DVWS G++ +
Sbjct: 168 YGRYSSESDVWSYGILLW 185
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 4e-13
Identities = 50/182 (27%), Positives = 88/182 (48%), Gaps = 15/182 (8%)
Query: 186 VAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGE 245
VAVK + M +D E +I++ L H L++ + + +Y+V EL + G
Sbjct: 33 VAVKTLKPGTM----DPKDFLAEAQIMKKLR-HPKLIQLYAVCTLEEPIYIVTELMKYGS 87
Query: 246 LLDRILSRGGKYTE-DDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKA 304
LL+ + G+ + + Q+ + +A+ Q +HRDL N L EN++ K
Sbjct: 88 LLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLV---GENNICKV 144
Query: 305 IDFGLSDFVRPDERLNDIVGSAY---YVAPE-VLHRSYSTEADVWSIGVIAY-ILLCGSR 359
DFGL+ ++ D G+ + + APE L+ +S ++DVWS G++ I+ G
Sbjct: 145 ADFGLARVIKEDI-YEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRM 203
Query: 360 PF 361
P+
Sbjct: 204 PY 205
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 5e-13
Identities = 58/226 (25%), Positives = 99/226 (43%), Gaps = 30/226 (13%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTG---HN 219
+G G FG C+ + K + VA+K + A E RR+ ++ G H
Sbjct: 12 IGAGEFGEVCSGRLKLPGKREIPVAIKTL------KAGYTEKQRRDFLSEASIMGQFDHP 65
Query: 220 NLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQ 279
N++ + V +V E E G L + G++T ++ I + + +
Sbjct: 66 NIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDM 125
Query: 280 GVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAY----------YV 329
G VHRDL N L + N V K DFGLS + D +AY +
Sbjct: 126 GYVHRDLAARNILVNS---NLVCKVSDFGLSRVLEDDPE------AAYTTRGGKIPIRWT 176
Query: 330 APEVL-HRSYSTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAV 373
APE + +R +++ +DVWS G++ + ++ G RP+W + + +A+
Sbjct: 177 APEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAI 222
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 5e-13
Identities = 51/183 (27%), Positives = 92/183 (50%), Gaps = 11/183 (6%)
Query: 207 REVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVM 266
RE+++L +V F+ A+ + + ME +GG L D++L + G+ E V
Sbjct: 52 RELQVLHECNS-PYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILGKVS 109
Query: 267 IQILNVVAFCHLQ-GVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGS 325
I ++ + + + ++HRD+KP N L ++ E +K DFG+S + D N VG+
Sbjct: 110 IAVIKGLTYLREKHKIMHRDVKPSNILVNSRGE---IKLCDFGVSGQL-IDSMANSFVGT 165
Query: 326 AYYVAPEVLHRS-YSTEADVWSIGVIAYILLCGSRPFW---ARTESGIFRAVLKADPSFD 381
Y++PE L + YS ++D+WS+G+ + G P A+ +F ++ DP+
Sbjct: 166 RSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAES 225
Query: 382 EAP 384
E
Sbjct: 226 ETS 228
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 5e-13
Identities = 81/309 (26%), Positives = 128/309 (41%), Gaps = 59/309 (19%)
Query: 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRAL 215
+Y++ +G+G G A ++VA+K I + + + RE KI L
Sbjct: 3 RYDIIRLIGKGGMGEVYLAYDPVC---SRRVALKKIREDLSENPLLKKRFLREAKIAADL 59
Query: 216 TGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRIL-------SRGGKYTEDDAKAVMIQ 268
H +V + D D VY M EG L +L S + E + +
Sbjct: 60 I-HPGIVPVYSICSDGDPVYYTMPYIEG-YTLKSLLKSVWQKESLSKELAEKTSVGAFLS 117
Query: 269 ILN----VVAFCHLQGVVHRDLKPENFLF---------------TTKDENSVLKAIDFGL 309
I + + + H +GV+HRDLKP+N L K E L ID
Sbjct: 118 IFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDE 177
Query: 310 -----SDFVRPDERLNDIVGSAYYVAPEVLHRSYSTEA-DVWSIGVIAYILLCGSRPFWA 363
S P + IVG+ Y+APE L ++E+ D++++GVI Y +L S P+
Sbjct: 178 RNICYSSMTIPGK----IVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPY-- 231
Query: 364 RTESG---IFRAVLKADPSFDEAPW----PSLSSEARDFVKRLLNKDPRKRLTAAQALSE 416
R + G +R V+ P + AP+ P LS + L DP +R ++ Q L +
Sbjct: 232 RRKKGRKISYRDVI-LSPI-EVAPYREIPPFLSQ----IAMKALAVDPAERYSSVQELKQ 285
Query: 417 LLICYQSYL 425
L + +L
Sbjct: 286 DL---EPHL 291
|
Length = 932 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 5e-13
Identities = 66/267 (24%), Positives = 121/267 (45%), Gaps = 27/267 (10%)
Query: 161 EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRR---EVKILRALTG 217
EE+GRG +G + G +AVK ++ + ++ +R ++ I
Sbjct: 7 EELGRGAYGVVDKMRHVP---TGTIMAVK-----RIRATVNSQEQKRLLMDLDISMRSVD 58
Query: 218 HNNLVKFFDAYEDTDNVYVVMELCEGG--ELLDRILSRGGKYTEDDAKAVMIQILNVVAF 275
V F+ A +V++ ME+ + + ++ +G ED + + I+ + +
Sbjct: 59 CPYTVTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEY 118
Query: 276 CHLQ-GVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVL 334
H + V+HRD+KP N L + N +K DFG+S ++ G Y+APE +
Sbjct: 119 LHSKLSVIHRDVKPSNVLI---NRNGQVKLCDFGISGYLVDSVAKTIDAGCKPYMAPERI 175
Query: 335 -----HRSYSTEADVWSIGVIAYILLCGSRPF--WARTESGIFRAVLKADPSFDEAPWPS 387
+ Y ++DVWS+G+ L G P+ W +T + V++ +PS + P
Sbjct: 176 NPELNQKGYDVKSDVWSLGITMIELATGRFPYDSW-KTPFQQLKQVVE-EPS-PQLPAEK 232
Query: 388 LSSEARDFVKRLLNKDPRKRLTAAQAL 414
S E +DFV + L K+ ++R + L
Sbjct: 233 FSPEFQDFVNKCLKKNYKERPNYPELL 259
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 9e-13
Identities = 69/242 (28%), Positives = 108/242 (44%), Gaps = 60/242 (24%)
Query: 156 KYELGEEVGRGHFGYTCAAKFKK--GELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILR 213
K+ELGE G FG A+ E VAVK + K + A +D +RE ++L
Sbjct: 10 KWELGE----GAFGKVFLAECHNLLPEQDKMLVAVKAL---KEASESARQDFQREAELLT 62
Query: 214 ALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAV-------- 265
L H ++V+F+ + + +V E G+L +R L G DAK +
Sbjct: 63 VLQ-HQHIVRFYGVCTEGRPLLMVFEYMRHGDL-NRFLRSHGP----DAKILAGGEDVAP 116
Query: 266 -------MIQILNVVA--FCHLQGV--VHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314
M+ I + +A +L + VHRDL N L + V+K DFG+S
Sbjct: 117 GQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLV---GQGLVVKIGDFGMS---- 169
Query: 315 PDERLNDIVGSAYY------------VAPE-VLHRSYSTEADVWSIGVIAY-ILLCGSRP 360
DI + YY + PE +L+R ++TE+D+WS GV+ + I G +P
Sbjct: 170 -----RDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224
Query: 361 FW 362
++
Sbjct: 225 WY 226
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 1e-12
Identities = 58/222 (26%), Positives = 100/222 (45%), Gaps = 37/222 (16%)
Query: 162 EVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHN-- 219
E+G G+ G + G +A K+I H + RE+K+L H
Sbjct: 8 ELGAGNGGVVTKVLHRP---SGLIMARKLI--HLEIKPAIRNQIIRELKVL-----HECN 57
Query: 220 --NLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCH 277
+V F+ A+ + + ME +GG L D++L + G+ E+ IL ++
Sbjct: 58 SPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEN--------ILGKISIAV 108
Query: 278 LQG---------VVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYY 328
L+G ++HRD+KP N L ++ E +K DFG+S + D N VG+ Y
Sbjct: 109 LRGLTYLREKHKIMHRDVKPSNILVNSRGE---IKLCDFGVSGQLI-DSMANSFVGTRSY 164
Query: 329 VAPEVLHRS-YSTEADVWSIGVIAYILLCGSRPFWARTESGI 369
++PE L + Y+ ++D+WS+G+ + G P +
Sbjct: 165 MSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKEL 206
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 2e-12
Identities = 48/156 (30%), Positives = 82/156 (52%), Gaps = 8/156 (5%)
Query: 207 REVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVM 266
RE+++L +V F+ A+ + + ME +GG L D++L + E+ V
Sbjct: 52 RELQVLHECNS-PYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKEAKRIPEEILGKVS 109
Query: 267 IQILNVVAFCHLQ-GVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGS 325
I +L +A+ + ++HRD+KP N L ++ E +K DFG+S + D N VG+
Sbjct: 110 IAVLRGLAYLREKHQIMHRDVKPSNILVNSRGE---IKLCDFGVSGQL-IDSMANSFVGT 165
Query: 326 AYYVAPEVLHRS-YSTEADVWSIGVIAYILLCGSRP 360
Y++PE L + YS ++D+WS+G+ L G P
Sbjct: 166 RSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 2e-12
Identities = 73/281 (25%), Positives = 126/281 (44%), Gaps = 50/281 (17%)
Query: 159 LGEEVGRGHFGYTCAAK-FKKGELKGQQ-VAVKVIPKHKMTTAIAIEDVRREVKILRALT 216
L E+G G FG A+ + K + VAVK + K T A +D +RE ++L L
Sbjct: 9 LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKAL---KDPTLAARKDFQREAELLTNLQ 65
Query: 217 GHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRG--------GKYTEDDAKAVMIQ 268
H ++VKF+ D D + +V E + G+L + + G G+ + + + Q
Sbjct: 66 -HEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQ 124
Query: 269 ILNV-------VAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLND 321
+L++ + + Q VHRDL N L N ++K DFG+S D
Sbjct: 125 MLHIASQIASGMVYLASQHFVHRDLATRNCLVGA---NLLVKIGDFGMS---------RD 172
Query: 322 IVGSAYY------------VAPE-VLHRSYSTEADVWSIGVIAY-ILLCGSRPFWARTES 367
+ + YY + PE +++R ++TE+DVWS GVI + I G +P++ + +
Sbjct: 173 VYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT 232
Query: 368 GIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRL 408
+ + + E P E D + ++P++RL
Sbjct: 233 EVIECITQG--RVLERP-RVCPKEVYDIMLGCWQREPQQRL 270
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 2e-12
Identities = 58/225 (25%), Positives = 99/225 (44%), Gaps = 22/225 (9%)
Query: 161 EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTG--- 217
E +G G FG C + K + VA+K + K T E RR+ ++ G
Sbjct: 10 EVIGAGEFGEVCRGRLKLPGKREIFVAIKTL-KSGYT-----EKQRRDFLSEASIMGQFD 63
Query: 218 HNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCH 277
H N++ + V ++ E E G L + G++T ++ I + +
Sbjct: 64 HPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLS 123
Query: 278 LQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAY-------YVA 330
VHRDL N L + N V K DFGLS F+ D+ + S+ + A
Sbjct: 124 EMNYVHRDLAARNILVNS---NLVCKVSDFGLSRFLE-DDTSDPTYTSSLGGKIPIRWTA 179
Query: 331 PE-VLHRSYSTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAV 373
PE + +R +++ +DVWS G++ + ++ G RP+W + + A+
Sbjct: 180 PEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAI 224
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 3e-12
Identities = 66/246 (26%), Positives = 111/246 (45%), Gaps = 44/246 (17%)
Query: 159 LGEEVGRGHFGYTCAAKFKK--GELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALT 216
L E+G G FG A+ E VAVK + K + A +D RE ++L L
Sbjct: 9 LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTL---KDASDNARKDFHREAELLTNLQ 65
Query: 217 GHNNLVKFFDAYEDTDNVYVVMELCEGGEL--------LDRILSRGGKYTEDDAKAVMIQ 268
H ++VKF+ + D + +V E + G+L D +L G + ++ M+
Sbjct: 66 -HEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLH 124
Query: 269 ILNVVA----FCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVG 324
I +A + Q VHRDL N L EN ++K DFG+S D+
Sbjct: 125 IAQQIAAGMVYLASQHFVHRDLATRNCLV---GENLLVKIGDFGMS---------RDVYS 172
Query: 325 SAYY------------VAPE-VLHRSYSTEADVWSIGVIAY-ILLCGSRPFWARTESGIF 370
+ YY + PE +++R ++TE+DVWS+GV+ + I G +P++ + + +
Sbjct: 173 TDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVI 232
Query: 371 RAVLKA 376
+ +
Sbjct: 233 ECITQG 238
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 5e-12
Identities = 62/235 (26%), Positives = 100/235 (42%), Gaps = 41/235 (17%)
Query: 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIE----DVRREVKI 211
+ LG+ +G G FG A+ + + V V KM A E D+ E+++
Sbjct: 13 RLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAV----KMLKDDATEKDLSDLVSEMEM 68
Query: 212 LRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSR---------------GGK 256
++ + H N++ +YVV+E G L D + +R
Sbjct: 69 MKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEET 128
Query: 257 YTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS------ 310
T+ D + Q+ + F + +HRDL N L T E+ V+K DFGL+
Sbjct: 129 LTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVT---EDHVMKIADFGLARDIHHI 185
Query: 311 DFVRP--DERLNDIVGSAYYVAPEVL-HRSYSTEADVWSIGVIAY-ILLCGSRPF 361
D+ R + RL ++APE L R Y+ ++DVWS GV+ + I G P+
Sbjct: 186 DYYRKTTNGRL-----PVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPY 235
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 6e-12
Identities = 70/306 (22%), Positives = 133/306 (43%), Gaps = 68/306 (22%)
Query: 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVI---PKHKMTTAIAIEDVRREVKILR 213
Y+LG +G G FG A ++VA+K + P++K RE+ I++
Sbjct: 68 YKLGNIIGNGSFGVVYEAICID---TSEKVAIKKVLQDPQYK----------NRELLIMK 114
Query: 214 ALTGHNNLVKFFDAY------EDTDNVY--VVMELCEGGELLDRILSRGGKYTEDDAKAV 265
L H N++ D Y ++ N++ VVME + + + + K+ + A+
Sbjct: 115 NLN-HINIIFLKDYYYTECFKKNEKNIFLNVVMEF------IPQTVHKYMKHYARNNHAL 167
Query: 266 MI--------QILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDE 317
+ Q+ +A+ H + + HRDLKP+N L LK DFG + + +
Sbjct: 168 PLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPN--THTLKLCDFGSAKNLLAGQ 225
Query: 318 RLNDIVGSAYYVAPEVL--HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLK 375
R + S +Y APE++ +Y+T D+WS+G I ++ G F ++ +++
Sbjct: 226 RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQ 285
Query: 376 A------------DPSFDEAPWPSLSS-------------EARDFVKRLLNKDPRKRLTA 410
+P++ + +P + +A +F+ + L +P KRL
Sbjct: 286 VLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNP 345
Query: 411 AQALSE 416
+AL++
Sbjct: 346 IEALAD 351
|
Length = 440 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 6e-12
Identities = 60/222 (27%), Positives = 101/222 (45%), Gaps = 20/222 (9%)
Query: 158 ELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTG 217
+L +++G G FG A + K +VAVK + M+ + E +++ L
Sbjct: 9 KLEKKLGAGQFGEVWMATYNKH----TKVAVKTMKPGSMSVEAFLA----EANVMKTLQ- 59
Query: 218 HNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILS-RGGKYTEDDAKAVMIQILNVVAFC 276
H+ LVK A + +Y++ E G LLD + S G K QI +AF
Sbjct: 60 HDKLVKL-HAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFI 118
Query: 277 HLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAY---YVAPEV 333
+ +HRDL+ N L + V K DFGL+ + +E G+ + + APE
Sbjct: 119 EQRNYIHRDLRAANILVSAS---LVCKIADFGLARVIEDNEYTAR-EGAKFPIKWTAPEA 174
Query: 334 L-HRSYSTEADVWSIGV-IAYILLCGSRPFWARTESGIFRAV 373
+ S++ ++DVWS G+ + I+ G P+ + + RA+
Sbjct: 175 INFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL 216
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 9e-12
Identities = 55/208 (26%), Positives = 95/208 (45%), Gaps = 22/208 (10%)
Query: 162 EVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNL 221
++G G +G +KK VAVK + + M +E+ +E +++ + H NL
Sbjct: 13 KLGGGQYGEVYEGVWKK---YSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-HPNL 64
Query: 222 VKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVM---IQILNVVAFCHL 278
V+ Y++ E G LLD + R E +A ++ QI + + +
Sbjct: 65 VQLLGVCTREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAMEYLEK 122
Query: 279 QGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAY---YVAPEVL- 334
+ +HRDL N L EN ++K DFGLS + + G+ + + APE L
Sbjct: 123 KNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLA 178
Query: 335 HRSYSTEADVWSIGVIAY-ILLCGSRPF 361
+ +S ++DVW+ GV+ + I G P+
Sbjct: 179 YNKFSIKSDVWAFGVLLWEIATYGMSPY 206
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 1e-11
Identities = 60/231 (25%), Positives = 92/231 (39%), Gaps = 36/231 (15%)
Query: 158 ELGEEVGRGHFG--YTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRAL 215
L +G G FG Y + + G+ QVAVK +P+ + D E I+
Sbjct: 9 TLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPE--SCSEQDESDFLMEALIMSKF 66
Query: 216 TGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILN---- 271
H N+V+ + ++++EL GG+L L E + M +L
Sbjct: 67 N-HQNIVRLIGVSFERLPRFILLELMAGGDLKS-FLRENRPRPERPSSLTMKDLLFCARD 124
Query: 272 VVAFCHL---QGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYY 328
V C +HRD+ N L T K V K DFG++ DI ++YY
Sbjct: 125 VAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMA---------RDIYRASYY 175
Query: 329 ------------VAPEV-LHRSYSTEADVWSIGVIAY-ILLCGSRPFWART 365
+ PE L ++++ DVWS GV+ + I G P+ RT
Sbjct: 176 RKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRT 226
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 2e-11
Identities = 68/250 (27%), Positives = 110/250 (44%), Gaps = 22/250 (8%)
Query: 168 FGYTCAAKFKKGELKGQ-QVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFD 226
G C + G G +VA+K + M ++ E +I++ L H+ LV +
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQ----EAQIMKKLR-HDKLVPLY- 67
Query: 227 AYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMI-QILNVVAFCHLQGVVHRD 285
A + +Y+V E G LLD + GKY + M QI + +A+ +HRD
Sbjct: 68 AVVSEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRD 127
Query: 286 LKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAY---YVAPE-VLHRSYSTE 341
L+ N L +N V K DFGL+ + D G+ + + APE L+ ++ +
Sbjct: 128 LRAANILVG---DNLVCKIADFGLARLIE-DNEYTARQGAKFPIKWTAPEAALYGRFTIK 183
Query: 342 ADVWSIGVIAYILLCGSR-PFWARTESGIFRAVLKADPSFDEAPWPSLSSEA-RDFVKRL 399
+DVWS G++ L+ R P+ + R VL+ P P E+ + +K
Sbjct: 184 SDVWSFGILLTELVTKGRVPY----PGMVNREVLEQVERGYRMPCPQGCPESLHELMKLC 239
Query: 400 LNKDPRKRLT 409
KDP +R T
Sbjct: 240 WKKDPDERPT 249
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 3e-11
Identities = 60/222 (27%), Positives = 95/222 (42%), Gaps = 33/222 (14%)
Query: 149 FSKHFANKYELGEEVGRGHFGYTCAAKFK-KGELKGQQVAVKVI-----PKHKMTTAIAI 202
F K + K +G GHFG + + G+ VAVK + ++
Sbjct: 1 FHKRYLKKIR---VLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNT------- 50
Query: 203 EDVRREVKILRALTGHNNLVKFFDAYEDTDN--VYVVMELCEGGELLDRILSRGGKYTED 260
++E+ IL+ L H N+VK+ + + ++ME G L D + K+ +
Sbjct: 51 SGWKKEINILKTLY-HENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYL----PKHKLN 105
Query: 261 DAKAVMI--QILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDER 318
A+ ++ QI +A+ H Q +HRDL N L D + ++K DFGL+ V
Sbjct: 106 LAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLL---DNDRLVKIGDFGLAKAVPEGHE 162
Query: 319 L----NDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILL 355
D ++ A E L +S +DVWS GV Y LL
Sbjct: 163 YYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELL 204
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 3e-11
Identities = 56/210 (26%), Positives = 99/210 (47%), Gaps = 13/210 (6%)
Query: 158 ELGEEVGRGHFGYTCAAKFK-KGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALT 216
E + +G G FG + +GE VA+KV+ + T+ A +++ E ++ A
Sbjct: 10 EKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREE--TSPKANKEILDEAYVM-ASV 66
Query: 217 GHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFC 276
H ++V+ + V ++ +L G LLD + + +QI +++
Sbjct: 67 DHPHVVRLL-GICLSSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYL 125
Query: 277 HLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAY---YVAPE- 332
+ +VHRDL N L T +K DFGL+ + DE+ G ++A E
Sbjct: 126 EEKRLVHRDLAARNVLVKTP---QHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALES 182
Query: 333 VLHRSYSTEADVWSIGVIAYILLC-GSRPF 361
+LHR Y+ ++DVWS GV + L+ G++P+
Sbjct: 183 ILHRIYTHKSDVWSYGVTVWELMTFGAKPY 212
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 3e-11
Identities = 61/231 (26%), Positives = 102/231 (44%), Gaps = 29/231 (12%)
Query: 155 NKYELGEEVGRGHFGYTCAAKF----KKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVK 210
+ LG+ +G G FG A+ K K VAVK++ T + D+ E++
Sbjct: 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD--ATDKDLSDLVSEME 69
Query: 211 ILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSR---GGKYTEDDAK---- 263
+++ + H N++ A +YV++E G L + + +R G Y+ D K
Sbjct: 70 MMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEE 129
Query: 264 --------AVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP 315
+ Q+ + + Q +HRDL N L T E++V+K DFGL+ V
Sbjct: 130 QLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVT---EDNVMKIADFGLARDVHN 186
Query: 316 DERLNDIVGS---AYYVAPEVL-HRSYSTEADVWSIGVIAY-ILLCGSRPF 361
+ ++APE L R Y+ ++DVWS GV+ + I G P+
Sbjct: 187 IDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPY 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 4e-11
Identities = 65/215 (30%), Positives = 103/215 (47%), Gaps = 41/215 (19%)
Query: 161 EEVGRGHFGYTCAAKFKK-GELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHN 219
+++G+G+FG ++ + G+ VAVK K + +TA + D RE++IL++L H+
Sbjct: 10 QQLGKGNFGSVELCRYDPLQDNTGEVVAVK---KLQHSTAEHLRDFEREIEILKSLQ-HD 65
Query: 220 NLVKF----FDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMI---QILNV 272
N+VK+ + A N+ +VME G L D + + D + +++ QI
Sbjct: 66 NIVKYKGVCYSA--GRRNLRLVMEYLPYGSLRDYLQKHRERL---DHRKLLLYASQICKG 120
Query: 273 VAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYV--- 329
+ + + VHRDL N L + EN V K DFGL+ + D+ YY
Sbjct: 121 MEYLGSKRYVHRDLATRNIL--VESENRV-KIGDFGLTKVLPQDKE--------YYKVRE 169
Query: 330 ---------APEVLHRS-YSTEADVWSIGVIAYIL 354
APE L S +S +DVWS GV+ Y L
Sbjct: 170 PGESPIFWYAPESLTESKFSVASDVWSFGVVLYEL 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 5e-11
Identities = 62/214 (28%), Positives = 92/214 (42%), Gaps = 28/214 (13%)
Query: 220 NLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQ 279
N+V D+V++V++ EGG+L I E+ K +++ + H +
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFL-NIPEECVKRWAAEMVVALDALHRE 104
Query: 280 GVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRSYS 339
G+V RDL P N L D+ ++ F V + V Y APEV S
Sbjct: 105 GIVCRDLNPNNILL---DDRGHIQLTYFSRWSEVED-SCDGEAV-ENMYCAPEVGGISEE 159
Query: 340 TEA-DVWSIGVIAYILLCG-----SRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEAR 393
TEA D WS+G I + LL G P SGI P + +S EAR
Sbjct: 160 TEACDWWSLGAILFELLTGKTLVECHP------SGINTHTTLNIPEW-------VSEEAR 206
Query: 394 DFVKRLLNKDPRKRLTAAQALSELLICYQSYLFF 427
+++LL +P +RL A A E + +S+ FF
Sbjct: 207 SLLQQLLQFNPTERLGAGVAGVEDI---KSHPFF 237
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 6e-11
Identities = 62/215 (28%), Positives = 100/215 (46%), Gaps = 24/215 (11%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQ--VAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNN 220
+GRG FG AK K E +G + V VK + K K + + RRE+ + R L+ H N
Sbjct: 13 LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQS--EFRRELDMFRKLS-HKN 69
Query: 221 LVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCH--L 278
+V+ + + Y+++E + G+L + + K ++ K + VA C
Sbjct: 70 VVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSK--DEKLKPPPLSTKQKVALCTQIA 127
Query: 279 QGV--------VHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDE--RLNDIVGSAYY 328
G+ VHRDL N L ++ + V K LS V E +L + + +
Sbjct: 128 LGMDHLSNARFVHRDLAARNCLVSS--QREV-KVSLLSLSKDVYNSEYYKLRNALIPLRW 184
Query: 329 VAPE-VLHRSYSTEADVWSIGVIAY-ILLCGSRPF 361
+APE V +ST++DVWS GV+ + + G PF
Sbjct: 185 LAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPF 219
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 6e-11
Identities = 63/223 (28%), Positives = 101/223 (45%), Gaps = 29/223 (13%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLV 222
+G G+FG A+ KK L+ A+K + ++ + D E+++L L H N++
Sbjct: 3 IGEGNFGQVLKARIKKDGLR-MDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNII 59
Query: 223 KFFDAYEDTDNVYVVMELCEGGELLD-----RILSRGGKYTEDDAKAVMI---QIL---- 270
A E +Y+ +E G LLD R+L + ++ A + Q+L
Sbjct: 60 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 119
Query: 271 ---NVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDE-RLNDIVGS- 325
+ + + +HRDL N L EN V K DFGLS R E + +G
Sbjct: 120 DVARGMDYLSQKQFIHRDLAARNILV---GENYVAKIADFGLS---RGQEVYVKKTMGRL 173
Query: 326 -AYYVAPEVLHRS-YSTEADVWSIGVIAY-ILLCGSRPFWART 365
++A E L+ S Y+T +DVWS GV+ + I+ G P+ T
Sbjct: 174 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT 216
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 1e-10
Identities = 69/250 (27%), Positives = 108/250 (43%), Gaps = 22/250 (8%)
Query: 168 FGYTCAAKFKKGELKGQ-QVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFD 226
G C + G G +VA+K + M+ E +E ++++ L H LV+ +
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP----EAFLQEAQVMKKLR-HEKLVQLY- 67
Query: 227 AYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMI-QILNVVAFCHLQGVVHRD 285
A + +Y+V E G LLD + GKY M QI + +A+ VHRD
Sbjct: 68 AVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 127
Query: 286 LKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAY---YVAPE-VLHRSYSTE 341
L+ N L EN V K DFGL+ + D G+ + + APE L+ ++ +
Sbjct: 128 LRAANILV---GENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEAALYGRFTIK 183
Query: 342 ADVWSIGVIAYILLCGSR-PFWARTESGIFRAVLKADPSFDEAPWPSLSSEA-RDFVKRL 399
+DVWS G++ L R P+ + R VL P P E+ D + +
Sbjct: 184 SDVWSFGILLTELTTKGRVPY----PGMVNREVLDQVERGYRMPCPPECPESLHDLMCQC 239
Query: 400 LNKDPRKRLT 409
K+P +R T
Sbjct: 240 WRKEPEERPT 249
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 2e-10
Identities = 74/286 (25%), Positives = 123/286 (43%), Gaps = 38/286 (13%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRR---EVKI 211
N + + +G G+FG A+ KK L+ A+K +M + +D R E+++
Sbjct: 7 NDIKFQDVIGEGNFGQVLKARIKKDGLR-MDAAIK-----RMKEYASKDDHRDFAGELEV 60
Query: 212 LRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLD-----RILSRGGKYTEDDAKAVM 266
L L H N++ A E +Y+ +E G LLD R+L + ++ A
Sbjct: 61 LCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST 120
Query: 267 IQILNVVAFC----------HLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPD 316
+ ++ F + +HRDL N L EN V K DFGLS R
Sbjct: 121 LSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV---GENYVAKIADFGLS---RGQ 174
Query: 317 E-RLNDIVGS--AYYVAPEVLHRS-YSTEADVWSIGVIAY-ILLCGSRPFWARTESGIFR 371
E + +G ++A E L+ S Y+T +DVWS GV+ + I+ G P+ T + ++
Sbjct: 175 EVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE 234
Query: 372 AVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSEL 417
K + + E D +++ + P +R + AQ L L
Sbjct: 235 ---KLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSL 277
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 2e-10
Identities = 45/148 (30%), Positives = 74/148 (50%), Gaps = 8/148 (5%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLV 222
+ RG FG + K + AVKV+ K M + V+ E L AL+ +V
Sbjct: 12 ISRGAFGKVYLGRKKN---NSKLYAVKVVKKADMINKNMVHQVQAERDAL-ALSKSPFIV 67
Query: 223 KFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVV 282
+ + + +NVY+VME GG++ +L G + E+ A + ++ + + H G++
Sbjct: 68 HLYYSLQSANNVYLVMEYLIGGDV-KSLLHIYGYFDEEMAVKYISEVALALDYLHRHGII 126
Query: 283 HRDLKPENFLFTTKDENSVLKAIDFGLS 310
HRDLKP+N L + + +K DFGLS
Sbjct: 127 HRDLKPDNMLISNEGH---IKLTDFGLS 151
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 2e-10
Identities = 54/220 (24%), Positives = 102/220 (46%), Gaps = 20/220 (9%)
Query: 158 ELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTG 217
+L +++G G FG + +VA+K + + M+ + E +++ L
Sbjct: 9 KLVKKLGAGQFGEVWMGYYNGH----TKVAIKSLKQGSMSPEAFLA----EANLMKQLQ- 59
Query: 218 HNNLVKFFDAYEDTDNVYVVMELCEGGELLDRI-LSRGGKYTEDDAKAVMIQILNVVAFC 276
H LV+ + A + +Y++ E E G L+D + G K T + + QI +AF
Sbjct: 60 HPRLVRLY-AVVTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFI 118
Query: 277 HLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAY---YVAPEV 333
+ +HRDL+ N L + E K DFGL+ + +E G+ + + APE
Sbjct: 119 ERKNYIHRDLRAANILVS---ETLCCKIADFGLARLIEDNEYTAR-EGAKFPIKWTAPEA 174
Query: 334 L-HRSYSTEADVWSIGV-IAYILLCGSRPFWARTESGIFR 371
+ + +++ ++DVWS G+ + I+ G P+ T + +
Sbjct: 175 INYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQ 214
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 2e-10
Identities = 63/260 (24%), Positives = 110/260 (42%), Gaps = 48/260 (18%)
Query: 181 LKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNN--LVKFFDAYEDTDNVYVVM 238
L + +AVKVIP I +E ++ + L L ++ ++ F+ A+ + + +
Sbjct: 24 LTRRILAVKVIP-----LDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICT 78
Query: 239 ELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQG--------VVHRDLKPEN 290
E +GG L D + + +L +A ++G ++HRD+KP N
Sbjct: 79 EFMDGGSL-------------DVYRKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSN 125
Query: 291 FLFTTKDENSVLKAIDFGLSDFVRPDERLNDI----VGSAYYVAPE-VLHRSYSTEADVW 345
L T+ + +K DFG+S + +N I VG+ Y+APE + Y +DVW
Sbjct: 126 MLVNTRGQ---VKLCDFGVST-----QLVNSIAKTYVGTNAYMAPERISGEQYGIHSDVW 177
Query: 346 SIGVIAYILLCGSRPF-WARTESGIFRAVLKADPSFDEAPWPSL-----SSEARDFVKRL 399
S+G+ L G P+ + G + DE P P L S + F+ +
Sbjct: 178 SLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDP-PVLPVGQFSEKFVHFITQC 236
Query: 400 LNKDPRKRLTAAQALSELLI 419
+ K P++R + I
Sbjct: 237 MRKQPKERPAPENLMDHPFI 256
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 2e-10
Identities = 60/227 (26%), Positives = 104/227 (45%), Gaps = 29/227 (12%)
Query: 159 LGEEVGRGHFGYTCAAKF----KKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRA 214
LG+ +G G FG A+ K+ + +VAVK++ T + D+ E+++++
Sbjct: 22 LGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSD--ATEKDLSDLISEMEMMKM 79
Query: 215 LTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSR---GGKYTED----------- 260
+ H N++ A +YV++E G L + + +R G +Y +
Sbjct: 80 IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSF 139
Query: 261 -DAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDER 318
D + Q+ + + + +HRDL N L T E++V+K DFGL+ D D
Sbjct: 140 KDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIADFGLARDIHHIDYY 196
Query: 319 LNDIVGS--AYYVAPEVL-HRSYSTEADVWSIGVIAY-ILLCGSRPF 361
G ++APE L R Y+ ++DVWS GV+ + I G P+
Sbjct: 197 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY 243
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 2e-10
Identities = 63/223 (28%), Positives = 102/223 (45%), Gaps = 29/223 (13%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLV 222
+G G+FG A KK LK A+K++ + + D E+++L L H N++
Sbjct: 10 IGEGNFGQVIRAMIKKDGLK-MNAAIKMLKEF--ASENDHRDFAGELEVLCKLGHHPNII 66
Query: 223 KFFDAYEDTDNVYVVMELCEGGELLD-----RILSRGGKYTEDDAKAVMI---QIL---- 270
A E+ +Y+ +E G LLD R+L + ++ A + Q+L
Sbjct: 67 NLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFAS 126
Query: 271 ---NVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDE-RLNDIVGS- 325
+ + + +HRDL N L EN K DFGLS R +E + +G
Sbjct: 127 DVATGMQYLSEKQFIHRDLAARNVLV---GENLASKIADFGLS---RGEEVYVKKTMGRL 180
Query: 326 -AYYVAPEVLHRS-YSTEADVWSIGVIAY-ILLCGSRPFWART 365
++A E L+ S Y+T++DVWS GV+ + I+ G P+ T
Sbjct: 181 PVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMT 223
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 4e-10
Identities = 57/202 (28%), Positives = 96/202 (47%), Gaps = 25/202 (12%)
Query: 162 EVGRGHFGYTCAAKFKKGELKGQQ----VAVKVIPKHKMTTAIAIEDVRREVKILRALTG 217
E+G G+FG KKG K ++ VAVK++ A+ +++ RE +++ L
Sbjct: 2 ELGSGNFG-----TVKKGMYKMKKSEKTVAVKILKNDNNDPALK-DELLREANVMQQL-- 53
Query: 218 HNN--LVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAF 275
+N +V+ E ++ +VMEL E G L ++ L + TE + ++ Q+ + +
Sbjct: 54 -DNPYIVRMIGICE-AESWMLVMELAELGPL-NKFLQKNKHVTEKNITELVHQVSMGMKY 110
Query: 276 CHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYY----VAP 331
VHRDL N L T+ K DFGLS + DE + AP
Sbjct: 111 LEETNFVHRDLAARNVLLVTQ---HYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAP 167
Query: 332 EVL-HRSYSTEADVWSIGVIAY 352
E + + +S+++DVWS GV+ +
Sbjct: 168 ECMNYYKFSSKSDVWSFGVLMW 189
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 5e-10
Identities = 74/272 (27%), Positives = 117/272 (43%), Gaps = 48/272 (17%)
Query: 161 EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVR--REVKILRALTGH 218
E+GRG FG K G +AVK I +T E R ++ ++ +
Sbjct: 10 GEIGRGAFGTVNKMLHKP---SGTIMAVKRI----RSTVDEKEQKRLLMDLDVVMRSSDC 62
Query: 219 NNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMI-QILNVVAFC- 276
+VKF+ A + ++ MEL +D L + KY + K+V+ +IL +A
Sbjct: 63 PYIVKFYGALFREGDCWICMEL------MDISLDKFYKYVYEVLKSVIPEEILGKIAVAT 116
Query: 277 -----HLQ---GVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDI-----V 323
+L+ ++HRD+KP N L D N +K DFG+S + ++ I
Sbjct: 117 VKALNYLKEELKIIHRDVKPSNILL---DRNGNIKLCDFGISGQL-----VDSIAKTRDA 168
Query: 324 GSAYYVAPEVLHRS----YSTEADVWSIGVIAYILLCGSRPFWARTESGIF---RAVLKA 376
G Y+APE + S Y +DVWS+G+ Y + G P+ + +F V+K
Sbjct: 169 GCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPY--PKWNSVFDQLTQVVKG 226
Query: 377 D-PSFDEAPWPSLSSEARDFVKRLLNKDPRKR 407
D P + S +F+ L KD KR
Sbjct: 227 DPPILSNSEEREFSPSFVNFINLCLIKDESKR 258
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 1e-09
Identities = 52/218 (23%), Positives = 100/218 (45%), Gaps = 32/218 (14%)
Query: 170 YTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYE 229
+ C K G+ + ++V VK + K RE+ IL+ ++ H ++ AY
Sbjct: 109 FVCT---KHGDEQRKKVIVKAVTGGK--------TPGREIDILKTIS-HRAIINLIHAYR 156
Query: 230 DTDNVYVVMEL--CEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLK 287
V +VM C+ +DR G + A + ++L +A+ H +G++HRD+K
Sbjct: 157 WKSTVCMVMPKYKCDLFTYVDRS----GPLPLEQAITIQRRLLEALAYLHGRGIIHRDVK 212
Query: 288 PENFLFTTKDENSVLKAIDFGLSDFVRPDERLND-----IVGSAYYVAPEVLH-RSYSTE 341
EN +F + EN+VL DFG + + D + G+ +PE+L Y +
Sbjct: 213 TEN-IFLDEPENAVLG--DFGAA--CKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAK 267
Query: 342 ADVWSIGVIAYILLCGSRPFWAR---TESGIFRAVLKA 376
D+WS G++ + + + + + + S R++++
Sbjct: 268 TDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRC 305
|
Length = 392 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 1e-09
Identities = 73/295 (24%), Positives = 125/295 (42%), Gaps = 45/295 (15%)
Query: 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQ----QVAVKVIPKHKMTTAIAIEDVRREVKI 211
LG+ +G G FG K LKG+ VAVK++ ++ ++ + D+ E +
Sbjct: 1 NLVLGKTLGEGEFGKV--VKATAFRLKGRAGYTTVAVKMLKEN--ASSSELRDLLSEFNL 56
Query: 212 LRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGEL--------------LDRILSRGGKY 257
L+ + H +++K + A + +++E + G L L +R Y
Sbjct: 57 LKQVN-HPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSY 115
Query: 258 TE-DDAKAVMIQILNVVAFCHLQG--------VVHRDLKPENFLFTTKDENSVLKAIDFG 308
+ D +A+ + L A+ +G +VHRDL N L E +K DFG
Sbjct: 116 LDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVA---EGRKMKISDFG 172
Query: 309 LSDFVRPDE----RLNDIVGSAYYVAPEVL-HRSYSTEADVWSIGVIAY-ILLCGSRPFW 362
LS V ++ R + ++A E L Y+T++DVWS GV+ + I+ G P+
Sbjct: 173 LSRDVYEEDSYVKRSKGRI-PVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYP 231
Query: 363 ARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSEL 417
+F +LK + + S E + + ++P KR T A EL
Sbjct: 232 GIAPERLF-NLLKTGYRMERP--ENCSEEMYNLMLTCWKQEPDKRPTFADISKEL 283
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 1e-09
Identities = 33/104 (31%), Positives = 51/104 (49%), Gaps = 4/104 (3%)
Query: 253 RGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312
R D A + QIL + + H Q ++HRD+K EN D + V D G + F
Sbjct: 150 RSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFI--NDVDQVCIG-DLGAAQF 206
Query: 313 VRPDERLNDIVGSAYYVAPEVLHRS-YSTEADVWSIGVIAYILL 355
+ G+ APEVL R Y+++AD+WS G++ + +L
Sbjct: 207 PVVAPAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 5e-09
Identities = 58/227 (25%), Positives = 101/227 (44%), Gaps = 29/227 (12%)
Query: 159 LGEEVGRGHFGYTCAAKF----KKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRA 214
LG+ +G G FG A+ K + VAVK++ + +A D+ E+++++
Sbjct: 16 LGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLA--DLISEMELMKL 73
Query: 215 LTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSR---GGKYTED----------- 260
+ H N++ +YV++E G L + + +R G YT D
Sbjct: 74 IGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSF 133
Query: 261 -DAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERL 319
D + Q+ + + + +HRDL N L T E++V+K DFGL+ V +
Sbjct: 134 KDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVT---EDNVMKIADFGLARGVHDIDYY 190
Query: 320 NDIVGS---AYYVAPEVL-HRSYSTEADVWSIGVIAY-ILLCGSRPF 361
++APE L R Y+ ++DVWS G++ + I G P+
Sbjct: 191 KKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPY 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 6e-09
Identities = 52/217 (23%), Positives = 91/217 (41%), Gaps = 12/217 (5%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLV 222
+G G FG K K VA+K + T +D E I+ + H+N++
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPG--YTEKQRQDFLSEASIMGQFS-HHNII 69
Query: 223 KFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVV 282
+ ++ E E G L + G+++ ++ I + + V
Sbjct: 70 RLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYV 129
Query: 283 HRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPD-ERLNDIVGSAY---YVAPEVL-HRS 337
HRDL N L + N K DFGLS + D E G + APE + +R
Sbjct: 130 HRDLAARNILV---NSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRK 186
Query: 338 YSTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAV 373
+++ +DVWS G++ + ++ G RP+W + + +A+
Sbjct: 187 FTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAI 223
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 6e-09
Identities = 56/208 (26%), Positives = 96/208 (46%), Gaps = 21/208 (10%)
Query: 158 ELGEEVGRGHFGYTCAAKFKKGELKGQ-QVAVKVIPKHKMTTAIAIEDVRREVKILRALT 216
+L +++G G FG + G G +VAVK + M+ +E E +I++ L
Sbjct: 9 QLIKKLGNGQFG-----EVWMGTWNGNTKVAVKTLKPGTMSPESFLE----EAQIMKKLR 59
Query: 217 GHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMI-QILNVVAF 275
H+ LV+ + A + +Y+V E G LLD + G+ + M Q+ +A+
Sbjct: 60 -HDKLVQLY-AVVSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAY 117
Query: 276 CHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAY---YVAPE 332
+HRDL+ N L + V K DFGL+ + D G+ + + APE
Sbjct: 118 IERMNYIHRDLRSANILV---GDGLVCKIADFGLARLIE-DNEYTARQGAKFPIKWTAPE 173
Query: 333 V-LHRSYSTEADVWSIGVIAYILLCGSR 359
L+ ++ ++DVWS G++ L+ R
Sbjct: 174 AALYGRFTIKSDVWSFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 6e-09
Identities = 34/135 (25%), Positives = 56/135 (41%), Gaps = 20/135 (14%)
Query: 180 ELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLV-KFFDAYEDTDNVYVVM 238
K + +K+ P + D REV IL+ L V K + E Y++M
Sbjct: 18 GTKDEDYVLKINP-----SREKGADREREVAILQLLARKGLPVPKVLASGESDGWSYLLM 72
Query: 239 ELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCH---LQGVVHRDLKPENFLFTT 295
E EG L + +E++ + + Q+ ++A H L + H DL P N L
Sbjct: 73 EWIEGETL--------DEVSEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILV-- 122
Query: 296 KDENSVLKAIDFGLS 310
D+ +L ID+ +
Sbjct: 123 -DDGKILGIIDWEYA 136
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 8e-09
Identities = 60/246 (24%), Positives = 95/246 (38%), Gaps = 66/246 (26%)
Query: 158 ELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAI------------EDV 205
EE+G G FG K KGEL G + T++AI ++
Sbjct: 8 RFLEELGEGAFG-----KVYKGELTGPN-------ERLSATSVAIKTLKENAEPKVQQEF 55
Query: 206 RREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRG-----GKYTED 260
R+E + L + H N+V ++ E G+L + ++ G + D
Sbjct: 56 RQEAE-LMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGD 114
Query: 261 DAKA----------VMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS 310
+ + IQI + + VHRDL N L E +K DFGLS
Sbjct: 115 ETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLV---GEGLTVKISDFGLS 171
Query: 311 DFVRPDERLNDIVGSAYY------------VAPE-VLHRSYSTEADVWSIGVIAY-ILLC 356
DI + YY + PE +L+ ++TE+D+WS GV+ + I
Sbjct: 172 ---------RDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSY 222
Query: 357 GSRPFW 362
G +P++
Sbjct: 223 GLQPYY 228
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 1e-08
Identities = 59/219 (26%), Positives = 101/219 (46%), Gaps = 40/219 (18%)
Query: 162 EVGRGHFGYTCAAKFKKG--ELKGQQ--VAVKVIPKHKMTTAIAIED-VRREVKILRALT 216
E+G G+FG C KKG +++ +Q VA+KV+ K ++ D + RE +I+ L
Sbjct: 2 ELGSGNFG--CV---KKGVYKMRKKQIDVAIKVL---KNENEKSVRDEMMREAEIMHQLD 53
Query: 217 GHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFC 276
+ +V+ E + + +VME+ GG L + + + T + +M Q+ + +
Sbjct: 54 -NPYIVRMIGVCE-AEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYL 111
Query: 277 HLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYY-------- 328
+ VHRDL N L + K DFGLS + D+ +YY
Sbjct: 112 EGKNFVHRDLAARNVLLVNQ---HYAKISDFGLSKALGADD--------SYYKARSAGKW 160
Query: 329 ----VAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPF 361
APE ++ R +S+ +DVWS G+ + G +P+
Sbjct: 161 PLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPY 199
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 1e-08
Identities = 67/292 (22%), Positives = 111/292 (38%), Gaps = 51/292 (17%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQ---VAVKVIPKHKMTTAIAIEDVRREVKI 211
N E ++G+G FG A+ G L + VAVK++ + A D +RE +
Sbjct: 5 NNIEYVRDIGQGAFGRVFQAR-APGLLPYEPFTMVAVKMLKEEASADMQA--DFQREAAL 61
Query: 212 LRALTGHNNLVKF---------------FDAYEDTDNV------YVVMELCEGGELLDRI 250
+ H N+VK + AY D + L +
Sbjct: 62 MAEFD-HPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKC 120
Query: 251 LSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS 310
+ + + Q+ +A+ + VHRDL N L EN V+K DFGLS
Sbjct: 121 GLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVG---ENMVVKIADFGLS 177
Query: 311 ------DFVRPDERLNDIVGSAYYVAPEVLHRSYSTEADVWSIGVIAY-ILLCGSRPFWA 363
D+ + E ND + + + + Y+TE+DVW+ GV+ + I G +P++
Sbjct: 178 RNIYSADYYKASE--NDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYG 235
Query: 364 RTESGIFRAVLKAD----PSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAA 411
+ V + P D P E + ++ +K P R + A
Sbjct: 236 MAHEEVIYYVRDGNVLSCP--DNCP-----LELYNLMRLCWSKLPSDRPSFA 280
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 2e-08
Identities = 43/136 (31%), Positives = 66/136 (48%), Gaps = 8/136 (5%)
Query: 231 TDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPEN 290
T V +V +L G LLD + + D +QI +++ +VHRDL N
Sbjct: 80 TSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARN 139
Query: 291 FLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAY---YVAPE-VLHRSYSTEADVWS 346
L K N V K DFGL+ + DE G ++A E +LHR ++ ++DVWS
Sbjct: 140 VL--VKSPNHV-KITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWS 196
Query: 347 IGVIAYILLC-GSRPF 361
GV + L+ G++P+
Sbjct: 197 YGVTVWELMTFGAKPY 212
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 4e-08
Identities = 32/131 (24%), Positives = 63/131 (48%), Gaps = 8/131 (6%)
Query: 236 VVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTT 295
+V +L G LLD + +QI + + +VHR+L N L +
Sbjct: 85 LVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKS 144
Query: 296 KDENSVLKAIDFGLSDFVRPDER---LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIA 351
+S+++ DFG++D + PD++ ++ ++A E + Y+ ++DVWS GV
Sbjct: 145 ---DSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTV 201
Query: 352 YILLC-GSRPF 361
+ ++ G+ P+
Sbjct: 202 WEMMSYGAEPY 212
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 8e-08
Identities = 54/193 (27%), Positives = 82/193 (42%), Gaps = 41/193 (21%)
Query: 249 RILSRGGKYTEDDAKAVMI-----------------QILNVVAFCHLQGVVHRDLKPENF 291
R R G Y + D + ++ Q+ ++F + +HRDL N
Sbjct: 186 RRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNI 245
Query: 292 LFTTKDENSVLKAIDFGLSDFVRPDERLNDIV-GSAY----YVAPE-VLHRSYSTEADVW 345
L T + K DFGL+ +R D N +V G+A ++APE + + Y+ E+DVW
Sbjct: 246 LLT---HGRITKICDFGLARDIRNDS--NYVVKGNARLPVKWMAPESIFNCVYTFESDVW 300
Query: 346 SIGVIAY-ILLCGSRPFWARTESGIFRAVLKA-----DPSFDEAPWPSLSSEARDFVKRL 399
S G++ + I GS P+ F ++K P AP SE D +K
Sbjct: 301 SYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPEC--AP-----SEMYDIMKSC 353
Query: 400 LNKDPRKRLTAAQ 412
+ DP KR T Q
Sbjct: 354 WDADPLKRPTFKQ 366
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 8e-08
Identities = 53/216 (24%), Positives = 94/216 (43%), Gaps = 32/216 (14%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLV 222
+G+GHFG + + AVK + +++T +E +E I++ + H N++
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSL--NRITDLEEVEQFLKEGIIMKDFS-HPNVL 59
Query: 223 KFFDAYEDTDNV-YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGV 281
++ VV+ + G+L + I S T D +Q+ + + +
Sbjct: 60 SLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKF 119
Query: 282 VHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYY------------- 328
VHRDL N + DE+ +K DFGL+ DI YY
Sbjct: 120 VHRDLAARNCML---DESFTVKVADFGLA---------RDIYDKEYYSVHNHTGAKLPVK 167
Query: 329 -VAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPF 361
+A E L + ++T++DVWS GV+ + L+ G+ P+
Sbjct: 168 WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY 203
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 1e-07
Identities = 41/136 (30%), Positives = 64/136 (47%), Gaps = 8/136 (5%)
Query: 231 TDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPEN 290
T V ++ +L G LLD + +QI + + + +VHRDL N
Sbjct: 80 TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARN 139
Query: 291 FLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAY---YVAPE-VLHRSYSTEADVWS 346
L T +K DFGL+ + DE+ G ++A E +LHR Y+ ++DVWS
Sbjct: 140 VLVKTPQH---VKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWS 196
Query: 347 IGVIAYILLC-GSRPF 361
GV + L+ GS+P+
Sbjct: 197 YGVTVWELMTFGSKPY 212
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 1e-07
Identities = 38/114 (33%), Positives = 58/114 (50%), Gaps = 18/114 (15%)
Query: 258 TEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS------- 310
T +D Q+ + F + +HRDL N L + EN+V+K DFGL+
Sbjct: 177 TLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLS---ENNVVKICDFGLARDIYKDP 233
Query: 311 DFVRP-DERLNDIVGSAYYVAPE-VLHRSYSTEADVWSIGVIAY-ILLCGSRPF 361
D+VR D RL ++APE + R Y+ ++DVWS GV+ + I G+ P+
Sbjct: 234 DYVRKGDARL-----PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 282
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 2e-07
Identities = 34/90 (37%), Positives = 51/90 (56%), Gaps = 18/90 (20%)
Query: 282 VHRDLKPENFLFTTKDENSVLKAIDFGLS-------DFVRP-DERLNDIVGSAYYVAPE- 332
+HRDL N L + EN+V+K DFGL+ D+VR D RL ++APE
Sbjct: 195 IHRDLAARNILLS---ENNVVKICDFGLARDIYKDPDYVRKGDARL-----PLKWMAPES 246
Query: 333 VLHRSYSTEADVWSIGVIAY-ILLCGSRPF 361
+ + Y+T++DVWS GV+ + I G+ P+
Sbjct: 247 IFDKVYTTQSDVWSFGVLLWEIFSLGASPY 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 3e-07
Identities = 59/237 (24%), Positives = 99/237 (41%), Gaps = 38/237 (16%)
Query: 155 NKYELGEEVGRGHFG--YTCAAK-------FKKGELKGQQVAVKVIPKHKMTTAIAIEDV 205
+ L E++G G FG + C A+ E GQ V V V T A D
Sbjct: 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDF 64
Query: 206 RREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTE------ 259
+E+KI+ L + N+++ D + ++ E E G+L ++ LS+ +
Sbjct: 65 LKEIKIMSRLK-NPNIIRLLGVCVSDDPLCMITEYMENGDL-NQFLSQREIESTFTHANN 122
Query: 260 ------DDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS--- 310
+ + +QI + + + VHRDL N L + +K DFG+S
Sbjct: 123 IPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLV---GNHYTIKIADFGMSRNL 179
Query: 311 ---DFVRPDERLNDIVGSAYYVAPE-VLHRSYSTEADVWSIGVIAY--ILLCGSRPF 361
D+ R R V ++A E +L ++T +DVW+ GV + LC +P+
Sbjct: 180 YSGDYYRIQGR---AVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPY 233
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 4e-07
Identities = 59/247 (23%), Positives = 99/247 (40%), Gaps = 24/247 (9%)
Query: 122 GSVKPNEAAIPEGSEPEPAAGLNKSFGFSKHFANKYELGEEVGRGHFG--YTCAAKFKKG 179
S + A P+ + P P A F + + +++ G FG + CA +
Sbjct: 117 ASHLDFDEAPPDAAGPVPLA--QAKLKHDDEFLAHFRVIDDLPAGAFGKIFICALRASTE 174
Query: 180 EL---KGQQVAVKVIPKHKMTTAIAIEDVRR-------EVKILRALTGHNNLVKFFDAYE 229
E +G + PK + A ++ R E+ L L H N++K +
Sbjct: 175 EAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLN-HENILKIEEILR 233
Query: 230 DTDNVYVVMELCE---GGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDL 286
N Y++ + + + D + +A+M Q+L V + H + ++HRD+
Sbjct: 234 SEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDI 293
Query: 287 KPENFLFTTKDENSVLKAIDFG-LSDFVRPDE-RLNDIVGSAYYVAPEVLHR-SYSTEAD 343
K EN +F D VL DFG F + E VG+ +PE+L Y D
Sbjct: 294 KLEN-IFLNCDGKIVLG--DFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITD 350
Query: 344 VWSIGVI 350
+WS G+I
Sbjct: 351 IWSCGLI 357
|
Length = 501 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 5e-07
Identities = 31/91 (34%), Positives = 47/91 (51%), Gaps = 10/91 (10%)
Query: 322 IVGSAYYVAPEVL-HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSF 380
I+G+ Y+APE+L + + D W++GV + L G PF T +F+ +L D
Sbjct: 540 ILGTPDYLAPELLLGKPHGPAVDWWALGVCLFEFLTGIPPFNDETPQQVFQNILNRD--- 596
Query: 381 DEAPWP----SLSSEARDFVKRLLNKDPRKR 407
PWP LS A++ ++ LL DP KR
Sbjct: 597 --IPWPEGEEKLSVNAQNAIEILLTMDPTKR 625
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 5e-07
Identities = 68/275 (24%), Positives = 120/275 (43%), Gaps = 40/275 (14%)
Query: 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALT 216
+ LG +G+G FG A+ K + Q+VAVK++ K + ++ IE+ RE ++
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKML-KADIFSSSDIEEFLREAACMKEFD 59
Query: 217 GHNNLVKFFD------AYEDTDNVYVVMELCEGGELLDRIL-SRGGK----YTEDDAKAV 265
H N++K A V++ + G+L +L SR G+
Sbjct: 60 -HPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRF 118
Query: 266 MIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS------DFVRPDERL 319
MI I + + + + +HRDL N + +EN + DFGLS D+ R
Sbjct: 119 MIDIASGMEYLSSKNFIHRDLAARNCML---NENMTVCVADFGLSKKIYSGDYYRQ---- 171
Query: 320 NDIVGSAY-----YVAPEVLHRS-YSTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRA 372
G A ++A E L + Y+T +DVW+ GV + I+ G P+ S I+
Sbjct: 172 ----GCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNY 227
Query: 373 VLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKR 407
++K + + P P + + + + + +P+ R
Sbjct: 228 LIKGNRL--KQP-PDCLEDVYELMCQCWSPEPKCR 259
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 8e-07
Identities = 38/117 (32%), Positives = 59/117 (50%), Gaps = 24/117 (20%)
Query: 258 TEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS------- 310
T +D Q+ + F + +HRDL N L + EN+V+K DFGL+
Sbjct: 172 TMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLS---ENNVVKICDFGLARDIYKDP 228
Query: 311 DFVRPDERLNDIVGSAY----YVAPE-VLHRSYSTEADVWSIGVIAY-ILLCGSRPF 361
D+VR GSA ++APE + + Y+T++DVWS GV+ + I G+ P+
Sbjct: 229 DYVRK--------GSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPY 277
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.4 bits (116), Expect = 2e-06
Identities = 41/152 (26%), Positives = 65/152 (42%), Gaps = 21/152 (13%)
Query: 174 AKFKKGELKGQQVAVKV-IPK----HKMTTAIAIEDVRREVKIL-RALTGHNN--LVKFF 225
A+ G+ G + +K IPK ++ I E RRE +I+ RA N V F
Sbjct: 10 AEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFV 69
Query: 226 DAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRD 285
D +VME EG L D +++ G + ++ + V H G++H D
Sbjct: 70 DPENFI----IVMEYIEGEPLKD-LINSNGMEELELSREIGRL----VGKLHSAGIIHGD 120
Query: 286 LKPENFLFTTKDENSVLKAIDFGLSDFVRPDE 317
L N + + + IDFGL++F + E
Sbjct: 121 LTTSNMILSGGK----IYLIDFGLAEFSKDLE 148
|
Length = 211 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 2e-06
Identities = 32/93 (34%), Positives = 48/93 (51%), Gaps = 7/93 (7%)
Query: 264 AVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLN--- 320
AV Q+L+ + + H +G++HRD+K EN L E+ L DFG + F R
Sbjct: 264 AVARQLLSAIDYIHGEGIIHRDIKTENVLVNGP-EDICLG--DFGAACFARGSWSTPFHY 320
Query: 321 DIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAY 352
I G+ APEVL Y+ D+WS G++ +
Sbjct: 321 GIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIF 353
|
Length = 461 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 2e-06
Identities = 56/223 (25%), Positives = 96/223 (43%), Gaps = 35/223 (15%)
Query: 161 EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVR--REVKILRALTGH 218
+E+G G FG K GE+ +V+ K +A E ++ E + R+L H
Sbjct: 1 KEIGNGWFG-----KVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQ-H 54
Query: 219 NNLVKFFDAYEDTDNVYVVMELCEGGELLDRILS-RGGKYTEDDAKAVM---IQILNVVA 274
+NL++ + +VME C G+L + S R + D + +I +
Sbjct: 55 SNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLL 114
Query: 275 FCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD-------FVRPDERLNDIVGSAY 327
H +H DL N L T + +K D+GLS +V PD+ +
Sbjct: 115 HLHKNNFIHSDLALRNCLLTA---DLTVKIGDYGLSHNKYKEDYYVTPDQLWVPL----R 167
Query: 328 YVAPEVLHRSY--------STEADVWSIGVIAYILL-CGSRPF 361
++APE++ + + E++VWS+GV + L GS+P+
Sbjct: 168 WIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPY 210
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 2e-06
Identities = 35/127 (27%), Positives = 59/127 (46%), Gaps = 12/127 (9%)
Query: 242 EGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSV 301
D +++ + D Q+ N + F + VHRDL N L E +
Sbjct: 221 PERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLIC---EGKL 277
Query: 302 LKAIDFGLS-DFVRPDERLNDIVGSAY----YVAPE-VLHRSYSTEADVWSIGVIAY-IL 354
+K DFGL+ D +R ++ GS + ++APE + + Y+T +DVWS G++ + I
Sbjct: 278 VKICDFGLARDIMRDSNYISK--GSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIF 335
Query: 355 LCGSRPF 361
G P+
Sbjct: 336 TLGGTPY 342
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 3e-06
Identities = 58/239 (24%), Positives = 102/239 (42%), Gaps = 26/239 (10%)
Query: 156 KYELGEEVGRGHFG--YTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVR--REVKI 211
K + E+G+G FG Y AK + +VA+K + + A E + E +
Sbjct: 7 KITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNE----AASMRERIEFLNEASV 62
Query: 212 LRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAV-----M 266
++ H+ +V+ V+MEL G+L + S + + +A M
Sbjct: 63 MKEFNCHH-VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKM 121
Query: 267 IQ----ILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDERLND 321
IQ I + +A+ + VHRDL N + E+ +K DFG++ D D
Sbjct: 122 IQMAGEIADGMAYLNANKFVHRDLAARNCMVA---EDFTVKIGDFGMTRDIYETDYYRKG 178
Query: 322 IVG--SAYYVAPEVLHRS-YSTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAVLKA 376
G +++PE L ++T +DVWS GV+ + I +P+ + + R V++
Sbjct: 179 GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEG 237
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 3e-06
Identities = 59/269 (21%), Positives = 107/269 (39%), Gaps = 41/269 (15%)
Query: 178 KGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVK----FFDAYEDTDN 233
KG ++V ++ K + I+ E+K LR + NN++K D +D
Sbjct: 38 KGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRID-SNNILKIYGFIIDIVDDLPR 96
Query: 234 VYVVMELCEGGELLDRILSRGGKYTEDD---AKAVMIQI---LNVVAFCHLQGVVHRDLK 287
+ +++E C G L R E D + + I + +++L
Sbjct: 97 LSLILEYCTRGYL------REVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLT 150
Query: 288 PENFLFTTKDENSVLKAIDFGLSDF--VRPDERLNDIVGSAYYVAPEVLH---RSYSTEA 342
+FL T EN LK I GL P + +N +V Y + ++L+ Y+ +
Sbjct: 151 SVSFLVT---ENYKLKIICHGLEKILSSPPFKNVNFMV----YFSYKMLNDIFSEYTIKD 203
Query: 343 DVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSF---DEAPWPSLSSEARDFVKRL 399
D++S+GV+ + + G PF T I+ ++ + S + P E + V+
Sbjct: 204 DIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCP-----LEIKCIVEAC 258
Query: 400 LNKDPRKRLTAAQALSELLICYQSYLFFY 428
+ D KR + E+L Y F+
Sbjct: 259 TSHDSIKRPN----IKEILYNLSLYKFYI 283
|
Length = 283 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 48.1 bits (115), Expect = 4e-06
Identities = 54/223 (24%), Positives = 97/223 (43%), Gaps = 32/223 (14%)
Query: 158 ELGEEVGRGHFGYTCA--AKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRR---EVKIL 212
EL +G+ AK K VAVK I + ED++ E+
Sbjct: 1 ELLTLIGKCFEDLMIVHLAKHKP---TNTLVAVKKINLDSCSK----EDLKLLQQEIITS 53
Query: 213 RALTGHNNLVKFFDAYEDTDNVYVVMELCEGG---ELLDRILSRGGKYTEDDAKAVMIQ- 268
R L H N++ + ++ +YVV L G +LL G A A +++
Sbjct: 54 RQLQ-HPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPEL---AIAFILKD 109
Query: 269 ILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSA-- 326
+LN + + H +G +HR +K + L + D VL + + +S ++ +R +
Sbjct: 110 VLNALDYIHSKGFIHRSVKASHILLSG-DGKVVLSGLRYSVS-MIKHGKRQRVVHDFPKS 167
Query: 327 -----YYVAPEVLHRS---YSTEADVWSIGVIAYILLCGSRPF 361
+++PEVL ++ Y+ ++D++S+G+ A L G PF
Sbjct: 168 SVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPF 210
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 46.9 bits (112), Expect = 5e-06
Identities = 42/150 (28%), Positives = 59/150 (39%), Gaps = 20/150 (13%)
Query: 174 AKFKKGELKGQQVAVKV-IPK---HK-MTTAIAIEDVRREVKILRALTGHNNLVKFFDAY 228
A + G VK IPK H + + E RRE +IL V Y
Sbjct: 10 AIIYLTDFLGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKA--REAGVPVPIVY 67
Query: 229 E-DTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLK 287
+ D DN +VME EG L D E+ ++ ++ +V H G+VH DL
Sbjct: 68 DVDPDNGLIVMEYIEGELLKD--------ALEEARPDLLREVGRLVGKLHKAGIVHGDLT 119
Query: 288 PENFLFTTKDENSVLKAIDFGLSDFVRPDE 317
N + + + IDFGL +F E
Sbjct: 120 TSNIILS----GGRIYFIDFGLGEFSDEVE 145
|
Length = 204 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 7e-06
Identities = 62/239 (25%), Positives = 95/239 (39%), Gaps = 45/239 (18%)
Query: 161 EEVGRGHFG--YTCAA---------KFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREV 209
E++G G FG + C +F KG+ + V V A D +EV
Sbjct: 11 EKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEV 70
Query: 210 KILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGEL--------LDRILSRGGKYTEDD 261
KIL L N+++ D D + ++ E E G+L LD G
Sbjct: 71 KILSRLK-DPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPA 129
Query: 262 AK----------AVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS- 310
V +QI + + + VHRDL N L EN +K DFG+S
Sbjct: 130 HCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLV---GENLTIKIADFGMSR 186
Query: 311 -----DFVRPDERLNDIVGSAYYVAPE-VLHRSYSTEADVWSIGVIAY--ILLCGSRPF 361
D+ R R V ++A E +L ++T +DVW+ GV + ++LC +P+
Sbjct: 187 NLYAGDYYRIQGR---AVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPY 242
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 8e-06
Identities = 63/247 (25%), Positives = 97/247 (39%), Gaps = 57/247 (23%)
Query: 155 NKYELGEEVGRGHFG------------YTCAAKFKKGELKGQ--QVAVKVIPKHKMTTAI 200
E++G G FG ++ A F + + VAVKV+ A
Sbjct: 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKA-FAENDNADAPVLVAVKVLRPDASDNAR 63
Query: 201 AIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTED 260
ED +EVKIL L+ N+ + + ++ME E G+L ++ L + T
Sbjct: 64 --EDFLKEVKILSRLS-DPNIARLLGVCTVDPPLCMIMEYMENGDL-NQFLQKHVAETSG 119
Query: 261 DAKAV----------MI-QILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGL 309
A M QI + + + VHRDL N L +N +K DFG+
Sbjct: 120 LACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLV---GKNYTIKIADFGM 176
Query: 310 SDFVRPDERLNDIVGSAYY------VAP-------EVLHRSYSTEADVWSIGVIAY-IL- 354
S ++ S YY P VL ++T++DVW+ GV + IL
Sbjct: 177 S---------RNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227
Query: 355 LCGSRPF 361
LC +P+
Sbjct: 228 LCREQPY 234
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 9e-06
Identities = 58/242 (23%), Positives = 95/242 (39%), Gaps = 59/242 (24%)
Query: 161 EEVGRGHFG--YTCAA----KFKKGELKGQQVAVKVIPKHKMTTAI----------AIED 204
E++G G FG + C A KF + ++ V + A+ A D
Sbjct: 11 EKLGEGQFGEVHLCEAEGMEKFMDKDF-----SLDVSGNQPVLVAVKMLREDANKNARND 65
Query: 205 VRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGEL---LDRILSRGGKYTED- 260
+E+KI+ L N+++ +D + ++ E E G+L L R + D
Sbjct: 66 FLKEIKIMSRLK-DPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADV 124
Query: 261 ------DAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS---- 310
+ QI + + + VHRDL N L +N +K DFG+S
Sbjct: 125 VTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLV---GKNYTIKIADFGMSRNLY 181
Query: 311 --DFVRPDERLNDIVGSAYYVAP-------EVLHRSYSTEADVWSIGVIAY--ILLCGSR 359
D+ R I G A V P +L ++T +DVW+ GV + + LC +
Sbjct: 182 SGDYYR-------IQGRA--VLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQ 232
Query: 360 PF 361
P+
Sbjct: 233 PY 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 9e-06
Identities = 33/100 (33%), Positives = 53/100 (53%), Gaps = 8/100 (8%)
Query: 267 IQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSA 326
+QI + + + +VHRDL N L K N V K DFGL+ + DE+ + G
Sbjct: 116 VQIAKGMMYLEERRLVHRDLAARNVL--VKSPNHV-KITDFGLARLLEGDEKEYNADGGK 172
Query: 327 Y---YVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPF 361
++A E +H R ++ ++DVWS GV + L+ G +P+
Sbjct: 173 MPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPY 212
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 4e-05
Identities = 58/251 (23%), Positives = 97/251 (38%), Gaps = 56/251 (22%)
Query: 161 EEVGRGHFGYTCAAKFKKGEL------KGQQVAVKVIPKHKMTTAIAIEDVRREVKILRA 214
EE+G FG K KG L Q VA+K + + + ++E ++
Sbjct: 11 EELGECAFG-----KIYKGHLYLPGMDHAQLVAIKTL--KDINNPQQWGEFQQEASLMAE 63
Query: 215 LTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSR------GGKYTED-------- 260
L H N+V V ++ E G+L + ++ R G ED
Sbjct: 64 LH-HPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLD 122
Query: 261 --DAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDER 318
D + IQI + + VH+DL N L E +K D GLS
Sbjct: 123 HGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILI---GEQLHVKISDLGLS-------- 171
Query: 319 LNDIVGSAYY------------VAPE-VLHRSYSTEADVWSIGVIAY-ILLCGSRPFWAR 364
+I + YY + PE +++ +S+++D+WS GV+ + I G +P++
Sbjct: 172 -REIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGF 230
Query: 365 TESGIFRAVLK 375
+ + V K
Sbjct: 231 SNQEVIEMVRK 241
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 4e-05
Identities = 59/233 (25%), Positives = 104/233 (44%), Gaps = 32/233 (13%)
Query: 159 LGEEVGRGHFGYTCAAKFKKGE--LKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALT 216
LG+ +G G FG + + + LK VAVK + K + T +ED E ++
Sbjct: 3 LGKTLGEGEFGSVMEGQLNQDDSILK---VAVKTM-KIAICTRSEMEDFLSEAVCMKEFD 58
Query: 217 GHNNLVKFFDA-YEDTDN-----VYVVMELCEGGELLDRIL-SRGGKYTEDDAKAVMIQI 269
H N+++ + ++ V++ + G+L +L SR G + ++++
Sbjct: 59 -HPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKF 117
Query: 270 LNVVA----FCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS------DFVRPDERL 319
+ +A + + +HRDL N + +EN + DFGLS D+ R R+
Sbjct: 118 MTDIASGMEYLSSKSFIHRDLAARNCML---NENMNVCVADFGLSKKIYNGDYYR-QGRI 173
Query: 320 NDIVGSAYYVAPEVL-HRSYSTEADVWSIGVIAY-ILLCGSRPFWARTESGIF 370
+ ++A E L R Y+T++DVWS GV + I G P+ S I+
Sbjct: 174 AKM--PVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIY 224
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 7e-05
Identities = 49/225 (21%), Positives = 89/225 (39%), Gaps = 30/225 (13%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALT----GH 218
+G G FG C K + VA+ T D +R + ALT H
Sbjct: 13 LGTGRFGELCRGCLKLPSKRELPVAIH-------TLRAGCSDKQRRGFLAEALTLGQFDH 65
Query: 219 NNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRG-GKYTEDDAKAVMIQILNVVAFCH 277
+N+V+ + + +V E G LD L + G+ ++ + + + +
Sbjct: 66 SNIVRLEGVITRGNTMMIVTEYMSNG-ALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLS 124
Query: 278 LQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGS------AYYVAP 331
G VH+ L L + + V K F +++ I + + AP
Sbjct: 125 EMGYVHKGLAAHKVLVNS---DLVCKISGFRRL----QEDKSEAIYTTMSGKSPVLWAAP 177
Query: 332 EVL--HRSYSTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAV 373
E + H +S+ +DVWS G++ + ++ G RP+W + + +AV
Sbjct: 178 EAIQYHH-FSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAV 221
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 8e-05
Identities = 62/247 (25%), Positives = 106/247 (42%), Gaps = 46/247 (18%)
Query: 156 KYELGEEVGRGHFG--YTCAAK-FKKGELKGQQVAVKVIPKHKMTTAIAIEDVR--REVK 210
K L E+G+G FG Y A+ KGE + +VAVK + + +A E + E
Sbjct: 7 KITLLRELGQGSFGMVYEGNARDIIKGEAE-TRVAVKTVNE----SASLRERIEFLNEAS 61
Query: 211 ILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAV----- 265
+++ T H+ +V+ VVMEL G+L + S + + +
Sbjct: 62 VMKGFTCHH-VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQE 120
Query: 266 MIQ----ILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLND 321
MIQ I + +A+ + + VHRDL N + + +K DFG++ D
Sbjct: 121 MIQMAAEIADGMAYLNAKKFVHRDLAARNCMVA---HDFTVKIGDFGMT---------RD 168
Query: 322 IVGSAYY------------VAPEVLHR-SYSTEADVWSIGVIAY-ILLCGSRPFWARTES 367
I + YY +APE L ++T +D+WS GV+ + I +P+ +
Sbjct: 169 IYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE 228
Query: 368 GIFRAVL 374
+ + V+
Sbjct: 229 QVLKFVM 235
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 1e-04
Identities = 52/233 (22%), Positives = 90/233 (38%), Gaps = 49/233 (21%)
Query: 159 LGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGH 218
LG+ +G G FG + + + +VAVK + K + T IE+ E ++ H
Sbjct: 3 LGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTM-KLDIHTYSEIEEFLSEAACMKDFD-H 60
Query: 219 NNLVKFF------DAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNV 272
N++K + + V++ + G+L +L + + +Q L
Sbjct: 61 PNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLY---SRLGGLPEKLPLQTL-- 115
Query: 273 VAF-----CHLQ-----GVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDI 322
+ F ++ +HRDL N + E+ + DFGLS I
Sbjct: 116 LKFMVDIALGMEYLSNRNFIHRDLAARNCML---REDMTVCVADFGLS---------KKI 163
Query: 323 VGSAYY------------VAPEVL-HRSYSTEADVWSIGVIAY-ILLCGSRPF 361
YY +A E L R Y++++DVW+ GV + I G P+
Sbjct: 164 YSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPY 216
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 1e-04
Identities = 27/74 (36%), Positives = 38/74 (51%), Gaps = 12/74 (16%)
Query: 265 VMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR------PDER 318
+M QIL + H G+VHRD+KP+N +F+ + + K ID G + +R P E
Sbjct: 260 IMRQILFALDGLHSTGIVHRDVKPQNIIFS--EGSGSFKIIDLGAAADLRVGINYIPKEF 317
Query: 319 LNDIVGSAYYVAPE 332
L D Y APE
Sbjct: 318 LLD----PRYAAPE 327
|
Length = 566 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 1e-04
Identities = 45/171 (26%), Positives = 75/171 (43%), Gaps = 18/171 (10%)
Query: 247 LDRILSRGGK--YTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKA 304
+ +LS G T D + Q+ + F + VHRDL N L + ++K
Sbjct: 222 VKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLA---QGKIVKI 278
Query: 305 IDFGLSDFVRPDERLNDIV--GSAY----YVAPE-VLHRSYSTEADVWSIGVIAY-ILLC 356
DFGL+ + D ++ V GS + ++APE + Y+T +DVWS G++ + I
Sbjct: 279 CDFGLARDIMHD---SNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSL 335
Query: 357 GSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKR 407
G P+ F +K+ + A + E D + + N +P KR
Sbjct: 336 GGTPYPGMIVDSTFYNKIKS--GYRMAKPDHATQEVYDIMVKCWNSEPEKR 384
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 2e-04
Identities = 55/237 (23%), Positives = 95/237 (40%), Gaps = 56/237 (23%)
Query: 161 EEVGRGHFGYTCAAKFKKGELKG-------QQVAVKVIPKHKMTTAIAIEDVRREVKILR 213
EE+G FG K KG L G Q VA+K + K K + E+ + E ++R
Sbjct: 11 EELGEDRFG-----KVYKGHLFGTAPGEQTQAVAIKTL-KDKAEGPLR-EEFKHEA-MMR 62
Query: 214 ALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKY----TEDDAKA----- 264
+ H N+V + ++ C +L + ++ R T+DD
Sbjct: 63 SRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLE 122
Query: 265 ------VMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDER 318
++ QI + F VVH+DL N L K +K D GL
Sbjct: 123 PADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLN---VKISDLGL--------- 170
Query: 319 LNDIVGSAYY------------VAPE-VLHRSYSTEADVWSIGVIAY-ILLCGSRPF 361
++ + YY ++PE +++ +S ++D+WS GV+ + + G +P+
Sbjct: 171 FREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPY 227
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 2e-04
Identities = 28/89 (31%), Positives = 45/89 (50%), Gaps = 11/89 (12%)
Query: 267 IQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSA 326
IQI +++ H +GV+H+D+ N + DE +K D LS + P + +G
Sbjct: 124 IQIACGMSYLHKRGVIHKDIAARNCVI---DEELQVKITDNALSRDLFPMDY--HCLGDN 178
Query: 327 YY-----VAPEVL-HRSYSTEADVWSIGV 349
+A E L ++ YS+ +DVWS GV
Sbjct: 179 ENRPVKWMALESLVNKEYSSASDVWSFGV 207
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|234331 TIGR03724, arch_bud32, Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Score = 41.8 bits (99), Expect = 2e-04
Identities = 41/152 (26%), Positives = 58/152 (38%), Gaps = 24/152 (15%)
Query: 174 AKFKKGELKGQQVAVKV-IPK---H-KMTTAIAIEDVRREVKILRAL--TGHNN-LVKFF 225
A G+ G + +K +PK H ++ I E R E ++L G N +V
Sbjct: 8 AIIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDV 67
Query: 226 DAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRD 285
D T +VME EG L D I + + + V H G+VH D
Sbjct: 68 DPDNKT----IVMEYIEGKPLKDVIEEGNDELLREIGRLV--------GKLHKAGIVHGD 115
Query: 286 LKPENFLFTTKDENSVLKAIDFGLSDFVRPDE 317
L N + D+ L IDFGL + E
Sbjct: 116 LTTSNIIVR--DDKLYL--IDFGLGKYSDEIE 143
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine [Unknown function, General]. Length = 199 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 41.6 bits (98), Expect = 2e-04
Identities = 43/178 (24%), Positives = 68/178 (38%), Gaps = 22/178 (12%)
Query: 244 GELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLK 303
L D + RG E++ AV +Q L + H + T D +LK
Sbjct: 1 VSLADILEVRGRPLNEEEIWAVCLQCLGALRELH-------RQAKSGNILLTWD--GLLK 51
Query: 304 AIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRP-F 361
G F Y++APEV+ SY+ +AD++S+G+ Y L P
Sbjct: 52 L--DGSVAFK---TPEQSRPDP-YFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYN 105
Query: 362 WARTESGIFRAVLKADPSFDEAPWPSLSS-----EARDFVKRLLNKDPRKRLTAAQAL 414
R S I +L P+ D +L DF++ ++ P++R A L
Sbjct: 106 EERELSAILEILLNGMPADDPRDRSNLEGVSAARSFEDFMRLCASRLPQRREAANHYL 163
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.4 bits (99), Expect = 4e-04
Identities = 22/46 (47%), Positives = 28/46 (60%), Gaps = 3/46 (6%)
Query: 263 KAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFG 308
K VM Q+L + H G+VHRD+KPEN L T + +K IDFG
Sbjct: 312 KGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQ---VKIIDFG 354
|
Length = 507 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 5e-04
Identities = 82/368 (22%), Positives = 136/368 (36%), Gaps = 79/368 (21%)
Query: 24 NTPVPANGTPIPAPSPLNAESQSNNNRTNVKGNDDAVIEGKKSPFFPFYSPSPAHYFFSK 83
+ P N +P N+ S +T + + A G K + +
Sbjct: 19 TSGAPVNALSGNSPKANNSAS---TGQTTSRSTNSARRSGSKRDR----ETATSTDSGRT 71
Query: 84 KSSPARSSANSTPNRFFKRPFPPPSPAKHIKAVLARRHGSVKPNEAAIPEGSEPEPAAGL 143
KS ++ P P K K A + S + + G + + +
Sbjct: 72 KSHEGAATTKQATTTPTTNVEVAPPPKKK-KVTYALPNQSREEGHFYVVLGEDIDVSTQ- 129
Query: 144 NKSFGFSKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVI---PKHKMTTAI 200
++++ +G G FG A +K + + AVK++ PK+ I
Sbjct: 130 ------------RFKILSLLGEGTFGKVVEAWDRK---RKEYCAVKIVRNVPKYTRDAKI 174
Query: 201 AI---EDVRRE--------VKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDR 249
I E VR+ +KI R +F +T ++ +VM G LLD
Sbjct: 175 EIQFMEKVRQADPADRFPLMKIQR----------YFQ--NETGHMCIVMPK-YGPCLLDW 221
Query: 250 ILSRGGKYTEDDAKAVMIQILNVVAFCHLQ-GVVHRDLKPENFLFTTKDENSVLKAIDFG 308
I+ + G ++ ++ Q + + H + ++H DLKPEN L T D +D
Sbjct: 222 IM-KHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSD-----TVVDPV 275
Query: 309 LSDFVRPDE---RLND-------------IVGSAYYVAPEV---LHRSYSTEADVWSIGV 349
+ + PD R+ D IV + +Y +PEV L YST D+WS+G
Sbjct: 276 TNRALPPDPCRVRICDLGGCCDERHSRTAIVSTRHYRSPEVVLGLGWMYST--DMWSMGC 333
Query: 350 IAYILLCG 357
I Y L G
Sbjct: 334 IIYELYTG 341
|
Length = 467 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 0.001
Identities = 53/217 (24%), Positives = 86/217 (39%), Gaps = 28/217 (12%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLV 222
+ RG G + K K + Q VK I + I D+ + L+ H N+V
Sbjct: 698 ISRGKKGASYKGKSIKNGM---QFVVKEINDVNSIPSSEIADMGK----LQ----HPNIV 746
Query: 223 KFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQ--- 279
K Y++ E EG L + + + + + + + I I + F H +
Sbjct: 747 KLIGLCRSEKGAYLIHEYIEGKNLSEVLRN----LSWERRRKIAIGIAKALRFLHCRCSP 802
Query: 280 GVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRSYS 339
VV +L PE + KDE + L + D S+ YVAPE
Sbjct: 803 AVVVGNLSPEKIIIDGKDEPHLR----LSLPGLLCTD---TKCFISSAYVAPETRETKDI 855
Query: 340 TE-ADVWSIGVIAYILLCGSRPFWARTESGIFRAVLK 375
TE +D++ G+I LL G P A E G+ ++++
Sbjct: 856 TEKSDIYGFGLILIELLTGKSP--ADAEFGVHGSIVE 890
|
Length = 968 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.002
Identities = 31/101 (30%), Positives = 50/101 (49%), Gaps = 12/101 (11%)
Query: 268 QILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIV-GSA 326
Q+ + F + +HRD+ N L T V K DFGL+ + D N +V G+A
Sbjct: 220 QVAQGMDFLASKNCIHRDVAARNVLLTDG---RVAKICDFGLARDIMNDS--NYVVKGNA 274
Query: 327 Y----YVAPE-VLHRSYSTEADVWSIGVIAY-ILLCGSRPF 361
++APE + Y+ ++DVWS G++ + I G P+
Sbjct: 275 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPY 315
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 38.8 bits (90), Expect = 0.004
Identities = 26/106 (24%), Positives = 40/106 (37%), Gaps = 21/106 (19%)
Query: 248 DRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDF 307
I R + K +M +L + + H G+ H D+KPEN + + + ID+
Sbjct: 114 KEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYI---IDY 170
Query: 308 GL-SDFVRPDERLNDIVGSAYYVAPEVLHRSYSTEADVWSIGVIAY 352
G+ S F+ I G H YS E G + Y
Sbjct: 171 GIASHFI--------IHGK---------HIEYSKEQKDLHRGTLYY 199
|
Length = 294 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 429 | |||
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 100.0 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 100.0 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 100.0 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.98 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.97 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.97 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.96 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.96 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.96 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.96 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.95 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.94 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.94 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.94 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.92 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.91 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.91 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.9 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.89 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.89 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.88 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.88 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.87 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.86 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.85 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.83 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.82 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.82 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.82 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.81 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.8 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.8 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.79 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.76 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.75 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.73 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.72 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.62 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.57 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.55 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.53 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.49 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.48 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.44 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.44 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.41 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.32 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.3 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.29 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.22 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.17 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 99.11 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.1 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 99.0 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.95 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.79 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.76 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.74 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.65 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.62 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.59 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.58 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.56 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.51 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.47 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.45 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.39 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.36 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.33 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.11 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.11 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.96 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.81 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.81 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.69 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.64 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.64 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.63 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.62 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.62 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.52 | |
| PLN02236 | 344 | choline kinase | 97.4 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 97.28 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.23 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 97.17 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 97.17 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 96.98 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.97 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.9 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.67 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 96.56 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 96.46 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.33 | |
| PF02958 | 294 | EcKinase: Ecdysteroid kinase; InterPro: IPR004119 | 96.32 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 96.23 | |
| PTZ00384 | 383 | choline kinase; Provisional | 96.22 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 96.2 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.17 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 95.8 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 95.73 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 95.67 | |
| PTZ00296 | 442 | choline kinase; Provisional | 95.58 |
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-59 Score=446.73 Aligned_cols=267 Identities=36% Similarity=0.625 Sum_probs=241.4
Q ss_pred ccccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHH----HHHHHHHHHHHHHHhcCCCCcceEEE
Q 014210 151 KHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAI----AIEDVRREVKILRALTGHNNLVKFFD 226 (429)
Q Consensus 151 ~~~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~----~~~~~~~Ei~il~~l~~h~nIv~l~~ 226 (429)
+.+.+.|.+.+.||+|+||.|-+|..++ +|+.||||++.+....... ....+.+|+++|++|+ |||||++++
T Consensus 168 ks~~d~yii~~~LGsGafg~Vkla~e~~---tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~-HP~IV~~~d 243 (475)
T KOG0615|consen 168 KSFNDYYIISKTLGSGAFGLVKLAYEKK---TGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLS-HPNIVRIKD 243 (475)
T ss_pred chhcceeEeeeeecCCceeEEEEEEEcc---cCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcC-CCCEEEEee
Confidence 4567889999999999999999998777 7999999999876554422 3345789999999999 999999999
Q ss_pred EEEeCCeEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEee
Q 014210 227 AYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAID 306 (429)
Q Consensus 227 ~~~~~~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~D 306 (429)
+|++.+..||||||++||+|++.+.. ++.+.+...+.++.|++.||.|||++||+||||||+|||+..++++-.+||+|
T Consensus 244 ~f~~~ds~YmVlE~v~GGeLfd~vv~-nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItD 322 (475)
T KOG0615|consen 244 FFEVPDSSYMVLEYVEGGELFDKVVA-NKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITD 322 (475)
T ss_pred eeecCCceEEEEEEecCccHHHHHHh-ccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecc
Confidence 99999999999999999999999854 46788999999999999999999999999999999999998877889999999
Q ss_pred cCCccccCCCccccccccCCcccCcccccC----CCCCcccHHHHHHHHHHHHcCCCCCCCCChHH-HHHHHHhcCCCCC
Q 014210 307 FGLSDFVRPDERLNDIVGSAYYVAPEVLHR----SYSTEADVWSIGVIAYILLCGSRPFWARTESG-IFRAVLKADPSFD 381 (429)
Q Consensus 307 FGla~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~-~~~~i~~~~~~~~ 381 (429)
||+|+.........+.|||+.|.|||++.+ .+..++|||||||+||-+++|.+||....... ..+.|.++...+.
T Consensus 323 FGlAK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~ 402 (475)
T KOG0615|consen 323 FGLAKVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFG 402 (475)
T ss_pred cchhhccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCccccc
Confidence 999999998888899999999999999963 24558999999999999999999998766555 7788999999999
Q ss_pred CCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhcc
Q 014210 382 EAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLICYQ 422 (429)
Q Consensus 382 ~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~ 422 (429)
...|..+++++.+||++||..||++||++.++|+|+||+..
T Consensus 403 p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~ 443 (475)
T KOG0615|consen 403 PLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDA 443 (475)
T ss_pred ChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhcc
Confidence 89999999999999999999999999999999999999844
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-57 Score=448.18 Aligned_cols=253 Identities=36% Similarity=0.637 Sum_probs=239.2
Q ss_pred CceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeE
Q 014210 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (429)
Q Consensus 155 ~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~ 234 (429)
.+|+..+.||+|||+.||.++... +|+.||+|++.+..+......+.+.+||+|++.|+ |||||+++++|++.+++
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~---tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~-HpnIV~f~~~FEDs~nV 93 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLD---TGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLK-HPNIVQFYHFFEDSNNV 93 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcC---CCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcC-CCcEEeeeeEeecCCce
Confidence 689999999999999999999765 69999999999988888888899999999999999 99999999999999999
Q ss_pred EEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccccC
Q 014210 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (429)
Q Consensus 235 ~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~ 314 (429)
|||+|+|+.++|..++. +.+.++|.+++.++.||+.||.|||+++|||||||..|+|| +++.+|||+|||||..+.
T Consensus 94 YivLELC~~~sL~el~K-rrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL---~~~~~VKIgDFGLAt~le 169 (592)
T KOG0575|consen 94 YIVLELCHRGSLMELLK-RRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFL---NENMNVKIGDFGLATQLE 169 (592)
T ss_pred EEEEEecCCccHHHHHH-hcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheee---cCcCcEEecccceeeeec
Confidence 99999999999988664 77899999999999999999999999999999999999999 889999999999999887
Q ss_pred CC-ccccccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHH
Q 014210 315 PD-ERLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEA 392 (429)
Q Consensus 315 ~~-~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 392 (429)
.+ ++..+.|||+.|.|||++.+ .++..+||||+||+||-||+|++||...+-.+.+..|...+..++. .++.++
T Consensus 170 ~~~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P~----~ls~~A 245 (592)
T KOG0575|consen 170 YDGERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMPS----HLSAEA 245 (592)
T ss_pred CcccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCccccc----ccCHHH
Confidence 54 78889999999999999874 6999999999999999999999999999999999999998887776 699999
Q ss_pred HHHHHHhcccCccCcCCHHHHHhhHhh
Q 014210 393 RDFVKRLLNKDPRKRLTAAQALSELLI 419 (429)
Q Consensus 393 ~~li~~~L~~dP~~Rps~~~iL~~~~~ 419 (429)
++||.+||+.||.+|||+++||+|.||
T Consensus 246 ~dLI~~lL~~~P~~Rpsl~~vL~h~Ff 272 (592)
T KOG0575|consen 246 KDLIRKLLRPNPSERPSLDEVLDHPFF 272 (592)
T ss_pred HHHHHHHhcCCcccCCCHHHHhcCHhh
Confidence 999999999999999999999999999
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-56 Score=422.32 Aligned_cols=257 Identities=28% Similarity=0.440 Sum_probs=225.7
Q ss_pred cCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~ 233 (429)
..+.+.++.||+|..|+||+++++. +++.+|+|++... .+....+++.+|++++++.. |||||.+||+|..++.
T Consensus 78 ~~dle~~~~lG~G~gG~V~kv~Hk~---t~~i~AlK~I~~~--~~~~~~~Qi~rEl~il~~~~-spyIV~~ygaF~~~~~ 151 (364)
T KOG0581|consen 78 LSDLERLGVLGSGNGGTVYKVRHKP---TGKIYALKVILLN--IDPALQKQILRELEILRSCQ-SPYIVGFYGAFYSNGE 151 (364)
T ss_pred HHHhhhhhhcccCCCcEEEEEEEcC---CCeEEEEEeeccc--CCHHHHHHHHHHHHHHhhCC-CCCeeeEeEEEEeCCc
Confidence 4577889999999999999999887 6999999999443 56777889999999999996 9999999999999994
Q ss_pred -EEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-cCceeccCCCCcEEEeecCCCceEEEeecCCcc
Q 014210 234 -VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHL-QGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (429)
Q Consensus 234 -~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~-~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~ 311 (429)
+.|+||||+||+|.+.+. ..++++|..+.+|+.+|++||.|||+ ++||||||||+|||+ +..|.|||||||.++
T Consensus 152 ~isI~mEYMDgGSLd~~~k-~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLv---NskGeVKicDFGVS~ 227 (364)
T KOG0581|consen 152 EISICMEYMDGGSLDDILK-RVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLV---NSKGEVKICDFGVSG 227 (364)
T ss_pred eEEeehhhcCCCCHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeee---ccCCCEEeccccccH
Confidence 999999999999988664 44789999999999999999999996 899999999999999 677889999999998
Q ss_pred ccCCCccccccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHcCCCCCCCC-----ChHHHHHHHHhcCCCCCCCCC
Q 014210 312 FVRPDERLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWAR-----TESGIFRAVLKADPSFDEAPW 385 (429)
Q Consensus 312 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~elltg~~Pf~~~-----~~~~~~~~i~~~~~~~~~~~~ 385 (429)
.+.+. ..++.+||..|||||.+.+ .|+.++||||||++++||++|+.||... ...+.+..|....+.....
T Consensus 228 ~lvnS-~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~-- 304 (364)
T KOG0581|consen 228 ILVNS-IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPE-- 304 (364)
T ss_pred Hhhhh-hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCc--
Confidence 87655 5678999999999999986 6999999999999999999999999764 4456667776644332221
Q ss_pred CCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhccc
Q 014210 386 PSLSSEARDFVKRLLNKDPRKRLTAAQALSELLICYQS 423 (429)
Q Consensus 386 ~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~~ 423 (429)
..++++|++||..||++||++|++++|+++|+|+....
T Consensus 305 ~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~ 342 (364)
T KOG0581|consen 305 GEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFE 342 (364)
T ss_pred ccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhcc
Confidence 15999999999999999999999999999999998543
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-56 Score=417.98 Aligned_cols=260 Identities=31% Similarity=0.605 Sum_probs=237.2
Q ss_pred cCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~ 233 (429)
.++|+++++||+|+||+||+++.++ +++.+|+|+++|.........+..++|..||.+++ ||.||+++..|++.+.
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~d---t~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~-hPFiv~l~ysFQt~~k 99 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKD---TGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIK-HPFIVKLIYSFQTEEK 99 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcc---cCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCC-CCcEeeeEEecccCCe
Confidence 5789999999999999999999885 79999999999988888888899999999999998 9999999999999999
Q ss_pred EEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCcccc
Q 014210 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (429)
Q Consensus 234 ~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~ 313 (429)
+|||+||+.||+|..+| ++.+.+++..++.++.+|+.||.|||++|||||||||+|||| |++|+++|+|||+++..
T Consensus 100 LylVld~~~GGeLf~hL-~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILL---d~~GHi~LtDFgL~k~~ 175 (357)
T KOG0598|consen 100 LYLVLDYLNGGELFYHL-QREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILL---DEQGHIKLTDFGLCKED 175 (357)
T ss_pred EEEEEeccCCccHHHHH-HhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeee---cCCCcEEEeccccchhc
Confidence 99999999999999877 566889999999999999999999999999999999999999 89999999999999965
Q ss_pred CC-CccccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHH
Q 014210 314 RP-DERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSE 391 (429)
Q Consensus 314 ~~-~~~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 391 (429)
.. +....+.|||+.|||||++. ..|+..+|+||||+++|||++|..||.+.+...+.++|++....... ..++.+
T Consensus 176 ~~~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p---~~ls~~ 252 (357)
T KOG0598|consen 176 LKDGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPP---GYLSEE 252 (357)
T ss_pred ccCCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCC---ccCCHH
Confidence 43 45667789999999999886 57999999999999999999999999999999999999887733322 248999
Q ss_pred HHHHHHHhcccCccCcC----CHHHHHhhHhhhccce
Q 014210 392 ARDFVKRLLNKDPRKRL----TAAQALSELLICYQSY 424 (429)
Q Consensus 392 ~~~li~~~L~~dP~~Rp----s~~~iL~~~~~~~~~~ 424 (429)
+++||+.+|..||++|. ++.+|-+|+||..-+|
T Consensus 253 ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW 289 (357)
T KOG0598|consen 253 ARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGINW 289 (357)
T ss_pred HHHHHHHHhccCHHHhcCCCCChHHhhcCcccccCCH
Confidence 99999999999999996 7899999999987554
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-54 Score=408.14 Aligned_cols=262 Identities=36% Similarity=0.652 Sum_probs=234.1
Q ss_pred cCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~ 233 (429)
..+|.+.++||+|+||+||+|++++ ++..||||.+.+... ....++.+..|+++|+.|+ |+|||++++++++++.
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~---~~~~VAIK~i~~~~l-~~k~~e~L~~Ei~iLkel~-H~nIV~l~d~~~~~~~ 83 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKK---SGTEVAIKCIAKKKL-NKKLVELLLSEIKILKELK-HPNIVRLLDCIEDDDF 83 (429)
T ss_pred cccceehhhccCcceEEEEEeEecc---CCceEEeeeehhhcc-CHHHHHHHHHHHHHHHhcC-CcceeeEEEEEecCCe
Confidence 4689999999999999999999998 579999999987653 5667788999999999999 9999999999999999
Q ss_pred EEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCC---ceEEEeecCCc
Q 014210 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDEN---SVLKAIDFGLS 310 (429)
Q Consensus 234 ~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~---~~vkL~DFGla 310 (429)
+|||||||.||+|.+||+.+ +.+++..++.++.||+.||++||+++||||||||+||||+....+ -.+||+|||+|
T Consensus 84 i~lVMEyC~gGDLs~yi~~~-~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA 162 (429)
T KOG0595|consen 84 IYLVMEYCNGGDLSDYIRRR-GRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFA 162 (429)
T ss_pred EEEEEEeCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence 99999999999999998655 589999999999999999999999999999999999999865333 68999999999
Q ss_pred cccCCCccccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCC
Q 014210 311 DFVRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLS 389 (429)
Q Consensus 311 ~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 389 (429)
+.+.+.....+.+|++.|||||++. ++|+.|+|+||+|++||+|++|+.||...+..+.+..+.++....+.. ...++
T Consensus 163 R~L~~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~-~~~~s 241 (429)
T KOG0595|consen 163 RFLQPGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVL-PAELS 241 (429)
T ss_pred hhCCchhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCch-hhhcc
Confidence 9999888888999999999999985 789999999999999999999999999999999888776654333322 23466
Q ss_pred HHHHHHHHHhcccCccCcCCHHHHHhhHhhhcc
Q 014210 390 SEARDFVKRLLNKDPRKRLTAAQALSELLICYQ 422 (429)
Q Consensus 390 ~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~ 422 (429)
....+|+..+|+.++.+|.+..+-+.|+++...
T Consensus 242 ~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~ 274 (429)
T KOG0595|consen 242 NPLRELLISLLQRNPKDRISFEDFFDHPFLAAN 274 (429)
T ss_pred CchhhhhhHHHhcCccccCchHHhhhhhhcccC
Confidence 777899999999999999999999999988653
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-54 Score=423.11 Aligned_cols=261 Identities=33% Similarity=0.624 Sum_probs=240.6
Q ss_pred cCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~ 233 (429)
.++|.+++.||+|+|++|++|+.+. +++.||||++.+..+......+-+.+|-.+|.+|.+||.|++||..|+|+..
T Consensus 72 ~~DF~Fg~~lGeGSYStV~~A~~~~---t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 72 PNDFKFGKILGEGSYSTVVLAREKA---TGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred hhhcchhheeccccceeEEEeeecC---CCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 5789999999999999999999887 7999999999887777777777889999999999889999999999999999
Q ss_pred EEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCcccc
Q 014210 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (429)
Q Consensus 234 ~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~ 313 (429)
+|+|+||+++|+|+++|.+. +.+++.+++.++.+|+.||+|||++|||||||||+|||| |+++++||+|||.|+.+
T Consensus 149 LYFvLe~A~nGdll~~i~K~-Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILL---d~dmhikITDFGsAK~l 224 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIKKY-GSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILL---DKDGHIKITDFGSAKIL 224 (604)
T ss_pred eEEEEEecCCCcHHHHHHHh-CcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeE---cCCCcEEEeeccccccC
Confidence 99999999999999998654 889999999999999999999999999999999999999 89999999999999887
Q ss_pred CCCccc--------------cccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCC
Q 014210 314 RPDERL--------------NDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADP 378 (429)
Q Consensus 314 ~~~~~~--------------~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~ 378 (429)
.+.... ..++||..|.+||+|.. ..+..+|||+|||+||.|+.|..||.+.++--++++|+..+.
T Consensus 225 ~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y 304 (604)
T KOG0592|consen 225 SPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDY 304 (604)
T ss_pred ChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhcc
Confidence 543211 34899999999999985 578899999999999999999999999999999999999998
Q ss_pred CCCCCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhcccee
Q 014210 379 SFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLICYQSYL 425 (429)
Q Consensus 379 ~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~~~~ 425 (429)
.|++ ++++.+.|||+++|..||++|+++++|.+|+||....|.
T Consensus 305 ~fp~----~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw~ 347 (604)
T KOG0592|consen 305 EFPE----GFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDWE 347 (604)
T ss_pred cCCC----CCCHHHHHHHHHHHccCccccccHHHHhhCcccccCChh
Confidence 8886 688999999999999999999999999999999987764
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-53 Score=388.40 Aligned_cols=257 Identities=31% Similarity=0.587 Sum_probs=239.9
Q ss_pred cCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~ 233 (429)
.++|+.++.||.|+||+|.+++.+. +|..+|+|++++.+.......+...+|..+|+.+. ||.++++++.|.+.++
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~---~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~-~PFlv~l~~t~~d~~~ 118 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKH---SGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVS-HPFLVKLYGTFKDNSN 118 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEcc---CCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhcc-CceeEEEEEeeccCCe
Confidence 4689999999999999999999887 58999999999988888888899999999999999 9999999999999999
Q ss_pred EEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCcccc
Q 014210 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (429)
Q Consensus 234 ~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~ 313 (429)
+||||||++||.|..++ ++.+++++..++.++.||+.||+|||+++|++|||||+|||| |.+|.+||+|||+|+.+
T Consensus 119 lymvmeyv~GGElFS~L-rk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLl---D~~G~iKitDFGFAK~v 194 (355)
T KOG0616|consen 119 LYMVMEYVPGGELFSYL-RKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLL---DQNGHIKITDFGFAKRV 194 (355)
T ss_pred EEEEEeccCCccHHHHH-HhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeee---ccCCcEEEEeccceEEe
Confidence 99999999999999977 456789999999999999999999999999999999999999 89999999999999988
Q ss_pred CCCccccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHH
Q 014210 314 RPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEA 392 (429)
Q Consensus 314 ~~~~~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 392 (429)
. .++.+.|||+.|+|||++. +.|+..+|+|+|||++|||+.|..||.+.+...++.+|++.+..++. .++.++
T Consensus 195 ~--~rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP~----~fs~~~ 268 (355)
T KOG0616|consen 195 S--GRTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFPS----YFSSDA 268 (355)
T ss_pred c--CcEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCCc----ccCHHH
Confidence 5 3478899999999999887 67999999999999999999999999999999999999999988875 689999
Q ss_pred HHHHHHhcccCccCcC-----CHHHHHhhHhhhccce
Q 014210 393 RDFVKRLLNKDPRKRL-----TAAQALSELLICYQSY 424 (429)
Q Consensus 393 ~~li~~~L~~dP~~Rp-----s~~~iL~~~~~~~~~~ 424 (429)
++||+.+|+.|-.+|. ...+|..|+||....|
T Consensus 269 kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~W 305 (355)
T KOG0616|consen 269 KDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVDW 305 (355)
T ss_pred HHHHHHHHhhhhHhhhcCcCCCccccccCcccccccH
Confidence 9999999999999993 5688999999987654
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-51 Score=409.50 Aligned_cols=268 Identities=56% Similarity=0.933 Sum_probs=252.2
Q ss_pred cccccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEE
Q 014210 150 SKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYE 229 (429)
Q Consensus 150 ~~~~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~ 229 (429)
...+...|++.++||+|.||.||+++.+. +|+.+|+|++.+.........+.+.+|+.+|++|.+|||||++++.|+
T Consensus 30 ~~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~---tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e 106 (382)
T KOG0032|consen 30 SEDIKEKYELGRELGRGQFGVVYLCREKS---TGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFE 106 (382)
T ss_pred cccccccEEehhhhCCCCceEEEEEEecC---CCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEE
Confidence 34567889999999999999999999887 599999999998877777777899999999999999999999999999
Q ss_pred eCCeEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCC-CceEEEeecC
Q 014210 230 DTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDE-NSVLKAIDFG 308 (429)
Q Consensus 230 ~~~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~-~~~vkL~DFG 308 (429)
+.+.+++|||+|.||+|++.|... .+++.++..++.||+.++.|||+.||+||||||+|+|+...++ ++.+|++|||
T Consensus 107 ~~~~~~lvmEL~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFG 184 (382)
T KOG0032|consen 107 DPDSVYLVMELCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFG 184 (382)
T ss_pred cCCeEEEEEEecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCC
Confidence 999999999999999999999877 3999999999999999999999999999999999999976654 4689999999
Q ss_pred CccccCCCccccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCC
Q 014210 309 LSDFVRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPS 387 (429)
Q Consensus 309 la~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 387 (429)
++............+||+.|+|||++. ..|+..+||||+||++|.|++|..||++.+..+.+..++..+..+....|+.
T Consensus 185 la~~~~~~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~ 264 (382)
T KOG0032|consen 185 LAKFIKPGERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDD 264 (382)
T ss_pred CceEccCCceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccc
Confidence 999988877888999999999999998 6899999999999999999999999999999999999999999999999999
Q ss_pred CCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhcc
Q 014210 388 LSSEARDFVKRLLNKDPRKRLTAAQALSELLICYQ 422 (429)
Q Consensus 388 ~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~ 422 (429)
++..+++||+.||..||.+|+++.++|+|+|++..
T Consensus 265 is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~ 299 (382)
T KOG0032|consen 265 ISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSI 299 (382)
T ss_pred cCHHHHHHHHHhcccCcccCCCHHHHhcCccccCC
Confidence 99999999999999999999999999999999864
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-52 Score=418.97 Aligned_cols=261 Identities=28% Similarity=0.507 Sum_probs=242.1
Q ss_pred cccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeC
Q 014210 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (429)
Q Consensus 152 ~~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~ 231 (429)
...++|.++++||+|+||+|+++..+. +++.+|||+++|..+.....++..+.|.+|+....+||.+++++..|+..
T Consensus 365 ~~l~~F~~l~vLGkGsFGkV~lae~k~---~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~ 441 (694)
T KOG0694|consen 365 LTLDDFRLLAVLGRGSFGKVLLAELKG---TNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTK 441 (694)
T ss_pred ccccceEEEEEeccCcCceEEEEEEcC---CCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccC
Confidence 345789999999999999999999887 68899999999999999999999999999999998999999999999999
Q ss_pred CeEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCcc
Q 014210 232 DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (429)
Q Consensus 232 ~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~ 311 (429)
+++|+||||+.||++.. ..+.+.+++..++.++..|+.||.|||++||||||||.+|||| |.+|++||+||||++
T Consensus 442 ~~l~fvmey~~Ggdm~~--~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLL---D~eGh~kiADFGlcK 516 (694)
T KOG0694|consen 442 EHLFFVMEYVAGGDLMH--HIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLL---DTEGHVKIADFGLCK 516 (694)
T ss_pred CeEEEEEEecCCCcEEE--EEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEE---cccCcEEeccccccc
Confidence 99999999999999433 2355789999999999999999999999999999999999999 899999999999998
Q ss_pred ccC-CCccccccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCC
Q 014210 312 FVR-PDERLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLS 389 (429)
Q Consensus 312 ~~~-~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 389 (429)
... .+..+.++|||+.|||||++.+ .|+..+|+|+|||+|||||.|+.||.++++++++..|+..++.++. .++
T Consensus 517 e~m~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~yP~----~ls 592 (694)
T KOG0694|consen 517 EGMGQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYPR----FLS 592 (694)
T ss_pred ccCCCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCC----ccc
Confidence 754 5678889999999999999985 6999999999999999999999999999999999999999998886 589
Q ss_pred HHHHHHHHHhcccCccCcCCH-----HHHHhhHhhhccce
Q 014210 390 SEARDFVKRLLNKDPRKRLTA-----AQALSELLICYQSY 424 (429)
Q Consensus 390 ~~~~~li~~~L~~dP~~Rps~-----~~iL~~~~~~~~~~ 424 (429)
.|+.++++++|.+||++|..+ .+|..|+||+.-.|
T Consensus 593 ~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w 632 (694)
T KOG0694|consen 593 KEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDW 632 (694)
T ss_pred HHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccCCH
Confidence 999999999999999999865 89999999987653
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-51 Score=409.04 Aligned_cols=259 Identities=40% Similarity=0.722 Sum_probs=234.3
Q ss_pred cccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcC-c-HHHHHHHHHHHHHHHHhcCCCCcceEEEEEE
Q 014210 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMT-T-AIAIEDVRREVKILRALTGHNNLVKFFDAYE 229 (429)
Q Consensus 152 ~~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~-~-~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~ 229 (429)
...++|++.+.||+|+||.|++|.... +|..||||++.+.... . ....+.+.+|+.+++++..||||+++++++.
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~---t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~ 90 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRL---TGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFA 90 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeecc---CCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEe
Confidence 346789999999999999999998776 6899999988765322 1 2345677899999999998999999999999
Q ss_pred eCCeEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCC-ceEEEeecC
Q 014210 230 DTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDEN-SVLKAIDFG 308 (429)
Q Consensus 230 ~~~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~-~~vkL~DFG 308 (429)
....+|+|||||.||+|+++|.+ .+++.+..++++++||++|++|||++||+||||||+|||+ +.+ +++||+|||
T Consensus 91 t~~~~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENill---d~~~~~~Kl~DFG 166 (370)
T KOG0583|consen 91 TPTKIYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILL---DGNEGNLKLSDFG 166 (370)
T ss_pred cCCeEEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEe---cCCCCCEEEeccc
Confidence 99999999999999999999988 7889999999999999999999999999999999999999 666 899999999
Q ss_pred Ccccc-CCCccccccccCCcccCcccccC-C-C-CCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCC
Q 014210 309 LSDFV-RPDERLNDIVGSAYYVAPEVLHR-S-Y-STEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAP 384 (429)
Q Consensus 309 la~~~-~~~~~~~~~~gt~~y~aPE~~~~-~-~-~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 384 (429)
++... ..+....+.+||+.|+|||++.+ . | +.++||||+||+||.|++|+.||...+....+..+.+....++..
T Consensus 167 ~s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~p~~- 245 (370)
T KOG0583|consen 167 LSAISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKIPSY- 245 (370)
T ss_pred cccccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccCCCC-
Confidence 99988 56778889999999999999985 3 5 478999999999999999999999988888888988887777753
Q ss_pred CCCC-CHHHHHHHHHhcccCccCcCCHHHHHhhHhhhc
Q 014210 385 WPSL-SSEARDFVKRLLNKDPRKRLTAAQALSELLICY 421 (429)
Q Consensus 385 ~~~~-s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~ 421 (429)
+ +.++.+||.+||..||.+|+++.+|+.|+||+.
T Consensus 246 ---~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 246 ---LLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred ---cCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 4 999999999999999999999999999999997
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-52 Score=407.31 Aligned_cols=266 Identities=31% Similarity=0.514 Sum_probs=236.4
Q ss_pred cccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeC
Q 014210 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (429)
Q Consensus 152 ~~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~ 231 (429)
.-.++|+++++||+|+||.||+|+.+. +|..+|+|+++++.+.....++.++.|-.+|.... .++||+||..|++.
T Consensus 138 ~~~~DFe~Lk~IgkGAfGeVrLarKk~---Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~d-s~~vVKLyYsFQD~ 213 (550)
T KOG0605|consen 138 LSLDDFELLKVIGKGAFGEVRLARKKD---TGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVD-SPWVVKLYYSFQDK 213 (550)
T ss_pred CCcccchhheeeccccceeEEEEEEcc---CCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcC-CCcEEEEEEEecCC
Confidence 346889999999999999999999777 79999999999999999999999999999999965 99999999999999
Q ss_pred CeEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCcc
Q 014210 232 DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (429)
Q Consensus 232 ~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~ 311 (429)
+++||||||++||++...| .+.+.|+++.++.++.+++.||+.||+.|+|||||||+|+|| |..|++||+||||+.
T Consensus 214 ~~LYLiMEylPGGD~mTLL-~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLi---D~~GHiKLSDFGLs~ 289 (550)
T KOG0605|consen 214 EYLYLIMEYLPGGDMMTLL-MRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLI---DAKGHIKLSDFGLST 289 (550)
T ss_pred CeeEEEEEecCCccHHHHH-HhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheee---cCCCCEeeccccccc
Confidence 9999999999999998866 456789999999999999999999999999999999999999 899999999999973
Q ss_pred ccCC----------------------Cc-c-------------------------ccccccCCcccCcccccC-CCCCcc
Q 014210 312 FVRP----------------------DE-R-------------------------LNDIVGSAYYVAPEVLHR-SYSTEA 342 (429)
Q Consensus 312 ~~~~----------------------~~-~-------------------------~~~~~gt~~y~aPE~~~~-~~~~~s 342 (429)
-+.. .. . ....+||+.|||||++.+ .|+..+
T Consensus 290 gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~c 369 (550)
T KOG0605|consen 290 GLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKEC 369 (550)
T ss_pred hhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccc
Confidence 2110 00 0 012579999999999875 699999
Q ss_pred cHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCcCC---HHHHHhhHhh
Q 014210 343 DVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLT---AAQALSELLI 419 (429)
Q Consensus 343 DiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps---~~~iL~~~~~ 419 (429)
|+||||||+||||.|.+||.+.+..+.+++|+.-........-..++.+++|||.+||+ ||++|.. ++||.+|+||
T Consensus 370 DwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF 448 (550)
T KOG0605|consen 370 DWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFF 448 (550)
T ss_pred cHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCcc
Confidence 99999999999999999999999999999999876555444445788999999999999 9999985 8999999999
Q ss_pred hccceee
Q 014210 420 CYQSYLF 426 (429)
Q Consensus 420 ~~~~~~~ 426 (429)
....|-.
T Consensus 449 ~~v~W~~ 455 (550)
T KOG0605|consen 449 KGVDWDH 455 (550)
T ss_pred ccCCcch
Confidence 9887654
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-53 Score=379.84 Aligned_cols=265 Identities=36% Similarity=0.721 Sum_probs=245.2
Q ss_pred cccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeC
Q 014210 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (429)
Q Consensus 152 ~~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~ 231 (429)
.+.+.|++-++||+|.|+.|+++.... +|+.+|+|++....... ...+++.+|+.|-+.|+ |||||+|++.+.+.
T Consensus 8 ~f~d~y~l~e~igkG~FSvVrRc~~~~---tg~~fa~kiin~~k~~~-~~~e~l~rEarIC~~Lq-HP~IvrL~~ti~~~ 82 (355)
T KOG0033|consen 8 KFSDNYDVKEELGKGAFSVVRRCVHKT---TGLEFAAKIINTKKLSA-RDFQKLEREARICRKLQ-HPNIVRLHDSIQEE 82 (355)
T ss_pred ccchhhhHHHHHccCchHHHHHHHhcc---chHHHHHHHhhhhhhcc-ccHHHHHHHHHHHHhcC-CCcEeehhhhhccc
Confidence 357889999999999999999887665 79999999997665444 36788999999999999 99999999999999
Q ss_pred CeEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCcc
Q 014210 232 DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (429)
Q Consensus 232 ~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~ 311 (429)
+..|||+|+|.|++|..-|..+ .-+++..+-..++||+++|.|+|.+||||||+||+|+|+.+++...-+||+|||+|.
T Consensus 83 ~~~ylvFe~m~G~dl~~eIV~R-~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi 161 (355)
T KOG0033|consen 83 SFHYLVFDLVTGGELFEDIVAR-EFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAI 161 (355)
T ss_pred ceeEEEEecccchHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEE
Confidence 9999999999999998877666 568999999999999999999999999999999999999988888899999999999
Q ss_pred ccCCCccccccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCH
Q 014210 312 FVRPDERLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSS 390 (429)
Q Consensus 312 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 390 (429)
.+..+......+||++|||||++.+ .|+..+|||+-||+||.|+.|++|||+.+...+++.|+.+...++...|+.+++
T Consensus 162 ~l~~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~ 241 (355)
T KOG0033|consen 162 EVNDGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTP 241 (355)
T ss_pred EeCCccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCH
Confidence 9886777788999999999999985 699999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHhcccCccCcCCHHHHHhhHhhhcc
Q 014210 391 EARDFVKRLLNKDPRKRLTAAQALSELLICYQ 422 (429)
Q Consensus 391 ~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~ 422 (429)
++++||++||..||.+|.|+.|+|.|+|++.-
T Consensus 242 ~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~r 273 (355)
T KOG0033|consen 242 EAKSLIRRMLTVNPKKRITADEALKHPWICNR 273 (355)
T ss_pred HHHHHHHHHhccChhhhccHHHHhCCchhcch
Confidence 99999999999999999999999999999863
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-52 Score=382.42 Aligned_cols=257 Identities=30% Similarity=0.549 Sum_probs=224.7
Q ss_pred CceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeE
Q 014210 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (429)
Q Consensus 155 ~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~ 234 (429)
++|+.+.++|+|+||.||+++.++ +|+.||||.+..+. .+....+-..+||++|++|+ |+|+|.++.+|.....+
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~---TgqIVAIKkF~Ese-dd~~VkKIAlREIrmLKqLk-H~NLVnLiEVFrrkrkl 76 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKD---TGQIVAIKKFVESE-DDPVVKKIALREIRMLKQLK-HENLVNLIEVFRRKRKL 76 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCC---cccEEEEEeeccCC-ccHHHHHHHHHHHHHHHhcc-cchHHHHHHHHHhccee
Confidence 579999999999999999999887 79999999986553 23334445689999999999 99999999999999999
Q ss_pred EEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccccC
Q 014210 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (429)
Q Consensus 235 ~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~ 314 (429)
+||+|||+. ++++.+......++.+.+++++.|++.|+.|||++++|||||||+|||| ..++++||||||+|+.+.
T Consensus 77 hLVFE~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILi---t~~gvvKLCDFGFAR~L~ 152 (396)
T KOG0593|consen 77 HLVFEYCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILI---TQNGVVKLCDFGFARTLS 152 (396)
T ss_pred EEEeeecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEE---ecCCcEEeccchhhHhhc
Confidence 999999976 6677777777789999999999999999999999999999999999999 688899999999999887
Q ss_pred -CCccccccccCCcccCcccccC--CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhc--------------C
Q 014210 315 -PDERLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKA--------------D 377 (429)
Q Consensus 315 -~~~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~--------------~ 377 (429)
+++....++.|.+|+|||.+.+ +|+..+|||++||++.||++|...|.+.++.+.+..|.+. +
T Consensus 153 ~pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N 232 (396)
T KOG0593|consen 153 APGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSN 232 (396)
T ss_pred CCcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccC
Confidence 7778889999999999998876 6999999999999999999999999999888876665442 2
Q ss_pred CCCCC-------------CCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhh
Q 014210 378 PSFDE-------------APWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLIC 420 (429)
Q Consensus 378 ~~~~~-------------~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~ 420 (429)
+.|.- ..++.++.-+.||++.||..||++|++.+|+|.|.+|.
T Consensus 233 ~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd 288 (396)
T KOG0593|consen 233 PFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFD 288 (396)
T ss_pred CceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHH
Confidence 22211 12345677889999999999999999999999999994
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-52 Score=402.33 Aligned_cols=263 Identities=35% Similarity=0.519 Sum_probs=232.2
Q ss_pred cccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeC
Q 014210 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (429)
Q Consensus 152 ~~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~ 231 (429)
.+.++|.++++||.|.||.||+|+-+. +|..||||.+++.-. . ...-.-.||++.|++|..|||||++.+++.+.
T Consensus 7 ~~m~RY~~i~klGDGTfGsV~la~~~~---~~~~VAIK~MK~Kf~-s-~ee~~nLREvksL~kln~hpniikL~Evi~d~ 81 (538)
T KOG0661|consen 7 IFMDRYTVIRKLGDGTFGSVYLAKSKE---TGELVAIKKMKKKFY-S-WEECMNLREVKSLRKLNPHPNIIKLKEVIRDN 81 (538)
T ss_pred hHHHHHHHHHHhcCCcceeEEEeeecC---CCceeeHHHHHhhhc-c-HHHHHHHHHHHHHHhcCCCCcchhhHHHhhcc
Confidence 356899999999999999999999776 689999999976432 2 22222468999999999999999999999998
Q ss_pred C-eEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCc
Q 014210 232 D-NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS 310 (429)
Q Consensus 232 ~-~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla 310 (429)
+ .+|||||||+. +|++.+..++..+++..++.|+.||++||+|+|.+|+.|||+||+|||+ ..+..+||+|||+|
T Consensus 82 ~~~L~fVfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi---~~~~~iKiaDFGLA 157 (538)
T KOG0661|consen 82 DRILYFVFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILI---SGNDVIKIADFGLA 157 (538)
T ss_pred CceEeeeHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEe---cccceeEecccccc
Confidence 8 89999999976 8999999998899999999999999999999999999999999999999 45778999999999
Q ss_pred cccCCCccccccccCCcccCccccc--CCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCC---
Q 014210 311 DFVRPDERLNDIVGSAYYVAPEVLH--RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPW--- 385 (429)
Q Consensus 311 ~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~--- 385 (429)
+..........++.|.+|+|||++. +-|+.+.|||++||+++|+.+.+..|.+.++.+.+.+|+.--....+..|
T Consensus 158 Rev~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg 237 (538)
T KOG0661|consen 158 REVRSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEG 237 (538)
T ss_pred cccccCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhH
Confidence 9999888899999999999999875 46999999999999999999999999999999988888764433333322
Q ss_pred -----------------------CCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhccc
Q 014210 386 -----------------------PSLSSEARDFVKRLLNKDPRKRLTAAQALSELLICYQS 423 (429)
Q Consensus 386 -----------------------~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~~ 423 (429)
+.++.++.+||.+||.+||.+|||+.|+|+|+||+...
T Consensus 238 ~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~ 298 (538)
T KOG0661|consen 238 YNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGR 298 (538)
T ss_pred HHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCccccccc
Confidence 34688999999999999999999999999999998654
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-52 Score=381.25 Aligned_cols=256 Identities=27% Similarity=0.550 Sum_probs=220.6
Q ss_pred cCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEE-EEEeCC
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFD-AYEDTD 232 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~-~~~~~~ 232 (429)
..+|+++++||+|.||.||++.... +|..||.|.+... ..+....+++..|+.+|++|+ |||||++++ .+.+++
T Consensus 18 l~~y~Il~~IG~GsFg~vykv~~~~---~g~l~a~K~i~f~-~md~k~rq~~v~Ei~lLkQL~-HpNIVqYy~~~f~~~~ 92 (375)
T KOG0591|consen 18 LADYQILKKIGRGSFGEVYKVQCLL---DGKLVALKKIQFG-MMDAKARQDCVKEISLLKQLN-HPNIVQYYAHSFIEDN 92 (375)
T ss_pred HHHHHHHHHHcCCcchheEEeeecc---Ccchhhhhhcchh-hccHHHHHHHHHHHHHHHhcC-CchHHHHHHHhhhccc
Confidence 4679999999999999999999776 6999999999854 456677788999999999999 999999999 555555
Q ss_pred e-EEEEEEecCCCcHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHH--cC--ceeccCCCCcEEEeecCCCceEEE
Q 014210 233 N-VYVVMELCEGGELLDRIL---SRGGKYTEDDAKAVMIQILNVVAFCHL--QG--VVHRDLKPENFLFTTKDENSVLKA 304 (429)
Q Consensus 233 ~-~~lv~E~~~ggsL~~~i~---~~~~~l~~~~~~~i~~qi~~gL~~LH~--~~--iiHrDIKp~NILl~~~~~~~~vkL 304 (429)
. ++||||||.+|+|...|. +....+++..+|+++.|++.||..+|. .. |+||||||.||+| +.+|+|||
T Consensus 93 evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl---~~~gvvKL 169 (375)
T KOG0591|consen 93 EVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFL---TANGVVKL 169 (375)
T ss_pred hhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEE---cCCCceee
Confidence 5 899999999999998775 345679999999999999999999999 44 9999999999999 78999999
Q ss_pred eecCCccccCCCcc-ccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCC
Q 014210 305 IDFGLSDFVRPDER-LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDE 382 (429)
Q Consensus 305 ~DFGla~~~~~~~~-~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~ 382 (429)
+|||+++.+..+.. ....+||++||+||+++ ..|+.+|||||+||++|||+..+.||.+.+-...-.+|.+.+.. .
T Consensus 170 GDfGL~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~--~ 247 (375)
T KOG0591|consen 170 GDFGLGRFLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYP--P 247 (375)
T ss_pred ccchhHhHhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCC--C
Confidence 99999999876654 35689999999999887 57999999999999999999999999999877777778776532 1
Q ss_pred CCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhh
Q 014210 383 APWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLI 419 (429)
Q Consensus 383 ~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~ 419 (429)
.+-..+|.++..||..|+..||+.||+...++.....
T Consensus 248 ~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 248 LPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred CcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 1113689999999999999999999996555554443
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-50 Score=397.13 Aligned_cols=256 Identities=29% Similarity=0.498 Sum_probs=223.5
Q ss_pred ccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCC
Q 014210 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (429)
Q Consensus 153 ~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~ 232 (429)
-...|...++||+|.-|.||.++... +++.||||++...... ..+-+.+|+.+|+.++ |+|||++++.|...+
T Consensus 271 P~~~y~~~~kigqgaSG~vy~A~~~~---~~~~VaiK~m~l~~Q~---~keLilnEi~Vm~~~~-H~NiVnfl~Sylv~d 343 (550)
T KOG0578|consen 271 PRSKYTDFKKIGQGATGGVYVARKIS---TKQEVAIKRMDLRKQP---KKELLLNEILVMRDLH-HPNIVNFLDSYLVGD 343 (550)
T ss_pred hhhhhcchhhhccccccceeeeeecc---CCceEEEEEEEeccCC---chhhhHHHHHHHHhcc-chHHHHHHHHhcccc
Confidence 35678999999999999999998776 6889999999765433 3356889999999998 999999999999999
Q ss_pred eEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccc
Q 014210 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (429)
Q Consensus 233 ~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~ 312 (429)
.+|+|||||+||+|.|.+. ...++|.++..|+++++.||+|||.+||||||||.+|||+ +.++.+||+|||++..
T Consensus 344 eLWVVMEym~ggsLTDvVt--~~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL---~~~g~vKltDFGFcaq 418 (550)
T KOG0578|consen 344 ELWVVMEYMEGGSLTDVVT--KTRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILL---TMDGSVKLTDFGFCAQ 418 (550)
T ss_pred eeEEEEeecCCCchhhhhh--cccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEe---ccCCcEEEeeeeeeec
Confidence 9999999999999999773 3459999999999999999999999999999999999999 7888899999999988
Q ss_pred cCCCc-cccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCH
Q 014210 313 VRPDE-RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSS 390 (429)
Q Consensus 313 ~~~~~-~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 390 (429)
+.... ...+.+||++|||||+.. +.|+.+.||||||++++||+-|+.||...+....+..|... .......+..++.
T Consensus 419 i~~~~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~n-g~P~lk~~~klS~ 497 (550)
T KOG0578|consen 419 ISEEQSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-GTPKLKNPEKLSP 497 (550)
T ss_pred cccccCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhc-CCCCcCCccccCH
Confidence 77665 456789999999999887 57999999999999999999999999876665555555433 2333344567999
Q ss_pred HHHHHHHHhcccCccCcCCHHHHHhhHhhhc
Q 014210 391 EARDFVKRLLNKDPRKRLTAAQALSELLICY 421 (429)
Q Consensus 391 ~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~ 421 (429)
+|++|+.+||+.|+++|+++.++|+|+||..
T Consensus 498 ~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~ 528 (550)
T KOG0578|consen 498 ELKDFLDRCLVVDVEQRASAKELLEHPFLKM 528 (550)
T ss_pred HHHHHHHHHhhcchhcCCCHHHHhcChhhhh
Confidence 9999999999999999999999999999953
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-50 Score=404.61 Aligned_cols=256 Identities=34% Similarity=0.630 Sum_probs=235.9
Q ss_pred cCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~ 233 (429)
-+-|++++-||.|+-|.|-+|++.. +|+.+|||++.+...........+.+||-||+-|. |||++++|++|++..+
T Consensus 11 iGpwkLgkTLG~Gstg~vrlakh~~---TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~-HpnVl~LydVwe~~~~ 86 (786)
T KOG0588|consen 11 IGPWKLGKTLGKGSTGCVRLAKHAE---TGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIE-HPNVLRLYDVWENKQH 86 (786)
T ss_pred ccceeccccccCCCCceehhhhccc---ccceeEEEeeccccccccccccchhhhhHHHHHhc-CCCeeeeeeeeccCce
Confidence 3569999999999999999998777 79999999998875555566678999999999998 9999999999999999
Q ss_pred EEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCcccc
Q 014210 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (429)
Q Consensus 234 ~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~ 313 (429)
+|+|+||++||.|++++..+ +.+++.++.+++.||+.|+.|||..+|+|||+||+|+|| |..+++||+|||||..-
T Consensus 87 lylvlEyv~gGELFdylv~k-G~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLL---d~~~nIKIADFGMAsLe 162 (786)
T KOG0588|consen 87 LYLVLEYVPGGELFDYLVRK-GPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLL---DVKNNIKIADFGMASLE 162 (786)
T ss_pred EEEEEEecCCchhHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhh---hcccCEeeeccceeecc
Confidence 99999999999999998755 679999999999999999999999999999999999999 77778999999999998
Q ss_pred CCCccccccccCCcccCcccccC-CC-CCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHH
Q 014210 314 RPDERLNDIVGSAYYVAPEVLHR-SY-STEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSE 391 (429)
Q Consensus 314 ~~~~~~~~~~gt~~y~aPE~~~~-~~-~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 391 (429)
.++.-..+.||++.|.+||++.| .| +.++||||.|||||.||+|++||++++...++.++.++....+ ..++.+
T Consensus 163 ~~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MP----s~Is~e 238 (786)
T KOG0588|consen 163 VPGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMP----SNISSE 238 (786)
T ss_pred cCCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCC----CcCCHH
Confidence 88888899999999999999886 34 7799999999999999999999999998889999988876666 479999
Q ss_pred HHHHHHHhcccCccCcCCHHHHHhhHhhhc
Q 014210 392 ARDFVKRLLNKDPRKRLTAAQALSELLICY 421 (429)
Q Consensus 392 ~~~li~~~L~~dP~~Rps~~~iL~~~~~~~ 421 (429)
+++||.+||..||++|.|.+||+.|+|+..
T Consensus 239 aQdLLr~ml~VDp~~RiT~~eI~kHP~l~g 268 (786)
T KOG0588|consen 239 AQDLLRRMLDVDPSTRITTEEILKHPFLSG 268 (786)
T ss_pred HHHHHHHHhccCccccccHHHHhhCchhhc
Confidence 999999999999999999999999999964
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-50 Score=393.03 Aligned_cols=260 Identities=35% Similarity=0.530 Sum_probs=230.4
Q ss_pred cccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeC
Q 014210 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (429)
Q Consensus 152 ~~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~ 231 (429)
...+.|+.+++||+|.||.||+|+... +|+.||+|.+..+.. .........+||.||++|. ||||++|.+...+.
T Consensus 114 r~~~~feki~kIGeGTyg~VYkAr~~~---tgkivALKKvr~d~~-~~~~~~t~~REI~ILr~l~-HpNIikL~eivt~~ 188 (560)
T KOG0600|consen 114 RRADSFEKIEKIGEGTYGQVYKARDLE---TGKIVALKKVRFDNE-KEGFPITAIREIKILRRLD-HPNIIKLEEIVTSK 188 (560)
T ss_pred cchHHHHHHHHhcCcchhheeEeeecc---cCcEEEEEEeecccC-CCcchHHHHHHHHHHHhcC-CCcccceeeEEEec
Confidence 346789999999999999999999776 799999999977643 3344456789999999998 99999999998876
Q ss_pred --CeEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCC
Q 014210 232 --DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGL 309 (429)
Q Consensus 232 --~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGl 309 (429)
+.+|||+|||+. +|...+...+-+|++.+++.++.||+.||+|||.+||+|||||.+|||| |.+|++||+||||
T Consensus 189 ~~~siYlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLi---dn~G~LKiaDFGL 264 (560)
T KOG0600|consen 189 LSGSIYLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILI---DNNGVLKIADFGL 264 (560)
T ss_pred CCceEEEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEE---cCCCCEEeccccc
Confidence 689999999987 8888776667789999999999999999999999999999999999999 8999999999999
Q ss_pred ccccCCCc--cccccccCCcccCcccccC--CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCC
Q 014210 310 SDFVRPDE--RLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPW 385 (429)
Q Consensus 310 a~~~~~~~--~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 385 (429)
|+++.... .....+-|.+|+|||.+.| .|+..+|+||.||||.||++|+..|.+.++.+.+..|.+......+..|
T Consensus 265 Ar~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W 344 (560)
T KOG0600|consen 265 ARFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYW 344 (560)
T ss_pred eeeccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhcc
Confidence 99776554 4567789999999998875 5999999999999999999999999999999999999886655555555
Q ss_pred C-------------------------CCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhh
Q 014210 386 P-------------------------SLSSEARDFVKRLLNKDPRKRLTAAQALSELLIC 420 (429)
Q Consensus 386 ~-------------------------~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~ 420 (429)
+ .++....+|+..||..||++|.|+.++|.+.||.
T Consensus 345 ~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~ 404 (560)
T KOG0600|consen 345 PVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFT 404 (560)
T ss_pred ccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCcccc
Confidence 4 2577889999999999999999999999999993
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-51 Score=369.95 Aligned_cols=262 Identities=36% Similarity=0.651 Sum_probs=239.4
Q ss_pred cccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCC-----cCcHHHHHHHHHHHHHHHHhcCCCCcceEEE
Q 014210 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHK-----MTTAIAIEDVRREVKILRALTGHNNLVKFFD 226 (429)
Q Consensus 152 ~~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~-----~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~ 226 (429)
.+-++|+-.+.||.|..+.|-++.++. +|+.+|+|++.... ..-.+.++...+|+.||+++.+||+|+++.+
T Consensus 14 ~fy~~y~pkeilgrgvss~vrRci~k~---t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D 90 (411)
T KOG0599|consen 14 GFYAKYEPKEILGRGVSSVVRRCIHKE---TGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQD 90 (411)
T ss_pred hHHhhcChHHHhcccchhhhhhhhhcc---cccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeee
Confidence 345678889999999999998888777 68999999984321 1223445667899999999999999999999
Q ss_pred EEEeCCeEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEee
Q 014210 227 AYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAID 306 (429)
Q Consensus 227 ~~~~~~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~D 306 (429)
+|+.+..+++|+|.|+.|.|.|++.+. -.+++...++|++|+++|++|||.++||||||||+|||+ +++.++||+|
T Consensus 91 ~yes~sF~FlVFdl~prGELFDyLts~-VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILl---ddn~~i~isD 166 (411)
T KOG0599|consen 91 VYESDAFVFLVFDLMPRGELFDYLTSK-VTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILL---DDNMNIKISD 166 (411)
T ss_pred eccCcchhhhhhhhcccchHHHHhhhh-eeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheee---ccccceEEec
Confidence 999999999999999999999998543 579999999999999999999999999999999999999 8999999999
Q ss_pred cCCccccCCCccccccccCCcccCccccc-------CCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCC
Q 014210 307 FGLSDFVRPDERLNDIVGSAYYVAPEVLH-------RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPS 379 (429)
Q Consensus 307 FGla~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~ 379 (429)
||+++.+.++......|||++|+|||.+. ..|+..+|+|+.||+||-|+.|..|||.....-+++.|+.+...
T Consensus 167 FGFa~~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyq 246 (411)
T KOG0599|consen 167 FGFACQLEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQ 246 (411)
T ss_pred cceeeccCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccc
Confidence 99999999999999999999999999874 35888999999999999999999999999998999999999999
Q ss_pred CCCCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhh
Q 014210 380 FDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLIC 420 (429)
Q Consensus 380 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~ 420 (429)
|....|.+++.+.+|||.+||+.||.+|.|++|+|+|+||.
T Consensus 247 F~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~ 287 (411)
T KOG0599|consen 247 FRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFI 287 (411)
T ss_pred cCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHH
Confidence 99999999999999999999999999999999999999994
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-50 Score=385.14 Aligned_cols=259 Identities=33% Similarity=0.536 Sum_probs=215.8
Q ss_pred cCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCC-
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD- 232 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~- 232 (429)
..+|...+.||+|+||.||++...+ +|...|||.+... .....+.+.+|+.+|.+|+ |||||+++|......
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~---~g~~~AvK~v~~~---~~~~~~~l~~Ei~iL~~l~-~p~IV~~~G~~~~~~~ 88 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKK---TGELMAVKSVELE---DSPTSESLEREIRILSRLN-HPNIVQYYGSSSSREN 88 (313)
T ss_pred cchhhhhccccCccceEEEEEEecC---CCcceeeeeeecc---cchhHHHHHHHHHHHHhCC-CCCEEeeCCccccccC
Confidence 3568899999999999999999877 4899999998654 2222677999999999999 999999999754444
Q ss_pred -eEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCC-CceEEEeecCCc
Q 014210 233 -NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDE-NSVLKAIDFGLS 310 (429)
Q Consensus 233 -~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~-~~~vkL~DFGla 310 (429)
.++|.|||+++|+|.+++...++++++..++++.+||++||+|||++|||||||||+|||+ +. ++.+||+|||++
T Consensus 89 ~~~~i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl---~~~~~~~KlaDFG~a 165 (313)
T KOG0198|consen 89 DEYNIFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILL---DPSNGDVKLADFGLA 165 (313)
T ss_pred eeeEeeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEE---eCCCCeEEeccCccc
Confidence 6899999999999999998776689999999999999999999999999999999999999 56 689999999999
Q ss_pred cccCC----CccccccccCCcccCcccccCCC--CCcccHHHHHHHHHHHHcCCCCCCCC-ChHHHHHHHHhcCCCCCCC
Q 014210 311 DFVRP----DERLNDIVGSAYYVAPEVLHRSY--STEADVWSIGVIAYILLCGSRPFWAR-TESGIFRAVLKADPSFDEA 383 (429)
Q Consensus 311 ~~~~~----~~~~~~~~gt~~y~aPE~~~~~~--~~~sDiwSlGvll~elltg~~Pf~~~-~~~~~~~~i~~~~~~~~~~ 383 (429)
+.... ........||+.|||||++.... ..++|||||||+++||+||+.||... .....+..+.... ..+ .
T Consensus 166 ~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~-~~P-~ 243 (313)
T KOG0198|consen 166 KKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGRED-SLP-E 243 (313)
T ss_pred cccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccC-CCC-C
Confidence 87763 12234578999999999988433 34999999999999999999999873 3333333333333 112 2
Q ss_pred CCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhccce
Q 014210 384 PWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLICYQSY 424 (429)
Q Consensus 384 ~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~~~ 424 (429)
....++.++++||.+||..||++|||+.++|.|+|++.+..
T Consensus 244 ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~ 284 (313)
T KOG0198|consen 244 IPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNSI 284 (313)
T ss_pred CCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence 33469999999999999999999999999999999987653
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-49 Score=388.58 Aligned_cols=252 Identities=28% Similarity=0.455 Sum_probs=215.9
Q ss_pred CceeEeceeeccCceEEEEEEEecCcccCeE-EEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCC-
Q 014210 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQ-VAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD- 232 (429)
Q Consensus 155 ~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~-vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~- 232 (429)
....+.+.||+|+||+||++... |+. ||||++......... .+.|.+|+.+|.+|+ |||||+++|+|.+..
T Consensus 41 ~~l~~~~~iG~G~~g~V~~~~~~-----g~~~vavK~~~~~~~~~~~-~~~f~~E~~il~~l~-HpNIV~f~G~~~~~~~ 113 (362)
T KOG0192|consen 41 DELPIEEVLGSGSFGTVYKGKWR-----GTDVVAVKIISDPDFDDES-RKAFRREASLLSRLR-HPNIVQFYGACTSPPG 113 (362)
T ss_pred HHhhhhhhcccCCceeEEEEEeC-----CceeEEEEEecchhcChHH-HHHHHHHHHHHHhCC-CCCeeeEEEEEcCCCC
Confidence 34556667999999999988744 566 999999876544444 789999999999999 999999999999988
Q ss_pred eEEEEEEecCCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHcC-ceeccCCCCcEEEeecCCCc-eEEEeecCC
Q 014210 233 NVYVVMELCEGGELLDRILS-RGGKYTEDDAKAVMIQILNVVAFCHLQG-VVHRDLKPENFLFTTKDENS-VLKAIDFGL 309 (429)
Q Consensus 233 ~~~lv~E~~~ggsL~~~i~~-~~~~l~~~~~~~i~~qi~~gL~~LH~~~-iiHrDIKp~NILl~~~~~~~-~vkL~DFGl 309 (429)
..+||||||++|+|.+++.. +...+++..+.+++.||++||.|||+++ |||||||++|||+ +.+. ++||+|||+
T Consensus 114 ~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv---~~~~~~~KI~DFGl 190 (362)
T KOG0192|consen 114 SLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILV---DLKGKTLKIADFGL 190 (362)
T ss_pred ceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEE---cCCCCEEEECCCcc
Confidence 79999999999999999987 4788999999999999999999999999 9999999999999 7775 999999999
Q ss_pred ccccCCC-ccccccccCCcccCcccccC---CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCC
Q 014210 310 SDFVRPD-ERLNDIVGSAYYVAPEVLHR---SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPW 385 (429)
Q Consensus 310 a~~~~~~-~~~~~~~gt~~y~aPE~~~~---~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 385 (429)
++..... .......||..|||||++.+ .|+.|+|||||||+||||+||+.||...........+..........
T Consensus 191 sr~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p-- 268 (362)
T KOG0192|consen 191 SREKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIP-- 268 (362)
T ss_pred ceeeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCC--
Confidence 9877654 34444789999999999984 49999999999999999999999999888766666655433322221
Q ss_pred CCCCHHHHHHHHHhcccCccCcCCHHHHHhhHh
Q 014210 386 PSLSSEARDFVKRLLNKDPRKRLTAAQALSELL 418 (429)
Q Consensus 386 ~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~ 418 (429)
..+++.+..||..||+.||++||++.+++..+-
T Consensus 269 ~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~ 301 (362)
T KOG0192|consen 269 KECPPHLSSLMERCWLVDPSRRPSFLEIVSRLE 301 (362)
T ss_pred ccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHH
Confidence 238899999999999999999999999987654
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-49 Score=359.02 Aligned_cols=259 Identities=31% Similarity=0.520 Sum_probs=230.2
Q ss_pred CceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeE
Q 014210 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (429)
Q Consensus 155 ~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~ 234 (429)
.+|..+++||+|.||.||+|++.+ +|+.||||.++..+..+... ....|||+.|+.++ |+||+.++++|-..+.+
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~---t~~~VAIKKIkl~~~kdGi~-~talREIK~Lqel~-h~nIi~LiD~F~~~~~l 76 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTE---TGKRVAIKKIKLGNAKDGIN-RTALREIKLLQELK-HPNIIELIDVFPHKSNL 76 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecC---CCcEEEEEEeeccccccCcc-HHHHHHHHHHHHcc-CcchhhhhhhccCCCce
Confidence 578899999999999999999776 79999999998765554433 34679999999999 99999999999999999
Q ss_pred EEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccccC
Q 014210 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (429)
Q Consensus 235 ~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~ 314 (429)
.||+|||+. +|...|..+...++..+++.++.++++||+|||++.|+||||||.|+|+ +.+|.+||+|||+++.+.
T Consensus 77 ~lVfEfm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLi---s~~g~lKiADFGLAr~f~ 152 (318)
T KOG0659|consen 77 SLVFEFMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLI---SSDGQLKIADFGLARFFG 152 (318)
T ss_pred EEEEEeccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEE---cCCCcEEeecccchhccC
Confidence 999999975 9999998888889999999999999999999999999999999999999 789999999999999886
Q ss_pred CCcc-ccccccCCcccCcccccC--CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCC----
Q 014210 315 PDER-LNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPS---- 387 (429)
Q Consensus 315 ~~~~-~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~---- 387 (429)
.... ....+-|.+|+|||.+-| .|+..+||||.||++.||+.|.+-|.+.++.+.+..|.+.-....+..||+
T Consensus 153 ~p~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~l 232 (318)
T KOG0659|consen 153 SPNRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSL 232 (318)
T ss_pred CCCcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCcccccc
Confidence 5443 334489999999998864 699999999999999999999999999999999999888766666655653
Q ss_pred --------------------CCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhcc
Q 014210 388 --------------------LSSEARDFVKRLLNKDPRKRLTAAQALSELLICYQ 422 (429)
Q Consensus 388 --------------------~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~ 422 (429)
.+.++.||+..||..||.+|+++.|+|.|.||...
T Consensus 233 pdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~ 287 (318)
T KOG0659|consen 233 PDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSL 287 (318)
T ss_pred ccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcC
Confidence 46788999999999999999999999999999864
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-50 Score=394.72 Aligned_cols=255 Identities=32% Similarity=0.591 Sum_probs=230.9
Q ss_pred CceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeE
Q 014210 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (429)
Q Consensus 155 ~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~ 234 (429)
++|.+.++||+|+||.||+|+.+. +++.||+|.+.|.. .....++.+.+|++|++.|+ |||||.++++|+...++
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~---t~~~vAik~i~K~g-r~~k~l~~l~~ev~i~r~lk-Hpniv~m~esfEt~~~~ 76 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKY---TIQVVAIKFIDKSG-RNEKELKNLRQEVRILRSLK-HPNIVEMLESFETSAHL 76 (808)
T ss_pred cchhHHHHhcCCccceeeeccccc---ceeEEEEEEehhcC-CchHHHHHHHHHHHHHHhcC-CcchhhHHHhhcccceE
Confidence 578999999999999999999776 68999999998865 45567788999999999999 99999999999999999
Q ss_pred EEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccccC
Q 014210 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (429)
Q Consensus 235 ~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~ 314 (429)
|+|+|||.| +|..++ +.++.++|+.++.|+.+++.||.|||+++|+|||+||.|||+ +.++.+|+||||+|+.+.
T Consensus 77 ~vVte~a~g-~L~~il-~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl---~~~~~~KlcdFg~Ar~m~ 151 (808)
T KOG0597|consen 77 WVVTEYAVG-DLFTIL-EQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILL---EKGGTLKLCDFGLARAMS 151 (808)
T ss_pred EEEehhhhh-hHHHHH-HhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeee---cCCCceeechhhhhhhcc
Confidence 999999976 988765 667889999999999999999999999999999999999999 889999999999999887
Q ss_pred CCcc-ccccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHH
Q 014210 315 PDER-LNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEA 392 (429)
Q Consensus 315 ~~~~-~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 392 (429)
.+.. ...+.||+.|||||+..+ .|+..+|+|||||++|||..|++||...........|++.....+. .++.++
T Consensus 152 ~~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~p~----~~S~~f 227 (808)
T KOG0597|consen 152 TNTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKPPS----TASSSF 227 (808)
T ss_pred cCceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCCcc----cccHHH
Confidence 6554 356789999999998875 6999999999999999999999999988888888888877655544 789999
Q ss_pred HHHHHHhcccCccCcCCHHHHHhhHhhhccc
Q 014210 393 RDFVKRLLNKDPRKRLTAAQALSELLICYQS 423 (429)
Q Consensus 393 ~~li~~~L~~dP~~Rps~~~iL~~~~~~~~~ 423 (429)
..|++.+|.+||.+|.+..+++.|+|.....
T Consensus 228 ~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~~ 258 (808)
T KOG0597|consen 228 VNFLQGLLIKDPAQRLTWTDLLGHPFWKGKI 258 (808)
T ss_pred HHHHHHHhhcChhhcccHHHHhcChHHhhhh
Confidence 9999999999999999999999999987643
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-50 Score=385.45 Aligned_cols=260 Identities=32% Similarity=0.621 Sum_probs=223.7
Q ss_pred cccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcH-----------HHHHHHHHHHHHHHHhcCCCC
Q 014210 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTA-----------IAIEDVRREVKILRALTGHNN 220 (429)
Q Consensus 152 ~~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~-----------~~~~~~~~Ei~il~~l~~h~n 220 (429)
...++|++++.||+|.||+|-+|+... +++.||||++.+...... ..++.+.+||.+|++|+ |+|
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~---~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~-H~n 169 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEV---DGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLH-HPN 169 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecC---CCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcC-CcC
Confidence 446889999999999999999998655 699999999976543221 12468899999999999 999
Q ss_pred cceEEEEEEeC--CeEEEEEEecCCCcHHHHHHhcCCC-CCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecC
Q 014210 221 LVKFFDAYEDT--DNVYVVMELCEGGELLDRILSRGGK-YTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKD 297 (429)
Q Consensus 221 Iv~l~~~~~~~--~~~~lv~E~~~ggsL~~~i~~~~~~-l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~ 297 (429)
||+|+.+..+. +.+|||+|||..|.+.. . -..+. +++.++++++++++.||+|||.+|||||||||+|+|| +
T Consensus 170 VV~LiEvLDDP~s~~~YlVley~s~G~v~w-~-p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl---~ 244 (576)
T KOG0585|consen 170 VVKLIEVLDDPESDKLYLVLEYCSKGEVKW-C-PPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLL---S 244 (576)
T ss_pred eeEEEEeecCcccCceEEEEEeccCCcccc-C-CCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEE---c
Confidence 99999998764 57999999999988653 2 22334 8999999999999999999999999999999999999 7
Q ss_pred CCceEEEeecCCcccc------CCCccccccccCCcccCcccccC-C----CCCcccHHHHHHHHHHHHcCCCCCCCCCh
Q 014210 298 ENSVLKAIDFGLSDFV------RPDERLNDIVGSAYYVAPEVLHR-S----YSTEADVWSIGVIAYILLCGSRPFWARTE 366 (429)
Q Consensus 298 ~~~~vkL~DFGla~~~------~~~~~~~~~~gt~~y~aPE~~~~-~----~~~~sDiwSlGvll~elltg~~Pf~~~~~ 366 (429)
++++|||+|||.+..+ ..+......+||+.|||||...+ . .+.+.||||+||+||+|+.|+.||.+...
T Consensus 245 ~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~ 324 (576)
T KOG0585|consen 245 SDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFE 324 (576)
T ss_pred CCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchH
Confidence 8899999999998766 22333455799999999998764 2 36688999999999999999999999999
Q ss_pred HHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhcc
Q 014210 367 SGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLICYQ 422 (429)
Q Consensus 367 ~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~ 422 (429)
.+.+.+|.+....+++. +.+.++++|||++||++||++|.+..+|..|+|....
T Consensus 325 ~~l~~KIvn~pL~fP~~--pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 325 LELFDKIVNDPLEFPEN--PEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD 378 (576)
T ss_pred HHHHHHHhcCcccCCCc--ccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence 99999999988777775 3788999999999999999999999999999998754
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-48 Score=375.70 Aligned_cols=261 Identities=26% Similarity=0.420 Sum_probs=219.0
Q ss_pred ceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEE
Q 014210 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVY 235 (429)
Q Consensus 156 ~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~~ 235 (429)
.|++.+.||+|+||.||++.... +|+.||||++.+...........+.+|+.+++++. |+||+++++++.+++..+
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~---~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-~~~iv~~~~~~~~~~~~~ 76 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRA---TGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVN-SRFVVSLAYAYETKDALC 76 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEec---CCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcC-CCcEEEEEEEEccCCeEE
Confidence 37889999999999999999876 58999999987654444444566889999999998 999999999999999999
Q ss_pred EEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccccC
Q 014210 236 VVMELCEGGELLDRILSRG-GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (429)
Q Consensus 236 lv~E~~~ggsL~~~i~~~~-~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~ 314 (429)
+||||+++|+|.+++.... ..+++..+..++.||+.||+|||+.||+||||||+|||+ ++++.+||+|||++....
T Consensus 77 lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill---~~~~~~kl~Dfg~~~~~~ 153 (285)
T cd05631 77 LVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILL---DDRGHIRISDLGLAVQIP 153 (285)
T ss_pred EEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEE---CCCCCEEEeeCCCcEEcC
Confidence 9999999999988776543 468999999999999999999999999999999999999 778889999999998765
Q ss_pred CCccccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHH
Q 014210 315 PDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEAR 393 (429)
Q Consensus 315 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 393 (429)
.........||..|+|||++. ..++.++|||||||++|||++|+.||...........+..............++.++.
T Consensus 154 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~ 233 (285)
T cd05631 154 EGETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAK 233 (285)
T ss_pred CCCeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHH
Confidence 544455678999999999886 4689999999999999999999999987654332222222211222223346899999
Q ss_pred HHHHHhcccCccCcCC-----HHHHHhhHhhhccc
Q 014210 394 DFVKRLLNKDPRKRLT-----AAQALSELLICYQS 423 (429)
Q Consensus 394 ~li~~~L~~dP~~Rps-----~~~iL~~~~~~~~~ 423 (429)
+||++||+.||++|++ +.++++|+||..-.
T Consensus 234 ~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~ 268 (285)
T cd05631 234 SICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNIN 268 (285)
T ss_pred HHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCC
Confidence 9999999999999997 89999999998654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-49 Score=376.28 Aligned_cols=260 Identities=30% Similarity=0.490 Sum_probs=226.8
Q ss_pred cCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~ 233 (429)
.+.|++.++||.|.-+.||+|+... .+..||||++..++.... ++.+.+|+..+..++ ||||++++..|..+..
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p---~~e~VAIK~inLEkc~~~--ld~l~kE~~~msl~~-HPNIv~~~~sFvv~~~ 98 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIP---TNEVVAIKIINLEKCNND--LDALRKEVQTMSLID-HPNIVTYHCSFVVDSE 98 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecc---cCCEEEEEEeehhhhhhh--HHHHHHHHHHhhhcC-CCCcceEEEEEEecce
Confidence 5789999999999999999999887 589999999987765544 788999999999998 9999999999999999
Q ss_pred EEEEEEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccc
Q 014210 234 VYVVMELCEGGELLDRILSR-GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (429)
Q Consensus 234 ~~lv~E~~~ggsL~~~i~~~-~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~ 312 (429)
+|+||.||.+|++++.+... ...++|..+..|++++++||.|||++|.||||||+.|||| +.+|.|||+|||.+-.
T Consensus 99 LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi---~~dG~VkLadFgvsa~ 175 (516)
T KOG0582|consen 99 LWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILI---DSDGTVKLADFGVSAS 175 (516)
T ss_pred eEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEE---cCCCcEEEcCceeeee
Confidence 99999999999999988754 3459999999999999999999999999999999999999 8999999999997654
Q ss_pred cCC-Cc----cccccccCCcccCccccc---CCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCC--
Q 014210 313 VRP-DE----RLNDIVGSAYYVAPEVLH---RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDE-- 382 (429)
Q Consensus 313 ~~~-~~----~~~~~~gt~~y~aPE~~~---~~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~-- 382 (429)
+.. +. +.+..+||++|||||++. ..|+.|+||||||++.+||.+|..||.....-.++-.-++..+....
T Consensus 176 l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~ 255 (516)
T KOG0582|consen 176 LFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTS 255 (516)
T ss_pred ecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccc
Confidence 332 22 125679999999999954 36999999999999999999999999988887777666666664332
Q ss_pred ----CCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhcc
Q 014210 383 ----APWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLICYQ 422 (429)
Q Consensus 383 ----~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~ 422 (429)
.....++..|+.+|..||++||++|||+.++|.|.||..-
T Consensus 256 ~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~ 299 (516)
T KOG0582|consen 256 GLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKA 299 (516)
T ss_pred cCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhc
Confidence 2234578899999999999999999999999999999753
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-50 Score=357.58 Aligned_cols=259 Identities=31% Similarity=0.579 Sum_probs=238.6
Q ss_pred ccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCC
Q 014210 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (429)
Q Consensus 153 ~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~ 232 (429)
..++|++++.||+|-||.||+|+.++ ++..||+|++-++.........++.+|++|-..|+ ||||+++|++|.+..
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekk---s~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~-hpnilrlY~~fhd~~ 95 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKK---SLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLR-HPNILRLYGYFHDSK 95 (281)
T ss_pred chhhccccccccCCccccEeEeeecc---CCcEEEEeeeeHHHHHHhcchhhhhheeEeecccC-CccHHhhhhheeccc
Confidence 35789999999999999999999887 68899999998888777888889999999999999 999999999999999
Q ss_pred eEEEEEEecCCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCcc
Q 014210 233 NVYVVMELCEGGELLDRILS-RGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (429)
Q Consensus 233 ~~~lv~E~~~ggsL~~~i~~-~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~ 311 (429)
.+||++||..+|+|+..+.+ +..++++..++.++.|++.||.|+|..+||||||||+|+|+ +..+.+||+|||.+.
T Consensus 96 riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLl---g~~~~lkiAdfGwsV 172 (281)
T KOG0580|consen 96 RIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLL---GSAGELKIADFGWSV 172 (281)
T ss_pred eeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhcc---CCCCCeeccCCCcee
Confidence 99999999999999998864 34579999999999999999999999999999999999999 677779999999986
Q ss_pred ccCCCccccccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCH
Q 014210 312 FVRPDERLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSS 390 (429)
Q Consensus 312 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 390 (429)
... .....+.|||..|.+||+..+ .++..+|+|++|++.||++.|..||......+.+..|.+.+..++ ..++.
T Consensus 173 ~~p-~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p----~~is~ 247 (281)
T KOG0580|consen 173 HAP-SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFP----STISG 247 (281)
T ss_pred ecC-CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCC----cccCh
Confidence 655 555678999999999998875 699999999999999999999999999999999999999888777 47999
Q ss_pred HHHHHHHHhcccCccCcCCHHHHHhhHhhhccc
Q 014210 391 EARDFVKRLLNKDPRKRLTAAQALSELLICYQS 423 (429)
Q Consensus 391 ~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~~ 423 (429)
++.|||.+||.++|.+|....|++.|+|+....
T Consensus 248 ~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a~~ 280 (281)
T KOG0580|consen 248 GAADLISRLLVKNPIERLALTEVMDHPWIVANG 280 (281)
T ss_pred hHHHHHHHHhccCccccccHHHHhhhHHHHhcC
Confidence 999999999999999999999999999997653
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-50 Score=378.58 Aligned_cols=257 Identities=33% Similarity=0.631 Sum_probs=238.4
Q ss_pred ccccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEe
Q 014210 151 KHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED 230 (429)
Q Consensus 151 ~~~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~ 230 (429)
..+..+|++.+.||+|.||.|-++.... .|+.||||.|.++.+.+.+.+-.+++||+||..|+ ||||+++|.+|+.
T Consensus 49 hnlkHRyE~~etLGkGTYGKVk~A~e~~---sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLN-HPhII~IyEVFEN 124 (668)
T KOG0611|consen 49 HNLKHRYEITETLGKGTYGKVKLAYEHK---SGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLN-HPHIIQIYEVFEN 124 (668)
T ss_pred cchhhHHHHHHHhcCCcccceeehhhcc---CCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcC-CCceeehhhhhcC
Confidence 3456789999999999999999988654 69999999999999999999999999999999999 9999999999999
Q ss_pred CCeEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCc
Q 014210 231 TDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS 310 (429)
Q Consensus 231 ~~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla 310 (429)
.+.++|||||..+|+|+|||.+ .+.+++.+++.+++||++|+.|||.++++|||||.+|||| |.++++||+|||++
T Consensus 125 kdKIvivMEYaS~GeLYDYiSe-r~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILL---D~N~NiKIADFGLS 200 (668)
T KOG0611|consen 125 KDKIVIVMEYASGGELYDYISE-RGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILL---DQNNNIKIADFGLS 200 (668)
T ss_pred CceEEEEEEecCCccHHHHHHH-hccccHHHHHHHHHHHHHHHHHHhhccceecccchhheee---cCCCCeeeeccchh
Confidence 9999999999999999999954 4789999999999999999999999999999999999999 89999999999999
Q ss_pred cccCCCccccccccCCcccCcccccCC-C-CCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCC
Q 014210 311 DFVRPDERLNDIVGSAYYVAPEVLHRS-Y-STEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSL 388 (429)
Q Consensus 311 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~-~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 388 (429)
..+..+...+++||++.|.+||+++|. | +..+|-|||||+||-|+.|..||++..+..+++.|..+....+. -
T Consensus 201 Nly~~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP~-----~ 275 (668)
T KOG0611|consen 201 NLYADKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREPE-----T 275 (668)
T ss_pred hhhccccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCCC-----C
Confidence 999988888999999999999999874 4 77899999999999999999999999999998888877655543 4
Q ss_pred CHHHHHHHHHhcccCccCcCCHHHHHhhHhhh
Q 014210 389 SSEARDFVKRLLNKDPRKRLTAAQALSELLIC 420 (429)
Q Consensus 389 s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~ 420 (429)
+.++..||++||..||++|-|+.+|-.|.|.+
T Consensus 276 PSdA~gLIRwmLmVNP~RRATieDiAsHWWvN 307 (668)
T KOG0611|consen 276 PSDASGLIRWMLMVNPERRATIEDIASHWWVN 307 (668)
T ss_pred CchHHHHHHHHHhcCcccchhHHHHhhhheee
Confidence 57789999999999999999999999999985
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-49 Score=374.69 Aligned_cols=262 Identities=29% Similarity=0.515 Sum_probs=236.9
Q ss_pred cCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~ 233 (429)
.+.|++++.||+|.-|.||+++.+. ++..+|+|++.+..+.....+.++..|-+||..+. ||.+++||..|+.+..
T Consensus 76 l~~f~llk~LG~GdiG~VyL~~l~~---t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lD-HPFlPTLYa~fet~~~ 151 (459)
T KOG0610|consen 76 LRHFRLLKRLGCGDIGTVYLVELRG---TNCLFAMKVMDKESLASRKKLKRAQTEREILSLLD-HPFLPTLYASFETDKY 151 (459)
T ss_pred HHHHHHHHHcCCCCceeEEEEEecC---CCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcC-CCccchhhheeeccce
Confidence 4679999999999999999999887 56999999999988888888899999999999998 9999999999999999
Q ss_pred EEEEEEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccc
Q 014210 234 VYVVMELCEGGELLDRILSR-GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (429)
Q Consensus 234 ~~lv~E~~~ggsL~~~i~~~-~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~ 312 (429)
.|++||||+||+|....+.+ ++.++++.++.++.+++-||+|||-.|||+|||||+|||| .++|+|-|+||.|+..
T Consensus 152 ~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILv---redGHIMLsDFDLS~~ 228 (459)
T KOG0610|consen 152 SCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILV---REDGHIMLSDFDLSLR 228 (459)
T ss_pred eEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEE---ecCCcEEeeecccccc
Confidence 99999999999998876554 4569999999999999999999999999999999999999 7899999999998632
Q ss_pred cC----------------------------------C-C----------------------ccccccccCCcccCccccc
Q 014210 313 VR----------------------------------P-D----------------------ERLNDIVGSAYYVAPEVLH 335 (429)
Q Consensus 313 ~~----------------------------------~-~----------------------~~~~~~~gt~~y~aPE~~~ 335 (429)
.. . . .+.+..+||-.|.|||++.
T Consensus 229 ~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~ 308 (459)
T KOG0610|consen 229 CPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIR 308 (459)
T ss_pred CCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeee
Confidence 10 0 0 0112357999999999998
Q ss_pred C-CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCcCC----H
Q 014210 336 R-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLT----A 410 (429)
Q Consensus 336 ~-~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps----~ 410 (429)
| ..+.++|+|+|||++|||+.|..||.+.+..+.+.+|+.....|++.+ .++.+++|||+++|.+||.+|.. +
T Consensus 309 G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~--~vs~~akDLIr~LLvKdP~kRlg~~rGA 386 (459)
T KOG0610|consen 309 GEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEP--EVSSAAKDLIRKLLVKDPSKRLGSKRGA 386 (459)
T ss_pred cCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCC--cchhHHHHHHHHHhccChhhhhccccch
Confidence 6 699999999999999999999999999999999999999999998875 78899999999999999999999 9
Q ss_pred HHHHhhHhhhccce
Q 014210 411 AQALSELLICYQSY 424 (429)
Q Consensus 411 ~~iL~~~~~~~~~~ 424 (429)
.||.+|+||+...|
T Consensus 387 ~eIK~HpFF~gVnW 400 (459)
T KOG0610|consen 387 AEIKRHPFFEGVNW 400 (459)
T ss_pred HHhhcCccccCCCh
Confidence 99999999998765
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-48 Score=377.81 Aligned_cols=256 Identities=27% Similarity=0.487 Sum_probs=224.0
Q ss_pred CceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeE
Q 014210 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (429)
Q Consensus 155 ~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~ 234 (429)
++|++.++||+|+||.||+|.... +|+.||||++...........+.+.+|+.+++++. ||||+++++++.+++.+
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~ 76 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRI---SEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVS-HPFIIRLFWTEHDQRFL 76 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcC---CCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCC-CCcHhhhHhhhccCCeE
Confidence 479999999999999999998776 58999999986544334455677899999999998 99999999999999999
Q ss_pred EEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccccC
Q 014210 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (429)
Q Consensus 235 ~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~ 314 (429)
++||||+++|+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++....
T Consensus 77 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli---~~~~~~kl~Dfg~~~~~~ 152 (291)
T cd05612 77 YMLMEYVPGGELFSYLRN-SGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILL---DKEGHIKLTDFGFAKKLR 152 (291)
T ss_pred EEEEeCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEE---CCCCCEEEEecCcchhcc
Confidence 999999999999998854 4579999999999999999999999999999999999999 678899999999998764
Q ss_pred CCccccccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHH
Q 014210 315 PDERLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEAR 393 (429)
Q Consensus 315 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 393 (429)
.. ....+||+.|+|||++.+ .++.++|||||||++|+|++|+.||......+.+..+......++. .++.++.
T Consensus 153 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~----~~~~~~~ 226 (291)
T cd05612 153 DR--TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPR----HLDLYAK 226 (291)
T ss_pred CC--cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcCCCc----cCCHHHH
Confidence 32 234679999999998874 5889999999999999999999999998888888888776654443 4689999
Q ss_pred HHHHHhcccCccCcCC-----HHHHHhhHhhhccce
Q 014210 394 DFVKRLLNKDPRKRLT-----AAQALSELLICYQSY 424 (429)
Q Consensus 394 ~li~~~L~~dP~~Rps-----~~~iL~~~~~~~~~~ 424 (429)
+||++||..||.+|++ +.++++|+||....+
T Consensus 227 ~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~ 262 (291)
T cd05612 227 DLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSVDW 262 (291)
T ss_pred HHHHHHcCCCHHHccCCccCCHHHHhcCccccCCCH
Confidence 9999999999999995 999999999976443
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-48 Score=382.67 Aligned_cols=255 Identities=31% Similarity=0.552 Sum_probs=223.9
Q ss_pred cCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~ 233 (429)
.++|++.+.||+|+||.||+|+.+. +|+.||||++.+.........+.+.+|+.+++++. |+||+++++++.+++.
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~ 92 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKG---TGEYYAIKCLKKREILKMKQVQHVAQEKSILMELS-HPFIVNMMCSFQDENR 92 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECC---CCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCC-CCCCCcEEEEEEcCCE
Confidence 4689999999999999999999776 58999999997654444455677899999999998 9999999999999999
Q ss_pred EEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCcccc
Q 014210 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (429)
Q Consensus 234 ~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~ 313 (429)
.|+||||+++|+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++...
T Consensus 93 ~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll---~~~~~~kl~Dfg~~~~~ 168 (329)
T PTZ00263 93 VYFLLEFVVGGELFTHLRK-AGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLL---DNKGHVKVTDFGFAKKV 168 (329)
T ss_pred EEEEEcCCCCChHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEE---CCCCCEEEeeccCceEc
Confidence 9999999999999998854 4678999999999999999999999999999999999999 78889999999999876
Q ss_pred CCCccccccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHH
Q 014210 314 RPDERLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEA 392 (429)
Q Consensus 314 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 392 (429)
... .....||+.|+|||++.+ .++.++|||||||++|||++|+.||........+..+......++. .++.++
T Consensus 169 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~p~----~~~~~~ 242 (329)
T PTZ00263 169 PDR--TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPN----WFDGRA 242 (329)
T ss_pred CCC--cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCcCCCC----CCCHHH
Confidence 432 234679999999998874 5889999999999999999999999988877777777766544432 478999
Q ss_pred HHHHHHhcccCccCcCC-----HHHHHhhHhhhcc
Q 014210 393 RDFVKRLLNKDPRKRLT-----AAQALSELLICYQ 422 (429)
Q Consensus 393 ~~li~~~L~~dP~~Rps-----~~~iL~~~~~~~~ 422 (429)
.+||++||+.||++|++ +.+++.|+||...
T Consensus 243 ~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~ 277 (329)
T PTZ00263 243 RDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGA 277 (329)
T ss_pred HHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCCC
Confidence 99999999999999997 7999999999764
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-48 Score=380.77 Aligned_cols=250 Identities=29% Similarity=0.535 Sum_probs=217.8
Q ss_pred ceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEe
Q 014210 161 EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMEL 240 (429)
Q Consensus 161 ~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~~lv~E~ 240 (429)
+.||+|+||.||+++.+. +|+.||||++.+...........+.+|+.++++++ |+||+++++++.+.+.+||||||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-hp~i~~~~~~~~~~~~~~lv~e~ 76 (323)
T cd05571 1 KLLGKGTFGKVILVREKA---TGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTR-HPFLTALKYSFQTHDRLCFVMEY 76 (323)
T ss_pred CeeeeCCCeEEEEEEECC---CCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCC-CCCCCCEEEEEEcCCEEEEEEeC
Confidence 479999999999998766 58999999997654444455667889999999998 99999999999999999999999
Q ss_pred cCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccccCC-Cccc
Q 014210 241 CEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP-DERL 319 (429)
Q Consensus 241 ~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~-~~~~ 319 (429)
+++|+|.+++. ..+.+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.... ....
T Consensus 77 ~~~~~L~~~l~-~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll---~~~~~~kl~DfG~a~~~~~~~~~~ 152 (323)
T cd05571 77 ANGGELFFHLS-RERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLML---DKDGHIKITDFGLCKEGISDGATM 152 (323)
T ss_pred CCCCcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEE---CCCCCEEEeeCCCCcccccCCCcc
Confidence 99999988875 44679999999999999999999999999999999999999 7788899999999875432 2334
Q ss_pred cccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHH
Q 014210 320 NDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKR 398 (429)
Q Consensus 320 ~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ 398 (429)
...+||+.|+|||++.+ .++.++|||||||++|||++|+.||........+..+......++ ..++.++.+||++
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~p----~~~~~~~~~li~~ 228 (323)
T cd05571 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFP----RTLSPEAKSLLAG 228 (323)
T ss_pred cceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHHHH
Confidence 45679999999998874 689999999999999999999999998887777777766554443 3689999999999
Q ss_pred hcccCccCcC-----CHHHHHhhHhhhcc
Q 014210 399 LLNKDPRKRL-----TAAQALSELLICYQ 422 (429)
Q Consensus 399 ~L~~dP~~Rp-----s~~~iL~~~~~~~~ 422 (429)
||+.||++|| ++.++++|+||...
T Consensus 229 ~L~~dP~~R~~~~~~~~~~ll~h~~f~~~ 257 (323)
T cd05571 229 LLKKDPKQRLGGGPEDAKEIMEHRFFASI 257 (323)
T ss_pred HccCCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 9999999999 89999999999764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-48 Score=383.97 Aligned_cols=260 Identities=27% Similarity=0.451 Sum_probs=219.5
Q ss_pred CceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeE
Q 014210 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (429)
Q Consensus 155 ~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~ 234 (429)
++|++.++||+|+||.||+++... +|+.||||++.+...........+.+|+.++.++. |+||+++++.+.+.+.+
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~-~~~iv~~~~~~~~~~~~ 76 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKD---TGHVYAMKILRKADMLEKEQVGHIRAERDILVEAD-SLWVVKMFYSFQDKLNL 76 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECC---CCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCC-CCCcceEEEEEecCCeE
Confidence 479999999999999999998765 58999999997654444555677889999999998 99999999999999999
Q ss_pred EEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccccC
Q 014210 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (429)
Q Consensus 235 ~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~ 314 (429)
|||||||+||+|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++...
T Consensus 77 ~lv~E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi---~~~~~vkL~DFGla~~~~ 152 (363)
T cd05628 77 YLIMEFLPGGDMMTLLMK-KDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLL---DSKGHVKLSDFGLCTGLK 152 (363)
T ss_pred EEEEcCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEE---CCCCCEEEeeccCccccc
Confidence 999999999999998854 4679999999999999999999999999999999999999 778899999999987543
Q ss_pred CCc------------------------------------cccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHcC
Q 014210 315 PDE------------------------------------RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCG 357 (429)
Q Consensus 315 ~~~------------------------------------~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~elltg 357 (429)
... .....+||+.|+|||++. ..++.++|||||||++|||++|
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G 232 (363)
T cd05628 153 KAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232 (363)
T ss_pred ccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhC
Confidence 211 012357999999999886 4689999999999999999999
Q ss_pred CCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCcc---CcCCHHHHHhhHhhhccc
Q 014210 358 SRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPR---KRLTAAQALSELLICYQS 423 (429)
Q Consensus 358 ~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~---~Rps~~~iL~~~~~~~~~ 423 (429)
+.||......+.+..+..............+++++++||.+|+. +|. .||++.++++|+||+...
T Consensus 233 ~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f~~~~ 300 (363)
T cd05628 233 YPPFCSETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNPFFEGVD 300 (363)
T ss_pred CCCCCCCCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCCCCCCCCC
Confidence 99999888888888777643333222233578999999999775 444 458999999999998654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-48 Score=361.52 Aligned_cols=260 Identities=30% Similarity=0.456 Sum_probs=227.1
Q ss_pred ccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEe--
Q 014210 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED-- 230 (429)
Q Consensus 153 ~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~-- 230 (429)
..+.|+.++.|++|+||.||+|+++. +++.||+|+++.+.....--+- -.+||.+|.+++ |||||.+-.+...
T Consensus 74 sv~efe~lnrI~EGtyGiVYRakdk~---t~eIVALKr~kmekek~GFPIt-sLREIniLl~~~-H~NIV~vkEVVvG~~ 148 (419)
T KOG0663|consen 74 SVEEFEKLNRIEEGTYGVVYRAKDKK---TDEIVALKRLKMEKEKEGFPIT-SLREINILLKAR-HPNIVEVKEVVVGSN 148 (419)
T ss_pred cHHHHHHHhhcccCcceeEEEeccCC---cceeEEeeecccccccCCCcch-hHHHHHHHHhcC-CCCeeeeEEEEeccc
Confidence 35789999999999999999999887 6899999999766543333332 358999999999 9999999888764
Q ss_pred CCeEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCc
Q 014210 231 TDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS 310 (429)
Q Consensus 231 ~~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla 310 (429)
-+.+|||||||+. +|...+.....++...+++.++.|+++||+|||.+.|+|||||++|+|+ .+.|.+||+|||+|
T Consensus 149 ~d~iy~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm---~~~G~lKiaDFGLA 224 (419)
T KOG0663|consen 149 MDKIYIVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLL---SHKGILKIADFGLA 224 (419)
T ss_pred cceeeeeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheee---ccCCcEEecccchh
Confidence 4579999999976 8888887777899999999999999999999999999999999999999 68889999999999
Q ss_pred cccCCC-ccccccccCCcccCcccccC--CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCC
Q 014210 311 DFVRPD-ERLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPS 387 (429)
Q Consensus 311 ~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 387 (429)
+.+... ......+-|.+|+|||.+.+ .|++..||||+|||+.||++++..|.+..+.+.+..|.+.-....+..|++
T Consensus 225 R~ygsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg 304 (419)
T KOG0663|consen 225 REYGSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPG 304 (419)
T ss_pred hhhcCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCC
Confidence 988644 34567889999999998875 599999999999999999999999999999999999887655555555542
Q ss_pred ----------------------------CCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhc
Q 014210 388 ----------------------------LSSEARDFVKRLLNKDPRKRLTAAQALSELLICY 421 (429)
Q Consensus 388 ----------------------------~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~ 421 (429)
+++...+|+..+|..||.+|.|+.+.|.|.||..
T Consensus 305 ~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e 366 (419)
T KOG0663|consen 305 YSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRE 366 (419)
T ss_pred ccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhccccccc
Confidence 4578899999999999999999999999999986
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-47 Score=377.47 Aligned_cols=258 Identities=31% Similarity=0.499 Sum_probs=222.5
Q ss_pred CceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeE
Q 014210 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (429)
Q Consensus 155 ~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~ 234 (429)
++|++.++||+|+||.||+|+... +|+.||||++.+.........+.+.+|++++..+. |+||+++++++.+.+..
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~iv~~~~~~~~~~~~ 76 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKD---TGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTK-SEWLVKLLYAFQDDEYL 76 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECC---CCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCC-CCCCccEEEEEEcCCEE
Confidence 479999999999999999999776 58899999997654344445677889999999998 99999999999999999
Q ss_pred EEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccccC
Q 014210 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (429)
Q Consensus 235 ~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~ 314 (429)
||||||++|++|.+++. ..+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++....
T Consensus 77 ~lv~e~~~g~~L~~~l~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~kL~Dfg~a~~~~ 152 (333)
T cd05600 77 YLAMEYVPGGDFRTLLN-NLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLI---DASGHIKLTDFGLSKGIV 152 (333)
T ss_pred EEEEeCCCCCCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE---CCCCCEEEEeCcCCcccc
Confidence 99999999999999875 44678999999999999999999999999999999999999 778899999999997654
Q ss_pred CCccccccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCC----CCCC
Q 014210 315 PDERLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPW----PSLS 389 (429)
Q Consensus 315 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~----~~~s 389 (429)
. ......||+.|+|||++.+ .++.++|||||||++|||++|+.||...+..+.+..+...........+ ..++
T Consensus 153 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s 230 (333)
T cd05600 153 T--YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLS 230 (333)
T ss_pred c--ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccC
Confidence 3 3345679999999998874 6899999999999999999999999988877777666553322222111 2578
Q ss_pred HHHHHHHHHhcccCccCcCCHHHHHhhHhhhcc
Q 014210 390 SEARDFVKRLLNKDPRKRLTAAQALSELLICYQ 422 (429)
Q Consensus 390 ~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~ 422 (429)
.++.+||.+||..+|.+|+++.+++.|+||...
T Consensus 231 ~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~~ 263 (333)
T cd05600 231 DEAWDLITKLINDPSRRFGSLEDIKNHPFFKEV 263 (333)
T ss_pred HHHHHHHHHHhhChhhhcCCHHHHHhCcccCCC
Confidence 999999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-47 Score=382.92 Aligned_cols=260 Identities=28% Similarity=0.507 Sum_probs=221.7
Q ss_pred CceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeE
Q 014210 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (429)
Q Consensus 155 ~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~ 234 (429)
++|++.++||+|+||.||+++... +|+.||||++.+...........+.+|+.+++.++ |+||+++++++.+++.+
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~-h~~iv~~~~~~~~~~~~ 76 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKD---TGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEAD-NPWVVKLYYSFQDENYL 76 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECC---CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCCCcceEEEEEcCCeE
Confidence 479999999999999999999776 58999999997544344455677889999999998 99999999999999999
Q ss_pred EEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccccC
Q 014210 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (429)
Q Consensus 235 ~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~ 314 (429)
|||||||++|+|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++..+.
T Consensus 77 ~lv~E~~~~g~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~---~~~~~~kl~Dfg~~~~~~ 152 (364)
T cd05599 77 YLIMEYLPGGDMMTLLMK-KDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLL---DAKGHIKLSDFGLCTGLK 152 (364)
T ss_pred EEEECCCCCcHHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEE---CCCCCEEEeecccceecc
Confidence 999999999999998754 4579999999999999999999999999999999999999 788899999999986543
Q ss_pred CCc---------------------------------------cccccccCCcccCccccc-CCCCCcccHHHHHHHHHHH
Q 014210 315 PDE---------------------------------------RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYIL 354 (429)
Q Consensus 315 ~~~---------------------------------------~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~el 354 (429)
... .....+||+.|+|||++. ..++.++|||||||++|||
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el 232 (364)
T cd05599 153 KSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEM 232 (364)
T ss_pred ccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHh
Confidence 211 011246999999999886 4689999999999999999
Q ss_pred HcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCcCC---HHHHHhhHhhhccc
Q 014210 355 LCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLT---AAQALSELLICYQS 423 (429)
Q Consensus 355 ltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps---~~~iL~~~~~~~~~ 423 (429)
++|+.||........+..++.............+++++.+||++||. +|.+|++ +.+++.|+||....
T Consensus 233 ~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~~~ 303 (364)
T cd05599 233 LVGYPPFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKGVD 303 (364)
T ss_pred hcCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCCCC
Confidence 99999999888777777776544333333333578999999999997 9999998 99999999997643
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-47 Score=383.36 Aligned_cols=260 Identities=28% Similarity=0.448 Sum_probs=218.1
Q ss_pred ceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEE
Q 014210 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVY 235 (429)
Q Consensus 156 ~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~~ 235 (429)
.|+++++||+|+||.||+|+... +++.||||++.+.........+.+.+|++++++++ |+||+++++++.+.+.+|
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~---~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~-h~~iv~l~~~~~~~~~~~ 77 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVD---THALYAMKTLRKKDVLNRNQVAHVKAERDILAEAD-NEWVVKLYYSFQDKDNLY 77 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECC---CCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcC-CCCeeeeEEEEecCCEEE
Confidence 68999999999999999998766 58999999997655455566778999999999998 999999999999999999
Q ss_pred EEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccccCC
Q 014210 236 VVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP 315 (429)
Q Consensus 236 lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~ 315 (429)
+|||||+||+|.+++.. .+.+++..++.++.||+.||.|||+.||+||||||+|||+ +.++++||+|||++..+..
T Consensus 78 lv~E~~~gg~L~~~l~~-~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili---~~~~~~kL~DFGl~~~~~~ 153 (381)
T cd05626 78 FVMDYIPGGDMMSLLIR-MEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILI---DLDGHIKLTDFGLCTGFRW 153 (381)
T ss_pred EEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEE---CCCCCEEEeeCcCCccccc
Confidence 99999999999998754 4578999999999999999999999999999999999999 7788999999999754311
Q ss_pred Cc------------------------------------------------cccccccCCcccCccccc-CCCCCcccHHH
Q 014210 316 DE------------------------------------------------RLNDIVGSAYYVAPEVLH-RSYSTEADVWS 346 (429)
Q Consensus 316 ~~------------------------------------------------~~~~~~gt~~y~aPE~~~-~~~~~~sDiwS 346 (429)
.. .....+||..|+|||++. ..++.++||||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwS 233 (381)
T cd05626 154 THNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWS 233 (381)
T ss_pred ccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceee
Confidence 00 012357999999999886 46899999999
Q ss_pred HHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcc--cCccCcCCHHHHHhhHhhhccc
Q 014210 347 IGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLN--KDPRKRLTAAQALSELLICYQS 423 (429)
Q Consensus 347 lGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~--~dP~~Rps~~~iL~~~~~~~~~ 423 (429)
|||++|||++|+.||...........+..............+++++.+||.+||. .++..|+++.+++.|+||....
T Consensus 234 lG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~~ 312 (381)
T cd05626 234 VGVILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEVD 312 (381)
T ss_pred hhhHHHHHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCCCC
Confidence 9999999999999998877766666665433333333344689999999999664 4555599999999999997643
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-47 Score=367.79 Aligned_cols=255 Identities=27% Similarity=0.425 Sum_probs=213.2
Q ss_pred CceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeE
Q 014210 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (429)
Q Consensus 155 ~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~ 234 (429)
++|++.++||+|+||.||+|+.+. +++.||+|++..... ......+.+|+.++++++ |+||+++++++.+++..
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~ 78 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKL---TENLVALKEIRLEHE--EGAPCTAIREVSLLKNLK-HANIVTLHDIIHTERCL 78 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECC---CCCEEEEEEeccccc--CCcchhHHHHHHHHHhCC-CCCEeeEEEEEcCCCeE
Confidence 579999999999999999998765 589999999865422 222346779999999998 99999999999999999
Q ss_pred EEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccccC
Q 014210 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (429)
Q Consensus 235 ~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~ 314 (429)
++||||+++ +|.+++......+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++...
T Consensus 79 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~---~~~~~~kl~DfG~~~~~~ 154 (288)
T cd07871 79 TLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLI---NEKGELKLADFGLARAKS 154 (288)
T ss_pred EEEEeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE---CCCCCEEECcCcceeecc
Confidence 999999975 8998887666678999999999999999999999999999999999999 778889999999987653
Q ss_pred CC-ccccccccCCcccCcccccC--CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCC---------
Q 014210 315 PD-ERLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDE--------- 382 (429)
Q Consensus 315 ~~-~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~--------- 382 (429)
.. .......++..|+|||++.+ .++.++|||||||++|+|++|+.||.+....+.+..+.........
T Consensus 155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07871 155 VPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSN 234 (288)
T ss_pred CCCccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccc
Confidence 22 22344578999999998754 5889999999999999999999999887766665554432111110
Q ss_pred -----------------CCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhh
Q 014210 383 -----------------APWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLI 419 (429)
Q Consensus 383 -----------------~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~ 419 (429)
...+.++.++.+||++||+.||.+|+|++|+|+|+||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 235 EEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred hhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 0123568899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-47 Score=382.85 Aligned_cols=263 Identities=27% Similarity=0.447 Sum_probs=225.7
Q ss_pred ccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCC
Q 014210 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (429)
Q Consensus 153 ~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~ 232 (429)
..++|++.++||+|+||.||+++... +|+.||||++.+.........+.+.+|+.+++.++ |+||+++++++.+++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~-h~~iv~~~~~~~~~~ 116 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKS---SKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHAN-SEWIVQLHYAFQDDK 116 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECC---CCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCC-CCCcceEEEEEecCC
Confidence 35789999999999999999998776 58999999997544334444566789999999998 999999999999999
Q ss_pred eEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccc
Q 014210 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (429)
Q Consensus 233 ~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~ 312 (429)
.+|||||||+||+|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++..
T Consensus 117 ~~~lv~Ey~~gg~L~~~l~~--~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl---~~~~~~kL~DfG~~~~ 191 (370)
T cd05596 117 YLYMVMEYMPGGDLVNLMSN--YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLL---DKSGHLKLADFGTCMK 191 (370)
T ss_pred EEEEEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE---cCCCCEEEEeccceee
Confidence 99999999999999987743 468999999999999999999999999999999999999 7888999999999976
Q ss_pred cCCCc--cccccccCCcccCcccccC-----CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCC
Q 014210 313 VRPDE--RLNDIVGSAYYVAPEVLHR-----SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPW 385 (429)
Q Consensus 313 ~~~~~--~~~~~~gt~~y~aPE~~~~-----~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 385 (429)
..... .....+||+.|+|||++.+ .++.++|||||||++|||++|+.||........+..+............
T Consensus 192 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 271 (370)
T cd05596 192 MDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDD 271 (370)
T ss_pred ccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCc
Confidence 64332 2235679999999998753 3788999999999999999999999998888888888765443333333
Q ss_pred CCCCHHHHHHHHHhcccCccC--cCCHHHHHhhHhhhccce
Q 014210 386 PSLSSEARDFVKRLLNKDPRK--RLTAAQALSELLICYQSY 424 (429)
Q Consensus 386 ~~~s~~~~~li~~~L~~dP~~--Rps~~~iL~~~~~~~~~~ 424 (429)
..++.++.+||++||+.+|.+ |+++.+++.|+||....+
T Consensus 272 ~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~~~ 312 (370)
T cd05596 272 IEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKNDQW 312 (370)
T ss_pred CCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCCCCh
Confidence 468999999999999999998 999999999999987554
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-48 Score=355.97 Aligned_cols=259 Identities=36% Similarity=0.649 Sum_probs=233.2
Q ss_pred cccCceeEe-ceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEe
Q 014210 152 HFANKYELG-EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED 230 (429)
Q Consensus 152 ~~~~~y~~~-~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~ 230 (429)
.++++|.+. ++||-|--|.|..+..+. +|+.+|+|++... ...++|++++-...+|+|||.++++|+.
T Consensus 58 ~itedY~is~qvLG~GinGkV~~C~~k~---T~ekfALKvL~Ds--------~KARrEVeLHw~~s~h~~iV~IidVyeN 126 (400)
T KOG0604|consen 58 SITEDYSISWQVLGAGINGKVVQCVHKR---TQEKFALKVLLDS--------PKARREVELHWMASGHPHIVSIIDVYEN 126 (400)
T ss_pred cchhhheehhhhhccccCCceEEEEecc---chhhhHHHHHhcC--------HHHHhHhhhhhhhcCCCceEEeehhhhh
Confidence 356788875 578999999999998777 6999999998533 3467999999999999999999999874
Q ss_pred C----CeEEEEEEecCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEe
Q 014210 231 T----DNVYVVMELCEGGELLDRILSRGG-KYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAI 305 (429)
Q Consensus 231 ~----~~~~lv~E~~~ggsL~~~i~~~~~-~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~ 305 (429)
. ..+.+|||.|+||+|+..|.+++. .++|.++..|+.||..|+.|||+.+|.||||||+|+|.+....|..+||+
T Consensus 127 s~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLt 206 (400)
T KOG0604|consen 127 SYQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLT 206 (400)
T ss_pred hccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEec
Confidence 3 457899999999999999987754 69999999999999999999999999999999999999988889999999
Q ss_pred ecCCccccCCCccccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHcCCCCCCCCCh----HHHHHHHHhcCCCC
Q 014210 306 DFGLSDFVRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTE----SGIFRAVLKADPSF 380 (429)
Q Consensus 306 DFGla~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~elltg~~Pf~~~~~----~~~~~~i~~~~~~~ 380 (429)
|||+|+.........+.+.|++|.|||++. +.|+...|+||+||++|.|+||..||+.... .++..+|..+...|
T Consensus 207 DfGFAK~t~~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~F 286 (400)
T KOG0604|consen 207 DFGFAKETQEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEF 286 (400)
T ss_pred ccccccccCCCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccC
Confidence 999999887777778899999999999997 5699999999999999999999999987654 36778899999999
Q ss_pred CCCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhc
Q 014210 381 DEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLICY 421 (429)
Q Consensus 381 ~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~ 421 (429)
+...|..+|++++|+|+.+|..+|++|.|+.++++|+|+..
T Consensus 287 P~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~ 327 (400)
T KOG0604|consen 287 PEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQ 327 (400)
T ss_pred CChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcc
Confidence 99999999999999999999999999999999999999975
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-47 Score=383.56 Aligned_cols=259 Identities=26% Similarity=0.456 Sum_probs=217.5
Q ss_pred CceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeE
Q 014210 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (429)
Q Consensus 155 ~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~ 234 (429)
++|+++++||+|+||.||+++... +|+.||||++.+.........+.+.+|+++++++. |+||+++++++.+.+.+
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~iv~~~~~~~~~~~~ 76 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKD---TGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESD-SPWVVSLYYSFQDAQYL 76 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECC---CCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCC-CCCcceEEEEEEcCCee
Confidence 479999999999999999998776 58999999986654444556678899999999998 99999999999999999
Q ss_pred EEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccccC
Q 014210 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (429)
Q Consensus 235 ~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~ 314 (429)
||||||++||+|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.+.
T Consensus 77 ~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll---~~~~~~kl~DfGla~~~~ 152 (377)
T cd05629 77 YLIMEFLPGGDLMTMLIK-YDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILI---DRGGHIKLSDFGLSTGFH 152 (377)
T ss_pred EEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEE---CCCCCEEEeecccccccc
Confidence 999999999999998754 4679999999999999999999999999999999999999 678899999999986331
Q ss_pred CCcc------------------------------------------------ccccccCCcccCccccc-CCCCCcccHH
Q 014210 315 PDER------------------------------------------------LNDIVGSAYYVAPEVLH-RSYSTEADVW 345 (429)
Q Consensus 315 ~~~~------------------------------------------------~~~~~gt~~y~aPE~~~-~~~~~~sDiw 345 (429)
.... ....+||+.|+|||++. ..++.++|||
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diw 232 (377)
T cd05629 153 KQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWW 232 (377)
T ss_pred cccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeE
Confidence 1000 01246999999999886 4689999999
Q ss_pred HHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCc---CCHHHHHhhHhhhcc
Q 014210 346 SIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKR---LTAAQALSELLICYQ 422 (429)
Q Consensus 346 SlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R---ps~~~iL~~~~~~~~ 422 (429)
||||++|||++|+.||......+.+..+..............++.++.+||.+||. +|.+| +++.+++.|+||...
T Consensus 233 SlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~~ 311 (377)
T cd05629 233 SLGAIMFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRGV 311 (377)
T ss_pred ecchhhhhhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCCC
Confidence 99999999999999998888777777776533222222223578999999999998 77765 599999999999754
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-47 Score=377.60 Aligned_cols=257 Identities=28% Similarity=0.489 Sum_probs=223.7
Q ss_pred cCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~ 233 (429)
.++|++.+.||+|+||.||+|..... .+..||||++.+.........+.+.+|+.+++.++ ||||+++++++.+++.
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~Iv~~~~~~~~~~~ 105 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNE--DFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYIN-HPFCVNLYGSFKDESY 105 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECC--CCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCC-CCCCcceEEEEEeCCE
Confidence 46899999999999999999986652 24789999986554444455677889999999998 9999999999999999
Q ss_pred EEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCcccc
Q 014210 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (429)
Q Consensus 234 ~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~ 313 (429)
.|+||||+++|+|.+++.. ...+++..+..++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||++...
T Consensus 106 ~~lv~Ey~~~g~L~~~i~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl---~~~~~ikL~DFG~a~~~ 181 (340)
T PTZ00426 106 LYLVLEFVIGGEFFTFLRR-NKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLL---DKDGFIKMTDFGFAKVV 181 (340)
T ss_pred EEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEE---CCCCCEEEecCCCCeec
Confidence 9999999999999998754 4579999999999999999999999999999999999999 77889999999999765
Q ss_pred CCCccccccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHH
Q 014210 314 RPDERLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEA 392 (429)
Q Consensus 314 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 392 (429)
.. ......||+.|+|||++.+ .++.++|||||||++|||++|+.||...+.......+......++ ..++.++
T Consensus 182 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p----~~~~~~~ 255 (340)
T PTZ00426 182 DT--RTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFP----KFLDNNC 255 (340)
T ss_pred CC--CcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCC----CCCCHHH
Confidence 43 2345689999999998864 588999999999999999999999998888777777776654443 3578999
Q ss_pred HHHHHHhcccCccCcC-----CHHHHHhhHhhhccc
Q 014210 393 RDFVKRLLNKDPRKRL-----TAAQALSELLICYQS 423 (429)
Q Consensus 393 ~~li~~~L~~dP~~Rp-----s~~~iL~~~~~~~~~ 423 (429)
.+||++||+.||++|+ +++++++|+||....
T Consensus 256 ~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~ 291 (340)
T PTZ00426 256 KHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNID 291 (340)
T ss_pred HHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCC
Confidence 9999999999999995 899999999998643
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-47 Score=380.26 Aligned_cols=260 Identities=33% Similarity=0.567 Sum_probs=224.4
Q ss_pred CceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeE
Q 014210 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (429)
Q Consensus 155 ~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~ 234 (429)
++|++.++||+|+||.||+|+... +|+.||||++.+...........+.+|++++..++ |+||+++++++.+++..
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~ 76 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKD---TGQVYAMKVLRKSDMIKRNQIAHVRAERDILADAD-SPWIVKLYYSFQDEEHL 76 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECC---CCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcC-CCCccchhhheecCCeE
Confidence 479999999999999999999776 58999999997654444455677899999999998 99999999999999999
Q ss_pred EEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccccC
Q 014210 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (429)
Q Consensus 235 ~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~ 314 (429)
++||||+++++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++....
T Consensus 77 ~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll---~~~~~~kL~Dfg~~~~~~ 152 (350)
T cd05573 77 YLVMEYMPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILI---DADGHIKLADFGLCKKMN 152 (350)
T ss_pred EEEEcCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEE---CCCCCEEeecCCCCccCc
Confidence 9999999999999988655 779999999999999999999999999999999999999 788899999999997664
Q ss_pred CCc------------------------------cccccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHcCCCCCCC
Q 014210 315 PDE------------------------------RLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWA 363 (429)
Q Consensus 315 ~~~------------------------------~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~elltg~~Pf~~ 363 (429)
... ......||..|+|||++.+ .++.++|||||||++|||++|+.||..
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~ 232 (350)
T cd05573 153 KAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYS 232 (350)
T ss_pred ccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCC
Confidence 433 2234579999999998874 689999999999999999999999998
Q ss_pred CChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCcCC-HHHHHhhHhhhccc
Q 014210 364 RTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLT-AAQALSELLICYQS 423 (429)
Q Consensus 364 ~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps-~~~iL~~~~~~~~~ 423 (429)
.........+..............+++++.+||++||. ||.+|++ +.+++.|+|+....
T Consensus 233 ~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~~~ 292 (350)
T cd05573 233 DTLQETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKGID 292 (350)
T ss_pred CCHHHHHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCCCC
Confidence 88777777776633333333334579999999999997 9999999 99999999997643
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-47 Score=374.91 Aligned_cols=251 Identities=29% Similarity=0.526 Sum_probs=217.6
Q ss_pred ceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEe
Q 014210 161 EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMEL 240 (429)
Q Consensus 161 ~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~~lv~E~ 240 (429)
+.||+|+||.||+++... +|+.||||++.+...........+.+|+++++.+. |+||+++++++.+++.++|||||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~---~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~lv~Ey 76 (328)
T cd05593 1 KLLGKGTFGKVILVREKA---SGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTR-HPFLTSLKYSFQTKDRLCFVMEY 76 (328)
T ss_pred CeeeeCCCEEEEEEEECC---CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCCCcceEEEEEcCCEEEEEEeC
Confidence 479999999999998765 58999999997654444556678889999999998 99999999999999999999999
Q ss_pred cCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccccCC-Cccc
Q 014210 241 CEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP-DERL 319 (429)
Q Consensus 241 ~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~-~~~~ 319 (429)
+++|+|.+++. ....+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.... ....
T Consensus 77 ~~~g~L~~~l~-~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll---~~~~~~kL~DfG~~~~~~~~~~~~ 152 (328)
T cd05593 77 VNGGELFFHLS-RERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLML---DKDGHIKITDFGLCKEGITDAATM 152 (328)
T ss_pred CCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEE---CCCCcEEEecCcCCccCCCccccc
Confidence 99999988774 44679999999999999999999999999999999999999 7788999999999876432 2233
Q ss_pred cccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHH
Q 014210 320 NDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKR 398 (429)
Q Consensus 320 ~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ 398 (429)
...+||+.|+|||++. ..++.++|||||||++|+|++|+.||...........+......++ ..++.++.+||++
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~p----~~~~~~~~~li~~ 228 (328)
T cd05593 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFP----RTLSADAKSLLSG 228 (328)
T ss_pred ccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCccCC----CCCCHHHHHHHHH
Confidence 4567999999999886 4689999999999999999999999988887777776665554443 3689999999999
Q ss_pred hcccCccCcC-----CHHHHHhhHhhhccc
Q 014210 399 LLNKDPRKRL-----TAAQALSELLICYQS 423 (429)
Q Consensus 399 ~L~~dP~~Rp-----s~~~iL~~~~~~~~~ 423 (429)
||+.||++|+ ++.++++|+||....
T Consensus 229 ~L~~dP~~R~~~~~~~~~~il~h~~~~~~~ 258 (328)
T cd05593 229 LLIKDPNKRLGGGPDDAKEIMRHSFFTGVN 258 (328)
T ss_pred HcCCCHHHcCCCCCCCHHHHhcCCCcCCCC
Confidence 9999999997 899999999997643
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-47 Score=377.02 Aligned_cols=260 Identities=30% Similarity=0.479 Sum_probs=224.1
Q ss_pred CceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeE
Q 014210 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (429)
Q Consensus 155 ~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~ 234 (429)
++|++.+.||+|+||.||+++... +|+.||||++.+.........+.+.+|+.+++.+. |+||+++++++.+++..
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~-~~~i~~~~~~~~~~~~~ 76 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKA---TGDIYAMKVMKKSVLLAQETVSFFEEERDILSISN-SPWIPQLQYAFQDKDNL 76 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECC---CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCCCcceeeEEecCCeE
Confidence 479999999999999999998765 58999999997654444456677889999999987 99999999999999999
Q ss_pred EEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccccC
Q 014210 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (429)
Q Consensus 235 ~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~ 314 (429)
+|||||+++|+|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++....
T Consensus 77 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll---~~~~~~kL~Dfg~a~~~~ 153 (330)
T cd05601 77 YLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLI---DRTGHIKLADFGSAARLT 153 (330)
T ss_pred EEEECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEE---CCCCCEEeccCCCCeECC
Confidence 99999999999999987766789999999999999999999999999999999999999 788899999999998765
Q ss_pred CCccc--cccccCCcccCccccc-------CCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCC
Q 014210 315 PDERL--NDIVGSAYYVAPEVLH-------RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPW 385 (429)
Q Consensus 315 ~~~~~--~~~~gt~~y~aPE~~~-------~~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 385 (429)
..... ....||..|+|||++. ..++.++|||||||++|||++|+.||........+..++...........
T Consensus 154 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 233 (330)
T cd05601 154 ANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPED 233 (330)
T ss_pred CCCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCC
Confidence 43322 2347999999999875 34788999999999999999999999888877777777665433322233
Q ss_pred CCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhcc
Q 014210 386 PSLSSEARDFVKRLLNKDPRKRLTAAQALSELLICYQ 422 (429)
Q Consensus 386 ~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~ 422 (429)
+.++.++.+||+.||+ ||++|+++.+++.|+||...
T Consensus 234 ~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~ 269 (330)
T cd05601 234 PKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKI 269 (330)
T ss_pred CCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCCC
Confidence 4689999999999998 99999999999999999754
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-47 Score=381.51 Aligned_cols=258 Identities=30% Similarity=0.501 Sum_probs=219.6
Q ss_pred ceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEE
Q 014210 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVY 235 (429)
Q Consensus 156 ~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~~ 235 (429)
+|+++++||+|+||.||+|+... +++.||||++.+.........+.+.+|+++++++. |+||+++++++.+++.+|
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~---~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~-h~~iv~~~~~~~~~~~~~ 77 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVD---TKALYAMKTLRKKDVLLRNQVAHVKAERDILAEAD-NEWVVRLYYSFQDKDNLY 77 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECC---CCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCC-CCcCCeEEEEEEeCCEEE
Confidence 68999999999999999998766 58999999997654444556678899999999998 999999999999999999
Q ss_pred EEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccccCC
Q 014210 236 VVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP 315 (429)
Q Consensus 236 lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~ 315 (429)
||||||++|+|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++..+..
T Consensus 78 lv~E~~~gg~L~~~l~~-~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl---~~~g~~kL~DFGla~~~~~ 153 (382)
T cd05625 78 FVMDYIPGGDMMSLLIR-MGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILI---DRDGHIKLTDFGLCTGFRW 153 (382)
T ss_pred EEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---CCCCCEEEeECCCCccccc
Confidence 99999999999998754 4578999999999999999999999999999999999999 7888999999999753210
Q ss_pred C------------------------------------------------ccccccccCCcccCccccc-CCCCCcccHHH
Q 014210 316 D------------------------------------------------ERLNDIVGSAYYVAPEVLH-RSYSTEADVWS 346 (429)
Q Consensus 316 ~------------------------------------------------~~~~~~~gt~~y~aPE~~~-~~~~~~sDiwS 346 (429)
. ......+||+.|+|||++. ..++.++||||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwS 233 (382)
T cd05625 154 THDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWS 233 (382)
T ss_pred cccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEe
Confidence 0 0012357999999999886 46899999999
Q ss_pred HHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCcCC---HHHHHhhHhhhcc
Q 014210 347 IGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLT---AAQALSELLICYQ 422 (429)
Q Consensus 347 lGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps---~~~iL~~~~~~~~ 422 (429)
|||++|||++|+.||......+....+..............+++++.+||.+|+ .||++|++ +.+++.|+||...
T Consensus 234 lGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~ 311 (382)
T cd05625 234 VGVILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFKTI 311 (382)
T ss_pred chHHHHHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCCc
Confidence 999999999999999988777766666654444444444578999999999976 59999997 9999999999764
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-47 Score=373.07 Aligned_cols=251 Identities=29% Similarity=0.537 Sum_probs=217.0
Q ss_pred ceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEe
Q 014210 161 EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMEL 240 (429)
Q Consensus 161 ~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~~lv~E~ 240 (429)
+.||+|+||.||+++... +|+.||+|++.+...........+.+|+++++.++ ||||+++++++.+++.+||||||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~i~~~~~~~~~~~~~~lv~E~ 76 (323)
T cd05595 1 KLLGKGTFGKVILVREKA---TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR-HPFLTALKYAFQTHDRLCFVMEY 76 (323)
T ss_pred CeeeeCCCEEEEEEEECC---CCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCC-CCCCcceeeEEecCCEEEEEEeC
Confidence 479999999999998765 58999999997654344455667889999999998 99999999999999999999999
Q ss_pred cCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccccCC-Cccc
Q 014210 241 CEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP-DERL 319 (429)
Q Consensus 241 ~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~-~~~~ 319 (429)
+++|+|..++. +.+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..... ....
T Consensus 77 ~~~~~L~~~l~-~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kL~Dfg~~~~~~~~~~~~ 152 (323)
T cd05595 77 ANGGELFFHLS-RERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLML---DKDGHIKITDFGLCKEGISDGATM 152 (323)
T ss_pred CCCCcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEE---cCCCCEEecccHHhccccCCCCcc
Confidence 99999988764 44679999999999999999999999999999999999999 7788899999999875432 2233
Q ss_pred cccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHH
Q 014210 320 NDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKR 398 (429)
Q Consensus 320 ~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ 398 (429)
....||..|+|||++. +.++.++|||||||++|||++|+.||........+..+......++ ..+++++.+||++
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~~p----~~~~~~~~~li~~ 228 (323)
T cd05595 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFP----RTLSPEAKSLLAG 228 (323)
T ss_pred ccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCC----CCCCHHHHHHHHH
Confidence 4567999999999886 4689999999999999999999999998887777777766554443 3689999999999
Q ss_pred hcccCccCcC-----CHHHHHhhHhhhccc
Q 014210 399 LLNKDPRKRL-----TAAQALSELLICYQS 423 (429)
Q Consensus 399 ~L~~dP~~Rp-----s~~~iL~~~~~~~~~ 423 (429)
||+.||++|+ ++.+++.|+||....
T Consensus 229 ~L~~dP~~R~~~~~~~~~~~l~h~~~~~~~ 258 (323)
T cd05595 229 LLKKDPKQRLGGGPSDAKEVMEHRFFLSIN 258 (323)
T ss_pred HccCCHHHhCCCCCCCHHHHHcCCCcCCCC
Confidence 9999999998 999999999997643
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-49 Score=378.80 Aligned_cols=255 Identities=28% Similarity=0.504 Sum_probs=223.0
Q ss_pred cCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~ 233 (429)
...|...+.||+|.||.||+|.+.. +++.||+|++... .....++++.+|+.+|..++ ++||.++|+.+..+..
T Consensus 12 ~~~~~~~~~IgrGsfG~Vyk~~d~~---t~k~vAiKii~Le--~~~deIediqqei~~Ls~~~-~~~it~yygsyl~g~~ 85 (467)
T KOG0201|consen 12 ELLYTKLELIGRGSFGEVYKAIDNK---TKKVVAIKIIDLE--EAEDEIEDIQQEISVLSQCD-SPNITEYYGSYLKGTK 85 (467)
T ss_pred ccccccchhccccccceeeeeeecc---ccceEEEEEechh--hcchhhHHHHHHHHHHHhcC-cchHHhhhhheeeccc
Confidence 3467788999999999999999776 6899999999765 34456788999999999998 8999999999999999
Q ss_pred EEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCcccc
Q 014210 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (429)
Q Consensus 234 ~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~ 313 (429)
+||+||||.||++.+.+ +.+..+.+..+..++++++.||.|||.++.+|||||+.|||+ .++|.+||+|||.+-.+
T Consensus 86 LwiiMey~~gGsv~~lL-~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~---s~~g~vkl~DfgVa~ql 161 (467)
T KOG0201|consen 86 LWIIMEYCGGGSVLDLL-KSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILL---SESGDVKLADFGVAGQL 161 (467)
T ss_pred HHHHHHHhcCcchhhhh-ccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeE---eccCcEEEEecceeeee
Confidence 99999999999999966 555666999999999999999999999999999999999999 56689999999999877
Q ss_pred CCCcc-ccccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHH
Q 014210 314 RPDER-LNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSE 391 (429)
Q Consensus 314 ~~~~~-~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 391 (429)
..... ..+.+||+.|||||++.+ .|+.++||||||++++||++|..||........+..|-+..+..... .+++.
T Consensus 162 ~~~~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP~L~~---~~S~~ 238 (467)
T KOG0201|consen 162 TNTVKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPPRLDG---DFSPP 238 (467)
T ss_pred echhhccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCCcccc---ccCHH
Confidence 65543 378999999999999985 79999999999999999999999997766644444444444444433 68999
Q ss_pred HHHHHHHhcccCccCcCCHHHHHhhHhhhc
Q 014210 392 ARDFVKRLLNKDPRKRLTAAQALSELLICY 421 (429)
Q Consensus 392 ~~~li~~~L~~dP~~Rps~~~iL~~~~~~~ 421 (429)
+++||..||++||+.||+|.++|.|.|+..
T Consensus 239 ~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~ 268 (467)
T KOG0201|consen 239 FKEFVEACLDKNPEFRPSAKELLKHKFIKR 268 (467)
T ss_pred HHHHHHHHhhcCcccCcCHHHHhhhHHHHh
Confidence 999999999999999999999999999975
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-47 Score=371.49 Aligned_cols=257 Identities=28% Similarity=0.460 Sum_probs=222.0
Q ss_pred ceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEE
Q 014210 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVY 235 (429)
Q Consensus 156 ~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~~ 235 (429)
+|++++.||+|+||.||+|+... +++.||||++.+.........+.+..|++++..+.+|++|+++++++.+.+.+|
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~---~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~ 77 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKG---TDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 77 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECC---CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEE
Confidence 58999999999999999998765 578999999976544444556778899999999985677999999999999999
Q ss_pred EEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccccC-
Q 014210 236 VVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR- 314 (429)
Q Consensus 236 lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~- 314 (429)
+||||+++|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++....
T Consensus 78 lv~E~~~~g~L~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill---~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05587 78 FVMEYVNGGDLMYHIQQ-VGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML---DAEGHIKIADFGMCKENIF 153 (324)
T ss_pred EEEcCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEE---cCCCCEEEeecCcceecCC
Confidence 99999999999988754 4578999999999999999999999999999999999999 678899999999986532
Q ss_pred CCccccccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHH
Q 014210 315 PDERLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEAR 393 (429)
Q Consensus 315 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 393 (429)
........+||..|+|||++.+ .++.++|||||||++|||++|+.||........+..+......++ ..++.++.
T Consensus 154 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~ 229 (324)
T cd05587 154 GGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYP----KSLSKEAV 229 (324)
T ss_pred CCCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHH
Confidence 2233345679999999998874 589999999999999999999999998888888888876655444 35899999
Q ss_pred HHHHHhcccCccCcCCH-----HHHHhhHhhhccc
Q 014210 394 DFVKRLLNKDPRKRLTA-----AQALSELLICYQS 423 (429)
Q Consensus 394 ~li~~~L~~dP~~Rps~-----~~iL~~~~~~~~~ 423 (429)
+||++||..||.+|++. .++++|+||....
T Consensus 230 ~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~~ 264 (324)
T cd05587 230 SICKGLLTKHPAKRLGCGPTGERDIREHAFFRRID 264 (324)
T ss_pred HHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCCC
Confidence 99999999999999986 8999999997643
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-47 Score=371.20 Aligned_cols=248 Identities=26% Similarity=0.512 Sum_probs=216.5
Q ss_pred eeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEecC
Q 014210 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCE 242 (429)
Q Consensus 163 IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~~lv~E~~~ 242 (429)
||+|+||.||+++... +++.||+|++.+...........+.+|+.++++++ |+||+++++++.+.+..++||||++
T Consensus 1 lg~G~~g~Vy~~~~~~---~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~ 76 (312)
T cd05585 1 IGKGSFGKVMQVRKRD---TQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVN-CPFIVPLKFSFQSPEKLYLVLAFIN 76 (312)
T ss_pred CCcCCCeEEEEEEECC---CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCcEeceeeEEecCCeEEEEEcCCC
Confidence 7999999999998766 58899999987654445556677889999999998 9999999999999999999999999
Q ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccccCCC-ccccc
Q 014210 243 GGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPD-ERLND 321 (429)
Q Consensus 243 ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~-~~~~~ 321 (429)
+|+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++..... .....
T Consensus 77 ~g~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili---~~~~~~kl~Dfg~~~~~~~~~~~~~~ 152 (312)
T cd05585 77 GGELFHHLQR-EGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILL---DYQGHIALCDFGLCKLNMKDDDKTNT 152 (312)
T ss_pred CCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEE---CCCCcEEEEECcccccCccCCCcccc
Confidence 9999998854 4679999999999999999999999999999999999999 77889999999999764322 23345
Q ss_pred cccCCcccCcccccC-CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhc
Q 014210 322 IVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLL 400 (429)
Q Consensus 322 ~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L 400 (429)
.+||+.|+|||++.+ .++.++|||||||++|||++|+.||........+..++.....++ ..+++++.+||.+||
T Consensus 153 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~~L 228 (312)
T cd05585 153 FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFP----DGFDRDAKDLLIGLL 228 (312)
T ss_pred ccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCCCC----CcCCHHHHHHHHHHc
Confidence 679999999998874 689999999999999999999999998888887777776554443 368899999999999
Q ss_pred ccCccCcC---CHHHHHhhHhhhcc
Q 014210 401 NKDPRKRL---TAAQALSELLICYQ 422 (429)
Q Consensus 401 ~~dP~~Rp---s~~~iL~~~~~~~~ 422 (429)
..||++|+ ++.++|.|+||...
T Consensus 229 ~~dp~~R~~~~~~~e~l~hp~~~~~ 253 (312)
T cd05585 229 SRDPTRRLGYNGAQEIKNHPFFSQL 253 (312)
T ss_pred CCCHHHcCCCCCHHHHHcCCCcCCC
Confidence 99999997 58999999999864
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-47 Score=374.65 Aligned_cols=260 Identities=29% Similarity=0.508 Sum_probs=217.4
Q ss_pred ceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCc-CcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeE
Q 014210 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKM-TTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (429)
Q Consensus 156 ~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~-~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~ 234 (429)
+|+++++||+|+||.||+++...+..+|+.||+|++.+... ......+.+.+|+.+++++.+|+||+++++++.+++.+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 48999999999999999998765555789999999865322 22334567889999999997799999999999999999
Q ss_pred EEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccccC
Q 014210 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (429)
Q Consensus 235 ~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~ 314 (429)
++||||+++|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++...
T Consensus 81 ~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili---~~~~~~kl~DfG~~~~~~ 156 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQ-RDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILL---DSEGHVVLTDFGLSKEFL 156 (332)
T ss_pred EEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEE---CCCCCEEEeeCcCCcccc
Confidence 999999999999998854 4569999999999999999999999999999999999999 678899999999997654
Q ss_pred CCc--cccccccCCcccCcccccC--CCCCcccHHHHHHHHHHHHcCCCCCCCCC----hHHHHHHHHhcCCCCCCCCCC
Q 014210 315 PDE--RLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWART----ESGIFRAVLKADPSFDEAPWP 386 (429)
Q Consensus 315 ~~~--~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlGvll~elltg~~Pf~~~~----~~~~~~~i~~~~~~~~~~~~~ 386 (429)
... .....+||..|+|||++.+ .++.++|||||||++|||++|+.||.... .......+....+.++ .
T Consensus 157 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~----~ 232 (332)
T cd05614 157 SEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFP----S 232 (332)
T ss_pred ccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCCCC----C
Confidence 332 2335679999999999874 47889999999999999999999996432 2333344444443332 3
Q ss_pred CCCHHHHHHHHHhcccCccCcC-----CHHHHHhhHhhhccc
Q 014210 387 SLSSEARDFVKRLLNKDPRKRL-----TAAQALSELLICYQS 423 (429)
Q Consensus 387 ~~s~~~~~li~~~L~~dP~~Rp-----s~~~iL~~~~~~~~~ 423 (429)
.++.++.+||.+||+.||++|| +++++++|+||....
T Consensus 233 ~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~ 274 (332)
T cd05614 233 FIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLD 274 (332)
T ss_pred CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCCC
Confidence 6889999999999999999999 889999999997643
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-47 Score=381.65 Aligned_cols=259 Identities=29% Similarity=0.476 Sum_probs=218.8
Q ss_pred CceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeE
Q 014210 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (429)
Q Consensus 155 ~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~ 234 (429)
++|+++++||+|+||.||+++... +|+.||||++.+.........+.+.+|+++++++. |+||+++++.+.+++.+
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~---~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-h~~iv~~~~~~~~~~~~ 76 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVD---TNALYAMKTLRKADVLMRNQAAHVKAERDILAEAD-NEWVVKLYYSFQDKDNL 76 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECC---CCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCC-CCCcceEEEEEEcCCEE
Confidence 479999999999999999998776 58999999986543333444567889999999998 99999999999999999
Q ss_pred EEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccccC
Q 014210 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (429)
Q Consensus 235 ~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~ 314 (429)
|||||||++|+|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++..+.
T Consensus 77 ~lv~E~~~~g~L~~~i~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill---~~~~~ikL~DFG~a~~~~ 152 (376)
T cd05598 77 YFVMDYIPGGDMMSLLIR-LGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILI---DRDGHIKLTDFGLCTGFR 152 (376)
T ss_pred EEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEE---CCCCCEEEEeCCCCcccc
Confidence 999999999999998854 4578999999999999999999999999999999999999 778899999999975321
Q ss_pred CC--------------------------------------------ccccccccCCcccCcccccC-CCCCcccHHHHHH
Q 014210 315 PD--------------------------------------------ERLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGV 349 (429)
Q Consensus 315 ~~--------------------------------------------~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGv 349 (429)
.. ......+||+.|||||++.+ .++.++|||||||
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGv 232 (376)
T cd05598 153 WTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV 232 (376)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccc
Confidence 00 00113579999999998874 6899999999999
Q ss_pred HHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCcC---CHHHHHhhHhhhcc
Q 014210 350 IAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRL---TAAQALSELLICYQ 422 (429)
Q Consensus 350 ll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp---s~~~iL~~~~~~~~ 422 (429)
++|||++|+.||......+....+..............++.++.+||.+|+ .+|.+|+ ++.+++.|+||...
T Consensus 233 ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~~ 307 (376)
T cd05598 233 ILYEMLVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKGI 307 (376)
T ss_pred eeeehhhCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCCC
Confidence 999999999999988877766666554444333344568999999999976 5999999 99999999999764
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-47 Score=371.79 Aligned_cols=252 Identities=30% Similarity=0.528 Sum_probs=218.0
Q ss_pred ceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEe
Q 014210 161 EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMEL 240 (429)
Q Consensus 161 ~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~~lv~E~ 240 (429)
++||+|+||.||+|+.+. +++.||||++.+.........+.+.+|+.++..+.+|+||+++++++.+.+.+||||||
T Consensus 1 ~~lg~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey 77 (320)
T cd05590 1 RVLGKGSFGKVMLARLKE---SGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEF 77 (320)
T ss_pred CeeeeCCCeEEEEEEEcC---CCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcC
Confidence 479999999999998776 58999999987644334445667788999998886799999999999999999999999
Q ss_pred cCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccccCC-Cccc
Q 014210 241 CEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP-DERL 319 (429)
Q Consensus 241 ~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~-~~~~ 319 (429)
+++|+|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.... ....
T Consensus 78 ~~~g~L~~~i~~-~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli---~~~~~~kL~DfG~~~~~~~~~~~~ 153 (320)
T cd05590 78 VNGGDLMFHIQK-SRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLL---DHEGHCKLADFGMCKEGIFNGKTT 153 (320)
T ss_pred CCCchHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEE---CCCCcEEEeeCCCCeecCcCCCcc
Confidence 999999987754 4679999999999999999999999999999999999999 7788999999999875432 2334
Q ss_pred cccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHH
Q 014210 320 NDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKR 398 (429)
Q Consensus 320 ~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ 398 (429)
....||+.|+|||++.+ .++.++|||||||++|||++|+.||........+..+.......+ ..++.++.+||++
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~li~~ 229 (320)
T cd05590 154 STFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYP----TWLSQDAVDILKA 229 (320)
T ss_pred cccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCC----CCCCHHHHHHHHH
Confidence 45679999999998874 688999999999999999999999999888888888876654443 2578999999999
Q ss_pred hcccCccCcCCH------HHHHhhHhhhccc
Q 014210 399 LLNKDPRKRLTA------AQALSELLICYQS 423 (429)
Q Consensus 399 ~L~~dP~~Rps~------~~iL~~~~~~~~~ 423 (429)
||+.||++|+++ ++++.|+||....
T Consensus 230 ~L~~dP~~R~~~~~~~~~~~~~~h~~f~~~~ 260 (320)
T cd05590 230 FMTKNPTMRLGSLTLGGEEAILRHPFFKELD 260 (320)
T ss_pred HcccCHHHCCCCCCCCCHHHHHcCCCcCCCC
Confidence 999999999998 9999999997643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-47 Score=370.65 Aligned_cols=257 Identities=26% Similarity=0.465 Sum_probs=222.8
Q ss_pred ceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEE
Q 014210 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVY 235 (429)
Q Consensus 156 ~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~~ 235 (429)
+|++.+.||+|+||.||+|+... +++.||||++.+.........+.+..|..++..+..|++|+++++++.+.+.+|
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~ 77 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKG---TDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLY 77 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECC---CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEE
Confidence 58899999999999999998765 588999999976544444555677889999988877999999999999999999
Q ss_pred EEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccccCC
Q 014210 236 VVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP 315 (429)
Q Consensus 236 lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~ 315 (429)
|||||+++|+|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++....
T Consensus 78 lv~E~~~~g~L~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill---~~~~~~kL~DfG~~~~~~~ 153 (323)
T cd05616 78 FVMEYVNGGDLMYQIQQ-VGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML---DSEGHIKIADFGMCKENMW 153 (323)
T ss_pred EEEcCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEE---CCCCcEEEccCCCceecCC
Confidence 99999999999988754 4579999999999999999999999999999999999999 7888999999999875432
Q ss_pred -CccccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHH
Q 014210 316 -DERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEAR 393 (429)
Q Consensus 316 -~~~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 393 (429)
.......+||+.|+|||++. +.++.++|||||||++|||++|+.||........+..+......++ ..++.++.
T Consensus 154 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~ 229 (323)
T cd05616 154 DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYP----KSMSKEAV 229 (323)
T ss_pred CCCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----CcCCHHHH
Confidence 23344567999999999887 4689999999999999999999999999888888888877665444 35899999
Q ss_pred HHHHHhcccCccCcCC-----HHHHHhhHhhhccc
Q 014210 394 DFVKRLLNKDPRKRLT-----AAQALSELLICYQS 423 (429)
Q Consensus 394 ~li~~~L~~dP~~Rps-----~~~iL~~~~~~~~~ 423 (429)
+||.+||+.||++|++ ..+++.|+||....
T Consensus 230 ~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~~ 264 (323)
T cd05616 230 AICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYID 264 (323)
T ss_pred HHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCCCC
Confidence 9999999999999998 48999999987644
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-46 Score=365.45 Aligned_cols=261 Identities=28% Similarity=0.422 Sum_probs=211.5
Q ss_pred cCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~ 233 (429)
.++|++.++||+|+||.||+|+.+. +|+.||||++...... .....+.+|+.+++++. |+||+++++++.+++.
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~--~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~ 77 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKV---NGKLVALKVIRLQEEE--GTPFTAIREASLLKGLK-HANIVLLHDIIHTKET 77 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECC---CCCEEEEEEecccccc--ccchhHHHHHHHHhhCC-CCCcCeEEEEEecCCe
Confidence 4789999999999999999998765 5889999998654322 22345778999999998 9999999999999999
Q ss_pred EEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCcccc
Q 014210 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (429)
Q Consensus 234 ~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~ 313 (429)
.++||||++ ++|.+++....+.+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++...
T Consensus 78 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill---~~~~~~kl~Dfg~~~~~ 153 (303)
T cd07869 78 LTLVFEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLI---SDTGELKLADFGLARAK 153 (303)
T ss_pred EEEEEECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCCEEECCCCcceec
Confidence 999999995 58888887777789999999999999999999999999999999999999 77888999999998754
Q ss_pred CCC-ccccccccCCcccCcccccC--CCCCcccHHHHHHHHHHHHcCCCCCCCCChH-HHHHHHHhcCCCCCCCC-----
Q 014210 314 RPD-ERLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTES-GIFRAVLKADPSFDEAP----- 384 (429)
Q Consensus 314 ~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlGvll~elltg~~Pf~~~~~~-~~~~~i~~~~~~~~~~~----- 384 (429)
... .......|+..|+|||++.+ .++.++|||||||++|||++|+.||...... ..+..+...........
T Consensus 154 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (303)
T cd07869 154 SVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVH 233 (303)
T ss_pred cCCCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchh
Confidence 322 22344678999999998754 4788999999999999999999999765432 22222221100000000
Q ss_pred ---------------------C--CCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhccce
Q 014210 385 ---------------------W--PSLSSEARDFVKRLLNKDPRKRLTAAQALSELLICYQSY 424 (429)
Q Consensus 385 ---------------------~--~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~~~ 424 (429)
+ ..++.++.+||.+||+.||++|||+.++|+|+||.....
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~~ 296 (303)
T cd07869 234 SLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLPP 296 (303)
T ss_pred hccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccCCh
Confidence 0 124578899999999999999999999999999987653
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-47 Score=370.57 Aligned_cols=252 Identities=28% Similarity=0.470 Sum_probs=218.7
Q ss_pred ceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEe
Q 014210 161 EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMEL 240 (429)
Q Consensus 161 ~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~~lv~E~ 240 (429)
++||+|+||.||+|+.+. +|+.||||++.+.........+.+..|++++..+.+|+||+++++++.+++..||||||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~ 77 (321)
T cd05591 1 KVLGKGSFGKVMLAELKG---TDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEY 77 (321)
T ss_pred CccccCCCeEEEEEEECC---CCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeC
Confidence 469999999999998765 58899999997654444555667888999998876799999999999999999999999
Q ss_pred cCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccccCC-Cccc
Q 014210 241 CEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP-DERL 319 (429)
Q Consensus 241 ~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~-~~~~ 319 (429)
+++++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..... ....
T Consensus 78 ~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill---~~~~~~kL~Dfg~~~~~~~~~~~~ 153 (321)
T cd05591 78 VNGGDLMFQIQR-SRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILL---DAEGHCKLADFGMCKEGILNGVTT 153 (321)
T ss_pred CCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEE---CCCCCEEEeecccceecccCCccc
Confidence 999999887754 4679999999999999999999999999999999999999 7788999999999875432 2233
Q ss_pred cccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHH
Q 014210 320 NDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKR 398 (429)
Q Consensus 320 ~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ 398 (429)
....||..|+|||++.+ .++.++|||||||++|||++|+.||........+..+......++. .++.++.+||++
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~~p~----~~~~~~~~ll~~ 229 (321)
T cd05591 154 TTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPV----WLSKEAVSILKA 229 (321)
T ss_pred cccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCC----CCCHHHHHHHHH
Confidence 45679999999998874 6899999999999999999999999999888888888776654432 478999999999
Q ss_pred hcccCccCcC-------CHHHHHhhHhhhccc
Q 014210 399 LLNKDPRKRL-------TAAQALSELLICYQS 423 (429)
Q Consensus 399 ~L~~dP~~Rp-------s~~~iL~~~~~~~~~ 423 (429)
||+.||++|+ ++.+++.|+||....
T Consensus 230 ~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~~~ 261 (321)
T cd05591 230 FMTKNPNKRLGCVASQGGEDAIKQHPFFKEID 261 (321)
T ss_pred HhccCHHHcCCCCCCCCCHHHHhcCCccCCCC
Confidence 9999999999 999999999997643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-46 Score=371.54 Aligned_cols=255 Identities=28% Similarity=0.405 Sum_probs=207.3
Q ss_pred cCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~ 233 (429)
.++|+.+++||+|+||.||+++... +|+.||||++... ......+.+.+|++++++++ |+||+++++++.+++.
T Consensus 73 ~~~~~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~ 146 (353)
T PLN00034 73 LSELERVNRIGSGAGGTVYKVIHRP---TGRLYALKVIYGN--HEDTVRRQICREIEILRDVN-HPNVVKCHDMFDHNGE 146 (353)
T ss_pred HHHHhhhhhccCCCCeEEEEEEECC---CCCEEEEEEEecC--CcHHHHHHHHHHHHHHHhCC-CCCcceeeeEeccCCe
Confidence 3678899999999999999998765 5899999998643 23445677899999999998 9999999999999999
Q ss_pred EEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCcccc
Q 014210 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (429)
Q Consensus 234 ~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~ 313 (429)
+++||||+++++|.+. ....+..+..++.||+.||.|||++||+||||||+|||+ ++++.+||+|||++...
T Consensus 147 ~~lv~e~~~~~~L~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~~~~kL~DfG~~~~~ 218 (353)
T PLN00034 147 IQVLLEFMDGGSLEGT-----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLI---NSAKNVKIADFGVSRIL 218 (353)
T ss_pred EEEEEecCCCCccccc-----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEE---cCCCCEEEcccccceec
Confidence 9999999999987542 345788889999999999999999999999999999999 77889999999999876
Q ss_pred CCCc-cccccccCCcccCcccccC------CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCC
Q 014210 314 RPDE-RLNDIVGSAYYVAPEVLHR------SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWP 386 (429)
Q Consensus 314 ~~~~-~~~~~~gt~~y~aPE~~~~------~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 386 (429)
.... ......||..|+|||++.. ..+.++|||||||++|||++|+.||......+....+.............
T Consensus 219 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (353)
T PLN00034 219 AQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPA 298 (353)
T ss_pred ccccccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCC
Confidence 4332 2345679999999998742 23568999999999999999999997433222221111111111122234
Q ss_pred CCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhcc
Q 014210 387 SLSSEARDFVKRLLNKDPRKRLTAAQALSELLICYQ 422 (429)
Q Consensus 387 ~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~ 422 (429)
.++.++.+||.+||+.||++||++.++|+|+||..-
T Consensus 299 ~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~ 334 (353)
T PLN00034 299 TASREFRHFISCCLQREPAKRWSAMQLLQHPFILRA 334 (353)
T ss_pred ccCHHHHHHHHHHccCChhhCcCHHHHhcCcccccC
Confidence 688999999999999999999999999999999753
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-46 Score=361.90 Aligned_cols=261 Identities=28% Similarity=0.426 Sum_probs=219.0
Q ss_pred ceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEE
Q 014210 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVY 235 (429)
Q Consensus 156 ~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~~ 235 (429)
.|++.++||+|+||.||++.... +++.||||++.............+.+|+.++++++ |+||+++++++.+++.++
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~ 76 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRA---TGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVN-SRFVVSLAYAYETKDALC 76 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcC---CCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcC-CCCEeeeeeeecCCCeEE
Confidence 48899999999999999998665 58999999987654444444566789999999998 999999999999999999
Q ss_pred EEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccccC
Q 014210 236 VVMELCEGGELLDRILSRG-GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (429)
Q Consensus 236 lv~E~~~ggsL~~~i~~~~-~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~ 314 (429)
+||||+++|+|.+++.... ..+++..+..++.||+.||.|||+.||+||||||+||++ ++++.++|+|||++....
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~~l~Dfg~~~~~~ 153 (285)
T cd05605 77 LVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILL---DDYGHIRISDLGLAVEIP 153 (285)
T ss_pred EEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEE---CCCCCEEEeeCCCceecC
Confidence 9999999999998876543 469999999999999999999999999999999999999 778899999999998765
Q ss_pred CCccccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHH
Q 014210 315 PDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEAR 393 (429)
Q Consensus 315 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 393 (429)
.........|+..|+|||++. ..++.++||||||+++|||++|+.||.+.........+..............++..+.
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (285)
T cd05605 154 EGETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAAR 233 (285)
T ss_pred CCCccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHH
Confidence 444445568999999999886 4688999999999999999999999987665443333322211122222346889999
Q ss_pred HHHHHhcccCccCcC-----CHHHHHhhHhhhccc
Q 014210 394 DFVKRLLNKDPRKRL-----TAAQALSELLICYQS 423 (429)
Q Consensus 394 ~li~~~L~~dP~~Rp-----s~~~iL~~~~~~~~~ 423 (429)
+||.+||+.||++|| ++.+++.|+||....
T Consensus 234 ~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~ 268 (285)
T cd05605 234 SICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTAN 268 (285)
T ss_pred HHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCCC
Confidence 999999999999999 999999999998643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-47 Score=377.93 Aligned_cols=262 Identities=26% Similarity=0.442 Sum_probs=222.6
Q ss_pred ccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCC
Q 014210 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (429)
Q Consensus 153 ~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~ 232 (429)
..++|++.++||+|+||.||+++... +++.||+|++.+.........+.+.+|+.+++.+. ||||+++++++.+++
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~-hp~iv~~~~~~~~~~ 116 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHKS---SQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN-SPWVVQLFCAFQDDK 116 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEECC---CCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCC-CCCEeeEEEEEEcCC
Confidence 35789999999999999999999776 58899999986544344444566889999999998 999999999999999
Q ss_pred eEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccc
Q 014210 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (429)
Q Consensus 233 ~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~ 312 (429)
.+|+|||||++|+|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++..
T Consensus 117 ~~~lv~Ey~~gg~L~~~l~~--~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl---~~~~~~kL~DFG~a~~ 191 (370)
T cd05621 117 YLYMVMEYMPGGDLVNLMSN--YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLL---DKHGHLKLADFGTCMK 191 (370)
T ss_pred EEEEEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEE---CCCCCEEEEeccccee
Confidence 99999999999999998743 468999999999999999999999999999999999999 7788999999999987
Q ss_pred cCCCc--cccccccCCcccCcccccC-----CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCC
Q 014210 313 VRPDE--RLNDIVGSAYYVAPEVLHR-----SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPW 385 (429)
Q Consensus 313 ~~~~~--~~~~~~gt~~y~aPE~~~~-----~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 385 (429)
..... .....+||+.|+|||++.+ .++.++|||||||++|||++|+.||......+.+..+............
T Consensus 192 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~ 271 (370)
T cd05621 192 MDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPED 271 (370)
T ss_pred cccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCc
Confidence 64332 2245679999999998853 2788999999999999999999999988888888888765433333323
Q ss_pred CCCCHHHHHHHHHhcccCccC--cCCHHHHHhhHhhhccc
Q 014210 386 PSLSSEARDFVKRLLNKDPRK--RLTAAQALSELLICYQS 423 (429)
Q Consensus 386 ~~~s~~~~~li~~~L~~dP~~--Rps~~~iL~~~~~~~~~ 423 (429)
..++..+++||..||..++.+ |+++.++++|+||....
T Consensus 272 ~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~~ 311 (370)
T cd05621 272 VEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKNDQ 311 (370)
T ss_pred ccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCCCC
Confidence 457999999999999866654 89999999999998654
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-46 Score=368.17 Aligned_cols=253 Identities=30% Similarity=0.518 Sum_probs=217.4
Q ss_pred eeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHH---HhcCCCCcceEEEEEEeCCe
Q 014210 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILR---ALTGHNNLVKFFDAYEDTDN 233 (429)
Q Consensus 157 y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~---~l~~h~nIv~l~~~~~~~~~ 233 (429)
|++.+.||+|+||.||+|+... +|+.||||++.+.........+.+.+|++++. .+. |+||+++++++.+.+.
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~-hp~i~~~~~~~~~~~~ 76 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKK---TGELYAIKALKKGDIIARDEVESLMCEKRIFETANSER-HPFLVNLFACFQTEDH 76 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECC---CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccC-CCChhceeeEEEcCCE
Confidence 6889999999999999998765 58999999997654334445567777877765 444 9999999999999999
Q ss_pred EEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCcccc
Q 014210 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (429)
Q Consensus 234 ~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~ 313 (429)
.|+||||+++++|..++. .+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++...
T Consensus 77 ~~lv~E~~~~~~L~~~~~--~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill---~~~~~~kL~Dfg~~~~~ 151 (324)
T cd05589 77 VCFVMEYAAGGDLMMHIH--TDVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLL---DTEGFVKIADFGLCKEG 151 (324)
T ss_pred EEEEEcCCCCCcHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEE---CCCCcEEeCcccCCccC
Confidence 999999999999988763 3579999999999999999999999999999999999999 77889999999998753
Q ss_pred CC-CccccccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHH
Q 014210 314 RP-DERLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSE 391 (429)
Q Consensus 314 ~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 391 (429)
.. .......+|+..|+|||++.+ .++.++|||||||++|||++|+.||........+..+......++ ..++.+
T Consensus 152 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~p----~~~~~~ 227 (324)
T cd05589 152 MGFGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYP----RFLSRE 227 (324)
T ss_pred CCCCCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----CCCCHH
Confidence 32 233445689999999998864 688999999999999999999999999888888888877665444 358899
Q ss_pred HHHHHHHhcccCccCcC-----CHHHHHhhHhhhcc
Q 014210 392 ARDFVKRLLNKDPRKRL-----TAAQALSELLICYQ 422 (429)
Q Consensus 392 ~~~li~~~L~~dP~~Rp-----s~~~iL~~~~~~~~ 422 (429)
+.+||++||+.||.+|| ++.+++.|+||...
T Consensus 228 ~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~ 263 (324)
T cd05589 228 AISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDI 263 (324)
T ss_pred HHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCC
Confidence 99999999999999999 79999999999764
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-47 Score=371.58 Aligned_cols=251 Identities=29% Similarity=0.532 Sum_probs=216.8
Q ss_pred ceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEe
Q 014210 161 EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMEL 240 (429)
Q Consensus 161 ~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~~lv~E~ 240 (429)
+.||+|+||.||+++... +|+.||+|++.+..........++.+|+++++.+. |+||+++++++.+.+.+||||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~---~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~-hp~i~~~~~~~~~~~~~~lv~E~ 76 (325)
T cd05594 1 KLLGKGTFGKVILVKEKA---TGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR-HPFLTALKYSFQTHDRLCFVMEY 76 (325)
T ss_pred CeeeeCCCEEEEEEEECC---CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCCCCceEEEEEcCCEEEEEEeC
Confidence 479999999999998765 68999999997654444455677889999999998 99999999999999999999999
Q ss_pred cCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-cCceeccCCCCcEEEeecCCCceEEEeecCCccccCC-Ccc
Q 014210 241 CEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHL-QGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP-DER 318 (429)
Q Consensus 241 ~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~-~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~-~~~ 318 (429)
+++|+|.+++. +...+++..++.++.||+.||.|||+ .||+||||||+|||+ +.++.+||+|||+++.... ...
T Consensus 77 ~~~~~L~~~l~-~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll---~~~~~~kL~Dfg~~~~~~~~~~~ 152 (325)
T cd05594 77 ANGGELFFHLS-RERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLML---DKDGHIKITDFGLCKEGIKDGAT 152 (325)
T ss_pred CCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEE---CCCCCEEEecCCCCeecCCCCcc
Confidence 99999988764 44679999999999999999999997 799999999999999 7788999999999875432 233
Q ss_pred ccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHH
Q 014210 319 LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVK 397 (429)
Q Consensus 319 ~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 397 (429)
.....||..|+|||++. +.++.++|||||||++|||++|+.||........+..+......++ ..+++++.+||+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~~~~~~~li~ 228 (325)
T cd05594 153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFP----RTLSPEAKSLLS 228 (325)
T ss_pred cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCCCC----CCCCHHHHHHHH
Confidence 34567999999999886 4689999999999999999999999998887777777766554443 358899999999
Q ss_pred HhcccCccCcC-----CHHHHHhhHhhhccc
Q 014210 398 RLLNKDPRKRL-----TAAQALSELLICYQS 423 (429)
Q Consensus 398 ~~L~~dP~~Rp-----s~~~iL~~~~~~~~~ 423 (429)
+||+.||++|+ ++.+++.|+||....
T Consensus 229 ~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~ 259 (325)
T cd05594 229 GLLKKDPKQRLGGGPDDAKEIMQHKFFAGIV 259 (325)
T ss_pred HHhhcCHHHhCCCCCCCHHHHhcCCCcCCCC
Confidence 99999999997 999999999998643
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-46 Score=368.22 Aligned_cols=254 Identities=31% Similarity=0.508 Sum_probs=217.3
Q ss_pred eceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcC-cHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEE
Q 014210 160 GEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMT-TAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVM 238 (429)
Q Consensus 160 ~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~-~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~~lv~ 238 (429)
+++||+|+||.||+++...+...|+.||||++.+.... .......+.+|+.+++.++ |+||+++++++.+++..|+||
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~iv~~~~~~~~~~~~~lv~ 79 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVK-HPFIVDLIYAFQTGGKLYLIL 79 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCC-CCchhceeeEEecCCeEEEEE
Confidence 36899999999999987655557899999998653321 2233456789999999998 999999999999999999999
Q ss_pred EecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccccCC-Cc
Q 014210 239 ELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP-DE 317 (429)
Q Consensus 239 E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~-~~ 317 (429)
||+++++|.+++.. .+.+.+..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.... ..
T Consensus 80 e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~ 155 (323)
T cd05584 80 EYLSGGELFMHLER-EGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILL---DAQGHVKLTDFGLCKESIHEGT 155 (323)
T ss_pred eCCCCchHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---CCCCCEEEeeCcCCeecccCCC
Confidence 99999999988754 4678999999999999999999999999999999999999 7788999999999875432 22
Q ss_pred cccccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHH
Q 014210 318 RLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFV 396 (429)
Q Consensus 318 ~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 396 (429)
......||..|+|||++.+ .++.++|||||||++|||++|+.||........+..+.......+ +.+++++.+||
T Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li 231 (323)
T cd05584 156 VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLP----PYLTPEARDLL 231 (323)
T ss_pred cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHH
Confidence 3345679999999998864 588899999999999999999999998888777777776554333 36889999999
Q ss_pred HHhcccCccCcC-----CHHHHHhhHhhhcc
Q 014210 397 KRLLNKDPRKRL-----TAAQALSELLICYQ 422 (429)
Q Consensus 397 ~~~L~~dP~~Rp-----s~~~iL~~~~~~~~ 422 (429)
++||+.||++|+ ++.+++.|+||...
T Consensus 232 ~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~ 262 (323)
T cd05584 232 KKLLKRNPSSRLGAGPGDAAEVQSHPFFRHV 262 (323)
T ss_pred HHHcccCHhHcCCCCCCCHHHHhcCCCcCCC
Confidence 999999999999 89999999999754
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-46 Score=359.86 Aligned_cols=256 Identities=29% Similarity=0.478 Sum_probs=211.1
Q ss_pred CceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeE
Q 014210 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (429)
Q Consensus 155 ~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~ 234 (429)
++|++.+.||+|+||.||+++.+. +++.||||++..... .....+.+.+|+.++++++ |+||+++++++.+++..
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~---~~~~~avK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~ 75 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKE---TKEIVAIKKFKDSEE-NEEVKETTLRELKMLRTLK-QENIVELKEAFRRRGKL 75 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECC---CCcEEEEEEEecccc-cccchhhHHHHHHHHHhCC-CccccchhhhEecCCEE
Confidence 479999999999999999998776 588999999875432 2344567889999999998 99999999999999999
Q ss_pred EEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccccC
Q 014210 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (429)
Q Consensus 235 ~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~ 314 (429)
++||||++++.+ +.+......+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||++....
T Consensus 76 ~lv~e~~~~~~l-~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill---~~~~~~kl~Dfg~~~~~~ 151 (287)
T cd07848 76 YLVFEYVEKNML-ELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLI---SHNDVLKLCDFGFARNLS 151 (287)
T ss_pred EEEEecCCCCHH-HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---cCCCcEEEeeccCccccc
Confidence 999999988655 4455555679999999999999999999999999999999999999 778889999999998764
Q ss_pred CCc--cccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcC--------------
Q 014210 315 PDE--RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKAD-------------- 377 (429)
Q Consensus 315 ~~~--~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~-------------- 377 (429)
... ......|+..|+|||++. ..++.++|||||||++|||++|+.||......+.+..+....
T Consensus 152 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (287)
T cd07848 152 EGSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSN 231 (287)
T ss_pred ccccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhcc
Confidence 332 223457899999999886 468999999999999999999999998776555443332211
Q ss_pred CCCCCC--------------CCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhh
Q 014210 378 PSFDEA--------------PWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLI 419 (429)
Q Consensus 378 ~~~~~~--------------~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~ 419 (429)
+.+... ....++.++.+||++||+.||++|||++++|+|+||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 232 PRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred chhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 100000 012368889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-46 Score=368.90 Aligned_cols=251 Identities=29% Similarity=0.500 Sum_probs=211.9
Q ss_pred ceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEe
Q 014210 161 EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMEL 240 (429)
Q Consensus 161 ~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~~lv~E~ 240 (429)
++||+|+||.||+++.+. +++.||||++.+.........+.+.+|+.++.++.+|+||+++++++.+.+.+||||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~---~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~ 77 (329)
T cd05588 1 RVIGRGSYAKVLLVELKK---TRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEF 77 (329)
T ss_pred CeEeeCCCeEEEEEEECC---CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeC
Confidence 479999999999999776 58999999997655455556677889999999997799999999999999999999999
Q ss_pred cCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCcccc-CCCccc
Q 014210 241 CEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV-RPDERL 319 (429)
Q Consensus 241 ~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~-~~~~~~ 319 (429)
|++|+|.+++. +.+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.. ......
T Consensus 78 ~~~g~L~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili---~~~~~~kL~Dfg~~~~~~~~~~~~ 153 (329)
T cd05588 78 VSGGDLMFHMQ-RQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLL---DAEGHIKLTDYGMCKEGIRPGDTT 153 (329)
T ss_pred CCCCCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEE---CCCCCEEECcCccccccccCCCcc
Confidence 99999988774 44679999999999999999999999999999999999999 67888999999998753 223344
Q ss_pred cccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHcCCCCCCCC---------ChHHHHHHHHhcCCCCCCCCCCCCC
Q 014210 320 NDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWAR---------TESGIFRAVLKADPSFDEAPWPSLS 389 (429)
Q Consensus 320 ~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~elltg~~Pf~~~---------~~~~~~~~i~~~~~~~~~~~~~~~s 389 (429)
...+||..|+|||++.+ .++.++|||||||++|+|++|+.||... ........+.......+ ..++
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p----~~~~ 229 (329)
T cd05588 154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIP----RSLS 229 (329)
T ss_pred ccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCC----CCCC
Confidence 56789999999998874 6899999999999999999999999532 11223344444433332 3588
Q ss_pred HHHHHHHHHhcccCccCcCC------HHHHHhhHhhhcc
Q 014210 390 SEARDFVKRLLNKDPRKRLT------AAQALSELLICYQ 422 (429)
Q Consensus 390 ~~~~~li~~~L~~dP~~Rps------~~~iL~~~~~~~~ 422 (429)
.++.+||++||+.||.+|++ +.+++.|+||...
T Consensus 230 ~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~ 268 (329)
T cd05588 230 VKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNI 268 (329)
T ss_pred HHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCC
Confidence 99999999999999999997 7999999999753
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-47 Score=368.60 Aligned_cols=260 Identities=35% Similarity=0.660 Sum_probs=237.3
Q ss_pred ccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCC
Q 014210 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (429)
Q Consensus 153 ~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~ 232 (429)
+..-|.+.+.||+|.|..|-++++. ++|..||||++.+.++.+. ....+.+|++.|+.++ |||||+||.+.....
T Consensus 16 IAGLYDLekTlG~GHFAVVKLArHV---FTGekVAVKviDKTKlD~~-st~hlfqEVRCMKLVQ-HpNiVRLYEViDTQT 90 (864)
T KOG4717|consen 16 IAGLYDLEKTLGRGHFAVVKLARHV---FTGEKVAVKVIDKTKLDTL-STGHLFQEVRCMKLVQ-HPNIVRLYEVIDTQT 90 (864)
T ss_pred eeeeehhhhhhcCCceehhhhhhhh---cccceeEEEEecccccchh-hhhHHHHHHHHHHHhc-CcCeeeeeehhcccc
Confidence 4567999999999999999888755 4799999999998775544 3456789999999988 999999999999999
Q ss_pred eEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccc
Q 014210 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (429)
Q Consensus 233 ~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~ 312 (429)
.+|||+|.-++|+|+|||.++...+.++.+++++.||+.|+.|||+..||||||||+||.+. ..-|.|||.|||++..
T Consensus 91 KlyLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFF--EKlGlVKLTDFGFSNk 168 (864)
T KOG4717|consen 91 KLYLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFF--EKLGLVKLTDFGFSNK 168 (864)
T ss_pred eEEEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEe--eecCceEeeecccccc
Confidence 99999999999999999999999999999999999999999999999999999999999987 6678999999999999
Q ss_pred cCCCccccccccCCcccCcccccC-CCC-CcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCH
Q 014210 313 VRPDERLNDIVGSAYYVAPEVLHR-SYS-TEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSS 390 (429)
Q Consensus 313 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~-~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 390 (429)
+.++....+.||+..|.|||++.| .|+ +++|||||||+||-|+||+.||...++.+.+..|+......+. .++.
T Consensus 169 f~PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvPs----hvS~ 244 (864)
T KOG4717|consen 169 FQPGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVPS----HVSK 244 (864)
T ss_pred CCCcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCch----hhhH
Confidence 999999999999999999999876 465 4789999999999999999999999999999999887766654 6899
Q ss_pred HHHHHHHHhcccCccCcCCHHHHHhhHhhhccc
Q 014210 391 EARDFVKRLLNKDPRKRLTAAQALSELLICYQS 423 (429)
Q Consensus 391 ~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~~ 423 (429)
+.++||..||..||.+|-+.++|..+.|++..+
T Consensus 245 eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D 277 (864)
T KOG4717|consen 245 ECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGD 277 (864)
T ss_pred HHHHHHHHHHhcCchhhccHHHHhccccccCCC
Confidence 999999999999999999999999999998653
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-46 Score=366.09 Aligned_cols=252 Identities=29% Similarity=0.528 Sum_probs=214.6
Q ss_pred ceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEe
Q 014210 161 EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMEL 240 (429)
Q Consensus 161 ~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~~lv~E~ 240 (429)
++||+|+||.||+|+... +++.||||++.+.........+.+..|..++..+.+|+||+++++++..++.+++||||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~ 77 (316)
T cd05592 1 KVLGKGSFGKVMLAELKG---TNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEY 77 (316)
T ss_pred CeeeeCCCeEEEEEEECC---CCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcC
Confidence 479999999999998765 58899999997654333444556677888887766699999999999999999999999
Q ss_pred cCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccccCC-Cccc
Q 014210 241 CEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP-DERL 319 (429)
Q Consensus 241 ~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~-~~~~ 319 (429)
++||+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.... ....
T Consensus 78 ~~gg~L~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill---~~~~~~kL~Dfg~a~~~~~~~~~~ 153 (316)
T cd05592 78 LNGGDLMFHIQS-SGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLL---DKDGHIKIADFGMCKENMNGEGKA 153 (316)
T ss_pred CCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEE---CCCCCEEEccCcCCeECCCCCCcc
Confidence 999999887754 4579999999999999999999999999999999999999 7788899999999976432 2334
Q ss_pred cccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHH
Q 014210 320 NDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKR 398 (429)
Q Consensus 320 ~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ 398 (429)
...+||..|+|||++.+ .++.++|||||||++|||++|+.||........+..+....+.++ ..++.++.+||++
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~ll~~ 229 (316)
T cd05592 154 STFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFP----RWISKEAKDCLSK 229 (316)
T ss_pred ccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHHHH
Confidence 45679999999998874 589999999999999999999999998888887777766554443 3578999999999
Q ss_pred hcccCccCcCCH-HHHHhhHhhhccc
Q 014210 399 LLNKDPRKRLTA-AQALSELLICYQS 423 (429)
Q Consensus 399 ~L~~dP~~Rps~-~~iL~~~~~~~~~ 423 (429)
||+.||++|+++ .+++.|+|+....
T Consensus 230 ~l~~~P~~R~~~~~~l~~h~~~~~~~ 255 (316)
T cd05592 230 LFERDPTKRLGVDGDIRQHPFFRGID 255 (316)
T ss_pred HccCCHHHcCCChHHHHcCcccCCCC
Confidence 999999999986 5888999987643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-46 Score=371.03 Aligned_cols=246 Identities=28% Similarity=0.456 Sum_probs=211.6
Q ss_pred CceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeE
Q 014210 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (429)
Q Consensus 155 ~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~ 234 (429)
+.+.++++||+|.||.||.|.... ...||+|.+....+.. +.|.+|+++|++|+ |+|||+|+++|..++.+
T Consensus 206 ~~l~l~~~LG~G~FG~V~~g~~~~----~~~vavk~ik~~~m~~----~~f~~Ea~iMk~L~-H~~lV~l~gV~~~~~pi 276 (468)
T KOG0197|consen 206 EELKLIRELGSGQFGEVWLGKWNG----STKVAVKTIKEGSMSP----EAFLREAQIMKKLR-HEKLVKLYGVCTKQEPI 276 (468)
T ss_pred HHHHHHHHhcCCccceEEEEEEcC----CCcccceEEeccccCh----hHHHHHHHHHHhCc-ccCeEEEEEEEecCCce
Confidence 446678999999999999998664 3489999986543332 56779999999999 99999999999999999
Q ss_pred EEEEEecCCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCcccc
Q 014210 235 YVVMELCEGGELLDRILS-RGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (429)
Q Consensus 235 ~lv~E~~~ggsL~~~i~~-~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~ 313 (429)
|||||||+.|+|++++.. .+..+...+...++.||++|++||+++++|||||-+.|||| +++..+||+|||||+..
T Consensus 277 yIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV---~~~~~vKIsDFGLAr~~ 353 (468)
T KOG0197|consen 277 YIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILV---DEDLVVKISDFGLARLI 353 (468)
T ss_pred EEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheee---ccCceEEEccccccccc
Confidence 999999999999999987 46689999999999999999999999999999999999999 88999999999999965
Q ss_pred CCCcccccc--ccCCcccCccccc-CCCCCcccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCC
Q 014210 314 RPDERLNDI--VGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLS 389 (429)
Q Consensus 314 ~~~~~~~~~--~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 389 (429)
.++...... .-...|+|||++. +.|+.+||||||||+||||+| |+.||...+..+.++.+.++..... .+.++
T Consensus 354 ~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~---P~~CP 430 (468)
T KOG0197|consen 354 GDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPR---PEGCP 430 (468)
T ss_pred CCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCC---CCCCC
Confidence 544432222 2345699999887 789999999999999999998 9999999999999888877653322 24799
Q ss_pred HHHHHHHHHhcccCccCcCCHHHHHh
Q 014210 390 SEARDFVKRLLNKDPRKRLTAAQALS 415 (429)
Q Consensus 390 ~~~~~li~~~L~~dP~~Rps~~~iL~ 415 (429)
.++.++++.||..+|++|||++.+..
T Consensus 431 ~~vY~lM~~CW~~~P~~RPtF~~L~~ 456 (468)
T KOG0197|consen 431 DEVYELMKSCWHEDPEDRPTFETLRE 456 (468)
T ss_pred HHHHHHHHHHhhCCcccCCCHHHHHH
Confidence 99999999999999999999996643
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-46 Score=374.38 Aligned_cols=260 Identities=28% Similarity=0.489 Sum_probs=219.7
Q ss_pred CceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeE
Q 014210 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (429)
Q Consensus 155 ~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~ 234 (429)
++|++.+.||+|+||.||+++.+. +|+.||||++.+...........+.+|+.++..+. |+||+++++.+.+++.+
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~iv~~~~~~~~~~~~ 76 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKD---TGHIYAMKILRKADMLEKEQVAHIRAERDILVEAD-GAWVVKMFYSFQDKRNL 76 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECC---CCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCC-CCCEeeEEEEEEcCCEE
Confidence 468999999999999999998776 58999999997544444555677889999999998 99999999999999999
Q ss_pred EEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccccC
Q 014210 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (429)
Q Consensus 235 ~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~ 314 (429)
|||||||+||+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++....
T Consensus 77 ~lv~E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli---~~~~~vkL~DfG~~~~~~ 152 (360)
T cd05627 77 YLIMEFLPGGDMMTLLMK-KDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLL---DAKGHVKLSDFGLCTGLK 152 (360)
T ss_pred EEEEeCCCCccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEE---CCCCCEEEeeccCCcccc
Confidence 999999999999998754 4679999999999999999999999999999999999999 778899999999986542
Q ss_pred CCc------------------------------------cccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHcC
Q 014210 315 PDE------------------------------------RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCG 357 (429)
Q Consensus 315 ~~~------------------------------------~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~elltg 357 (429)
... .....+||+.|+|||++. ..++.++|||||||++|||++|
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG 232 (360)
T cd05627 153 KAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232 (360)
T ss_pred cccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccC
Confidence 211 012357999999999886 4689999999999999999999
Q ss_pred CCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCcC---CHHHHHhhHhhhccc
Q 014210 358 SRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRL---TAAQALSELLICYQS 423 (429)
Q Consensus 358 ~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp---s~~~iL~~~~~~~~~ 423 (429)
+.||........+..++.............++.++++||.+|+ .||.+|+ ++.+++.|+||....
T Consensus 233 ~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~~ 300 (360)
T cd05627 233 YPPFCSETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKSHPFFEGVD 300 (360)
T ss_pred CCCCCCCCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcCCCCCCCC
Confidence 9999988888777777654332222222347899999999977 4999998 489999999998653
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-46 Score=366.08 Aligned_cols=252 Identities=27% Similarity=0.504 Sum_probs=214.5
Q ss_pred ceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEe
Q 014210 161 EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMEL 240 (429)
Q Consensus 161 ~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~~lv~E~ 240 (429)
++||+|+||.||+|+.+. +|+.||||++.+.........+.+..|..++..+.+|+||+++++++.+.+.+|+||||
T Consensus 1 ~~lg~G~~g~V~~~~~~~---~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~ 77 (316)
T cd05620 1 KVLGKGSFGKVLLAELKG---KGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEF 77 (316)
T ss_pred CeeeeCCCeEEEEEEECC---CCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECC
Confidence 479999999999999776 58999999987543322334566778888888775699999999999999999999999
Q ss_pred cCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccccCC-Cccc
Q 014210 241 CEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP-DERL 319 (429)
Q Consensus 241 ~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~-~~~~ 319 (429)
+.+|+|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.... ....
T Consensus 78 ~~~g~L~~~i~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~ 153 (316)
T cd05620 78 LNGGDLMFHIQD-KGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVML---DRDGHIKIADFGMCKENVFGDNRA 153 (316)
T ss_pred CCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEE---CCCCCEEeCccCCCeecccCCCce
Confidence 999999988754 4678999999999999999999999999999999999999 7788999999999875322 2334
Q ss_pred cccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHH
Q 014210 320 NDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKR 398 (429)
Q Consensus 320 ~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ 398 (429)
...+||..|+|||++.+ .++.++|||||||++|||++|+.||........+..+....+.++. .++.++.+||++
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~li~~ 229 (316)
T cd05620 154 STFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPR----WITKESKDILEK 229 (316)
T ss_pred eccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC----CCCHHHHHHHHH
Confidence 45679999999998874 6899999999999999999999999988887777777655544432 478999999999
Q ss_pred hcccCccCcCCH-HHHHhhHhhhccc
Q 014210 399 LLNKDPRKRLTA-AQALSELLICYQS 423 (429)
Q Consensus 399 ~L~~dP~~Rps~-~~iL~~~~~~~~~ 423 (429)
||+.||++|+++ .+++.|+||....
T Consensus 230 ~l~~dP~~R~~~~~~~~~h~~f~~~~ 255 (316)
T cd05620 230 LFERDPTRRLGVVGNIRGHPFFKTIN 255 (316)
T ss_pred HccCCHHHcCCChHHHHcCCCcCCCC
Confidence 999999999998 5788899997654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-46 Score=367.07 Aligned_cols=261 Identities=28% Similarity=0.490 Sum_probs=219.6
Q ss_pred CceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeE
Q 014210 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (429)
Q Consensus 155 ~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~ 234 (429)
++|++.+.||+|+||.||+++... +++.||||++.+.........+.+.+|+.++..++ |+||+++++++.+++.+
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~ 76 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKN---TGQVYAMKILNKWEMLKRAETACFREERDVLVNGD-RRWITNLHYAFQDENNL 76 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECC---CCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCC-CCCCCceEEEEecCCeE
Confidence 479999999999999999998776 58899999986543344445567889999999987 99999999999999999
Q ss_pred EEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccccC
Q 014210 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (429)
Q Consensus 235 ~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~ 314 (429)
|+||||++||+|.+++......+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++....
T Consensus 77 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill---~~~~~~kl~Dfg~~~~~~ 153 (331)
T cd05597 77 YLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLL---DKNGHIRLADFGSCLRLL 153 (331)
T ss_pred EEEEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEE---CCCCCEEEEECCceeecC
Confidence 99999999999999987666789999999999999999999999999999999999999 778899999999987654
Q ss_pred CCccc--cccccCCcccCccccc------CCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCC-CCC
Q 014210 315 PDERL--NDIVGSAYYVAPEVLH------RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDE-APW 385 (429)
Q Consensus 315 ~~~~~--~~~~gt~~y~aPE~~~------~~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~-~~~ 385 (429)
..... ....||+.|+|||++. +.++.++|||||||++|||++|+.||......+.+..+......... ...
T Consensus 154 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 233 (331)
T cd05597 154 ADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDV 233 (331)
T ss_pred CCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCcc
Confidence 33322 2356999999999885 34788999999999999999999999888777777776654332221 122
Q ss_pred CCCCHHHHHHHHHhcccCccC--cCCHHHHHhhHhhhcc
Q 014210 386 PSLSSEARDFVKRLLNKDPRK--RLTAAQALSELLICYQ 422 (429)
Q Consensus 386 ~~~s~~~~~li~~~L~~dP~~--Rps~~~iL~~~~~~~~ 422 (429)
+.++.++.+||++||+.++++ |+++.+++.|+||...
T Consensus 234 ~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~ 272 (331)
T cd05597 234 TDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGI 272 (331)
T ss_pred CCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCC
Confidence 358999999999999765544 7899999999999754
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-46 Score=373.45 Aligned_cols=263 Identities=27% Similarity=0.454 Sum_probs=222.7
Q ss_pred cccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeC
Q 014210 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (429)
Q Consensus 152 ~~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~ 231 (429)
...++|++.+.||+|+||.||+++.+. +++.||+|++.+.........+.+.+|+.+++.++ ||||+++++++.++
T Consensus 40 ~~~~~y~i~~~lG~G~fg~Vy~~~~~~---~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~-hp~iv~~~~~~~~~ 115 (371)
T cd05622 40 MKAEDYEVVKVIGRGAFGEVQLVRHKS---TRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN-SPWVVQLFYAFQDD 115 (371)
T ss_pred cchhhcEEEEEEeecCCeEEEEEEECC---CCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCC-CCCCCeEEEEEEcC
Confidence 345899999999999999999998776 58999999986543334444566889999999988 99999999999999
Q ss_pred CeEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCcc
Q 014210 232 DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (429)
Q Consensus 232 ~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~ 311 (429)
+..++|||||+||+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.
T Consensus 116 ~~~~lv~Ey~~gg~L~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll---~~~~~ikL~DfG~a~ 190 (371)
T cd05622 116 RYLYMVMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLL---DKSGHLKLADFGTCM 190 (371)
T ss_pred CEEEEEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEE---CCCCCEEEEeCCcee
Confidence 999999999999999988743 458999999999999999999999999999999999999 678899999999997
Q ss_pred ccCCCc--cccccccCCcccCcccccC-----CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCC
Q 014210 312 FVRPDE--RLNDIVGSAYYVAPEVLHR-----SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAP 384 (429)
Q Consensus 312 ~~~~~~--~~~~~~gt~~y~aPE~~~~-----~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 384 (429)
...... .....+||+.|+|||++.+ .++.++|||||||++|||++|+.||...+....+..++..........
T Consensus 191 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 270 (371)
T cd05622 191 KMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPD 270 (371)
T ss_pred EcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCC
Confidence 764332 2235679999999998853 278899999999999999999999999888888888876554333333
Q ss_pred CCCCCHHHHHHHHHhcccCccC--cCCHHHHHhhHhhhccc
Q 014210 385 WPSLSSEARDFVKRLLNKDPRK--RLTAAQALSELLICYQS 423 (429)
Q Consensus 385 ~~~~s~~~~~li~~~L~~dP~~--Rps~~~iL~~~~~~~~~ 423 (429)
...++.++++||..||..++.+ |+++.++++|+||....
T Consensus 271 ~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~~ 311 (371)
T cd05622 271 DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQ 311 (371)
T ss_pred cCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCCC
Confidence 4578999999999999854443 78999999999997643
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-46 Score=366.09 Aligned_cols=252 Identities=29% Similarity=0.500 Sum_probs=217.8
Q ss_pred ceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEe
Q 014210 161 EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMEL 240 (429)
Q Consensus 161 ~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~~lv~E~ 240 (429)
++||+|+||.||+|+... +++.||||++.+.........+.+.+|++++..+.+|+||+++++++.+.+.+|+||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~ 77 (318)
T cd05570 1 KVLGKGSFGKVLLAELKG---TDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEY 77 (318)
T ss_pred CeeeeCCCeEEEEEEECC---CCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcC
Confidence 479999999999998766 58899999997654444455667889999999886799999999999999999999999
Q ss_pred cCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccccC-CCccc
Q 014210 241 CEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR-PDERL 319 (429)
Q Consensus 241 ~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~-~~~~~ 319 (429)
++||+|.+++.. .+.+++..+..++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||++.... .....
T Consensus 78 ~~~~~L~~~~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~~~~ 153 (318)
T cd05570 78 VNGGDLMFHIQR-SGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLL---DSEGHIKIADFGMCKEGILGGVTT 153 (318)
T ss_pred CCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEE---CCCCcEEecccCCCeecCcCCCcc
Confidence 999999887754 4579999999999999999999999999999999999999 778899999999986532 22233
Q ss_pred cccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHH
Q 014210 320 NDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKR 398 (429)
Q Consensus 320 ~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ 398 (429)
...+|+..|+|||++.+ .++.++|||||||++|+|++|+.||........+..+......++ ..++.++.+||++
T Consensus 154 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~li~~ 229 (318)
T cd05570 154 STFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYP----RWLSKEAKSILKS 229 (318)
T ss_pred cceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCC----CcCCHHHHHHHHH
Confidence 45679999999998874 689999999999999999999999998888777777766655443 3588999999999
Q ss_pred hcccCccCcCCH-----HHHHhhHhhhccc
Q 014210 399 LLNKDPRKRLTA-----AQALSELLICYQS 423 (429)
Q Consensus 399 ~L~~dP~~Rps~-----~~iL~~~~~~~~~ 423 (429)
||+.||++||++ .+++.|+|+....
T Consensus 230 ~l~~dP~~R~s~~~~~~~~ll~~~~~~~~~ 259 (318)
T cd05570 230 FLTKNPEKRLGCLPTGEQDIKGHPFFREID 259 (318)
T ss_pred HccCCHHHcCCCCCCCHHHHhcCCCcCCCC
Confidence 999999999999 9999999997654
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-46 Score=357.43 Aligned_cols=258 Identities=29% Similarity=0.413 Sum_probs=210.5
Q ss_pred CceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhc--CCCCcceEEEEEE---
Q 014210 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALT--GHNNLVKFFDAYE--- 229 (429)
Q Consensus 155 ~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~--~h~nIv~l~~~~~--- 229 (429)
++|++.++||+|+||.||+|+.... .|+.||||++....... .....+.+|+.+++.+. .||||+++++++.
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~--~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~ 77 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKN--GGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 77 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCC--CCeEEEEEEEecccCCC-CchHHHHHHHHHHHhhcccCCCCcceEEEEEeccc
Confidence 4799999999999999999986542 37889999986543222 22244567888887764 4999999999985
Q ss_pred --eCCeEEEEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEee
Q 014210 230 --DTDNVYVVMELCEGGELLDRILSRG-GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAID 306 (429)
Q Consensus 230 --~~~~~~lv~E~~~ggsL~~~i~~~~-~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~D 306 (429)
....+++||||++ ++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|
T Consensus 78 ~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~---~~~~~~kl~D 153 (290)
T cd07862 78 TDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILV---TSSGQIKLAD 153 (290)
T ss_pred CCCCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEE---cCCCCEEEcc
Confidence 3456899999996 58888886543 458999999999999999999999999999999999999 6788899999
Q ss_pred cCCccccCCCccccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCC---
Q 014210 307 FGLSDFVRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDE--- 382 (429)
Q Consensus 307 FGla~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~--- 382 (429)
||++.............||..|+|||++. ..++.++|||||||++|||++|+.||......+.+..+.........
T Consensus 154 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~ 233 (290)
T cd07862 154 FGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 233 (290)
T ss_pred ccceEeccCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhc
Confidence 99998765554455667999999999886 46899999999999999999999999988877777666543211100
Q ss_pred --------------------CCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhh
Q 014210 383 --------------------APWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLI 419 (429)
Q Consensus 383 --------------------~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~ 419 (429)
...+.+++.+.+||.+||+.||++||++.++|.|+||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 234 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred hhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 1123578899999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-45 Score=374.97 Aligned_cols=258 Identities=24% Similarity=0.357 Sum_probs=202.4
Q ss_pred ccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhc-----CCCCcceEEEE
Q 014210 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALT-----GHNNLVKFFDA 227 (429)
Q Consensus 153 ~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~-----~h~nIv~l~~~ 227 (429)
..++|+++++||+|+||.||+|.... .++.||||++... .....++..|+.+++++. +|.+|++++++
T Consensus 127 ~~~~y~i~~~lG~G~fg~V~~a~~~~---~~~~vAvK~i~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~ 199 (467)
T PTZ00284 127 STQRFKILSLLGEGTFGKVVEAWDRK---RKEYCAVKIVRNV----PKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRY 199 (467)
T ss_pred CCCcEEEEEEEEeccCEEEEEEEEcC---CCeEEEEEEEecc----hhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEE
Confidence 46789999999999999999998766 5889999998542 223345667888888776 24468999999
Q ss_pred EEeC-CeEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-cCceeccCCCCcEEEeecC--------
Q 014210 228 YEDT-DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHL-QGVVHRDLKPENFLFTTKD-------- 297 (429)
Q Consensus 228 ~~~~-~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~-~~iiHrDIKp~NILl~~~~-------- 297 (429)
+..+ ++.+||||++ |++|.+++... +.+++..++.|+.||+.||.|||+ .|||||||||+|||+...+
T Consensus 200 ~~~~~~~~~iv~~~~-g~~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~ 277 (467)
T PTZ00284 200 FQNETGHMCIVMPKY-GPCLLDWIMKH-GPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTN 277 (467)
T ss_pred EEcCCceEEEEEecc-CCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccc
Confidence 8765 5789999998 77888887544 679999999999999999999998 5999999999999995322
Q ss_pred -----CCceEEEeecCCccccCCCccccccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHH
Q 014210 298 -----ENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFR 371 (429)
Q Consensus 298 -----~~~~vkL~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~ 371 (429)
+...+||+|||++.... ......+||..|+|||++.+ .++.++|||||||++|||++|+.||......+.+.
T Consensus 278 ~~~~~~~~~vkl~DfG~~~~~~--~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~ 355 (467)
T PTZ00284 278 RALPPDPCRVRICDLGGCCDER--HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLH 355 (467)
T ss_pred cccCCCCceEEECCCCccccCc--cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence 12259999999876432 23345789999999998875 69999999999999999999999998777655544
Q ss_pred HHHhcCCCCCCC------------------------------------CCC--CCCHHHHHHHHHhcccCccCcCCHHHH
Q 014210 372 AVLKADPSFDEA------------------------------------PWP--SLSSEARDFVKRLLNKDPRKRLTAAQA 413 (429)
Q Consensus 372 ~i~~~~~~~~~~------------------------------------~~~--~~s~~~~~li~~~L~~dP~~Rps~~~i 413 (429)
.+.+....++.. .+. ..++.+.|||.+||++||++|||+.|+
T Consensus 356 ~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~ 435 (467)
T PTZ00284 356 LMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQM 435 (467)
T ss_pred HHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHH
Confidence 333221111000 000 114567899999999999999999999
Q ss_pred HhhHhhhc
Q 014210 414 LSELLICY 421 (429)
Q Consensus 414 L~~~~~~~ 421 (429)
|+|+||..
T Consensus 436 L~Hp~~~~ 443 (467)
T PTZ00284 436 TTHPYVLK 443 (467)
T ss_pred hcCccccc
Confidence 99999976
|
|
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-46 Score=364.42 Aligned_cols=257 Identities=28% Similarity=0.466 Sum_probs=221.5
Q ss_pred ceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEE
Q 014210 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVY 235 (429)
Q Consensus 156 ~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~~ 235 (429)
+|++.+.||+|+||.||+|+... +|+.||||++.+.........+.+..|+.++..+.+|++|+++++++.+.+.+|
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~ 77 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKG---TDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLY 77 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECC---CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEE
Confidence 47889999999999999998766 589999999976543344555678889999998886789999999999999999
Q ss_pred EEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccccCC
Q 014210 236 VVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP 315 (429)
Q Consensus 236 lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~ 315 (429)
+||||++||+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.....
T Consensus 78 lv~Ey~~~g~L~~~i~~-~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill---~~~~~ikL~Dfg~~~~~~~ 153 (323)
T cd05615 78 FVMEYVNGGDLMYHIQQ-VGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVML---DSEGHIKIADFGMCKEHMV 153 (323)
T ss_pred EEEcCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEE---CCCCCEEEeccccccccCC
Confidence 99999999999988744 4679999999999999999999999999999999999999 7788999999999875432
Q ss_pred C-ccccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHH
Q 014210 316 D-ERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEAR 393 (429)
Q Consensus 316 ~-~~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 393 (429)
. .......||..|+|||++. +.++.++|||||||++|||++|+.||........+..++......+ ..++.++.
T Consensus 154 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p----~~~~~~~~ 229 (323)
T cd05615 154 DGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYP----KSLSKEAV 229 (323)
T ss_pred CCccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----ccCCHHHH
Confidence 2 2334567999999999886 4689999999999999999999999998888888888877655443 35889999
Q ss_pred HHHHHhcccCccCcCC-----HHHHHhhHhhhccc
Q 014210 394 DFVKRLLNKDPRKRLT-----AAQALSELLICYQS 423 (429)
Q Consensus 394 ~li~~~L~~dP~~Rps-----~~~iL~~~~~~~~~ 423 (429)
+|+.+||+.||.+|++ ..++++|+||....
T Consensus 230 ~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~~ 264 (323)
T cd05615 230 SICKGLMTKHPSKRLGCGPEGERDIREHAFFRRID 264 (323)
T ss_pred HHHHHHcccCHhhCCCCCCCCHHHHhcCcccCCCC
Confidence 9999999999999997 57999999998654
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-46 Score=352.85 Aligned_cols=261 Identities=31% Similarity=0.484 Sum_probs=225.1
Q ss_pred cCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCC-cceEEEEEEeCC
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNN-LVKFFDAYEDTD 232 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~n-Iv~l~~~~~~~~ 232 (429)
...|+.+++||+|.||+||+|+.+. +|+.||+|.+....... -.-....+|+.+|++|+ |+| ||++++++...+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~---~g~~VALKkirl~~~~E-G~P~taiREisllk~L~-~~~~iv~L~dv~~~~~ 84 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKR---TGKFVALKKIRLEFEEE-GVPSTAIREISLLKRLS-HANHIVRLHDVIHTSN 84 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEec---CCCEEEEEEEecccccc-CCCchhhHHHHHHHHhC-CCcceEEEEeeeeecc
Confidence 4568889999999999999999887 68999999997653321 12234579999999999 999 999999999877
Q ss_pred ------eEEEEEEecCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEE
Q 014210 233 ------NVYVVMELCEGGELLDRILSRG---GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLK 303 (429)
Q Consensus 233 ------~~~lv~E~~~ggsL~~~i~~~~---~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vk 303 (429)
.+++|+||++- +|.+++.... ..++...++.++.||+.||+|||++||+||||||+|||| ++.|.+|
T Consensus 85 ~~~~~~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi---~~~G~lK 160 (323)
T KOG0594|consen 85 NHRGIGKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLI---SSSGVLK 160 (323)
T ss_pred cccccceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEE---CCCCcEe
Confidence 79999999965 9999887665 358889999999999999999999999999999999999 6799999
Q ss_pred EeecCCccccC-CCccccccccCCcccCcccccC--CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCC
Q 014210 304 AIDFGLSDFVR-PDERLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSF 380 (429)
Q Consensus 304 L~DFGla~~~~-~~~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~ 380 (429)
|+|||+|+... +.......++|..|+|||++.+ .|+...||||+||+++||++++..|.+..+.+.+..|.+.-...
T Consensus 161 laDFGlAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP 240 (323)
T KOG0594|consen 161 LADFGLARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTP 240 (323)
T ss_pred eeccchHHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCC
Confidence 99999999776 4445677899999999999875 59999999999999999999999999999988888887765555
Q ss_pred CCCCCCC--------------------------CCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhccc
Q 014210 381 DEAPWPS--------------------------LSSEARDFVKRLLNKDPRKRLTAAQALSELLICYQS 423 (429)
Q Consensus 381 ~~~~~~~--------------------------~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~~ 423 (429)
.+..||+ .+.+..+++.+||+.+|.+|.|+..+|.|+||....
T Consensus 241 ~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~ 309 (323)
T KOG0594|consen 241 NEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELP 309 (323)
T ss_pred CccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccc
Confidence 5555543 235889999999999999999999999999998653
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-46 Score=354.41 Aligned_cols=260 Identities=33% Similarity=0.592 Sum_probs=219.0
Q ss_pred cccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEe-
Q 014210 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED- 230 (429)
Q Consensus 152 ~~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~- 230 (429)
....+|..++.||+|+||.||.+..+. +|+.||||.+.. .+......++..+|+++|+.++ |+||+.+++.+..
T Consensus 19 ~i~~~y~~~~~iG~GAyGvVcsA~~~~---t~~~VAIKKi~~-~F~~~~~akRtlRElklLr~~~-HeNIi~l~di~~p~ 93 (359)
T KOG0660|consen 19 EIPRYYVLIEPIGRGAYGVVCSAKDKR---TGEKVAIKKILN-PFENQIDAKRTLRELKLLRHLR-HENIIGLLDIFRPP 93 (359)
T ss_pred eccceecccccccCcceeeEEEEEEcC---CCCEeehhhhhh-hhhchHHHHHHHHHHHHHHHhc-CCCcceEEeecccc
Confidence 445677778999999999999999887 689999999853 2456667788999999999999 9999999999865
Q ss_pred ----CCeEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEee
Q 014210 231 ----TDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAID 306 (429)
Q Consensus 231 ----~~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~D 306 (429)
-+.+|+|+|+|+ .+|...| +.+..+++..+..++.||++||+|+|+.+|+||||||.|+|+ +.+-.+||||
T Consensus 94 ~~~~f~DvYiV~elMe-tDL~~ii-k~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~---n~~c~lKI~D 168 (359)
T KOG0660|consen 94 SRDKFNDVYLVFELME-TDLHQII-KSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLL---NADCDLKICD 168 (359)
T ss_pred cccccceeEEehhHHh-hHHHHHH-HcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheee---ccCCCEEecc
Confidence 456999999994 4776655 555569999999999999999999999999999999999999 6677799999
Q ss_pred cCCccccCC---CccccccccCCcccCccccc--CCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhc-----
Q 014210 307 FGLSDFVRP---DERLNDIVGSAYYVAPEVLH--RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKA----- 376 (429)
Q Consensus 307 FGla~~~~~---~~~~~~~~gt~~y~aPE~~~--~~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~----- 376 (429)
||+|+.... +......+.|.+|.|||++. ..|+...||||+||+|.||++|+..|.+....+.+..|+..
T Consensus 169 FGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~ 248 (359)
T KOG0660|consen 169 FGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPS 248 (359)
T ss_pred ccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCC
Confidence 999998864 44556788999999999875 46999999999999999999999999877766555544432
Q ss_pred ------------------CCCCCCCC----CCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhc
Q 014210 377 ------------------DPSFDEAP----WPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLICY 421 (429)
Q Consensus 377 ------------------~~~~~~~~----~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~ 421 (429)
.+..+..+ ++..++++.||+.+||..||.+|+|++|+|+|+|+..
T Consensus 249 ~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~ 315 (359)
T KOG0660|consen 249 EEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAP 315 (359)
T ss_pred HHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhh
Confidence 22222222 3578999999999999999999999999999999863
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-47 Score=370.81 Aligned_cols=256 Identities=30% Similarity=0.508 Sum_probs=230.2
Q ss_pred cCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~ 233 (429)
.++|+++++||+|+||.+++++++. +++.|++|.+........ ..+...+|+.++++++ |||||.+++.|++++.
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~---~~~~~vlK~I~l~~~t~~-~r~~A~~E~~lis~~~-hP~iv~y~ds~~~~~~ 77 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKS---DDKLYVLKKINLEKLTEP-ERRSAIQEMDLLSKLL-HPNIVEYKDSFEEDGQ 77 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhcc---CCceEEEEEEeccccCch-hhHHHHHHHHHHHhcc-CCCeeeeccchhcCCc
Confidence 4689999999999999999998776 578999999977654443 3457889999999998 9999999999999988
Q ss_pred -EEEEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCcc
Q 014210 234 -VYVVMELCEGGELLDRILSRG-GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (429)
Q Consensus 234 -~~lv~E~~~ggsL~~~i~~~~-~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~ 311 (429)
++|||+||+||+|.+.|.+.+ ..++++.+..++.||+.|+.|||+++|+|||||+.||++ ..+..|||+|||+|+
T Consensus 78 ~l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifl---tk~~~VkLgDfGlaK 154 (426)
T KOG0589|consen 78 LLCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFL---TKDKKVKLGDFGLAK 154 (426)
T ss_pred eEEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhc---cccCceeecchhhhh
Confidence 999999999999999998765 579999999999999999999999999999999999999 566678999999999
Q ss_pred ccCCCc-cccccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCC
Q 014210 312 FVRPDE-RLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLS 389 (429)
Q Consensus 312 ~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 389 (429)
.+.... .....+||++||.||++.+ .|+.|+|||||||++|||++-+.+|.+.+..+...+|.+...... ...++
T Consensus 155 ~l~~~~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Pl---p~~ys 231 (426)
T KOG0589|consen 155 ILNPEDSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPL---PSMYS 231 (426)
T ss_pred hcCCchhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCC---Ccccc
Confidence 998776 6778999999999999986 699999999999999999999999999999999988887762222 23689
Q ss_pred HHHHHHHHHhcccCccCcCCHHHHHhhHhhh
Q 014210 390 SEARDFVKRLLNKDPRKRLTAAQALSELLIC 420 (429)
Q Consensus 390 ~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~ 420 (429)
.+++.||+.||..+|+.||++.++|.++.++
T Consensus 232 ~el~~lv~~~l~~~P~~RPsa~~LL~~P~l~ 262 (426)
T KOG0589|consen 232 SELRSLVKSMLRKNPEHRPSALELLRRPHLL 262 (426)
T ss_pred HHHHHHHHHHhhcCCccCCCHHHHhhChhhh
Confidence 9999999999999999999999999998776
|
|
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-46 Score=365.54 Aligned_cols=252 Identities=27% Similarity=0.489 Sum_probs=211.7
Q ss_pred ceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEe
Q 014210 161 EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMEL 240 (429)
Q Consensus 161 ~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~~lv~E~ 240 (429)
+.||+|+||.||+++... +++.||+|++.+.........+.+.+|+.++.++.+|+||+++++++.+++..+|||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~ 77 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKK---TERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEY 77 (329)
T ss_pred CeeeeCCCeEEEEEEECC---CCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeC
Confidence 479999999999999776 58899999997765455566677889999998886699999999999999999999999
Q ss_pred cCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccccC-CCccc
Q 014210 241 CEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR-PDERL 319 (429)
Q Consensus 241 ~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~-~~~~~ 319 (429)
+++|+|..++. ..+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++... .....
T Consensus 78 ~~~~~L~~~~~-~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili---~~~~~~kL~DfG~~~~~~~~~~~~ 153 (329)
T cd05618 78 VNGGDLMFHMQ-RQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLL---DSEGHIKLTDYGMCKEGLRPGDTT 153 (329)
T ss_pred CCCCCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEE---CCCCCEEEeeCCccccccCCCCcc
Confidence 99999988764 44679999999999999999999999999999999999999 778899999999987542 23334
Q ss_pred cccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHcCCCCCCCC---------ChHHHHHHHHhcCCCCCCCCCCCCC
Q 014210 320 NDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWAR---------TESGIFRAVLKADPSFDEAPWPSLS 389 (429)
Q Consensus 320 ~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~elltg~~Pf~~~---------~~~~~~~~i~~~~~~~~~~~~~~~s 389 (429)
....||..|+|||++.+ .++.++|||||||++|||++|+.||... ........+......++ ..++
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p----~~~~ 229 (329)
T cd05618 154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP----RSLS 229 (329)
T ss_pred ccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCC----CCCC
Confidence 45689999999998874 6889999999999999999999999521 11223344444443333 3688
Q ss_pred HHHHHHHHHhcccCccCcCC------HHHHHhhHhhhccc
Q 014210 390 SEARDFVKRLLNKDPRKRLT------AAQALSELLICYQS 423 (429)
Q Consensus 390 ~~~~~li~~~L~~dP~~Rps------~~~iL~~~~~~~~~ 423 (429)
.++.+||++||+.||++|++ +.+++.|+||....
T Consensus 230 ~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~~ 269 (329)
T cd05618 230 VKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVD 269 (329)
T ss_pred HHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCCC
Confidence 99999999999999999998 58999999997654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=355.23 Aligned_cols=254 Identities=25% Similarity=0.404 Sum_probs=208.8
Q ss_pred eeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEecC
Q 014210 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCE 242 (429)
Q Consensus 163 IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~~lv~E~~~ 242 (429)
||+|+||.||++..+. +|+.||||++.+.........+.+..|+++++.++ |+||+++++++..++..++||||++
T Consensus 1 lg~G~~g~Vy~~~~~~---~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-~~~i~~~~~~~~~~~~~~lv~e~~~ 76 (280)
T cd05608 1 LGKGGFGEVSACQMRA---TGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVH-SRFIVSLAYAFQTKTDLCLVMTIMN 76 (280)
T ss_pred CCCCCceeEEEEEEcc---CCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCC-CCcEeeeeEEEcCCCeEEEEEeCCC
Confidence 7999999999998765 58999999987654444445567889999999998 9999999999999999999999999
Q ss_pred CCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccccCCCc-c
Q 014210 243 GGELLDRILS---RGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDE-R 318 (429)
Q Consensus 243 ggsL~~~i~~---~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~-~ 318 (429)
+|+|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++....... .
T Consensus 77 ~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili---~~~~~~~l~dfg~~~~~~~~~~~ 153 (280)
T cd05608 77 GGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLL---DNDGNVRISDLGLAVELKDGQSK 153 (280)
T ss_pred CCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEeeCccceecCCCCcc
Confidence 9999887643 34569999999999999999999999999999999999999 678889999999987654332 2
Q ss_pred ccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHH
Q 014210 319 LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVK 397 (429)
Q Consensus 319 ~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 397 (429)
.....||..|+|||++. +.++.++||||||+++|||++|+.||...........+..............++.++.+|+.
T Consensus 154 ~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 233 (280)
T cd05608 154 TKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCE 233 (280)
T ss_pred ccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcccCCHHHHHHHH
Confidence 33467999999999887 46889999999999999999999999765432222222211111111222468899999999
Q ss_pred HhcccCccCcC-----CHHHHHhhHhhhccc
Q 014210 398 RLLNKDPRKRL-----TAAQALSELLICYQS 423 (429)
Q Consensus 398 ~~L~~dP~~Rp-----s~~~iL~~~~~~~~~ 423 (429)
+||+.||++|+ +++++++|+||+...
T Consensus 234 ~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~~ 264 (280)
T cd05608 234 ALLAKDPEKRLGFRDGNCDGLRTHPLFRDLN 264 (280)
T ss_pred HHhcCCHHHhcCCCCCCHHHHhcChhhhcCC
Confidence 99999999999 889999999998643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-45 Score=360.32 Aligned_cols=257 Identities=24% Similarity=0.399 Sum_probs=213.8
Q ss_pred cCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~ 233 (429)
.++|++.+.||+|+||.||+++... +|..||+|++... ......+++.+|++++++++ |+||+++++++.+++.
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~~a~k~~~~~--~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~ 77 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKP---SGLIMARKLIHLE--IKPAIRNQIIRELQVLHECN-SPYIVGFYGAFYSDGE 77 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECC---CCcEEEEEEeecc--cCHHHHHHHHHHHHHHHHCC-CCCCCeEEEEEEECCE
Confidence 4789999999999999999998776 5889999998653 23445678999999999998 9999999999999999
Q ss_pred EEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHc-CceeccCCCCcEEEeecCCCceEEEeecCCccc
Q 014210 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQ-GVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (429)
Q Consensus 234 ~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~-~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~ 312 (429)
.++||||+++++|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+|||+ +.++.+||+|||++..
T Consensus 78 ~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~ 153 (331)
T cd06649 78 ISICMEHMDGGSLDQVLKE-AKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILV---NSRGEIKLCDFGVSGQ 153 (331)
T ss_pred EEEEeecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEE---cCCCcEEEccCccccc
Confidence 9999999999999988754 45689999999999999999999986 69999999999999 6788899999999876
Q ss_pred cCCCccccccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcC--------------
Q 014210 313 VRPDERLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKAD-------------- 377 (429)
Q Consensus 313 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~-------------- 377 (429)
... .......|+..|+|||++.+ .++.++|||||||++|||++|+.||......+... ++...
T Consensus 154 ~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 231 (331)
T cd06649 154 LID-SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEA-IFGRPVVDGEEGEPHSISP 231 (331)
T ss_pred ccc-cccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-HhcccccccccCCccccCc
Confidence 643 23345679999999998874 58999999999999999999999997655433221 11100
Q ss_pred -------------------------------CCCCCCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhcc
Q 014210 378 -------------------------------PSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLICYQ 422 (429)
Q Consensus 378 -------------------------------~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~ 422 (429)
...+......++.++.+||.+||++||++||++.++|+|+|++..
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 307 (331)
T cd06649 232 RPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRS 307 (331)
T ss_pred ccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhc
Confidence 000111112478899999999999999999999999999999754
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-47 Score=351.74 Aligned_cols=263 Identities=29% Similarity=0.528 Sum_probs=241.2
Q ss_pred cccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeC
Q 014210 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (429)
Q Consensus 152 ~~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~ 231 (429)
...++|..+++||+|.||+|.+++-+. +|+.+|||++++..+........-..|-++|+..+ ||.+..|-..|+..
T Consensus 165 vTm~dFdfLKvLGkGTFGKVIL~rEKa---t~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~-HPFLt~LKYsFQt~ 240 (516)
T KOG0690|consen 165 VTMEDFDFLKVLGKGTFGKVILCREKA---TGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCR-HPFLTSLKYSFQTQ 240 (516)
T ss_pred eccchhhHHHHhcCCccceEEEEeecc---cCceeehhhhhhhheeehHHhhhhhhHHHHHHhcc-CcHHHHhhhhhccC
Confidence 345789999999999999999998776 79999999999988877777888889999999998 99999999999999
Q ss_pred CeEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCcc
Q 014210 232 DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (429)
Q Consensus 232 ~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~ 311 (429)
+++|+||||..||.|.-++ ++...+++..++.+...|+.||.|||+++||+||||.+|.|+ |.+|++||+|||+++
T Consensus 241 drlCFVMeyanGGeLf~HL-srer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlL---DkDGHIKitDFGLCK 316 (516)
T KOG0690|consen 241 DRLCFVMEYANGGELFFHL-SRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLL---DKDGHIKITDFGLCK 316 (516)
T ss_pred ceEEEEEEEccCceEeeeh-hhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhhee---ccCCceEeeecccch
Confidence 9999999999999998776 556789999999999999999999999999999999999999 899999999999998
Q ss_pred ccC-CCccccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCC
Q 014210 312 FVR-PDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLS 389 (429)
Q Consensus 312 ~~~-~~~~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 389 (429)
.-. .+....+.|||+.|+|||++. ..|+..+|+|.+||++|||+||++||.+..+...+..|+..+..|+. .++
T Consensus 317 E~I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kFPr----~ls 392 (516)
T KOG0690|consen 317 EEIKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKFPR----TLS 392 (516)
T ss_pred hcccccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccCCc----cCC
Confidence 643 345678899999999999998 57999999999999999999999999999999999999999988886 589
Q ss_pred HHHHHHHHHhcccCccCcC-----CHHHHHhhHhhhccceee
Q 014210 390 SEARDFVKRLLNKDPRKRL-----TAAQALSELLICYQSYLF 426 (429)
Q Consensus 390 ~~~~~li~~~L~~dP~~Rp-----s~~~iL~~~~~~~~~~~~ 426 (429)
++++.|+..+|.+||.+|. ++.+|.+|.||....|.-
T Consensus 393 ~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~ 434 (516)
T KOG0690|consen 393 PEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWEA 434 (516)
T ss_pred HHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCHHH
Confidence 9999999999999999998 589999999999877653
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-45 Score=364.35 Aligned_cols=261 Identities=26% Similarity=0.461 Sum_probs=219.9
Q ss_pred CceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeE
Q 014210 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (429)
Q Consensus 155 ~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~ 234 (429)
++|++.++||+|+||.||+++.+. +++.||+|++.+.........+.+.+|+.++..+. |+||+++++++.+.+.+
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~ 76 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKN---ADKVFAMKILNKWEMLKRAETACFREERDVLVNGD-NQWITTLHYAFQDENNL 76 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECC---CCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCC-CCCEeeEEEEEecCCEE
Confidence 479999999999999999998776 57899999986543333444556889999999987 99999999999999999
Q ss_pred EEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccccC
Q 014210 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (429)
Q Consensus 235 ~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~ 314 (429)
+|||||+++|+|.+++.+....+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++....
T Consensus 77 ~lv~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili---~~~~~~kL~DfG~a~~~~ 153 (332)
T cd05623 77 YLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILM---DMNGHIRLADFGSCLKLM 153 (332)
T ss_pred EEEEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEE---CCCCCEEEeecchheecc
Confidence 99999999999999987766789999999999999999999999999999999999999 778899999999987654
Q ss_pred CCcc--ccccccCCcccCccccc------CCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCC-CCC
Q 014210 315 PDER--LNDIVGSAYYVAPEVLH------RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDE-APW 385 (429)
Q Consensus 315 ~~~~--~~~~~gt~~y~aPE~~~------~~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~-~~~ 385 (429)
.... ....+||+.|+|||++. +.++.++|||||||++|||++|+.||........+..+......... ...
T Consensus 154 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~ 233 (332)
T cd05623 154 EDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQV 233 (332)
T ss_pred cCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCcc
Confidence 3322 23457999999999874 35788999999999999999999999988877777777665432221 122
Q ss_pred CCCCHHHHHHHHHhcccCccC--cCCHHHHHhhHhhhcc
Q 014210 386 PSLSSEARDFVKRLLNKDPRK--RLTAAQALSELLICYQ 422 (429)
Q Consensus 386 ~~~s~~~~~li~~~L~~dP~~--Rps~~~iL~~~~~~~~ 422 (429)
..+++++.+||++||+.++.+ |+++.++++|+||+..
T Consensus 234 ~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~ 272 (332)
T cd05623 234 TDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGI 272 (332)
T ss_pred ccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCC
Confidence 468999999999999765554 6899999999999764
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-46 Score=365.83 Aligned_cols=254 Identities=29% Similarity=0.493 Sum_probs=217.7
Q ss_pred eceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEE
Q 014210 160 GEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVME 239 (429)
Q Consensus 160 ~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~~lv~E 239 (429)
++.||+|+||.||+++...+..+|+.||+|++.+... .......+.+|++++++++ |+||+++++++.+++..|+|||
T Consensus 1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e 78 (318)
T cd05582 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATL-KVRDRVRTKMERDILAEVN-HPFIVKLHYAFQTEGKLYLILD 78 (318)
T ss_pred CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHhCC-CCCcccEEEEEEcCCEEEEEEc
Confidence 3689999999999998765555789999999865432 2233456788999999998 9999999999999999999999
Q ss_pred ecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccccCCC-cc
Q 014210 240 LCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPD-ER 318 (429)
Q Consensus 240 ~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~-~~ 318 (429)
|+++|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++...... ..
T Consensus 79 ~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~kL~Dfg~~~~~~~~~~~ 154 (318)
T cd05582 79 FLRGGDLFTRLSK-EVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILL---DEEGHIKLTDFGLSKESIDHEKK 154 (318)
T ss_pred CCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEE---CCCCcEEEeeccCCcccCCCCCc
Confidence 9999999988743 4579999999999999999999999999999999999999 77888999999998765443 23
Q ss_pred ccccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHH
Q 014210 319 LNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVK 397 (429)
Q Consensus 319 ~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 397 (429)
.....||..|+|||++.+ .++.++|||||||++|||++|+.||........+..+.......+ ..+++++.+||+
T Consensus 155 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~~~p----~~~~~~~~~li~ 230 (318)
T cd05582 155 AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMP----QFLSPEAQSLLR 230 (318)
T ss_pred eecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHHH
Confidence 345679999999998874 688999999999999999999999998888777777776554433 358899999999
Q ss_pred HhcccCccCcCC-----HHHHHhhHhhhccc
Q 014210 398 RLLNKDPRKRLT-----AAQALSELLICYQS 423 (429)
Q Consensus 398 ~~L~~dP~~Rps-----~~~iL~~~~~~~~~ 423 (429)
+||+.||++||+ +.+++.|+||....
T Consensus 231 ~~l~~~P~~R~~a~~~~~~~~~~~~~~~~~~ 261 (318)
T cd05582 231 ALFKRNPANRLGAGPDGVEEIKRHPFFSTID 261 (318)
T ss_pred HHhhcCHhHcCCCCCCCHHHHhCCCCcCCCC
Confidence 999999999999 78899999997643
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-45 Score=363.08 Aligned_cols=256 Identities=30% Similarity=0.484 Sum_probs=207.0
Q ss_pred ceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeC----
Q 014210 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT---- 231 (429)
Q Consensus 156 ~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~---- 231 (429)
+|++.++||+|+||.||+|+... +|+.||||++.... .......++.+|++++++++ |+||+++++++...
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~ 75 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTH---TGEKVAIKKINDVF-EHVSDATRILREIKLLRLLR-HPDIVEIKHIMLPPSRRE 75 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECC---CCCEEEEEEechhh-ccchhHHHHHHHHHHHHhCC-CCCEeeecceEeccCCCC
Confidence 58999999999999999998765 58999999986432 22334457889999999998 99999999988643
Q ss_pred -CeEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCc
Q 014210 232 -DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS 310 (429)
Q Consensus 232 -~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla 310 (429)
..+|+|||||. ++|.+++. ....+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 76 ~~~~~lv~e~~~-~~L~~~l~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll---~~~~~~kL~Dfg~~ 150 (338)
T cd07859 76 FKDIYVVFELME-SDLHQVIK-ANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILA---NADCKLKICDFGLA 150 (338)
T ss_pred CceEEEEEecCC-CCHHHHHH-hcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---CCCCcEEEccCccc
Confidence 35899999995 68888774 44579999999999999999999999999999999999999 78889999999999
Q ss_pred cccCCCc----cccccccCCcccCccccc---CCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHh--------
Q 014210 311 DFVRPDE----RLNDIVGSAYYVAPEVLH---RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLK-------- 375 (429)
Q Consensus 311 ~~~~~~~----~~~~~~gt~~y~aPE~~~---~~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~-------- 375 (429)
+...... .....+||..|+|||++. ..++.++|||||||++|||++|+.||........+..+..
T Consensus 151 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 230 (338)
T cd07859 151 RVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPE 230 (338)
T ss_pred cccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence 7643222 123467999999999875 3688899999999999999999999976654332221111
Q ss_pred -------------------cCCCCCCCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhc
Q 014210 376 -------------------ADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLICY 421 (429)
Q Consensus 376 -------------------~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~ 421 (429)
..+......++.+++++.+||.+||+.||++||++.++|+|+||..
T Consensus 231 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~ 295 (338)
T cd07859 231 TISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKG 295 (338)
T ss_pred HHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhh
Confidence 1111111223467889999999999999999999999999999975
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=361.60 Aligned_cols=252 Identities=29% Similarity=0.489 Sum_probs=213.5
Q ss_pred ceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEe
Q 014210 161 EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMEL 240 (429)
Q Consensus 161 ~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~~lv~E~ 240 (429)
++||+|+||.||+|+... +++.||||++.+.........+.+..|..++..+.+||||+++++++.+.+.++|||||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey 77 (316)
T cd05619 1 KMLGKGSFGKVFLAELKG---TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEY 77 (316)
T ss_pred CeeeeCCCEEEEEEEECC---CCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeC
Confidence 479999999999998776 58899999987543222334456778888888765699999999999999999999999
Q ss_pred cCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccccCC-Cccc
Q 014210 241 CEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP-DERL 319 (429)
Q Consensus 241 ~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~-~~~~ 319 (429)
+++|+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..... ....
T Consensus 78 ~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~ 153 (316)
T cd05619 78 LNGGDLMFHIQS-CHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILL---DTDGHIKIADFGMCKENMLGDAKT 153 (316)
T ss_pred CCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEE---CCCCCEEEccCCcceECCCCCCce
Confidence 999999988754 4578999999999999999999999999999999999999 6788899999999875322 2234
Q ss_pred cccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHH
Q 014210 320 NDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKR 398 (429)
Q Consensus 320 ~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ 398 (429)
....||..|+|||++.+ .++.++|||||||++|||++|+.||........+..+....+.++ ..++.++.+||.+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~li~~ 229 (316)
T cd05619 154 CTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYP----RWLTREAKDILVK 229 (316)
T ss_pred eeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----ccCCHHHHHHHHH
Confidence 45679999999998874 689999999999999999999999998887777777665544333 2478999999999
Q ss_pred hcccCccCcCCHH-HHHhhHhhhccc
Q 014210 399 LLNKDPRKRLTAA-QALSELLICYQS 423 (429)
Q Consensus 399 ~L~~dP~~Rps~~-~iL~~~~~~~~~ 423 (429)
||+.||++|+++. ++++|+||....
T Consensus 230 ~l~~~P~~R~~~~~~l~~h~~~~~~~ 255 (316)
T cd05619 230 LFVREPERRLGVKGDIRQHPFFREID 255 (316)
T ss_pred HhccCHhhcCCChHHHHcCcccCCCC
Confidence 9999999999996 899999997643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-46 Score=363.33 Aligned_cols=251 Identities=29% Similarity=0.528 Sum_probs=212.2
Q ss_pred ceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHH-HHHhcCCCCcceEEEEEEeCCeEEEEEE
Q 014210 161 EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKI-LRALTGHNNLVKFFDAYEDTDNVYVVME 239 (429)
Q Consensus 161 ~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~i-l~~l~~h~nIv~l~~~~~~~~~~~lv~E 239 (429)
+.||+|+||.||+|+... +|+.||||++.+..........++.+|..+ ++.++ |+||+++++++.+.+..++|||
T Consensus 1 ~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~-hp~iv~~~~~~~~~~~~~lv~e 76 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKA---DGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVK-HPFLVGLHYSFQTADKLYFVLD 76 (323)
T ss_pred CeeeeCCCeEEEEEEECC---CCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCC-CCCCCCeeEEEEeCCEEEEEEc
Confidence 479999999999999776 589999999875433333444556666664 46676 9999999999999999999999
Q ss_pred ecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccccCC-Ccc
Q 014210 240 LCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP-DER 318 (429)
Q Consensus 240 ~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~-~~~ 318 (429)
|+++|+|.+++. +.+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..... ...
T Consensus 77 ~~~~g~L~~~l~-~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll---~~~~~~kl~Dfg~~~~~~~~~~~ 152 (323)
T cd05575 77 YVNGGELFFHLQ-RERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILL---DSQGHVVLTDFGLCKEGIEHSKT 152 (323)
T ss_pred CCCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEE---CCCCcEEEeccCCCcccccCCCc
Confidence 999999988775 45679999999999999999999999999999999999999 7788999999999875432 233
Q ss_pred ccccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHH
Q 014210 319 LNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVK 397 (429)
Q Consensus 319 ~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 397 (429)
....+||..|+|||++.+ .++.++|||||||++|||++|+.||........+..++...... .+.++.++.+||+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~----~~~~~~~~~~li~ 228 (323)
T cd05575 153 TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRL----KPNISVSARHLLE 228 (323)
T ss_pred cccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCC----CCCCCHHHHHHHH
Confidence 445679999999998874 68999999999999999999999999888877777777654333 2467999999999
Q ss_pred HhcccCccCcCCH----HHHHhhHhhhccc
Q 014210 398 RLLNKDPRKRLTA----AQALSELLICYQS 423 (429)
Q Consensus 398 ~~L~~dP~~Rps~----~~iL~~~~~~~~~ 423 (429)
+||+.||++||++ .+++.|+||....
T Consensus 229 ~~l~~~p~~R~~~~~~~~~il~~~~~~~~~ 258 (323)
T cd05575 229 GLLQKDRTKRLGAKDDFLEIKNHVFFSSIN 258 (323)
T ss_pred HHhhcCHHhCCCCCCCHHHHHcCCCcCCCC
Confidence 9999999999988 6999999997543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-45 Score=353.56 Aligned_cols=258 Identities=29% Similarity=0.462 Sum_probs=216.4
Q ss_pred ceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEE
Q 014210 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVY 235 (429)
Q Consensus 156 ~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~~ 235 (429)
.|++.+.||+|+||.||++.... +++.||||.+...........+.+.+|+.++++++ |++|+.+++.+.+++..+
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~---~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-~~~i~~~~~~~~~~~~~~ 76 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRA---TGKMYACKKLEKKRIKKRKGESMALNEKQILEKVN-SRFVVSLAYAYETKDALC 76 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcC---CCceEEEEEEehhhccchHHHHHHHHHHHHHHhCC-CCCeeeeeEEEecCCEEE
Confidence 47888999999999999998776 58999999987655444555567789999999998 999999999999999999
Q ss_pred EEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccccC
Q 014210 236 VVMELCEGGELLDRILSRG-GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (429)
Q Consensus 236 lv~E~~~ggsL~~~i~~~~-~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~ 314 (429)
+||||++|++|.+++.... ..+++..+..++.|++.||.|||+.||+||||||+||++ +.++.++|+|||++....
T Consensus 77 lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~---~~~~~~~l~Dfg~~~~~~ 153 (285)
T cd05630 77 LVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILL---DDHGHIRISDLGLAVHVP 153 (285)
T ss_pred EEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEE---CCCCCEEEeeccceeecC
Confidence 9999999999998875443 469999999999999999999999999999999999999 678889999999987665
Q ss_pred CCccccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHcCCCCCCCCChH---HHHHHHHhcCCCCCCCCCCCCCH
Q 014210 315 PDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTES---GIFRAVLKADPSFDEAPWPSLSS 390 (429)
Q Consensus 315 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~elltg~~Pf~~~~~~---~~~~~i~~~~~~~~~~~~~~~s~ 390 (429)
.........|+..|+|||++. +.++.++||||||+++|+|++|+.||...... .....+.... .......++.
T Consensus 154 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~ 230 (285)
T cd05630 154 EGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV---QEEYSEKFSP 230 (285)
T ss_pred CCccccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhh---hhhcCccCCH
Confidence 444445568999999999886 46899999999999999999999999765432 1222222211 1122346889
Q ss_pred HHHHHHHHhcccCccCcCC-----HHHHHhhHhhhccc
Q 014210 391 EARDFVKRLLNKDPRKRLT-----AAQALSELLICYQS 423 (429)
Q Consensus 391 ~~~~li~~~L~~dP~~Rps-----~~~iL~~~~~~~~~ 423 (429)
++.+||++||+.||++|++ +.+++.|+||....
T Consensus 231 ~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~~ 268 (285)
T cd05630 231 DARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQIN 268 (285)
T ss_pred HHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhccC
Confidence 9999999999999999999 99999999998643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-45 Score=358.09 Aligned_cols=258 Identities=27% Similarity=0.415 Sum_probs=214.2
Q ss_pred cCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~ 233 (429)
.++|.+.++||+|+||.||+|+.+. +++.||||++..... ......+.+|+.++++++ |+||+++++++..++.
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~ 78 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSKL---TENLVALKEIRLEHE--EGAPCTAIREVSLLKDLK-HANIVTLHDIVHTDKS 78 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEecC---CCCeEEEEEeecccc--CCcchhHHHHHHHHHhCC-CCCcceEEEEEeeCCe
Confidence 3679999999999999999998765 578999999865432 222345778999999998 9999999999999999
Q ss_pred EEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCcccc
Q 014210 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (429)
Q Consensus 234 ~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~ 313 (429)
.++||||+++ +|.+++...+..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++...
T Consensus 79 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill---~~~~~~kl~Dfg~~~~~ 154 (309)
T cd07872 79 LTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLI---NERGELKLADFGLARAK 154 (309)
T ss_pred EEEEEeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCCEEECccccceec
Confidence 9999999975 8888887766779999999999999999999999999999999999999 67888999999998765
Q ss_pred CCCc-cccccccCCcccCcccccC--CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCC----------
Q 014210 314 RPDE-RLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSF---------- 380 (429)
Q Consensus 314 ~~~~-~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~---------- 380 (429)
.... ......++..|+|||++.+ .++.++||||||+++|+|++|+.||...+..+.+..+.+.....
T Consensus 155 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (309)
T cd07872 155 SVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISS 234 (309)
T ss_pred CCCccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcc
Confidence 3322 2334578999999998753 57899999999999999999999998777665554443321110
Q ss_pred ---------C-------CCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhc
Q 014210 381 ---------D-------EAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLICY 421 (429)
Q Consensus 381 ---------~-------~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~ 421 (429)
. ....+.++.++.+||++||+.||.+|+|+.++|.|+||+.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~ 291 (309)
T cd07872 235 NDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRS 291 (309)
T ss_pred hhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhh
Confidence 0 0112357889999999999999999999999999999985
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-45 Score=351.22 Aligned_cols=261 Identities=29% Similarity=0.451 Sum_probs=220.1
Q ss_pred ceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEE
Q 014210 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVY 235 (429)
Q Consensus 156 ~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~~ 235 (429)
.|+..+.||+|+||.||++.... +|+.||+|++.............+.+|++++++++ |+||+.+++++.+++..+
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~-~~~i~~~~~~~~~~~~~~ 76 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRA---TGKMYACKRLEKKRIKKRKGESMALNEKQILEKVN-SQFVVNLAYAYETKDALC 76 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECC---CCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcC-CcCceeEEEEEecCCEEE
Confidence 37888999999999999998776 58999999987654444445566789999999998 999999999999999999
Q ss_pred EEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccccC
Q 014210 236 VVMELCEGGELLDRILSRG-GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (429)
Q Consensus 236 lv~E~~~ggsL~~~i~~~~-~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~ 314 (429)
++|||+++++|.+++.... ..+++..+..++.|++.||.|||+.||+||||||+||++ ++++.+||+|||++....
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili---~~~~~~kl~Dfg~~~~~~ 153 (285)
T cd05632 77 LVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILL---DDYGHIRISDLGLAVKIP 153 (285)
T ss_pred EEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEE---CCCCCEEEecCCcceecC
Confidence 9999999999988876543 469999999999999999999999999999999999999 677889999999987655
Q ss_pred CCccccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHH
Q 014210 315 PDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEAR 393 (429)
Q Consensus 315 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 393 (429)
.........|+..|+|||++. ..++.++|+||||+++|+|++|..||...........+..............++.++.
T Consensus 154 ~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (285)
T cd05632 154 EGESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAK 233 (285)
T ss_pred CCCcccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHH
Confidence 444445567999999999886 4689999999999999999999999987665544444333222222333456889999
Q ss_pred HHHHHhcccCccCcCC-----HHHHHhhHhhhccc
Q 014210 394 DFVKRLLNKDPRKRLT-----AAQALSELLICYQS 423 (429)
Q Consensus 394 ~li~~~L~~dP~~Rps-----~~~iL~~~~~~~~~ 423 (429)
+|+..||+.||++||+ +.+++.|+||+...
T Consensus 234 ~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~ 268 (285)
T cd05632 234 SICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMN 268 (285)
T ss_pred HHHHHHccCCHhHcCCCcccChHHHHcChhhhcCC
Confidence 9999999999999999 89999999998754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=363.93 Aligned_cols=261 Identities=26% Similarity=0.459 Sum_probs=219.7
Q ss_pred CceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeE
Q 014210 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (429)
Q Consensus 155 ~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~ 234 (429)
++|++.++||+|+||.||+++.+. +++.||||++.+...........+.+|+.++..+. |+||+++++++.+++..
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~l~~~~~~~~~~ 76 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKH---TERIYAMKILNKWEMLKRAETACFREERNVLVNGD-CQWITTLHYAFQDENYL 76 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECC---CCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEcCCEE
Confidence 479999999999999999998776 58899999986543333444566888999999987 99999999999999999
Q ss_pred EEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccccC
Q 014210 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (429)
Q Consensus 235 ~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~ 314 (429)
||||||++||+|.+++......+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++....
T Consensus 77 ~lv~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill---~~~~~~kl~DfG~a~~~~ 153 (331)
T cd05624 77 YLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLL---DMNGHIRLADFGSCLKMN 153 (331)
T ss_pred EEEEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEE---cCCCCEEEEeccceeecc
Confidence 99999999999999987766789999999999999999999999999999999999999 678889999999997665
Q ss_pred CCccc--cccccCCcccCcccccC------CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCC-CCC
Q 014210 315 PDERL--NDIVGSAYYVAPEVLHR------SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDE-APW 385 (429)
Q Consensus 315 ~~~~~--~~~~gt~~y~aPE~~~~------~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~-~~~ 385 (429)
..... ....||..|+|||++.+ .++.++|||||||++|||++|+.||......+.+..+......... ...
T Consensus 154 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~ 233 (331)
T cd05624 154 QDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHI 233 (331)
T ss_pred CCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCcc
Confidence 43322 23579999999998763 5788999999999999999999999888777777777654332221 122
Q ss_pred CCCCHHHHHHHHHhcccCccC--cCCHHHHHhhHhhhcc
Q 014210 386 PSLSSEARDFVKRLLNKDPRK--RLTAAQALSELLICYQ 422 (429)
Q Consensus 386 ~~~s~~~~~li~~~L~~dP~~--Rps~~~iL~~~~~~~~ 422 (429)
..+++++.+||.+||+.++++ |+++++++.|+||...
T Consensus 234 ~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~ 272 (331)
T cd05624 234 TDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGI 272 (331)
T ss_pred ccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCC
Confidence 457899999999999876655 5799999999999754
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-45 Score=360.65 Aligned_cols=258 Identities=26% Similarity=0.393 Sum_probs=207.1
Q ss_pred cCceeEeceeeccCceEEEEEEEec--CcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeC
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKK--GELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~--~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~ 231 (429)
.++|++.++||+|+||.||+|.... ....++.||||++... ......+.+.+|+.++.++.+|+||++++++|...
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEG--ATASEHKALMSELKILIHIGNHLNVVNLLGACTKP 83 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccc--cchHHHHHHHHHHHHHHHhccCcceeeEEeEecCC
Confidence 5789999999999999999997542 2235678999998643 23444567899999999995599999999998765
Q ss_pred -CeEEEEEEecCCCcHHHHHHhcC--------------------------------------------------------
Q 014210 232 -DNVYVVMELCEGGELLDRILSRG-------------------------------------------------------- 254 (429)
Q Consensus 232 -~~~~lv~E~~~ggsL~~~i~~~~-------------------------------------------------------- 254 (429)
+.+++||||+++|+|.+++....
T Consensus 84 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (338)
T cd05102 84 NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQET 163 (338)
T ss_pred CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhc
Confidence 45899999999999999886431
Q ss_pred -----CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccccCCCcc---ccccccCC
Q 014210 255 -----GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDER---LNDIVGSA 326 (429)
Q Consensus 255 -----~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~---~~~~~gt~ 326 (429)
..+++..+..++.||+.||+|||++||+||||||+|||+ ++++.+||+|||+++....... .....++.
T Consensus 164 ~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~---~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~ 240 (338)
T cd05102 164 DDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILL---SENNVVKICDFGLARDIYKDPDYVRKGSARLPL 240 (338)
T ss_pred cccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEE---cCCCcEEEeecccccccccCcchhcccCCCCCc
Confidence 247888999999999999999999999999999999999 6788899999999976543221 12334667
Q ss_pred cccCccccc-CCCCCcccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCc
Q 014210 327 YYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDP 404 (429)
Q Consensus 327 ~y~aPE~~~-~~~~~~sDiwSlGvll~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP 404 (429)
.|+|||++. +.++.++|||||||++|||++ |..||........+...+...... .....+++++.+||.+||+.||
T Consensus 241 ~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dp 318 (338)
T cd05102 241 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRM--RAPENATPEIYRIMLACWQGDP 318 (338)
T ss_pred cccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCC--CCCCCCCHHHHHHHHHHccCCh
Confidence 899999876 568999999999999999997 999998765444443333322211 1224678999999999999999
Q ss_pred cCcCCHHHHHhhHh
Q 014210 405 RKRLTAAQALSELL 418 (429)
Q Consensus 405 ~~Rps~~~iL~~~~ 418 (429)
++||++.++++.+-
T Consensus 319 ~~RPs~~el~~~l~ 332 (338)
T cd05102 319 KERPTFSALVEILG 332 (338)
T ss_pred hhCcCHHHHHHHHH
Confidence 99999999988653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-45 Score=360.92 Aligned_cols=252 Identities=28% Similarity=0.488 Sum_probs=211.3
Q ss_pred ceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEe
Q 014210 161 EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMEL 240 (429)
Q Consensus 161 ~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~~lv~E~ 240 (429)
++||+|+||.||+|+... .++.||||++.+.........+.+.+|+.++.++.+|+||+++++++.+.+.+|+||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~ 77 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKK---NDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEY 77 (327)
T ss_pred CeeeeCCCeEEEEEEECC---CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeC
Confidence 479999999999998776 58899999997655455566677899999999997799999999999999999999999
Q ss_pred cCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccccC-CCccc
Q 014210 241 CEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR-PDERL 319 (429)
Q Consensus 241 ~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~-~~~~~ 319 (429)
+++|+|.+++. ..+.+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++.... .....
T Consensus 78 ~~~~~L~~~~~-~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili---~~~~~~kl~Dfg~~~~~~~~~~~~ 153 (327)
T cd05617 78 VNGGDLMFHMQ-RQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLL---DADGHIKLTDYGMCKEGLGPGDTT 153 (327)
T ss_pred CCCCcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE---eCCCCEEEeccccceeccCCCCce
Confidence 99999988774 44679999999999999999999999999999999999999 678889999999987532 23334
Q ss_pred cccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHcCCCCCCCC-------ChHHHHHHHHhcCCCCCCCCCCCCCHH
Q 014210 320 NDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWAR-------TESGIFRAVLKADPSFDEAPWPSLSSE 391 (429)
Q Consensus 320 ~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~elltg~~Pf~~~-------~~~~~~~~i~~~~~~~~~~~~~~~s~~ 391 (429)
...+||+.|+|||++. ..++.++|||||||++|||++|+.||... ........+......++ ..++.+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p----~~~~~~ 229 (327)
T cd05617 154 STFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIP----RFLSVK 229 (327)
T ss_pred ecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCC----CCCCHH
Confidence 5678999999999886 46899999999999999999999999532 12223334433332222 358899
Q ss_pred HHHHHHHhcccCccCcCC------HHHHHhhHhhhccc
Q 014210 392 ARDFVKRLLNKDPRKRLT------AAQALSELLICYQS 423 (429)
Q Consensus 392 ~~~li~~~L~~dP~~Rps------~~~iL~~~~~~~~~ 423 (429)
+.++|++||+.||++|++ +.+++.|+||....
T Consensus 230 ~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~ 267 (327)
T cd05617 230 ASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSID 267 (327)
T ss_pred HHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCCC
Confidence 999999999999999998 57999999997643
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-46 Score=372.72 Aligned_cols=265 Identities=31% Similarity=0.461 Sum_probs=221.4
Q ss_pred cccccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCC-----CCcceE
Q 014210 150 SKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGH-----NNLVKF 224 (429)
Q Consensus 150 ~~~~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h-----~nIv~l 224 (429)
.+.+..+|++++.||+|.||.|.+|.+.+ +++.||||+++.. .....+-..|+.+|..|+.| -|+|++
T Consensus 181 ~d~i~~rY~V~e~LGkGtFGQVvk~~d~~---T~e~VAIKIiKN~----k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm 253 (586)
T KOG0667|consen 181 NDHIAYRYEVLEVLGKGSFGQVVKAYDHK---TGEIVAIKIIKNK----KRFLRQAQIEIRILELLNKHDPDDKYNIVRM 253 (586)
T ss_pred cceeEEEEEEEEEecccccceeEEEEecC---CCcEEEEEeeccC----hHHHHHHHHHHHHHHHHhccCCCCCeeEEEe
Confidence 34566689999999999999999999777 6999999999653 44556777899999999843 389999
Q ss_pred EEEEEeCCeEEEEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEE
Q 014210 225 FDAYEDTDNVYVVMELCEGGELLDRILSRG-GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLK 303 (429)
Q Consensus 225 ~~~~~~~~~~~lv~E~~~ggsL~~~i~~~~-~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vk 303 (429)
+++|...+++|||+|.++ .+|+++|..+. ..++...++.++.||+.||.+||+.||||+||||+||||...+.. .||
T Consensus 254 ~d~F~fr~HlciVfELL~-~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~-~vK 331 (586)
T KOG0667|consen 254 LDYFYFRNHLCIVFELLS-TNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRS-RIK 331 (586)
T ss_pred eeccccccceeeeehhhh-hhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcC-cee
Confidence 999999999999999995 59999997654 359999999999999999999999999999999999999765544 799
Q ss_pred EeecCCccccCCCccccccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCC
Q 014210 304 AIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDE 382 (429)
Q Consensus 304 L~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~ 382 (429)
|+|||.++... +....++.+..|+|||++.| .|+.+.||||||||++||++|.+.|.+.++.+.+..|.+.....+.
T Consensus 332 VIDFGSSc~~~--q~vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~ 409 (586)
T KOG0667|consen 332 VIDFGSSCFES--QRVYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPP 409 (586)
T ss_pred EEecccccccC--CcceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCH
Confidence 99999998764 33448899999999998875 7999999999999999999999999888888877665542211110
Q ss_pred --------------C---------------------------------CCC------------CCCHHHHHHHHHhcccC
Q 014210 383 --------------A---------------------------------PWP------------SLSSEARDFVKRLLNKD 403 (429)
Q Consensus 383 --------------~---------------------------------~~~------------~~s~~~~~li~~~L~~d 403 (429)
. ..+ .-...|.|||++||.+|
T Consensus 410 ~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~d 489 (586)
T KOG0667|consen 410 KMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWD 489 (586)
T ss_pred HHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccC
Confidence 0 001 11357899999999999
Q ss_pred ccCcCCHHHHHhhHhhhcccee
Q 014210 404 PRKRLTAAQALSELLICYQSYL 425 (429)
Q Consensus 404 P~~Rps~~~iL~~~~~~~~~~~ 425 (429)
|.+|+|+.++|+|+|+......
T Consensus 490 P~~R~tp~qal~Hpfl~~~~~~ 511 (586)
T KOG0667|consen 490 PAERITPAQALNHPFLTGTSLE 511 (586)
T ss_pred chhcCCHHHHhcCccccccccc
Confidence 9999999999999999865543
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-45 Score=372.37 Aligned_cols=256 Identities=25% Similarity=0.387 Sum_probs=207.4
Q ss_pred ccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeC-
Q 014210 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT- 231 (429)
Q Consensus 153 ~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~- 231 (429)
..++|+++++||+|+||.||+|.... +++.||||++.... ....+|+.+++.++ |+||+++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~---~~~~vAiK~i~~~~-------~~~~~Ei~il~~l~-h~niv~l~~~~~~~~ 132 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICID---TSEKVAIKKVLQDP-------QYKNRELLIMKNLN-HINIIFLKDYYYTEC 132 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECC---CCCEEEEEEEecCc-------chHHHHHHHHHhcC-CCCCcceeeeEeecc
Confidence 35689999999999999999998765 58899999885431 22457999999998 99999999987432
Q ss_pred -------CeEEEEEEecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCce
Q 014210 232 -------DNVYVVMELCEGGELLDRILS---RGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSV 301 (429)
Q Consensus 232 -------~~~~lv~E~~~ggsL~~~i~~---~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~ 301 (429)
..+++||||+++ +|.+++.. .+..+++..++.++.||+.||.|||++||+||||||+|||++ ..++.
T Consensus 133 ~~~~~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~--~~~~~ 209 (440)
T PTZ00036 133 FKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLID--PNTHT 209 (440)
T ss_pred cccCCCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEc--CCCCc
Confidence 246799999975 67666542 456799999999999999999999999999999999999993 23347
Q ss_pred EEEeecCCccccCCCccccccccCCcccCcccccC--CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCC-
Q 014210 302 LKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADP- 378 (429)
Q Consensus 302 vkL~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~- 378 (429)
+||+|||+++............||+.|+|||++.+ .++.++|||||||++|||++|..||.+....+.+..++....
T Consensus 210 vkL~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~ 289 (440)
T PTZ00036 210 LKLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGT 289 (440)
T ss_pred eeeeccccchhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Confidence 99999999987765555556788999999998754 589999999999999999999999988776666555543211
Q ss_pred -----------CCCCCC-------------CCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhcc
Q 014210 379 -----------SFDEAP-------------WPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLICYQ 422 (429)
Q Consensus 379 -----------~~~~~~-------------~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~ 422 (429)
.+.... ....+.++.+||++||+.||.+|+++.++|.|+||...
T Consensus 290 p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~ 357 (440)
T PTZ00036 290 PTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDL 357 (440)
T ss_pred CCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhh
Confidence 010000 12367899999999999999999999999999999653
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-46 Score=364.99 Aligned_cols=250 Identities=30% Similarity=0.535 Sum_probs=212.4
Q ss_pred eeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhc--CCCCcceEEEEEEeCCeEEEEEEe
Q 014210 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALT--GHNNLVKFFDAYEDTDNVYVVMEL 240 (429)
Q Consensus 163 IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~--~h~nIv~l~~~~~~~~~~~lv~E~ 240 (429)
||+|+||.||+|+.+. +|+.||||++.+...........+..|..++.++. +|+||+++++++.+.+..|+||||
T Consensus 1 lG~G~~g~Vy~~~~~~---~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~ 77 (330)
T cd05586 1 IGKGTFGQVYQVRKKD---TRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDY 77 (330)
T ss_pred CCCCCceEEEEEEECC---CCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcC
Confidence 7999999999998765 58999999986544334444555667777777664 699999999999999999999999
Q ss_pred cCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccccCC-Cccc
Q 014210 241 CEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP-DERL 319 (429)
Q Consensus 241 ~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~-~~~~ 319 (429)
+++|+|.+++. +.+.+++..++.++.||++||+|||++||+||||||+|||+ +.++.+||+|||++..... ....
T Consensus 78 ~~~g~L~~~l~-~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili---~~~~~~kl~Dfg~a~~~~~~~~~~ 153 (330)
T cd05586 78 MSGGELFWHLQ-KEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILL---DATGHIALCDFGLSKANLTDNKTT 153 (330)
T ss_pred CCCChHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEE---CCCCCEEEecCCcCcCCCCCCCCc
Confidence 99999988775 45679999999999999999999999999999999999999 6788899999999876432 2334
Q ss_pred cccccCCcccCcccccC--CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHH
Q 014210 320 NDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVK 397 (429)
Q Consensus 320 ~~~~gt~~y~aPE~~~~--~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 397 (429)
...+||..|+|||++.+ .++.++|||||||++|+|++|+.||........+..+......++. ..++.++.+||+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~---~~~~~~~~~li~ 230 (330)
T cd05586 154 NTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPK---NVLSDEGRQFVK 230 (330)
T ss_pred cCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCCC---ccCCHHHHHHHH
Confidence 56789999999998864 4789999999999999999999999988877777777665544433 257899999999
Q ss_pred HhcccCccCcC----CHHHHHhhHhhhcc
Q 014210 398 RLLNKDPRKRL----TAAQALSELLICYQ 422 (429)
Q Consensus 398 ~~L~~dP~~Rp----s~~~iL~~~~~~~~ 422 (429)
+||+.||.+|| ++.++++|+||...
T Consensus 231 ~~L~~~P~~R~~~~~~~~~ll~h~~~~~~ 259 (330)
T cd05586 231 GLLNRNPQHRLGAHRDAVELKEHPFFADI 259 (330)
T ss_pred HHcCCCHHHCCCCCCCHHHHhcCccccCC
Confidence 99999999998 79999999999753
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-45 Score=362.60 Aligned_cols=262 Identities=25% Similarity=0.378 Sum_probs=210.8
Q ss_pred CCcCccccccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceE
Q 014210 145 KSFGFSKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKF 224 (429)
Q Consensus 145 ~~~~~~~~~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l 224 (429)
.++...+.++++|...+.||+|+||.||+|...+ |..||||++....... ..+|.+|+.++.+++ |+|||+|
T Consensus 65 fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~----~~~vAVK~~~~~~~~~---~~eF~~Ei~~ls~l~-H~Nlv~L 136 (361)
T KOG1187|consen 65 FSYDELRKATNNFSESNLIGEGGFGTVYKGVLSD----GTVVAVKRLSSNSGQG---EREFLNEVEILSRLR-HPNLVKL 136 (361)
T ss_pred eeHHHHHHHHhCCchhcceecCCCeEEEEEEECC----CCEEEEEEecCCCCcc---hhHHHHHHHHHhcCC-CcCcccE
Confidence 3444456678999999999999999999999876 5899999886543221 456999999999999 9999999
Q ss_pred EEEEEeCC-eEEEEEEecCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCC
Q 014210 225 FDAYEDTD-NVYVVMELCEGGELLDRILSRGG-KYTEDDAKAVMIQILNVVAFCHLQG---VVHRDLKPENFLFTTKDEN 299 (429)
Q Consensus 225 ~~~~~~~~-~~~lv~E~~~ggsL~~~i~~~~~-~l~~~~~~~i~~qi~~gL~~LH~~~---iiHrDIKp~NILl~~~~~~ 299 (429)
+|||.+.+ +.+||+|||++|+|.+++..... .++|..+.+|+.++++||+|||+.. |||||||++|||| |++
T Consensus 137 lGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILL---D~~ 213 (361)
T KOG1187|consen 137 LGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILL---DED 213 (361)
T ss_pred EEEEecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeE---CCC
Confidence 99999999 59999999999999999987766 8999999999999999999999964 9999999999999 899
Q ss_pred ceEEEeecCCccccCC-Ccccccc-ccCCcccCccccc-CCCCCcccHHHHHHHHHHHHcCCCCCCCCC---hH---HHH
Q 014210 300 SVLKAIDFGLSDFVRP-DERLNDI-VGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWART---ES---GIF 370 (429)
Q Consensus 300 ~~vkL~DFGla~~~~~-~~~~~~~-~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~elltg~~Pf~~~~---~~---~~~ 370 (429)
++.||+|||+|+.... ....... .||.+|+|||++. +..+.++|||||||+|+||+||+.+.+... .. ...
T Consensus 214 ~~aKlsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~ 293 (361)
T KOG1187|consen 214 FNAKLSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWA 293 (361)
T ss_pred CCEEccCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHH
Confidence 9999999999977665 4444444 8999999999886 689999999999999999999998886432 11 111
Q ss_pred HHHHhcC-C-CCCCCCC--CCCC-----HHHHHHHHHhcccCccCcCCHHHHHhhH
Q 014210 371 RAVLKAD-P-SFDEAPW--PSLS-----SEARDFVKRLLNKDPRKRLTAAQALSEL 417 (429)
Q Consensus 371 ~~i~~~~-~-~~~~~~~--~~~s-----~~~~~li~~~L~~dP~~Rps~~~iL~~~ 417 (429)
...+... . ...+... ..+. ..+..+..+|++.+|.+||++.|++..+
T Consensus 294 ~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L 349 (361)
T KOG1187|consen 294 KPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKEL 349 (361)
T ss_pred HHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHH
Confidence 1122211 0 0111110 1223 2356778899999999999999997766
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-45 Score=350.14 Aligned_cols=256 Identities=27% Similarity=0.410 Sum_probs=208.4
Q ss_pred ceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhc--CCCCcceEEEEEEe---
Q 014210 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALT--GHNNLVKFFDAYED--- 230 (429)
Q Consensus 156 ~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~--~h~nIv~l~~~~~~--- 230 (429)
+|++.+.||+|+||.||+|+.+. +|+.||+|++....... .....+.+|+.+++++. +|+||+++++++.+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~---~~~~~aiK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~ 76 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPH---SGHFVALKSVRVQTNED-GLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRT 76 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECC---CCcEEEEEEeccCcCCC-CCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccC
Confidence 58999999999999999999776 58999999986542222 22234567888887764 49999999999865
Q ss_pred --CCeEEEEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeec
Q 014210 231 --TDNVYVVMELCEGGELLDRILSRG-GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDF 307 (429)
Q Consensus 231 --~~~~~lv~E~~~ggsL~~~i~~~~-~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DF 307 (429)
....+++|||+.+ +|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+||
T Consensus 77 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili---~~~~~~kl~df 152 (288)
T cd07863 77 DRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILV---TSGGQVKLADF 152 (288)
T ss_pred CCCceEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---CCCCCEEECcc
Confidence 3458999999975 8888776543 358999999999999999999999999999999999999 67888999999
Q ss_pred CCccccCCCccccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCC------
Q 014210 308 GLSDFVRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSF------ 380 (429)
Q Consensus 308 Gla~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~------ 380 (429)
|++.............||..|+|||++. ..++.++|||||||++|+|++|+.||......+.+..+.......
T Consensus 153 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (288)
T cd07863 153 GLARIYSCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP 232 (288)
T ss_pred CccccccCcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCc
Confidence 9998775544445567899999999886 468999999999999999999999998877766655554321000
Q ss_pred -----------------CCCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhh
Q 014210 381 -----------------DEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLI 419 (429)
Q Consensus 381 -----------------~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~ 419 (429)
.....+.++.++.+||.+||+.||++||++.+++.|+||
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 233 RDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred ccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 001124578899999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-45 Score=361.20 Aligned_cols=250 Identities=28% Similarity=0.498 Sum_probs=211.9
Q ss_pred ceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHH-HHHhcCCCCcceEEEEEEeCCeEEEEEE
Q 014210 161 EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKI-LRALTGHNNLVKFFDAYEDTDNVYVVME 239 (429)
Q Consensus 161 ~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~i-l~~l~~h~nIv~l~~~~~~~~~~~lv~E 239 (429)
++||+|+||.||+++... +|+.||||++.+...........+.+|..+ ++.++ |+||+++++++..++..|+|||
T Consensus 1 ~~lG~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~-hp~iv~~~~~~~~~~~~~lv~e 76 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKL---DGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVK-HPFLVGLHYSFQTTEKLYFVLD 76 (325)
T ss_pred CceeeCCCeEEEEEEECC---CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCC-CCCCccEEEEEecCCEEEEEEc
Confidence 479999999999998765 589999999876443344445566677665 55566 9999999999999999999999
Q ss_pred ecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccccC-CCcc
Q 014210 240 LCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR-PDER 318 (429)
Q Consensus 240 ~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~-~~~~ 318 (429)
|+++|+|..++. ..+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.... ....
T Consensus 77 ~~~~~~L~~~l~-~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll---~~~~~~kL~DfG~~~~~~~~~~~ 152 (325)
T cd05604 77 FVNGGELFFHLQ-RERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILL---DSQGHVVLTDFGLCKEGIAQSDT 152 (325)
T ss_pred CCCCCCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEE---CCCCCEEEeecCCcccCCCCCCC
Confidence 999999988774 45679999999999999999999999999999999999999 778899999999987542 2233
Q ss_pred ccccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHH
Q 014210 319 LNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVK 397 (429)
Q Consensus 319 ~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 397 (429)
....+||..|+|||++.+ .++.++|||||||++|||++|+.||...+....+..++...... .+..+.++.++|+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~ll~ 228 (325)
T cd05604 153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVL----RPGASLTAWSILE 228 (325)
T ss_pred cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCccC----CCCCCHHHHHHHH
Confidence 445679999999998874 68999999999999999999999999888878777777654332 2468899999999
Q ss_pred HhcccCccCcCCH----HHHHhhHhhhcc
Q 014210 398 RLLNKDPRKRLTA----AQALSELLICYQ 422 (429)
Q Consensus 398 ~~L~~dP~~Rps~----~~iL~~~~~~~~ 422 (429)
+||..||.+||++ .+++.|+||...
T Consensus 229 ~ll~~~p~~R~~~~~~~~~i~~h~~f~~~ 257 (325)
T cd05604 229 ELLEKDRQRRLGAKEDFLEIQEHPFFESL 257 (325)
T ss_pred HHhccCHHhcCCCCCCHHHHhcCCCcCCC
Confidence 9999999999977 599999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-46 Score=350.22 Aligned_cols=255 Identities=29% Similarity=0.482 Sum_probs=215.6
Q ss_pred cCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCC-
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD- 232 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~- 232 (429)
.-.|+..+++|.|+||.||.|.... +++.||||..-.+... -.+|+++|+++. |||||+++-+|....
T Consensus 23 ~i~~~~~~liG~GsFg~Vyq~~~~e---~~~~vAIKKv~~d~r~-------knrEl~im~~l~-HpNIV~L~~~f~~~~~ 91 (364)
T KOG0658|consen 23 EISYEAVRLIGSGSFGVVYQAKLRE---TEEEVAIKKVLQDKRY-------KNRELQIMRKLD-HPNIVRLLYFFSSSTE 91 (364)
T ss_pred EEEEEeeEEEeecccceEEEEEEcC---CCceeEEEEecCCCCc-------CcHHHHHHHhcC-CcCeeeEEEEEEecCC
Confidence 4468899999999999999999887 4899999987443221 237999999888 999999999886432
Q ss_pred ----eEEEEEEecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEe
Q 014210 233 ----NVYVVMELCEGGELLDRILS---RGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAI 305 (429)
Q Consensus 233 ----~~~lv~E~~~ggsL~~~i~~---~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~ 305 (429)
...+|||||+. +|.+.+.. .+.+++.-.++-+..||++||.|||+.||+||||||.|+|++ .+.+.+|||
T Consensus 92 ~d~~~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD--~~tg~LKic 168 (364)
T KOG0658|consen 92 SDEVYLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVD--PDTGVLKIC 168 (364)
T ss_pred CchhHHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEc--CCCCeEEec
Confidence 34589999986 88887764 367899999999999999999999999999999999999995 456999999
Q ss_pred ecCCccccCCCccccccccCCcccCcccccC--CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcC------
Q 014210 306 DFGLSDFVRPDERLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKAD------ 377 (429)
Q Consensus 306 DFGla~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~------ 377 (429)
|||.|+.+..++....+..|.+|+|||.+.+ .|+.+.||||.||++.||+-|+..|.+.+..+.+..|.+.-
T Consensus 169 DFGSAK~L~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e 248 (364)
T KOG0658|consen 169 DFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTRE 248 (364)
T ss_pred cCCcceeeccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHH
Confidence 9999999988888888999999999998865 69999999999999999999999999988887777665421
Q ss_pred ------CCCC--------CCC-----CCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhcc
Q 014210 378 ------PSFD--------EAP-----WPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLICYQ 422 (429)
Q Consensus 378 ------~~~~--------~~~-----~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~ 422 (429)
+... ... ....++++.+|+.++|..+|.+|.++.|+|.|+||..-
T Consensus 249 ~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdel 312 (364)
T KOG0658|consen 249 DIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDEL 312 (364)
T ss_pred HHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHh
Confidence 1111 111 13468999999999999999999999999999999753
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-45 Score=359.64 Aligned_cols=250 Identities=28% Similarity=0.518 Sum_probs=209.3
Q ss_pred ceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHH-HHHhcCCCCcceEEEEEEeCCeEEEEEE
Q 014210 161 EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKI-LRALTGHNNLVKFFDAYEDTDNVYVVME 239 (429)
Q Consensus 161 ~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~i-l~~l~~h~nIv~l~~~~~~~~~~~lv~E 239 (429)
+.||+|+||.||+|+... +++.||+|++.+...........+.+|... ++.+. |+||+++++++.+.+..|+|||
T Consensus 1 ~~lg~G~fg~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~-h~~Iv~~~~~~~~~~~~~lv~e 76 (325)
T cd05602 1 KVIGKGSFGKVLLARHKA---EEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVK-HPFLVGLHFSFQTADKLYFVLD 76 (325)
T ss_pred CeeeeCCCeEEEEEEECC---CCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCC-CCCCCceeEEEEcCCeEEEEEe
Confidence 479999999999998776 578999999875433333334455556554 56666 9999999999999999999999
Q ss_pred ecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccccCC-Ccc
Q 014210 240 LCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP-DER 318 (429)
Q Consensus 240 ~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~-~~~ 318 (429)
|+++++|.+++.. .+.+.+..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.... ...
T Consensus 77 ~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili---~~~~~~kl~DfG~a~~~~~~~~~ 152 (325)
T cd05602 77 YINGGELFYHLQR-ERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILL---DSQGHIVLTDFGLCKENIEHNGT 152 (325)
T ss_pred CCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEE---CCCCCEEEccCCCCcccccCCCC
Confidence 9999999987754 4678999999999999999999999999999999999999 6788899999999875432 233
Q ss_pred ccccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHH
Q 014210 319 LNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVK 397 (429)
Q Consensus 319 ~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 397 (429)
....+||+.|+|||++.+ .++.++|||||||++|||++|+.||......+.+..+....... .+.++.++.+||+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~----~~~~~~~~~~li~ 228 (325)
T cd05602 153 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQL----KPNITNSARHLLE 228 (325)
T ss_pred cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCcCC----CCCCCHHHHHHHH
Confidence 445679999999998874 68899999999999999999999999888887777776554332 2468999999999
Q ss_pred HhcccCccCcCCHH----HHHhhHhhhcc
Q 014210 398 RLLNKDPRKRLTAA----QALSELLICYQ 422 (429)
Q Consensus 398 ~~L~~dP~~Rps~~----~iL~~~~~~~~ 422 (429)
+||+.||.+|+++. +++.|+|+...
T Consensus 229 ~~l~~~p~~R~~~~~~~~~i~~~~~~~~~ 257 (325)
T cd05602 229 GLLQKDRTKRLGAKDDFMEIKNHIFFSPI 257 (325)
T ss_pred HHcccCHHHCCCCCCCHHHHhcCcccCCC
Confidence 99999999999876 88999988653
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-45 Score=348.44 Aligned_cols=250 Identities=26% Similarity=0.432 Sum_probs=207.7
Q ss_pred eeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEecC
Q 014210 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCE 242 (429)
Q Consensus 163 IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~~lv~E~~~ 242 (429)
||+|+||.||+++.+. +|+.||+|++.............+..|++++++++ |+||++++++++++...++||||++
T Consensus 1 lg~G~~g~Vy~~~~~~---~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~i~~~~~~~~~~~~~~lv~e~~~ 76 (277)
T cd05607 1 LGKGGFGEVCAVQVKN---TGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVN-SPFIVNLAYAFESKTHLCLVMSLMN 76 (277)
T ss_pred CCCCCceEEEEEEEcc---CCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcC-CCcEEEEEEEEecCCeEEEEEecCC
Confidence 7999999999998776 58999999986544333334455677999999997 9999999999999999999999999
Q ss_pred CCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccccCCCccccc
Q 014210 243 GGELLDRILSRG-GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLND 321 (429)
Q Consensus 243 ggsL~~~i~~~~-~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~ 321 (429)
|++|.+++.... ..+++..+..++.||+.||+|||+.||+||||||+|||+ +.++.+||+|||++...........
T Consensus 77 g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili---~~~~~~~l~Dfg~~~~~~~~~~~~~ 153 (277)
T cd05607 77 GGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLL---DDQGNCRLSDLGLAVELKDGKTITQ 153 (277)
T ss_pred CCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEE---cCCCCEEEeeceeeeecCCCceeec
Confidence 999988876543 358999999999999999999999999999999999999 6788899999999987655444455
Q ss_pred cccCCcccCccccc-CCCCCcccHHHHHHHHHHHHcCCCCCCCCChH----HHHHHHHhcCCCCCCCCCCCCCHHHHHHH
Q 014210 322 IVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTES----GIFRAVLKADPSFDEAPWPSLSSEARDFV 396 (429)
Q Consensus 322 ~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~elltg~~Pf~~~~~~----~~~~~i~~~~~~~~~~~~~~~s~~~~~li 396 (429)
..|+..|+|||++. +.++.++|||||||++|||++|+.||...... ............. ....++.++.+||
T Consensus 154 ~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li 230 (277)
T cd05607 154 RAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKF---EHQNFTEESKDIC 230 (277)
T ss_pred cCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhcccccc---ccccCCHHHHHHH
Confidence 67999999999886 46899999999999999999999999754332 2233333322222 1236899999999
Q ss_pred HHhcccCccCcCCH----HHHHhhHhhhcc
Q 014210 397 KRLLNKDPRKRLTA----AQALSELLICYQ 422 (429)
Q Consensus 397 ~~~L~~dP~~Rps~----~~iL~~~~~~~~ 422 (429)
++||+.||++||++ .+++.|+||+..
T Consensus 231 ~~~L~~~P~~R~~~~~~~~~~~~h~~f~~~ 260 (277)
T cd05607 231 RLFLAKKPEDRLGSREKNDDPRKHEFFKTI 260 (277)
T ss_pred HHHhccCHhhCCCCccchhhhhcChhhcCC
Confidence 99999999999999 778899999764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-44 Score=371.23 Aligned_cols=255 Identities=30% Similarity=0.433 Sum_probs=218.4
Q ss_pred CceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeE
Q 014210 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (429)
Q Consensus 155 ~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~ 234 (429)
..|.+.++||+|+||.||+|....+ .++.||+|.+.. ........+.+|+.+++.++ |+|||++++++.+++..
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~--~~~~vv~K~~~~---~~~~~~~~~~~E~~~l~~l~-Hpniv~~~~~~~~~~~~ 140 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSD--PKEKVVAKFVML---NDERQAAYARSELHCLAACD-HFGIVKHFDDFKSDDKL 140 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCC--CCeEEEEEEccc---CCHHHHHHHHHHHHHHHhCC-CCCEeEEEEEEEECCEE
Confidence 4599999999999999999986552 267899997743 23444567889999999998 99999999999999999
Q ss_pred EEEEEecCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCcc
Q 014210 235 YVVMELCEGGELLDRILSR---GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (429)
Q Consensus 235 ~lv~E~~~ggsL~~~i~~~---~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~ 311 (429)
||||||++||+|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++
T Consensus 141 ~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll---~~~~~~kL~DFgla~ 217 (478)
T PTZ00267 141 LLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFL---MPTGIIKLGDFGFSK 217 (478)
T ss_pred EEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEE---CCCCcEEEEeCcCce
Confidence 9999999999999887542 4468999999999999999999999999999999999999 678899999999998
Q ss_pred ccCCCc---cccccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCC
Q 014210 312 FVRPDE---RLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPS 387 (429)
Q Consensus 312 ~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 387 (429)
...... .....+||+.|+|||++.+ .++.++|||||||++|||++|+.||......+.+..++...... ....
T Consensus 218 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~---~~~~ 294 (478)
T PTZ00267 218 QYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDP---FPCP 294 (478)
T ss_pred ecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC---CCcc
Confidence 764332 2345679999999998864 68999999999999999999999999888888777777654321 1235
Q ss_pred CCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhc
Q 014210 388 LSSEARDFVKRLLNKDPRKRLTAAQALSELLICY 421 (429)
Q Consensus 388 ~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~ 421 (429)
++.++.+||.+||..||++||++.+++.++|+..
T Consensus 295 ~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~ 328 (478)
T PTZ00267 295 VSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKY 328 (478)
T ss_pred CCHHHHHHHHHHhccChhhCcCHHHHHhCHHHHH
Confidence 8899999999999999999999999999999864
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-45 Score=360.29 Aligned_cols=253 Identities=25% Similarity=0.420 Sum_probs=215.4
Q ss_pred cCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~ 233 (429)
.+.+.+++.||+|.||+||+|+... .||||++.... .+.+..+.|++|+.++++-+ |.||+-+.|+|...+.
T Consensus 391 ~~ev~l~~rIGsGsFGtV~Rg~whG------dVAVK~Lnv~~-pt~~qlqaFKnEVa~lkkTR-H~NIlLFMG~~~~p~~ 462 (678)
T KOG0193|consen 391 PEEVLLGERIGSGSFGTVYRGRWHG------DVAVKLLNVDD-PTPEQLQAFKNEVAVLKKTR-HENILLFMGACMNPPL 462 (678)
T ss_pred HHHhhccceeccccccceeeccccc------ceEEEEEecCC-CCHHHHHHHHHHHHHHhhcc-hhhheeeehhhcCCce
Confidence 4567789999999999999998664 49999998765 34557889999999999999 9999999999998887
Q ss_pred EEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCcccc
Q 014210 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (429)
Q Consensus 234 ~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~ 313 (429)
.||+.||+|.+|+.+|+....+++....+.|++||++|+.|||.++|||||||..||+| .+++.|||+|||++...
T Consensus 463 -AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl---~~~~kVkIgDFGLatvk 538 (678)
T KOG0193|consen 463 -AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFL---HEDLKVKIGDFGLATVK 538 (678)
T ss_pred -eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEE---ccCCcEEEecccceeee
Confidence 99999999999999998888899999999999999999999999999999999999999 67799999999998542
Q ss_pred ---CCCccccccccCCcccCccccc----CCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCC-CCCCCC
Q 014210 314 ---RPDERLNDIVGSAYYVAPEVLH----RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPS-FDEAPW 385 (429)
Q Consensus 314 ---~~~~~~~~~~gt~~y~aPE~~~----~~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~-~~~~~~ 385 (429)
..+.......|...|||||+++ ..|+..+||||||+++|||+||.+||.....+.++..+-++... ......
T Consensus 539 ~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~~~ 618 (678)
T KOG0193|consen 539 TRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSKIR 618 (678)
T ss_pred eeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchhhh
Confidence 3344455667889999999886 25899999999999999999999999876666655554444221 122233
Q ss_pred CCCCHHHHHHHHHhcccCccCcCCHHHHHhhHh
Q 014210 386 PSLSSEARDFVKRLLNKDPRKRLTAAQALSELL 418 (429)
Q Consensus 386 ~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~ 418 (429)
..+++++++|+..||..++++||.+.+||..+.
T Consensus 619 s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~ 651 (678)
T KOG0193|consen 619 SNCPKAMKRLLSDCWKFDREERPLFPQLLSKLE 651 (678)
T ss_pred ccCHHHHHHHHHHHHhcCcccCccHHHHHHHHH
Confidence 457789999999999999999999999998443
|
|
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-45 Score=358.13 Aligned_cols=250 Identities=29% Similarity=0.516 Sum_probs=209.9
Q ss_pred ceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHH-HHHHhcCCCCcceEEEEEEeCCeEEEEEE
Q 014210 161 EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVK-ILRALTGHNNLVKFFDAYEDTDNVYVVME 239 (429)
Q Consensus 161 ~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~-il~~l~~h~nIv~l~~~~~~~~~~~lv~E 239 (429)
++||+|+||.||+|+... +|+.||+|++.+..........++.+|+. +++.++ |+||+++++++.+.+..|+|||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~-h~~iv~~~~~~~~~~~~~lv~e 76 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKS---DGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLK-HPFLVGLHYSFQTAEKLYFVLD 76 (321)
T ss_pred CeeeeCCCEEEEEEEECC---CCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCC-CCCccceeeEEEcCCEEEEEEc
Confidence 479999999999999766 58999999987644333444455666665 466776 9999999999999999999999
Q ss_pred ecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccccC-CCcc
Q 014210 240 LCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR-PDER 318 (429)
Q Consensus 240 ~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~-~~~~ 318 (429)
||++++|..++. ....+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||++.... ....
T Consensus 77 ~~~~~~L~~~l~-~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~~~~~~~~~~~ 152 (321)
T cd05603 77 YVNGGELFFHLQ-RERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILL---DSQGHVVLTDFGLCKEGVEPEET 152 (321)
T ss_pred CCCCCCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEE---CCCCCEEEccCCCCccCCCCCCc
Confidence 999999988774 44678999999999999999999999999999999999999 778899999999987532 2333
Q ss_pred ccccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHH
Q 014210 319 LNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVK 397 (429)
Q Consensus 319 ~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 397 (429)
....+||+.|+|||++.+ .++.++|||||||++|||++|+.||...+....+..++......+ +..+.++.++|.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~li~ 228 (321)
T cd05603 153 TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLP----GGKTVAACDLLV 228 (321)
T ss_pred cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCC----CCCCHHHHHHHH
Confidence 445679999999998874 689999999999999999999999998887777777765543332 357899999999
Q ss_pred HhcccCccCcCCH----HHHHhhHhhhcc
Q 014210 398 RLLNKDPRKRLTA----AQALSELLICYQ 422 (429)
Q Consensus 398 ~~L~~dP~~Rps~----~~iL~~~~~~~~ 422 (429)
+||+.||++|+++ .+++.|+|+...
T Consensus 229 ~~l~~~p~~R~~~~~~~~~~~~~~~~~~~ 257 (321)
T cd05603 229 GLLHKDQRRRLGAKADFLEIKNHVFFSPI 257 (321)
T ss_pred HHccCCHhhcCCCCCCHHHHhCCCCcCCC
Confidence 9999999999875 599999998643
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=360.68 Aligned_cols=257 Identities=28% Similarity=0.480 Sum_probs=209.2
Q ss_pred ccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCC
Q 014210 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (429)
Q Consensus 153 ~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~ 232 (429)
..++|++.+.||+|+||.||+++... +|+.||||++.... ........+.+|+.+++.++ |+||+++++++...+
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~ 93 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTV---LGINVAVKKLSRPF-QNQTHAKRAYRELVLLKCVN-HKNIISLLNVFTPQK 93 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcC---CCceeEEEEecccc-cchhHHHHHHHHHHHHHhCC-CCCEeeeeeeeccCC
Confidence 46899999999999999999998765 58999999986543 33445567889999999998 999999999986543
Q ss_pred ------eEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEee
Q 014210 233 ------NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAID 306 (429)
Q Consensus 233 ------~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~D 306 (429)
..|+||||+++ +|.+.+. ..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|
T Consensus 94 ~~~~~~~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~---~~~~~~kl~D 166 (359)
T cd07876 94 SLEEFQDVYLVMELMDA-NLCQVIH---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILD 166 (359)
T ss_pred CccccceeEEEEeCCCc-CHHHHHh---ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE---CCCCCEEEec
Confidence 57999999975 6666553 358899999999999999999999999999999999999 7788999999
Q ss_pred cCCccccCCCccccccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhc---------
Q 014210 307 FGLSDFVRPDERLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKA--------- 376 (429)
Q Consensus 307 FGla~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~--------- 376 (429)
||+++............||..|+|||++.+ .++.++|||||||++|+|++|+.||........+..+++.
T Consensus 167 fg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 246 (359)
T cd07876 167 FGLARTACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFM 246 (359)
T ss_pred CCCccccccCccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHH
Confidence 999987654444556789999999998874 6899999999999999999999999876654433322221
Q ss_pred -------------CCCCCCC----------------CCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhc
Q 014210 377 -------------DPSFDEA----------------PWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLICY 421 (429)
Q Consensus 377 -------------~~~~~~~----------------~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~ 421 (429)
.+..... .....+.++.+||.+||+.||++|||+.|+|.|+|+..
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~ 320 (359)
T cd07876 247 NRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITV 320 (359)
T ss_pred HHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhh
Confidence 1111100 00124678999999999999999999999999999964
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-44 Score=353.66 Aligned_cols=258 Identities=24% Similarity=0.397 Sum_probs=211.6
Q ss_pred cCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~ 233 (429)
.++|++.++||+|+||.||++.... +|..+|+|++... ......+.+.+|++++++++ |+||++++++|.+++.
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~---~~~~~a~k~~~~~--~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~ 77 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKP---SGLIMARKLIHLE--IKPAIRNQIIRELQVLHECN-SPYIVGFYGAFYSDGE 77 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECC---CCcEEEEEEeecc--cCHHHHHHHHHHHHHHHHCC-CCcccceeEEEEECCE
Confidence 5789999999999999999998765 5889999998653 23445567899999999998 9999999999999999
Q ss_pred EEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHc-CceeccCCCCcEEEeecCCCceEEEeecCCccc
Q 014210 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQ-GVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (429)
Q Consensus 234 ~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~-~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~ 312 (429)
.++||||+++++|.+++.. .+.+++..+..++.||+.||.|||+. +|+||||||+|||+ +.++.+||+|||++..
T Consensus 78 ~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili---~~~~~~kL~Dfg~~~~ 153 (333)
T cd06650 78 ISICMEHMDGGSLDQVLKK-AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILV---NSRGEIKLCDFGVSGQ 153 (333)
T ss_pred EEEEEecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEE---cCCCCEEEeeCCcchh
Confidence 9999999999999998754 45689999999999999999999985 79999999999999 6778899999999876
Q ss_pred cCCCccccccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHH---hc------------
Q 014210 313 VRPDERLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVL---KA------------ 376 (429)
Q Consensus 313 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~---~~------------ 376 (429)
... .......|+..|+|||++.+ .++.++|||||||++|+|++|+.||...........+. ..
T Consensus 154 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (333)
T cd06650 154 LID-SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPR 232 (333)
T ss_pred hhh-hccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccC
Confidence 532 22344679999999999875 58899999999999999999999997554332211110 00
Q ss_pred ---------------------------CCCCCCCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhcc
Q 014210 377 ---------------------------DPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLICYQ 422 (429)
Q Consensus 377 ---------------------------~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~ 422 (429)
....+......++.++.+||.+||++||++||++.+++.|+||+..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 305 (333)
T cd06650 233 PPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 305 (333)
T ss_pred CccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcC
Confidence 0000000112367899999999999999999999999999999765
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-44 Score=369.53 Aligned_cols=259 Identities=30% Similarity=0.468 Sum_probs=219.9
Q ss_pred cccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeC
Q 014210 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (429)
Q Consensus 152 ~~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~ 231 (429)
...++|++.++||+|+||.||+++... +|+.||||++..... .......+.+|+.++..+. |+||+++++.+...
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~---~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~~l~~~~-h~~iv~~~~~~~~~ 103 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVS---DGEPFAVKVVDMEGM-SEADKNRAQAEVCCLLNCD-FFSIVKCHEDFAKK 103 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcC---CCCEEEEEEEecccC-CHHHHHHHHHHHHHHhcCC-CCcEEEeecceecc
Confidence 345799999999999999999998766 589999999876543 4455677889999999998 99999999877543
Q ss_pred C--------eEEEEEEecCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCc
Q 014210 232 D--------NVYVVMELCEGGELLDRILSR---GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENS 300 (429)
Q Consensus 232 ~--------~~~lv~E~~~ggsL~~~i~~~---~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~ 300 (429)
+ .+++||||+++|+|.+++..+ ...+++..++.++.||+.||.|||+.||+||||||+|||+ +.++
T Consensus 104 ~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl---~~~~ 180 (496)
T PTZ00283 104 DPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILL---CSNG 180 (496)
T ss_pred cccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEE---eCCC
Confidence 2 368999999999999988653 3468999999999999999999999999999999999999 6788
Q ss_pred eEEEeecCCccccCCC---ccccccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhc
Q 014210 301 VLKAIDFGLSDFVRPD---ERLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKA 376 (429)
Q Consensus 301 ~vkL~DFGla~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~ 376 (429)
.+||+|||+++..... ......+||+.|+|||++.+ .++.++|||||||++|||++|+.||........+..++..
T Consensus 181 ~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~ 260 (496)
T PTZ00283 181 LVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAG 260 (496)
T ss_pred CEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcC
Confidence 9999999998765432 22345679999999999874 6899999999999999999999999988877777777654
Q ss_pred CCCCCCCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhc
Q 014210 377 DPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLICY 421 (429)
Q Consensus 377 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~ 421 (429)
.... ..+.+++++.+||.+||+.||.+||++.+++.|+|+..
T Consensus 261 ~~~~---~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~ 302 (496)
T PTZ00283 261 RYDP---LPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKL 302 (496)
T ss_pred CCCC---CCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHH
Confidence 4321 22468999999999999999999999999999998753
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-44 Score=348.49 Aligned_cols=262 Identities=26% Similarity=0.412 Sum_probs=215.7
Q ss_pred cCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~ 233 (429)
.++|++.++||+|+||.||+++... +++.||+|.+..... ......+.+|+.++++++ |+||+++++++.+.+.
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~---~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~-h~nI~~~~~~~~~~~~ 78 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKL---TDNLVALKEIRLEHE--EGAPCTAIREVSLLKDLK-HANIVTLHDIIHTEKS 78 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcC---CCcEEEEEEEecccc--cCchhHHHHHHHHHHhcC-CCCcceEEEEEecCCe
Confidence 3679999999999999999998765 588999999865432 222345778999999998 9999999999999999
Q ss_pred EEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCcccc
Q 014210 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (429)
Q Consensus 234 ~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~ 313 (429)
.++||||++ ++|.+++......+++..++.++.||+.||.|||+.||+|+||||+|||+ +.++.+||+|||++...
T Consensus 79 ~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~dfg~~~~~ 154 (301)
T cd07873 79 LTLVFEYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLI---NERGELKLADFGLARAK 154 (301)
T ss_pred EEEEEeccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEE---CCCCcEEECcCcchhcc
Confidence 999999997 58988887777789999999999999999999999999999999999999 67888999999998764
Q ss_pred CCCc-cccccccCCcccCcccccC--CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCC--------
Q 014210 314 RPDE-RLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDE-------- 382 (429)
Q Consensus 314 ~~~~-~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~-------- 382 (429)
.... ......++..|+|||++.+ .++.++||||||+++|||++|+.||...+..+.+..+.........
T Consensus 155 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (301)
T cd07873 155 SIPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILS 234 (301)
T ss_pred CCCCCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhc
Confidence 3222 2234567899999998754 4788999999999999999999999887766555444332111000
Q ss_pred ------------------CCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhcccee
Q 014210 383 ------------------APWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLICYQSYL 425 (429)
Q Consensus 383 ------------------~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~~~~ 425 (429)
...+.++.++.+||.+||+.||.+|||+.++|.|+||+.-...
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~~~ 295 (301)
T cd07873 235 NEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLGER 295 (301)
T ss_pred cccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccch
Confidence 1123578899999999999999999999999999999865543
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-44 Score=361.39 Aligned_cols=251 Identities=18% Similarity=0.313 Sum_probs=203.3
Q ss_pred cCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~ 233 (429)
..+|+++++||+|+||.||++.... +++.||||.... ..+.+|++++++|+ ||||+++++++..++.
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~---~~~~vaiK~~~~---------~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~ 157 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNK---TCEHVVIKAGQR---------GGTATEAHILRAIN-HPSIIQLKGTFTYNKF 157 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECC---CCCEEEEechhh---------hhhHHHHHHHHhCC-CCCCCCEeEEEEECCe
Confidence 4679999999999999999998776 689999997532 34678999999998 9999999999999999
Q ss_pred EEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCcccc
Q 014210 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (429)
Q Consensus 234 ~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~ 313 (429)
.++|||++. ++|..++... ..+++..++.++.||+.||.|||++|||||||||+|||+ +.++.+||+|||++...
T Consensus 158 ~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll---~~~~~vkL~DFG~a~~~ 232 (391)
T PHA03212 158 TCLILPRYK-TDLYCYLAAK-RNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFI---NHPGDVCLGDFGAACFP 232 (391)
T ss_pred eEEEEecCC-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEE---cCCCCEEEEeCCccccc
Confidence 999999995 6888877544 568999999999999999999999999999999999999 67788999999999754
Q ss_pred CCC--ccccccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHcCCCCCCCCC-------hHHHHHHHHhcCC-----
Q 014210 314 RPD--ERLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWART-------ESGIFRAVLKADP----- 378 (429)
Q Consensus 314 ~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~elltg~~Pf~~~~-------~~~~~~~i~~~~~----- 378 (429)
... .......||+.|+|||++.+ .++.++|||||||++|||++|+.||.... ....+..+.....
T Consensus 233 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~ 312 (391)
T PHA03212 233 VDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNE 312 (391)
T ss_pred ccccccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhh
Confidence 322 23345689999999998864 68999999999999999999998875421 1111211211100
Q ss_pred ---------------------CCC--CCCC---CCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhcc
Q 014210 379 ---------------------SFD--EAPW---PSLSSEARDFVKRLLNKDPRKRLTAAQALSELLICYQ 422 (429)
Q Consensus 379 ---------------------~~~--~~~~---~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~ 422 (429)
..+ ...| ..++.++.+||.+||+.||++|||+.|+|+|+||+..
T Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~ 382 (391)
T PHA03212 313 FPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDI 382 (391)
T ss_pred cCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccC
Confidence 000 0001 1356789999999999999999999999999999764
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=342.38 Aligned_cols=254 Identities=40% Similarity=0.686 Sum_probs=210.9
Q ss_pred eeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEE
Q 014210 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYV 236 (429)
Q Consensus 157 y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~~l 236 (429)
|++++.||+|+||.||+++... +++.||+|++........ ......+|+.++++++ |+||+++++++.+.+..++
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~---~~~~~~~K~~~~~~~~~~-~~~~~~~e~~~~~~l~-~~~i~~~~~~~~~~~~~~~ 75 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKK---NGQKVAVKIIDKSEIEEE-EREENIREIKILRRLR-HPNIVQILDVFQDDNYLYI 75 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETT---TTEEEEEEEEESTTHHHH-HHHHHHHHHHHHHHHT-BTTBCHEEEEEEESSEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECC---CCeEEEEEEecccccccc-ccchhhhhhhcccccc-ccccccccccccccccccc
Confidence 7899999999999999999777 588999999976532222 2234456999999996 9999999999999999999
Q ss_pred EEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCcccc-CC
Q 014210 237 VMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV-RP 315 (429)
Q Consensus 237 v~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~-~~ 315 (429)
||||+++++|.+++. ....+++..++.++.||++||.+||+.||+|+||||+|||+ ++++.++|+|||.+... ..
T Consensus 76 v~~~~~~~~L~~~l~-~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~---~~~~~~~l~Dfg~~~~~~~~ 151 (260)
T PF00069_consen 76 VMEYCPGGSLQDYLQ-KNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILL---DENGEVKLIDFGSSVKLSEN 151 (260)
T ss_dssp EEEEETTEBHHHHHH-HHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEE---STTSEEEESSGTTTEESTST
T ss_pred ccccccccccccccc-ccccccccccccccccccccccccccccccccccccccccc---cccccccccccccccccccc
Confidence 999999999998886 55678999999999999999999999999999999999999 78889999999998763 33
Q ss_pred CccccccccCCcccCccccc--CCCCCcccHHHHHHHHHHHHcCCCCCCCCC---hHHHHHHHHhcCCCCCCCCCCCCCH
Q 014210 316 DERLNDIVGSAYYVAPEVLH--RSYSTEADVWSIGVIAYILLCGSRPFWART---ESGIFRAVLKADPSFDEAPWPSLSS 390 (429)
Q Consensus 316 ~~~~~~~~gt~~y~aPE~~~--~~~~~~sDiwSlGvll~elltg~~Pf~~~~---~~~~~~~i~~~~~~~~~~~~~~~s~ 390 (429)
........++..|+|||++. ..++.++||||||+++|+|++|..||.... ....+...+................
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (260)
T PF00069_consen 152 NENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSE 231 (260)
T ss_dssp TSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHH
Confidence 34455678999999999987 568999999999999999999999998773 2333333333221111111112348
Q ss_pred HHHHHHHHhcccCccCcCCHHHHHhhHhh
Q 014210 391 EARDFVKRLLNKDPRKRLTAAQALSELLI 419 (429)
Q Consensus 391 ~~~~li~~~L~~dP~~Rps~~~iL~~~~~ 419 (429)
++.+||++||+.||++||++.++++|+||
T Consensus 232 ~l~~li~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 232 ELRDLIKKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp HHHHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred HHHHHHHHHccCChhHCcCHHHHhcCCCC
Confidence 99999999999999999999999999997
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-46 Score=390.96 Aligned_cols=264 Identities=28% Similarity=0.454 Sum_probs=233.0
Q ss_pred cccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeC
Q 014210 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (429)
Q Consensus 152 ~~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~ 231 (429)
.-.++|+++++||+|+||.|.+++++. +++.||+|++++..+........|..|-++|..-. .+.||+++.+|.|+
T Consensus 72 l~~~DfeilKvIGrGaFGEV~lVr~k~---t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~n-s~Wiv~LhyAFQD~ 147 (1317)
T KOG0612|consen 72 LKAEDFEILKVIGRGAFGEVALVRHKS---TEKVYAMKILNKWEMLKRAETACFREERDIMVFGN-SEWIVQLHYAFQDE 147 (1317)
T ss_pred CCHHhhHHHHHhcccccceeEEEEeec---cccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCC-cHHHHHHHHHhcCc
Confidence 346889999999999999999999887 68999999998866665556677889999998766 89999999999999
Q ss_pred CeEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCcc
Q 014210 232 DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (429)
Q Consensus 232 ~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~ 311 (429)
+++|+|||||+||+|...+.... .+++..++.++..|+.||..||+.|+|||||||+|||| |..|++||+|||.+-
T Consensus 148 ~~LYlVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLl---d~~GHikLADFGsCl 223 (1317)
T KOG0612|consen 148 RYLYLVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLL---DKSGHIKLADFGSCL 223 (1317)
T ss_pred cceEEEEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEe---cccCcEeeccchhHH
Confidence 99999999999999999775554 89999999999999999999999999999999999999 899999999999987
Q ss_pred ccCCCccc--cccccCCcccCccccc------CCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCC
Q 014210 312 FVRPDERL--NDIVGSAYYVAPEVLH------RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEA 383 (429)
Q Consensus 312 ~~~~~~~~--~~~~gt~~y~aPE~~~------~~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~ 383 (429)
.+..+... ...+|||.|.+||++. +.|+..+|+||+||++|||+.|..||++..--+.+.+|+.....+..+
T Consensus 224 km~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP 303 (1317)
T KOG0612|consen 224 KMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFP 303 (1317)
T ss_pred hcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCC
Confidence 77755543 4578999999999984 358999999999999999999999999999999999998874333332
Q ss_pred CCCCCCHHHHHHHHHhcccCccCcCC---HHHHHhhHhhhccce
Q 014210 384 PWPSLSSEARDFVKRLLNKDPRKRLT---AAQALSELLICYQSY 424 (429)
Q Consensus 384 ~~~~~s~~~~~li~~~L~~dP~~Rps---~~~iL~~~~~~~~~~ 424 (429)
.-..+|+++++||+.+|+ +|+.|.. ++++..|+||.+..|
T Consensus 304 ~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W 346 (1317)
T KOG0612|consen 304 DETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDW 346 (1317)
T ss_pred cccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCCh
Confidence 234699999999999997 6999999 999999999988765
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-44 Score=359.06 Aligned_cols=258 Identities=31% Similarity=0.486 Sum_probs=212.0
Q ss_pred ceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCC---
Q 014210 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD--- 232 (429)
Q Consensus 156 ~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~--- 232 (429)
+|+++++||+|+||.||++.... +|+.||||++.... ......+++.+|+++++.++ |+||+++++++...+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~ 75 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPR---DGKRVALKKMPNVF-QNLVSCKRVFRELKMLCFFK-HDNVLSALDILQPPHIDP 75 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECC---CCCEEEEEeccccc-cchHHHHHHHHHHHHHHhCC-CCCcCCHhheecCCCccc
Confidence 47889999999999999998765 58999999986432 33345567889999999998 999999999998876
Q ss_pred --eEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCc
Q 014210 233 --NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS 310 (429)
Q Consensus 233 --~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla 310 (429)
..|+||||+. ++|.+.+. ....+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||++
T Consensus 76 ~~~~~lv~e~~~-~~l~~~~~-~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili---~~~~~~kL~Dfg~a 150 (372)
T cd07853 76 FEEIYVVTELMQ-SDLHKIIV-SPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLV---NSNCVLKICDFGLA 150 (372)
T ss_pred cceEEEEeeccc-cCHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEE---CCCCCEEeccccce
Confidence 7899999996 57877664 44679999999999999999999999999999999999999 77889999999999
Q ss_pred cccCCCc--cccccccCCcccCcccccC--CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcC---------
Q 014210 311 DFVRPDE--RLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKAD--------- 377 (429)
Q Consensus 311 ~~~~~~~--~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~--------- 377 (429)
....... ......++..|+|||++.+ .++.++|||||||++|||++|+.||.+......+..+....
T Consensus 151 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~ 230 (372)
T cd07853 151 RVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMR 230 (372)
T ss_pred eecccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHH
Confidence 7654332 2234568999999998865 47889999999999999999999998877665554443210
Q ss_pred -------------C-CCCC-----CCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhccc
Q 014210 378 -------------P-SFDE-----APWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLICYQS 423 (429)
Q Consensus 378 -------------~-~~~~-----~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~~ 423 (429)
. ..+. ......++++.+||.+||+.||++|||+.++|.|+||....
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~ 295 (372)
T cd07853 231 SACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEGR 295 (372)
T ss_pred HhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCCc
Confidence 0 0000 11234688999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-45 Score=330.65 Aligned_cols=257 Identities=26% Similarity=0.417 Sum_probs=224.7
Q ss_pred CceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeE
Q 014210 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (429)
Q Consensus 155 ~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~ 234 (429)
++.+.+..||.|.-|.|++++++. +|...|||.+.+. ...+..+++...++++...+++|+||+.+|||..+..+
T Consensus 92 ndl~~l~dlGsGtcG~V~k~~~rs---~~~iiAVK~M~rt--~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV 166 (391)
T KOG0983|consen 92 NDLENLGDLGSGTCGQVWKMRFRS---TGHIIAVKQMRRT--GNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDV 166 (391)
T ss_pred HHhhhHHhhcCCCccceEEEEEcc---cceEEEEEeeccc--CCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchH
Confidence 456678899999999999999887 6899999999865 55667788999999998888899999999999999999
Q ss_pred EEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHc-CceeccCCCCcEEEeecCCCceEEEeecCCcccc
Q 014210 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQ-GVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (429)
Q Consensus 235 ~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~-~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~ 313 (429)
+|.||.|. .-+...+..-.+.++|..+.++...+++||.||-++ ||||||+||+|||+ |+.|++||||||.+..+
T Consensus 167 ~IcMelMs-~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILl---De~GniKlCDFGIsGrl 242 (391)
T KOG0983|consen 167 FICMELMS-TCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILL---DERGNIKLCDFGISGRL 242 (391)
T ss_pred HHHHHHHH-HHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEE---ccCCCEEeeccccccee
Confidence 99999994 344444445567899999999999999999999875 89999999999999 89999999999999988
Q ss_pred CCCccccccccCCcccCccccc----CCCCCcccHHHHHHHHHHHHcCCCCCCC-CChHHHHHHHHhcCCCCCCCCCCCC
Q 014210 314 RPDERLNDIVGSAYYVAPEVLH----RSYSTEADVWSIGVIAYILLCGSRPFWA-RTESGIFRAVLKADPSFDEAPWPSL 388 (429)
Q Consensus 314 ~~~~~~~~~~gt~~y~aPE~~~----~~~~~~sDiwSlGvll~elltg~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~ 388 (429)
.+........|-+.|||||.+. ..|+.++||||||++|+||+||+.||.. .++-+.+.++++.++.... .-..+
T Consensus 243 vdSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~-~~~gF 321 (391)
T KOG0983|consen 243 VDSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLP-GHMGF 321 (391)
T ss_pred ecccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCC-cccCc
Confidence 8777778889999999999985 3599999999999999999999999976 5677889999987763332 22348
Q ss_pred CHHHHHHHHHhcccCccCcCCHHHHHhhHhhhc
Q 014210 389 SSEARDFVKRLLNKDPRKRLTAAQALSELLICY 421 (429)
Q Consensus 389 s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~ 421 (429)
+++|.+|+..||++|+.+||...++|+|+|+..
T Consensus 322 Sp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ 354 (391)
T KOG0983|consen 322 SPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKR 354 (391)
T ss_pred CHHHHHHHHHHhhcCcccCcchHHHhcCcceee
Confidence 999999999999999999999999999998753
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=338.21 Aligned_cols=254 Identities=18% Similarity=0.304 Sum_probs=213.3
Q ss_pred cCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~ 233 (429)
.++|++.+.||+|+||.||+|..+.....+..||+|.+... ......+.+.+|+.++++++ |+||+++++++..++.
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~--~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~ 80 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAG--CSDKQRRGFLAEALTLGQFD-HSNIVRLEGVITRGNT 80 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCC--CCHHHHHHHHHHHHHHhcCC-CCCcCeEEEEEecCCC
Confidence 46799999999999999999987654446789999998654 23444567899999999997 9999999999999999
Q ss_pred EEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCcccc
Q 014210 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (429)
Q Consensus 234 ~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~ 313 (429)
.++||||+++|+|.+++......+++..++.++.||+.||+|||++|++||||||+|||+ +.++.+||+|||.+...
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili---~~~~~~~l~dfg~~~~~ 157 (266)
T cd05064 81 MMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLV---NSDLVCKISGFRRLQED 157 (266)
T ss_pred cEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEE---cCCCcEEECCCcccccc
Confidence 999999999999999887666789999999999999999999999999999999999999 67889999999987654
Q ss_pred CCCcccc--ccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCC
Q 014210 314 RPDERLN--DIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLS 389 (429)
Q Consensus 314 ~~~~~~~--~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 389 (429)
....... ...++..|+|||++. +.++.++|||||||++|||++ |+.||+.....+....+..... . .....++
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~-~--~~~~~~~ 234 (266)
T cd05064 158 KSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFR-L--PAPRNCP 234 (266)
T ss_pred cccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCC-C--CCCCCCC
Confidence 3222111 233567899999876 568999999999999999775 9999998887776666644322 1 2234688
Q ss_pred HHHHHHHHHhcccCccCcCCHHHHHhh
Q 014210 390 SEARDFVKRLLNKDPRKRLTAAQALSE 416 (429)
Q Consensus 390 ~~~~~li~~~L~~dP~~Rps~~~iL~~ 416 (429)
..+.+++.+||+.+|++||++.+|++.
T Consensus 235 ~~~~~li~~c~~~~p~~RP~~~~i~~~ 261 (266)
T cd05064 235 NLLHQLMLDCWQKERGERPRFSQIHSI 261 (266)
T ss_pred HHHHHHHHHHcCCCchhCCCHHHHHHH
Confidence 999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-44 Score=355.38 Aligned_cols=256 Identities=27% Similarity=0.464 Sum_probs=208.3
Q ss_pred ccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeC-
Q 014210 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT- 231 (429)
Q Consensus 153 ~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~- 231 (429)
..++|++.+.||+|+||.||++.... .++.||||++.... ......+.+.+|+.+++.++ |+||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~ 89 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAV---LDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVN-HKNIISLLNVFTPQK 89 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecC---CCceEEEEEeCCcc-cChHHHHHHHHHHHHHHHhC-CCchhceeeeeeccc
Confidence 45789999999999999999998655 58899999986543 33444567889999999998 99999999988643
Q ss_pred -----CeEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEee
Q 014210 232 -----DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAID 306 (429)
Q Consensus 232 -----~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~D 306 (429)
...++||||+++ +|.+.+. ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|
T Consensus 90 ~~~~~~~~~lv~e~~~~-~l~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill---~~~~~~kl~D 162 (355)
T cd07874 90 SLEEFQDVYLVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILD 162 (355)
T ss_pred cccccceeEEEhhhhcc-cHHHHHh---hcCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEE---CCCCCEEEee
Confidence 357999999975 6666553 358999999999999999999999999999999999999 6788999999
Q ss_pred cCCccccCCCccccccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhc---------
Q 014210 307 FGLSDFVRPDERLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKA--------- 376 (429)
Q Consensus 307 FGla~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~--------- 376 (429)
||+++............||..|+|||++.+ .++.++|||||||++|+|++|+.||.+....+.+..++..
T Consensus 163 fg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 242 (355)
T cd07874 163 FGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM 242 (355)
T ss_pred CcccccCCCccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 999987655544556789999999998875 6899999999999999999999999876654443332221
Q ss_pred -------------CCCCC----------------CCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhh
Q 014210 377 -------------DPSFD----------------EAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLIC 420 (429)
Q Consensus 377 -------------~~~~~----------------~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~ 420 (429)
.+... .......+.++.+||.+||+.||++|||+.|+|+|+|++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~ 315 (355)
T cd07874 243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYIN 315 (355)
T ss_pred HhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchh
Confidence 11100 001112457889999999999999999999999999996
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-45 Score=340.63 Aligned_cols=262 Identities=34% Similarity=0.597 Sum_probs=226.8
Q ss_pred cCceeE-eceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCC
Q 014210 154 ANKYEL-GEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (429)
Q Consensus 154 ~~~y~~-~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~ 232 (429)
.+-|++ .+.||+|+|+.|--+.... +|+.||||++.+. ......++.+|++++.+.++|+||++|+++|+++.
T Consensus 76 ~d~YkLt~e~LGeGAyasVqtcv~i~---t~~EYAVKiidKq---~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~ 149 (463)
T KOG0607|consen 76 EDMYKLTSELLGEGAYASVQTCVSIQ---TGKEYAVKIIDKQ---PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDT 149 (463)
T ss_pred HHHHHhHHHHhcCccceeeeeeeeec---cchhhhhhhhhcC---CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccc
Confidence 344555 5678999999988777555 6999999999775 44556789999999999999999999999999999
Q ss_pred eEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccc
Q 014210 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (429)
Q Consensus 233 ~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~ 312 (429)
.+|||||.|.||.|+.+|+++ .-+++.++.++..+|+.||.|||.+||.|||+||+|||....+.---||||||.++.-
T Consensus 150 ~FYLVfEKm~GGplLshI~~~-~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg 228 (463)
T KOG0607|consen 150 RFYLVFEKMRGGPLLSHIQKR-KHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSG 228 (463)
T ss_pred eEEEEEecccCchHHHHHHHh-hhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccc
Confidence 999999999999999999765 5699999999999999999999999999999999999997655556799999998643
Q ss_pred cCCC--------ccccccccCCcccCccccc---C---CCCCcccHHHHHHHHHHHHcCCCCCCCCC-------------
Q 014210 313 VRPD--------ERLNDIVGSAYYVAPEVLH---R---SYSTEADVWSIGVIAYILLCGSRPFWART------------- 365 (429)
Q Consensus 313 ~~~~--------~~~~~~~gt~~y~aPE~~~---~---~~~~~sDiwSlGvll~elltg~~Pf~~~~------------- 365 (429)
.... ....+.+|+..|||||+.. + .|+.+.|.|||||+||.|++|..||.+..
T Consensus 229 ~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr 308 (463)
T KOG0607|consen 229 IKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCR 308 (463)
T ss_pred cccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccH
Confidence 2111 1234568999999999753 3 48999999999999999999999994432
Q ss_pred --hHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhcc
Q 014210 366 --ESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLICYQ 422 (429)
Q Consensus 366 --~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~ 422 (429)
.+..+..|.++...|++.-|..++.+++|||..+|..|+.+|.++.+++.|+|++..
T Consensus 309 ~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~ 367 (463)
T KOG0607|consen 309 VCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRC 367 (463)
T ss_pred HHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCcccccc
Confidence 245788999999999999999999999999999999999999999999999999754
|
|
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-44 Score=382.08 Aligned_cols=267 Identities=31% Similarity=0.536 Sum_probs=220.2
Q ss_pred CccccccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEE
Q 014210 148 GFSKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDA 227 (429)
Q Consensus 148 ~~~~~~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~ 227 (429)
...+...++|+++++||+|+||.||+|+... .++.||+|++..... .......+.+|+.++++|. |+|||+++++
T Consensus 6 ~~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~---tg~~vAlKvIk~~~l-~e~~~~~~~~EI~IL~~L~-HPNIVrl~d~ 80 (1021)
T PTZ00266 6 DDGESRLNEYEVIKKIGNGRFGEVFLVKHKR---TQEFFCWKAISYRGL-KEREKSQLVIEVNVMRELK-HKNIVRYIDR 80 (1021)
T ss_pred cCCccccCCEEEEEEEecCCCeEEEEEEECC---CCeEEEEEEEecccc-CHHHHHHHHHHHHHHHHcC-CCCcCeEEEE
Confidence 3445567899999999999999999999776 588999999875432 3345577899999999998 9999999999
Q ss_pred EEe--CCeEEEEEEecCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHc-------CceeccCCCCcEEEee
Q 014210 228 YED--TDNVYVVMELCEGGELLDRILSR---GGKYTEDDAKAVMIQILNVVAFCHLQ-------GVVHRDLKPENFLFTT 295 (429)
Q Consensus 228 ~~~--~~~~~lv~E~~~ggsL~~~i~~~---~~~l~~~~~~~i~~qi~~gL~~LH~~-------~iiHrDIKp~NILl~~ 295 (429)
|.+ .+.+|||||||++++|.++|... ...+++..++.|+.||+.||.|||+. +||||||||+||||..
T Consensus 81 f~de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s 160 (1021)
T PTZ00266 81 FLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLST 160 (1021)
T ss_pred EEecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeec
Confidence 865 35689999999999999988643 35799999999999999999999995 4999999999999953
Q ss_pred c--------------CCCceEEEeecCCccccCCCccccccccCCcccCccccc---CCCCCcccHHHHHHHHHHHHcCC
Q 014210 296 K--------------DENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLH---RSYSTEADVWSIGVIAYILLCGS 358 (429)
Q Consensus 296 ~--------------~~~~~vkL~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~sDiwSlGvll~elltg~ 358 (429)
. +....+||+|||++.............||+.|+|||++. ..++.++|||||||+||||++|+
T Consensus 161 ~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk 240 (1021)
T PTZ00266 161 GIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGK 240 (1021)
T ss_pred CccccccccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCC
Confidence 2 224469999999998765544445668999999999875 34889999999999999999999
Q ss_pred CCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhcc
Q 014210 359 RPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLICYQ 422 (429)
Q Consensus 359 ~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~ 422 (429)
.||........+...+...+.. +...++.++.+||..||+.+|.+||++.|+|.|+|+...
T Consensus 241 ~PF~~~~~~~qli~~lk~~p~l---pi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i 301 (1021)
T PTZ00266 241 TPFHKANNFSQLISELKRGPDL---PIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNV 301 (1021)
T ss_pred CCCCcCCcHHHHHHHHhcCCCC---CcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhc
Confidence 9997665544444444443332 234678999999999999999999999999999999743
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-46 Score=360.78 Aligned_cols=259 Identities=35% Similarity=0.603 Sum_probs=234.4
Q ss_pred ceeE--eceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe
Q 014210 156 KYEL--GEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (429)
Q Consensus 156 ~y~~--~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~ 233 (429)
-|++ .+.||+|.||+||-|++++ +|+.||||+|.+.++...+. .++++|+.||+.++ ||.||.+...|+..+.
T Consensus 563 vYQif~devLGSGQFG~VYgg~hRk---tGrdVAvKvIdKlrFp~kqe-sqlR~EVaILq~l~-HPGiV~le~M~ET~er 637 (888)
T KOG4236|consen 563 VYQIFADEVLGSGQFGTVYGGKHRK---TGRDVAVKVIDKLRFPTKQE-SQLRNEVAILQNLH-HPGIVNLECMFETPER 637 (888)
T ss_pred HHHhhhHhhccCCcceeeecceecc---cCceeeeeeeecccCCCchH-HHHHHHHHHHHhcC-CCCeeEEEEeecCCce
Confidence 3444 6889999999999999887 79999999999877665443 78999999999999 9999999999999999
Q ss_pred EEEEEEecCCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccc
Q 014210 234 VYVVMELCEGGELLDRILS-RGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (429)
Q Consensus 234 ~~lv~E~~~ggsL~~~i~~-~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~ 312 (429)
+++|||.+.| +.++.|+. ..+++++...+.++.||+.||.|||.++|+|+||||+|||+...+.--.+||||||+|+.
T Consensus 638 vFVVMEKl~G-DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARi 716 (888)
T KOG4236|consen 638 VFVVMEKLHG-DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARI 716 (888)
T ss_pred EEEEehhhcc-hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceee
Confidence 9999999955 77777764 567899999999999999999999999999999999999998776677899999999999
Q ss_pred cCCCccccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHH
Q 014210 313 VRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSE 391 (429)
Q Consensus 313 ~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 391 (429)
..+..-....+||+.|+|||+++ +.|+...||||.||++|--+.|..||.. ++++-..|.+....++..+|.+++++
T Consensus 717 IgEksFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNE--dEdIndQIQNAaFMyPp~PW~eis~~ 794 (888)
T KOG4236|consen 717 IGEKSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNE--DEDINDQIQNAAFMYPPNPWSEISPE 794 (888)
T ss_pred cchhhhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCC--ccchhHHhhccccccCCCchhhcCHH
Confidence 98877778899999999999997 5799999999999999999999999954 45667788889999999999999999
Q ss_pred HHHHHHHhcccCccCcCCHHHHHhhHhhhcc
Q 014210 392 ARDFVKRLLNKDPRKRLTAAQALSELLICYQ 422 (429)
Q Consensus 392 ~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~ 422 (429)
+.|||..+|+..-++|.+.++.|.|+|++.-
T Consensus 795 AidlIn~LLqVkm~kRysvdk~lsh~Wlq~y 825 (888)
T KOG4236|consen 795 AIDLINNLLQVKMRKRYSVDKSLSHPWLQDY 825 (888)
T ss_pred HHHHHHHHHHHHHHHhcchHhhccchhhhcc
Confidence 9999999999999999999999999999853
|
|
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-45 Score=363.70 Aligned_cols=257 Identities=26% Similarity=0.432 Sum_probs=225.8
Q ss_pred cCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~ 233 (429)
.+.|.-++.||.|+||-||.+++.. +.+.||||.++.+...+.+.-.++..||.+|++|. |||++.+-|+|..+..
T Consensus 25 Eklf~dLrEIGHGSFGAVYfArd~~---n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~-HPntieYkgCyLre~T 100 (948)
T KOG0577|consen 25 EKLFSDLREIGHGSFGAVYFARDVR---NSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLR-HPNTIEYKGCYLREHT 100 (948)
T ss_pred HHHHHHHHHhcCCccceeEEeeccC---ccceeeeeeccccccccHHHHHHHHHHHHHHHhcc-CCCcccccceeeccch
Confidence 3568889999999999999999777 68899999998776667777788999999999999 9999999999999999
Q ss_pred EEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCcccc
Q 014210 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (429)
Q Consensus 234 ~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~ 313 (429)
.|||||||- |+-.|.+.-....+.+..+..|+.+.+.||.|||+++.||||||..|||+ .+.|.|||+|||.|...
T Consensus 101 aWLVMEYCl-GSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILL---se~g~VKLaDFGSAsi~ 176 (948)
T KOG0577|consen 101 AWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILL---SEPGLVKLADFGSASIM 176 (948)
T ss_pred HHHHHHHHh-ccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEe---cCCCeeeeccccchhhc
Confidence 999999995 58788777777889999999999999999999999999999999999999 78999999999999876
Q ss_pred CCCccccccccCCcccCccccc----CCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCC
Q 014210 314 RPDERLNDIVGSAYYVAPEVLH----RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLS 389 (429)
Q Consensus 314 ~~~~~~~~~~gt~~y~aPE~~~----~~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 389 (429)
.+ .+.++||++|||||++. |.|+-++||||||++..||.-.++|+...+.-..+.-|...+.+.. ..+.|+
T Consensus 177 ~P---AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtL--qs~eWS 251 (948)
T KOG0577|consen 177 AP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTL--QSNEWS 251 (948)
T ss_pred Cc---hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCC--CCchhH
Confidence 54 35689999999999873 6899999999999999999999999877766555555555443222 235789
Q ss_pred HHHHHHHHHhcccCccCcCCHHHHHhhHhhhccc
Q 014210 390 SEARDFVKRLLNKDPRKRLTAAQALSELLICYQS 423 (429)
Q Consensus 390 ~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~~ 423 (429)
..|..||..||++-|.+|||++++|.|.|....+
T Consensus 252 ~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R~R 285 (948)
T KOG0577|consen 252 DYFRNFVDSCLQKIPQERPTSEELLKHRFVLRER 285 (948)
T ss_pred HHHHHHHHHHHhhCcccCCcHHHHhhcchhccCC
Confidence 9999999999999999999999999999987543
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-44 Score=355.38 Aligned_cols=256 Identities=26% Similarity=0.447 Sum_probs=210.2
Q ss_pred ccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeC-
Q 014210 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT- 231 (429)
Q Consensus 153 ~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~- 231 (429)
..++|++.+.||+|+||.||++.... .++.||||++.... ........+.+|+.+++.++ |+||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~ii~~~~~~~~~~ 96 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAI---LERNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVN-HKNIIGLLNVFTPQK 96 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECC---CCcEEEEEEeCccc-cCchhHHHHHHHHHHHHhcC-CCCccccceeecccc
Confidence 45789999999999999999998665 58899999986543 23344567889999999998 99999999987543
Q ss_pred -----CeEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEee
Q 014210 232 -----DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAID 306 (429)
Q Consensus 232 -----~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~D 306 (429)
...|+||||+++ +|.+.+. ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|
T Consensus 97 ~~~~~~~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kL~D 169 (364)
T cd07875 97 SLEEFQDVYIVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILD 169 (364)
T ss_pred cccccCeEEEEEeCCCC-CHHHHHH---hcCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEE---CCCCcEEEEe
Confidence 357999999965 6777663 348899999999999999999999999999999999999 7788999999
Q ss_pred cCCccccCCCccccccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCC------
Q 014210 307 FGLSDFVRPDERLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPS------ 379 (429)
Q Consensus 307 FGla~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~------ 379 (429)
||+++............||..|+|||++.+ .++.++|||||||++|+|++|+.||......+.+..++.....
T Consensus 170 fG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 249 (364)
T cd07875 170 FGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFM 249 (364)
T ss_pred CCCccccCCCCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 999987655444556789999999998874 6899999999999999999999999887776665555432111
Q ss_pred ----------------CCC----------------CCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhh
Q 014210 380 ----------------FDE----------------APWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLIC 420 (429)
Q Consensus 380 ----------------~~~----------------~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~ 420 (429)
+.. ......+.++.+||.+||+.||++|||+.++|+|+|+.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~ 322 (364)
T cd07875 250 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYIN 322 (364)
T ss_pred HhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccc
Confidence 000 00011356789999999999999999999999999996
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=341.91 Aligned_cols=244 Identities=20% Similarity=0.275 Sum_probs=208.5
Q ss_pred ceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEe----CCeEEE
Q 014210 161 EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED----TDNVYV 236 (429)
Q Consensus 161 ~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~----~~~~~l 236 (429)
..||+|++|.||+|.. +|+.||||++...........+.+.+|+.++++++ |+||+++++++.+ ...+++
T Consensus 26 ~~i~~g~~~~v~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~~~g~~~~~~~~~~~~~l 99 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-----NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRID-SNNILKIYGFIIDIVDDLPRLSL 99 (283)
T ss_pred eEEeeCCceEEEEEEE-----CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcC-CCCEEEEeeeEEecccCCCceEE
Confidence 6799999999999975 37899999997765445555678899999999998 9999999999877 346899
Q ss_pred EEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHc-CceeccCCCCcEEEeecCCCceEEEeecCCccccCC
Q 014210 237 VMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQ-GVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP 315 (429)
Q Consensus 237 v~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~-~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~ 315 (429)
||||+++|+|.+++.+ ...+++.....++.|++.||.|||+. +++||||||+|||+ ++++.+||+|||+++....
T Consensus 100 v~Ey~~~g~L~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill---~~~~~~kl~dfg~~~~~~~ 175 (283)
T PHA02988 100 ILEYCTRGYLREVLDK-EKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLV---TENYKLKIICHGLEKILSS 175 (283)
T ss_pred EEEeCCCCcHHHHHhh-CCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEE---CCCCcEEEcccchHhhhcc
Confidence 9999999999998854 45789999999999999999999985 99999999999999 7788999999999876543
Q ss_pred CccccccccCCcccCccccc---CCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHH
Q 014210 316 DERLNDIVGSAYYVAPEVLH---RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEA 392 (429)
Q Consensus 316 ~~~~~~~~gt~~y~aPE~~~---~~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 392 (429)
.. ....|+..|+|||++. +.++.++|||||||++|||++|+.||...+..+.+..+.......... ..+++++
T Consensus 176 ~~--~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~--~~~~~~l 251 (283)
T PHA02988 176 PP--FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLP--LDCPLEI 251 (283)
T ss_pred cc--ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCC--CcCcHHH
Confidence 22 3456889999999986 468999999999999999999999999888777777776554433321 2588999
Q ss_pred HHHHHHhcccCccCcCCHHHHHhhHh
Q 014210 393 RDFVKRLLNKDPRKRLTAAQALSELL 418 (429)
Q Consensus 393 ~~li~~~L~~dP~~Rps~~~iL~~~~ 418 (429)
.+||.+||+.||++||++.+++..+-
T Consensus 252 ~~li~~cl~~dp~~Rps~~ell~~l~ 277 (283)
T PHA02988 252 KCIVEACTSHDSIKRPNIKEILYNLS 277 (283)
T ss_pred HHHHHHHhcCCcccCcCHHHHHHHHH
Confidence 99999999999999999999997653
|
|
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-46 Score=366.48 Aligned_cols=258 Identities=29% Similarity=0.481 Sum_probs=226.8
Q ss_pred cCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~ 233 (429)
.+-|+++..||.|+||.||++..+. ++-..|-|+| ...+.+.++++.-||+||..+. ||+||+|++.|..++.
T Consensus 31 ~d~WeIiGELGDGAFGKVyKA~nke---t~~lAAaKvI---etkseEELEDylVEIeILa~Cd-HP~ivkLl~ayy~enk 103 (1187)
T KOG0579|consen 31 RDHWEIIGELGDGAFGKVYKAVNKE---TKLLAAAKVI---ETKSEEELEDYLVEIEILAECD-HPVIVKLLSAYYFENK 103 (1187)
T ss_pred HHHHHHHhhhcCccchhhhhhhccc---chhhhhhhhh---cccchhHHhhhhhhhhhhhcCC-ChHHHHHHHHHhccCc
Confidence 3568999999999999999998775 5667788988 4467788899999999999998 9999999999999999
Q ss_pred EEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCcccc
Q 014210 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (429)
Q Consensus 234 ~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~ 313 (429)
+||..|||.||-+...+.+.+..+++.++..++.|++.||.|||+++|||||||..|||+ .-+|.++|+|||.+...
T Consensus 104 LwiliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~---TldGdirLADFGVSAKn 180 (1187)
T KOG0579|consen 104 LWILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILL---TLDGDIRLADFGVSAKN 180 (1187)
T ss_pred eEEEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEE---EecCcEeeecccccccc
Confidence 999999999999988888999999999999999999999999999999999999999999 57788999999986433
Q ss_pred -CCCccccccccCCcccCccccc------CCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCC
Q 014210 314 -RPDERLNDIVGSAYYVAPEVLH------RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWP 386 (429)
Q Consensus 314 -~~~~~~~~~~gt~~y~aPE~~~------~~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 386 (429)
........++||++|||||++. ..|+.++||||||++|.||..+.+|-...+.-.++.+|.+.++.-... ..
T Consensus 181 ~~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlq-PS 259 (1187)
T KOG0579|consen 181 KSTRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQ-PS 259 (1187)
T ss_pred hhHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccC-cc
Confidence 3334456789999999999863 369999999999999999999999988777777777777766554433 24
Q ss_pred CCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhcc
Q 014210 387 SLSSEARDFVKRLLNKDPRKRLTAAQALSELLICYQ 422 (429)
Q Consensus 387 ~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~ 422 (429)
.|+..|.||+++||.+||+.||++.++|.|+|++..
T Consensus 260 ~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~ 295 (1187)
T KOG0579|consen 260 HWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNA 295 (1187)
T ss_pred hhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccccC
Confidence 689999999999999999999999999999999843
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-43 Score=341.96 Aligned_cols=257 Identities=23% Similarity=0.310 Sum_probs=206.6
Q ss_pred cCceeEeceeeccCceEEEEEEEecCc-------------ccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCC
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGE-------------LKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNN 220 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~-------------~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~n 220 (429)
.++|++.++||+|+||.||+|....+. ..+..||||++... .......++.+|++++.+++ |+|
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~-h~n 80 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPD--ANKNARNDFLKEVKILSRLK-DPN 80 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCC--CCHHHHHHHHHHHHHHhhcC-CCC
Confidence 468999999999999999999864321 13568999998654 23445677999999999998 999
Q ss_pred cceEEEEEEeCCeEEEEEEecCCCcHHHHHHhcC------------------CCCCHHHHHHHHHHHHHHHHHHHHcCce
Q 014210 221 LVKFFDAYEDTDNVYVVMELCEGGELLDRILSRG------------------GKYTEDDAKAVMIQILNVVAFCHLQGVV 282 (429)
Q Consensus 221 Iv~l~~~~~~~~~~~lv~E~~~ggsL~~~i~~~~------------------~~l~~~~~~~i~~qi~~gL~~LH~~~ii 282 (429)
|+++++++.+.+..++||||+++|+|.+++.... ..+++..++.++.||+.||.|||+.||+
T Consensus 81 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~iv 160 (304)
T cd05096 81 IIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFV 160 (304)
T ss_pred eeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 9999999999999999999999999999885432 2468889999999999999999999999
Q ss_pred eccCCCCcEEEeecCCCceEEEeecCCccccCCCcc---ccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHc--
Q 014210 283 HRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDER---LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-- 356 (429)
Q Consensus 283 HrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~ellt-- 356 (429)
||||||+|||+ +.++.+||+|||++........ .....++..|+|||++. +.++.++||||||+++|||++
T Consensus 161 H~dlkp~Nill---~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~ 237 (304)
T cd05096 161 HRDLATRNCLV---GENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLC 237 (304)
T ss_pred ccCcchhheEE---cCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHcc
Confidence 99999999999 6788899999999976543321 22345678899999875 578999999999999999986
Q ss_pred CCCCCCCCChHHHHHHHHhc---C-CCCCCCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhh
Q 014210 357 GSRPFWARTESGIFRAVLKA---D-PSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSE 416 (429)
Q Consensus 357 g~~Pf~~~~~~~~~~~i~~~---~-~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~ 416 (429)
+..||........+..+... . ........+.++.++.+||.+||+.||++||++.+|.+.
T Consensus 238 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~ 301 (304)
T cd05096 238 KEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAF 301 (304)
T ss_pred CCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence 66788776665554433221 1 111111224678999999999999999999999999654
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=341.42 Aligned_cols=256 Identities=29% Similarity=0.579 Sum_probs=222.9
Q ss_pred CceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeE
Q 014210 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (429)
Q Consensus 155 ~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~ 234 (429)
++|++.+.||+|+||.||++.... .++.||+|++.+.........+.+.+|+++++++. |+||+++++++.+++..
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~ 76 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKG---SGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIR-HPFLVNLYGSFQDDSNL 76 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcC---CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCCccceeeEEEcCCeE
Confidence 479999999999999999998776 58999999987655445556678899999999998 99999999999999999
Q ss_pred EEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccccC
Q 014210 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (429)
Q Consensus 235 ~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~ 314 (429)
++||||+++++|.+++... +.+++..+..++.||+.||.|||+.||+|+||+|+|||+ +.++.+||+|||++....
T Consensus 77 ~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili---~~~~~~kl~dfg~~~~~~ 152 (290)
T cd05580 77 YLVMEYVPGGELFSHLRKS-GRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLL---DSDGYIKITDFGFAKRVK 152 (290)
T ss_pred EEEEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEE---CCCCCEEEeeCCCccccC
Confidence 9999999999999987554 679999999999999999999999999999999999999 778889999999998765
Q ss_pred CCccccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHH
Q 014210 315 PDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEAR 393 (429)
Q Consensus 315 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 393 (429)
.. .....++..|+|||.+. +.++.++||||||+++|+|++|+.||...........+......++ ..++..+.
T Consensus 153 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~ 226 (290)
T cd05580 153 GR--TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFP----SFFSPDAK 226 (290)
T ss_pred CC--CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCccCC----ccCCHHHH
Confidence 44 34557899999999876 4578899999999999999999999988776666666665444333 25689999
Q ss_pred HHHHHhcccCccCcC-----CHHHHHhhHhhhccce
Q 014210 394 DFVKRLLNKDPRKRL-----TAAQALSELLICYQSY 424 (429)
Q Consensus 394 ~li~~~L~~dP~~Rp-----s~~~iL~~~~~~~~~~ 424 (429)
++|++||..||.+|+ ++++++.|+||....+
T Consensus 227 ~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~ 262 (290)
T cd05580 227 DLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGIDW 262 (290)
T ss_pred HHHHHHccCCHHHccCcccCCHHHHHcCcccccCCH
Confidence 999999999999999 9999999999976553
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-44 Score=353.67 Aligned_cols=262 Identities=27% Similarity=0.434 Sum_probs=214.6
Q ss_pred cccccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEE
Q 014210 150 SKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYE 229 (429)
Q Consensus 150 ~~~~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~ 229 (429)
...-+..|+++++||+||-+.||++...+ .+.+|+|.+... ..+.+.+.-+.+|+..|.+|++|.+||+||||-.
T Consensus 356 i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~----~~iyalkkv~~~-~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv 430 (677)
T KOG0596|consen 356 IKVKGREYEILKQIGSGGSSKVFKVLNSD----KQIYALKKVVLL-EADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEV 430 (677)
T ss_pred EEECcchhhHHHhhcCCCcceeeeeecCC----CcchhhhHHHHh-hcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeec
Confidence 34557889999999999999999997554 567888876543 3567788899999999999999999999999999
Q ss_pred eCCeEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCC
Q 014210 230 DTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGL 309 (429)
Q Consensus 230 ~~~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGl 309 (429)
.++.+||||||-+ -+|...|.++...+....++.+..|++.++.++|++||||.||||.|+|+ -.|.+||+|||.
T Consensus 431 ~d~~lYmvmE~Gd-~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLl----VkG~LKLIDFGI 505 (677)
T KOG0596|consen 431 TDGYLYMVMECGD-IDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLL----VKGRLKLIDFGI 505 (677)
T ss_pred cCceEEEEeeccc-ccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEE----EeeeEEeeeech
Confidence 9999999999864 48888887776666666999999999999999999999999999999999 478899999999
Q ss_pred ccccCCCccc---cccccCCcccCcccccC------------CCCCcccHHHHHHHHHHHHcCCCCCCCCC-hHHHHHHH
Q 014210 310 SDFVRPDERL---NDIVGSAYYVAPEVLHR------------SYSTEADVWSIGVIAYILLCGSRPFWART-ESGIFRAV 373 (429)
Q Consensus 310 a~~~~~~~~~---~~~~gt~~y~aPE~~~~------------~~~~~sDiwSlGvll~elltg~~Pf~~~~-~~~~~~~i 373 (429)
|.....+... ...+||..||+||++.. ..++++|||||||+||+|+.|+.||.... ....+..|
T Consensus 506 A~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI 585 (677)
T KOG0596|consen 506 ANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAI 585 (677)
T ss_pred hcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhh
Confidence 9988766532 45689999999998731 15789999999999999999999995433 33344445
Q ss_pred HhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhcc
Q 014210 374 LKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLICYQ 422 (429)
Q Consensus 374 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~ 422 (429)
...+...+....+. ..++.++++.||.+||++||++.++|+|+|++.+
T Consensus 586 ~~P~~~Iefp~~~~-~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~~ 633 (677)
T KOG0596|consen 586 TDPNHEIEFPDIPE-NDELIDVMKCCLARDPKKRWSIPELLQHPFLQIQ 633 (677)
T ss_pred cCCCccccccCCCC-chHHHHHHHHHHhcCcccCCCcHHHhcCcccccc
Confidence 44433222221111 2349999999999999999999999999999874
|
|
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=351.22 Aligned_cols=251 Identities=20% Similarity=0.307 Sum_probs=203.0
Q ss_pred cCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~ 233 (429)
..+|++++.||+|+||.||+|+... +++.||+|+..+. ....|+.++++++ |+||+++++++.+.+.
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~valK~~~~~---------~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~ 131 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPG---QPDPVVLKIGQKG---------TTLIEAMLLQNVN-HPSVIRMKDTLVSGAI 131 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECC---CCceEEEEeCCcc---------ccHHHHHHHHhCC-CCCCcChhheEEeCCe
Confidence 4579999999999999999998765 5789999985432 1346999999998 9999999999999999
Q ss_pred EEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCcccc
Q 014210 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (429)
Q Consensus 234 ~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~ 313 (429)
.++|||++. ++|.+++......+++..++.|+.||+.||.|||++|||||||||+|||+ +.++.+||+|||++...
T Consensus 132 ~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill---~~~~~~kl~DfG~a~~~ 207 (357)
T PHA03209 132 TCMVLPHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFI---NDVDQVCIGDLGAAQFP 207 (357)
T ss_pred eEEEEEccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCCEEEecCcccccc
Confidence 999999995 58899887777789999999999999999999999999999999999999 77888999999999765
Q ss_pred CCCccccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHcCCCCCCCCCh----------HHHHHHHHhcC----C
Q 014210 314 RPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTE----------SGIFRAVLKAD----P 378 (429)
Q Consensus 314 ~~~~~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~elltg~~Pf~~~~~----------~~~~~~i~~~~----~ 378 (429)
..........||..|+|||++. ..++.++|||||||++|||+++..++..... ...+..++... .
T Consensus 208 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 287 (357)
T PHA03209 208 VVAPAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPE 287 (357)
T ss_pred ccCcccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChh
Confidence 4444445677999999999886 4689999999999999999986655532211 11111111110 0
Q ss_pred CCCC--------------------------CCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhc
Q 014210 379 SFDE--------------------------APWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLICY 421 (429)
Q Consensus 379 ~~~~--------------------------~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~ 421 (429)
.++. .....++.++.+||.+||+.||++|||+.|+|+|+||+.
T Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~ 356 (357)
T PHA03209 288 EFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ 356 (357)
T ss_pred hcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence 0110 001245678889999999999999999999999999974
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=344.25 Aligned_cols=260 Identities=32% Similarity=0.554 Sum_probs=222.8
Q ss_pred CceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeE
Q 014210 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (429)
Q Consensus 155 ~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~ 234 (429)
++|++.+.||+|+||.||++.... +++.||||.+...........+.+.+|+++++.+. |+||+++++.+.+.+..
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~ 76 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKG---TGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLD-HPFLPTLYASFQTETYL 76 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcC---CCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCC-CCCchhheeeeecCCEE
Confidence 479999999999999999998765 58999999997765554456678999999999998 99999999999999999
Q ss_pred EEEEEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCcccc
Q 014210 235 YVVMELCEGGELLDRILSR-GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (429)
Q Consensus 235 ~lv~E~~~ggsL~~~i~~~-~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~ 313 (429)
++||||+.+++|.+++... +..+++..++.++.||+.||+|||+.||+|+||||+||++ +.++.++|+|||++...
T Consensus 77 ~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili---~~~~~~~l~dfg~~~~~ 153 (316)
T cd05574 77 CLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILL---HESGHIMLSDFDLSKQS 153 (316)
T ss_pred EEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEE---cCCCCEEEeecchhhcc
Confidence 9999999999999987653 3579999999999999999999999999999999999999 67788999999998654
Q ss_pred CCCc------------------------------cccccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHcCCCCCC
Q 014210 314 RPDE------------------------------RLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFW 362 (429)
Q Consensus 314 ~~~~------------------------------~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~elltg~~Pf~ 362 (429)
.... ......|+..|+|||++.+ .++.++||||||+++|+|++|+.||.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~ 233 (316)
T cd05574 154 DVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFK 233 (316)
T ss_pred cccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCC
Confidence 3211 1123468899999998864 58889999999999999999999998
Q ss_pred CCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCcCC----HHHHHhhHhhhccc
Q 014210 363 ARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLT----AAQALSELLICYQS 423 (429)
Q Consensus 363 ~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps----~~~iL~~~~~~~~~ 423 (429)
.......+..+......+... ..++.++.+||++||..||++||+ ++++|.|+||+.-.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~~ 296 (316)
T cd05574 234 GSNRDETFSNILKKEVTFPGS--PPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVN 296 (316)
T ss_pred CCchHHHHHHHhcCCccCCCc--cccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcCC
Confidence 888777777776554443332 237899999999999999999999 99999999998744
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=354.11 Aligned_cols=258 Identities=26% Similarity=0.376 Sum_probs=208.8
Q ss_pred cCceeEeceeeccCceEEEEEEEecC--cccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeC
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKG--ELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~--~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~ 231 (429)
.++|++.++||+|+||.||+|..... ..++..||||++.... .....+.+.+|+.+++.+..||||++++++|.+.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~ 111 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHINIVNLLGACTVG 111 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCc--CcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccC
Confidence 45899999999999999999975421 1246789999986442 2334567889999999995599999999999999
Q ss_pred CeEEEEEEecCCCcHHHHHHhcC---------------------------------------------------------
Q 014210 232 DNVYVVMELCEGGELLDRILSRG--------------------------------------------------------- 254 (429)
Q Consensus 232 ~~~~lv~E~~~ggsL~~~i~~~~--------------------------------------------------------- 254 (429)
+..++|||||++|+|.+++....
T Consensus 112 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (375)
T cd05104 112 GPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRS 191 (375)
T ss_pred CcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccc
Confidence 99999999999999999886432
Q ss_pred -----------------CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccccCCCc
Q 014210 255 -----------------GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDE 317 (429)
Q Consensus 255 -----------------~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~ 317 (429)
..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.......
T Consensus 192 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill---~~~~~~kl~DfG~a~~~~~~~ 268 (375)
T cd05104 192 GSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILL---THGRITKICDFGLARDIRNDS 268 (375)
T ss_pred ceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEE---ECCCcEEEecCccceeccCcc
Confidence 247888999999999999999999999999999999999 567789999999997664332
Q ss_pred cc---cccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHH
Q 014210 318 RL---NDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEA 392 (429)
Q Consensus 318 ~~---~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 392 (429)
.. ....++..|+|||++. ..++.++|||||||++|||++ |..||........+...+....... .....+.++
T Consensus 269 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l 346 (375)
T cd05104 269 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRML--SPECAPSEM 346 (375)
T ss_pred cccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCC--CCCCCCHHH
Confidence 21 1233456799999886 468999999999999999997 8999977655544444444332211 123467899
Q ss_pred HHHHHHhcccCccCcCCHHHHHhhHh
Q 014210 393 RDFVKRLLNKDPRKRLTAAQALSELL 418 (429)
Q Consensus 393 ~~li~~~L~~dP~~Rps~~~iL~~~~ 418 (429)
.+||.+||+.||++||++.++++.+.
T Consensus 347 ~~li~~cl~~dP~~RPs~~eil~~l~ 372 (375)
T cd05104 347 YDIMKSCWDADPLKRPTFKQIVQLIE 372 (375)
T ss_pred HHHHHHHccCChhHCcCHHHHHHHHH
Confidence 99999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-43 Score=330.99 Aligned_cols=253 Identities=26% Similarity=0.475 Sum_probs=217.2
Q ss_pred ceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEE
Q 014210 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVY 235 (429)
Q Consensus 156 ~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~~ 235 (429)
+|.+.+.||+|+||.||++.... +|+.|++|.+..... .....+.+.+|++++++++ |+||+++++++.+.+..+
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~---~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~ 75 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKA---DKRVYAMKQIDLSKM-NRREREEAIDEARVLAKLD-SSYIIRYYESFLDKGKLN 75 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcC---CCcEEEEEEeehhhC-CHHHHHHHHHHHHHHHhcC-CCCeehheeeeccCCEEE
Confidence 48889999999999999998776 589999999865432 3455678999999999998 999999999999999999
Q ss_pred EEEEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccccC
Q 014210 236 VVMELCEGGELLDRILSR-GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (429)
Q Consensus 236 lv~E~~~ggsL~~~i~~~-~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~ 314 (429)
+||||+++++|.+++... ...+++..++.++.||+.||.|||+.||+|+||||+||++ +.++.+||+|||++....
T Consensus 76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili---~~~~~~~l~df~~~~~~~ 152 (256)
T cd08529 76 IVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFL---DAYDNVKIGDLGVAKLLS 152 (256)
T ss_pred EEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEE---eCCCCEEEcccccceecc
Confidence 999999999999988764 4679999999999999999999999999999999999999 677889999999988665
Q ss_pred CCcc-ccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHH
Q 014210 315 PDER-LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEA 392 (429)
Q Consensus 315 ~~~~-~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 392 (429)
.... .....|+..|+|||++. +.++.++||||||+++|+|++|+.||...........+......... ..++.++
T Consensus 153 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~ 229 (256)
T cd08529 153 DNTNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVS---QMYSQQL 229 (256)
T ss_pred CccchhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCc---cccCHHH
Confidence 4332 23456889999999876 45889999999999999999999999888776666666554322211 2578999
Q ss_pred HHHHHHhcccCccCcCCHHHHHhhHhh
Q 014210 393 RDFVKRLLNKDPRKRLTAAQALSELLI 419 (429)
Q Consensus 393 ~~li~~~L~~dP~~Rps~~~iL~~~~~ 419 (429)
.++|.+||+.+|++||++.++++|+|+
T Consensus 230 ~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 230 AQLIDQCLTKDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred HHHHHHHccCCcccCcCHHHHhhCCCC
Confidence 999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=352.34 Aligned_cols=251 Identities=24% Similarity=0.345 Sum_probs=203.6
Q ss_pred cCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~ 233 (429)
...|.+.+.||+|+||.||++.... .++.||||.... ..+.+|++++++|+ |+|||++++++..++.
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~---~~~~vavK~~~~---------~~~~~E~~iL~~L~-HpnIv~l~~~~~~~~~ 234 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPD---YPQRVVVKAGWY---------ASSVHEARLLRRLS-HPAVLALLDVRVVGGL 234 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECC---CCCEEEEecccc---------cCHHHHHHHHHHCC-CCCCCcEEEEEEECCE
Confidence 5679999999999999999998776 588999996421 23568999999998 9999999999999999
Q ss_pred EEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCcccc
Q 014210 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (429)
Q Consensus 234 ~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~ 313 (429)
.+||||++. ++|.+++......+++..++.|+.||+.||.|||++|||||||||+|||| +.++.+||+|||+++..
T Consensus 235 ~~lv~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl---~~~~~vkL~DFGla~~~ 310 (461)
T PHA03211 235 TCLVLPKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLV---NGPEDICLGDFGAACFA 310 (461)
T ss_pred EEEEEEccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEE---CCCCCEEEcccCCceec
Confidence 999999995 68998887766789999999999999999999999999999999999999 67788999999999765
Q ss_pred CCCcc---ccccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHcCCCCCCCCC--------hHHHHHHHHhcCCC--
Q 014210 314 RPDER---LNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWART--------ESGIFRAVLKADPS-- 379 (429)
Q Consensus 314 ~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~elltg~~Pf~~~~--------~~~~~~~i~~~~~~-- 379 (429)
..... .....||..|+|||++.+ .++.++|||||||+||||++|..++.... ...+.+.+......
T Consensus 311 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~ 390 (461)
T PHA03211 311 RGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVD 390 (461)
T ss_pred ccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccc
Confidence 43321 224579999999998874 58999999999999999999887653321 12222222221110
Q ss_pred -C------------------------CCCCC---CCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhc
Q 014210 380 -F------------------------DEAPW---PSLSSEARDFVKRLLNKDPRKRLTAAQALSELLICY 421 (429)
Q Consensus 380 -~------------------------~~~~~---~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~ 421 (429)
+ ....| ..++.++.+||.+||+.||++|||+.|+|+|+||+.
T Consensus 391 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 391 EFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred cCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence 0 00111 135668999999999999999999999999999974
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-44 Score=347.63 Aligned_cols=252 Identities=29% Similarity=0.442 Sum_probs=194.8
Q ss_pred eceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEe--CCeEEEE
Q 014210 160 GEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED--TDNVYVV 237 (429)
Q Consensus 160 ~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~--~~~~~lv 237 (429)
+++||+|+||.||+|+.+.+ ..++.||+|++..... ...+.+|++++++++ |+||+++++++.. +..++++
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~-~~~~~~aiK~~~~~~~-----~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~lv 78 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDG-KDDRDYALKQIEGTGI-----SMSACREIALLRELK-HPNVISLQKVFLSHADRKVWLL 78 (317)
T ss_pred ccccccCCCeEEEEEEEccC-CCCceEEEEEECCCCC-----cHHHHHHHHHHHhcC-CCCCcceeeeEecCCCcEEEEE
Confidence 56899999999999987643 2478999999864321 234678999999998 9999999999864 4568999
Q ss_pred EEecCCCcHHHHHHhc--------CCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeec-CCCceEEEeecC
Q 014210 238 MELCEGGELLDRILSR--------GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTK-DENSVLKAIDFG 308 (429)
Q Consensus 238 ~E~~~ggsL~~~i~~~--------~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~-~~~~~vkL~DFG 308 (429)
|||+. ++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||+... +.++.+||+|||
T Consensus 79 ~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG 157 (317)
T cd07868 79 FDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMG 157 (317)
T ss_pred EeccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecC
Confidence 99996 4887776432 1258999999999999999999999999999999999999543 356789999999
Q ss_pred CccccCCCc----cccccccCCcccCcccccC--CCCCcccHHHHHHHHHHHHcCCCCCCCCChH---------HHHHHH
Q 014210 309 LSDFVRPDE----RLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTES---------GIFRAV 373 (429)
Q Consensus 309 la~~~~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlGvll~elltg~~Pf~~~~~~---------~~~~~i 373 (429)
+++...... ......||..|+|||++.+ .++.++|||||||++|||++|+.||...... ..+..+
T Consensus 158 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~ 237 (317)
T cd07868 158 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRI 237 (317)
T ss_pred ceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHH
Confidence 998764322 2345678999999998864 4889999999999999999999999643321 122222
Q ss_pred HhcCCCCC----------------------------------CCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhh
Q 014210 374 LKADPSFD----------------------------------EAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLI 419 (429)
Q Consensus 374 ~~~~~~~~----------------------------------~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~ 419 (429)
........ .......+.++.+||++||+.||++|+|++|+|+|+||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 238 FNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred HHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 11100000 00011235678999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-46 Score=344.08 Aligned_cols=254 Identities=26% Similarity=0.512 Sum_probs=220.7
Q ss_pred cCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~ 233 (429)
.+-|.++++||+|+||.||++.++. +|+.+|||.+.. ...++++..|+.|++++. .+++|++||.|.....
T Consensus 32 EEVFDi~~KLGEGSYGSV~KAIH~E---sG~v~AIK~VPV-----~sDLQEIIKEISIMQQC~-S~yVVKYYGSYFK~sD 102 (502)
T KOG0574|consen 32 EEVFDIVGKLGEGSYGSVHKAIHRE---SGHVLAIKKVPV-----DTDLQEIIKEISIMQQCK-SKYVVKYYGSYFKHSD 102 (502)
T ss_pred HHHHHHHHHhcCCcchHHHHHHHhc---cCcEEEEEecCc-----cchHHHHHHHHHHHHHcC-CchhhhhhhhhccCCc
Confidence 3458899999999999999999887 799999998743 345688999999999998 9999999999999999
Q ss_pred EEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCcccc
Q 014210 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (429)
Q Consensus 234 ~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~ 313 (429)
+|||||||..|++.+.+..++..++++++..+++..++||+|||...-||||||..|||+ +.+|+.||+|||.|..+
T Consensus 103 LWIVMEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILL---NT~G~AKLADFGVAGQL 179 (502)
T KOG0574|consen 103 LWIVMEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILL---NTDGIAKLADFGVAGQL 179 (502)
T ss_pred eEeehhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEE---cccchhhhhhccccchh
Confidence 999999999999999999999999999999999999999999999999999999999999 78899999999999877
Q ss_pred CCCc-cccccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHh--cCCCCCCCCCCCCC
Q 014210 314 RPDE-RLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLK--ADPSFDEAPWPSLS 389 (429)
Q Consensus 314 ~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~--~~~~~~~~~~~~~s 389 (429)
.+.- ..++..||+.|||||++.. .|+.++||||||++..||..|+.||..-.. ++.|.. ..+.........++
T Consensus 180 TDTMAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHP---MRAIFMIPT~PPPTF~KPE~WS 256 (502)
T KOG0574|consen 180 TDTMAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHP---MRAIFMIPTKPPPTFKKPEEWS 256 (502)
T ss_pred hhhHHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccc---cceeEeccCCCCCCCCChHhhh
Confidence 5443 3467889999999999986 799999999999999999999999965433 344332 12222222224589
Q ss_pred HHHHHHHHHhcccCccCcCCHHHHHhhHhhhcc
Q 014210 390 SEARDFVKRLLNKDPRKRLTAAQALSELLICYQ 422 (429)
Q Consensus 390 ~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~ 422 (429)
.+|.|||++||-++|++|-++.++++|+|+...
T Consensus 257 ~~F~DFi~~CLiK~PE~R~TA~~L~~H~FiknA 289 (502)
T KOG0574|consen 257 SEFNDFIRSCLIKKPEERKTALRLCEHTFIKNA 289 (502)
T ss_pred hHHHHHHHHHhcCCHHHHHHHHHHhhhhhhcCC
Confidence 999999999999999999999999999999754
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=353.49 Aligned_cols=257 Identities=25% Similarity=0.359 Sum_probs=208.4
Q ss_pred cCceeEeceeeccCceEEEEEEEecC--cccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeC
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKG--ELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~--~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~ 231 (429)
.++|++.+.||+|+||.||+|+.... ..+++.||||++.... .....+.+.+|+++++.+.+|+|||+++++|.+.
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~ 114 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA--HTDEREALMSELKILSHLGQHKNIVNLLGACTHG 114 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCC--CHHHHHHHHHHHHHHHhhccCCceeeEeeEecCC
Confidence 46899999999999999999986431 1245689999996542 3344567889999999995599999999999999
Q ss_pred CeEEEEEEecCCCcHHHHHHhcC---------------------------------------------------------
Q 014210 232 DNVYVVMELCEGGELLDRILSRG--------------------------------------------------------- 254 (429)
Q Consensus 232 ~~~~lv~E~~~ggsL~~~i~~~~--------------------------------------------------------- 254 (429)
+..++|||||++|+|.+++....
T Consensus 115 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (374)
T cd05106 115 GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQS 194 (374)
T ss_pred CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccc
Confidence 99999999999999999885421
Q ss_pred ------------CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccccCCCccc---
Q 014210 255 ------------GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERL--- 319 (429)
Q Consensus 255 ------------~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~--- 319 (429)
..+++..+++++.||+.||.|||++||+||||||+|||+ ++++.+||+|||+++........
T Consensus 195 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~---~~~~~~kL~DfGla~~~~~~~~~~~~ 271 (374)
T cd05106 195 SDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLL---TDGRVAKICDFGLARDIMNDSNYVVK 271 (374)
T ss_pred ccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEE---eCCCeEEEeeceeeeeccCCcceeec
Confidence 247888999999999999999999999999999999999 67888999999999765433221
Q ss_pred cccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHH
Q 014210 320 NDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVK 397 (429)
Q Consensus 320 ~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 397 (429)
....++..|||||++. +.++.++|||||||++|||++ |+.||........+..+......... ...+++++.+||.
T Consensus 272 ~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~ 349 (374)
T cd05106 272 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSR--PDFAPPEIYSIMK 349 (374)
T ss_pred cCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccC--CCCCCHHHHHHHH
Confidence 1223556799999875 568999999999999999997 99999876655444444443322211 1246899999999
Q ss_pred HhcccCccCcCCHHHHHhhH
Q 014210 398 RLLNKDPRKRLTAAQALSEL 417 (429)
Q Consensus 398 ~~L~~dP~~Rps~~~iL~~~ 417 (429)
+||+.||++||++.++++.+
T Consensus 350 ~cl~~dp~~RPs~~~l~~~l 369 (374)
T cd05106 350 MCWNLEPTERPTFSQISQLI 369 (374)
T ss_pred HHcCCChhhCcCHHHHHHHH
Confidence 99999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-43 Score=333.54 Aligned_cols=256 Identities=30% Similarity=0.512 Sum_probs=217.5
Q ss_pred CceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeE
Q 014210 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (429)
Q Consensus 155 ~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~ 234 (429)
++|++.+.||.|+||.||+|.... ++..+|+|++...... ...+.+.+|+++++.+. |+||+++++.+.+++..
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~---~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~ 74 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLP---NNEKVAIKRIDLEKCQ--TSVDELRKEVQAMSQCN-HPNVVKYYTSFVVGDEL 74 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcC---CCcEEEEEEeccCCcc--hHHHHHHHHHHHHHhcC-CCCEEEEEEEEeeCCEE
Confidence 479999999999999999998665 5889999998654322 25678999999999998 99999999999999999
Q ss_pred EEEEEecCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccc
Q 014210 235 YVVMELCEGGELLDRILSR--GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (429)
Q Consensus 235 ~lv~E~~~ggsL~~~i~~~--~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~ 312 (429)
+++||++++++|.+++... ...+++..++.++.||+.||+|||+.||+||||||+||++ ++++.+||+|||++..
T Consensus 75 ~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~---~~~~~~~l~df~~~~~ 151 (267)
T cd06610 75 WLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILL---GEDGSVKIADFGVSAS 151 (267)
T ss_pred EEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEE---cCCCCEEEcccchHHH
Confidence 9999999999999988654 2468999999999999999999999999999999999999 6778899999999876
Q ss_pred cCCCccc-----cccccCCcccCcccccC--CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCC-
Q 014210 313 VRPDERL-----NDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAP- 384 (429)
Q Consensus 313 ~~~~~~~-----~~~~gt~~y~aPE~~~~--~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~- 384 (429)
....... ....|+..|+|||++.. .++.++|+||||+++|+|++|+.||........+..+....+......
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (267)
T cd06610 152 LADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGA 231 (267)
T ss_pred hccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCcc
Confidence 6543222 34568999999998764 588999999999999999999999987776666666655433222211
Q ss_pred -CCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhh
Q 014210 385 -WPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLI 419 (429)
Q Consensus 385 -~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~ 419 (429)
+..++.++.+||.+||..||++||++.+++.|+||
T Consensus 232 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 232 DYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred ccccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 23678999999999999999999999999999996
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-44 Score=370.20 Aligned_cols=256 Identities=27% Similarity=0.468 Sum_probs=214.8
Q ss_pred cCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEE-EEe--
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDA-YED-- 230 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~-~~~-- 230 (429)
..++++.+.|.+|||+.||+|+... .|..||+|++-. .+...++.+++||++|++|++|+|||.|+|. ...
T Consensus 36 ~~~v~V~~vLAEGGFa~VYla~~~~---~~~~~AlKrm~~---~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~ 109 (738)
T KOG1989|consen 36 SHRVTVEKVLAEGGFAQVYLAQDVK---GGKKYALKRMYV---NDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRS 109 (738)
T ss_pred CEEEEEEEEEccCCcEEEEEEEecC---CCceeeeeeeec---CCHHHHHHHHHHHHHHHHhcCCCceeeEecccccccc
Confidence 5678999999999999999999877 358999999843 4788889999999999999999999999993 321
Q ss_pred -C---CeEEEEEEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcC--ceeccCCCCcEEEeecCCCceEE
Q 014210 231 -T---DNVYVVMELCEGGELLDRILSR-GGKYTEDDAKAVMIQILNVVAFCHLQG--VVHRDLKPENFLFTTKDENSVLK 303 (429)
Q Consensus 231 -~---~~~~lv~E~~~ggsL~~~i~~~-~~~l~~~~~~~i~~qi~~gL~~LH~~~--iiHrDIKp~NILl~~~~~~~~vk 303 (429)
+ .+++|.||||.||.|.|++..+ ...|++.++++|+.|+++|+.+||... |||||||-+|||| ..++.+|
T Consensus 110 ~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLl---s~~g~~K 186 (738)
T KOG1989|consen 110 SNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLL---SADGNYK 186 (738)
T ss_pred CCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEE---cCCCCEE
Confidence 1 2578999999999999999765 345999999999999999999999998 9999999999999 7788999
Q ss_pred EeecCCccccCCCc-ccc---------ccccCCcccCccccc----CCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHH
Q 014210 304 AIDFGLSDFVRPDE-RLN---------DIVGSAYYVAPEVLH----RSYSTEADVWSIGVIAYILLCGSRPFWARTESGI 369 (429)
Q Consensus 304 L~DFGla~~~~~~~-~~~---------~~~gt~~y~aPE~~~----~~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~ 369 (429)
|||||.+....... ... ...-|+.|+|||++. ..++.|+|||+|||+||-|+....||+....
T Consensus 187 LCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~--- 263 (738)
T KOG1989|consen 187 LCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK--- 263 (738)
T ss_pred eCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc---
Confidence 99999986532221 111 123689999999874 3589999999999999999999999987643
Q ss_pred HHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhccce
Q 014210 370 FRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLICYQSY 424 (429)
Q Consensus 370 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~~~ 424 (429)
.+|+.....++. .+.++..+++||+.||+.||.+||++-|++.+.+...+.-
T Consensus 264 -laIlng~Y~~P~--~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~ 315 (738)
T KOG1989|consen 264 -LAILNGNYSFPP--FPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKP 315 (738)
T ss_pred -eeEEeccccCCC--CccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCC
Confidence 355666655554 3689999999999999999999999999999988765543
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-44 Score=352.56 Aligned_cols=256 Identities=26% Similarity=0.503 Sum_probs=208.6
Q ss_pred ccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeC-
Q 014210 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT- 231 (429)
Q Consensus 153 ~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~- 231 (429)
+.++|++++.||+|+||.||+|.... +++.||||++.... ......+.+.+|+.++++++ |+||+++++++...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~ 87 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTR---LRQKVAVKKLSRPF-QSLIHARRTYRELRLLKHMK-HENVIGLLDVFTPAT 87 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECC---CCCEEEEEEeCchh-hhhHHHHHHHHHHHHHHhcC-CCchhhhhhhhcccc
Confidence 45789999999999999999998765 58899999986532 23334566789999999998 99999999988643
Q ss_pred -----CeEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEee
Q 014210 232 -----DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAID 306 (429)
Q Consensus 232 -----~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~D 306 (429)
...|++||++ +++|.+++ ....+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|
T Consensus 88 ~~~~~~~~~~~~~~~-~~~l~~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~---~~~~~~kl~D 161 (343)
T cd07878 88 SIENFNEVYLVTNLM-GADLNNIV--KCQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAV---NEDCELRILD 161 (343)
T ss_pred cccccCcEEEEeecC-CCCHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEE---CCCCCEEEcC
Confidence 3579999998 67887765 34579999999999999999999999999999999999999 7788899999
Q ss_pred cCCccccCCCccccccccCCcccCcccccC--CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCC------
Q 014210 307 FGLSDFVRPDERLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADP------ 378 (429)
Q Consensus 307 FGla~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~------ 378 (429)
||++..... ......||..|+|||++.+ .++.++|||||||++|+|++|+.||........+..+.....
T Consensus 162 fg~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 239 (343)
T cd07878 162 FGLARQADD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEV 239 (343)
T ss_pred CccceecCC--CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 999986543 2345679999999998864 588999999999999999999999977665444443332110
Q ss_pred -----------------CCCC----CCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhc
Q 014210 379 -----------------SFDE----APWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLICY 421 (429)
Q Consensus 379 -----------------~~~~----~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~ 421 (429)
.... ..+...++.+.+||.+||+.||.+|||+.++|.|+||..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~ 303 (343)
T cd07878 240 LKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQ 303 (343)
T ss_pred HHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhc
Confidence 0000 012346778899999999999999999999999999974
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=338.62 Aligned_cols=255 Identities=30% Similarity=0.438 Sum_probs=208.4
Q ss_pred ceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEE
Q 014210 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVY 235 (429)
Q Consensus 156 ~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~~ 235 (429)
+|++.+.||+|++|.||+|+... +|+.||||++..... .....+.+.+|+.+++++. |+||+++++++.+++..+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~---~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~ 75 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKK---TGQIVAMKKIRLESE-EEGVPSTAIREISLLKELQ-HPNIVCLQDVLMQESRLY 75 (285)
T ss_pred CceEeeEecccCceEEEEEEECC---CCcEEEEEEeccccc-cCCchHHHHHHHHHHHhcC-CCCEeeeEEEEeeCCeEE
Confidence 58899999999999999998765 588999999865432 2233466889999999998 999999999999999999
Q ss_pred EEEEecCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCcccc
Q 014210 236 VVMELCEGGELLDRILSRG--GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (429)
Q Consensus 236 lv~E~~~ggsL~~~i~~~~--~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~ 313 (429)
+||||++ ++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++...
T Consensus 76 ~v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~ 151 (285)
T cd07861 76 LIFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLI---DNKGVIKLADFGLARAF 151 (285)
T ss_pred EEEecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEE---cCCCcEEECcccceeec
Confidence 9999997 58888775432 579999999999999999999999999999999999999 77889999999998765
Q ss_pred CCCc-cccccccCCcccCcccccC--CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCC----------
Q 014210 314 RPDE-RLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSF---------- 380 (429)
Q Consensus 314 ~~~~-~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~---------- 380 (429)
.... ......++..|+|||++.+ .++.++||||||+++|+|++|+.||...........+.......
T Consensus 152 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (285)
T cd07861 152 GIPVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTS 231 (285)
T ss_pred CCCcccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchh
Confidence 4322 2233467889999998764 47889999999999999999999998766544433332211100
Q ss_pred ---------------CCCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhh
Q 014210 381 ---------------DEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLI 419 (429)
Q Consensus 381 ---------------~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~ 419 (429)
.......++.++.+||++||+.||++||++.+++.|+||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 232 LPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred hHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 011123578999999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-43 Score=332.24 Aligned_cols=255 Identities=26% Similarity=0.459 Sum_probs=212.5
Q ss_pred CceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcC--cHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCC
Q 014210 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMT--TAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (429)
Q Consensus 155 ~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~--~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~ 232 (429)
++|++.+.||+|++|.||++.... +|+.||||++...... .....+.+.+|+++++++. |+||+++++++++++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~---~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~ 77 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVD---TGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQ-HERIVQYYGCLRDDE 77 (263)
T ss_pred CcccccceecCCCceEEEEEEEcC---CCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCC-CCCeeeeEEEEccCC
Confidence 579999999999999999998665 5889999998654322 2234567899999999998 999999999999999
Q ss_pred eEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccc
Q 014210 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (429)
Q Consensus 233 ~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~ 312 (429)
..++||||+++++|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+||++ ++++.+||+|||++..
T Consensus 78 ~~~~v~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv---~~~~~~~l~dfg~~~~ 153 (263)
T cd06625 78 TLSIFMEYMPGGSVKDQLKA-YGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILR---DSAGNVKLGDFGASKR 153 (263)
T ss_pred eEEEEEEECCCCcHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCCCEEEeeccccee
Confidence 99999999999999988754 4568999999999999999999999999999999999999 6778899999999876
Q ss_pred cCCCccc----cccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCC
Q 014210 313 VRPDERL----NDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPS 387 (429)
Q Consensus 313 ~~~~~~~----~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 387 (429)
....... ....++..|+|||++.+ .++.++||||||+++|||++|+.||...........+...... ......
T Consensus 154 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~ 231 (263)
T cd06625 154 LQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTN--PQLPSH 231 (263)
T ss_pred ccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCC--CCCCcc
Confidence 5432211 33568889999998874 5889999999999999999999999776555444444332221 112236
Q ss_pred CCHHHHHHHHHhcccCccCcCCHHHHHhhHhh
Q 014210 388 LSSEARDFVKRLLNKDPRKRLTAAQALSELLI 419 (429)
Q Consensus 388 ~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~ 419 (429)
++.++.+||++||..||.+||++.+++.|+||
T Consensus 232 ~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 232 VSPDARNFLRRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred CCHHHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence 88999999999999999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-43 Score=352.93 Aligned_cols=257 Identities=21% Similarity=0.365 Sum_probs=208.2
Q ss_pred cccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeC
Q 014210 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (429)
Q Consensus 152 ~~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~ 231 (429)
....+|++++.||+|+||.||++.... ...++.||||.+... ....+|++++++|+ |+||+++++++...
T Consensus 89 ~~~~~y~i~~~Lg~G~~g~Vy~~~~~~-~~~~~~v~vK~~~~~--------~~~~~E~~il~~l~-h~~iv~~~~~~~~~ 158 (392)
T PHA03207 89 VVRMQYNILSSLTPGSEGEVFVCTKHG-DEQRKKVIVKAVTGG--------KTPGREIDILKTIS-HRAIINLIHAYRWK 158 (392)
T ss_pred hccCceEEEEeecCCCCeEEEEEEEcC-CccceeEEEEecccc--------ccHHHHHHHHHhcC-CCCccceeeeEeeC
Confidence 345689999999999999999997543 235789999988543 23468999999998 99999999999999
Q ss_pred CeEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCcc
Q 014210 232 DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (429)
Q Consensus 232 ~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~ 311 (429)
+..+++||++. ++|.+++ .....+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.
T Consensus 159 ~~~~lv~e~~~-~~l~~~l-~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill---~~~~~~~l~DfG~a~ 233 (392)
T PHA03207 159 STVCMVMPKYK-CDLFTYV-DRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFL---DEPENAVLGDFGAAC 233 (392)
T ss_pred CEEEEEehhcC-CCHHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE---cCCCCEEEccCcccc
Confidence 99999999995 5888887 555789999999999999999999999999999999999999 778889999999997
Q ss_pred ccCCCcc---ccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHcCCCCCCCCCh---HHHHHHHHhcCC----CC
Q 014210 312 FVRPDER---LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTE---SGIFRAVLKADP----SF 380 (429)
Q Consensus 312 ~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~elltg~~Pf~~~~~---~~~~~~i~~~~~----~~ 380 (429)
....... .....||..|+|||++. ..++.++|||||||++|||++|+.||.+... ...+..+.+... .+
T Consensus 234 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~ 313 (392)
T PHA03207 234 KLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEF 313 (392)
T ss_pred ccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCcccc
Confidence 6543322 23467999999999987 4689999999999999999999999976432 222222222110 00
Q ss_pred CC--------------------CC------CCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhccc
Q 014210 381 DE--------------------AP------WPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLICYQS 423 (429)
Q Consensus 381 ~~--------------------~~------~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~~ 423 (429)
+. .. ...++.++.+||++||..||++||++.++|.|+||....
T Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~~ 382 (392)
T PHA03207 314 PQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKEP 382 (392)
T ss_pred CCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhccc
Confidence 00 00 013567899999999999999999999999999998654
|
|
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-43 Score=337.88 Aligned_cols=257 Identities=29% Similarity=0.476 Sum_probs=216.8
Q ss_pred cCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~ 233 (429)
.+.|+++++||.|+||.||+|+... +|+.|++|++.. ......+.+.+|+.+++.+. |+||+++++++..++.
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~---~~~~~~~k~~~~---~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~ 83 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKE---TGALAAAKVIET---KSEEELEDYMVEIEILATCN-HPYIVKLLGAFYWDGK 83 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECC---CCceEEEEEecc---CCHHHHHHHHHHHHHHHhCC-CCcEeeeEEEEEeCCe
Confidence 4679999999999999999998766 588999999864 34556678899999999998 9999999999999999
Q ss_pred EEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCcccc
Q 014210 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (429)
Q Consensus 234 ~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~ 313 (429)
.++||||+++++|..++.+....+++..++.++.||+.+|.|||+.||+||||||+||++ +.++.+||+|||++...
T Consensus 84 ~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili---~~~~~~kl~dfg~~~~~ 160 (292)
T cd06644 84 LWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLL---TLDGDIKLADFGVSAKN 160 (292)
T ss_pred EEEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEE---cCCCCEEEccCccceec
Confidence 999999999999988877666789999999999999999999999999999999999999 67788999999998654
Q ss_pred CCC-ccccccccCCcccCccccc------CCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCC
Q 014210 314 RPD-ERLNDIVGSAYYVAPEVLH------RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWP 386 (429)
Q Consensus 314 ~~~-~~~~~~~gt~~y~aPE~~~------~~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 386 (429)
... .......++..|+|||++. ..++.++|||||||++|||++|+.||........+..+....... .....
T Consensus 161 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~ 239 (292)
T cd06644 161 VKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPT-LSQPS 239 (292)
T ss_pred cccccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCcc-CCCCc
Confidence 322 2223456889999999874 246889999999999999999999998766555554444332211 11123
Q ss_pred CCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhc
Q 014210 387 SLSSEARDFVKRLLNKDPRKRLTAAQALSELLICY 421 (429)
Q Consensus 387 ~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~ 421 (429)
.++.++.+||++||..||++||++.++++|+|+..
T Consensus 240 ~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 274 (292)
T cd06644 240 KWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSS 274 (292)
T ss_pred ccCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence 57889999999999999999999999999999864
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-43 Score=335.72 Aligned_cols=255 Identities=28% Similarity=0.490 Sum_probs=210.9
Q ss_pred ccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeC-
Q 014210 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT- 231 (429)
Q Consensus 153 ~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~- 231 (429)
..+.|++.+.||+|+||.||+|.... +++.||+|++.... .....+.+|+.+++++.+|+||+++++++...
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~---~~~~~aik~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~ 76 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVK---TGQLAAIKVMDVTG----DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKN 76 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcC---CCcEEEEEEEEcCC----ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecC
Confidence 45789999999999999999998766 58899999986432 22356889999999996699999999998753
Q ss_pred -----CeEEEEEEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEe
Q 014210 232 -----DNVYVVMELCEGGELLDRILSR-GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAI 305 (429)
Q Consensus 232 -----~~~~lv~E~~~ggsL~~~i~~~-~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~ 305 (429)
...|++|||+++++|.+++... ...+++..+..++.||+.||.|||+++|+||||||+||++ ++++.+||+
T Consensus 77 ~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili---~~~~~~~l~ 153 (272)
T cd06637 77 PPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLL---TENAEVKLV 153 (272)
T ss_pred CCCCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEE---CCCCCEEEc
Confidence 4689999999999999988764 3568999999999999999999999999999999999999 678889999
Q ss_pred ecCCccccCCC-ccccccccCCcccCccccc------CCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCC
Q 014210 306 DFGLSDFVRPD-ERLNDIVGSAYYVAPEVLH------RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADP 378 (429)
Q Consensus 306 DFGla~~~~~~-~~~~~~~gt~~y~aPE~~~------~~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~ 378 (429)
|||++...... .......|+..|+|||++. ..++.++|||||||++|||++|+.||...........+....
T Consensus 154 Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~- 232 (272)
T cd06637 154 DFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP- 232 (272)
T ss_pred cCCCceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCC-
Confidence 99998765432 2334567899999999874 247889999999999999999999997665544433332221
Q ss_pred CCCCCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhh
Q 014210 379 SFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLI 419 (429)
Q Consensus 379 ~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~ 419 (429)
........++.++.+||.+||+.||.+||++.+++.|+||
T Consensus 233 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 233 -APRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred -CCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 2222234578999999999999999999999999999996
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-43 Score=337.32 Aligned_cols=258 Identities=31% Similarity=0.506 Sum_probs=219.4
Q ss_pred cCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~ 233 (429)
.++|++.+.||.|+||.||++.... +++.||+|++.. ......+.+.+|++++++++ |+||+++++++.+++.
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~---~~~~~~iK~~~~---~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~ 76 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKE---TGLFAAAKIIQI---ESEEELEDFMVEIDILSECK-HPNIVGLYEAYFYENK 76 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcC---CCcEEEEEEEee---CCHHHHHHHHHHHHHHHhCC-CCceeEEEEEEecCCe
Confidence 4679999999999999999998765 588999999854 34455677889999999998 9999999999999999
Q ss_pred EEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCcccc
Q 014210 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (429)
Q Consensus 234 ~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~ 313 (429)
.++||||+++++|.+++...+..+++..++.++.|++.||.|||++||+|+||||+||++ +.++.+||+|||++...
T Consensus 77 ~~lv~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili---~~~~~~~l~d~g~~~~~ 153 (280)
T cd06611 77 LWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILL---TLDGDVKLADFGVSAKN 153 (280)
T ss_pred EEEEeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEE---CCCCCEEEccCccchhh
Confidence 999999999999999887766789999999999999999999999999999999999999 77889999999988655
Q ss_pred CCC-ccccccccCCcccCccccc------CCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCC
Q 014210 314 RPD-ERLNDIVGSAYYVAPEVLH------RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWP 386 (429)
Q Consensus 314 ~~~-~~~~~~~gt~~y~aPE~~~------~~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 386 (429)
... .......++..|+|||++. ..++.++||||||+++|+|++|+.||........+..+........ ....
T Consensus 154 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~ 232 (280)
T cd06611 154 KSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTL-DQPS 232 (280)
T ss_pred cccccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCc-CCcc
Confidence 332 2233456899999999874 2367899999999999999999999988776665555554432211 1123
Q ss_pred CCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhcc
Q 014210 387 SLSSEARDFVKRLLNKDPRKRLTAAQALSELLICYQ 422 (429)
Q Consensus 387 ~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~ 422 (429)
.++.++.+||.+||+.||.+||++.++|+|+|+...
T Consensus 233 ~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (280)
T cd06611 233 KWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQ 268 (280)
T ss_pred cCCHHHHHHHHHHhccChhhCcCHHHHhcChhhccc
Confidence 578999999999999999999999999999999754
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=340.91 Aligned_cols=255 Identities=31% Similarity=0.505 Sum_probs=207.7
Q ss_pred ceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEE
Q 014210 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVY 235 (429)
Q Consensus 156 ~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~~ 235 (429)
+|++.++||+|+||.||+|+... +|+.||+|++..... .......+.+|+.++++++ |+||+++++++.+.+..+
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~---~g~~~~~k~~~~~~~-~~~~~~~~~~ei~~l~~l~-h~~i~~~~~~~~~~~~~~ 75 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRE---THEIVALKRVRLDDD-DEGVPSSALREICLLKELK-HKNIVRLYDVLHSDKKLT 75 (284)
T ss_pred CceeEEEecccCCeEEEEEEECC---CCcEEEEEEeecccc-cccCccchhHHHHHHHhcC-CCCeeeHHHHhccCCceE
Confidence 58999999999999999998776 588999999865432 2223356778999999998 999999999999999999
Q ss_pred EEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccccCC
Q 014210 236 VVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP 315 (429)
Q Consensus 236 lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~ 315 (429)
+|+||++ ++|.+++....+.+++..++.++.||++||.|||++||+||||||+||++ +.++.+||+|||++.....
T Consensus 76 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~---~~~~~~~l~dfg~~~~~~~ 151 (284)
T cd07839 76 LVFEYCD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLI---NKNGELKLADFGLARAFGI 151 (284)
T ss_pred EEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEE---cCCCcEEECccchhhccCC
Confidence 9999996 48888887667789999999999999999999999999999999999999 6778899999999976543
Q ss_pred Cc-cccccccCCcccCcccccC--CCCCcccHHHHHHHHHHHHcCCCCCCC-CChHHHHHHHHhcCC-------------
Q 014210 316 DE-RLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWA-RTESGIFRAVLKADP------------- 378 (429)
Q Consensus 316 ~~-~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlGvll~elltg~~Pf~~-~~~~~~~~~i~~~~~------------- 378 (429)
.. ......++..|+|||++.+ .++.++|||||||++|+|++|..||.. .+....+..+.+...
T Consensus 152 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd07839 152 PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKL 231 (284)
T ss_pred CCCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhc
Confidence 32 2234567899999998764 378899999999999999999998643 333333333322110
Q ss_pred -CCC-----------CCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhh
Q 014210 379 -SFD-----------EAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLI 419 (429)
Q Consensus 379 -~~~-----------~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~ 419 (429)
... ....+.+++++.+||++||+.||.+|||+.+++.|+||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 232 PDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred ccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 000 01123578899999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-43 Score=339.78 Aligned_cols=255 Identities=25% Similarity=0.416 Sum_probs=210.3
Q ss_pred CceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeE
Q 014210 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (429)
Q Consensus 155 ~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~ 234 (429)
++|++.+.||+|+||.||+++... +|..+|+|.+... ......+++.+|++++++++ |+||+++++++.+++.+
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~---~~~~~a~k~~~~~--~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~ 74 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRP---SGLIMARKLIHLE--IKPAIRNQIIRELKVLHECN-SPYIVGFYGAFYSDGEI 74 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcC---CCeEEEEEEeccc--cCHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEeeCCEE
Confidence 469999999999999999998765 5889999998643 23445567889999999997 99999999999999999
Q ss_pred EEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-cCceeccCCCCcEEEeecCCCceEEEeecCCcccc
Q 014210 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHL-QGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (429)
Q Consensus 235 ~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~-~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~ 313 (429)
++||||+++++|.+++... +.+++..+..++.||+.||.|||+ .+|+||||||+|||+ +.++.+||+|||++...
T Consensus 75 ~lv~ey~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~ 150 (308)
T cd06615 75 SICMEHMDGGSLDQVLKKA-GRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILV---NSRGEIKLCDFGVSGQL 150 (308)
T ss_pred EEEeeccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEE---ecCCcEEEccCCCcccc
Confidence 9999999999999987544 678999999999999999999998 599999999999999 67788999999998765
Q ss_pred CCCccccccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCC-------------
Q 014210 314 RPDERLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPS------------- 379 (429)
Q Consensus 314 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~------------- 379 (429)
... ......|+..|+|||++.+ .++.++||||||+++|+|++|+.||......... .+......
T Consensus 151 ~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 228 (308)
T cd06615 151 IDS-MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELE-AMFGRPVSEGEAKESHRPVSG 228 (308)
T ss_pred ccc-ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHH-HhhcCccccccccCCcccccC
Confidence 322 2345678999999998864 5888999999999999999999999655433222 11111100
Q ss_pred ----------------------CCCCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhc
Q 014210 380 ----------------------FDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLICY 421 (429)
Q Consensus 380 ----------------------~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~ 421 (429)
.+..+...++.++.+||.+||..||++||++.+++.|+||..
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~ 292 (308)
T cd06615 229 HPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKR 292 (308)
T ss_pred CCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhh
Confidence 011111236789999999999999999999999999999975
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=338.35 Aligned_cols=260 Identities=28% Similarity=0.478 Sum_probs=219.3
Q ss_pred CceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeE
Q 014210 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (429)
Q Consensus 155 ~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~ 234 (429)
++|++.+.||+|+||.||++.... .++.||||.+...........+.+.+|+++++.++ |+||+++++.+..++..
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~---~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~ 76 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKE---TRQRFAMKKINKQNLILRNQIQQVFVERDILTFAE-NPFVVSMFCSFETKRHL 76 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECC---CCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCC-CCCeeeeEEEEecCCEE
Confidence 468999999999999999998766 58899999987654444455677889999999998 99999999999999999
Q ss_pred EEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccccC
Q 014210 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (429)
Q Consensus 235 ~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~ 314 (429)
++||||++|++|.+++... +.+++..+..++.|++.||.|||++||+||||||+||++ +.++.+||+|||+++...
T Consensus 77 ~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll---~~~~~~~l~dfg~~~~~~ 152 (305)
T cd05609 77 CMVMEYVEGGDCATLLKNI-GALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLI---TSMGHIKLTDFGLSKIGL 152 (305)
T ss_pred EEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEE---CCCCCEEEeeCCCccccC
Confidence 9999999999999887544 679999999999999999999999999999999999999 678889999999986421
Q ss_pred CCc----------------cccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcC
Q 014210 315 PDE----------------RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKAD 377 (429)
Q Consensus 315 ~~~----------------~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~ 377 (429)
... ......++..|+|||.+. ..++.++||||||+++|||++|..||.+....+.+..+....
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~ 232 (305)
T cd05609 153 MSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDD 232 (305)
T ss_pred cCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc
Confidence 110 011245788999999875 468999999999999999999999999888777777766654
Q ss_pred CCCCCCCCCCCCHHHHHHHHHhcccCccCcCC---HHHHHhhHhhhccc
Q 014210 378 PSFDEAPWPSLSSEARDFVKRLLNKDPRKRLT---AAQALSELLICYQS 423 (429)
Q Consensus 378 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps---~~~iL~~~~~~~~~ 423 (429)
...+... ..++.++.+||++||+.||++||+ +.++|+|+|++...
T Consensus 233 ~~~~~~~-~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~ 280 (305)
T cd05609 233 IEWPEGD-EALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLD 280 (305)
T ss_pred cCCCCcc-ccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCC
Confidence 4333322 257899999999999999999998 79999999996543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-43 Score=334.79 Aligned_cols=255 Identities=20% Similarity=0.352 Sum_probs=214.3
Q ss_pred cCceeEeceeeccCceEEEEEEEecCc--ccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeC
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGE--LKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~--~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~ 231 (429)
.++|++.+.||+|+||.||+|...... ...+.||+|.+... .......++.+|+.++.+++ |+||+++++++.+.
T Consensus 4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~--~~~~~~~~~~~ei~~l~~l~-h~~i~~~~~~~~~~ 80 (283)
T cd05048 4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKEN--AEPKVQQEFRQEAELMSDLQ-HPNIVCLLGVCTKE 80 (283)
T ss_pred hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccC--CCHHHHHHHHHHHHHHHhcC-CcccceEEEEEcCC
Confidence 357999999999999999999876532 24578999998643 33445677899999999998 99999999999999
Q ss_pred CeEEEEEEecCCCcHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeec
Q 014210 232 DNVYVVMELCEGGELLDRILSRG---------------GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTK 296 (429)
Q Consensus 232 ~~~~lv~E~~~ggsL~~~i~~~~---------------~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~ 296 (429)
+..+++|||+++++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+||++
T Consensus 81 ~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~--- 157 (283)
T cd05048 81 QPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLV--- 157 (283)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEE---
Confidence 99999999999999999886532 458899999999999999999999999999999999999
Q ss_pred CCCceEEEeecCCccccCCCc---cccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHc-CCCCCCCCChHHHHH
Q 014210 297 DENSVLKAIDFGLSDFVRPDE---RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFR 371 (429)
Q Consensus 297 ~~~~~vkL~DFGla~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~ellt-g~~Pf~~~~~~~~~~ 371 (429)
++++.+||+|||++....... ......++..|+|||.+. +.++.++|||||||++|||++ |..||.+....+...
T Consensus 158 ~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~ 237 (283)
T cd05048 158 GEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIE 237 (283)
T ss_pred cCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 677889999999987653322 123345678899999875 578999999999999999998 999999888777776
Q ss_pred HHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhH
Q 014210 372 AVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSEL 417 (429)
Q Consensus 372 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~ 417 (429)
.+....... ....++.++.+|+++||+.||.+||++.++++++
T Consensus 238 ~i~~~~~~~---~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l 280 (283)
T cd05048 238 MIRSRQLLP---CPEDCPARVYALMIECWNEIPARRPRFKDIHTRL 280 (283)
T ss_pred HHHcCCcCC---CcccCCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 665443222 1246899999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=328.89 Aligned_cols=248 Identities=26% Similarity=0.447 Sum_probs=209.2
Q ss_pred CceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeE
Q 014210 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (429)
Q Consensus 155 ~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~ 234 (429)
++|++.+.||+|+||.||+++.+. +..+|+|.+..... ..+++.+|+.++++++ |+||+++++++.+.+..
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~----~~~~a~K~~~~~~~----~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~ 74 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRA----QIKVAIKAINEGAM----SEEDFIEEAKVMMKLS-HPKLVQLYGVCTQQKPL 74 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEecc----CceEEEEecccCCc----cHHHHHHHHHHHHHCC-CCCceeEEEEEccCCCE
Confidence 568999999999999999997654 56799998764432 2356889999999998 99999999999999999
Q ss_pred EEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccccC
Q 014210 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (429)
Q Consensus 235 ~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~ 314 (429)
++||||+++|+|.+++....+.+++..++.++.||+.||+|||+.||+||||||+||++ +.++.+||+|||++....
T Consensus 75 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i---~~~~~~kl~d~g~~~~~~ 151 (256)
T cd05114 75 YIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLV---SSTGVVKVSDFGMTRYVL 151 (256)
T ss_pred EEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEE---cCCCeEEECCCCCccccC
Confidence 99999999999999887666679999999999999999999999999999999999999 678899999999987654
Q ss_pred CCccc--cccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCH
Q 014210 315 PDERL--NDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLSS 390 (429)
Q Consensus 315 ~~~~~--~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 390 (429)
..... ....++..|+|||++. ..++.++||||||+++|||++ |+.||......+.+..+........ ....+.
T Consensus 152 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~---~~~~~~ 228 (256)
T cd05114 152 DDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYR---PKLASM 228 (256)
T ss_pred CCceeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCC---CCCCCH
Confidence 32221 2233556899999886 468899999999999999999 9999988887777777665432211 124678
Q ss_pred HHHHHHHHhcccCccCcCCHHHHHhhH
Q 014210 391 EARDFVKRLLNKDPRKRLTAAQALSEL 417 (429)
Q Consensus 391 ~~~~li~~~L~~dP~~Rps~~~iL~~~ 417 (429)
++.+||.+||+.||++||++.++++.+
T Consensus 229 ~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 229 TVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred HHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-43 Score=344.11 Aligned_cols=256 Identities=20% Similarity=0.295 Sum_probs=204.6
Q ss_pred Eeceeecc--CceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEE
Q 014210 159 LGEEVGRG--HFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYV 236 (429)
Q Consensus 159 ~~~~IG~G--~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~~l 236 (429)
++++||+| +|++||+++.+. +|+.||||++..... .....+.+.+|+.+++.++ ||||++++++|.+++..++
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~---~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~-hpniv~~~~~~~~~~~~~l 76 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKP---TGEYVTVRRINLEAC-TNEMVTFLQGELHVSKLFN-HPNIVPYRATFIADNELWV 76 (327)
T ss_pred hhhhccccccceEEEEEEeecc---cCcEEEEEEechhhc-cHHHHHHHHHHHHHHHhcC-CCCeeeEEEEEEECCEEEE
Confidence 57889999 678999998776 689999999865432 3345567889999999997 9999999999999999999
Q ss_pred EEEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccccCC
Q 014210 237 VMELCEGGELLDRILSR-GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP 315 (429)
Q Consensus 237 v~E~~~ggsL~~~i~~~-~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~ 315 (429)
||||+++|+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.++++|||.......
T Consensus 77 v~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~---~~~~~~~l~~~~~~~~~~~ 153 (327)
T cd08227 77 VTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILI---SVDGKVYLSGLRSNLSMIN 153 (327)
T ss_pred EEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEE---ecCCcEEEcccchhhcccc
Confidence 99999999999988654 3458999999999999999999999999999999999999 6777899999986543321
Q ss_pred Cc--------cccccccCCcccCcccccC---CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCC---
Q 014210 316 DE--------RLNDIVGSAYYVAPEVLHR---SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFD--- 381 (429)
Q Consensus 316 ~~--------~~~~~~gt~~y~aPE~~~~---~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~--- 381 (429)
.. ......++..|+|||++.+ .++.++|||||||++|||++|+.||....................
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 233 (327)
T cd08227 154 HGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDT 233 (327)
T ss_pred ccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccc
Confidence 11 1122356778999999863 488999999999999999999999976554433333222111000
Q ss_pred ---------------------------------------CCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhcc
Q 014210 382 ---------------------------------------EAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLICYQ 422 (429)
Q Consensus 382 ---------------------------------------~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~ 422 (429)
......+++++.+||++||+.||++|||+.++++|+||+.-
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~ 313 (327)
T cd08227 234 TTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQI 313 (327)
T ss_pred cchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhc
Confidence 00112357789999999999999999999999999999753
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-43 Score=334.51 Aligned_cols=258 Identities=31% Similarity=0.502 Sum_probs=216.8
Q ss_pred CceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeE
Q 014210 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (429)
Q Consensus 155 ~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~ 234 (429)
+.|++.++||+|+||.||++.... ++..+++|.+... .....+.+.+|+++++.+. |+||+++++++.+.+..
T Consensus 5 ~~~~i~~~lg~g~~g~v~~~~~~~---~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~-h~~ii~~~~~~~~~~~~ 77 (282)
T cd06643 5 EFWEIIGELGDGAFGKVYKAQNKE---TGVLAAAKVIDTK---SEEELEDYMVEIDILASCD-HPNIVKLLDAFYYENNL 77 (282)
T ss_pred HHHHHHhhcccCCCeEEEEEEECC---CCeEEEEEEeCCC---CHHHHHHHHHHHHHHHHCC-CCCeeeEEEEEeeCCEE
Confidence 347889999999999999998765 5789999998543 3455677889999999998 99999999999999999
Q ss_pred EEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccccC
Q 014210 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (429)
Q Consensus 235 ~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~ 314 (429)
++||||+++++|..++......+++..+..++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||++....
T Consensus 78 ~~v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili---~~~~~~kl~dfg~~~~~~ 154 (282)
T cd06643 78 WILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILF---TLDGDIKLADFGVSAKNT 154 (282)
T ss_pred EEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEE---ccCCCEEEcccccccccc
Confidence 99999999999988876666789999999999999999999999999999999999999 677889999999986653
Q ss_pred CC-ccccccccCCcccCccccc------CCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCC
Q 014210 315 PD-ERLNDIVGSAYYVAPEVLH------RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPS 387 (429)
Q Consensus 315 ~~-~~~~~~~gt~~y~aPE~~~------~~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 387 (429)
.. .......++..|+|||++. ..++.++|||||||++|||++|+.||......+....+........ .....
T Consensus 155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~ 233 (282)
T cd06643 155 RTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTL-AQPSR 233 (282)
T ss_pred ccccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCC-CCccc
Confidence 22 2234457899999999873 2477899999999999999999999987776665555544332211 11235
Q ss_pred CCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhccc
Q 014210 388 LSSEARDFVKRLLNKDPRKRLTAAQALSELLICYQS 423 (429)
Q Consensus 388 ~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~~ 423 (429)
++.++.+||++||+.||.+||++.+++.|+|+....
T Consensus 234 ~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 269 (282)
T cd06643 234 WSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVNS 269 (282)
T ss_pred cCHHHHHHHHHHccCChhhCcCHHHHhcCCCEeccC
Confidence 789999999999999999999999999999987543
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-44 Score=341.45 Aligned_cols=260 Identities=28% Similarity=0.466 Sum_probs=236.4
Q ss_pred cCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~ 233 (429)
..+|..+.+||+|+||.|.++..+. +.+.+|||+++++........+.-..|-++|.....-|.+++++.+|+.-+.
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkg---tdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR 424 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKG---TDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR 424 (683)
T ss_pred ecccceEEEeccCccceeeeecccC---cchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence 5789999999999999999998665 5789999999998888777788888899999877778899999999999999
Q ss_pred EEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCcccc
Q 014210 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (429)
Q Consensus 234 ~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~ 313 (429)
+|+||||+.||+|..+|++ -+++.+..+..++.+|+-||-+||++|||+||||.+|||| |.+|++||+|||+++.-
T Consensus 425 LyFVMEyvnGGDLMyhiQQ-~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmL---d~eGHiKi~DFGmcKEn 500 (683)
T KOG0696|consen 425 LYFVMEYVNGGDLMYHIQQ-VGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML---DSEGHIKIADFGMCKEN 500 (683)
T ss_pred eeeEEEEecCchhhhHHHH-hcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEe---ccCCceEeeeccccccc
Confidence 9999999999999988754 4789999999999999999999999999999999999999 89999999999999753
Q ss_pred -CCCccccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHH
Q 014210 314 -RPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSE 391 (429)
Q Consensus 314 -~~~~~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 391 (429)
..+..+.+.+||+.|+|||++. ..|+..+|+||+||+||||+.|+.||++..+.+.++.|......++. .+|.|
T Consensus 501 i~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsyPK----slSkE 576 (683)
T KOG0696|consen 501 IFDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSYPK----SLSKE 576 (683)
T ss_pred ccCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcCcc----cccHH
Confidence 3455677899999999999876 68999999999999999999999999999999999999999888876 69999
Q ss_pred HHHHHHHhcccCccCcCCH-----HHHHhhHhhhccce
Q 014210 392 ARDFVKRLLNKDPRKRLTA-----AQALSELLICYQSY 424 (429)
Q Consensus 392 ~~~li~~~L~~dP~~Rps~-----~~iL~~~~~~~~~~ 424 (429)
+.++++.+|.+.|.+|... .+|-.|+||+...|
T Consensus 577 Av~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDW 614 (683)
T KOG0696|consen 577 AVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRIDW 614 (683)
T ss_pred HHHHHHHHhhcCCccccCCCCccccchhhCcchhhccH
Confidence 9999999999999999865 78889999987665
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-45 Score=348.69 Aligned_cols=260 Identities=28% Similarity=0.477 Sum_probs=230.7
Q ss_pred cCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~ 233 (429)
.+.|+.-++||+||||.||-++++. +|+.+|.|.+.+.............+|-.||.+++ .+.||.+-.+|+..+.
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvra---TGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~-s~FiVslaYAfeTkd~ 259 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRA---TGKMYACKKLDKKRIKKRKGETMALNEKQILEKVS-SPFIVSLAYAFETKDA 259 (591)
T ss_pred ccceeeeEEEecccccceeEEEEec---chhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhc-cCcEEEEeeeecCCCc
Confidence 4678899999999999999999887 79999999998877777777778899999999998 8999999999999999
Q ss_pred EEEEEEecCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccc
Q 014210 234 VYVVMELCEGGELLDRILSRGG-KYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (429)
Q Consensus 234 ~~lv~E~~~ggsL~~~i~~~~~-~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~ 312 (429)
++|||..|.||+|.-+|...+. .+++..++.++.+|+.||++||+++||+||+||+|||| |+.|+++|+|+|+|..
T Consensus 260 LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILL---Dd~GhvRISDLGLAve 336 (591)
T KOG0986|consen 260 LCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILL---DDHGHVRISDLGLAVE 336 (591)
T ss_pred eEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheee---ccCCCeEeeccceEEe
Confidence 9999999999999888876653 69999999999999999999999999999999999999 8999999999999999
Q ss_pred cCCCccccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHH----HHHHHhcCCCCCCCCCCC
Q 014210 313 VRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGI----FRAVLKADPSFDEAPWPS 387 (429)
Q Consensus 313 ~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~----~~~i~~~~~~~~~~~~~~ 387 (429)
+..+......+||.+|||||+++ +.|+...|+|||||+||||+.|+.||....+... -+.++.....+. ..
T Consensus 337 i~~g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~----~k 412 (591)
T KOG0986|consen 337 IPEGKPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYS----DK 412 (591)
T ss_pred cCCCCccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhcc----cc
Confidence 98888888889999999999987 4699999999999999999999999977655433 333444333333 47
Q ss_pred CCHHHHHHHHHhcccCccCcCC-----HHHHHhhHhhhccce
Q 014210 388 LSSEARDFVKRLLNKDPRKRLT-----AAQALSELLICYQSY 424 (429)
Q Consensus 388 ~s~~~~~li~~~L~~dP~~Rps-----~~~iL~~~~~~~~~~ 424 (429)
+++++++|.+.+|++||++|.. ++++.+|+||....|
T Consensus 413 FS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw 454 (591)
T KOG0986|consen 413 FSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNW 454 (591)
T ss_pred cCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCH
Confidence 9999999999999999999985 569999999987655
|
|
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=327.40 Aligned_cols=254 Identities=28% Similarity=0.489 Sum_probs=217.0
Q ss_pred ceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEE
Q 014210 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVY 235 (429)
Q Consensus 156 ~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~~ 235 (429)
+|++.+.||+|+||.||++.... +++.+|||++..... .....+.+.+|++++++++ |+||+++++.+..++..+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~---~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~ 75 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKA---DQKLVIIKQIPVEQM-TKDERLAAQNECQVLKLLS-HPNIIEYYENFLEDKALM 75 (256)
T ss_pred CceEEEEecccCceEEEEEEEcC---CCcEEEEEEEecccc-ccHHHHHHHHHHHHHhhCC-CCchhheeeeEecCCEEE
Confidence 58999999999999999998765 589999999876543 3344678999999999998 999999999999999999
Q ss_pred EEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccccC
Q 014210 236 VVMELCEGGELLDRILSRG-GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (429)
Q Consensus 236 lv~E~~~ggsL~~~i~~~~-~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~ 314 (429)
+||||+++++|.+++.... ..+++..+..++.|++.+|.|||++||+|+||||+||+++ +++..+||+|||++....
T Consensus 76 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~--~~~~~~~l~d~~~~~~~~ 153 (256)
T cd08220 76 IVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLD--KHKMVVKIGDFGISKILS 153 (256)
T ss_pred EEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc--CCCCEEEEccCCCceecC
Confidence 9999999999999987653 4589999999999999999999999999999999999994 345578999999998776
Q ss_pred CCccccccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHH
Q 014210 315 PDERLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEAR 393 (429)
Q Consensus 315 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 393 (429)
.........++..|+|||.+.+ .++.++||||||+++|+|++|+.||...........+....... ....++.++.
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~ 230 (256)
T cd08220 154 SKSKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAP---ISDRYSPDLR 230 (256)
T ss_pred CCccccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCCC---CCCCcCHHHH
Confidence 5554455678999999998874 57889999999999999999999998776666555554433221 1235789999
Q ss_pred HHHHHhcccCccCcCCHHHHHhhHhh
Q 014210 394 DFVKRLLNKDPRKRLTAAQALSELLI 419 (429)
Q Consensus 394 ~li~~~L~~dP~~Rps~~~iL~~~~~ 419 (429)
+||.+||+.||++||++.++++|+|+
T Consensus 231 ~li~~~l~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 231 QLILSMLNLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred HHHHHHccCChhhCCCHHHHhhCCCC
Confidence 99999999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-43 Score=333.58 Aligned_cols=254 Identities=28% Similarity=0.473 Sum_probs=207.6
Q ss_pred cCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~ 233 (429)
.++|++.++||+|+||.||+|+... +|+.||+|++.... ......+.+|+.+++++. |+||+++++++..++.
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~---~~~~~aik~~~~~~---~~~~~~~~~e~~~l~~~~-h~~ii~~~~~~~~~~~ 80 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLH---TGELAAVKIIKLEP---GDDFSLIQQEIFMVKECK-HCNIVAYFGSYLSREK 80 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECC---CCeEEEEEEEecCc---cchHHHHHHHHHHHHhcC-CCCeeeeeEEEEeCCE
Confidence 4689999999999999999998765 58899999985432 223456889999999998 9999999999999999
Q ss_pred EEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCcccc
Q 014210 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (429)
Q Consensus 234 ~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~ 313 (429)
.++||||+++++|.+++.. .+.+++..+..++.|++.||.|||+.||+||||||+||++ +.++.+||+|||++...
T Consensus 81 ~~iv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill---~~~~~~~l~dfg~~~~~ 156 (267)
T cd06646 81 LWICMEYCGGGSLQDIYHV-TGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILL---TDNGDVKLADFGVAAKI 156 (267)
T ss_pred EEEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE---CCCCCEEECcCccceee
Confidence 9999999999999987754 4678999999999999999999999999999999999999 67788999999999766
Q ss_pred CCCc-cccccccCCcccCccccc----CCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCC-CCCCC
Q 014210 314 RPDE-RLNDIVGSAYYVAPEVLH----RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDE-APWPS 387 (429)
Q Consensus 314 ~~~~-~~~~~~gt~~y~aPE~~~----~~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~-~~~~~ 387 (429)
.... ......|+..|+|||.+. ..++.++|||||||++|||++|+.||...........+......... .....
T Consensus 157 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (267)
T cd06646 157 TATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTK 236 (267)
T ss_pred cccccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccc
Confidence 4322 223457889999999873 34788999999999999999999999655433222222111111111 11134
Q ss_pred CCHHHHHHHHHhcccCccCcCCHHHHHhhHh
Q 014210 388 LSSEARDFVKRLLNKDPRKRLTAAQALSELL 418 (429)
Q Consensus 388 ~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~ 418 (429)
++.++.+||++||+.||++||+++++|+|+|
T Consensus 237 ~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 237 WSSTFHNFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred cCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence 7899999999999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=333.68 Aligned_cols=251 Identities=23% Similarity=0.381 Sum_probs=208.1
Q ss_pred CceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeE
Q 014210 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (429)
Q Consensus 155 ~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~ 234 (429)
++|++.++||+|+||.||+|+... +++.||+|++... ......+.+.+|+++++++. |+||+++++++...+..
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~---~~~~~aiK~~~~~--~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~ 74 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLL---TRRILAVKVIPLD--ITVELQKQIMSELEILYKCD-SPYIIGFYGAFFVENRI 74 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcC---CCcEEEEEEEecC--CChHHHHHHHHHHHHHHhCC-CCCeeeEEEEEEECCEE
Confidence 368899999999999999998765 5889999998654 23445567899999999998 99999999999999999
Q ss_pred EEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccccC
Q 014210 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (429)
Q Consensus 235 ~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~ 314 (429)
++||||+++++|..+ ..+++..+..++.||+.||.|||+.||+|+||||+|||+ +.++.+||+|||++....
T Consensus 75 ~lv~e~~~~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill---~~~~~~~l~dfg~~~~~~ 146 (279)
T cd06619 75 SICTEFMDGGSLDVY-----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLV---NTRGQVKLCDFGVSTQLV 146 (279)
T ss_pred EEEEecCCCCChHHh-----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEE---CCCCCEEEeeCCcceecc
Confidence 999999999988543 357899999999999999999999999999999999999 778899999999997654
Q ss_pred CCccccccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHcCCCCCCCCChH-------HHHHHHHhcCCCCCCCCCC
Q 014210 315 PDERLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTES-------GIFRAVLKADPSFDEAPWP 386 (429)
Q Consensus 315 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~elltg~~Pf~~~~~~-------~~~~~i~~~~~~~~~~~~~ 386 (429)
.. ......|+..|+|||++.+ .++.++||||||+++|+|++|+.||...... .....+.... .......
T Consensus 147 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 223 (279)
T cd06619 147 NS-IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED--PPVLPVG 223 (279)
T ss_pred cc-cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccC--CCCCCCC
Confidence 32 3345689999999998864 6899999999999999999999999643211 2222222222 1122234
Q ss_pred CCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhcc
Q 014210 387 SLSSEARDFVKRLLNKDPRKRLTAAQALSELLICYQ 422 (429)
Q Consensus 387 ~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~ 422 (429)
.++.++.+||.+||+.||++||++.++++|+|++..
T Consensus 224 ~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~ 259 (279)
T cd06619 224 QFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQY 259 (279)
T ss_pred cCCHHHHHHHHHHhhCChhhCCCHHHHhcCcccccc
Confidence 578999999999999999999999999999999754
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-43 Score=334.45 Aligned_cols=253 Identities=29% Similarity=0.470 Sum_probs=208.3
Q ss_pred eeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeC--CeE
Q 014210 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT--DNV 234 (429)
Q Consensus 157 y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~--~~~ 234 (429)
|++.++||+|+||.||++.... +++.||+|++.+... ... .....+|+.++.++.+|+||+++++++.+. +.+
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~---~~~~~aik~~~~~~~-~~~-~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~ 75 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRK---TGKYYAIKCMKKHFK-SLE-QVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRL 75 (282)
T ss_pred CceEeeccccccceEEEEEEcC---CCcEEEEEEehhccC-Cch-hhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcE
Confidence 6789999999999999998765 588999999865422 222 233457999999998899999999999987 889
Q ss_pred EEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccccC
Q 014210 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (429)
Q Consensus 235 ~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~ 314 (429)
++||||++ ++|.+.+......+++..++.++.||+.||+|||+.||+||||||+||++ +. +.+||+|||++....
T Consensus 76 ~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l---~~-~~~kl~dfg~~~~~~ 150 (282)
T cd07831 76 ALVFELMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILI---KD-DILKLADFGSCRGIY 150 (282)
T ss_pred EEEEecCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEE---cC-CCeEEEecccccccc
Confidence 99999996 58888887666789999999999999999999999999999999999999 55 899999999998775
Q ss_pred CCccccccccCCcccCccccc--CCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCC-------------
Q 014210 315 PDERLNDIVGSAYYVAPEVLH--RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPS------------- 379 (429)
Q Consensus 315 ~~~~~~~~~gt~~y~aPE~~~--~~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~------------- 379 (429)
.........++..|+|||++. +.++.++|||||||++|||++|..||...+..+.+..+......
T Consensus 151 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (282)
T cd07831 151 SKPPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSR 230 (282)
T ss_pred cCCCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccc
Confidence 544445567899999999764 34788999999999999999999999877665554444321110
Q ss_pred -----CCC-------CCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhh
Q 014210 380 -----FDE-------APWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLI 419 (429)
Q Consensus 380 -----~~~-------~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~ 419 (429)
++. ...+.++.++.+||++||+.||++||++.+++.|+||
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 231 HMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred cccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 000 0013568999999999999999999999999999996
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=327.18 Aligned_cols=253 Identities=27% Similarity=0.498 Sum_probs=217.8
Q ss_pred ceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEE
Q 014210 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVY 235 (429)
Q Consensus 156 ~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~~ 235 (429)
+|++.+.||.|+||.||.++... +|+.+++|.+.... .+.....++.+|++++++++ |+||+++++++.+.+..+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~---~~~~~~~k~~~~~~-~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~~ 75 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTE---DDSLVVWKEVNLTR-LSEKERRDALNEIVILSLLQ-HPNIIAYYNHFMDDNTLL 75 (256)
T ss_pred CceEeeEecccCCceEEEEEEcC---CCcEEEEEEEeecc-cchhHHHHHHHHHHHHHhCC-CCCeeEEEeEEecCCeEE
Confidence 58999999999999999988665 58899999986543 23345567889999999997 999999999999999999
Q ss_pred EEEEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccccC
Q 014210 236 VVMELCEGGELLDRILSR-GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (429)
Q Consensus 236 lv~E~~~ggsL~~~i~~~-~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~ 314 (429)
++||||++++|.+++... ...+++..+..++.|++.||.|||+.|++|+||||+||++ ++++.+||+|||++....
T Consensus 76 ~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~---~~~~~~kl~d~~~~~~~~ 152 (256)
T cd08221 76 IEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFL---TKAGLIKLGDFGISKILG 152 (256)
T ss_pred EEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEE---eCCCCEEECcCcceEEcc
Confidence 999999999999988665 4568999999999999999999999999999999999999 677889999999987664
Q ss_pred CCc-cccccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHH
Q 014210 315 PDE-RLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEA 392 (429)
Q Consensus 315 ~~~-~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 392 (429)
... ......++..|+|||++.+ .++.++||||||+++|||++|+.||......+....+......... ..++.++
T Consensus 153 ~~~~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~ 229 (256)
T cd08221 153 SEYSMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVV---SVYSSEL 229 (256)
T ss_pred cccccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCc---cccCHHH
Confidence 433 2345678999999998764 5788999999999999999999999888777777776654433221 4678999
Q ss_pred HHHHHHhcccCccCcCCHHHHHhhHhh
Q 014210 393 RDFVKRLLNKDPRKRLTAAQALSELLI 419 (429)
Q Consensus 393 ~~li~~~L~~dP~~Rps~~~iL~~~~~ 419 (429)
.+||.+||+.||++||++.++|.++|+
T Consensus 230 ~~~i~~~l~~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 230 ISLVHSLLQQDPEKRPTADEVLDQPLL 256 (256)
T ss_pred HHHHHHHcccCcccCCCHHHHhhCcCC
Confidence 999999999999999999999999885
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=328.61 Aligned_cols=255 Identities=25% Similarity=0.401 Sum_probs=214.6
Q ss_pred cCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~ 233 (429)
.++|++.+.||+|+||.||+|...........||||++... .......++.+|+.++++++ |+||+++++++.+.+.
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~--~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~ 79 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAG--SSDKQRLDFLTEASIMGQFD-HPNIIRLEGVVTKSRP 79 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCC--CChHHHHHHHHHHHHHHhCC-CCCcceEeEEEecCCc
Confidence 35799999999999999999988754334578999998654 34445567889999999998 9999999999999999
Q ss_pred EEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCcccc
Q 014210 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (429)
Q Consensus 234 ~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~ 313 (429)
.+++|||+++++|.+++....+.+++..++.++.|++.||.|||+++|+|+||||+|||+ ++++.+||+|||++...
T Consensus 80 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili---~~~~~~~l~dfg~~~~~ 156 (266)
T cd05033 80 VMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILV---NSNLVCKVSDFGLSRRL 156 (266)
T ss_pred eEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEE---cCCCCEEECccchhhcc
Confidence 999999999999999987766789999999999999999999999999999999999999 67888999999999876
Q ss_pred CCC-ccc--cccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCC
Q 014210 314 RPD-ERL--NDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSL 388 (429)
Q Consensus 314 ~~~-~~~--~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 388 (429)
... ... ....++..|+|||.+. ..++.++||||||+++|+|++ |..||...........+...... + ....+
T Consensus 157 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~-~--~~~~~ 233 (266)
T cd05033 157 EDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRL-P--PPMDC 233 (266)
T ss_pred cccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCC-C--CCCCC
Confidence 421 111 1223457899999886 468999999999999999998 99999887777666666543211 1 12357
Q ss_pred CHHHHHHHHHhcccCccCcCCHHHHHhhH
Q 014210 389 SSEARDFVKRLLNKDPRKRLTAAQALSEL 417 (429)
Q Consensus 389 s~~~~~li~~~L~~dP~~Rps~~~iL~~~ 417 (429)
+.++.+|+.+||+.||++||++.++++++
T Consensus 234 ~~~l~~li~~cl~~~p~~Rp~~~ei~~~l 262 (266)
T cd05033 234 PSALYQLMLDCWQKDRNERPTFSQIVSTL 262 (266)
T ss_pred CHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 89999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-43 Score=334.83 Aligned_cols=256 Identities=32% Similarity=0.500 Sum_probs=214.8
Q ss_pred ceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEE
Q 014210 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVY 235 (429)
Q Consensus 156 ~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~~ 235 (429)
+|++.+.||+|+||.||+|.... +|+.||||++..... .....+.+.+|+.++++++ |+||+++++++.+++..+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~---~~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~ 75 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRE---TGETVALKKVALRRL-EGGIPNQALREIKALQACQ-HPYVVKLLDVFPHGSGFV 75 (286)
T ss_pred CceEEeecccCCCcEEEEEEECC---CCceEEEEEEEcccc-cchhhHHHHHHHHHHHhCC-CCCCcceeeEEecCCeeE
Confidence 58999999999999999998766 489999999876432 2334567899999999998 999999999999999999
Q ss_pred EEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccccCC
Q 014210 236 VVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP 315 (429)
Q Consensus 236 lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~ 315 (429)
+||||+ +++|.+++......+++..++.++.||+.||.|||+.||+|+||||+||++ +.++.++|+|||++.....
T Consensus 76 ~v~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~---~~~~~~~l~dfg~~~~~~~ 151 (286)
T cd07832 76 LVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLI---SADGVLKIADFGLARLFSE 151 (286)
T ss_pred EEeccc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEE---cCCCcEEEeeeeecccccC
Confidence 999999 999999887767789999999999999999999999999999999999999 6788899999999887654
Q ss_pred Cc--cccccccCCcccCcccccC--CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCC-----------
Q 014210 316 DE--RLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSF----------- 380 (429)
Q Consensus 316 ~~--~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~----------- 380 (429)
.. ......++..|+|||++.+ .++.++||||||+++|||++|+.+|........+..++......
T Consensus 152 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07832 152 EEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSL 231 (286)
T ss_pred CCCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCc
Confidence 33 2344578999999998753 46889999999999999999988887776655555444321100
Q ss_pred --------C-------CCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhh
Q 014210 381 --------D-------EAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLIC 420 (429)
Q Consensus 381 --------~-------~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~ 420 (429)
. ....+..+.++.+||++||+.||++||++.++|.|+||.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 232 PDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred chhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 0 011235678999999999999999999999999999973
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=332.42 Aligned_cols=256 Identities=30% Similarity=0.516 Sum_probs=217.2
Q ss_pred CceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeE
Q 014210 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (429)
Q Consensus 155 ~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~ 234 (429)
++|++.+.||.|+||.||+++... +|+.||+|++.... .......+.+|+++++.++ |+||+++++++.++...
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~---~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~ 74 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKR---TNQVVAIKVIDLEE--AEDEIEDIQQEIQFLSQCR-SPYITKYYGSFLKGSKL 74 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECC---CCeEEEEEEeeccc--cchHHHHHHHHHHHHHHcC-CCCeeeeeEEEEECCeE
Confidence 478999999999999999998765 58999999986542 2344567889999999998 99999999999999999
Q ss_pred EEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccccC
Q 014210 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (429)
Q Consensus 235 ~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~ 314 (429)
++|+||+++++|.+++... .+++..++.++.||+.||.|||+.+|+|+||+|+||++ ++++.++|+|||++....
T Consensus 75 ~~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i---~~~~~~~l~d~g~~~~~~ 149 (274)
T cd06609 75 WIIMEYCGGGSCLDLLKPG--KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILL---SEEGDVKLADFGVSGQLT 149 (274)
T ss_pred EEEEEeeCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE---CCCCCEEEcccccceeec
Confidence 9999999999999988543 78999999999999999999999999999999999999 778889999999997765
Q ss_pred CC-ccccccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHH
Q 014210 315 PD-ERLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEA 392 (429)
Q Consensus 315 ~~-~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 392 (429)
.. .......++..|+|||++.+ .++.++||||||+++|+|++|+.||...........+......... ...++.++
T Consensus 150 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 227 (274)
T cd06609 150 STMSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLE--GNKFSKPF 227 (274)
T ss_pred ccccccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCCCc--ccccCHHH
Confidence 43 23345678899999998864 5899999999999999999999999876655555444443322211 11278999
Q ss_pred HHHHHHhcccCccCcCCHHHHHhhHhhhccc
Q 014210 393 RDFVKRLLNKDPRKRLTAAQALSELLICYQS 423 (429)
Q Consensus 393 ~~li~~~L~~dP~~Rps~~~iL~~~~~~~~~ 423 (429)
.++|.+||..||++||++.+++.|+|+....
T Consensus 228 ~~~l~~~l~~~p~~Rpt~~~il~~~~~~~~~ 258 (274)
T cd06609 228 KDFVSLCLNKDPKERPSAKELLKHKFIKKAK 258 (274)
T ss_pred HHHHHHHhhCChhhCcCHHHHhhChhhcCCC
Confidence 9999999999999999999999999998654
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-43 Score=334.35 Aligned_cols=256 Identities=29% Similarity=0.499 Sum_probs=209.6
Q ss_pred CceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeE
Q 014210 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (429)
Q Consensus 155 ~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~ 234 (429)
++|++.+.||+|+||.||+++.+. +|+.||+|++..... .....+.+.+|+.+++++. |+||+++++++.+.+..
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~---~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~ 75 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRE---TGQIVAIKKFVESED-DPVIKKIALREIRMLKQLK-HPNLVNLIEVFRRKRKL 75 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECC---CCcEEEEEEEeeccc-CccccHHHHHHHHHHHhCC-CCCEeeeeeEEeeCCEE
Confidence 479999999999999999998765 589999999865432 2223356789999999998 99999999999999999
Q ss_pred EEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccccC
Q 014210 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (429)
Q Consensus 235 ~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~ 314 (429)
++||||++++.|..+ ......+++..++.++.||+.||.|||+.||+||||||+||++ +.++.+||+|||++....
T Consensus 76 ~~v~e~~~~~~l~~~-~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~ 151 (286)
T cd07847 76 HLVFEYCDHTVLNEL-EKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILI---TKQGQIKLCDFGFARILT 151 (286)
T ss_pred EEEEeccCccHHHHH-HhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEE---cCCCcEEECccccceecC
Confidence 999999988766554 4455679999999999999999999999999999999999999 677889999999998765
Q ss_pred CCc-cccccccCCcccCcccccC--CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCC------------
Q 014210 315 PDE-RLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPS------------ 379 (429)
Q Consensus 315 ~~~-~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~------------ 379 (429)
... ......++..|+|||++.+ .++.++||||||+++|+|++|+.||......+....+......
T Consensus 152 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07847 152 GPGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTN 231 (286)
T ss_pred CCcccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccc
Confidence 433 2334568889999998754 4788999999999999999999999876655444333221000
Q ss_pred -------CCC--------CCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhh
Q 014210 380 -------FDE--------APWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLI 419 (429)
Q Consensus 380 -------~~~--------~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~ 419 (429)
.+. ..++.++.++.+||.+||+.||++||++.+++.|+||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 232 QFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred cccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 000 1124578899999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=327.04 Aligned_cols=253 Identities=23% Similarity=0.499 Sum_probs=212.8
Q ss_pred ceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEe-CCeE
Q 014210 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED-TDNV 234 (429)
Q Consensus 156 ~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~-~~~~ 234 (429)
.|++.+.||+|++|.||++..+. +++.||+|.+.... ......+.+.+|++++++++ |+|++++++.+.. ++.+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~---~~~~~~~k~~~~~~-~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~ 75 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRT---DGKQYVIKKLNLRN-ASRRERKAAEQEAQLLSQLK-HPNIVAYRESWEGEDGLL 75 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcC---CCcEEEEEEEehhh-cCHHHHHHHHHHHHHHHhCC-CCCeeeeeeeecCCCCEE
Confidence 48999999999999999998766 47899999986533 23445567889999999998 9999999998864 4468
Q ss_pred EEEEEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCcccc
Q 014210 235 YVVMELCEGGELLDRILSR-GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (429)
Q Consensus 235 ~lv~E~~~ggsL~~~i~~~-~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~ 313 (429)
+++|||+++++|.+++... ...+++.+++.++.|++.||.+||+.||+||||||+||++ +.++.++|+|||++...
T Consensus 76 ~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~---~~~~~~~l~df~~~~~~ 152 (257)
T cd08223 76 YIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFL---TRTNIIKVGDLGIARVL 152 (257)
T ss_pred EEEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEE---ecCCcEEEecccceEEe
Confidence 9999999999999988764 4468999999999999999999999999999999999999 67888999999998766
Q ss_pred CCCc-cccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHH
Q 014210 314 RPDE-RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSE 391 (429)
Q Consensus 314 ~~~~-~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 391 (429)
.... ......++..|+|||++. +.++.++||||||+++++|++|+.||...........+...... .....++.+
T Consensus 153 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~ 229 (257)
T cd08223 153 ENQCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLP---PMPKDYSPE 229 (257)
T ss_pred cccCCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCC---CCccccCHH
Confidence 4322 223456889999999876 45888999999999999999999999877766655555443321 122468899
Q ss_pred HHHHHHHhcccCccCcCCHHHHHhhHhh
Q 014210 392 ARDFVKRLLNKDPRKRLTAAQALSELLI 419 (429)
Q Consensus 392 ~~~li~~~L~~dP~~Rps~~~iL~~~~~ 419 (429)
+.+||.+||+.||++||++.+++.|+||
T Consensus 230 ~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 230 LGELIATMLSKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred HHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 9999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-43 Score=335.49 Aligned_cols=258 Identities=26% Similarity=0.407 Sum_probs=212.3
Q ss_pred CceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeE
Q 014210 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (429)
Q Consensus 155 ~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~ 234 (429)
++|++++.||+|+||.||+++... +|+.||+|.+... ........+.+|+.+++++. |+||+++++++...+..
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~---~~~~~a~k~~~~~--~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~ 74 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRP---TGVTMAMKEIRLE--LDESKFNQIIMELDILHKAV-SPYIVDFYGAFFIEGAV 74 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcC---CCcEEEEEEeecc--cCHHHHHHHHHHHHHHHhcC-CCcHHhhhhheecCCeE
Confidence 468999999999999999998765 5899999988643 23444577899999999997 99999999999999999
Q ss_pred EEEEEecCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH-cCceeccCCCCcEEEeecCCCceEEEeecCCcc
Q 014210 235 YVVMELCEGGELLDRILSR--GGKYTEDDAKAVMIQILNVVAFCHL-QGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (429)
Q Consensus 235 ~lv~E~~~ggsL~~~i~~~--~~~l~~~~~~~i~~qi~~gL~~LH~-~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~ 311 (429)
++||||+++++|..++... ...+++..+..++.||+.||.|||+ .||+||||||+||++ +.++.+||+|||++.
T Consensus 75 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~ 151 (286)
T cd06622 75 YMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLV---NGNGQVKLCDFGVSG 151 (286)
T ss_pred EEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEE---CCCCCEEEeecCCcc
Confidence 9999999999998877543 2479999999999999999999997 599999999999999 668889999999987
Q ss_pred ccCCCccccccccCCcccCcccccC-------CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCC
Q 014210 312 FVRPDERLNDIVGSAYYVAPEVLHR-------SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAP 384 (429)
Q Consensus 312 ~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 384 (429)
.... .......++..|+|||++.+ .++.++|||||||++|+|++|+.||........+..+...........
T Consensus 152 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 230 (286)
T cd06622 152 NLVA-SLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTL 230 (286)
T ss_pred cccC-CccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCC
Confidence 6532 22334568889999998753 257899999999999999999999976555444433322111122222
Q ss_pred CCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhcc
Q 014210 385 WPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLICYQ 422 (429)
Q Consensus 385 ~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~ 422 (429)
.+.++.++.+||.+||+.||++||++.+++.|+|+...
T Consensus 231 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~ 268 (286)
T cd06622 231 PSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKY 268 (286)
T ss_pred CcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhc
Confidence 34589999999999999999999999999999998654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=328.40 Aligned_cols=254 Identities=26% Similarity=0.500 Sum_probs=211.2
Q ss_pred CceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeE
Q 014210 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (429)
Q Consensus 155 ~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~ 234 (429)
++|++.++||+|+||.||+|+... +|+.||||.+.............+.+|++++++++ |+||+++++++.+.+..
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~---~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~ 77 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLL---DRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLN-HPNVIKYLDSFIEDNEL 77 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeC---CCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCC-CcceeeeeeeEEECCeE
Confidence 579999999999999999999776 58999999887655555666778899999999998 99999999999999999
Q ss_pred EEEEEecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCcc
Q 014210 235 YVVMELCEGGELLDRILS---RGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (429)
Q Consensus 235 ~lv~E~~~ggsL~~~i~~---~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~ 311 (429)
+++|||+++++|.+++.. ....+++..++.++.||+.||.|||++||+|+||||+|||+ +.++.++|+|||++.
T Consensus 78 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~---~~~~~~~l~d~g~~~ 154 (267)
T cd08228 78 NIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFI---TATGVVKLGDLGLGR 154 (267)
T ss_pred EEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEE---cCCCCEEECccccce
Confidence 999999999999887753 23458999999999999999999999999999999999999 677889999999987
Q ss_pred ccCCCcc-ccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHcCCCCCCCCCh--HHHHHHHHhcCCCCCCCCCCC
Q 014210 312 FVRPDER-LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTE--SGIFRAVLKADPSFDEAPWPS 387 (429)
Q Consensus 312 ~~~~~~~-~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~elltg~~Pf~~~~~--~~~~~~i~~~~~~~~~~~~~~ 387 (429)
....... .....|+..|+|||.+. ..++.++||||||+++|||++|+.||..... ......+.... ........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 232 (267)
T cd08228 155 FFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCD--YPPLPTEH 232 (267)
T ss_pred eccchhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCC--CCCCChhh
Confidence 7643322 23456889999999876 4688899999999999999999999965432 23333332211 22222335
Q ss_pred CCHHHHHHHHHhcccCccCcCCHHHHHhhH
Q 014210 388 LSSEARDFVKRLLNKDPRKRLTAAQALSEL 417 (429)
Q Consensus 388 ~s~~~~~li~~~L~~dP~~Rps~~~iL~~~ 417 (429)
++.++.+||.+||+.+|++||++.++++.+
T Consensus 233 ~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~ 262 (267)
T cd08228 233 YSEKLRELVSMCIYPDPDQRPDIGYVHQIA 262 (267)
T ss_pred cCHHHHHHHHHHCCCCcccCcCHHHHHHHH
Confidence 778999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-43 Score=332.54 Aligned_cols=254 Identities=28% Similarity=0.473 Sum_probs=209.0
Q ss_pred cCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~ 233 (429)
.++|++.++||+|+||.||+|+... +++.||+|++... .......+.+|+.+++.+. |+||+++++++.+.+.
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~---~~~~~~ik~~~~~---~~~~~~~~~~e~~~~~~l~-h~~ii~~~~~~~~~~~ 80 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVN---TGELAAIKVIKLE---PGEDFAVVQQEIIMMKDCK-HSNIVAYFGSYLRRDK 80 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcC---CCcEEEEEEEecC---chhHHHHHHHHHHHHHhCC-CCCeeeEEEEEEeCCE
Confidence 4689999999999999999998765 5889999998643 2233456789999999997 9999999999999999
Q ss_pred EEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCcccc
Q 014210 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (429)
Q Consensus 234 ~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~ 313 (429)
.++||||+++++|.+++.. .+.+++..++.++.||+.||.|||+.||+|+||||+||++ +.++.+||+|||++...
T Consensus 81 ~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili---~~~~~~~l~dfg~~~~~ 156 (267)
T cd06645 81 LWICMEFCGGGSLQDIYHV-TGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILL---TDNGHVKLADFGVSAQI 156 (267)
T ss_pred EEEEEeccCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCCEEECcceeeeEc
Confidence 9999999999999997744 4579999999999999999999999999999999999999 67788999999998755
Q ss_pred CCCc-cccccccCCcccCccccc----CCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCC-CCCCC
Q 014210 314 RPDE-RLNDIVGSAYYVAPEVLH----RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDE-APWPS 387 (429)
Q Consensus 314 ~~~~-~~~~~~gt~~y~aPE~~~----~~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~-~~~~~ 387 (429)
.... ......|+..|+|||++. +.++.++|||||||++|+|++|..||..................... .....
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (267)
T cd06645 157 TATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMK 236 (267)
T ss_pred cCcccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCC
Confidence 3222 223457899999999873 35888999999999999999999999765543333332222211111 11124
Q ss_pred CCHHHHHHHHHhcccCccCcCCHHHHHhhHh
Q 014210 388 LSSEARDFVKRLLNKDPRKRLTAAQALSELL 418 (429)
Q Consensus 388 ~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~ 418 (429)
++..+.+||++||..||++||++.+++.|+|
T Consensus 237 ~~~~~~~li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 237 WSNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred CCHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence 7889999999999999999999999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=335.49 Aligned_cols=258 Identities=30% Similarity=0.452 Sum_probs=208.8
Q ss_pred CceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe-
Q 014210 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN- 233 (429)
Q Consensus 155 ~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~- 233 (429)
++|++.+.||+|+||.||+|.... +|+.||||++.... ........+.+|+.+++++.+|+||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~---~~~~v~lK~~~~~~-~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~ 76 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKN---TGKLVALKKTRLEM-DEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKN 76 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECC---CCcEEEEEeehhhc-cccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCC
Confidence 479999999999999999998765 58999999986542 2222345678899999999868999999999987665
Q ss_pred ----EEEEEEecCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCC-CceEEE
Q 014210 234 ----VYVVMELCEGGELLDRILSRG----GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDE-NSVLKA 304 (429)
Q Consensus 234 ----~~lv~E~~~ggsL~~~i~~~~----~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~-~~~vkL 304 (429)
.|+||||+++ +|.+++.... ..+++..++.++.||+.||.|||++||+||||||+||++ +. ++.+||
T Consensus 77 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~---~~~~~~~kl 152 (295)
T cd07837 77 GKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLV---DKQKGLLKI 152 (295)
T ss_pred CCceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEE---ecCCCeEEE
Confidence 8999999986 8888876532 358999999999999999999999999999999999999 45 788999
Q ss_pred eecCCccccCCC-ccccccccCCcccCcccccC--CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCC
Q 014210 305 IDFGLSDFVRPD-ERLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFD 381 (429)
Q Consensus 305 ~DFGla~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~ 381 (429)
+|||++...... .......+++.|+|||++.+ .++.++||||||+++|+|++|..||...+.......+........
T Consensus 153 ~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~ 232 (295)
T cd07837 153 ADLGLGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPT 232 (295)
T ss_pred eecccceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 999998765322 22233457889999998753 478899999999999999999999987766555444433211000
Q ss_pred ------------------------CCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhh
Q 014210 382 ------------------------EAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLIC 420 (429)
Q Consensus 382 ------------------------~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~ 420 (429)
....+.++.++.+||.+||..||.+||++.++|.|+|++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 233 EQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred hhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 011245789999999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=327.83 Aligned_cols=255 Identities=30% Similarity=0.490 Sum_probs=214.4
Q ss_pred cCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~ 233 (429)
.++|++.+.||.|+||.||+|.... +++.+++|++.... ....+.+.+|++++++++ |+||+++++++.+++.
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~---~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~ 74 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIA---TGELVAIKVIKLEP---GDDFEIIQQEISMLKECR-HPNIVAYFGSYLRRDK 74 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecC---CCCEEEEEEEEcCc---hhhHHHHHHHHHHHHhCC-CCChhceEEEEEeCCE
Confidence 3689999999999999999998766 47889999986542 235578899999999998 9999999999999999
Q ss_pred EEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCcccc
Q 014210 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (429)
Q Consensus 234 ~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~ 313 (429)
.+++|||+++++|.+++......+++..++.++.|++.||.|||++||+|+||||+||++ +.++.+||+|||++...
T Consensus 75 ~~l~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i---~~~~~~~l~d~g~~~~~ 151 (262)
T cd06613 75 LWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILL---TEDGDVKLADFGVSAQL 151 (262)
T ss_pred EEEEEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEE---CCCCCEEECccccchhh
Confidence 999999999999999887665789999999999999999999999999999999999999 67888999999998765
Q ss_pred CCCc-cccccccCCcccCccccc-C---CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCC-CCCCCC
Q 014210 314 RPDE-RLNDIVGSAYYVAPEVLH-R---SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFD-EAPWPS 387 (429)
Q Consensus 314 ~~~~-~~~~~~gt~~y~aPE~~~-~---~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~-~~~~~~ 387 (429)
.... ......++..|+|||++. . .++.++||||||+++|+|++|+.||...........+........ ......
T Consensus 152 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (262)
T cd06613 152 TATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEK 231 (262)
T ss_pred hhhhhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhh
Confidence 4332 234457889999999875 3 588899999999999999999999987765554444443321111 111234
Q ss_pred CCHHHHHHHHHhcccCccCcCCHHHHHhhHh
Q 014210 388 LSSEARDFVKRLLNKDPRKRLTAAQALSELL 418 (429)
Q Consensus 388 ~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~ 418 (429)
++.++.+||++||..||.+||++.+++.|.|
T Consensus 232 ~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 232 WSPVFHDFIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred hhHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence 6788999999999999999999999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=353.88 Aligned_cols=255 Identities=34% Similarity=0.586 Sum_probs=230.6
Q ss_pred cCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~ 233 (429)
...|.+.+.||+|.|+.|.++++.. +|..||||++.+...... .++.+.+|+++++.|. |||||+++.+.+....
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~---t~~~VaiK~idkt~ln~~-~~~k~~rev~imk~l~-HPnIvkl~~v~~t~~~ 129 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHIL---TGTEVAIKIIDKTQLNPS-KRQKLGREVDIMKSLN-HPNIVKLFSVIETEAT 129 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecC---CCceEEEEEehhcccChH-HHHHHHHHHHHHHhcC-Ccceeeeeeeeeecce
Confidence 5679999999999999999999776 699999999988764444 4445899999999999 9999999999999999
Q ss_pred EEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCcccc
Q 014210 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (429)
Q Consensus 234 ~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~ 313 (429)
+|+||||+.+|.+++|+... +.+.+..++.++.|++++++|||+++|||||||++|||| +.+.++||+|||++..+
T Consensus 130 lylV~eya~~ge~~~yl~~~-gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL---~~~mnikIaDfgfS~~~ 205 (596)
T KOG0586|consen 130 LYLVMEYASGGELFDYLVKH-GRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILL---DENMNIKIADFGFSTFF 205 (596)
T ss_pred eEEEEEeccCchhHHHHHhc-ccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhccc---ccccceeeeccccceee
Confidence 99999999999999998554 667789999999999999999999999999999999999 88999999999999999
Q ss_pred CCCccccccccCCcccCcccccCC--CCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHH
Q 014210 314 RPDERLNDIVGSAYYVAPEVLHRS--YSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSE 391 (429)
Q Consensus 314 ~~~~~~~~~~gt~~y~aPE~~~~~--~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 391 (429)
.......+++|++.|.|||++.+. -+.++|+||+|++||-|++|.+||++.+-.+.-..++......+. .++.+
T Consensus 206 ~~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rIp~----~ms~d 281 (596)
T KOG0586|consen 206 DYGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRIPF----YMSCD 281 (596)
T ss_pred cccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeecccc----eeech
Confidence 988888999999999999999863 477999999999999999999999998877776777766665554 47889
Q ss_pred HHHHHHHhcccCccCcCCHHHHHhhHhhhc
Q 014210 392 ARDFVKRLLNKDPRKRLTAAQALSELLICY 421 (429)
Q Consensus 392 ~~~li~~~L~~dP~~Rps~~~iL~~~~~~~ 421 (429)
..+||+++|-.+|.+|++.++++.|.|++.
T Consensus 282 ce~lLrk~lvl~Pskr~~~dqim~~~W~n~ 311 (596)
T KOG0586|consen 282 CEDLLRKFLVLNPSKRGPCDQIMKDRWRND 311 (596)
T ss_pred hHHHHHHhhccCccccCCHHHhhhhcccch
Confidence 999999999999999999999999999874
|
|
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=333.11 Aligned_cols=258 Identities=30% Similarity=0.510 Sum_probs=208.6
Q ss_pred ccccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEE-
Q 014210 151 KHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYE- 229 (429)
Q Consensus 151 ~~~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~- 229 (429)
....++|++.+.||+|+||.||++.... .|+.+|+|++.... ...+++.+|+.+++++.+|+||+++++++.
T Consensus 14 ~~~~~~~~~~~~lg~g~~~~vy~~~~~~---~~~~~~ik~~~~~~----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 86 (286)
T cd06638 14 PDPSDTWEIIETIGKGTYGKVFKVLNKK---NGSKAAVKILDPIH----DIDEEIEAEYNILKALSDHPNVVKFYGMYYK 86 (286)
T ss_pred CCcccceeeeeeeccCCCcEEEEEEECC---CCceeEEEeecccc----chHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence 3457899999999999999999998766 58899999875421 123567889999999966999999999884
Q ss_pred ----eCCeEEEEEEecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceE
Q 014210 230 ----DTDNVYVVMELCEGGELLDRILS---RGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVL 302 (429)
Q Consensus 230 ----~~~~~~lv~E~~~ggsL~~~i~~---~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~v 302 (429)
.++..++||||+++++|.+++.. ....+++..++.++.|++.||.|||+.+|+||||||+||++ +.++.+
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili---~~~~~~ 163 (286)
T cd06638 87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILL---TTEGGV 163 (286)
T ss_pred cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEE---CCCCCE
Confidence 34578999999999999887653 34578999999999999999999999999999999999999 677789
Q ss_pred EEeecCCccccCCCc-cccccccCCcccCccccc------CCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHh
Q 014210 303 KAIDFGLSDFVRPDE-RLNDIVGSAYYVAPEVLH------RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLK 375 (429)
Q Consensus 303 kL~DFGla~~~~~~~-~~~~~~gt~~y~aPE~~~------~~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~ 375 (429)
||+|||++....... ......|+..|+|||++. ..++.++|||||||++|||++|+.||........+..+..
T Consensus 164 kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~ 243 (286)
T cd06638 164 KLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPR 243 (286)
T ss_pred EEccCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccc
Confidence 999999987654322 233457899999999874 3478899999999999999999999987655443333222
Q ss_pred cCCCCCCCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhh
Q 014210 376 ADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLI 419 (429)
Q Consensus 376 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~ 419 (429)
... ........++.++.+||.+||+.||++||++.+++.|+|+
T Consensus 244 ~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 244 NPP-PTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred cCC-CcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 211 1111112467899999999999999999999999999986
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=331.58 Aligned_cols=255 Identities=27% Similarity=0.420 Sum_probs=214.2
Q ss_pred cCceeEeceeeccCceEEEEEEEecC--cccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeC
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKG--ELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~--~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~ 231 (429)
.++|.+.+.||+|+||.||+|..... ...++.||||++... ......+.+.+|+++++++. |+||+++++++...
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~ 80 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKET--ASNDARKDFEREAELLTNFQ-HENIVKFYGVCTEG 80 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeeccc--CCHHHHHHHHHHHHHHHhcC-CCCchheeeEEecC
Confidence 35789999999999999999987653 235688999998654 33445678999999999998 99999999999999
Q ss_pred CeEEEEEEecCCCcHHHHHHhcC-------------CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCC
Q 014210 232 DNVYVVMELCEGGELLDRILSRG-------------GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDE 298 (429)
Q Consensus 232 ~~~~lv~E~~~ggsL~~~i~~~~-------------~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~ 298 (429)
+..++||||+++++|.+++...+ ..+++..+..++.||+.||.|||++||+||||||+|||+ +.
T Consensus 81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili---~~ 157 (280)
T cd05049 81 DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLV---GY 157 (280)
T ss_pred CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEE---cC
Confidence 99999999999999999986542 357899999999999999999999999999999999999 77
Q ss_pred CceEEEeecCCccccCCCcc---ccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHH
Q 014210 299 NSVLKAIDFGLSDFVRPDER---LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAV 373 (429)
Q Consensus 299 ~~~vkL~DFGla~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~ellt-g~~Pf~~~~~~~~~~~i 373 (429)
++.+||+|||++........ .....++..|+|||++. +.++.++||||||+++|||++ |..||...........+
T Consensus 158 ~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~ 237 (280)
T cd05049 158 DLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECI 237 (280)
T ss_pred CCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Confidence 88999999999875432221 22334678899999886 468999999999999999998 99999887777776666
Q ss_pred HhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhH
Q 014210 374 LKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSEL 417 (429)
Q Consensus 374 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~ 417 (429)
........ ...++.++.+||.+||+.||++||++.++++.+
T Consensus 238 ~~~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l 278 (280)
T cd05049 238 TQGRLLQR---PRTCPSEVYDIMLGCWKRDPQQRINIKDIHERL 278 (280)
T ss_pred HcCCcCCC---CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHh
Confidence 64433222 236889999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-42 Score=333.14 Aligned_cols=255 Identities=23% Similarity=0.343 Sum_probs=208.3
Q ss_pred CceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeE
Q 014210 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (429)
Q Consensus 155 ~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~ 234 (429)
++|++.+.||+|+||.||+|..+.+. ....+++|.+... ......+.+.+|+.++.++.+|+||+++++++.+.+..
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~-~~~~~~ik~~~~~--~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~ 78 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDG-LKMNAAIKMLKEF--ASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYL 78 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCC-CcceeEEEEcccc--CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcc
Confidence 57999999999999999999876532 1245788887532 34445677899999999996699999999999999999
Q ss_pred EEEEEecCCCcHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCC
Q 014210 235 YVVMELCEGGELLDRILSRG---------------GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDEN 299 (429)
Q Consensus 235 ~lv~E~~~ggsL~~~i~~~~---------------~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~ 299 (429)
+++|||+++++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||+ +++
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill---~~~ 155 (297)
T cd05089 79 YIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLV---GEN 155 (297)
T ss_pred eEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEE---CCC
Confidence 99999999999999886532 358899999999999999999999999999999999999 678
Q ss_pred ceEEEeecCCccccCCCccccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcC
Q 014210 300 SVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKAD 377 (429)
Q Consensus 300 ~~vkL~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~ellt-g~~Pf~~~~~~~~~~~i~~~~ 377 (429)
+.+||+|||++..............+..|+|||++. ..++.++|||||||++|||++ |..||........+..+....
T Consensus 156 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~ 235 (297)
T cd05089 156 LASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY 235 (297)
T ss_pred CeEEECCcCCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC
Confidence 889999999986432221111223356799999876 468999999999999999997 999998887777666665432
Q ss_pred CCCCCCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHh
Q 014210 378 PSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELL 418 (429)
Q Consensus 378 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~ 418 (429)
. ......++.++.+||.+||+.||.+||++.++++.+.
T Consensus 236 ~---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 273 (297)
T cd05089 236 R---MEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLS 273 (297)
T ss_pred C---CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 1 1122358899999999999999999999999987754
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-42 Score=333.57 Aligned_cols=256 Identities=30% Similarity=0.494 Sum_probs=216.0
Q ss_pred cCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~ 233 (429)
..+|++.++||.|+||.||++.... +|+.||||.+.... ....+.+.+|+.+++.++ |+||+++++++.+.+.
T Consensus 18 ~~~y~~~~~lg~g~~g~vy~~~~~~---~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~ 90 (296)
T cd06655 18 KKKYTRYEKIGQGASGTVFTAIDVA---TGQEVAIKQINLQK---QPKKELIINEILVMKELK-NPNIVNFLDSFLVGDE 90 (296)
T ss_pred cceEEEEEEEecCCCeEEEEEEEcC---CCcEEEEEEEeccc---CchHHHHHHHHHHHHhcC-CCceeeeeeeEecCce
Confidence 4679999999999999999998655 58999999986532 223467889999999998 9999999999999999
Q ss_pred EEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCcccc
Q 014210 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (429)
Q Consensus 234 ~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~ 313 (429)
.++||||+++++|.+++.. ..+++..+..++.|++.||.|||+.|++||||||+||++ +.++.+||+|||++...
T Consensus 91 ~~lv~e~~~~~~L~~~~~~--~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili---~~~~~~kl~dfg~~~~~ 165 (296)
T cd06655 91 LFVVMEYLAGGSLTDVVTE--TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLL---GMDGSVKLTDFGFCAQI 165 (296)
T ss_pred EEEEEEecCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEccCccchhc
Confidence 9999999999999987743 468999999999999999999999999999999999999 67888999999998765
Q ss_pred CCCcc-ccccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHH
Q 014210 314 RPDER-LNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSE 391 (429)
Q Consensus 314 ~~~~~-~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 391 (429)
..... .....++..|+|||.+.+ .++.++|||||||++|+|++|+.||........+..+...... .......++.+
T Consensus 166 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 244 (296)
T cd06655 166 TPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTP-ELQNPEKLSPI 244 (296)
T ss_pred ccccccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCc-ccCCcccCCHH
Confidence 44332 234578899999998864 5889999999999999999999999887765555444433221 12223468899
Q ss_pred HHHHHHHhcccCccCcCCHHHHHhhHhhhcc
Q 014210 392 ARDFVKRLLNKDPRKRLTAAQALSELLICYQ 422 (429)
Q Consensus 392 ~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~ 422 (429)
+.+||++||..||.+||++.+++.|+|++.-
T Consensus 245 ~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~ 275 (296)
T cd06655 245 FRDFLNRCLEMDVEKRGSAKELLQHPFLKLA 275 (296)
T ss_pred HHHHHHHHhhcChhhCCCHHHHhhChHhhhc
Confidence 9999999999999999999999999999853
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=334.29 Aligned_cols=256 Identities=29% Similarity=0.482 Sum_probs=214.4
Q ss_pred cCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~ 233 (429)
..+|++.+.||+|+||.||++.... +++.||+|.+..... ...+.+.+|+.+++.+. |+||+++++.+.+++.
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~---~~~~v~ik~~~~~~~---~~~~~~~~e~~~l~~~~-h~~v~~~~~~~~~~~~ 91 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVA---TGQEVAIRQMNLQQQ---PKKELIINEILVMRENK-NPNIVNYLDSYLVGDE 91 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECC---CCcEEEEEEEecCCc---chHHHHHHHHHHHHhCC-CCCEeeEEEEEEeCCE
Confidence 4789999999999999999998655 588999999865432 23466889999999997 9999999999999999
Q ss_pred EEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCcccc
Q 014210 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (429)
Q Consensus 234 ~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~ 313 (429)
.++||||+++++|.+++.. ..+++..+..++.|++.||.|||+.||+||||||+|||+ +.++.+||+|||++...
T Consensus 92 ~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill---~~~~~~kl~dfg~~~~~ 166 (296)
T cd06654 92 LWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL---GMDGSVKLTDFGFCAQI 166 (296)
T ss_pred EEEeecccCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---cCCCCEEECccccchhc
Confidence 9999999999999998743 468999999999999999999999999999999999999 67888999999998765
Q ss_pred CCCcc-ccccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHH
Q 014210 314 RPDER-LNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSE 391 (429)
Q Consensus 314 ~~~~~-~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 391 (429)
..... .....++..|+|||.+.+ .++.++|||||||++|+|++|+.||...........+.... .........++..
T Consensus 167 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 245 (296)
T cd06654 167 TPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNG-TPELQNPEKLSAI 245 (296)
T ss_pred cccccccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCC-CCCCCCccccCHH
Confidence 43322 234578899999998864 57899999999999999999999998776654443333222 1111223468899
Q ss_pred HHHHHHHhcccCccCcCCHHHHHhhHhhhcc
Q 014210 392 ARDFVKRLLNKDPRKRLTAAQALSELLICYQ 422 (429)
Q Consensus 392 ~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~ 422 (429)
+.+||.+||..||++||++.++++|+|+...
T Consensus 246 l~~li~~~l~~~p~~Rpt~~eil~~~~~~~~ 276 (296)
T cd06654 246 FRDFLNRCLDMDVEKRGSAKELLQHQFLKIA 276 (296)
T ss_pred HHHHHHHHCcCCcccCcCHHHHhhChhhhcc
Confidence 9999999999999999999999999999754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=327.39 Aligned_cols=253 Identities=28% Similarity=0.501 Sum_probs=210.7
Q ss_pred ceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCc------HHHHHHHHHHHHHHHHhcCCCCcceEEEEEE
Q 014210 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTT------AIAIEDVRREVKILRALTGHNNLVKFFDAYE 229 (429)
Q Consensus 156 ~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~------~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~ 229 (429)
+|.+.+.||+|+||.||+|.... .++.||+|++....... ....+.+.+|+.++++++ |+||+++++++.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~---~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~ 76 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNAS---SGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQ-HENIVQYLGSSL 76 (267)
T ss_pred CccccceeecCCCeEEEEEEecC---CCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcC-CCCeeeEEEEEE
Confidence 47888999999999999998665 57899999886543221 234467889999999998 999999999999
Q ss_pred eCCeEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCC
Q 014210 230 DTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGL 309 (429)
Q Consensus 230 ~~~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGl 309 (429)
+.+..+++|||+++++|.+++.. .+.+++..+..++.|++.||.|||+.|++||||||+||++ +.++.+||+|||+
T Consensus 77 ~~~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~---~~~~~~~l~dfg~ 152 (267)
T cd06628 77 DADHLNIFLEYVPGGSVAALLNN-YGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILV---DNKGGIKISDFGI 152 (267)
T ss_pred eCCccEEEEEecCCCCHHHHHHh-ccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEE---cCCCCEEecccCC
Confidence 99999999999999999988754 4678999999999999999999999999999999999999 7788899999999
Q ss_pred ccccCCCc-------cccccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCC
Q 014210 310 SDFVRPDE-------RLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFD 381 (429)
Q Consensus 310 a~~~~~~~-------~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~ 381 (429)
++...... ......|+..|+|||.+.+ .++.++||||||+++|+|++|+.||........+..+.... .
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~---~ 229 (267)
T cd06628 153 SKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENA---S 229 (267)
T ss_pred CcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccC---C
Confidence 87664221 1123458889999998864 68889999999999999999999998766554444443321 1
Q ss_pred CCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhh
Q 014210 382 EAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLI 419 (429)
Q Consensus 382 ~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~ 419 (429)
......++.++.+||++||+.||.+||++.+++.|+||
T Consensus 230 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 230 PEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred CcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 11223578999999999999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=337.51 Aligned_cols=260 Identities=28% Similarity=0.438 Sum_probs=213.0
Q ss_pred cCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeC--
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT-- 231 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~-- 231 (429)
.++|++.+.||+|+||.||+|..+. +|+.||+|++....... .....+.+|+.++++++ |+||+++++++.+.
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~---~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~ 80 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTT---SGEIVALKKVRMDNERD-GIPISSLREITLLLNLR-HPNIVELKEVVVGKHL 80 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECC---CCcEEEEEEEEeccCCC-CCcchhhHHHHHHHhCC-CCCCcceEEEEecCCC
Confidence 5689999999999999999998765 58999999986543222 22234568999999998 99999999998765
Q ss_pred CeEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCcc
Q 014210 232 DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (429)
Q Consensus 232 ~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~ 311 (429)
+..++||||+++ +|.+++......+++..++.++.||+.||.|||+.||+||||||+||++ +.++.+||+|||++.
T Consensus 81 ~~~~lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~---~~~~~~kL~dfg~~~ 156 (309)
T cd07845 81 DSIFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLL---TDKGCLKIADFGLAR 156 (309)
T ss_pred CeEEEEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---CCCCCEEECccceee
Confidence 568999999965 8888876656789999999999999999999999999999999999999 678889999999998
Q ss_pred ccCCCc-cccccccCCcccCcccccC--CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCC-----
Q 014210 312 FVRPDE-RLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEA----- 383 (429)
Q Consensus 312 ~~~~~~-~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~----- 383 (429)
...... ......++..|+|||++.+ .++.++||||||+++|||++|+.||...+..+.+..+..........
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (309)
T cd07845 157 TYGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGF 236 (309)
T ss_pred ecCCccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhh
Confidence 765432 2233456788999998753 47899999999999999999999998888777766665422111000
Q ss_pred --------------C-------CCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhcc
Q 014210 384 --------------P-------WPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLICYQ 422 (429)
Q Consensus 384 --------------~-------~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~ 422 (429)
. ...+++++.+||++||+.||++||++.+++.|+||...
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~ 296 (309)
T cd07845 237 SDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEK 296 (309)
T ss_pred hcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccC
Confidence 0 12358899999999999999999999999999999743
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=325.73 Aligned_cols=250 Identities=31% Similarity=0.531 Sum_probs=213.0
Q ss_pred ceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEE
Q 014210 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVY 235 (429)
Q Consensus 156 ~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~~ 235 (429)
+|++.++||+|+||.||+++... +++.||+|.+.... .....+.+.+|+.+++.++ |+||+++++++.+++.++
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~---~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~ 74 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVN---SDQKYAMKEIRLPK--SSSAVEDSRKEAVLLAKMK-HPNIVAFKESFEADGHLY 74 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcC---CCceEEEEEEEcCc--chHHHHHHHHHHHHHHhCC-CCCcceEEEEEEECCEEE
Confidence 58899999999999999998765 58999999986432 3345677889999999998 999999999999999999
Q ss_pred EEEEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccccC
Q 014210 236 VVMELCEGGELLDRILSR-GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (429)
Q Consensus 236 lv~E~~~ggsL~~~i~~~-~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~ 314 (429)
++|||+++++|.+++... ...+++..++.++.||+.||.|||++||+|+||||+||++ ++++.++|+|||++....
T Consensus 75 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili---~~~~~~~l~dfg~~~~~~ 151 (255)
T cd08219 75 IVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFL---TQNGKVKLGDFGSARLLT 151 (255)
T ss_pred EEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEE---CCCCcEEEcccCcceeec
Confidence 999999999999988653 4568999999999999999999999999999999999999 778889999999987664
Q ss_pred CCc-cccccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHH
Q 014210 315 PDE-RLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEA 392 (429)
Q Consensus 315 ~~~-~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 392 (429)
... ......|+..|+|||++.+ .++.++|+||||+++|+|++|..||...........+....... ....++.++
T Consensus 152 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~ 228 (255)
T cd08219 152 SPGAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKP---LPSHYSYEL 228 (255)
T ss_pred ccccccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCC---CCcccCHHH
Confidence 332 2234678999999998864 58899999999999999999999998877666666655443222 123578999
Q ss_pred HHHHHHhcccCccCcCCHHHHHhhH
Q 014210 393 RDFVKRLLNKDPRKRLTAAQALSEL 417 (429)
Q Consensus 393 ~~li~~~L~~dP~~Rps~~~iL~~~ 417 (429)
.+||.+||+.||++||++.+++...
T Consensus 229 ~~li~~~l~~~P~~Rp~~~~il~~~ 253 (255)
T cd08219 229 RSLIKQMFKRNPRSRPSATTILSRG 253 (255)
T ss_pred HHHHHHHHhCCcccCCCHHHHhhcc
Confidence 9999999999999999999999754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=336.73 Aligned_cols=257 Identities=21% Similarity=0.297 Sum_probs=210.5
Q ss_pred cCceeEeceeeccCceEEEEEEEecCc-ccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCC
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGE-LKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~-~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~ 232 (429)
..+|++.+.||+|+||.||+|+...+. .....||||++... ......+++.+|+.+++.+. |+||++++++|...
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~l~~l~-h~niv~~~g~~~~~- 81 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASVD-NPHVCRLLGICLTS- 81 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEecccc--CCHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEcCC-
Confidence 467999999999999999999866422 23456999998643 34455678899999999998 99999999998764
Q ss_pred eEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccc
Q 014210 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (429)
Q Consensus 233 ~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~ 312 (429)
..++++||+++|+|.+++......+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.
T Consensus 82 ~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill---~~~~~~kl~DfG~a~~ 158 (316)
T cd05108 82 TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLV---KTPQHVKITDFGLAKL 158 (316)
T ss_pred CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEe---cCCCcEEEcccccccc
Confidence 5689999999999999998777789999999999999999999999999999999999999 6778899999999987
Q ss_pred cCCCccc---cccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCC
Q 014210 313 VRPDERL---NDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPS 387 (429)
Q Consensus 313 ~~~~~~~---~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 387 (429)
....... ....++..|+|||++. ..++.++||||||+++|||++ |+.||.+....... .++......+. .+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~-~~~~~~~~~~~--~~~ 235 (316)
T cd05108 159 LGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-SILEKGERLPQ--PPI 235 (316)
T ss_pred ccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHH-HHHhCCCCCCC--CCC
Confidence 6543322 1223466899999876 568999999999999999997 99999877655543 33333322222 235
Q ss_pred CCHHHHHHHHHhcccCccCcCCHHHHHhhHhhh
Q 014210 388 LSSEARDFVKRLLNKDPRKRLTAAQALSELLIC 420 (429)
Q Consensus 388 ~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~ 420 (429)
++.++.++|.+||..||.+||++.+++.++.-.
T Consensus 236 ~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~ 268 (316)
T cd05108 236 CTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 268 (316)
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 788999999999999999999999999975543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=330.67 Aligned_cols=258 Identities=25% Similarity=0.391 Sum_probs=207.5
Q ss_pred CceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeE
Q 014210 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (429)
Q Consensus 155 ~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~ 234 (429)
++|++.+.||+|+||.||+++.+. +|+.||||++...... ....++..|+.++.+..+|+||+++++++..++..
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~---~~~~vaiK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~ 75 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVP---TGTIMAVKRIRATVNS--QEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDV 75 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcC---CCcEEEEEEEecCCCc--HHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcE
Confidence 479999999999999999998776 5899999998754322 23345667777655555599999999999999999
Q ss_pred EEEEEecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHc-CceeccCCCCcEEEeecCCCceEEEeecCCc
Q 014210 235 YVVMELCEGGELLDRILS---RGGKYTEDDAKAVMIQILNVVAFCHLQ-GVVHRDLKPENFLFTTKDENSVLKAIDFGLS 310 (429)
Q Consensus 235 ~lv~E~~~ggsL~~~i~~---~~~~l~~~~~~~i~~qi~~gL~~LH~~-~iiHrDIKp~NILl~~~~~~~~vkL~DFGla 310 (429)
+++|||++ |+|.+++.. ....+++..++.++.||+.||.|||++ +++||||||+|||+ +.++.+||+|||++
T Consensus 76 ~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~---~~~~~~kl~dfg~~ 151 (283)
T cd06617 76 WICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLI---NRNGQVKLCDFGIS 151 (283)
T ss_pred EEEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEE---CCCCCEEEeecccc
Confidence 99999996 577776654 335689999999999999999999998 99999999999999 77889999999999
Q ss_pred cccCCCccccccccCCcccCcccccC-----CCCCcccHHHHHHHHHHHHcCCCCCCCCC-hHHHHHHHHhcCCCCCCCC
Q 014210 311 DFVRPDERLNDIVGSAYYVAPEVLHR-----SYSTEADVWSIGVIAYILLCGSRPFWART-ESGIFRAVLKADPSFDEAP 384 (429)
Q Consensus 311 ~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~sDiwSlGvll~elltg~~Pf~~~~-~~~~~~~i~~~~~~~~~~~ 384 (429)
.............++..|+|||++.+ .++.++|+||||+++|+|++|+.||.... ..+.+..+..... ...+
T Consensus 152 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~ 229 (283)
T cd06617 152 GYLVDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPS--PQLP 229 (283)
T ss_pred cccccccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCC--CCCC
Confidence 87654333344578899999998753 46889999999999999999999996532 2233333332211 1111
Q ss_pred CCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhccc
Q 014210 385 WPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLICYQS 423 (429)
Q Consensus 385 ~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~~ 423 (429)
...++.++.+||.+||..+|.+||++.+++.|+||....
T Consensus 230 ~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 268 (283)
T cd06617 230 AEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHL 268 (283)
T ss_pred ccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhcc
Confidence 235789999999999999999999999999999998754
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=327.54 Aligned_cols=253 Identities=29% Similarity=0.543 Sum_probs=214.0
Q ss_pred cCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~ 233 (429)
.++|++.+.||+|+||.||++.... +++.|++|.+.... ..+++.+|++++++++ |+||+++++++.+...
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~---~~~~~~~k~~~~~~-----~~~~~~~e~~~~~~l~-~~~i~~~~~~~~~~~~ 72 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKE---TGQVVAIKVVPVEE-----DLQEIIKEISILKQCD-SPYIVKYYGSYFKNTD 72 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcC---CCcEEEEEEeecHH-----HHHHHHHHHHHHHhCC-CCcEeeeeeeeecCCc
Confidence 3679999999999999999998776 47899999985431 2678999999999997 9999999999999999
Q ss_pred EEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCcccc
Q 014210 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (429)
Q Consensus 234 ~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~ 313 (429)
.|++|||+++++|.+++......+++..++.++.||+.||.|||+.+|+|+||+|+||++ +.++.+||+|||++...
T Consensus 73 ~~l~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~---~~~~~~~l~dfg~~~~~ 149 (256)
T cd06612 73 LWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILL---NEEGQAKLADFGVSGQL 149 (256)
T ss_pred EEEEEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEE---CCCCcEEEcccccchhc
Confidence 999999999999999887767789999999999999999999999999999999999999 67888999999998876
Q ss_pred CCCc-cccccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHH
Q 014210 314 RPDE-RLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSE 391 (429)
Q Consensus 314 ~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 391 (429)
.... ......++..|+|||++.+ .++.++||||||+++|+|++|+.||...........+...... .......++.+
T Consensus 150 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 228 (256)
T cd06612 150 TDTMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPP-TLSDPEKWSPE 228 (256)
T ss_pred ccCccccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCC-CCCchhhcCHH
Confidence 5433 2334568899999998864 5888999999999999999999999776554443333222111 11112357789
Q ss_pred HHHHHHHhcccCccCcCCHHHHHhhHhh
Q 014210 392 ARDFVKRLLNKDPRKRLTAAQALSELLI 419 (429)
Q Consensus 392 ~~~li~~~L~~dP~~Rps~~~iL~~~~~ 419 (429)
+.+||.+||+.||++||++.++|.|+||
T Consensus 229 ~~~~i~~~l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 229 FNDFVKKCLVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred HHHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence 9999999999999999999999999996
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=329.67 Aligned_cols=251 Identities=30% Similarity=0.502 Sum_probs=206.0
Q ss_pred eEeceeeccCceEEEEEEEe-cCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEE
Q 014210 158 ELGEEVGRGHFGYTCAAKFK-KGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYV 236 (429)
Q Consensus 158 ~~~~~IG~G~fg~V~~~~~~-~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~~l 236 (429)
++.+.||.|.||.||+|... .+...+..|+||++... ......+++.+|++++++++ |+||++++|++...+..++
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~--~~~~~~~~~~~e~~~l~~l~-h~ni~~~~g~~~~~~~~~l 78 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS--SSEEEEEEFLNEIQILRKLR-HPNIVKLYGFCIENEPLFL 78 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT--SSHHHHHHHHHHHHHHHTHS-BTTBE-EEEEEESSSSEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc--cccccceeeeeccccccccc-ccccccccccccccccccc
Confidence 56789999999999999998 44446889999999542 44556788999999999996 9999999999998888999
Q ss_pred EEEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccccCC
Q 014210 237 VMELCEGGELLDRILSR-GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP 315 (429)
Q Consensus 237 v~E~~~ggsL~~~i~~~-~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~ 315 (429)
|||||++|+|.+++... ...+++..+..|+.||++||.|||+++|+|+||+++|||+ +.++.+||+|||++.....
T Consensus 79 v~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill---~~~~~~Kl~~f~~~~~~~~ 155 (259)
T PF07714_consen 79 VMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILL---DSNGQVKLSDFGLSRPISE 155 (259)
T ss_dssp EEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEE---ETTTEEEEESTTTGEETTT
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccc
Confidence 99999999999999877 6789999999999999999999999999999999999999 6788999999999977632
Q ss_pred Ccc---ccccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCH
Q 014210 316 DER---LNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLSS 390 (429)
Q Consensus 316 ~~~---~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 390 (429)
... .........|+|||.+.. .++.++||||||+++|||++ |+.||...........+.+..... ....++.
T Consensus 156 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~ 232 (259)
T PF07714_consen 156 KSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLP---IPDNCPK 232 (259)
T ss_dssp SSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETT---SBTTSBH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccce---eccchhH
Confidence 222 223456778999999864 58999999999999999999 789998887777777764433211 1235899
Q ss_pred HHHHHHHHhcccCccCcCCHHHHHhhH
Q 014210 391 EARDFVKRLLNKDPRKRLTAAQALSEL 417 (429)
Q Consensus 391 ~~~~li~~~L~~dP~~Rps~~~iL~~~ 417 (429)
++.++|..||..||++||++.++++.+
T Consensus 233 ~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 233 DIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp HHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 999999999999999999999999764
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-42 Score=330.69 Aligned_cols=257 Identities=27% Similarity=0.455 Sum_probs=211.6
Q ss_pred ccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeC-
Q 014210 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT- 231 (429)
Q Consensus 153 ~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~- 231 (429)
..++|++.+.||+|+||.||++.... +|+.+|+|++.... .....+.+|+.+++++.+|+||+++++++...
T Consensus 20 ~~~~y~~~~~l~~g~~~~vy~~~~~~---~~~~~aik~~~~~~----~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~ 92 (291)
T cd06639 20 PTDTWEIIETIGKGTYGKVYKVTNKK---DGSLAAVKILDPIS----DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKAD 92 (291)
T ss_pred CCCCeEEEEEeecCCCeEEEEEEECC---CCCEEEEEEecccc----cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEecc
Confidence 46889999999999999999998766 58899999986432 22356788999999996699999999998754
Q ss_pred ----CeEEEEEEecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEE
Q 014210 232 ----DNVYVVMELCEGGELLDRILS---RGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKA 304 (429)
Q Consensus 232 ----~~~~lv~E~~~ggsL~~~i~~---~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL 304 (429)
+..++||||+++++|.+++.. ....+++..++.++.|++.||.|||+.||+||||||+||++ +.++.+||
T Consensus 93 ~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili---~~~~~~kl 169 (291)
T cd06639 93 KLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILL---TTEGGVKL 169 (291)
T ss_pred ccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEE---cCCCCEEE
Confidence 358999999999999987753 35679999999999999999999999999999999999999 67788999
Q ss_pred eecCCccccCCCc-cccccccCCcccCcccccC------CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcC
Q 014210 305 IDFGLSDFVRPDE-RLNDIVGSAYYVAPEVLHR------SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKAD 377 (429)
Q Consensus 305 ~DFGla~~~~~~~-~~~~~~gt~~y~aPE~~~~------~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~ 377 (429)
+|||++....... ......|+..|+|||++.. .++.++|||||||++|||++|+.||........+..+.+..
T Consensus 170 ~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~ 249 (291)
T cd06639 170 VDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNP 249 (291)
T ss_pred eecccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCC
Confidence 9999987654322 2234578899999998753 26789999999999999999999998776655555544332
Q ss_pred CCCCCCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhh
Q 014210 378 PSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLIC 420 (429)
Q Consensus 378 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~ 420 (429)
.... .....++.++.+||.+||+.||++||++.++++|+||+
T Consensus 250 ~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 250 PPTL-LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred CCCC-CcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 2111 11234678899999999999999999999999999985
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=331.80 Aligned_cols=254 Identities=29% Similarity=0.505 Sum_probs=209.6
Q ss_pred cCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEe---
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED--- 230 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~--- 230 (429)
.+.|++.+.||.|+||.||+|+... .++.+|+|++... .....++..|+.+++++.+|+||+++++++..
T Consensus 15 ~~~~~~~~~lg~g~~~~v~~~~~~~---~~~~~a~K~~~~~----~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~ 87 (282)
T cd06636 15 AGIFELVEVVGNGTYGQVYKGRHVK---TGQLAAIKVMDVT----EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSP 87 (282)
T ss_pred hhhhhhheeeccCCCeEEEEEEEcC---CCcEEEEEEEecC----hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccc
Confidence 4689999999999999999999776 5889999998543 23346688999999999779999999999853
Q ss_pred ---CCeEEEEEEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEee
Q 014210 231 ---TDNVYVVMELCEGGELLDRILSR-GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAID 306 (429)
Q Consensus 231 ---~~~~~lv~E~~~ggsL~~~i~~~-~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~D 306 (429)
.+..+++|||+++|+|.+++... ...+++..++.++.||+.||.|||+.||+|+||||+||++ ++++.+||+|
T Consensus 88 ~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili---~~~~~~~l~d 164 (282)
T cd06636 88 PGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLL---TENAEVKLVD 164 (282)
T ss_pred cCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEee
Confidence 46789999999999999988653 3468999999999999999999999999999999999999 6788899999
Q ss_pred cCCccccCCC-ccccccccCCcccCccccc------CCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCC
Q 014210 307 FGLSDFVRPD-ERLNDIVGSAYYVAPEVLH------RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPS 379 (429)
Q Consensus 307 FGla~~~~~~-~~~~~~~gt~~y~aPE~~~------~~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~ 379 (429)
||++...... .......|+..|+|||++. ..++.++|||||||++|||++|..||...........+.....
T Consensus 165 fg~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~- 243 (282)
T cd06636 165 FGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPP- 243 (282)
T ss_pred CcchhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCC-
Confidence 9998765422 2334567899999999874 3478899999999999999999999976654443333332221
Q ss_pred CCCCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhh
Q 014210 380 FDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLI 419 (429)
Q Consensus 380 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~ 419 (429)
.......++.++.+||.+||+.||.+||++.++|.|+||
T Consensus 244 -~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 244 -PKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred -CCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 111223588999999999999999999999999999996
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-43 Score=330.64 Aligned_cols=252 Identities=33% Similarity=0.574 Sum_probs=216.5
Q ss_pred ceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEE
Q 014210 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVY 235 (429)
Q Consensus 156 ~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~~ 235 (429)
+|++.++||.|+||.||+++... +++.||+|++.+.........+.+.+|++++++++ |+||+++++.+.+++..+
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~---~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~ 76 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRD---TKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELN-HPFLVNLWYSFQDEENMY 76 (258)
T ss_pred CceEEEEeccCCCceEEEEEEcc---CCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCC-CCChHHHHHhhcCCCeEE
Confidence 58999999999999999998765 58899999997765555566788999999999998 999999999999999999
Q ss_pred EEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccccCC
Q 014210 236 VVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP 315 (429)
Q Consensus 236 lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~ 315 (429)
+||||+.|++|.+++... ..+++..+..++.||++||.|||+.||+|+||||+||++ ++++.++|+|||++.....
T Consensus 77 lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~---~~~~~~~l~d~~~~~~~~~ 152 (258)
T cd05578 77 LVVDLLLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILL---DEQGHVHITDFNIATKVTP 152 (258)
T ss_pred EEEeCCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEE---cCCCCEEEeecccccccCC
Confidence 999999999999887554 689999999999999999999999999999999999999 7788899999999987665
Q ss_pred CccccccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHcCCCCCCCCCh--HHHHHHHHh-cCCCCCCCCCCCCCHH
Q 014210 316 DERLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTE--SGIFRAVLK-ADPSFDEAPWPSLSSE 391 (429)
Q Consensus 316 ~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~elltg~~Pf~~~~~--~~~~~~i~~-~~~~~~~~~~~~~s~~ 391 (429)
........|+..|+|||++.+ .++.++|+||||+++|+|++|+.||..... ...+..... .... ..+.++.+
T Consensus 153 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~ 228 (258)
T cd05578 153 DTLTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVL----YPATWSTE 228 (258)
T ss_pred CccccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcccccc----CcccCcHH
Confidence 544455678899999998864 578999999999999999999999987663 222222222 2222 22357899
Q ss_pred HHHHHHHhcccCccCcCCH--HHHHhhHhh
Q 014210 392 ARDFVKRLLNKDPRKRLTA--AQALSELLI 419 (429)
Q Consensus 392 ~~~li~~~L~~dP~~Rps~--~~iL~~~~~ 419 (429)
+.++|.+||+.||.+||++ .+++.|+||
T Consensus 229 ~~~~i~~~l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 229 AIDAINKLLERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred HHHHHHHHccCChhHcCCccHHHHhcCCCC
Confidence 9999999999999999999 999999986
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-44 Score=357.91 Aligned_cols=248 Identities=28% Similarity=0.469 Sum_probs=213.3
Q ss_pred eeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEec
Q 014210 162 EVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELC 241 (429)
Q Consensus 162 ~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~~lv~E~~ 241 (429)
+||+|.||+||.|++.. +...+|||.+.. ...+..+-+..||.++++|+ |.|||+++|.+.+++.+-|.||-+
T Consensus 582 VLGKGTYG~VYA~RD~~---tqvrIaIKEIpe---kdsr~~QPLhEEIaLH~~Lr-HkNIVrYLGs~senGf~kIFMEqV 654 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMD---TQVRIAIKEIPE---KDSREVQPLHEEIALHSTLR-HKNIVRYLGSVSENGFFKIFMEQV 654 (1226)
T ss_pred EeecCceeEEEeecccc---ceeEEEeeeccc---ccchhhccHHHHHHHHHHHh-hHhHHHHhhccCCCCeEEEEeecC
Confidence 68999999999999877 578899999854 44556677899999999999 999999999999999999999999
Q ss_pred CCCcHHHHHHhcCCCC--CHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccccCCC-cc
Q 014210 242 EGGELLDRILSRGGKY--TEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPD-ER 318 (429)
Q Consensus 242 ~ggsL~~~i~~~~~~l--~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~-~~ 318 (429)
+||+|.+.+..+-+++ .+..+..+.+||++||.|||++.|||||||-+|||++ .-.|.+||+|||-++.+..- .-
T Consensus 655 PGGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvN--TySGvlKISDFGTsKRLAginP~ 732 (1226)
T KOG4279|consen 655 PGGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVN--TYSGVLKISDFGTSKRLAGINPC 732 (1226)
T ss_pred CCCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEe--eccceEEecccccchhhccCCcc
Confidence 9999999998888888 8999999999999999999999999999999999997 56789999999999876433 33
Q ss_pred ccccccCCcccCccccc---CCCCCcccHHHHHHHHHHHHcCCCCCCCCC-hHHHHHHH--HhcCCCCCCCCCCCCCHHH
Q 014210 319 LNDIVGSAYYVAPEVLH---RSYSTEADVWSIGVIAYILLCGSRPFWART-ESGIFRAV--LKADPSFDEAPWPSLSSEA 392 (429)
Q Consensus 319 ~~~~~gt~~y~aPE~~~---~~~~~~sDiwSlGvll~elltg~~Pf~~~~-~~~~~~~i--~~~~~~~~~~~~~~~s~~~ 392 (429)
+.++.||..|||||++. +.|+.++|||||||++.||.||++||.... .+..+.++ .+.-+..+ .+++.++
T Consensus 733 TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iP----eelsaea 808 (1226)
T KOG4279|consen 733 TETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIP----EELSAEA 808 (1226)
T ss_pred ccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCc----HHHHHHH
Confidence 45788999999999985 359999999999999999999999996532 22222222 22233333 3689999
Q ss_pred HHHHHHhcccCccCcCCHHHHHhhHhhhcc
Q 014210 393 RDFVKRLLNKDPRKRLTAAQALSELLICYQ 422 (429)
Q Consensus 393 ~~li~~~L~~dP~~Rps~~~iL~~~~~~~~ 422 (429)
+.||.+|+.+||.+||++.++|..+|++..
T Consensus 809 k~FilrcFepd~~~R~sA~~LL~DpFlq~~ 838 (1226)
T KOG4279|consen 809 KNFILRCFEPDPCDRPSAKDLLQDPFLQHN 838 (1226)
T ss_pred HHHHHHHcCCCcccCccHHHhccCcccccC
Confidence 999999999999999999999999999753
|
|
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-42 Score=328.43 Aligned_cols=259 Identities=21% Similarity=0.334 Sum_probs=212.5
Q ss_pred ccCceeEeceeeccCceEEEEEEEecC--cccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEe
Q 014210 153 FANKYELGEEVGRGHFGYTCAAKFKKG--ELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED 230 (429)
Q Consensus 153 ~~~~y~~~~~IG~G~fg~V~~~~~~~~--~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~ 230 (429)
.+++|.+.+.||+|+||.||+|..... ...+..||+|.+... ........+.+|+.+++++. |+||+++++++.+
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~--~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~ 80 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPES--CSEQDESDFLMEALIMSKFN-HQNIVRLIGVSFE 80 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCC--CCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEcc
Confidence 357899999999999999999987652 124688999988543 33444567899999999998 9999999999999
Q ss_pred CCeEEEEEEecCCCcHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEE
Q 014210 231 TDNVYVVMELCEGGELLDRILSRG------GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKA 304 (429)
Q Consensus 231 ~~~~~lv~E~~~ggsL~~~i~~~~------~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL 304 (429)
.+..++||||++|++|.+++.... ..+++..+..++.||+.||.|||+++++||||||+|||++..+++..+||
T Consensus 81 ~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 81 RLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred CCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEe
Confidence 999999999999999999886543 25899999999999999999999999999999999999965444567999
Q ss_pred eecCCccccCCCccc---cccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCC
Q 014210 305 IDFGLSDFVRPDERL---NDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPS 379 (429)
Q Consensus 305 ~DFGla~~~~~~~~~---~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~ellt-g~~Pf~~~~~~~~~~~i~~~~~~ 379 (429)
+|||+++........ .....+..|+|||++. +.++.++|||||||++|||++ |+.||...+.......+......
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~ 240 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGRL 240 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcC
Confidence 999999876322211 1223356799999876 569999999999999999997 99999887777666555443211
Q ss_pred CCCCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhH
Q 014210 380 FDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSEL 417 (429)
Q Consensus 380 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~ 417 (429)
.....++.++.+|+.+||+.||++||++.++++|+
T Consensus 241 ---~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l 275 (277)
T cd05036 241 ---DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERI 275 (277)
T ss_pred ---CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHh
Confidence 11246789999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=335.10 Aligned_cols=259 Identities=30% Similarity=0.462 Sum_probs=212.9
Q ss_pred ceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcC--cHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe
Q 014210 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMT--TAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (429)
Q Consensus 156 ~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~--~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~ 233 (429)
+|++.+.||+|+||.||+|.... +|+.||||++...... .......+.+|++++++++ |+||+++++++.+.+.
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~---~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~ 76 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKE---TGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK-HPNIIGLLDVFGHKSN 76 (298)
T ss_pred CceeeeeeeeccccEEEEEEECC---CCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcC-CCCChhhhheeecCCE
Confidence 58899999999999999998765 4889999999765433 1233456778999999998 9999999999999999
Q ss_pred EEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCcccc
Q 014210 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (429)
Q Consensus 234 ~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~ 313 (429)
.++||||+ +++|.+++......+++..++.++.||++||.|||++||+|+||||+|||+ +.++.+||+|||++...
T Consensus 77 ~~lv~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill---~~~~~~~l~dfg~~~~~ 152 (298)
T cd07841 77 INLVFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLI---ASDGVLKLADFGLARSF 152 (298)
T ss_pred EEEEEccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEE---cCCCCEEEccceeeeec
Confidence 99999999 889999886554479999999999999999999999999999999999999 67888999999999776
Q ss_pred CCCc-cccccccCCcccCcccccC--CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCC--------
Q 014210 314 RPDE-RLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDE-------- 382 (429)
Q Consensus 314 ~~~~-~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~-------- 382 (429)
.... ......++..|+|||.+.+ .++.++|||||||++|||++|..+|......+.+..+.........
T Consensus 153 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (298)
T cd07841 153 GSPNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTS 232 (298)
T ss_pred cCCCccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhccc
Confidence 5432 2334467888999998753 5788999999999999999998888776665555444332111000
Q ss_pred ----------------CCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhcc
Q 014210 383 ----------------APWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLICYQ 422 (429)
Q Consensus 383 ----------------~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~ 422 (429)
..+...+.++.+||.+||++||++||++.++|.|+||...
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~ 288 (298)
T cd07841 233 LPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSND 288 (298)
T ss_pred ccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCC
Confidence 1123457889999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=334.76 Aligned_cols=254 Identities=24% Similarity=0.365 Sum_probs=206.1
Q ss_pred cCceeEeceeeccCceEEEEEEEecCcccC--eEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeC
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKG--QQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g--~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~ 231 (429)
.++|++.+.||+|+||.||+|+... +| ..+|+|.+... ......+.+.+|++++.++.+|+||+++++++.++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~---~~~~~~~~ik~~~~~--~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~ 80 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKK---DGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR 80 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEcc---CCceeeEEEEEeccc--CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCC
Confidence 4689999999999999999998765 34 35677776532 34455678899999999995599999999999999
Q ss_pred CeEEEEEEecCCCcHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeec
Q 014210 232 DNVYVVMELCEGGELLDRILSRG---------------GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTK 296 (429)
Q Consensus 232 ~~~~lv~E~~~ggsL~~~i~~~~---------------~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~ 296 (429)
+..|+||||+++++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili--- 157 (303)
T cd05088 81 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV--- 157 (303)
T ss_pred CCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEe---
Confidence 99999999999999999886432 258899999999999999999999999999999999999
Q ss_pred CCCceEEEeecCCccccCCCccccccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHH
Q 014210 297 DENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVL 374 (429)
Q Consensus 297 ~~~~~vkL~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~ellt-g~~Pf~~~~~~~~~~~i~ 374 (429)
+.++.+||+|||++.............++..|+|||++.+ .++.++|||||||++|||++ |..||......+....+.
T Consensus 158 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~ 237 (303)
T cd05088 158 GENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP 237 (303)
T ss_pred cCCCcEEeCccccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHh
Confidence 6788899999999864322111122234567999998764 57899999999999999998 999998777666555443
Q ss_pred hcCCCCCCCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHh
Q 014210 375 KADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELL 418 (429)
Q Consensus 375 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~ 418 (429)
... .......++.++.+||.+||+.||++||++.+++.++.
T Consensus 238 ~~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~ 278 (303)
T cd05088 238 QGY---RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLN 278 (303)
T ss_pred cCC---cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 321 11112347899999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-42 Score=324.99 Aligned_cols=253 Identities=27% Similarity=0.546 Sum_probs=216.3
Q ss_pred ceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEE
Q 014210 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVY 235 (429)
Q Consensus 156 ~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~~ 235 (429)
+|++.++||+|+||.||+++... .|+.||+|++..... .....+++.+|+.++++++ |+||+++++++.+.+..+
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~---~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~ 75 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKE---DGKQYVIKEINISKM-SPKEREESRKEVAVLSNMK-HPNIVQYQESFEENGNLY 75 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcC---CCCEEEEEEEEhHhC-ChHHHHHHHHHHHHHHhCC-CCCeeeeEeeecCCCeEE
Confidence 58999999999999999998766 588999999865432 2344567899999999998 999999999999999999
Q ss_pred EEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccccC
Q 014210 236 VVMELCEGGELLDRILSRG-GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (429)
Q Consensus 236 lv~E~~~ggsL~~~i~~~~-~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~ 314 (429)
+||||+.+++|.+++.... ..+++..+..++.|++.||.|||++|++|+||+|+|||+ +.++.++|+|||++....
T Consensus 76 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~---~~~~~~~l~d~~~~~~~~ 152 (256)
T cd08218 76 IVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFL---TKDGTIKLGDFGIARVLN 152 (256)
T ss_pred EEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEE---cCCCCEEEeeccceeecC
Confidence 9999999999999886543 468999999999999999999999999999999999999 677789999999997664
Q ss_pred CCcc-ccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHH
Q 014210 315 PDER-LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEA 392 (429)
Q Consensus 315 ~~~~-~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 392 (429)
.... .....|+..|+|||++. +.++.++|+||||+++++|++|+.||......+....++....... ...++.++
T Consensus 153 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~ 229 (256)
T cd08218 153 STVELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPV---SSHYSYDL 229 (256)
T ss_pred cchhhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCCC---cccCCHHH
Confidence 3322 22346888999999886 4578899999999999999999999988777777766665443221 23578999
Q ss_pred HHHHHHhcccCccCcCCHHHHHhhHhh
Q 014210 393 RDFVKRLLNKDPRKRLTAAQALSELLI 419 (429)
Q Consensus 393 ~~li~~~L~~dP~~Rps~~~iL~~~~~ 419 (429)
.++|.+||+.+|++||++.+++.|+||
T Consensus 230 ~~li~~~l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 230 RNLVSQLFKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred HHHHHHHhhCChhhCcCHHHHhhCcCC
Confidence 999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-42 Score=327.04 Aligned_cols=254 Identities=28% Similarity=0.447 Sum_probs=210.1
Q ss_pred ceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCc---CcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCC
Q 014210 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKM---TTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (429)
Q Consensus 156 ~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~---~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~ 232 (429)
+|.+.+.||+|+||.||+|... +|+.+|||.+..... ......+.+.+|++++++++ |+||+++++++.+.+
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~----~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~ 75 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTN----QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLK-HVNIVQYLGTCLDDN 75 (265)
T ss_pred CccccceEeccCCeEEEEEEEc----CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcC-CCCEeeEeeEeecCC
Confidence 4788999999999999999753 478999998864321 22344567899999999998 999999999999999
Q ss_pred eEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccc
Q 014210 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (429)
Q Consensus 233 ~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~ 312 (429)
..+++|||+++++|.+++.+ .+.+++..+..++.||+.||+|||+.+|+|+||||+||++ +.++.+||+|||++..
T Consensus 76 ~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~ 151 (265)
T cd06631 76 TISIFMEFVPGGSISSILNR-FGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVML---MPNGIIKLIDFGCARR 151 (265)
T ss_pred eEEEEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEE---CCCCeEEeccchhhHh
Confidence 99999999999999988854 3578999999999999999999999999999999999999 7788999999999875
Q ss_pred cCCC-------ccccccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCC
Q 014210 313 VRPD-------ERLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAP 384 (429)
Q Consensus 313 ~~~~-------~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 384 (429)
.... .......|+..|+|||++.+ .++.++||||||+++|+|++|+.||...........+.......+. .
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~ 230 (265)
T cd06631 152 LAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPR-L 230 (265)
T ss_pred hhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCC-C
Confidence 4211 11234568999999998874 5789999999999999999999999876554444333333222221 2
Q ss_pred CCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhh
Q 014210 385 WPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLI 419 (429)
Q Consensus 385 ~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~ 419 (429)
...++.++.+||++||+.||++||++.+++.|+||
T Consensus 231 ~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 231 PDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred CCCCCHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 24688999999999999999999999999999996
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-43 Score=361.97 Aligned_cols=256 Identities=25% Similarity=0.402 Sum_probs=221.5
Q ss_pred cCceeEeceeeccCceEEEEEEEecCc--ccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeC
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGE--LKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~--~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~ 231 (429)
..+.+..++||+|.||+||+|+..... ...+.||||.++.. .+.+..++|++|++++..|+ |+|||+|+|+|.++
T Consensus 485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~--a~~~~~~dF~REaeLla~l~-H~nIVrLlGVC~~~ 561 (774)
T KOG1026|consen 485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDK--AENQARQDFRREAELLAELQ-HPNIVRLLGVCREG 561 (774)
T ss_pred hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhccc--ccHHHHHHHHHHHHHHHhcc-CCCeEEEEEEEccC
Confidence 466788999999999999999877543 24578999998754 56668899999999999999 99999999999999
Q ss_pred CeEEEEEEecCCCcHHHHHHhcC---------C----CCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCC
Q 014210 232 DNVYVVMELCEGGELLDRILSRG---------G----KYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDE 298 (429)
Q Consensus 232 ~~~~lv~E~~~ggsL~~~i~~~~---------~----~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~ 298 (429)
+-+++|+|||..|||.++|..+. . .++..+...|+.||+.|++||-++.+|||||-..|+|| ++
T Consensus 562 ~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLV---ge 638 (774)
T KOG1026|consen 562 DPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLV---GE 638 (774)
T ss_pred CeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhcee---cc
Confidence 99999999999999999997542 1 27889999999999999999999999999999999999 89
Q ss_pred CceEEEeecCCccccCCCcccc---ccccCCcccCcccc-cCCCCCcccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHH
Q 014210 299 NSVLKAIDFGLSDFVRPDERLN---DIVGSAYYVAPEVL-HRSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAV 373 (429)
Q Consensus 299 ~~~vkL~DFGla~~~~~~~~~~---~~~gt~~y~aPE~~-~~~~~~~sDiwSlGvll~ellt-g~~Pf~~~~~~~~~~~i 373 (429)
+..|||+||||++.....+... ...-..+||+||.+ .+.|+++||||||||+|||+++ |+.||.+.+.++.+..+
T Consensus 639 ~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i 718 (774)
T KOG1026|consen 639 NLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECI 718 (774)
T ss_pred ceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHH
Confidence 9999999999998765444322 22345789999955 5899999999999999999997 99999999999999998
Q ss_pred HhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHh
Q 014210 374 LKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELL 418 (429)
Q Consensus 374 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~ 418 (429)
..+.. ......++.++.+|+..||+.+|.+||++.||-..+-
T Consensus 719 ~~g~l---L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~ 760 (774)
T KOG1026|consen 719 RAGQL---LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQ 760 (774)
T ss_pred HcCCc---ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHH
Confidence 87764 2233479999999999999999999999999966543
|
|
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-42 Score=333.21 Aligned_cols=257 Identities=26% Similarity=0.430 Sum_probs=216.5
Q ss_pred ccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCC
Q 014210 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (429)
Q Consensus 153 ~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~ 232 (429)
..+.|++.++||+|+||.||+|.... .|+.||+|++...........+++.+|+++++.++ |+||+++++++.+++
T Consensus 13 ~~~~y~~~~~lg~g~~g~vy~~~~~~---~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~~~~~~~~~~ 88 (307)
T cd06607 13 PEKLFTDLREIGHGSFGAVYFARDVR---TNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLR-HPNTIEYKGCYLREH 88 (307)
T ss_pred cchhhhhheeecCCCCeEEEEEEEcC---CCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCC-CCCEEEEEEEEEeCC
Confidence 34679999999999999999998765 58899999986554445555677899999999998 999999999999999
Q ss_pred eEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccc
Q 014210 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (429)
Q Consensus 233 ~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~ 312 (429)
..++||||++ |+|.+.+......+++..+..++.||+.||.|||+.||+||||+|+||++ +.++.+||+|||++..
T Consensus 89 ~~~lv~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~---~~~~~~kL~dfg~~~~ 164 (307)
T cd06607 89 TAWLVMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILL---TEPGTVKLADFGSASL 164 (307)
T ss_pred eEEEEHHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEE---CCCCCEEEeecCccee
Confidence 9999999997 57777776666779999999999999999999999999999999999999 7788999999999876
Q ss_pred cCCCccccccccCCcccCccccc----CCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCC
Q 014210 313 VRPDERLNDIVGSAYYVAPEVLH----RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSL 388 (429)
Q Consensus 313 ~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 388 (429)
.... ....++..|+|||++. +.++.++||||||+++|||++|+.||...........+...... ......+
T Consensus 165 ~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~ 239 (307)
T cd06607 165 VSPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSP--TLSSNDW 239 (307)
T ss_pred cCCC---CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCC--CCCchhh
Confidence 5432 2456888999999873 45888999999999999999999999877665544444332221 1112347
Q ss_pred CHHHHHHHHHhcccCccCcCCHHHHHhhHhhhcc
Q 014210 389 SSEARDFVKRLLNKDPRKRLTAAQALSELLICYQ 422 (429)
Q Consensus 389 s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~ 422 (429)
+.++.+||.+||+.||++||++.+++.|+|+...
T Consensus 240 ~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 273 (307)
T cd06607 240 SDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRE 273 (307)
T ss_pred CHHHHHHHHHHhcCChhhCcCHHHHhcChhhccc
Confidence 8899999999999999999999999999999754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-42 Score=325.72 Aligned_cols=253 Identities=31% Similarity=0.476 Sum_probs=211.5
Q ss_pred ceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEe
Q 014210 161 EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMEL 240 (429)
Q Consensus 161 ~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~~lv~E~ 240 (429)
+.||+|+||.||+|.... .|+.||||++.+...........+..|..++....+|+||+++++++.+++..|+||||
T Consensus 2 ~~l~~g~~~~v~~a~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~ 78 (260)
T cd05611 2 KPISKGAFGSVYLAKKRS---TGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEY 78 (260)
T ss_pred ccCCcCCCeeEEEEEecC---CCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEec
Confidence 579999999999998765 58899999987654333344455666766665555699999999999999999999999
Q ss_pred cCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccccCCCcccc
Q 014210 241 CEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLN 320 (429)
Q Consensus 241 ~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~ 320 (429)
+++++|.+++.. .+.+++..+..++.||+.||.|||+.||+||||+|+||++ ++++.+||+|||++..... ..
T Consensus 79 ~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~---~~ 151 (260)
T cd05611 79 LNGGDCASLIKT-LGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLI---DQTGHLKLTDFGLSRNGLE---NK 151 (260)
T ss_pred cCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---CCCCcEEEeecccceeccc---cc
Confidence 999999987754 4578999999999999999999999999999999999999 6778899999999876543 23
Q ss_pred ccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHh
Q 014210 321 DIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRL 399 (429)
Q Consensus 321 ~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~ 399 (429)
...++..|+|||.+.+ .++.++||||||+++|+|++|..||........+..+..............++.++.++|.+|
T Consensus 152 ~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 231 (260)
T cd05611 152 KFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRL 231 (260)
T ss_pred cCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHH
Confidence 4568899999998864 478899999999999999999999988877777766665554444444456899999999999
Q ss_pred cccCccCcC---CHHHHHhhHhhhccc
Q 014210 400 LNKDPRKRL---TAAQALSELLICYQS 423 (429)
Q Consensus 400 L~~dP~~Rp---s~~~iL~~~~~~~~~ 423 (429)
|+.||++|| ++.|+|.|+||....
T Consensus 232 l~~~p~~R~~~~~~~~~l~~~~~~~~~ 258 (260)
T cd05611 232 LCMDPAKRLGANGYQEIKSHPFFKSIN 258 (260)
T ss_pred ccCCHHHccCCCcHHHHHcChHhhcCC
Confidence 999999999 557999999997643
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-42 Score=345.73 Aligned_cols=257 Identities=23% Similarity=0.364 Sum_probs=208.0
Q ss_pred cCceeEeceeeccCceEEEEEEEecC--cccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeC
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKG--ELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~--~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~ 231 (429)
.++|.++++||+|+||.||+|..... ...+..||||++... ......+.+.+|+++++++..||||++++++|.+.
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~--~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~ 113 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPT--ARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKS 113 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCC--CChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccC
Confidence 56899999999999999999986532 123567999998653 33444567899999999997799999999999999
Q ss_pred CeEEEEEEecCCCcHHHHHHhcC---------------------------------------------------------
Q 014210 232 DNVYVVMELCEGGELLDRILSRG--------------------------------------------------------- 254 (429)
Q Consensus 232 ~~~~lv~E~~~ggsL~~~i~~~~--------------------------------------------------------- 254 (429)
+.+|||||||++|+|.+++....
T Consensus 114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (400)
T cd05105 114 GPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLE 193 (400)
T ss_pred CceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhh
Confidence 99999999999999998876421
Q ss_pred --------------------------------------CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeec
Q 014210 255 --------------------------------------GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTK 296 (429)
Q Consensus 255 --------------------------------------~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~ 296 (429)
..+++..+..++.||+.||.|||+.+|+||||||+|||+
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill--- 270 (400)
T cd05105 194 IKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLL--- 270 (400)
T ss_pred hhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEE---
Confidence 247888899999999999999999999999999999999
Q ss_pred CCCceEEEeecCCccccCCCcc---ccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHc-CCCCCCCCChHHHHH
Q 014210 297 DENSVLKAIDFGLSDFVRPDER---LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFR 371 (429)
Q Consensus 297 ~~~~~vkL~DFGla~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~ellt-g~~Pf~~~~~~~~~~ 371 (429)
+.++.+||+|||+++....... .....++..|+|||++. ..++.++|||||||++|||++ |..||........+.
T Consensus 271 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~ 350 (400)
T cd05105 271 AQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFY 350 (400)
T ss_pred eCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHH
Confidence 6778899999999976543322 22345678899999876 468999999999999999997 999997765444443
Q ss_pred HHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhH
Q 014210 372 AVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSEL 417 (429)
Q Consensus 372 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~ 417 (429)
.......... ....++.++.+||.+||+.||++||++.++.+.+
T Consensus 351 ~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l 394 (400)
T cd05105 351 NKIKSGYRMA--KPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIV 394 (400)
T ss_pred HHHhcCCCCC--CCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHH
Confidence 3333322221 2246789999999999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=337.97 Aligned_cols=252 Identities=29% Similarity=0.456 Sum_probs=193.7
Q ss_pred eceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEe--CCeEEEE
Q 014210 160 GEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED--TDNVYVV 237 (429)
Q Consensus 160 ~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~--~~~~~lv 237 (429)
..+||+|+||.||+|+.+.+. ++..||+|.+..... ...+.+|++++++++ |+||+++++++.. +...++|
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~-~~~~~a~k~~~~~~~-----~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~lv 78 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGK-DEKEYALKQIEGTGI-----SMSACREIALLRELK-HPNVIALQKVFLSHSDRKVWLL 78 (317)
T ss_pred ceEeccCCCeeEEEEEecCCC-ccceEEEEEecCCCC-----cHHHHHHHHHHHhCC-CCCeeeEEEEEeccCCCeEEEE
Confidence 468999999999999866432 468999999864321 235778999999998 9999999999854 5678999
Q ss_pred EEecCCCcHHHHHHhc--------CCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeec-CCCceEEEeecC
Q 014210 238 MELCEGGELLDRILSR--------GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTK-DENSVLKAIDFG 308 (429)
Q Consensus 238 ~E~~~ggsL~~~i~~~--------~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~-~~~~~vkL~DFG 308 (429)
|||+.+ +|.+++... ...+++..++.++.||+.||.|||+.||+||||||+|||+... +.++.+||+|||
T Consensus 79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG 157 (317)
T cd07867 79 FDYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMG 157 (317)
T ss_pred EeeeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeecc
Confidence 999965 777776422 2258899999999999999999999999999999999999533 456789999999
Q ss_pred CccccCCCc----cccccccCCcccCcccccC--CCCCcccHHHHHHHHHHHHcCCCCCCCCChH---------HHHHHH
Q 014210 309 LSDFVRPDE----RLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTES---------GIFRAV 373 (429)
Q Consensus 309 la~~~~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlGvll~elltg~~Pf~~~~~~---------~~~~~i 373 (429)
+++...... ......||..|+|||++.+ .++.++|||||||++|||++|+.||....+. ..+..+
T Consensus 158 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~ 237 (317)
T cd07867 158 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRI 237 (317)
T ss_pred ceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHH
Confidence 998764322 2234578999999998864 4789999999999999999999999644321 111111
Q ss_pred HhcCC--------------CCC--------------------CCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhh
Q 014210 374 LKADP--------------SFD--------------------EAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLI 419 (429)
Q Consensus 374 ~~~~~--------------~~~--------------------~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~ 419 (429)
..... .+. .......+..+.+||.+||+.||.+|||+.|+|+|+||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 238 FSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred HHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 11000 000 00011235678899999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=333.57 Aligned_cols=256 Identities=29% Similarity=0.507 Sum_probs=210.4
Q ss_pred CceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeE
Q 014210 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (429)
Q Consensus 155 ~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~ 234 (429)
++|++.++||+|+||.||+|.... .|+.||+|++.+..... ...+.+.+|++++++++ |+||+++++++.+++..
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~---~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~ 75 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKE---TGQIVAIKKFLESEDDK-MVKKIAMREIRMLKQLR-HENLVNLIEVFRRKKRL 75 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECC---CCCEEEEEeHhhccCcc-hhhHHHHHHHHHHHhcC-CcchhhHHHhcccCCeE
Confidence 479999999999999999998765 48899999986643322 34567889999999998 99999999999999999
Q ss_pred EEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccccC
Q 014210 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (429)
Q Consensus 235 ~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~ 314 (429)
++||||+++++|.++. .....+++..++.++.||+.||.|||+.||+|+||+|+||++ ++++.+||+|||++....
T Consensus 76 ~lv~e~~~~~~l~~~~-~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~---~~~~~~~l~dfg~~~~~~ 151 (286)
T cd07846 76 YLVFEFVDHTVLDDLE-KYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILV---SQSGVVKLCDFGFARTLA 151 (286)
T ss_pred EEEEecCCccHHHHHH-hccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE---CCCCcEEEEeeeeeeecc
Confidence 9999999988776654 444569999999999999999999999999999999999999 778899999999987654
Q ss_pred CCc-cccccccCCcccCcccccC--CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCC-----------
Q 014210 315 PDE-RLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSF----------- 380 (429)
Q Consensus 315 ~~~-~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~----------- 380 (429)
... ......++..|+|||++.+ .++.++||||||+++|||++|+.||......+.+..+......+
T Consensus 152 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07846 152 APGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKN 231 (286)
T ss_pred CCccccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccc
Confidence 332 2334568899999998764 47889999999999999999999997666544433333211110
Q ss_pred --------CC--------CCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhh
Q 014210 381 --------DE--------APWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLI 419 (429)
Q Consensus 381 --------~~--------~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~ 419 (429)
.. ..++.++..+.+||++||+.||++||++.+++.|+||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 232 PLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred hHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 00 1134678899999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-42 Score=327.77 Aligned_cols=256 Identities=19% Similarity=0.310 Sum_probs=209.7
Q ss_pred ccCceeEeceeeccCceEEEEEEEecC--cccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEe
Q 014210 153 FANKYELGEEVGRGHFGYTCAAKFKKG--ELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED 230 (429)
Q Consensus 153 ~~~~y~~~~~IG~G~fg~V~~~~~~~~--~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~ 230 (429)
..++|++.++||+|+||.||++..... ...+..||||++... .......++.+|+.+++.+. |+||+++++++.+
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~--~~~~~~~~~~~e~~~l~~l~-~~~iv~~~~~~~~ 80 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEA--ASMRERIEFLNEASVMKEFN-CHHVVRLLGVVSQ 80 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEecccc--CCHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEcC
Confidence 467899999999999999999986531 124678999998543 22334567889999999998 9999999999999
Q ss_pred CCeEEEEEEecCCCcHHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCce
Q 014210 231 TDNVYVVMELCEGGELLDRILSRG---------GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSV 301 (429)
Q Consensus 231 ~~~~~lv~E~~~ggsL~~~i~~~~---------~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~ 301 (429)
++..++||||+++++|.+++.... ..+++..+..++.|++.||.|||+.|++||||||+|||+ ++++.
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~---~~~~~ 157 (277)
T cd05062 81 GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMV---AEDFT 157 (277)
T ss_pred CCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEE---cCCCC
Confidence 999999999999999999886532 235788899999999999999999999999999999999 67888
Q ss_pred EEEeecCCccccCCCccc---cccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhc
Q 014210 302 LKAIDFGLSDFVRPDERL---NDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKA 376 (429)
Q Consensus 302 vkL~DFGla~~~~~~~~~---~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~ellt-g~~Pf~~~~~~~~~~~i~~~ 376 (429)
+||+|||++......... ....++..|+|||++. +.++.++|||||||++|||++ |..||...........+...
T Consensus 158 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~ 237 (277)
T cd05062 158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEG 237 (277)
T ss_pred EEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Confidence 999999998755432211 1234577899999886 468999999999999999999 78999887776666655544
Q ss_pred CCCCCCCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhH
Q 014210 377 DPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSEL 417 (429)
Q Consensus 377 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~ 417 (429)
..... ...++.++.+||.+||+.||++||++.+++.++
T Consensus 238 ~~~~~---~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l 275 (277)
T cd05062 238 GLLDK---PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSI 275 (277)
T ss_pred CcCCC---CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHh
Confidence 32211 235788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=340.29 Aligned_cols=259 Identities=27% Similarity=0.392 Sum_probs=208.0
Q ss_pred cCceeEeceeeccCceEEEEEEEec--CcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeC
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKK--GELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~--~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~ 231 (429)
.++|++.+.||+|+||.||+|+... +..+++.||+|++... ......+.+.+|+.++.++.+|+||++++++|...
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~--~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~ 83 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEG--ATASEYKALMTELKILIHIGHHLNVVNLLGACTKP 83 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCC--CCHHHHHHHHHHHHHHHhhccCcchhheeeeEecC
Confidence 4689999999999999999997543 2235789999998643 23344567889999999996699999999988654
Q ss_pred -CeEEEEEEecCCCcHHHHHHhcC--------------------------------------------------------
Q 014210 232 -DNVYVVMELCEGGELLDRILSRG-------------------------------------------------------- 254 (429)
Q Consensus 232 -~~~~lv~E~~~ggsL~~~i~~~~-------------------------------------------------------- 254 (429)
..++++|||+++++|.+++....
T Consensus 84 ~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (337)
T cd05054 84 GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGD 163 (337)
T ss_pred CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhh
Confidence 56889999999999999885432
Q ss_pred ----CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccccCCCcc---ccccccCCc
Q 014210 255 ----GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDER---LNDIVGSAY 327 (429)
Q Consensus 255 ----~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~---~~~~~gt~~ 327 (429)
..+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++..+..... .....++..
T Consensus 164 ~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill---~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~ 240 (337)
T cd05054 164 ELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILL---SENNVVKICDFGLARDIYKDPDYVRKGDARLPLK 240 (337)
T ss_pred HHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEE---eCCCcEEEeccccchhcccCcchhhccCCCCCcc
Confidence 267999999999999999999999999999999999999 6678899999999987543321 223456778
Q ss_pred ccCccccc-CCCCCcccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCcc
Q 014210 328 YVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPR 405 (429)
Q Consensus 328 y~aPE~~~-~~~~~~sDiwSlGvll~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~ 405 (429)
|+|||++. ..++.++|||||||++|||++ |..||......+.+...+....... ....+++++.+++.+||+.+|+
T Consensus 241 y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~~cl~~~p~ 318 (337)
T cd05054 241 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMR--APEYATPEIYSIMLDCWHNNPE 318 (337)
T ss_pred ccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCC--CCccCCHHHHHHHHHHccCChh
Confidence 99999776 569999999999999999997 9999977554444444433322211 1235788999999999999999
Q ss_pred CcCCHHHHHhhHhh
Q 014210 406 KRLTAAQALSELLI 419 (429)
Q Consensus 406 ~Rps~~~iL~~~~~ 419 (429)
+||++.++++++--
T Consensus 319 ~RPs~~ell~~l~~ 332 (337)
T cd05054 319 DRPTFSELVEILGD 332 (337)
T ss_pred hCcCHHHHHHHHHH
Confidence 99999999998743
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=330.64 Aligned_cols=254 Identities=30% Similarity=0.459 Sum_probs=209.3
Q ss_pred eeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEecC
Q 014210 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCE 242 (429)
Q Consensus 163 IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~~lv~E~~~ 242 (429)
||+|+||.||++.... +|+.||+|++.+.........+.+.+|++++++++ |+||+++++++...+..|+||||++
T Consensus 1 lg~g~~g~vy~~~~~~---~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e~~~ 76 (277)
T cd05577 1 LGKGGFGEVCACQVKA---TGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVS-SRFIVSLAYAFETKDDLCLVMTLMN 76 (277)
T ss_pred CCCCCceeEEEEEEcC---CCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCC-CCCEeeeeeEEecCCeEEEEEecCC
Confidence 6999999999998665 58999999987654334444556788999999998 9999999999999999999999999
Q ss_pred CCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccccCCCccccc
Q 014210 243 GGELLDRILSRG-GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLND 321 (429)
Q Consensus 243 ggsL~~~i~~~~-~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~ 321 (429)
+++|.+++.... ..+++..++.++.|++.||.|||+.||+||||+|+||++ ++++.+||+|||++...........
T Consensus 77 ~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~---~~~~~~~l~dfg~~~~~~~~~~~~~ 153 (277)
T cd05577 77 GGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLL---DDHGNVRISDLGLAVELKGGKKIKG 153 (277)
T ss_pred CCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE---CCCCCEEEccCcchhhhccCCcccc
Confidence 999999886654 369999999999999999999999999999999999999 7788899999999876654444445
Q ss_pred cccCCcccCccccc-CCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhc
Q 014210 322 IVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLL 400 (429)
Q Consensus 322 ~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L 400 (429)
..++..|+|||++. +.++.++||||||+++|+|++|+.||...........+..............+++++.+||++||
T Consensus 154 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 233 (277)
T cd05577 154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALL 233 (277)
T ss_pred ccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHHc
Confidence 67888999999876 45888999999999999999999999765432222222222222222233467899999999999
Q ss_pred ccCccCcC-----CHHHHHhhHhhhccc
Q 014210 401 NKDPRKRL-----TAAQALSELLICYQS 423 (429)
Q Consensus 401 ~~dP~~Rp-----s~~~iL~~~~~~~~~ 423 (429)
+.||++|| ++.+++.|+||....
T Consensus 234 ~~~p~~R~~~~~~~~~~ll~h~~~~~~~ 261 (277)
T cd05577 234 QKDPEKRLGCRGGSADEVREHPLFKDLN 261 (277)
T ss_pred cCChhHccCCCcccHHHHHhChhhhcCC
Confidence 99999999 899999999997544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-42 Score=322.57 Aligned_cols=245 Identities=24% Similarity=0.395 Sum_probs=203.0
Q ss_pred ceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEe
Q 014210 161 EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMEL 240 (429)
Q Consensus 161 ~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~~lv~E~ 240 (429)
++||+|+||.||+|+... +|+.||+|.+... ........+.+|+++++++. |+||+++++++.+.+..++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~---~~~~~a~k~~~~~--~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~ 74 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRA---DNTPVAVKSCRET--LPPDLKAKFLQEARILKQYS-HPNIVRLIGVCTQKQPIYIVMEL 74 (252)
T ss_pred CccCcccCccEEEEEEec---CCceEEEEecCcc--CCHHHHHHHHHHHHHHHhCC-CCCcceEEEEEcCCCCeEEEEee
Confidence 479999999999999876 5889999987543 33445577899999999998 99999999999999999999999
Q ss_pred cCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccccCCCcccc
Q 014210 241 CEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLN 320 (429)
Q Consensus 241 ~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~ 320 (429)
+++++|.+++......+++..++.++.|++.||.|||++||+||||||+|||+ +.++.+||+|||++..........
T Consensus 75 ~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~---~~~~~~kl~dfg~~~~~~~~~~~~ 151 (252)
T cd05084 75 VQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLV---TEKNVLKISDFGMSREEEDGVYAS 151 (252)
T ss_pred ccCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEE---cCCCcEEECccccCcccccccccc
Confidence 99999999887666679999999999999999999999999999999999999 677889999999987644221111
Q ss_pred ---ccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHH
Q 014210 321 ---DIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDF 395 (429)
Q Consensus 321 ---~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 395 (429)
....+..|+|||.+. +.++.++||||||+++|||++ |..||...........+...... .....++.++.+|
T Consensus 152 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~l 228 (252)
T cd05084 152 TGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRL---PCPELCPDAVYRL 228 (252)
T ss_pred cCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCC---CCcccCCHHHHHH
Confidence 112345699999876 468899999999999999997 99999777665555544432211 1223578999999
Q ss_pred HHHhcccCccCcCCHHHHHhhH
Q 014210 396 VKRLLNKDPRKRLTAAQALSEL 417 (429)
Q Consensus 396 i~~~L~~dP~~Rps~~~iL~~~ 417 (429)
|++||+.||++||++.++++.+
T Consensus 229 i~~~l~~~p~~Rps~~~~~~~l 250 (252)
T cd05084 229 MERCWEYDPGQRPSFSTVHQEL 250 (252)
T ss_pred HHHHcCCChhhCcCHHHHHHHH
Confidence 9999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-42 Score=324.48 Aligned_cols=248 Identities=25% Similarity=0.414 Sum_probs=208.6
Q ss_pred CceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeE
Q 014210 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (429)
Q Consensus 155 ~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~ 234 (429)
++|++.+.||+|+||.||+++... +..+|||.+..... ..+++.+|+.+++++. |+||+++++++.+.+..
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~----~~~~aik~~~~~~~----~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~ 74 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRG----QYDVAIKMIKEGSM----SEDEFIEEAKVMMKLS-HEKLVQLYGVCTKQRPI 74 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecC----CCcEEEEEcCCCcc----cHHHHHHHHHHHhcCC-CCCeeeEEEEEccCCCc
Confidence 578999999999999999997543 45699998864322 2356889999999998 99999999999999999
Q ss_pred EEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccccC
Q 014210 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (429)
Q Consensus 235 ~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~ 314 (429)
+++|||+.+++|.+++......+++..++.++.||+.||.|||+.||+|+||||+|||+ +.++.+||+|||++....
T Consensus 75 ~lv~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili---~~~~~~kl~d~g~~~~~~ 151 (256)
T cd05113 75 YIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLV---DDQGCVKVSDFGLSRYVL 151 (256)
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEE---cCCCCEEECCCccceecC
Confidence 99999999999999887655679999999999999999999999999999999999999 677889999999987654
Q ss_pred CCccc--cccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCH
Q 014210 315 PDERL--NDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLSS 390 (429)
Q Consensus 315 ~~~~~--~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 390 (429)
..... ....++..|++||++. +.++.++||||||+++|+|++ |..||...........+......... ...+.
T Consensus 152 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~ 228 (256)
T cd05113 152 DDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRP---HLASE 228 (256)
T ss_pred CCceeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCCC---CCCCH
Confidence 33221 1223567899999886 468899999999999999998 99999877777666666654433222 24689
Q ss_pred HHHHHHHHhcccCccCcCCHHHHHhhH
Q 014210 391 EARDFVKRLLNKDPRKRLTAAQALSEL 417 (429)
Q Consensus 391 ~~~~li~~~L~~dP~~Rps~~~iL~~~ 417 (429)
++.+++.+||+.||++||++.+++.++
T Consensus 229 ~~~~li~~cl~~~p~~Rp~~~~ll~~~ 255 (256)
T cd05113 229 KVYAIMYSCWHEKAEERPTFQQLLSSI 255 (256)
T ss_pred HHHHHHHHHcCCCcccCCCHHHHHHhh
Confidence 999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-42 Score=326.89 Aligned_cols=256 Identities=30% Similarity=0.512 Sum_probs=211.0
Q ss_pred ccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCC
Q 014210 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (429)
Q Consensus 153 ~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~ 232 (429)
..++|++.+.||+|+||.||+|.... +++.+++|++.... ...+++.+|+.+++++.+|+||+++++++.+..
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~---~~~~~~~k~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~ 76 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKK---TGQLVAIKIMDIIE----DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKN 76 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECC---CCcEEEEEEEecCc----hhHHHHHHHHHHHHHhcCCCChheEEEEEEecC
Confidence 35899999999999999999998765 57899999986532 234678999999999966999999999997644
Q ss_pred ------eEEEEEEecCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEE
Q 014210 233 ------NVYVVMELCEGGELLDRILSR---GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLK 303 (429)
Q Consensus 233 ------~~~lv~E~~~ggsL~~~i~~~---~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vk 303 (429)
..++||||+++++|.+++... +..+++..++.++.|++.||.|||+.||+|+||+|+||++ +.++.+|
T Consensus 77 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~---~~~~~~~ 153 (275)
T cd06608 77 PPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILL---TKNAEVK 153 (275)
T ss_pred CCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEE---ccCCeEE
Confidence 489999999999998877543 4679999999999999999999999999999999999999 6788899
Q ss_pred EeecCCccccCCCc-cccccccCCcccCcccccC------CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhc
Q 014210 304 AIDFGLSDFVRPDE-RLNDIVGSAYYVAPEVLHR------SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKA 376 (429)
Q Consensus 304 L~DFGla~~~~~~~-~~~~~~gt~~y~aPE~~~~------~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~ 376 (429)
|+|||++....... ......|+..|+|||++.. .++.++||||||+++|+|++|+.||...........+...
T Consensus 154 l~d~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~ 233 (275)
T cd06608 154 LVDFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRN 233 (275)
T ss_pred ECCCccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhcc
Confidence 99999987654322 2234568999999998742 3678999999999999999999999766555544444443
Q ss_pred CCCCCCCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhh
Q 014210 377 DPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLI 419 (429)
Q Consensus 377 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~ 419 (429)
.... ......++.++.+||++||..||++|||+.+++.|+|+
T Consensus 234 ~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 234 PPPT-LKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred CCCC-CCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 2211 11112378899999999999999999999999999995
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-42 Score=329.99 Aligned_cols=262 Identities=28% Similarity=0.430 Sum_probs=213.0
Q ss_pred CceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeE
Q 014210 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (429)
Q Consensus 155 ~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~ 234 (429)
++|++.++||+|++|.||+|.... +|+.||||.+..... .....+.+.+|+++++++. |+||+++++++.+.+..
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~---~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~ 76 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRV---TNETIALKKIRLEQE-DEGVPSTAIREISLLKEMQ-HGNIVRLQDVVHSEKRL 76 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecC---CCcEEEEEehhhccc-cccchHHHHHHHHHHHhcc-CCCEeeEEEEEecCCeE
Confidence 579999999999999999998765 588999999865432 2233456889999999998 99999999999999999
Q ss_pred EEEEEecCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCcccc
Q 014210 235 YVVMELCEGGELLDRILSRGG-KYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (429)
Q Consensus 235 ~lv~E~~~ggsL~~~i~~~~~-~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~ 313 (429)
++||||++ ++|.+++..... .+++..++.++.||+.||+|||++||+||||||+||+++ ..++.+||+|||++...
T Consensus 77 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~--~~~~~~kl~dfg~~~~~ 153 (294)
T PLN00009 77 YLVFEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLID--RRTNALKLADFGLARAF 153 (294)
T ss_pred EEEEeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEE--CCCCEEEEccccccccc
Confidence 99999996 588887755433 468899999999999999999999999999999999994 24567999999999765
Q ss_pred CCCc-cccccccCCcccCcccccC--CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCC-------
Q 014210 314 RPDE-RLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEA------- 383 (429)
Q Consensus 314 ~~~~-~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~------- 383 (429)
.... ......++..|+|||++.+ .++.++||||||+++|+|++|+.||......+.+..+..........
T Consensus 154 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (294)
T PLN00009 154 GIPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTS 233 (294)
T ss_pred CCCccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccc
Confidence 4322 2234567899999998764 47889999999999999999999998777666555544321111110
Q ss_pred ------------------CCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhccce
Q 014210 384 ------------------PWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLICYQSY 424 (429)
Q Consensus 384 ------------------~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~~~ 424 (429)
..+.++.++.+||.+||+.||++||++.+++.|+||.....
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~~~ 292 (294)
T PLN00009 234 LPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLGD 292 (294)
T ss_pred chhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHHhc
Confidence 12457889999999999999999999999999999987654
|
|
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=327.15 Aligned_cols=254 Identities=20% Similarity=0.338 Sum_probs=210.9
Q ss_pred CceeEeceeeccCceEEEEEEEec-CcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe
Q 014210 155 NKYELGEEVGRGHFGYTCAAKFKK-GELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (429)
Q Consensus 155 ~~y~~~~~IG~G~fg~V~~~~~~~-~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~ 233 (429)
+.|++.++||+|+||.||+|.... +...++.||+|.+... .......++.+|+.++++++ |+||+++++++...+.
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~ 81 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDI--NNPQQWGEFQQEASLMAELH-HPNIVCLLGVVTQEQP 81 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCC--CCHHHHHHHHHHHHHHhhCC-CCCeeeEEEEEecCCc
Confidence 578999999999999999998643 2235789999998643 33455678899999999998 9999999999999999
Q ss_pred EEEEEEecCCCcHHHHHHhcC----------------CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecC
Q 014210 234 VYVVMELCEGGELLDRILSRG----------------GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKD 297 (429)
Q Consensus 234 ~~lv~E~~~ggsL~~~i~~~~----------------~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~ 297 (429)
.|+||||+++++|.+++..+. ..+++..+..++.||+.||.|||++||+||||||+|||+ +
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili---~ 158 (283)
T cd05090 82 VCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILI---G 158 (283)
T ss_pred eEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEE---c
Confidence 999999999999999885331 247889999999999999999999999999999999999 6
Q ss_pred CCceEEEeecCCccccCCCc---cccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHc-CCCCCCCCChHHHHHH
Q 014210 298 ENSVLKAIDFGLSDFVRPDE---RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRA 372 (429)
Q Consensus 298 ~~~~vkL~DFGla~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~ellt-g~~Pf~~~~~~~~~~~ 372 (429)
+++.+||+|||++....... ......++..|+|||++. +.++.++||||||+++|||++ |..||...........
T Consensus 159 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~ 238 (283)
T cd05090 159 EQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEM 238 (283)
T ss_pred CCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 77889999999997654332 123344567899999876 568999999999999999998 9999988776666555
Q ss_pred HHhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhH
Q 014210 373 VLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSEL 417 (429)
Q Consensus 373 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~ 417 (429)
+...... .....++.++.++|.+||+.||++||++.++++++
T Consensus 239 ~~~~~~~---~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l 280 (283)
T cd05090 239 VRKRQLL---PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRL 280 (283)
T ss_pred HHcCCcC---CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHh
Confidence 5443321 12346889999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-42 Score=331.01 Aligned_cols=256 Identities=28% Similarity=0.460 Sum_probs=205.1
Q ss_pred cCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~ 233 (429)
.++|++.+.||+|++|.||++..+. +|+.||||.+...... .....+.+|++++++++ |+||+++++++.+++.
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~---~~~~~~iK~~~~~~~~--~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~ 77 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKL---TGQLVALKEIRLEHEE--GAPFTAIREASLLKDLK-HANIVTLHDIIHTKKT 77 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcC---CCcEEEEEEEeccccc--CCchhHHHHHHHHhhCC-CcceeeEEEEEecCCe
Confidence 4689999999999999999998765 5889999998654221 12234678999999998 9999999999999999
Q ss_pred EEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCcccc
Q 014210 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (429)
Q Consensus 234 ~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~ 313 (429)
.++||||+.+ +|.+++......+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||++...
T Consensus 78 ~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~---~~~~~~kl~dfg~~~~~ 153 (291)
T cd07844 78 LTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLI---SERGELKLADFGLARAK 153 (291)
T ss_pred EEEEEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEE---cCCCCEEECcccccccc
Confidence 9999999975 8999887666689999999999999999999999999999999999999 77888999999998654
Q ss_pred CCCc-cccccccCCcccCcccccC--CCCCcccHHHHHHHHHHHHcCCCCCCCCC-hHHHHHHHHhcCCC----------
Q 014210 314 RPDE-RLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWART-ESGIFRAVLKADPS---------- 379 (429)
Q Consensus 314 ~~~~-~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlGvll~elltg~~Pf~~~~-~~~~~~~i~~~~~~---------- 379 (429)
.... ......++..|+|||++.+ .++.++||||||+++|+|++|+.||.... ..+.+..+.+....
T Consensus 154 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (291)
T cd07844 154 SVPSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVS 233 (291)
T ss_pred CCCCccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhh
Confidence 3221 1223356889999998753 47889999999999999999999997654 22222222111000
Q ss_pred ----C------------CCCCCCCCC--HHHHHHHHHhcccCccCcCCHHHHHhhHhh
Q 014210 380 ----F------------DEAPWPSLS--SEARDFVKRLLNKDPRKRLTAAQALSELLI 419 (429)
Q Consensus 380 ----~------------~~~~~~~~s--~~~~~li~~~L~~dP~~Rps~~~iL~~~~~ 419 (429)
. .....+.++ .++.+||.+||+.||++||++.+++.|+||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 234 SNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred hccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 0 000112344 888999999999999999999999999997
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=328.00 Aligned_cols=255 Identities=26% Similarity=0.407 Sum_probs=212.3
Q ss_pred cCceeEeceeeccCceEEEEEEEecC--cccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeC
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKG--ELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~--~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~ 231 (429)
..+|.+.+.||+|+||.||++..... ..++..+|+|.+... .....+.+.+|+++++++. |+||+++++++...
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~---~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~ 79 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---SDNARKDFHREAELLTNLQ-HEHIVKFYGVCVEG 79 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc---CHHHHHHHHHHHHHHHhCC-CCCcceEEEEEecC
Confidence 46799999999999999999986542 224567999988543 3455678999999999998 99999999999999
Q ss_pred CeEEEEEEecCCCcHHHHHHhcC------------CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCC
Q 014210 232 DNVYVVMELCEGGELLDRILSRG------------GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDEN 299 (429)
Q Consensus 232 ~~~~lv~E~~~ggsL~~~i~~~~------------~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~ 299 (429)
+..++||||+++++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||+ +++
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili---~~~ 156 (288)
T cd05093 80 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLV---GEN 156 (288)
T ss_pred CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEE---ccC
Confidence 99999999999999999886432 248999999999999999999999999999999999999 678
Q ss_pred ceEEEeecCCccccCCCcc---ccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHH
Q 014210 300 SVLKAIDFGLSDFVRPDER---LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVL 374 (429)
Q Consensus 300 ~~vkL~DFGla~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~ellt-g~~Pf~~~~~~~~~~~i~ 374 (429)
+.+||+|||++........ .....++..|+|||++. ..++.++||||||+++|+|++ |..||...........+.
T Consensus 157 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~ 236 (288)
T cd05093 157 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECIT 236 (288)
T ss_pred CcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 8999999999876543221 12334577899999887 468999999999999999998 999998877777777766
Q ss_pred hcCCCCCCCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHh
Q 014210 375 KADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELL 418 (429)
Q Consensus 375 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~ 418 (429)
....... ...++.++.+|+.+||+.||.+||++.+++..+-
T Consensus 237 ~~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~ 277 (288)
T cd05093 237 QGRVLQR---PRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQ 277 (288)
T ss_pred cCCcCCC---CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHH
Confidence 5442221 1357899999999999999999999999976543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-42 Score=322.82 Aligned_cols=253 Identities=35% Similarity=0.554 Sum_probs=214.2
Q ss_pred ceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEe--CCe
Q 014210 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED--TDN 233 (429)
Q Consensus 156 ~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~--~~~ 233 (429)
+|++.+.||.|+||.||++.... +|+.||+|++..... .....+++.+|++++++++ |+||+++++++.. +..
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~---~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~ 75 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKS---DGKILVWKEIDYGNM-TEKEKQQLVSEVNILRELK-HPNIVRYYDRIIDRSNQT 75 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecC---CCCEEEEEEEecccC-CHHHHHHHHHHHHHHHhcC-CCccceeeeeeecCCCCE
Confidence 58899999999999999998766 588999999865433 3455677899999999998 9999999998864 456
Q ss_pred EEEEEEecCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHH-----HcCceeccCCCCcEEEeecCCCceEEEe
Q 014210 234 VYVVMELCEGGELLDRILSR---GGKYTEDDAKAVMIQILNVVAFCH-----LQGVVHRDLKPENFLFTTKDENSVLKAI 305 (429)
Q Consensus 234 ~~lv~E~~~ggsL~~~i~~~---~~~l~~~~~~~i~~qi~~gL~~LH-----~~~iiHrDIKp~NILl~~~~~~~~vkL~ 305 (429)
.+++|||+++++|.+++... ...+++..++.++.||+.||.||| +.+|+|+||||+||++ +.++.+||+
T Consensus 76 ~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili---~~~~~~kl~ 152 (265)
T cd08217 76 LYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFL---DANNNVKLG 152 (265)
T ss_pred EEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEE---ecCCCEEEe
Confidence 89999999999999988653 567999999999999999999999 8899999999999999 677899999
Q ss_pred ecCCccccCCCcc-ccccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCC
Q 014210 306 DFGLSDFVRPDER-LNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEA 383 (429)
Q Consensus 306 DFGla~~~~~~~~-~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~ 383 (429)
|||++........ .....++..|+|||++.+ .++.++|+||||+++|+|++|+.||...........+...... .
T Consensus 153 d~g~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~---~ 229 (265)
T cd08217 153 DFGLAKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFR---R 229 (265)
T ss_pred cccccccccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCCC---C
Confidence 9999987754443 345678999999998864 5788999999999999999999999887755555555443321 1
Q ss_pred CCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhh
Q 014210 384 PWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLI 419 (429)
Q Consensus 384 ~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~ 419 (429)
....++.++.+|+.+||+.+|++||++.++++|+|+
T Consensus 230 ~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 230 IPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred CccccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence 223678999999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-42 Score=327.13 Aligned_cols=256 Identities=29% Similarity=0.518 Sum_probs=213.5
Q ss_pred ceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhc--CCCCcceEEEEEEeCCe
Q 014210 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALT--GHNNLVKFFDAYEDTDN 233 (429)
Q Consensus 156 ~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~--~h~nIv~l~~~~~~~~~ 233 (429)
.|++.+.||+|+||.||+|.... +|+.||||++... ......+++.+|+.+++++. .|+|++++++++.++..
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~---~~~~~~iK~~~~~--~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~ 76 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVP---TGRVVALKIINLD--TPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPR 76 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcC---CCcEEEEEEecCC--CCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCE
Confidence 58889999999999999998765 5899999998653 23345567889999999996 59999999999999999
Q ss_pred EEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCcccc
Q 014210 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (429)
Q Consensus 234 ~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~ 313 (429)
.++||||+++++|.+++.. +.+++..++.++.||+.||.|||+.||+|+||+|+||++ +.++.++|+|||++...
T Consensus 77 ~~lv~e~~~~~~L~~~~~~--~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i---~~~~~~~l~dfg~~~~~ 151 (277)
T cd06917 77 LWIIMEYAEGGSVRTLMKA--GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILV---TNTGNVKLCDFGVAALL 151 (277)
T ss_pred EEEEEecCCCCcHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEE---cCCCCEEEccCCceeec
Confidence 9999999999999987743 479999999999999999999999999999999999999 66888999999998776
Q ss_pred CCCc-cccccccCCcccCcccccC--CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCH
Q 014210 314 RPDE-RLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSS 390 (429)
Q Consensus 314 ~~~~-~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 390 (429)
.... ......|+..|+|||.+.+ .++.++|+||||+++|+|++|+.||...........+.... .+......++.
T Consensus 152 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 229 (277)
T cd06917 152 NQNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSK--PPRLEDNGYSK 229 (277)
T ss_pred CCCccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccCC--CCCCCcccCCH
Confidence 5433 2334578999999998764 46889999999999999999999998766544433332221 11222224788
Q ss_pred HHHHHHHHhcccCccCcCCHHHHHhhHhhhccc
Q 014210 391 EARDFVKRLLNKDPRKRLTAAQALSELLICYQS 423 (429)
Q Consensus 391 ~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~~ 423 (429)
++.+||.+||+.||++||++.+++.|+|++...
T Consensus 230 ~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~~~ 262 (277)
T cd06917 230 LLREFVAACLDEEPKERLSAEELLKSKWIKAHS 262 (277)
T ss_pred HHHHHHHHHcCCCcccCcCHHHHhhChHhhccc
Confidence 999999999999999999999999999997654
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=333.85 Aligned_cols=256 Identities=31% Similarity=0.461 Sum_probs=210.7
Q ss_pred CceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeC--C
Q 014210 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT--D 232 (429)
Q Consensus 155 ~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~--~ 232 (429)
++|++.+.||.|+||.||+|.... +++.+|+|.+...... ......+.+|+.+++++. |+||+++++++... +
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~---~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~ 79 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKK---TGEIVALKKLKMEKEK-EGFPITSLREINILLKLQ-HPNIVTVKEVVVGSNLD 79 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECC---CCcEEEEEEEeecccc-ccchhhHHHHHHHHHhcC-CCCEEEEEEEEEecCCC
Confidence 579999999999999999998765 5889999998654332 223345678999999998 99999999999887 8
Q ss_pred eEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccc
Q 014210 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (429)
Q Consensus 233 ~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~ 312 (429)
..||||||+++ +|.+.+......+++..++.++.||+.||+|||+.||+|+||||+|||+ +.++.+||+|||++..
T Consensus 80 ~~~lv~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili---~~~~~~~l~d~g~~~~ 155 (293)
T cd07843 80 KIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLL---NNRGILKICDFGLARE 155 (293)
T ss_pred cEEEEehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEE---CCCCcEEEeecCceee
Confidence 89999999975 8888876666679999999999999999999999999999999999999 7788999999999887
Q ss_pred cCCC-ccccccccCCcccCcccccC--CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCC---------
Q 014210 313 VRPD-ERLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSF--------- 380 (429)
Q Consensus 313 ~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~--------- 380 (429)
.... .......++..|+|||++.+ .++.++||||||+++|+|++|..||........+..+.......
T Consensus 156 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (293)
T cd07843 156 YGSPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFS 235 (293)
T ss_pred ccCCccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhh
Confidence 6543 23334567889999998864 36889999999999999999999998777665555443221100
Q ss_pred -----------------CCCCCCC--CCHHHHHHHHHhcccCccCcCCHHHHHhhHhh
Q 014210 381 -----------------DEAPWPS--LSSEARDFVKRLLNKDPRKRLTAAQALSELLI 419 (429)
Q Consensus 381 -----------------~~~~~~~--~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~ 419 (429)
....++. +++.+.+||++||+.||++||++.|+|.|+||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 236 ELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred ccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 0011122 48889999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-42 Score=325.75 Aligned_cols=254 Identities=26% Similarity=0.512 Sum_probs=210.4
Q ss_pred CceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeE
Q 014210 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (429)
Q Consensus 155 ~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~ 234 (429)
++|++.+.||+|+||.||+++... +|+.+|||.+...........+++.+|+.+++.+. |+||+++++++.+++..
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~---~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~ 77 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLL---DGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN-HPNVIKYYASFIEDNEL 77 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecC---CCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHcc-CCchhhhhheeEeCCeE
Confidence 478999999999999999998765 58899999887654455556678899999999997 99999999999999999
Q ss_pred EEEEEecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCcc
Q 014210 235 YVVMELCEGGELLDRILS---RGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (429)
Q Consensus 235 ~lv~E~~~ggsL~~~i~~---~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~ 311 (429)
+++|||+++++|.+++.. ....+++..++.++.||+.||.|||++||+|+||||+||++ +.++.++|+|||++.
T Consensus 78 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili---~~~~~~~l~dfg~~~ 154 (267)
T cd08229 78 NIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFI---TATGVVKLGDLGLGR 154 (267)
T ss_pred EEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---cCCCCEEECcchhhh
Confidence 999999999999987753 24568999999999999999999999999999999999999 677889999999987
Q ss_pred ccCCCcc-ccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHcCCCCCCCCChH--HHHHHHHhcCCCCCCCCCCC
Q 014210 312 FVRPDER-LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTES--GIFRAVLKADPSFDEAPWPS 387 (429)
Q Consensus 312 ~~~~~~~-~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~elltg~~Pf~~~~~~--~~~~~i~~~~~~~~~~~~~~ 387 (429)
....... .....|+..|+|||++. ..++.++||||||+++|+|++|..||...... .....+... ......+..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 232 (267)
T cd08229 155 FFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQC--DYPPLPSDH 232 (267)
T ss_pred ccccCCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcC--CCCCCCccc
Confidence 6643322 23457889999999886 45888999999999999999999999754432 222222221 222223345
Q ss_pred CCHHHHHHHHHhcccCccCcCCHHHHHhhH
Q 014210 388 LSSEARDFVKRLLNKDPRKRLTAAQALSEL 417 (429)
Q Consensus 388 ~s~~~~~li~~~L~~dP~~Rps~~~iL~~~ 417 (429)
++.++.+||.+||+.||.+|||+.+|++..
T Consensus 233 ~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~ 262 (267)
T cd08229 233 YSEELRQLVNMCINPDPEKRPDITYVYDVA 262 (267)
T ss_pred ccHHHHHHHHHhcCCCcccCCCHHHHHHHH
Confidence 789999999999999999999999887643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-42 Score=323.92 Aligned_cols=250 Identities=30% Similarity=0.544 Sum_probs=212.7
Q ss_pred eeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEecC
Q 014210 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCE 242 (429)
Q Consensus 163 IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~~lv~E~~~ 242 (429)
||.|+||.||+++... .++.||+|++.+.........+.+.+|+.+++++. |+||+++++++.+++..+++|||++
T Consensus 1 lg~g~~~~v~~~~~~~---~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~ 76 (262)
T cd05572 1 LGVGGFGRVELVKVKS---KNRTFALKCVKKRHIVETGQQEHIFSEKEILEECN-HPFIVKLYRTFKDKKYIYMLMEYCL 76 (262)
T ss_pred CCCCCceEEEEEEECC---CCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCC-CCCEeeeeeeEEcCCccEEEEecCC
Confidence 6999999999999765 58899999997665555556678999999999997 9999999999999999999999999
Q ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccccCCCcccccc
Q 014210 243 GGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDI 322 (429)
Q Consensus 243 ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~ 322 (429)
+++|.+++... ..+++..+..++.||+.||.|||++|++|+||||+||++ +.++.+||+|||++............
T Consensus 77 ~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv---~~~~~~~l~df~~~~~~~~~~~~~~~ 152 (262)
T cd05572 77 GGELWTILRDR-GLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLL---DSNGYVKLVDFGFAKKLKSGQKTWTF 152 (262)
T ss_pred CCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEE---cCCCCEEEeeCCcccccCcccccccc
Confidence 99999988543 568999999999999999999999999999999999999 67888999999999877654444456
Q ss_pred ccCCcccCccccc-CCCCCcccHHHHHHHHHHHHcCCCCCCCCC--hHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHh
Q 014210 323 VGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWART--ESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRL 399 (429)
Q Consensus 323 ~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~elltg~~Pf~~~~--~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~ 399 (429)
.++..|++||++. ..++.++|+||||+++|+|++|..||.... ....+..+........ .....+.++.+||++|
T Consensus 153 ~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~i~~~ 230 (262)
T cd05572 153 CGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLE--FPNYIDKAAKDLIKQL 230 (262)
T ss_pred cCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCC--CCcccCHHHHHHHHHH
Confidence 7899999999876 468899999999999999999999998766 4455555553221111 1124588999999999
Q ss_pred cccCccCcCC-----HHHHHhhHhhhcc
Q 014210 400 LNKDPRKRLT-----AAQALSELLICYQ 422 (429)
Q Consensus 400 L~~dP~~Rps-----~~~iL~~~~~~~~ 422 (429)
|+.||++|++ +.|+++|+||...
T Consensus 231 l~~~p~~R~~~~~~~~~~l~~~~~~~~~ 258 (262)
T cd05572 231 LRRNPEERLGNLKGGIKDIKKHKWFNGF 258 (262)
T ss_pred ccCChhhCcCCcccCHHHHhcChhhhCC
Confidence 9999999999 9999999999864
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=322.72 Aligned_cols=249 Identities=24% Similarity=0.428 Sum_probs=209.7
Q ss_pred cCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~ 233 (429)
.++|++.++||+|+||.||+|.... ++.||+|.+.... ...+.+.+|+.++++++ |+||+++++++.+.+.
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~----~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~ 75 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNN----STKVAVKTLKPGT----MSVQAFLEEANLMKTLQ-HDKLVRLYAVVTKEEP 75 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecC----CceEEEEEccCCc----hhHHHHHHHHHHHHhCC-CCCeeeEEEEEcCCCC
Confidence 4689999999999999999998553 5779999875432 23467899999999998 9999999999999999
Q ss_pred EEEEEEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccc
Q 014210 234 VYVVMELCEGGELLDRILSR-GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (429)
Q Consensus 234 ~~lv~E~~~ggsL~~~i~~~-~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~ 312 (429)
.+++|||+++++|.+++... ...+++..+..++.||+.||+|||+.+++||||||+||++ +.++.+||+|||++..
T Consensus 76 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili---~~~~~~~l~dfg~~~~ 152 (261)
T cd05072 76 IYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLV---SESLMCKIADFGLARV 152 (261)
T ss_pred cEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEe---cCCCcEEECCCcccee
Confidence 99999999999999988654 4578999999999999999999999999999999999999 6788999999999977
Q ss_pred cCCCcc--ccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCC
Q 014210 313 VRPDER--LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSL 388 (429)
Q Consensus 313 ~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 388 (429)
...... .....++..|+|||++. +.++.++||||||+++|+|++ |..||...........+..... ......+
T Consensus 153 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~ 229 (261)
T cd05072 153 IEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYR---MPRMENC 229 (261)
T ss_pred cCCCceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCC---CCCCCCC
Confidence 643321 12234567899999876 468889999999999999998 9999988877776666654322 1222468
Q ss_pred CHHHHHHHHHhcccCccCcCCHHHHHhhH
Q 014210 389 SSEARDFVKRLLNKDPRKRLTAAQALSEL 417 (429)
Q Consensus 389 s~~~~~li~~~L~~dP~~Rps~~~iL~~~ 417 (429)
+.++.+||.+||..||++||+++++++.+
T Consensus 230 ~~~~~~li~~~l~~~p~~Rp~~~~i~~~l 258 (261)
T cd05072 230 PDELYDIMKTCWKEKAEERPTFDYLQSVL 258 (261)
T ss_pred CHHHHHHHHHHccCCcccCcCHHHHHHHH
Confidence 89999999999999999999999998743
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-42 Score=330.21 Aligned_cols=255 Identities=29% Similarity=0.475 Sum_probs=209.1
Q ss_pred ceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEE
Q 014210 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVY 235 (429)
Q Consensus 156 ~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~~ 235 (429)
+|++.+.||.|+||.||+|+... +|+.||||++.... ......+.+.+|++++++++ |+||+++++++.+++..+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~---~~~~~~ik~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~ 75 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKL---TGEVVALKKIRLDT-ETEGVPSTAIREISLLKELN-HPNIVKLLDVIHTENKLY 75 (284)
T ss_pred CceeeeeecCCCceEEEEEEECC---CCCEEEEEEccccc-cccccchHHHHHHHHHHhcC-CCCCcchhhhcccCCcEE
Confidence 48899999999999999998765 58899999986543 22233457889999999998 999999999999999999
Q ss_pred EEEEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccccC
Q 014210 236 VVMELCEGGELLDRILSR-GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (429)
Q Consensus 236 lv~E~~~ggsL~~~i~~~-~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~ 314 (429)
+||||+. ++|.+++... ...+++..++.++.||+.||+|||+.|++|+||+|+||++ +.++.+||+|||++....
T Consensus 76 ~v~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill---~~~~~~~l~dfg~~~~~~ 151 (284)
T cd07860 76 LVFEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLI---NTEGAIKLADFGLARAFG 151 (284)
T ss_pred EEeeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCCEEEeeccchhhcc
Confidence 9999996 5888877653 4578999999999999999999999999999999999999 778889999999987654
Q ss_pred CCc-cccccccCCcccCcccccC--CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCC----------
Q 014210 315 PDE-RLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFD---------- 381 (429)
Q Consensus 315 ~~~-~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~---------- 381 (429)
... ......++..|+|||++.+ .++.++||||||+++|||++|+.||....+...+..+.+......
T Consensus 152 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd07860 152 VPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSL 231 (284)
T ss_pred cCccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHH
Confidence 322 2234467889999998764 368899999999999999999999987766554444332211110
Q ss_pred ---------------CCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhh
Q 014210 382 ---------------EAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLI 419 (429)
Q Consensus 382 ---------------~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~ 419 (429)
....+.++.++.+||.+||+.||++||++.+++.|+||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 232 PDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred HHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 01123578899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=327.01 Aligned_cols=255 Identities=26% Similarity=0.448 Sum_probs=212.9
Q ss_pred CceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeE
Q 014210 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (429)
Q Consensus 155 ~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~ 234 (429)
++|++.+.||+|+||.||++..+. +++.||+|++.... .....+++.+|+++++++. |+||+++++.+...+..
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~---~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~ 74 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRP---TGKIMAVKTIRLEI--NEAIQKQILRELDILHKCN-SPYIVGFYGAFYNNGDI 74 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcC---CCcEEEEEEEeccc--ChHHHHHHHHHHHHHHHCC-CCchhhhheeeecCCEE
Confidence 468889999999999999998775 58999999986642 2355677899999999998 99999999999999999
Q ss_pred EEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-cCceeccCCCCcEEEeecCCCceEEEeecCCcccc
Q 014210 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHL-QGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (429)
Q Consensus 235 ~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~-~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~ 313 (429)
+++|||+++++|.+++......+++..+..++.||+.||+|||+ .|++|+||||+||++ ++++.+||+|||.+...
T Consensus 75 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~---~~~~~~~l~d~g~~~~~ 151 (265)
T cd06605 75 SICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILV---NSRGQIKLCDFGVSGQL 151 (265)
T ss_pred EEEEEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEE---CCCCCEEEeecccchhh
Confidence 99999999999999887665789999999999999999999999 999999999999999 67888999999998765
Q ss_pred CCCccccccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHcCCCCCCCCC-----hHHHHHHHHhcCCCCCCCCCCC
Q 014210 314 RPDERLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWART-----ESGIFRAVLKADPSFDEAPWPS 387 (429)
Q Consensus 314 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~elltg~~Pf~~~~-----~~~~~~~i~~~~~~~~~~~~~~ 387 (429)
...... ...++..|+|||.+.+ .++.++||||||+++|+|++|+.||.... ....+..+..... .......
T Consensus 152 ~~~~~~-~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 228 (265)
T cd06605 152 VNSLAK-TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPP--PRLPSGK 228 (265)
T ss_pred HHHHhh-cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCC--CCCChhh
Confidence 432222 2678899999998864 58899999999999999999999996542 2223333333221 1111112
Q ss_pred CCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhc
Q 014210 388 LSSEARDFVKRLLNKDPRKRLTAAQALSELLICY 421 (429)
Q Consensus 388 ~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~ 421 (429)
++.++.+||.+||..||++||++.+++.|+||+.
T Consensus 229 ~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~ 262 (265)
T cd06605 229 FSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKK 262 (265)
T ss_pred cCHHHHHHHHHHcCCCchhCcCHHHHhhCchhhc
Confidence 7899999999999999999999999999999963
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-42 Score=333.14 Aligned_cols=260 Identities=28% Similarity=0.467 Sum_probs=215.3
Q ss_pred ccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCC
Q 014210 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (429)
Q Consensus 153 ~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~ 232 (429)
..++|.+.+.||+|+||.||++.... +|+.||+|.+.... ....+.+.+|+.+++.++ |+||+++++++..++
T Consensus 17 ~~~~y~~~~~lg~g~~g~v~~~~~~~---~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~ 89 (297)
T cd06656 17 PKKKYTRFEKIGQGASGTVYTAIDIA---TGQEVAIKQMNLQQ---QPKKELIINEILVMRENK-NPNIVNYLDSYLVGD 89 (297)
T ss_pred hhhhceeeeeeccCCCeEEEEEEECC---CCCEEEEEEEecCc---cchHHHHHHHHHHHHhCC-CCCEeeEEEEEecCC
Confidence 35789999999999999999998655 58899999986533 223466889999999997 999999999999999
Q ss_pred eEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccc
Q 014210 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (429)
Q Consensus 233 ~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~ 312 (429)
..++||||+++++|.+++.+ ..+++..+..++.|++.||.|||+.||+||||||+|||+ +.++.+||+|||++..
T Consensus 90 ~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili---~~~~~~~l~Dfg~~~~ 164 (297)
T cd06656 90 ELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILL---GMDGSVKLTDFGFCAQ 164 (297)
T ss_pred EEEEeecccCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEECcCccceE
Confidence 99999999999999998743 468999999999999999999999999999999999999 6788899999999876
Q ss_pred cCCCcc-ccccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCH
Q 014210 313 VRPDER-LNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSS 390 (429)
Q Consensus 313 ~~~~~~-~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 390 (429)
...... .....++..|+|||.+.+ .++.++||||||+++|+|++|..||...........+.... .........++.
T Consensus 165 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 243 (297)
T cd06656 165 ITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNG-TPELQNPERLSA 243 (297)
T ss_pred ccCCccCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCC-CCCCCCccccCH
Confidence 543332 234578899999998864 58899999999999999999999997765433322222211 111112245788
Q ss_pred HHHHHHHHhcccCccCcCCHHHHHhhHhhhcccee
Q 014210 391 EARDFVKRLLNKDPRKRLTAAQALSELLICYQSYL 425 (429)
Q Consensus 391 ~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~~~~ 425 (429)
.+.+||.+||..||++||++.+++.|+|++.....
T Consensus 244 ~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~ 278 (297)
T cd06656 244 VFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAKPL 278 (297)
T ss_pred HHHHHHHHHccCChhhCcCHHHHhcCchhcccccc
Confidence 99999999999999999999999999999866543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=323.27 Aligned_cols=253 Identities=22% Similarity=0.334 Sum_probs=208.8
Q ss_pred eeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe---
Q 014210 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN--- 233 (429)
Q Consensus 157 y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~--- 233 (429)
|.+++.||+|+||.||+|....+...+..||||++.... ......+.+.+|+.+++.+. |+||+++++++.+.+.
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~ 78 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDI-HTYSEIEEFLSEAACMKDFD-HPNVMKLIGVCFEASSLQK 78 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCc-CCHHHHHHHHHHHHHHHhCC-CCCeeeEEeeeccCCcccc
Confidence 568899999999999999887654456889999986543 33445678999999999998 9999999998876554
Q ss_pred ---EEEEEEecCCCcHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEe
Q 014210 234 ---VYVVMELCEGGELLDRILSR-----GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAI 305 (429)
Q Consensus 234 ---~~lv~E~~~ggsL~~~i~~~-----~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~ 305 (429)
.+++|||+++++|..++... ...+++..++.++.|++.||.|||+++|+||||||+||++ ++++.+||+
T Consensus 79 ~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~ 155 (273)
T cd05035 79 IPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCML---REDMTVCVA 155 (273)
T ss_pred CcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEE---CCCCeEEEC
Confidence 79999999999999887543 2368999999999999999999999999999999999999 778899999
Q ss_pred ecCCccccCCCccc---cccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCC
Q 014210 306 DFGLSDFVRPDERL---NDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSF 380 (429)
Q Consensus 306 DFGla~~~~~~~~~---~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~ 380 (429)
|||+++........ ....++..|+|||++. +.++.++||||||+++|||++ |..||........+..+.......
T Consensus 156 dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~ 235 (273)
T cd05035 156 DFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLK 235 (273)
T ss_pred CccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC
Confidence 99999866433221 1223567899999886 468999999999999999999 999998877777666665443211
Q ss_pred CCCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhH
Q 014210 381 DEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSEL 417 (429)
Q Consensus 381 ~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~ 417 (429)
....++.++.++|.+||+.||.+||++.+++.++
T Consensus 236 ---~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l 269 (273)
T cd05035 236 ---QPEDCLDELYDLMYSCWRADPKDRPTFTKLREVL 269 (273)
T ss_pred ---CCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 2236889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=321.78 Aligned_cols=255 Identities=31% Similarity=0.535 Sum_probs=211.2
Q ss_pred ceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEE
Q 014210 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVY 235 (429)
Q Consensus 156 ~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~~ 235 (429)
+|++.+.||+|+||.||++.... +++.||+|++...... ....+.+.+|+.++++++ |+||+++++++...+..+
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~---~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~~~~l~-~~~i~~~~~~~~~~~~~~ 75 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLD---TGELMAVKEIRIQDND-PKTIKEIADEMKVLELLK-HPNLVKYYGVEVHREKVY 75 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECC---CCcEEEEEEEECcccc-hHHHHHHHHHHHHHHhCC-CCChhheeeeEecCCEEE
Confidence 58999999999999999998765 5889999998765432 456788999999999998 999999999999999999
Q ss_pred EEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccccCC
Q 014210 236 VVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP 315 (429)
Q Consensus 236 lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~ 315 (429)
+|+||+++++|.+++.. ...+++..++.++.|++.||.|||+.||+|+||+|+||++ ++++.+||+|||++.....
T Consensus 76 lv~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~---~~~~~~kl~d~g~~~~~~~ 151 (264)
T cd06626 76 IFMEYCSGGTLEELLEH-GRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFL---DHNGVIKLGDFGCAVKLKN 151 (264)
T ss_pred EEEecCCCCcHHHHHhh-cCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEcccccccccCC
Confidence 99999999999998754 3568999999999999999999999999999999999999 6788899999999877644
Q ss_pred Ccc-----ccccccCCcccCcccccC-C---CCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCC
Q 014210 316 DER-----LNDIVGSAYYVAPEVLHR-S---YSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWP 386 (429)
Q Consensus 316 ~~~-----~~~~~gt~~y~aPE~~~~-~---~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 386 (429)
... .....++..|+|||++.+ . ++.++||||||+++|+|++|+.||.......................+.
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (264)
T cd06626 152 NTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSL 231 (264)
T ss_pred CCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCccc
Confidence 332 123567889999998864 3 7889999999999999999999997653332222222222222222233
Q ss_pred CCCHHHHHHHHHhcccCccCcCCHHHHHhhHhh
Q 014210 387 SLSSEARDFVKRLLNKDPRKRLTAAQALSELLI 419 (429)
Q Consensus 387 ~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~ 419 (429)
.++.++.+||++||+.||.+||++.+++.|+|+
T Consensus 232 ~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 232 QLSPEGKDFLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred ccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 468999999999999999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=325.18 Aligned_cols=256 Identities=27% Similarity=0.471 Sum_probs=211.1
Q ss_pred ceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCc-------CcHHHHHHHHHHHHHHHHhcCCCCcceEEEEE
Q 014210 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKM-------TTAIAIEDVRREVKILRALTGHNNLVKFFDAY 228 (429)
Q Consensus 156 ~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~-------~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~ 228 (429)
+|.+.+.||.|+||.||+|.... +|+.||||.+..... ......+.+.+|+.+++++. |+||+++++++
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~---~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~ 77 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVT---TGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLD-HLNIVQYLGFE 77 (272)
T ss_pred ceeecceecccCceEEEEEeecC---CCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcC-CCCcceEEEEe
Confidence 58899999999999999998665 588999998753211 11223456889999999998 99999999999
Q ss_pred EeCCeEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecC
Q 014210 229 EDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFG 308 (429)
Q Consensus 229 ~~~~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFG 308 (429)
...+..++||||+++++|.+++... +.+++..++.++.||+.||.|||+++++||||||+||++ +.++.+||+|||
T Consensus 78 ~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~---~~~~~~~l~d~~ 153 (272)
T cd06629 78 TTEEYLSIFLEYVPGGSIGSCLRTY-GRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLV---DADGICKISDFG 153 (272)
T ss_pred ccCCceEEEEecCCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEE---cCCCeEEEeecc
Confidence 9999999999999999999987544 679999999999999999999999999999999999999 778899999999
Q ss_pred CccccCCCc---cccccccCCcccCcccccC---CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhc--CCCC
Q 014210 309 LSDFVRPDE---RLNDIVGSAYYVAPEVLHR---SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKA--DPSF 380 (429)
Q Consensus 309 la~~~~~~~---~~~~~~gt~~y~aPE~~~~---~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~--~~~~ 380 (429)
++....... ......|+..|+|||++.. .++.++|+||||+++|+|++|..||........+..+... ...+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 233 (272)
T cd06629 154 ISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPI 233 (272)
T ss_pred ccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcC
Confidence 987654221 1234568899999998763 3788999999999999999999999765554444333222 2233
Q ss_pred CCCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhh
Q 014210 381 DEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLI 419 (429)
Q Consensus 381 ~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~ 419 (429)
+....+.++.++.+||.+||..||++||++.++|+|+|+
T Consensus 234 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 234 PPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred CccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 333445678999999999999999999999999999985
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=322.39 Aligned_cols=250 Identities=22% Similarity=0.375 Sum_probs=210.1
Q ss_pred cCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~ 233 (429)
..+|.+.++||+|+||.||+|...+ .++.||+|++... ....+++.+|+++++++. |+||+++++++..++.
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~---~~~~~~~K~~~~~----~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~ 76 (263)
T cd05052 5 RTDITMKHKLGGGQYGEVYEGVWKK---YSLTVAVKTLKED----TMEVEEFLKEAAVMKEIK-HPNLVQLLGVCTREPP 76 (263)
T ss_pred hHHeEEeeecCCcccceEEEEEEec---CCceEEEEEecCC----chHHHHHHHHHHHHHhCC-CCChhheEEEEcCCCC
Confidence 3569999999999999999998776 5889999998643 233567889999999998 9999999999999999
Q ss_pred EEEEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccc
Q 014210 234 VYVVMELCEGGELLDRILSRG-GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (429)
Q Consensus 234 ~~lv~E~~~ggsL~~~i~~~~-~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~ 312 (429)
++++|||+++++|.+++.... ..+++..++.++.|++.||+|||++||+||||||+|||+ ++++.+||+|||++..
T Consensus 77 ~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~---~~~~~~kl~df~~~~~ 153 (263)
T cd05052 77 FYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV---GENHLVKVADFGLSRL 153 (263)
T ss_pred cEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEE---cCCCcEEeCCCccccc
Confidence 999999999999999886543 468999999999999999999999999999999999999 6788899999999977
Q ss_pred cCCCccc--cccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCC
Q 014210 313 VRPDERL--NDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSL 388 (429)
Q Consensus 313 ~~~~~~~--~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 388 (429)
....... ....++..|+|||.+. +.++.++||||||+++|||++ |..||......+....+..... ......+
T Consensus 154 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~ 230 (263)
T cd05052 154 MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYR---MERPEGC 230 (263)
T ss_pred cccceeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCC---CCCCCCC
Confidence 6543221 1223456799999876 468899999999999999998 9999988776666665544321 1222468
Q ss_pred CHHHHHHHHHhcccCccCcCCHHHHHhhH
Q 014210 389 SSEARDFVKRLLNKDPRKRLTAAQALSEL 417 (429)
Q Consensus 389 s~~~~~li~~~L~~dP~~Rps~~~iL~~~ 417 (429)
+.++.+||.+||+.||++||++.++++.+
T Consensus 231 ~~~~~~li~~cl~~~p~~Rp~~~~l~~~l 259 (263)
T cd05052 231 PPKVYELMRACWQWNPSDRPSFAEIHQAF 259 (263)
T ss_pred CHHHHHHHHHHccCCcccCCCHHHHHHHH
Confidence 89999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-42 Score=332.12 Aligned_cols=257 Identities=29% Similarity=0.450 Sum_probs=204.3
Q ss_pred cCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCC-
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD- 232 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~- 232 (429)
.++|++.++||+|+||.||+++... +|+.||||++...... ......+.+|++++++++ |+||+++++++...+
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~---~~~~~aik~~~~~~~~-~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~ 85 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKK---TKQIVALKKVLMENEK-EGFPITALREIKILQLLK-HENVVNLIEICRTKAT 85 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECC---CCcEEEEEEEeccCCc-CCchhHHHHHHHHHHhCC-CCCccceEEEEecccc
Confidence 3579999999999999999998665 5899999988643222 222234678999999998 999999999987654
Q ss_pred -------eEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEe
Q 014210 233 -------NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAI 305 (429)
Q Consensus 233 -------~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~ 305 (429)
..++||||+. ++|.+.+......+++..++.++.||+.||.|||++||+|+||||+||++ +.++.+||+
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~---~~~~~~kl~ 161 (310)
T cd07865 86 PYNRYKGSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILI---TKDGILKLA 161 (310)
T ss_pred cccCCCceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE---CCCCcEEEC
Confidence 4599999996 48888887666689999999999999999999999999999999999999 778899999
Q ss_pred ecCCccccCCCcc-----ccccccCCcccCcccccC--CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCC
Q 014210 306 DFGLSDFVRPDER-----LNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADP 378 (429)
Q Consensus 306 DFGla~~~~~~~~-----~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~ 378 (429)
|||++........ .....++..|+|||++.+ .++.++||||||+++|||++|+.||...........+.....
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~ 241 (310)
T cd07865 162 DFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCG 241 (310)
T ss_pred cCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 9999876543221 123467889999998764 378899999999999999999999977665544333322111
Q ss_pred CCCCCCC----------------------------CCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhh
Q 014210 379 SFDEAPW----------------------------PSLSSEARDFVKRLLNKDPRKRLTAAQALSELLI 419 (429)
Q Consensus 379 ~~~~~~~----------------------------~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~ 419 (429)
..+...+ ...+..+.+||.+||+.||.+||++.++|+|+||
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 242 SITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred CCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 1111100 0125678899999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=345.55 Aligned_cols=259 Identities=26% Similarity=0.385 Sum_probs=219.8
Q ss_pred cCceeEeceeeccCceEEEEEEEecCcc-cCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCC
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGEL-KGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~ 232 (429)
.++-.+.++||+|.||.||+|+++.... ....||||....+.......+.++.+|.++++.|+ |+|||++||++.+..
T Consensus 156 H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~-H~NVVr~yGVa~~~~ 234 (474)
T KOG0194|consen 156 HSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLN-HPNVVRFYGVAVLEE 234 (474)
T ss_pred ccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCC-CCCEEEEEEEEcCCC
Confidence 4556678999999999999999987532 11239999987655566788899999999999998 999999999999999
Q ss_pred eEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccc
Q 014210 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (429)
Q Consensus 233 ~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~ 312 (429)
-++||||+|.||+|.+++.+..+.++..+...++.++++||+|||++++|||||-..|+|+ ..++.+||+|||+++.
T Consensus 235 Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~---~~~~~vKISDFGLs~~ 311 (474)
T KOG0194|consen 235 PLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLY---SKKGVVKISDFGLSRA 311 (474)
T ss_pred ccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHhee---cCCCeEEeCccccccC
Confidence 9999999999999999998877789999999999999999999999999999999999999 6677799999999876
Q ss_pred cCCCcccc-ccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCC
Q 014210 313 VRPDERLN-DIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLS 389 (429)
Q Consensus 313 ~~~~~~~~-~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 389 (429)
........ ...-...|+|||.+. +.|+.++|||||||++||+.+ |..||.+.........|.......... ...+
T Consensus 312 ~~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~--~~~p 389 (474)
T KOG0194|consen 312 GSQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIP--SKTP 389 (474)
T ss_pred CcceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCC--CCCH
Confidence 54211111 112457899999987 579999999999999999998 889999999998888886644333322 2678
Q ss_pred HHHHHHHHHhcccCccCcCCHHHHHhhHh
Q 014210 390 SEARDFVKRLLNKDPRKRLTAAQALSELL 418 (429)
Q Consensus 390 ~~~~~li~~~L~~dP~~Rps~~~iL~~~~ 418 (429)
.++..++.+|+..||++|+++.++.+.+-
T Consensus 390 ~~~~~~~~~c~~~~p~~R~tm~~i~~~l~ 418 (474)
T KOG0194|consen 390 KELAKVMKQCWKKDPEDRPTMSTIKKKLE 418 (474)
T ss_pred HHHHHHHHHhccCChhhccCHHHHHHHHH
Confidence 89999999999999999999999977543
|
|
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=328.67 Aligned_cols=256 Identities=27% Similarity=0.419 Sum_probs=204.7
Q ss_pred cCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~ 233 (429)
.++|.+.+.||+|+||.||+|.... +|+.||||++..... ......+.+|+.+++.+. |+||+++++++.+++.
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~---~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~ 77 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRI---NGQLVALKVISMKTE--EGVPFTAIREASLLKGLK-HANIVLLHDIIHTKET 77 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcC---CCcEEEEEEecccCc--CCCcHHHHHHHHHHHhcC-CCCEeEEEEEEecCCe
Confidence 5789999999999999999998765 588999999865432 222345678999999998 9999999999999999
Q ss_pred EEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCcccc
Q 014210 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (429)
Q Consensus 234 ~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~ 313 (429)
.++||||+. ++|.+++......+.+..++.++.||+.||.|||+.||+|+||||+|||+ +.++.+||+|||+++..
T Consensus 78 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~---~~~~~~~l~Dfg~~~~~ 153 (291)
T cd07870 78 LTFVFEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLI---SYLGELKLADFGLARAK 153 (291)
T ss_pred EEEEEeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEE---cCCCcEEEecccccccc
Confidence 999999995 68888776666678999999999999999999999999999999999999 67788999999998764
Q ss_pred CCC-ccccccccCCcccCcccccC--CCCCcccHHHHHHHHHHHHcCCCCCCCCChH-HHHHHHHhcC------------
Q 014210 314 RPD-ERLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTES-GIFRAVLKAD------------ 377 (429)
Q Consensus 314 ~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlGvll~elltg~~Pf~~~~~~-~~~~~i~~~~------------ 377 (429)
... .......++..|+|||++.+ .++.++||||||+++|||++|+.||...... +.+..+....
T Consensus 154 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (291)
T cd07870 154 SIPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVS 233 (291)
T ss_pred CCCCCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhh
Confidence 322 22334567899999998864 4788999999999999999999999765432 2222211100
Q ss_pred --CCCCC------------CCCC--CCCHHHHHHHHHhcccCccCcCCHHHHHhhHhh
Q 014210 378 --PSFDE------------APWP--SLSSEARDFVKRLLNKDPRKRLTAAQALSELLI 419 (429)
Q Consensus 378 --~~~~~------------~~~~--~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~ 419 (429)
+.+.. ..+. ..+.++.+||.+||..||++|||+.+++.|+||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 234 KLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred hcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 00000 0001 135789999999999999999999999999996
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=322.40 Aligned_cols=254 Identities=24% Similarity=0.401 Sum_probs=212.4
Q ss_pred CceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeE
Q 014210 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (429)
Q Consensus 155 ~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~ 234 (429)
.+|++.+.||+|+||.||+|+.+.....+..+|+|.+... ......+.+.+|+.++++++ ||||+++++++.+++..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~ 80 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAG--YTEKQRRDFLSEASIMGQFD-HPNIIHLEGVVTKSKPV 80 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCC--CCHHHHHHHHHHHHHHHhCC-CCCcceEEEEEecCCcc
Confidence 5799999999999999999987654334568999998653 23444578899999999998 99999999999999999
Q ss_pred EEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccccC
Q 014210 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (429)
Q Consensus 235 ~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~ 314 (429)
++||||+++++|.+++......+++..+..++.|++.||.|||++||+||||||+|||+ +.++.+||+|||++....
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili---~~~~~~~l~dfg~~~~~~ 157 (267)
T cd05066 81 MIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILV---NSNLVCKVSDFGLSRVLE 157 (267)
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEE---CCCCeEEeCCCCcccccc
Confidence 99999999999999987766789999999999999999999999999999999999999 678899999999998764
Q ss_pred CCccc----cccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCC
Q 014210 315 PDERL----NDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSL 388 (429)
Q Consensus 315 ~~~~~----~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 388 (429)
..... ....++..|+|||++. +.++.++|+||||+++|||++ |..||......+....+.... .. .....+
T Consensus 158 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~-~~--~~~~~~ 234 (267)
T cd05066 158 DDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGY-RL--PAPMDC 234 (267)
T ss_pred cccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCC-cC--CCCCCC
Confidence 33211 1122356799999887 468999999999999999886 999998877766666555432 11 122357
Q ss_pred CHHHHHHHHHhcccCccCcCCHHHHHhhH
Q 014210 389 SSEARDFVKRLLNKDPRKRLTAAQALSEL 417 (429)
Q Consensus 389 s~~~~~li~~~L~~dP~~Rps~~~iL~~~ 417 (429)
++++.+|+.+||+.+|.+||++.++++.+
T Consensus 235 ~~~~~~li~~~l~~~p~~Rp~~~~i~~~l 263 (267)
T cd05066 235 PAALHQLMLDCWQKDRNERPKFEQIVSIL 263 (267)
T ss_pred CHHHHHHHHHHcccCchhCCCHHHHHHHH
Confidence 89999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=322.68 Aligned_cols=254 Identities=24% Similarity=0.405 Sum_probs=211.9
Q ss_pred CceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeE
Q 014210 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (429)
Q Consensus 155 ~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~ 234 (429)
+.|++.+.||+|+||.||+|..+.....+..||||++... ......+++.+|+.+++++. |+||+++++++.+++..
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~ 80 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSG--YTEKQRRDFLSEASIMGQFD-HPNIIHLEGVVTKSRPV 80 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCC--CCHHHHHHHHHHHHHHHhCC-CcCcceEEEEECCCCce
Confidence 4689999999999999999998764333457999998653 24555678999999999998 99999999999999999
Q ss_pred EEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccccC
Q 014210 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (429)
Q Consensus 235 ~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~ 314 (429)
++||||+++++|.+++....+.+++..++.++.|++.||.|||++|++|+||||+||++ +.++.+||+|||++....
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili---~~~~~~kl~dfg~~~~~~ 157 (269)
T cd05065 81 MIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILV---NSNLVCKVSDFGLSRFLE 157 (269)
T ss_pred EEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEE---cCCCcEEECCCccccccc
Confidence 99999999999999887767789999999999999999999999999999999999999 678889999999987654
Q ss_pred CCcccc----ccc--cCCcccCccccc-CCCCCcccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCCCCC
Q 014210 315 PDERLN----DIV--GSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWP 386 (429)
Q Consensus 315 ~~~~~~----~~~--gt~~y~aPE~~~-~~~~~~sDiwSlGvll~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 386 (429)
...... ... .+..|+|||++. +.++.++||||||+++|||++ |..||+..........+.... ......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~---~~~~~~ 234 (269)
T cd05065 158 DDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDY---RLPPPM 234 (269)
T ss_pred cCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCC---cCCCcc
Confidence 322111 111 235799999886 568999999999999999886 999999887776666654322 112234
Q ss_pred CCCHHHHHHHHHhcccCccCcCCHHHHHhhH
Q 014210 387 SLSSEARDFVKRLLNKDPRKRLTAAQALSEL 417 (429)
Q Consensus 387 ~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~ 417 (429)
.++.++.+++.+||..+|.+||++.+++..+
T Consensus 235 ~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l 265 (269)
T cd05065 235 DCPTALHQLMLDCWQKDRNARPKFGQIVSTL 265 (269)
T ss_pred cCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 6789999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=346.71 Aligned_cols=240 Identities=27% Similarity=0.404 Sum_probs=204.2
Q ss_pred EeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEE
Q 014210 159 LGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVM 238 (429)
Q Consensus 159 ~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~~lv~ 238 (429)
.++=||.|+-|-||+|+++ ++.||||.++. .-..+|+-|++|+ |+||+.|.|+|....-+||||
T Consensus 128 ELeWlGSGaQGAVF~Grl~-----netVAVKKV~e----------lkETdIKHLRkLk-H~NII~FkGVCtqsPcyCIiM 191 (904)
T KOG4721|consen 128 ELEWLGSGAQGAVFLGRLH-----NETVAVKKVRE----------LKETDIKHLRKLK-HPNIITFKGVCTQSPCYCIIM 191 (904)
T ss_pred hhhhhccCcccceeeeecc-----CceehhHHHhh----------hhhhhHHHHHhcc-CcceeeEeeeecCCceeEEee
Confidence 3667999999999999865 57899997632 1236888899999 999999999999999999999
Q ss_pred EecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccccCCCcc
Q 014210 239 ELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDER 318 (429)
Q Consensus 239 E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 318 (429)
|||..|.|...+ +.+..++......|..+|+.|+.|||.++|||||||.-||||+ .+..|||+|||.++.......
T Consensus 192 EfCa~GqL~~VL-ka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs---~~d~VKIsDFGTS~e~~~~ST 267 (904)
T KOG4721|consen 192 EFCAQGQLYEVL-KAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILIS---YDDVVKISDFGTSKELSDKST 267 (904)
T ss_pred eccccccHHHHH-hccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEee---ccceEEeccccchHhhhhhhh
Confidence 999999999866 5567899999999999999999999999999999999999995 455699999999988876666
Q ss_pred ccccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHH
Q 014210 319 LNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVK 397 (429)
Q Consensus 319 ~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 397 (429)
...++||..|||||++++ ..+.|+|||||||+|||||||..||..-....++..+-. ..........+++-|+-||+
T Consensus 268 kMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGs--NsL~LpvPstcP~GfklL~K 345 (904)
T KOG4721|consen 268 KMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGS--NSLHLPVPSTCPDGFKLLLK 345 (904)
T ss_pred hhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccC--CcccccCcccCchHHHHHHH
Confidence 678899999999999985 689999999999999999999999976554433322211 12222334568899999999
Q ss_pred HhcccCccCcCCHHHHHhhHhhh
Q 014210 398 RLLNKDPRKRLTAAQALSELLIC 420 (429)
Q Consensus 398 ~~L~~dP~~Rps~~~iL~~~~~~ 420 (429)
+||+-.|..||++.+||.|+=+.
T Consensus 346 qcw~sKpRNRPSFrqil~HldIa 368 (904)
T KOG4721|consen 346 QCWNSKPRNRPSFRQILLHLDIA 368 (904)
T ss_pred HHHhcCCCCCccHHHHHHHHhhc
Confidence 99999999999999999998664
|
|
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-42 Score=327.91 Aligned_cols=254 Identities=19% Similarity=0.306 Sum_probs=211.7
Q ss_pred CceeEeceeeccCceEEEEEEEecCc--ccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCC
Q 014210 155 NKYELGEEVGRGHFGYTCAAKFKKGE--LKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (429)
Q Consensus 155 ~~y~~~~~IG~G~fg~V~~~~~~~~~--~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~ 232 (429)
.+|++.++||+|+||.||+|...... ..++.||||++... ......+.+.+|+.++..+. |+||+++++++.+.+
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~~~~l~-h~~iv~~~~~~~~~~ 81 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDK--AEGPLREEFKHEAMMRSRLQ-HPNIVCLLGVVTKEQ 81 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCC--CCHHHHHHHHHHHHHHhcCC-CCCcCeEEEEEcCCC
Confidence 46889999999999999999876421 24688999998754 23444577899999999998 999999999999999
Q ss_pred eEEEEEEecCCCcHHHHHHhc---------------CCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecC
Q 014210 233 NVYVVMELCEGGELLDRILSR---------------GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKD 297 (429)
Q Consensus 233 ~~~lv~E~~~ggsL~~~i~~~---------------~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~ 297 (429)
..++++||+.+++|.+++..+ ...+++..++.++.|++.||.|||++||+||||||+|||+ +
T Consensus 82 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~---~ 158 (283)
T cd05091 82 PLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLV---F 158 (283)
T ss_pred ceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEe---c
Confidence 999999999999999988532 2358889999999999999999999999999999999999 6
Q ss_pred CCceEEEeecCCccccCCCcc---ccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHc-CCCCCCCCChHHHHHH
Q 014210 298 ENSVLKAIDFGLSDFVRPDER---LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRA 372 (429)
Q Consensus 298 ~~~~vkL~DFGla~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~ellt-g~~Pf~~~~~~~~~~~ 372 (429)
+++.+||+|||+++....... .....++..|+|||++. +.++.++||||||+++|||++ |..||......+.+..
T Consensus 159 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~ 238 (283)
T cd05091 159 DKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEM 238 (283)
T ss_pred CCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 777899999999876543221 22344677899999875 578999999999999999998 8889988777777777
Q ss_pred HHhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhH
Q 014210 373 VLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSEL 417 (429)
Q Consensus 373 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~ 417 (429)
+....... ....++.++.+|+.+||+.+|++||++.+|++.+
T Consensus 239 i~~~~~~~---~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l 280 (283)
T cd05091 239 IRNRQVLP---CPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRL 280 (283)
T ss_pred HHcCCcCC---CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHh
Confidence 66654322 1246889999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-42 Score=328.57 Aligned_cols=252 Identities=25% Similarity=0.392 Sum_probs=201.0
Q ss_pred eeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhc--CCCCcceEEEEEEeCCeEEEEEE
Q 014210 162 EVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALT--GHNNLVKFFDAYEDTDNVYVVME 239 (429)
Q Consensus 162 ~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~--~h~nIv~l~~~~~~~~~~~lv~E 239 (429)
.||+|+||.||++.... +|+.+|||++.+.............+|..+++.+. +|+||+.+++++..++..++|||
T Consensus 1 ~lg~G~~g~Vy~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e 77 (279)
T cd05633 1 IIGRGGFGEVYGCRKAD---TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILD 77 (279)
T ss_pred CcccCCCeEEEEEEECC---CCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEe
Confidence 48999999999998765 58999999987654433333344455555544432 49999999999999999999999
Q ss_pred ecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccccCCCccc
Q 014210 240 LCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERL 319 (429)
Q Consensus 240 ~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 319 (429)
|+++++|.+++.. .+.+++..+..++.||+.||.|||+.||+||||||+|||+ ++++.+||+|||++...... ..
T Consensus 78 ~~~~~~L~~~i~~-~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~---~~~~~~~l~dfg~~~~~~~~-~~ 152 (279)
T cd05633 78 LMNGGDLHYHLSQ-HGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILL---DEHGHVRISDLGLACDFSKK-KP 152 (279)
T ss_pred cCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEE---CCCCCEEEccCCcceecccc-Cc
Confidence 9999999887754 4579999999999999999999999999999999999999 77889999999998655432 22
Q ss_pred cccccCCcccCccccc--CCCCCcccHHHHHHHHHHHHcCCCCCCCCChH--HHHHHHHhcCCCCCCCCCCCCCHHHHHH
Q 014210 320 NDIVGSAYYVAPEVLH--RSYSTEADVWSIGVIAYILLCGSRPFWARTES--GIFRAVLKADPSFDEAPWPSLSSEARDF 395 (429)
Q Consensus 320 ~~~~gt~~y~aPE~~~--~~~~~~sDiwSlGvll~elltg~~Pf~~~~~~--~~~~~i~~~~~~~~~~~~~~~s~~~~~l 395 (429)
....|+..|+|||++. ..++.++|||||||++|+|++|+.||...... ....... ........+.++.++.+|
T Consensus 153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~l 229 (279)
T cd05633 153 HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT---LTVNVELPDSFSPELKSL 229 (279)
T ss_pred cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHh---hcCCcCCccccCHHHHHH
Confidence 3457899999999875 34789999999999999999999999754321 1121111 111222334688999999
Q ss_pred HHHhcccCccCcC-----CHHHHHhhHhhhccce
Q 014210 396 VKRLLNKDPRKRL-----TAAQALSELLICYQSY 424 (429)
Q Consensus 396 i~~~L~~dP~~Rp-----s~~~iL~~~~~~~~~~ 424 (429)
|++||+.||++|+ ++.++++|+||+.-.+
T Consensus 230 i~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~~ 263 (279)
T cd05633 230 LEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGIDW 263 (279)
T ss_pred HHHHhcCCHHHhcCCCCCCHHHHHhCccccCCCH
Confidence 9999999999999 6999999999987554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=326.44 Aligned_cols=254 Identities=20% Similarity=0.309 Sum_probs=206.7
Q ss_pred ccCceeEeceeeccCceEEEEEEEecC--cccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEe
Q 014210 153 FANKYELGEEVGRGHFGYTCAAKFKKG--ELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED 230 (429)
Q Consensus 153 ~~~~y~~~~~IG~G~fg~V~~~~~~~~--~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~ 230 (429)
..++|++.++||+|+||.||+|..+.. ...+..||+|.+.... .......+.+|+.+++++. |+||+++++++.+
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~ 80 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA--SLRERIEFLNEASVMKGFT-CHHVVRLLGVVSK 80 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC--CHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEcC
Confidence 357899999999999999999976531 1246689999986442 2334456789999999998 9999999999999
Q ss_pred CCeEEEEEEecCCCcHHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCce
Q 014210 231 TDNVYVVMELCEGGELLDRILSRG---------GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSV 301 (429)
Q Consensus 231 ~~~~~lv~E~~~ggsL~~~i~~~~---------~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~ 301 (429)
.+..++||||+++|+|.+++.... ..+++..+..++.||+.||.|||+++|+||||||+|||+ ++++.
T Consensus 81 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili---~~~~~ 157 (288)
T cd05061 81 GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMV---AHDFT 157 (288)
T ss_pred CCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEE---cCCCc
Confidence 999999999999999999986532 235678899999999999999999999999999999999 67888
Q ss_pred EEEeecCCccccCCCcc---ccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhc
Q 014210 302 LKAIDFGLSDFVRPDER---LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKA 376 (429)
Q Consensus 302 vkL~DFGla~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~ellt-g~~Pf~~~~~~~~~~~i~~~ 376 (429)
+||+|||+++....... .....++..|+|||.+. +.++.++|||||||++|||++ |..||......+....+...
T Consensus 158 ~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~ 237 (288)
T cd05061 158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDG 237 (288)
T ss_pred EEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence 99999999875533221 11224567899999876 568999999999999999998 78899887776666655543
Q ss_pred CCCCCCCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHh
Q 014210 377 DPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALS 415 (429)
Q Consensus 377 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~ 415 (429)
..... ....+.++.+||.+||+.||++||++.++++
T Consensus 238 ~~~~~---~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 273 (288)
T cd05061 238 GYLDQ---PDNCPERVTDLMRMCWQFNPKMRPTFLEIVN 273 (288)
T ss_pred CCCCC---CCCCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 22111 1246789999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=329.82 Aligned_cols=253 Identities=28% Similarity=0.486 Sum_probs=211.6
Q ss_pred CceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeE
Q 014210 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (429)
Q Consensus 155 ~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~ 234 (429)
+.|+..+.||+|+||.||+|.... .|+.||+|++.... .....+.+.+|+++++++. |+||+++++++..++..
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~---~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~ 77 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNR---TKEVVAIKIIDLEE--AEDEIEDIQQEITVLSQCD-SPYITRYYGSYLKGTKL 77 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcC---CCeEEEEEEecccc--chHHHHHHHHHHHHHHcCC-CCccHhhhcccccCCce
Confidence 467888999999999999998765 57899999986442 2345578999999999998 99999999999999999
Q ss_pred EEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccccC
Q 014210 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (429)
Q Consensus 235 ~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~ 314 (429)
++||||+++++|.+++. .+.+++..++.++.||+.||.|||++|++|+||+|+||++ ++++.+||+|||++....
T Consensus 78 ~lv~e~~~~~~L~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i---~~~~~~~l~dfg~~~~~~ 152 (277)
T cd06642 78 WIIMEYLGGGSALDLLK--PGPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLL---SEQGDVKLADFGVAGQLT 152 (277)
T ss_pred EEEEEccCCCcHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEE---eCCCCEEEcccccccccc
Confidence 99999999999998773 3578999999999999999999999999999999999999 677889999999997665
Q ss_pred CCc-cccccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHH
Q 014210 315 PDE-RLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEA 392 (429)
Q Consensus 315 ~~~-~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 392 (429)
... ......++..|+|||++.+ .++.++||||||+++|||++|+.||...........+...... .....++.++
T Consensus 153 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~ 229 (277)
T cd06642 153 DTQIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPP---TLEGQYSKPF 229 (277)
T ss_pred CcchhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCCCC---CCCcccCHHH
Confidence 332 2233468899999998874 5888999999999999999999999766554444333222211 1112578899
Q ss_pred HHHHHHhcccCccCcCCHHHHHhhHhhhc
Q 014210 393 RDFVKRLLNKDPRKRLTAAQALSELLICY 421 (429)
Q Consensus 393 ~~li~~~L~~dP~~Rps~~~iL~~~~~~~ 421 (429)
.+||.+||+.+|++||++.+++.|+|+..
T Consensus 230 ~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 258 (277)
T cd06642 230 KEFVEACLNKDPRFRPTAKELLKHKFITR 258 (277)
T ss_pred HHHHHHHccCCcccCcCHHHHHHhHHHHH
Confidence 99999999999999999999999999864
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=326.86 Aligned_cols=256 Identities=24% Similarity=0.421 Sum_probs=211.6
Q ss_pred cCceeEeceeeccCceEEEEEEEecCc--ccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeC
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGE--LKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~--~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~ 231 (429)
.++|++.+.||+|+||.||++...... .....+|+|++... .......++.+|+.+++++.+|+||+++++++..+
T Consensus 11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 88 (293)
T cd05053 11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDD--ATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE 88 (293)
T ss_pred HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCC--CCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC
Confidence 578999999999999999999876432 24578999998654 23445567899999999995599999999999999
Q ss_pred CeEEEEEEecCCCcHHHHHHhc---------------CCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeec
Q 014210 232 DNVYVVMELCEGGELLDRILSR---------------GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTK 296 (429)
Q Consensus 232 ~~~~lv~E~~~ggsL~~~i~~~---------------~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~ 296 (429)
+..+++|||+++|+|.+++..+ ...+++..+..++.||+.||.|||+.||+||||||+|||+
T Consensus 89 ~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~--- 165 (293)
T cd05053 89 GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLV--- 165 (293)
T ss_pred CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEE---
Confidence 9999999999999999988642 3468999999999999999999999999999999999999
Q ss_pred CCCceEEEeecCCccccCCCcc---ccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHc-CCCCCCCCChHHHHH
Q 014210 297 DENSVLKAIDFGLSDFVRPDER---LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFR 371 (429)
Q Consensus 297 ~~~~~vkL~DFGla~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~ellt-g~~Pf~~~~~~~~~~ 371 (429)
+.++.+||+|||++........ .....++..|+|||++. ..++.++|||||||++|||++ |..||........+.
T Consensus 166 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~ 245 (293)
T cd05053 166 TEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFK 245 (293)
T ss_pred cCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHH
Confidence 6788999999999986543321 11223456799999876 468999999999999999997 999998877666665
Q ss_pred HHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhH
Q 014210 372 AVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSEL 417 (429)
Q Consensus 372 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~ 417 (429)
.+..... .. .....+.++.+||.+||..||++|||+.++++++
T Consensus 246 ~~~~~~~-~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l 288 (293)
T cd05053 246 LLKEGYR-ME--KPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDL 288 (293)
T ss_pred HHHcCCc-CC--CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHH
Confidence 5544321 11 2235789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=363.66 Aligned_cols=255 Identities=27% Similarity=0.405 Sum_probs=208.3
Q ss_pred CceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeE
Q 014210 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (429)
Q Consensus 155 ~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~ 234 (429)
++|++.++||+|+||.||+|+... +|+.||||++...........+++.+|+++++++. ||||+++++++.+++..
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~---tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~-HPNIVkl~~v~~d~~~l 77 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPV---CSRRVALKKIREDLSENPLLKKRFLREAKIAADLI-HPGIVPVYSICSDGDPV 77 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECC---CCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCC-CcCcCeEEEEEeeCCEE
Confidence 579999999999999999998765 58999999997654445556678999999999998 99999999999999999
Q ss_pred EEEEEecCCCcHHHHHHhc----------CCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEE
Q 014210 235 YVVMELCEGGELLDRILSR----------GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKA 304 (429)
Q Consensus 235 ~lv~E~~~ggsL~~~i~~~----------~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL 304 (429)
++||||++|++|.+++... ...+++..+..++.||++||+|||++||+||||||+|||+ +.++.+||
T Consensus 78 yLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILL---d~dg~vKL 154 (932)
T PRK13184 78 YYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILL---GLFGEVVI 154 (932)
T ss_pred EEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEE---cCCCCEEE
Confidence 9999999999999987532 1345677889999999999999999999999999999999 77888999
Q ss_pred eecCCccccCCCc-------------------cccccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHcCCCCCCCC
Q 014210 305 IDFGLSDFVRPDE-------------------RLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWAR 364 (429)
Q Consensus 305 ~DFGla~~~~~~~-------------------~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~elltg~~Pf~~~ 364 (429)
+|||++....... .....+||+.|||||++.+ .++.++|||||||++|||++|+.||...
T Consensus 155 iDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~ 234 (932)
T PRK13184 155 LDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRK 234 (932)
T ss_pred EecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCc
Confidence 9999997652110 1123579999999998864 6899999999999999999999999775
Q ss_pred ChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhH
Q 014210 365 TESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSEL 417 (429)
Q Consensus 365 ~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~ 417 (429)
.............+ ....++..+++.+.+++.+||+.||++|++..+.+.+.
T Consensus 235 ~~~ki~~~~~i~~P-~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~ 286 (932)
T PRK13184 235 KGRKISYRDVILSP-IEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQD 286 (932)
T ss_pred chhhhhhhhhccCh-hhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 54433322111111 11123346889999999999999999998877766654
|
|
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=319.52 Aligned_cols=248 Identities=27% Similarity=0.432 Sum_probs=211.5
Q ss_pred ceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEe
Q 014210 161 EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMEL 240 (429)
Q Consensus 161 ~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~~lv~E~ 240 (429)
+.||+|+||.||++........+..|++|++....... ..+.+.+|+++++.+. |+||+++++++.+.+..++||||
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~lv~e~ 77 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE--ERKDFLKEARVMKKLG-HPNVVRLLGVCTEEEPLYLVLEY 77 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh--HHHHHHHHHHHHhhcC-CCChheeeeeecCCCceEEEEEe
Confidence 47999999999999987643347899999987653222 5678999999999998 99999999999999999999999
Q ss_pred cCCCcHHHHHHhc--------CCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccc
Q 014210 241 CEGGELLDRILSR--------GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (429)
Q Consensus 241 ~~ggsL~~~i~~~--------~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~ 312 (429)
+++++|.+++... ...+++..++.++.||+.||+|||++||+||||||+||++ +.++.+||+|||.+..
T Consensus 78 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili---~~~~~~~l~dfg~~~~ 154 (262)
T cd00192 78 MEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLV---GEDLVVKISDFGLSRD 154 (262)
T ss_pred ccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEE---CCCCcEEEcccccccc
Confidence 9999999998765 4789999999999999999999999999999999999999 7778999999999987
Q ss_pred cCCCc---cccccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCC
Q 014210 313 VRPDE---RLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPS 387 (429)
Q Consensus 313 ~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 387 (429)
..... ......++..|+|||++.. .++.++||||||+++|+|++ |..||...........+...... .....
T Consensus 155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~ 231 (262)
T cd00192 155 VYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRL---PKPEY 231 (262)
T ss_pred cccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC---CCCcc
Confidence 65432 2334567889999998864 68899999999999999999 69999888777777666653211 12235
Q ss_pred CCHHHHHHHHHhcccCccCcCCHHHHHhhH
Q 014210 388 LSSEARDFVKRLLNKDPRKRLTAAQALSEL 417 (429)
Q Consensus 388 ~s~~~~~li~~~L~~dP~~Rps~~~iL~~~ 417 (429)
++.++.++|.+||+.||++||++.+++.++
T Consensus 232 ~~~~~~~li~~~l~~~p~~Rps~~~l~~~l 261 (262)
T cd00192 232 CPDELYELMLSCWQLDPEDRPTFSELVERL 261 (262)
T ss_pred CChHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=320.85 Aligned_cols=254 Identities=30% Similarity=0.485 Sum_probs=213.4
Q ss_pred ceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCc--CcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe
Q 014210 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKM--TTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (429)
Q Consensus 156 ~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~--~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~ 233 (429)
+|+..+.||+|+||.||+|.... +++.|++|++..... ...+..+.+.+|+.++++++ |+||+++++++.+++.
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~---~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~ 76 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLD---DGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQ-HPNIVQYLGTEREEDN 76 (258)
T ss_pred CccccceeeecCCceEEEEEEcC---CCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcC-CCCchheeeeEecCCe
Confidence 47788999999999999998765 488999999865332 23445678999999999997 9999999999999999
Q ss_pred EEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCcccc
Q 014210 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (429)
Q Consensus 234 ~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~ 313 (429)
.+++|||+++++|.+++.. ...+++..+..++.||+.||.|||+.||+|+||+|+||++ +.++.+||+|||++...
T Consensus 77 ~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~---~~~~~~kl~d~~~~~~~ 152 (258)
T cd06632 77 LYIFLELVPGGSLAKLLKK-YGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILV---DTNGVVKLADFGMAKQV 152 (258)
T ss_pred EEEEEEecCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEccCccceec
Confidence 9999999999999988754 3568999999999999999999999999999999999999 67889999999998776
Q ss_pred CCCccccccccCCcccCcccccC-C-CCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHH
Q 014210 314 RPDERLNDIVGSAYYVAPEVLHR-S-YSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSE 391 (429)
Q Consensus 314 ~~~~~~~~~~gt~~y~aPE~~~~-~-~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 391 (429)
..........|+..|++||.+.. . ++.++|+||||+++|+|++|+.||...........+..... . ......++++
T Consensus 153 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~-~-~~~~~~~~~~ 230 (258)
T cd06632 153 VEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKE-L-PPIPDHLSDE 230 (258)
T ss_pred cccccccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhccc-C-CCcCCCcCHH
Confidence 54444455678999999998753 4 78999999999999999999999977665444444333111 1 1122467899
Q ss_pred HHHHHHHhcccCccCcCCHHHHHhhHhh
Q 014210 392 ARDFVKRLLNKDPRKRLTAAQALSELLI 419 (429)
Q Consensus 392 ~~~li~~~L~~dP~~Rps~~~iL~~~~~ 419 (429)
+.+||++||+.||.+||++.+++.|+|+
T Consensus 231 ~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 231 AKDFILKCLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred HHHHHHHHhhcCcccCcCHHHHhcCCCC
Confidence 9999999999999999999999999985
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=329.26 Aligned_cols=257 Identities=23% Similarity=0.399 Sum_probs=210.6
Q ss_pred cCceeEeceeeccCceEEEEEEEecCc----ccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEE
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGE----LKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYE 229 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~----~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~ 229 (429)
.++|.+.+.||+|+||.||+++..... ..+..+|+|++... .......++.+|+.+++++.+|+||+++++++.
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSD--ATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 94 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCC--CChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEe
Confidence 478999999999999999999864311 23467999998754 234455678899999999966999999999999
Q ss_pred eCCeEEEEEEecCCCcHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEe
Q 014210 230 DTDNVYVVMELCEGGELLDRILSRG---------------GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFT 294 (429)
Q Consensus 230 ~~~~~~lv~E~~~ggsL~~~i~~~~---------------~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~ 294 (429)
+.+..|+||||+++|+|.+++..+. ..+++..+..++.||+.||+|||++|++||||||+|||+
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill- 173 (307)
T cd05098 95 QDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV- 173 (307)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEE-
Confidence 9999999999999999999987542 258899999999999999999999999999999999999
Q ss_pred ecCCCceEEEeecCCccccCCCcc---ccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHc-CCCCCCCCChHHH
Q 014210 295 TKDENSVLKAIDFGLSDFVRPDER---LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGI 369 (429)
Q Consensus 295 ~~~~~~~vkL~DFGla~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~ellt-g~~Pf~~~~~~~~ 369 (429)
+.++.+||+|||++........ .....++..|+|||++. +.++.++|||||||++|||++ |..||......+.
T Consensus 174 --~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~ 251 (307)
T cd05098 174 --TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 251 (307)
T ss_pred --cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHH
Confidence 6778899999999876543221 11223456899999876 458899999999999999998 8899987776666
Q ss_pred HHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHh
Q 014210 370 FRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELL 418 (429)
Q Consensus 370 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~ 418 (429)
+..+..... . .....++.++.+||.+||..+|++||++.+++.++.
T Consensus 252 ~~~~~~~~~-~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~ 297 (307)
T cd05098 252 FKLLKEGHR-M--DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 297 (307)
T ss_pred HHHHHcCCC-C--CCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHH
Confidence 555543321 1 122367899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=326.98 Aligned_cols=258 Identities=22% Similarity=0.276 Sum_probs=210.7
Q ss_pred cCceeEeceeeccCceEEEEEEEecCc-------------ccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCC
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGE-------------LKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNN 220 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~-------------~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~n 220 (429)
.++|+++++||+|+||.||++...... ..+..||+|++... ......+.+.+|++++++++ |+|
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~--~~~~~~~~~~~e~~~l~~l~-~~~ 80 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPD--ASDNAREDFLKEVKILSRLS-DPN 80 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCc--cCHHHHHHHHHHHHHHHhcC-CCC
Confidence 468999999999999999999865422 12467999998754 23355678999999999998 999
Q ss_pred cceEEEEEEeCCeEEEEEEecCCCcHHHHHHhcC----------CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCc
Q 014210 221 LVKFFDAYEDTDNVYVVMELCEGGELLDRILSRG----------GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPEN 290 (429)
Q Consensus 221 Iv~l~~~~~~~~~~~lv~E~~~ggsL~~~i~~~~----------~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~N 290 (429)
|+++++++..++..+++|||+++++|.+++.... ..+++..++.++.||+.||.|||+.||+||||||+|
T Consensus 81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~N 160 (296)
T cd05051 81 IARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRN 160 (296)
T ss_pred EeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhc
Confidence 9999999999999999999999999999886543 268999999999999999999999999999999999
Q ss_pred EEEeecCCCceEEEeecCCccccCCCc---cccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHc--CCCCCCCC
Q 014210 291 FLFTTKDENSVLKAIDFGLSDFVRPDE---RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC--GSRPFWAR 364 (429)
Q Consensus 291 ILl~~~~~~~~vkL~DFGla~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~ellt--g~~Pf~~~ 364 (429)
|++ +.++.++|+|||++....... ......++..|+|||++. +.++.++||||||+++|||++ +..||...
T Consensus 161 ili---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~ 237 (296)
T cd05051 161 CLV---GKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHL 237 (296)
T ss_pred eee---cCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCc
Confidence 999 677899999999987654332 123345678899999876 478999999999999999998 78888777
Q ss_pred ChHHHHHHHHhc----CCCCCCCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhH
Q 014210 365 TESGIFRAVLKA----DPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSEL 417 (429)
Q Consensus 365 ~~~~~~~~i~~~----~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~ 417 (429)
.....+..+... ...........++.++.+||.+||+.||++||++.++++.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L 294 (296)
T cd05051 238 TDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFL 294 (296)
T ss_pred ChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHh
Confidence 766665555432 11111112235679999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=321.60 Aligned_cols=255 Identities=21% Similarity=0.346 Sum_probs=212.3
Q ss_pred cCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~ 233 (429)
.++|+..+.||+|+||.||+|...........+|||.+... ......+++.+|+++++++. |+||+++++++.+.+.
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~ 80 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPG--YTEKQRQDFLSEASIMGQFS-HHNIIRLEGVVTKFKP 80 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEecccc--CCHHHHHHHHHHHHHHhcCC-CCCeeEEEEEEccCCC
Confidence 45789999999999999999998764333458999998653 23444577899999999998 9999999999999999
Q ss_pred EEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCcccc
Q 014210 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (429)
Q Consensus 234 ~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~ 313 (429)
.++||||+++++|.+++....+.+++..+..++.|++.||.|||+.||+||||||+||++ +.++.+||+|||++...
T Consensus 81 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili---~~~~~~kl~dfg~~~~~ 157 (268)
T cd05063 81 AMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILV---NSNLECKVSDFGLSRVL 157 (268)
T ss_pred cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEE---cCCCcEEECCCccceec
Confidence 999999999999999887767789999999999999999999999999999999999999 67888999999998765
Q ss_pred CCCccc----cccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCC
Q 014210 314 RPDERL----NDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPS 387 (429)
Q Consensus 314 ~~~~~~----~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 387 (429)
...... .....+..|+|||++. +.++.++||||||+++|||++ |+.||+.....+....+...... .....
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~---~~~~~ 234 (268)
T cd05063 158 EDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRL---PAPMD 234 (268)
T ss_pred ccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCC---CCCCC
Confidence 432211 1112345799999876 568899999999999999997 99999888877776666543211 11235
Q ss_pred CCHHHHHHHHHhcccCccCcCCHHHHHhhH
Q 014210 388 LSSEARDFVKRLLNKDPRKRLTAAQALSEL 417 (429)
Q Consensus 388 ~s~~~~~li~~~L~~dP~~Rps~~~iL~~~ 417 (429)
++.++.+|+.+||+.||++||++.++++.+
T Consensus 235 ~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l 264 (268)
T cd05063 235 CPSAVYQLMLQCWQQDRARRPRFVDIVNLL 264 (268)
T ss_pred CCHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 789999999999999999999999999765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=325.93 Aligned_cols=257 Identities=26% Similarity=0.395 Sum_probs=212.5
Q ss_pred cCceeEeceeeccCceEEEEEEEecC--cccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeC
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKG--ELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~--~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~ 231 (429)
..+|.+.+.||+|+||.||+++.... ...+..+++|.+.. ......+.+.+|+++++++. |+||+++++++...
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~---~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~ 79 (291)
T cd05094 4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKD---PTLAARKDFQREAELLTNLQ-HEHIVKFYGVCGDG 79 (291)
T ss_pred hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCC---ccHHHHHHHHHHHHHHhcCC-CCCcceEEEEEccC
Confidence 35799999999999999999986542 23467799999853 33445567899999999998 99999999999999
Q ss_pred CeEEEEEEecCCCcHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeec
Q 014210 232 DNVYVVMELCEGGELLDRILSRG---------------GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTK 296 (429)
Q Consensus 232 ~~~~lv~E~~~ggsL~~~i~~~~---------------~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~ 296 (429)
+..++||||+++++|.+++.... +.+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~--- 156 (291)
T cd05094 80 DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLV--- 156 (291)
T ss_pred CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEE---
Confidence 99999999999999999986532 358999999999999999999999999999999999999
Q ss_pred CCCceEEEeecCCccccCCCcc---ccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHc-CCCCCCCCChHHHHH
Q 014210 297 DENSVLKAIDFGLSDFVRPDER---LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFR 371 (429)
Q Consensus 297 ~~~~~vkL~DFGla~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~ellt-g~~Pf~~~~~~~~~~ 371 (429)
+.++.+||+|||++........ .....++..|+|||++. ..++.++||||||+++|||++ |+.||..........
T Consensus 157 ~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~ 236 (291)
T cd05094 157 GANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIE 236 (291)
T ss_pred ccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 6788999999999976543321 23345678899999876 468889999999999999998 999998777766665
Q ss_pred HHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhh
Q 014210 372 AVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLIC 420 (429)
Q Consensus 372 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~ 420 (429)
.+....... .....+.++.+||.+||+.||++||++.++++.+.--
T Consensus 237 ~~~~~~~~~---~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~ 282 (291)
T cd05094 237 CITQGRVLE---RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHAL 282 (291)
T ss_pred HHhCCCCCC---CCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence 554433221 1235788999999999999999999999998876443
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=321.69 Aligned_cols=248 Identities=25% Similarity=0.432 Sum_probs=207.1
Q ss_pred CceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeE
Q 014210 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (429)
Q Consensus 155 ~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~ 234 (429)
.+|++.+.||+|+||.||+++.+. +..+|+|++.+.... .+++.+|+++++++. |+||+++++++.+.+..
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~----~~~~~iK~~~~~~~~----~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~ 74 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRG----KIDVAIKMIREGAMS----EDDFIEEAKVMMKLS-HPNLVQLYGVCTKQRPI 74 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecC----CccEEEEEeccCCCC----HHHHHHHHHHHHhCC-CCCEEEEEEEEcCCCce
Confidence 468899999999999999997643 567999998654322 246788999999998 99999999999999999
Q ss_pred EEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccccC
Q 014210 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (429)
Q Consensus 235 ~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~ 314 (429)
++||||+++++|.+++......+++..++.++.||+.||.|||+.||+||||||+||++ +.++.+||+|||+++...
T Consensus 75 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i---~~~~~~kl~dfg~~~~~~ 151 (256)
T cd05059 75 FIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLV---GEDNVVKVSDFGLARYVL 151 (256)
T ss_pred EEEEecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEE---CCCCcEEECCcccceecc
Confidence 99999999999999987766689999999999999999999999999999999999999 678889999999987654
Q ss_pred CCccc--cccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCH
Q 014210 315 PDERL--NDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLSS 390 (429)
Q Consensus 315 ~~~~~--~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 390 (429)
..... ....++..|+|||.+. ..++.++||||||+++|+|++ |+.||......+....+..... ......++.
T Consensus 152 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~ 228 (256)
T cd05059 152 DDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYR---LYRPKLAPT 228 (256)
T ss_pred cccccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCc---CCCCCCCCH
Confidence 32211 1122345799999876 568899999999999999999 8999987777666655544321 112235789
Q ss_pred HHHHHHHHhcccCccCcCCHHHHHhhH
Q 014210 391 EARDFVKRLLNKDPRKRLTAAQALSEL 417 (429)
Q Consensus 391 ~~~~li~~~L~~dP~~Rps~~~iL~~~ 417 (429)
++.+|+.+||+.+|++||++.++++.+
T Consensus 229 ~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 229 EVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred HHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-42 Score=330.42 Aligned_cols=258 Identities=24% Similarity=0.352 Sum_probs=207.7
Q ss_pred CceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeE
Q 014210 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (429)
Q Consensus 155 ~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~ 234 (429)
++|+..++||+|+||.||++.... +|+.||||.+..... ......+.+|+.++.++.+|+||+++++++.+++..
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~---~~~~~aiK~~~~~~~--~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~ 78 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKP---SGTIMAVKRIRSTVD--EKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDC 78 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECC---CCCEEEEEEehhccC--hHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcE
Confidence 467788999999999999998765 589999999865432 245567899999999997799999999999999999
Q ss_pred EEEEEecCCCcHHHHH---Hh-cCCCCCHHHHHHHHHHHHHHHHHHHHc-CceeccCCCCcEEEeecCCCceEEEeecCC
Q 014210 235 YVVMELCEGGELLDRI---LS-RGGKYTEDDAKAVMIQILNVVAFCHLQ-GVVHRDLKPENFLFTTKDENSVLKAIDFGL 309 (429)
Q Consensus 235 ~lv~E~~~ggsL~~~i---~~-~~~~l~~~~~~~i~~qi~~gL~~LH~~-~iiHrDIKp~NILl~~~~~~~~vkL~DFGl 309 (429)
+++|||+.. ++.+.. .. ....+++..+..++.|++.||+|||+. +|+||||||+|||+ +.++.+||+|||+
T Consensus 79 ~~~~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~---~~~~~~kl~dfg~ 154 (288)
T cd06616 79 WICMELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILL---DRNGNIKLCDFGI 154 (288)
T ss_pred EEEEecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEE---ccCCcEEEeecch
Confidence 999999964 554432 22 346799999999999999999999985 99999999999999 6778899999999
Q ss_pred ccccCCCccccccccCCcccCcccccC----CCCCcccHHHHHHHHHHHHcCCCCCCCCCh-HHHHHHHHhcC-CCCCCC
Q 014210 310 SDFVRPDERLNDIVGSAYYVAPEVLHR----SYSTEADVWSIGVIAYILLCGSRPFWARTE-SGIFRAVLKAD-PSFDEA 383 (429)
Q Consensus 310 a~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~sDiwSlGvll~elltg~~Pf~~~~~-~~~~~~i~~~~-~~~~~~ 383 (429)
+.............|+..|+|||++.+ .++.++|||||||++|+|++|+.||..... .+.+..+.... +.....
T Consensus 155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd06616 155 SGQLVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNS 234 (288)
T ss_pred hHHhccCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCc
Confidence 876554443344578999999998864 488899999999999999999999965432 12222222222 222222
Q ss_pred CCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhc
Q 014210 384 PWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLICY 421 (429)
Q Consensus 384 ~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~ 421 (429)
.+..++.++.+||++||+.||++||++.+++.|+||+.
T Consensus 235 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 272 (288)
T cd06616 235 EEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKD 272 (288)
T ss_pred CCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhc
Confidence 22358899999999999999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=327.94 Aligned_cols=256 Identities=25% Similarity=0.398 Sum_probs=212.2
Q ss_pred cCceeEeceeeccCceEEEEEEEec----CcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEE
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKK----GELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYE 229 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~----~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~ 229 (429)
..+|.+.+.||+|+||.||+++... ....+..||+|.+... ......+++.+|+.+++.+.+|+||+++++++.
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 91 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDD--ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 91 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccc--cchHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence 5789999999999999999997532 2224678999998643 334556789999999999956999999999999
Q ss_pred eCCeEEEEEEecCCCcHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEe
Q 014210 230 DTDNVYVVMELCEGGELLDRILSRG---------------GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFT 294 (429)
Q Consensus 230 ~~~~~~lv~E~~~ggsL~~~i~~~~---------------~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~ 294 (429)
..+..++||||+++|+|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||+
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nili- 170 (304)
T cd05101 92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLV- 170 (304)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEEE-
Confidence 9999999999999999999887532 357888999999999999999999999999999999999
Q ss_pred ecCCCceEEEeecCCccccCCCcc---ccccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHc-CCCCCCCCChHHH
Q 014210 295 TKDENSVLKAIDFGLSDFVRPDER---LNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLC-GSRPFWARTESGI 369 (429)
Q Consensus 295 ~~~~~~~vkL~DFGla~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~ellt-g~~Pf~~~~~~~~ 369 (429)
+.++.+||+|||+++....... .....++..|+|||++.+ .++.++||||||+++|+|++ |..||...+..+.
T Consensus 171 --~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~ 248 (304)
T cd05101 171 --TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL 248 (304)
T ss_pred --cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHH
Confidence 6778899999999986643221 222345678999998864 58999999999999999998 8899988877777
Q ss_pred HHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhH
Q 014210 370 FRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSEL 417 (429)
Q Consensus 370 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~ 417 (429)
+..+....... ....++.++.+||.+||+.+|.+||++.++++.+
T Consensus 249 ~~~~~~~~~~~---~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l 293 (304)
T cd05101 249 FKLLKEGHRMD---KPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDL 293 (304)
T ss_pred HHHHHcCCcCC---CCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHH
Confidence 66664433221 1236789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=326.32 Aligned_cols=256 Identities=27% Similarity=0.489 Sum_probs=215.0
Q ss_pred CceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeE
Q 014210 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (429)
Q Consensus 155 ~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~ 234 (429)
..|+..++||.|+||.||+|.... .++.||||++... ......+.+.+|+.+++++. |+||+++++++.+++..
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~---~~~~vaiK~~~~~--~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~ 77 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNR---TQQVVAIKIIDLE--EAEDEIEDIQQEITVLSQCD-SPYVTKYYGSYLKGTKL 77 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEcc---CCEEEEEEEEecc--ccHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEECCEE
Confidence 468889999999999999998765 5789999998654 23445678999999999997 99999999999999999
Q ss_pred EEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccccC
Q 014210 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (429)
Q Consensus 235 ~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~ 314 (429)
++||||+++++|.+++. .+.+++..+..++.|++.||.|||+.+++|+||+|+||++ +.++.++|+|||++....
T Consensus 78 ~lv~e~~~~~~L~~~i~--~~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~---~~~~~~~l~dfg~~~~~~ 152 (277)
T cd06640 78 WIIMEYLGGGSALDLLR--AGPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLL---SEQGDVKLADFGVAGQLT 152 (277)
T ss_pred EEEEecCCCCcHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEE---cCCCCEEEcccccceecc
Confidence 99999999999999874 3568999999999999999999999999999999999999 677889999999997654
Q ss_pred CCc-cccccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHH
Q 014210 315 PDE-RLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEA 392 (429)
Q Consensus 315 ~~~-~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 392 (429)
... ......++..|+|||++.+ .++.++|+||||+++|||++|..||...........+..... ......++.++
T Consensus 153 ~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~ 229 (277)
T cd06640 153 DTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNP---PTLTGEFSKPF 229 (277)
T ss_pred CCccccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCCC---CCCchhhhHHH
Confidence 333 2234568889999998864 588999999999999999999999987665554443332221 11223577899
Q ss_pred HHHHHHhcccCccCcCCHHHHHhhHhhhccce
Q 014210 393 RDFVKRLLNKDPRKRLTAAQALSELLICYQSY 424 (429)
Q Consensus 393 ~~li~~~L~~dP~~Rps~~~iL~~~~~~~~~~ 424 (429)
.+||.+||+.+|++||++.+++.|+|+.....
T Consensus 230 ~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~ 261 (277)
T cd06640 230 KEFIDACLNKDPSFRPTAKELLKHKFIVKNAK 261 (277)
T ss_pred HHHHHHHcccCcccCcCHHHHHhChHhhhcch
Confidence 99999999999999999999999999976543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=327.26 Aligned_cols=254 Identities=27% Similarity=0.469 Sum_probs=209.1
Q ss_pred ceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEE
Q 014210 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVY 235 (429)
Q Consensus 156 ~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~~ 235 (429)
+|++.++||.|++|.||+|+... +|+.||||++..... ....+.+.+|+.++++++ |+||+++++++.+.+..+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~---~~~~~~iK~~~~~~~--~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~ 74 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRT---TGEIVALKEIHLDAE--EGTPSTAIREISLMKELK-HENIVRLHDVIHTENKLM 74 (284)
T ss_pred CceEeeeeccCCceEEEEEEECC---CCeEEEEEEeccccc--ccchHHHHHHHHHHHhhc-CCCEeeeeeeEeeCCcEE
Confidence 58999999999999999999765 589999999875432 223356778999999998 999999999999999999
Q ss_pred EEEEecCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCcccc
Q 014210 236 VVMELCEGGELLDRILSRG--GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (429)
Q Consensus 236 lv~E~~~ggsL~~~i~~~~--~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~ 313 (429)
|||||+++ +|.+++.... ..+++..+..++.||+.||.|||+.||+||||||+||++ ++++.+||+|||++...
T Consensus 75 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~---~~~~~~~l~d~g~~~~~ 150 (284)
T cd07836 75 LVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLI---NKRGELKLADFGLARAF 150 (284)
T ss_pred EEEecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEE---CCCCcEEEeecchhhhh
Confidence 99999975 8888876544 468999999999999999999999999999999999999 67888999999998765
Q ss_pred CCCc-cccccccCCcccCcccccC--CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCC---------
Q 014210 314 RPDE-RLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFD--------- 381 (429)
Q Consensus 314 ~~~~-~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~--------- 381 (429)
.... ......++..|++||++.+ .++.++||||||+++|+|++|+.||......+.+..+.+......
T Consensus 151 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd07836 151 GIPVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQ 230 (284)
T ss_pred cCCccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhc
Confidence 4322 2234567889999998754 468899999999999999999999987776655554433210000
Q ss_pred -----C-----------CCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhh
Q 014210 382 -----E-----------APWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLI 419 (429)
Q Consensus 382 -----~-----------~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~ 419 (429)
. ...+.++.++.++|.+||+.||++||++.+++.|+||
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 231 LPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred CchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 0 0112467889999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=320.19 Aligned_cols=255 Identities=30% Similarity=0.454 Sum_probs=215.9
Q ss_pred CceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeE
Q 014210 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (429)
Q Consensus 155 ~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~ 234 (429)
++|++.+.||+|++|.||+++... +|+.|+||++..... ....+.+.+|+.++.+++ |+||+++++++...+..
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~---~~~~~~vk~~~~~~~--~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~ 74 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKP---TGKIYALKKIHVDGD--EEFRKQLLRELKTLRSCE-SPYVVKCYGAFYKEGEI 74 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcC---CCcEEEEEEeccCcc--hHHHHHHHHHHHHHHhcC-CCCeeeEEEEEccCCeE
Confidence 468999999999999999998776 589999999865432 245678999999999998 99999999999999999
Q ss_pred EEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-cCceeccCCCCcEEEeecCCCceEEEeecCCcccc
Q 014210 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHL-QGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (429)
Q Consensus 235 ~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~-~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~ 313 (429)
++||||+++++|.+++... ..+++..++.++.||++||.|||+ .|++||||+|+||++ +.++.++|+|||++...
T Consensus 75 ~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~---~~~~~~~l~df~~~~~~ 150 (264)
T cd06623 75 SIVLEYMDGGSLADLLKKV-GKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLI---NSKGEVKIADFGISKVL 150 (264)
T ss_pred EEEEEecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEE---CCCCCEEEccCccceec
Confidence 9999999999999988654 679999999999999999999999 999999999999999 77889999999998876
Q ss_pred CCCccc-cccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHcCCCCCCCCC---hHHHHHHHHhcCCCCCCCCCCC-
Q 014210 314 RPDERL-NDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWART---ESGIFRAVLKADPSFDEAPWPS- 387 (429)
Q Consensus 314 ~~~~~~-~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~elltg~~Pf~~~~---~~~~~~~i~~~~~~~~~~~~~~- 387 (429)
...... ....++..|+|||.+.+ .++.++||||||+++|+|++|+.||.... .......+....... ....
T Consensus 151 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~ 227 (264)
T cd06623 151 ENTLDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPS---LPAEE 227 (264)
T ss_pred ccCCCcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCC---CCccc
Confidence 543332 25678899999998764 57889999999999999999999997763 333444443222111 1123
Q ss_pred CCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhcc
Q 014210 388 LSSEARDFVKRLLNKDPRKRLTAAQALSELLICYQ 422 (429)
Q Consensus 388 ~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~ 422 (429)
++..+.++|++||..+|++||++.++++|+|++..
T Consensus 228 ~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~~~~~ 262 (264)
T cd06623 228 FSPEFRDFISACLQKDPKKRPSAAELLQHPFIKKA 262 (264)
T ss_pred CCHHHHHHHHHHccCChhhCCCHHHHHhCHHHHhc
Confidence 78999999999999999999999999999999754
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=327.16 Aligned_cols=258 Identities=26% Similarity=0.378 Sum_probs=211.8
Q ss_pred ccCceeEeceeeccCceEEEEEEEecC--cccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEe
Q 014210 153 FANKYELGEEVGRGHFGYTCAAKFKKG--ELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED 230 (429)
Q Consensus 153 ~~~~y~~~~~IG~G~fg~V~~~~~~~~--~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~ 230 (429)
..++|++.+.||+|+||.||++..... ...+..||||++.... .....+.+.+|+++++++.+|+||+++++++..
T Consensus 33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 110 (302)
T cd05055 33 PRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA--HSSEREALMSELKIMSHLGNHENIVNLLGACTI 110 (302)
T ss_pred cHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC--ChHHHHHHHHHHHHHHhccCCCCcceEEEEEec
Confidence 357899999999999999999986432 2246789999986542 334456789999999999559999999999999
Q ss_pred CCeEEEEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCC
Q 014210 231 TDNVYVVMELCEGGELLDRILSRG-GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGL 309 (429)
Q Consensus 231 ~~~~~lv~E~~~ggsL~~~i~~~~-~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGl 309 (429)
.+..+++|||+.+|+|.+++.... ..+++.++..++.||+.||.|||+++|+|+||||+|||+ +.++.+||+|||+
T Consensus 111 ~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~~l~dfg~ 187 (302)
T cd05055 111 GGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLL---THGKIVKICDFGL 187 (302)
T ss_pred CCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEE---cCCCeEEECCCcc
Confidence 999999999999999999886543 348999999999999999999999999999999999999 6778899999999
Q ss_pred ccccCCCcc---ccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCCC
Q 014210 310 SDFVRPDER---LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAP 384 (429)
Q Consensus 310 a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 384 (429)
+........ .....++..|+|||++. +.++.++|||||||++|||++ |..||........+........... .
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~--~ 265 (302)
T cd05055 188 ARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMA--Q 265 (302)
T ss_pred cccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcCC--C
Confidence 976543321 12234567899999876 468999999999999999998 9999987766555555544332221 2
Q ss_pred CCCCCHHHHHHHHHhcccCccCcCCHHHHHhhH
Q 014210 385 WPSLSSEARDFVKRLLNKDPRKRLTAAQALSEL 417 (429)
Q Consensus 385 ~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~ 417 (429)
....+.++.+||.+||+.+|++||++.+++..+
T Consensus 266 ~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l 298 (302)
T cd05055 266 PEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLI 298 (302)
T ss_pred CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence 235789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=322.59 Aligned_cols=255 Identities=22% Similarity=0.334 Sum_probs=211.6
Q ss_pred cCceeEeceeeccCceEEEEEEEecCc--ccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeC
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGE--LKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~--~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~ 231 (429)
.++|.+.++||+|+||.||++..+... ..+..||+|.+... ........+.+|+.+++.+. |+||+++++++.+.
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~--~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~ 81 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNEN--ASMRERIEFLNEASVMKEFN-CHHVVRLLGVVSTG 81 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCc--cCHHHHHHHHHHHHHHHhCC-CCceeEEEEEEcCC
Confidence 468999999999999999999877532 34688999998543 23344567889999999997 99999999999999
Q ss_pred CeEEEEEEecCCCcHHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceE
Q 014210 232 DNVYVVMELCEGGELLDRILSRG---------GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVL 302 (429)
Q Consensus 232 ~~~~lv~E~~~ggsL~~~i~~~~---------~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~v 302 (429)
+..++||||+++++|.+++.... ..+++..+..++.||+.||.|||+.+|+||||||+|||+ +.++.+
T Consensus 82 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill---~~~~~~ 158 (277)
T cd05032 82 QPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMV---AEDLTV 158 (277)
T ss_pred CCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEE---cCCCCE
Confidence 99999999999999999886432 347889999999999999999999999999999999999 778899
Q ss_pred EEeecCCccccCCCcc---ccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcC
Q 014210 303 KAIDFGLSDFVRPDER---LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKAD 377 (429)
Q Consensus 303 kL~DFGla~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~ellt-g~~Pf~~~~~~~~~~~i~~~~ 377 (429)
||+|||+++....... .....++..|+|||++. +.++.++||||||+++|||++ |..||...........+....
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~ 238 (277)
T cd05032 159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGG 238 (277)
T ss_pred EECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcCC
Confidence 9999999876543321 22345678899999876 568899999999999999998 999998877777666555332
Q ss_pred CCCCCCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhH
Q 014210 378 PSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSEL 417 (429)
Q Consensus 378 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~ 417 (429)
.. .....++.++.+||.+||+.+|++||++.++++.+
T Consensus 239 ~~---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l 275 (277)
T cd05032 239 HL---DLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSL 275 (277)
T ss_pred CC---CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHh
Confidence 11 11235789999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=322.40 Aligned_cols=255 Identities=25% Similarity=0.414 Sum_probs=207.2
Q ss_pred CceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCc--CcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeC-
Q 014210 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKM--TTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT- 231 (429)
Q Consensus 155 ~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~--~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~- 231 (429)
.+|++.+.||+|+||.||++.... +|+.||+|++..... ......+.+.+|+.++++++ |+||+++++++.+.
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~---~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~ 77 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVD---TGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ-HERIVQYYGCLRDRA 77 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcC---CCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcC-CCCeeeEEEEEEcCC
Confidence 468999999999999999998765 588999998864432 22344567899999999998 99999999998763
Q ss_pred -CeEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCc
Q 014210 232 -DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS 310 (429)
Q Consensus 232 -~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla 310 (429)
+..+++|||+++++|.+++.. ...+++..++.++.||+.||+|||+.+|+||||||+||++ +.++.+||+|||++
T Consensus 78 ~~~~~l~~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~---~~~~~~~l~dfg~~ 153 (266)
T cd06651 78 EKTLTIFMEYMPGGSVKDQLKA-YGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILR---DSAGNVKLGDFGAS 153 (266)
T ss_pred CCEEEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEE---CCCCCEEEccCCCc
Confidence 578999999999999988754 3568999999999999999999999999999999999999 67888999999998
Q ss_pred cccCCC----ccccccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCC
Q 014210 311 DFVRPD----ERLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPW 385 (429)
Q Consensus 311 ~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 385 (429)
...... .......++..|+|||++.+ .++.++|||||||++|||++|+.||...........+..... .+ ...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~-~~-~~~ 231 (266)
T cd06651 154 KRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPT-NP-QLP 231 (266)
T ss_pred cccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCC-CC-CCc
Confidence 765321 12233568899999998864 588999999999999999999999987655444443332211 11 112
Q ss_pred CCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhh
Q 014210 386 PSLSSEARDFVKRLLNKDPRKRLTAAQALSELLIC 420 (429)
Q Consensus 386 ~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~ 420 (429)
..+++.+.+|| +||..+|++||++++++.|+||+
T Consensus 232 ~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 232 SHISEHARDFL-GCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred hhcCHHHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence 34688899999 67778999999999999999986
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=320.99 Aligned_cols=255 Identities=26% Similarity=0.465 Sum_probs=208.3
Q ss_pred CceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCC--cCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeC-
Q 014210 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHK--MTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT- 231 (429)
Q Consensus 155 ~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~--~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~- 231 (429)
++|++.+.||+|+||.||++.... +|+.||||++.... .......+.+.+|+.+++++. |+||+++++++.+.
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~---~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~ 77 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDAD---TGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL-HERIVQYYGCLRDPM 77 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcC---CCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcC-CCCeeeEEeEeccCC
Confidence 579999999999999999998765 58899999875432 123345678899999999998 99999999998764
Q ss_pred -CeEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCc
Q 014210 232 -DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS 310 (429)
Q Consensus 232 -~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla 310 (429)
..++++|||+++++|.+++... ..+++..+..++.|++.||.|||+.+|+|+||||+|||+ +.++.+||+|||++
T Consensus 78 ~~~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~---~~~~~~~l~Dfg~~ 153 (265)
T cd06652 78 ERTLSIFMEHMPGGSIKDQLKSY-GALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILR---DSVGNVKLGDFGAS 153 (265)
T ss_pred CceEEEEEEecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEe---cCCCCEEECcCccc
Confidence 4688999999999999987544 568999999999999999999999999999999999999 67888999999998
Q ss_pred cccCCC----ccccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCC
Q 014210 311 DFVRPD----ERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPW 385 (429)
Q Consensus 311 ~~~~~~----~~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 385 (429)
...... .......++..|+|||++. ..++.++||||||+++|||++|+.||...........+.... ..+ ...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~-~~~-~~~ 231 (265)
T cd06652 154 KRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQP-TNP-VLP 231 (265)
T ss_pred cccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCC-CCC-CCc
Confidence 765321 1223456889999999876 458899999999999999999999997765544444333221 111 122
Q ss_pred CCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhh
Q 014210 386 PSLSSEARDFVKRLLNKDPRKRLTAAQALSELLIC 420 (429)
Q Consensus 386 ~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~ 420 (429)
..++..+.++|.+||. +|++||++.++++|+|+.
T Consensus 232 ~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 232 PHVSDHCRDFLKRIFV-EAKLRPSADELLRHTFVH 265 (265)
T ss_pred hhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence 3577889999999995 999999999999999973
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=338.12 Aligned_cols=256 Identities=27% Similarity=0.483 Sum_probs=208.0
Q ss_pred ccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeC-
Q 014210 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT- 231 (429)
Q Consensus 153 ~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~- 231 (429)
+.++|++.+.||+|+||.||++.... +|+.||||++.+.. ......+.+.+|+.+++++. |+||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~---~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~ 88 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTV---TGQNVAIKKLSRPF-QNVTHAKRAYRELVLMKLVN-HKNIIGLLNVFTPQK 88 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECC---CCCEEEEEecCccc-cChhHHHHHHHHHHHHHhcC-CCCCcceeeeeccCC
Confidence 46889999999999999999998776 58999999986532 23344566788999999998 99999999998644
Q ss_pred -----CeEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEee
Q 014210 232 -----DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAID 306 (429)
Q Consensus 232 -----~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~D 306 (429)
...|+||||+.+ +|.+.+... +++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|
T Consensus 89 ~~~~~~~~~lv~e~~~~-~l~~~~~~~---l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~---~~~~~~kL~D 161 (353)
T cd07850 89 SLEEFQDVYLVMELMDA-NLCQVIQMD---LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILD 161 (353)
T ss_pred CccccCcEEEEEeccCC-CHHHHHhhc---CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEE---CCCCCEEEcc
Confidence 357999999964 888776432 8999999999999999999999999999999999999 7788999999
Q ss_pred cCCccccCCCccccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcC--------
Q 014210 307 FGLSDFVRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKAD-------- 377 (429)
Q Consensus 307 FGla~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~-------- 377 (429)
||++.............++..|+|||++. ..++.++|||||||++|+|++|+.||........+..+....
T Consensus 162 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 241 (353)
T cd07850 162 FGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFM 241 (353)
T ss_pred CccceeCCCCCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 99998765544444567899999999876 468999999999999999999999997766544443332211
Q ss_pred --------------CCCC---------CCC--------CCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhh
Q 014210 378 --------------PSFD---------EAP--------WPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLIC 420 (429)
Q Consensus 378 --------------~~~~---------~~~--------~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~ 420 (429)
+... ... ....+.++.+||.+||+.||++||++.++|.|+|+.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~ 315 (353)
T cd07850 242 SRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYIN 315 (353)
T ss_pred HHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHh
Confidence 0000 000 113466789999999999999999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=319.83 Aligned_cols=254 Identities=27% Similarity=0.531 Sum_probs=210.5
Q ss_pred CceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeE
Q 014210 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (429)
Q Consensus 155 ~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~ 234 (429)
++|++.+.||+|+||.||+|.... +|+.||+|.+...........+.+.+|+++++++. |+||+++++++.+.+..
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~---~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~-~~~i~~~~~~~~~~~~~ 77 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLL---DGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD-HPNVIKYLASFIENNEL 77 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcC---CCCEEEEEEeecccccchhhHHHHHHHHHHHHhCC-CCCeeeeeeeeecCCeE
Confidence 579999999999999999998775 58999999987655455555678999999999998 99999999999999999
Q ss_pred EEEEEecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCcc
Q 014210 235 YVVMELCEGGELLDRILS---RGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (429)
Q Consensus 235 ~lv~E~~~ggsL~~~i~~---~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~ 311 (429)
++||||+++++|.+++.. ....+++..++.++.||+.||.|||+.||+||||||+||++ +.++.++|+|||++.
T Consensus 78 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~---~~~~~~~l~d~~~~~ 154 (267)
T cd08224 78 NIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFI---TATGVVKLGDLGLGR 154 (267)
T ss_pred EEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEE---CCCCcEEEeccceee
Confidence 999999999999988753 23468999999999999999999999999999999999999 678889999999987
Q ss_pred ccCCCc-cccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHcCCCCCCCCChH--HHHHHHHhcCCCCCCCCCCC
Q 014210 312 FVRPDE-RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTES--GIFRAVLKADPSFDEAPWPS 387 (429)
Q Consensus 312 ~~~~~~-~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~elltg~~Pf~~~~~~--~~~~~i~~~~~~~~~~~~~~ 387 (429)
...... ......++..|+|||.+. ..++.++||||||+++|+|++|+.||...... .....+... .....+...
T Consensus 155 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 232 (267)
T cd08224 155 FFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKC--DYPPLPADH 232 (267)
T ss_pred eccCCCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcC--CCCCCChhh
Confidence 654322 223456889999999876 45889999999999999999999999654321 222222221 122222236
Q ss_pred CCHHHHHHHHHhcccCccCcCCHHHHHhhH
Q 014210 388 LSSEARDFVKRLLNKDPRKRLTAAQALSEL 417 (429)
Q Consensus 388 ~s~~~~~li~~~L~~dP~~Rps~~~iL~~~ 417 (429)
++.++.++|.+||..+|++||++.+++..+
T Consensus 233 ~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~ 262 (267)
T cd08224 233 YSEELRDLVSRCINPDPEKRPDISYVLQVA 262 (267)
T ss_pred cCHHHHHHHHHHcCCCcccCCCHHHHHHHH
Confidence 788999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=321.90 Aligned_cols=254 Identities=27% Similarity=0.420 Sum_probs=205.3
Q ss_pred CceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeE
Q 014210 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (429)
Q Consensus 155 ~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~ 234 (429)
+.+.....||+|+||.||+|+... ++..||+|.+... .....+.+.+|+.++++++ |+||+++++++.+++..
T Consensus 8 ~~~~~~~~lg~g~~g~v~~~~~~~---~~~~v~~k~~~~~---~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~ 80 (268)
T cd06624 8 DENGERVVLGKGTYGIVYAARDLS---TQVRIAIKEIPER---DSRYVQPLHEEIALHSYLK-HRNIVQYLGSDSENGFF 80 (268)
T ss_pred ccCCceEEEecCCceEEEEeEecC---CCcEEEEEEecCC---CHHHHHHHHHHHHHHHhcC-CCCeeeeeeeeccCCEE
Confidence 344455689999999999998765 5789999988543 3445578899999999998 99999999999999999
Q ss_pred EEEEEecCCCcHHHHHHhcCCCC--CHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccc
Q 014210 235 YVVMELCEGGELLDRILSRGGKY--TEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (429)
Q Consensus 235 ~lv~E~~~ggsL~~~i~~~~~~l--~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~ 312 (429)
++||||+++++|.+++......+ ++..+..++.||+.||.|||++||+||||||+||+++ ..++.+||+|||++..
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~--~~~~~~~l~dfg~~~~ 158 (268)
T cd06624 81 KIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVN--TYSGVVKISDFGTSKR 158 (268)
T ss_pred EEEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEc--CCCCeEEEecchhhee
Confidence 99999999999999887655555 8899999999999999999999999999999999994 2356899999999876
Q ss_pred cCCCc-cccccccCCcccCcccccC---CCCCcccHHHHHHHHHHHHcCCCCCCCCChHH-HHHHHHhcCCCCCCCCCCC
Q 014210 313 VRPDE-RLNDIVGSAYYVAPEVLHR---SYSTEADVWSIGVIAYILLCGSRPFWARTESG-IFRAVLKADPSFDEAPWPS 387 (429)
Q Consensus 313 ~~~~~-~~~~~~gt~~y~aPE~~~~---~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~-~~~~i~~~~~~~~~~~~~~ 387 (429)
..... ......|+..|+|||++.+ .++.++||||||+++|+|++|+.||....... ........ .........
T Consensus 159 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~ 236 (268)
T cd06624 159 LAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMF--KIHPEIPES 236 (268)
T ss_pred cccCCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhh--ccCCCCCcc
Confidence 54322 2234568899999998753 37889999999999999999999996543221 11111110 111112235
Q ss_pred CCHHHHHHHHHhcccCccCcCCHHHHHhhHhh
Q 014210 388 LSSEARDFVKRLLNKDPRKRLTAAQALSELLI 419 (429)
Q Consensus 388 ~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~ 419 (429)
+++++.+||++||+.+|.+||++.+++.|+||
T Consensus 237 ~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 237 LSAEAKNFILRCFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred cCHHHHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence 78999999999999999999999999999996
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=318.69 Aligned_cols=246 Identities=24% Similarity=0.344 Sum_probs=202.0
Q ss_pred ceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEe
Q 014210 161 EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMEL 240 (429)
Q Consensus 161 ~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~~lv~E~ 240 (429)
++||+|+||.||+|.++.. .+++.+|+|++.... ......+++.+|+.+++++. |+||+++++++. .+..++||||
T Consensus 1 ~~lg~G~~g~v~~~~~~~~-~~~~~~aiK~~~~~~-~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~-~~~~~lv~e~ 76 (257)
T cd05116 1 GELGSGNFGTVKKGMYKMK-KSEKTVAVKILKNDN-NDPALKDELLREANVMQQLD-NPYIVRMIGICE-AESWMLVMEL 76 (257)
T ss_pred CcCCCcCCcceEEeEEecC-CCceEEEEEEccCCC-CcHHHHHHHHHHHHHHHhCC-CCCcceEEEEEc-CCCcEEEEec
Confidence 3689999999999976432 257899999986442 34456678999999999998 999999999885 4567899999
Q ss_pred cCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccccCCCcc--
Q 014210 241 CEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDER-- 318 (429)
Q Consensus 241 ~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~-- 318 (429)
+++++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||+ ++++.+||+|||++........
T Consensus 77 ~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill---~~~~~~kl~Dfg~~~~~~~~~~~~ 152 (257)
T cd05116 77 AELGPLNKFLQK-NKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLL---VTQHYAKISDFGLSKALGADENYY 152 (257)
T ss_pred CCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEE---cCCCeEEECCCccccccCCCCCee
Confidence 999999998754 4579999999999999999999999999999999999999 6788899999999976643322
Q ss_pred --ccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHH
Q 014210 319 --LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARD 394 (429)
Q Consensus 319 --~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 394 (429)
.....++..|+|||.+. ..++.++||||||+++|||++ |..||......+....+.+.... .....++.++.+
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~~---~~~~~~~~~l~~ 229 (257)
T cd05116 153 KAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERM---ECPQRCPPEMYD 229 (257)
T ss_pred eecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCC---CCCCCCCHHHHH
Confidence 11223457899999886 468889999999999999997 99999887777666666543321 122368899999
Q ss_pred HHHHhcccCccCcCCHHHHHhhH
Q 014210 395 FVKRLLNKDPRKRLTAAQALSEL 417 (429)
Q Consensus 395 li~~~L~~dP~~Rps~~~iL~~~ 417 (429)
||.+||+.||++||++.+|...+
T Consensus 230 li~~~~~~~p~~Rp~~~~i~~~l 252 (257)
T cd05116 230 LMKLCWTYGVDERPGFAVVELRL 252 (257)
T ss_pred HHHHHhccCchhCcCHHHHHHHH
Confidence 99999999999999999998755
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=325.76 Aligned_cols=254 Identities=31% Similarity=0.494 Sum_probs=211.0
Q ss_pred eeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeC--CeE
Q 014210 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT--DNV 234 (429)
Q Consensus 157 y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~--~~~ 234 (429)
|++.++||+|+||.||+|.... .|+.+|+|++.... ......+.+.+|+++++++. |+||+++++++.+. +..
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~---~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~ 75 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKK---TGELVALKKIRMEN-EKEGFPITAIREIKLLQKLR-HPNIVRLKEIVTSKGKGSI 75 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECC---CCeEEEEEEEeccc-ccccchHHHHHHHHHHHhcc-CCCeeeheeeEecCCCCcE
Confidence 6789999999999999998776 58899999997653 23334466889999999998 99999999999988 889
Q ss_pred EEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccccC
Q 014210 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (429)
Q Consensus 235 ~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~ 314 (429)
++||||+++ +|.+++......+++..++.++.||+.||+|||+.|++|+||||+||++ ++++.+||+|||++....
T Consensus 76 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~---~~~~~~~l~d~g~~~~~~ 151 (287)
T cd07840 76 YMVFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILI---NNDGVLKLADFGLARPYT 151 (287)
T ss_pred EEEeccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEE---cCCCCEEEccccceeecc
Confidence 999999975 8888886665689999999999999999999999999999999999999 778899999999998765
Q ss_pred CCc--cccccccCCcccCcccccC--CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCC-----
Q 014210 315 PDE--RLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPW----- 385 (429)
Q Consensus 315 ~~~--~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~----- 385 (429)
... ......++..|+|||.+.+ .++.++||||||+++|||++|+.||........+..+...........|
T Consensus 152 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (287)
T cd07840 152 KRNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSK 231 (287)
T ss_pred CCCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhcccccc
Confidence 433 2334567889999997653 4788999999999999999999999887766655555442111111111
Q ss_pred ---------------------CC-CCHHHHHHHHHhcccCccCcCCHHHHHhhHhh
Q 014210 386 ---------------------PS-LSSEARDFVKRLLNKDPRKRLTAAQALSELLI 419 (429)
Q Consensus 386 ---------------------~~-~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~ 419 (429)
.. ++.++.++|++||+.||++||++.+++.|+||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 232 LPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred chhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 12 38899999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-41 Score=328.08 Aligned_cols=258 Identities=22% Similarity=0.377 Sum_probs=211.5
Q ss_pred cCceeEeceeeccCceEEEEEEEecC----cccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEE
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKG----ELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYE 229 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~----~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~ 229 (429)
.++|.+.++||+|+||.||+++.... ...+..+|+|++... .......++.+|+.+++++.+|+||+++++++.
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 88 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDN--ATDKDLADLISEMELMKLIGKHKNIINLLGVCT 88 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCC--CChHHHHHHHHHHHHHHhccCCCCeeeEEEEEc
Confidence 46899999999999999999975421 123568999998653 234556778999999999966999999999999
Q ss_pred eCCeEEEEEEecCCCcHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEe
Q 014210 230 DTDNVYVVMELCEGGELLDRILSRG---------------GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFT 294 (429)
Q Consensus 230 ~~~~~~lv~E~~~ggsL~~~i~~~~---------------~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~ 294 (429)
+.+..+++|||+++|+|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||+
T Consensus 89 ~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill- 167 (314)
T cd05099 89 QEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLV- 167 (314)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEE-
Confidence 9999999999999999999986532 358899999999999999999999999999999999999
Q ss_pred ecCCCceEEEeecCCccccCCCcc---ccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHc-CCCCCCCCChHHH
Q 014210 295 TKDENSVLKAIDFGLSDFVRPDER---LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGI 369 (429)
Q Consensus 295 ~~~~~~~vkL~DFGla~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~ellt-g~~Pf~~~~~~~~ 369 (429)
++++.+||+|||+++....... .....++..|+|||++. +.++.++||||||+++|||++ |..||......+.
T Consensus 168 --~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~ 245 (314)
T cd05099 168 --TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEEL 245 (314)
T ss_pred --cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 6778899999999976543221 11223446799999876 468899999999999999999 8999988777776
Q ss_pred HHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhh
Q 014210 370 FRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLI 419 (429)
Q Consensus 370 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~ 419 (429)
+..+...... .....++.++.+||.+||..||++||++.+++..+.-
T Consensus 246 ~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~ 292 (314)
T cd05099 246 FKLLREGHRM---DKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDK 292 (314)
T ss_pred HHHHHcCCCC---CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHH
Confidence 6665543211 1123578899999999999999999999999986653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=322.63 Aligned_cols=254 Identities=27% Similarity=0.493 Sum_probs=213.2
Q ss_pred CceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeE
Q 014210 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (429)
Q Consensus 155 ~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~ 234 (429)
+-|++.++||+|+||.||+|.... +++.||||++.... .....+.+.+|+.+++++. |+||+++++++.+++..
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~---~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~ 77 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNR---TQKVVAIKIIDLEE--AEDEIEDIQQEITVLSQCD-SPYVTKYYGSYLKDTKL 77 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECC---CCcEEEEEEecccc--chHHHHHHHHHHHHHHhcC-CCCEeEEEEEEEeCCeE
Confidence 357889999999999999998655 58899999986442 2344567899999999998 99999999999999999
Q ss_pred EEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccccC
Q 014210 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (429)
Q Consensus 235 ~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~ 314 (429)
++||||+++++|.+++. ...+++..+..++.|++.+|.|||+.|++|+||||+||++ +.++.++|+|||++....
T Consensus 78 ~lv~e~~~~~~l~~~i~--~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i---~~~~~~~l~dfg~~~~~~ 152 (277)
T cd06641 78 WIIMEYLGGGSALDLLE--PGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLL---SEHGEVKLADFGVAGQLT 152 (277)
T ss_pred EEEEEeCCCCcHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEE---CCCCCEEEeecccceecc
Confidence 99999999999998774 3568999999999999999999999999999999999999 677889999999987654
Q ss_pred CCc-cccccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHH
Q 014210 315 PDE-RLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEA 392 (429)
Q Consensus 315 ~~~-~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 392 (429)
... ......++..|+|||.+.+ .++.++|+|||||++|+|++|..||...........+...... .....++.++
T Consensus 153 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~ 229 (277)
T cd06641 153 DTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPP---TLEGNYSKPL 229 (277)
T ss_pred cchhhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCCC---CCCcccCHHH
Confidence 322 2234568889999998764 5788999999999999999999999876655555444332221 1223578999
Q ss_pred HHHHHHhcccCccCcCCHHHHHhhHhhhcc
Q 014210 393 RDFVKRLLNKDPRKRLTAAQALSELLICYQ 422 (429)
Q Consensus 393 ~~li~~~L~~dP~~Rps~~~iL~~~~~~~~ 422 (429)
.++|.+||+.+|.+||++.+++.|+|+...
T Consensus 230 ~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~~ 259 (277)
T cd06641 230 KEFVEACLNKEPSFRPTAKELLKHKFIVRF 259 (277)
T ss_pred HHHHHHHccCChhhCcCHHHHHhCHHHhhh
Confidence 999999999999999999999999999764
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-41 Score=318.69 Aligned_cols=249 Identities=24% Similarity=0.382 Sum_probs=207.6
Q ss_pred cCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~ 233 (429)
.++|++.+.||+|+||.||+|.... ++.||||.+..... ..+++.+|+.++++++ |+||+++++++...+.
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~----~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~ 75 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNN----TTPVAVKTLKPGTM----DPKDFLAEAQIMKKLR-HPKLIQLYAVCTLEEP 75 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecC----CeEEEEEeeCCCcc----cHHHHHHHHHHHHHCC-CCCccceeEEEecCCC
Confidence 4679999999999999999998543 57899999865432 2456889999999998 9999999999999999
Q ss_pred EEEEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccc
Q 014210 234 VYVVMELCEGGELLDRILSRG-GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (429)
Q Consensus 234 ~~lv~E~~~ggsL~~~i~~~~-~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~ 312 (429)
.+++|||+++++|.+++.... ..+++..+..++.|++.||.|||+.||+||||||+||++ ++++.+||+|||++..
T Consensus 76 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~~l~dfg~~~~ 152 (261)
T cd05068 76 IYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLV---GENNICKVADFGLARV 152 (261)
T ss_pred eeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEE---cCCCCEEECCcceEEE
Confidence 999999999999999886543 468999999999999999999999999999999999999 6788899999999987
Q ss_pred cCCCccc--cccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCC
Q 014210 313 VRPDERL--NDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSL 388 (429)
Q Consensus 313 ~~~~~~~--~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 388 (429)
....... .....+..|+|||++. ..++.++||||||+++|||++ |+.||........+..+..... . .....+
T Consensus 153 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~-~--~~~~~~ 229 (261)
T cd05068 153 IKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYR-M--PCPPGC 229 (261)
T ss_pred ccCCcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC-C--CCCCcC
Confidence 6532211 1112345799999876 468999999999999999999 9999988776666665544321 1 122357
Q ss_pred CHHHHHHHHHhcccCccCcCCHHHHHhhH
Q 014210 389 SSEARDFVKRLLNKDPRKRLTAAQALSEL 417 (429)
Q Consensus 389 s~~~~~li~~~L~~dP~~Rps~~~iL~~~ 417 (429)
+.++.+||.+||+.||.+||++.+++..+
T Consensus 230 ~~~~~~li~~~l~~~P~~Rp~~~~l~~~l 258 (261)
T cd05068 230 PKELYDIMLDCWKEDPDDRPTFETLQWKL 258 (261)
T ss_pred CHHHHHHHHHHhhcCcccCCCHHHHHHHH
Confidence 89999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-42 Score=330.63 Aligned_cols=256 Identities=30% Similarity=0.535 Sum_probs=213.2
Q ss_pred cCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~ 233 (429)
.+.|.....||+|+||.||++.... ++..||||.+... .....+.+.+|+.+++.+. |+||+++++.+...+.
T Consensus 21 ~~~~~~~~~lg~g~~g~v~~~~~~~---~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~-h~~ii~~~~~~~~~~~ 93 (292)
T cd06658 21 REYLDSFIKIGEGSTGIVCIATEKH---TGKQVAVKKMDLR---KQQRRELLFNEVVIMRDYH-HENVVDMYNSYLVGDE 93 (292)
T ss_pred HHHHhhhhcccCCCCeEEEEEEECC---CCCEEEEEEEecc---hHHHHHHHHHHHHHHHhCC-CCcHHHHHHheecCCe
Confidence 3556667889999999999998665 5889999998542 3344567889999999998 9999999999999999
Q ss_pred EEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCcccc
Q 014210 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (429)
Q Consensus 234 ~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~ 313 (429)
.++||||+++++|.+++. .+.+++..++.++.||+.||.|||++||+||||||+||++ ++++.+||+|||++...
T Consensus 94 ~~lv~e~~~~~~L~~~~~--~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill---~~~~~~kL~dfg~~~~~ 168 (292)
T cd06658 94 LWVVMEFLEGGALTDIVT--HTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILL---TSDGRIKLSDFGFCAQV 168 (292)
T ss_pred EEEEEeCCCCCcHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEE---cCCCCEEEccCcchhhc
Confidence 999999999999988763 3468999999999999999999999999999999999999 67788999999998754
Q ss_pred CCCc-cccccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHH
Q 014210 314 RPDE-RLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSE 391 (429)
Q Consensus 314 ~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 391 (429)
.... ......|+..|+|||.+.+ .++.++||||||+++|||++|+.||........+..+......... ....++.+
T Consensus 169 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 247 (292)
T cd06658 169 SKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVK-DSHKVSSV 247 (292)
T ss_pred ccccccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCccc-cccccCHH
Confidence 3222 2234578999999998864 6889999999999999999999999877766655554433222211 12357889
Q ss_pred HHHHHHHhcccCccCcCCHHHHHhhHhhhcc
Q 014210 392 ARDFVKRLLNKDPRKRLTAAQALSELLICYQ 422 (429)
Q Consensus 392 ~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~ 422 (429)
+.+||.+||..||.+||++.++++|+||...
T Consensus 248 ~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~ 278 (292)
T cd06658 248 LRGFLDLMLVREPSQRATAQELLQHPFLKLA 278 (292)
T ss_pred HHHHHHHHccCChhHCcCHHHHhhChhhhcc
Confidence 9999999999999999999999999999743
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-41 Score=322.20 Aligned_cols=255 Identities=21% Similarity=0.294 Sum_probs=207.6
Q ss_pred cCceeEeceeeccCceEEEEEEEecC-cccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCC
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKG-ELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~-~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~ 232 (429)
.++|++.++||+|+||.||+|+.... ......||||++... ......+++.+|+.+++.+. |+||+++++++.. .
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~--~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~-~ 81 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLREN--TSPKANKEILDEAYVMAGVG-SPYVCRLLGICLT-S 81 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCC--CCHHHHHHHHHHHHHHHhcC-CCCCceEEEEEcC-C
Confidence 46899999999999999999986542 112346899998643 34455677899999999998 9999999999875 4
Q ss_pred eEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccc
Q 014210 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (429)
Q Consensus 233 ~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~ 312 (429)
..+++|||+++|+|.+++.+..+.+++..+..++.||+.||.|||++||+||||||+|||+ ++++.+||+|||+++.
T Consensus 82 ~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~---~~~~~~kL~dfG~~~~ 158 (279)
T cd05109 82 TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLV---KSPNHVKITDFGLARL 158 (279)
T ss_pred CcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEE---cCCCcEEECCCCceee
Confidence 5789999999999999987766789999999999999999999999999999999999999 6677899999999987
Q ss_pred cCCCccc---cccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCC
Q 014210 313 VRPDERL---NDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPS 387 (429)
Q Consensus 313 ~~~~~~~---~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 387 (429)
....... ....++..|+|||++. ..++.++||||||+++|||++ |..||...........+.... ... ....
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~-~~~--~~~~ 235 (279)
T cd05109 159 LDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGE-RLP--QPPI 235 (279)
T ss_pred cccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCC-cCC--CCcc
Confidence 6533322 1223467899999876 468999999999999999998 899997766555544443322 111 1246
Q ss_pred CCHHHHHHHHHhcccCccCcCCHHHHHhhHh
Q 014210 388 LSSEARDFVKRLLNKDPRKRLTAAQALSELL 418 (429)
Q Consensus 388 ~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~ 418 (429)
++.++.++|.+||+.||++||++.+++..+-
T Consensus 236 ~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~ 266 (279)
T cd05109 236 CTIDVYMIMVKCWMIDSECRPRFRELVDEFS 266 (279)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 7899999999999999999999999997643
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=326.20 Aligned_cols=256 Identities=34% Similarity=0.554 Sum_probs=209.4
Q ss_pred CceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeE
Q 014210 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (429)
Q Consensus 155 ~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~ 234 (429)
++|++.++||+|+||.||+|.... +++.||||++.... ......+.+.+|+++++++. |+||+++++++.+++..
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~---~~~~v~vK~~~~~~-~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~ 75 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKA---TGEIVAIKKFKESE-DDEDVKKTALREVKVLRQLR-HENIVNLKEAFRRKGRL 75 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCC---CCcEEEEehhhhhc-ccccchhHHHHHHHHHHhcC-CCCeeehhheEEECCEE
Confidence 479999999999999999998776 48899999986533 23344577899999999999 99999999999999999
Q ss_pred EEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccccC
Q 014210 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (429)
Q Consensus 235 ~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~ 314 (429)
++||||++++.+ +.+......+++..++.++.||+.||.|||+.||+|+||+|+||++ ++++.+||+|||++....
T Consensus 76 ~iv~e~~~~~~l-~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~---~~~~~~kl~d~g~~~~~~ 151 (288)
T cd07833 76 YLVFEYVERTLL-ELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILV---SESGVLKLCDFGFARALR 151 (288)
T ss_pred EEEEecCCCCHH-HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---CCCCCEEEEeeecccccC
Confidence 999999987555 4444555679999999999999999999999999999999999999 678899999999988765
Q ss_pred CCc--cccccccCCcccCccccc-C-CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcC-------------
Q 014210 315 PDE--RLNDIVGSAYYVAPEVLH-R-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKAD------------- 377 (429)
Q Consensus 315 ~~~--~~~~~~gt~~y~aPE~~~-~-~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~------------- 377 (429)
... ......++..|+|||++. . .++.++||||||+++|+|++|+.||......+.+..+....
T Consensus 152 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (288)
T cd07833 152 ARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSS 231 (288)
T ss_pred CCccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhccc
Confidence 443 334567889999999876 3 57889999999999999999999997765544433322110
Q ss_pred -CCCC-----C---------CCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhh
Q 014210 378 -PSFD-----E---------APWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLI 419 (429)
Q Consensus 378 -~~~~-----~---------~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~ 419 (429)
.... . .....++.++.+||++||..||++||++.+++.|+||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 232 NPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred CccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 0000 0 0011248899999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-43 Score=348.95 Aligned_cols=254 Identities=24% Similarity=0.430 Sum_probs=218.3
Q ss_pred eEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCC-cCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe--E
Q 014210 158 ELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHK-MTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN--V 234 (429)
Q Consensus 158 ~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~-~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~--~ 234 (429)
+...+||+|.|-+||+|.+.. +|..||--.++..+ ......+++|..|+.+|+.|+ |+||+++|++|.+..+ +
T Consensus 43 k~~evLGrGafKtVYka~De~---~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~-H~NIirfy~SW~d~~n~~i 118 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEE---EGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLK-HPNIIRFYDSWVDTDNKTI 118 (632)
T ss_pred ehhhhcccccceeeeeccccc---cchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCC-CCceeeeeeheecCCCcee
Confidence 567899999999999998644 68888866554332 345667789999999999999 9999999999998766 8
Q ss_pred EEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC--ceeccCCCCcEEEeecCCCceEEEeecCCccc
Q 014210 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQG--VVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (429)
Q Consensus 235 ~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~--iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~ 312 (429)
.+|+|.+..|+|..|+. +.++++...++.|++||++||.|||++. |||||||-+||+|+ +..|.|||+|+|||..
T Consensus 119 n~iTEL~TSGtLr~Y~k-k~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFin--G~~G~VKIGDLGLAtl 195 (632)
T KOG0584|consen 119 NFITELFTSGTLREYRK-KHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVN--GNLGEVKIGDLGLATL 195 (632)
T ss_pred eeeeecccCCcHHHHHH-HhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEc--CCcCceeecchhHHHH
Confidence 89999999999999875 4477999999999999999999999996 99999999999997 7788999999999998
Q ss_pred cCCCccccccccCCcccCcccccCCCCCcccHHHHHHHHHHHHcCCCCCCC-CChHHHHHHHHhcCCCCCCCCCCCCCHH
Q 014210 313 VRPDERLNDIVGSAYYVAPEVLHRSYSTEADVWSIGVIAYILLCGSRPFWA-RTESGIFRAVLKADPSFDEAPWPSLSSE 391 (429)
Q Consensus 313 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~sDiwSlGvll~elltg~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 391 (429)
.+.... ...+||+.|||||+....|+..+|||||||+|+||+|+..||.. .+...++.++..+..+.... ..-+++
T Consensus 196 ~r~s~a-ksvIGTPEFMAPEmYEE~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~--kV~dPe 272 (632)
T KOG0584|consen 196 LRKSHA-KSVIGTPEFMAPEMYEENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALS--KVKDPE 272 (632)
T ss_pred hhcccc-ceeccCccccChHHHhhhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhh--ccCCHH
Confidence 875444 44899999999999999999999999999999999999999965 55667777777665333222 223789
Q ss_pred HHHHHHHhcccCccCcCCHHHHHhhHhhhcc
Q 014210 392 ARDFVKRLLNKDPRKRLTAAQALSELLICYQ 422 (429)
Q Consensus 392 ~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~ 422 (429)
+++||.+||.. .++|+|+.++|.|+||+..
T Consensus 273 vr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 273 VREFIEKCLAT-KSERLSAKELLKDPFFDED 302 (632)
T ss_pred HHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence 99999999999 9999999999999999876
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=326.65 Aligned_cols=261 Identities=30% Similarity=0.520 Sum_probs=215.3
Q ss_pred ceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcC-cHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeE
Q 014210 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMT-TAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (429)
Q Consensus 156 ~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~-~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~ 234 (429)
+|++.+.||.|+||.||+++...+..+|+.||+|++...... .....+.+.+|+++++++.+|+||++++++++.++..
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 488999999999999999987654446899999998653222 2233466889999999997799999999999999999
Q ss_pred EEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccccC
Q 014210 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (429)
Q Consensus 235 ~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~ 314 (429)
++||||+++++|.+++... ..+++..+..++.||+.||.|||+.|++||||||+|||+ +.++.+||+|||++....
T Consensus 81 ~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~---~~~~~~kl~dfg~~~~~~ 156 (290)
T cd05613 81 HLILDYINGGELFTHLSQR-ERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILL---DSNGHVVLTDFGLSKEFH 156 (290)
T ss_pred EEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEE---CCCCCEEEeeCccceecc
Confidence 9999999999999988654 568999999999999999999999999999999999999 678899999999997664
Q ss_pred CCc--cccccccCCcccCcccccC---CCCCcccHHHHHHHHHHHHcCCCCCCCCCh----HHHHHHHHhcCCCCCCCCC
Q 014210 315 PDE--RLNDIVGSAYYVAPEVLHR---SYSTEADVWSIGVIAYILLCGSRPFWARTE----SGIFRAVLKADPSFDEAPW 385 (429)
Q Consensus 315 ~~~--~~~~~~gt~~y~aPE~~~~---~~~~~sDiwSlGvll~elltg~~Pf~~~~~----~~~~~~i~~~~~~~~~~~~ 385 (429)
... ......|+..|+|||.+.+ .++.++||||||+++|+|++|..||..... ..+...+....+.++
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~---- 232 (290)
T cd05613 157 EDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYP---- 232 (290)
T ss_pred cccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCCCC----
Confidence 332 2234568999999998763 467899999999999999999999964322 233333333333322
Q ss_pred CCCCHHHHHHHHHhcccCccCcC-----CHHHHHhhHhhhccce
Q 014210 386 PSLSSEARDFVKRLLNKDPRKRL-----TAAQALSELLICYQSY 424 (429)
Q Consensus 386 ~~~s~~~~~li~~~L~~dP~~Rp-----s~~~iL~~~~~~~~~~ 424 (429)
..++..+.+||++||+.||++|+ ++.+++.|+||+...+
T Consensus 233 ~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~ 276 (290)
T cd05613 233 QEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINW 276 (290)
T ss_pred ccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCCH
Confidence 35789999999999999999997 8999999999987664
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=352.05 Aligned_cols=265 Identities=20% Similarity=0.290 Sum_probs=199.4
Q ss_pred cccccCceeEeceeeccCceEEEEEEEecCcccCeEEEEE--------------EccCCCcCcHHHHHHHHHHHHHHHHh
Q 014210 150 SKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVK--------------VIPKHKMTTAIAIEDVRREVKILRAL 215 (429)
Q Consensus 150 ~~~~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK--------------~~~~~~~~~~~~~~~~~~Ei~il~~l 215 (429)
...+.++|+++++||+|+||.||++..+.. .+..+++| ++.+...........+.+|+.+++++
T Consensus 143 ~~~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l 220 (501)
T PHA03210 143 DDEFLAHFRVIDDLPAGAFGKIFICALRAS--TEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRL 220 (501)
T ss_pred chhhhhccEEEeEecCCCCcceEEEEEecc--chhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhC
Confidence 345678999999999999999999876542 12222222 12111122334556789999999999
Q ss_pred cCCCCcceEEEEEEeCCeEEEEEEecCCCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcE
Q 014210 216 TGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSR----GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENF 291 (429)
Q Consensus 216 ~~h~nIv~l~~~~~~~~~~~lv~E~~~ggsL~~~i~~~----~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NI 291 (429)
+ |+|||++++++.+.+..|+|+|++. ++|.+++... ........++.|+.||+.||.|||++|||||||||+||
T Consensus 221 ~-HpnIv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NI 298 (501)
T PHA03210 221 N-HENILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENI 298 (501)
T ss_pred C-CCCcCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHE
Confidence 8 9999999999999999999999995 5778776533 22345677889999999999999999999999999999
Q ss_pred EEeecCCCceEEEeecCCccccCCCcc--ccccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHcCCCCCCCCC---
Q 014210 292 LFTTKDENSVLKAIDFGLSDFVRPDER--LNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWART--- 365 (429)
Q Consensus 292 Ll~~~~~~~~vkL~DFGla~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~elltg~~Pf~~~~--- 365 (429)
|+ +.++.+||+|||++..+..... ....+||..|+|||++.+ .++.++|||||||++|||++|..+++...
T Consensus 299 Ll---~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~ 375 (501)
T PHA03210 299 FL---NCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGK 375 (501)
T ss_pred EE---CCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCC
Confidence 99 6788899999999987654322 234679999999998874 68999999999999999999986654322
Q ss_pred hHHHHHHHHhcCC----CCCC----------------C--------CCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhH
Q 014210 366 ESGIFRAVLKADP----SFDE----------------A--------PWPSLSSEARDFVKRLLNKDPRKRLTAAQALSEL 417 (429)
Q Consensus 366 ~~~~~~~i~~~~~----~~~~----------------~--------~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~ 417 (429)
....+..++.... .++. . ....++.++.++|.+||+.||.+||++.|+|.|+
T Consensus 376 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp 455 (501)
T PHA03210 376 PGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALP 455 (501)
T ss_pred HHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhCh
Confidence 2222222222110 0000 0 0013567888999999999999999999999999
Q ss_pred hhhc
Q 014210 418 LICY 421 (429)
Q Consensus 418 ~~~~ 421 (429)
||..
T Consensus 456 ~f~~ 459 (501)
T PHA03210 456 LFSA 459 (501)
T ss_pred hhhc
Confidence 9964
|
|
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-41 Score=317.82 Aligned_cols=245 Identities=23% Similarity=0.353 Sum_probs=202.1
Q ss_pred eeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEec
Q 014210 162 EVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELC 241 (429)
Q Consensus 162 ~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~~lv~E~~ 241 (429)
.||+|+||.||+|...... .+..||+|++... ......+.+.+|+.++++++ |+||++++++++ .+..++||||+
T Consensus 2 ~ig~G~~g~v~~~~~~~~~-~~~~vavk~~~~~--~~~~~~~~~~~E~~~l~~l~-h~~ii~~~~~~~-~~~~~lv~e~~ 76 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRK-KQIDVAIKVLKNE--NEKSVRDEMMREAEIMHQLD-NPYIVRMIGVCE-AEALMLVMEMA 76 (257)
T ss_pred ccCCCCcccEEEEEEecCC-CceeEEEEEcccc--cChHHHHHHHHHHHHHHhcC-CCCeEEEEEEEc-CCCeEEEEEeC
Confidence 4899999999999765321 4678999998654 33445577999999999998 999999999885 45789999999
Q ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccccCCCccc--
Q 014210 242 EGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERL-- 319 (429)
Q Consensus 242 ~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~-- 319 (429)
++++|.+++......+++..+++++.||+.||.|||++|++||||||+|||+ +.++.+||+|||++.....+...
T Consensus 77 ~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~---~~~~~~kl~dfg~~~~~~~~~~~~~ 153 (257)
T cd05115 77 SGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLL---VNQHYAKISDFGLSKALGADDSYYK 153 (257)
T ss_pred CCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEE---cCCCcEEeccCCccccccCCcccee
Confidence 9999999887667789999999999999999999999999999999999999 67788999999999765433221
Q ss_pred --cccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHH
Q 014210 320 --NDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDF 395 (429)
Q Consensus 320 --~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 395 (429)
....++..|+|||++. +.++.++||||||+++|||++ |..||......+....+....... ..+..++++.++
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~l 230 (257)
T cd05115 154 ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLD---CPAECPPEMYAL 230 (257)
T ss_pred ccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCC---CCCCCCHHHHHH
Confidence 1122356899999876 468899999999999999996 999998887777666555443211 223578999999
Q ss_pred HHHhcccCccCcCCHHHHHhhH
Q 014210 396 VKRLLNKDPRKRLTAAQALSEL 417 (429)
Q Consensus 396 i~~~L~~dP~~Rps~~~iL~~~ 417 (429)
|.+||..||++||++.++++.+
T Consensus 231 i~~c~~~~~~~Rp~~~~i~~~l 252 (257)
T cd05115 231 MKDCWIYKWEDRPNFAKVEERM 252 (257)
T ss_pred HHHHcCCChhhCcCHHHHHHHH
Confidence 9999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=326.17 Aligned_cols=258 Identities=27% Similarity=0.407 Sum_probs=210.9
Q ss_pred cCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~ 233 (429)
.++|++.+.||+|+||.||+|.... +|+.||||++.+.. ......++.+|+.++.++.+|+||+++++++.+...
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~---~~~~~avK~~~~~~--~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~ 88 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKK---TGHVMAVKQMRRTG--NKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSD 88 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECC---CCeEEEEEEEeccC--ChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCe
Confidence 4679999999999999999998765 58999999987543 223345677788888887779999999999999999
Q ss_pred EEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-cCceeccCCCCcEEEeecCCCceEEEeecCCccc
Q 014210 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHL-QGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (429)
Q Consensus 234 ~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~-~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~ 312 (429)
.+++|||+. ++|.+.+......+++..+..++.||+.||.|||+ .||+||||+|+||++ ++++.+||+|||++..
T Consensus 89 ~~~v~e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill---~~~~~~kL~dfg~~~~ 164 (296)
T cd06618 89 VFICMELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILL---DASGNVKLCDFGISGR 164 (296)
T ss_pred EEEEeeccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEE---cCCCCEEECccccchh
Confidence 999999995 47777666656689999999999999999999997 599999999999999 6788999999999877
Q ss_pred cCCCccccccccCCcccCcccccC-----CCCCcccHHHHHHHHHHHHcCCCCCCCCCh-HHHHHHHHhcCCCCCCCCCC
Q 014210 313 VRPDERLNDIVGSAYYVAPEVLHR-----SYSTEADVWSIGVIAYILLCGSRPFWARTE-SGIFRAVLKADPSFDEAPWP 386 (429)
Q Consensus 313 ~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~sDiwSlGvll~elltg~~Pf~~~~~-~~~~~~i~~~~~~~~~~~~~ 386 (429)
...........++..|+|||++.+ .++.++||||||+++|+|++|+.||..... .+.+..++....... ....
T Consensus 165 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~ 243 (296)
T cd06618 165 LVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSL-PPNE 243 (296)
T ss_pred ccCCCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCC-CCCC
Confidence 654444444568889999998863 378899999999999999999999975332 334444444332111 1112
Q ss_pred CCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhc
Q 014210 387 SLSSEARDFVKRLLNKDPRKRLTAAQALSELLICY 421 (429)
Q Consensus 387 ~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~ 421 (429)
.++.++.+||.+||+.||.+||++.+++.|+|++.
T Consensus 244 ~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 278 (296)
T cd06618 244 GFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRR 278 (296)
T ss_pred CCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhc
Confidence 47899999999999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=319.92 Aligned_cols=253 Identities=28% Similarity=0.541 Sum_probs=212.2
Q ss_pred ceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEE
Q 014210 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVY 235 (429)
Q Consensus 156 ~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~~ 235 (429)
+|++.+.||+|+||.||++.... .|..||+|.+..... .....+.+.+|+.++++++ |+||+++++.+.+.+..+
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~---~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~~~-h~~i~~~~~~~~~~~~~~ 75 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKS---DSEHCVIKEIDLTKM-PVKEKEASKKEVILLAKMK-HPNIVTFFASFQENGRLF 75 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcC---CCceEEEEEeeHhhc-cchhhHHHHHHHHHHHhCC-CCChhhhhheeccCCeEE
Confidence 58899999999999999998776 588999999865432 2234567889999999998 999999999999999999
Q ss_pred EEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCC-ceEEEeecCCcccc
Q 014210 236 VVMELCEGGELLDRILSRG-GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDEN-SVLKAIDFGLSDFV 313 (429)
Q Consensus 236 lv~E~~~ggsL~~~i~~~~-~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~-~~vkL~DFGla~~~ 313 (429)
+|+||+++++|.+++.... ..+++..+..++.||+.||.|||+.+|+|+||||+||+++ ++ ..+||+|||.+...
T Consensus 76 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~---~~~~~~~l~d~~~~~~~ 152 (257)
T cd08225 76 IVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLS---KNGMVAKLGDFGIARQL 152 (257)
T ss_pred EEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEc---CCCCeEEecccccchhc
Confidence 9999999999999886543 3589999999999999999999999999999999999994 44 46799999998776
Q ss_pred CCCcc-ccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHH
Q 014210 314 RPDER-LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSE 391 (429)
Q Consensus 314 ~~~~~-~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 391 (429)
..... .....|+..|+|||++. ..++.++|+||||+++|||++|..||...........+...... ...+.++.+
T Consensus 153 ~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~ 229 (257)
T cd08225 153 NDSMELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFA---PISPNFSRD 229 (257)
T ss_pred cCCcccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCC---CCCCCCCHH
Confidence 54332 23346889999999876 46889999999999999999999999877665555554443221 122467899
Q ss_pred HHHHHHHhcccCccCcCCHHHHHhhHhh
Q 014210 392 ARDFVKRLLNKDPRKRLTAAQALSELLI 419 (429)
Q Consensus 392 ~~~li~~~L~~dP~~Rps~~~iL~~~~~ 419 (429)
+.++|.+||..+|++||++.+++.|+||
T Consensus 230 ~~~~i~~~l~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 230 LRSLISQLFKVSPRDRPSITSILKRPFL 257 (257)
T ss_pred HHHHHHHHhccChhhCcCHHHHhhCCCC
Confidence 9999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=323.33 Aligned_cols=249 Identities=22% Similarity=0.401 Sum_probs=199.3
Q ss_pred cCceeEecee--eccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeC
Q 014210 154 ANKYELGEEV--GRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (429)
Q Consensus 154 ~~~y~~~~~I--G~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~ 231 (429)
.++|++.+.+ |+|+||.||+++.+. +|+.+|+|++....... .|+.+...+.+|+||+++++++...
T Consensus 13 ~~~~~~~~~~~lg~g~~g~v~~~~~~~---~~~~~~~k~~~~~~~~~--------~e~~~~~~~~~h~~iv~~~~~~~~~ 81 (267)
T PHA03390 13 LKNCEIVKKLKLIDGKFGKVSVLKHKP---TQKLFVQKIIKAKNFNA--------IEPMVHQLMKDNPNFIKLYYSVTTL 81 (267)
T ss_pred HHhhccccceeecCCCceEEEEEEEcC---CCcEEEEEEEehhhcch--------hhHHHHHHhhcCCCEEEEEEEEecC
Confidence 4567777776 999999999998766 58899999986532211 1333333344599999999999999
Q ss_pred CeEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCc-eEEEeecCCc
Q 014210 232 DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENS-VLKAIDFGLS 310 (429)
Q Consensus 232 ~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~-~vkL~DFGla 310 (429)
+..++||||+++++|.+++... ..+++..++.++.||++||.|||+.||+||||||+||++ +.++ .++|+|||++
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~---~~~~~~~~l~dfg~~ 157 (267)
T PHA03390 82 KGHVLIMDYIKDGDLFDLLKKE-GKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLY---DRAKDRIYLCDYGLC 157 (267)
T ss_pred CeeEEEEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEE---eCCCCeEEEecCccc
Confidence 9999999999999999988554 489999999999999999999999999999999999999 4555 8999999998
Q ss_pred cccCCCccccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCC
Q 014210 311 DFVRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLS 389 (429)
Q Consensus 311 ~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 389 (429)
...... ....++..|+|||++. ..++.++||||||+++|+|++|+.||........-...+..........++.++
T Consensus 158 ~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (267)
T PHA03390 158 KIIGTP---SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKNVS 234 (267)
T ss_pred eecCCC---ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCcccccC
Confidence 765432 2346889999999886 468899999999999999999999997554433211111111122223334689
Q ss_pred HHHHHHHHHhcccCccCcCC-HHHHHhhHhhh
Q 014210 390 SEARDFVKRLLNKDPRKRLT-AAQALSELLIC 420 (429)
Q Consensus 390 ~~~~~li~~~L~~dP~~Rps-~~~iL~~~~~~ 420 (429)
..+.+||.+||+.||.+|++ ++++|+|+||.
T Consensus 235 ~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~ 266 (267)
T PHA03390 235 KNANDFVQSMLKYNINYRLTNYNEIIKHPFLK 266 (267)
T ss_pred HHHHHHHHHHhccChhhCCchHHHHhcCCccc
Confidence 99999999999999999996 59999999986
|
|
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=322.29 Aligned_cols=257 Identities=24% Similarity=0.410 Sum_probs=208.4
Q ss_pred ceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCc---HHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCC
Q 014210 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTT---AIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (429)
Q Consensus 156 ~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~---~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~ 232 (429)
+|+..+.||+|+||.||++.... +|+.||+|++....... ....+.+.+|++++++++ |+||+++++++.+.+
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~---~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~ 76 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVK---TGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLN-HPHIIRMLGATCEDS 76 (268)
T ss_pred CccccceecCcCceEEEEEEEcC---CCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcC-CCceehhhceeccCC
Confidence 47888999999999999998655 58899999986543221 234578899999999998 999999999999999
Q ss_pred eEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCC-ceEEEeecCCcc
Q 014210 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDEN-SVLKAIDFGLSD 311 (429)
Q Consensus 233 ~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~-~~vkL~DFGla~ 311 (429)
..++||||+++++|.+++.. .+.+++..++.++.||+.||.|||++||+|+||||+||++ +.+ ..+||+|||++.
T Consensus 77 ~~~~v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~---~~~~~~~~l~dfg~~~ 152 (268)
T cd06630 77 HFNLFVEWMAGGSVSHLLSK-YGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLI---DSTGQRLRIADFGAAA 152 (268)
T ss_pred eEEEEEeccCCCcHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCCCEEEEccccccc
Confidence 99999999999999987754 4578999999999999999999999999999999999999 444 469999999987
Q ss_pred ccCCCc-----cccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcC-CCCCCCC
Q 014210 312 FVRPDE-----RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKAD-PSFDEAP 384 (429)
Q Consensus 312 ~~~~~~-----~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~-~~~~~~~ 384 (429)
...... ......++..|+|||++. ..++.++||||||+++|+|++|..||...........+.... .......
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (268)
T cd06630 153 RLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSI 232 (268)
T ss_pred ccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCC
Confidence 654321 122356889999999876 468899999999999999999999996544332222222211 1111122
Q ss_pred CCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhh
Q 014210 385 WPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLIC 420 (429)
Q Consensus 385 ~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~ 420 (429)
...++.++.++|.+||..||++||++.+++.|+||+
T Consensus 233 ~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 233 PEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred chhhCHHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 235789999999999999999999999999999974
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=326.71 Aligned_cols=255 Identities=24% Similarity=0.421 Sum_probs=211.0
Q ss_pred cCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~ 233 (429)
.++|++.++||+|+||.||++.... .|+.||+|++... ......+++.+|+++++.++ |+||+++++++.+.+.
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~---~~~~~a~k~~~~~--~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~ 77 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIP---TGTVMAKKVVHIG--AKSSVRKQILRELQIMHECR-SPYIVSFYGAFLNENN 77 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcC---CCcEEEEEEEEec--CcchHHHHHHHHHHHHHHcC-CCCcceEeeeEecCCE
Confidence 3679999999999999999998765 5889999988643 23445678999999999998 9999999999999999
Q ss_pred EEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-cCceeccCCCCcEEEeecCCCceEEEeecCCccc
Q 014210 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHL-QGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (429)
Q Consensus 234 ~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~-~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~ 312 (429)
+++||||+++++|.+++.. .+.+++..+..++.+++.+|.|||+ .+++||||||+||++ ++++.++|+|||++..
T Consensus 78 ~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~---~~~~~~~l~d~gl~~~ 153 (284)
T cd06620 78 ICMCMEFMDCGSLDRIYKK-GGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILV---NSRGQIKLCDFGVSGE 153 (284)
T ss_pred EEEEEecCCCCCHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEE---CCCCcEEEccCCcccc
Confidence 9999999999999887754 4578999999999999999999997 589999999999999 6788899999999865
Q ss_pred cCCCccccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHcCCCCCCCCChH-----------HHHHHHHhcCCCC
Q 014210 313 VRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTES-----------GIFRAVLKADPSF 380 (429)
Q Consensus 313 ~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~elltg~~Pf~~~~~~-----------~~~~~i~~~~~~~ 380 (429)
... .......|+..|+|||++. +.++.++|||||||++|+|++|+.||...... +.+..+......
T Consensus 154 ~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 231 (284)
T cd06620 154 LIN-SIADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPP- 231 (284)
T ss_pred hhh-hccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCC-
Confidence 432 2233567899999999875 56889999999999999999999999765432 222233222211
Q ss_pred CCCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhc
Q 014210 381 DEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLICY 421 (429)
Q Consensus 381 ~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~ 421 (429)
......++.++.+||.+||+.||++||++.++++|+|+..
T Consensus 232 -~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~ 271 (284)
T cd06620 232 -RLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQ 271 (284)
T ss_pred -CCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence 1111237789999999999999999999999999998843
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=321.60 Aligned_cols=252 Identities=34% Similarity=0.551 Sum_probs=215.2
Q ss_pred eeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEecC
Q 014210 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCE 242 (429)
Q Consensus 163 IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~~lv~E~~~ 242 (429)
||.|+||.||+++... +|+.+++|++...........+.+.+|+++++++. |+||+++++.+..++..|++|||++
T Consensus 1 lg~g~~~~vy~~~~~~---~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~~lv~e~~~ 76 (265)
T cd05579 1 ISKGAYGRVFLAKKKS---TGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQ-SPYVVKLYYSFQGKKNLYLVMEYLP 76 (265)
T ss_pred CCCCCceEEEEEEECC---CCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCC-CcchhHHHHheecCcEEEEEEecCC
Confidence 6899999999998765 58999999997655444566778999999999998 9999999999999999999999999
Q ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccccCCCc-----
Q 014210 243 GGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDE----- 317 (429)
Q Consensus 243 ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~----- 317 (429)
+++|.+++... +.+++..++.++.||+.||.|||+.||+|+||+|+||++ +.++.+||+|||++.......
T Consensus 77 ~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~ 152 (265)
T cd05579 77 GGDLASLLENV-GSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILI---DSNGHLKLTDFGLSKVGLVRRQINLN 152 (265)
T ss_pred CCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEE---cCCCCEEEEecccchhcccCcccccc
Confidence 99999887554 479999999999999999999999999999999999999 778899999999987654331
Q ss_pred ----cccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHH
Q 014210 318 ----RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEA 392 (429)
Q Consensus 318 ----~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 392 (429)
......++..|++||.+. ..++.++||||||+++|+|++|..||........+..+.......+.. ..++.++
T Consensus 153 ~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 230 (265)
T cd05579 153 DDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPED--VEVSDEA 230 (265)
T ss_pred cccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCcc--ccCCHHH
Confidence 223456888999999876 458889999999999999999999998888877777776644333322 1248999
Q ss_pred HHHHHHhcccCccCcCCH---HHHHhhHhhhccce
Q 014210 393 RDFVKRLLNKDPRKRLTA---AQALSELLICYQSY 424 (429)
Q Consensus 393 ~~li~~~L~~dP~~Rps~---~~iL~~~~~~~~~~ 424 (429)
.+||++||+.+|++||++ .++|.|+||...+|
T Consensus 231 ~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~~~ 265 (265)
T cd05579 231 IDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGIDW 265 (265)
T ss_pred HHHHHHHhcCCHhhcCCCccHHHHhcCccccCCCC
Confidence 999999999999999999 99999999986543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-41 Score=322.17 Aligned_cols=254 Identities=24% Similarity=0.404 Sum_probs=210.9
Q ss_pred cCceeEeceeeccCceEEEEEEEec--CcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeC
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKK--GELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~--~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~ 231 (429)
.++|.+.++||+|+||.||+++... ...++..+|+|.+.. ......+.+.+|+++++++. |+||+++++++.+.
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~---~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~ 79 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKE---ASESARQDFQREAELLTVLQ-HQHIVRFYGVCTEG 79 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCc---CCHHHHHHHHHHHHHHhcCC-CCCCceEEEEEecC
Confidence 4678899999999999999997543 222567899998754 34455678999999999997 99999999999999
Q ss_pred CeEEEEEEecCCCcHHHHHHhcC--------------CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecC
Q 014210 232 DNVYVVMELCEGGELLDRILSRG--------------GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKD 297 (429)
Q Consensus 232 ~~~~lv~E~~~ggsL~~~i~~~~--------------~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~ 297 (429)
+..+++|||+++++|.+++.... ..+++..++.++.||+.||+|||+.||+||||||+|||+ +
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~---~ 156 (280)
T cd05092 80 RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLV---G 156 (280)
T ss_pred CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEE---c
Confidence 99999999999999999886543 358899999999999999999999999999999999999 6
Q ss_pred CCceEEEeecCCccccCCCcc---ccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHc-CCCCCCCCChHHHHHH
Q 014210 298 ENSVLKAIDFGLSDFVRPDER---LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRA 372 (429)
Q Consensus 298 ~~~~vkL~DFGla~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~ellt-g~~Pf~~~~~~~~~~~ 372 (429)
+++.+||+|||++........ .....++..|+|||++. ..++.++|||||||++|||++ |..||......+.+..
T Consensus 157 ~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~ 236 (280)
T cd05092 157 QGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIEC 236 (280)
T ss_pred CCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHH
Confidence 788899999999875543221 12234567899999876 468999999999999999998 9999987777776666
Q ss_pred HHhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhH
Q 014210 373 VLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSEL 417 (429)
Q Consensus 373 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~ 417 (429)
+....... ....++..+.+||.+||+.||.+||++.+++..+
T Consensus 237 ~~~~~~~~---~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l 278 (280)
T cd05092 237 ITQGRELE---RPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRL 278 (280)
T ss_pred HHcCccCC---CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHH
Confidence 65543221 1236889999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-41 Score=326.88 Aligned_cols=257 Identities=26% Similarity=0.433 Sum_probs=217.7
Q ss_pred cCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~ 233 (429)
.+.|+..+.||+|+||.||+++... +|..||+|++............++.+|+++++++. |+|++++++++.+++.
T Consensus 24 ~~~f~~~~~lg~G~~~~v~~~~~~~---~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~ 99 (317)
T cd06635 24 EKLFTDLREIGHGSFGAVYFARDVR---TNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIK-HPNSIEYKGCYLREHT 99 (317)
T ss_pred hhhhhhhheeccCCCeEEEEEEEcC---CCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCC-CCCEEEEEEEEeeCCe
Confidence 3558899999999999999998765 58899999987654455556678999999999998 9999999999999999
Q ss_pred EEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCcccc
Q 014210 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (429)
Q Consensus 234 ~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~ 313 (429)
.++||||+.| +|.+.+......+++..+..++.||+.||.|||+.||+||||+|+||++ +.++.+||+|||++...
T Consensus 100 ~~lv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~---~~~~~~kl~dfg~~~~~ 175 (317)
T cd06635 100 AWLVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILL---TEPGQVKLADFGSASIA 175 (317)
T ss_pred EEEEEeCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEE---CCCCCEEEecCCCcccc
Confidence 9999999975 8888776667789999999999999999999999999999999999999 67788999999998754
Q ss_pred CCCccccccccCCcccCccccc----CCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCC
Q 014210 314 RPDERLNDIVGSAYYVAPEVLH----RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLS 389 (429)
Q Consensus 314 ~~~~~~~~~~gt~~y~aPE~~~----~~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 389 (429)
... ....|+..|+|||++. +.++.++|||||||++|||++|+.||...........+....... .....++
T Consensus 176 ~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 250 (317)
T cd06635 176 SPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPT--LQSNEWS 250 (317)
T ss_pred CCc---ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCC--CCCcccc
Confidence 432 3456889999999863 458889999999999999999999998776666555555443221 1223578
Q ss_pred HHHHHHHHHhcccCccCcCCHHHHHhhHhhhccc
Q 014210 390 SEARDFVKRLLNKDPRKRLTAAQALSELLICYQS 423 (429)
Q Consensus 390 ~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~~ 423 (429)
..+.+||.+||+.+|.+||++.+++.|+|+....
T Consensus 251 ~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~ 284 (317)
T cd06635 251 DYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRER 284 (317)
T ss_pred HHHHHHHHHHccCCcccCcCHHHHHhChhhhccC
Confidence 8999999999999999999999999999986544
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=323.17 Aligned_cols=251 Identities=27% Similarity=0.405 Sum_probs=200.8
Q ss_pred eeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHh--cCCCCcceEEEEEEeCCeEEEEEE
Q 014210 162 EVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRAL--TGHNNLVKFFDAYEDTDNVYVVME 239 (429)
Q Consensus 162 ~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l--~~h~nIv~l~~~~~~~~~~~lv~E 239 (429)
.||+|+||.||+++... +|+.||+|++.+...........+..|..+++.+ .+|++|+++++++.+.+..++|||
T Consensus 1 ~ig~g~~g~Vy~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e 77 (278)
T cd05606 1 IIGRGGFGEVYGCRKAD---TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILD 77 (278)
T ss_pred CcccCCCeEEEEEEEec---CCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEe
Confidence 48999999999998765 5889999998765433333333344454444333 249999999999999999999999
Q ss_pred ecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccccCCCccc
Q 014210 240 LCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERL 319 (429)
Q Consensus 240 ~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 319 (429)
|+.|++|.+++. ..+.+++..++.++.|+++||.|||+.+|+||||||+||++ +.++.+||+|||++...... ..
T Consensus 78 ~~~g~~L~~~l~-~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili---~~~~~~kl~dfg~~~~~~~~-~~ 152 (278)
T cd05606 78 LMNGGDLHYHLS-QHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILL---DEHGHVRISDLGLACDFSKK-KP 152 (278)
T ss_pred cCCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEE---CCCCCEEEccCcCccccCcc-CC
Confidence 999999988774 45679999999999999999999999999999999999999 67888999999998765432 22
Q ss_pred cccccCCcccCcccccC--CCCCcccHHHHHHHHHHHHcCCCCCCCCC---hHHHHHHHHhcCCCCCCCCCCCCCHHHHH
Q 014210 320 NDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWART---ESGIFRAVLKADPSFDEAPWPSLSSEARD 394 (429)
Q Consensus 320 ~~~~gt~~y~aPE~~~~--~~~~~sDiwSlGvll~elltg~~Pf~~~~---~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 394 (429)
....|+..|+|||++.+ .++.++||||||+++|||++|+.||.... .......+...... ....++.++.+
T Consensus 153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~s~~~~~ 228 (278)
T cd05606 153 HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVE----LPDSFSPELRS 228 (278)
T ss_pred cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCC----CCCcCCHHHHH
Confidence 34579999999999863 48899999999999999999999997653 22222222222222 22357899999
Q ss_pred HHHHhcccCccCcC-----CHHHHHhhHhhhccce
Q 014210 395 FVKRLLNKDPRKRL-----TAAQALSELLICYQSY 424 (429)
Q Consensus 395 li~~~L~~dP~~Rp-----s~~~iL~~~~~~~~~~ 424 (429)
+|.+||..||.+|+ ++.++++|+|+....+
T Consensus 229 li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~~ 263 (278)
T cd05606 229 LLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLDW 263 (278)
T ss_pred HHHHHhhcCHHhccCCCCCCHHHHHhCccccCCCc
Confidence 99999999999999 9999999999987654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-41 Score=323.40 Aligned_cols=253 Identities=25% Similarity=0.360 Sum_probs=206.9
Q ss_pred ceeEeceeeccCceEEEEEEEecC--cccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe
Q 014210 156 KYELGEEVGRGHFGYTCAAKFKKG--ELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (429)
Q Consensus 156 ~y~~~~~IG~G~fg~V~~~~~~~~--~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~ 233 (429)
+|++.+.||+|+||.||+|..... ......+++|.+... ......+++.+|+.+++.+. |+||+++++.+..++.
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~ 77 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKEN--ASSSELRDLLSEFNLLKQVN-HPHVIKLYGACSQDGP 77 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCC--CCHHHHHHHHHHHHHHhhCC-CCCEeeEEEEEecCCC
Confidence 478899999999999999986531 123467999988653 23445578999999999998 9999999999999999
Q ss_pred EEEEEEecCCCcHHHHHHhc-----------------------CCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCc
Q 014210 234 VYVVMELCEGGELLDRILSR-----------------------GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPEN 290 (429)
Q Consensus 234 ~~lv~E~~~ggsL~~~i~~~-----------------------~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~N 290 (429)
.+++|||+.+++|.+++... ...+++..++.++.|++.||+|||++||+||||||+|
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~n 157 (290)
T cd05045 78 LLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARN 157 (290)
T ss_pred cEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhhe
Confidence 99999999999999987642 1347899999999999999999999999999999999
Q ss_pred EEEeecCCCceEEEeecCCccccCCCcc---ccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHc-CCCCCCCCC
Q 014210 291 FLFTTKDENSVLKAIDFGLSDFVRPDER---LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWART 365 (429)
Q Consensus 291 ILl~~~~~~~~vkL~DFGla~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~ellt-g~~Pf~~~~ 365 (429)
||+ ++++.+||+|||++........ .....++..|+|||++. ..++.++||||||+++|||++ |+.||....
T Consensus 158 ill---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~ 234 (290)
T cd05045 158 VLV---AEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIA 234 (290)
T ss_pred EEE---cCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCC
Confidence 999 6778899999999876543322 12234567899999875 458999999999999999998 999998877
Q ss_pred hHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhH
Q 014210 366 ESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSEL 417 (429)
Q Consensus 366 ~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~ 417 (429)
.......+.... .. .....++.++.+||..||+.||++||++.+++..+
T Consensus 235 ~~~~~~~~~~~~-~~--~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l 283 (290)
T cd05045 235 PERLFNLLKTGY-RM--ERPENCSEEMYNLMLTCWKQEPDKRPTFADISKEL 283 (290)
T ss_pred HHHHHHHHhCCC-CC--CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHH
Confidence 666655444322 11 12246789999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-41 Score=316.80 Aligned_cols=248 Identities=25% Similarity=0.406 Sum_probs=208.3
Q ss_pred ceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEe
Q 014210 161 EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMEL 240 (429)
Q Consensus 161 ~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~~lv~E~ 240 (429)
++||+|++|.||+|...........||||++...... ...+.+.+|+.++++++ |+||+++++++.+ ...++||||
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~-~~~~~v~e~ 76 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLD-HENLIRLYGVVLT-HPLMMVTEL 76 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH--HHHHHHHHHHHHHhhcC-CCCccceeEEEcC-CeEEEEEEe
Confidence 4789999999999988764333457999999765433 56678999999999998 9999999999988 889999999
Q ss_pred cCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccccCCCcc-
Q 014210 241 CEGGELLDRILSRG-GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDER- 318 (429)
Q Consensus 241 ~~ggsL~~~i~~~~-~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~- 318 (429)
+++++|.+++.... ..+++..++.++.|++.||.|||+.|++|+||||+||++ +.++.+||+|||++........
T Consensus 77 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~---~~~~~~kl~dfg~~~~~~~~~~~ 153 (257)
T cd05040 77 APLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILL---ASDDKVKIGDFGLMRALPQNEDH 153 (257)
T ss_pred cCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEE---ecCCEEEeccccccccccccccc
Confidence 99999999987665 578999999999999999999999999999999999999 6778999999999987644221
Q ss_pred ---ccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHH
Q 014210 319 ---LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEAR 393 (429)
Q Consensus 319 ---~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 393 (429)
.....++..|+|||++. ..++.++||||||+++|||++ |..||......+.+..+........ ....++.++.
T Consensus 154 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~ 231 (257)
T cd05040 154 YVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLE--RPEACPQDIY 231 (257)
T ss_pred eecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCC--CCccCCHHHH
Confidence 11245678899999886 468999999999999999998 9999988777777666654322221 1235789999
Q ss_pred HHHHHhcccCccCcCCHHHHHhhH
Q 014210 394 DFVKRLLNKDPRKRLTAAQALSEL 417 (429)
Q Consensus 394 ~li~~~L~~dP~~Rps~~~iL~~~ 417 (429)
+++.+||+.+|++||++.++++.+
T Consensus 232 ~li~~~l~~~p~~Rps~~~~~~~l 255 (257)
T cd05040 232 NVMLQCWAHNPADRPTFAALREFL 255 (257)
T ss_pred HHHHHHCCCCcccCCCHHHHHHHh
Confidence 999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=333.32 Aligned_cols=259 Identities=26% Similarity=0.385 Sum_probs=205.5
Q ss_pred cCceeEeceeeccCceEEEEEEEec--CcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeC
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKK--GELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~--~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~ 231 (429)
.++|++++.||+|+||.||+|.... ...+++.||||++.... .......+.+|+.++.++.+|+||+++++++...
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACTKP 83 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC--ChHHHHHHHHHHHHHHhccCCccHhhhcceeecC
Confidence 4689999999999999999998543 22368899999986532 3344567889999999997699999999988654
Q ss_pred -CeEEEEEEecCCCcHHHHHHhcC--------------------------------------------------------
Q 014210 232 -DNVYVVMELCEGGELLDRILSRG-------------------------------------------------------- 254 (429)
Q Consensus 232 -~~~~lv~E~~~ggsL~~~i~~~~-------------------------------------------------------- 254 (429)
...+++||||++|+|.+++....
T Consensus 84 ~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (343)
T cd05103 84 GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEE 163 (343)
T ss_pred CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchh
Confidence 46899999999999999886432
Q ss_pred ----------CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccccCCCcc---ccc
Q 014210 255 ----------GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDER---LND 321 (429)
Q Consensus 255 ----------~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~---~~~ 321 (429)
..+++..+..++.||++||+|||++||+||||||+|||+ ++++.+||+|||++........ ...
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 240 (343)
T cd05103 164 EEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILL---SENNVVKICDFGLARDIYKDPDYVRKGD 240 (343)
T ss_pred hhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEE---cCCCcEEEEecccccccccCcchhhcCC
Confidence 236788889999999999999999999999999999999 6788999999999876533221 122
Q ss_pred cccCCcccCccccc-CCCCCcccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHh
Q 014210 322 IVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRL 399 (429)
Q Consensus 322 ~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~ 399 (429)
..++..|+|||++. ..++.++||||||+++|+|++ |..||........+...+........ ...+++++.+++..|
T Consensus 241 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~c 318 (343)
T cd05103 241 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRA--PDYTTPEMYQTMLDC 318 (343)
T ss_pred CCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCC--CCCCCHHHHHHHHHH
Confidence 34567799999875 468999999999999999996 99999765443333333332222211 124678999999999
Q ss_pred cccCccCcCCHHHHHhhHhh
Q 014210 400 LNKDPRKRLTAAQALSELLI 419 (429)
Q Consensus 400 L~~dP~~Rps~~~iL~~~~~ 419 (429)
|+.||++||++.++++++--
T Consensus 319 l~~~p~~Rps~~eil~~l~~ 338 (343)
T cd05103 319 WHGEPSQRPTFSELVEHLGN 338 (343)
T ss_pred ccCChhhCcCHHHHHHHHHH
Confidence 99999999999999998643
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-41 Score=338.73 Aligned_cols=257 Identities=24% Similarity=0.364 Sum_probs=208.7
Q ss_pred cCceeEeceeeccCceEEEEEEEec--CcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeC
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKK--GELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~--~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~ 231 (429)
.++|.++++||+|+||.||+|+... ....++.||||++.... .....+.+.+|++++.++..|+|||+++++|...
T Consensus 36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~ 113 (401)
T cd05107 36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA--RSSEKQALMSELKIMSHLGPHLNIVNLLGACTKG 113 (401)
T ss_pred HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC--ChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccC
Confidence 4678899999999999999998653 12246789999996542 2333457889999999997799999999999999
Q ss_pred CeEEEEEEecCCCcHHHHHHhcC---------------------------------------------------------
Q 014210 232 DNVYVVMELCEGGELLDRILSRG--------------------------------------------------------- 254 (429)
Q Consensus 232 ~~~~lv~E~~~ggsL~~~i~~~~--------------------------------------------------------- 254 (429)
+..+||||||++|+|.+++....
T Consensus 114 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (401)
T cd05107 114 GPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQ 193 (401)
T ss_pred CCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchh
Confidence 99999999999999999886432
Q ss_pred ----------------------------------------CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEe
Q 014210 255 ----------------------------------------GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFT 294 (429)
Q Consensus 255 ----------------------------------------~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~ 294 (429)
..+++..++.++.||+.||.|||+.+|+||||||+|||+
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl- 272 (401)
T cd05107 194 DMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLI- 272 (401)
T ss_pred cchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEE-
Confidence 136777889999999999999999999999999999999
Q ss_pred ecCCCceEEEeecCCccccCCCcc---ccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHc-CCCCCCCCChHHH
Q 014210 295 TKDENSVLKAIDFGLSDFVRPDER---LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGI 369 (429)
Q Consensus 295 ~~~~~~~vkL~DFGla~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~ellt-g~~Pf~~~~~~~~ 369 (429)
++++.+||+|||+++....... .....++..|+|||++. ..++.++|||||||++|||++ |..||......+.
T Consensus 273 --~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~ 350 (401)
T cd05107 273 --CEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQ 350 (401)
T ss_pred --eCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHH
Confidence 6678899999999976533221 12345678899999886 458899999999999999998 8999977665555
Q ss_pred HHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhH
Q 014210 370 FRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSEL 417 (429)
Q Consensus 370 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~ 417 (429)
....+....... ....++.++.+||.+||+.+|.+||++.+++..+
T Consensus 351 ~~~~~~~~~~~~--~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L 396 (401)
T cd05107 351 FYNAIKRGYRMA--KPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLV 396 (401)
T ss_pred HHHHHHcCCCCC--CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 444443332211 2235789999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=320.56 Aligned_cols=250 Identities=25% Similarity=0.420 Sum_probs=211.7
Q ss_pred cCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~ 233 (429)
..+|++.++||.|+||.||+|.... ++.+|+|++... ......++.+|+.+++.++ |+||+++++++.+.+.
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~----~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~ 76 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKN----RVRVAIKILKSD---DLLKQQDFQKEVQALKRLR-HKHLISLFAVCSVGEP 76 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecC----CCcEEEEecccc---chhhHHHHHHHHHHHhcCC-CcchhheeeeEecCCC
Confidence 4679999999999999999998765 688999998653 2334567889999999998 9999999999999999
Q ss_pred EEEEEEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccc
Q 014210 234 VYVVMELCEGGELLDRILSR-GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (429)
Q Consensus 234 ~~lv~E~~~ggsL~~~i~~~-~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~ 312 (429)
.++||||+++++|.+++... +..+++..++.++.||+.||.|||++||+||||||+|||+ ++++.+||+|||++..
T Consensus 77 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv---~~~~~~kl~d~g~~~~ 153 (261)
T cd05148 77 VYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILV---GEDLVCKVADFGLARL 153 (261)
T ss_pred eEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEE---cCCceEEEccccchhh
Confidence 99999999999999998753 4568999999999999999999999999999999999999 6788999999999976
Q ss_pred cCCCcc-ccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCC
Q 014210 313 VRPDER-LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLS 389 (429)
Q Consensus 313 ~~~~~~-~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 389 (429)
...... .....++..|++||++. +.++.++||||||+++|+|++ |+.||......+.+..+..... ......++
T Consensus 154 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~ 230 (261)
T cd05148 154 IKEDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYR---MPCPAKCP 230 (261)
T ss_pred cCCccccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCc---CCCCCCCC
Confidence 643321 12334567899999876 468889999999999999998 8999988777777776654321 12224688
Q ss_pred HHHHHHHHHhcccCccCcCCHHHHHhhH
Q 014210 390 SEARDFVKRLLNKDPRKRLTAAQALSEL 417 (429)
Q Consensus 390 ~~~~~li~~~L~~dP~~Rps~~~iL~~~ 417 (429)
.++.++|.+||+.||++||++.++++.+
T Consensus 231 ~~~~~~i~~~l~~~p~~Rpt~~~l~~~L 258 (261)
T cd05148 231 QEIYKIMLECWAAEPEDRPSFKALREEL 258 (261)
T ss_pred HHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence 9999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-41 Score=321.57 Aligned_cols=254 Identities=19% Similarity=0.314 Sum_probs=205.2
Q ss_pred cCceeEeceeeccCceEEEEEEEecCc-ccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCC
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGE-LKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~-~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~ 232 (429)
.++|++.+.||+|+||.||+|...... .....+++|.+... .......++..|+.+++++. |+||+++++++. ..
T Consensus 6 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~~~~~l~~l~-h~~iv~~~~~~~-~~ 81 (279)
T cd05111 6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR--SGRQTFQEITDHMLAMGSLD-HAYIVRLLGICP-GA 81 (279)
T ss_pred HhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc--cchHHHHHHHHHHHHHhcCC-CCCcceEEEEEC-CC
Confidence 357899999999999999999875421 11235888887432 23344567888999999998 999999999875 45
Q ss_pred eEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccc
Q 014210 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (429)
Q Consensus 233 ~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~ 312 (429)
..++++||+++|+|.+++....+.+++..+..++.||+.||.|||++|++||||||+|||+ ++++.+||+|||+++.
T Consensus 82 ~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili---~~~~~~kl~Dfg~~~~ 158 (279)
T cd05111 82 SLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILL---KSDSIVQIADFGVADL 158 (279)
T ss_pred ccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEE---cCCCcEEEcCCcccee
Confidence 5789999999999999998777789999999999999999999999999999999999999 7788999999999986
Q ss_pred cCCCcc---ccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCC
Q 014210 313 VRPDER---LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPS 387 (429)
Q Consensus 313 ~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 387 (429)
...... .....++..|+|||++. +.++.++||||||+++|||++ |+.||...........+.+.. ... ....
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~-~~~--~~~~ 235 (279)
T cd05111 159 LYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGE-RLA--QPQI 235 (279)
T ss_pred ccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCC-cCC--CCCC
Confidence 643322 22345677899999876 568999999999999999998 999998776555444333322 111 1124
Q ss_pred CCHHHHHHHHHhcccCccCcCCHHHHHhhH
Q 014210 388 LSSEARDFVKRLLNKDPRKRLTAAQALSEL 417 (429)
Q Consensus 388 ~s~~~~~li~~~L~~dP~~Rps~~~iL~~~ 417 (429)
++.++.+++.+||..||++||++.+++..+
T Consensus 236 ~~~~~~~li~~c~~~~p~~Rps~~el~~~l 265 (279)
T cd05111 236 CTIDVYMVMVKCWMIDENVRPTFKELANEF 265 (279)
T ss_pred CCHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 678899999999999999999999998855
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=334.78 Aligned_cols=256 Identities=30% Similarity=0.540 Sum_probs=205.5
Q ss_pred ccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeC-
Q 014210 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT- 231 (429)
Q Consensus 153 ~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~- 231 (429)
++++|++.++||+|+||.||+|.... +|+.||||++... ........+.+|+.++++++ |+||+++++++...
T Consensus 3 ~~~~y~i~~~lg~G~~g~vy~~~~~~---~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~ 76 (336)
T cd07849 3 VGPRYQNLSYIGEGAYGMVCSATHKP---TGVKVAIKKISPF--EHQTFCQRTLREIKILRRFK-HENIIGILDIIRPPS 76 (336)
T ss_pred cccceEEEEEEEecCCeEEEEEEEcC---CCCeEEEEEeccc--ccchhHHHHHHHHHHHHhCC-CCCcCchhheeeccc
Confidence 45789999999999999999998765 5899999998542 23344566889999999998 99999999987654
Q ss_pred ----CeEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeec
Q 014210 232 ----DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDF 307 (429)
Q Consensus 232 ----~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DF 307 (429)
...+++|||+.+ +|.+.+ ....+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+||
T Consensus 77 ~~~~~~~~lv~e~~~~-~l~~~~--~~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill---~~~~~~kl~df 150 (336)
T cd07849 77 FESFNDVYIVQELMET-DLYKLI--KTQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLL---NTNCDLKICDF 150 (336)
T ss_pred ccccceEEEEehhccc-CHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEE---CCCCCEEECcc
Confidence 358999999965 887766 34579999999999999999999999999999999999999 77888999999
Q ss_pred CCccccCCCcc----ccccccCCcccCccccc--CCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcC----
Q 014210 308 GLSDFVRPDER----LNDIVGSAYYVAPEVLH--RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKAD---- 377 (429)
Q Consensus 308 Gla~~~~~~~~----~~~~~gt~~y~aPE~~~--~~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~---- 377 (429)
|++........ .....|+..|+|||++. ..++.++|||||||++|+|++|+.||........+..+....
T Consensus 151 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~ 230 (336)
T cd07849 151 GLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPS 230 (336)
T ss_pred cceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCC
Confidence 99876543221 12357899999999764 358899999999999999999999997655433322221100
Q ss_pred -------------------CCCCC----CCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhh
Q 014210 378 -------------------PSFDE----APWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLIC 420 (429)
Q Consensus 378 -------------------~~~~~----~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~ 420 (429)
+.... ...+.++.++.+||.+||+.||++||++.+++.|+|+.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~ 296 (336)
T cd07849 231 QEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLE 296 (336)
T ss_pred HHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCcccc
Confidence 00000 01235688899999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=324.76 Aligned_cols=254 Identities=32% Similarity=0.637 Sum_probs=219.2
Q ss_pred CceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeE
Q 014210 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (429)
Q Consensus 155 ~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~ 234 (429)
++|.+.+.||+|+||.||++.... +|+.||+|++.+.........+.+.+|+++++++.+|+||+++++++.+++..
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~---~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~ 77 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKE---TNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENL 77 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcC---CCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceE
Confidence 479999999999999999998776 58999999997755555556678899999999997799999999999999999
Q ss_pred EEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccccC
Q 014210 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (429)
Q Consensus 235 ~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~ 314 (429)
++||||+++++|.+++... +.+++..++.++.|++.||.|||+.|++|+||||+||++ +.++.++|+|||++....
T Consensus 78 ~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i---~~~~~~~l~df~~~~~~~ 153 (280)
T cd05581 78 YFVLEYAPNGELLQYIRKY-GSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILL---DKDMHIKITDFGTAKVLD 153 (280)
T ss_pred EEEEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEE---CCCCCEEecCCccccccC
Confidence 9999999999999988544 579999999999999999999999999999999999999 678889999999987654
Q ss_pred CCc---------------------cccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHH
Q 014210 315 PDE---------------------RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRA 372 (429)
Q Consensus 315 ~~~---------------------~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~ 372 (429)
... ......++..|+|||++. ..++.++||||||+++++|++|+.||........+..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~ 233 (280)
T cd05581 154 PNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQK 233 (280)
T ss_pred CccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHH
Confidence 322 122346789999999876 4578899999999999999999999988877666666
Q ss_pred HHhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCcCCH----HHHHhhHhh
Q 014210 373 VLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTA----AQALSELLI 419 (429)
Q Consensus 373 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~----~~iL~~~~~ 419 (429)
+......++ ..+++++.+||++||+.||.+||++ .++++|+||
T Consensus 234 ~~~~~~~~~----~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 234 ILKLEYSFP----PNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred HHhcCCCCC----CccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 654443333 3578999999999999999999999 999999996
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-41 Score=320.88 Aligned_cols=253 Identities=25% Similarity=0.352 Sum_probs=199.0
Q ss_pred Cce-eEeceeeccCceEEEEEEEecC-cccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeC-
Q 014210 155 NKY-ELGEEVGRGHFGYTCAAKFKKG-ELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT- 231 (429)
Q Consensus 155 ~~y-~~~~~IG~G~fg~V~~~~~~~~-~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~- 231 (429)
++| ++.+.||+|+||.||++..+.. ...++.||+|++... ......+.+.+|+++++++. |+||+++++++...
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~ 79 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRE--CGQQNTSGWKKEINILKTLY-HENIVKYKGCCSEQG 79 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccc--cChHHHHHHHHHHHHHHhCC-CCCEeeEEEEEecCC
Confidence 455 9999999999999998765422 225789999998654 22344567889999999998 99999999988754
Q ss_pred -CeEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCc
Q 014210 232 -DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS 310 (429)
Q Consensus 232 -~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla 310 (429)
...++||||+++++|.+++.. ..+++..++.++.|++.||.|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 80 ~~~~~lv~e~~~~~~l~~~~~~--~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili---~~~~~~~l~dfg~~ 154 (283)
T cd05080 80 GKGLQLIMEYVPLGSLRDYLPK--HKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLL---DNDRLVKIGDFGLA 154 (283)
T ss_pred CceEEEEecCCCCCCHHHHHHH--cCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEE---cCCCcEEEeecccc
Confidence 458999999999999998854 469999999999999999999999999999999999999 67788999999998
Q ss_pred cccCCCcc----ccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHcCCCCCCCCChH--H------------HHH
Q 014210 311 DFVRPDER----LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTES--G------------IFR 371 (429)
Q Consensus 311 ~~~~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~elltg~~Pf~~~~~~--~------------~~~ 371 (429)
........ .....++..|+|||++. +.++.++||||||+++|||++|..||...... + .+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd05080 155 KAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLI 234 (283)
T ss_pred cccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhh
Confidence 76643322 11234566799999876 56899999999999999999999998543211 0 011
Q ss_pred HHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhH
Q 014210 372 AVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSEL 417 (429)
Q Consensus 372 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~ 417 (429)
......... .....++.++.+|+.+||+.||++||++.+++..+
T Consensus 235 ~~~~~~~~~--~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l 278 (283)
T cd05080 235 ELLERGMRL--PCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPIL 278 (283)
T ss_pred hhhhcCCCC--CCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHH
Confidence 111111111 11235789999999999999999999999999754
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=324.67 Aligned_cols=254 Identities=30% Similarity=0.453 Sum_probs=208.0
Q ss_pred eeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEE
Q 014210 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYV 236 (429)
Q Consensus 157 y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~~l 236 (429)
|++.++||.|++|.||+|.... +|+.||||++...... ....+.+.+|++++++++ |+||+++++++.+++..++
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~---~~~~~~ik~~~~~~~~-~~~~~~~~~E~~~l~~l~-~~~iv~~~~~~~~~~~~~i 75 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKL---TGEIVALKKIRLETED-EGVPSTAIREISLLKELN-HPNIVRLLDVVHSENKLYL 75 (283)
T ss_pred CchheEecCCCCeEEEEEEEcC---CCCEEEEEEeeccccc-ccchhHHHHHHHHHHhcC-CCCccCHhheeccCCeEEE
Confidence 6788999999999999998766 5899999998754322 223356788999999998 9999999999999999999
Q ss_pred EEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccccCC
Q 014210 237 VMELCEGGELLDRILSRG-GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP 315 (429)
Q Consensus 237 v~E~~~ggsL~~~i~~~~-~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~ 315 (429)
+|||++ ++|.+++.... ..+++..++.++.||++||.|||+.+++||||+|+||++ +.++.+||+|||++.....
T Consensus 76 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~---~~~~~~~l~df~~~~~~~~ 151 (283)
T cd07835 76 VFEFLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLI---DREGALKLADFGLARAFGV 151 (283)
T ss_pred EEeccC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEE---cCCCcEEEeecccccccCC
Confidence 999995 68888876543 368999999999999999999999999999999999999 6688899999999876542
Q ss_pred Cc-cccccccCCcccCcccccC--CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCC-------------
Q 014210 316 DE-RLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPS------------- 379 (429)
Q Consensus 316 ~~-~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~------------- 379 (429)
.. ......++..|+|||++.+ .++.++||||||+++|+|++|+.||........+..+.+....
T Consensus 152 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd07835 152 PVRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLP 231 (283)
T ss_pred CccccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhch
Confidence 22 2233467889999998754 4688999999999999999999999877665544443332110
Q ss_pred ------------CCCCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhh
Q 014210 380 ------------FDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLI 419 (429)
Q Consensus 380 ------------~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~ 419 (429)
......+.++.++.+||.+||+.||++||++.+++.|+||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 232 DYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred hhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 0011124577899999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=313.23 Aligned_cols=244 Identities=26% Similarity=0.372 Sum_probs=202.7
Q ss_pred ceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEe
Q 014210 161 EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMEL 240 (429)
Q Consensus 161 ~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~~lv~E~ 240 (429)
++||+|+||.||++.... ++.+|+|++... ........+.+|+++++++. |+||+++++++...+..++||||
T Consensus 1 ~~ig~g~~g~vy~~~~~~----~~~~a~K~~~~~--~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~ 73 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKD----KTPVAVKTCKED--LPQELKIKFLSEARILKQYD-HPNIVKLIGVCTQRQPIYIVMEL 73 (250)
T ss_pred CccCCCCCceEEEEEecC----CcEEEEEecCCc--CCHHHHHHHHHHHHHHHhCC-CCCcCeEEEEEecCCccEEEEEC
Confidence 478999999999998543 788999998653 23344457889999999997 99999999999999999999999
Q ss_pred cCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccccCCCccc-
Q 014210 241 CEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERL- 319 (429)
Q Consensus 241 ~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~- 319 (429)
+++++|.+++......+++..+..++.|++.+|.|||++|++||||||+||++ +.++.+||+|||++.........
T Consensus 74 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili---~~~~~~~l~d~g~~~~~~~~~~~~ 150 (250)
T cd05085 74 VPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLV---GENNVLKISDFGMSRQEDDGIYSS 150 (250)
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEE---cCCCeEEECCCccceecccccccc
Confidence 99999999887666678999999999999999999999999999999999999 67888999999998654322211
Q ss_pred -cccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHH
Q 014210 320 -NDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFV 396 (429)
Q Consensus 320 -~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 396 (429)
....++..|+|||++. +.++.++||||||+++|+|++ |..||...........+...... .....++.++.+|+
T Consensus 151 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li 227 (250)
T cd05085 151 SGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRM---SCPQKCPDDVYKVM 227 (250)
T ss_pred CCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCC---CCCCCCCHHHHHHH
Confidence 1223456799999886 468889999999999999998 99999877766655555443211 12235789999999
Q ss_pred HHhcccCccCcCCHHHHHhhH
Q 014210 397 KRLLNKDPRKRLTAAQALSEL 417 (429)
Q Consensus 397 ~~~L~~dP~~Rps~~~iL~~~ 417 (429)
.+||+.+|++||++.++++.+
T Consensus 228 ~~~l~~~p~~Rp~~~~l~~~l 248 (250)
T cd05085 228 QRCWDYKPENRPKFSELQKEL 248 (250)
T ss_pred HHHcccCcccCCCHHHHHHHh
Confidence 999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=312.28 Aligned_cols=252 Identities=34% Similarity=0.581 Sum_probs=212.8
Q ss_pred ceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEE
Q 014210 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVY 235 (429)
Q Consensus 156 ~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~~ 235 (429)
+|++.+.||+|++|.||++.... +|+.+++|++..... ...+.+.+|+.+++++. |+||+++++++...+..+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~---~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~ 73 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKR---TGKEVAIKVIKLESK---EKKEKIINEIQILKKCK-HPNIVKYYGSYLKKDELW 73 (253)
T ss_pred CceeeeeeccCCceEEEEEEECC---CCcEEEEEEecccch---hHHHHHHHHHHHHHhCC-CCCEeEEEEEEecCCeEE
Confidence 47889999999999999998775 588999999865432 45578899999999999 999999999999999999
Q ss_pred EEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccccCC
Q 014210 236 VVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP 315 (429)
Q Consensus 236 lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~ 315 (429)
+++||+++++|.+++......+++..+..++.|++.+|.|||+.|++|+||+|+||++ +.++.++|+|||.+.....
T Consensus 74 l~~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i---~~~~~~~l~d~~~~~~~~~ 150 (253)
T cd05122 74 IVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILL---TSDGEVKLIDFGLSAQLSD 150 (253)
T ss_pred EEEecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEE---ccCCeEEEeeccccccccc
Confidence 9999999999999886665689999999999999999999999999999999999999 6788899999999887655
Q ss_pred CccccccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHH
Q 014210 316 DERLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARD 394 (429)
Q Consensus 316 ~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 394 (429)
........++..|++||.+.+ .++.++||||||+++|+|++|+.||...........+....... ......++.++.+
T Consensus 151 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 229 (253)
T cd05122 151 TKARNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPG-LRNPEKWSDEFKD 229 (253)
T ss_pred cccccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCC-cCcccccCHHHHH
Confidence 443445678999999998864 57889999999999999999999998765444443333322111 1111234899999
Q ss_pred HHHHhcccCccCcCCHHHHHhhHh
Q 014210 395 FVKRLLNKDPRKRLTAAQALSELL 418 (429)
Q Consensus 395 li~~~L~~dP~~Rps~~~iL~~~~ 418 (429)
||++||+.||++||++.++|.|+|
T Consensus 230 ~i~~~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 230 FLKKCLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred HHHHHccCChhhCCCHHHHhcCCC
Confidence 999999999999999999999987
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-41 Score=314.32 Aligned_cols=253 Identities=31% Similarity=0.569 Sum_probs=217.3
Q ss_pred ceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEE
Q 014210 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVY 235 (429)
Q Consensus 156 ~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~~ 235 (429)
+|++.+.||+|+||.||++.... +++.||+|++.... ......+.+.+|+++++.++ |+|++++++.+...+..+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~---~~~~~~ik~~~~~~-~~~~~~~~~~~e~~~l~~l~-~~~~~~~~~~~~~~~~~~ 75 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKS---DGKLYVLKEIDLSN-MSEKEREDALNEVKILKKLN-HPNIIKYYESFEEKGKLC 75 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcC---CCcEEEEEEeeccc-CChHHHHHHHHHHHHHHhcC-CCChhheEEEEecCCEEE
Confidence 58899999999999999999765 58899999986543 23455677899999999998 999999999999999999
Q ss_pred EEEEecCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccc
Q 014210 236 VVMELCEGGELLDRILSR---GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (429)
Q Consensus 236 lv~E~~~ggsL~~~i~~~---~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~ 312 (429)
+||||+++++|.+++... +..+++..+..++.+|+.||.|||+.|++|+||+|+||++ +.++.+||+|||++..
T Consensus 76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~---~~~~~~~l~d~~~~~~ 152 (258)
T cd08215 76 IVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFL---TSNGLVKLGDFGISKV 152 (258)
T ss_pred EEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEE---cCCCcEEECCccceee
Confidence 999999999999988765 3779999999999999999999999999999999999999 6778899999999977
Q ss_pred cCCCc-cccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCH
Q 014210 313 VRPDE-RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSS 390 (429)
Q Consensus 313 ~~~~~-~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 390 (429)
..... ......|+..|+|||.+. ..++.++|+||||+++++|++|+.||................... ....++.
T Consensus 153 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~ 229 (258)
T cd08215 153 LSSTVDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPP---IPSQYSS 229 (258)
T ss_pred cccCcceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCC---CCCCCCH
Confidence 65443 233457889999999876 458889999999999999999999998777666666555433221 1236889
Q ss_pred HHHHHHHHhcccCccCcCCHHHHHhhHhh
Q 014210 391 EARDFVKRLLNKDPRKRLTAAQALSELLI 419 (429)
Q Consensus 391 ~~~~li~~~L~~dP~~Rps~~~iL~~~~~ 419 (429)
++.++|++||..+|++||++.++|.|+||
T Consensus 230 ~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 230 ELRNLVSSLLQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence 99999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=321.05 Aligned_cols=257 Identities=27% Similarity=0.455 Sum_probs=208.1
Q ss_pred CceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeC--C
Q 014210 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT--D 232 (429)
Q Consensus 155 ~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~--~ 232 (429)
++|+..+.||.|++|.||++.... +++.||+|++.... ......++.+|++++++++ |+||++++++|.+. +
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~---~~~~~~~k~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~ 74 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKN---TGMIFALKTITTDP--NPDLQKQILRELEINKSCK-SPYIVKYYGAFLDESSS 74 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECC---CCeEEEEEEEecCC--chHHHHHHHHHHHHHHhCC-CCCeeeeeeEEEccCCC
Confidence 468999999999999999999876 58999999986542 2345577899999999998 99999999998654 4
Q ss_pred eEEEEEEecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCC
Q 014210 233 NVYVVMELCEGGELLDRILS---RGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGL 309 (429)
Q Consensus 233 ~~~lv~E~~~ggsL~~~i~~---~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGl 309 (429)
.+++||||+++++|.+++.. ....+++..+..++.||+.||.|||+.|++|+||+|+||++ ++++.+||+|||+
T Consensus 75 ~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~---~~~~~~~l~dfg~ 151 (287)
T cd06621 75 SIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILL---TRKGQVKLCDFGV 151 (287)
T ss_pred eEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---ecCCeEEEeeccc
Confidence 68999999999999887643 34568999999999999999999999999999999999999 6778899999999
Q ss_pred ccccCCCccccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHcCCCCCCCCC-----hHHHHHHHHhcCC-CCCC
Q 014210 310 SDFVRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWART-----ESGIFRAVLKADP-SFDE 382 (429)
Q Consensus 310 a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~elltg~~Pf~~~~-----~~~~~~~i~~~~~-~~~~ 382 (429)
+....... .....++..|+|||.+. ..++.++||||||+++|+|++|+.||.... ..+....+..... ....
T Consensus 152 ~~~~~~~~-~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (287)
T cd06621 152 SGELVNSL-AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKD 230 (287)
T ss_pred cccccccc-cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhcc
Confidence 87654222 23456788999999876 468999999999999999999999997652 2233333322111 1111
Q ss_pred CCC--CCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhc
Q 014210 383 APW--PSLSSEARDFVKRLLNKDPRKRLTAAQALSELLICY 421 (429)
Q Consensus 383 ~~~--~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~ 421 (429)
... ..+++++.+||.+||..||++||++.|++.|+|+..
T Consensus 231 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~ 271 (287)
T cd06621 231 EPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKA 271 (287)
T ss_pred CCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCccccc
Confidence 111 135688999999999999999999999999999954
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=317.95 Aligned_cols=252 Identities=22% Similarity=0.329 Sum_probs=203.4
Q ss_pred eeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeC-----
Q 014210 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT----- 231 (429)
Q Consensus 157 y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~----- 231 (429)
|.++++||+|+||.||+|+..... ....||||.+.... ......+.+.+|++++++++ |+||+++++++...
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~-~~~~~a~k~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~ 77 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDD-SILKVAVKTMKIAI-CTRSEMEDFLSEAVCMKEFD-HPNVMRLIGVCLQTVESEG 77 (272)
T ss_pred CccccccCcccCceEEEeEEccCC-CeeeEEEEecccCc-CCHHHHHHHHHHHHHHHhCC-CCCcceEEEEEccCCcccC
Confidence 356789999999999999876521 12369999986543 34455678899999999998 99999999987532
Q ss_pred -CeEEEEEEecCCCcHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEe
Q 014210 232 -DNVYVVMELCEGGELLDRILSR-----GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAI 305 (429)
Q Consensus 232 -~~~~lv~E~~~ggsL~~~i~~~-----~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~ 305 (429)
...+++|||+++|+|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||+ ++++.+||+
T Consensus 78 ~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~ 154 (272)
T cd05075 78 YPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCML---NENMNVCVA 154 (272)
T ss_pred CCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEE---cCCCCEEEC
Confidence 2478999999999998877532 2358999999999999999999999999999999999999 678889999
Q ss_pred ecCCccccCCCcc---ccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCC
Q 014210 306 DFGLSDFVRPDER---LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSF 380 (429)
Q Consensus 306 DFGla~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~ 380 (429)
|||++........ .....++..|++||++. ..++.++||||||+++|||++ |+.||...........+.......
T Consensus 155 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~ 234 (272)
T cd05075 155 DFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLK 234 (272)
T ss_pred CCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCC
Confidence 9999987643321 11224567899999886 468999999999999999999 899998777666666555433211
Q ss_pred CCCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhH
Q 014210 381 DEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSEL 417 (429)
Q Consensus 381 ~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~ 417 (429)
..+.++..+.++|.+||+.||++||++.+++.++
T Consensus 235 ---~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l 268 (272)
T cd05075 235 ---QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCEL 268 (272)
T ss_pred ---CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 1236789999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=360.96 Aligned_cols=254 Identities=22% Similarity=0.398 Sum_probs=219.4
Q ss_pred cCceeEeceeeccCceEEEEEEEecCccc--CeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeC
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGELK--GQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~~~--g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~ 231 (429)
.++..+.+.||+|.||.||.|....-... -..||||.+.+. .+.+.+.+|.+|..+|+++. |||||+++|++.+.
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~--~~~~~~~~Fl~Ea~~m~~f~-HpNiv~liGv~l~~ 767 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL--SSEQEVSDFLKEALLMSKFD-HPNIVSLIGVCLDS 767 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc--CCHHHHHHHHHHHHHHhcCC-CcceeeEEEeecCC
Confidence 46678899999999999999998764322 345888887654 67888899999999999999 99999999999999
Q ss_pred CeEEEEEEecCCCcHHHHHHhc------CCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEe
Q 014210 232 DNVYVVMELCEGGELLDRILSR------GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAI 305 (429)
Q Consensus 232 ~~~~lv~E~~~ggsL~~~i~~~------~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~ 305 (429)
...+|++|||+||+|+.+|.+. ...++..++..++.||++|+.||+++++|||||-..|+|| ++..+|||+
T Consensus 768 ~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL---~~~r~VKIa 844 (1025)
T KOG1095|consen 768 GPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLL---DERRVVKIA 844 (1025)
T ss_pred CCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheee---cccCcEEEc
Confidence 9999999999999999999876 5679999999999999999999999999999999999999 778999999
Q ss_pred ecCCccccCCCcccc---ccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCC
Q 014210 306 DFGLSDFVRPDERLN---DIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSF 380 (429)
Q Consensus 306 DFGla~~~~~~~~~~---~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~ 380 (429)
|||||+.....+... ...-...|||||.+. +.|+.|+|||||||+|||+++ |..||.+....+++..++++.
T Consensus 845 DFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~gg--- 921 (1025)
T KOG1095|consen 845 DFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGG--- 921 (1025)
T ss_pred ccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCC---
Confidence 999998443332211 112335799999987 789999999999999999998 899999999888888777766
Q ss_pred CCCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhh
Q 014210 381 DEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSE 416 (429)
Q Consensus 381 ~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~ 416 (429)
.....+.++..+.++|.+||+.+|++||++..|+..
T Consensus 922 RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q 957 (1025)
T KOG1095|consen 922 RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQ 957 (1025)
T ss_pred ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhh
Confidence 223335799999999999999999999999999874
|
|
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-41 Score=323.15 Aligned_cols=258 Identities=21% Similarity=0.303 Sum_probs=206.5
Q ss_pred cCceeEeceeeccCceEEEEEEEecCc-----------ccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcc
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGE-----------LKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLV 222 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~-----------~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv 222 (429)
.++|++.++||+|+||.||+++..... .....||||.+... ......+.+.+|+++++++. |+||+
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~ei~~l~~l~-h~~i~ 80 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRAD--VTKTARNDFLKEIKIMSRLK-NPNII 80 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCC--CCHHHHHHHHHHHHHHHhCC-CCCcC
Confidence 468999999999999999998764311 12346999998654 23445667999999999998 99999
Q ss_pred eEEEEEEeCCeEEEEEEecCCCcHHHHHHhcC-----------CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcE
Q 014210 223 KFFDAYEDTDNVYVVMELCEGGELLDRILSRG-----------GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENF 291 (429)
Q Consensus 223 ~l~~~~~~~~~~~lv~E~~~ggsL~~~i~~~~-----------~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NI 291 (429)
++++++...+..++||||+++++|.+++.... ..+++..+..++.||+.||.|||++|++||||||+||
T Consensus 81 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Ni 160 (295)
T cd05097 81 RLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNC 160 (295)
T ss_pred eEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhE
Confidence 99999999999999999999999999885432 2468899999999999999999999999999999999
Q ss_pred EEeecCCCceEEEeecCCccccCCCcc---ccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHc--CCCCCCCCC
Q 014210 292 LFTTKDENSVLKAIDFGLSDFVRPDER---LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC--GSRPFWART 365 (429)
Q Consensus 292 Ll~~~~~~~~vkL~DFGla~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~ellt--g~~Pf~~~~ 365 (429)
|+ ++++.+||+|||++........ .....++..|+|||++. +.++.++||||||+++|+|++ +..||....
T Consensus 161 ll---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~ 237 (295)
T cd05097 161 LV---GNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLS 237 (295)
T ss_pred EE---cCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccC
Confidence 99 6777899999999876543221 12334567899999875 568999999999999999988 678888776
Q ss_pred hHHHHHHHHhc----CCCCCCCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhH
Q 014210 366 ESGIFRAVLKA----DPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSEL 417 (429)
Q Consensus 366 ~~~~~~~i~~~----~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~ 417 (429)
.......+.+. .........+.++..+.+||.+||+.||++||++.++++.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l 293 (295)
T cd05097 238 DEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFL 293 (295)
T ss_pred hHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence 66555544321 11111112335789999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=315.17 Aligned_cols=246 Identities=23% Similarity=0.341 Sum_probs=202.1
Q ss_pred ceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEe
Q 014210 161 EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMEL 240 (429)
Q Consensus 161 ~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~~lv~E~ 240 (429)
++||+|+||.||+|........+..||+|.+...... ...+++.+|+.+++++. |+||+++++++. .+..++||||
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~-~~~~~~v~e~ 76 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA--AGKKEFLREASVMAQLD-HPCIVRLIGVCK-GEPLMLVMEL 76 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch--HHHHHHHHHHHHHHhcC-CCCeeeEEEEEc-CCceEEEEEe
Confidence 4799999999999987654334589999998765432 45577899999999998 999999999876 4568999999
Q ss_pred cCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccccCCCcccc
Q 014210 241 CEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLN 320 (429)
Q Consensus 241 ~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~ 320 (429)
+++++|.+++... ..+++..+..++.|++.||+|||+.+|+|+||||+|||+ +.++.+||+|||++..........
T Consensus 77 ~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili---~~~~~~kl~df~~~~~~~~~~~~~ 152 (257)
T cd05060 77 APLGPLLKYLKKR-REIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLL---VNRHQAKISDFGMSRALGAGSDYY 152 (257)
T ss_pred CCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEE---cCCCcEEeccccccceeecCCccc
Confidence 9999999988654 479999999999999999999999999999999999999 678889999999998664433211
Q ss_pred ----ccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHH
Q 014210 321 ----DIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARD 394 (429)
Q Consensus 321 ----~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 394 (429)
...++..|+|||.+. +.++.++||||||+++|+|++ |..||...........+..... ......++.++.+
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~ 229 (257)
T cd05060 153 RATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGER---LPRPEECPQEIYS 229 (257)
T ss_pred ccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCc---CCCCCCCCHHHHH
Confidence 112346799999876 468999999999999999998 9999987776655555544322 1223468899999
Q ss_pred HHHHhcccCccCcCCHHHHHhhH
Q 014210 395 FVKRLLNKDPRKRLTAAQALSEL 417 (429)
Q Consensus 395 li~~~L~~dP~~Rps~~~iL~~~ 417 (429)
||.+||..||++||++.++++.+
T Consensus 230 li~~cl~~~p~~Rp~~~~l~~~l 252 (257)
T cd05060 230 IMLSCWKYRPEDRPTFSELESTF 252 (257)
T ss_pred HHHHHhcCChhhCcCHHHHHHHH
Confidence 99999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=327.04 Aligned_cols=259 Identities=29% Similarity=0.450 Sum_probs=211.1
Q ss_pred cccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeC
Q 014210 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (429)
Q Consensus 152 ~~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~ 231 (429)
...++|++.+.||+|+||.||+|..+. +|+.||||++..... .......+.+|++++++++ |+||+++++++.+.
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~---~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~l~-h~~i~~~~~~~~~~ 78 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKD---TGELVALKKVRLDNE-KEGFPITAIREIKILRQLN-HRNIVNLKEIVTDK 78 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECC---CCcEEEEEEEeeccc-ccCchHHHHHHHHHHHhCC-CCCeeeeeheecCc
Confidence 446789999999999999999999876 588999999865432 2223356778999999998 99999999998765
Q ss_pred C----------eEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCce
Q 014210 232 D----------NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSV 301 (429)
Q Consensus 232 ~----------~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~ 301 (429)
. .+++||||+++ ++.+.+......+++..++.++.||+.||.|||+.||+|+||||+||++ ++++.
T Consensus 79 ~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili---~~~~~ 154 (302)
T cd07864 79 QDALDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILL---NNKGQ 154 (302)
T ss_pred chhhhccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---CCCCc
Confidence 5 79999999976 7777776665679999999999999999999999999999999999999 77889
Q ss_pred EEEeecCCccccCCCcc--ccccccCCcccCcccccC--CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcC
Q 014210 302 LKAIDFGLSDFVRPDER--LNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKAD 377 (429)
Q Consensus 302 vkL~DFGla~~~~~~~~--~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~ 377 (429)
+||+|||++........ .....++..|+|||++.+ .++.++|||||||++|||++|+.||......+.+..+....
T Consensus 155 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~ 234 (302)
T cd07864 155 IKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLC 234 (302)
T ss_pred EEeCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Confidence 99999999977643331 223356788999998753 47889999999999999999999998776665555444321
Q ss_pred CCCCC--------------------------CCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhh
Q 014210 378 PSFDE--------------------------APWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLI 419 (429)
Q Consensus 378 ~~~~~--------------------------~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~ 419 (429)
..... ..+..++.++.+||.+||+.||++||++.+++.|+|+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 235 GSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred CCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 11000 0123468999999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-41 Score=321.86 Aligned_cols=255 Identities=31% Similarity=0.558 Sum_probs=213.6
Q ss_pred CceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeE
Q 014210 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (429)
Q Consensus 155 ~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~ 234 (429)
..|...+.||+|++|.||++.... .++.+++|++... .....+.+.+|+.+++.+. |+||+++++++...+..
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~---~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~~~-h~~vv~~~~~~~~~~~~ 91 (285)
T cd06648 19 SYLDNFVKIGEGSTGIVCIATDKS---TGRQVAVKKMDLR---KQQRRELLFNEVVIMRDYQ-HPNIVEMYSSYLVGDEL 91 (285)
T ss_pred HhhhcceEeccCCCeEEEEEEECC---CCCEEEEEEEecc---chhHHHHHHHHHHHHHHcC-CCChheEEEEEEcCCeE
Confidence 345667899999999999998665 4789999988532 3334466889999999998 99999999999999999
Q ss_pred EEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccccC
Q 014210 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (429)
Q Consensus 235 ~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~ 314 (429)
++++||+++++|.+++.. ..+++..+..++.||+.||+|||++||+||||||+||++ +.++.+||+|||++....
T Consensus 92 ~~v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~~l~d~g~~~~~~ 166 (285)
T cd06648 92 WVVMEFLEGGALTDIVTH--TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILL---TSDGRVKLSDFGFCAQVS 166 (285)
T ss_pred EEEEeccCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEE---cCCCcEEEcccccchhhc
Confidence 999999999999988755 578999999999999999999999999999999999999 778899999999887554
Q ss_pred CCc-cccccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHH
Q 014210 315 PDE-RLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEA 392 (429)
Q Consensus 315 ~~~-~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 392 (429)
... ......|+..|+|||++.+ .++.++||||||+++|+|++|+.||........+..+......... ....++.++
T Consensus 167 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l 245 (285)
T cd06648 167 KEVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLK-NLHKVSPRL 245 (285)
T ss_pred cCCcccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCc-ccccCCHHH
Confidence 322 2233568999999998864 5889999999999999999999999877766666655544322221 123478999
Q ss_pred HHHHHHhcccCccCcCCHHHHHhhHhhhcc
Q 014210 393 RDFVKRLLNKDPRKRLTAAQALSELLICYQ 422 (429)
Q Consensus 393 ~~li~~~L~~dP~~Rps~~~iL~~~~~~~~ 422 (429)
.+||.+||+.||++||++.++++|+|+..-
T Consensus 246 ~~li~~~l~~~p~~Rpt~~~il~~~~~~~~ 275 (285)
T cd06648 246 RSFLDRMLVRDPAQRATAAELLNHPFLAKA 275 (285)
T ss_pred HHHHHHHcccChhhCcCHHHHccCcccccC
Confidence 999999999999999999999999999653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=318.19 Aligned_cols=248 Identities=24% Similarity=0.362 Sum_probs=200.7
Q ss_pred ceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEe
Q 014210 161 EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMEL 240 (429)
Q Consensus 161 ~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~~lv~E~ 240 (429)
+.||+|+||.||+|+.+++. ....+++|.+... ......+.+.+|++++.++.+|+||+++++++...+..+++|||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~-~~~~~~~k~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~ 77 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDG-LRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEY 77 (270)
T ss_pred CcCCCCCCceEEEEEEcCCC-CeeEEEEEEcccc--CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEe
Confidence 46899999999999887631 1245788987532 33445567899999999996699999999999999999999999
Q ss_pred cCCCcHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEe
Q 014210 241 CEGGELLDRILSRG---------------GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAI 305 (429)
Q Consensus 241 ~~ggsL~~~i~~~~---------------~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~ 305 (429)
+++|+|.+++.... ..+++..++.++.|++.||+|||+.|++||||||+|||+ ++++.+||+
T Consensus 78 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili---~~~~~~kl~ 154 (270)
T cd05047 78 APHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV---GENYVAKIA 154 (270)
T ss_pred CCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEE---cCCCeEEEC
Confidence 99999999886532 247899999999999999999999999999999999999 778899999
Q ss_pred ecCCccccCCCccccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCC
Q 014210 306 DFGLSDFVRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEA 383 (429)
Q Consensus 306 DFGla~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~ 383 (429)
|||++..............+..|+|||++. ..++.++||||||+++|||++ |+.||......+.+..+...... .
T Consensus 155 dfgl~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~---~ 231 (270)
T cd05047 155 DFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRL---E 231 (270)
T ss_pred CCCCccccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCCCC---C
Confidence 999985432111111223356799999876 468899999999999999997 99999877766666655433211 1
Q ss_pred CCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhH
Q 014210 384 PWPSLSSEARDFVKRLLNKDPRKRLTAAQALSEL 417 (429)
Q Consensus 384 ~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~ 417 (429)
....++.++.+|+.+||+.||.+||++.+++..+
T Consensus 232 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l 265 (270)
T cd05047 232 KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSL 265 (270)
T ss_pred CCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHH
Confidence 2235788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=328.40 Aligned_cols=258 Identities=24% Similarity=0.391 Sum_probs=211.5
Q ss_pred cCceeEeceeeccCceEEEEEEEecCc----ccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEE
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGE----LKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYE 229 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~----~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~ 229 (429)
..+|.+++.||+|+||.||+++..... ..+..||+|++... ......+++.+|+++++++.+|+||+++++++.
T Consensus 11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 88 (334)
T cd05100 11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD--ATDKDLSDLVSEMEMMKMIGKHKNIINLLGACT 88 (334)
T ss_pred HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc--cCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEc
Confidence 457999999999999999999764311 13457999988643 344556789999999999966999999999999
Q ss_pred eCCeEEEEEEecCCCcHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEe
Q 014210 230 DTDNVYVVMELCEGGELLDRILSRG---------------GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFT 294 (429)
Q Consensus 230 ~~~~~~lv~E~~~ggsL~~~i~~~~---------------~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~ 294 (429)
+.+.++++|||+++|+|.+++..+. ..+++..+..++.||+.||.|||++||+||||||+|||+
T Consensus 89 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill- 167 (334)
T cd05100 89 QDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLV- 167 (334)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEE-
Confidence 9999999999999999999886532 247889999999999999999999999999999999999
Q ss_pred ecCCCceEEEeecCCccccCCCcc---ccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHc-CCCCCCCCChHHH
Q 014210 295 TKDENSVLKAIDFGLSDFVRPDER---LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGI 369 (429)
Q Consensus 295 ~~~~~~~vkL~DFGla~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~ellt-g~~Pf~~~~~~~~ 369 (429)
+.++.+||+|||+++....... .....++..|+|||++. ..++.++||||||+++|||++ |..||......+.
T Consensus 168 --~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~ 245 (334)
T cd05100 168 --TEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL 245 (334)
T ss_pred --cCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHH
Confidence 6778899999999876543221 12223456799999886 468899999999999999998 8999988877777
Q ss_pred HHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhh
Q 014210 370 FRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLI 419 (429)
Q Consensus 370 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~ 419 (429)
+..+...... .....++.++.+||.+||+.+|++||++.+++.++.-
T Consensus 246 ~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~ 292 (334)
T cd05100 246 FKLLKEGHRM---DKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDR 292 (334)
T ss_pred HHHHHcCCCC---CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHH
Confidence 6666543221 1123578899999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=324.32 Aligned_cols=255 Identities=27% Similarity=0.422 Sum_probs=215.0
Q ss_pred CceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeE
Q 014210 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (429)
Q Consensus 155 ~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~ 234 (429)
+.|...++||+|+||.||+|+... +|+.|++|++...........+.+.+|++++++++ |+|++++++++.+.+..
T Consensus 21 ~~~~~~~~lg~g~~g~v~~~~~~~---~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~ 96 (313)
T cd06633 21 EIFVGLHEIGHGSFGAVYFATNSH---TNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLK-HPNTIEYKGCYLKEHTA 96 (313)
T ss_pred HHhhcceeeccCCCeEEEEEEECC---CCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCC-CCCCccEEEEEEeCCEE
Confidence 447778899999999999998655 58999999987654445556677889999999998 99999999999999999
Q ss_pred EEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccccC
Q 014210 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (429)
Q Consensus 235 ~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~ 314 (429)
|+||||+. ++|.+.+......+++..+..++.||+.+|.|||+.||+|+||||+||++ +.++.+||+|||++....
T Consensus 97 ~lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili---~~~~~~kL~dfg~~~~~~ 172 (313)
T cd06633 97 WLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILL---TEPGQVKLADFGSASKSS 172 (313)
T ss_pred EEEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEE---CCCCCEEEeecCCCcccC
Confidence 99999996 58888877667789999999999999999999999999999999999999 677889999999986543
Q ss_pred CCccccccccCCcccCccccc----CCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCH
Q 014210 315 PDERLNDIVGSAYYVAPEVLH----RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSS 390 (429)
Q Consensus 315 ~~~~~~~~~gt~~y~aPE~~~----~~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 390 (429)
. .....|+..|+|||++. +.++.++||||||+++|+|++|..||...........+..... +......++.
T Consensus 173 ~---~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~ 247 (313)
T cd06633 173 P---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDS--PTLQSNEWTD 247 (313)
T ss_pred C---CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC--CCCCccccCH
Confidence 2 23467899999999873 4588899999999999999999999987765555554443322 2222345778
Q ss_pred HHHHHHHHhcccCccCcCCHHHHHhhHhhhcc
Q 014210 391 EARDFVKRLLNKDPRKRLTAAQALSELLICYQ 422 (429)
Q Consensus 391 ~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~ 422 (429)
.+.+||.+||+.+|.+||++.+++.|+|++..
T Consensus 248 ~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~ 279 (313)
T cd06633 248 SFRGFVDYCLQKIPQERPASAELLRHDFVRRD 279 (313)
T ss_pred HHHHHHHHHccCChhhCcCHHHHhcCcccCCC
Confidence 89999999999999999999999999999753
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=329.01 Aligned_cols=261 Identities=31% Similarity=0.500 Sum_probs=203.9
Q ss_pred ceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeC--Ce
Q 014210 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT--DN 233 (429)
Q Consensus 156 ~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~--~~ 233 (429)
+|++.++||+|+||.||+|..... ..|+.||||++...........+.+.+|+.++++++ |+||+++++++.+. +.
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~-~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~ 78 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNG-KDGKEYAIKKFKGDKEQYTGISQSACREIALLRELK-HENVVSLVEVFLEHADKS 78 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCC-CCCCeEEEEEeccccccccCccHHHHHHHHHHHhcC-CCCccceEEEEeCCCCce
Confidence 588999999999999999987652 147899999997643223333466789999999998 99999999999988 78
Q ss_pred EEEEEEecCCCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEee-cCCCceEEEeecC
Q 014210 234 VYVVMELCEGGELLDRILSR----GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTT-KDENSVLKAIDFG 308 (429)
Q Consensus 234 ~~lv~E~~~ggsL~~~i~~~----~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~-~~~~~~vkL~DFG 308 (429)
.++||||+++ +|.+.+... ...+++..++.++.||+.||.|||+.+|+||||||+|||++. .+.++.+||+|||
T Consensus 79 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg 157 (316)
T cd07842 79 VYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLG 157 (316)
T ss_pred EEEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCc
Confidence 9999999975 677766432 236899999999999999999999999999999999999942 1128899999999
Q ss_pred CccccCCCcc----ccccccCCcccCcccccC--CCCCcccHHHHHHHHHHHHcCCCCCCCCChHH---------HHHHH
Q 014210 309 LSDFVRPDER----LNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESG---------IFRAV 373 (429)
Q Consensus 309 la~~~~~~~~----~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~---------~~~~i 373 (429)
++........ .....++..|+|||++.+ .++.++||||||+++|+|++|+.||....... .+..+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (316)
T cd07842 158 LARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERI 237 (316)
T ss_pred cccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHH
Confidence 9886543221 234567899999998764 47889999999999999999999997544321 11111
Q ss_pred HhcC--------------C-------CCCCCCCC------------CCCHHHHHHHHHhcccCccCcCCHHHHHhhHhh
Q 014210 374 LKAD--------------P-------SFDEAPWP------------SLSSEARDFVKRLLNKDPRKRLTAAQALSELLI 419 (429)
Q Consensus 374 ~~~~--------------~-------~~~~~~~~------------~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~ 419 (429)
...- + .......+ ..+.++.++|.+||+.||++||++.+++.|+||
T Consensus 238 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 238 FEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred HHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence 1100 0 00001111 467789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=321.92 Aligned_cols=258 Identities=19% Similarity=0.284 Sum_probs=205.7
Q ss_pred cCceeEeceeeccCceEEEEEEEec-------------CcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCC
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKK-------------GELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNN 220 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~-------------~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~n 220 (429)
.++|++.++||+|+||.||+++... ...++..||+|++... ......+++.+|+.++++++ |+|
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~--~~~~~~~~~~~E~~~l~~l~-~~~ 80 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLRED--ANKNARNDFLKEIKIMSRLK-DPN 80 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEecccc--CCHHHHHHHHHHHHHHHhCC-CCC
Confidence 4679999999999999999986432 1113567999998654 23445678999999999998 999
Q ss_pred cceEEEEEEeCCeEEEEEEecCCCcHHHHHHhcC----------CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCc
Q 014210 221 LVKFFDAYEDTDNVYVVMELCEGGELLDRILSRG----------GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPEN 290 (429)
Q Consensus 221 Iv~l~~~~~~~~~~~lv~E~~~ggsL~~~i~~~~----------~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~N 290 (429)
|+++++++.+.+..++||||+++++|.+++.... ..+++..+..++.||+.||+|||+.||+||||||+|
T Consensus 81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~N 160 (296)
T cd05095 81 IIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRN 160 (296)
T ss_pred cceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChhe
Confidence 9999999999999999999999999999886532 247788999999999999999999999999999999
Q ss_pred EEEeecCCCceEEEeecCCccccCCCcc---ccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHc--CCCCCCCC
Q 014210 291 FLFTTKDENSVLKAIDFGLSDFVRPDER---LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC--GSRPFWAR 364 (429)
Q Consensus 291 ILl~~~~~~~~vkL~DFGla~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~ellt--g~~Pf~~~ 364 (429)
||+ +.++.+||+|||++........ .....++..|++||+.. +.++.++|||||||++|||++ |..||...
T Consensus 161 ili---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~ 237 (296)
T cd05095 161 CLV---GKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQL 237 (296)
T ss_pred EEE---cCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCcccc
Confidence 999 6778899999999876543321 12234467899999754 678999999999999999998 78999776
Q ss_pred ChHHHHHHHHh---c-CCCCCCCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhH
Q 014210 365 TESGIFRAVLK---A-DPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSEL 417 (429)
Q Consensus 365 ~~~~~~~~i~~---~-~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~ 417 (429)
........... . ...........++..+.+||.+||+.||++||++.++++.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l 294 (296)
T cd05095 238 SDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATL 294 (296)
T ss_pred ChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHH
Confidence 66554443321 1 11111111235779999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=316.53 Aligned_cols=247 Identities=24% Similarity=0.385 Sum_probs=204.2
Q ss_pred cCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~ 233 (429)
.++|+++++||+|+||.||+|+... ...||||++..... ..+++.+|++++++++ |+||+++++++. .+.
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~----~~~valK~~~~~~~----~~~~~~~E~~~l~~l~-~~~i~~~~~~~~-~~~ 74 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNG----TTRVAIKTLKPGTM----SPEAFLQEAQVMKKLR-HEKLVQLYAVVS-EEP 74 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecC----CceEEEEecccCcc----CHHHHHHHHHHHHhCC-CCCcceEEEEEC-CCC
Confidence 4679999999999999999997654 34699999875332 2356889999999998 999999999875 456
Q ss_pred EEEEEEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccc
Q 014210 234 VYVVMELCEGGELLDRILSR-GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (429)
Q Consensus 234 ~~lv~E~~~ggsL~~~i~~~-~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~ 312 (429)
.++||||+++++|.+++... ...+++..+..++.|++.||.|||+.+|+||||||+||++ ++++.+||+|||++..
T Consensus 75 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill---~~~~~~~L~dfg~~~~ 151 (262)
T cd05071 75 IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV---GENLVCKVADFGLARL 151 (262)
T ss_pred cEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEE---cCCCcEEeccCCceee
Confidence 89999999999999998654 3468999999999999999999999999999999999999 6788899999999976
Q ss_pred cCCCccc--cccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCC
Q 014210 313 VRPDERL--NDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSL 388 (429)
Q Consensus 313 ~~~~~~~--~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 388 (429)
....... ....++..|+|||++. +.++.++||||||+++|+|++ |..||...........+...... .....+
T Consensus 152 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~ 228 (262)
T cd05071 152 IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM---PCPPEC 228 (262)
T ss_pred ccccccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCC---CCcccc
Confidence 5433221 2334667899999875 568999999999999999999 88899887776666655443221 112468
Q ss_pred CHHHHHHHHHhcccCccCcCCHHHHHhh
Q 014210 389 SSEARDFVKRLLNKDPRKRLTAAQALSE 416 (429)
Q Consensus 389 s~~~~~li~~~L~~dP~~Rps~~~iL~~ 416 (429)
+.++.+||.+||+.||++||++.+++..
T Consensus 229 ~~~l~~li~~~l~~~p~~Rp~~~~~~~~ 256 (262)
T cd05071 229 PESLHDLMCQCWRKEPEERPTFEYLQAF 256 (262)
T ss_pred CHHHHHHHHHHccCCcccCCCHHHHHHH
Confidence 8999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=314.75 Aligned_cols=248 Identities=22% Similarity=0.326 Sum_probs=199.7
Q ss_pred ceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEE-eCCeEEEEEE
Q 014210 161 EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYE-DTDNVYVVME 239 (429)
Q Consensus 161 ~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~-~~~~~~lv~E 239 (429)
+.||+|+||.||+|........+..||||.+... ......+.+.+|+.+++.++ |+||+++++++. .++..+++||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~lv~e 77 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI--TDLEEVEQFLKEGIIMKDFS-HPNVLSLLGICLPSEGSPLVVLP 77 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCcc--CCHHHHHHHHHHHHHHccCC-CCCcceEEEEeecCCCCcEEEEe
Confidence 4689999999999987654434678999987532 33455678889999999997 999999999876 4556899999
Q ss_pred ecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccccCCCc--
Q 014210 240 LCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDE-- 317 (429)
Q Consensus 240 ~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~-- 317 (429)
|+.+++|.+++......+.+..+..++.||+.||.|||+.+|+||||||+|||+ +.++.+||+|||++.......
T Consensus 78 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili---~~~~~~kl~dfg~~~~~~~~~~~ 154 (262)
T cd05058 78 YMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCML---DESFTVKVADFGLARDIYDKEYY 154 (262)
T ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEE---cCCCcEEECCccccccccCCcce
Confidence 999999999987666678888899999999999999999999999999999999 678889999999987654321
Q ss_pred ---cccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHcC-CCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHH
Q 014210 318 ---RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCG-SRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEA 392 (429)
Q Consensus 318 ---~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~elltg-~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 392 (429)
......++..|+|||.+. ..++.++||||||+++|||++| ..||...........+........ ...++..+
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~ 231 (262)
T cd05058 155 SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQ---PEYCPDPL 231 (262)
T ss_pred eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCC---CCcCCHHH
Confidence 112334577899999876 5688999999999999999995 566766555555555444322111 12467899
Q ss_pred HHHHHHhcccCccCcCCHHHHHhhH
Q 014210 393 RDFVKRLLNKDPRKRLTAAQALSEL 417 (429)
Q Consensus 393 ~~li~~~L~~dP~~Rps~~~iL~~~ 417 (429)
.+++.+||+.+|++||++.+++..+
T Consensus 232 ~~li~~cl~~~p~~Rp~~~~il~~l 256 (262)
T cd05058 232 YEVMLSCWHPKPEMRPTFSELVSRI 256 (262)
T ss_pred HHHHHHHcCCChhhCCCHHHHHHHH
Confidence 9999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=327.00 Aligned_cols=254 Identities=30% Similarity=0.548 Sum_probs=211.8
Q ss_pred ceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEE
Q 014210 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVY 235 (429)
Q Consensus 156 ~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~~ 235 (429)
.|+....||+|+||.||++.... +++.||||++.... ....+.+.+|+.+++.+. |+||+++++++..++..+
T Consensus 22 ~~~~~~~ig~g~~g~v~~~~~~~---~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~-hp~i~~~~~~~~~~~~~~ 94 (297)
T cd06659 22 LLENYIKIGEGSTGIVCIAREKH---SGRQVAVKMMDLRK---QQRRELLFNEVVIMRDYQ-HQNVVEMYKSYLVGEELW 94 (297)
T ss_pred hHHhhhhcCCCCceeEEEEEEcC---CCCEEEEEEEEecc---cchHHHHHHHHHHHHhCC-CCchhhhhhheeeCCeEE
Confidence 34456689999999999998765 58899999985432 223466889999999998 999999999999999999
Q ss_pred EEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccccCC
Q 014210 236 VVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP 315 (429)
Q Consensus 236 lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~ 315 (429)
+||||+++++|.+++.. ..+++..++.++.||+.||.|||+.||+||||||+||++ +.++.+||+|||++.....
T Consensus 95 iv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill---~~~~~~kL~dfg~~~~~~~ 169 (297)
T cd06659 95 VLMEFLQGGALTDIVSQ--TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILL---TLDGRVKLSDFGFCAQISK 169 (297)
T ss_pred EEEecCCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEE---ccCCcEEEeechhHhhccc
Confidence 99999999999886633 568999999999999999999999999999999999999 7788999999999875543
Q ss_pred Cc-cccccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHH
Q 014210 316 DE-RLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEAR 393 (429)
Q Consensus 316 ~~-~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 393 (429)
.. ......|+..|+|||++.+ .++.++||||||+++|||++|+.||........+..+.... .........++.++.
T Consensus 170 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~ 248 (297)
T cd06659 170 DVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSP-PPKLKNAHKISPVLR 248 (297)
T ss_pred ccccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccC-CCCccccCCCCHHHH
Confidence 22 2234578999999998864 68899999999999999999999998777666555544332 222223346789999
Q ss_pred HHHHHhcccCccCcCCHHHHHhhHhhhcc
Q 014210 394 DFVKRLLNKDPRKRLTAAQALSELLICYQ 422 (429)
Q Consensus 394 ~li~~~L~~dP~~Rps~~~iL~~~~~~~~ 422 (429)
+||.+||+.+|.+||++.++++|+|+...
T Consensus 249 ~~i~~~l~~~P~~Rps~~~ll~~~~~~~~ 277 (297)
T cd06659 249 DFLERMLTREPQERATAQELLDHPFLLQT 277 (297)
T ss_pred HHHHHHhcCCcccCcCHHHHhhChhhccC
Confidence 99999999999999999999999998654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=315.29 Aligned_cols=244 Identities=25% Similarity=0.411 Sum_probs=203.7
Q ss_pred CceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEE-eCCe
Q 014210 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYE-DTDN 233 (429)
Q Consensus 155 ~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~-~~~~ 233 (429)
++|++.+.||+|+||.||++... |..||+|.+... ...+.+.+|+.+++++. |+||+++++++. +++.
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-----~~~~~~k~~~~~-----~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~ 74 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-----GNKVAVKCIKND-----ATAQAFLAEASVMTQLR-HSNLVQLLGVIVEEKGG 74 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-----CCcEEEEEeCCC-----chHHHHHHHHHHHHhCC-CCCeeeEEEEEEcCCCc
Confidence 57999999999999999998643 678999998543 22457889999999998 999999999764 5567
Q ss_pred EEEEEEecCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccc
Q 014210 234 VYVVMELCEGGELLDRILSRGG-KYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (429)
Q Consensus 234 ~~lv~E~~~ggsL~~~i~~~~~-~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~ 312 (429)
.+++|||+++++|.+++.+... .+++..+..++.||+.||.|||++||+||||||+||++ ++++.+||+|||++..
T Consensus 75 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~---~~~~~~kl~dfg~~~~ 151 (256)
T cd05082 75 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLV---SEDNVAKVSDFGLTKE 151 (256)
T ss_pred eEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEE---cCCCcEEecCCcccee
Confidence 8999999999999999876544 48999999999999999999999999999999999999 6788999999999876
Q ss_pred cCCCccccccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCH
Q 014210 313 VRPDERLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLSS 390 (429)
Q Consensus 313 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 390 (429)
..... ....++..|+|||++.+ .++.++||||||+++|||++ |+.||...........+.+.... ...+.+++
T Consensus 152 ~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~ 226 (256)
T cd05082 152 ASSTQ--DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKM---DAPDGCPP 226 (256)
T ss_pred ccccC--CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCC---CCCCCCCH
Confidence 53322 23345678999998864 58889999999999999997 99999877766666555443221 22346889
Q ss_pred HHHHHHHHhcccCccCcCCHHHHHhhH
Q 014210 391 EARDFVKRLLNKDPRKRLTAAQALSEL 417 (429)
Q Consensus 391 ~~~~li~~~L~~dP~~Rps~~~iL~~~ 417 (429)
++.+||.+||+.||++||++.++++++
T Consensus 227 ~~~~li~~~l~~~p~~Rpt~~~l~~~l 253 (256)
T cd05082 227 VVYDVMKQCWHLDAATRPSFLQLREQL 253 (256)
T ss_pred HHHHHHHHHhcCChhhCcCHHHHHHHH
Confidence 999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=320.38 Aligned_cols=255 Identities=24% Similarity=0.330 Sum_probs=210.4
Q ss_pred cCceeEeceeeccCceEEEEEEEecC--cccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeC
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKG--ELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~--~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~ 231 (429)
.++|++.+.||+|+||.||+|..... ...+..||+|++... .......++.+|+.+++++. |+||+++++++.++
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~ei~~l~~l~-h~~iv~~~~~~~~~ 80 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE--ASADMQADFQREAALMAEFD-HPNIVKLLGVCAVG 80 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCC--cCHHHHHHHHHHHHHHHhcC-CCchheEEEEEcCC
Confidence 46899999999999999999986531 124788999998653 33455677999999999998 99999999999999
Q ss_pred CeEEEEEEecCCCcHHHHHHhcC---------------------CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCc
Q 014210 232 DNVYVVMELCEGGELLDRILSRG---------------------GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPEN 290 (429)
Q Consensus 232 ~~~~lv~E~~~ggsL~~~i~~~~---------------------~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~N 290 (429)
+..+++|||+++++|.+++.... ..+++..++.++.||+.||.|||+++++||||||+|
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~n 160 (288)
T cd05050 81 KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRN 160 (288)
T ss_pred CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhh
Confidence 99999999999999999886432 247888999999999999999999999999999999
Q ss_pred EEEeecCCCceEEEeecCCccccCCCcc---ccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHc-CCCCCCCCC
Q 014210 291 FLFTTKDENSVLKAIDFGLSDFVRPDER---LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWART 365 (429)
Q Consensus 291 ILl~~~~~~~~vkL~DFGla~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~ellt-g~~Pf~~~~ 365 (429)
||+ +.++.+||+|||++........ ......+..|+|||.+. +.++.++|||||||++|||++ |..||....
T Consensus 161 il~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~ 237 (288)
T cd05050 161 CLV---GENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMA 237 (288)
T ss_pred eEe---cCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 999 6788999999999875533221 12233466799999876 568999999999999999997 889998877
Q ss_pred hHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhH
Q 014210 366 ESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSEL 417 (429)
Q Consensus 366 ~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~ 417 (429)
..+....+....... ....++.++.+||.+||+.||.+||++.|+++.+
T Consensus 238 ~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l 286 (288)
T cd05050 238 HEEVIYYVRDGNVLS---CPDNCPLELYNLMRLCWSKLPSDRPSFASINRIL 286 (288)
T ss_pred HHHHHHHHhcCCCCC---CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHh
Confidence 777766665443221 1235789999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=316.24 Aligned_cols=255 Identities=24% Similarity=0.369 Sum_probs=209.6
Q ss_pred cCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~ 233 (429)
.++|.+.++||+|+||.||+|...........||||..... ......+.+.+|+.+++++. |+||+++++++.+ +.
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~--~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~-~~ 80 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNC--TSPSVREKFLQEAYIMRQFD-HPHIVKLIGVITE-NP 80 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCc--CCHHHHHHHHHHHHHHHhCC-CCchhceeEEEcC-CC
Confidence 46789999999999999999987654323457999988543 22455678999999999998 9999999998875 55
Q ss_pred EEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCcccc
Q 014210 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (429)
Q Consensus 234 ~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~ 313 (429)
.++||||+++++|.+++......+++..++.++.||+.||+|||+.|++||||||+|||+ +.++.+||+|||++...
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili---~~~~~~~l~d~g~~~~~ 157 (270)
T cd05056 81 VWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLV---SSPDCVKLGDFGLSRYL 157 (270)
T ss_pred cEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEE---ecCCCeEEccCceeeec
Confidence 789999999999999987666679999999999999999999999999999999999999 66778999999998765
Q ss_pred CCCccc--cccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCC
Q 014210 314 RPDERL--NDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLS 389 (429)
Q Consensus 314 ~~~~~~--~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 389 (429)
...... ....++..|+|||.+. ..++.++||||||+++|||++ |..||......+.+..+.+.... .....++
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~---~~~~~~~ 234 (270)
T cd05056 158 EDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERL---PMPPNCP 234 (270)
T ss_pred ccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcC---CCCCCCC
Confidence 433221 1223446799999876 468899999999999999986 99999887776666555443322 1234688
Q ss_pred HHHHHHHHHhcccCccCcCCHHHHHhhHh
Q 014210 390 SEARDFVKRLLNKDPRKRLTAAQALSELL 418 (429)
Q Consensus 390 ~~~~~li~~~L~~dP~~Rps~~~iL~~~~ 418 (429)
.++.+||.+||..+|++||++.+++..+-
T Consensus 235 ~~~~~li~~~l~~~P~~Rpt~~~~~~~l~ 263 (270)
T cd05056 235 PTLYSLMTKCWAYDPSKRPRFTELKAQLS 263 (270)
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 99999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=313.63 Aligned_cols=246 Identities=27% Similarity=0.431 Sum_probs=208.3
Q ss_pred cCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~ 233 (429)
.++|++.+.||.|+||.||++... |+.||||.+..... ..+++.+|+.+++++. |+||+++++++.+.+.
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~-----~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~ 74 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR-----GQKVAVKCLKDDST----AAQAFLAEASVMTTLR-HPNLVQLLGVVLQGNP 74 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec-----CcEEEEEEeccchh----HHHHHHHHHHHHHhcC-CcceeeeEEEEcCCCC
Confidence 467999999999999999998743 68899999865421 4577899999999998 9999999999999999
Q ss_pred EEEEEEecCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccc
Q 014210 234 VYVVMELCEGGELLDRILSRGG-KYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (429)
Q Consensus 234 ~~lv~E~~~ggsL~~~i~~~~~-~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~ 312 (429)
.++||||+++++|.+++..... .+++..++.++.|++.||.|||++||+||||||+||++ +.++.+||+|||++..
T Consensus 75 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili---~~~~~~~l~d~g~~~~ 151 (256)
T cd05039 75 LYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLV---SEDLVAKVSDFGLAKE 151 (256)
T ss_pred eEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEE---eCCCCEEEcccccccc
Confidence 9999999999999998865543 69999999999999999999999999999999999999 6788899999999987
Q ss_pred cCCCccccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCH
Q 014210 313 VRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLSS 390 (429)
Q Consensus 313 ~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 390 (429)
...... ....+..|+|||++. +.++.++||||||+++|||++ |+.||...........+..... . .....+++
T Consensus 152 ~~~~~~--~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~-~--~~~~~~~~ 226 (256)
T cd05039 152 ASQGQD--SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYR-M--EAPEGCPP 226 (256)
T ss_pred cccccc--cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCC-C--CCccCCCH
Confidence 633222 334567899999876 568889999999999999997 9999988777666555543321 1 11235789
Q ss_pred HHHHHHHHhcccCccCcCCHHHHHhhH
Q 014210 391 EARDFVKRLLNKDPRKRLTAAQALSEL 417 (429)
Q Consensus 391 ~~~~li~~~L~~dP~~Rps~~~iL~~~ 417 (429)
++.+||.+||..+|++||++.+++..+
T Consensus 227 ~~~~li~~~l~~~p~~Rp~~~~l~~~l 253 (256)
T cd05039 227 EVYKVMKDCWELDPAKRPTFKQLREQL 253 (256)
T ss_pred HHHHHHHHHhccChhhCcCHHHHHHHH
Confidence 999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-41 Score=331.43 Aligned_cols=259 Identities=31% Similarity=0.494 Sum_probs=209.0
Q ss_pred ccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeC-
Q 014210 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT- 231 (429)
Q Consensus 153 ~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~- 231 (429)
+.++|++.+.||+|+||.||+++... +|+.||||.+.... ........+.+|+.+++.+. |+||+++++++...
T Consensus 3 ~~~~y~~~~~lg~G~~~~vy~~~~~~---~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~ni~~~~~~~~~~~ 77 (337)
T cd07858 3 VDTKYVPIKPIGRGAYGIVCSAKNSE---TNEKVAIKKIANAF-DNRIDAKRTLREIKLLRHLD-HENVIAIKDIMPPPH 77 (337)
T ss_pred cccceeEEEEeccCCCeEEEEEEecC---CCCeEEEEEecccc-cccchhHHHHHHHHHHHhcC-CCCccchHHheeccc
Confidence 45789999999999999999998765 68999999986532 23333456788999999998 99999999988654
Q ss_pred ----CeEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeec
Q 014210 232 ----DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDF 307 (429)
Q Consensus 232 ----~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DF 307 (429)
...++||||+. ++|.+++. ..+.+++..++.++.||+.||.|||+++++||||||+|||+ +.++.+||+||
T Consensus 78 ~~~~~~~~lv~e~~~-~~L~~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~---~~~~~~kL~Df 152 (337)
T cd07858 78 REAFNDVYIVYELMD-TDLHQIIR-SSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLL---NANCDLKICDF 152 (337)
T ss_pred ccccCcEEEEEeCCC-CCHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEE---cCCCCEEECcC
Confidence 35899999996 58888764 45679999999999999999999999999999999999999 67788999999
Q ss_pred CCccccCCC-ccccccccCCcccCccccc--CCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhc--------
Q 014210 308 GLSDFVRPD-ERLNDIVGSAYYVAPEVLH--RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKA-------- 376 (429)
Q Consensus 308 Gla~~~~~~-~~~~~~~gt~~y~aPE~~~--~~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~-------- 376 (429)
|++...... .......++..|+|||++. ..++.++||||||+++|+|++|+.||...+.......+...
T Consensus 153 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 232 (337)
T cd07858 153 GLARTTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEED 232 (337)
T ss_pred ccccccCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHH
Confidence 999876443 2233456889999999875 35889999999999999999999999765543322222110
Q ss_pred ---------------CCCCC----CCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhc
Q 014210 377 ---------------DPSFD----EAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLICY 421 (429)
Q Consensus 377 ---------------~~~~~----~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~ 421 (429)
.+... ...++.++.++.+||++||+.||++||++.++|+|+|+..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~ 296 (337)
T cd07858 233 LGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLAS 296 (337)
T ss_pred hhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhh
Confidence 00000 1123468899999999999999999999999999999975
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=312.94 Aligned_cols=248 Identities=26% Similarity=0.470 Sum_probs=207.9
Q ss_pred CceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeE
Q 014210 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (429)
Q Consensus 155 ~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~ 234 (429)
.+|++.+.||+|+||.||++.... +..+|+|++...... ..++.+|+++++++. |+||+++++++.+....
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~----~~~~~~k~~~~~~~~----~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~ 74 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLE----KRKVAIKTIREGAMS----EEDFIEEAQVMMKLS-HPKLVQLYGVCTERSPI 74 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeC----CCeEEEEECCCCCCC----HHHHHHHHHHHHhCC-CCCeeeEEEEEccCCce
Confidence 578999999999999999997653 678999998654322 346889999999998 99999999999999999
Q ss_pred EEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccccC
Q 014210 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (429)
Q Consensus 235 ~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~ 314 (429)
+++|||+++++|.+++....+.+++..++.++.|++.||+|||+.+++|+||||+||++ +.++.+||+|||++....
T Consensus 75 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i---~~~~~~~l~d~g~~~~~~ 151 (256)
T cd05112 75 CLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLV---GENQVVKVSDFGMTRFVL 151 (256)
T ss_pred EEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEE---cCCCeEEECCCcceeecc
Confidence 99999999999999887666778999999999999999999999999999999999999 677889999999987553
Q ss_pred CCcc--ccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCH
Q 014210 315 PDER--LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLSS 390 (429)
Q Consensus 315 ~~~~--~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 390 (429)
.... .....++..|+|||++. +.++.++||||||+++|||++ |+.||...........+........ ....+.
T Consensus 152 ~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~ 228 (256)
T cd05112 152 DDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYK---PRLASQ 228 (256)
T ss_pred cCcccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCCC---CCCCCH
Confidence 3221 11233557899999886 568889999999999999998 9999988777666666544322221 123689
Q ss_pred HHHHHHHHhcccCccCcCCHHHHHhhH
Q 014210 391 EARDFVKRLLNKDPRKRLTAAQALSEL 417 (429)
Q Consensus 391 ~~~~li~~~L~~dP~~Rps~~~iL~~~ 417 (429)
++.+|+.+||+.+|++||++.++++++
T Consensus 229 ~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 229 SVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred HHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-41 Score=324.26 Aligned_cols=257 Identities=29% Similarity=0.482 Sum_probs=213.1
Q ss_pred cCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~ 233 (429)
.++|++.+.||+|+||.||++.... +++.||+|.+... .....+.+.+|+.++++++ |+||+++++++...+.
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~---~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~-hp~i~~~~~~~~~~~~ 90 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVA---TGQEVAIKQMNLQ---QQPKKELIINEILVMRENK-HPNIVNYLDSYLVGDE 90 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcC---CCCEEEEEEeccc---cchHHHHHHHHHHHHhhcC-CCCeeehhheeeeCCc
Confidence 4789999999999999999998655 4788999998543 2233467889999999998 9999999999999999
Q ss_pred EEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCcccc
Q 014210 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (429)
Q Consensus 234 ~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~ 313 (429)
.|+|+||+++++|.+++.+ ..+++..+..++.|++.||.|||++|++||||||+||++ +.++.+||+|||++...
T Consensus 91 ~~lv~e~~~~~~L~~~~~~--~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili---~~~~~~kL~dfg~~~~~ 165 (293)
T cd06647 91 LWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL---GMDGSVKLTDFGFCAQI 165 (293)
T ss_pred EEEEEecCCCCcHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEE---cCCCCEEEccCcceecc
Confidence 9999999999999998743 458899999999999999999999999999999999999 67788999999988765
Q ss_pred CCCc-cccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHH
Q 014210 314 RPDE-RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSE 391 (429)
Q Consensus 314 ~~~~-~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 391 (429)
.... ......++..|++||.+. +.++.++||||||+++|+|++|+.||........+..+.... .........++.+
T Consensus 166 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 244 (293)
T cd06647 166 TPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNG-TPELQNPEKLSAI 244 (293)
T ss_pred cccccccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCC-CCCCCCccccCHH
Confidence 4333 223456889999999876 468889999999999999999999997765544333332211 1111223357889
Q ss_pred HHHHHHHhcccCccCcCCHHHHHhhHhhhccc
Q 014210 392 ARDFVKRLLNKDPRKRLTAAQALSELLICYQS 423 (429)
Q Consensus 392 ~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~~ 423 (429)
+.+||.+||..+|.+||++.+++.|+||+...
T Consensus 245 l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~ 276 (293)
T cd06647 245 FRDFLNRCLEMDVEKRGSAKELLQHPFLKIAK 276 (293)
T ss_pred HHHHHHHHccCChhhCcCHHHHhcCHHHhcCc
Confidence 99999999999999999999999999998764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=314.98 Aligned_cols=249 Identities=23% Similarity=0.398 Sum_probs=206.0
Q ss_pred ccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCC
Q 014210 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (429)
Q Consensus 153 ~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~ 232 (429)
..++|+++++||+|+||.||+|.... ++.||+|.+..... ..+++.+|+.++++++ |+||+++++++. .+
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~----~~~~a~K~~~~~~~----~~~~~~~E~~~l~~l~-h~~i~~~~~~~~-~~ 73 (260)
T cd05067 4 PRETLKLVKKLGAGQFGEVWMGYYNG----HTKVAIKSLKQGSM----SPEAFLAEANLMKQLQ-HPRLVRLYAVVT-QE 73 (260)
T ss_pred chHHceeeeeeccCccceEEeeecCC----CceEEEEEecCCCC----cHHHHHHHHHHHHhcC-CcCeeeEEEEEc-cC
Confidence 35789999999999999999998654 68899999865432 2357889999999998 999999999874 46
Q ss_pred eEEEEEEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCcc
Q 014210 233 NVYVVMELCEGGELLDRILSR-GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (429)
Q Consensus 233 ~~~lv~E~~~ggsL~~~i~~~-~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~ 311 (429)
..+++|||+.+++|.+++... +..+++..+..++.|++.||+|||+.|++||||||+||++ +.++.++|+|||++.
T Consensus 74 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i---~~~~~~~l~dfg~~~ 150 (260)
T cd05067 74 PIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILV---SETLCCKIADFGLAR 150 (260)
T ss_pred CcEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEE---cCCCCEEEccCccee
Confidence 789999999999999988654 3478999999999999999999999999999999999999 678889999999987
Q ss_pred ccCCCcc--ccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCC
Q 014210 312 FVRPDER--LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPS 387 (429)
Q Consensus 312 ~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 387 (429)
....... .....++..|+|||++. +.++.++||||||+++|||++ |+.||......+....+..... . .....
T Consensus 151 ~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~-~--~~~~~ 227 (260)
T cd05067 151 LIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYR-M--PRPDN 227 (260)
T ss_pred ecCCCCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCC-C--CCCCC
Confidence 6642221 12334567899999886 468889999999999999999 9999987776666555433221 1 12235
Q ss_pred CCHHHHHHHHHhcccCccCcCCHHHHHhhH
Q 014210 388 LSSEARDFVKRLLNKDPRKRLTAAQALSEL 417 (429)
Q Consensus 388 ~s~~~~~li~~~L~~dP~~Rps~~~iL~~~ 417 (429)
++.++.+||.+||+.||++||++++++..+
T Consensus 228 ~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l 257 (260)
T cd05067 228 CPEELYELMRLCWKEKPEERPTFEYLRSVL 257 (260)
T ss_pred CCHHHHHHHHHHccCChhhCCCHHHHHHHh
Confidence 789999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=319.04 Aligned_cols=258 Identities=28% Similarity=0.483 Sum_probs=217.7
Q ss_pred cccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeC
Q 014210 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (429)
Q Consensus 152 ~~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~ 231 (429)
...+.|++.+.||+|+||.||++.... .++.|++|++..... ..+.+.+|++++++++ |+||+++++++...
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~---~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~ 87 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRA---TGKEVAIKKMRLRKQ----NKELIINEILIMKDCK-HPNIVDYYDSYLVG 87 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEcc---CCcEEEEEEEecCch----hHHHHHHHHHHHHHCC-CCCeeEEEEEEEEC
Confidence 456789999999999999999998775 578999999865422 4567889999999998 99999999999999
Q ss_pred CeEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCcc
Q 014210 232 DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (429)
Q Consensus 232 ~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~ 311 (429)
+..++++||+++++|.+++......+++..+..++.||+.||.|||+.||+|+||||+||++ +.++.+||+|||++.
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i---~~~~~~~l~d~~~~~ 164 (286)
T cd06614 88 DELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILL---SKDGSVKLADFGFAA 164 (286)
T ss_pred CEEEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEE---cCCCCEEECccchhh
Confidence 99999999999999999987665589999999999999999999999999999999999999 677889999999886
Q ss_pred ccCCCc-cccccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCC
Q 014210 312 FVRPDE-RLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLS 389 (429)
Q Consensus 312 ~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 389 (429)
...... ......++..|++||++.+ .++.++|+||||+++|+|++|+.||...........+...... .......++
T Consensus 165 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 243 (286)
T cd06614 165 QLTKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIP-PLKNPEKWS 243 (286)
T ss_pred hhccchhhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC-CCcchhhCC
Confidence 554322 2234467889999998764 5899999999999999999999999876665554444433221 111223478
Q ss_pred HHHHHHHHHhcccCccCcCCHHHHHhhHhhhc
Q 014210 390 SEARDFVKRLLNKDPRKRLTAAQALSELLICY 421 (429)
Q Consensus 390 ~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~ 421 (429)
.++.+||++||+.+|.+||++.+++.|+|+..
T Consensus 244 ~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 275 (286)
T cd06614 244 PEFKDFLNKCLVKDPEKRPSAEELLQHPFLKK 275 (286)
T ss_pred HHHHHHHHHHhccChhhCcCHHHHhhChHhhc
Confidence 99999999999999999999999999999976
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=316.24 Aligned_cols=255 Identities=22% Similarity=0.308 Sum_probs=211.1
Q ss_pred cCceeEeceeeccCceEEEEEEEecCc-ccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCC
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGE-LKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~-~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~ 232 (429)
..+|++.+.||+|+||.||+|..+... .....+|+|.+.... ......++.+|+.+++++. |+||+++++++.. .
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~-~ 81 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET--SPKANKEILDEAYVMASVD-HPHVVRLLGICLS-S 81 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCC--CHHHHHHHHHHHHHHHhCC-CCCcceEEEEEec-C
Confidence 468999999999999999999876522 123479999886543 3455677899999999997 9999999999987 7
Q ss_pred eEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccc
Q 014210 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (429)
Q Consensus 233 ~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~ 312 (429)
..++||||+++|+|.+++......+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.
T Consensus 82 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~---~~~~~~kL~dfg~~~~ 158 (279)
T cd05057 82 QVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLV---KTPQHVKITDFGLAKL 158 (279)
T ss_pred ceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEE---cCCCeEEECCCccccc
Confidence 8899999999999999987777779999999999999999999999999999999999999 6778899999999987
Q ss_pred cCCCcccc---ccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCC
Q 014210 313 VRPDERLN---DIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPS 387 (429)
Q Consensus 313 ~~~~~~~~---~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 387 (429)
........ ...++..|+|||.+. +.++.++||||||+++|||++ |+.||......+....+..... ... ...
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~-~~~--~~~ 235 (279)
T cd05057 159 LDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGER-LPQ--PPI 235 (279)
T ss_pred ccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCC-CCC--CCC
Confidence 65333221 122356799999876 568899999999999999998 9999988777766666654332 111 134
Q ss_pred CCHHHHHHHHHhcccCccCcCCHHHHHhhHh
Q 014210 388 LSSEARDFVKRLLNKDPRKRLTAAQALSELL 418 (429)
Q Consensus 388 ~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~ 418 (429)
.+.++.+++.+||..||.+||++.++++.+-
T Consensus 236 ~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~ 266 (279)
T cd05057 236 CTIDVYMVLVKCWMIDAESRPTFKELINEFS 266 (279)
T ss_pred CCHHHHHHHHHHcCCChhhCCCHHHHHHHHH
Confidence 6789999999999999999999999887543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=315.00 Aligned_cols=248 Identities=21% Similarity=0.327 Sum_probs=197.0
Q ss_pred ceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEe
Q 014210 161 EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMEL 240 (429)
Q Consensus 161 ~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~~lv~E~ 240 (429)
++||+|+||.||+|....+ .++..+|+|.+.... .......+.+|+.++++++ |+||+++++++.+....++||||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~-~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~ 76 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSG-YTPAQVVVKELRVSA--SVQEQMKFLEEAQPYRSLQ-HSNLLQCLGQCTEVTPYLLVMEF 76 (269)
T ss_pred CcccccCCceEEEEEEcCC-CCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhCC-CCCEeeEEEEEcCCCCcEEEEEC
Confidence 4699999999999987542 356789999886542 2344567889999999998 99999999999999999999999
Q ss_pred cCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccccCCC
Q 014210 241 CEGGELLDRILSRG----GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPD 316 (429)
Q Consensus 241 ~~ggsL~~~i~~~~----~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~ 316 (429)
+++|+|.+++.... ...++..+..++.|++.||.|||+.+++||||||+||++ +.++.+||+|||++......
T Consensus 77 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~---~~~~~~kL~dfg~~~~~~~~ 153 (269)
T cd05087 77 CPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLL---TADLTVKIGDYGLSHNKYKE 153 (269)
T ss_pred CCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEE---cCCCcEEECCccccccccCc
Confidence 99999999886432 246778889999999999999999999999999999999 67788999999998754332
Q ss_pred cc---ccccccCCcccCcccccC--------CCCCcccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhc-CCCCCCC
Q 014210 317 ER---LNDIVGSAYYVAPEVLHR--------SYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKA-DPSFDEA 383 (429)
Q Consensus 317 ~~---~~~~~gt~~y~aPE~~~~--------~~~~~sDiwSlGvll~ellt-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~ 383 (429)
.. .....++..|+|||++.+ .++.++||||||+++|||++ |+.||............... .......
T Consensus 154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 233 (269)
T cd05087 154 DYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKP 233 (269)
T ss_pred ceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCC
Confidence 21 123457788999998753 25779999999999999996 99999776655544333222 2222221
Q ss_pred C-CCCCCHHHHHHHHHhcccCccCcCCHHHHHhh
Q 014210 384 P-WPSLSSEARDFVKRLLNKDPRKRLTAAQALSE 416 (429)
Q Consensus 384 ~-~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~ 416 (429)
. ....++++.++++.|+ .+|++||++.+++..
T Consensus 234 ~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~ 266 (269)
T cd05087 234 RLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLL 266 (269)
T ss_pred ccCCCCChHHHHHHHHHh-cCcccCCCHHHHHHH
Confidence 1 1246788999999998 689999999999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=318.83 Aligned_cols=255 Identities=29% Similarity=0.430 Sum_probs=209.1
Q ss_pred eeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhc--CCCCcceEEEEEEeCCe-
Q 014210 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALT--GHNNLVKFFDAYEDTDN- 233 (429)
Q Consensus 157 y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~--~h~nIv~l~~~~~~~~~- 233 (429)
|++.+.||+|+||.||+++... +|+.||||++..... .......+.+|+.+++++. .|+||+++++++.+.+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~---~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~ 76 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLN---TGRFVALKKVRVPLS-EEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTD 76 (287)
T ss_pred CeEEEEecccCceEEEEEEECC---CCCEEEEEEeccccc-cchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCC
Confidence 6789999999999999999765 588999999865432 2222345678888888775 49999999999998776
Q ss_pred ----EEEEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecC
Q 014210 234 ----VYVVMELCEGGELLDRILSRG-GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFG 308 (429)
Q Consensus 234 ----~~lv~E~~~ggsL~~~i~~~~-~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFG 308 (429)
.+++|||+.+ +|.+++.... ..+++..++.++.||+.||.|||+.+|+|+||||+||++ +.++.+||+|||
T Consensus 77 ~~~~~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili---~~~~~~~l~dfg 152 (287)
T cd07838 77 RELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILV---TSDGQVKIADFG 152 (287)
T ss_pred CCceeEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEE---ccCCCEEEeccC
Confidence 9999999975 8888776543 369999999999999999999999999999999999999 677899999999
Q ss_pred CccccCCCccccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCC-------
Q 014210 309 LSDFVRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSF------- 380 (429)
Q Consensus 309 la~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~------- 380 (429)
++.............++..|+|||++. ..++.++||||||+++|+|++|+.||......+.+..+.......
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (287)
T cd07838 153 LARIYSFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPR 232 (287)
T ss_pred cceeccCCcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCC
Confidence 998775554445566889999999886 468889999999999999999999998887776666554421100
Q ss_pred ---------C-------CCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhh
Q 014210 381 ---------D-------EAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLI 419 (429)
Q Consensus 381 ---------~-------~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~ 419 (429)
. ....+.++.++.+||.+||+.||++||++.+++.|+||
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 233 NVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred CcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 0 00012456788999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=314.42 Aligned_cols=247 Identities=23% Similarity=0.380 Sum_probs=204.2
Q ss_pred cCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~ 233 (429)
.++|++.++||+|+||.||+|.... +..+|+|.+..... ..+.+.+|+.++++++ |+||+++++++. .+.
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~----~~~~~~k~~~~~~~----~~~~~~~E~~~l~~l~-~~~i~~~~~~~~-~~~ 74 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNG----NTKVAVKTLKPGTM----SPESFLEEAQIMKKLR-HDKLVQLYAVVS-EEP 74 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecC----CceeEEEEecCCCC----CHHHHHHHHHHHHhcC-CCceEEEEeEEC-CCC
Confidence 4689999999999999999997553 56799999865432 2356889999999998 999999999885 456
Q ss_pred EEEEEEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccc
Q 014210 234 VYVVMELCEGGELLDRILSR-GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (429)
Q Consensus 234 ~~lv~E~~~ggsL~~~i~~~-~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~ 312 (429)
.+++|||+++++|.+++... ...+++..++.++.|++.||.|||+.||+||||||+||++ ++++.+||+|||++..
T Consensus 75 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili---~~~~~~~l~dfg~~~~ 151 (260)
T cd05070 75 IYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILV---GDGLVCKIADFGLARL 151 (260)
T ss_pred cEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEE---eCCceEEeCCceeeee
Confidence 89999999999999988654 3468999999999999999999999999999999999999 6788899999999976
Q ss_pred cCCCccc--cccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCC
Q 014210 313 VRPDERL--NDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSL 388 (429)
Q Consensus 313 ~~~~~~~--~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 388 (429)
....... ....++..|+|||++. +.++.++||||||+++|+|++ |..||......+....+...... ......
T Consensus 152 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~ 228 (260)
T cd05070 152 IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRM---PCPQDC 228 (260)
T ss_pred ccCcccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC---CCCCcC
Confidence 5433221 2234566899999876 468899999999999999999 89999887776666665443221 112367
Q ss_pred CHHHHHHHHHhcccCccCcCCHHHHHhh
Q 014210 389 SSEARDFVKRLLNKDPRKRLTAAQALSE 416 (429)
Q Consensus 389 s~~~~~li~~~L~~dP~~Rps~~~iL~~ 416 (429)
+.++.+||.+||..||++|||+.+++.-
T Consensus 229 ~~~~~~li~~~l~~~p~~Rpt~~~l~~~ 256 (260)
T cd05070 229 PISLHELMLQCWKKDPEERPTFEYLQSF 256 (260)
T ss_pred CHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 8999999999999999999999998854
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-41 Score=331.86 Aligned_cols=258 Identities=31% Similarity=0.528 Sum_probs=207.8
Q ss_pred cCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEe---
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED--- 230 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~--- 230 (429)
.++|++.+.||+|+||.||+|..+. +|+.||+|++.... ........+.+|+.++++++ |+||+++++++..
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~---~~~~valK~~~~~~-~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~ 78 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTR---SGKKVAIKKIPHAF-DVPTLAKRTLRELKILRHFK-HDNIIAIRDILRPPGA 78 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcC---CCCEEEEEEecccc-ccccchHHHHHHHHHHHhcC-CCCccCHHHhccccCC
Confidence 4789999999999999999998776 58999999987542 22334567788999999998 9999999998763
Q ss_pred -CCeEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCC
Q 014210 231 -TDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGL 309 (429)
Q Consensus 231 -~~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGl 309 (429)
...+++||||+. ++|.+++. ....+++..++.++.||+.||.|||+.||+||||||+||++ ++++.+||+|||+
T Consensus 79 ~~~~~~lv~e~~~-~~l~~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~---~~~~~~kl~dfg~ 153 (334)
T cd07855 79 DFKDVYVVMDLME-SDLHHIIH-SDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLV---NEDCELRIGDFGM 153 (334)
T ss_pred CCceEEEEEehhh-hhHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---cCCCcEEeccccc
Confidence 356899999995 58887764 44569999999999999999999999999999999999999 7788999999999
Q ss_pred ccccCCCcc-----ccccccCCcccCcccccC--CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhc------
Q 014210 310 SDFVRPDER-----LNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKA------ 376 (429)
Q Consensus 310 a~~~~~~~~-----~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~------ 376 (429)
+........ .....|+..|+|||++.+ .++.++||||||+++|||++|+.||........+..+...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~ 233 (334)
T cd07855 154 ARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSE 233 (334)
T ss_pred ceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChh
Confidence 876543221 124578999999998753 5889999999999999999999999765543332222111
Q ss_pred -----------------CCCCCCC----CCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhc
Q 014210 377 -----------------DPSFDEA----PWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLICY 421 (429)
Q Consensus 377 -----------------~~~~~~~----~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~ 421 (429)
....... ..+.++.++.+||++||+.||++||++.+++.|+||..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~ 299 (334)
T cd07855 234 EVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQ 299 (334)
T ss_pred HhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhh
Confidence 1111111 12457899999999999999999999999999999963
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=310.47 Aligned_cols=253 Identities=31% Similarity=0.516 Sum_probs=212.8
Q ss_pred ceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeC--Ce
Q 014210 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT--DN 233 (429)
Q Consensus 156 ~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~--~~ 233 (429)
+|.+.+.||+|++|.||+|.... +|+.|++|++..... .....+.+.+|+.+++++. |+||+++++.+.+. +.
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~---~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~ 75 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKD---TGELMAVKSVELSGD-SEEELEALEREIRILSSLQ-HPNIVRYYGSERDEEKNT 75 (260)
T ss_pred CceeeeEeeecCceEEEEEEECC---CCcEEEEEEeecccc-chHHHHHHHHHHHHHHHcC-CCCEeeEEEEEecCCCCe
Confidence 48889999999999999998775 588999999865432 2456678999999999998 99999999999988 88
Q ss_pred EEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCcccc
Q 014210 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (429)
Q Consensus 234 ~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~ 313 (429)
.+++|||+++++|.+++.... .+++..++.++.|++.||.|||+.|++|+||+|+||++ +.++.+||+|||.+...
T Consensus 76 ~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i---~~~~~~~l~d~~~~~~~ 151 (260)
T cd06606 76 LNIFLEYVSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILV---DSDGVVKLADFGCAKRL 151 (260)
T ss_pred EEEEEEecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE---cCCCCEEEcccccEEec
Confidence 999999999999999886544 89999999999999999999999999999999999999 66788999999999877
Q ss_pred CCCcc---ccccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHcCCCCCCCCC-hHHHHHHHHhcCCCCCCCCCCCC
Q 014210 314 RPDER---LNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWART-ESGIFRAVLKADPSFDEAPWPSL 388 (429)
Q Consensus 314 ~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~elltg~~Pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~ 388 (429)
..... .....++..|++||.+.+ .++.++||||||+++|+|++|..||.... .......+... .........+
T Consensus 152 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~ 229 (260)
T cd06606 152 GDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSS--GEPPEIPEHL 229 (260)
T ss_pred ccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhcccc--CCCcCCCccc
Confidence 65543 445678899999998874 48899999999999999999999997765 22222222211 1111222356
Q ss_pred CHHHHHHHHHhcccCccCcCCHHHHHhhHhh
Q 014210 389 SSEARDFVKRLLNKDPRKRLTAAQALSELLI 419 (429)
Q Consensus 389 s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~ 419 (429)
+.++.+||.+||..||++||++.+++.|+||
T Consensus 230 ~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 230 SEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred CHHHHHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence 8999999999999999999999999999996
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=314.95 Aligned_cols=249 Identities=20% Similarity=0.337 Sum_probs=198.9
Q ss_pred ceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEe
Q 014210 161 EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMEL 240 (429)
Q Consensus 161 ~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~~lv~E~ 240 (429)
++||+|+||.||+|....+ .....+|+|.+... ........+.+|+.+++.++ |+||+++++++.+.+..++||||
T Consensus 1 ~~lg~G~fg~v~~~~~~~~-~~~~~~~~k~~~~~--~~~~~~~~~~~e~~~~~~l~-h~nii~~~~~~~~~~~~~lv~e~ 76 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRG-MSKARVVVKELRAS--ATPDEQLLFLQEVQPYRELN-HPNVLQCLGQCIESIPYLLVLEF 76 (269)
T ss_pred CcCCccCCceEEEEEEecC-CCCeEEEEeecCcc--CChHHHHHHHHHHHHHHhCC-CCCcceEEEEECCCCceEEEEEe
Confidence 4699999999999976554 24678999987543 23445567889999999997 99999999999999999999999
Q ss_pred cCCCcHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccccCCC
Q 014210 241 CEGGELLDRILSRGG----KYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPD 316 (429)
Q Consensus 241 ~~ggsL~~~i~~~~~----~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~ 316 (429)
+++|+|.+++..... ..++..+..++.||+.||+|||++||+||||||+|||+ ++++.+||+|||++......
T Consensus 77 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill---~~~~~~kl~dfg~~~~~~~~ 153 (269)
T cd05042 77 CPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQL---TADLSVKIGDYGLALEQYPE 153 (269)
T ss_pred CCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEe---cCCCcEEEeccccccccccc
Confidence 999999998865432 35688899999999999999999999999999999999 77888999999998654322
Q ss_pred cc---ccccccCCcccCccccc--------CCCCCcccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCC-CCCCC
Q 014210 317 ER---LNDIVGSAYYVAPEVLH--------RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADP-SFDEA 383 (429)
Q Consensus 317 ~~---~~~~~gt~~y~aPE~~~--------~~~~~~sDiwSlGvll~ellt-g~~Pf~~~~~~~~~~~i~~~~~-~~~~~ 383 (429)
.. .....++..|+|||++. ..++.++|||||||++|||++ |..||......+.+..+..... .....
T Consensus 154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 233 (269)
T cd05042 154 DYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKP 233 (269)
T ss_pred hheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCC
Confidence 21 12334667899999863 246779999999999999998 7889887776666655544322 22221
Q ss_pred -CCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhH
Q 014210 384 -PWPSLSSEARDFVKRLLNKDPRKRLTAAQALSEL 417 (429)
Q Consensus 384 -~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~ 417 (429)
....++.++.+++..|+ .||++||++.+++..+
T Consensus 234 ~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l 267 (269)
T cd05042 234 QLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELL 267 (269)
T ss_pred cccccCCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence 12357889999999998 5999999999998754
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=319.18 Aligned_cols=255 Identities=25% Similarity=0.408 Sum_probs=203.9
Q ss_pred CceeEeceeeccCceEEEEEEEec-CcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeC--
Q 014210 155 NKYELGEEVGRGHFGYTCAAKFKK-GELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT-- 231 (429)
Q Consensus 155 ~~y~~~~~IG~G~fg~V~~~~~~~-~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~-- 231 (429)
..|+++++||+|+||.||+++... +...+..||+|.+... ......+.+.+|+.+++++. |+||+++++++.+.
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~--~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~ 80 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPE--SGGNHIADLKKEIEILRNLY-HENIVKYKGICTEDGG 80 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCcc--ccHHHHHHHHHHHHHHHhCC-CCCeeeeeeEEecCCC
Confidence 457899999999999999997542 2336889999998643 33445577999999999998 99999999999875
Q ss_pred CeEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCcc
Q 014210 232 DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (429)
Q Consensus 232 ~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~ 311 (429)
...++||||++|++|.+++.+....+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.
T Consensus 81 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~---~~~~~~~l~dfg~~~ 157 (284)
T cd05079 81 NGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLV---ESEHQVKIGDFGLTK 157 (284)
T ss_pred CceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEE---cCCCCEEECCCcccc
Confidence 56899999999999999886665678999999999999999999999999999999999999 677889999999998
Q ss_pred ccCCCcc----ccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHcCCCCCCCCCh--------------HHHHHH
Q 014210 312 FVRPDER----LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTE--------------SGIFRA 372 (429)
Q Consensus 312 ~~~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~elltg~~Pf~~~~~--------------~~~~~~ 372 (429)
....... .....++..|+|||++. +.++.++||||||+++|||++++.|+..... ......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05079 158 AIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVR 237 (284)
T ss_pred ccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHH
Confidence 6643321 12345677899999876 4688999999999999999998776532111 011111
Q ss_pred HHhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhH
Q 014210 373 VLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSEL 417 (429)
Q Consensus 373 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~ 417 (429)
....... ...+..++.++.+||.+||+.||++||++.+++.++
T Consensus 238 ~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l 280 (284)
T cd05079 238 VLEEGKR--LPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGF 280 (284)
T ss_pred HHHcCcc--CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHH
Confidence 1111111 122346889999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=329.41 Aligned_cols=258 Identities=27% Similarity=0.487 Sum_probs=211.9
Q ss_pred cccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeC
Q 014210 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (429)
Q Consensus 152 ~~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~ 231 (429)
.+.++|++.+.||+|+||.||++.... +|..||||++.+.. ......+.+.+|++++++++ |+||+++++++..+
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~ 86 (343)
T cd07880 12 EVPDRYRDLKQVGSGAYGTVCSALDRR---TGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMK-HENVIGLLDVFTPD 86 (343)
T ss_pred ccccceEEEEEeeecCCeEEEEEEECC---CCcEEEEEEecccc-cchHHHHHHHHHHHHHHhcC-CCCccceeeeecCC
Confidence 357889999999999999999998665 58999999986432 33444567889999999998 99999999998765
Q ss_pred C------eEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEe
Q 014210 232 D------NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAI 305 (429)
Q Consensus 232 ~------~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~ 305 (429)
. ..++||||+ +++|.+++. ...+++..++.++.||+.||.|||+.||+||||||+||++ +.++.+||+
T Consensus 87 ~~~~~~~~~~lv~e~~-~~~l~~~~~--~~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill---~~~~~~kl~ 160 (343)
T cd07880 87 LSLDRFHDFYLVMPFM-GTDLGKLMK--HEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAV---NEDCELKIL 160 (343)
T ss_pred ccccccceEEEEEecC-CCCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCCCEEEe
Confidence 4 468999999 678887664 3579999999999999999999999999999999999999 677889999
Q ss_pred ecCCccccCCCccccccccCCcccCcccccC--CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCC--
Q 014210 306 DFGLSDFVRPDERLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFD-- 381 (429)
Q Consensus 306 DFGla~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~-- 381 (429)
|||++..... ......++..|+|||++.+ .++.++|+||||+++|+|++|+.||........+..+++......
T Consensus 161 dfg~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 238 (343)
T cd07880 161 DFGLARQTDS--EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKE 238 (343)
T ss_pred eccccccccc--CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHH
Confidence 9999876532 2234567899999998764 478899999999999999999999987766555544433221110
Q ss_pred -------------------------CCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhcc
Q 014210 382 -------------------------EAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLICYQ 422 (429)
Q Consensus 382 -------------------------~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~ 422 (429)
...++.++.++.++|.+||+.||++||++.+++.|+||+..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~ 304 (343)
T cd07880 239 FVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEF 304 (343)
T ss_pred HHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhh
Confidence 11224678899999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=324.06 Aligned_cols=258 Identities=26% Similarity=0.421 Sum_probs=215.9
Q ss_pred ccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCC
Q 014210 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (429)
Q Consensus 153 ~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~ 232 (429)
..+.|...+.||+|+||.||+|+... .++.||||.+...........+++.+|+++++.++ |+|++++++++...+
T Consensus 13 ~~~~~~~~~~lg~g~~g~v~~~~~~~---~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~ 88 (308)
T cd06634 13 PEKLFSDLREIGHGSFGAVYFARDVR---NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR-HPNTIQYRGCYLREH 88 (308)
T ss_pred cHHHHHHHHheeeCCCEEEEEEEEcC---CCcEEEEEEEecccccChHHHHHHHHHHHHHHhCC-CCCcccEEEEEEcCC
Confidence 35668889999999999999999765 58899999986543344455667889999999998 999999999999999
Q ss_pred eEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccc
Q 014210 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (429)
Q Consensus 233 ~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~ 312 (429)
..++||||+. |+|.+.+......+++..+..++.|++.||.|||+.+++||||||+|||+ +.++.+||+|||++..
T Consensus 89 ~~~lv~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~---~~~~~~kl~dfg~~~~ 164 (308)
T cd06634 89 TAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILL---SEPGLVKLGDFGSASI 164 (308)
T ss_pred eeEEEEEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEE---CCCCcEEECCccccee
Confidence 9999999996 58888776666779999999999999999999999999999999999999 6778899999999876
Q ss_pred cCCCccccccccCCcccCccccc----CCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCC
Q 014210 313 VRPDERLNDIVGSAYYVAPEVLH----RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSL 388 (429)
Q Consensus 313 ~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 388 (429)
.... ....++..|+|||++. +.++.++|||||||++|+|++|..||...........+...... ......+
T Consensus 165 ~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~ 239 (308)
T cd06634 165 MAPA---NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESP--ALQSGHW 239 (308)
T ss_pred ecCc---ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCC--CcCcccc
Confidence 5432 2456889999999864 45788999999999999999999999776655444444433221 1112357
Q ss_pred CHHHHHHHHHhcccCccCcCCHHHHHhhHhhhccc
Q 014210 389 SSEARDFVKRLLNKDPRKRLTAAQALSELLICYQS 423 (429)
Q Consensus 389 s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~~ 423 (429)
+.++.+||++||+.+|++||++.+++.|+|+....
T Consensus 240 ~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~~ 274 (308)
T cd06634 240 SEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRER 274 (308)
T ss_pred cHHHHHHHHHHhhCCcccCCCHHHHhhCccccccC
Confidence 88999999999999999999999999999987653
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-42 Score=308.04 Aligned_cols=254 Identities=25% Similarity=0.396 Sum_probs=207.9
Q ss_pred cccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeC
Q 014210 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (429)
Q Consensus 152 ~~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~ 231 (429)
...++|++.++||+|||+.||+++... ++..+|+|.+..+ ..+.++...+|++..++++ |||+++++++...+
T Consensus 18 In~~Ryri~~~LgeGGfsfv~LV~~~s---~~~~YAlKkI~c~---~~~~~e~~~rEid~~rkf~-s~~vl~l~dh~l~~ 90 (302)
T KOG2345|consen 18 INNKRYRIQRLLGEGGFSFVDLVKGLS---TGHLYALKKILCH---SQEDIEEALREIDNHRKFN-SPNVLRLVDHQLRE 90 (302)
T ss_pred EcCceEEEeeeecCCCceeeeeecccC---cccchhhheeecc---chHHHHHHHHHHHHHHhhC-CcchHHHHHHHHHh
Confidence 346899999999999999999998444 6899999998553 4567788999999999999 99999999987644
Q ss_pred C-----eEEEEEEecCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHcC--ceeccCCCCcEEEeecCCCce
Q 014210 232 D-----NVYVVMELCEGGELLDRILSR---GGKYTEDDAKAVMIQILNVVAFCHLQG--VVHRDLKPENFLFTTKDENSV 301 (429)
Q Consensus 232 ~-----~~~lv~E~~~ggsL~~~i~~~---~~~l~~~~~~~i~~qi~~gL~~LH~~~--iiHrDIKp~NILl~~~~~~~~ 301 (429)
. ..||++.|...|+|++.|... +..+++.++..|+.+|++||++||+.. +.||||||.|||+ .+.+.
T Consensus 91 ~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILl---s~~~~ 167 (302)
T KOG2345|consen 91 EKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILL---SDSGL 167 (302)
T ss_pred hccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEe---cCCCc
Confidence 3 499999999999999998653 347999999999999999999999998 9999999999999 55788
Q ss_pred EEEeecCCccccCCCcc----------ccccccCCcccCccccc----CCCCCcccHHHHHHHHHHHHcCCCCCCCCChH
Q 014210 302 LKAIDFGLSDFVRPDER----------LNDIVGSAYYVAPEVLH----RSYSTEADVWSIGVIAYILLCGSRPFWARTES 367 (429)
Q Consensus 302 vkL~DFGla~~~~~~~~----------~~~~~gt~~y~aPE~~~----~~~~~~sDiwSlGvll~elltg~~Pf~~~~~~ 367 (429)
++|.|||.+....-.-. ......|..|+|||.+. ...+.++|||||||+||+|+.|..||+..-..
T Consensus 168 ~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~ 247 (302)
T KOG2345|consen 168 PVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQ 247 (302)
T ss_pred eEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhc
Confidence 99999999876431110 11234788999999986 24788999999999999999999999543222
Q ss_pred H--HHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhH
Q 014210 368 G--IFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSEL 417 (429)
Q Consensus 368 ~--~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~ 417 (429)
+ +..++......++... .+++.+.+||+.||+.||.+||++.+++.+.
T Consensus 248 GgSlaLAv~n~q~s~P~~~--~yse~l~~lik~mlqvdP~qRP~i~~ll~~~ 297 (302)
T KOG2345|consen 248 GGSLALAVQNAQISIPNSS--RYSEALHQLIKSMLQVDPNQRPTIPELLSKL 297 (302)
T ss_pred CCeEEEeeeccccccCCCC--CccHHHHHHHHHHhcCCcccCCCHHHHHHHH
Confidence 1 1223344444444443 4899999999999999999999999999875
|
|
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=312.81 Aligned_cols=248 Identities=24% Similarity=0.378 Sum_probs=204.4
Q ss_pred cCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~ 233 (429)
.++|++.++||+|+||.||++.... +..+|+|++..... ..+.+.+|+.+++++. |+||+++++++. .+.
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~----~~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~-h~~i~~~~~~~~-~~~ 74 (260)
T cd05069 5 RESLRLDVKLGQGCFGEVWMGTWNG----TTKVAIKTLKPGTM----MPEAFLQEAQIMKKLR-HDKLVPLYAVVS-EEP 74 (260)
T ss_pred hHHeeeeeeecCcCCCeEEEEEEcC----CceEEEEEcccCCc----cHHHHHHHHHHHHhCC-CCCeeeEEEEEc-CCC
Confidence 3679999999999999999997654 34699998754322 2356889999999998 999999999875 456
Q ss_pred EEEEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccc
Q 014210 234 VYVVMELCEGGELLDRILSRG-GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (429)
Q Consensus 234 ~~lv~E~~~ggsL~~~i~~~~-~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~ 312 (429)
.+++|||+++++|.+++.... ..+++..+..++.||+.||.|||+.||+|+||||+||++ ++++.+||+|||++..
T Consensus 75 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill---~~~~~~~l~dfg~~~~ 151 (260)
T cd05069 75 IYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILV---GDNLVCKIADFGLARL 151 (260)
T ss_pred cEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEE---cCCCeEEECCCccceE
Confidence 899999999999999886543 358999999999999999999999999999999999999 7788999999999976
Q ss_pred cCCCcc--ccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCC
Q 014210 313 VRPDER--LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSL 388 (429)
Q Consensus 313 ~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 388 (429)
...... .....++..|+|||++. +.++.++||||||+++|||++ |..||......+....+..... . .....+
T Consensus 152 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~-~--~~~~~~ 228 (260)
T cd05069 152 IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYR-M--PCPQGC 228 (260)
T ss_pred ccCCcccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-C--CCCccc
Confidence 543321 12234667899999876 568899999999999999999 9999988777766665544321 1 122367
Q ss_pred CHHHHHHHHHhcccCccCcCCHHHHHhhH
Q 014210 389 SSEARDFVKRLLNKDPRKRLTAAQALSEL 417 (429)
Q Consensus 389 s~~~~~li~~~L~~dP~~Rps~~~iL~~~ 417 (429)
+.++.+||++||.+||++||+++++++.+
T Consensus 229 ~~~~~~li~~~l~~~p~~Rp~~~~i~~~l 257 (260)
T cd05069 229 PESLHELMKLCWKKDPDERPTFEYIQSFL 257 (260)
T ss_pred CHHHHHHHHHHccCCcccCcCHHHHHHHH
Confidence 89999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=292.24 Aligned_cols=260 Identities=30% Similarity=0.504 Sum_probs=223.7
Q ss_pred CceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeE
Q 014210 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (429)
Q Consensus 155 ~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~ 234 (429)
.+|...++||+|.||+||+++.++ +++.||+|++..+...+. .-....+|+.+++.|+ |.|||++++....+..+
T Consensus 2 ~~ydkmekigegtygtvfkarn~~---t~eivalkrvrlddddeg-vpssalreicllkelk-hknivrl~dvlhsdkkl 76 (292)
T KOG0662|consen 2 QKYDKMEKIGEGTYGTVFKARNRE---THEIVALKRVRLDDDDEG-VPSSALREICLLKELK-HKNIVRLHDVLHSDKKL 76 (292)
T ss_pred cchHHHHhhcCCcceeeEecccCC---ccceEEEEEEeccCCCCC-CcHHHHHHHHHHHHhh-hcceeehhhhhccCcee
Confidence 357778999999999999999777 689999999876543332 2245679999999999 99999999999999999
Q ss_pred EEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccccC
Q 014210 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (429)
Q Consensus 235 ~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~ 314 (429)
-+|+|||+. +|..++..-++.++.+.++.++.|+++||.|+|++++.|||+||.|.|| +.+|.+||+|||+++.+.
T Consensus 77 tlvfe~cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnlli---n~ngelkladfglarafg 152 (292)
T KOG0662|consen 77 TLVFEFCDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLI---NRNGELKLADFGLARAFG 152 (292)
T ss_pred EEeHHHhhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEe---ccCCcEEecccchhhhcC
Confidence 999999965 8999998889999999999999999999999999999999999999999 788899999999998775
Q ss_pred CCc-cccccccCCcccCcccccC--CCCCcccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCC---
Q 014210 315 PDE-RLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPS--- 387 (429)
Q Consensus 315 ~~~-~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlGvll~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~--- 387 (429)
-.- -....+-|.+|.+|+++-+ -|++..|+||-||++.|+.. |+..|.+....+.+..|.+.-....+..||.
T Consensus 153 ipvrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~ 232 (292)
T KOG0662|consen 153 IPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTK 232 (292)
T ss_pred CceEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCcccc
Confidence 332 2345678999999999875 48999999999999999986 7777888888888888887666666666653
Q ss_pred ----------------------CCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhccc
Q 014210 388 ----------------------LSSEARDFVKRLLNKDPRKRLTAAQALSELLICYQS 423 (429)
Q Consensus 388 ----------------------~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~~ 423 (429)
++..-+||++.+|..+|.+|.+++.+|+|++|...+
T Consensus 233 lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~s 290 (292)
T KOG0662|consen 233 LPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDFS 290 (292)
T ss_pred CCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCccccccC
Confidence 234568999999999999999999999999987643
|
|
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=310.81 Aligned_cols=251 Identities=28% Similarity=0.436 Sum_probs=210.0
Q ss_pred eeEeceeeccCceEEEEEEEecCc-ccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEE
Q 014210 157 YELGEEVGRGHFGYTCAAKFKKGE-LKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVY 235 (429)
Q Consensus 157 y~~~~~IG~G~fg~V~~~~~~~~~-~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~~ 235 (429)
+++.+.||.|+||.||+++..... ..+..||+|++.... .....+.+.+|+.+++.+. |+||+++++++.+.+..+
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~ 77 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDA--DEQQIEEFLREARIMRKLD-HPNIVKLLGVCTEEEPLM 77 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCC--ChHHHHHHHHHHHHHHhcC-CCchheEEEEEcCCCeeE
Confidence 357789999999999999877531 234889999986542 2235678999999999996 999999999999999999
Q ss_pred EEEEecCCCcHHHHHHhcCCC-CCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccccC
Q 014210 236 VVMELCEGGELLDRILSRGGK-YTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (429)
Q Consensus 236 lv~E~~~ggsL~~~i~~~~~~-l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~ 314 (429)
++|||+++++|.+++...... +++..+..++.||+.||.|||+.|++|+||||+||++ +.++.+||+|||++....
T Consensus 78 ~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~---~~~~~~~l~dfg~~~~~~ 154 (258)
T smart00219 78 IVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLV---GENLVVKISDFGLSRDLY 154 (258)
T ss_pred EEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEE---ccCCeEEEcccCCceecc
Confidence 999999999999988665444 9999999999999999999999999999999999999 778899999999997765
Q ss_pred CCcccc--ccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCH
Q 014210 315 PDERLN--DIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLSS 390 (429)
Q Consensus 315 ~~~~~~--~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 390 (429)
...... ...++..|+|||.+. ..++.++||||||+++++|++ |+.||........+..+........ ...++.
T Consensus 155 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~ 231 (258)
T smart00219 155 DDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLPK---PENCPP 231 (258)
T ss_pred cccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCC---CCcCCH
Confidence 442222 233678999999885 468999999999999999998 8899988777777766655443222 234889
Q ss_pred HHHHHHHHhcccCccCcCCHHHHHhh
Q 014210 391 EARDFVKRLLNKDPRKRLTAAQALSE 416 (429)
Q Consensus 391 ~~~~li~~~L~~dP~~Rps~~~iL~~ 416 (429)
++.+++.+||..||++|||+.+++..
T Consensus 232 ~~~~~i~~~l~~~p~~Rpt~~~ll~~ 257 (258)
T smart00219 232 EIYKLMLQCWAEDPEDRPTFSELVEI 257 (258)
T ss_pred HHHHHHHHHCcCChhhCcCHHHHHhh
Confidence 99999999999999999999999874
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-41 Score=324.29 Aligned_cols=257 Identities=30% Similarity=0.455 Sum_probs=206.5
Q ss_pred cCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCC-
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD- 232 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~- 232 (429)
.++|++.++||+|+||.||+|..+. +|+.||||++....... .....+.+|++++++++ |+||+++++++.+..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~---~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~ 81 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIK---TGRVVALKKILMHNEKD-GFPITALREIKILKKLK-HPNVVPLIDMAVERPD 81 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECC---CCcEEEEEEEEeccCCC-CcchhHHHHHHHHHhcC-CCCccchhhheecccc
Confidence 5799999999999999999998766 58899999986543222 22245678999999998 999999999875433
Q ss_pred -------eEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEe
Q 014210 233 -------NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAI 305 (429)
Q Consensus 233 -------~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~ 305 (429)
.+++||||+.+ +|...+......+++..++.++.||++||.|||++||+|+||||+|||+ ++++.+||+
T Consensus 82 ~~~~~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~---~~~~~~~l~ 157 (311)
T cd07866 82 KSKRKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILI---DNQGILKIA 157 (311)
T ss_pred cccccCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---CCCCCEEEC
Confidence 47999999965 7777776666689999999999999999999999999999999999999 778899999
Q ss_pred ecCCccccCCCcc------------ccccccCCcccCcccccC--CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHH
Q 014210 306 DFGLSDFVRPDER------------LNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFR 371 (429)
Q Consensus 306 DFGla~~~~~~~~------------~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~ 371 (429)
|||++........ .....++..|+|||++.+ .++.++||||||+++|||++|+.||...+......
T Consensus 158 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~ 237 (311)
T cd07866 158 DFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLH 237 (311)
T ss_pred cCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 9999876543221 123457888999998753 47889999999999999999999998777665555
Q ss_pred HHHhcCCCCCC--------------------------CCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhh
Q 014210 372 AVLKADPSFDE--------------------------APWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLI 419 (429)
Q Consensus 372 ~i~~~~~~~~~--------------------------~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~ 419 (429)
.+......... ..+..+.+++.+||.+||+.||++||++.+++.|+||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 238 LIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred HHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 44432111000 0112455788999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-40 Score=312.12 Aligned_cols=253 Identities=26% Similarity=0.461 Sum_probs=209.0
Q ss_pred CceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCC--cCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeC-
Q 014210 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHK--MTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT- 231 (429)
Q Consensus 155 ~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~--~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~- 231 (429)
.+|++.+.||+|+||.||+++... +|+.||+|++.... .........+.+|++++++++ |+||+++++++.+.
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~---~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~-h~~i~~~~~~~~~~~ 77 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDAD---TGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR-HDRIVQYYGCLRDPE 77 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcC---CCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcC-CCCcceEEEEEEcCC
Confidence 479999999999999999998765 58999999875422 123455678899999999998 99999999998764
Q ss_pred -CeEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCc
Q 014210 232 -DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS 310 (429)
Q Consensus 232 -~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla 310 (429)
+..+++|||+++++|.+++... +.+++..++.++.||+.||.|||+.||+|+||||+||++ +.++.++|+|||++
T Consensus 78 ~~~~~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i---~~~~~~~l~dfg~~ 153 (264)
T cd06653 78 EKKLSIFVEYMPGGSIKDQLKAY-GALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILR---DSAGNVKLGDFGAS 153 (264)
T ss_pred CCEEEEEEEeCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEE---cCCCCEEECccccc
Confidence 4688999999999999987543 458999999999999999999999999999999999999 67788999999998
Q ss_pred cccCCC----ccccccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCC
Q 014210 311 DFVRPD----ERLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPW 385 (429)
Q Consensus 311 ~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 385 (429)
...... .......++..|+|||++.+ .++.++|||||||++|+|++|+.||...........+.... ......
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~~p 231 (264)
T cd06653 154 KRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQP--TKPMLP 231 (264)
T ss_pred cccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCC--CCCCCC
Confidence 765321 12234568899999998864 58899999999999999999999998766555554443322 112223
Q ss_pred CCCCHHHHHHHHHhcccCccCcCCHHHHHhhHh
Q 014210 386 PSLSSEARDFVKRLLNKDPRKRLTAAQALSELL 418 (429)
Q Consensus 386 ~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~ 418 (429)
..+++++.++|++||. ++.+||++.+++.|+|
T Consensus 232 ~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~ 263 (264)
T cd06653 232 DGVSDACRDFLKQIFV-EEKRRPTAEFLLRHPF 263 (264)
T ss_pred cccCHHHHHHHHHHhc-CcccCccHHHHhcCCC
Confidence 4688999999999999 5799999999999987
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=326.70 Aligned_cols=255 Identities=19% Similarity=0.303 Sum_probs=201.7
Q ss_pred eceeecc--CceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEE
Q 014210 160 GEEVGRG--HFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVV 237 (429)
Q Consensus 160 ~~~IG~G--~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~~lv 237 (429)
..+||+| +||.||+++... .|+.||||++..... .....+.+.+|+.+++.++ |+||++++++|..++..++|
T Consensus 3 ~~~ig~g~~~~~~v~~a~~~~---~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~~~~l~-h~niv~~~~~~~~~~~~~~v 77 (328)
T cd08226 3 QVEIGRGFCNLTSVYLARHTP---TGTLVTVRITDLENC-TEEHLKALQNEVVLSHFFR-HPNIMTSWTVFTTGSWLWVI 77 (328)
T ss_pred HHHhCCcccCceeEEEEEEcC---CCcEEEEEEeccccC-CHHHHHHHHHHHHHHHhCC-CCCcceEeeeEecCCceEEE
Confidence 3567777 889999998765 589999999865432 3345578899999999998 99999999999999999999
Q ss_pred EEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccccCCC
Q 014210 238 MELCEGGELLDRILSRG-GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPD 316 (429)
Q Consensus 238 ~E~~~ggsL~~~i~~~~-~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~ 316 (429)
|||+.+++|.+++.... ..+++..+..++.||+.||+|||+.||+||||||+|||+ +.++.+|++||+.+......
T Consensus 78 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill---~~~~~~~~~~~~~~~~~~~~ 154 (328)
T cd08226 78 SPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILI---SGDGLVSLSGLSHLYSLVRN 154 (328)
T ss_pred EecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---eCCCcEEEechHHHhhhhcc
Confidence 99999999998876543 358999999999999999999999999999999999999 66788999999865332211
Q ss_pred ccc--------cccccCCcccCcccccC---CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCC----
Q 014210 317 ERL--------NDIVGSAYYVAPEVLHR---SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFD---- 381 (429)
Q Consensus 317 ~~~--------~~~~gt~~y~aPE~~~~---~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~---- 381 (429)
... ....++..|+|||++.+ .++.++|||||||++|||++|+.||............+...+..+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (328)
T cd08226 155 GQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDIT 234 (328)
T ss_pred CccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCcccc
Confidence 110 11234567999999864 378899999999999999999999977655444333332211100
Q ss_pred ---------------------------------------CCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhcc
Q 014210 382 ---------------------------------------EAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLICYQ 422 (429)
Q Consensus 382 ---------------------------------------~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~ 422 (429)
......++.++.+||++||+.||++|||+.++|+|+||...
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~ 314 (328)
T cd08226 235 TFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQV 314 (328)
T ss_pred ccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHH
Confidence 00012356789999999999999999999999999999754
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-41 Score=330.71 Aligned_cols=257 Identities=31% Similarity=0.504 Sum_probs=207.4
Q ss_pred ccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeC-
Q 014210 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT- 231 (429)
Q Consensus 153 ~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~- 231 (429)
+..+|++.+.||.|+||.||+|.... +|+.||+|++.... ....+.+.+|++++++++ |+||+++++++...
T Consensus 3 ~~~~y~~~~~Lg~g~~g~vy~~~~~~---~~~~v~iK~i~~~~---~~~~~~~~~Ei~~l~~l~-h~~i~~~~~~~~~~~ 75 (342)
T cd07854 3 LGSRYMDLRPLGCGSNGLVFSAVDSD---CDKRVAVKKIVLTD---PQSVKHALREIKIIRRLD-HDNIVKVYEVLGPSG 75 (342)
T ss_pred cCcceEEEEEecCCCCEEEEEEEECC---CCcEEEEEEEecCC---CchHHHHHHHHHHHHhcC-CCcchhhHhhhcccc
Confidence 35799999999999999999998765 58999999985543 244567889999999997 99999999876544
Q ss_pred -------------CeEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCC
Q 014210 232 -------------DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDE 298 (429)
Q Consensus 232 -------------~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~ 298 (429)
...++||||++ ++|.+++. .+.+++..++.++.||+.||.|||+.||+||||||+||+++ .+
T Consensus 76 ~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~--~~ 150 (342)
T cd07854 76 SDLTEDVGSLTELNSVYIVQEYME-TDLANVLE--QGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFIN--TE 150 (342)
T ss_pred cccccccccccccceEEEEeeccc-ccHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEc--CC
Confidence 35799999997 58887663 35689999999999999999999999999999999999994 35
Q ss_pred CceEEEeecCCccccCCCcc----ccccccCCcccCccccc--CCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHH
Q 014210 299 NSVLKAIDFGLSDFVRPDER----LNDIVGSAYYVAPEVLH--RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRA 372 (429)
Q Consensus 299 ~~~vkL~DFGla~~~~~~~~----~~~~~gt~~y~aPE~~~--~~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~ 372 (429)
++.+||+|||++........ .....++..|+|||++. ..++.++|||||||++|+|++|+.||...........
T Consensus 151 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~ 230 (342)
T cd07854 151 DLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQL 230 (342)
T ss_pred CceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 56799999999876532211 12346788999999765 3578899999999999999999999987766555554
Q ss_pred HHhcCCCCC----------------------C----CCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhc
Q 014210 373 VLKADPSFD----------------------E----APWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLICY 421 (429)
Q Consensus 373 i~~~~~~~~----------------------~----~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~ 421 (429)
++...+... . ...+.++.++.+||.+||+.||++||++.++|.|+||+.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~ 305 (342)
T cd07854 231 ILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSC 305 (342)
T ss_pred HHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCcccc
Confidence 443221100 0 012357889999999999999999999999999999973
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=327.85 Aligned_cols=264 Identities=27% Similarity=0.432 Sum_probs=211.6
Q ss_pred ccCceeE-eceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHH-----------HHHHHHHHHHHHHHhcCCCC
Q 014210 153 FANKYEL-GEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAI-----------AIEDVRREVKILRALTGHNN 220 (429)
Q Consensus 153 ~~~~y~~-~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~-----------~~~~~~~Ei~il~~l~~h~n 220 (429)
+.++|.. .+.||.|+||.||+|.... .|+.||||++......... ....+.+|+++++++. |+|
T Consensus 6 ~~~ry~~~~~~ig~G~~g~vy~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~ 81 (335)
T PTZ00024 6 ISERYIQKGAHLGEGTYGKVEKAYDTL---TGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIK-HEN 81 (335)
T ss_pred cccchhhhhhcccCCCceeEEEEEECC---CCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCC-Ccc
Confidence 4567765 5779999999999998765 5899999998654322210 1124779999999998 999
Q ss_pred cceEEEEEEeCCeEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCc
Q 014210 221 LVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENS 300 (429)
Q Consensus 221 Iv~l~~~~~~~~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~ 300 (429)
|+++++++..++..++||||++ ++|.+++. ....+++..+..++.||+.||.|||+.||+|+||||+||++ +.++
T Consensus 82 iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~-~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill---~~~~ 156 (335)
T PTZ00024 82 IMGLVDVYVEGDFINLVMDIMA-SDLKKVVD-RKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFI---NSKG 156 (335)
T ss_pred eeeeeEEEecCCcEEEEEeccc-cCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEE---CCCC
Confidence 9999999999999999999997 58888774 44579999999999999999999999999999999999999 6788
Q ss_pred eEEEeecCCccccCCC---------------ccccccccCCcccCcccccC--CCCCcccHHHHHHHHHHHHcCCCCCCC
Q 014210 301 VLKAIDFGLSDFVRPD---------------ERLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWA 363 (429)
Q Consensus 301 ~vkL~DFGla~~~~~~---------------~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlGvll~elltg~~Pf~~ 363 (429)
.+||+|||++...... .......++..|+|||++.+ .++.++||||||+++|||++|..||..
T Consensus 157 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~ 236 (335)
T PTZ00024 157 ICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPG 236 (335)
T ss_pred CEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 9999999998765411 11123356888999998864 478899999999999999999999988
Q ss_pred CChHHHHHHHHhcCCCCCCC------------------------CCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhh
Q 014210 364 RTESGIFRAVLKADPSFDEA------------------------PWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLI 419 (429)
Q Consensus 364 ~~~~~~~~~i~~~~~~~~~~------------------------~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~ 419 (429)
....+.+..+.......... ..+..+.++.+||++||+.||++||++.++|.|+||
T Consensus 237 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~ 316 (335)
T PTZ00024 237 ENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYF 316 (335)
T ss_pred CCHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCccc
Confidence 87766665554321111100 012457889999999999999999999999999999
Q ss_pred hcccee
Q 014210 420 CYQSYL 425 (429)
Q Consensus 420 ~~~~~~ 425 (429)
+.....
T Consensus 317 ~~~~~~ 322 (335)
T PTZ00024 317 KSDPLP 322 (335)
T ss_pred CCCCCC
Confidence 876543
|
|
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=311.50 Aligned_cols=248 Identities=27% Similarity=0.417 Sum_probs=208.4
Q ss_pred cCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~ 233 (429)
.++|++.++||+|+||.||++.... ++.||||.+..... ..+++.+|+.+++++. |+||+++++++.+...
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~----~~~~~vK~~~~~~~----~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~ 75 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNG----TTKVAVKTLKPGTM----SPEAFLQEAQIMKKLR-HDKLVQLYAVCSEEEP 75 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcC----CceEEEEEecCCcc----CHHHHHHHHHHHhhCC-CCCEeeeeeeeecCCc
Confidence 5789999999999999999998653 57799999875432 2356889999999998 9999999999999899
Q ss_pred EEEEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccc
Q 014210 234 VYVVMELCEGGELLDRILSRG-GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (429)
Q Consensus 234 ~~lv~E~~~ggsL~~~i~~~~-~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~ 312 (429)
.++||||+++++|.+++.... ..+++..+..++.||+.||.|||++||+|+||||+||++ +.++.+||+|||++..
T Consensus 76 ~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili---~~~~~~~l~d~g~~~~ 152 (261)
T cd05034 76 IYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILV---GENLVCKIADFGLARL 152 (261)
T ss_pred eEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEE---cCCCCEEECcccccee
Confidence 999999999999999887654 478999999999999999999999999999999999999 6788999999999876
Q ss_pred cCCCccc--cccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCC
Q 014210 313 VRPDERL--NDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSL 388 (429)
Q Consensus 313 ~~~~~~~--~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 388 (429)
....... ....++..|+|||.+. +.++.++||||||+++|+|++ |+.||........+..+...... ......
T Consensus 153 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~ 229 (261)
T cd05034 153 IEDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRM---PRPPNC 229 (261)
T ss_pred ccchhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC---CCCCCC
Confidence 6432211 1223456899999886 468889999999999999998 99999887777777766543221 112356
Q ss_pred CHHHHHHHHHhcccCccCcCCHHHHHhh
Q 014210 389 SSEARDFVKRLLNKDPRKRLTAAQALSE 416 (429)
Q Consensus 389 s~~~~~li~~~L~~dP~~Rps~~~iL~~ 416 (429)
+.++.+++.+||+.||++||++.++++-
T Consensus 230 ~~~~~~~i~~~l~~~p~~Rp~~~~l~~~ 257 (261)
T cd05034 230 PEELYDLMLQCWDKDPEERPTFEYLQSF 257 (261)
T ss_pred CHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence 8999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=318.90 Aligned_cols=254 Identities=34% Similarity=0.506 Sum_probs=209.2
Q ss_pred eeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEE
Q 014210 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYV 236 (429)
Q Consensus 157 y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~~l 236 (429)
|++.+.||+|+||.||+|.... +++.|+||++...... .......+|+..++++.+|+||+++++++.+++..++
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~---~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~l 75 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKE---TGELVAIKKMKKKFYS--WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYF 75 (283)
T ss_pred CeeheeeccCCceEEEEEEECC---CCcEEEEEEehhhccc--hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEE
Confidence 6788999999999999999765 4789999998654221 2223456799999999889999999999999999999
Q ss_pred EEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccccCC
Q 014210 237 VMELCEGGELLDRILSRG-GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP 315 (429)
Q Consensus 237 v~E~~~ggsL~~~i~~~~-~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~ 315 (429)
||||+ +++|.+++.... ..+++..+..++.|++.+|.|||++||+|+||+|+||++ +.++.++|+|||++.....
T Consensus 76 v~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i---~~~~~~~l~d~~~~~~~~~ 151 (283)
T cd07830 76 VFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLV---SGPEVVKIADFGLAREIRS 151 (283)
T ss_pred EEecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEE---cCCCCEEEeecccceeccC
Confidence 99999 779998886654 478999999999999999999999999999999999999 7788999999999987765
Q ss_pred CccccccccCCcccCccccc--CCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCC------------
Q 014210 316 DERLNDIVGSAYYVAPEVLH--RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFD------------ 381 (429)
Q Consensus 316 ~~~~~~~~gt~~y~aPE~~~--~~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~------------ 381 (429)
........++..|+|||++. ..++.++|+||||++++||++|+.||......+.+..+........
T Consensus 152 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd07830 152 RPPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLAS 231 (283)
T ss_pred CCCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhc
Confidence 54445567899999999875 3478899999999999999999999977766555444332111100
Q ss_pred --------------CCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhh
Q 014210 382 --------------EAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLI 419 (429)
Q Consensus 382 --------------~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~ 419 (429)
....+..+.++.+||++||+.||++||++.|++.|+||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 232 KLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred cccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 00112346889999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-41 Score=316.91 Aligned_cols=245 Identities=20% Similarity=0.280 Sum_probs=196.3
Q ss_pred ceeeccCceEEEEEEEecCc----ccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEE
Q 014210 161 EEVGRGHFGYTCAAKFKKGE----LKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYV 236 (429)
Q Consensus 161 ~~IG~G~fg~V~~~~~~~~~----~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~~l 236 (429)
+.||+|+||.||+|..+... .....||+|.+... .....+.+.+|+.+++.+. |+||+++++++..++..++
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~~~-h~~iv~~~~~~~~~~~~~l 76 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS---HRNYSESFFEAASMMSQLS-HKHLVLNYGVCVCGDESIM 76 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcch---hHHHHHHHHHHHHHHHhCC-CCChhheeeEEEeCCCcEE
Confidence 46999999999999875421 23456888887432 3344567889999999998 9999999999999999999
Q ss_pred EEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCC-----CceEEEeecCCcc
Q 014210 237 VMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDE-----NSVLKAIDFGLSD 311 (429)
Q Consensus 237 v~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~-----~~~vkL~DFGla~ 311 (429)
||||+++|+|.+++......+++..+..++.||+.||+|||+.||+||||||+|||++.++. ...+||+|||++.
T Consensus 77 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~ 156 (258)
T cd05078 77 VQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI 156 (258)
T ss_pred EEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEeccccccc
Confidence 99999999999998776667999999999999999999999999999999999999964322 1248999999986
Q ss_pred ccCCCccccccccCCcccCcccccC--CCCCcccHHHHHHHHHHHHcCC-CCCCCCChHHHHHHHHhcCCCCCCCCCCCC
Q 014210 312 FVRPDERLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGS-RPFWARTESGIFRAVLKADPSFDEAPWPSL 388 (429)
Q Consensus 312 ~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlGvll~elltg~-~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 388 (429)
..... ....++..|+|||++.+ .++.++||||||+++|||++|. .||......... .+.......+. ..
T Consensus 157 ~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~-~~~~~~~~~~~----~~ 228 (258)
T cd05078 157 TVLPK---EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKL-QFYEDRHQLPA----PK 228 (258)
T ss_pred ccCCc---hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHH-HHHHccccCCC----CC
Confidence 65432 23568889999999874 4788999999999999999995 565554443332 23333332222 35
Q ss_pred CHHHHHHHHHhcccCccCcCCHHHHHhhH
Q 014210 389 SSEARDFVKRLLNKDPRKRLTAAQALSEL 417 (429)
Q Consensus 389 s~~~~~li~~~L~~dP~~Rps~~~iL~~~ 417 (429)
+.++.+||.+||+.||++||+++++++.+
T Consensus 229 ~~~~~~li~~~l~~~p~~Rps~~~il~~l 257 (258)
T cd05078 229 WTELANLINQCMDYEPDFRPSFRAIIRDL 257 (258)
T ss_pred cHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 68899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-43 Score=371.23 Aligned_cols=257 Identities=32% Similarity=0.549 Sum_probs=221.5
Q ss_pred ccccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEe
Q 014210 151 KHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED 230 (429)
Q Consensus 151 ~~~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~ 230 (429)
....-+|.....||.|.||.||-+...+ +|...|||.+...... ......+.+|..++..++ |||+|++||+-..
T Consensus 1231 snV~~rWqrg~~Ig~G~fG~VYtavN~~---tGellAvKEI~iq~~~-~k~~~~i~eEm~vlE~ln-HpNlV~YyGVEvH 1305 (1509)
T KOG4645|consen 1231 SNVTFRWQRGNFIGGGTFGKVYTAVNLD---TGELLAVKEIKIQDSD-HKTFKLIAEEMKVLEGLN-HPNLVRYYGVEVH 1305 (1509)
T ss_pred ccceeeeccccccCCcceeeeEEeecCC---ccchhhhhhhhcCccc-cccCcchHHHHHHHHhcc-CccccccCceeec
Confidence 3455678899999999999999998666 6999999998765544 666788999999999999 9999999999999
Q ss_pred CCeEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCc
Q 014210 231 TDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS 310 (429)
Q Consensus 231 ~~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla 310 (429)
.+.++|.||||+||+|.+.+ ++++..++...+.+..|++.|+.|||+.|||||||||+||+| +.+|.+|++|||.|
T Consensus 1306 Rekv~IFMEyC~~GsLa~ll-~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~L---d~~g~iK~~DFGsa 1381 (1509)
T KOG4645|consen 1306 REKVYIFMEYCEGGSLASLL-EHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILL---DFNGLIKYGDFGSA 1381 (1509)
T ss_pred HHHHHHHHHHhccCcHHHHH-HhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceee---ecCCcEEeecccce
Confidence 99999999999999999854 677778999999999999999999999999999999999999 78889999999999
Q ss_pred cccCCCc-----cccccccCCcccCcccccC----CCCCcccHHHHHHHHHHHHcCCCCCCCCChH-HHHHHHHh-cCCC
Q 014210 311 DFVRPDE-----RLNDIVGSAYYVAPEVLHR----SYSTEADVWSIGVIAYILLCGSRPFWARTES-GIFRAVLK-ADPS 379 (429)
Q Consensus 311 ~~~~~~~-----~~~~~~gt~~y~aPE~~~~----~~~~~sDiwSlGvll~elltg~~Pf~~~~~~-~~~~~i~~-~~~~ 379 (429)
....... ..+..+||+.|||||++.+ +...++|||||||+++||+||+.||.....+ .++..+.. ..|.
T Consensus 1382 ~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq 1461 (1509)
T KOG4645|consen 1382 VKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQ 1461 (1509)
T ss_pred eEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCC
Confidence 8765432 3456789999999999864 4677899999999999999999999765544 45555544 3455
Q ss_pred CCCCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhh
Q 014210 380 FDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLIC 420 (429)
Q Consensus 380 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~ 420 (429)
+++ .++.+..|||.+||..||++|+++.|+|.|.|-.
T Consensus 1462 ~P~----~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~ 1498 (1509)
T KOG4645|consen 1462 IPE----RLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGK 1498 (1509)
T ss_pred Cch----hhhHhHHHHHHHHHhcCchhhhHHHHHHHhhccc
Confidence 555 3999999999999999999999999999998754
|
|
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-40 Score=314.12 Aligned_cols=256 Identities=21% Similarity=0.295 Sum_probs=209.9
Q ss_pred cCceeEeceeeccCceEEEEEEEecCc-ccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEe-C
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGE-LKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED-T 231 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~-~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~-~ 231 (429)
.++|++.+.||+|+||.||+|...... ..+..|++|++... ......+.+.+|+.+++++. |+||+++++++.+ +
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~ 81 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH--ASEIQVTLLLQESCLLYGLS-HQNILPILHVCIEDG 81 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC--CCHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEecCC
Confidence 578999999999999999999877522 23688999998643 45556678899999999997 9999999998776 4
Q ss_pred CeEEEEEEecCCCcHHHHHHhcC-------CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEE
Q 014210 232 DNVYVVMELCEGGELLDRILSRG-------GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKA 304 (429)
Q Consensus 232 ~~~~lv~E~~~ggsL~~~i~~~~-------~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL 304 (429)
...++++||+++++|.+++.... ..+++..++.++.||+.||+|||+.+++||||||+||++ ++++.+||
T Consensus 82 ~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~---~~~~~~kl 158 (280)
T cd05043 82 EPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVI---DEELQVKI 158 (280)
T ss_pred CCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEE---cCCCcEEE
Confidence 67899999999999999886532 458999999999999999999999999999999999999 67789999
Q ss_pred eecCCccccCCCccc---cccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCC
Q 014210 305 IDFGLSDFVRPDERL---NDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPS 379 (429)
Q Consensus 305 ~DFGla~~~~~~~~~---~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~ellt-g~~Pf~~~~~~~~~~~i~~~~~~ 379 (429)
+|||+++.+...... ....++..|+|||++. ..++.++||||||+++|||++ |+.||......+....+.... .
T Consensus 159 ~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-~ 237 (280)
T cd05043 159 TDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGY-R 237 (280)
T ss_pred CCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCC-C
Confidence 999999865433221 2234567899999886 458899999999999999998 999998776655544443322 2
Q ss_pred CCCCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHh
Q 014210 380 FDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELL 418 (429)
Q Consensus 380 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~ 418 (429)
.. ....+++++.+++.+||+.||++||++.+++..+-
T Consensus 238 ~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 274 (280)
T cd05043 238 LA--QPINCPDELFAVMACCWALDPEERPSFSQLVQCLT 274 (280)
T ss_pred CC--CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHH
Confidence 21 22357899999999999999999999999997653
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=314.04 Aligned_cols=245 Identities=20% Similarity=0.245 Sum_probs=194.0
Q ss_pred ceeeccCceEEEEEEEecCc---------ccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeC
Q 014210 161 EEVGRGHFGYTCAAKFKKGE---------LKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (429)
Q Consensus 161 ~~IG~G~fg~V~~~~~~~~~---------~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~ 231 (429)
+.||+|+||.||+|...... .....|++|++... .......+.+|+.+++.+. ||||+++++++.++
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~---~~~~~~~~~~~~~~l~~l~-hp~iv~~~~~~~~~ 76 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPS---HRDISLAFFETASMMRQVS-HKHIVLLYGVCVRD 76 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChh---hhhHHHHHHHHHHHHHhCC-CCCEeeEEEEEecC
Confidence 46899999999999854311 13456899987543 2334457888999999998 99999999999999
Q ss_pred CeEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecC----CCceEEEeec
Q 014210 232 DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKD----ENSVLKAIDF 307 (429)
Q Consensus 232 ~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~----~~~~vkL~DF 307 (429)
...++||||+++++|..++......+++..++.++.||+.||+|||++||+||||||+|||+.... ....+|++||
T Consensus 77 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~ 156 (262)
T cd05077 77 VENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDP 156 (262)
T ss_pred CCCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence 999999999999999888766667899999999999999999999999999999999999995322 1124899999
Q ss_pred CCccccCCCccccccccCCcccCccccc--CCCCCcccHHHHHHHHHHHH-cCCCCCCCCChHHHHHHHHhcCCCCCCCC
Q 014210 308 GLSDFVRPDERLNDIVGSAYYVAPEVLH--RSYSTEADVWSIGVIAYILL-CGSRPFWARTESGIFRAVLKADPSFDEAP 384 (429)
Q Consensus 308 Gla~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~sDiwSlGvll~ell-tg~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 384 (429)
|++...... ....++..|+|||++. +.++.++|||||||++|||+ +|+.||......+... ....... .
T Consensus 157 g~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~-~~~~~~~----~ 228 (262)
T cd05077 157 GIPITVLSR---QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKER-FYEGQCM----L 228 (262)
T ss_pred CCCccccCc---ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHH-HHhcCcc----C
Confidence 998655322 2346788999999875 45889999999999999998 5888887655433322 2222211 1
Q ss_pred CCCCCHHHHHHHHHhcccCccCcCCHHHHHhhH
Q 014210 385 WPSLSSEARDFVKRLLNKDPRKRLTAAQALSEL 417 (429)
Q Consensus 385 ~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~ 417 (429)
....+.++.+||.+||+.||++||++.+|+++.
T Consensus 229 ~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 229 VTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred CCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 123568899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=319.21 Aligned_cols=254 Identities=33% Similarity=0.538 Sum_probs=211.3
Q ss_pred eeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEE
Q 014210 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYV 236 (429)
Q Consensus 157 y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~~l 236 (429)
|++.+.||.|++|.||++.... +|+.+++|++.... ........+.+|+.++++++ |+||+++++++.+++..++
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~---~~~~~~ik~~~~~~-~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~ 75 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKL---TGEIVAIKKIKLRF-ESEGIPKTALREIKLLKELN-HPNIIKLLDVFRHKGDLYL 75 (283)
T ss_pred CccceeeecCCCceEEEEEcCC---CCcEEEEEEecccc-ccchhHHHHHHHHHHHHHhc-CCCcchHHHhhccCCCEEE
Confidence 5778899999999999998765 58999999986543 22244567889999999998 9999999999999999999
Q ss_pred EEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccccCCC
Q 014210 237 VMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPD 316 (429)
Q Consensus 237 v~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~ 316 (429)
||||+++ +|.+++......+++..+..++.||+.||.|||+.||+|+||||+||++ +.++.+||+|||.+......
T Consensus 76 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili---~~~~~~~l~df~~~~~~~~~ 151 (283)
T cd05118 76 VFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLI---NTEGVLKLADFGLARSFGSP 151 (283)
T ss_pred EEeccCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEE---CCCCcEEEeeeeeeEecCCC
Confidence 9999975 8888887766789999999999999999999999999999999999999 67788999999998776544
Q ss_pred c-cccccccCCcccCcccccC--CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCC------------
Q 014210 317 E-RLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFD------------ 381 (429)
Q Consensus 317 ~-~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~------------ 381 (429)
. ......++..|+|||.+.+ .++.++||||||+++|+|++|+.||......+.+..+........
T Consensus 152 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd05118 152 VRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLAR 231 (283)
T ss_pred cccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhh
Confidence 3 2334568889999998763 578899999999999999999999977766555444432211100
Q ss_pred --------------CCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhh
Q 014210 382 --------------EAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLI 419 (429)
Q Consensus 382 --------------~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~ 419 (429)
...++.++.++.+||.+||+.||.+||++.+++.|+||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 232 NYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred hhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 01123578899999999999999999999999999996
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=327.67 Aligned_cols=260 Identities=30% Similarity=0.479 Sum_probs=209.5
Q ss_pred cccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeC
Q 014210 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (429)
Q Consensus 152 ~~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~ 231 (429)
.+.++|++.+.||+|+||.||+|.... +|+.+|||++.+.. ........+.+|+.+++++.+|+||+++++++...
T Consensus 4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~---~~~~~~vK~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~ 79 (337)
T cd07852 4 HILRKYEILQKLGKGAYGIVWKAIDRR---TKEVVALKKIFDAF-RNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAE 79 (337)
T ss_pred hhhhHHHHhHhhcCCCCeeEEEEEEcC---CCeEEEEEeecccc-CcchhhhhhhHHHHHHHHhcCCCCccceeeeeccC
Confidence 456889999999999999999998765 58899999885432 23334456778999999994499999999998654
Q ss_pred --CeEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCC
Q 014210 232 --DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGL 309 (429)
Q Consensus 232 --~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGl 309 (429)
...++||||++ ++|.+++... .+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||+
T Consensus 80 ~~~~~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill---~~~~~~kl~d~g~ 153 (337)
T cd07852 80 NDKDIYLVFEYME-TDLHAVIRAN--ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILL---NSDCRVKLADFGL 153 (337)
T ss_pred CCceEEEEecccc-cCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---cCCCcEEEeeccc
Confidence 36899999997 4888877443 78999999999999999999999999999999999999 7888999999999
Q ss_pred ccccCCCc------cccccccCCcccCccccc--CCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCC---
Q 014210 310 SDFVRPDE------RLNDIVGSAYYVAPEVLH--RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADP--- 378 (429)
Q Consensus 310 a~~~~~~~------~~~~~~gt~~y~aPE~~~--~~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~--- 378 (429)
+....... ......|+..|+|||++. ..++.++||||||+++|+|++|+.||...........+.....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~ 233 (337)
T cd07852 154 ARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPS 233 (337)
T ss_pred hhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 87654332 223456899999999875 3578899999999999999999999976655443333222111
Q ss_pred ------------------------CCCCCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhc
Q 014210 379 ------------------------SFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLICY 421 (429)
Q Consensus 379 ------------------------~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~ 421 (429)
.......+.++.++.+||.+||+.||++||++.+++.|+|++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~ 300 (337)
T cd07852 234 AEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQ 300 (337)
T ss_pred HHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhh
Confidence 1111122347899999999999999999999999999999965
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-40 Score=313.78 Aligned_cols=256 Identities=24% Similarity=0.357 Sum_probs=211.4
Q ss_pred CceeEeceeeccCceEEEEEEEecCc--ccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCC
Q 014210 155 NKYELGEEVGRGHFGYTCAAKFKKGE--LKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (429)
Q Consensus 155 ~~y~~~~~IG~G~fg~V~~~~~~~~~--~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~ 232 (429)
++|++.+.||+|+||.||+|+.+... ...+.|++|.+... ......+++.+|+++++++. |+||+++++++.+.+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~ 81 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKT--KDENLQSEFRRELDMFRKLS-HKNVVRLLGLCREAE 81 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCc--cchHHHHHHHHHHHHHHhcC-CcceeeeEEEECCCC
Confidence 67999999999999999999976432 24578999988543 23335678999999999998 999999999999999
Q ss_pred eEEEEEEecCCCcHHHHHHhcC--------CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEE
Q 014210 233 NVYVVMELCEGGELLDRILSRG--------GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKA 304 (429)
Q Consensus 233 ~~~lv~E~~~ggsL~~~i~~~~--------~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL 304 (429)
..++||||+++++|.+++.... ..+++..+..++.||+.||.|||+.||+||||||+|||+ +.++.++|
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili---~~~~~~~l 158 (275)
T cd05046 82 PHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLV---SSQREVKV 158 (275)
T ss_pred cceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEE---eCCCcEEE
Confidence 9999999999999999886543 158999999999999999999999999999999999999 67788999
Q ss_pred eecCCccccCCCc--cccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCC
Q 014210 305 IDFGLSDFVRPDE--RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSF 380 (429)
Q Consensus 305 ~DFGla~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~ 380 (429)
+|||++....... ......++..|+|||.+. +.++.++||||||+++|+|++ |..||........+..+.......
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~ 238 (275)
T cd05046 159 SLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLEL 238 (275)
T ss_pred cccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCC
Confidence 9999986543222 223445678899999876 457889999999999999998 889997766666666555433322
Q ss_pred CCCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHh
Q 014210 381 DEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELL 418 (429)
Q Consensus 381 ~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~ 418 (429)
. ....++.++.++|.+||+.||++||++.++++++.
T Consensus 239 ~--~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 239 P--VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred C--CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 2 12357899999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-40 Score=308.24 Aligned_cols=252 Identities=32% Similarity=0.565 Sum_probs=213.5
Q ss_pred ceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEE
Q 014210 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVY 235 (429)
Q Consensus 156 ~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~~ 235 (429)
+|++.+.||+|++|.||++.... .++.|++|.+...... ....+.+.+|++++.++. |+|++++++++.+.+..+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~---~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~ 75 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLE---TGDFVAIKQISLEKIK-EEALKSIMQEIDLLKNLK-HPNIVKYIGSIETSDSLY 75 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcC---CCcEEEEEEecccccC-HHHHHHHHHHHHHHHhCC-CCCccEEEEEEEeCCEEE
Confidence 58899999999999999998765 5789999999765432 345678999999999998 999999999999999999
Q ss_pred EEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccccCC
Q 014210 236 VVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP 315 (429)
Q Consensus 236 lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~ 315 (429)
++|||+++++|.+++... ..+++..++.++.|++.||.|||+.||+||||||+||++ +.++.+||+|||++.....
T Consensus 76 ~v~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i---~~~~~~~l~d~~~~~~~~~ 151 (254)
T cd06627 76 IILEYAENGSLRQIIKKF-GPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILT---TKDGVVKLADFGVATKLND 151 (254)
T ss_pred EEEecCCCCcHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEE---CCCCCEEEeccccceecCC
Confidence 999999999999887544 679999999999999999999999999999999999999 6678899999999977654
Q ss_pred Ccc-ccccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHH
Q 014210 316 DER-LNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEAR 393 (429)
Q Consensus 316 ~~~-~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 393 (429)
... .....++..|+|||.+.+ .++.++|||+||+++|+|++|+.||+................ ......++.++.
T Consensus 152 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~ 228 (254)
T cd06627 152 VSKDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDH---PPLPEGISPELK 228 (254)
T ss_pred CcccccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCC---CCCCCCCCHHHH
Confidence 332 234568899999998764 478899999999999999999999987665444444432221 122346789999
Q ss_pred HHHHHhcccCccCcCCHHHHHhhHhh
Q 014210 394 DFVKRLLNKDPRKRLTAAQALSELLI 419 (429)
Q Consensus 394 ~li~~~L~~dP~~Rps~~~iL~~~~~ 419 (429)
++|.+||..+|++||++.+++.++||
T Consensus 229 ~~i~~~l~~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 229 DFLMQCFQKDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred HHHHHHHhCChhhCcCHHHHhcCCCC
Confidence 99999999999999999999999886
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-40 Score=314.21 Aligned_cols=254 Identities=26% Similarity=0.401 Sum_probs=201.8
Q ss_pred CceeEeceeeccCceEEEEEEEec-CcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEe--C
Q 014210 155 NKYELGEEVGRGHFGYTCAAKFKK-GELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED--T 231 (429)
Q Consensus 155 ~~y~~~~~IG~G~fg~V~~~~~~~-~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~--~ 231 (429)
+.|++.+.||+|+||.||++..+. +..+++.||||++... .....+.+.+|+++++++. |+||+++++++.. .
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~ 79 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS---TAEHLRDFEREIEILKSLQ-HDNIVKYKGVCYSAGR 79 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC---CHHHHHHHHHHHHHHHhCC-CCCeeEEEEEEccCCC
Confidence 578999999999999999997642 2235889999998543 3455678899999999998 9999999998754 3
Q ss_pred CeEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCcc
Q 014210 232 DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (429)
Q Consensus 232 ~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~ 311 (429)
..+++||||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ ++++.+||+|||++.
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili---~~~~~~~l~dfg~~~ 156 (284)
T cd05081 80 RNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILV---ESENRVKIGDFGLTK 156 (284)
T ss_pred CceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEE---CCCCeEEECCCcccc
Confidence 46899999999999999987666679999999999999999999999999999999999999 778889999999998
Q ss_pred ccCCCccc----cccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHcCCCCCCCCChH---------------HHHH
Q 014210 312 FVRPDERL----NDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTES---------------GIFR 371 (429)
Q Consensus 312 ~~~~~~~~----~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~elltg~~Pf~~~~~~---------------~~~~ 371 (429)
........ ....++..|+|||++.+ .++.++||||||+++|||++|..++...... ..+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd05081 157 VLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLI 236 (284)
T ss_pred cccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHH
Confidence 76433221 11223456999998864 6888999999999999999988776432211 0111
Q ss_pred HHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhH
Q 014210 372 AVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSEL 417 (429)
Q Consensus 372 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~ 417 (429)
.++....... ....++.++.+||.+||..+|++|||+.+++..+
T Consensus 237 ~~~~~~~~~~--~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l 280 (284)
T cd05081 237 ELLKNNGRLP--APPGCPAEIYAIMKECWNNDPSQRPSFSELALQV 280 (284)
T ss_pred HHHhcCCcCC--CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHH
Confidence 1222221111 2246789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-40 Score=308.90 Aligned_cols=244 Identities=25% Similarity=0.375 Sum_probs=202.7
Q ss_pred ceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEe
Q 014210 161 EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMEL 240 (429)
Q Consensus 161 ~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~~lv~E~ 240 (429)
++||+|+||.||++.... ++.||+|++..... ....+.+.+|+++++++. |+||+++++++.+.+..++||||
T Consensus 1 ~~lg~g~~g~v~~~~~~~----~~~v~~K~~~~~~~--~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~v~e~ 73 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG----NTEVAVKTCRSTLP--PDLKRKFLQEAEILKQYD-HPNIVKLIGVCVQKQPIYIVMEL 73 (251)
T ss_pred CccccCCCceEEEEEEeC----CCcEEEEeccccCC--HHHHHHHHHHHHHHHhCC-CCCeEEEEEEEecCCCeEEEEEc
Confidence 479999999999998654 78999999865432 245678999999999998 99999999999999999999999
Q ss_pred cCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccccCCCccc-
Q 014210 241 CEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERL- 319 (429)
Q Consensus 241 ~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~- 319 (429)
+.+++|.+++......+++..+..++.+++.+|.|||+++++||||||+|||+ +.++.+||+|||++.........
T Consensus 74 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili---~~~~~~~l~d~g~~~~~~~~~~~~ 150 (251)
T cd05041 74 VPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLV---GENNVLKISDFGMSREEEGGIYTV 150 (251)
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEE---cCCCcEEEeeccccccccCCccee
Confidence 99999999987766778999999999999999999999999999999999999 67888999999998765422111
Q ss_pred --cccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHH
Q 014210 320 --NDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDF 395 (429)
Q Consensus 320 --~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 395 (429)
....++..|+|||++. +.++.++||||||+++|||++ |..||...........+.... .. .....++.++.+|
T Consensus 151 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~-~~--~~~~~~~~~~~~l 227 (251)
T cd05041 151 SDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGY-RM--PAPQLCPEEIYRL 227 (251)
T ss_pred ccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCC-CC--CCCccCCHHHHHH
Confidence 1123356799999876 468899999999999999998 889997776655555543322 11 1223578999999
Q ss_pred HHHhcccCccCcCCHHHHHhhH
Q 014210 396 VKRLLNKDPRKRLTAAQALSEL 417 (429)
Q Consensus 396 i~~~L~~dP~~Rps~~~iL~~~ 417 (429)
|.+||..+|.+||++.++++.+
T Consensus 228 i~~~l~~~p~~Rp~~~ell~~l 249 (251)
T cd05041 228 MLQCWAYDPENRPSFSEIYNEL 249 (251)
T ss_pred HHHHhccChhhCcCHHHHHHHh
Confidence 9999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=316.04 Aligned_cols=244 Identities=20% Similarity=0.243 Sum_probs=194.9
Q ss_pred eeeccCceEEEEEEEecC---------------------cccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCC
Q 014210 162 EVGRGHFGYTCAAKFKKG---------------------ELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNN 220 (429)
Q Consensus 162 ~IG~G~fg~V~~~~~~~~---------------------~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~n 220 (429)
+||+|+||.||+|..... ......|++|++... .......+.+|+.+++.++ |+|
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~---~~~~~~~~~~~~~~~~~l~-h~n 77 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPS---HRDIALAFFETASLMSQVS-HIH 77 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChH---HHHHHHHHHHHHHHHhcCC-CCC
Confidence 699999999999975421 112356899988543 2334456888999999998 999
Q ss_pred cceEEEEEEeCCeEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeec----
Q 014210 221 LVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTK---- 296 (429)
Q Consensus 221 Iv~l~~~~~~~~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~---- 296 (429)
|+++++++.+.+..++||||+++|+|..++....+.+++..+..++.||++||+|||++||+||||||+|||++..
T Consensus 78 iv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~ 157 (274)
T cd05076 78 LAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAE 157 (274)
T ss_pred eeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCccc
Confidence 9999999999999999999999999988886666789999999999999999999999999999999999999532
Q ss_pred CCCceEEEeecCCccccCCCccccccccCCcccCcccccC--CCCCcccHHHHHHHHHHHH-cCCCCCCCCChHHHHHHH
Q 014210 297 DENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILL-CGSRPFWARTESGIFRAV 373 (429)
Q Consensus 297 ~~~~~vkL~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlGvll~ell-tg~~Pf~~~~~~~~~~~i 373 (429)
+....+||+|||++...... ....++..|+|||.+.+ .++.++||||||+++|||+ +|+.||.......... .
T Consensus 158 ~~~~~~kl~d~g~~~~~~~~---~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~-~ 233 (274)
T cd05076 158 GTSPFIKLSDPGVSFTALSR---EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKER-F 233 (274)
T ss_pred CccceeeecCCccccccccc---cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHH-H
Confidence 12335899999987654322 22357788999998864 5789999999999999984 7999998766544433 2
Q ss_pred HhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhH
Q 014210 374 LKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSEL 417 (429)
Q Consensus 374 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~ 417 (429)
.......+. ..+.++.+||.+||+.+|++||++.++|.++
T Consensus 234 ~~~~~~~~~----~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 234 YEKKHRLPE----PSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred HHhccCCCC----CCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 222222222 3567899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=337.68 Aligned_cols=261 Identities=26% Similarity=0.478 Sum_probs=237.0
Q ss_pred cCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~ 233 (429)
..+++++..||-||||.|-++..... ...+|+|++++....+....+.+..|-.||..++ .+.||++|-.|.+...
T Consensus 419 l~dl~~iaTLGvGgFGRVELV~~~~~---~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~-s~fIvrLYrTfrd~ky 494 (732)
T KOG0614|consen 419 LSDLKRIATLGVGGFGRVELVKVNSQ---KATFALKILKKKHIVDTKQQEHVFSERNIMMECR-SDFIVRLYRTFRDSKY 494 (732)
T ss_pred hhhhhhhhhcccCccceEEEEEeccc---chHHHHHHHhHhhccchhHHHHHHhHHHHHHhcC-chHHHHHHHHhccchh
Confidence 35667788899999999999987763 2359999999988888888899999999999998 9999999999999999
Q ss_pred EEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCcccc
Q 014210 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (429)
Q Consensus 234 ~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~ 313 (429)
+|+.||-|-||.|+..+ ...+.+++..++.++..+++|++|||++|||+|||||+|.|+ |.+|-+||.|||+|+..
T Consensus 495 vYmLmEaClGGElWTiL-rdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllL---d~~Gy~KLVDFGFAKki 570 (732)
T KOG0614|consen 495 VYMLMEACLGGELWTIL-RDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLL---DNRGYLKLVDFGFAKKI 570 (732)
T ss_pred hhhhHHhhcCchhhhhh-hhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheee---ccCCceEEeehhhHHHh
Confidence 99999999999999866 455789999999999999999999999999999999999999 89999999999999999
Q ss_pred CCCccccccccCCcccCcccc-cCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHH
Q 014210 314 RPDERLNDIVGSAYYVAPEVL-HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEA 392 (429)
Q Consensus 314 ~~~~~~~~~~gt~~y~aPE~~-~~~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 392 (429)
..+..++++|||+.|.|||++ ++.++..+|+|+||+++|||++|.+||.+.+.-..++.|+++....... ..+++.+
T Consensus 571 ~~g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~P--r~I~k~a 648 (732)
T KOG0614|consen 571 GSGRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFP--RRITKTA 648 (732)
T ss_pred ccCCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcc--cccchhH
Confidence 999999999999999999965 5789999999999999999999999999999999999999876444332 4688999
Q ss_pred HHHHHHhcccCccCcCC-----HHHHHhhHhhhccce
Q 014210 393 RDFVKRLLNKDPRKRLT-----AAQALSELLICYQSY 424 (429)
Q Consensus 393 ~~li~~~L~~dP~~Rps-----~~~iL~~~~~~~~~~ 424 (429)
.+||+++...+|.+|.. +.+|-.|.||....|
T Consensus 649 ~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdw 685 (732)
T KOG0614|consen 649 TDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDW 685 (732)
T ss_pred HHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCCh
Confidence 99999999999999997 799999999988765
|
|
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=309.73 Aligned_cols=249 Identities=26% Similarity=0.418 Sum_probs=206.4
Q ss_pred ccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCC
Q 014210 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (429)
Q Consensus 153 ~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~ 232 (429)
..++|++.++||+|+||.||++.... +..+|+|.+... ....+.+.+|++++++++ |+||+++++++.+ .
T Consensus 4 ~~~~~~~~~~lg~g~~~~vy~~~~~~----~~~~~iK~~~~~----~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~-~ 73 (260)
T cd05073 4 PRESLKLEKKLGAGQFGEVWMATYNK----HTKVAVKTMKPG----SMSVEAFLAEANVMKTLQ-HDKLVKLHAVVTK-E 73 (260)
T ss_pred cccceeEEeEecCccceEEEEEEecC----CccEEEEecCCC----hhHHHHHHHHHHHHHhcC-CCCcceEEEEEcC-C
Confidence 35789999999999999999997544 567999987643 233567889999999998 9999999999887 7
Q ss_pred eEEEEEEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCcc
Q 014210 233 NVYVVMELCEGGELLDRILSR-GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (429)
Q Consensus 233 ~~~lv~E~~~ggsL~~~i~~~-~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~ 311 (429)
..+++|||+++++|.+++... ...+++..+..++.||+.||.|||+.|++||||||+||++ +.++.+||+|||++.
T Consensus 74 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i---~~~~~~~l~d~~~~~ 150 (260)
T cd05073 74 PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILV---SASLVCKIADFGLAR 150 (260)
T ss_pred CeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEE---cCCCcEEECCCccee
Confidence 789999999999999998654 4568999999999999999999999999999999999999 678899999999987
Q ss_pred ccCCCcc--ccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCC
Q 014210 312 FVRPDER--LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPS 387 (429)
Q Consensus 312 ~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 387 (429)
....... .....++..|+|||++. +.++.++||||||+++|+|++ |+.||...........+..... ......
T Consensus 151 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~ 227 (260)
T cd05073 151 VIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYR---MPRPEN 227 (260)
T ss_pred eccCCCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCC---CCCccc
Confidence 6543221 12234567799999886 458889999999999999998 9999988776666655544322 122246
Q ss_pred CCHHHHHHHHHhcccCccCcCCHHHHHhhH
Q 014210 388 LSSEARDFVKRLLNKDPRKRLTAAQALSEL 417 (429)
Q Consensus 388 ~s~~~~~li~~~L~~dP~~Rps~~~iL~~~ 417 (429)
++.++.+++.+||+.||++||++.+++..+
T Consensus 228 ~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L 257 (260)
T cd05073 228 CPEELYNIMMRCWKNRPEERPTFEYIQSVL 257 (260)
T ss_pred CCHHHHHHHHHHcccCcccCcCHHHHHHHH
Confidence 889999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=327.35 Aligned_cols=257 Identities=35% Similarity=0.552 Sum_probs=213.9
Q ss_pred ceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCC---
Q 014210 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD--- 232 (429)
Q Consensus 156 ~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~--- 232 (429)
+|++.+.||.|+||.||+|+... +|+.||||++.... ......+.+.+|+.+++.++ |+||+++++++.+.+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~---~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~ 75 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKR---TGRKVAIKKISNVF-DDLIDAKRILREIKLLRHLR-HENIIGLLDILRPPSPED 75 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCC---CCcEEEEEeecccc-ccchhhhhHHHHHHHHHhcC-CcchhhhhhhhcccCccc
Confidence 58999999999999999998665 58899999986532 22445567899999999998 999999999998775
Q ss_pred --eEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCc
Q 014210 233 --NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS 310 (429)
Q Consensus 233 --~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla 310 (429)
.+|++|||++ ++|.+++. ....+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.++|+|||++
T Consensus 76 ~~~~~lv~e~~~-~~l~~~l~-~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili---~~~~~~~L~dfg~~ 150 (330)
T cd07834 76 FNDVYIVTELME-TDLHKVIK-SPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILV---NSNCDLKICDFGLA 150 (330)
T ss_pred ccceEEEecchh-hhHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCCCEEEcccCce
Confidence 7899999997 47887764 44589999999999999999999999999999999999999 67789999999999
Q ss_pred cccCCCc----cccccccCCcccCcccccC--CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCC-
Q 014210 311 DFVRPDE----RLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEA- 383 (429)
Q Consensus 311 ~~~~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~- 383 (429)
....... ......++..|+|||++.+ .++.++||||||+++|+|++|+.||......+.+..+..........
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 230 (330)
T cd07834 151 RGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEED 230 (330)
T ss_pred EeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhH
Confidence 8765443 2344568899999998864 58889999999999999999999998877766665554422111110
Q ss_pred --------------------------CCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhcc
Q 014210 384 --------------------------PWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLICYQ 422 (429)
Q Consensus 384 --------------------------~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~ 422 (429)
..+.++.++.+||.+||++||++||++.+++.|+||...
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 295 (330)
T cd07834 231 LKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQL 295 (330)
T ss_pred hhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhh
Confidence 123468899999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=337.03 Aligned_cols=261 Identities=28% Similarity=0.484 Sum_probs=222.3
Q ss_pred CceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeE
Q 014210 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (429)
Q Consensus 155 ~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~ 234 (429)
.-|..++.||-|+||.|++++..+ +...||+|.+.+...........++.|-+||.... .+.||+||..|.+++.+
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvD---T~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEAD-n~WVVrLyySFQDkdnL 704 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVD---TRALYAMKTLRKADVLMRNQVAHVKAERDILAEAD-NEWVVRLYYSFQDKDNL 704 (1034)
T ss_pred cceEEEeeecccccceeEEEeecc---hhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcC-CcceEEEEEEeccCCce
Confidence 348889999999999999998666 46789999998887777777888999999999987 89999999999999999
Q ss_pred EEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccccC
Q 014210 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (429)
Q Consensus 235 ~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~ 314 (429)
|+||||++||++...|.+. +-+.|..++.++.++..|+++.|..|+|||||||+|||| |.+|++||+||||+.-++
T Consensus 705 YFVMdYIPGGDmMSLLIrm-gIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILI---DrdGHIKLTDFGLCTGfR 780 (1034)
T KOG0608|consen 705 YFVMDYIPGGDMMSLLIRM-GIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILI---DRDGHIKLTDFGLCTGFR 780 (1034)
T ss_pred EEEEeccCCccHHHHHHHh-ccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEE---ccCCceeeeeccccccce
Confidence 9999999999999977654 679999999999999999999999999999999999999 899999999999974321
Q ss_pred ---------CCcc----------------------------------ccccccCCcccCccccc-CCCCCcccHHHHHHH
Q 014210 315 ---------PDER----------------------------------LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVI 350 (429)
Q Consensus 315 ---------~~~~----------------------------------~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvl 350 (429)
.+.. ....+||+.|+|||++. ..|+.-+|+||.||+
T Consensus 781 WTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvi 860 (1034)
T KOG0608|consen 781 WTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVI 860 (1034)
T ss_pred eccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHH
Confidence 1110 01257999999999887 479999999999999
Q ss_pred HHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCcC---CHHHHHhhHhhhccce
Q 014210 351 AYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRL---TAAQALSELLICYQSY 424 (429)
Q Consensus 351 l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp---s~~~iL~~~~~~~~~~ 424 (429)
||||+.|+.||...+..+.-.++++-........--.+++|+.+||.++.+ ++++|. .++++..|+||..-+|
T Consensus 861 l~em~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc~-sad~RLGkng~d~vKaHpfFkgIDf 936 (1034)
T KOG0608|consen 861 LYEMLVGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLCC-SADSRLGKNGADQVKAHPFFKGIDF 936 (1034)
T ss_pred HHHHhhCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHhc-ChhhhhcccchhhhhcCccccccch
Confidence 999999999999988877666666554444444455799999999998654 678887 4678999999987654
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=339.29 Aligned_cols=253 Identities=34% Similarity=0.518 Sum_probs=214.4
Q ss_pred cccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeC
Q 014210 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (429)
Q Consensus 152 ~~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~ 231 (429)
.+.+.|++...+|.|+|+.|-.+.... +++..+||++.+.. .+..+|+.++....+|+||+++++.+.++
T Consensus 319 ~~~~~y~~~~~~~~gs~s~~~~~~~~~---t~~~~~vkii~~~~-------~~~~~e~~~~~~~~~h~niv~~~~v~~~~ 388 (612)
T KOG0603|consen 319 PFTESYEFREELGEGSFSAVKYCESSP---TDQEPAVKIISKRA-------DDNQDEIPISLLVRDHPNIVKSHDVYEDG 388 (612)
T ss_pred CcchhhccccccCCCCccceeeeeccc---cccchhheeccccc-------cccccccchhhhhcCCCcceeecceecCC
Confidence 357789999999999999988887666 68999999997652 23447888888888899999999999999
Q ss_pred CeEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCcc
Q 014210 232 DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (429)
Q Consensus 232 ~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~ 311 (429)
.+.|+|||.+.|+.|++.+.... ....++..|+.+|+.++.|||++|||||||||+|||+. +..++++|+|||.++
T Consensus 389 ~~~~~v~e~l~g~ell~ri~~~~--~~~~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~--~~~g~lrltyFG~a~ 464 (612)
T KOG0603|consen 389 KEIYLVMELLDGGELLRRIRSKP--EFCSEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLD--GSAGHLRLTYFGFWS 464 (612)
T ss_pred ceeeeeehhccccHHHHHHHhcc--hhHHHHHHHHHHHHHHHHHHHhcCeeecCCChhheeec--CCCCcEEEEEechhh
Confidence 99999999999999998875432 23378888999999999999999999999999999995 477889999999998
Q ss_pred ccCCCccccccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHcCCCCCCCCChH-HHHHHHHhcCCCCCCCCCCCCC
Q 014210 312 FVRPDERLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTES-GIFRAVLKADPSFDEAPWPSLS 389 (429)
Q Consensus 312 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~elltg~~Pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~s 389 (429)
....+ ....+-|..|.|||++.. .|+.++||||||++||+|++|+.||...... +++..+.... +. ..+|
T Consensus 465 ~~~~~--~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~~--~s----~~vS 536 (612)
T KOG0603|consen 465 ELERS--CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMPK--FS----ECVS 536 (612)
T ss_pred hCchh--hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCCc--cc----cccC
Confidence 87655 445678899999999874 6999999999999999999999999877766 3444443322 22 3699
Q ss_pred HHHHHHHHHhcccCccCcCCHHHHHhhHhhhccceee
Q 014210 390 SEARDFVKRLLNKDPRKRLTAAQALSELLICYQSYLF 426 (429)
Q Consensus 390 ~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~~~~~ 426 (429)
.++++||++||+.||.+|+++.+++.|+|+..+.+++
T Consensus 537 ~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~~~~~t~p 573 (612)
T KOG0603|consen 537 DEAKDLLQQLLQVDPALRLGADEIGAHPWFLSHPTFP 573 (612)
T ss_pred HHHHHHHHHhccCChhhCcChhhhccCcchhcCCCCC
Confidence 9999999999999999999999999999996665543
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-40 Score=351.00 Aligned_cols=150 Identities=28% Similarity=0.481 Sum_probs=136.1
Q ss_pred cCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~ 233 (429)
.++|.++++||+|+||.||+|+... .++.||||++.+...........+.+|+.+++.++ |+||+++++++...+.
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~---~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~-hp~Iv~~~~~~~~~~~ 78 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKN---NSKLYAVKVVKKADMINKNMVHQVQAERDALALSK-SPFIVHLYYSLQSANN 78 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECC---CCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcC-CCCcCeEEEEEEECCE
Confidence 3689999999999999999999775 58999999997766566666788999999999998 9999999999999999
Q ss_pred EEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCcc
Q 014210 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (429)
Q Consensus 234 ~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~ 311 (429)
+||||||+.|++|.+++.. .+.+++..++.|+.||+.||.|||.+|||||||||+|||| +.++.+||+|||+++
T Consensus 79 ~~lVmEy~~g~~L~~li~~-~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl---~~~g~vkL~DFGls~ 152 (669)
T cd05610 79 VYLVMEYLIGGDVKSLLHI-YGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLI---SNEGHIKLTDFGLSK 152 (669)
T ss_pred EEEEEeCCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEE---cCCCCEEEEeCCCCc
Confidence 9999999999999998754 4568999999999999999999999999999999999999 677889999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=323.71 Aligned_cols=258 Identities=31% Similarity=0.496 Sum_probs=206.0
Q ss_pred ceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeC----
Q 014210 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT---- 231 (429)
Q Consensus 156 ~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~---- 231 (429)
+|++.+.||+|+||.||+++..... .+..||||++.... ......+.+.+|+.+++++.+|+||+++++++...
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~-~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 78 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETS-EEETVAIKKITNVF-SKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNF 78 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCC-cCceEEEEEecccc-ccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccC
Confidence 5889999999999999999876521 27889999986432 22334566789999999997799999999976433
Q ss_pred CeEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCcc
Q 014210 232 DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (429)
Q Consensus 232 ~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~ 311 (429)
..++++|||+. ++|.+++. ....+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||++.
T Consensus 79 ~~~~~~~e~~~-~~L~~~l~-~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili---~~~~~~kl~Dfg~a~ 153 (332)
T cd07857 79 NELYLYEELME-ADLHQIIR-SGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLV---NADCELKICDFGLAR 153 (332)
T ss_pred CcEEEEEeccc-CCHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEE---cCCCCEEeCcCCCce
Confidence 45789999995 58888764 45679999999999999999999999999999999999999 678889999999997
Q ss_pred ccCCCc-----cccccccCCcccCcccccC--CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCC------
Q 014210 312 FVRPDE-----RLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADP------ 378 (429)
Q Consensus 312 ~~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~------ 378 (429)
...... ......|+..|+|||++.+ .++.++||||||+++|+|++|+.||........+..++....
T Consensus 154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 233 (332)
T cd07857 154 GFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEET 233 (332)
T ss_pred ecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 654322 1234578999999998753 588999999999999999999999977655444433322110
Q ss_pred ---------------------CCCCCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhh
Q 014210 379 ---------------------SFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLIC 420 (429)
Q Consensus 379 ---------------------~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~ 420 (429)
......++.++.++.+||.+||+.||++||++.+++.|+|++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~ 296 (332)
T cd07857 234 LSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLA 296 (332)
T ss_pred HHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhh
Confidence 001112345688999999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=319.16 Aligned_cols=260 Identities=31% Similarity=0.522 Sum_probs=211.6
Q ss_pred ceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcC-cHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeE
Q 014210 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMT-TAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (429)
Q Consensus 156 ~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~-~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~ 234 (429)
+|++.+.||+|+||.||+++.......++.||||++.+.... .....+.+.+|++++.++.+|+||+++++.+..++..
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 488999999999999999986654446889999998653222 2334467889999999997799999999999999999
Q ss_pred EEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccccC
Q 014210 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (429)
Q Consensus 235 ~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~ 314 (429)
++||||+++++|.+++.. ...+++..++.++.|+++||.|||+.|++||||||+||++ +.++.++|+|||++....
T Consensus 81 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~ 156 (288)
T cd05583 81 HLILDYVNGGELFTHLYQ-REHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILL---DSEGHVVLTDFGLSKEFL 156 (288)
T ss_pred EEEEecCCCCcHHHHHhh-cCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEE---CCCCCEEEEECccccccc
Confidence 999999999999988754 3568999999999999999999999999999999999999 677889999999987654
Q ss_pred CCcc--ccccccCCcccCcccccCC---CCCcccHHHHHHHHHHHHcCCCCCCCCC----hHHHHHHHHhcCCCCCCCCC
Q 014210 315 PDER--LNDIVGSAYYVAPEVLHRS---YSTEADVWSIGVIAYILLCGSRPFWART----ESGIFRAVLKADPSFDEAPW 385 (429)
Q Consensus 315 ~~~~--~~~~~gt~~y~aPE~~~~~---~~~~sDiwSlGvll~elltg~~Pf~~~~----~~~~~~~i~~~~~~~~~~~~ 385 (429)
.... .....|+..|+|||.+.+. .+.++||||||+++|||++|..||.... .......+....... .
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~----~ 232 (288)
T cd05583 157 AEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPF----P 232 (288)
T ss_pred cccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCCCC----C
Confidence 3322 2235688999999987642 6889999999999999999999995432 223333333333222 2
Q ss_pred CCCCHHHHHHHHHhcccCccCcCC---HHHHHhhHhhhccc
Q 014210 386 PSLSSEARDFVKRLLNKDPRKRLT---AAQALSELLICYQS 423 (429)
Q Consensus 386 ~~~s~~~~~li~~~L~~dP~~Rps---~~~iL~~~~~~~~~ 423 (429)
..++.++.+||.+||+.||++||| +.++|.|+|++.-.
T Consensus 233 ~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~ 273 (288)
T cd05583 233 KTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGID 273 (288)
T ss_pred cccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCC
Confidence 357899999999999999999998 56779999997644
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=318.32 Aligned_cols=254 Identities=30% Similarity=0.538 Sum_probs=211.4
Q ss_pred eeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEE
Q 014210 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYV 236 (429)
Q Consensus 157 y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~~l 236 (429)
|....+||+|+||.||++..+. +|+.||||++.. ......+.+.+|+.+++.+. |+||+++++++.+++..++
T Consensus 22 ~~~~~~lg~g~~g~v~~~~~~~---~~~~v~iK~~~~---~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~l 94 (292)
T cd06657 22 LDNFIKIGEGSTGIVCIATVKS---SGKLVAVKKMDL---RKQQRRELLFNEVVIMRDYQ-HENVVEMYNSYLVGDELWV 94 (292)
T ss_pred hhhHHHcCCCCCeEEEEEEEcC---CCeEEEEEEecc---cchhHHHHHHHHHHHHHhcC-CcchhheeeEEEeCCEEEE
Confidence 4445789999999999998775 589999998743 23345567899999999998 9999999999999999999
Q ss_pred EEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccccCCC
Q 014210 237 VMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPD 316 (429)
Q Consensus 237 v~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~ 316 (429)
||||+++++|.+++. ...+++..++.++.|++.||+|||+.||+|+||||+||++ ++++.++|+|||++......
T Consensus 95 v~e~~~~~~L~~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv---~~~~~~~l~dfg~~~~~~~~ 169 (292)
T cd06657 95 VMEFLEGGALTDIVT--HTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILL---THDGRVKLSDFGFCAQVSKE 169 (292)
T ss_pred EEecCCCCcHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCCEEEcccccceecccc
Confidence 999999999988663 3468999999999999999999999999999999999999 77888999999998765433
Q ss_pred c-cccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHH
Q 014210 317 E-RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARD 394 (429)
Q Consensus 317 ~-~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 394 (429)
. ......|+..|++||.+. ..++.++|+||||+++|+|++|..||...........+....+.. ......++.++.+
T Consensus 170 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~ 248 (292)
T cd06657 170 VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPK-LKNLHKVSPSLKG 248 (292)
T ss_pred cccccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcc-cCCcccCCHHHHH
Confidence 2 223456889999999876 467889999999999999999999998766655544443332222 1123467899999
Q ss_pred HHHHhcccCccCcCCHHHHHhhHhhhccc
Q 014210 395 FVKRLLNKDPRKRLTAAQALSELLICYQS 423 (429)
Q Consensus 395 li~~~L~~dP~~Rps~~~iL~~~~~~~~~ 423 (429)
||.+||+.||.+||++.+++.|+||....
T Consensus 249 li~~~l~~~P~~R~~~~~ll~~~~~~~~~ 277 (292)
T cd06657 249 FLDRLLVRDPAQRATAAELLKHPFLAKAG 277 (292)
T ss_pred HHHHHHhCCcccCcCHHHHhcChHHhccC
Confidence 99999999999999999999999997654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=315.47 Aligned_cols=259 Identities=27% Similarity=0.499 Sum_probs=233.3
Q ss_pred cCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~ 233 (429)
.++|.++.+||+|+|.+|.++++++ +.+.+|+|++++.-..+.+.++.++.|-.+..+..+||.+|-++.+|+.+..
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~---t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesr 325 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKK---TDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESR 325 (593)
T ss_pred cccceeeeeecCcchhhhhheehcc---cceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccce
Confidence 4689999999999999999999988 6899999999998888889999999999999999999999999999999999
Q ss_pred EEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccc-
Q 014210 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF- 312 (429)
Q Consensus 234 ~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~- 312 (429)
+++|.||++||+|.-++ ++.++++++.++.+..+|+.||.|||++|||+||||.+|+|+ |..|++||+|+|+++.
T Consensus 326 lffvieyv~ggdlmfhm-qrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvll---daeghikltdygmcke~ 401 (593)
T KOG0695|consen 326 LFFVIEYVNGGDLMFHM-QRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLL---DAEGHIKLTDYGMCKEG 401 (593)
T ss_pred EEEEEEEecCcceeeeh-hhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEE---ccCCceeecccchhhcC
Confidence 99999999999998765 456789999999999999999999999999999999999999 8899999999999986
Q ss_pred cCCCccccccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHcCCCCCC--------CCChHHHHHHHHhcCCCCCCC
Q 014210 313 VRPDERLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFW--------ARTESGIFRAVLKADPSFDEA 383 (429)
Q Consensus 313 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~elltg~~Pf~--------~~~~~~~~~~i~~~~~~~~~~ 383 (429)
+.+++.+.+.+||+.|.|||++++ .|+..+|+|+|||+++||+.|+.||+ ..+++-.++.|++.....+.
T Consensus 402 l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiripr- 480 (593)
T KOG0695|consen 402 LGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIPR- 480 (593)
T ss_pred CCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccccc-
Confidence 455677889999999999999996 69999999999999999999999993 34566677888877766554
Q ss_pred CCCCCCHHHHHHHHHhcccCccCcCC------HHHHHhhHhhhccc
Q 014210 384 PWPSLSSEARDFVKRLLNKDPRKRLT------AAQALSELLICYQS 423 (429)
Q Consensus 384 ~~~~~s~~~~~li~~~L~~dP~~Rps------~~~iL~~~~~~~~~ 423 (429)
.++-.+..+++..|++||.+|.. ..++..|.||+...
T Consensus 481 ---slsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~id 523 (593)
T KOG0695|consen 481 ---SLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSID 523 (593)
T ss_pred ---eeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCC
Confidence 57888899999999999999974 57889999998544
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=326.02 Aligned_cols=258 Identities=23% Similarity=0.327 Sum_probs=216.3
Q ss_pred cccccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEE
Q 014210 150 SKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYE 229 (429)
Q Consensus 150 ~~~~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~ 229 (429)
.+...+...+.++||+|-||.|.+++... +..||||.++.. .......+|.+|+++|.+|+ |||||.++|+|.
T Consensus 533 ~EfPRs~L~~~ekiGeGqFGEVhLCeveg----~lkVAVK~Lr~~--a~~~~r~~F~kEIkiLsqLk-hPNIveLvGVC~ 605 (807)
T KOG1094|consen 533 VEFPRSRLRFKEKIGEGQFGEVHLCEVEG----PLKVAVKILRPD--ATKNARNDFLKEIKILSRLK-HPNIVELLGVCV 605 (807)
T ss_pred hhcchhheehhhhhcCcccceeEEEEecC----ceEEEEeecCcc--cchhHHHHHHHHHHHHhccC-CCCeeEEEeeee
Confidence 34456778899999999999999998764 689999999765 44555688999999999997 999999999999
Q ss_pred eCCeEEEEEEecCCCcHHHHHHhcCCC-CCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecC
Q 014210 230 DTDNVYVVMELCEGGELLDRILSRGGK-YTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFG 308 (429)
Q Consensus 230 ~~~~~~lv~E~~~ggsL~~~i~~~~~~-l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFG 308 (429)
.++.+++|+|||++|+|.+++.++... +.-....+|+.||+.|++||.+.++|||||.+.|||+ |.++++||+|||
T Consensus 606 ~DePicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv---~~e~~iKiadfg 682 (807)
T KOG1094|consen 606 QDDPLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLV---DGEFTIKIADFG 682 (807)
T ss_pred cCCchHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceee---cCcccEEecCcc
Confidence 999999999999999999999776443 3556667799999999999999999999999999999 899999999999
Q ss_pred CccccCCCccc---cccccCCcccCccc-ccCCCCCcccHHHHHHHHHHHH--cCCCCCCCCChHHHHHHHHhcCCCC--
Q 014210 309 LSDFVRPDERL---NDIVGSAYYVAPEV-LHRSYSTEADVWSIGVIAYILL--CGSRPFWARTESGIFRAVLKADPSF-- 380 (429)
Q Consensus 309 la~~~~~~~~~---~~~~gt~~y~aPE~-~~~~~~~~sDiwSlGvll~ell--tg~~Pf~~~~~~~~~~~i~~~~~~~-- 380 (429)
+++.+...+.. ...+-..+|||+|. +.+.+++++|+|+||+++||++ |.+.||...+++...++.......-
T Consensus 683 msR~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~ 762 (807)
T KOG1094|consen 683 MSRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGR 762 (807)
T ss_pred cccccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCc
Confidence 99876555432 34566789999995 5689999999999999999886 5789999888887776654322111
Q ss_pred --CCCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhH
Q 014210 381 --DEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSEL 417 (429)
Q Consensus 381 --~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~ 417 (429)
.....+.++.++.+||.+||..|-++||+++++-.++
T Consensus 763 ~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~l 801 (807)
T KOG1094|consen 763 QVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFL 801 (807)
T ss_pred ceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHH
Confidence 1223346889999999999999999999999986544
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=326.23 Aligned_cols=257 Identities=30% Similarity=0.522 Sum_probs=207.4
Q ss_pred cccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeC
Q 014210 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (429)
Q Consensus 152 ~~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~ 231 (429)
.+.++|.+.+.||+|+||.||++.... +|+.||||++.+.. ......+.+.+|+.++++++ |+||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~v~~~~~~~---~~~~vaiK~~~~~~-~~~~~~~~~~~Ei~~l~~l~-h~~iv~~~~~~~~~ 88 (345)
T cd07877 14 EVPERYQNLSPVGSGAYGSVCAAFDTK---TGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMK-HENVIGLLDVFTPA 88 (345)
T ss_pred hccCceEEEEEeeecCCeEEEEEEEcC---CCeEEEEEEecCcc-hhhHHHHHHHHHHHHHHHcC-CCcccceeeeeeec
Confidence 456899999999999999999998665 58999999986532 23334566889999999998 99999999988643
Q ss_pred ------CeEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEe
Q 014210 232 ------DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAI 305 (429)
Q Consensus 232 ------~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~ 305 (429)
+..+++++++ +++|.+.+. ...+++..++.++.||++||.|||++||+||||||+||++ +.++.+||+
T Consensus 89 ~~~~~~~~~~lv~~~~-~~~L~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll---~~~~~~kl~ 162 (345)
T cd07877 89 RSLEEFNDVYLVTHLM-GADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKIL 162 (345)
T ss_pred ccccccccEEEEehhc-ccCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEE---cCCCCEEEe
Confidence 3478889887 778877663 3469999999999999999999999999999999999999 678889999
Q ss_pred ecCCccccCCCccccccccCCcccCcccccC--CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCC-----
Q 014210 306 DFGLSDFVRPDERLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADP----- 378 (429)
Q Consensus 306 DFGla~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~----- 378 (429)
|||++..... ......++..|+|||++.+ .++.++||||||+++|+|++|+.||........+..+.....
T Consensus 163 dfg~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 240 (345)
T cd07877 163 DFGLARHTDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 240 (345)
T ss_pred cccccccccc--cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 9999876532 2344578899999998754 578899999999999999999999976665444433322111
Q ss_pred ------------------CCCC----CCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhc
Q 014210 379 ------------------SFDE----APWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLICY 421 (429)
Q Consensus 379 ------------------~~~~----~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~ 421 (429)
..+. ..+...++++.+||.+||+.||.+|+++.+++.|+||+.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~ 305 (345)
T cd07877 241 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 305 (345)
T ss_pred HHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhh
Confidence 0000 111246789999999999999999999999999999973
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=310.15 Aligned_cols=252 Identities=27% Similarity=0.446 Sum_probs=213.5
Q ss_pred ceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEE
Q 014210 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVY 235 (429)
Q Consensus 156 ~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~~ 235 (429)
+|++.++||+|+||.||++.... +|+.+|+|.+..... ......++.+|++++++++ |+||+++++++.+....+
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~---~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~ 75 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLS---DNQFYALKEVDLGSM-SQKEREDAVNEIRILASVN-HPNIISYKEAFLDGNKLC 75 (256)
T ss_pred CceEeeeecCCCceeEEEEEECC---CCCEEEEEEEehhhc-cHHHHHHHHHHHHHHHhCC-CCCchhhhhhhccCCEEE
Confidence 58999999999999999998665 588999999865443 2344567789999999998 999999999999999999
Q ss_pred EEEEecCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccc
Q 014210 236 VVMELCEGGELLDRILSR---GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (429)
Q Consensus 236 lv~E~~~ggsL~~~i~~~---~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~ 312 (429)
+||||+++++|.+++... ...+++..++.++.|++.||.|||+.|++|+||+|+||++ +.++.+||+|||++..
T Consensus 76 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~---~~~~~~kl~d~g~~~~ 152 (256)
T cd08530 76 IVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILL---VANDLVKIGDLGISKV 152 (256)
T ss_pred EEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEE---ecCCcEEEeeccchhh
Confidence 999999999999887552 3568999999999999999999999999999999999999 5677899999999987
Q ss_pred cCCCccccccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHH
Q 014210 313 VRPDERLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSE 391 (429)
Q Consensus 313 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 391 (429)
.... ......++..|++||.+.+ .++.++|+||||+++|+|++|+.||...........+........ ...++.+
T Consensus 153 ~~~~-~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~ 228 (256)
T cd08530 153 LKKN-MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPI---PPIYSQD 228 (256)
T ss_pred hccC-CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCC---chhhCHH
Confidence 6544 3334568899999998864 578899999999999999999999988776655555544332111 1257899
Q ss_pred HHHHHHHhcccCccCcCCHHHHHhhHhh
Q 014210 392 ARDFVKRLLNKDPRKRLTAAQALSELLI 419 (429)
Q Consensus 392 ~~~li~~~L~~dP~~Rps~~~iL~~~~~ 419 (429)
+.++|.+||+.+|++||++.++++|+++
T Consensus 229 ~~~li~~~l~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 229 LQNFIRSMLQVKPKLRPNCDKILASPAV 256 (256)
T ss_pred HHHHHHHHcCCCcccCCCHHHHhcCCCC
Confidence 9999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=316.51 Aligned_cols=254 Identities=32% Similarity=0.523 Sum_probs=211.0
Q ss_pred eeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEE
Q 014210 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYV 236 (429)
Q Consensus 157 y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~~l 236 (429)
|++.+.||+|+||.||+|+... +++.||+|++.... ......+.+.+|+.+++++. |+||+++++++.+.+..++
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~---~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~~ 75 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKK---TGEIVALKKIRLDN-EEEGIPSTALREISLLKELK-HPNIVKLLDVIHTERKLYL 75 (282)
T ss_pred CeeehcccccCcceEEEeeecC---CCcEEEEEEecccc-ccccccHHHHHHHHHHHhcC-CCCHHHHHhhhhcCCceEE
Confidence 6778999999999999998776 58999999987643 23334466789999999998 9999999999999999999
Q ss_pred EEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccccCCC
Q 014210 237 VMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPD 316 (429)
Q Consensus 237 v~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~ 316 (429)
||||++ ++|.+++......+++..++.++.|++.||.|||++||+||||+|+||++ ++++.+||+|||++......
T Consensus 76 v~e~~~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~---~~~~~~~l~d~g~~~~~~~~ 151 (282)
T cd07829 76 VFEYCD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILI---NRDGVLKLADFGLARAFGIP 151 (282)
T ss_pred EecCcC-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEE---cCCCCEEEecCCcccccCCC
Confidence 999997 58999887665679999999999999999999999999999999999999 67889999999998776443
Q ss_pred c-cccccccCCcccCcccccC--CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCC-------------
Q 014210 317 E-RLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSF------------- 380 (429)
Q Consensus 317 ~-~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~------------- 380 (429)
. ......++..|+|||.+.+ .++.++||||||+++|||++|+.||......+.+..+.......
T Consensus 152 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (282)
T cd07829 152 LRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPD 231 (282)
T ss_pred ccccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccc
Confidence 2 2334456788999998753 68889999999999999999999998877665555443311100
Q ss_pred -----C-------CCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhh
Q 014210 381 -----D-------EAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLI 419 (429)
Q Consensus 381 -----~-------~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~ 419 (429)
. ....+.++.++.+||++||..||++||++.+++.|+||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 232 YKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred ccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 0 01123457899999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=325.57 Aligned_cols=256 Identities=29% Similarity=0.548 Sum_probs=207.4
Q ss_pred ccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCC
Q 014210 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (429)
Q Consensus 153 ~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~ 232 (429)
+.++|.+.+.||+|+||.||+|.... +|+.||||++.+.. ........+.+|+.+++++. |+||+++++++....
T Consensus 13 ~~~~y~~~~~ig~g~~g~v~~~~~~~---~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~ 87 (342)
T cd07879 13 LPERYTSLKQVGSGAYGSVCSAIDKR---TGEKVAIKKLSRPF-QSEIFAKRAYRELTLLKHMQ-HENVIGLLDVFTSAV 87 (342)
T ss_pred cccceEEEEEeeecCCeEEEEEEeCC---CCcEEEEEEecCcc-ccccchhHHHHHHHHHHhcC-CCCccchhheecccc
Confidence 45789999999999999999998765 58999999986532 22334456889999999998 999999999987543
Q ss_pred ------eEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEee
Q 014210 233 ------NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAID 306 (429)
Q Consensus 233 ------~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~D 306 (429)
..++||||+.. +|..++ +..+++..+..++.||+.||.|||+.||+||||||+|||+ +.++.+||+|
T Consensus 88 ~~~~~~~~~lv~e~~~~-~l~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll---~~~~~~kL~d 160 (342)
T cd07879 88 SGDEFQDFYLVMPYMQT-DLQKIM---GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAV---NEDCELKILD 160 (342)
T ss_pred cCCCCceEEEEeccccc-CHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEee
Confidence 46999999964 665543 3468999999999999999999999999999999999999 6788999999
Q ss_pred cCCccccCCCccccccccCCcccCcccccC--CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcC-------
Q 014210 307 FGLSDFVRPDERLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKAD------- 377 (429)
Q Consensus 307 FGla~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~------- 377 (429)
||++..... ......++..|+|||++.+ .++.++|||||||++|||++|+.||........+..++...
T Consensus 161 fg~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 238 (342)
T cd07879 161 FGLARHADA--EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEF 238 (342)
T ss_pred CCCCcCCCC--CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence 999876532 2234567889999998764 47889999999999999999999998776555544443311
Q ss_pred ----------------CCCCC----CCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhcc
Q 014210 378 ----------------PSFDE----APWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLICYQ 422 (429)
Q Consensus 378 ----------------~~~~~----~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~ 422 (429)
+.... ..++..+.++.+||++||+.||++||++.+++.|+||+..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~ 303 (342)
T cd07879 239 VQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSF 303 (342)
T ss_pred HHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhc
Confidence 00110 1123577889999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=310.54 Aligned_cols=253 Identities=23% Similarity=0.366 Sum_probs=206.3
Q ss_pred eeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCC----
Q 014210 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD---- 232 (429)
Q Consensus 157 y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~---- 232 (429)
|.+.+.||+|+||.||+|.......+|+.||||++.... ......+++.+|+++++++. |+||+++++++...+
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~~ 78 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADI-FSSSDIEEFLREAACMKEFD-HPNVIKLIGVSLRSRAKGR 78 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEecccc-CChHHHHHHHHHHHHHhcCC-CCCcceEEEEEccCCCCCc
Confidence 677899999999999999887655568999999986543 34455678899999999998 999999999886542
Q ss_pred --eEEEEEEecCCCcHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEe
Q 014210 233 --NVYVVMELCEGGELLDRILSRG-----GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAI 305 (429)
Q Consensus 233 --~~~lv~E~~~ggsL~~~i~~~~-----~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~ 305 (429)
..++++||+.+|+|.+++.... ..+++..++.++.||+.||+|||+.||+||||||+||++ +.++.+||+
T Consensus 79 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili---~~~~~~kl~ 155 (273)
T cd05074 79 LPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCML---NENMTVCVA 155 (273)
T ss_pred ccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEE---cCCCCEEEC
Confidence 2478999999999988765321 257899999999999999999999999999999999999 678889999
Q ss_pred ecCCccccCCCcc---ccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCC
Q 014210 306 DFGLSDFVRPDER---LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSF 380 (429)
Q Consensus 306 DFGla~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~ 380 (429)
|||++........ .....++..|++||.+. +.++.++||||||+++|||++ |+.||......+....+.......
T Consensus 156 dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~ 235 (273)
T cd05074 156 DFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLK 235 (273)
T ss_pred cccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCcCC
Confidence 9999886543321 12234567899999876 458889999999999999999 899998777666666555433211
Q ss_pred CCCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhH
Q 014210 381 DEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSEL 417 (429)
Q Consensus 381 ~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~ 417 (429)
..+..+.++.+++.+||+.+|++||++.++++++
T Consensus 236 ---~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l 269 (273)
T cd05074 236 ---QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQL 269 (273)
T ss_pred ---CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 1235779999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=327.40 Aligned_cols=257 Identities=29% Similarity=0.546 Sum_probs=211.5
Q ss_pred cccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeC
Q 014210 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (429)
Q Consensus 152 ~~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~ 231 (429)
.+.++|++.+.||+|+||.||+|+... +++.||||++.... ......+.+.+|+.+++++. |+||+++++++...
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~---~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~ 86 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTK---TGRKVAIKKLSRPF-QSAIHAKRTYRELRLLKHMD-HENVIGLLDVFTPA 86 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECC---CCcEEEEEeccccc-chhhHHHHHHHHHHHHHhcc-CCCHHHHHHHhhcc
Confidence 356889999999999999999998776 58899999986532 23334566788999999997 99999999988765
Q ss_pred Ce------EEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEe
Q 014210 232 DN------VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAI 305 (429)
Q Consensus 232 ~~------~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~ 305 (429)
+. .++|+||+ +++|.+++.. ..+++..++.++.||+.||.|||+.||+||||||+||++ +.++.+||+
T Consensus 87 ~~~~~~~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill---~~~~~~kL~ 160 (343)
T cd07851 87 SSLEDFQDVYLVTHLM-GADLNNIVKC--QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAV---NEDCELKIL 160 (343)
T ss_pred ccccccccEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---CCCCCEEEc
Confidence 54 89999999 6699887743 579999999999999999999999999999999999999 678889999
Q ss_pred ecCCccccCCCccccccccCCcccCcccccC--CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCC--
Q 014210 306 DFGLSDFVRPDERLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFD-- 381 (429)
Q Consensus 306 DFGla~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~-- 381 (429)
|||++...... .....++..|+|||.+.+ .++.++||||||+++|+|++|+.||......+.+..+........
T Consensus 161 dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~ 238 (343)
T cd07851 161 DFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEE 238 (343)
T ss_pred ccccccccccc--ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHH
Confidence 99999766432 344578889999998754 578899999999999999999999987766665555443221100
Q ss_pred ---------------------C----CCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhc
Q 014210 382 ---------------------E----APWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLICY 421 (429)
Q Consensus 382 ---------------------~----~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~ 421 (429)
. .....++.++.+||.+||+.||++|||+.+++.|+||+.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~ 303 (343)
T cd07851 239 LLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAE 303 (343)
T ss_pred HHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccc
Confidence 0 011246889999999999999999999999999999974
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-40 Score=308.28 Aligned_cols=245 Identities=35% Similarity=0.630 Sum_probs=211.4
Q ss_pred eeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEecC
Q 014210 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCE 242 (429)
Q Consensus 163 IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~~lv~E~~~ 242 (429)
||+|+||.||++.... .++.||+|++.+...........+.+|+.+++++. |+||+++++.++.++..++||||++
T Consensus 1 lg~G~~~~v~~~~~~~---~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v~e~~~ 76 (250)
T cd05123 1 LGKGSFGKVLLVRKKD---TGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRIN-HPFIVKLHYAFQTEEKLYLVLEYAP 76 (250)
T ss_pred CCCCCceEEEEEEECC---CCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcC-CCcHHHHHHHeecCCeeEEEEecCC
Confidence 6999999999998765 58899999998766555556778999999999998 9999999999999999999999999
Q ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccccCCC-ccccc
Q 014210 243 GGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPD-ERLND 321 (429)
Q Consensus 243 ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~-~~~~~ 321 (429)
+++|.+++... ..+++..+..++.||+.||.|||+.+++|+||||+||++ +.++.++|+|||++...... .....
T Consensus 77 ~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~---~~~~~~~l~d~~~~~~~~~~~~~~~~ 152 (250)
T cd05123 77 GGELFSHLSKE-GRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILL---DADGHIKLTDFGLAKELSSEGSRTNT 152 (250)
T ss_pred CCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEE---cCCCcEEEeecCcceecccCCCcccC
Confidence 99999988544 468999999999999999999999999999999999999 67788999999998776443 23445
Q ss_pred cccCCcccCcccccC-CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhc
Q 014210 322 IVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLL 400 (429)
Q Consensus 322 ~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L 400 (429)
..++..|++||.+.+ .++.++|+||||+++|+|++|+.||...........+......++ ..++.++.+||++||
T Consensus 153 ~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~~i~~~l 228 (250)
T cd05123 153 FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFP----EFLSPEARDLISGLL 228 (250)
T ss_pred CcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCC----CCCCHHHHHHHHHHh
Confidence 678899999998764 578899999999999999999999987776666666655333322 246899999999999
Q ss_pred ccCccCcCCH---HHHHhhHhh
Q 014210 401 NKDPRKRLTA---AQALSELLI 419 (429)
Q Consensus 401 ~~dP~~Rps~---~~iL~~~~~ 419 (429)
..||++||++ .+++.|+||
T Consensus 229 ~~~p~~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 229 QKDPTKRLGSGGAEEIKAHPFF 250 (250)
T ss_pred cCCHhhCCCcccHHHHHhCCCC
Confidence 9999999999 999999986
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=309.59 Aligned_cols=255 Identities=27% Similarity=0.518 Sum_probs=210.8
Q ss_pred ceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCC-------cCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEE
Q 014210 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHK-------MTTAIAIEDVRREVKILRALTGHNNLVKFFDAY 228 (429)
Q Consensus 156 ~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~-------~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~ 228 (429)
.|++.+.||+|+||.||++....+ .++.+|||++.... ........++.+|+.++.+..+|+||+++++++
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~--~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~ 78 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNN--GQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTF 78 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCC--CCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeE
Confidence 478899999999999999987653 36889999875321 133445567788999888744599999999999
Q ss_pred EeCCeEEEEEEecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-cCceeccCCCCcEEEeecCCCceEEE
Q 014210 229 EDTDNVYVVMELCEGGELLDRILS---RGGKYTEDDAKAVMIQILNVVAFCHL-QGVVHRDLKPENFLFTTKDENSVLKA 304 (429)
Q Consensus 229 ~~~~~~~lv~E~~~ggsL~~~i~~---~~~~l~~~~~~~i~~qi~~gL~~LH~-~~iiHrDIKp~NILl~~~~~~~~vkL 304 (429)
.+++..+++|||+++++|.+++.. ....+++..++.++.|++.||.|||+ .+|+|+||||+|||+ +.++.+||
T Consensus 79 ~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~---~~~~~~~l 155 (269)
T cd08528 79 LENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIML---GEDDKVTI 155 (269)
T ss_pred ccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEE---CCCCcEEE
Confidence 999999999999999999887743 45579999999999999999999996 689999999999999 67888999
Q ss_pred eecCCccccCCCccccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCC
Q 014210 305 IDFGLSDFVRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEA 383 (429)
Q Consensus 305 ~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~ 383 (429)
+|||++.............|+..|++||++. +.++.++||||||+++|+|++|+.||...........+....... .
T Consensus 156 ~dfg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--~ 233 (269)
T cd08528 156 TDFGLAKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEP--L 233 (269)
T ss_pred ecccceeecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCc--C
Confidence 9999998766554445667899999999886 458899999999999999999999998776655555554433221 1
Q ss_pred CCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhH
Q 014210 384 PWPSLSSEARDFVKRLLNKDPRKRLTAAQALSEL 417 (429)
Q Consensus 384 ~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~ 417 (429)
....++.++.+||++||+.||++||++.++..+.
T Consensus 234 ~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~ 267 (269)
T cd08528 234 PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMI 267 (269)
T ss_pred CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHh
Confidence 1225789999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=308.21 Aligned_cols=249 Identities=19% Similarity=0.275 Sum_probs=197.9
Q ss_pred ceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEe
Q 014210 161 EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMEL 240 (429)
Q Consensus 161 ~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~~lv~E~ 240 (429)
++||+|+||.||+++...+. ....+++|.+... ......+.+.+|+.+++.++ |+||+++++.+.+....++||||
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~-~~~~~~~k~~~~~--~~~~~~~~~~~e~~~~~~l~-h~~iv~~~~~~~~~~~~~lv~e~ 76 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDT-GVARVVVKELKAN--ASSKEQNEFLQQGDPYRILQ-HPNILQCLGQCVEAIPYLLVFEY 76 (268)
T ss_pred CcCCCCcCceEEEEEEEcCC-CcceEEEEEecCC--CChHHHHHHHHHHHHHhccC-CcchhheEEEecCCCccEEEEec
Confidence 46999999999999765432 3456778876543 23345678999999999998 99999999999999999999999
Q ss_pred cCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccccCCCc
Q 014210 241 CEGGELLDRILSRG---GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDE 317 (429)
Q Consensus 241 ~~ggsL~~~i~~~~---~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~ 317 (429)
+++|+|.+++.+.. ..+++..++.++.||+.||+|||+.+|+||||||+|||+ +.++.+||+|||++.......
T Consensus 77 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~---~~~~~~~l~Dfg~~~~~~~~~ 153 (268)
T cd05086 77 CELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFL---TSDLTVKVGDYGIGPSRYKED 153 (268)
T ss_pred CCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEE---cCCccEEecccccccccCcch
Confidence 99999999886542 346778889999999999999999999999999999999 678889999999986432221
Q ss_pred ---cccccccCCcccCcccccC--------CCCCcccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCC-C-CC
Q 014210 318 ---RLNDIVGSAYYVAPEVLHR--------SYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSF-D-EA 383 (429)
Q Consensus 318 ---~~~~~~gt~~y~aPE~~~~--------~~~~~sDiwSlGvll~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~-~-~~ 383 (429)
......++..|+|||++.. .++.++||||||+++|||++ |..||......+.+..+++..... . ..
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (268)
T cd05086 154 YIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQ 233 (268)
T ss_pred hhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCc
Confidence 1234568889999998742 35678999999999999996 577887777777766665543221 1 11
Q ss_pred CCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhH
Q 014210 384 PWPSLSSEARDFVKRLLNKDPRKRLTAAQALSEL 417 (429)
Q Consensus 384 ~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~ 417 (429)
....+++.+.+++..|| .+|++||++.++++.+
T Consensus 234 ~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l 266 (268)
T cd05086 234 LELPYSERWYEVLQFCW-LSPEKRATAEEVHRLL 266 (268)
T ss_pred cCCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHh
Confidence 12357899999999999 6799999999998754
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=320.28 Aligned_cols=254 Identities=22% Similarity=0.312 Sum_probs=197.8
Q ss_pred EeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEE
Q 014210 159 LGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVM 238 (429)
Q Consensus 159 ~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~~lv~ 238 (429)
+++.+|.|++ ||+++... +|+.||||++.... ......+.+.+|++++++++ |+||+++++++.+.+..+++|
T Consensus 6 i~~~~~~~~~--v~~~~~~~---~~~~~avK~~~~~~-~~~~~~~~~~~Ei~~l~~l~-h~~i~~~~~~~~~~~~~~~~~ 78 (314)
T cd08216 6 IGKCFEDLMI--VHLAKHKP---TNTLVAVKKINLDS-CSKEDLKLLQQEIITSRQLQ-HPNILPYVTSFIVDSELYVVS 78 (314)
T ss_pred hhHhhcCCce--EEEEEecC---CCCEEEEEEEeccc-cchhHHHHHHHHHHHHHhcC-CcchhhhhheeecCCeEEEEE
Confidence 3444444444 45444443 58999999987643 34456678999999999998 999999999999999999999
Q ss_pred EecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccccCCCc
Q 014210 239 ELCEGGELLDRILSR-GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDE 317 (429)
Q Consensus 239 E~~~ggsL~~~i~~~-~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~ 317 (429)
||+++++|.+++... ...+++..+..++.||+.||.|||+++|+||||||+|||+ +.++.+||+|||.+.......
T Consensus 79 e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili---~~~~~~kl~d~~~~~~~~~~~ 155 (314)
T cd08216 79 PLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILL---SGDGKVVLSGLRYSVSMIKHG 155 (314)
T ss_pred eccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEE---ecCCceEEecCccceeecccc
Confidence 999999999988654 3568999999999999999999999999999999999999 677889999999886543221
Q ss_pred --------cccccccCCcccCcccccC---CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCC------
Q 014210 318 --------RLNDIVGSAYYVAPEVLHR---SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSF------ 380 (429)
Q Consensus 318 --------~~~~~~gt~~y~aPE~~~~---~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~------ 380 (429)
......++..|+|||++.+ .++.++|||||||++|||++|..||...................
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (314)
T cd08216 156 KRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKST 235 (314)
T ss_pred ccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCc
Confidence 1233457788999998864 47889999999999999999999997655443332222111000
Q ss_pred ------------------------CCCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhcc
Q 014210 381 ------------------------DEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLICYQ 422 (429)
Q Consensus 381 ------------------------~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~ 422 (429)
.......++.++.+||.+||+.||++||++.++|.|+||..-
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~ 301 (314)
T cd08216 236 YPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQC 301 (314)
T ss_pred hhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhh
Confidence 000001245688999999999999999999999999999754
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=308.35 Aligned_cols=243 Identities=20% Similarity=0.243 Sum_probs=191.9
Q ss_pred ceeeccCceEEEEEEEecCc-------ccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe
Q 014210 161 EEVGRGHFGYTCAAKFKKGE-------LKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (429)
Q Consensus 161 ~~IG~G~fg~V~~~~~~~~~-------~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~ 233 (429)
+.||+|+||.||+|...... .....+++|++.... . ....+.+|+.+++++. |+||+++++++.. +.
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~-~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~-~~ 74 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH---R-DSLAFFETASLMSQLS-HKHLVKLYGVCVR-DE 74 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccch---h-hHHHHHHHHHHHHcCC-CcchhheeeEEec-CC
Confidence 46899999999999987632 011458888775432 1 1577889999999998 9999999999988 77
Q ss_pred EEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecC----CCceEEEeecCC
Q 014210 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKD----ENSVLKAIDFGL 309 (429)
Q Consensus 234 ~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~----~~~~vkL~DFGl 309 (429)
.++||||+++|+|.+++......+++..+..++.||+.||.|||++||+||||||+|||++..+ ....+||+|||+
T Consensus 75 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~ 154 (259)
T cd05037 75 NIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI 154 (259)
T ss_pred cEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCc
Confidence 8999999999999998876665899999999999999999999999999999999999994322 112799999999
Q ss_pred ccccCCCccccccccCCcccCcccccC---CCCCcccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCCCC
Q 014210 310 SDFVRPDERLNDIVGSAYYVAPEVLHR---SYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPW 385 (429)
Q Consensus 310 a~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~sDiwSlGvll~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 385 (429)
+..... .....++..|+|||++.+ .++.++||||||+++|||++ |..||............. .......
T Consensus 155 a~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~-~~~~~~~--- 227 (259)
T cd05037 155 PITVLS---REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQ-DQHRLPM--- 227 (259)
T ss_pred cccccc---ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHh-cCCCCCC---
Confidence 876543 223456778999999864 48889999999999999999 588886665433333222 1111111
Q ss_pred CCCCHHHHHHHHHhcccCccCcCCHHHHHhhH
Q 014210 386 PSLSSEARDFVKRLLNKDPRKRLTAAQALSEL 417 (429)
Q Consensus 386 ~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~ 417 (429)
....++.+||.+||..||++||++.++++.+
T Consensus 228 -~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l 258 (259)
T cd05037 228 -PDCAELANLINQCWTYDPTKRPSFRAILRDL 258 (259)
T ss_pred -CCchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 1237899999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=315.58 Aligned_cols=256 Identities=21% Similarity=0.306 Sum_probs=206.6
Q ss_pred cCceeEeceeeccCceEEEEEEEecCc-ccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCC
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGE-LKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~-~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~ 232 (429)
.++|+..+.||+|+||.||+|....+. .....||+|++... .......++.+|+.+++++. |+||+++++++...
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~~~~l~-h~niv~~~~~~~~~- 81 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNET--TGPKANVEFMDEALIMASMD-HPHLVRLLGVCLSP- 81 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEecccc--CCHHHHHHHHHHHHHHHhCC-CCCcccEEEEEcCC-
Confidence 467899999999999999999876521 11246899988643 23344457889999999997 99999999998754
Q ss_pred eEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccc
Q 014210 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (429)
Q Consensus 233 ~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~ 312 (429)
..++++||+++|+|.+++......+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..
T Consensus 82 ~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill---~~~~~~kL~Dfg~~~~ 158 (303)
T cd05110 82 TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLV---KSPNHVKITDFGLARL 158 (303)
T ss_pred CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeee---cCCCceEEcccccccc
Confidence 4679999999999999987776779999999999999999999999999999999999999 6677899999999986
Q ss_pred cCCCcc---ccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCC
Q 014210 313 VRPDER---LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPS 387 (429)
Q Consensus 313 ~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 387 (429)
...... .....++..|+|||++. ..++.++||||||+++|||++ |..||........... +........ .+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~-~~~~~~~~~--~~~ 235 (303)
T cd05110 159 LEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDL-LEKGERLPQ--PPI 235 (303)
T ss_pred ccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-HHCCCCCCC--CCC
Confidence 643322 12234567899999876 468899999999999999997 9999977665544333 333322221 245
Q ss_pred CCHHHHHHHHHhcccCccCcCCHHHHHhhHhh
Q 014210 388 LSSEARDFVKRLLNKDPRKRLTAAQALSELLI 419 (429)
Q Consensus 388 ~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~ 419 (429)
++.++.+++..||..||++||++.+++..+.-
T Consensus 236 ~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~ 267 (303)
T cd05110 236 CTIDVYMVMVKCWMIDADSRPKFKELAAEFSR 267 (303)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 78899999999999999999999999887654
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=311.92 Aligned_cols=255 Identities=26% Similarity=0.401 Sum_probs=206.3
Q ss_pred CceeEeceeeccCceEEEEEEEecC-cccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEe--C
Q 014210 155 NKYELGEEVGRGHFGYTCAAKFKKG-ELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED--T 231 (429)
Q Consensus 155 ~~y~~~~~IG~G~fg~V~~~~~~~~-~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~--~ 231 (429)
+.|++.+.||+|+||.||++..... ..+++.||||++...... ...+.+.+|+++++++. |+||+++++++.. .
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~ei~~l~~l~-~~~i~~~~~~~~~~~~ 80 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE--QHRSDFEREIEILRTLD-HENIVKYKGVCEKPGG 80 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch--HHHHHHHHHHHHHHhCC-CCChheEEeeeecCCC
Confidence 5688899999999999999986532 235789999998754322 45678999999999997 9999999999987 5
Q ss_pred CeEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCcc
Q 014210 232 DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (429)
Q Consensus 232 ~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~ 311 (429)
...+++|||+++++|.+++......+++..+..++.||+.||+|||+.||+|+||||+||++ +.++.+||+|||++.
T Consensus 81 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~ 157 (284)
T cd05038 81 RSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILV---ESEDLVKISDFGLAK 157 (284)
T ss_pred CceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEE---cCCCCEEEccccccc
Confidence 57999999999999999987766679999999999999999999999999999999999999 677899999999998
Q ss_pred ccCCCccc----cccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHcCCCCCCCCChHH--------------HHHH
Q 014210 312 FVRPDERL----NDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESG--------------IFRA 372 (429)
Q Consensus 312 ~~~~~~~~----~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~--------------~~~~ 372 (429)
........ ....++..|++||.+. ..++.++||||||+++|||++|+.||....... .+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05038 158 VLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLE 237 (284)
T ss_pred ccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHH
Confidence 76532211 1234556799999876 468889999999999999999999986533221 1222
Q ss_pred HHhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhH
Q 014210 373 VLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSEL 417 (429)
Q Consensus 373 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~ 417 (429)
.+........ ...++.++.+|+.+||+.||++||++.+++..+
T Consensus 238 ~~~~~~~~~~--~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l 280 (284)
T cd05038 238 LLKEGERLPR--PPSCPDEVYDLMKLCWEAEPQDRPSFADLILIV 280 (284)
T ss_pred HHHcCCcCCC--CccCCHHHHHHHHHHhccChhhCCCHHHHHHHH
Confidence 2222222221 235678999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=320.15 Aligned_cols=256 Identities=33% Similarity=0.539 Sum_probs=207.0
Q ss_pred cccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEe-
Q 014210 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED- 230 (429)
Q Consensus 152 ~~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~- 230 (429)
.++++|++.+.||.|+||.||++.... +|+.||||++.+.. ......+.+.+|+++++++. ||||++++++|..
T Consensus 7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~---~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~ 81 (328)
T cd07856 7 EITNRYVDLQPVGMGAFGLVCSARDQL---TGQNVAIKKIMKPF-STPVLAKRTYRELKLLKHLR-HENIISLSDIFISP 81 (328)
T ss_pred ccccceEEEEeecccCCeEEEEEEECC---CCCEEEEEEecccc-cccchhHHHHHHHHHHHhcC-CCCeeeEeeeEecC
Confidence 457899999999999999999998665 58999999886542 22334467889999999998 9999999999876
Q ss_pred CCeEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCc
Q 014210 231 TDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS 310 (429)
Q Consensus 231 ~~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla 310 (429)
.+..+++|||+ +++|.+++. ...+++..+..++.||++||.|||+.||+||||||+|||+ ++++.+||+|||++
T Consensus 82 ~~~~~lv~e~~-~~~L~~~~~--~~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili---~~~~~~~l~dfg~~ 155 (328)
T cd07856 82 LEDIYFVTELL-GTDLHRLLT--SRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILI---NENCDLKICDFGLA 155 (328)
T ss_pred CCcEEEEeehh-ccCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeE---CCCCCEEeCccccc
Confidence 56789999999 568877663 3568899999999999999999999999999999999999 77889999999998
Q ss_pred cccCCCccccccccCCcccCcccccC--CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcC-----------
Q 014210 311 DFVRPDERLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKAD----------- 377 (429)
Q Consensus 311 ~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~----------- 377 (429)
..... ......++..|+|||++.+ .++.++||||||+++|+|++|+.||........+..+.+..
T Consensus 156 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (328)
T cd07856 156 RIQDP--QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTI 233 (328)
T ss_pred cccCC--CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence 75432 2334567889999998754 58899999999999999999999997665433222211100
Q ss_pred ----------------CCCCCCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhh
Q 014210 378 ----------------PSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLIC 420 (429)
Q Consensus 378 ----------------~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~ 420 (429)
........+.++.++.++|++||+.+|++||++.+++.|+|+.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~ 292 (328)
T cd07856 234 CSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLA 292 (328)
T ss_pred cchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccc
Confidence 0000011235788999999999999999999999999999994
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=310.33 Aligned_cols=251 Identities=24% Similarity=0.366 Sum_probs=201.2
Q ss_pred ceeeccCceEEEEEEEecCc---ccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEE
Q 014210 161 EEVGRGHFGYTCAAKFKKGE---LKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVV 237 (429)
Q Consensus 161 ~~IG~G~fg~V~~~~~~~~~---~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~~lv 237 (429)
+.||+|+||.||+|+..... ..++.+|||.+.+. ........+.+|+.+++.+. |+||+++++++.+.+..++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~--~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v 77 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKG--ATDQEKKEFLKEAHLMSNFN-HPNIVKLLGVCLLNEPQYII 77 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcc--cchhhHHHHHHHHHHHHhcC-CCCeeeEeeeecCCCCeEEE
Confidence 46899999999999876421 23478999988643 22334567889999999998 99999999999999999999
Q ss_pred EEecCCCcHHHHHHhc------CCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecC--CCceEEEeecCC
Q 014210 238 MELCEGGELLDRILSR------GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKD--ENSVLKAIDFGL 309 (429)
Q Consensus 238 ~E~~~ggsL~~~i~~~------~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~--~~~~vkL~DFGl 309 (429)
|||+++++|.+++... ...+++..+..++.||+.||.|||+.+++|+||||+|||++..+ ....+||+|||+
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 78 MELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred EeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 9999999999998643 23478999999999999999999999999999999999995322 223799999999
Q ss_pred ccccCCCcc---ccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCCC
Q 014210 310 SDFVRPDER---LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAP 384 (429)
Q Consensus 310 a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 384 (429)
+........ .....++..|+|||++. +.++.++||||||+++|||++ |+.||...........+.... .. ..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~-~~--~~ 234 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGG-RL--QK 234 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCC-cc--CC
Confidence 876543221 12234567899999876 568999999999999999998 999998776665555443322 11 12
Q ss_pred CCCCCHHHHHHHHHhcccCccCcCCHHHHHhhH
Q 014210 385 WPSLSSEARDFVKRLLNKDPRKRLTAAQALSEL 417 (429)
Q Consensus 385 ~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~ 417 (429)
...++.++.+||.+||..+|.+||++.++++.+
T Consensus 235 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l 267 (269)
T cd05044 235 PENCPDKIYQLMTNCWAQDPSERPTFDRIQEIL 267 (269)
T ss_pred cccchHHHHHHHHHHcCCCcccCCCHHHHHHHH
Confidence 246789999999999999999999999998764
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=306.72 Aligned_cols=243 Identities=26% Similarity=0.446 Sum_probs=201.6
Q ss_pred CceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeE
Q 014210 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (429)
Q Consensus 155 ~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~ 234 (429)
++|++.+.||+|+||.||++.. .++.||+|.+... ...+.+.+|+.++++++ |+||+++++++..+ ..
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-----~~~~~~iK~~~~~-----~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~-~~ 73 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-----TGQKVAVKNIKCD-----VTAQAFLEETAVMTKLH-HKNLVRLLGVILHN-GL 73 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-----CCCceEEEeecCc-----chHHHHHHHHHHHHhCC-CCCcCeEEEEEcCC-Cc
Confidence 5799999999999999998752 4788999998542 12356889999999998 99999999998765 47
Q ss_pred EEEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCcccc
Q 014210 235 YVVMELCEGGELLDRILSRG-GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (429)
Q Consensus 235 ~lv~E~~~ggsL~~~i~~~~-~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~ 313 (429)
+++|||+++++|.+++.... ..+++..+..++.|++.||.|||+.|++||||||+||++ +.++.+||+|||++...
T Consensus 74 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili---~~~~~~kl~Dfg~~~~~ 150 (254)
T cd05083 74 YIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILV---SEDGVAKVSDFGLARVG 150 (254)
T ss_pred EEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEE---cCCCcEEECCCccceec
Confidence 99999999999999987554 368999999999999999999999999999999999999 67788999999998764
Q ss_pred CCCccccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHH
Q 014210 314 RPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSE 391 (429)
Q Consensus 314 ~~~~~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 391 (429)
... ......+..|+|||.+. +.++.++||||||+++|||++ |+.||......+....+.+... ......++.+
T Consensus 151 ~~~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~ 225 (254)
T cd05083 151 SMG--VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYR---MEPPEGCPAD 225 (254)
T ss_pred ccc--CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCC---CCCCCcCCHH
Confidence 322 22234457899999876 568899999999999999997 9999987776665555544321 1123468899
Q ss_pred HHHHHHHhcccCccCcCCHHHHHhhH
Q 014210 392 ARDFVKRLLNKDPRKRLTAAQALSEL 417 (429)
Q Consensus 392 ~~~li~~~L~~dP~~Rps~~~iL~~~ 417 (429)
+.+||++||+.+|++||++.+++..+
T Consensus 226 ~~~li~~~l~~~p~~Rp~~~~l~~~l 251 (254)
T cd05083 226 VYVLMTSCWETEPKKRPSFHKLREKL 251 (254)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 99999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=309.40 Aligned_cols=253 Identities=28% Similarity=0.496 Sum_probs=205.0
Q ss_pred ceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCc--CcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe
Q 014210 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKM--TTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (429)
Q Consensus 156 ~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~--~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~ 233 (429)
+|.+.++||+|+||.||+++.... +..+++|++..... .......++.+|+.++++++ |+||+++++++.+.+.
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~ 76 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKA---VAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLD-HPAIVKFHASFLERDA 76 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCC---CCcceEEEeccccccccCcchHHHHHHHHHHHHhCC-CCcHHHHHHHHhcCCc
Confidence 588999999999999999987653 44455555433221 12223345778999999998 9999999999999999
Q ss_pred EEEEEEecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCc
Q 014210 234 VYVVMELCEGGELLDRILS---RGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS 310 (429)
Q Consensus 234 ~~lv~E~~~ggsL~~~i~~---~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla 310 (429)
.++||||+++++|.+.+.. ....+++..++.++.|++.||.|||+.|++|+||||+||++. ++.+||+|||++
T Consensus 77 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~----~~~~~l~d~g~~ 152 (260)
T cd08222 77 FCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLK----NNLLKIGDFGVS 152 (260)
T ss_pred eEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEee----cCCEeecccCce
Confidence 9999999999999887754 345799999999999999999999999999999999999993 345999999998
Q ss_pred cccCCCc-cccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCC
Q 014210 311 DFVRPDE-RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSL 388 (429)
Q Consensus 311 ~~~~~~~-~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 388 (429)
....... ......|+..|+|||.+. ..++.++|+||||+++|+|++|..||...........+....... ....+
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~ 229 (260)
T cd08222 153 RLLMGSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPS---LPETY 229 (260)
T ss_pred eecCCCcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCC---Ccchh
Confidence 7664332 233456888999999876 457889999999999999999999998766655555554432221 12357
Q ss_pred CHHHHHHHHHhcccCccCcCCHHHHHhhHhh
Q 014210 389 SSEARDFVKRLLNKDPRKRLTAAQALSELLI 419 (429)
Q Consensus 389 s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~ 419 (429)
+.++.++|.+||..||++||++.++++|+||
T Consensus 230 ~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 230 SRQLNSIMQSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred cHHHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence 8999999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-41 Score=352.65 Aligned_cols=255 Identities=33% Similarity=0.547 Sum_probs=200.3
Q ss_pred ccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEe--
Q 014210 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED-- 230 (429)
Q Consensus 153 ~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~-- 230 (429)
...+|+.++.||+||||.||+++.+- +|+.||||+|.... +......+.+|+.+|.+|+ |||||++|..|.+
T Consensus 477 Y~~DFEEL~lLGkGGFG~VvkVRNKl---DGr~YAIKKIpl~~--s~~~~skI~rEVk~LArLn-HpNVVRYysAWVEs~ 550 (1351)
T KOG1035|consen 477 YLNDFEELELLGKGGFGSVVKVRNKL---DGREYAIKKIPLKA--SDKLYSKILREVKLLARLN-HPNVVRYYSAWVEST 550 (1351)
T ss_pred HhhhhHHHHHhcCCCCceEEEEeecc---cchhhhhhhccCch--HHHHHHHHHHHHHHHhhcC-CcceeeeehhhhccC
Confidence 45779999999999999999999776 69999999997643 5566678999999999999 9999999987611
Q ss_pred ----------------------------------------------------------------------------C---
Q 014210 231 ----------------------------------------------------------------------------T--- 231 (429)
Q Consensus 231 ----------------------------------------------------------------------------~--- 231 (429)
.
T Consensus 551 ~~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~ 630 (1351)
T KOG1035|consen 551 AELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNL 630 (1351)
T ss_pred CccccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccc
Confidence 0
Q ss_pred --------------------------------------CeEEEEEEecCCCcHHHHHHhcCCCC-CHHHHHHHHHHHHHH
Q 014210 232 --------------------------------------DNVYVVMELCEGGELLDRILSRGGKY-TEDDAKAVMIQILNV 272 (429)
Q Consensus 232 --------------------------------------~~~~lv~E~~~ggsL~~~i~~~~~~l-~~~~~~~i~~qi~~g 272 (429)
-.+||.||||+...|.+++ .++... ....+|+++++|++|
T Consensus 631 S~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI-~~N~~~~~~d~~wrLFreIlEG 709 (1351)
T KOG1035|consen 631 SNTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDII-RRNHFNSQRDEAWRLFREILEG 709 (1351)
T ss_pred ccccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHH-HhcccchhhHHHHHHHHHHHHH
Confidence 1368999999885555544 444333 588899999999999
Q ss_pred HHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccccC-------------------CCccccccccCCcccCccc
Q 014210 273 VAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR-------------------PDERLNDIVGSAYYVAPEV 333 (429)
Q Consensus 273 L~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~-------------------~~~~~~~~~gt~~y~aPE~ 333 (429)
|.|+|++|||||||||.||++ +++..|||+|||+|+... ++......+||.-|+|||+
T Consensus 710 LaYIH~~giIHRDLKP~NIFL---d~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEl 786 (1351)
T KOG1035|consen 710 LAYIHDQGIIHRDLKPRNIFL---DSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPEL 786 (1351)
T ss_pred HHHHHhCceeeccCCcceeEE---cCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHH
Confidence 999999999999999999999 788889999999997721 1112345689999999999
Q ss_pred ccC----CCCCcccHHHHHHHHHHHHcCCCCCCCCChH-HHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCcC
Q 014210 334 LHR----SYSTEADVWSIGVIAYILLCGSRPFWARTES-GIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRL 408 (429)
Q Consensus 334 ~~~----~~~~~sDiwSlGvll~elltg~~Pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp 408 (429)
+.+ .|+.|+|||||||+|+||+. ||....+. .++..+.+...+.+...+..--+.-..+|++||+.||++||
T Consensus 787 l~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRP 863 (1351)
T KOG1035|consen 787 LSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRP 863 (1351)
T ss_pred hcccccccccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCC
Confidence 863 59999999999999999984 57544443 33344433333333222223335567999999999999999
Q ss_pred CHHHHHhhHhhh
Q 014210 409 TAAQALSELLIC 420 (429)
Q Consensus 409 s~~~iL~~~~~~ 420 (429)
||.|+|.+.|+.
T Consensus 864 tA~eLL~s~llp 875 (1351)
T KOG1035|consen 864 TATELLNSELLP 875 (1351)
T ss_pred CHHHHhhccCCC
Confidence 999999998876
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-41 Score=309.08 Aligned_cols=267 Identities=29% Similarity=0.442 Sum_probs=214.7
Q ss_pred cCceeEeceeeccCceEEEEEEEecCcc-cCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEe-C
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGEL-KGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED-T 231 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~-~ 231 (429)
...|+..+.||+|.||.||+|..+++.. ..+.+|||.+...+..+.. .....+|+.+++.|+ |+||+.|..+|.. +
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGi-S~SAcREiaL~REl~-h~nvi~Lv~Vfl~~d 100 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGI-SMSACREIALLRELK-HPNVISLVKVFLSHD 100 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCc-CHHHHHHHHHHHHhc-CCcchhHHHHHhccC
Confidence 3579999999999999999997665432 2357999998765433332 245679999999999 9999999999987 7
Q ss_pred CeEEEEEEecCCCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeec-CCCceEEEee
Q 014210 232 DNVYVVMELCEGGELLDRILSR----GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTK-DENSVLKAID 306 (429)
Q Consensus 232 ~~~~lv~E~~~ggsL~~~i~~~----~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~-~~~~~vkL~D 306 (429)
..+++++||.+. +|+..|+.. ...++...++.|+.||+.|+.|||++=|+||||||.|||+..+ .+.|+|||+|
T Consensus 101 ~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaD 179 (438)
T KOG0666|consen 101 KKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIAD 179 (438)
T ss_pred ceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeec
Confidence 789999999976 888888643 3468999999999999999999999999999999999999633 3568999999
Q ss_pred cCCccccCCCc----cccccccCCcccCcccccC--CCCCcccHHHHHHHHHHHHcCCCCCCCCCh---------HHHHH
Q 014210 307 FGLSDFVRPDE----RLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTE---------SGIFR 371 (429)
Q Consensus 307 FGla~~~~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlGvll~elltg~~Pf~~~~~---------~~~~~ 371 (429)
||+++.+...- .....+-|.+|+|||.+.| .|+.+.|||++||++.||++.++.|.+..+ .+.+.
T Consensus 180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~ 259 (438)
T KOG0666|consen 180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLD 259 (438)
T ss_pred ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHH
Confidence 99999875432 3345788999999998875 599999999999999999999998854322 23455
Q ss_pred HHHhcCCCCCCCCCCC---------------------------------CCHHHHHHHHHhcccCccCcCCHHHHHhhHh
Q 014210 372 AVLKADPSFDEAPWPS---------------------------------LSSEARDFVKRLLNKDPRKRLTAAQALSELL 418 (429)
Q Consensus 372 ~i~~~~~~~~~~~~~~---------------------------------~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~ 418 (429)
.|++.-.......|+. -++...+|+.+||+.||.+|.|++++|+|.|
T Consensus 260 rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~y 339 (438)
T KOG0666|consen 260 RIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPY 339 (438)
T ss_pred HHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcccc
Confidence 6655443334444432 1445789999999999999999999999999
Q ss_pred hhccc
Q 014210 419 ICYQS 423 (429)
Q Consensus 419 ~~~~~ 423 (429)
|....
T Consensus 340 F~~d~ 344 (438)
T KOG0666|consen 340 FTEDP 344 (438)
T ss_pred cccCC
Confidence 98763
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=337.95 Aligned_cols=254 Identities=24% Similarity=0.428 Sum_probs=224.6
Q ss_pred CceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeE
Q 014210 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (429)
Q Consensus 155 ~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~ 234 (429)
....+.++||.|.||.||+|+++........||||.++.. .......+|..|..||.++. ||||++|.|+.....-+
T Consensus 629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~G--ytekqrrdFL~EAsIMGQFd-HPNIIrLEGVVTks~Pv 705 (996)
T KOG0196|consen 629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAG--YTEKQRRDFLSEASIMGQFD-HPNIIRLEGVVTKSKPV 705 (996)
T ss_pred hheEEEEEEecccccceecccccCCCCcceeEEEeeeccC--ccHHHHhhhhhhhhhcccCC-CCcEEEEEEEEecCcee
Confidence 4567899999999999999999875445678999999754 56677789999999999998 99999999999999999
Q ss_pred EEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccccC
Q 014210 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (429)
Q Consensus 235 ~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~ 314 (429)
.||+|||++|+|..+|.++.+.++.-++..+++.|+.|++||-+.|+|||||-..|||+ +.+.++|++|||+++.+.
T Consensus 706 MIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILV---NsnLvCKVsDFGLSRvle 782 (996)
T KOG0196|consen 706 MIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILV---NSNLVCKVSDFGLSRVLE 782 (996)
T ss_pred EEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheee---ccceEEEeccccceeecc
Confidence 99999999999999999999999999999999999999999999999999999999999 889999999999999776
Q ss_pred CCcc--cccccc--CCcccCccccc-CCCCCcccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCC
Q 014210 315 PDER--LNDIVG--SAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSL 388 (429)
Q Consensus 315 ~~~~--~~~~~g--t~~y~aPE~~~-~~~~~~sDiwSlGvll~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 388 (429)
++.. ..+.-| ..+|.|||++. +.++.+|||||+||+|||.++ |..|||..+.++.+..|.++- ...+..++
T Consensus 783 dd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gy---RLPpPmDC 859 (996)
T KOG0196|consen 783 DDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGY---RLPPPMDC 859 (996)
T ss_pred cCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhcc---CCCCCCCC
Confidence 5541 122222 36899999886 889999999999999999885 999999999999999887653 33344589
Q ss_pred CHHHHHHHHHhcccCccCcCCHHHHHhhH
Q 014210 389 SSEARDFVKRLLNKDPRKRLTAAQALSEL 417 (429)
Q Consensus 389 s~~~~~li~~~L~~dP~~Rps~~~iL~~~ 417 (429)
+..+..|+..||++|-.+||.+.||+.++
T Consensus 860 P~aL~qLMldCWqkdR~~RP~F~qiV~~l 888 (996)
T KOG0196|consen 860 PAALYQLMLDCWQKDRNRRPKFAQIVSTL 888 (996)
T ss_pred cHHHHHHHHHHHHHHhhcCCCHHHHHHHH
Confidence 99999999999999999999999998754
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-40 Score=335.74 Aligned_cols=259 Identities=28% Similarity=0.501 Sum_probs=219.0
Q ss_pred cCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEe---
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED--- 230 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~--- 230 (429)
++.|++.+.||.|.+|+||+++.++ .|+..|||++..... ..+++..|.++|+.+..|||++.+||+|..
T Consensus 18 ~d~~ei~evig~Gtygkv~k~k~~~---~~~~aa~kI~~~~~d----~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~ 90 (953)
T KOG0587|consen 18 ADIFEIIEVIGNGTYGKVYKGRHVK---TGQLAAIKIMDPTED----EEEEIELEYNMLKKYSHHPNVATFYGAFIKKDP 90 (953)
T ss_pred CCccEEEEEEeeccceeEEEEeeee---cCceeeeEeecCCcc----ccHHHHHHHHHHHhccCCCCcceEEEEEEEecC
Confidence 5789999999999999999999877 688999999864432 235688899999999999999999999864
Q ss_pred --CCeEEEEEEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeec
Q 014210 231 --TDNVYVVMELCEGGELLDRILSR-GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDF 307 (429)
Q Consensus 231 --~~~~~lv~E~~~ggsL~~~i~~~-~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DF 307 (429)
++++|||||||.||+..|.+... +.++.|..+..|++.++.||.+||...+||||||-.|||+ ..++.|||+||
T Consensus 91 ~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLL---T~e~~VKLvDF 167 (953)
T KOG0587|consen 91 GNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLL---TENAEVKLVDF 167 (953)
T ss_pred CCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEE---eccCcEEEeee
Confidence 56899999999999999988643 6689999999999999999999999999999999999999 67888999999
Q ss_pred CCccccCCC-ccccccccCCcccCccccc------CCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCC
Q 014210 308 GLSDFVRPD-ERLNDIVGSAYYVAPEVLH------RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSF 380 (429)
Q Consensus 308 Gla~~~~~~-~~~~~~~gt~~y~aPE~~~------~~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~ 380 (429)
|.+..+... .+.++.+||+.|||||++. ..|+.++|+||||++..||.-|.+|+-+...--.+..| ...|..
T Consensus 168 GvSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~I-pRNPPP 246 (953)
T KOG0587|consen 168 GVSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI-PRNPPP 246 (953)
T ss_pred eeeeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccC-CCCCCc
Confidence 998776543 3456789999999999985 24788999999999999999999998665543222222 223333
Q ss_pred CCCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhccc
Q 014210 381 DEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLICYQS 423 (429)
Q Consensus 381 ~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~~ 423 (429)
....+..++++|.+||..||.+|..+||+..++|+|+|+..+.
T Consensus 247 kLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e~~ 289 (953)
T KOG0587|consen 247 KLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITEQP 289 (953)
T ss_pred cccchhhHHHHHHHHHHHHHhhccccCcchhhhccCCcccccc
Confidence 4444567899999999999999999999999999999998654
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=308.96 Aligned_cols=260 Identities=15% Similarity=0.185 Sum_probs=189.1
Q ss_pred ccccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHH--------HHHHHHHHHHHHHhcCCCCcc
Q 014210 151 KHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIA--------IEDVRREVKILRALTGHNNLV 222 (429)
Q Consensus 151 ~~~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~--------~~~~~~Ei~il~~l~~h~nIv 222 (429)
+...++|++.++||+|+||.||+|....+...+..+|+|+........... ......++..+..+. |+||+
T Consensus 8 ~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~-h~~i~ 86 (294)
T PHA02882 8 DITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNID-HLGIP 86 (294)
T ss_pred ccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCC-CCCCC
Confidence 345689999999999999999999877643336678888653322111000 011122333444555 99999
Q ss_pred eEEEEEEeCC----eEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCC
Q 014210 223 KFFDAYEDTD----NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDE 298 (429)
Q Consensus 223 ~l~~~~~~~~----~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~ 298 (429)
++++++.... ..+++||++.. ++.+.+ ......++..++.++.||+.||.|||+.+|+||||||+|||+ +.
T Consensus 87 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~-~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill---~~ 161 (294)
T PHA02882 87 KYYGCGSFKRCRMYYRFILLEKLVE-NTKEIF-KRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMV---DG 161 (294)
T ss_pred cEEEeeeEecCCceEEEEEEehhcc-CHHHHH-HhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cC
Confidence 9999876544 35788888743 555544 333456889999999999999999999999999999999999 67
Q ss_pred CceEEEeecCCccccCCCc--------cccccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHH
Q 014210 299 NSVLKAIDFGLSDFVRPDE--------RLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGI 369 (429)
Q Consensus 299 ~~~vkL~DFGla~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~ 369 (429)
++.+||+|||+++.+.... ......||+.|+|||++.+ .++.++|||||||++|||++|+.||........
T Consensus 162 ~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~ 241 (294)
T PHA02882 162 NNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGN 241 (294)
T ss_pred CCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchH
Confidence 7889999999997664222 1123469999999998874 589999999999999999999999977643221
Q ss_pred -HHHHHh---cCCCCCCCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhh
Q 014210 370 -FRAVLK---ADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSE 416 (429)
Q Consensus 370 -~~~i~~---~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~ 416 (429)
...... ..........+.+++++.++++.|+..+|++||++.++++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~ 292 (294)
T PHA02882 242 LIHAAKCDFIKRLHEGKIKIKNANKFIYDFIECVTKLSYEEKPDYDALIKI 292 (294)
T ss_pred HHHHhHHHHHHHhhhhhhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHh
Confidence 111100 01111112234678999999999999999999999999864
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=306.41 Aligned_cols=258 Identities=22% Similarity=0.321 Sum_probs=214.3
Q ss_pred cCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~ 233 (429)
.++.+-+..||.|.||.|++-.++. +|+..|||+|+.... .....++..|++...+-.++||||++||++..++.
T Consensus 63 ~~~Lqdlg~iG~G~fG~V~KM~hk~---sg~~mAVKrIr~~n~--~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGd 137 (361)
T KOG1006|consen 63 SDNLQDLGEIGNGAFGTVNKMLHKP---SGKLMAVKRIRSNNI--EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGD 137 (361)
T ss_pred cchHHHHHHhcCCcchhhhhhhcCc---cCcEEEEEEeeeccc--hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCc
Confidence 4566778899999999999998887 799999999976533 55667899999999988889999999999999999
Q ss_pred EEEEEEecCCCcHHHHHH---h-cCCCCCHHHHHHHHHHHHHHHHHHHHc-CceeccCCCCcEEEeecCCCceEEEeecC
Q 014210 234 VYVVMELCEGGELLDRIL---S-RGGKYTEDDAKAVMIQILNVVAFCHLQ-GVVHRDLKPENFLFTTKDENSVLKAIDFG 308 (429)
Q Consensus 234 ~~lv~E~~~ggsL~~~i~---~-~~~~l~~~~~~~i~~qi~~gL~~LH~~-~iiHrDIKp~NILl~~~~~~~~vkL~DFG 308 (429)
.||.||.|+- +|..+.. . ....++|+.+..|....+.||.||-+. +||||||||+|||+ +..|.|||||||
T Consensus 138 cWiCMELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILl---dr~G~vKLCDFG 213 (361)
T KOG1006|consen 138 CWICMELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILL---DRHGDVKLCDFG 213 (361)
T ss_pred eeeeHHHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEE---ecCCCEeeeccc
Confidence 9999999964 6544332 2 345799999999999999999999865 89999999999999 889999999999
Q ss_pred CccccCCCccccccccCCcccCccccc---CCCCCcccHHHHHHHHHHHHcCCCCCCCCC-hHHHHHHHHhcCCCCCCCC
Q 014210 309 LSDFVRPDERLNDIVGSAYYVAPEVLH---RSYSTEADVWSIGVIAYILLCGSRPFWART-ESGIFRAVLKADPSFDEAP 384 (429)
Q Consensus 309 la~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~sDiwSlGvll~elltg~~Pf~~~~-~~~~~~~i~~~~~~~~~~~ 384 (429)
.+..+.+.-.....+|-..|||||.+. ..|+.+||+||||++|||+.||..||..-. .-+.+..+..+++......
T Consensus 214 IcGqLv~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~ 293 (361)
T KOG1006|consen 214 ICGQLVDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFD 293 (361)
T ss_pred chHhHHHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCc
Confidence 997776555556678899999999985 359999999999999999999999995422 2344445555555443322
Q ss_pred C--CCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhh
Q 014210 385 W--PSLSSEARDFVKRLLNKDPRKRLTAAQALSELLIC 420 (429)
Q Consensus 385 ~--~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~ 420 (429)
. -.++..+..||..||.+|-++||...+++.++|.+
T Consensus 294 ~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr 331 (361)
T KOG1006|consen 294 KECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYR 331 (361)
T ss_pred ccccccCHHHHHHHHHHhhcccccCcchhhhhcCchhh
Confidence 2 24789999999999999999999999999998875
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=304.93 Aligned_cols=260 Identities=29% Similarity=0.503 Sum_probs=217.3
Q ss_pred cCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEe---
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED--- 230 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~--- 230 (429)
.+.|+...+||+|.||.||+|+.++ +|+.||+|++-.......-. ....+|+++|..|+ |+|++.++..|..
T Consensus 16 ~~~yek~~kigqGtfgeVFkAr~~n---~~kkvalkkvlmeneKeGfp-italreikiL~~lk-Henv~nliEic~tk~T 90 (376)
T KOG0669|consen 16 VSKYEKLAKIGQGTFGEVFKARSKN---TGKKVALKKVLMENEKEGFP-ITALREIKILQLLK-HENVVNLIEICRTKAT 90 (376)
T ss_pred chHHHHHHhcCCchHHHHHHHhhcC---ccchhHHHHHHHhccccCCc-HHHHHHHHHHHHhc-chhHHHHHHHHhhccC
Confidence 5678999999999999999999887 58889998764322122222 33568999999999 9999999988753
Q ss_pred -----CCeEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEe
Q 014210 231 -----TDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAI 305 (429)
Q Consensus 231 -----~~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~ 305 (429)
...+|+||++|+. +|...+..+.-+++...+++++.+++.||.|+|...|+|||+|++|+|| +.++++||+
T Consensus 91 p~~r~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLI---t~dgilklA 166 (376)
T KOG0669|consen 91 PTNRDRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLI---TKDGILKLA 166 (376)
T ss_pred CcccccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEE---cCCceEEee
Confidence 2358999999976 8888776666789999999999999999999999999999999999999 788999999
Q ss_pred ecCCccccCCCc-----cccccccCCcccCcccccC--CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCC
Q 014210 306 DFGLSDFVRPDE-----RLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADP 378 (429)
Q Consensus 306 DFGla~~~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~ 378 (429)
|||+++.+.... .....+-|..|++||.+.| .|+.+.|||.-||++.||+++.+.+.+.++...+..|.....
T Consensus 167 DFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcG 246 (376)
T KOG0669|consen 167 DFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCG 246 (376)
T ss_pred ccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhc
Confidence 999997664322 2344567999999998764 699999999999999999999999999999888877766555
Q ss_pred CCCCCCCCCC-------------------------------CHHHHHHHHHhcccCccCcCCHHHHHhhHhhhcc
Q 014210 379 SFDEAPWPSL-------------------------------SSEARDFVKRLLNKDPRKRLTAAQALSELLICYQ 422 (429)
Q Consensus 379 ~~~~~~~~~~-------------------------------s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~ 422 (429)
.+....||++ ++++.+|+.++|..||.+|+++.++|.|.||-.+
T Consensus 247 s~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kd 321 (376)
T KOG0669|consen 247 SITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKD 321 (376)
T ss_pred cCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcC
Confidence 5665566542 3478899999999999999999999999999643
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=329.06 Aligned_cols=248 Identities=29% Similarity=0.488 Sum_probs=201.4
Q ss_pred CceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCC--
Q 014210 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD-- 232 (429)
Q Consensus 155 ~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~-- 232 (429)
..|...+.||+|+||.||+++.+. +|+.||||.+.+.. .....+.+.+|+++|++|+ |+|||++++.-++..
T Consensus 13 y~W~~~e~LG~Ga~g~V~rgrnke---tG~~vAvK~~~~~~--~~r~~e~~~~EieilkKLn-h~NIVk~f~iee~~~~~ 86 (732)
T KOG4250|consen 13 YLWEMDERLGKGAFGNVYRGRNKE---TGRLVAVKTFNKES--SLRPRERWCREIEILKKLN-HPNIVKLFDIEETKFLG 86 (732)
T ss_pred cceeehhhhcCCccceeeeecccc---cccchhHHhhhhhc--ccchHHHHHHHHHHHHHcC-chhhhhhcccCCccccC
Confidence 457788999999999999999777 79999999987643 4455677899999999999 999999999876654
Q ss_pred ----eEEEEEEecCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecC-CCceEEEe
Q 014210 233 ----NVYVVMELCEGGELLDRILSR--GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKD-ENSVLKAI 305 (429)
Q Consensus 233 ----~~~lv~E~~~ggsL~~~i~~~--~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~-~~~~vkL~ 305 (429)
...+|||||.||||...+.+. ...+++.+...++.++..||.|||++|||||||||.||++.... .....||+
T Consensus 87 ~~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLt 166 (732)
T KOG4250|consen 87 LVTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLT 166 (732)
T ss_pred cccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeee
Confidence 468999999999999988643 34699999999999999999999999999999999999996543 44579999
Q ss_pred ecCCccccCCCccccccccCCcccCccccc--CCCCCcccHHHHHHHHHHHHcCCCCCCCCC----hHHHHHHHHhcCCC
Q 014210 306 DFGLSDFVRPDERLNDIVGSAYYVAPEVLH--RSYSTEADVWSIGVIAYILLCGSRPFWART----ESGIFRAVLKADPS 379 (429)
Q Consensus 306 DFGla~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~sDiwSlGvll~elltg~~Pf~~~~----~~~~~~~i~~~~~~ 379 (429)
|||.|+.+.++......+||..|.+||++. +.|+..+|.|||||++|+.+||.+||...- ..+++..++...+.
T Consensus 167 DfG~Arel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~ 246 (732)
T KOG4250|consen 167 DFGAARELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPS 246 (732)
T ss_pred cccccccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCC
Confidence 999999999888889999999999999887 568999999999999999999999995322 12233333332221
Q ss_pred CCC---------------------CCCCCCCHHHHHHHHHhcccCccCcC
Q 014210 380 FDE---------------------APWPSLSSEARDFVKRLLNKDPRKRL 408 (429)
Q Consensus 380 ~~~---------------------~~~~~~s~~~~~li~~~L~~dP~~Rp 408 (429)
-.. ...+.+-..+..++..+|..+|++|.
T Consensus 247 ~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~ 296 (732)
T KOG4250|consen 247 GVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRG 296 (732)
T ss_pred ceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence 110 00011223456788889999999998
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-40 Score=310.03 Aligned_cols=266 Identities=29% Similarity=0.466 Sum_probs=214.3
Q ss_pred cCccccccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcC-CC----Cc
Q 014210 147 FGFSKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTG-HN----NL 221 (429)
Q Consensus 147 ~~~~~~~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~-h~----nI 221 (429)
+..++.++++|.+...+|+|.||.|..+.+.+ .+..||||+++. -....+..+-|+++|.++.. .| -+
T Consensus 81 ~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~---~~~~vAlKIik~----V~kYreAa~iEi~vLqki~~~DP~g~~rc 153 (415)
T KOG0671|consen 81 YQVGDILTNRYEIVDLLGEGTFGKVVECWDRE---TKEHVALKIIKN----VDKYREAALIEIEVLQKINESDPNGKFRC 153 (415)
T ss_pred EEeccccccceehhhhhcCCcccceEEEeecC---CCceehHHHHHH----HHHHhhHHHHHHHHHHHHHhcCCCCceEE
Confidence 34556778999999999999999999998776 489999999852 24445666789999999952 22 48
Q ss_pred ceEEEEEEeCCeEEEEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecC---
Q 014210 222 VKFFDAYEDTDNVYVVMELCEGGELLDRILSRG-GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKD--- 297 (429)
Q Consensus 222 v~l~~~~~~~~~~~lv~E~~~ggsL~~~i~~~~-~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~--- 297 (429)
|++.++|+-.++++||+|.+ |-|+.+++.+.+ ..++...++.++.||+++++|||+.+++|.||||+|||+...+
T Consensus 154 v~m~~wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~ 232 (415)
T KOG0671|consen 154 VQMRDWFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFK 232 (415)
T ss_pred EeeehhhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEE
Confidence 88999999999999999999 669999986643 3699999999999999999999999999999999999996321
Q ss_pred --------------CCceEEEeecCCccccCCCccccccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHcCCCCCC
Q 014210 298 --------------ENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFW 362 (429)
Q Consensus 298 --------------~~~~vkL~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~elltg~~Pf~ 362 (429)
.+..|||+|||.|....+ ....++.|..|+|||++.+ ++++++||||+||||+||.+|...|.
T Consensus 233 ~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e--~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFq 310 (415)
T KOG0671|consen 233 TYNPKKKVCFIRPLKSTAIKVIDFGSATFDHE--HHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQ 310 (415)
T ss_pred EeccCCccceeccCCCcceEEEecCCcceecc--CcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecc
Confidence 134699999999977543 3467899999999998876 79999999999999999999999997
Q ss_pred CCChHH---HHHHHHhcCCCCC-------------CCCCCC--------------------------CCHHHHHHHHHhc
Q 014210 363 ARTESG---IFRAVLKADPSFD-------------EAPWPS--------------------------LSSEARDFVKRLL 400 (429)
Q Consensus 363 ~~~~~~---~~~~i~~~~~~~~-------------~~~~~~--------------------------~s~~~~~li~~~L 400 (429)
.....+ +++.|+...|..- ...|++ -..++.|||++||
T Consensus 311 tHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL 390 (415)
T KOG0671|consen 311 THENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRML 390 (415)
T ss_pred cCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHH
Confidence 666444 4555543221110 001111 1236889999999
Q ss_pred ccCccCcCCHHHHHhhHhhhcc
Q 014210 401 NKDPRKRLTAAQALSELLICYQ 422 (429)
Q Consensus 401 ~~dP~~Rps~~~iL~~~~~~~~ 422 (429)
..||.+|+|+.|+|.|+||..-
T Consensus 391 ~fDP~~RiTl~EAL~HpFF~~~ 412 (415)
T KOG0671|consen 391 EFDPARRITLREALSHPFFARL 412 (415)
T ss_pred ccCccccccHHHHhcCHHhhcC
Confidence 9999999999999999999754
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-39 Score=321.27 Aligned_cols=256 Identities=24% Similarity=0.376 Sum_probs=216.4
Q ss_pred CceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeE
Q 014210 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (429)
Q Consensus 155 ~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~ 234 (429)
++..+.++||+|.||.|++|....-..+-..||||++..+... ....+|.+|+.+|.+|+ |+|+++|||+..+ ..+
T Consensus 110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~--~~mddflrEas~M~~L~-H~hliRLyGvVl~-qp~ 185 (1039)
T KOG0199|consen 110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLN--AIMDDFLREASHMLKLQ-HPHLIRLYGVVLD-QPA 185 (1039)
T ss_pred HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccc--hhHHHHHHHHHHHHhcc-CcceeEEeeeecc-chh
Confidence 5677889999999999999987764334567999999765432 26788999999999999 9999999999987 678
Q ss_pred EEEEEecCCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCcccc
Q 014210 235 YVVMELCEGGELLDRILS-RGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (429)
Q Consensus 235 ~lv~E~~~ggsL~~~i~~-~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~ 313 (429)
.+|||.+++|+|++.+.. ....|....+..++.||+.||.||..++.|||||-..|+|| -....|||+||||.+.+
T Consensus 186 mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlll---asprtVKI~DFGLmRaL 262 (1039)
T KOG0199|consen 186 MMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLL---ASPRTVKICDFGLMRAL 262 (1039)
T ss_pred hHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhhee---cccceeeeecccceecc
Confidence 899999999999999987 45678999999999999999999999999999999999999 45667999999999988
Q ss_pred CCCcccccc----ccCCcccCccccc-CCCCCcccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCC
Q 014210 314 RPDERLNDI----VGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPS 387 (429)
Q Consensus 314 ~~~~~~~~~----~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 387 (429)
..++..... .-...|+|||.++ +.|+.++|||+|||++|||++ |+.||.+.....++..|-+++ .....+.
T Consensus 263 g~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~e---rLpRPk~ 339 (1039)
T KOG0199|consen 263 GENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGE---RLPRPKY 339 (1039)
T ss_pred CCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccc---cCCCCCC
Confidence 655543222 2345799999886 789999999999999999998 899999999888887775322 1222346
Q ss_pred CCHHHHHHHHHhcccCccCcCCHHHHHhhHhhh
Q 014210 388 LSSEARDFVKRLLNKDPRKRLTAAQALSELLIC 420 (429)
Q Consensus 388 ~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~ 420 (429)
+++++.+++++||..+|.+||++..|....+++
T Consensus 340 csedIY~imk~cWah~paDRptFsair~~~~l~ 372 (1039)
T KOG0199|consen 340 CSEDIYQIMKNCWAHNPADRPTFSAIREDLVLA 372 (1039)
T ss_pred ChHHHHHHHHHhccCCccccccHHHHHHhHHHH
Confidence 899999999999999999999999997666654
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=312.06 Aligned_cols=269 Identities=30% Similarity=0.482 Sum_probs=221.3
Q ss_pred cCccccccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHH----HHHHHHHHHHHHHHhcCCCCcc
Q 014210 147 FGFSKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAI----AIEDVRREVKILRALTGHNNLV 222 (429)
Q Consensus 147 ~~~~~~~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~----~~~~~~~Ei~il~~l~~h~nIv 222 (429)
|.....+.++|-++.+||+|||+.||++-+.. ..+.||||+-...+.+..+ ..+...+|.+|.+.|. |+.||
T Consensus 455 FkDHptLn~RYLlLhLLGrGGFSEVyKAFDl~---EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLD-HpRIV 530 (775)
T KOG1151|consen 455 FKDHPTLNDRYLLLHLLGRGGFSEVYKAFDLT---EQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELD-HPRIV 530 (775)
T ss_pred hccCcchHHHHHHHHHhccccHHHHHHhcccc---hhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccC-cceee
Confidence 33345667899999999999999999997655 5788999987655444433 3455679999999998 99999
Q ss_pred eEEEEEE-eCCeEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC--ceeccCCCCcEEEeecCCC
Q 014210 223 KFFDAYE-DTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQG--VVHRDLKPENFLFTTKDEN 299 (429)
Q Consensus 223 ~l~~~~~-~~~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~--iiHrDIKp~NILl~~~~~~ 299 (429)
++|++|. +.+.+|-|+|||+|.+|.-|+ .....+++.+++.|+.||+.||.||.+.. |||-||||.||||......
T Consensus 531 KlYDyfslDtdsFCTVLEYceGNDLDFYL-KQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~Gtac 609 (775)
T KOG1151|consen 531 KLYDYFSLDTDSFCTVLEYCEGNDLDFYL-KQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTAC 609 (775)
T ss_pred eeeeeeeeccccceeeeeecCCCchhHHH-HhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCccc
Confidence 9999997 566799999999999976665 55678999999999999999999999985 9999999999999888888
Q ss_pred ceEEEeecCCccccCCCcc--------ccccccCCcccCccccc-C----CCCCcccHHHHHHHHHHHHcCCCCCCCC-C
Q 014210 300 SVLKAIDFGLSDFVRPDER--------LNDIVGSAYYVAPEVLH-R----SYSTEADVWSIGVIAYILLCGSRPFWAR-T 365 (429)
Q Consensus 300 ~~vkL~DFGla~~~~~~~~--------~~~~~gt~~y~aPE~~~-~----~~~~~sDiwSlGvll~elltg~~Pf~~~-~ 365 (429)
|.+||+|||+++.+..+.. +....||.+|++||.+. + .++.++||||+||++|..+.|+.||-.. +
T Consensus 610 GeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqs 689 (775)
T KOG1151|consen 610 GEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQS 689 (775)
T ss_pred ceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchh
Confidence 9999999999999865432 24567999999999774 2 3788999999999999999999999654 3
Q ss_pred hHHHHH--HHHh-cCCCCCCCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhcc
Q 014210 366 ESGIFR--AVLK-ADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLICYQ 422 (429)
Q Consensus 366 ~~~~~~--~i~~-~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~ 422 (429)
..++++ .|++ .+..|+. .|.++.++++||++||+..-++|.+..++..+++|.-+
T Consensus 690 QQdILqeNTIlkAtEVqFP~--KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllPh 747 (775)
T KOG1151|consen 690 QQDILQENTILKATEVQFPP--KPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLPH 747 (775)
T ss_pred HHHHHhhhchhcceeccCCC--CCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccch
Confidence 334433 2333 2344443 36899999999999999999999999999999988643
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=295.79 Aligned_cols=228 Identities=24% Similarity=0.315 Sum_probs=185.3
Q ss_pred cCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEecCCCc
Q 014210 166 GHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGE 245 (429)
Q Consensus 166 G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~~lv~E~~~ggs 245 (429)
|.||.||+++... +|+.||+|++.+.. .+.+|...+.... |+||+++++++.+.+..++||||++||+
T Consensus 4 g~~~~v~~~~~~~---~~~~~~~K~i~~~~--------~~~~~~~~~~~~~-~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 71 (237)
T cd05576 4 GVIDKVLLVMDTR---TQQTFILKGLRKSS--------EYSRERLTIIPHC-VPNMVCLHKYIVSEDSVFLVLQHAEGGK 71 (237)
T ss_pred cccceEEEEEEcc---CCcEEEEEeecchh--------hhhhHHHHHHhcC-CCceeehhhheecCCeEEEEEecCCCCC
Confidence 8899999999776 68999999986542 1234444454555 9999999999999999999999999999
Q ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccccCCCccccccccC
Q 014210 246 LLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGS 325 (429)
Q Consensus 246 L~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~gt 325 (429)
|.+++... ..+++..+..++.|++.||.|||++||+||||||+||++ +.++.++|+|||++...... .....++
T Consensus 72 L~~~l~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~~l~df~~~~~~~~~--~~~~~~~ 145 (237)
T cd05576 72 LWSHISKF-LNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILL---DDRGHIQLTYFSRWSEVEDS--CDGEAVE 145 (237)
T ss_pred HHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEE---cCCCCEEEecccchhccccc--cccCCcC
Confidence 99988654 469999999999999999999999999999999999999 67788999999987655432 2334567
Q ss_pred CcccCccccc-CCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCc
Q 014210 326 AYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDP 404 (429)
Q Consensus 326 ~~y~aPE~~~-~~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP 404 (429)
..|+|||++. +.++.++||||||+++|||++|+.||...... + ...... ...+.++.++.+||.+||+.||
T Consensus 146 ~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-----~-~~~~~~--~~~~~~~~~~~~li~~~l~~dp 217 (237)
T cd05576 146 NMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG-----I-NTHTTL--NIPEWVSEEARSLLQQLLQFNP 217 (237)
T ss_pred ccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh-----c-cccccc--CCcccCCHHHHHHHHHHccCCH
Confidence 7899999886 46889999999999999999999887543221 0 000011 1123578999999999999999
Q ss_pred cCcCCH-----HHHHhhHhh
Q 014210 405 RKRLTA-----AQALSELLI 419 (429)
Q Consensus 405 ~~Rps~-----~~iL~~~~~ 419 (429)
++|+++ .+++.|+||
T Consensus 218 ~~R~~~~~~~~~~~~~h~~~ 237 (237)
T cd05576 218 TERLGAGVAGVEDIKSHPFF 237 (237)
T ss_pred HHhcCCCccchHHHHcCCCC
Confidence 999996 999999986
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=313.51 Aligned_cols=250 Identities=24% Similarity=0.390 Sum_probs=210.1
Q ss_pred eeEeceeeccCceEEEEEEEecCc-ccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEE
Q 014210 157 YELGEEVGRGHFGYTCAAKFKKGE-LKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVY 235 (429)
Q Consensus 157 y~~~~~IG~G~fg~V~~~~~~~~~-~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~~ 235 (429)
..+.++||+|.||.||+|.+..-. ...-.||||..+.+ .+....+.|..|..+++++. |||||+++|+|.+. ..|
T Consensus 391 Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d--~t~d~tekflqEa~iMrnfd-HphIikLIGv~~e~-P~W 466 (974)
T KOG4257|consen 391 ITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTD--CTPDDTEKFLQEASIMRNFD-HPHIIKLIGVCVEQ-PMW 466 (974)
T ss_pred ccHHHhhcCCcccceeeeEecccccCcceeeeeehhccC--CChhhHHHHHHHHHHHHhCC-Ccchhheeeeeecc-cee
Confidence 344678999999999999876532 12345889987654 34445788999999999998 99999999999765 579
Q ss_pred EEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccccCC
Q 014210 236 VVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP 315 (429)
Q Consensus 236 lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~ 315 (429)
||||.++-|.|..|+..+...++...+..++.||+.+|.|||+.++|||||-..|||+ .....|||+|||+++.+.+
T Consensus 467 ivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLV---sSp~CVKLaDFGLSR~~ed 543 (974)
T KOG4257|consen 467 IVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILV---SSPQCVKLADFGLSRYLED 543 (974)
T ss_pred EEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheee---cCcceeeecccchhhhccc
Confidence 9999999999999999888899999999999999999999999999999999999999 5677899999999999887
Q ss_pred Ccccccccc--CCcccCccccc-CCCCCcccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHH
Q 014210 316 DERLNDIVG--SAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSE 391 (429)
Q Consensus 316 ~~~~~~~~g--t~~y~aPE~~~-~~~~~~sDiwSlGvll~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 391 (429)
+.......| ..-|||||-++ +.++.++|||.|||++||+++ |..||.+....+.+-.+.+++. ....+.+++.
T Consensus 544 ~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeR---lP~P~nCPp~ 620 (974)
T KOG4257|consen 544 DAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGER---LPCPPNCPPA 620 (974)
T ss_pred cchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCC---CCCCCCCChH
Confidence 665443333 35699999877 789999999999999999986 9999988877776655555442 2233579999
Q ss_pred HHHHHHHhcccCccCcCCHHHHHhh
Q 014210 392 ARDFVKRLLNKDPRKRLTAAQALSE 416 (429)
Q Consensus 392 ~~~li~~~L~~dP~~Rps~~~iL~~ 416 (429)
+..|+.+||..||.+||.+.++...
T Consensus 621 LYslmskcWayeP~kRPrftei~~~ 645 (974)
T KOG4257|consen 621 LYSLMSKCWAYEPSKRPRFTEIKAI 645 (974)
T ss_pred HHHHHHHHhccCcccCCcHHHHHHH
Confidence 9999999999999999999887653
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=311.24 Aligned_cols=246 Identities=23% Similarity=0.389 Sum_probs=208.6
Q ss_pred eeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEE
Q 014210 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYV 236 (429)
Q Consensus 157 y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~~l 236 (429)
.....+||-|.||.||.|..++ ....||||.++.+ .-.+++|..|..+|+.++ |||+|+|+|+|..+..+||
T Consensus 269 ItMkhKLGGGQYGeVYeGvWKk---yslTvAVKtLKED----tMeveEFLkEAAvMKeik-HpNLVqLLGVCT~EpPFYI 340 (1157)
T KOG4278|consen 269 ITMKHKLGGGQYGEVYEGVWKK---YSLTVAVKTLKED----TMEVEEFLKEAAVMKEIK-HPNLVQLLGVCTHEPPFYI 340 (1157)
T ss_pred eeeeeccCCCcccceeeeeeec---cceeeehhhhhhc----chhHHHHHHHHHHHHhhc-CccHHHHhhhhccCCCeEE
Confidence 3446789999999999999888 4677999998643 445688999999999999 9999999999999999999
Q ss_pred EEEecCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccccCC
Q 014210 237 VMELCEGGELLDRILSRGG-KYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP 315 (429)
Q Consensus 237 v~E~~~ggsL~~~i~~~~~-~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~ 315 (429)
|+|||..|+|++|+.+.++ .++.-.+..++-||.+|++||..+++|||||-..|+|+ +++..|||+|||+++++..
T Consensus 341 iTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLV---gEnhiVKvADFGLsRlMtg 417 (1157)
T KOG4278|consen 341 ITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV---GENHIVKVADFGLSRLMTG 417 (1157)
T ss_pred EEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccc---cccceEEeeccchhhhhcC
Confidence 9999999999999987654 46777788999999999999999999999999999999 8999999999999999875
Q ss_pred Cccccc--cccCCcccCccccc-CCCCCcccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHH
Q 014210 316 DERLND--IVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSE 391 (429)
Q Consensus 316 ~~~~~~--~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 391 (429)
+..+.. ..-..-|.|||-+. ..++.|+|||+|||+|||+.| |..||.+......+..+.+ ...... ..++++.
T Consensus 418 DTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEk-gyRM~~--PeGCPpk 494 (1157)
T KOG4278|consen 418 DTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEK-GYRMDG--PEGCPPK 494 (1157)
T ss_pred CceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhc-cccccC--CCCCCHH
Confidence 543321 22345799999876 679999999999999999997 8899988776666554443 333222 2479999
Q ss_pred HHHHHHHhcccCccCcCCHHHHHhh
Q 014210 392 ARDFVKRLLNKDPRKRLTAAQALSE 416 (429)
Q Consensus 392 ~~~li~~~L~~dP~~Rps~~~iL~~ 416 (429)
+.+|++.||+++|.+||++.++-+.
T Consensus 495 VYeLMraCW~WsPsDRPsFaeiHqa 519 (1157)
T KOG4278|consen 495 VYELMRACWNWSPSDRPSFAEIHQA 519 (1157)
T ss_pred HHHHHHHHhcCCcccCccHHHHHHH
Confidence 9999999999999999999988653
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=322.72 Aligned_cols=260 Identities=21% Similarity=0.278 Sum_probs=178.1
Q ss_pred ccCceeEeceeeccCceEEEEEEEecC-cccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEE----
Q 014210 153 FANKYELGEEVGRGHFGYTCAAKFKKG-ELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDA---- 227 (429)
Q Consensus 153 ~~~~y~~~~~IG~G~fg~V~~~~~~~~-~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~---- 227 (429)
..++|++.++||+|+||.||+|+...+ ...+..||||++..... .+...+| . ++... +.+++.++..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~-----~e~~~~e-~-l~~~~-~~~~~~~~~~~~~~ 201 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA-----VEIWMNE-R-VRRAC-PNSCADFVYGFLEP 201 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch-----hHHHHHH-H-HHhhc-hhhHHHHHHhhhcc
Confidence 357899999999999999999998762 11278999998753211 1111111 1 11111 2222222221
Q ss_pred --EEeCCeEEEEEEecCCCcHHHHHHhcCCC-------------------CCHHHHHHHHHHHHHHHHHHHHcCceeccC
Q 014210 228 --YEDTDNVYVVMELCEGGELLDRILSRGGK-------------------YTEDDAKAVMIQILNVVAFCHLQGVVHRDL 286 (429)
Q Consensus 228 --~~~~~~~~lv~E~~~ggsL~~~i~~~~~~-------------------l~~~~~~~i~~qi~~gL~~LH~~~iiHrDI 286 (429)
...++..+|||||+.+++|.+++...... ..+..+..++.||+.||.|||++||+||||
T Consensus 202 ~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDL 281 (566)
T PLN03225 202 VSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDV 281 (566)
T ss_pred cccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcC
Confidence 24566799999999999999887643211 123456789999999999999999999999
Q ss_pred CCCcEEEeecCCCceEEEeecCCccccCCCc--cccccccCCcccCcccccC-----------------------CCCCc
Q 014210 287 KPENFLFTTKDENSVLKAIDFGLSDFVRPDE--RLNDIVGSAYYVAPEVLHR-----------------------SYSTE 341 (429)
Q Consensus 287 Kp~NILl~~~~~~~~vkL~DFGla~~~~~~~--~~~~~~gt~~y~aPE~~~~-----------------------~~~~~ 341 (429)
||+|||++ ++++.+||+|||+++.+.... ......+++.|||||++.. .++.+
T Consensus 282 KP~NILl~--~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k 359 (566)
T PLN03225 282 KPQNIIFS--EGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDR 359 (566)
T ss_pred CHHHEEEe--CCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCC
Confidence 99999994 245789999999998654332 2345688999999996521 23456
Q ss_pred ccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcC-CCC-------CC----------CCCCCCCHHHHHHHHHhcccC
Q 014210 342 ADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKAD-PSF-------DE----------APWPSLSSEARDFVKRLLNKD 403 (429)
Q Consensus 342 sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~-~~~-------~~----------~~~~~~s~~~~~li~~~L~~d 403 (429)
+|||||||+||||+++..++.. ....+..++... ... .. ........++.+||++||+.|
T Consensus 360 ~DVwSlGviL~el~~~~~~~~~--~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~d 437 (566)
T PLN03225 360 FDIYSAGLIFLQMAFPNLRSDS--NLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFK 437 (566)
T ss_pred cccHHHHHHHHHHHhCcCCCch--HHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCC
Confidence 7999999999999998776532 222222222111 000 00 000112345669999999999
Q ss_pred ccCcCCHHHHHhhHhhhccce
Q 014210 404 PRKRLTAAQALSELLICYQSY 424 (429)
Q Consensus 404 P~~Rps~~~iL~~~~~~~~~~ 424 (429)
|++|||+.++|+|+||+....
T Consensus 438 P~kR~ta~e~L~Hpff~~~~~ 458 (566)
T PLN03225 438 GRQRISAKAALAHPYFDREGL 458 (566)
T ss_pred cccCCCHHHHhCCcCcCCCCc
Confidence 999999999999999986543
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=297.72 Aligned_cols=269 Identities=27% Similarity=0.436 Sum_probs=209.1
Q ss_pred CCCCcCcccccc-CceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcC----
Q 014210 143 LNKSFGFSKHFA-NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTG---- 217 (429)
Q Consensus 143 ~~~~~~~~~~~~-~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~---- 217 (429)
-...+.+++.|. .+|.+.++||+|.|++||++.+.. ..+.||+|+.+.. ....+....||++|++++.
T Consensus 65 GYHpV~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq---~~r~VAlKVvKSA----qhYtEaAlDEIklL~~v~~~Dp~ 137 (590)
T KOG1290|consen 65 GYHPVRIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQ---NKRYVALKVVKSA----QHYTEAALDEIKLLQQVREGDPN 137 (590)
T ss_pred CCceeeccccccCceEEEEEeccccccceeEEEeecc---CCeEEEEEEEehh----hHHHHHHHHHHHHHHHHHhcCCC
Confidence 344556677777 999999999999999999999766 5789999998543 3444567799999999873
Q ss_pred ---CCCcceEEEEEEe----CCeEEEEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHc-CceeccCCC
Q 014210 218 ---HNNLVKFFDAYED----TDNVYVVMELCEGGELLDRILSRG-GKYTEDDAKAVMIQILNVVAFCHLQ-GVVHRDLKP 288 (429)
Q Consensus 218 ---h~nIv~l~~~~~~----~~~~~lv~E~~~ggsL~~~i~~~~-~~l~~~~~~~i~~qi~~gL~~LH~~-~iiHrDIKp 288 (429)
..+||+|+++|.. +.++++|+|++ |.+|+..|...+ +.++...++.|++||+.||.|||.. ||||.||||
T Consensus 138 ~~~~~~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKP 216 (590)
T KOG1290|consen 138 DPGKKCVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKP 216 (590)
T ss_pred CCCCceeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCc
Confidence 2379999999975 45899999999 778999887543 4699999999999999999999986 999999999
Q ss_pred CcEEEeecCC----------------------------------------------------------------------
Q 014210 289 ENFLFTTKDE---------------------------------------------------------------------- 298 (429)
Q Consensus 289 ~NILl~~~~~---------------------------------------------------------------------- 298 (429)
+|||+...+.
T Consensus 217 ENvLl~~~e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~ 296 (590)
T KOG1290|consen 217 ENVLLCSTEIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEE 296 (590)
T ss_pred ceeeeeccccchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccc
Confidence 9999964310
Q ss_pred -----------------------------------------C--------------------------------------
Q 014210 299 -----------------------------------------N-------------------------------------- 299 (429)
Q Consensus 299 -----------------------------------------~-------------------------------------- 299 (429)
.
T Consensus 297 ~~~~~s~n~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~ 376 (590)
T KOG1290|consen 297 EPNQESYNNEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIAS 376 (590)
T ss_pred cccccccccccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCcccccc
Confidence 0
Q ss_pred --------------ceEEEeecCCccccCCCccccccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHcCCCCCCCC
Q 014210 300 --------------SVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWAR 364 (429)
Q Consensus 300 --------------~~vkL~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~elltg~~Pf~~~ 364 (429)
..|||+|||.|+.+ .......+.|..|+|||++.+ .|+..+||||++|+++||+||...|...
T Consensus 377 n~~v~p~~~~~~~di~vKIaDlGNACW~--~khFT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePh 454 (590)
T KOG1290|consen 377 NPLVNPDIPLPECDIRVKIADLGNACWV--HKHFTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPH 454 (590)
T ss_pred ccccCCCCCCCccceeEEEeeccchhhh--hhhhchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCC
Confidence 02677788877765 334455678999999998875 6999999999999999999999999432
Q ss_pred ------ChHHHHHHHHhcCCCCC-------------------------CCCCC---------CC----CHHHHHHHHHhc
Q 014210 365 ------TESGIFRAVLKADPSFD-------------------------EAPWP---------SL----SSEARDFVKRLL 400 (429)
Q Consensus 365 ------~~~~~~~~i~~~~~~~~-------------------------~~~~~---------~~----s~~~~~li~~~L 400 (429)
.+++.+..|++.-...+ ..+|+ .+ ..+|.+||.-||
T Consensus 455 sG~~Y~rDEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmL 534 (590)
T KOG1290|consen 455 SGENYSRDEDHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPML 534 (590)
T ss_pred CCCCCCccHHHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHH
Confidence 12333333332211111 11122 12 347889999999
Q ss_pred ccCccCcCCHHHHHhhHhhhc
Q 014210 401 NKDPRKRLTAAQALSELLICY 421 (429)
Q Consensus 401 ~~dP~~Rps~~~iL~~~~~~~ 421 (429)
+.+|++|+||.+.|.|+|++.
T Consensus 535 ef~PeKR~tA~~cl~hPwLn~ 555 (590)
T KOG1290|consen 535 EFDPEKRPTAAQCLKHPWLNP 555 (590)
T ss_pred hcCccccccHHHHhcCccccC
Confidence 999999999999999999984
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-37 Score=312.55 Aligned_cols=263 Identities=23% Similarity=0.291 Sum_probs=190.8
Q ss_pred ccCceeEeceeeccCceEEEEEEEec-------------CcccCeEEEEEEccCCCcCcHH-----------HHHHHHHH
Q 014210 153 FANKYELGEEVGRGHFGYTCAAKFKK-------------GELKGQQVAVKVIPKHKMTTAI-----------AIEDVRRE 208 (429)
Q Consensus 153 ~~~~y~~~~~IG~G~fg~V~~~~~~~-------------~~~~g~~vAvK~~~~~~~~~~~-----------~~~~~~~E 208 (429)
..++|++.++||+|+||.||+|.... ....++.||||++......... ..+....|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 36789999999999999999996421 1124678999998543211000 11223457
Q ss_pred HHHHHHhcCCCC-----cceEEEEEEe--------CCeEEEEEEecCCCcHHHHHHhcC---------------------
Q 014210 209 VKILRALTGHNN-----LVKFFDAYED--------TDNVYVVMELCEGGELLDRILSRG--------------------- 254 (429)
Q Consensus 209 i~il~~l~~h~n-----Iv~l~~~~~~--------~~~~~lv~E~~~ggsL~~~i~~~~--------------------- 254 (429)
+.++.+++ |.+ +++++++|.. .+..+|||||+++++|.+++....
T Consensus 223 ~~~l~~l~-~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~ 301 (507)
T PLN03224 223 AYMCAKIK-RNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM 301 (507)
T ss_pred HHHHHHhh-cccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence 77788887 444 4677887753 356899999999999998875421
Q ss_pred --CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccccCCCccccc--cccCCcccC
Q 014210 255 --GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLND--IVGSAYYVA 330 (429)
Q Consensus 255 --~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~--~~gt~~y~a 330 (429)
..+++..++.++.||+.+|.|||+.+|+||||||+|||+ +.++.+||+|||++........... ..+|+.|+|
T Consensus 302 ~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl---~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~a 378 (507)
T PLN03224 302 PQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLV---TVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSP 378 (507)
T ss_pred ccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEE---CCCCcEEEEeCcCccccccCCccCccccCCCcceeC
Confidence 134677899999999999999999999999999999999 6778899999999976544332222 234789999
Q ss_pred cccccCC---------------------CC--CcccHHHHHHHHHHHHcCCC-CCCCCChH-----------HHHHHHHh
Q 014210 331 PEVLHRS---------------------YS--TEADVWSIGVIAYILLCGSR-PFWARTES-----------GIFRAVLK 375 (429)
Q Consensus 331 PE~~~~~---------------------~~--~~sDiwSlGvll~elltg~~-Pf~~~~~~-----------~~~~~i~~ 375 (429)
||++... ++ .+.||||+||++|+|++|.. ||...... ...+.+..
T Consensus 379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~ 458 (507)
T PLN03224 379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKG 458 (507)
T ss_pred hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcc
Confidence 9987421 11 24699999999999999986 66432111 11111111
Q ss_pred cCCCCCCCCCCCCCHHHHHHHHHhcccCc---cCcCCHHHHHhhHhhhc
Q 014210 376 ADPSFDEAPWPSLSSEARDFVKRLLNKDP---RKRLTAAQALSELLICY 421 (429)
Q Consensus 376 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP---~~Rps~~~iL~~~~~~~ 421 (429)
.. .....+...+++.+|||++||..+| .+|+|+.|+|+|+||..
T Consensus 459 ~~--~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~ 505 (507)
T PLN03224 459 QK--YDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP 505 (507)
T ss_pred cC--CCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence 22 2233456789999999999999866 78999999999999964
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=282.28 Aligned_cols=242 Identities=43% Similarity=0.733 Sum_probs=202.5
Q ss_pred CceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEecCCCcH
Q 014210 167 HFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGEL 246 (429)
Q Consensus 167 ~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~~lv~E~~~ggsL 246 (429)
+||.||++.... +|+.+|+|++........ .+.+.+|++.+++++ |+||+++++++......+++|||+++++|
T Consensus 1 ~~g~v~~~~~~~---~~~~~~~k~~~~~~~~~~--~~~~~~e~~~~~~l~-~~~i~~~~~~~~~~~~~~l~~e~~~~~~L 74 (244)
T smart00220 1 SFGKVYLARDKK---TGKLVAIKVIKKEKIKKK--RERILREISILKKLK-HPNIVRLYDVFEDEDKLYLVMEYCDGGDL 74 (244)
T ss_pred CceEEEEEEECC---CCcEEEEEEecccccccH--HHHHHHHHHHHHhCC-CCcHHHHHhheeeCCEEEEEEeCCCCCCH
Confidence 589999998765 588999999865433221 578999999999996 99999999999999999999999999999
Q ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccccCCCccccccccCC
Q 014210 247 LDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSA 326 (429)
Q Consensus 247 ~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~gt~ 326 (429)
.+++.... .+++..++.++.+++.+|.|||+.+|+|+||+|+||++ +.++.++|+|||.+.............++.
T Consensus 75 ~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~ 150 (244)
T smart00220 75 FDLLKKRG-RLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILL---DEDGHVKLADFGLARQLDPGGLLTTFVGTP 150 (244)
T ss_pred HHHHHhcc-CCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEE---CCCCcEEEccccceeeeccccccccccCCc
Confidence 99875543 38999999999999999999999999999999999999 667889999999998876554556677899
Q ss_pred cccCccccc-CCCCCcccHHHHHHHHHHHHcCCCCCCC-CChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCc
Q 014210 327 YYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWA-RTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDP 404 (429)
Q Consensus 327 ~y~aPE~~~-~~~~~~sDiwSlGvll~elltg~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP 404 (429)
.|++||.+. ..++.++|||+||+++++|++|..||.. ......+..+.... .........++.++.+++.+||..||
T Consensus 151 ~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~~p 229 (244)
T smart00220 151 EYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPK-PPFPPPEWKISPEAKDLIRKLLVKDP 229 (244)
T ss_pred CCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccC-CCCccccccCCHHHHHHHHHHccCCc
Confidence 999999886 5688899999999999999999999987 44333433333322 22222222288999999999999999
Q ss_pred cCcCCHHHHHhhHhh
Q 014210 405 RKRLTAAQALSELLI 419 (429)
Q Consensus 405 ~~Rps~~~iL~~~~~ 419 (429)
++||++.+++.|+||
T Consensus 230 ~~Rp~~~~~~~~~~~ 244 (244)
T smart00220 230 EKRLTAEEALQHPFF 244 (244)
T ss_pred hhccCHHHHhhCCCC
Confidence 999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=280.02 Aligned_cols=254 Identities=28% Similarity=0.571 Sum_probs=209.3
Q ss_pred ccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCC
Q 014210 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (429)
Q Consensus 153 ~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~ 232 (429)
..++|++.+++|+|-++.||.|.... +.+.++||+++. -..+.+.+|++||..|.+|+||+++++...+..
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~---~~eK~ViKiLKP------VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~ 106 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINIT---NNEKCVIKILKP------VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPE 106 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccC---CCceEEEeeech------HHHHHHHHHHHHHHhccCCCCeeehhhhhcCcc
Confidence 46789999999999999999998655 578899999843 334678999999999999999999999988754
Q ss_pred --eEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCc
Q 014210 233 --NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS 310 (429)
Q Consensus 233 --~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla 310 (429)
...||+||+.+.+..... ..++..+++.++.+++.||.|||+.||+|||+||.|++|+ .+...++|+|+|+|
T Consensus 107 SktpaLiFE~v~n~Dfk~ly----~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmId--h~~rkLrlIDWGLA 180 (338)
T KOG0668|consen 107 SKTPSLIFEYVNNTDFKQLY----PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMID--HELRKLRLIDWGLA 180 (338)
T ss_pred ccCchhHhhhhccccHHHHh----hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeec--hhhceeeeeecchH
Confidence 467999999887755433 5689999999999999999999999999999999999996 34567999999999
Q ss_pred cccCCCccccccccCCcccCccccc--CCCCCcccHHHHHHHHHHHHcCCCCCCC-CChHHHHHHHHh------------
Q 014210 311 DFVRPDERLNDIVGSAYYVAPEVLH--RSYSTEADVWSIGVIAYILLCGSRPFWA-RTESGIFRAVLK------------ 375 (429)
Q Consensus 311 ~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~sDiwSlGvll~elltg~~Pf~~-~~~~~~~~~i~~------------ 375 (429)
.+.-++...+..+.+.+|--||.+- ..|+...|+|||||+|..|+..+.||.. ....+.+.+|.+
T Consensus 181 EFYHp~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~ 260 (338)
T KOG0668|consen 181 EFYHPGKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLN 260 (338)
T ss_pred hhcCCCceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHH
Confidence 9998888888888999999999885 5799999999999999999999999843 333333322211
Q ss_pred -----cCCCCCC-------CCCC---------CCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhc
Q 014210 376 -----ADPSFDE-------APWP---------SLSSEARDFVKRLLNKDPRKRLTAAQALSELLICY 421 (429)
Q Consensus 376 -----~~~~~~~-------~~~~---------~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~ 421 (429)
.++.+.. .+|. -+++++.|||.++|..|-.+|+|+.|++.|+||..
T Consensus 261 KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~ 327 (338)
T KOG0668|consen 261 KYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAP 327 (338)
T ss_pred HHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHH
Confidence 1111111 1121 25799999999999999999999999999999974
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=306.88 Aligned_cols=267 Identities=25% Similarity=0.455 Sum_probs=222.9
Q ss_pred CCCcCccccccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcC-----C
Q 014210 144 NKSFGFSKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTG-----H 218 (429)
Q Consensus 144 ~~~~~~~~~~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~-----h 218 (429)
...+.+++.+.++|.+..-.|+|-|+.|+.|.+.. .|+.||||+|....... +.=.+|++||++|.. -
T Consensus 421 YYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~---r~~~vAiKIIRnNE~M~----KtGl~EleiLkKL~~AD~Edk 493 (752)
T KOG0670|consen 421 YYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQA---RGQEVAIKIIRNNEVMH----KTGLKELEILKKLNDADPEDK 493 (752)
T ss_pred eEEEehhhhhcceeEEEeccccceeeeeeeccccC---CCCeeEEEEeecchHHh----hhhhHHHHHHHHhhccCchhh
Confidence 34556678888999999999999999999998665 58899999997543322 334589999999983 3
Q ss_pred CCcceEEEEEEeCCeEEEEEEecCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeec
Q 014210 219 NNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGG--KYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTK 296 (429)
Q Consensus 219 ~nIv~l~~~~~~~~~~~lv~E~~~ggsL~~~i~~~~~--~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~ 296 (429)
-|+++|+-.|...+++|||+|-+ ..+|.+.+..-+. .|....++.++.|++.||..|-..||+|.||||+|||++
T Consensus 494 ~Hclrl~r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVN-- 570 (752)
T KOG0670|consen 494 FHCLRLFRHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVN-- 570 (752)
T ss_pred hHHHHHHHHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEec--
Confidence 48999999999999999999998 4588888876544 488899999999999999999999999999999999996
Q ss_pred CCCceEEEeecCCccccCCCccccccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHh
Q 014210 297 DENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLK 375 (429)
Q Consensus 297 ~~~~~vkL~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~ 375 (429)
....++||||||.|....... ...+..+..|.|||++.| .|+...|+||+||+||||.||+..|.+.+...++...+.
T Consensus 571 E~k~iLKLCDfGSA~~~~ene-itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me 649 (752)
T KOG0670|consen 571 ESKNILKLCDFGSASFASENE-ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFME 649 (752)
T ss_pred cCcceeeeccCcccccccccc-ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHH
Confidence 456689999999998776443 445566778999998876 799999999999999999999999999999888877766
Q ss_pred cCCCCCCCCCC-------------------------------------------------CCC-------HHHHHHHHHh
Q 014210 376 ADPSFDEAPWP-------------------------------------------------SLS-------SEARDFVKRL 399 (429)
Q Consensus 376 ~~~~~~~~~~~-------------------------------------------------~~s-------~~~~~li~~~ 399 (429)
....++..+.. .++ .+|.+||..|
T Consensus 650 ~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkm 729 (752)
T KOG0670|consen 650 LKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKM 729 (752)
T ss_pred hcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHH
Confidence 65555543221 011 3678999999
Q ss_pred cccCccCcCCHHHHHhhHhhhc
Q 014210 400 LNKDPRKRLTAAQALSELLICY 421 (429)
Q Consensus 400 L~~dP~~Rps~~~iL~~~~~~~ 421 (429)
|..||++|.+..|+|.|+||+.
T Consensus 730 l~LdP~KRit~nqAL~HpFi~~ 751 (752)
T KOG0670|consen 730 LILDPEKRITVNQALKHPFITE 751 (752)
T ss_pred hccChhhcCCHHHHhcCCcccC
Confidence 9999999999999999999975
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=266.49 Aligned_cols=214 Identities=26% Similarity=0.431 Sum_probs=181.5
Q ss_pred cCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~ 233 (429)
.+....+..||+|++|.|-+.++.. +|+..|+|.+... ...+..+++.+|+++..+...+|.+|.+||...+++.
T Consensus 45 ad~L~~i~elGrGayG~vekmrh~~---sg~imAvKri~~t--vn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regd 119 (282)
T KOG0984|consen 45 ADDLVGIEELGRGAYGVVEKMRHIQ---SGTIMAVKRIRAT--VNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGD 119 (282)
T ss_pred hhhhhhhhhhcCCccchhhheeecc---CCeEEEEeeehhh--cChHHHHHHHHhhhhhccCCCCCeEEEeehhhhcccc
Confidence 4556678899999999998888776 7999999999754 3356667889999999998889999999999999999
Q ss_pred EEEEEEecCCCcHHHHH---HhcCCCCCHHHHHHHHHHHHHHHHHHHHc-CceeccCCCCcEEEeecCCCceEEEeecCC
Q 014210 234 VYVVMELCEGGELLDRI---LSRGGKYTEDDAKAVMIQILNVVAFCHLQ-GVVHRDLKPENFLFTTKDENSVLKAIDFGL 309 (429)
Q Consensus 234 ~~lv~E~~~ggsL~~~i---~~~~~~l~~~~~~~i~~qi~~gL~~LH~~-~iiHrDIKp~NILl~~~~~~~~vkL~DFGl 309 (429)
+||.||.|+- ||..+. ..+++.++|..+.+|+..++.||.|||++ .|||||+||+|||+ +.+|+||+||||.
T Consensus 120 vwIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLI---n~~GqVKiCDFGI 195 (282)
T KOG0984|consen 120 VWICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILI---NYDGQVKICDFGI 195 (282)
T ss_pred EEEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEE---ccCCcEEEccccc
Confidence 9999999964 665543 35688999999999999999999999987 89999999999999 8899999999999
Q ss_pred ccccCCCccccccccCCcccCccccc-----CCCCCcccHHHHHHHHHHHHcCCCCCCC-CChHHHHHHHHhc
Q 014210 310 SDFVRPDERLNDIVGSAYYVAPEVLH-----RSYSTEADVWSIGVIAYILLCGSRPFWA-RTESGIFRAVLKA 376 (429)
Q Consensus 310 a~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~sDiwSlGvll~elltg~~Pf~~-~~~~~~~~~i~~~ 376 (429)
+..+.+.-......|-..|||||.+. ..|+.++||||||++++||.+++.||.. .++-..+.++.+.
T Consensus 196 sG~L~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVee 268 (282)
T KOG0984|consen 196 SGYLVDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEE 268 (282)
T ss_pred ceeehhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcC
Confidence 98776555445567889999999885 2589999999999999999999999954 4555555555543
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=309.49 Aligned_cols=255 Identities=26% Similarity=0.428 Sum_probs=209.6
Q ss_pred cCceeEeceeeccCceEEEEEEEecCccc----CeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEE
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGELK----GQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYE 229 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~~~----g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~ 229 (429)
.++..+.+.||+|.||.|++|..+.-... ...||||.++... .....+.+..|+++++.+..|+||+.++|+|.
T Consensus 295 ~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~--~~~~~~~~~~El~~m~~~g~H~niv~llG~~t 372 (609)
T KOG0200|consen 295 RENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENA--SSSEKKDLMSELNVLKELGKHPNIVNLLGACT 372 (609)
T ss_pred hhhccccceeecccccceEeEEEeecccccccceEEEEEEeccccc--CcHHHHHHHHHHHHHHHhcCCcchhhheeeec
Confidence 44556777999999999999987643322 5689999987653 33667889999999999999999999999999
Q ss_pred eCCeEEEEEEecCCCcHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEe
Q 014210 230 DTDNVYVVMELCEGGELLDRILSRG---------------GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFT 294 (429)
Q Consensus 230 ~~~~~~lv~E~~~ggsL~~~i~~~~---------------~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~ 294 (429)
+.+.+++|+||+..|+|++++.... ..++..+...++.||+.|++||++..+|||||-..|||+
T Consensus 373 ~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi- 451 (609)
T KOG0200|consen 373 QDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLI- 451 (609)
T ss_pred cCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEe-
Confidence 9999999999999999999997765 348999999999999999999999999999999999999
Q ss_pred ecCCCceEEEeecCCccccCCCcccc--cccc--CCcccCcccccC-CCCCcccHHHHHHHHHHHHc-CCCCCCCCC-hH
Q 014210 295 TKDENSVLKAIDFGLSDFVRPDERLN--DIVG--SAYYVAPEVLHR-SYSTEADVWSIGVIAYILLC-GSRPFWART-ES 367 (429)
Q Consensus 295 ~~~~~~~vkL~DFGla~~~~~~~~~~--~~~g--t~~y~aPE~~~~-~~~~~sDiwSlGvll~ellt-g~~Pf~~~~-~~ 367 (429)
.++..+||+|||+++......... .-.| ...|||||.+.. .|+.++|||||||+||||++ |..||.+-. ..
T Consensus 452 --~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~ 529 (609)
T KOG0200|consen 452 --TKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTE 529 (609)
T ss_pred --cCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHH
Confidence 778899999999998655444332 1222 345999998875 79999999999999999998 889998754 45
Q ss_pred HHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhh
Q 014210 368 GIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSE 416 (429)
Q Consensus 368 ~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~ 416 (429)
+.+..+..+. .... ...++.++.++++.||+.+|++||++.++...
T Consensus 530 ~l~~~l~~G~-r~~~--P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~ 575 (609)
T KOG0200|consen 530 ELLEFLKEGN-RMEQ--PEHCSDEIYDLMKSCWNADPEDRPTFSECVEF 575 (609)
T ss_pred HHHHHHhcCC-CCCC--CCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence 5554333332 2222 23579999999999999999999999988653
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=312.00 Aligned_cols=248 Identities=31% Similarity=0.497 Sum_probs=195.7
Q ss_pred eeEeceeeccCce-EEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEE
Q 014210 157 YELGEEVGRGHFG-YTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVY 235 (429)
Q Consensus 157 y~~~~~IG~G~fg-~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~~ 235 (429)
|.-.+.+|.|.-| .||+|.+ .|+.||||++-. .......+||..|+.-..|+|||++|+.-.+.+.+|
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y-----e~R~VAVKrll~------e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~Y 579 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY-----EGREVAVKRLLE------EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLY 579 (903)
T ss_pred eccHHHcccCCCCcEEEEEee-----CCceehHHHHhh------HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEE
Confidence 3445678999887 6777764 478999998732 223456899999999999999999999988999999
Q ss_pred EEEEecCCCcHHHHHHhcCC--CC-CHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeec--CCCceEEEeecCCc
Q 014210 236 VVMELCEGGELLDRILSRGG--KY-TEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTK--DENSVLKAIDFGLS 310 (429)
Q Consensus 236 lv~E~~~ggsL~~~i~~~~~--~l-~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~--~~~~~vkL~DFGla 310 (429)
|+.|.|.. +|.+++..... .+ ..-..+.++.|+++||++||+.+||||||||.||||... +....++|+|||++
T Consensus 580 IalELC~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfgls 658 (903)
T KOG1027|consen 580 IALELCAC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLS 658 (903)
T ss_pred EEehHhhh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccc
Confidence 99999965 99999976311 11 114568889999999999999999999999999999754 33458999999999
Q ss_pred cccCCCc----cccccccCCcccCcccccCC-CCCcccHHHHHHHHHHHHcC-CCCCCCCChHHHHHHHHhcCCCCCCCC
Q 014210 311 DFVRPDE----RLNDIVGSAYYVAPEVLHRS-YSTEADVWSIGVIAYILLCG-SRPFWARTESGIFRAVLKADPSFDEAP 384 (429)
Q Consensus 311 ~~~~~~~----~~~~~~gt~~y~aPE~~~~~-~~~~sDiwSlGvll~elltg-~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 384 (429)
+.+..+. +.....||.+|+|||++.+. -+.++|||||||++|..++| ..||-...+. -.+|+..........
T Consensus 659 Kkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R--~~NIl~~~~~L~~L~ 736 (903)
T KOG1027|consen 659 KKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLER--QANILTGNYTLVHLE 736 (903)
T ss_pred cccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHh--hhhhhcCccceeeec
Confidence 9886554 34567899999999999854 56688999999999998886 9999654433 234555544433321
Q ss_pred CCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhh
Q 014210 385 WPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLI 419 (429)
Q Consensus 385 ~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~ 419 (429)
+....++.+||.+||++||..||++.++|.|++|
T Consensus 737 -~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlF 770 (903)
T KOG1027|consen 737 -PLPDCEAKDLISRMLNPDPQLRPSATDVLNHPLF 770 (903)
T ss_pred -cCchHHHHHHHHHhcCCCcccCCCHHHHhCCCcc
Confidence 1122289999999999999999999999999987
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=329.99 Aligned_cols=243 Identities=24% Similarity=0.324 Sum_probs=185.9
Q ss_pred CceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeE
Q 014210 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (429)
Q Consensus 155 ~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~ 234 (429)
..|...++||+|+||.||+|+.+. .|+.||||++...... ...|++++++++ |||||+++++|.+.+..
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~~-------~~~~~~~l~~l~-HpnIv~~~~~~~~~~~~ 758 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIK---NGMQFVVKEINDVNSI-------PSSEIADMGKLQ-HPNIVKLIGLCRSEKGA 758 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECC---CCcEEEEEEccCCccc-------cHHHHHHHhhCC-CCCcceEEEEEEcCCCC
Confidence 457778899999999999998765 5889999998643211 135688899997 99999999999999999
Q ss_pred EEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HcCceeccCCCCcEEEeecCCCceEEEeecCCcc
Q 014210 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCH---LQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (429)
Q Consensus 235 ~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH---~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~ 311 (429)
++|||||++|+|.+++. .++|..+.+++.||++||+||| +.+|+||||||+||++ +.++..++. ||...
T Consensus 759 ~lv~Ey~~~g~L~~~l~----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~---~~~~~~~~~-~~~~~ 830 (968)
T PLN00113 759 YLIHEYIEGKNLSEVLR----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIII---DGKDEPHLR-LSLPG 830 (968)
T ss_pred EEEEeCCCCCcHHHHHh----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEE---CCCCceEEE-ecccc
Confidence 99999999999999883 4899999999999999999999 6699999999999999 566666665 66554
Q ss_pred ccCCCccccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHcCCCCCCCCCh--HHHHH---HHHhc-------CC
Q 014210 312 FVRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTE--SGIFR---AVLKA-------DP 378 (429)
Q Consensus 312 ~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~elltg~~Pf~~~~~--~~~~~---~i~~~-------~~ 378 (429)
....+ ....+|..|||||++. +.++.++|||||||++|||++|+.||..... ..... ..... ++
T Consensus 831 ~~~~~---~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 907 (968)
T PLN00113 831 LLCTD---TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDP 907 (968)
T ss_pred ccccC---CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCc
Confidence 33222 2336889999999887 4699999999999999999999999854221 11111 00000 01
Q ss_pred CCCCCC--CCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhh
Q 014210 379 SFDEAP--WPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLI 419 (429)
Q Consensus 379 ~~~~~~--~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~ 419 (429)
...... ......++.+++.+||+.||++||++.++++.+--
T Consensus 908 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~ 950 (968)
T PLN00113 908 SIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLES 950 (968)
T ss_pred cccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHH
Confidence 110000 00112356789999999999999999999988653
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-35 Score=280.26 Aligned_cols=249 Identities=27% Similarity=0.448 Sum_probs=195.5
Q ss_pred ccccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHH--hcCCCCcceEEEEE
Q 014210 151 KHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRA--LTGHNNLVKFFDAY 228 (429)
Q Consensus 151 ~~~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~--l~~h~nIv~l~~~~ 228 (429)
+.+..+..+.+.||+|.||.||+|+. .|..||||++... ..+.+.+|.+|++. |+ |+||+.+++.-
T Consensus 207 RTiarqI~L~e~IGkGRyGEVwrG~w-----rGe~VAVKiF~sr------dE~SWfrEtEIYqTvmLR-HENILgFIaaD 274 (513)
T KOG2052|consen 207 RTIARQIVLQEIIGKGRFGEVWRGRW-----RGEDVAVKIFSSR------DERSWFRETEIYQTVMLR-HENILGFIAAD 274 (513)
T ss_pred HhhhheeEEEEEecCccccceeeccc-----cCCceEEEEeccc------chhhhhhHHHHHHHHHhc-cchhhhhhhcc
Confidence 56778899999999999999998874 4889999998532 23557788888775 55 99999999876
Q ss_pred EeCC----eEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHc--------CceeccCCCCcEEEeec
Q 014210 229 EDTD----NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQ--------GVVHRDLKPENFLFTTK 296 (429)
Q Consensus 229 ~~~~----~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~--------~iiHrDIKp~NILl~~~ 296 (429)
..++ ++|||.+|.+.|||+||+.. ..++-+...+++..++.||++||-. .|.|||||..|||+
T Consensus 275 ~~~~gs~TQLwLvTdYHe~GSL~DyL~r--~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILV--- 349 (513)
T KOG2052|consen 275 NKDNGSWTQLWLVTDYHEHGSLYDYLNR--NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV--- 349 (513)
T ss_pred ccCCCceEEEEEeeecccCCcHHHHHhh--ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEE---
Confidence 6543 58999999999999999954 6799999999999999999999975 39999999999999
Q ss_pred CCCceEEEeecCCccccCCCc-----cccccccCCcccCcccccCCCCC-------cccHHHHHHHHHHHHcC-------
Q 014210 297 DENSVLKAIDFGLSDFVRPDE-----RLNDIVGSAYYVAPEVLHRSYST-------EADVWSIGVIAYILLCG------- 357 (429)
Q Consensus 297 ~~~~~vkL~DFGla~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~-------~sDiwSlGvll~elltg------- 357 (429)
..++.+-|+|+|||.....+. ..+..+||.+|||||++...... .+||||||+++||++..
T Consensus 350 Kkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~ 429 (513)
T KOG2052|consen 350 KKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIV 429 (513)
T ss_pred ccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEe
Confidence 789999999999997765542 34567999999999999754322 58999999999999753
Q ss_pred ---CCCCCCCC----hHHHHHHHHhc---CCCCCCCCCCCCC--HHHHHHHHHhcccCccCcCCHHHHHhhH
Q 014210 358 ---SRPFWART----ESGIFRAVLKA---DPSFDEAPWPSLS--SEARDFVKRLLNKDPRKRLTAAQALSEL 417 (429)
Q Consensus 358 ---~~Pf~~~~----~~~~~~~i~~~---~~~~~~~~~~~~s--~~~~~li~~~L~~dP~~Rps~~~iL~~~ 417 (429)
+.||.+.. ..+.++++... .|..+ ..|...+ ..+.+|++.||..||.-|.|+-.|...+
T Consensus 430 eey~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ip-nrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl 500 (513)
T KOG2052|consen 430 EEYQLPYYDVVPSDPSFEEMRKVVCVQKLRPNIP-NRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTL 500 (513)
T ss_pred hhhcCCcccCCCCCCCHHHHhcceeecccCCCCC-cccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHH
Confidence 57885432 23444444332 22222 2233221 3567889999999999999997775543
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=281.18 Aligned_cols=249 Identities=25% Similarity=0.362 Sum_probs=191.7
Q ss_pred cCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhc-CCCCcceEEEEEEeCC
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALT-GHNNLVKFFDAYEDTD 232 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~-~h~nIv~l~~~~~~~~ 232 (429)
....++.++||+|.||.||+|++. ++.||||++. .+..+.+.+|-+|+.... .|+||++++++-....
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL~-----~~~VAVKifp------~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t 277 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQLD-----NRLVAVKIFP------EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGT 277 (534)
T ss_pred CCchhhHHHhhcCccceeehhhcc-----CceeEEEecC------HHHHHHHHhHHHHHhccCccchhHHHhhchhccCC
Confidence 345678899999999999999865 5899999984 344567888888876532 4999999999876655
Q ss_pred ----eEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHc---------CceeccCCCCcEEEeecCCC
Q 014210 233 ----NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQ---------GVVHRDLKPENFLFTTKDEN 299 (429)
Q Consensus 233 ----~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~---------~iiHrDIKp~NILl~~~~~~ 299 (429)
.++||+||.+.|+|.+|+. ...++|....+|+.-+++||+|||+. .|+|||||..|||| ..+
T Consensus 278 ~~~~eywLVt~fh~kGsL~dyL~--~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLv---K~D 352 (534)
T KOG3653|consen 278 ADRMEYWLVTEFHPKGSLCDYLK--ANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLV---KND 352 (534)
T ss_pred ccccceeEEeeeccCCcHHHHHH--hccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEE---ccC
Confidence 7899999999999999994 45799999999999999999999975 49999999999999 788
Q ss_pred ceEEEeecCCccccCCCcc---ccccccCCcccCcccccCCCCC-------cccHHHHHHHHHHHHcCCC----------
Q 014210 300 SVLKAIDFGLSDFVRPDER---LNDIVGSAYYVAPEVLHRSYST-------EADVWSIGVIAYILLCGSR---------- 359 (429)
Q Consensus 300 ~~vkL~DFGla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~-------~sDiwSlGvll~elltg~~---------- 359 (429)
+...|+|||+|..+..+.. ....+||.+|||||++.+..+. +.||||+|.+||||++...
T Consensus 353 lTccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Y 432 (534)
T KOG3653|consen 353 LTCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEY 432 (534)
T ss_pred CcEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcc
Confidence 9999999999988765543 2347899999999999875332 4799999999999998533
Q ss_pred --CCCC-----CChHHHHHHH--HhcCCCCCCCCCCC-CCHHHHHHHHHhcccCccCcCCHHHHHhhHh
Q 014210 360 --PFWA-----RTESGIFRAV--LKADPSFDEAPWPS-LSSEARDFVKRLLNKDPRKRLTAAQALSELL 418 (429)
Q Consensus 360 --Pf~~-----~~~~~~~~~i--~~~~~~~~~~~~~~-~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~ 418 (429)
||.. .+-+++-..+ .+..|.++..+... .-.-+.+.+..||+.|++.|.|+.=+-+..+
T Consensus 433 qlpfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~ 501 (534)
T KOG3653|consen 433 QLPFEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMA 501 (534)
T ss_pred cCchhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHH
Confidence 3321 1112222222 22334444332221 2245789999999999999999976655444
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=298.72 Aligned_cols=251 Identities=24% Similarity=0.326 Sum_probs=212.6
Q ss_pred ceeEeceeeccCceEEEEEEEecC-cccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeE
Q 014210 156 KYELGEEVGRGHFGYTCAAKFKKG-ELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (429)
Q Consensus 156 ~y~~~~~IG~G~fg~V~~~~~~~~-~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~ 234 (429)
..+..++||+|+||+||+|.+... +--.-+||||++... ...+...++..|+-+|.+|. |+||++|+++|.... +
T Consensus 697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~--t~~~~s~e~LdeAl~masld-Hpnl~RLLgvc~~s~-~ 772 (1177)
T KOG1025|consen 697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEF--TSPKASIELLDEALRMASLD-HPNLLRLLGVCMLST-L 772 (1177)
T ss_pred hhhhhceeccccceeEEeeeEecCCceecceeEEEEeecc--CCchhhHHHHHHHHHHhcCC-CchHHHHhhhcccch-H
Confidence 456688999999999999987653 223457999998654 55556678999999999998 999999999998766 7
Q ss_pred EEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccccC
Q 014210 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (429)
Q Consensus 235 ~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~ 314 (429)
-||++||++|.|+||++.+...+-.+....|..||++||.|||++++|||||-..|||+ .+-..+||.|||+++...
T Consensus 773 qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLV---ksP~hvkitdfgla~ll~ 849 (1177)
T KOG1025|consen 773 QLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLV---KSPNHVKITDFGLAKLLA 849 (1177)
T ss_pred HHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheee---cCCCeEEEEecchhhccC
Confidence 89999999999999999999999999999999999999999999999999999999999 566789999999999887
Q ss_pred CCccccc---cccCCcccCccccc-CCCCCcccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCC
Q 014210 315 PDERLND---IVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLS 389 (429)
Q Consensus 315 ~~~~~~~---~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 389 (429)
.+...-. ....+-|||-|.++ ..|+.++|||||||++||++| |..||.+...+++-..+.+++. .. ..+.++
T Consensus 850 ~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geR-Ls--qPpiCt 926 (1177)
T KOG1025|consen 850 PDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGER-LS--QPPICT 926 (1177)
T ss_pred cccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhcccc-CC--CCCCcc
Confidence 6653222 22345699999776 679999999999999999998 9999999888777665555443 22 235789
Q ss_pred HHHHHHHHHhcccCccCcCCHHHHHhh
Q 014210 390 SEARDFVKRLLNKDPRKRLTAAQALSE 416 (429)
Q Consensus 390 ~~~~~li~~~L~~dP~~Rps~~~iL~~ 416 (429)
-++..++-+||..|+..||+++++...
T Consensus 927 iDVy~~mvkCwmid~~~rp~fkel~~~ 953 (1177)
T KOG1025|consen 927 IDVYMVMVKCWMIDADSRPTFKELAEE 953 (1177)
T ss_pred HHHHHHHHHHhccCcccCccHHHHHHH
Confidence 999999999999999999999988653
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-37 Score=277.78 Aligned_cols=261 Identities=29% Similarity=0.474 Sum_probs=208.7
Q ss_pred eeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeC-----
Q 014210 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT----- 231 (429)
Q Consensus 157 y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~----- 231 (429)
.+-.+.||.|.||.||.+.+-. +|+.||+|.+.. ...+-..-+++.+|+++|.-++ |.|++..++.-.-.
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPR---dgrrvalkK~pn-vfq~L~s~krvFre~kmLcfFk-HdNVLSaLDILQPph~dfF 129 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPR---SGKRVALKKMPN-VFQNLASCKRVFREIKMLSSFR-HDNVLSLLDILQPANPSFF 129 (449)
T ss_pred CCCCCcccccceeEEEeccCCC---CccchhHhhcch-HHHHHHHHHHHHHHHHHHHhhc-cccHHHHHHhcCCCCchHH
Confidence 3445789999999999988665 699999998753 2344455678899999999998 99999998876543
Q ss_pred CeEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCcc
Q 014210 232 DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (429)
Q Consensus 232 ~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~ 311 (429)
..+|+++|.|.. +|.+.|.. ...++.+.++-++.||++||+|||+.+|.||||||.|.|+ +.|-++||||||+++
T Consensus 130 qEiYV~TELmQS-DLHKIIVS-PQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLV---NSNCvLKICDFGLAR 204 (449)
T KOG0664|consen 130 QELYVLTELMQS-DLHKIIVS-PQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLV---NSNCILKICDFGLAR 204 (449)
T ss_pred HHHHHHHHHHHh-hhhheecc-CCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEe---ccCceEEeccccccc
Confidence 357889999954 77776543 3568999999999999999999999999999999999999 788899999999999
Q ss_pred ccCCCcc--ccccccCCcccCcccccC--CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhc-----------
Q 014210 312 FVRPDER--LNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKA----------- 376 (429)
Q Consensus 312 ~~~~~~~--~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~----------- 376 (429)
....++. ....+-|.+|+|||++.| .|+...||||.||++.||+..+..|........++.|...
T Consensus 205 vee~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ 284 (449)
T KOG0664|consen 205 TWDQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKY 284 (449)
T ss_pred ccchhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHH
Confidence 8766553 345678999999999875 5999999999999999999999999777665554443321
Q ss_pred ------------CCCCCCCC-------CCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhccceeee
Q 014210 377 ------------DPSFDEAP-------WPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLICYQSYLFF 427 (429)
Q Consensus 377 ------------~~~~~~~~-------~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~~~~~~ 427 (429)
....+... ...-..+..+++..+|..||++|.+..+++.|+++..-++.|+
T Consensus 285 ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~R~r~~ 354 (449)
T KOG0664|consen 285 ACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEGRLRFH 354 (449)
T ss_pred HhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccccccceeee
Confidence 11111000 0123457889999999999999999999999999988887664
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=274.72 Aligned_cols=255 Identities=28% Similarity=0.495 Sum_probs=206.2
Q ss_pred ccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEe--
Q 014210 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED-- 230 (429)
Q Consensus 153 ~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~-- 230 (429)
...+|.-++.+|.|.- .|+.+- +...++.||+|.+... ......-++..+|+.++..+. |+||++++.+|.-
T Consensus 15 v~~Ry~nL~p~~~g~~-~v~~a~---D~v~~~~v~ikk~~~p-f~n~~~akra~rel~l~~~v~-~~nii~l~n~ftP~~ 88 (369)
T KOG0665|consen 15 VPKRYVNLKPIGSGAQ-IVVAAF---DQVLGRPVAIKKLSRP-FQNQTHAKRAYRELKLMKCVN-HKNIISLLNVFTPQK 88 (369)
T ss_pred eeeeeeeecccCCCCc-eEEecc---hhhccCceehhhhcCc-cccCccchhhhhhhhhhhhhc-ccceeeeeeccCccc
Confidence 3467888899999987 565554 3346899999988654 333444467789999999998 9999999999863
Q ss_pred ----CCeEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEee
Q 014210 231 ----TDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAID 306 (429)
Q Consensus 231 ----~~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~D 306 (429)
....|+|||+|.. +|...++ -.++-..+..|+.|++.|++|||+.||+||||||+||++ ..+..+||.|
T Consensus 89 ~l~~~~e~y~v~e~m~~-nl~~vi~---~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv---~~~~~lKi~d 161 (369)
T KOG0665|consen 89 TLEEFQEVYLVMELMDA-NLCQVIL---MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVV---NSDCTLKILD 161 (369)
T ss_pred cHHHHHhHHHHHHhhhh-HHHHHHH---HhcchHHHHHHHHHHHHHHHHHHhcceeecccCccccee---cchhheeecc
Confidence 3468999999965 8888776 457889999999999999999999999999999999999 7788899999
Q ss_pred cCCccccCCCccccccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCC-------
Q 014210 307 FGLSDFVRPDERLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADP------- 378 (429)
Q Consensus 307 FGla~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~------- 378 (429)
||+++....+-....++.|.+|.|||++-+ .+...+||||+||++.||++|+..|.+....+.+.++...-.
T Consensus 162 fg~ar~e~~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~ 241 (369)
T KOG0665|consen 162 FGLARTEDTDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFM 241 (369)
T ss_pred chhhcccCcccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHH
Confidence 999998887767788999999999998764 588999999999999999999999987766555444322111
Q ss_pred ------------------------CCCCCCCCC-------CCHHHHHHHHHhcccCccCcCCHHHHHhhHhhh
Q 014210 379 ------------------------SFDEAPWPS-------LSSEARDFVKRLLNKDPRKRLTAAQALSELLIC 420 (429)
Q Consensus 379 ------------------------~~~~~~~~~-------~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~ 420 (429)
.++...|+. -+..+.+|+.+||-.||++|.+++++|+|++++
T Consensus 242 ~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~ 314 (369)
T KOG0665|consen 242 KQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK 314 (369)
T ss_pred HHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeee
Confidence 111111111 134678999999999999999999999999997
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=295.79 Aligned_cols=259 Identities=29% Similarity=0.468 Sum_probs=212.0
Q ss_pred ccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCC
Q 014210 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (429)
Q Consensus 153 ~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~ 232 (429)
-.++|+++..||.|.||.||+++++. +++..|||+++... .....-+..|+-+++..+ |+|||.+++.+...+
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~---s~elaavkvVkLep---~dd~~~iqqei~~~~dc~-h~nivay~gsylr~d 85 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKR---SGELAAVKVVKLEP---GDDFSGIQQEIGMLRDCR-HPNIVAYFGSYLRRD 85 (829)
T ss_pred CccchhheeeecCCcccchhhhcccc---cCchhhheeeeccC---CccccccccceeeeecCC-CcChHHHHhhhhhhc
Confidence 35789999999999999999999887 79999999996543 333455778999999998 999999999999999
Q ss_pred eEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccc
Q 014210 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (429)
Q Consensus 233 ~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~ 312 (429)
.+||+||||.||+|.+.. .-.+.+++.++..+++..++||+|||+.|=+|||||-.|||+ .+.+.+||.|||.+..
T Consensus 86 klwicMEycgggslQdiy-~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanill---td~gDvklaDfgvsaq 161 (829)
T KOG0576|consen 86 KLWICMEYCGGGSLQDIY-HVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILL---TDEGDVKLADFGVSAQ 161 (829)
T ss_pred CcEEEEEecCCCccccee-eecccchhHHHHHHHhhhhccchhhhcCCcccccccccceee---cccCceeecccCchhh
Confidence 999999999999998844 556789999999999999999999999999999999999999 6788899999998755
Q ss_pred cCCC-ccccccccCCcccCcccc----cCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCC-CCCC
Q 014210 313 VRPD-ERLNDIVGSAYYVAPEVL----HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDE-APWP 386 (429)
Q Consensus 313 ~~~~-~~~~~~~gt~~y~aPE~~----~~~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~-~~~~ 386 (429)
.... .......||++|||||+. .+.|...+|||++|++..|+--.+.|.........+...-+..+..+. .-..
T Consensus 162 itati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~ 241 (829)
T KOG0576|consen 162 ITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKT 241 (829)
T ss_pred hhhhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCc
Confidence 4322 233567899999999975 367999999999999999999888886544433222222222211111 1123
Q ss_pred CCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhcc
Q 014210 387 SLSSEARDFVKRLLNKDPRKRLTAAQALSELLICYQ 422 (429)
Q Consensus 387 ~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~ 422 (429)
.+++-|.+|++.+|.++|++||+++.+|.|+|....
T Consensus 242 kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~ 277 (829)
T KOG0576|consen 242 KWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT 277 (829)
T ss_pred cchHHHHHHHHHHhcCCCccCCChhhheeceeeccc
Confidence 578899999999999999999999999999987643
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=278.77 Aligned_cols=201 Identities=32% Similarity=0.590 Sum_probs=174.9
Q ss_pred CceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHH-----HHHHHHHHHHhc--CCCCcceEEEE
Q 014210 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIED-----VRREVKILRALT--GHNNLVKFFDA 227 (429)
Q Consensus 155 ~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~-----~~~Ei~il~~l~--~h~nIv~l~~~ 227 (429)
..|..++.+|+|+||.|++|.+++ +...|+||.|.|.+.......++ +-.||+||..|+ .|+||++++++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~---n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdf 637 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKE---NNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDF 637 (772)
T ss_pred ccceeeeeccccccceEEEeeecc---cceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhe
Confidence 359999999999999999999988 47899999998765544333322 457999999997 48999999999
Q ss_pred EEeCCeEEEEEEec-CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEee
Q 014210 228 YEDTDNVYVVMELC-EGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAID 306 (429)
Q Consensus 228 ~~~~~~~~lv~E~~-~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~D 306 (429)
|++++++||+||-. +|-+|+++| +....++|..++.|++|++.|+++||+.||||||||-+||.+ +.+|.+||+|
T Consensus 638 FEddd~yyl~te~hg~gIDLFd~I-E~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenviv---d~~g~~klid 713 (772)
T KOG1152|consen 638 FEDDDYYYLETEVHGEGIDLFDFI-EFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIV---DSNGFVKLID 713 (772)
T ss_pred eecCCeeEEEecCCCCCcchhhhh-hccCccchHHHHHHHHHHHhccccccccCceecccccccEEE---ecCCeEEEee
Confidence 99999999999976 456899988 556789999999999999999999999999999999999999 8999999999
Q ss_pred cCCccccCCCccccccccCCcccCcccccCC--CCCcccHHHHHHHHHHHHcCCCCCCC
Q 014210 307 FGLSDFVRPDERLNDIVGSAYYVAPEVLHRS--YSTEADVWSIGVIAYILLCGSRPFWA 363 (429)
Q Consensus 307 FGla~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~sDiwSlGvll~elltg~~Pf~~ 363 (429)
||.+.... ......++||..|.|||++.|. .+..-|||+||++||-++....||++
T Consensus 714 fgsaa~~k-sgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 714 FGSAAYTK-SGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred ccchhhhc-CCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 99986654 4456778999999999999864 47778999999999999999999864
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=272.66 Aligned_cols=261 Identities=26% Similarity=0.431 Sum_probs=202.7
Q ss_pred ccccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEe
Q 014210 151 KHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED 230 (429)
Q Consensus 151 ~~~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~ 230 (429)
..+.+.|.++++||+|.|+.||++.+.........||+|.+... ..-.++.+|+++|..+.++.||+++.+++..
T Consensus 32 p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~t-----s~p~ri~~El~~L~~~gG~~ni~~~~~~~rn 106 (418)
T KOG1167|consen 32 PFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRT-----SSPSRILNELEMLYRLGGSDNIIKLNGCFRN 106 (418)
T ss_pred hhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccc-----cCchHHHHHHHHHHHhccchhhhcchhhhcc
Confidence 35568899999999999999999987764345789999988432 2235688999999999999999999999999
Q ss_pred CCeEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCc
Q 014210 231 TDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS 310 (429)
Q Consensus 231 ~~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla 310 (429)
++++.+||||++..+..+++ ..++...++.++..++.||.++|.+|||||||||.|+|.+ ...+.-.|+|||+|
T Consensus 107 nd~v~ivlp~~~H~~f~~l~----~~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n--~~t~rg~LvDFgLA 180 (418)
T KOG1167|consen 107 NDQVAIVLPYFEHDRFRDLY----RSLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYN--RRTQRGVLVDFGLA 180 (418)
T ss_pred CCeeEEEecccCccCHHHHH----hcCCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccc--cccCCceEEechhH
Confidence 99999999999988877766 3467999999999999999999999999999999999997 34556788999998
Q ss_pred cccC-----------------C--Cc--------------------------cccccccCCcccCcccccC--CCCCccc
Q 014210 311 DFVR-----------------P--DE--------------------------RLNDIVGSAYYVAPEVLHR--SYSTEAD 343 (429)
Q Consensus 311 ~~~~-----------------~--~~--------------------------~~~~~~gt~~y~aPE~~~~--~~~~~sD 343 (429)
.... . +. ......||++|.|||++.+ .-++++|
T Consensus 181 ~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiD 260 (418)
T KOG1167|consen 181 QRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAID 260 (418)
T ss_pred HHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccc
Confidence 6210 0 00 0011469999999999874 5788999
Q ss_pred HHHHHHHHHHHHcCCCCCCCCChH-HH------------HHHHHh--cC-------------------------------
Q 014210 344 VWSIGVIAYILLCGSRPFWARTES-GI------------FRAVLK--AD------------------------------- 377 (429)
Q Consensus 344 iwSlGvll~elltg~~Pf~~~~~~-~~------------~~~i~~--~~------------------------------- 377 (429)
|||.||+++.+++++.||....++ +. +++... +.
T Consensus 261 iws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~ 340 (418)
T KOG1167|consen 261 IWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSR 340 (418)
T ss_pred eeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccccc
Confidence 999999999999999999432211 00 000000 00
Q ss_pred C--CCCCCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhcc
Q 014210 378 P--SFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLICYQ 422 (429)
Q Consensus 378 ~--~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~ 422 (429)
. ...+......+..+.||+.+||..||.+|.+++++|.|+||...
T Consensus 341 q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~ 387 (418)
T KOG1167|consen 341 QPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEA 387 (418)
T ss_pred ccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcch
Confidence 0 00001112245578999999999999999999999999999643
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-31 Score=241.72 Aligned_cols=211 Identities=44% Similarity=0.809 Sum_probs=183.5
Q ss_pred eeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEecC
Q 014210 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCE 242 (429)
Q Consensus 163 IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~~lv~E~~~ 242 (429)
||+|++|.||++.... .|+.++||++....... ..+.+.+|+++++.+. |++|+++++++......+++|||++
T Consensus 1 l~~g~~~~v~~~~~~~---~~~~~~~K~~~~~~~~~--~~~~~~~e~~~~~~l~-~~~i~~~~~~~~~~~~~~~~~e~~~ 74 (215)
T cd00180 1 LGEGGFGTVYLARDKK---TGKKVAIKIIKKEDSSS--LLEELLREIEILKKLN-HPNIVKLYGVFEDENHLYLVMEYCE 74 (215)
T ss_pred CCcCCceEEEEEEecC---CCcEEEEEEeccccchh--HHHHHHHHHHHHHhcC-CCCeeeEeeeeecCCeEEEEEecCC
Confidence 6899999999998765 58899999986543221 4567899999999998 8999999999999999999999999
Q ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCC-CceEEEeecCCccccCCCc-ccc
Q 014210 243 GGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDE-NSVLKAIDFGLSDFVRPDE-RLN 320 (429)
Q Consensus 243 ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~-~~~vkL~DFGla~~~~~~~-~~~ 320 (429)
+++|.+++......+++..++.++.+++++|.+||+.|++|+||+|.||++ +. ++.++|+|||.+....... ...
T Consensus 75 ~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~---~~~~~~~~l~d~~~~~~~~~~~~~~~ 151 (215)
T cd00180 75 GGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILL---DSDNGKVKLADFGLSKLLTSDKSLLK 151 (215)
T ss_pred CCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEE---eCCCCcEEEecCCceEEccCCcchhh
Confidence 899999886554578999999999999999999999999999999999999 45 6789999999997664332 133
Q ss_pred ccccCCcccCcccccC--CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHH
Q 014210 321 DIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKR 398 (429)
Q Consensus 321 ~~~gt~~y~aPE~~~~--~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ 398 (429)
...+...|++||.+.. .++.+.|+|+||+++++| .++.+++..
T Consensus 152 ~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-----------------------------------~~~~~~l~~ 196 (215)
T cd00180 152 TIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-----------------------------------PELKDLIRK 196 (215)
T ss_pred cccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH-----------------------------------HHHHHHHHH
Confidence 4567889999998875 678899999999999998 678999999
Q ss_pred hcccCccCcCCHHHHHhhH
Q 014210 399 LLNKDPRKRLTAAQALSEL 417 (429)
Q Consensus 399 ~L~~dP~~Rps~~~iL~~~ 417 (429)
||+.||++||++.+++.++
T Consensus 197 ~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 197 MLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred HhhCCcccCcCHHHHhhCC
Confidence 9999999999999999764
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.9e-33 Score=251.51 Aligned_cols=256 Identities=25% Similarity=0.398 Sum_probs=203.4
Q ss_pred ccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEE-EEEeC
Q 014210 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFD-AYEDT 231 (429)
Q Consensus 153 ~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~-~~~~~ 231 (429)
+.+.|.+.+.||+|.||.+.+++++. +.+.+++|.+.+. ...+++|.+|..---.|..|.||+.-|+ .|+..
T Consensus 22 l~d~y~I~k~lgeG~FgkIlL~eHr~---s~t~ivlKavp~p----~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~ 94 (378)
T KOG1345|consen 22 LEDVYTINKQLGEGRFGKILLAEHRQ---SKTRIVLKAVPRP----QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTS 94 (378)
T ss_pred hhhhhhHHHHhcccceeeEEeeeccC---CceEEEeeccCcc----hhhHHHHHHHhccceeeccchhhhHHHHHHhhcC
Confidence 56789999999999999999999887 6889999998654 3345788899888778888999998776 46777
Q ss_pred CeEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCcc
Q 014210 232 DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (429)
Q Consensus 232 ~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~ 311 (429)
+..+++|||++.|+|...+. ...+-|...++++.|+++||.|+|++++||||||.+||||...| ..+|||||||+.+
T Consensus 95 d~YvF~qE~aP~gdL~snv~--~~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~d-f~rvKlcDFG~t~ 171 (378)
T KOG1345|consen 95 DAYVFVQEFAPRGDLRSNVE--AAGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDAD-FYRVKLCDFGLTR 171 (378)
T ss_pred ceEEEeeccCccchhhhhcC--cccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCC-ccEEEeeeccccc
Confidence 88899999999999988763 34588999999999999999999999999999999999997544 4489999999986
Q ss_pred ccCCCccccccccCCcccCccccc----CC--CCCcccHHHHHHHHHHHHcCCCCCCCCC----hHHHHHHHHhcCCCCC
Q 014210 312 FVRPDERLNDIVGSAYYVAPEVLH----RS--YSTEADVWSIGVIAYILLCGSRPFWART----ESGIFRAVLKADPSFD 381 (429)
Q Consensus 312 ~~~~~~~~~~~~gt~~y~aPE~~~----~~--~~~~sDiwSlGvll~elltg~~Pf~~~~----~~~~~~~i~~~~~~~~ 381 (429)
... ........+..|.+||... +. ....+|||.||+++|.++||..||.... .-..+.+.++....-.
T Consensus 172 k~g--~tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~ 249 (378)
T KOG1345|consen 172 KVG--TTVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPAL 249 (378)
T ss_pred ccC--ceehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccC
Confidence 552 3333444566799999753 22 4667899999999999999999995321 1223344444443333
Q ss_pred CCCCCCCCHHHHHHHHHhcccCccCc---CCHHHHHhhHhhh
Q 014210 382 EAPWPSLSSEARDFVKRLLNKDPRKR---LTAAQALSELLIC 420 (429)
Q Consensus 382 ~~~~~~~s~~~~~li~~~L~~dP~~R---ps~~~iL~~~~~~ 420 (429)
...+.-+++.+..+.++-|..++++| .++......+|..
T Consensus 250 P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E 291 (378)
T KOG1345|consen 250 PKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKE 291 (378)
T ss_pred chhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHH
Confidence 34455689999999999999999999 6666666777764
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.7e-31 Score=241.09 Aligned_cols=212 Identities=42% Similarity=0.746 Sum_probs=178.4
Q ss_pred eeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEE
Q 014210 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYV 236 (429)
Q Consensus 157 y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~~l 236 (429)
|.+.+.||.|++|.||++.... +++.+|+|.+...... ...+.+.+|++.++++. |+|++++++++......++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~---~~~~~~iK~~~~~~~~--~~~~~~~~e~~~~~~~~-~~~i~~~~~~~~~~~~~~~ 74 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKG---TGELVAVKVLKKEKTE--KQREEFLREIRILKKLK-HPNIVKLYGVFEDPEPLYL 74 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcC---CCcEEEEEeeccccch--HHHHHHHHHHHHHHhCC-CCChhhheeeeecCCceEE
Confidence 5678999999999999998775 4789999998754322 35678999999999997 9999999999999999999
Q ss_pred EEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccccCCC
Q 014210 237 VMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPD 316 (429)
Q Consensus 237 v~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~ 316 (429)
++||+++++|.+++......+++..++.++.+++.+|.+||+.+++|+||++.||++ +.++.++|+|||.+......
T Consensus 75 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v---~~~~~~~l~d~g~~~~~~~~ 151 (225)
T smart00221 75 VMEYCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILL---GMDGLVKLADFGLARFIHRD 151 (225)
T ss_pred EEeccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCCCEEEeeCceeeEecCc
Confidence 999999999999886544338999999999999999999999999999999999999 66688999999998876544
Q ss_pred c--cccccccCCcccCcccc-c-CCCCCcccHHHHHHHHHHHHcCCCCCCC-CChH-HHHHHHHhcC
Q 014210 317 E--RLNDIVGSAYYVAPEVL-H-RSYSTEADVWSIGVIAYILLCGSRPFWA-RTES-GIFRAVLKAD 377 (429)
Q Consensus 317 ~--~~~~~~gt~~y~aPE~~-~-~~~~~~sDiwSlGvll~elltg~~Pf~~-~~~~-~~~~~i~~~~ 377 (429)
. ......++..|++||.+ . ..++.++|||+||+++++|++|+.||.. .... .+.+.+....
T Consensus 152 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 218 (225)
T smart00221 152 LAALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFGV 218 (225)
T ss_pred ccccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcCC
Confidence 3 33456788899999987 3 3577799999999999999999999977 3333 4555554443
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=247.05 Aligned_cols=257 Identities=20% Similarity=0.262 Sum_probs=207.6
Q ss_pred cccCceeEeceeeccCceEEEEEEEecCcc--cCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEE
Q 014210 152 HFANKYELGEEVGRGHFGYTCAAKFKKGEL--KGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYE 229 (429)
Q Consensus 152 ~~~~~y~~~~~IG~G~fg~V~~~~~~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~ 229 (429)
....++++..++-+|.||.||.|...+... +.+.|-+|.++.. .+......+..|-..+..+. |+|+..+.+++.
T Consensus 281 v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~--AS~iQv~~~L~es~lly~~s-H~nll~V~~V~i 357 (563)
T KOG1024|consen 281 VQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQH--ASQIQVNLLLQESMLLYGAS-HPNLLSVLGVSI 357 (563)
T ss_pred hhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhc--ccHHHHHHHHHHHHHHhcCc-CCCccceeEEEe
Confidence 345779999999999999999997665332 4567888887644 56777788999999999998 999999999887
Q ss_pred eC-CeEEEEEEecCCCcHHHHHHh-----cC--CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCce
Q 014210 230 DT-DNVYVVMELCEGGELLDRILS-----RG--GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSV 301 (429)
Q Consensus 230 ~~-~~~~lv~E~~~ggsL~~~i~~-----~~--~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~ 301 (429)
++ ...+.++.++.-|+|..++.. .. ..++-.++..++.|++.|++|||++||||.||-..|++| |+..+
T Consensus 358 e~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvI---dd~Lq 434 (563)
T KOG1024|consen 358 EDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVI---DDQLQ 434 (563)
T ss_pred eccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhccee---hhhee
Confidence 54 567888999988999988862 21 247778889999999999999999999999999999999 88899
Q ss_pred EEEeecCCccccCCCcccc---ccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhc
Q 014210 302 LKAIDFGLSDFVRPDERLN---DIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKA 376 (429)
Q Consensus 302 vkL~DFGla~~~~~~~~~~---~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~ellt-g~~Pf~~~~~~~~~~~i~~~ 376 (429)
|||+|=.+++.+.+.+... ..-....||++|.+. ..|+..+|+|||||+||||+| |+.||..-+..++..-+ ++
T Consensus 435 VkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~yl-kd 513 (563)
T KOG1024|consen 435 VKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYL-KD 513 (563)
T ss_pred EEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHH-hc
Confidence 9999999998765444221 112345799999887 579999999999999999997 89999777766655444 33
Q ss_pred CCCCCCCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhH
Q 014210 377 DPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSEL 417 (429)
Q Consensus 377 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~ 417 (429)
....... -+++.|+..++..||..+|++||+.+|+...+
T Consensus 514 GyRlaQP--~NCPDeLf~vMacCWallpeeRPsf~Qlv~cL 552 (563)
T KOG1024|consen 514 GYRLAQP--FNCPDELFTVMACCWALLPEERPSFSQLVICL 552 (563)
T ss_pred cceecCC--CCCcHHHHHHHHHHHhcCcccCCCHHHHHHHH
Confidence 3333322 36999999999999999999999999987654
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.7e-31 Score=286.57 Aligned_cols=197 Identities=18% Similarity=0.246 Sum_probs=147.6
Q ss_pred CCcceEEEEE-------EeCCeEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcE
Q 014210 219 NNLVKFFDAY-------EDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENF 291 (429)
Q Consensus 219 ~nIv~l~~~~-------~~~~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NI 291 (429)
.||++++++| .+.+.++++|||+ +++|.+++......+++..++.++.||++||.|||++|||||||||+||
T Consensus 33 ~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP~Ni 111 (793)
T PLN00181 33 DYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVRPSCF 111 (793)
T ss_pred HHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCCchhE
Confidence 6888888877 2334678889988 5699999866566799999999999999999999999999999999999
Q ss_pred EEee----------------cCCCceEEEeecCCccccCCCc-----------------cccccccCCcccCccccc-CC
Q 014210 292 LFTT----------------KDENSVLKAIDFGLSDFVRPDE-----------------RLNDIVGSAYYVAPEVLH-RS 337 (429)
Q Consensus 292 Ll~~----------------~~~~~~vkL~DFGla~~~~~~~-----------------~~~~~~gt~~y~aPE~~~-~~ 337 (429)
||.. .+.++.+||+|||+++...... .....+||+.|||||++. ..
T Consensus 112 Ll~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~ 191 (793)
T PLN00181 112 VMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGSS 191 (793)
T ss_pred EEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhccCC
Confidence 9942 1234567788888776432100 011246899999999876 46
Q ss_pred CCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhH
Q 014210 338 YSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSEL 417 (429)
Q Consensus 338 ~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~ 417 (429)
++.++|||||||+||||++|..|+.... ..+..+.... .+... .....+..+++.+||++||.+||++.++|+|+
T Consensus 192 ~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~~--~~~~~-~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h~ 266 (793)
T PLN00181 192 SNCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHRV--LPPQI-LLNWPKEASFCLWLLHPEPSCRPSMSELLQSE 266 (793)
T ss_pred CCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHhh--cChhh-hhcCHHHHHHHHHhCCCChhhCcChHHHhhch
Confidence 9999999999999999999988875322 1222221111 11111 11235677999999999999999999999999
Q ss_pred hhhc
Q 014210 418 LICY 421 (429)
Q Consensus 418 ~~~~ 421 (429)
||..
T Consensus 267 ~~~~ 270 (793)
T PLN00181 267 FINE 270 (793)
T ss_pred hhhh
Confidence 9964
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.9e-29 Score=223.45 Aligned_cols=250 Identities=22% Similarity=0.298 Sum_probs=206.1
Q ss_pred cCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~ 233 (429)
..+|+++++||.|+||.+|+|.... +|..||||+-+... .. .++..|..+++.|++-..|..+..++.+.++
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~---~ge~VAiK~Es~~a-~h----pqL~yEskvY~iL~~g~GiP~i~~y~~e~~y 85 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISIT---SGEEVAIKLESSKA-KH----PQLLYESKVYRILQGGVGIPHIRHYGTEKDY 85 (341)
T ss_pred ccceEEEEeecCCchhheeeeeecc---CCceEEEEeecccC-CC----cchhHHHHHHHHhccCCCCchhhhhcccccc
Confidence 5789999999999999999998766 69999999975432 22 3577899999999988899999999999999
Q ss_pred EEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCcccc
Q 014210 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (429)
Q Consensus 234 ~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~ 313 (429)
-.+|||.+ |-+|.+.+.--...++..++..++-|++.-++|+|.+++|||||||+|+|++-......+.|+|||+++.+
T Consensus 86 nvlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky 164 (341)
T KOG1163|consen 86 NVLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY 164 (341)
T ss_pred ceeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhh
Confidence 99999999 78999988777788999999999999999999999999999999999999977667778999999999987
Q ss_pred CCCcc--------ccccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHcCCCCCCCCChH---HHHHHHHhcCCCCC
Q 014210 314 RPDER--------LNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTES---GIFRAVLKADPSFD 381 (429)
Q Consensus 314 ~~~~~--------~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~elltg~~Pf~~~~~~---~~~~~i~~~~~~~~ 381 (429)
.+... .....||.+|.+=....+ .-+.+.|+-|+|.+|..+.-|.+||.+.... ..+.+|.+.....+
T Consensus 165 ~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~ 244 (341)
T KOG1163|consen 165 RDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTP 244 (341)
T ss_pred ccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCC
Confidence 54332 234679999998776654 4678899999999999999999999876544 34445554443322
Q ss_pred -CCCCCCCCHHHHHHHHHhcccCccCcCCHHH
Q 014210 382 -EAPWPSLSSEARDFVKRLLNKDPRKRLTAAQ 412 (429)
Q Consensus 382 -~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~ 412 (429)
+..-.+++.||.-.+..|-...-++-|+..-
T Consensus 245 ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~y 276 (341)
T KOG1163|consen 245 IEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMY 276 (341)
T ss_pred HHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHH
Confidence 2223578899999999998888888888753
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.9e-28 Score=236.60 Aligned_cols=256 Identities=23% Similarity=0.290 Sum_probs=198.6
Q ss_pred ceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhc---CCCCcceEEEEE-EeC
Q 014210 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALT---GHNNLVKFFDAY-EDT 231 (429)
Q Consensus 156 ~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~---~h~nIv~l~~~~-~~~ 231 (429)
+|.+.++||+|+||.||+|...... ...+|+|+......... ..+..|+.++..+. +-.++..+++.+ ..+
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~--~~~~a~K~e~~~~~~~~---~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~ 93 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEK--NKEYAKKLEKKELGSKP---SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTE 93 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCC--CeeEEEEEEEecccCCC---ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCC
Confidence 8999999999999999999877643 46899998755321111 15778999999987 246999999999 578
Q ss_pred CeEEEEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCC--CceEEEeecC
Q 014210 232 DNVYVVMELCEGGELLDRILSRG-GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDE--NSVLKAIDFG 308 (429)
Q Consensus 232 ~~~~lv~E~~~ggsL~~~i~~~~-~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~--~~~vkL~DFG 308 (429)
+..||||+.+ |.+|.+...... +.++..++.+|+.|++.+|++||+.|+|||||||+|++++..+. ...++|.|||
T Consensus 94 ~~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfG 172 (322)
T KOG1164|consen 94 DFNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFG 172 (322)
T ss_pred ceeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecC
Confidence 8899999998 789999765554 78999999999999999999999999999999999999975432 2679999999
Q ss_pred Ccc--ccCCCc--------c-ccccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhc
Q 014210 309 LSD--FVRPDE--------R-LNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKA 376 (429)
Q Consensus 309 la~--~~~~~~--------~-~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~ 376 (429)
+++ .+.... . .....||..|.++.+..+ ..+.+.|+||++.++.||+.|.+||...........+.+.
T Consensus 173 lar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~ 252 (322)
T KOG1164|consen 173 LARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKD 252 (322)
T ss_pred CCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHH
Confidence 998 321111 1 123459999999998875 6899999999999999999999999765543222222221
Q ss_pred CCCCCCC-CCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhH
Q 014210 377 DPSFDEA-PWPSLSSEARDFVKRLLNKDPRKRLTAAQALSEL 417 (429)
Q Consensus 377 ~~~~~~~-~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~ 417 (429)
....... .....+.++.++...+-..+..++|....+....
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l 294 (322)
T KOG1164|consen 253 PRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELL 294 (322)
T ss_pred hhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHH
Confidence 1111111 2234568899999988889999999999887664
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-28 Score=218.96 Aligned_cols=163 Identities=28% Similarity=0.412 Sum_probs=130.2
Q ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccccCCCccccccc
Q 014210 244 GELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIV 323 (429)
Q Consensus 244 gsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~ 323 (429)
|+|.+++..++..+++..++.|+.||+.||.|||+++ ||+|||+ +.++.+|+ ||++....... ..
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~---~~~~~~~~--fG~~~~~~~~~----~~ 65 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILL---TWDGLLKL--DGSVAFKTPEQ----SR 65 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeE---cCccceee--ccceEeecccc----CC
Confidence 6899988776778999999999999999999999998 9999999 77888999 99987664332 26
Q ss_pred cCCcccCccccc-CCCCCcccHHHHHHHHHHHHcCCCCCCCCChH-HHHHHHHhcCCCCCC---CCCCCCCH--HHHHHH
Q 014210 324 GSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTES-GIFRAVLKADPSFDE---APWPSLSS--EARDFV 396 (429)
Q Consensus 324 gt~~y~aPE~~~-~~~~~~sDiwSlGvll~elltg~~Pf~~~~~~-~~~~~i~~~~~~~~~---~~~~~~s~--~~~~li 396 (429)
||+.|||||++. +.++.++|||||||++|||++|+.||...... ..+..+......... .....++. ++.+||
T Consensus 66 g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 145 (176)
T smart00750 66 VDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFM 145 (176)
T ss_pred CcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHH
Confidence 899999999886 46899999999999999999999999765432 333333332221111 01112333 699999
Q ss_pred HHhcccCccCcCCHHHHHhhHhhhc
Q 014210 397 KRLLNKDPRKRLTAAQALSELLICY 421 (429)
Q Consensus 397 ~~~L~~dP~~Rps~~~iL~~~~~~~ 421 (429)
.+||..||++||++.+++.|+|+..
T Consensus 146 ~~cl~~~p~~Rp~~~~ll~~~~~~~ 170 (176)
T smart00750 146 RVCASRLPQRREAANHYLAHCRALF 170 (176)
T ss_pred HHHHhcccccccCHHHHHHHHHHHH
Confidence 9999999999999999999999864
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-26 Score=222.11 Aligned_cols=256 Identities=36% Similarity=0.621 Sum_probs=206.1
Q ss_pred eeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEE
Q 014210 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYV 236 (429)
Q Consensus 157 y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~~l 236 (429)
|.+.+.||.|+||.||++... ..+++|.+.............+.+|+.++..+..+++|+++++.+......++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~------~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 75 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR------KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYL 75 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec------cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEE
Confidence 788999999999999999865 67999999776544444678899999999999933489999999988888899
Q ss_pred EEEecCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCc-eEEEeecCCcccc
Q 014210 237 VMELCEGGELLDRILSRG--GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENS-VLKAIDFGLSDFV 313 (429)
Q Consensus 237 v~E~~~ggsL~~~i~~~~--~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~-~vkL~DFGla~~~ 313 (429)
+++++.++++.+.+.... ..+.......++.|++.++.|+|+.+++||||||+||++ +... .++++|||++...
T Consensus 76 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~---~~~~~~~~l~dfg~~~~~ 152 (384)
T COG0515 76 VMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILL---DRDGRVVKLIDFGLAKLL 152 (384)
T ss_pred EEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeee---cCCCCeEEEeccCcceec
Confidence 999999999986654433 279999999999999999999999999999999999999 5555 7999999999765
Q ss_pred CCCc-------cccccccCCcccCcccccC----CCCCcccHHHHHHHHHHHHcCCCCCCCCCh----HHHHHHHHhcCC
Q 014210 314 RPDE-------RLNDIVGSAYYVAPEVLHR----SYSTEADVWSIGVIAYILLCGSRPFWARTE----SGIFRAVLKADP 378 (429)
Q Consensus 314 ~~~~-------~~~~~~gt~~y~aPE~~~~----~~~~~sDiwSlGvll~elltg~~Pf~~~~~----~~~~~~i~~~~~ 378 (429)
.... ......|+..|++||.+.+ .+....|+|++|++++++++|..||..... ......+.....
T Consensus 153 ~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 232 (384)
T COG0515 153 PDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPT 232 (384)
T ss_pred CCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCC
Confidence 4433 2466789999999998864 578899999999999999999999876653 333333333332
Q ss_pred C-CCCCCCCCC----CHHHHHHHHHhcccCccCcCCHHHHHhhHhhhc
Q 014210 379 S-FDEAPWPSL----SSEARDFVKRLLNKDPRKRLTAAQALSELLICY 421 (429)
Q Consensus 379 ~-~~~~~~~~~----s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~ 421 (429)
. ......... ...+.+++..|+..+|..|.+..+...+.+...
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~ 280 (384)
T COG0515 233 PSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAH 280 (384)
T ss_pred cccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhC
Confidence 2 222222222 257899999999999999999999888765543
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.4e-27 Score=218.99 Aligned_cols=251 Identities=20% Similarity=0.343 Sum_probs=202.9
Q ss_pred ccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCC
Q 014210 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (429)
Q Consensus 153 ~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~ 232 (429)
.+-.|+++++||+|+||..+.|...- +++.||||.-.... ..-+++.|.+.++.|.+.++|...|.+..++-
T Consensus 26 VG~hyrVGkKIGeGsFG~lf~G~Nl~---nne~VAIKfEPrkS-----~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~ 97 (449)
T KOG1165|consen 26 VGPHYRVGKKIGEGSFGVLFLGKNLY---NNEPVAIKFEPRKS-----EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGK 97 (449)
T ss_pred ecccceeccccccCcceeeecccccc---cCceEEEEeccccC-----CcchHHHHHHHHHHHcCCCCCCceeeeccccc
Confidence 35679999999999999999887443 68999999864321 12467899999999999999999999999998
Q ss_pred eEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeec--CCCceEEEeecCCc
Q 014210 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTK--DENSVLKAIDFGLS 310 (429)
Q Consensus 233 ~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~--~~~~~vkL~DFGla 310 (429)
+-.||||.+ |-+|.|.+.--+++++...+..++.|++.-++|+|++.+|+|||||+|+||+.. .....+.|+|||+|
T Consensus 98 ~NiLVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmA 176 (449)
T KOG1165|consen 98 YNILVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMA 176 (449)
T ss_pred hhhhhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccch
Confidence 999999999 789999887778899999999999999999999999999999999999999642 23447999999999
Q ss_pred cccCCCccc--------cccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHcCCCCCCCCC---hHHHHHHHHhcCC
Q 014210 311 DFVRPDERL--------NDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWART---ESGIFRAVLKADP 378 (429)
Q Consensus 311 ~~~~~~~~~--------~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~elltg~~Pf~~~~---~~~~~~~i~~~~~ 378 (429)
+.+.+.... ....||.+||+-.... +.-+.+.|+-|||-++...|-|.+||.+.. ..+.+++|-....
T Consensus 177 K~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr 256 (449)
T KOG1165|consen 177 KEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKR 256 (449)
T ss_pred hhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccc
Confidence 988754432 3467999999987655 457889999999999999999999997654 3445555543322
Q ss_pred C-CCCCCCCCCCHHHHHHHHHhcccCccCcCCHHH
Q 014210 379 S-FDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQ 412 (429)
Q Consensus 379 ~-~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~ 412 (429)
. ..+....+++.||..-++..-..+-.+-|+.+-
T Consensus 257 ~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdy 291 (449)
T KOG1165|consen 257 STPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDY 291 (449)
T ss_pred cCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHH
Confidence 1 122222467889999888888888888888754
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.6e-29 Score=248.37 Aligned_cols=246 Identities=27% Similarity=0.450 Sum_probs=213.0
Q ss_pred eeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEec
Q 014210 162 EVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELC 241 (429)
Q Consensus 162 ~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~~lv~E~~ 241 (429)
.+|.|.||.|++++-..+...|..+|+|++.+......... ....|-.++..++.|+.+|+++..++.+...++++++.
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~-~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~ 79 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT-HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFL 79 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhccccccccccccc-ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhc
Confidence 37999999999998777777899999999876544333322 56678888998888999999999999999999999999
Q ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccccCCCccccc
Q 014210 242 EGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLND 321 (429)
Q Consensus 242 ~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~ 321 (429)
.||+|...+. ....+++.....+...++-+++++|+.+|+|||+|++||++ +.+|++|+.|||+++..-.....
T Consensus 80 rgg~lft~l~-~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enill---d~~Ghi~~tdfglske~v~~~~~-- 153 (612)
T KOG0603|consen 80 RGGDLFTRLS-KEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLL---LLEGHIKLTDFGLSKEAVKEKIA-- 153 (612)
T ss_pred ccchhhhccc-cCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceee---cccCccccCCchhhhHhHhhhhc--
Confidence 9999887663 34568889999999999999999999999999999999999 89999999999999876544333
Q ss_pred cccCCcccCcccccCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcc
Q 014210 322 IVGSAYYVAPEVLHRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLN 401 (429)
Q Consensus 322 ~~gt~~y~aPE~~~~~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~ 401 (429)
|||..|||||+++ .....+|.||||++++||++|..||.. +++..|++.....+. .++.++.+++..++.
T Consensus 154 -cgt~eymApEI~~-gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~~~p~----~l~~~a~~~~~~l~~ 223 (612)
T KOG0603|consen 154 -CGTYEYRAPEIIN-GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAELEMPR----ELSAEARSLFRQLFK 223 (612)
T ss_pred -ccchhhhhhHhhh-ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhccCCch----hhhHHHHHHHHHHHh
Confidence 9999999999998 677889999999999999999999977 778888887777765 578899999999999
Q ss_pred cCccCcCCH-----HHHHhhHhhhccce
Q 014210 402 KDPRKRLTA-----AQALSELLICYQSY 424 (429)
Q Consensus 402 ~dP~~Rps~-----~~iL~~~~~~~~~~ 424 (429)
.+|..|.-. .++++|.+++.+.+
T Consensus 224 r~p~nrLg~~~~~~~eik~h~f~~~i~~ 251 (612)
T KOG0603|consen 224 RNPENRLGAGPDGVDEIKQHEFFQSIDW 251 (612)
T ss_pred hCHHHHhccCcchhHHHhccchheeeeH
Confidence 999999855 79999999987765
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.2e-26 Score=227.01 Aligned_cols=166 Identities=21% Similarity=0.251 Sum_probs=129.9
Q ss_pred cccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCc--CcHHHHHHHHHHHHHHHHhcCCCCcce-EEEEE
Q 014210 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKM--TTAIAIEDVRREVKILRALTGHNNLVK-FFDAY 228 (429)
Q Consensus 152 ~~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~--~~~~~~~~~~~Ei~il~~l~~h~nIv~-l~~~~ 228 (429)
.+.++|.+.+.||+|+||.||+|+++.. +|+.||||++..... ......+.+.+|+++|++|. |+|++. +++
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~-h~~iv~~l~~-- 89 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGD--PGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVR-GIGVVPQLLA-- 89 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCC--CCeEEEEEEecccccccccHHHHHHHHHHHHHHHhcc-CCCCCcEEEE--
Confidence 4568899999999999999999987642 367789998753211 13345667999999999998 999885 544
Q ss_pred EeCCeEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccC-CCCcEEEeecCCCceEEEeec
Q 014210 229 EDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDL-KPENFLFTTKDENSVLKAIDF 307 (429)
Q Consensus 229 ~~~~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDI-Kp~NILl~~~~~~~~vkL~DF 307 (429)
.+..|||||||+|++|.. + .. .. ...++.|++++|.|||++||+|||| ||+|||+ +.++.+||+||
T Consensus 90 --~~~~~LVmE~~~G~~L~~-~-~~---~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv---~~~~~ikLiDF 156 (365)
T PRK09188 90 --TGKDGLVRGWTEGVPLHL-A-RP---HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLM---GPDGEAAVIDF 156 (365)
T ss_pred --cCCcEEEEEccCCCCHHH-h-Cc---cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEE---cCCCCEEEEEC
Confidence 246799999999998862 2 11 11 1567899999999999999999999 9999999 66778999999
Q ss_pred CCccccCCCcc---------ccccccCCcccCccccc
Q 014210 308 GLSDFVRPDER---------LNDIVGSAYYVAPEVLH 335 (429)
Q Consensus 308 Gla~~~~~~~~---------~~~~~gt~~y~aPE~~~ 335 (429)
|+++.+..... .....+++.|+|||.+.
T Consensus 157 GlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~ 193 (365)
T PRK09188 157 QLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALT 193 (365)
T ss_pred ccceecccCcchhhhhhhhhhhhhhccCccCCcccCC
Confidence 99987654321 13456888999999985
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.2e-28 Score=253.13 Aligned_cols=263 Identities=30% Similarity=0.414 Sum_probs=197.5
Q ss_pred Cce-eEeceeeccCceEEEEEEEecCcccCeEEEEEEccC---CCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEe
Q 014210 155 NKY-ELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPK---HKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED 230 (429)
Q Consensus 155 ~~y-~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~---~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~ 230 (429)
+.| .....+|.|.+|.|+.+..... .+.++.|.+.. ...........+..|+.+-..|. |+|++..+..+.+
T Consensus 317 ~~y~~~~~~~g~ga~g~~~~~~~~~~---~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~-h~~~~e~l~~~~~ 392 (601)
T KOG0590|consen 317 EKYGKPGRVLGSGAYGSVRIAKRRSD---LKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLS-HPNIIETLDIVQE 392 (601)
T ss_pred cccCCccceeeecccCceEEEEecCC---CccchhhhhhcccCCcccHHHHhhhhhhheeeccccc-CCchhhhHHHHhh
Confidence 445 4578899999997776655442 34444444321 11122222333677888888888 9999888877777
Q ss_pred CCeEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCc
Q 014210 231 TDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS 310 (429)
Q Consensus 231 ~~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla 310 (429)
....+-.||||++ +|...+. ..+.+...++..++.|++.||.|||+.||.|||||++|+++ ..++.+||+|||.+
T Consensus 393 ~~~~~~~mE~~~~-Dlf~~~~-~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~---~~~g~lki~Dfg~~ 467 (601)
T KOG0590|consen 393 IDGILQSMEYCPY-DLFSLVM-SNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLV---TENGILKIIDFGAA 467 (601)
T ss_pred cccchhhhhcccH-HHHHHHh-cccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEE---ecCCceEEeecCcc
Confidence 6666666999999 9998774 44689999999999999999999999999999999999999 68889999999998
Q ss_pred cccCCCc-----cccccccCCcccCcccccC-CCCC-cccHHHHHHHHHHHHcCCCCCCCCChHHHH-HHHH-hc---CC
Q 014210 311 DFVRPDE-----RLNDIVGSAYYVAPEVLHR-SYST-EADVWSIGVIAYILLCGSRPFWARTESGIF-RAVL-KA---DP 378 (429)
Q Consensus 311 ~~~~~~~-----~~~~~~gt~~y~aPE~~~~-~~~~-~sDiwSlGvll~elltg~~Pf~~~~~~~~~-~~i~-~~---~~ 378 (429)
..+.... .....+|+..|+|||++.+ .|+. ..||||.|++++.|++|+.||......+.. .... .. ..
T Consensus 468 ~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~ 547 (601)
T KOG0590|consen 468 SVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIF 547 (601)
T ss_pred eeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccc
Confidence 7765332 2356789999999999874 5766 579999999999999999999654333221 1110 01 11
Q ss_pred CCCCCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhccceee
Q 014210 379 SFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLICYQSYLF 426 (429)
Q Consensus 379 ~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~~~~~ 426 (429)
.-+...+..++.+.+.+|.+||+.||.+|.++++|++..|++.-..+.
T Consensus 548 ~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~~c~ 595 (601)
T KOG0590|consen 548 EGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIECCH 595 (601)
T ss_pred cChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcceEE
Confidence 111222345788899999999999999999999999999999877664
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.1e-25 Score=201.37 Aligned_cols=176 Identities=17% Similarity=0.166 Sum_probs=136.3
Q ss_pred ccccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHH------HHHHHHHHHHhcCCCCcceE
Q 014210 151 KHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIED------VRREVKILRALTGHNNLVKF 224 (429)
Q Consensus 151 ~~~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~------~~~Ei~il~~l~~h~nIv~l 224 (429)
+.+.++|++.++||.|+||.||++.. ++..+|||++...........+. +.+|+..+.+|. |++|..+
T Consensus 27 ~~l~~~y~~~~~l~~~~f~~v~l~~~-----~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~-~~GI~~~ 100 (232)
T PRK10359 27 DFLSYNIKTIKVFRNIDDTKVSLIDT-----DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVR-SEGLASL 100 (232)
T ss_pred HHhhCceEEEEEecCCCceEEEEEec-----CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHH-HCCCCcc
Confidence 45678999999999999999998643 25679999997655445444444 579999999998 9999999
Q ss_pred EEEEEeC--------CeEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeec
Q 014210 225 FDAYEDT--------DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTK 296 (429)
Q Consensus 225 ~~~~~~~--------~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~ 296 (429)
.+++.+. +..+|+|||++|.+|.+.. .+++ ....+|+.+|..||+.|++||||||+||++
T Consensus 101 ~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~-----~~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili--- 168 (232)
T PRK10359 101 NDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMP-----EISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIV--- 168 (232)
T ss_pred eEeeeecccccccccCCeEEEEEEECCccHHHhh-----hccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEE---
Confidence 9987644 3578999999999987752 2333 346699999999999999999999999999
Q ss_pred CCCceEEEeecCCccccCCCccccccccCCcccCcccccCCCCCcccHHHHHHHHHHHH
Q 014210 297 DENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRSYSTEADVWSIGVIAYILL 355 (429)
Q Consensus 297 ~~~~~vkL~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~sDiwSlGvll~ell 355 (429)
+.++ ++|+|||.......+..... =++...|+.++|+|+||+++..+.
T Consensus 169 ~~~g-i~liDfg~~~~~~e~~a~d~----------~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 169 SKNG-LRIIDLSGKRCTAQRKAKDR----------IDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred eCCC-EEEEECCCcccccchhhHHH----------HHHHhHhcccccccceeEeehHHH
Confidence 4556 99999998866543322211 022345778999999999987553
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.2e-23 Score=190.19 Aligned_cols=189 Identities=20% Similarity=0.210 Sum_probs=143.3
Q ss_pred eEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcH-HHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEE
Q 014210 158 ELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTA-IAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYV 236 (429)
Q Consensus 158 ~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~-~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~~l 236 (429)
.+...|++|+||+|+++.. .+..++.+.+........ .....+.+|+++|++|.+|++|++++++ +..++
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-----~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~l 75 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-----GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHL 75 (218)
T ss_pred ccceeecCCCcceEEEeec-----CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEE
Confidence 4677899999999996653 367888887755433222 2223578999999999878999999986 45699
Q ss_pred EEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccC-CCCcEEEeecCCCceEEEeecCCccccCC
Q 014210 237 VMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDL-KPENFLFTTKDENSVLKAIDFGLSDFVRP 315 (429)
Q Consensus 237 v~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDI-Kp~NILl~~~~~~~~vkL~DFGla~~~~~ 315 (429)
+|||+.|.+|...+. .. ...++.|++.+|+++|++||+|||| ||+|||+ +.++.++|+|||++.....
T Consensus 76 vmeyI~G~~L~~~~~-------~~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv---~~~g~i~LIDFG~A~~~~~ 144 (218)
T PRK12274 76 DRSYLAGAAMYQRPP-------RG-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLV---QEDGSPAVIDFQLAVRGNP 144 (218)
T ss_pred EEeeecCccHHhhhh-------hh-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEE---cCCCCEEEEECCCceecCC
Confidence 999999988765331 11 2357889999999999999999999 7999999 6677899999999986554
Q ss_pred Cccc--------------cccccCCcccCccccc--CCCC-CcccHHHHHHHHHHHHcCCCCCCCCCh
Q 014210 316 DERL--------------NDIVGSAYYVAPEVLH--RSYS-TEADVWSIGVIAYILLCGSRPFWARTE 366 (429)
Q Consensus 316 ~~~~--------------~~~~gt~~y~aPE~~~--~~~~-~~sDiwSlGvll~elltg~~Pf~~~~~ 366 (429)
.... .....++.|++|+... ...+ ...++++.|.-+|.++|++.+++.+.+
T Consensus 145 ~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~~ 212 (218)
T PRK12274 145 RARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDNE 212 (218)
T ss_pred cchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccCC
Confidence 3321 0123577788887532 2333 467999999999999999999987664
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.8e-24 Score=202.92 Aligned_cols=236 Identities=24% Similarity=0.375 Sum_probs=155.1
Q ss_pred CceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcC---------CCCcceEE
Q 014210 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTG---------HNNLVKFF 225 (429)
Q Consensus 155 ~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~---------h~nIv~l~ 225 (429)
..+...+.||.|+++.||.+.+.. +|+.+|||++...........+++++|.-....+.+ |-.++.-+
T Consensus 12 r~l~~~~~i~~g~~~~v~~v~d~~---t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~ 88 (288)
T PF14531_consen 12 RTLVRGRIIGKGGFSIVFEVTDVE---TGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPL 88 (288)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETT---TTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---S
T ss_pred eEEEEccccccCCceEEEEEEEcc---CCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeee
Confidence 356778999999999999999776 799999999865554555667888888766655442 22333333
Q ss_pred EEEEe---------C---C-----eEEEEEEecCCCcHHHHHH---hcCCC---CCHHHHHHHHHHHHHHHHHHHHcCce
Q 014210 226 DAYED---------T---D-----NVYVVMELCEGGELLDRIL---SRGGK---YTEDDAKAVMIQILNVVAFCHLQGVV 282 (429)
Q Consensus 226 ~~~~~---------~---~-----~~~lv~E~~~ggsL~~~i~---~~~~~---l~~~~~~~i~~qi~~gL~~LH~~~ii 282 (429)
+...- . . +.+++|+-+. ++|.+.+. ..... +.......+..|+++.+++||..|||
T Consensus 89 d~~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlV 167 (288)
T PF14531_consen 89 DLLRIPGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLV 167 (288)
T ss_dssp EEEEETTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred EEEEEcCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceE
Confidence 33321 1 1 3467888885 48877653 22222 22334455668999999999999999
Q ss_pred eccCCCCcEEEeecCCCceEEEeecCCccccCCCccccccccCCcccCcccccC---------CCCCcccHHHHHHHHHH
Q 014210 283 HRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHR---------SYSTEADVWSIGVIAYI 353 (429)
Q Consensus 283 HrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~~---------~~~~~sDiwSlGvll~e 353 (429)
|+||||+|+++ +.+|.++|+||+....... .......+..|.+||.... .++.+.|.|+||+++|.
T Consensus 168 Hgdi~~~nfll---~~~G~v~Lg~F~~~~r~g~--~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~ 242 (288)
T PF14531_consen 168 HGDIKPENFLL---DQDGGVFLGDFSSLVRAGT--RYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYS 242 (288)
T ss_dssp EST-SGGGEEE----TTS-EEE--GGGEEETTE--EEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHH
T ss_pred ecccceeeEEE---cCCCCEEEcChHHHeecCc--eeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHH
Confidence 99999999999 7899999999998765432 2222445678999997632 26778999999999999
Q ss_pred HHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCc
Q 014210 354 LLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKR 407 (429)
Q Consensus 354 lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R 407 (429)
|+||+.||........... .+. .. ..+++.+++||+.+|+.||.+|
T Consensus 243 lWC~~lPf~~~~~~~~~~~------~f~-~C-~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 243 LWCGRLPFGLSSPEADPEW------DFS-RC-RDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHHSS-STCCCGGGSTSGG------GGT-TS-S---HHHHHHHHHHT-SSGGGS
T ss_pred HHHccCCCCCCCccccccc------cch-hc-CCcCHHHHHHHHHHccCCcccC
Confidence 9999999975543221111 111 11 1688999999999999999998
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.4e-23 Score=190.29 Aligned_cols=142 Identities=18% Similarity=0.188 Sum_probs=108.9
Q ss_pred eceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHH-----------------------HHHHHHHHHHHHHHhc
Q 014210 160 GEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAI-----------------------AIEDVRREVKILRALT 216 (429)
Q Consensus 160 ~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~-----------------------~~~~~~~Ei~il~~l~ 216 (429)
.+.||+|+||.||+|... +|+.||||+++........ ......+|++++.++.
T Consensus 2 ~~~ig~G~~~~Vy~a~~~----~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 77 (190)
T cd05147 2 NGCISTGKEANVYHATTA----NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLV 77 (190)
T ss_pred CCccccccceEEEEEECC----CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHH
Confidence 568999999999999864 4899999999654211100 0123356999999998
Q ss_pred CCCCcceEEEEEEeCCeEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH-HHcCceeccCCCCcEEEee
Q 014210 217 GHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFC-HLQGVVHRDLKPENFLFTT 295 (429)
Q Consensus 217 ~h~nIv~l~~~~~~~~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~L-H~~~iiHrDIKp~NILl~~ 295 (429)
++++.....+... ..+|||||++|+++...+. ....+++..+..++.||+.+|.+| |+.||+||||||+|||++
T Consensus 78 -~~~v~~p~~~~~~--~~~iVmE~i~g~~l~~~~~-~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~- 152 (190)
T cd05147 78 -TAGIPCPEPILLK--SHVLVMEFIGDDGWAAPRL-KDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH- 152 (190)
T ss_pred -HCCCCCCcEEEec--CCEEEEEEeCCCCCcchhh-hcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-
Confidence 7776444333222 2389999999877655433 346789999999999999999999 799999999999999994
Q ss_pred cCCCceEEEeecCCcccc
Q 014210 296 KDENSVLKAIDFGLSDFV 313 (429)
Q Consensus 296 ~~~~~~vkL~DFGla~~~ 313 (429)
++.++|+|||++...
T Consensus 153 ---~~~v~LiDFG~a~~~ 167 (190)
T cd05147 153 ---DGKLYIIDVSQSVEH 167 (190)
T ss_pred ---CCcEEEEEccccccC
Confidence 357999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.9e-23 Score=219.71 Aligned_cols=223 Identities=29% Similarity=0.492 Sum_probs=171.0
Q ss_pred ccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCC
Q 014210 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (429)
Q Consensus 153 ~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~ 232 (429)
...+|..++.|..|+||-||+++++. +-+.+|+|+ .+.. .+.+- ++.. .+.|.+|
T Consensus 81 ~e~df~~IklisngAygavylvrh~~---trqrfa~ki-Nkq~--------lilRn--ilt~-a~npfvv---------- 135 (1205)
T KOG0606|consen 81 SESDFNTIKLISNGAYGAVYLVRHKE---TRQRFAMKI-NKQN--------LILRN--ILTF-AGNPFVV---------- 135 (1205)
T ss_pred CccccceeEeeccCCCCceeeeeccc---cccchhhcc-cccc--------hhhhc--cccc-cCCccee----------
Confidence 35789999999999999999999886 568899964 3221 01111 2222 1244444
Q ss_pred eEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccc
Q 014210 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (429)
Q Consensus 233 ~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~ 312 (429)
|+-...+ ..-+.++.+. +.+++|||+.||+|||+||+|.|| ..-|++|+.|||+++.
T Consensus 136 -----------gDc~tll-k~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllI---T~mGhiKlTDfgLsk~ 192 (1205)
T KOG0606|consen 136 -----------GDCATLL-KNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLI---TSMGHIKLTDFGLSKK 192 (1205)
T ss_pred -----------chhhhhc-ccCCCCcchh--------hHHhHhhccCCeecCCCCCCccee---eecccccccchhhhhh
Confidence 3433333 2223444333 789999999999999999999999 6778899999999865
Q ss_pred cCCCc----------------cccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHh
Q 014210 313 VRPDE----------------RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLK 375 (429)
Q Consensus 313 ~~~~~----------------~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~ 375 (429)
..+.. .....+||+.|.|||++. +.|+..+|+|++|+++||.+-|+.||.+++.++.+..++.
T Consensus 193 GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~vis 272 (1205)
T KOG0606|consen 193 GLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVIS 272 (1205)
T ss_pred hhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhh
Confidence 43221 113468999999999776 6799999999999999999999999999999999999999
Q ss_pred cCCCCCCCCCCCCCHHHHHHHHHhcccCccCcC---CHHHHHhhHhhhccce
Q 014210 376 ADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRL---TAAQALSELLICYQSY 424 (429)
Q Consensus 376 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp---s~~~iL~~~~~~~~~~ 424 (429)
.+..+++.. ..+++|++++|.++|+.+|..|. .+.++.+|.||+.-+|
T Consensus 273 d~i~wpE~d-ea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw 323 (1205)
T KOG0606|consen 273 DDIEWPEED-EALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDW 323 (1205)
T ss_pred hhccccccC-cCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeeccc
Confidence 888888773 45889999999999999999995 5677778888775443
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.1e-22 Score=182.77 Aligned_cols=144 Identities=17% Similarity=0.183 Sum_probs=112.2
Q ss_pred eceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcH-----------------------HHHHHHHHHHHHHHHhc
Q 014210 160 GEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTA-----------------------IAIEDVRREVKILRALT 216 (429)
Q Consensus 160 ~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~-----------------------~~~~~~~~Ei~il~~l~ 216 (429)
.+.||+|+||.||+|+.. +|+.||||++........ .....+.+|.+.+.++.
T Consensus 2 ~~~ig~G~~~~Vy~a~~~----~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 77 (190)
T cd05145 2 NGCISTGKEANVYHARTG----DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLY 77 (190)
T ss_pred CceeecCCCcEEEEEEcC----CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHH
Confidence 578999999999999854 489999999876421100 01223468999999998
Q ss_pred CCCCcceEEEEEEeCCeEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-cCceeccCCCCcEEEee
Q 014210 217 GHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHL-QGVVHRDLKPENFLFTT 295 (429)
Q Consensus 217 ~h~nIv~l~~~~~~~~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~-~~iiHrDIKp~NILl~~ 295 (429)
|+++.....+.... .+|||||++|+++...+. ....++...+..++.|++.+|.+||+ .||+||||||+|||+
T Consensus 78 -~~~i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l-~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll-- 151 (190)
T cd05145 78 -EAGVPVPEPILLKK--NVLVMEFIGDDGSPAPRL-KDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILY-- 151 (190)
T ss_pred -hCCCCCceEEEecC--CEEEEEEecCCCchhhhh-hhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEE--
Confidence 88875554444333 489999999876544333 23568899999999999999999999 999999999999999
Q ss_pred cCCCceEEEeecCCccccCC
Q 014210 296 KDENSVLKAIDFGLSDFVRP 315 (429)
Q Consensus 296 ~~~~~~vkL~DFGla~~~~~ 315 (429)
+ ++.++|+|||++.....
T Consensus 152 -~-~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 152 -H-DGKPYIIDVSQAVELDH 169 (190)
T ss_pred -E-CCCEEEEEcccceecCC
Confidence 4 57799999999977643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.1e-23 Score=190.26 Aligned_cols=242 Identities=19% Similarity=0.262 Sum_probs=185.5
Q ss_pred ceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEE
Q 014210 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVY 235 (429)
Q Consensus 156 ~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~~ 235 (429)
...+..+|.+...|..|+|+ |.|..+++|++..... +....++|..|.-.|+-+. ||||+.+++.|....++.
T Consensus 191 ~lnl~tkl~e~hsgelwrgr-----wqgndivakil~vr~~-t~risrdfneefp~lrifs-hpnilpvlgacnsppnlv 263 (448)
T KOG0195|consen 191 SLNLITKLAESHSGELWRGR-----WQGNDIVAKILNVREV-TARISRDFNEEFPALRIFS-HPNILPVLGACNSPPNLV 263 (448)
T ss_pred hhhhhhhhccCCCccccccc-----ccCcchhhhhhhhhhc-chhhcchhhhhCcceeeec-CCchhhhhhhccCCCCce
Confidence 44566778888888877765 5577888898865443 3444567888998888888 999999999999999999
Q ss_pred EEEEecCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHcC--ceeccCCCCcEEEeecCCCceEEEe--ecCCc
Q 014210 236 VVMELCEGGELLDRILSRGG-KYTEDDAKAVMIQILNVVAFCHLQG--VVHRDLKPENFLFTTKDENSVLKAI--DFGLS 310 (429)
Q Consensus 236 lv~E~~~ggsL~~~i~~~~~-~l~~~~~~~i~~qi~~gL~~LH~~~--iiHrDIKp~NILl~~~~~~~~vkL~--DFGla 310 (429)
+|..||+.|+|+..+++... .++..++.+++.+|++|++|||+.. |.---|....+++ |++...+|. |--++
T Consensus 264 ~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmi---dedltarismad~kfs 340 (448)
T KOG0195|consen 264 IISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMI---DEDLTARISMADTKFS 340 (448)
T ss_pred EeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEe---cchhhhheecccceee
Confidence 99999999999998876544 4788999999999999999999985 3344688899999 777766654 22221
Q ss_pred cccCCCccccccccCCcccCcccccCC---C-CCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCC
Q 014210 311 DFVRPDERLNDIVGSAYYVAPEVLHRS---Y-STEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWP 386 (429)
Q Consensus 311 ~~~~~~~~~~~~~gt~~y~aPE~~~~~---~-~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 386 (429)
. . .......+.||+||.+++. . -..+|+|||++++|||.|...||.....-+.--++.-..... ...|
T Consensus 341 f--q----e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv--~ipp 412 (448)
T KOG0195|consen 341 F--Q----EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRV--HIPP 412 (448)
T ss_pred e--e----ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccc--cCCC
Confidence 1 1 1123457889999998743 2 336899999999999999999997766554433332222111 2236
Q ss_pred CCCHHHHHHHHHhcccCccCcCCHHHHHh
Q 014210 387 SLSSEARDFVKRLLNKDPRKRLTAAQALS 415 (429)
Q Consensus 387 ~~s~~~~~li~~~L~~dP~~Rps~~~iL~ 415 (429)
+++..+..|++-|++.||.+||.+++|+-
T Consensus 413 gis~hm~klm~icmnedpgkrpkfdmivp 441 (448)
T KOG0195|consen 413 GISRHMNKLMNICMNEDPGKRPKFDMIVP 441 (448)
T ss_pred CccHHHHHHHHHHhcCCCCcCCCcceehh
Confidence 89999999999999999999999988764
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.9e-23 Score=219.96 Aligned_cols=239 Identities=25% Similarity=0.333 Sum_probs=174.6
Q ss_pred ceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCC-cCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeE
Q 014210 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHK-MTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (429)
Q Consensus 156 ~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~-~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~ 234 (429)
+|...+.||++.|=+|+++++.+ |. |+||++-+.. ...-....+...|++ . .+..+||++.+...-+.+..-
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~e----G~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~-~l~~~pn~lPfqk~~~t~kAA 96 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDRE----GL-VVVKVFVKQDPTISLRPFKQRLEEIK-F-ALMKAPNCLPFQKVLVTDKAA 96 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCC----ce-EEEEEEeccCCCCCchHHHHHHHHHH-H-HhhcCCcccchHHHHHhhHHH
Confidence 68889999999999999998776 54 9999986543 223333344445555 3 333599999998887777778
Q ss_pred EEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCcccc-
Q 014210 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV- 313 (429)
Q Consensus 235 ~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~- 313 (429)
|||-+|+.. +|+|.+. .+.-+..-+.+.|+.||+.||.-+|..||+|+|||.+||||+ .-.-+.|+||..-+-.
T Consensus 97 ylvRqyvkh-nLyDRlS-TRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiT---SWNW~~LtDFAsFKPtY 171 (1431)
T KOG1240|consen 97 YLVRQYVKH-NLYDRLS-TRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILIT---SWNWLYLTDFASFKPTY 171 (1431)
T ss_pred HHHHHHHhh-hhhhhhc-cchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEe---eechhhhhcccccCCcc
Confidence 999999965 8999873 335577888899999999999999999999999999999994 4556899999876532
Q ss_pred -CCCcc--c----cccccCCcccCcccccC-----------C-CCCcccHHHHHHHHHHHHc-CCCCCCCC-------Ch
Q 014210 314 -RPDER--L----NDIVGSAYYVAPEVLHR-----------S-YSTEADVWSIGVIAYILLC-GSRPFWAR-------TE 366 (429)
Q Consensus 314 -~~~~~--~----~~~~gt~~y~aPE~~~~-----------~-~~~~sDiwSlGvll~ellt-g~~Pf~~~-------~~ 366 (429)
..++. . .+...-..|.|||.+.. . .+.+.||||+||+++||++ |+.+|.-. ..
T Consensus 172 LPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~ 251 (1431)
T KOG1240|consen 172 LPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGN 251 (1431)
T ss_pred CCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccC
Confidence 11211 1 11122346999998732 1 5678999999999999998 68888210 00
Q ss_pred HHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhh
Q 014210 367 SGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSE 416 (429)
Q Consensus 367 ~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~ 416 (429)
....+.+++.. -+..++.||..|++.||++|.++++.|+.
T Consensus 252 ~~~~e~~Le~I----------ed~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 252 ADDPEQLLEKI----------EDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred ccCHHHHHHhC----------cCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 11111222211 13467999999999999999999999986
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.4e-21 Score=177.70 Aligned_cols=139 Identities=20% Similarity=0.280 Sum_probs=107.0
Q ss_pred EeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhc----CCCCcceEEEEEEeCC--
Q 014210 159 LGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALT----GHNNLVKFFDAYEDTD-- 232 (429)
Q Consensus 159 ~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~----~h~nIv~l~~~~~~~~-- 232 (429)
-.+.||+|+||.||. +.. ++.. +||++.... ....+.+.+|+++++.|. .|+||++++|+++++.
T Consensus 6 ~~~~LG~G~~~~Vy~--hp~---~~~k-~IKv~~~~~---~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~ 76 (210)
T PRK10345 6 EQSPLGTGRHRKCYA--HPE---DAQR-CIKIVYHRG---DGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGT 76 (210)
T ss_pred CcceecCCCceEEEE--CCC---CcCe-EEEEEeccc---cchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCC
Confidence 457899999999995 333 3444 699886532 223467899999999994 3899999999999874
Q ss_pred -eEE-EEEEe--cCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHH-HHHHHcCceeccCCCCcEEEeecC-CCceEEEee
Q 014210 233 -NVY-VVMEL--CEGGELLDRILSRGGKYTEDDAKAVMIQILNVV-AFCHLQGVVHRDLKPENFLFTTKD-ENSVLKAID 306 (429)
Q Consensus 233 -~~~-lv~E~--~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL-~~LH~~~iiHrDIKp~NILl~~~~-~~~~vkL~D 306 (429)
.++ +|||| +.+++|.+++.+ +.+++. ..++.|++.++ +|||+++||||||||+|||++..+ .+..++|+|
T Consensus 77 g~v~~~I~e~~G~~~~tL~~~l~~--~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiD 152 (210)
T PRK10345 77 GYVYDVIADFDGKPSITLTEFAEQ--CRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCD 152 (210)
T ss_pred eEEEEEEecCCCCcchhHHHHHHc--ccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEE
Confidence 434 78999 557999998844 346666 36678888887 999999999999999999996543 345899999
Q ss_pred cCCc
Q 014210 307 FGLS 310 (429)
Q Consensus 307 FGla 310 (429)
|+-+
T Consensus 153 g~G~ 156 (210)
T PRK10345 153 NIGE 156 (210)
T ss_pred CCCC
Confidence 5444
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.9e-21 Score=208.29 Aligned_cols=199 Identities=22% Similarity=0.310 Sum_probs=158.2
Q ss_pred ccccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEe
Q 014210 151 KHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED 230 (429)
Q Consensus 151 ~~~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~ 230 (429)
+.-+.+|.|.++||+|+||.||+|...+ |+.||||+-+....+.-..-.+++.-++ ... -+-|..+..++.-
T Consensus 694 ~~~~~~~~I~~e~G~g~y~~vy~a~~~~----~~~~alK~e~P~~~WEfYI~~q~~~RLk-~~~---~~~~~~~~~a~~~ 765 (974)
T KOG1166|consen 694 EVGGEKFCISKEIGEGSYGSVYVATHSN----GKLVALKVEKPPNPWEFYICLQVMERLK-PQM---LPSIMHISSAHVF 765 (974)
T ss_pred eecceeEEEEeeeccccceEEEEeecCC----CcEEEEEeecCCCceeeeehHHHHHhhc-hhh---hcchHHHHHHHcc
Confidence 3446889999999999999999998665 8999999976655444322223333332 111 2345555555556
Q ss_pred CCeEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeec----CCCceEEEee
Q 014210 231 TDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTK----DENSVLKAID 306 (429)
Q Consensus 231 ~~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~----~~~~~vkL~D 306 (429)
.+.-+||+||.+.|+|++++. ..+.++|..+..++.|+++.++.||..+|||+||||+|+||... .+..-++|+|
T Consensus 766 ~~~S~lv~ey~~~Gtlld~~N-~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lID 844 (974)
T KOG1166|consen 766 QNASVLVSEYSPYGTLLDLIN-TNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLID 844 (974)
T ss_pred CCcceeeeeccccccHHHhhc-cCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEe
Confidence 677799999999999999885 66779999999999999999999999999999999999999632 3355799999
Q ss_pred cCCcc---ccCCCccccccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHcCC
Q 014210 307 FGLSD---FVRPDERLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGS 358 (429)
Q Consensus 307 FGla~---~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~elltg~ 358 (429)
||.+- .+.+.......++|-.+--+|+..| .+++.+|.|.|+-+++.||.|+
T Consensus 845 fG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~ 900 (974)
T KOG1166|consen 845 FGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGK 900 (974)
T ss_pred cccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHH
Confidence 99874 3444556677889999999998875 6999999999999999999985
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.2e-20 Score=180.41 Aligned_cols=256 Identities=27% Similarity=0.418 Sum_probs=175.1
Q ss_pred cccCceeEeceeeccCceEEEEEEEecCcc----c----------------------------CeEEEEEEccCCCc--C
Q 014210 152 HFANKYELGEEVGRGHFGYTCAAKFKKGEL----K----------------------------GQQVAVKVIPKHKM--T 197 (429)
Q Consensus 152 ~~~~~y~~~~~IG~G~fg~V~~~~~~~~~~----~----------------------------g~~vAvK~~~~~~~--~ 197 (429)
.-.++|++++-||+|.-..||.++...+.. + --+.|||.+-.-.. .
T Consensus 154 FtiddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~~~~s~ 233 (598)
T KOG4158|consen 154 FTIDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNFEHDSG 233 (598)
T ss_pred cchhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhcccccCCc
Confidence 345789999999999999999988764110 0 01346665522111 1
Q ss_pred cHHHHHHHHHHHHH--------------HH-------HhcCCCCcceEEEEEEe--------------------------
Q 014210 198 TAIAIEDVRREVKI--------------LR-------ALTGHNNLVKFFDAYED-------------------------- 230 (429)
Q Consensus 198 ~~~~~~~~~~Ei~i--------------l~-------~l~~h~nIv~l~~~~~~-------------------------- 230 (429)
+...++..-+|+-- .+ +|..|||||+++++|.+
T Consensus 234 ~~~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g 313 (598)
T KOG4158|consen 234 DAHILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAG 313 (598)
T ss_pred hHHHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccC
Confidence 12222333333311 11 12359999999998753
Q ss_pred -CCeEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecC-CCceEEEeecC
Q 014210 231 -TDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKD-ENSVLKAIDFG 308 (429)
Q Consensus 231 -~~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~-~~~~vkL~DFG 308 (429)
...+|+||...+. +|..++-. ...+.....-++.|+++|+.|||++||.|||+|.+|||+.-+| +--.+.|+|||
T Consensus 314 ~~~tlylvMkrY~~-tLr~yl~~--~~~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFG 390 (598)
T KOG4158|consen 314 EPKTLYLVMKRYRQ-TLREYLWT--RHRSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFG 390 (598)
T ss_pred CCceEEEehhcchh-hHHHHHhc--CCCchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccc
Confidence 2258999998865 88888844 3467888889999999999999999999999999999997543 33478899999
Q ss_pred CccccCCC-------ccccccccCCcccCcccccC---C---C-CCcccHHHHHHHHHHHHcCCCCCCCCChHHH-HHHH
Q 014210 309 LSDFVRPD-------ERLNDIVGSAYYVAPEVLHR---S---Y-STEADVWSIGVIAYILLCGSRPFWARTESGI-FRAV 373 (429)
Q Consensus 309 la~~~~~~-------~~~~~~~gt~~y~aPE~~~~---~---~-~~~sDiwSlGvll~elltg~~Pf~~~~~~~~-~~~i 373 (429)
++-.-... ...-...|...-||||+... . . -.|+|.|+.|.+.||++....||+...+... .+..
T Consensus 391 CcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Y 470 (598)
T KOG4158|consen 391 CCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTY 470 (598)
T ss_pred eeeeccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhh
Confidence 86332111 11123457888999999863 2 1 2379999999999999999999987432211 0111
Q ss_pred HhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCcCCHHHH
Q 014210 374 LKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQA 413 (429)
Q Consensus 374 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~i 413 (429)
.+.. .......+++.+++|+..+|+.||++|++..-+
T Consensus 471 qe~q---LPalp~~vpp~~rqlV~~lL~r~pskRvsp~iA 507 (598)
T KOG4158|consen 471 QESQ---LPALPSRVPPVARQLVFDLLKRDPSKRVSPNIA 507 (598)
T ss_pred hhhh---CCCCcccCChHHHHHHHHHhcCCccccCCccHH
Confidence 1111 111223688999999999999999999987644
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.83 E-value=4.9e-20 Score=172.75 Aligned_cols=146 Identities=21% Similarity=0.205 Sum_probs=111.6
Q ss_pred ceeEeceeeccCceEEEEEE-EecCcccCeEEEEEEccCCCcCc---------------------HHHHHHHHHHHHHHH
Q 014210 156 KYELGEEVGRGHFGYTCAAK-FKKGELKGQQVAVKVIPKHKMTT---------------------AIAIEDVRREVKILR 213 (429)
Q Consensus 156 ~y~~~~~IG~G~fg~V~~~~-~~~~~~~g~~vAvK~~~~~~~~~---------------------~~~~~~~~~Ei~il~ 213 (429)
-|++.+.||+|+||.||+|. ... +|+.||||++....... ......+.+|+.+++
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~---~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~ 105 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDG---SGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQ 105 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCC---CCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHH
Confidence 48899999999999999997 333 58999999986532110 011234678999999
Q ss_pred HhcCCC--CcceEEEEEEeCCeEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC-ceeccCCCCc
Q 014210 214 ALTGHN--NLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQG-VVHRDLKPEN 290 (429)
Q Consensus 214 ~l~~h~--nIv~l~~~~~~~~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~-iiHrDIKp~N 290 (429)
++. +. .+.+++++ ...+|||||++|++|..... ....+....+..++.||+.+|.+||+.| |+||||||+|
T Consensus 106 ~L~-~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~N 179 (237)
T smart00090 106 RLY-EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRL-KDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYN 179 (237)
T ss_pred HHH-hcCCCCCeeeEe----cCceEEEEEecCCccccccc-ccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhh
Confidence 997 43 34444442 23489999999888765442 2345667778899999999999999999 9999999999
Q ss_pred EEEeecCCCceEEEeecCCccccC
Q 014210 291 FLFTTKDENSVLKAIDFGLSDFVR 314 (429)
Q Consensus 291 ILl~~~~~~~~vkL~DFGla~~~~ 314 (429)
||+ + ++.++|+|||++....
T Consensus 180 Ili---~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 180 ILV---H-DGKVVIIDVSQSVELD 199 (237)
T ss_pred EEE---E-CCCEEEEEChhhhccC
Confidence 999 4 5679999999987544
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=6.6e-20 Score=184.61 Aligned_cols=200 Identities=31% Similarity=0.406 Sum_probs=159.1
Q ss_pred HHhcCCCCcceEEEEEEeCCeEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCc-eeccCCCCcE
Q 014210 213 RALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGV-VHRDLKPENF 291 (429)
Q Consensus 213 ~~l~~h~nIv~l~~~~~~~~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~i-iHrDIKp~NI 291 (429)
+.+. |.|+.+++|.+.++...++|.+||..|+|.|.+....-++++--...++++|+.||.|||.--| .|+.++..|+
T Consensus 2 ~~l~-h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC 80 (484)
T KOG1023|consen 2 RQLD-HDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC 80 (484)
T ss_pred cccc-hhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence 4566 9999999999999999999999999999999998777789999999999999999999999866 9999999999
Q ss_pred EEeecCCCceEEEeecCCccccCCC---ccccccccCCcccCcccccCC--------CCCcccHHHHHHHHHHHHcCCCC
Q 014210 292 LFTTKDENSVLKAIDFGLSDFVRPD---ERLNDIVGSAYYVAPEVLHRS--------YSTEADVWSIGVIAYILLCGSRP 360 (429)
Q Consensus 292 Ll~~~~~~~~vkL~DFGla~~~~~~---~~~~~~~gt~~y~aPE~~~~~--------~~~~sDiwSlGvll~elltg~~P 360 (429)
++ |....+||+|||+....... .......-..-|.|||.+.+. .+.+.||||||++++|+++.+.|
T Consensus 81 lv---d~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~ 157 (484)
T KOG1023|consen 81 LV---DSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGP 157 (484)
T ss_pred ee---eeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCc
Confidence 99 88999999999998766421 111112234569999998642 46679999999999999999999
Q ss_pred CCCC----ChHHHHHHHHh-cCCCCCCCCC--CCCCHHHHHHHHHhcccCccCcCCHHHHHhh
Q 014210 361 FWAR----TESGIFRAVLK-ADPSFDEAPW--PSLSSEARDFVKRLLNKDPRKRLTAAQALSE 416 (429)
Q Consensus 361 f~~~----~~~~~~~~i~~-~~~~~~~~~~--~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~ 416 (429)
|... ...+++..+.+ ....+....+ ....+++..+++.||..+|.+||+++++-..
T Consensus 158 ~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~ 220 (484)
T KOG1023|consen 158 FDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSK 220 (484)
T ss_pred cccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhh
Confidence 9652 22345555544 2211211111 1456689999999999999999999988554
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.82 E-value=4.7e-21 Score=189.77 Aligned_cols=247 Identities=23% Similarity=0.331 Sum_probs=163.3
Q ss_pred eeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEE-------EEE
Q 014210 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFD-------AYE 229 (429)
Q Consensus 157 y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~-------~~~ 229 (429)
..+.+..+..+++.+...+.+.+......+..|.... ..........+++-.+.-...|+. .-+.+ .+.
T Consensus 246 ~~~~k~~~~~~~~~~~~~q~~~~~s~~E~~~s~~~~~---d~~~~~~~~~r~~~~l~~~~~~~~-s~~~d~~~s~~~~~~ 321 (516)
T KOG1033|consen 246 SSISKSSERVSSGIVFEKQGKNNSSLREWLKSKRADV---DSLCACKYTFRQLGVLVDSSHSNR-SILEDLRPSLFESSK 321 (516)
T ss_pred ccccccccccccCCchhhhhcccchhhhhccchhhhc---cchhhhhhhhhhhhheeccccCCc-ccccCCCCchhhhcc
Confidence 3444455555555544443333221223333333321 222333445556666655553333 32222 111
Q ss_pred -----eCCeEEEEEEecCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceE
Q 014210 230 -----DTDNVYVVMELCEGGELLDRILSR--GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVL 302 (429)
Q Consensus 230 -----~~~~~~lv~E~~~ggsL~~~i~~~--~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~v 302 (429)
...++||.|++|...+|.++|..+ ....++...+.++.|++.|++| +|.+|||+||.||+. ..+..+
T Consensus 322 ~~~v~~~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~---~~d~q~ 395 (516)
T KOG1033|consen 322 RNKVGKKVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFF---SDDDQL 395 (516)
T ss_pred ccccccccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhcccccccc---ccchhh
Confidence 123588999999999999998633 3467889999999999999999 999999999999999 556689
Q ss_pred EEeecCCccccCCCc-------cccccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHH
Q 014210 303 KAIDFGLSDFVRPDE-------RLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAV 373 (429)
Q Consensus 303 kL~DFGla~~~~~~~-------~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~ellt-g~~Pf~~~~~~~~~~~i 373 (429)
||.|||+........ .....+||..||+||++.+ .|+.++|||+||++|+||+. =...|. ....+..+
T Consensus 396 kIgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~e---r~~t~~d~ 472 (516)
T KOG1033|consen 396 KIGDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFE---RIATLTDI 472 (516)
T ss_pred hhhhhhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHH---HHHhhhhh
Confidence 999999987765554 5567899999999999984 79999999999999999997 222221 11222222
Q ss_pred HhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhh
Q 014210 374 LKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLI 419 (429)
Q Consensus 374 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~ 419 (429)
..+. ++...+.++ ++-.+|+.+||.+.|.+||++.+.-.|.|.
T Consensus 473 r~g~--ip~~~~~d~-p~e~~ll~~lls~~p~~RP~~~~~~~~~~~ 515 (516)
T KOG1033|consen 473 RDGI--IPPEFLQDY-PEEYTLLQQLLSPSPEERPSAIEVALHEFL 515 (516)
T ss_pred hcCC--CChHHhhcC-cHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence 2222 221122233 344699999999999999988777777664
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=3.4e-19 Score=163.91 Aligned_cols=138 Identities=27% Similarity=0.369 Sum_probs=113.3
Q ss_pred eceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcH-----HHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeE
Q 014210 160 GEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTA-----IAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (429)
Q Consensus 160 ~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~-----~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~ 234 (429)
++.||+|++|.||+|.. .|..++||+......... ....++.+|+.++..+. |++|.....++.+.+..
T Consensus 1 ~~~l~~G~~~~vy~~~~-----~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~i~~p~~~~~~~~~~ 74 (211)
T PRK14879 1 MKLIKRGAEAEIYLGDF-----LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRAR-KAGVNVPAVYFVDPENF 74 (211)
T ss_pred CcccccCceEEEEEEee-----CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHH-HCCCCCCeEEEEeCCCC
Confidence 36799999999999975 367899998654322211 12346789999999998 89988877777778888
Q ss_pred EEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccc
Q 014210 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (429)
Q Consensus 235 ~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~ 312 (429)
+++|||++|++|.+.+.... . .+..++.+++.+|.+||+.|++|+|++|.|||+. ++.++|+|||++..
T Consensus 75 ~lv~e~~~G~~L~~~~~~~~----~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~----~~~~~liDf~~a~~ 143 (211)
T PRK14879 75 IIVMEYIEGEPLKDLINSNG----M-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS----GGKIYLIDFGLAEF 143 (211)
T ss_pred EEEEEEeCCcCHHHHHHhcc----H-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE----CCCEEEEECCcccC
Confidence 99999999999998774322 2 8889999999999999999999999999999994 56799999999865
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.81 E-value=4.3e-19 Score=161.77 Aligned_cols=134 Identities=26% Similarity=0.337 Sum_probs=106.7
Q ss_pred eeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCc-----HHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEE
Q 014210 162 EVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTT-----AIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYV 236 (429)
Q Consensus 162 ~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~-----~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~~l 236 (429)
.||+|+||.||++.. .|..+++|+........ ....+++.+|++++..+. |+++.....++.+.+..++
T Consensus 1 ~ig~G~~~~vy~~~~-----~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~i~~p~~~~~~~~~~~l 74 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-----LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRAR-KAGVNTPVVYDVDPDNKTI 74 (199)
T ss_pred CCCCCceEEEEEeec-----CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHH-HCCCCCCEEEEEECCCCEE
Confidence 489999999999972 36789999865432221 223466789999999998 7776655555666777899
Q ss_pred EEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCcccc
Q 014210 237 VMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (429)
Q Consensus 237 v~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~ 313 (429)
||||++|++|.+.+..... .++.+++.+|.+||+.|++|+|++|+|||+. ++.++|+|||++...
T Consensus 75 v~e~~~g~~l~~~~~~~~~--------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~----~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 75 VMEYIEGKPLKDVIEEGND--------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR----DDKLYLIDFGLGKYS 139 (199)
T ss_pred EEEEECCccHHHHHhhcHH--------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE----CCcEEEEECCCCcCC
Confidence 9999999999887643211 8899999999999999999999999999994 677999999998653
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.80 E-value=5.6e-19 Score=184.95 Aligned_cols=143 Identities=21% Similarity=0.296 Sum_probs=113.5
Q ss_pred cccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCc-----CcHHHHHHHHHHHHHHHHhcCCCCcceEEE
Q 014210 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKM-----TTAIAIEDVRREVKILRALTGHNNLVKFFD 226 (429)
Q Consensus 152 ~~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~-----~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~ 226 (429)
.....|...++||+|+||.||++.... ..+++|+...... ......+++.+|+++++.++ |++++..+.
T Consensus 330 ~~~~~~~~~~~iG~G~~g~Vy~~~~~~-----~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~i~~p~~ 403 (535)
T PRK09605 330 EVKRRKIPDHLIGKGAEADIKKGEYLG-----RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEAR-RAGVPTPVI 403 (535)
T ss_pred ccccccCccceeccCCcEEEEEEeecC-----ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhc-ccCCCeeEE
Confidence 334556778999999999999987543 3344444321111 11223466889999999998 999998888
Q ss_pred EEEeCCeEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEee
Q 014210 227 AYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAID 306 (429)
Q Consensus 227 ~~~~~~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~D 306 (429)
++.+.+..++||||++|++|.+++. ....++.+++.+|.+||+.||+||||||+|||+ .++.++|+|
T Consensus 404 ~~~~~~~~~lv~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl----~~~~~~liD 470 (535)
T PRK09605 404 YDVDPEEKTIVMEYIGGKDLKDVLE---------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV----RDDRLYLID 470 (535)
T ss_pred EEEeCCCCEEEEEecCCCcHHHHHH---------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE----ECCcEEEEe
Confidence 8888778899999999999988774 457899999999999999999999999999999 245699999
Q ss_pred cCCcccc
Q 014210 307 FGLSDFV 313 (429)
Q Consensus 307 FGla~~~ 313 (429)
||+++..
T Consensus 471 FGla~~~ 477 (535)
T PRK09605 471 FGLGKYS 477 (535)
T ss_pred CcccccC
Confidence 9999764
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.80 E-value=4.4e-19 Score=161.92 Aligned_cols=141 Identities=25% Similarity=0.279 Sum_probs=108.9
Q ss_pred ceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCc-------------------HHHHHHHHHHHHHHHHhc
Q 014210 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTT-------------------AIAIEDVRREVKILRALT 216 (429)
Q Consensus 156 ~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~-------------------~~~~~~~~~Ei~il~~l~ 216 (429)
.|.+.+.||+|+||.||++... +|+.||||++....... ........+|+.++..+.
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 91 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDP----DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALY 91 (198)
T ss_pred hhhcCCccccCcceEEEEEEcC----CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHH
Confidence 4888999999999999999754 48999999876432100 011123678999999997
Q ss_pred CCC--CcceEEEEEEeCCeEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEe
Q 014210 217 GHN--NLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFT 294 (429)
Q Consensus 217 ~h~--nIv~l~~~~~~~~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~ 294 (429)
|. .+...++ .+..++||||++|++|.+... ......++.+|+.++.++|+.||+||||||+||++
T Consensus 92 -~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~-------~~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill- 158 (198)
T cd05144 92 -EEGFPVPKPID----WNRHAVVMEYIDGVELYRVRV-------LEDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILV- 158 (198)
T ss_pred -HcCCCCCceee----cCCceEEEEEeCCcchhhccc-------cccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEE-
Confidence 66 4555554 345689999999988765421 14567889999999999999999999999999999
Q ss_pred ecCCCceEEEeecCCccccCC
Q 014210 295 TKDENSVLKAIDFGLSDFVRP 315 (429)
Q Consensus 295 ~~~~~~~vkL~DFGla~~~~~ 315 (429)
++++.++|+|||++.....
T Consensus 159 --~~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 159 --DDDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred --cCCCcEEEEECCccccCCC
Confidence 6688999999999966543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.79 E-value=3.8e-21 Score=201.59 Aligned_cols=261 Identities=26% Similarity=0.464 Sum_probs=212.4
Q ss_pred CceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeE
Q 014210 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (429)
Q Consensus 155 ~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~ 234 (429)
..|.+.+.||+|.|+.|-......+ ....+|+|.+.... ......+.+..|..+-+.+.+|.|++.+++...+.+..
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~--~~~~~a~~~~s~~~-~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~ 96 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRD--PESSSATKPISIPP-KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSY 96 (601)
T ss_pred ccccccccccccccchhhhhhhcCC--CcceeeccCCCCCC-CccchhhhcCccccccccccccccccccCCccCCCccc
Confidence 4577788899999998876654332 35667888775443 33445566778999988888899999999999999999
Q ss_pred EEEEEecCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHH-HcCceeccCCCCcEEEeecCCCc-eEEEeecCCcc
Q 014210 235 YVVMELCEGGELLDRILSRGG-KYTEDDAKAVMIQILNVVAFCH-LQGVVHRDLKPENFLFTTKDENS-VLKAIDFGLSD 311 (429)
Q Consensus 235 ~lv~E~~~ggsL~~~i~~~~~-~l~~~~~~~i~~qi~~gL~~LH-~~~iiHrDIKp~NILl~~~~~~~-~vkL~DFGla~ 311 (429)
++++||..|+++.+-+..... .++...+..++.|+..++.|+| ..++.||||||+|.++ +..+ .+|+.|||+|.
T Consensus 97 ~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l---~~s~~~l~~~df~~At 173 (601)
T KOG0590|consen 97 LLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLL---DESGSALKIADFGLAT 173 (601)
T ss_pred ccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchh---ccCCCcccCCCchhhc
Confidence 999999999999887733333 6888999999999999999999 9999999999999999 6666 89999999998
Q ss_pred ccCC-Cc---ccccccc-CCcccCcccccC--CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHH-HHHHHhcCCCCCCC
Q 014210 312 FVRP-DE---RLNDIVG-SAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGI-FRAVLKADPSFDEA 383 (429)
Q Consensus 312 ~~~~-~~---~~~~~~g-t~~y~aPE~~~~--~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~-~~~i~~~~~~~~~~ 383 (429)
.+.. +. .....+| ++.|+|||...+ ......|+||.|+++.-+++|..||........ +.........+...
T Consensus 174 ~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 253 (601)
T KOG0590|consen 174 AYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQL 253 (601)
T ss_pred cccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccC
Confidence 7765 22 2345678 999999998876 356678999999999999999999966544332 23333333455677
Q ss_pred CCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhc
Q 014210 384 PWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLICY 421 (429)
Q Consensus 384 ~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~ 421 (429)
+|..++....+++..+|..+|..|.+.+++-.+.|+..
T Consensus 254 ~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 254 PWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred ccccCChhhhhcccccccCCchhccccccccccccccc
Confidence 88899999999999999999999999999999999876
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.76 E-value=1e-18 Score=176.12 Aligned_cols=261 Identities=21% Similarity=0.275 Sum_probs=203.2
Q ss_pred cccCceeEeceeec--cCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEE
Q 014210 152 HFANKYELGEEVGR--GHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYE 229 (429)
Q Consensus 152 ~~~~~y~~~~~IG~--G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~ 229 (429)
.+...|.+.+.+|. |.+|.||.+.... ..++..+|+|.-+. .........+-.+|+.-.+++..|+|.++.+..|+
T Consensus 111 ~~~~~~~~~~~~g~~~g~~~s~~~~~~~~-~~s~~~~a~k~s~~-p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e 188 (524)
T KOG0601|consen 111 FFDQRFPISSRTGSLPGSKGSVFKSRCTN-SESPHKFAVKKSKI-PFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWE 188 (524)
T ss_pred hhhhhcccccccccCCCCCceeecccCCc-ccCCcccccccccC-CCCCccccccccchhhcccccCccccccccCcccc
Confidence 44567888999999 9999999988622 12688999997322 22333333445688888889989999999999999
Q ss_pred eCCeEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHH----HHHHHHHcCceeccCCCCcEEEeecCCC-ceEEE
Q 014210 230 DTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILN----VVAFCHLQGVVHRDLKPENFLFTTKDEN-SVLKA 304 (429)
Q Consensus 230 ~~~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~----gL~~LH~~~iiHrDIKp~NILl~~~~~~-~~vkL 304 (429)
..+..++-+|+| +.+|..+.......+++..++.++.+... ||..+|..+|+|-|+||+||++ ..+ ...++
T Consensus 189 ~~~~lfiqtE~~-~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~---~~~~~s~~~ 264 (524)
T KOG0601|consen 189 GSGILFIQTELC-GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFT---TSDWTSCKL 264 (524)
T ss_pred cCCcceeeeccc-cchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheec---ccccceeec
Confidence 999999999999 46999988888778999999999999999 9999999999999999999999 455 78999
Q ss_pred eecCCccccCCCccc------cccccCCcccCcccccCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCC
Q 014210 305 IDFGLSDFVRPDERL------NDIVGSAYYVAPEVLHRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADP 378 (429)
Q Consensus 305 ~DFGla~~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~ 378 (429)
+|||+........-. ....|...|++||.+++-++..+|||+||.++++..++.............+ +-. .
T Consensus 265 ~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~-~r~--~ 341 (524)
T KOG0601|consen 265 TDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQ-LRQ--G 341 (524)
T ss_pred CCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccc-ccc--c
Confidence 999998877654421 2236788899999999999999999999999999999876653321111100 000 0
Q ss_pred CCCCCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhc
Q 014210 379 SFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLICY 421 (429)
Q Consensus 379 ~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~ 421 (429)
..+.......+.++...+.+|++.++..|++++.++.+.++..
T Consensus 342 ~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s 384 (524)
T KOG0601|consen 342 YIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHS 384 (524)
T ss_pred cCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccc
Confidence 0111122345667777999999999999999999999887754
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.75 E-value=9e-18 Score=151.46 Aligned_cols=141 Identities=23% Similarity=0.233 Sum_probs=100.1
Q ss_pred eceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHH---------------------HHHHHHHHHHHhcCC
Q 014210 160 GEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIE---------------------DVRREVKILRALTGH 218 (429)
Q Consensus 160 ~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~---------------------~~~~Ei~il~~l~~h 218 (429)
.+.||+|+||.||+|... +|+.||||++............ ....|...+.++..+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~----~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~ 77 (187)
T cd05119 2 GGPIGTGKEADVYLALDG----DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEA 77 (187)
T ss_pred CcccccccceeEEEEECC----CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHc
Confidence 578999999999999754 4889999998654322111111 124677777777622
Q ss_pred -CCcceEEEEEEeCCeEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-cCceeccCCCCcEEEeec
Q 014210 219 -NNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHL-QGVVHRDLKPENFLFTTK 296 (429)
Q Consensus 219 -~nIv~l~~~~~~~~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~-~~iiHrDIKp~NILl~~~ 296 (429)
-.+.+.+++ ...++||||++++.+......... . ...++.++.+++.++.++|. .||+||||||+||++
T Consensus 78 ~~~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~-~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili--- 148 (187)
T cd05119 78 GVPVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR-L-LEDPEELYDQILELMRKLYREAGLVHGDLSEYNILV--- 148 (187)
T ss_pred CCCCCceEec----CCCEEEEEEeCCCCccChhhhhhh-h-cccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEE---
Confidence 234555543 245899999998543321111111 1 16788999999999999999 999999999999999
Q ss_pred CCCceEEEeecCCccccC
Q 014210 297 DENSVLKAIDFGLSDFVR 314 (429)
Q Consensus 297 ~~~~~vkL~DFGla~~~~ 314 (429)
+ ++.++|+|||++....
T Consensus 149 ~-~~~~~liDfg~a~~~~ 165 (187)
T cd05119 149 D-DGKVYIIDVPQAVEID 165 (187)
T ss_pred E-CCcEEEEECccccccc
Confidence 4 6789999999996554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.73 E-value=5.7e-17 Score=152.25 Aligned_cols=139 Identities=22% Similarity=0.265 Sum_probs=104.0
Q ss_pred eceee-ccCceEEEEEEEecCcccCeEEEEEEccCCCc----------CcHHHHHHHHHHHHHHHHhcCCCCc--ceEEE
Q 014210 160 GEEVG-RGHFGYTCAAKFKKGELKGQQVAVKVIPKHKM----------TTAIAIEDVRREVKILRALTGHNNL--VKFFD 226 (429)
Q Consensus 160 ~~~IG-~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~----------~~~~~~~~~~~Ei~il~~l~~h~nI--v~l~~ 226 (429)
...|| .||.|.||.+... +..++||++..... .+......+.+|++++.+|. |++| +..++
T Consensus 36 ~~~lg~~~g~gtv~~v~~~-----~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~-~~gi~vP~pl~ 109 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP-----GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLY-EAGLPVPRPIA 109 (239)
T ss_pred CceeecCCCCccEEEEEeC-----CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHH-hCCCCCceeEe
Confidence 45677 8888999888643 57899998743211 11233456889999999998 7774 67777
Q ss_pred EEEeCCe----EEEEEEecCC-CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCce
Q 014210 227 AYEDTDN----VYVVMELCEG-GELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSV 301 (429)
Q Consensus 227 ~~~~~~~----~~lv~E~~~g-gsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~ 301 (429)
+...... .+||||+++| .+|.+++.. ..+++.. +.+|+.+|.+||+.||+||||||+|||+ +.++.
T Consensus 110 ~~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~--~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv---~~~~~ 180 (239)
T PRK01723 110 ARVVRHGLFYRADILIERIEGARDLVALLQE--APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILL---DPDGK 180 (239)
T ss_pred eeeeecCcceeeeEEEEecCCCCCHHHHHhc--CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEE---cCCCC
Confidence 6544322 3599999997 588777633 3455543 5789999999999999999999999999 55668
Q ss_pred EEEeecCCcccc
Q 014210 302 LKAIDFGLSDFV 313 (429)
Q Consensus 302 vkL~DFGla~~~ 313 (429)
++|+|||.+...
T Consensus 181 v~LIDfg~~~~~ 192 (239)
T PRK01723 181 FWLIDFDRGELR 192 (239)
T ss_pred EEEEECCCcccC
Confidence 999999988664
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.72 E-value=4.2e-17 Score=140.28 Aligned_cols=133 Identities=25% Similarity=0.332 Sum_probs=111.5
Q ss_pred EeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCC-CCcceEEEEEEeCCeEEEE
Q 014210 159 LGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGH-NNLVKFFDAYEDTDNVYVV 237 (429)
Q Consensus 159 ~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h-~nIv~l~~~~~~~~~~~lv 237 (429)
+.+.||+|.++.||++... +..++||+...... ...+.+|+.+++.+..+ .++++++++....+..+++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~-----~~~~~iK~~~~~~~-----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v 71 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTK-----DEDYVLKINPSREK-----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLL 71 (155)
T ss_pred cceecccccccceEEEEec-----CCeEEEEecCCCCc-----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEE
Confidence 4678999999999999853 36799999865422 45788999999999844 6899999998888889999
Q ss_pred EEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEEeecCCccc
Q 014210 238 MELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQ---GVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (429)
Q Consensus 238 ~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~---~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~ 312 (429)
|||++|+.+..+ +......++.+++.+|++||.. +++|+||+|+|||+ +..+.++|+|||.+..
T Consensus 72 ~e~~~g~~~~~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~---~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 72 MEWIEGETLDEV--------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILV---DDGKILGIIDWEYAGY 138 (155)
T ss_pred EEecCCeecccC--------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEE---ECCcEEEEEecccccC
Confidence 999988776542 5667788899999999999985 69999999999999 4567899999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.62 E-value=1.2e-14 Score=147.91 Aligned_cols=145 Identities=22% Similarity=0.243 Sum_probs=99.2
Q ss_pred eceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcH---------------------------H----HH------
Q 014210 160 GEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTA---------------------------I----AI------ 202 (429)
Q Consensus 160 ~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~---------------------------~----~~------ 202 (429)
.+.||.|++|.||+|+.++ |+.||||+........- . ..
T Consensus 122 ~~plasaSigQVh~A~l~~----G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~E 197 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVD----GKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRE 197 (437)
T ss_pred CcceeeeehhheEEEEecC----CCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHH
Confidence 3679999999999999764 88999999854320000 0 00
Q ss_pred HHHHHHHHHHHHhc----CCCCcceEEEEEEeCCeEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHH-HHHHHH
Q 014210 203 EDVRREVKILRALT----GHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILN-VVAFCH 277 (429)
Q Consensus 203 ~~~~~Ei~il~~l~----~h~nIv~l~~~~~~~~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~-gL~~LH 277 (429)
-++.+|...+.++. ++++|.--.-+++.....+|||||++|++|.+......... ....++.+++. .+..+|
T Consensus 198 ldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~---~~~~ia~~~~~~~l~ql~ 274 (437)
T TIGR01982 198 LDLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGL---DRKALAENLARSFLNQVL 274 (437)
T ss_pred HCHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCC---CHHHHHHHHHHHHHHHHH
Confidence 02445555555553 34443322223333455799999999999887654322222 23456666665 478899
Q ss_pred HcCceeccCCCCcEEEeecCCCceEEEeecCCccccC
Q 014210 278 LQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (429)
Q Consensus 278 ~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~ 314 (429)
..|++|+|+||.||++ +.++.++|+|||++..+.
T Consensus 275 ~~g~~H~D~hPgNilv---~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 275 RDGFFHADLHPGNIFV---LKDGKIIALDFGIVGRLS 308 (437)
T ss_pred hCCceeCCCCcccEEE---CCCCcEEEEeCCCeeECC
Confidence 9999999999999999 677889999999997664
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.57 E-value=3e-14 Score=147.06 Aligned_cols=150 Identities=20% Similarity=0.360 Sum_probs=93.0
Q ss_pred CceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcC--------------------------c-----HHHHH
Q 014210 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMT--------------------------T-----AIAIE 203 (429)
Q Consensus 155 ~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~--------------------------~-----~~~~~ 203 (429)
..|+. +.||+|++|.||+|+.++ +|+.||||++...... + .+..+
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~---~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~ 195 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKD---NGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEK 195 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECC---CCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHH
Confidence 44665 789999999999999876 4899999999654100 0 01223
Q ss_pred HHHHHHHHHH------Hhc---CCCCcceEEEE-EEeCCeEEEEEEecCCCcHHHHHH-hcCC----CCCHHHHHHHHHH
Q 014210 204 DVRREVKILR------ALT---GHNNLVKFFDA-YEDTDNVYVVMELCEGGELLDRIL-SRGG----KYTEDDAKAVMIQ 268 (429)
Q Consensus 204 ~~~~Ei~il~------~l~---~h~nIv~l~~~-~~~~~~~~lv~E~~~ggsL~~~i~-~~~~----~l~~~~~~~i~~q 268 (429)
.+.+|+++.+ ++. .+.+.+.+-.+ ++-....+|||||++|+.+.+.-. ...+ .+.+..+..++.|
T Consensus 196 ~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q 275 (537)
T PRK04750 196 TLHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ 275 (537)
T ss_pred HHHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH
Confidence 3344444433 332 12222222222 222445689999999999876421 1222 2333444444444
Q ss_pred HHHHHHHHHHcCceeccCCCCcEEEeecC-CCceEEEeecCCccccCC
Q 014210 269 ILNVVAFCHLQGVVHRDLKPENFLFTTKD-ENSVLKAIDFGLSDFVRP 315 (429)
Q Consensus 269 i~~gL~~LH~~~iiHrDIKp~NILl~~~~-~~~~vkL~DFGla~~~~~ 315 (429)
+ +..|++|+|+||.||++..++ .++.++++|||++..+..
T Consensus 276 i-------f~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 276 V-------FRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred H-------HhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 4 458999999999999994221 123899999999977643
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.55 E-value=6.1e-16 Score=163.71 Aligned_cols=263 Identities=25% Similarity=0.375 Sum_probs=200.3
Q ss_pred ccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCC
Q 014210 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (429)
Q Consensus 153 ~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~ 232 (429)
.-+.+.+.+-+.+|.++.++.++-.. .|-..++|+..+.........+.+..+-.++-... +|-++...-.+....
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~---sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~-~P~v~~~~~s~~~rs 877 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAG---SGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPR-SPAVVRSFPSFPCRS 877 (1205)
T ss_pred CCccceecccccCCCCcccccCCccc---cccccchhhhccchhhccccccccCCccCccccCC-CCceecccCCCCCCC
Confidence 34678888899999999988776433 45556666654433333333333444444433223 566666655555677
Q ss_pred eEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccc
Q 014210 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (429)
Q Consensus 233 ~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~ 312 (429)
..+|+++|..+++|...++.. +..+.+-++..+..+...++|||...++|||++|.|+|+ ..++..++.|||....
T Consensus 878 P~~L~~~~~~~~~~~Skl~~~-~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~---~~~gh~~l~~~~t~~~ 953 (1205)
T KOG0606|consen 878 PLPLVGHYLNGGDLPSKLHNS-GCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLI---AYDGHRPLTDFGTLSK 953 (1205)
T ss_pred CcchhhHHhccCCchhhhhcC-CCcccccccchhHHHHhhhhccccchhhcccccccchhh---cccCCcccCccccccc
Confidence 889999999999988766443 456777888889999999999999999999999999999 7888899999984322
Q ss_pred cCC---------------------C-----------ccccccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHcCCC
Q 014210 313 VRP---------------------D-----------ERLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSR 359 (429)
Q Consensus 313 ~~~---------------------~-----------~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~elltg~~ 359 (429)
... . .......||+.|.+||.+.+ .....+|+|++|++++|.++|..
T Consensus 954 vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~p 1033 (1205)
T KOG0606|consen 954 VGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIP 1033 (1205)
T ss_pred cccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCC
Confidence 100 0 01123568999999998764 68889999999999999999999
Q ss_pred CCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCcCCHH---HHHhhHhhhccce
Q 014210 360 PFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAA---QALSELLICYQSY 424 (429)
Q Consensus 360 Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~---~iL~~~~~~~~~~ 424 (429)
||...+.+.+++.+++.+...+..+ ...+.++++++..+|..++.+|..+. ++-.|.||+...+
T Consensus 1034 p~na~tpq~~f~ni~~~~~~~p~g~-~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~~~ 1100 (1205)
T KOG0606|consen 1034 PFNAETPQQIFENILNRDIPWPEGP-EEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDVDW 1100 (1205)
T ss_pred CCCCcchhhhhhccccCCCCCCCCc-cccChhhhhhhhhhhccCchhccCcccccccccCCccCCCCc
Confidence 9999999999999988876655443 24688999999999999999999988 8899999887654
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.53 E-value=5.6e-15 Score=149.26 Aligned_cols=252 Identities=21% Similarity=0.206 Sum_probs=186.5
Q ss_pred cCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~ 233 (429)
..+|.++..||.|.|+.|+.+.... ..+..|++|.+.+.-......+ .-..|+.+...+.-|.+++.++..|...++
T Consensus 264 ~~df~~v~~i~~~~~~~~~~~~~r~--~~~~~Y~~ke~~~~l~~~~~di-~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~ 340 (524)
T KOG0601|consen 264 LTDFGLVSKISDGNFSSVFKVSKRP--EGDCIYAAKELLNGLATFASDI-FSLGEVILEAILGSHLPSVGKNSSWSQLRQ 340 (524)
T ss_pred cCCcceeEEccCCccccceeeeecC--CCCceEeChhhhccccchHhhh-cchhhhhHhhHhhcccccCCCCCCcccccc
Confidence 4578899999999999999877331 2588999998866543333332 234788888888889999999999999999
Q ss_pred EEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCcccc
Q 014210 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (429)
Q Consensus 234 ~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~ 313 (429)
.||-.|||.++++...+ .....+++...+++..|++.++.++|+..++|+|+||+||++.+++ +..++.|||....+
T Consensus 341 ~~ip~e~~~~~s~~l~~-~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~--~~~~~~~~~~~t~~ 417 (524)
T KOG0601|consen 341 GYIPLEFCEGGSSSLRS-VTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDG--FFSKLGDFGCWTRL 417 (524)
T ss_pred ccCchhhhcCcchhhhh-HHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccch--hhhhcccccccccc
Confidence 99999999999876655 2223578889999999999999999999999999999999995432 78999999998642
Q ss_pred CCCccccccccCCccc-CcccccC--CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCH
Q 014210 314 RPDERLNDIVGSAYYV-APEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSS 390 (429)
Q Consensus 314 ~~~~~~~~~~gt~~y~-aPE~~~~--~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 390 (429)
. -......+.-+++ ..|++.. .+..+.|+||||+.+.|.+++...-+.... ...+..... ...+....
T Consensus 418 ~--~~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~---~~~i~~~~~----p~~~~~~~ 488 (524)
T KOG0601|consen 418 A--FSSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ---SLTIRSGDT----PNLPGLKL 488 (524)
T ss_pred c--eecccccccccccccchhhccccccccccccccccccccccccCcccCccccc---ceeeecccc----cCCCchHH
Confidence 1 1112223334445 3565543 477799999999999999998654332221 111222211 11234558
Q ss_pred HHHHHHHHhcccCccCcCCHHHHHhhHhhh
Q 014210 391 EARDFVKRLLNKDPRKRLTAAQALSELLIC 420 (429)
Q Consensus 391 ~~~~li~~~L~~dP~~Rps~~~iL~~~~~~ 420 (429)
++..+.+.++..|+..|+.+.++..|.-+.
T Consensus 489 ~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~ 518 (524)
T KOG0601|consen 489 QLQVLLKVMINPDRKRRPSAVELSLHSEFY 518 (524)
T ss_pred hhhhhhhhhcCCccccchhhhhhcccchhh
Confidence 889999999999999999999988776543
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.49 E-value=1.8e-13 Score=121.11 Aligned_cols=129 Identities=17% Similarity=0.204 Sum_probs=95.1
Q ss_pred eceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEE
Q 014210 160 GEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVME 239 (429)
Q Consensus 160 ~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~~lv~E 239 (429)
.+.|+.|.++.||+++.. |+.|++|+...... ....+.+|+.+++.+.+...+.+++++.. ...++|||
T Consensus 3 ~~~l~~G~~~~vy~~~~~-----~~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e 71 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-----NKKYVVRIPGNGTE----LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITE 71 (170)
T ss_pred eeecCCcccCceEEEEEC-----CeEEEEEeCCCCcc----cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEE
Confidence 457889999999998743 67899999754321 12346789999999974333455665443 34589999
Q ss_pred ecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCc-----eeccCCCCcEEEeecCCCceEEEeecCCccc
Q 014210 240 LCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGV-----VHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (429)
Q Consensus 240 ~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~i-----iHrDIKp~NILl~~~~~~~~vkL~DFGla~~ 312 (429)
|++|.++.+. ......++.+++++|..||..++ +|+|++|.||+++ ++.++|+|||.+..
T Consensus 72 ~i~G~~l~~~---------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~----~~~~~liDf~~a~~ 136 (170)
T cd05151 72 FIEGSELLTE---------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD----DGRLWLIDWEYAGM 136 (170)
T ss_pred ecCCCccccc---------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE----CCeEEEEecccccC
Confidence 9999876542 11123467899999999999985 9999999999994 45699999998854
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.48 E-value=6.2e-14 Score=131.85 Aligned_cols=198 Identities=18% Similarity=0.221 Sum_probs=139.4
Q ss_pred HHHhcCCCCcceEEEEEEeCC-----eEEEEEEecCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHcC--c
Q 014210 212 LRALTGHNNLVKFFDAYEDTD-----NVYVVMELCEGGELLDRILSR---GGKYTEDDAKAVMIQILNVVAFCHLQG--V 281 (429)
Q Consensus 212 l~~l~~h~nIv~l~~~~~~~~-----~~~lv~E~~~ggsL~~~i~~~---~~~l~~~~~~~i~~qi~~gL~~LH~~~--i 281 (429)
|..+. |.|||+++.||.+.. ...++.|||..|++..+|++. ...+.....++|+-||+.||.|||+.. |
T Consensus 121 llqlv-HsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppi 199 (458)
T KOG1266|consen 121 LLQLV-HSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPI 199 (458)
T ss_pred HHHHH-HHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCcc
Confidence 34455 899999999997654 478999999999999888653 346888999999999999999999985 9
Q ss_pred eeccCCCCcEEEeecCCCceEEEeecCCcccc-----CCCccccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHH
Q 014210 282 VHRDLKPENFLFTTKDENSVLKAIDFGLSDFV-----RPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILL 355 (429)
Q Consensus 282 iHrDIKp~NILl~~~~~~~~vkL~DFGla~~~-----~~~~~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~ell 355 (429)
+|+++..+-|++ ..++.+|+.--.-...- ..........+-++|.+||.-. ...+..+|||+||+..+||.
T Consensus 200 ihgnlTc~tifi---q~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema 276 (458)
T KOG1266|consen 200 IHGNLTCDTIFI---QHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA 276 (458)
T ss_pred ccCCcchhheee---cCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence 999999999999 67888887532211110 0001112234668899999654 35667899999999999998
Q ss_pred cCCCCCCC-CChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhh
Q 014210 356 CGSRPFWA-RTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLIC 420 (429)
Q Consensus 356 tg~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~ 420 (429)
.|..--.. ......-..+.+...... ..--+++|..||.-.|..||++.++|.|+.+-
T Consensus 277 ilEiq~tnseS~~~~ee~ia~~i~~le-------n~lqr~~i~kcl~~eP~~rp~ar~llfHpllf 335 (458)
T KOG1266|consen 277 ILEIQSTNSESKVEVEENIANVIIGLE-------NGLQRGSITKCLEGEPNGRPDARLLLFHPLLF 335 (458)
T ss_pred HheeccCCCcceeehhhhhhhheeecc-------CccccCcCcccccCCCCCCcchhhhhcCceee
Confidence 87643211 111111111111111111 11235789999999999999999999998764
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.44 E-value=1.6e-12 Score=117.53 Aligned_cols=145 Identities=16% Similarity=0.158 Sum_probs=101.7
Q ss_pred eceeeccCceEEEEEEEecC---cccCeEEEEEEccCCC---------------cC----cHHHHHHH----HHHHHHHH
Q 014210 160 GEEVGRGHFGYTCAAKFKKG---ELKGQQVAVKVIPKHK---------------MT----TAIAIEDV----RREVKILR 213 (429)
Q Consensus 160 ~~~IG~G~fg~V~~~~~~~~---~~~g~~vAvK~~~~~~---------------~~----~~~~~~~~----~~Ei~il~ 213 (429)
...||.|-.+.||.|....+ ...+..+|||+++... .. .....+.+ ++|.+.|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 45789999999999974321 1135789999874211 00 01112223 48999999
Q ss_pred HhcCC-CCcceEEEEEEeCCeEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH-HHcCceeccCCCCcE
Q 014210 214 ALTGH-NNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFC-HLQGVVHRDLKPENF 291 (429)
Q Consensus 214 ~l~~h-~nIv~l~~~~~~~~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~L-H~~~iiHrDIKp~NI 291 (429)
++... -++.+.+++ ..-+|||||+.+..+..... +...++...+..+..+++.+|..| |+.||||+||++.||
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~L-kd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NI 156 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKL-KDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNM 156 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhh-hccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHE
Confidence 99843 366677764 45589999997654422221 223456677788899999999999 899999999999999
Q ss_pred EEeecCCCceEEEeecCCcccc
Q 014210 292 LFTTKDENSVLKAIDFGLSDFV 313 (429)
Q Consensus 292 Ll~~~~~~~~vkL~DFGla~~~ 313 (429)
|+. ++.++|+|||.+-..
T Consensus 157 L~~----~~~v~iIDF~qav~~ 174 (197)
T cd05146 157 LWH----DGKVWFIDVSQSVEP 174 (197)
T ss_pred EEE----CCcEEEEECCCceeC
Confidence 994 356999999987554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.44 E-value=1.2e-12 Score=114.49 Aligned_cols=149 Identities=20% Similarity=0.238 Sum_probs=114.3
Q ss_pred EeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcC-----cHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe
Q 014210 159 LGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMT-----TAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (429)
Q Consensus 159 ~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~-----~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~ 233 (429)
.+..|-+|+.++|+++.+ .|+.+.||.-...... ......+..+|++.|.++. --.|.--.-++.+...
T Consensus 11 ~l~likQGAEArv~~~~~-----~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~-~~GI~~P~l~~~D~~~ 84 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF-----SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCR-ALGIPAPRLIFIDTYG 84 (229)
T ss_pred cceeeeccceeeEeeecc-----CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHH-HhCCCCceEEEEecCC
Confidence 577889999998887763 5788888854322222 2334456789999999987 4566655556777777
Q ss_pred EEEEEEecCC-CcHHHHHHhcCCCCCH-HHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCcc
Q 014210 234 VYVVMELCEG-GELLDRILSRGGKYTE-DDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (429)
Q Consensus 234 ~~lv~E~~~g-gsL~~~i~~~~~~l~~-~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~ 311 (429)
-.|+|||++| .++.+++.+....-.+ .....++.+|-+.|.-||..+|||+||..+||+|...+....+.|+|||++.
T Consensus 85 ~~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~ 164 (229)
T KOG3087|consen 85 GQIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSS 164 (229)
T ss_pred CeEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchh
Confidence 7999999987 3677888766443333 3448899999999999999999999999999999877777778999999986
Q ss_pred cc
Q 014210 312 FV 313 (429)
Q Consensus 312 ~~ 313 (429)
..
T Consensus 165 ~s 166 (229)
T KOG3087|consen 165 VS 166 (229)
T ss_pred cc
Confidence 53
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.41 E-value=4.7e-12 Score=111.21 Aligned_cols=135 Identities=26% Similarity=0.344 Sum_probs=102.2
Q ss_pred ceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcH-----HHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEE
Q 014210 161 EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTA-----IAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVY 235 (429)
Q Consensus 161 ~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~-----~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~~ 235 (429)
..|++|+-+.++.+.+ .|..+++|.-.......+ ...++..+|..++.++. --.|..-+-+..+.+...
T Consensus 2 ~~i~~GAEa~i~~~~~-----~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~-~~GV~~P~v~dvD~~~~~ 75 (204)
T COG3642 2 DLIKQGAEAIIYLTDF-----LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAR-EAGVPVPIVYDVDPDNGL 75 (204)
T ss_pred chhhCCcceeEEeeec-----cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHH-HcCCCCCeEEEEcCCCCE
Confidence 4578999999988854 355677875433222222 23345679999999998 556666666677788889
Q ss_pred EEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCcccc
Q 014210 236 VVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (429)
Q Consensus 236 lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~ 313 (429)
|+|||++|-.|.+.+... ...++..+-.-+.-||..||||+||.++||++. ++.+.++||||+...
T Consensus 76 I~me~I~G~~lkd~l~~~--------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~----~~~i~~IDfGLg~~s 141 (204)
T COG3642 76 IVMEYIEGELLKDALEEA--------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILS----GGRIYFIDFGLGEFS 141 (204)
T ss_pred EEEEEeCChhHHHHHHhc--------chHHHHHHHHHHHHHHhcCeecCCCccceEEEe----CCcEEEEECCccccc
Confidence 999999987777777443 366778888889999999999999999999994 334999999999754
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.32 E-value=4.3e-11 Score=122.65 Aligned_cols=162 Identities=22% Similarity=0.328 Sum_probs=121.5
Q ss_pred cCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEecCCCcHHHHHHhcCCCCCHHH
Q 014210 182 KGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDD 261 (429)
Q Consensus 182 ~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~ 261 (429)
++.+|.|..++... ....+.+.+-++.|+.|+ ||||+++++.++.++.+|||+|-+. -|..++.+.+ ...
T Consensus 36 ~~~~vsVF~~~~~~---~~~~~~~~~A~k~lKtlR-HP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~----~~~ 105 (690)
T KOG1243|consen 36 DGGPVSVFVYKRSN---GEVTELAKRAVKRLKTLR-HPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELG----KEE 105 (690)
T ss_pred cCCceEEEEEeCCC---chhhHHHHHHHHHhhhcc-CchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhH----HHH
Confidence 57888888875442 244566788899999999 9999999999999999999999985 4555564433 666
Q ss_pred HHHHHHHHHHHHHHHHH-cCceeccCCCCcEEEeecCCCceEEEeecCCccccCCCcc-ccccccCCcccCcccccCCCC
Q 014210 262 AKAVMIQILNVVAFCHL-QGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDER-LNDIVGSAYYVAPEVLHRSYS 339 (429)
Q Consensus 262 ~~~i~~qi~~gL~~LH~-~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~ 339 (429)
+.-.+.||+.||.|||+ .+++|++|.-+.|++ ++.|.+||++|.++........ .....--..|..|+.+... .
T Consensus 106 v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfV---n~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s-~ 181 (690)
T KOG1243|consen 106 VCLGLFQILAALSFLNDDCNLVHGNVCKDSVFV---NESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPS-E 181 (690)
T ss_pred HHHHHHHHHHHHHHHhccCCeeeccEeeeeEEE---cCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCcc-c
Confidence 67778999999999985 579999999999999 7888999999998865432221 1111111234555543211 1
Q ss_pred CcccHHHHHHHHHHHHcC
Q 014210 340 TEADVWSIGVIAYILLCG 357 (429)
Q Consensus 340 ~~sDiwSlGvll~elltg 357 (429)
-..|.|-||++++|++.|
T Consensus 182 ~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 182 WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred cchhhhhHHHHHHHHhCc
Confidence 235999999999999999
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.30 E-value=1e-09 Score=109.45 Aligned_cols=212 Identities=17% Similarity=0.215 Sum_probs=155.0
Q ss_pred eEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEe----CCeEEEEEEecCC-
Q 014210 169 GYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED----TDNVYVVMELCEG- 243 (429)
Q Consensus 169 g~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~----~~~~~lv~E~~~g- 243 (429)
.+.|++.... +|..|++|++...+.... .....-+++++++. |.|||++.++|.. +..+++|++|.++
T Consensus 290 ~Ttyk~~s~~---DG~~YvLkRlhg~r~~~~---nk~t~lve~wkkl~-h~NvV~frevf~t~tF~D~SlvlvYDYyP~s 362 (655)
T KOG3741|consen 290 ITTYKATSNV---DGNAYVLKRLHGDRDQST---NKDTSLVEAWKKLC-HTNVVPFREVFLTYTFGDLSLVLVYDYYPSS 362 (655)
T ss_pred ceeEeeeecc---CCceeeeeeeccccccCc---ccchHHHHHHHHhc-cCceeehhhhhhhhccCcceEEEEEecCCCC
Confidence 3778877555 699999999944332222 12234577889998 9999999999873 4468999999986
Q ss_pred CcHHHHHHh--------------cCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCC
Q 014210 244 GELLDRILS--------------RGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGL 309 (429)
Q Consensus 244 gsL~~~i~~--------------~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGl 309 (429)
++|.+.... .+.+.+|..+|.++.||..||.++|+.|+.-+-|.+.+||+ +.+.+++|...|.
T Consensus 363 ~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv---~G~~RIriS~C~i 439 (655)
T KOG3741|consen 363 PTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILV---TGKMRIRISGCGI 439 (655)
T ss_pred chHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEe---eCcceEEEecccc
Confidence 467765431 23468899999999999999999999999999999999999 5566899999888
Q ss_pred ccccCCCccccccccCCcccCcccccCCCCCcccHHHHHHHHHHHHcCCCCCCCCCh-HH-HHHHHHhcCCCCCCCCCCC
Q 014210 310 SDFVRPDERLNDIVGSAYYVAPEVLHRSYSTEADVWSIGVIAYILLCGSRPFWARTE-SG-IFRAVLKADPSFDEAPWPS 387 (429)
Q Consensus 310 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~sDiwSlGvll~elltg~~Pf~~~~~-~~-~~~~i~~~~~~~~~~~~~~ 387 (429)
.+....+.. |-+. --.+-|.=-||.+++.|.||..--+.... .. .+..| .+.
T Consensus 440 ~Dvl~~d~~-------------~~le--~~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~I-----------~~~ 493 (655)
T KOG3741|consen 440 MDVLQEDPT-------------EPLE--SQQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTRI-----------TTT 493 (655)
T ss_pred eeeecCCCC-------------cchh--HHhhhhHHHHHHHHHHHhhcccccccccchHHHHHHHh-----------hhh
Confidence 877665541 1111 12356899999999999999644222211 11 12222 135
Q ss_pred CCHHHHHHHHHhcccCccCcCCHHHHHhhH
Q 014210 388 LSSEARDFVKRLLNKDPRKRLTAAQALSEL 417 (429)
Q Consensus 388 ~s~~~~~li~~~L~~dP~~Rps~~~iL~~~ 417 (429)
++.++.++|..+...++++ -++.+++.+.
T Consensus 494 yS~D~rn~v~yl~s~~~~~-ksI~~llp~~ 522 (655)
T KOG3741|consen 494 YSTDLRNVVEYLESLNFRE-KSIQDLLPMI 522 (655)
T ss_pred hhHHHHHHHHHHHhcCccc-ccHHHHHHHH
Confidence 8899999999999999987 7888887654
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.29 E-value=2.3e-11 Score=112.12 Aligned_cols=143 Identities=27% Similarity=0.433 Sum_probs=104.7
Q ss_pred ceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCC-CCcceEEEEEEeC---CeEEE
Q 014210 161 EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGH-NNLVKFFDAYEDT---DNVYV 236 (429)
Q Consensus 161 ~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h-~nIv~l~~~~~~~---~~~~l 236 (429)
+.|+.|..+.||++...+ |+.++||+....... ....++.+|+++++.+..+ -.+.+++.+.... +..++
T Consensus 4 ~~l~~G~~n~~~~v~~~~----g~~~ilK~~~~~~~~--~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~ 77 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGG----GRRLVLRRPPPGALL--PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFY 77 (223)
T ss_pred eecCCCccceEEEEEecC----CcceEEEeCCCcccC--cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceE
Confidence 568999999999988643 678999997544221 1345688999999999842 3467778777654 36789
Q ss_pred EEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH--------------------------------------
Q 014210 237 VMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHL-------------------------------------- 278 (429)
Q Consensus 237 v~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~-------------------------------------- 278 (429)
||||++|.++.+.+.. ..++......++.+++++|..||+
T Consensus 78 v~e~i~G~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (223)
T cd05154 78 VMERVDGRVLRDRLLR--PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPP 155 (223)
T ss_pred EEEEeCCEecCCCCCC--CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccH
Confidence 9999999877654321 346777777777788777777773
Q ss_pred ------------------cCceeccCCCCcEEEeecCCCceEEEeecCCccc
Q 014210 279 ------------------QGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (429)
Q Consensus 279 ------------------~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~ 312 (429)
..++|+|+++.|||++.. .++.+.|+||+.+..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~-~~~~~~iID~e~~~~ 206 (223)
T cd05154 156 AMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPD-EPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCC-CCcEEEEEecccccc
Confidence 236999999999999421 156789999998754
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.22 E-value=6e-10 Score=106.12 Aligned_cols=128 Identities=17% Similarity=0.170 Sum_probs=92.6
Q ss_pred cCeEEEEEEccCCCcCcHHHHH----------HHHHHHHHHHHhcCCCCc--ceEEEEEEe-----CCeEEEEEEecCCC
Q 014210 182 KGQQVAVKVIPKHKMTTAIAIE----------DVRREVKILRALTGHNNL--VKFFDAYED-----TDNVYVVMELCEGG 244 (429)
Q Consensus 182 ~g~~vAvK~~~~~~~~~~~~~~----------~~~~Ei~il~~l~~h~nI--v~l~~~~~~-----~~~~~lv~E~~~gg 244 (429)
.|+.|.||........ ...+ .+.+|...+.+|. ..+| ...+++++. ...-+||||++++.
T Consensus 44 ~g~~~~vKr~~~~~~~--~~~k~l~~~~~p~~~a~rE~~~l~~L~-~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~ 120 (268)
T PRK15123 44 AGKSYFLKWHRGTGWG--EIFKNLLSLRMPVLGADREWRAIHRLH-EVGVDTMTGVAFGERGSNPATRTSFIITEDLAPT 120 (268)
T ss_pred CCEEEEEEEecCCcHH--HHhhhhcccccccHHHHHHHHHHHHHH-HcCCCCCCeeEEEEecCCCccceeEEEEeeCCCC
Confidence 4778999976432211 1111 3779999998886 3333 334555543 23478999999876
Q ss_pred -cHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEee----cCCCceEEEeecCCccc
Q 014210 245 -ELLDRILSR-GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTT----KDENSVLKAIDFGLSDF 312 (429)
Q Consensus 245 -sL~~~i~~~-~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~----~~~~~~vkL~DFGla~~ 312 (429)
+|.+++... ....+......++.+++..+.-||+.||+|+|+++.|||+.. .+++..+.|+||+.+..
T Consensus 121 ~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 121 ISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI 194 (268)
T ss_pred ccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence 787776432 345667788899999999999999999999999999999963 13457899999998853
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.17 E-value=7.3e-10 Score=108.04 Aligned_cols=244 Identities=17% Similarity=0.172 Sum_probs=162.6
Q ss_pred eeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcce--------EEEEE
Q 014210 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVK--------FFDAY 228 (429)
Q Consensus 157 y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~--------l~~~~ 228 (429)
......||+|+-+.+|-.--. ...+-|++.+..... . .+.+..|.+.-.||-+-. |+|-
T Consensus 13 i~~gr~LgqGgea~ly~l~e~------~d~VAKIYh~Pppa~---~---aqk~a~la~~p~~p~~~~rvaWPqa~L~G~- 79 (637)
T COG4248 13 IPPGRPLGQGGEADLYTLGEV------RDQVAKIYHAPPPAA---Q---AQKVAELAATPDAPLLNYRVAWPQATLHGG- 79 (637)
T ss_pred cCCCccccCCccceeeecchh------hchhheeecCCCchH---H---HHHHHHhccCCCCcchhhhhcccHHHhhCC-
Confidence 345678999999988854321 224558875432111 1 123344445444654333 1111
Q ss_pred EeCCeEEEEEEecCCCcHHHHHHh------cCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceE
Q 014210 229 EDTDNVYVVMELCEGGELLDRILS------RGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVL 302 (429)
Q Consensus 229 ~~~~~~~lv~E~~~ggsL~~~i~~------~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~v 302 (429)
.....+.+.|..+.|..--..+.. ......|+-+.++++.|+.+.+.||+.|.+-+|++++|+|+ .+++.|
T Consensus 80 ~~~~~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lV---sd~~~V 156 (637)
T COG4248 80 RRGKVIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLV---SDDSKV 156 (637)
T ss_pred CccceeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceee---ecCceE
Confidence 122237788998887632222221 12347899999999999999999999999999999999999 677889
Q ss_pred EEeecCCccccCCCccccccccCCcccCccccc-CC-----CCCcccHHHHHHHHHHHHcC-CCCCCCCCh----HHHHH
Q 014210 303 KAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLH-RS-----YSTEADVWSIGVIAYILLCG-SRPFWARTE----SGIFR 371 (429)
Q Consensus 303 kL~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~-~~-----~~~~sDiwSlGvll~elltg-~~Pf~~~~~----~~~~~ 371 (429)
.|.|-..-..-..+......+|...|.+||.-. +. -+...|.|.|||++++|+.| +.||.+... ...+.
T Consensus 157 ~LVdsDsfqi~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E 236 (637)
T COG4248 157 VLVDSDSFQINANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLE 236 (637)
T ss_pred EEEcccceeeccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcch
Confidence 999866554445555666788999999999754 32 35578999999999999987 999954211 01111
Q ss_pred -HHH--------h----cCCCCCCCCCCCCCHHHHHHHHHhccc--CccCcCCHHHHHhh
Q 014210 372 -AVL--------K----ADPSFDEAPWPSLSSEARDFVKRLLNK--DPRKRLTAAQALSE 416 (429)
Q Consensus 372 -~i~--------~----~~~~~~~~~~~~~s~~~~~li~~~L~~--dP~~Rps~~~iL~~ 416 (429)
.|. + ..+.....+|.-+++++..|+.+|+.. ++.-||+++..+..
T Consensus 237 ~~Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aA 296 (637)
T COG4248 237 TDIAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAA 296 (637)
T ss_pred hhhhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Confidence 111 1 123333455667899999999999965 46789999876653
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.11 E-value=1.8e-09 Score=99.11 Aligned_cols=143 Identities=18% Similarity=0.205 Sum_probs=99.7
Q ss_pred eEEEEEEEecCcccCeEEEEEEccCCCcCc----HHHHHHHHHHHHHHHHhcCCC--CcceEEEEEEeCC----eEEEEE
Q 014210 169 GYTCAAKFKKGELKGQQVAVKVIPKHKMTT----AIAIEDVRREVKILRALTGHN--NLVKFFDAYEDTD----NVYVVM 238 (429)
Q Consensus 169 g~V~~~~~~~~~~~g~~vAvK~~~~~~~~~----~~~~~~~~~Ei~il~~l~~h~--nIv~l~~~~~~~~----~~~lv~ 238 (429)
+.++.+........++.+-+|.+...-..+ ........+|...+.+|. .. .+.+.+++.+... .-+||+
T Consensus 18 ~~~~~~~~~~~~~~~~~y~~k~~~~~~~~~~~~~~~~~~ra~~E~~~~~~L~-~~Gi~tP~pva~~~~r~~~~~~s~lit 96 (206)
T PF06293_consen 18 RGGWFGVQRVVDLVGRRYYRKRLWNKLRRDRLRFPLRRSRAKREWRNLQRLR-EAGIPTPEPVAYGERRKGGGYRSYLIT 96 (206)
T ss_pred ceEEEEEEccccccceEEEECCeechhccchhhhcccchHHHHHHHHHHHHH-HcCCCCCcEEEEEEEcCCCceeEEEEE
Confidence 344444444334456777777643211111 122345778888888886 33 3455666665532 358999
Q ss_pred EecCCC-cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCcccc
Q 014210 239 ELCEGG-ELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (429)
Q Consensus 239 E~~~gg-sL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~ 313 (429)
|++++. +|.+++... ...+......++.+++..+.-||+.||+|+|+++.|||+..++....+.|+||+.++..
T Consensus 97 e~l~~~~~L~~~~~~~-~~~~~~~~~~ll~~l~~~i~~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 97 EALPGAQDLRDLLQQW-EQLDPSQRRELLRALARLIAKLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred EeCCCcccHHHHHHhh-cccchhhHHHHHHHHHHHHHHHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 999885 677766442 23778888999999999999999999999999999999965554558999999987654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.10 E-value=5.9e-10 Score=100.37 Aligned_cols=130 Identities=25% Similarity=0.295 Sum_probs=82.3
Q ss_pred EEEEEEEecCcccCeEEEEEEccCCC-----------------------cCcHHHHHHHHHHHHHHHHhcCCC-CcceEE
Q 014210 170 YTCAAKFKKGELKGQQVAVKVIPKHK-----------------------MTTAIAIEDVRREVKILRALTGHN-NLVKFF 225 (429)
Q Consensus 170 ~V~~~~~~~~~~~g~~vAvK~~~~~~-----------------------~~~~~~~~~~~~Ei~il~~l~~h~-nIv~l~ 225 (429)
.||.|...+ |..+|||+..... ...........+|.+.|.++...- ++.+.+
T Consensus 1 ~Vy~~~~~~----~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~ 76 (188)
T PF01163_consen 1 DVYHAIDPD----GEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPY 76 (188)
T ss_dssp EEEEEEECT----TEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EE
T ss_pred CEEEEECCC----CCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEE
Confidence 378777544 7899999874321 112233455789999999998432 566776
Q ss_pred EEEEeCCeEEEEEEecC--CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH-HHHcCceeccCCCCcEEEeecCCCceE
Q 014210 226 DAYEDTDNVYVVMELCE--GGELLDRILSRGGKYTEDDAKAVMIQILNVVAF-CHLQGVVHRDLKPENFLFTTKDENSVL 302 (429)
Q Consensus 226 ~~~~~~~~~~lv~E~~~--ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~-LH~~~iiHrDIKp~NILl~~~~~~~~v 302 (429)
++. ..+|||||++ |..+. .+... .++......++.+++..+.. +|..||||+||.+.|||+. ++ .+
T Consensus 77 ~~~----~~~ivME~I~~~G~~~~-~l~~~--~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~---~~-~~ 145 (188)
T PF01163_consen 77 DYN----RNVIVMEYIGEDGVPLP-RLKDV--DLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVD---DG-KV 145 (188)
T ss_dssp EEE----TTEEEEE--EETTEEGG-CHHHC--GGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEE---TT-CE
T ss_pred EEe----CCEEEEEecCCCccchh-hHHhc--cccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEee---cc-eE
Confidence 542 2379999998 54443 33322 12255667788888885555 5799999999999999994 33 79
Q ss_pred EEeecCCccccC
Q 014210 303 KAIDFGLSDFVR 314 (429)
Q Consensus 303 kL~DFGla~~~~ 314 (429)
.|+|||.+....
T Consensus 146 ~iIDf~qav~~~ 157 (188)
T PF01163_consen 146 YIIDFGQAVDSS 157 (188)
T ss_dssp EE--GTTEEETT
T ss_pred EEEecCcceecC
Confidence 999999886543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.00 E-value=1.5e-10 Score=119.03 Aligned_cols=151 Identities=24% Similarity=0.255 Sum_probs=108.5
Q ss_pred HHHHHHHHHHHc-CceeccCCCCcEEEeecCCCceEEEeecCCccccCCCcccc----------ccccCCcccCcccccC
Q 014210 268 QILNVVAFCHLQ-GVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLN----------DIVGSAYYVAPEVLHR 336 (429)
Q Consensus 268 qi~~gL~~LH~~-~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~----------~~~gt~~y~aPE~~~~ 336 (429)
+++.||.|+|.. ++||++|.|++|.+ +.++.+||+.|+++.......... -......|.|||++..
T Consensus 107 ~v~dgl~flh~sAk~VH~ni~p~~i~~---na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 107 NVADGLAFLHRSAKVVHGNIQPEAIVV---NANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred cccchhhhhccCcceeecccchhheee---ccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 344999999987 89999999999999 788899999999876544311110 1234567999998875
Q ss_pred -CCCCcccHHHHHHHHHHHH-cCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCcCCHHHHH
Q 014210 337 -SYSTEADVWSIGVIAYILL-CGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQAL 414 (429)
Q Consensus 337 -~~~~~sDiwSlGvll~ell-tg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL 414 (429)
..+.++|+||||+++|.+. .|+..+..................-....-..++.|+++=|+++|..|...||++.+++
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~ 263 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLL 263 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhhh
Confidence 5677999999999999888 55555544432222211111111111111146899999999999999999999999999
Q ss_pred hhHhhhc
Q 014210 415 SELLICY 421 (429)
Q Consensus 415 ~~~~~~~ 421 (429)
..+||.+
T Consensus 264 ~~~ff~D 270 (700)
T KOG2137|consen 264 SIPFFSD 270 (700)
T ss_pred cccccCC
Confidence 8888864
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.95 E-value=7.2e-09 Score=96.53 Aligned_cols=139 Identities=26% Similarity=0.267 Sum_probs=102.8
Q ss_pred eeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCC-------------------cCcHHHHHHHHHHHHHHHHhcC
Q 014210 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHK-------------------MTTAIAIEDVRREVKILRALTG 217 (429)
Q Consensus 157 y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~-------------------~~~~~~~~~~~~Ei~il~~l~~ 217 (429)
..++++||.|--+.||.|...+ |.++|||.-.... .+-.......++|.++|.+|..
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~----g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~ 168 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPK----GRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYP 168 (304)
T ss_pred HhhccccccCccceEEEEECCC----CCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhh
Confidence 4578999999999999998664 8899999642110 0111223346789999999974
Q ss_pred C-CCcceEEEEEEeCCeEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeec
Q 014210 218 H-NNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTK 296 (429)
Q Consensus 218 h-~nIv~l~~~~~~~~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~ 296 (429)
+ -.+.+-++ .+...+||||++|..|... +++......++..|++-+.-+-..||||+|+..=|||+
T Consensus 169 ~G~~VP~P~~----~nRHaVvMe~ieG~eL~~~------r~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV--- 235 (304)
T COG0478 169 EGVKVPKPIA----WNRHAVVMEYIEGVELYRL------RLDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILV--- 235 (304)
T ss_pred cCCCCCCccc----cccceeeeehcccceeecc------cCcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEE---
Confidence 4 35666665 4566899999998665431 22455666777777777777779999999999999999
Q ss_pred CCCceEEEeecCCccc
Q 014210 297 DENSVLKAIDFGLSDF 312 (429)
Q Consensus 297 ~~~~~vkL~DFGla~~ 312 (429)
++++.++++||--+..
T Consensus 236 ~~dg~~~vIDwPQ~v~ 251 (304)
T COG0478 236 TEDGDIVVIDWPQAVP 251 (304)
T ss_pred ecCCCEEEEeCccccc
Confidence 7788899999986643
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.79 E-value=3.3e-08 Score=101.86 Aligned_cols=146 Identities=19% Similarity=0.222 Sum_probs=96.8
Q ss_pred ceeeccCceEEEEEEEecCcccCeEEEEEEccCCCc---------------------------Cc----HHHHHH-----
Q 014210 161 EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKM---------------------------TT----AIAIED----- 204 (429)
Q Consensus 161 ~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~---------------------------~~----~~~~~~----- 204 (429)
+-|+.++-|.||+|+.+. |+.||||+....-. .- .+..+.
T Consensus 131 ~PiAsASIaQVH~A~L~s----G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~El 206 (517)
T COG0661 131 EPIASASIAQVHRAVLKS----GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREEL 206 (517)
T ss_pred CchhhhhHhhheeEEecC----CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHh
Confidence 678999999999999886 89999999854210 00 011111
Q ss_pred -HHHHHHHHHHhc----CCCCcceEEEEEEeCCeEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHH-HHHHHH
Q 014210 205 -VRREVKILRALT----GHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNV-VAFCHL 278 (429)
Q Consensus 205 -~~~Ei~il~~l~----~h~nIv~l~~~~~~~~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~g-L~~LH~ 278 (429)
+.+|..-+.+++ +.++|.--.=||+-.....|+|||++|-.+.+...-+...++... ++..++++ +.-+-.
T Consensus 207 Dy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~---ia~~~~~~f~~q~~~ 283 (517)
T COG0661 207 DYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKE---LAELLVRAFLRQLLR 283 (517)
T ss_pred CHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHH---HHHHHHHHHHHHHHh
Confidence 334444444443 345554444456666778999999999888776433334455333 33333322 233445
Q ss_pred cCceeccCCCCcEEEeecCCCceEEEeecCCccccCCC
Q 014210 279 QGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPD 316 (429)
Q Consensus 279 ~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~ 316 (429)
.|++|.|.+|.||++ +.++.+.+.|||+.....+.
T Consensus 284 dgffHaDpHpGNi~v---~~~g~i~~lDfGi~g~l~~~ 318 (517)
T COG0661 284 DGFFHADPHPGNILV---RSDGRIVLLDFGIVGRLDPK 318 (517)
T ss_pred cCccccCCCccceEE---ecCCcEEEEcCcceecCCHH
Confidence 799999999999999 67789999999998776544
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.76 E-value=2.4e-07 Score=84.27 Aligned_cols=143 Identities=15% Similarity=0.121 Sum_probs=100.1
Q ss_pred eeccCceEEEEEEEecCcccCeEEEEEEccCCCcCc---HHHHHHHHHHHHHHHHhcCC-CCcceEEEEEE-e----CCe
Q 014210 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTT---AIAIEDVRREVKILRALTGH-NNLVKFFDAYE-D----TDN 233 (429)
Q Consensus 163 IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~---~~~~~~~~~Ei~il~~l~~h-~nIv~l~~~~~-~----~~~ 233 (429)
-|+||-+-|+...+. |+.+-||+....-..+ +.....|.+|+..+.+|... -.+.+.. ++. . ...
T Consensus 26 ~~rgG~SgV~r~~~~-----g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~r 99 (216)
T PRK09902 26 YRRNGMSGVQCVERN-----GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWR 99 (216)
T ss_pred cCCCCcceEEEEEeC-----CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceE
Confidence 466888888886543 4578899764221111 34556789999999998721 1244444 332 1 124
Q ss_pred EEEEEEecCCC-cHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCcc
Q 014210 234 VYVVMELCEGG-ELLDRILSR-GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (429)
Q Consensus 234 ~~lv~E~~~gg-sL~~~i~~~-~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~ 311 (429)
-+||+|-+.|- +|.+++.+. -...+......++.+++..|.-||+.|+.|+|+.+.|||+...+ +..++++||.-++
T Consensus 100 A~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g-~~~v~lIDlEk~r 178 (216)
T PRK09902 100 ALLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEG-KAEAGFLDLEKSR 178 (216)
T ss_pred EEEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCC-CeeEEEEEhhccc
Confidence 68999988643 676665432 23568888899999999999999999999999999999994322 3359999998765
Q ss_pred c
Q 014210 312 F 312 (429)
Q Consensus 312 ~ 312 (429)
.
T Consensus 179 ~ 179 (216)
T PRK09902 179 R 179 (216)
T ss_pred h
Confidence 4
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.74 E-value=2.1e-07 Score=85.10 Aligned_cols=143 Identities=21% Similarity=0.271 Sum_probs=93.1
Q ss_pred cccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHH------HHHHHHHHHHhc--CCCCcce
Q 014210 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIED------VRREVKILRALT--GHNNLVK 223 (429)
Q Consensus 152 ~~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~------~~~Ei~il~~l~--~h~nIv~ 223 (429)
.+.++|++.+++-......|.+... +|+.+++|..........+.... ..+++..+.++. +...+..
T Consensus 28 i~~~~~~~~kv~k~~~r~~ValIei-----~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~ 102 (229)
T PF06176_consen 28 ILDNNYKIIKVFKNTKRNYVALIEI-----DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPAD 102 (229)
T ss_pred HHhCCceEEEeecCCCccEEEEEEE-----CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCcccccc
Confidence 4567888889888888777766543 47889999875432111111111 234455455543 2334444
Q ss_pred EEEEEEe-----CCeEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCC
Q 014210 224 FFDAYED-----TDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDE 298 (429)
Q Consensus 224 l~~~~~~-----~~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~ 298 (429)
++.+.+. ....+|+|||++|..|.+.. .+++ .+...|..++.-||+.|++|+|+.|.|++++
T Consensus 103 ~yl~~ekk~~~~~~~~~ll~EYIeG~~l~d~~-----~i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~---- 169 (229)
T PF06176_consen 103 PYLAAEKKIFRYTSSYVLLMEYIEGVELNDIE-----DIDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVS---- 169 (229)
T ss_pred ceeeeeeeeccceeEEEEEEEEecCeecccch-----hcCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEE----
Confidence 4444332 23456899999998776532 1333 2456677889999999999999999999994
Q ss_pred CceEEEeecCCccc
Q 014210 299 NSVLKAIDFGLSDF 312 (429)
Q Consensus 299 ~~~vkL~DFGla~~ 312 (429)
++.++++||+..+.
T Consensus 170 ~~~i~iID~~~k~~ 183 (229)
T PF06176_consen 170 NNGIRIIDTQGKRM 183 (229)
T ss_pred CCcEEEEECccccc
Confidence 33499999986643
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.65 E-value=4.7e-07 Score=84.34 Aligned_cols=73 Identities=22% Similarity=0.245 Sum_probs=54.8
Q ss_pred ceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCC-CcceEEEEEEeCCeEEEEEE
Q 014210 161 EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHN-NLVKFFDAYEDTDNVYVVME 239 (429)
Q Consensus 161 ~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~-nIv~l~~~~~~~~~~~lv~E 239 (429)
..||+|..+.||+. .|..+++|+..... ....+.+|.++++.+.... -+.+.+++.++.+...+|||
T Consensus 7 ~~i~~G~t~~~y~~-------~~~~~VlR~~~~~~-----~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e 74 (226)
T TIGR02172 7 TQTGEGGNGESYTH-------KTGKWMLKLYNPGF-----DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYE 74 (226)
T ss_pred eeecCCCCcceeEe-------cCCCEEEEeCCCCC-----CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeee
Confidence 57899999999973 14568899875321 2245789999999997332 25778888888888899999
Q ss_pred ecCCCc
Q 014210 240 LCEGGE 245 (429)
Q Consensus 240 ~~~ggs 245 (429)
+++|..
T Consensus 75 ~i~G~~ 80 (226)
T TIGR02172 75 LIVGKR 80 (226)
T ss_pred ecCCcc
Confidence 998863
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.62 E-value=1.4e-06 Score=78.76 Aligned_cols=130 Identities=25% Similarity=0.281 Sum_probs=94.4
Q ss_pred cCceeEeceeeccCc-eEEEEEEEecCcccCeEEEEEEccCCCcCc------------------HHHHHHHHHHHHHHHH
Q 014210 154 ANKYELGEEVGRGHF-GYTCAAKFKKGELKGQQVAVKVIPKHKMTT------------------AIAIEDVRREVKILRA 214 (429)
Q Consensus 154 ~~~y~~~~~IG~G~f-g~V~~~~~~~~~~~g~~vAvK~~~~~~~~~------------------~~~~~~~~~Ei~il~~ 214 (429)
+.+++.++.||.|.- |.||+++.. |+.+|||++..-.... .....-|..|.+...+
T Consensus 36 ~~~I~flefLg~g~~~~~V~kv~I~-----g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgR 110 (207)
T PF13095_consen 36 GDDIEFLEFLGHGSHDGYVFKVEID-----GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGR 110 (207)
T ss_pred CCcEeeeeecCCCCceeEEEEEEEC-----CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHH
Confidence 378999999999999 999998754 7899999932211000 0223457889998888
Q ss_pred hcC--CCCc--ceEEEEEEeC------------------CeEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHH
Q 014210 215 LTG--HNNL--VKFFDAYEDT------------------DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNV 272 (429)
Q Consensus 215 l~~--h~nI--v~l~~~~~~~------------------~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~g 272 (429)
|+. +.++ |+++||..-. ....||.||++... .....-+.+|++-
T Consensus 111 Lke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~--------------~~~~~~~~~~~~d 176 (207)
T PF13095_consen 111 LKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP--------------PLQIRDIPQMLRD 176 (207)
T ss_pred HHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc--------------ccchhHHHHHHHH
Confidence 873 4456 9999987322 12468888886543 1123345678888
Q ss_pred HHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCc
Q 014210 273 VAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS 310 (429)
Q Consensus 273 L~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla 310 (429)
|..+|..||+-+|+|+.|..= -||+|||.+
T Consensus 177 l~~~~k~gI~~~Dv~~~ny~~--------G~lvDfs~~ 206 (207)
T PF13095_consen 177 LKILHKLGIVPRDVKPRNYRG--------GKLVDFSSS 206 (207)
T ss_pred HHHHHHCCeeeccCccccccC--------CEEEecccC
Confidence 899999999999999999874 589999965
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.59 E-value=3.2e-09 Score=108.38 Aligned_cols=245 Identities=17% Similarity=0.164 Sum_probs=166.4
Q ss_pred cCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCC-cceEEEEEEeCC
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNN-LVKFFDAYEDTD 232 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~n-Iv~l~~~~~~~~ 232 (429)
++-+.....+++|+++++++.+... -+....+.+... ....-++++|.+++ ||| .+..++-++.++
T Consensus 241 ~kws~~fh~fvK~altknpKkRpta----eklL~h~fvs~~--------l~~rl~~eLLdK~n-~P~~~v~~~~d~~~E~ 307 (829)
T KOG0576|consen 241 TKWSEFFHNFVKGALTKNPKKRPTA----EKLLQHPFVSQT--------LSRRLAIELLDKVN-NPNPVVRYLEDYDGED 307 (829)
T ss_pred ccchHHHHHHHHHHhcCCCccCCCh----hhheeceeeccc--------hhhHHHHHHHHHcc-CCCCcccccccCCccc
Confidence 4556677889999999988776443 233335555322 34567899999998 999 778888788888
Q ss_pred eEEEEEEecCCC-cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCcc
Q 014210 233 NVYVVMELCEGG-ELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (429)
Q Consensus 233 ~~~lv~E~~~gg-sL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~ 311 (429)
..++.|+++.++ +...........+..-+...+.+.-+++|++||+.-=+||| ||+.. ++..|+.||+...
T Consensus 308 ~~~i~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s----~~~~~~~~~~v~~ 379 (829)
T KOG0576|consen 308 YLWIPMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGS----EEEVKLLDFAVPP 379 (829)
T ss_pred ccchhhhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----ccccc----ccccccccccCCc
Confidence 999999999887 22211111112344555666777888999999998778999 88873 4668999999988
Q ss_pred ccCCCccccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCH
Q 014210 312 FVRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSS 390 (429)
Q Consensus 312 ~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 390 (429)
.+......+...+++.|+|||+.. +.+....|.|++|+-..+|.-|..|-...... ...+-.....+....-..++.
T Consensus 380 ~L~~~~~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~P~~~--~~~~g~~p~s~~L~~~~aw~~ 457 (829)
T KOG0576|consen 380 QLTRTMKPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSSPPAV--LPMIGNGPNSPMLTDKSAWSP 457 (829)
T ss_pred ccCcccccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCCCccc--cCCCCCCCCccccchhhhcCc
Confidence 877666667889999999999765 57899999999999777787777664321100 000000000000000001111
Q ss_pred HHH-HHHHHhcccCccCcCCHHHHHhhHhhhc
Q 014210 391 EAR-DFVKRLLNKDPRKRLTAAQALSELLICY 421 (429)
Q Consensus 391 ~~~-~li~~~L~~dP~~Rps~~~iL~~~~~~~ 421 (429)
.+. ++...|+..-|..|+....++-+.+|..
T Consensus 458 ~~~~~~~~~~~~g~P~~pkv~mgacfsKvfng 489 (829)
T KOG0576|consen 458 VFHRDFPAPCLNGLPPTPKVHMGACFSKVFNG 489 (829)
T ss_pred ccccCCcccccCCCCCCCcchhhHHHHHHhcc
Confidence 122 4778899999999999998888887753
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.58 E-value=4.2e-07 Score=93.61 Aligned_cols=148 Identities=17% Similarity=0.240 Sum_probs=92.3
Q ss_pred eceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcC----------------------------cHHHHHHHHHHHHH
Q 014210 160 GEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMT----------------------------TAIAIEDVRREVKI 211 (429)
Q Consensus 160 ~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~----------------------------~~~~~~~~~~Ei~i 211 (429)
.+.||.-+.|.|++|+.+. |+.||||+....-.. -.+..+.+..|++.
T Consensus 166 ~~piaaASlaQVhrA~L~~----G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF 241 (538)
T KOG1235|consen 166 EEPIAAASLAQVHRARLKN----GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDF 241 (538)
T ss_pred cchhhhcchhheEEEEecC----CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcch
Confidence 3679999999999999887 899999997543100 01111222233333
Q ss_pred HHH------hc---CCCC------cceEEEEEEeCCeEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Q 014210 212 LRA------LT---GHNN------LVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFC 276 (429)
Q Consensus 212 l~~------l~---~h~n------Iv~l~~~~~~~~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~L 276 (429)
++. ++ .|-+ |.++| |.-.....|+||||+|..+.|.-.-....++...+..-+.++..-+ +
T Consensus 242 ~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy--~~~st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~~~q--I 317 (538)
T KOG1235|consen 242 TKEAKNAERFRENFKDFSLLTYVLVPKVY--WDLSTKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAYLEQ--I 317 (538)
T ss_pred HHHHHhHHHHHHHHHhcccccceeCCeeh--hhcCcceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHHHHH--H
Confidence 222 21 1333 33343 3344567999999999876554333344566665444443332222 3
Q ss_pred HHcCceeccCCCCcEEEeec-CCCceEEEeecCCccccCC
Q 014210 277 HLQGVVHRDLKPENFLFTTK-DENSVLKAIDFGLSDFVRP 315 (429)
Q Consensus 277 H~~~iiHrDIKp~NILl~~~-~~~~~vkL~DFGla~~~~~ 315 (429)
-..|++|.|-.|.||++... ..++.+.+-|||+......
T Consensus 318 f~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 318 FKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred HhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 34589999999999999633 3567899999999876543
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.56 E-value=8.6e-07 Score=96.47 Aligned_cols=208 Identities=22% Similarity=0.244 Sum_probs=146.8
Q ss_pred HHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeE----EEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Q 014210 200 IAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV----YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAF 275 (429)
Q Consensus 200 ~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~----~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~ 275 (429)
..+.....|+..+.++. |+|++.++.|..+.... .+..|+|..-++...+ +.-+.++...++.+..++++||.|
T Consensus 224 ~~i~~~E~e~~~l~k~~-~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~-q~v~~i~~~~~r~~~~~~~~GL~~ 301 (1351)
T KOG1035|consen 224 KEIQTTEIELESLSKIA-HDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLL-QSVGSIPLETLRILHQKLLEGLAY 301 (1351)
T ss_pred HHHHHHHHHHHHHHhhc-cccccceeEEeehhhcchHHHHHHHhhcCccchHHHH-hhccccCHHHHHHHHHHHhhhHHH
Confidence 34445567788888888 99999999987655432 3456788887877755 455789999999999999999999
Q ss_pred HHHcCceeccCCCCcEEEeecCCCceEEEe--ecCCccccCCCccccccccCCcccCcccccCC---CCCcccHHHHHHH
Q 014210 276 CHLQGVVHRDLKPENFLFTTKDENSVLKAI--DFGLSDFVRPDERLNDIVGSAYYVAPEVLHRS---YSTEADVWSIGVI 350 (429)
Q Consensus 276 LH~~~iiHrDIKp~NILl~~~~~~~~vkL~--DFGla~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~sDiwSlGvl 350 (429)
+|+....|.-+..+-..-...+..+.+.++ ||+....+...........+..+.++|..... .....|+|++|.+
T Consensus 302 ~h~~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll 381 (1351)
T KOG1035|consen 302 LHSLSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLL 381 (1351)
T ss_pred HHHhccceeEEecccccccccCccceeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHHH
Confidence 999966665554442222223556677777 99988777655544445566778888877643 3344699999999
Q ss_pred HHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhcc
Q 014210 351 AYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLICYQ 422 (429)
Q Consensus 351 l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~ 422 (429)
+..+..|..+-.- ......++.. ....+..+++.+|+..+.++|+++.+++.|+|+..+
T Consensus 382 ~~~~~~~~~i~~~---~~~~~~~l~~----------~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~~ 440 (1351)
T KOG1035|consen 382 LLQLSQGEDISEK---SAVPVSLLDV----------LSTSELLDALPKCLDEDSEERLSALELLTHPFLRFP 440 (1351)
T ss_pred HhhhhhcCccccc---ccchhhhhcc----------ccchhhhhhhhhhcchhhhhccchhhhhhchhcccc
Confidence 9999887654210 0111111111 111267899999999999999999999999998654
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.51 E-value=5.3e-07 Score=79.09 Aligned_cols=131 Identities=24% Similarity=0.411 Sum_probs=92.9
Q ss_pred eeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEE
Q 014210 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYV 236 (429)
Q Consensus 157 y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~~l 236 (429)
-++.+.|++|++|.||++... |..+|+|+-.. +.....+..|+++|..+.+-.--.++|.|..+ ++
T Consensus 24 ~~v~~~L~KG~~s~Vyl~~~~-----~~~~a~Kvrr~-----ds~r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i 89 (201)
T COG2112 24 LRVEKELAKGTTSVVYLGEWR-----GGEVALKVRRR-----DSPRRNLEKEAKILEILAGEGVTPEVYFYGED----FI 89 (201)
T ss_pred hhhhhhhhcccccEEEEeecc-----CceEEEEEecC-----CcchhhHHHHHHHHHHhhhcCCCceEEEechh----hh
Confidence 356788999999999998743 67899998643 23346688999999999866666677776654 45
Q ss_pred EEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCC-C-CcEEEeecCCCceEEEeecCCcccc
Q 014210 237 VMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLK-P-ENFLFTTKDENSVLKAIDFGLSDFV 313 (429)
Q Consensus 237 v~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIK-p-~NILl~~~~~~~~vkL~DFGla~~~ 313 (429)
.|||++|-.|.+... .. + ++-+..+++.---|-..||-|..|. | .||++ .++.+.|+||..|...
T Consensus 90 ~me~i~G~~L~~~~~--~~--~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv----~~~~~~iIDFd~At~k 156 (201)
T COG2112 90 RMEYIDGRPLGKLEI--GG--D----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLV----NDRDVYIIDFDSATFK 156 (201)
T ss_pred hhhhhcCcchhhhhh--cc--c----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEe----cCCcEEEEEccchhhc
Confidence 699999988776432 11 2 3334445555555667799999886 3 45666 3336999999998743
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.47 E-value=3.2e-06 Score=78.07 Aligned_cols=141 Identities=18% Similarity=0.241 Sum_probs=83.1
Q ss_pred eceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCC-CcceEEEEEEe---CCeEE
Q 014210 160 GEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHN-NLVKFFDAYED---TDNVY 235 (429)
Q Consensus 160 ~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~-nIv~l~~~~~~---~~~~~ 235 (429)
++.|+.|..+.||++.... ..+++|+... ......+.+|+.+++.|..+. -+.+++.+... ....+
T Consensus 2 i~~l~~G~~n~~~~v~~~~-----~~~vlK~~~~-----~~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~ 71 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-----GRYVLKFYRP-----PDAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPY 71 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-----SEEEEEEESS-----HHHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEE
T ss_pred CccCCCCCeeeEEEEEECC-----cEEEEEEeCC-----CCCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccce
Confidence 4678999999999987443 4899998632 245677889999999997442 25677765433 33578
Q ss_pred EEEEecCCCcHHH----------------HH---Hhc---CCCCCHHH---------HHHH------------HHHHHH-
Q 014210 236 VVMELCEGGELLD----------------RI---LSR---GGKYTEDD---------AKAV------------MIQILN- 271 (429)
Q Consensus 236 lv~E~~~ggsL~~----------------~i---~~~---~~~l~~~~---------~~~i------------~~qi~~- 271 (429)
++|++++|..+.. .+ +.. ...+.... .... ...+..
T Consensus 72 ~~~~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 151 (239)
T PF01636_consen 72 LLMEYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEER 151 (239)
T ss_dssp EEEEEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHH
T ss_pred EEEEEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHH
Confidence 9999999987766 11 011 01111100 0000 111222
Q ss_pred HHHHHHH-------cCceeccCCCCcEEEeecCCCceEEEeecCCccc
Q 014210 272 VVAFCHL-------QGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (429)
Q Consensus 272 gL~~LH~-------~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~ 312 (429)
.+..+++ ..++|+|+.+.|||++ ++++.+-|+||+.+..
T Consensus 152 ~~~~~~~~~~~~~~~~~~HgD~~~~Nil~~--~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 152 LLQELEALLPKPLPPVLIHGDLHPGNILVD--PSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHHHHHHHHHCCSCEEEE-SS-SGGGEEEE--SSTTEEEE--GTT-EE
T ss_pred HHHHHHhhhccCCCcEEEEeccccccceee--eccceeEEEecccceE
Confidence 3333432 3599999999999995 3556668999997743
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.45 E-value=2.5e-06 Score=80.19 Aligned_cols=76 Identities=18% Similarity=0.214 Sum_probs=54.4
Q ss_pred eeeccCc-eEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEe
Q 014210 162 EVGRGHF-GYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMEL 240 (429)
Q Consensus 162 ~IG~G~f-g~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~~lv~E~ 240 (429)
.|-.|.. ..||++... +..+.||+..... ..++.+|+++++.+..+--+.+++++....+..++|||+
T Consensus 5 ~~~~g~~~~~v~~~~~~-----~~~~~vk~~~~~~------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~ 73 (244)
T cd05150 5 RVTEGQSGATVYRLDGK-----NPGLYLKIAPSGP------TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSA 73 (244)
T ss_pred ecCCCCCcCeEEEEcCC-----CCcEEEEecCCCc------ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEe
Confidence 3445555 578887532 3578889875332 245778999999998665566888888777778999999
Q ss_pred cCCCcHHH
Q 014210 241 CEGGELLD 248 (429)
Q Consensus 241 ~~ggsL~~ 248 (429)
++|.+|..
T Consensus 74 i~G~~l~~ 81 (244)
T cd05150 74 VPGVPAAA 81 (244)
T ss_pred eCCccHhH
Confidence 99876653
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.39 E-value=1.1e-05 Score=73.24 Aligned_cols=135 Identities=20% Similarity=0.305 Sum_probs=96.6
Q ss_pred eceeeccCceEEEEEEEecCcccCeEEEEEEccCCCc-------------CcHHHHHHHHHHHHHHHHhc-----CCCCc
Q 014210 160 GEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKM-------------TTAIAIEDVRREVKILRALT-----GHNNL 221 (429)
Q Consensus 160 ~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~-------------~~~~~~~~~~~Ei~il~~l~-----~h~nI 221 (429)
...||+|+.=.||.- . ......||++..... ......++..+|+.-+..+. .+.+|
T Consensus 6 ~~~i~~G~~R~cy~H--P----~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i 79 (199)
T PF10707_consen 6 SDLIAQGGERDCYQH--P----DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHI 79 (199)
T ss_pred CcccccCCCceEEEC--C----CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCccccc
Confidence 457899998888743 2 245578898865430 00112455667777766665 37799
Q ss_pred ceEEEEEEeCCeEEEEEEecCCC------cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEee
Q 014210 222 VKFFDAYEDTDNVYVVMELCEGG------ELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTT 295 (429)
Q Consensus 222 v~l~~~~~~~~~~~lv~E~~~gg------sL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~ 295 (429)
.+++|+.+++....+|+|.+... +|.+++ ..+.++. .+...+-+-..||-+.+|+.+|++|.||++..
T Consensus 80 ~r~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l--~~~~~~~----~~~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~ 153 (199)
T PF10707_consen 80 PRFYGFVETNLGLGLVVELIRDADGNISPTLEDYL--KEGGLTE----ELRQALDEFKRYLLDHHIVIRDLNPHNIVVQR 153 (199)
T ss_pred ccEeEEEecCCceEEEEEEEECCCCCcCccHHHHH--HcCCccH----HHHHHHHHHHHHHHHcCCeecCCCcccEEEEe
Confidence 99999999999999999987432 577766 2334555 34444556667889999999999999999987
Q ss_pred cCCCc-eEEEee
Q 014210 296 KDENS-VLKAID 306 (429)
Q Consensus 296 ~~~~~-~vkL~D 306 (429)
.+++. .+.|+|
T Consensus 154 ~~~~~~~lvlID 165 (199)
T PF10707_consen 154 RDSGEFRLVLID 165 (199)
T ss_pred cCCCceEEEEEe
Confidence 76666 788888
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.36 E-value=4.7e-06 Score=77.15 Aligned_cols=146 Identities=18% Similarity=0.187 Sum_probs=92.4
Q ss_pred CceeEece---eeccCceEEEEEEEecCcccCeEEEEEEccCCCcCc---------------------HHHHHHHHHHHH
Q 014210 155 NKYELGEE---VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTT---------------------AIAIEDVRREVK 210 (429)
Q Consensus 155 ~~y~~~~~---IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~---------------------~~~~~~~~~Ei~ 210 (429)
++..+... |+.|--+.||+|... .+..+|||++......- ........+|..
T Consensus 45 ~rg~i~~~~g~istGKEA~Vy~a~~~----~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~ 120 (268)
T COG1718 45 SRGVITELVGCISTGKEANVYLAETG----DGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFR 120 (268)
T ss_pred cCCceeeeEeeecCCcceEEEeeccC----CCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHH
Confidence 44444444 455555689988753 37899999984321100 011112356777
Q ss_pred HHHHhcC-CCCcceEEEEEEeCCeEEEEEEecCCCcHH-HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-cCceeccCC
Q 014210 211 ILRALTG-HNNLVKFFDAYEDTDNVYVVMELCEGGELL-DRILSRGGKYTEDDAKAVMIQILNVVAFCHL-QGVVHRDLK 287 (429)
Q Consensus 211 il~~l~~-h~nIv~l~~~~~~~~~~~lv~E~~~ggsL~-~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~-~~iiHrDIK 287 (429)
-|+++.. +=.+.+-+++. +-.|||||+....+- -.+ ..-.+...++..+..++++.+.-|-. .|+||+||.
T Consensus 121 NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~L--kDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLS 194 (268)
T COG1718 121 NLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRL--KDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLS 194 (268)
T ss_pred HHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCc--ccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccch
Confidence 7777651 12333444432 237999999543110 011 11223444788899999999998877 899999999
Q ss_pred CCcEEEeecCCCceEEEeecCCccccC
Q 014210 288 PENFLFTTKDENSVLKAIDFGLSDFVR 314 (429)
Q Consensus 288 p~NILl~~~~~~~~vkL~DFGla~~~~ 314 (429)
.=|||+ . ++.+.|+|||-+....
T Consensus 195 EyNiL~---~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 195 EYNILV---H-DGEPYIIDVSQAVTID 217 (268)
T ss_pred hhheEE---E-CCeEEEEECccccccC
Confidence 999999 4 6679999999886543
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.33 E-value=7.7e-06 Score=90.30 Aligned_cols=83 Identities=24% Similarity=0.361 Sum_probs=58.0
Q ss_pred eceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCc--ceEEEEEEeC---CeE
Q 014210 160 GEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNL--VKFFDAYEDT---DNV 234 (429)
Q Consensus 160 ~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nI--v~l~~~~~~~---~~~ 234 (429)
++.|+.|.+..+|+.....+. ....+++|+....... .....+.+|+++++.|..|.+| .+++.+|.+. +..
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~-~~~~~VLR~~p~~~~~--~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~ 119 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGG-SVKRYVLRKKPPGKLL--QSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTA 119 (822)
T ss_pred EEEeCCCCcCceEEEEECCCC-cceeEEEEeCCCCccC--ccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCc
Confidence 567888989999987654321 1246888876543211 1234688999999999756654 7888888764 467
Q ss_pred EEEEEecCCCc
Q 014210 235 YVVMELCEGGE 245 (429)
Q Consensus 235 ~lv~E~~~ggs 245 (429)
|+||||++|..
T Consensus 120 flVME~v~G~~ 130 (822)
T PLN02876 120 FYIMEYLEGRI 130 (822)
T ss_pred eEEEEecCCcc
Confidence 89999998864
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.11 E-value=1.2e-05 Score=72.72 Aligned_cols=101 Identities=21% Similarity=0.252 Sum_probs=80.5
Q ss_pred HHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEecCCCcHHHHH--HhcCCCCCHHHHHHHHHHHHHHHHHHHH---cC
Q 014210 206 RREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRI--LSRGGKYTEDDAKAVMIQILNVVAFCHL---QG 280 (429)
Q Consensus 206 ~~Ei~il~~l~~h~nIv~l~~~~~~~~~~~lv~E~~~ggsL~~~i--~~~~~~l~~~~~~~i~~qi~~gL~~LH~---~~ 280 (429)
.+|.-+++.+.+.+++.+++|+|-. ++|.||...+++.... ...-..-+|..+.+|+.++++.+++|+. ..
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 4688899999966799999999933 7799999877664210 0111346899999999999999999998 34
Q ss_pred ceeccCCCCcEEEeecCCCceEEEeecCCcccc
Q 014210 281 VVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (429)
Q Consensus 281 iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~ 313 (429)
+.-.|++++|+-+ ++++.+|++|...+...
T Consensus 83 ~~lcDv~~~nfgv---~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 83 FYLCDVSPDNFGV---NDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEEeecchHHeEE---eCCCcEEEEechhcchh
Confidence 7788999999999 67788999999987543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.11 E-value=2e-05 Score=73.77 Aligned_cols=73 Identities=22% Similarity=0.186 Sum_probs=46.4
Q ss_pred ceeeccCce-EEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCC--CcceEEEEEEeC---CeE
Q 014210 161 EEVGRGHFG-YTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHN--NLVKFFDAYEDT---DNV 234 (429)
Q Consensus 161 ~~IG~G~fg-~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~--nIv~l~~~~~~~---~~~ 234 (429)
+.|+.||.. .||+. +..+++|+.... ....++.+|.+++..|..+- -+.++++..... +..
T Consensus 3 ~~~~~gG~~n~vy~~--------~~~~VlR~~~~~-----~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~ 69 (235)
T cd05155 3 EPVDSGGTDNATFRL--------GDDMSVRLPSAA-----GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWP 69 (235)
T ss_pred eeccCCCcccceEEc--------CCceEEEcCCcc-----chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcc
Confidence 457777776 57764 234778875431 12357889999999987431 344555544332 235
Q ss_pred EEEEEecCCCcH
Q 014210 235 YVVMELCEGGEL 246 (429)
Q Consensus 235 ~lv~E~~~ggsL 246 (429)
+++||+++|.++
T Consensus 70 ~~l~~~i~G~~l 81 (235)
T cd05155 70 WSVYRWLEGETA 81 (235)
T ss_pred eEEEEeecCCCC
Confidence 889999998665
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.96 E-value=0.0001 Score=68.68 Aligned_cols=77 Identities=21% Similarity=0.280 Sum_probs=49.1
Q ss_pred eceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEE
Q 014210 160 GEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVME 239 (429)
Q Consensus 160 ~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~~lv~E 239 (429)
++.|..|-...+|++....+ .++.|++|+..... . ..-+..+|+.+++.+..+.-..++++.+. + .++||
T Consensus 3 i~~l~gG~tN~~~~v~~~~~--~~~~~vlR~~~~~~--~--~~~d~~~E~~~~~~l~~~gl~P~v~~~~~--~--~~l~e 72 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKED--NQDAVLVRVYGNKT--E--LIIDRERELRIHKLLSKHGLAPKLYATFQ--N--GLIYE 72 (235)
T ss_pred EEEcCCcccceEEEEEcCCC--CCCeEEEEEccCCc--c--ceecHHHHHHHHHHHHhCCCCCeEEEEeC--C--cEEEE
Confidence 35666777779998864321 24678999864321 1 11234579999999974545566665443 2 47999
Q ss_pred ecCCCcH
Q 014210 240 LCEGGEL 246 (429)
Q Consensus 240 ~~~ggsL 246 (429)
|++|.++
T Consensus 73 ~i~G~~l 79 (235)
T cd05157 73 FIPGRTL 79 (235)
T ss_pred eeCCCcC
Confidence 9998654
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.81 E-value=0.00057 Score=68.74 Aligned_cols=81 Identities=20% Similarity=0.264 Sum_probs=55.3
Q ss_pred eceeeccCceEEEEEEEecCcccCeEEEEEEccCCCc--Cc--HHHHHHHHHHHHHHHHhcCC--CCcceEEEEEEeCCe
Q 014210 160 GEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKM--TT--AIAIEDVRREVKILRALTGH--NNLVKFFDAYEDTDN 233 (429)
Q Consensus 160 ~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~--~~--~~~~~~~~~Ei~il~~l~~h--~nIv~l~~~~~~~~~ 233 (429)
.+.||.|.+..||++....+ ++.|+||.-..... .. ....++...|.+.|+.+..+ .++.+++.+ +.+.
T Consensus 31 ~~elggGn~N~VyrV~~~~g---~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~ 105 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEG---GKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEEL 105 (401)
T ss_pred eeEcCCCceEEEEEEEeCCC---CeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCC
Confidence 46789999999999986541 25899998531110 01 12446677888888887533 457778776 3455
Q ss_pred EEEEEEecCCCc
Q 014210 234 VYVVMELCEGGE 245 (429)
Q Consensus 234 ~~lv~E~~~ggs 245 (429)
.++||||+++..
T Consensus 106 ~~lVME~L~~~~ 117 (401)
T PRK09550 106 AVTVMEDLSDHK 117 (401)
T ss_pred CEEEEecCCCcc
Confidence 789999998744
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.81 E-value=2.2e-05 Score=75.28 Aligned_cols=137 Identities=18% Similarity=0.281 Sum_probs=95.6
Q ss_pred ceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCc-----------------CcHHHHH--HHHHHHHHHHHhc
Q 014210 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKM-----------------TTAIAIE--DVRREVKILRALT 216 (429)
Q Consensus 156 ~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~-----------------~~~~~~~--~~~~Ei~il~~l~ 216 (429)
-+.++++||-|--+.||.+.... |++.++|+-..... .+=..+. ...+|...|+.|.
T Consensus 93 v~svGnqIGVGKESDIY~v~d~~----G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~ 168 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVADEE----GNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALY 168 (465)
T ss_pred hhhhccccccccccceEEEecCC----CCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHH
Confidence 36789999999999999987665 78899996422110 0000111 2357889999887
Q ss_pred CCCC-cceEEEEEEeCCeEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEee
Q 014210 217 GHNN-LVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTT 295 (429)
Q Consensus 217 ~h~n-Iv~l~~~~~~~~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~ 295 (429)
.|.. +.+.++ .+..++|||++.|-.|...- .......+...+..-+.-|-.+|+||+|..==||++
T Consensus 169 e~gfpVPkpiD----~~RH~Vvmelv~g~Pl~~v~-------~v~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv-- 235 (465)
T KOG2268|consen 169 ERGFPVPKPID----HNRHCVVMELVDGYPLRQVR-------HVEDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMV-- 235 (465)
T ss_pred HcCCCCCCccc----ccceeeHHHhhcccceeeee-------ecCChHHHHHHHHHHHHHHHHcCceecccchheeEE--
Confidence 5543 334444 45668999999886654321 123344556666677778899999999999999999
Q ss_pred cCCCceEEEeecCCc
Q 014210 296 KDENSVLKAIDFGLS 310 (429)
Q Consensus 296 ~~~~~~vkL~DFGla 310 (429)
+++..++++||--+
T Consensus 236 -~dd~~i~vIDFPQm 249 (465)
T KOG2268|consen 236 -KDDDKIVVIDFPQM 249 (465)
T ss_pred -ecCCCEEEeechHh
Confidence 66778999999754
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.69 E-value=0.00034 Score=68.22 Aligned_cols=141 Identities=16% Similarity=0.163 Sum_probs=80.3
Q ss_pred EeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCC-CcceEEEEE------EeC
Q 014210 159 LGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHN-NLVKFFDAY------EDT 231 (429)
Q Consensus 159 ~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~-nIv~l~~~~------~~~ 231 (429)
..+.|+.|....+|++... +..+++|+.... .. .+++..|++++..|..+- .+.+++... ..+
T Consensus 26 ~i~~~~~G~~n~~y~v~t~-----~~~~vLK~~~~~--~~---~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~ 95 (307)
T TIGR00938 26 SLKGIAEGVENSNYLLTTD-----VGRYILTLYEKR--VK---AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLA 95 (307)
T ss_pred eccccCCccccceEEEEeC-----CCcEEEEEecCC--CC---HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcC
Confidence 3566777766788987532 335888986432 11 234567788888875221 244444421 234
Q ss_pred CeEEEEEEecCCCcHH----H----------HHHhcCCCC-----------CHHHHH------------HHHHHHHHHHH
Q 014210 232 DNVYVVMELCEGGELL----D----------RILSRGGKY-----------TEDDAK------------AVMIQILNVVA 274 (429)
Q Consensus 232 ~~~~lv~E~~~ggsL~----~----------~i~~~~~~l-----------~~~~~~------------~i~~qi~~gL~ 274 (429)
+..+++|||++|..+. + .++.....+ .|.... .....+...++
T Consensus 96 g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~ 175 (307)
T TIGR00938 96 GKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELD 175 (307)
T ss_pred CeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHH
Confidence 5678999999885421 1 111110100 010000 01112334555
Q ss_pred HHHH-------cCceeccCCCCcEEEeecCCCceEEEeecCCccc
Q 014210 275 FCHL-------QGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (429)
Q Consensus 275 ~LH~-------~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~ 312 (429)
++.. .++||+|+++.||++ +.++.+.|+||+.+..
T Consensus 176 ~l~~~~~~~~~~~l~HgD~~~~Nvl~---~~~~~~~vIDfd~~~~ 217 (307)
T TIGR00938 176 YLDKFWPRDLPRGVIHADLFPDNVLF---DGDSVKGVIDFYFACT 217 (307)
T ss_pred HHHhhhhhcCCCccCCCCCCcCcEEE---ECCceEEEeecccccC
Confidence 5543 479999999999999 4556678999998743
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.64 E-value=0.0005 Score=66.48 Aligned_cols=139 Identities=18% Similarity=0.175 Sum_probs=82.1
Q ss_pred eceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCC-CcceEEEE------EEeCC
Q 014210 160 GEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHN-NLVKFFDA------YEDTD 232 (429)
Q Consensus 160 ~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~-nIv~l~~~------~~~~~ 232 (429)
.+.|..|....+|++... +..+++|+... . ..+++..|++++..|..+. .+.+++.. ...++
T Consensus 19 i~~i~~G~~n~~y~v~~~-----~~~~vLr~~~~---~---~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~ 87 (296)
T cd05153 19 FEGISAGIENTNYFVTTD-----SGRYVLTLFEK---V---SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAG 87 (296)
T ss_pred eecccCccccceEEEEeC-----CCcEEEEEcCC---C---ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCC
Confidence 556666766789987532 34689998753 1 1245778888888886332 24555442 23345
Q ss_pred eEEEEEEecCCCcHHH--------------HHHhcCCC----------CCHHHH--H--------HHHHHHHHHHHHHHH
Q 014210 233 NVYVVMELCEGGELLD--------------RILSRGGK----------YTEDDA--K--------AVMIQILNVVAFCHL 278 (429)
Q Consensus 233 ~~~lv~E~~~ggsL~~--------------~i~~~~~~----------l~~~~~--~--------~i~~qi~~gL~~LH~ 278 (429)
..+++++|++|..+.. .++..... ..+... . .....+...+.++..
T Consensus 88 ~~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~ 167 (296)
T cd05153 88 KPAALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDA 167 (296)
T ss_pred ceEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHh
Confidence 6789999998865421 01110000 011110 0 011122334445443
Q ss_pred -------cCceeccCCCCcEEEeecCCCceEEEeecCCccc
Q 014210 279 -------QGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (429)
Q Consensus 279 -------~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~ 312 (429)
.+++|+|+.|.|||+ +++..+.|+||+.+..
T Consensus 168 ~~~~~~~~~l~HgD~~~~Nil~---~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 168 FDPSDLPRGVIHADLFRDNVLF---DGDELSGVIDFYFACT 205 (296)
T ss_pred hhhhcCCCcCCccCcCcccEEE---eCCceEEEeehhhhcC
Confidence 369999999999999 5566678999998753
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.64 E-value=0.00025 Score=67.15 Aligned_cols=134 Identities=21% Similarity=0.212 Sum_probs=74.4
Q ss_pred eeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEecC
Q 014210 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCE 242 (429)
Q Consensus 163 IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~~lv~E~~~ 242 (429)
+..|-.+.+|+.. . .|+.+++|+..... .... -+..+|..+++.+..+.-..+++.... -++||||++
T Consensus 4 ~~~G~tn~~y~~~--~---~~~~~vlR~~~~~~--~~~~-~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~ 71 (256)
T TIGR02721 4 LSGGLTNRSWRIE--H---PGISFVWRPQSPVC--KALG-VDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLE 71 (256)
T ss_pred CCCcCcCCeEEEE--e---CCccEEEeeCCccc--cccc-CcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEecc
Confidence 3445566788765 1 36678899764321 1111 135789999999974433345554432 268999999
Q ss_pred CCcHHH----------H-------HHhc---CCCCCHH-HHHHHHHHH---------HHHHHHHHHc--------Cceec
Q 014210 243 GGELLD----------R-------ILSR---GGKYTED-DAKAVMIQI---------LNVVAFCHLQ--------GVVHR 284 (429)
Q Consensus 243 ggsL~~----------~-------i~~~---~~~l~~~-~~~~i~~qi---------~~gL~~LH~~--------~iiHr 284 (429)
|..+.. . ++.. ...++.. .+..+..++ ...+..+-.. .++|+
T Consensus 72 G~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~ 151 (256)
T TIGR02721 72 GEVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHM 151 (256)
T ss_pred CcccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecC
Confidence 865421 0 1111 1112211 112221111 1222222221 48999
Q ss_pred cCCCCcEEEeecCCCceEEEeecCCccc
Q 014210 285 DLKPENFLFTTKDENSVLKAIDFGLSDF 312 (429)
Q Consensus 285 DIKp~NILl~~~~~~~~vkL~DFGla~~ 312 (429)
|+.+.||+++ +++ ++|+||..+..
T Consensus 152 Dl~~~Nil~~---~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 152 DVHAYNLVVT---PQG-LKLIDWEYASD 175 (256)
T ss_pred CCCcCcEEEe---CCC-CEEEeccccCc
Confidence 9999999994 444 78999998854
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.63 E-value=0.00036 Score=67.70 Aligned_cols=79 Identities=14% Similarity=0.172 Sum_probs=48.6
Q ss_pred ceeeccCceEEEEEEEecC---cccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEE
Q 014210 161 EEVGRGHFGYTCAAKFKKG---ELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVV 237 (429)
Q Consensus 161 ~~IG~G~fg~V~~~~~~~~---~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~~lv 237 (429)
+.|..|--..+|++....+ ...++.+++|+..... ....+..+|++++..+..+.-..++++++.. .+|
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~----~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v 75 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV----ELLIDRERELVVFARLSERNLGPKLYGIFPN----GRI 75 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC----cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cch
Confidence 3444455558887764331 1135789999964421 1223567899999998854444566665542 358
Q ss_pred EEecCCCcHH
Q 014210 238 MELCEGGELL 247 (429)
Q Consensus 238 ~E~~~ggsL~ 247 (429)
+||++|..+.
T Consensus 76 ~e~i~G~~l~ 85 (302)
T cd05156 76 EEFIPSRTLT 85 (302)
T ss_pred hheeCCCcCC
Confidence 9999887653
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.62 E-value=1.6e-05 Score=88.70 Aligned_cols=206 Identities=15% Similarity=0.007 Sum_probs=134.9
Q ss_pred HHHHHHHHHHhcCCCCcceEEEEEEe--CCeEEEEEEecCCCcHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHc
Q 014210 205 VRREVKILRALTGHNNLVKFFDAYED--TDNVYVVMELCEGGELLDRILSRGG---KYTEDDAKAVMIQILNVVAFCHLQ 279 (429)
Q Consensus 205 ~~~Ei~il~~l~~h~nIv~l~~~~~~--~~~~~lv~E~~~ggsL~~~i~~~~~---~l~~~~~~~i~~qi~~gL~~LH~~ 279 (429)
...|.+.++... |++++..+.-... ....+++++||.+|.+.+.|.+.-. .++..-+.....+.+....-+|+.
T Consensus 1276 ll~e~de~~~~~-h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~ 1354 (2724)
T KOG1826|consen 1276 LLSERDELREAK-HYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSL 1354 (2724)
T ss_pred hhhhhhhhhhhh-ceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhc
Confidence 445555555566 8888877664432 3456899999999999998865332 344444555555557777777765
Q ss_pred C-----ceeccCCCCcEEEeecCCCceEEEeecCCccccCCC-ccccccccCCcccCcccccC-CCCCcccHHHHHHHHH
Q 014210 280 G-----VVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPD-ERLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAY 352 (429)
Q Consensus 280 ~-----iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~ 352 (429)
. .+|+++|+-|.+| ..+.++|++++|+.+...+. ......++++.|+++++.+. .++.++|+|..|+.+|
T Consensus 1355 tnlg~T~v~~~Lkf~lpmI---Vtny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly 1431 (2724)
T KOG1826|consen 1355 TNLGNTNVSKSLKFTLPMI---VTNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLY 1431 (2724)
T ss_pred ccCCccchhhhhhhhccce---ecCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHH
Confidence 2 7999999999999 77888999999999844333 33455678899999998875 5777799999999999
Q ss_pred HHHcCCCCCCCCChHHHHHHHHhcCCCCCCC-CCC-CCCHHHHHHHHHhcccCccCcCCHHHHHhhHhh
Q 014210 353 ILLCGSRPFWARTESGIFRAVLKADPSFDEA-PWP-SLSSEARDFVKRLLNKDPRKRLTAAQALSELLI 419 (429)
Q Consensus 353 elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~-~~~-~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~ 419 (429)
++..|..+|. ...+.++++....... ..+ -.+.+.......+|-+.-..||.-..++..+.+
T Consensus 1432 ~rs~~n~~fi-----~flq~~Lkgiidn~tf~sIe~l~pgdaNve~~~~Ll~K~~~rp~q~isls~d~~ 1495 (2724)
T KOG1826|consen 1432 LRSDGNAYFI-----FFLQPALKGIIDNHTFFSIEKLKPGDANVEALHRLLWKYMERPGQYISLSRDHF 1495 (2724)
T ss_pred HHhcccHHHH-----HHHHHHHcCcccccccccccccCCCcccHHHHHHHHHHhhhcchhhhhcccccc
Confidence 9988877762 2222333221111100 000 123344445555555556677776666654443
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.62 E-value=0.0016 Score=63.69 Aligned_cols=139 Identities=17% Similarity=0.185 Sum_probs=74.9
Q ss_pred eceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCC-CcceEEE------EEEeCC
Q 014210 160 GEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHN-NLVKFFD------AYEDTD 232 (429)
Q Consensus 160 ~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~-nIv~l~~------~~~~~~ 232 (429)
.+.|+.|....+|++... +..+++|++.. ... +.+..|+.++..|..+. .+.+.+. +....+
T Consensus 27 ~~~l~~G~~n~~y~v~t~-----~g~~vLK~~~~---~~~---~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g 95 (319)
T PRK05231 27 LKGIAEGIENSNFFLTTT-----QGEYVLTLFER---LTA---EDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAG 95 (319)
T ss_pred cchhccccccceEEEEeC-----CCcEEEEEecc---CCh---HHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCC
Confidence 345666776788987643 23689998741 122 33445666666665211 1334332 123356
Q ss_pred eEEEEEEecCCCcHH-----------H---HHHhcCCC----------CCH-HHH-HH-----------HHHH-HHHHHH
Q 014210 233 NVYVVMELCEGGELL-----------D---RILSRGGK----------YTE-DDA-KA-----------VMIQ-ILNVVA 274 (429)
Q Consensus 233 ~~~lv~E~~~ggsL~-----------~---~i~~~~~~----------l~~-~~~-~~-----------i~~q-i~~gL~ 274 (429)
..++++||++|..+. . .++..... +.+ ... .. .+.+ +...+.
T Consensus 96 ~~~~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 175 (319)
T PRK05231 96 KPAAIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLA 175 (319)
T ss_pred EEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHH
Confidence 679999999886431 1 11111100 111 110 11 1111 111223
Q ss_pred HHH-------HcCceeccCCCCcEEEeecCCCceEEEeecCCccc
Q 014210 275 FCH-------LQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (429)
Q Consensus 275 ~LH-------~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~ 312 (429)
.+. ..++||+|+++.|||+ +.+...-|+||+.+..
T Consensus 176 ~~~~~~~~~lp~~liHgD~~~~Nil~---~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 176 FLASAAWPALPRGVIHADLFRDNVLF---EGDRLSGFIDFYFACN 217 (319)
T ss_pred hhhccccccCCcccCCCCCCCCcEEE---ECCceEEEEecccccC
Confidence 332 1379999999999999 4455568999998754
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.52 E-value=0.001 Score=65.09 Aligned_cols=143 Identities=17% Similarity=0.160 Sum_probs=94.5
Q ss_pred eEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCc----------------------CcHHH-HHHHHHHHHHHHH
Q 014210 158 ELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKM----------------------TTAIA-IEDVRREVKILRA 214 (429)
Q Consensus 158 ~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~----------------------~~~~~-~~~~~~Ei~il~~ 214 (429)
.+...|..|--+.||.|.-. .|..+|||+++.+.+ ....- .-....|++-|++
T Consensus 147 ~inGCiSTGKEANVYHat~~----dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkR 222 (520)
T KOG2270|consen 147 EINGCISTGKEANVYHATEE----DGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKR 222 (520)
T ss_pred ecccccccCccceeEeeecC----CCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHH
Confidence 34566778888899988644 478899999843210 00001 1124578888888
Q ss_pred hcCCCCcceEEEEEEeCCeEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH-HcCceeccCCCCcEEE
Q 014210 215 LTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCH-LQGVVHRDLKPENFLF 293 (429)
Q Consensus 215 l~~h~nIv~l~~~~~~~~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH-~~~iiHrDIKp~NILl 293 (429)
|+ ...|..---... ...+|||+|+.. +-+-.=.-+...++...+..+-.|++.-+.-|- ..++||.||.==|+|+
T Consensus 223 l~-~aGIP~PePIlL--k~hVLVM~FlGr-dgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Ly 298 (520)
T KOG2270|consen 223 LN-NAGIPCPEPILL--KNHVLVMEFLGR-DGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLY 298 (520)
T ss_pred HH-hcCCCCCCceee--ecceEeeeeccC-CCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheE
Confidence 87 333322111111 123799999953 322211223456788889999999999988885 5599999999999999
Q ss_pred eecCCCceEEEeecCCccc
Q 014210 294 TTKDENSVLKAIDFGLSDF 312 (429)
Q Consensus 294 ~~~~~~~~vkL~DFGla~~ 312 (429)
.+|.++|+|-+-+..
T Consensus 299 ----hdG~lyiIDVSQSVE 313 (520)
T KOG2270|consen 299 ----HDGKLYIIDVSQSVE 313 (520)
T ss_pred ----ECCEEEEEEcccccc
Confidence 578899999987643
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.40 E-value=0.0018 Score=64.22 Aligned_cols=141 Identities=14% Similarity=0.231 Sum_probs=80.9
Q ss_pred eeeccCceEEEEEEEecCc-ccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEe
Q 014210 162 EVGRGHFGYTCAAKFKKGE-LKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMEL 240 (429)
Q Consensus 162 ~IG~G~fg~V~~~~~~~~~-~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~~lv~E~ 240 (429)
.|-.|-.-.+|++....+. ..++.|++|+.... ....++ ..+|..+++.+..+.--.++++.+.. + .|+||
T Consensus 43 ~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~---t~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~-g---~v~ef 114 (344)
T PLN02236 43 PLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEG---VELFFD-RDDEIRTFECMSRHGQGPRLLGRFPN-G---RVEEF 114 (344)
T ss_pred EcCCcccceeEEEEeCCCCCCCCCeEEEEEccCC---CCeeec-hHHHHHHHHHHHHcCCCCceEEEECC-c---eEEEe
Confidence 4434555688887654321 13578999987543 122222 36899999999855555567776633 2 58999
Q ss_pred cCCCcHHHH-----------------HHhcC---C--CCCHHHHHHHHHHH-----------------HHHHHHH----H
Q 014210 241 CEGGELLDR-----------------ILSRG---G--KYTEDDAKAVMIQI-----------------LNVVAFC----H 277 (429)
Q Consensus 241 ~~ggsL~~~-----------------i~~~~---~--~l~~~~~~~i~~qi-----------------~~gL~~L----H 277 (429)
+++.+|... ++... . ...+..+.++..++ ...+..| .
T Consensus 115 i~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~ 194 (344)
T PLN02236 115 IHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELS 194 (344)
T ss_pred eCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhc
Confidence 987654311 11111 0 11123333332221 1112222 1
Q ss_pred ----HcCceeccCCCCcEEEeecCCCceEEEeecCCccc
Q 014210 278 ----LQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (429)
Q Consensus 278 ----~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~ 312 (429)
...++|+|+++.|||+. ++++.++|+||..+..
T Consensus 195 ~~~~~~~~cH~Dl~~~Nil~~--~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 195 GDDQEIGFCHNDLQYGNIMID--EETRAITIIDYEYASY 231 (344)
T ss_pred ccCCCceEEeCCCCcCcEEEe--CCCCcEEEEeehhccc
Confidence 12489999999999995 2346799999998854
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.28 E-value=0.00083 Score=68.24 Aligned_cols=162 Identities=22% Similarity=0.240 Sum_probs=102.1
Q ss_pred HHHHHHHHHHHhcCCCCcceEEEEEEeC-CeEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCce
Q 014210 204 DVRREVKILRALTGHNNLVKFFDAYEDT-DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVV 282 (429)
Q Consensus 204 ~~~~Ei~il~~l~~h~nIv~l~~~~~~~-~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ii 282 (429)
++.....+++.+. |+|+.+++++-... ....+|||++ +.+|.+.+..+. +-..... .+|+.
T Consensus 28 ~ilgr~~~lktl~-~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~--l~~~s~~--------------~~~~~ 89 (725)
T KOG1093|consen 28 QILGRFQYLKSLQ-HDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN--LKDESLL--------------AHGVL 89 (725)
T ss_pred HHhhhhHHHHhhc-CccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc--cchhhhc--------------ccccc
Confidence 4556777888888 99999999987644 3478899999 679998775543 1111111 12222
Q ss_pred eccCCCCcEEEeecCCCceEEEeecCCccccCCCccccccccCCcccCcccccCCCCCcccHHHHHHHHHHHHcCCCCCC
Q 014210 283 HRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRSYSTEADVWSIGVIAYILLCGSRPFW 362 (429)
Q Consensus 283 HrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~sDiwSlGvll~elltg~~Pf~ 362 (429)
| -|| ++++| -++... ... ..+|+||||+|.++.|+.-|...|.
T Consensus 90 ~-----~~~----------~~~td-~~~t~~------~~~---------------~~pKsdVwsl~~i~~el~L~~~l~~ 132 (725)
T KOG1093|consen 90 H-----LNI----------IYITD-HFLTKY------PSP---------------IGPKSDVWSLGFIILELYLGISLEA 132 (725)
T ss_pred e-----ehh----------hhccc-cccccC------CCC---------------CCcchhhhhHHHHHHHHHHhhHHHH
Confidence 2 122 33344 111000 001 1149999999999999999988876
Q ss_pred CCChHHHHHHHHhcCCCCCCCC--------CCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhh
Q 014210 363 ARTESGIFRAVLKADPSFDEAP--------WPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLIC 420 (429)
Q Consensus 363 ~~~~~~~~~~i~~~~~~~~~~~--------~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~ 420 (429)
.....+....+++-........ .-.+++.+.++.+.|+-..|..||...+...+.-|.
T Consensus 133 ~~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i~~ 198 (725)
T KOG1093|consen 133 ELTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRCSFT 198 (725)
T ss_pred HHHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhcCccHH
Confidence 6666655555544321111110 013567788999999999999999888887776554
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.23 E-value=0.0036 Score=60.14 Aligned_cols=31 Identities=32% Similarity=0.430 Sum_probs=24.9
Q ss_pred CceeccCCCCcEEEeecCC-CceEEEeecCCcccc
Q 014210 280 GVVHRDLKPENFLFTTKDE-NSVLKAIDFGLSDFV 313 (429)
Q Consensus 280 ~iiHrDIKp~NILl~~~~~-~~~vkL~DFGla~~~ 313 (429)
.++|+|+++.|||++ . ....-|+||+.+...
T Consensus 186 ~lvHGD~~~~Nilv~---~~~~~~gviDWe~a~iG 217 (276)
T cd05152 186 VLVHGDLHPGHILID---EDARVTGLIDWTEAKVG 217 (276)
T ss_pred eeEeCCCCCCcEEEe---CCCCEEEEECcHhcccC
Confidence 389999999999994 3 345679999988654
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=97.17 E-value=0.011 Score=57.51 Aligned_cols=30 Identities=27% Similarity=0.518 Sum_probs=24.5
Q ss_pred cCceeccCCCCcEEEeecCCCceEEEeecCCccc
Q 014210 279 QGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (429)
Q Consensus 279 ~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~ 312 (429)
.+++|+|+.+.||+++ . +.+.|+||+.+..
T Consensus 187 ~~liHgD~~~~Nil~~---~-~~i~lIDfd~~~~ 216 (313)
T TIGR02906 187 RGFCHQDYAYHNILLK---D-NEVYVIDFDYCTI 216 (313)
T ss_pred CceEcCCCCcccEEEe---C-CcEEEEECccccc
Confidence 4789999999999994 3 4578999997643
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=97.17 E-value=0.0031 Score=62.16 Aligned_cols=145 Identities=14% Similarity=0.196 Sum_probs=80.0
Q ss_pred eeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEE
Q 014210 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYV 236 (429)
Q Consensus 157 y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~~l 236 (429)
.++.. |..|=-..+|++........+..|++|+..... ... =+..+|..+++.+..+.--.++++++. ++ +
T Consensus 17 i~i~~-l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t---~~~-IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~ 87 (330)
T PLN02421 17 FSVER-ISGGITNLLLKVSVKEENGNEVSVTVRLFGPNT---DYV-IDRERELQAIKYLSAAGFGAKLLGVFG-NG---M 87 (330)
T ss_pred eEEEE-eCCcccceEEEEEecCCCCCCceEEEEEecCCc---CeE-echHHHHHHHHHHHhcCCCCceeEEeC-Cc---E
Confidence 34333 333555578887654322123478999875421 111 223689999999985444456776663 32 5
Q ss_pred EEEecCCCcHHH----------HH-------HhcC---C--CCCHHHHHHHHHHH----------------------HHH
Q 014210 237 VMELCEGGELLD----------RI-------LSRG---G--KYTEDDAKAVMIQI----------------------LNV 272 (429)
Q Consensus 237 v~E~~~ggsL~~----------~i-------~~~~---~--~l~~~~~~~i~~qi----------------------~~g 272 (429)
|.+|++|..|.. .+ +... . .-.+..+..+..++ ..-
T Consensus 88 i~~fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 167 (330)
T PLN02421 88 IQSFINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDE 167 (330)
T ss_pred eehhhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHH
Confidence 899997764421 11 1111 0 11233333333222 111
Q ss_pred HHHHH----HcC----ceeccCCCCcEEEeecCCCceEEEeecCCccc
Q 014210 273 VAFCH----LQG----VVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (429)
Q Consensus 273 L~~LH----~~~----iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~ 312 (429)
+..+. ..+ ++|.|+.+.|||+. ++++.++|+||..|..
T Consensus 168 ~~~l~~~~~~~~~~~v~CHnDl~~~NiL~~--~~~~~l~lID~EYag~ 213 (330)
T PLN02421 168 IVELKEITDSLKAPVVFAHNDLLSGNLMLN--EDEGKLYFIDFEYGSY 213 (330)
T ss_pred HHHHHHHhccCCCCeEEEECCCCcccEEEe--CCCCcEEEEcccccCC
Confidence 22221 112 69999999999994 2346799999998854
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=96.98 E-value=0.0054 Score=59.56 Aligned_cols=106 Identities=11% Similarity=0.011 Sum_probs=71.0
Q ss_pred eeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCC--CCcceEEEEEEeC---
Q 014210 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGH--NNLVKFFDAYEDT--- 231 (429)
Q Consensus 157 y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h--~nIv~l~~~~~~~--- 231 (429)
-.-.+.||.|..+.||.....+ | .+.+|..+. . .....+.+|.+.|+.|..+ -.+.++++++.++
T Consensus 16 ~~~~~~i~~G~~~~vy~~~~~~----~-~~~~k~~~~---~--~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~ 85 (297)
T PRK10593 16 LSRVECISEQPYAALWALYDSQ----G-NPMPLMARS---F--STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSP 85 (297)
T ss_pred hheeeecCCccceeEEEEEcCC----C-CEEEEEecc---c--ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcC
Confidence 3446789999999999875332 3 477787422 1 0124688999999999854 3688899888653
Q ss_pred CeEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH
Q 014210 232 DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHL 278 (429)
Q Consensus 232 ~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~ 278 (429)
+..+||||+++|.++.+ . .........+..+++++|.-||+
T Consensus 86 g~~~LVmE~i~G~~~~~-~-----~~~~~~~~~l~~~l~~~La~LH~ 126 (297)
T PRK10593 86 GPDVLLLERLRGVSVEA-P-----ARTPERWEQLKDQIVEGLLAWHR 126 (297)
T ss_pred CCeEEEEeccCCEecCC-C-----CCCHHHHHHHHHHHHHHHHHHhC
Confidence 66899999999876643 0 12233344555566666666665
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.97 E-value=0.0081 Score=58.55 Aligned_cols=130 Identities=22% Similarity=0.305 Sum_probs=74.7
Q ss_pred CeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCC-CCcceEEEEEEeCC--eEEEEEEecCCCcH---------H-HH
Q 014210 183 GQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGH-NNLVKFFDAYEDTD--NVYVVMELCEGGEL---------L-DR 249 (429)
Q Consensus 183 g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h-~nIv~l~~~~~~~~--~~~lv~E~~~ggsL---------~-~~ 249 (429)
++.++|. ... ............+|..+++.+..- --+...+++|.++. ..|.||+|++|..+ . .+
T Consensus 48 ~~~~vlR-~P~-~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~~~~~~~~~~ 125 (321)
T COG3173 48 GQKYVLR-KPP-RGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSALPPESLGRQF 125 (321)
T ss_pred CceEEEe-cCC-ccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcCCcccchHHH
Confidence 6777877 332 122333446678899999988632 23344566666655 67999999988321 1 11
Q ss_pred HH--------hc------C----CC---CCHHHHHHHHH--------------HHHHHHHHHHHc--------CceeccC
Q 014210 250 IL--------SR------G----GK---YTEDDAKAVMI--------------QILNVVAFCHLQ--------GVVHRDL 286 (429)
Q Consensus 250 i~--------~~------~----~~---l~~~~~~~i~~--------------qi~~gL~~LH~~--------~iiHrDI 286 (429)
+. +- + ++ ....++..+.. .+..-..+|+.+ .++|+|+
T Consensus 126 ~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~~~~~~~lvHGD~ 205 (321)
T COG3173 126 ALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPPWAGPPVLVHGDY 205 (321)
T ss_pred HHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCCcCCCceeeeCCc
Confidence 11 00 0 00 01111111111 122335556554 3899999
Q ss_pred CCCcEEEeecCCCceEEEeecCCccccCCCc
Q 014210 287 KPENFLFTTKDENSVLKAIDFGLSDFVRPDE 317 (429)
Q Consensus 287 Kp~NILl~~~~~~~~vkL~DFGla~~~~~~~ 317 (429)
.+.||++. .++-+=|.||+++....+..
T Consensus 206 ~~gNlii~---~~~~~gVlDwe~~~lGDP~~ 233 (321)
T COG3173 206 RPGNLIID---PGRPTGVLDWELATLGDPLE 233 (321)
T ss_pred ccCCEEEe---CCCeeEEEeccccccCCcHH
Confidence 99999994 44458899999997755433
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.90 E-value=0.0094 Score=58.99 Aligned_cols=79 Identities=20% Similarity=0.185 Sum_probs=49.4
Q ss_pred ceeeccCceEEEEEEEecCcccCeEEEEEEccCC----CcCcHHHHHHHHHHHHHHHHhcCC-C-CcceEEEEEEeCCeE
Q 014210 161 EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKH----KMTTAIAIEDVRREVKILRALTGH-N-NLVKFFDAYEDTDNV 234 (429)
Q Consensus 161 ~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~----~~~~~~~~~~~~~Ei~il~~l~~h-~-nIv~l~~~~~~~~~~ 234 (429)
++||-|....||++.... .++.|+||.-... ...-.-..++..-|...|+.+... | ++.++|. .+.+..
T Consensus 1 ~EigdGnlN~VfrV~~~~---g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~--~D~e~~ 75 (370)
T TIGR01767 1 QEVGDGNLNLVFHVYDQE---GDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH--FDTEMA 75 (370)
T ss_pred CcCCCCceEEEEEEEcCC---CCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE--Eccccc
Confidence 368999999999998532 2367999964211 001133345566788888776532 3 4555554 344555
Q ss_pred EEEEEecCCC
Q 014210 235 YVVMELCEGG 244 (429)
Q Consensus 235 ~lv~E~~~gg 244 (429)
.+|||+++..
T Consensus 76 ~~vMEdL~~~ 85 (370)
T TIGR01767 76 VTVMEDLSHH 85 (370)
T ss_pred eehHhhCccc
Confidence 7899999654
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.67 E-value=0.028 Score=56.69 Aligned_cols=78 Identities=14% Similarity=0.106 Sum_probs=51.1
Q ss_pred EeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCc-CcH---HHHHHHHHHHHHHHHhcCC--CCcceEEEEEEeCC
Q 014210 159 LGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKM-TTA---IAIEDVRREVKILRALTGH--NNLVKFFDAYEDTD 232 (429)
Q Consensus 159 ~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~-~~~---~~~~~~~~Ei~il~~l~~h--~nIv~l~~~~~~~~ 232 (429)
..+.||-|.-..||++... +..++||+-..... ... ....+-..|.+.|+.+... .++.+++.++.+
T Consensus 36 ~~~eiggGn~N~VyrV~~~-----~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded-- 108 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVSS-----SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRT-- 108 (418)
T ss_pred eEEEcCCCceeeEEEEEcC-----CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCC--
Confidence 3677899999999997742 34699997642111 110 1334455667777665422 478889888874
Q ss_pred eEEEEEEecCC
Q 014210 233 NVYVVMELCEG 243 (429)
Q Consensus 233 ~~~lv~E~~~g 243 (429)
.-+++|||+++
T Consensus 109 ~~vlvME~L~~ 119 (418)
T PLN02756 109 MALIGMRYLEP 119 (418)
T ss_pred CCEEEEeecCC
Confidence 35788999977
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=96.56 E-value=0.0052 Score=56.34 Aligned_cols=120 Identities=20% Similarity=0.200 Sum_probs=59.8
Q ss_pred CeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEecCCCcHHH-------HH-----
Q 014210 183 GQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLD-------RI----- 250 (429)
Q Consensus 183 g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~~lv~E~~~ggsL~~-------~i----- 250 (429)
++.|+|++.... ....-...+|..+++.+..+..-.++++++.. .+|+||++|..|.. .+
T Consensus 2 ~~~~~~Ri~g~~----t~~~idr~~E~~~~~~l~~~g~~p~~~~~~~~----g~v~e~i~g~~l~~~~~~~~~~~~~iA~ 73 (211)
T PF01633_consen 2 PEKYLVRIPGEG----TENFIDRENENEALKLLSEAGLGPKIIYFFEN----GRVEEFIEGRTLSPEDFRNPEILKRIAK 73 (211)
T ss_dssp TSEEEEEEEESC----GCSHHHHHHHHHHHHHHHHTTSSS-EEEEETT----EEEEE--SSEE--CGGGGSHHHHHHHHH
T ss_pred CCEEEEEeCCCC----cccccCHHHHHHHHHHHHHcCCCCeEEEEcCC----CcEEEEecccccChhhccChHHHHHHHH
Confidence 467888887443 12223556899999999855566677776533 25779996654311 11
Q ss_pred -----Hh--c--C--CCCCHHHHHHH----------------------HHHHHHHHHHHHH--------cCceeccCCCC
Q 014210 251 -----LS--R--G--GKYTEDDAKAV----------------------MIQILNVVAFCHL--------QGVVHRDLKPE 289 (429)
Q Consensus 251 -----~~--~--~--~~l~~~~~~~i----------------------~~qi~~gL~~LH~--------~~iiHrDIKp~ 289 (429)
+. . . ...-+..+..+ +..+..-+..+.+ .-++|.|+.+.
T Consensus 74 ~l~~lH~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~v~cHnDl~~~ 153 (211)
T PF01633_consen 74 LLAKLHSIPISPNSKKPDLWDRIDKYMNKKSEFLFKRKKKKKSIDKEDLEDLQEELEELEKLLEKSNSPLVFCHNDLNPG 153 (211)
T ss_dssp HHHHHHTHHHTTSSSS-HHHHHHHHHHHHHHTCCCCHHTTTCHHHHHHHHHHHHHHHHHHHHHHTSCGGEEEE-S--SGG
T ss_pred HHHHHhhcccccccCcchHHHHhhhhccchhhhhhhhhhhccccccCCHHHHHHHHhhhhhhhhccCCCceEeeccCccc
Confidence 00 1 0 00112222222 1112222222221 24799999999
Q ss_pred cEEEeecCCCceEEEeecCCccc
Q 014210 290 NFLFTTKDENSVLKAIDFGLSDF 312 (429)
Q Consensus 290 NILl~~~~~~~~vkL~DFGla~~ 312 (429)
|||+. +.++.++|+||..|..
T Consensus 154 Nil~~--~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 154 NILIN--NKDGEVKLIDFEYAGY 174 (211)
T ss_dssp GEEET--SSSSCEEE--GTT-EE
T ss_pred cEEec--cCCCeEEEecHHHHhh
Confidence 99993 4566799999998754
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.46 E-value=0.047 Score=53.69 Aligned_cols=69 Identities=12% Similarity=0.079 Sum_probs=41.4
Q ss_pred eEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCC-CcceEE---E--EEEeCCeEEEEEEecC
Q 014210 169 GYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHN-NLVKFF---D--AYEDTDNVYVVMELCE 242 (429)
Q Consensus 169 g~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~-nIv~l~---~--~~~~~~~~~lv~E~~~ 242 (429)
..||++...+ |..+++|+..... ....++..|++.+..|..+. .++... | ....++..+.++++++
T Consensus 39 N~vy~v~~~~----~~~~vlKv~r~~~----~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~ 110 (325)
T PRK11768 39 NRVYQFGDED----GRRVVAKFYRPER----WSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRG 110 (325)
T ss_pred ceEEEEecCC----CCEEEEEEcCccc----CCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeC
Confidence 5788776433 6679999875332 12355677888888776321 122211 1 1233567788999998
Q ss_pred CCc
Q 014210 243 GGE 245 (429)
Q Consensus 243 ggs 245 (429)
|..
T Consensus 111 G~~ 113 (325)
T PRK11768 111 GRA 113 (325)
T ss_pred CCC
Confidence 753
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.33 E-value=0.042 Score=52.99 Aligned_cols=76 Identities=22% Similarity=0.209 Sum_probs=47.9
Q ss_pred eEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhc--CCCCcceEEEEEEeCCeEE
Q 014210 158 ELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALT--GHNNLVKFFDAYEDTDNVY 235 (429)
Q Consensus 158 ~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~--~h~nIv~l~~~~~~~~~~~ 235 (429)
+..+.|+-|....+|+.. . .++.+.||+-. ......+..|.+-|+.|. .--.+.+.+++....+.-+
T Consensus 20 ~~~~~v~GG~i~~a~~~~--~---~~~~~FvK~~~------~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~f 88 (288)
T PF03881_consen 20 TSIEPVSGGDINEAYRLD--T---DGGSYFVKVNS------ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAF 88 (288)
T ss_dssp -EEEEE--SSSSEEEEEE--T---TS-EEEEEEEE------GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCE
T ss_pred eeeEecCCCChhheEEEE--C---CCccEEEEecC------hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCce
Confidence 345678888888888766 2 47889999853 223356788999999984 2345778999888877789
Q ss_pred EEEEecCCC
Q 014210 236 VVMELCEGG 244 (429)
Q Consensus 236 lv~E~~~gg 244 (429)
|||||++.+
T Consensus 89 Llle~l~~~ 97 (288)
T PF03881_consen 89 LLLEFLEMG 97 (288)
T ss_dssp EEEE-----
T ss_pred EEEEeecCC
Confidence 999999876
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PF02958 EcKinase: Ecdysteroid kinase; InterPro: IPR004119 This family includes proteins of unknown function | Back alignment and domain information |
|---|
Probab=96.32 E-value=0.069 Score=51.49 Aligned_cols=79 Identities=20% Similarity=0.207 Sum_probs=49.2
Q ss_pred eccCceEEEEEEEec-----CcccCeEEEEEEccCCCcCc--HHHHHHHHHHHHHHHHhcC------------CCCcceE
Q 014210 164 GRGHFGYTCAAKFKK-----GELKGQQVAVKVIPKHKMTT--AIAIEDVRREVKILRALTG------------HNNLVKF 224 (429)
Q Consensus 164 G~G~fg~V~~~~~~~-----~~~~g~~vAvK~~~~~~~~~--~~~~~~~~~Ei~il~~l~~------------h~nIv~l 224 (429)
|.|-.|.+|++.+.- +......++||......... ......+.+|+.+++.+-. ...+.++
T Consensus 2 Gd~y~s~~~rv~v~~~~~~~~~~~~~s~ivK~~p~~~~~~~~~~~~~~f~~E~~fY~~~~p~l~~~~~~~~~~~~~~P~~ 81 (294)
T PF02958_consen 2 GDNYLSDMYRVTVTYELKGDGKNEPLSLIVKSPPTNPSRREFLREMGSFRREIFFYRELLPELEELQKEAGDPFKFFPKC 81 (294)
T ss_pred CCcceeEEEEEEEEEEEccCCCceEEEEEEEeCCCchhhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHhccccceeeceE
Confidence 677778888887744 12234578999976322111 1233557899998876641 1234566
Q ss_pred EEEEEeCCeEEEEEEecC
Q 014210 225 FDAYEDTDNVYVVMELCE 242 (429)
Q Consensus 225 ~~~~~~~~~~~lv~E~~~ 242 (429)
+....+.+..+||||-+.
T Consensus 82 ~~~~~~~~~~~lvlEDL~ 99 (294)
T PF02958_consen 82 YYADEDPGDEVLVLEDLS 99 (294)
T ss_pred EEeccCCCceeeehhhhh
Confidence 666655556789998773
|
All known members of this group are proteins from drosophila and Caenorhabditis elegans. |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.23 E-value=0.033 Score=54.81 Aligned_cols=119 Identities=14% Similarity=0.195 Sum_probs=77.0
Q ss_pred CCCcceEEEEE-EeCCeEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHc-CceeccCCCCcEEEee
Q 014210 218 HNNLVKFFDAY-EDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQ-GVVHRDLKPENFLFTT 295 (429)
Q Consensus 218 h~nIv~l~~~~-~~~~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~-~iiHrDIKp~NILl~~ 295 (429)
-++..+.+-+- .+..+.|++|++. |+.|. .+ ....++++..++.+.+..+.-+... ..-|||+..+||||
T Consensus 284 ~~~~e~~~vv~~de~~y~yl~~kdh-gt~is-~i----k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLI-- 355 (488)
T COG5072 284 SVFLETLKVVSLDETLYLYLHFKDH-GTPIS-II----KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILI-- 355 (488)
T ss_pred chhhhcceEEecCCceEEEEEEecC-Cceee-ee----ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceee--
Confidence 44444444443 3344577888876 54542 12 3456888899999988888777665 68999999999999
Q ss_pred cCCCceEEEeecCCccccCCCccccccccCCcccCcccccCCCCCcccHHHHHHH
Q 014210 296 KDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRSYSTEADVWSIGVI 350 (429)
Q Consensus 296 ~~~~~~vkL~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~sDiwSlGvl 350 (429)
+ +|+|-|+||-+++.-..... +-....--|-.+.|.-+..-|||-+--.
T Consensus 356 -d-~GnvtLIDfklsRl~~~q~~----isy~rldhp~lF~G~dd~QFeIYrlMr~ 404 (488)
T COG5072 356 -D-EGNVTLIDFKLSRLSYSQGI----ISYNRLDHPDLFNGVDDYQFEIYRLMRR 404 (488)
T ss_pred -e-cCceEEEEeeeeecccCCce----eeccccCchhhhcCccceeeeHHHHHHH
Confidence 6 88999999999985432221 1112233344455545666677765433
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.22 E-value=0.03 Score=56.28 Aligned_cols=78 Identities=19% Similarity=0.298 Sum_probs=46.3
Q ss_pred ceeeccCceEEEEEEEecCc---ccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEE
Q 014210 161 EEVGRGHFGYTCAAKFKKGE---LKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVV 237 (429)
Q Consensus 161 ~~IG~G~fg~V~~~~~~~~~---~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~~lv 237 (429)
+.|..|--..+|++....+. ...+.|.+.+... .....+ +-.+|+++++.|..+.--.++++.+.. +++
T Consensus 56 ~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~---~~~l~I-dR~~E~~i~~~Ls~~glgP~l~~~f~~----g~l 127 (383)
T PTZ00384 56 KKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSST---YNSLVI-DNDLQYNIAKLLGDNNFGPKIIGRFGD----FTI 127 (383)
T ss_pred EEeCCcccceEEEEEecCCCCCccccceEEEEeccC---CCceEe-ccHHHHHHHHHHHhCCCCCeEEEecCC----EEE
Confidence 34444666688887654321 1112355554321 111111 235799999999866666777777643 689
Q ss_pred EEecCCCcH
Q 014210 238 MELCEGGEL 246 (429)
Q Consensus 238 ~E~~~ggsL 246 (429)
+||++|..|
T Consensus 128 ~efIeGr~l 136 (383)
T PTZ00384 128 QEWVEGNTM 136 (383)
T ss_pred EEEeccccC
Confidence 999998754
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.20 E-value=0.018 Score=57.33 Aligned_cols=61 Identities=23% Similarity=0.203 Sum_probs=44.8
Q ss_pred EEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH-HHcCceeccCCCCcEEEeec
Q 014210 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFC-HLQGVVHRDLKPENFLFTTK 296 (429)
Q Consensus 234 ~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~L-H~~~iiHrDIKp~NILl~~~ 296 (429)
..|+-+|+.|-++..++... ..++...++++.-.++||.-+ --.+++|.|+.|.||++...
T Consensus 320 ~vl~E~~~~Gl~v~~~v~~~--~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf~ 381 (565)
T KOG1236|consen 320 LVLVETYERGLSVLRFVKWK--SQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRFN 381 (565)
T ss_pred ceeeeeccccccHHhhhhcc--cChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEec
Confidence 45677788888888877443 346667777777666666544 44589999999999999643
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.17 E-value=0.13 Score=50.15 Aligned_cols=30 Identities=33% Similarity=0.469 Sum_probs=26.5
Q ss_pred CceeccCCCCcEEEeecCCCceEEEeecCCccc
Q 014210 280 GVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (429)
Q Consensus 280 ~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~ 312 (429)
++||+|+.++|||+ +.++.+.|+||..+..
T Consensus 197 ~lcHgD~~~~Nvl~---~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLY---DETRGGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEE---cCCCCEEEEEhhhccc
Confidence 69999999999999 6677799999998754
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.80 E-value=0.12 Score=50.82 Aligned_cols=132 Identities=19% Similarity=0.252 Sum_probs=75.6
Q ss_pred CceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcc-----eEEE----EEEeCCeEEEE
Q 014210 167 HFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLV-----KFFD----AYEDTDNVYVV 237 (429)
Q Consensus 167 ~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv-----~l~~----~~~~~~~~~lv 237 (429)
.-..||+....+ | .+++|+.... ....++.-|+..+..|..+.--| .+=| ........+-+
T Consensus 37 ~eN~~f~~~~~~----g-~~iLki~~~~-----~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~l 106 (331)
T COG2334 37 EENSNFRVQTED----G-RYILKIYRPG-----WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAAL 106 (331)
T ss_pred ccCceEEEEecC----C-CeEEEEecCC-----CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEE
Confidence 445678776554 3 3499998653 22355778888888887432211 1111 11111367889
Q ss_pred EEecCCCcHHH-----H----------HHhcCC-----------CCCHH----H---------HHHHHHHHHHHHHHHHH
Q 014210 238 MELCEGGELLD-----R----------ILSRGG-----------KYTED----D---------AKAVMIQILNVVAFCHL 278 (429)
Q Consensus 238 ~E~~~ggsL~~-----~----------i~~~~~-----------~l~~~----~---------~~~i~~qi~~gL~~LH~ 278 (429)
++|++|..+.. . ++.... ...|. . -.....++...++.+.+
T Consensus 107 f~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~ 186 (331)
T COG2334 107 FEYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLA 186 (331)
T ss_pred EEecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHh
Confidence 99999876651 1 111000 12222 0 01123344455555554
Q ss_pred c--------C--ceeccCCCCcEEEeecCCCc-eEEEeecCCcc
Q 014210 279 Q--------G--VVHRDLKPENFLFTTKDENS-VLKAIDFGLSD 311 (429)
Q Consensus 279 ~--------~--iiHrDIKp~NILl~~~~~~~-~vkL~DFGla~ 311 (429)
. + +||+|+.++||++ +.+. .+.++|||.+.
T Consensus 187 ~~~~~lp~~~~~iIH~D~~~~NVl~---d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 187 RLPAHLPALGDQIIHGDLHPDNVLF---DDDTDVSGFIDFDDAG 227 (331)
T ss_pred hchhhCCcccceeeecCCCccceeE---cCCCCeeeEEEccccc
Confidence 2 3 9999999999999 4444 58899999774
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=95.73 E-value=0.073 Score=53.47 Aligned_cols=80 Identities=20% Similarity=0.177 Sum_probs=51.3
Q ss_pred eceeeccCceEEEEEEEecCcccCeEEEEEEccCC---CcCcHHHHHHHHHHHHHHHHhcC-CC-CcceEEEEEEeCCeE
Q 014210 160 GEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKH---KMTTAIAIEDVRREVKILRALTG-HN-NLVKFFDAYEDTDNV 234 (429)
Q Consensus 160 ~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~---~~~~~~~~~~~~~Ei~il~~l~~-h~-nIv~l~~~~~~~~~~ 234 (429)
.+.||-|.-..||++.... .++.|+||.-..- ...-.-..++..-|.+.|+.+.. .| ++.++|.+ +.+..
T Consensus 34 ~~eigdGnlN~VfrV~~~~---~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~ 108 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQ---KNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMN 108 (409)
T ss_pred eeEcCCCceEEEEEEeeCC---CCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHh
Confidence 6788999999999998643 2457999964211 00113345667778888887653 23 45566543 44455
Q ss_pred EEEEEecCCC
Q 014210 235 YVVMELCEGG 244 (429)
Q Consensus 235 ~lv~E~~~gg 244 (429)
.+|||+++..
T Consensus 109 ~~vMEdL~~~ 118 (409)
T PRK12396 109 CCVMEDLSDH 118 (409)
T ss_pred hHHHHhCccc
Confidence 7899998653
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=95.67 E-value=0.081 Score=48.93 Aligned_cols=58 Identities=21% Similarity=0.208 Sum_probs=44.4
Q ss_pred CeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcC--CCCcceEEEEEEeCCeEEEEEEecCCCcH
Q 014210 183 GQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTG--HNNLVKFFDAYEDTDNVYVVMELCEGGEL 246 (429)
Q Consensus 183 g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~--h~nIv~l~~~~~~~~~~~lv~E~~~ggsL 246 (429)
...+.||+ .....+..|..|+.-|..+.. --.+.+++.+..+.++.|+||||++-+.+
T Consensus 39 ~~~~FvK~------n~~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~~ 98 (286)
T COG3001 39 TDPFFVKC------NQREQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGPL 98 (286)
T ss_pred CcceEEEe------cchhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCCC
Confidence 46789997 344556678889888887762 23577889889999999999999987543
|
|
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.58 E-value=0.15 Score=52.41 Aligned_cols=79 Identities=9% Similarity=0.091 Sum_probs=48.0
Q ss_pred EeceeeccCceEEEEEEEecCc-----ccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe
Q 014210 159 LGEEVGRGHFGYTCAAKFKKGE-----LKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (429)
Q Consensus 159 ~~~~IG~G~fg~V~~~~~~~~~-----~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~ 233 (429)
.++.|..|---.+|++....+. ..++.|.+++.-.. ....+ +..+|..+++.+..+.--.++++.+. +
T Consensus 109 ~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~---te~lI-dR~~E~~v~~~ls~~gi~P~l~~~f~--g- 181 (442)
T PTZ00296 109 RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKD---VDELY-NPISEFEVYKTMSKYRIAPQLLNTFS--G- 181 (442)
T ss_pred EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCC---cccee-CHHHHHHHHHHHHHCCCCCceEEEeC--C-
Confidence 3455555555688888765321 12568999987432 22222 34679999988884433346666552 2
Q ss_pred EEEEEEecCCCc
Q 014210 234 VYVVMELCEGGE 245 (429)
Q Consensus 234 ~~lv~E~~~ggs 245 (429)
+.|.||++|..
T Consensus 182 -g~I~efi~g~~ 192 (442)
T PTZ00296 182 -GRIEEWLYGDP 192 (442)
T ss_pred -CEEEEeeCCcc
Confidence 55799998763
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 429 | ||||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-53 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-52 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 3e-52 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-51 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-51 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 2e-51 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 2e-51 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 3e-51 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 4e-51 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-51 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 5e-51 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 8e-51 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 9e-51 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 9e-51 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-51 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-50 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-50 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 5e-50 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 6e-50 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-49 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-45 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 3e-45 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 8e-45 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-44 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-44 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 1e-43 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-43 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 4e-43 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 4e-43 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 7e-43 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 9e-43 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 1e-42 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-42 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 4e-41 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-41 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-40 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-40 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-40 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 2e-40 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-40 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-40 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-40 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-40 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 3e-40 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 3e-40 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 3e-40 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-40 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-40 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 3e-40 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 4e-40 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 4e-40 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 4e-40 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 7e-40 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 8e-40 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-39 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 3e-39 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 5e-39 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 8e-39 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 9e-39 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-38 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 3e-38 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 4e-38 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 4e-38 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-37 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 3e-37 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 4e-37 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 4e-37 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-36 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 1e-35 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-35 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-35 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-35 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 3e-35 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 3e-35 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 3e-35 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-35 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 4e-35 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 5e-35 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-35 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 8e-35 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 8e-35 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 8e-35 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 9e-35 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-34 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-34 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-34 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-34 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-34 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 4e-34 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 4e-34 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 6e-34 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 7e-34 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-33 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 3e-33 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 1e-32 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 2e-32 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 2e-32 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 2e-32 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 2e-32 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 2e-32 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 2e-32 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 2e-32 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 2e-32 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-32 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 2e-32 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 2e-32 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 4e-32 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 1e-31 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-31 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-31 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-31 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-31 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-31 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 4e-31 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 5e-31 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 6e-31 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 6e-31 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 6e-31 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 7e-31 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 7e-31 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 8e-31 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 8e-31 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 8e-31 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 8e-31 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-30 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-30 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 1e-30 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-30 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-30 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-30 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-30 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-30 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 3e-30 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 3e-30 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 3e-30 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 4e-30 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 4e-30 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 5e-30 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 5e-30 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 6e-30 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 6e-30 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 6e-30 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 6e-30 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 6e-30 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 7e-30 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 7e-30 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 7e-30 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 8e-30 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 9e-30 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-29 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-29 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-29 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-29 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-29 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-29 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-29 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 3e-29 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 9e-29 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-28 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 1e-28 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-28 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-28 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-28 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-28 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-28 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-28 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 1e-28 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-28 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 1e-28 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-28 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-28 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-28 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-28 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-28 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-28 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-28 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-28 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-28 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-28 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 3e-28 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 5e-28 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 6e-28 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 6e-28 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 8e-28 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-28 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-27 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-27 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-27 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-27 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-27 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-27 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-27 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-27 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-27 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-27 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-27 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-27 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-27 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-27 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-27 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-27 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 3e-27 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 3e-27 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 3e-27 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 3e-27 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 3e-27 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 3e-27 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-27 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 4e-27 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 4e-27 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-27 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-27 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 4e-27 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 5e-27 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 5e-27 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 5e-27 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 5e-27 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 6e-27 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 6e-27 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 6e-27 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 6e-27 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 6e-27 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-27 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 6e-27 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 6e-27 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 7e-27 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 8e-27 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 1e-26 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 1e-26 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 1e-26 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 1e-26 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 1e-26 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 1e-26 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 1e-26 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 1e-26 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-26 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 1e-26 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-26 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-26 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-26 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-26 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-26 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-26 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-26 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-26 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 2e-26 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-26 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-26 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-26 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 3e-26 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-26 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 3e-26 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 3e-26 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-26 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 3e-26 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 3e-26 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 4e-26 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 4e-26 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 4e-26 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 4e-26 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 6e-26 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 7e-26 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 8e-26 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 9e-26 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 9e-26 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-25 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-25 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-25 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-25 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 3e-25 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 3e-25 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 3e-25 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 3e-25 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 4e-25 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 4e-25 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 5e-25 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 5e-25 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 5e-25 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 5e-25 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 5e-25 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 5e-25 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 6e-25 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 6e-25 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 7e-25 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 7e-25 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 8e-25 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 8e-25 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-24 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-24 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-24 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-24 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-24 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-24 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-24 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 3e-24 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-24 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 4e-24 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 4e-24 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 5e-24 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 5e-24 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 5e-24 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 6e-24 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 6e-24 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 7e-24 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 7e-24 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-23 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 5e-23 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 5e-23 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 5e-23 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 8e-23 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-22 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-22 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-22 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-22 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 3e-22 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 3e-22 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 3e-22 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 4e-22 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 4e-22 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 4e-22 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 4e-22 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 4e-22 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 4e-22 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 5e-22 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 6e-22 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 6e-22 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 7e-22 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 1e-21 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-21 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 1e-21 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 1e-21 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-21 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-21 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-21 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 3e-21 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-21 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 3e-21 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-21 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-21 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-21 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 5e-21 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 5e-21 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 5e-21 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 5e-21 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 5e-21 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 5e-21 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-21 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 5e-21 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 5e-21 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 6e-21 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 6e-21 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 6e-21 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 6e-21 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 6e-21 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 6e-21 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 6e-21 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 6e-21 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 6e-21 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 6e-21 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 6e-21 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 7e-21 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 7e-21 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 7e-21 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 7e-21 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 7e-21 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 7e-21 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 7e-21 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 8e-21 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 8e-21 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 9e-21 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-20 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 1e-20 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-20 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 2e-20 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 2e-20 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-20 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-20 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-20 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-20 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 3e-20 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 3e-20 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 3e-20 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 4e-20 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 4e-20 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 4e-20 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 4e-20 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 4e-20 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 4e-20 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 4e-20 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 4e-20 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 5e-20 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 5e-20 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 5e-20 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-20 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 5e-20 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 6e-20 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 6e-20 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 6e-20 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 6e-20 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 7e-20 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 7e-20 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 7e-20 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 7e-20 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 7e-20 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 7e-20 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 7e-20 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 7e-20 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 7e-20 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 7e-20 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 7e-20 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 7e-20 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 7e-20 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 7e-20 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 7e-20 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 7e-20 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 7e-20 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 7e-20 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 7e-20 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 7e-20 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 7e-20 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 7e-20 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 7e-20 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 8e-20 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 8e-20 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 8e-20 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 8e-20 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 8e-20 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 8e-20 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-19 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-19 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-19 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 1e-19 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-19 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-19 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-19 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-19 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-19 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 2e-19 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-19 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 2e-19 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-19 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-19 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-19 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-19 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-19 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-19 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-19 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 2e-19 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-19 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 2e-19 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-19 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-19 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 3e-19 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 3e-19 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-19 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 3e-19 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 3e-19 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 3e-19 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 3e-19 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 3e-19 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-19 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 3e-19 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-19 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-19 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 3e-19 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 3e-19 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 3e-19 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 3e-19 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 3e-19 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 3e-19 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 3e-19 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 4e-19 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 4e-19 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 4e-19 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 4e-19 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 4e-19 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 4e-19 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 4e-19 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 5e-19 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 5e-19 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 5e-19 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 5e-19 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 5e-19 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 5e-19 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 5e-19 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 5e-19 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 6e-19 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-19 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 6e-19 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 6e-19 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 6e-19 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 7e-19 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 7e-19 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 7e-19 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 7e-19 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 7e-19 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 7e-19 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 8e-19 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 8e-19 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 9e-19 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 9e-19 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 9e-19 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-18 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-18 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-18 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 1e-18 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 1e-18 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-18 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 1e-18 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-18 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-18 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-18 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-18 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 3e-18 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 3e-18 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 3e-18 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 4e-18 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 4e-18 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-18 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 5e-18 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 5e-18 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 5e-18 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 5e-18 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 6e-18 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 6e-18 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 7e-18 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 8e-18 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-17 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-17 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-17 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-17 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-17 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-17 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-17 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-17 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-17 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-17 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 3e-17 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-17 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 4e-17 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-17 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 4e-17 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 6e-17 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 6e-17 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 6e-17 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 7e-17 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 8e-17 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 8e-17 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 8e-17 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 1e-16 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-16 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 2e-16 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 2e-16 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 2e-16 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 2e-16 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 3e-16 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 3e-16 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 3e-16 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 3e-16 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 3e-16 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 3e-16 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 3e-16 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 3e-16 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 3e-16 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 3e-16 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-16 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 4e-16 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 4e-16 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 4e-16 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 4e-16 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 4e-16 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 4e-16 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 4e-16 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 4e-16 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 4e-16 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 4e-16 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 4e-16 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 4e-16 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 4e-16 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 4e-16 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 4e-16 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 4e-16 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 4e-16 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 4e-16 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 4e-16 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 4e-16 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 4e-16 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 4e-16 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 5e-16 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 5e-16 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 6e-16 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 6e-16 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 6e-16 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 6e-16 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 7e-16 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 8e-16 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 8e-16 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 9e-16 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 1e-15 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-15 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 2e-15 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-15 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-15 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 3e-15 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 3e-15 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 4e-15 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 4e-15 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 4e-15 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 4e-15 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 4e-15 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 4e-15 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 4e-15 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 4e-15 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 4e-15 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 5e-15 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 5e-15 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 5e-15 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-15 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 5e-15 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 5e-15 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 5e-15 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 6e-15 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 6e-15 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 6e-15 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 6e-15 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 8e-15 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 8e-15 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 9e-15 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 9e-15 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 1e-14 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 1e-14 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-14 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-14 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 2e-14 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-14 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-14 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-14 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-14 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 2e-14 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-14 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 3e-14 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 3e-14 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-14 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 4e-14 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-14 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 4e-14 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 4e-14 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 4e-14 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 5e-14 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 5e-14 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 5e-14 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 5e-14 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 5e-14 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 5e-14 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 6e-14 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 7e-14 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 7e-14 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 8e-14 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 8e-14 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 8e-14 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 9e-14 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 9e-14 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 9e-14 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 1e-13 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-13 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 1e-13 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 1e-13 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 1e-13 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-13 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 1e-13 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 1e-13 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 1e-13 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-13 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 1e-13 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 1e-13 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 1e-13 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 1e-13 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 1e-13 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-13 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 1e-13 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-13 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 1e-13 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-13 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-13 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-13 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-13 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-13 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-13 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-13 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-13 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-13 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-13 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-13 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-13 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-13 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-13 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-13 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 2e-13 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-13 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 3e-13 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 3e-13 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 3e-13 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 3e-13 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 3e-13 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 3e-13 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 3e-13 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 3e-13 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 3e-13 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 3e-13 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 3e-13 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-13 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 3e-13 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 3e-13 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-13 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-13 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 4e-13 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 4e-13 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 4e-13 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-13 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 4e-13 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 4e-13 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 4e-13 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 4e-13 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-13 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 5e-13 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-13 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-13 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 5e-13 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 5e-13 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 5e-13 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 5e-13 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 6e-13 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-13 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 6e-13 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 6e-13 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-13 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 7e-13 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 7e-13 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 7e-13 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 7e-13 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 7e-13 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 7e-13 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 8e-13 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 8e-13 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 8e-13 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 8e-13 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 8e-13 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 9e-13 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 9e-13 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 9e-13 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 9e-13 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 1e-12 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-12 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-12 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 1e-12 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-12 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-12 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-12 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-12 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-12 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 3e-12 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 3e-12 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 3e-12 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 3e-12 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 3e-12 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 3e-12 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 3e-12 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 4e-12 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 4e-12 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 4e-12 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 4e-12 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 4e-12 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 5e-12 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 5e-12 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 5e-12 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 5e-12 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 5e-12 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 5e-12 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 6e-12 | ||
| 1eh4_A | 298 | Binary Complex Of Casein Kinase-1 From S. Pombe Wit | 6e-12 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 6e-12 | ||
| 2csn_A | 297 | Binary Complex Of Casein Kinase-1 With Cki7 Length | 6e-12 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 6e-12 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 7e-12 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 8e-12 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 9e-12 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-11 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 1e-11 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 1e-11 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 1e-11 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 1e-11 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 1e-11 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-11 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-11 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-11 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 2e-11 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-11 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-11 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 2e-11 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-11 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-11 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-11 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-11 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-11 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-11 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-11 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-11 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-11 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-11 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-11 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-11 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 3e-11 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-11 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 3e-11 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 3e-11 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 3e-11 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 3e-11 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-11 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 3e-11 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 3e-11 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-11 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 3e-11 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-11 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 3e-11 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-11 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 3e-11 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 3e-11 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 3e-11 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 3e-11 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 3e-11 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 3e-11 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 3e-11 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 3e-11 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 3e-11 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 4e-11 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 4e-11 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 4e-11 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 4e-11 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 4e-11 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 4e-11 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 4e-11 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 4e-11 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 4e-11 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 5e-11 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 5e-11 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 5e-11 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 5e-11 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 5e-11 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 6e-11 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 6e-11 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 6e-11 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 7e-11 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 7e-11 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 8e-11 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 8e-11 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 9e-11 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 9e-11 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-10 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-10 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 1e-10 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-10 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-10 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-10 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-10 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-10 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-10 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-10 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-10 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-10 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-10 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 2e-10 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-10 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-10 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 3e-10 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 3e-10 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 3e-10 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 3e-10 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 3e-10 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 3e-10 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 3e-10 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 3e-10 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-10 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-10 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-10 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 4e-10 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-10 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 4e-10 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 4e-10 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 4e-10 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 4e-10 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 4e-10 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 4e-10 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 5e-10 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 5e-10 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-10 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 6e-10 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 6e-10 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-10 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 6e-10 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 7e-10 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-10 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 7e-10 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 7e-10 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 9e-10 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-09 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-09 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 1e-09 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 1e-09 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 1e-09 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 1e-09 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 1e-09 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-09 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-09 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 2e-09 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-09 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 2e-09 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-09 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 3e-09 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 3e-09 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 3e-09 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 4e-09 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 4e-09 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 4e-09 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 4e-09 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 4e-09 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 4e-09 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 5e-09 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 5e-09 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 5e-09 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 6e-09 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 6e-09 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 6e-09 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 6e-09 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 7e-09 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-08 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 1e-08 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 1e-08 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 2e-08 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 2e-08 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-08 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-08 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-08 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-08 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 2e-08 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-08 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 3e-08 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 3e-08 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 4e-08 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 4e-08 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 4e-08 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 4e-08 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 4e-08 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 4e-08 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-08 | ||
| 4hni_A | 296 | Crystal Structure Of Ck1e In Complex With Pf4800567 | 5e-08 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-08 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 5e-08 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 5e-08 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 5e-08 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 7e-08 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 7e-08 | ||
| 3uys_A | 296 | Crystal Structure Of Apo Human Ck1d Length = 296 | 9e-08 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 9e-08 | ||
| 1ckj_A | 317 | Casein Kinase I Delta Truncation Mutant Containing | 9e-08 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 1e-07 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 1e-07 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-07 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 1e-07 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-07 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-07 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-07 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 2e-07 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 2e-07 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-07 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-07 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 2e-07 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-07 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 2e-07 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-07 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 3e-07 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 3e-07 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-07 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 3e-07 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 3e-07 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 3e-07 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 3e-07 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 3e-07 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 3e-07 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 3e-07 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 4e-07 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 4e-07 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-07 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-07 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 4e-07 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 5e-07 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 9e-07 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 9e-07 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 1e-06 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 1e-06 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 1e-06 |
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1EH4|A Chain A, Binary Complex Of Casein Kinase-1 From S. Pombe With An Atp Competitive Inhibitor, Ic261 Length = 298 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2CSN|A Chain A, Binary Complex Of Casein Kinase-1 With Cki7 Length = 297 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 455 bits (1172), Expect = e-160
Identities = 108/363 (29%), Positives = 164/363 (45%), Gaps = 26/363 (7%)
Query: 71 FYSPSPAHYFFSKKSSPARSSANSTPN------RFFKRPFPPPSPAKHIKAVLARRHGSV 124
+ S F+K+ AR PN R F R A++
Sbjct: 5 HHHSSGVDNKFNKERRRARREIRHLPNLNREQRRAFIRSLRDDPSQSANLLAEAKKLNDA 64
Query: 125 KPNEAAIPEGSEPEPAAGLNKSFGFSKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQ 184
+P P L + +K F KY+ + +GRG + G
Sbjct: 65 QPKGTENLYFQSMGPEDEL-PDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRA---TGH 120
Query: 185 QVAVKVIPKHKMTTAI-----AIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVME 239
+ AVK++ + E RRE ILR + GH +++ D+YE + +++V +
Sbjct: 121 EFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFD 180
Query: 240 LCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDEN 299
L GEL D + + +E + +++M +L V+F H +VHRDLKPEN L D+N
Sbjct: 181 LMRKGELFDYLTEKV-ALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILL---DDN 236
Query: 300 SVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVL-------HRSYSTEADVWSIGVIAY 352
++ DFG S + P E+L ++ G+ Y+APE+L H Y E D+W+ GVI +
Sbjct: 237 MQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILF 296
Query: 353 ILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQ 412
LL GS PFW R + + R +++ F W SS +D + RLL DP RLTA Q
Sbjct: 297 TLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQ 356
Query: 413 ALS 415
AL
Sbjct: 357 ALQ 359
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 442 bits (1138), Expect = e-156
Identities = 102/277 (36%), Positives = 160/277 (57%), Gaps = 6/277 (2%)
Query: 139 PAAGLNKSFGFSKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTT 198
+ ++ F FA +Y + +G+G FG K + Q+ AVKVI K
Sbjct: 6 HHSSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRI---TQQEYAVKVINKASAKN 62
Query: 199 AIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYT 258
+ REV++L+ L H N++K F+ ED+ + Y+V EL GGEL D I+ R +++
Sbjct: 63 K-DTSTILREVELLKKLD-HPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRK-RFS 119
Query: 259 EDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDER 318
E DA ++ Q+ + + + H +VHRDLKPEN L +K+++ +K IDFGLS + + +
Sbjct: 120 EHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK 179
Query: 319 LNDIVGSAYYVAPEVLHRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADP 378
+ D +G+AYY+APEVL +Y + DVWS GVI YILL G+ PF+ + E I + V
Sbjct: 180 MKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKY 239
Query: 379 SFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALS 415
+FD W ++S +A+D ++++L P R+TA Q L
Sbjct: 240 AFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 446 bits (1148), Expect = e-155
Identities = 102/274 (37%), Positives = 159/274 (58%), Gaps = 6/274 (2%)
Query: 142 GLNKSFGFSKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIA 201
++ F FA +Y + +G+G FG K + Q+ AVKVI K
Sbjct: 9 SGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRI---TQQEYAVKVINKASAKNK-D 64
Query: 202 IEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDD 261
+ REV++L+ L H N++K F+ ED+ + Y+V EL GGEL D I+ R +++E D
Sbjct: 65 TSTILREVELLKKL-DHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRK-RFSEHD 122
Query: 262 AKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLND 321
A ++ Q+ + + + H +VHRDLKPEN L +K+++ +K IDFGLS + + ++ D
Sbjct: 123 AARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKD 182
Query: 322 IVGSAYYVAPEVLHRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFD 381
+G+AYY+APEVL +Y + DVWS GVI YILL G+ PF+ + E I + V +FD
Sbjct: 183 RIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFD 242
Query: 382 EAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALS 415
W ++S +A+D ++++L P R+TA Q L
Sbjct: 243 LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 435 bits (1121), Expect = e-153
Identities = 96/280 (34%), Positives = 156/280 (55%), Gaps = 10/280 (3%)
Query: 139 PAAGLNKSFGFSKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTT 198
+ ++ F + + ++G G FG + + G + +K I K +
Sbjct: 6 HHSSGRENLYFQGTIDDLFIFKRKLGSGAFGDVHLVEERS---SGLERVIKTINKDRS-- 60
Query: 199 AIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSR---GG 255
+ +E + E+++L++L H N++K F+ +ED N+Y+VME CEGGELL+RI+S G
Sbjct: 61 QVPMEQIEAEIEVLKSL-DHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGK 119
Query: 256 KYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP 315
+E +M Q++N +A+ H Q VVH+DLKPEN LF +S +K IDFGL++ +
Sbjct: 120 ALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKS 179
Query: 316 DERLNDIVGSAYYVAPEVLHRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLK 375
DE + G+A Y+APEV R + + D+WS GV+ Y LL G PF + + +
Sbjct: 180 DEHSTNAAGTALYMAPEVFKRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATY 239
Query: 376 ADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALS 415
+P++ P L+ +A D +K++L KDP +R +AAQ L
Sbjct: 240 KEPNYAVECRP-LTPQAVDLLKQMLTKDPERRPSAAQVLH 278
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 434 bits (1118), Expect = e-153
Identities = 102/263 (38%), Positives = 158/263 (60%), Gaps = 8/263 (3%)
Query: 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKIL 212
Y L +GRG +G A K + A K IPK+ + ++ ++E++I+
Sbjct: 7 INQYYTLENTIGRGSWGEVKIAVQKGT---RIRRAAKKIPKYFVE---DVDRFKQEIEIM 60
Query: 213 RALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNV 272
++L H N+++ ++ +ED ++Y+VMELC GGEL +R++ + + E DA +M +L+
Sbjct: 61 KSLD-HPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKR-VFRESDAARIMKDVLSA 118
Query: 273 VAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPE 332
VA+CH V HRDLKPENFLF T +S LK IDFGL+ +P + + VG+ YYV+P+
Sbjct: 119 VAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQ 178
Query: 333 VLHRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEA 392
VL Y E D WS GV+ Y+LLCG PF A T+S + + + +F E W ++S +A
Sbjct: 179 VLEGLYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQA 238
Query: 393 RDFVKRLLNKDPRKRLTAAQALS 415
++RLL K P++R+T+ QAL
Sbjct: 239 ESLIRRLLTKSPKQRITSLQALE 261
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 434 bits (1118), Expect = e-150
Identities = 111/305 (36%), Positives = 161/305 (52%), Gaps = 18/305 (5%)
Query: 121 HGSVKPNEAAIPEGSEPEPAAGLNKSFGFSKHFANKYELGEEVGRGHFGYTCAAKFKKGE 180
H E +G P + K G Y ++G G +G K K G
Sbjct: 5 HHHSSGRENLYFQGIAINPGMYVRKKEG---KIGESYFKVRKLGSGAYGEVLLCKEKNG- 60
Query: 181 LKGQQVAVKVIPKHKMTTAIAI----------EDVRREVKILRALTGHNNLVKFFDAYED 230
+ A+KVI K + E++ E+ +L++L H N++K FD +ED
Sbjct: 61 --HSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL-DHPNIIKLFDVFED 117
Query: 231 TDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPEN 290
Y+V E EGGEL ++I++R K+ E DA +M QIL+ + + H +VHRD+KPEN
Sbjct: 118 KKYFYLVTEFYEGGELFEQIINRH-KFDECDAANIMKQILSGICYLHKHNIVHRDIKPEN 176
Query: 291 FLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRSYSTEADVWSIGVI 350
L K+ +K +DFGLS F D +L D +G+AYY+APEVL + Y+ + DVWS GVI
Sbjct: 177 ILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKKKYNEKCDVWSCGVI 236
Query: 351 AYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTA 410
YILLCG PF + + I + V K FD W ++S EA++ +K +L D KR TA
Sbjct: 237 MYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTA 296
Query: 411 AQALS 415
+AL+
Sbjct: 297 EEALN 301
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 432 bits (1114), Expect = e-149
Identities = 102/266 (38%), Positives = 159/266 (59%), Gaps = 5/266 (1%)
Query: 150 SKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREV 209
+ F+++Y+ +G+G FG K K GQ+ AVKVI K ++ E + REV
Sbjct: 21 TAIFSDRYKGQRVLGKGSFGEVILCKDKI---TGQECAVKVISKRQVKQKTDKESLLREV 77
Query: 210 KILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQI 269
++L+ L H N++K ++ +ED Y+V E+ GGEL D I+SR +++E DA ++ Q+
Sbjct: 78 QLLKQL-DHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRK-RFSEVDAARIIRQV 135
Query: 270 LNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYV 329
L+ + + H +VHRDLKPEN L +K +++ ++ IDFGLS +++ D +G+AYY+
Sbjct: 136 LSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYI 195
Query: 330 APEVLHRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLS 389
APEVLH +Y + DVWS GVI YILL G PF E I + V K +F+ W +S
Sbjct: 196 APEVLHGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVS 255
Query: 390 SEARDFVKRLLNKDPRKRLTAAQALS 415
A+D ++++L P R++A AL
Sbjct: 256 ESAKDLIRKMLTYVPSMRISARDALD 281
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 423 bits (1089), Expect = e-148
Identities = 77/266 (28%), Positives = 134/266 (50%), Gaps = 10/266 (3%)
Query: 151 KHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVK 210
K KY + E++GRG FG + K + V++E+
Sbjct: 1 KELYEKYMIAEDLGRGEFGIVHRCVETS---SKKTYMAKFVKVKGTD----QVLVKKEIS 53
Query: 211 ILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQIL 270
IL H N++ +++E + + ++ E G ++ +RI + + E + + + Q+
Sbjct: 54 ILNIA-RHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVC 112
Query: 271 NVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVA 330
+ F H + H D++PEN ++ T+ +S +K I+FG + ++P + + + Y A
Sbjct: 113 EALQFLHSHNIGHFDIRPENIIYQTR-RSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYA 171
Query: 331 PEVL-HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLS 389
PEV H ST D+WS+G + Y+LL G PF A T I ++ A+ +FDE + +S
Sbjct: 172 PEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEIS 231
Query: 390 SEARDFVKRLLNKDPRKRLTAAQALS 415
EA DFV RLL K+ + R+TA++AL
Sbjct: 232 IEAMDFVDRLLVKERKSRMTASEALQ 257
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 427 bits (1099), Expect = e-147
Identities = 101/266 (37%), Positives = 163/266 (61%), Gaps = 6/266 (2%)
Query: 150 SKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREV 209
H + Y+ +++G G +G + K + A+K+I K ++T+ + + EV
Sbjct: 32 KGHLSEMYQRVKKLGSGAYGEVLLCRDKVT---HVERAIKIIRKTSVSTS-SNSKLLEEV 87
Query: 210 KILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQI 269
+L+ L H N++K +D +ED N Y+VME +GGEL D I+ R K+ E DA ++ Q+
Sbjct: 88 AVLKLL-DHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRM-KFNEVDAAVIIKQV 145
Query: 270 LNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYV 329
L+ V + H +VHRDLKPEN L +K++++++K +DFGLS +++ + +G+AYY+
Sbjct: 146 LSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYI 205
Query: 330 APEVLHRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLS 389
APEVL + Y + DVWSIGVI +ILL G PF +T+ I R V K +FD W ++S
Sbjct: 206 APEVLRKKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVS 265
Query: 390 SEARDFVKRLLNKDPRKRLTAAQALS 415
A+D +K++L D ++R++A QAL
Sbjct: 266 EGAKDLIKQMLQFDSQRRISAQQALE 291
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 415 bits (1070), Expect = e-146
Identities = 94/267 (35%), Positives = 149/267 (55%), Gaps = 7/267 (2%)
Query: 150 SKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREV 209
S F++ Y++ EE+G+G F K G + A K+I K++ A + + RE
Sbjct: 1 STKFSDNYDVKEELGKGAFSVVRRCVHKTT---GLEFAAKIINTKKLS-ARDFQKLEREA 56
Query: 210 KILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQI 269
+I R L H N+V+ D+ ++ Y+V +L GGEL + I++R Y+E DA + QI
Sbjct: 57 RICRKLQ-HPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVARE-FYSEADASHCIQQI 114
Query: 270 LNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYV 329
L +A+CH G+VHR+LKPEN L +K + + +K DFGL+ V E + G+ Y+
Sbjct: 115 LESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYL 174
Query: 330 APEVLHRS-YSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSL 388
+PEVL + YS D+W+ GVI YILL G PFW + ++ + + W ++
Sbjct: 175 SPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTV 234
Query: 389 SSEARDFVKRLLNKDPRKRLTAAQALS 415
+ EA+ + +L +P+KR+TA QAL
Sbjct: 235 TPEAKSLIDSMLTVNPKKRITADQALK 261
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 412 bits (1061), Expect = e-142
Identities = 92/268 (34%), Positives = 144/268 (53%), Gaps = 8/268 (2%)
Query: 150 SKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREV 209
F +Y+L EE+G+G F GQ+ A +I K++ + + RE
Sbjct: 6 CTRFTEEYQLFEELGKGAFSVVRRCVKVL---AGQEYAAMIINTKKLSA-RDHQKLEREA 61
Query: 210 KILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQI 269
+I R L H N+V+ D+ + + Y++ +L GGEL + I++R Y+E DA + QI
Sbjct: 62 RICRLL-KHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVARE-YYSEADASHCIQQI 119
Query: 270 LNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR-PDERLNDIVGSAYY 328
L V CH GVVHR+LKPEN L +K + + +K DFGL+ V + G+ Y
Sbjct: 120 LEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGY 179
Query: 329 VAPEVLHRS-YSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPS 387
++PEVL + Y D+W+ GVI YILL G PFW + +++ + F W +
Sbjct: 180 LSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDT 239
Query: 388 LSSEARDFVKRLLNKDPRKRLTAAQALS 415
++ EA+D + ++L +P KR+TAA+AL
Sbjct: 240 VTPEAKDLINKMLTINPSKRITAAEALK 267
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 404 bits (1041), Expect = e-141
Identities = 93/279 (33%), Positives = 139/279 (49%), Gaps = 20/279 (7%)
Query: 150 SKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAI------E 203
+ F YE E +GRG K ++ AVK+I + A E
Sbjct: 12 THGFYENYEPKEILGRGVSSVVRRCIHKPT---CKEYAVKIIDVTGGGSFSAEEVQELRE 68
Query: 204 DVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAK 263
+EV ILR ++GH N+++ D YE ++V +L + GEL D + + +E + +
Sbjct: 69 ATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV-TLSEKETR 127
Query: 264 AVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIV 323
+M +L V+ H +VHRDLKPEN L D++ +K DFG S + P E+L ++
Sbjct: 128 KIMRALLEVICALHKLNIVHRDLKPENILL---DDDMNIKLTDFGFSCQLDPGEKLREVC 184
Query: 324 GSAYYVAPEVL-------HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKA 376
G+ Y+APE++ H Y E D+WS GVI Y LL GS PFW R + + R ++
Sbjct: 185 GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSG 244
Query: 377 DPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALS 415
+ F W S +D V R L P+KR TA +AL+
Sbjct: 245 NYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 406 bits (1046), Expect = e-141
Identities = 87/273 (31%), Positives = 141/273 (51%), Gaps = 12/273 (4%)
Query: 150 SKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTT--AIAIEDVRR 207
F + YEL E +G+G F ++ GQQ AVK++ K T+ ++ ED++R
Sbjct: 19 DVLFEDVYELCEVIGKGPFSVVRRCINRE---TGQQFAVKIVDVAKFTSSPGLSTEDLKR 75
Query: 208 EVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRG---GKYTEDDAKA 264
E I L H ++V+ + Y +Y+V E +G +L I+ R Y+E A
Sbjct: 76 EASICHML-KHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASH 134
Query: 265 VMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDERLNDIV 323
M QIL + +CH ++HRD+KP L +K+ ++ +K FG++ V
Sbjct: 135 YMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRV 194
Query: 324 GSAYYVAPEVLHRS-YSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDE 382
G+ +++APEV+ R Y DVW GVI +ILL G PF+ T+ +F ++K +
Sbjct: 195 GTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYG-TKERLFEGIIKGKYKMNP 253
Query: 383 APWPSLSSEARDFVKRLLNKDPRKRLTAAQALS 415
W +S A+D V+R+L DP +R+T +AL+
Sbjct: 254 RQWSHISESAKDLVRRMLMLDPAERITVYEALN 286
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 407 bits (1047), Expect = e-141
Identities = 97/291 (33%), Positives = 158/291 (54%), Gaps = 9/291 (3%)
Query: 126 PNEAAIPEGSEPEPAAGLNKSFGFSKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQ 185
P+ A++ G + + + S F++ Y++ EE+G+G F K G +
Sbjct: 2 PHMASMTGGQQMGRGSEFMMNA--STKFSDNYDVKEELGKGAFSVVRRCVHKTT---GLE 56
Query: 186 VAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGE 245
A K+I K++ A + + RE +I R L H N+V+ D+ ++ Y+V +L GGE
Sbjct: 57 FAAKIINTKKLS-ARDFQKLEREARICRKLQ-HPNIVRLHDSIQEESFHYLVFDLVTGGE 114
Query: 246 LLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAI 305
L + I++R Y+E DA + QIL +A+CH G+VHR+LKPEN L +K + + +K
Sbjct: 115 LFEDIVARE-FYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLA 173
Query: 306 DFGLSDFVRPDERLNDIVGSAYYVAPEVLHRS-YSTEADVWSIGVIAYILLCGSRPFWAR 364
DFGL+ V E + G+ Y++PEVL + YS D+W+ GVI YILL G PFW
Sbjct: 174 DFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDE 233
Query: 365 TESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALS 415
+ ++ + + W +++ EA+ + +L +P+KR+TA QAL
Sbjct: 234 DQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK 284
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 402 bits (1035), Expect = e-140
Identities = 81/268 (30%), Positives = 136/268 (50%), Gaps = 7/268 (2%)
Query: 151 KHFANKYEL-GEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREV 209
++F N Y L +E+GRG F K GQ+ A K + K + ++ E+
Sbjct: 24 ENFNNFYILTSKELGRGKFAVVRQCISKST---GQEYAAKFLKKRRRG-QDCRAEILHEI 79
Query: 210 KILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRG-GKYTEDDAKAVMIQ 268
+L ++ + YE+T + +++E GGE+ L +E+D ++ Q
Sbjct: 80 AVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQ 139
Query: 269 ILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYY 328
IL V + H +VH DLKP+N L ++ +K +DFG+S + L +I+G+ Y
Sbjct: 140 ILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEY 199
Query: 329 VAPEVLHRS-YSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPS 387
+APE+L+ +T D+W+IG+IAY+LL + PF + + + + + E + S
Sbjct: 200 LAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSS 259
Query: 388 LSSEARDFVKRLLNKDPRKRLTAAQALS 415
+S A DF++ LL K+P KR TA LS
Sbjct: 260 VSQLATDFIQSLLVKNPEKRPTAEICLS 287
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 396 bits (1020), Expect = e-138
Identities = 97/268 (36%), Positives = 154/268 (57%), Gaps = 10/268 (3%)
Query: 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTT---AIAIEDVRREV 209
+ YE+GEE+G G F + K G++ A K I K ++++ ++ E++ REV
Sbjct: 3 VEDHYEMGEELGSGQFAIVRKCRQKG---TGKEYAAKFIKKRRLSSSRRGVSREEIEREV 59
Query: 210 KILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQI 269
ILR + H N++ D +E+ +V +++EL GGEL D + + TED+A + QI
Sbjct: 60 NILREIR-HPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKE-SLTEDEATQFLKQI 117
Query: 270 LNVVAFCHLQGVVHRDLKPENFLFTTKD-ENSVLKAIDFGLSDFVRPDERLNDIVGSAYY 328
L+ V + H + + H DLKPEN + K+ N +K IDFG++ + +I G+ +
Sbjct: 118 LDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEF 177
Query: 329 VAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPS 387
VAPE+++ EAD+WSIGVI YILL G+ PF T+ + + FDE + +
Sbjct: 178 VAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSN 237
Query: 388 LSSEARDFVKRLLNKDPRKRLTAAQALS 415
S A+DF++RLL KDP++R+T AQ+L
Sbjct: 238 TSELAKDFIRRLLVKDPKRRMTIAQSLE 265
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 396 bits (1018), Expect = e-136
Identities = 93/337 (27%), Positives = 149/337 (44%), Gaps = 30/337 (8%)
Query: 90 SSANSTPNRFFKRPFPPPSPAKHIKAVLARRHGSVKPNEAAIPEGSEPEPAAGLNKSFGF 149
+S +P F P PPP P L P + + K+
Sbjct: 4 NSQGQSPPVPFPAPAPPPQPPTP---ALPHPPAQPPPPPPQQFPQFHVKSGLQIKKN--- 57
Query: 150 SKHFANKYEL-GEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRRE 208
+ Y++ + +G G G K+ ++ A+K++ RRE
Sbjct: 58 --AIIDDYKVTSQVLGLGINGKVLQIFNKRT---QEKFALKMLQD--------CPKARRE 104
Query: 209 VKILRALTGHNNLVKFFDAYEDT----DNVYVVMELCEGGELLDRILSRGGK-YTEDDAK 263
V++ + ++V+ D YE+ + +VME +GGEL RI RG + +TE +A
Sbjct: 105 VELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREAS 164
Query: 264 AVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIV 323
+M I + + H + HRD+KPEN L+T+K N++LK DFG + L
Sbjct: 165 EIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPC 224
Query: 324 GSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWA----RTESGIFRAVLKADP 378
+ YYVAPEVL Y D+WS+GVI YILLCG PF++ G+ +
Sbjct: 225 YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY 284
Query: 379 SFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALS 415
F W +S E + ++ LL +P +R+T + ++
Sbjct: 285 EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 321
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 400 bits (1030), Expect = e-136
Identities = 95/334 (28%), Positives = 149/334 (44%), Gaps = 11/334 (3%)
Query: 85 SSPARSSANSTPNRFFKRPFPPPSPAKHIKAVLARRHGSVKPNEAAIPEGSEPEPAAGLN 144
+ S P P + + K ++ + +
Sbjct: 85 ENKHGQSKPCEPTAPVLIPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYY 144
Query: 145 KSFGFSK--HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAI 202
K H + Y++ EE+G G FG + G A K + +
Sbjct: 145 PQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERA---TGNNFAAKFVMTPHESD---K 198
Query: 203 EDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDA 262
E VR+E++ + L H LV DA+ED + + ++ E GGEL +++ K +ED+A
Sbjct: 199 ETVRKEIQTMSVLR-HPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEA 257
Query: 263 KAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDI 322
M Q+ + H VH DLKPEN +FTTK N LK IDFGL+ + P + +
Sbjct: 258 VEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNE-LKLIDFGLTAHLDPKQSVKVT 316
Query: 323 VGSAYYVAPEVL-HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFD 381
G+A + APEV + D+WS+GV++YILL G PF + R V D + D
Sbjct: 317 TGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMD 376
Query: 382 EAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALS 415
++ + +S + +DF+++LL DP R+T QAL
Sbjct: 377 DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE 410
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 388 bits (999), Expect = e-134
Identities = 107/313 (34%), Positives = 156/313 (49%), Gaps = 15/313 (4%)
Query: 105 PPPSPAKHIKAVLARRHGSVKPNEAAIPEGSEPEPAAGLNKSFGFSKHFANKYELGEEVG 164
S L + S AA S + ++ +E+ E+G
Sbjct: 6 HHSSGVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRD---ALSDFFEVESELG 62
Query: 165 RGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKF 224
RG K K + A+KV+ K + VR E+ +L L+ H N++K
Sbjct: 63 RGATSIVYRCKQKG---TQKPYALKVLKKTV-----DKKIVRTEIGVLLRLS-HPNIIKL 113
Query: 225 FDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHR 284
+ +E + +V+EL GGEL DRI+ +G Y+E DA + QIL VA+ H G+VHR
Sbjct: 114 KEIFETPTEISLVLELVTGGELFDRIVEKG-YYSERDAADAVKQILEAVAYLHENGIVHR 172
Query: 285 DLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHR-SYSTEAD 343
DLKPEN L+ T ++ LK DFGLS V + + G+ Y APE+L +Y E D
Sbjct: 173 DLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCAYGPEVD 232
Query: 344 VWSIGVIAYILLCGSRPFWART-ESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNK 402
+WS+G+I YILLCG PF+ + +FR +L + F W +S A+D V++L+
Sbjct: 233 MWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLVRKLIVL 292
Query: 403 DPRKRLTAAQALS 415
DP+KRLT QAL
Sbjct: 293 DPKKRLTTFQALQ 305
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 386 bits (994), Expect = e-134
Identities = 94/270 (34%), Positives = 149/270 (55%), Gaps = 10/270 (3%)
Query: 151 KHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTT---AIAIEDVRR 207
++ + Y+ GEE+G G F + K G Q A K I K + + ++ ED+ R
Sbjct: 7 ENVDDYYDTGEELGSGQFAVVKKCREKST---GLQYAAKFIKKRRTKSSRRGVSREDIER 63
Query: 208 EVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMI 267
EV IL+ + H N++ + YE+ +V +++EL GGEL D + + TE++A +
Sbjct: 64 EVSILKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE-SLTEEEATEFLK 121
Query: 268 QILNVVAFCHLQGVVHRDLKPENFLFTTKD-ENSVLKAIDFGLSDFVRPDERLNDIVGSA 326
QILN V + H + H DLKPEN + ++ +K IDFGL+ + +I G+
Sbjct: 122 QILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTP 181
Query: 327 YYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPW 385
+VAPE+++ EAD+WSIGVI YILL G+ PF T+ V + F++ +
Sbjct: 182 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYF 241
Query: 386 PSLSSEARDFVKRLLNKDPRKRLTAAQALS 415
+ S+ A+DF++RLL KDP+KR+T +L
Sbjct: 242 SNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 384 bits (989), Expect = e-132
Identities = 97/342 (28%), Positives = 161/342 (47%), Gaps = 19/342 (5%)
Query: 85 SSPARSSANSTPNRFFKRPFPPPSPAKHIKAVLARRHGSVKPNEAAIPEGSE------PE 138
SS + + K S + H +A + + + + P
Sbjct: 9 SSGVDLGTENLYFQSMKNSGDQDSRSGHNEAKEVWSNADLTERMPVKSKRTSALAVDIPA 68
Query: 139 PAAGLNKSFGFSKH--FANKYELG--EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKH 194
P A + +K + Y + E +G G FG + G ++A K+I
Sbjct: 69 PPAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETAT---GLKLAAKIIKTR 125
Query: 195 KMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRG 254
M E+V+ E+ ++ L H NL++ +DA+E +++ +VME +GGEL DRI+
Sbjct: 126 GMKD---KEEVKNEISVMNQL-DHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDES 181
Query: 255 GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314
TE D M QI + H ++H DLKPEN L +D +K IDFGL+ +
Sbjct: 182 YNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQ-IKIIDFGLARRYK 240
Query: 315 PDERLNDIVGSAYYVAPEVLHRS-YSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAV 373
P E+L G+ ++APEV++ S D+WS+GVIAY+LL G PF ++ +
Sbjct: 241 PREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNI 300
Query: 374 LKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALS 415
L ++ + +S EA++F+ +LL K+ R++A++AL
Sbjct: 301 LACRWDLEDEEFQDISEEAKEFISKLLIKEKSWRISASEALK 342
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 381 bits (980), Expect = e-132
Identities = 108/267 (40%), Positives = 147/267 (55%), Gaps = 10/267 (3%)
Query: 150 SKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREV 209
+ + + E +G G F K + G+ A+K I K + E+
Sbjct: 4 TTNIRKTFIFMEVLGSGAFSEVFLVKQRLT---GKLFALKCIKKSPAFR---DSSLENEI 57
Query: 210 KILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQI 269
+L+ + H N+V D YE T + Y+VM+L GGEL DRIL RG YTE DA V+ Q+
Sbjct: 58 AVLKKIK-HENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERG-VYTEKDASLVIQQV 115
Query: 270 LNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYV 329
L+ V + H G+VHRDLKPEN L+ T +ENS + DFGLS + ++ G+ YV
Sbjct: 116 LSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN-GIMSTACGTPGYV 174
Query: 330 APEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSL 388
APEVL + YS D WSIGVI YILLCG PF+ TES +F + + F+ W +
Sbjct: 175 APEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDI 234
Query: 389 SSEARDFVKRLLNKDPRKRLTAAQALS 415
S A+DF+ LL KDP +R T +ALS
Sbjct: 235 SESAKDFICHLLEKDPNERYTCEKALS 261
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 382 bits (983), Expect = e-132
Identities = 90/319 (28%), Positives = 144/319 (45%), Gaps = 54/319 (16%)
Query: 146 SFGFSKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKM--TTAIAIE 203
G KY L +G+G +G A + A+K++ K+K+ +E
Sbjct: 17 QGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQT---RAIRAIKIMNKNKIRQINPKDVE 73
Query: 204 DVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGK------- 256
++ EV++++ L H N+ + ++ YED + +VMELC GG LLD++
Sbjct: 74 RIKTEVRLMKKLH-HPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAM 132
Query: 257 --------------------------------YTEDDAKAVMIQILNVVAFCHLQGVVHR 284
E +M QI + + + H QG+ HR
Sbjct: 133 DVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHR 192
Query: 285 DLKPENFLFTTKDENSVLKAIDFGLSDFVRP-----DERLNDIVGSAYYVAPEVLH---R 336
D+KPENFLF+T +++ +K +DFGLS + G+ Y+VAPEVL+
Sbjct: 193 DIKPENFLFST-NKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNE 251
Query: 337 SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFV 396
SY + D WS GV+ ++LL G+ PF ++ VL F+ + LS ARD +
Sbjct: 252 SYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLL 311
Query: 397 KRLLNKDPRKRLTAAQALS 415
LLN++ +R A +AL
Sbjct: 312 SNLLNRNVDERFDAMRALQ 330
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 382 bits (982), Expect = e-132
Identities = 95/277 (34%), Positives = 146/277 (52%), Gaps = 22/277 (7%)
Query: 150 SKHFANKYELG---EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVR 206
F Y+L + +G G F KK Q AVK+I K + +
Sbjct: 3 DSPFYQHYDLDLKDKPLGEGSFSICRKCVHKK---SNQAFAVKIISKRME------ANTQ 53
Query: 207 REVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVM 266
+E+ L+ GH N+VK + + D + ++VMEL GGEL +RI + ++E +A +M
Sbjct: 54 KEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKK-HFSETEASYIM 112
Query: 267 IQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPD-ERLNDIVGS 325
++++ V+ H GVVHRDLKPEN LFT +++N +K IDFG + PD + L +
Sbjct: 113 RKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFT 172
Query: 326 AYYVAPEVLHRS-YSTEADVWSIGVIAYILLCGSRPFWARTES-------GIFRAVLKAD 377
+Y APE+L+++ Y D+WS+GVI Y +L G PF + S I + + K D
Sbjct: 173 LHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGD 232
Query: 378 PSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQAL 414
SF+ W ++S EA+D ++ LL DP KRL +
Sbjct: 233 FSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLR 269
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 383 bits (985), Expect = e-131
Identities = 92/267 (34%), Positives = 134/267 (50%), Gaps = 9/267 (3%)
Query: 150 SKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREV 209
+ Y++ EE+G G FG K G+ K I V+ E+
Sbjct: 46 QGSVYDYYDILEELGSGAFGVVHRCVEKA---TGRVFVAKFINTPYPLD---KYTVKNEI 99
Query: 210 KILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQI 269
I+ L H L+ DA+ED + +++E GGEL DRI + K +E + M Q
Sbjct: 100 SIMNQLH-HPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQA 158
Query: 270 LNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYV 329
+ H +VH D+KPEN + TK +S +K IDFGL+ + PDE + +A +
Sbjct: 159 CEGLKHMHEHSIVHLDIKPENIMCETKKASS-VKIIDFGLATKLNPDEIVKVTTATAEFA 217
Query: 330 APEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSL 388
APE++ R D+W+IGV+ Y+LL G PF + + V + D FDE + S+
Sbjct: 218 APEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSV 277
Query: 389 SSEARDFVKRLLNKDPRKRLTAAQALS 415
S EA+DF+K LL K+PRKRLT AL
Sbjct: 278 SPEAKDFIKNLLQKEPRKRLTVHDALE 304
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 377 bits (971), Expect = e-130
Identities = 92/296 (31%), Positives = 141/296 (47%), Gaps = 37/296 (12%)
Query: 149 FSKHFANKYELGEEV-GRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRR 207
FS F + Y+L E+V G G Q+ AVK+I K V R
Sbjct: 6 FSGRFEDVYQLQEDVLGEGAHARVQTCINLI---TSQEYAVKIIEKQPGHI---RSRVFR 59
Query: 208 EVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMI 267
EV++L GH N+++ + +E+ D Y+V E GG +L I R + E +A V+
Sbjct: 60 EVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRR-HFNELEASVVVQ 118
Query: 268 QILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDI----- 322
+ + + F H +G+ HRDLKPEN L ++ S +K DF L ++ + + I
Sbjct: 119 DVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPEL 178
Query: 323 ---VGSAYYVAPEVL------HRSYSTEADVWSIGVIAYILLCGSRPFWAR--------- 364
GSA Y+APEV+ Y D+WS+GVI YILL G PF R
Sbjct: 179 LTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDR 238
Query: 365 ------TESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQAL 414
++ +F ++ + F + W +S A+D + +LL +D ++RL+AAQ L
Sbjct: 239 GEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVL 294
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 375 bits (966), Expect = e-129
Identities = 94/270 (34%), Positives = 148/270 (54%), Gaps = 10/270 (3%)
Query: 151 KHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTT---AIAIEDVRR 207
+ + Y++GEE+G G F + K G + A K I K + ++ E++ R
Sbjct: 8 QKVEDFYDIGEELGSGQFAIVKKCREKST---GLEYAAKFIKKRQSRASRRGVSREEIER 64
Query: 208 EVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMI 267
EV ILR + H+N++ D YE+ +V +++EL GGEL D + + +E++A + +
Sbjct: 65 EVSILRQVL-HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKE-SLSEEEATSFIK 122
Query: 268 QILNVVAFCHLQGVVHRDLKPENFLFTTKDEN-SVLKAIDFGLSDFVRPDERLNDIVGSA 326
QIL+ V + H + + H DLKPEN + K+ +K IDFGL+ + +I G+
Sbjct: 123 QILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTP 182
Query: 327 YYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPW 385
+VAPE+++ EAD+WSIGVI YILL G+ PF T+ + FDE +
Sbjct: 183 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFF 242
Query: 386 PSLSSEARDFVKRLLNKDPRKRLTAAQALS 415
S A+DF+++LL K+ RKRLT +AL
Sbjct: 243 SHTSELAKDFIRKLLVKETRKRLTIQEALR 272
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 372 bits (958), Expect = e-128
Identities = 96/310 (30%), Positives = 149/310 (48%), Gaps = 34/310 (10%)
Query: 117 LARRHGSVKPNEAAIPEGSEPEPAAGLNKSFGFSKHFANKYELGEEV-GRGHFGYTCAAK 175
+A H + +G EP+ + Y+L ++V G G G
Sbjct: 1 MAHHHHHHSSGLEVLFQGPEPK-----------KYAVTDDYQLSKQVLGLGVNGKVLECF 49
Query: 176 FKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN-- 233
++ GQ+ A+K++ R+EV +G ++V D YE+ +
Sbjct: 50 HRR---TGQKCALKLLYDSP--------KARQEVDHHWQASGGPHIVCILDVYENMHHGK 98
Query: 234 --VYVVMELCEGGELLDRILSRGGK-YTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPEN 290
+ ++ME EGGEL RI RG + +TE +A +M I + F H + HRD+KPEN
Sbjct: 99 RCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPEN 158
Query: 291 FLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGV 349
L+T+K++++VLK DFG + + L + YYVAPEVL Y D+WS+GV
Sbjct: 159 LLYTSKEKDAVLKLTDFGFAKETTQNA-LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGV 217
Query: 350 IAYILLCGSRPFWARTES----GIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPR 405
I YILLCG PF++ T G+ R + F W +S +A+ ++ LL DP
Sbjct: 218 IMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPT 277
Query: 406 KRLTAAQALS 415
+RLT Q ++
Sbjct: 278 ERLTITQFMN 287
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 373 bits (960), Expect = e-128
Identities = 94/270 (34%), Positives = 146/270 (54%), Gaps = 10/270 (3%)
Query: 151 KHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTT---AIAIEDVRR 207
+ + Y++GEE+G G F + K G + A K I K + + E++ R
Sbjct: 8 QKVEDFYDIGEELGSGQFAIVKKCREKST---GLEYAAKFIKKRQSRASRRGVCREEIER 64
Query: 208 EVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMI 267
EV ILR + H N++ D YE+ +V +++EL GGEL D + + +E++A + +
Sbjct: 65 EVSILRQVL-HPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKE-SLSEEEATSFIK 122
Query: 268 QILNVVAFCHLQGVVHRDLKPENFLFTTKD-ENSVLKAIDFGLSDFVRPDERLNDIVGSA 326
QIL+ V + H + + H DLKPEN + K+ +K IDFGL+ + +I G+
Sbjct: 123 QILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTP 182
Query: 327 YYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPW 385
+VAPE+++ EAD+WSIGVI YILL G+ PF T+ + FDE +
Sbjct: 183 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFF 242
Query: 386 PSLSSEARDFVKRLLNKDPRKRLTAAQALS 415
S A+DF+++LL K+ RKRLT +AL
Sbjct: 243 SQTSELAKDFIRKLLVKETRKRLTIQEALR 272
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 367 bits (943), Expect = e-126
Identities = 99/271 (36%), Positives = 139/271 (51%), Gaps = 17/271 (6%)
Query: 150 SKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREV 209
S F + YE+ E++G G + K + AVK+I K K D E+
Sbjct: 17 SIQFTDGYEVKEDIGVGSYSVCKRCIHKA---TNMEFAVKIIDKSK-------RDPTEEI 66
Query: 210 KILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQI 269
+IL H N++ D Y+D VYVV EL +GGELLD+IL + ++E +A AV+ I
Sbjct: 67 EILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQ-KFFSEREASAVLFTI 125
Query: 270 LNVVAFCHLQGVVHRDLKPENFLFTTKDEN-SVLKAIDFGLSDFVRPDER-LNDIVGSAY 327
V + H QGVVHRDLKP N L+ + N ++ DFG + +R + L +A
Sbjct: 126 TKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTAN 185
Query: 328 YVAPEVLHRS-YSTEADVWSIGVIAYILLCGSRPFWAR---TESGIFRAVLKADPSFDEA 383
+VAPEVL R Y D+WS+GV+ Y +L G PF T I + S
Sbjct: 186 FVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGG 245
Query: 384 PWPSLSSEARDFVKRLLNKDPRKRLTAAQAL 414
W S+S A+D V ++L+ DP +RLTAA L
Sbjct: 246 YWNSVSDTAKDLVSKMLHVDPHQRLTAALVL 276
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 364 bits (937), Expect = e-125
Identities = 89/276 (32%), Positives = 145/276 (52%), Gaps = 16/276 (5%)
Query: 149 FSKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTT-----AIAIE 203
+ K ++Y + + +G G G A +K ++VA+K+I K K A
Sbjct: 4 YPKALRDEYIMSKTLGSGACGEVKLAFERKT---CKKVAIKIISKRKFAIGSAREADPAL 60
Query: 204 DVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAK 263
+V E++IL+ L H ++K + ++ ++ Y+V+EL EGGEL D+++ + E K
Sbjct: 61 NVETEIEILKKL-NHPCIIKIKNFFD-AEDYYIVLELMEGGELFDKVVGNK-RLKEATCK 117
Query: 264 AVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIV 323
Q+L V + H G++HRDLKPEN L ++++E+ ++K DFG S + + +
Sbjct: 118 LYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLC 177
Query: 324 GSAYYVAPEVL----HRSYSTEADVWSIGVIAYILLCGSRPFWA-RTESGIFRAVLKADP 378
G+ Y+APEVL Y+ D WS+GVI +I L G PF RT+ + +
Sbjct: 178 GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKY 237
Query: 379 SFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQAL 414
+F W +S +A D VK+LL DP+ R T +AL
Sbjct: 238 NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEAL 273
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 363 bits (933), Expect = e-125
Identities = 76/291 (26%), Positives = 126/291 (43%), Gaps = 44/291 (15%)
Query: 134 GSEPEPAAGLNKSFGFSKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPK 193
G + + K+ + + +G G G K+ ++ A+K++
Sbjct: 1 GPHVKSGLQIKKNAIIDDY----KVTSQVLGLGINGKVLQIFNKRT---QEKFALKMLQD 53
Query: 194 HKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT----DNVYVVMELCEGGELLDR 249
RREV++ + ++V+ D YE+ + +VME +GGEL R
Sbjct: 54 --------CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSR 105
Query: 250 ILSRGGK-YTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFG 308
I RG + +TE +A +M I + + H + HRD+KPEN L+T+K N++LK DFG
Sbjct: 106 IQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG 165
Query: 309 LSDFVRPDERLNDIVGSAYYVAPEVLHRSYSTEADVWSIGVIAYILLCGSRPFWA----R 364
A E Y D+WS+GVI YILLCG PF++
Sbjct: 166 F--------------------AKETTGEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA 205
Query: 365 TESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALS 415
G+ + F W +S E + ++ LL +P +R+T + ++
Sbjct: 206 ISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 256
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 358 bits (920), Expect = e-121
Identities = 88/276 (31%), Positives = 145/276 (52%), Gaps = 16/276 (5%)
Query: 149 FSKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTT-----AIAIE 203
+ K ++Y + + +G G G A +K ++VA+++I K K A
Sbjct: 129 YPKALRDEYIMSKTLGSGACGEVKLAFERKT---CKKVAIRIISKRKFAIGSAREADPAL 185
Query: 204 DVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAK 263
+V E++IL+ L H ++K + ++ ++ Y+V+EL EGGEL D+++ + E K
Sbjct: 186 NVETEIEILKKLN-HPCIIKIKNFFDA-EDYYIVLELMEGGELFDKVVGNK-RLKEATCK 242
Query: 264 AVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIV 323
Q+L V + H G++HRDLKPEN L ++++E+ ++K DFG S + + +
Sbjct: 243 LYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLC 302
Query: 324 GSAYYVAPEVL----HRSYSTEADVWSIGVIAYILLCGSRPFWA-RTESGIFRAVLKADP 378
G+ Y+APEVL Y+ D WS+GVI +I L G PF RT+ + +
Sbjct: 303 GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKY 362
Query: 379 SFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQAL 414
+F W +S +A D VK+LL DP+ R T +AL
Sbjct: 363 NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEAL 398
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 317 bits (813), Expect = e-105
Identities = 77/299 (25%), Positives = 130/299 (43%), Gaps = 44/299 (14%)
Query: 149 FSKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRRE 208
F + N + +G G G +G +G+ VAVK + + E
Sbjct: 9 FEQSLKNLVVSEKILGYGSSGTVV----FQGSFQGRPVAVKRMLIDFC------DIALME 58
Query: 209 VKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRG------GKYTEDDA 262
+K+L H N+++++ + +Y+ +ELC L D + S+ E +
Sbjct: 59 IKLLTESDDHPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNP 117
Query: 263 KAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKD----------ENSVLKAIDFGLSDF 312
+++ QI + VA H ++HRDLKP+N L +T EN + DFGL
Sbjct: 118 ISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKK 177
Query: 313 VRPDE-----RLNDIVGSAYYVAPEVL--------HRSYSTEADVWSIGVIAYILLC-GS 358
+ + LN+ G++ + APE+L R + D++S+G + Y +L G
Sbjct: 178 LDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGK 237
Query: 359 RPFWAR--TESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALS 415
PF + ES I R + D SL +EA D + ++++ DP KR TA + L
Sbjct: 238 HPFGDKYSRESNIIRGIFSLDE-MKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 315 bits (808), Expect = e-104
Identities = 67/272 (24%), Positives = 120/272 (44%), Gaps = 25/272 (9%)
Query: 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRAL 215
+ + +G G G +G + VAVK I REV++LR
Sbjct: 25 SFCPKDVLGHGAEGTIV----YRGMFDNRDVAVKRILPECF------SFADREVQLLRES 74
Query: 216 TGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAF 275
H N++++F +D Y+ +ELC L + + + + + ++ Q + +A
Sbjct: 75 DEHPNVIRYFCTEKDRQFQYIAIELC-AATLQEYVEQKDFAHLGLEPITLLQQTTSGLAH 133
Query: 276 CHLQGVVHRDLKPENFLFTTKDENSVLKAI--DFGLSDFVRPDE----RLNDIVGSAYYV 329
H +VHRDLKP N L + + + +KA+ DFGL + R + + G+ ++
Sbjct: 134 LHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWI 193
Query: 330 APEVL----HRSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFD-EA 383
APE+L + + D++S G + Y ++ GS PF + +L S D
Sbjct: 194 APEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQAN--ILLGACSLDCLH 251
Query: 384 PWPSLSSEARDFVKRLLNKDPRKRLTAAQALS 415
P AR+ +++++ DP+KR +A L
Sbjct: 252 PEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 270 bits (693), Expect = 1e-88
Identities = 72/296 (24%), Positives = 127/296 (42%), Gaps = 43/296 (14%)
Query: 150 SKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREV 209
S +A+ +E +G+G FG A+ + A+K I + + + EV
Sbjct: 1 SLRYASDFEEIAVLGQGAFGQVVKARNALD---SRYYAIKKIRHTEE----KLSTILSEV 53
Query: 210 KILRALTGHNNLVKFFDAYEDTDN-------------VYVVMELCEGGELLDRILSRGGK 256
+L +L H +V+++ A+ + N +++ ME CE G L D I S
Sbjct: 54 MLLASLN-HQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLN 112
Query: 257 YTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS------ 310
D+ + QIL +++ H QG++HRDLKP N DE+ +K DFGL+
Sbjct: 113 QQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFI---DESRNVKIGDFGLAKNVHRS 169
Query: 311 ---------DFVRPDERLNDIVGSAYYVAPEVLHRS--YSTEADVWSIGVIAYILLCGSR 359
+ + L +G+A YVA EVL + Y+ + D++S+G+I + ++
Sbjct: 170 LDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP-- 227
Query: 360 PFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALS 415
I + + F + + ++ L++ DP KR A L+
Sbjct: 228 FSTGMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 270 bits (691), Expect = 3e-88
Identities = 70/304 (23%), Positives = 115/304 (37%), Gaps = 49/304 (16%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELK--GQQVAVKVIPKHKMTTAIAIEDVRREVKIL 212
+ + L + +G+G +G K G A+KV + + RE ++L
Sbjct: 9 HLWLLSDILGQGATA-----NVFRGRHKKTGDLFAIKVFNNISFLRPV--DVQMREFEVL 61
Query: 213 RALTGHNNLVKFFDAYED--TDNVYVVMELCEGGELLDRILSRG--GKYTEDDAKAVMIQ 268
+ L H N+VK F E+ T + ++ME C G L + E + V+
Sbjct: 62 KKLN-HKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRD 120
Query: 269 ILNVVAFCHLQGVVHRDLKPENFL-FTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAY 327
++ + G+VHR++KP N + +D SV K DFG + + DE+ + G+
Sbjct: 121 VVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEE 180
Query: 328 YVAPEVL---------HRSYSTEADVWSIGVIAYILLCGSRPFWA----RTESGIFRAVL 374
Y+ P++ + Y D+WSIGV Y GS PF R + ++
Sbjct: 181 YLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII 240
Query: 375 KADP-----------------SFDEAPWPSLSSEARD----FVKRLLNKDPRKRLTAAQA 413
P S D SLS + + +L D K Q
Sbjct: 241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQF 300
Query: 414 LSEL 417
+E
Sbjct: 301 FAET 304
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 265 bits (678), Expect = 3e-85
Identities = 70/304 (23%), Positives = 115/304 (37%), Gaps = 49/304 (16%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELK--GQQVAVKVIPKHKMTTAIAIEDVRREVKIL 212
+ + L + +G+G +G K G A+KV + + RE ++L
Sbjct: 9 HLWLLSDILGQGATA-----NVFRGRHKKTGDLFAIKVFNNISFLRPV--DVQMREFEVL 61
Query: 213 RALTGHNNLVKFFDAYED--TDNVYVVMELCEGGELLDRILSRG--GKYTEDDAKAVMIQ 268
+ L H N+VK F E+ T + ++ME C G L + E + V+
Sbjct: 62 KKLN-HKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRD 120
Query: 269 ILNVVAFCHLQGVVHRDLKPENFL-FTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAY 327
++ + G+VHR++KP N + +D SV K DFG + + DE+ + G+
Sbjct: 121 VVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEE 180
Query: 328 YVAPEVL---------HRSYSTEADVWSIGVIAYILLCGSRPFWA----RTESGIFRAVL 374
Y+ P++ + Y D+WSIGV Y GS PF R + ++
Sbjct: 181 YLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII 240
Query: 375 KADP-----------------SFDEAPWPSLSSEARD----FVKRLLNKDPRKRLTAAQA 413
P S D SLS + + +L D K Q
Sbjct: 241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQF 300
Query: 414 LSEL 417
+E
Sbjct: 301 FAET 304
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 259 bits (664), Expect = 3e-84
Identities = 68/278 (24%), Positives = 121/278 (43%), Gaps = 30/278 (10%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKG-ELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILR 213
Y + +++G G K + K Q A+K + + ++ R E+ L
Sbjct: 28 RIYSILKQIGSGGSS-----KVFQVLNEKKQIYAIKYVNLEEADNQ-TLDSYRNEIAYLN 81
Query: 214 ALTGHN-NLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNV 272
L H+ +++ +D +Y+VME C +L + + + K+ +L
Sbjct: 82 KLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKK-SIDPWERKSYWKNMLEA 139
Query: 273 VAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDER---LNDIVGSAYYV 329
V H G+VH DLKP NFL + +LK IDFG+++ ++PD + VG+ Y+
Sbjct: 140 VHTIHQHGIVHSDLKPANFLIV----DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYM 195
Query: 330 APEVLHRS------------YSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKAD 377
PE + S ++DVWS+G I Y + G PF I + D
Sbjct: 196 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-ISKLHAIID 254
Query: 378 PSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALS 415
P+ + + +D +K L +DP++R++ + L+
Sbjct: 255 PNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 292
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 257 bits (660), Expect = 7e-84
Identities = 84/261 (32%), Positives = 126/261 (48%), Gaps = 18/261 (6%)
Query: 156 KYELGEEVGRGHFGYTCAAKFKKGELK--GQQVAVKVIPKHKMTTAIAIEDVRREVKILR 213
+Y G +G+G F AK + + A K++PK + E + E+ I R
Sbjct: 16 RYVRGRFLGKGGF-----AKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHR 70
Query: 214 ALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVV 273
+L H ++V F +ED D V+VV+ELC LL+ R TE +A+ + QI+
Sbjct: 71 SLA-HQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRK-ALTEPEARYYLRQIVLGC 128
Query: 274 AFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV-RPDERLNDIVGSAYYVAPE 332
+ H V+HRDLK N +E+ +K DFGL+ V ER + G+ Y+APE
Sbjct: 129 QYLHRNRVIHRDLKLGNLFL---NEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPE 185
Query: 333 VL-HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSE 391
VL + +S E DVWSIG I Y LL G PF + + K + S P ++
Sbjct: 186 VLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSI---P-KHINPV 241
Query: 392 ARDFVKRLLNKDPRKRLTAAQ 412
A ++++L DP R T +
Sbjct: 242 AASLIQKMLQTDPTARPTINE 262
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 256 bits (657), Expect = 1e-83
Identities = 83/263 (31%), Positives = 142/263 (53%), Gaps = 13/263 (4%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRA 214
+++G +G+G F A+ G +VA+K+I K M A ++ V+ EVKI
Sbjct: 11 EDFKVGNLLGKGSFAGVYRAESIH---TGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQ 67
Query: 215 LTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVA 274
L H ++++ ++ +ED++ VY+V+E+C GE+ + +R ++E++A+ M QI+ +
Sbjct: 68 LK-HPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGML 126
Query: 275 FCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV-RPDERLNDIVGSAYYVAPEV 333
+ H G++HRDL N L N +K DFGL+ + P E+ + G+ Y++PE+
Sbjct: 127 YLHSHGILHRDLTLSNLLL---TRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEI 183
Query: 334 L-HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEA 392
++ E+DVWS+G + Y LL G PF T V+ AD P LS EA
Sbjct: 184 ATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEM---P-SFLSIEA 239
Query: 393 RDFVKRLLNKDPRKRLTAAQALS 415
+D + +LL ++P RL+ + L
Sbjct: 240 KDLIHQLLRRNPADRLSLSSVLD 262
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 256 bits (656), Expect = 9e-83
Identities = 89/299 (29%), Positives = 131/299 (43%), Gaps = 18/299 (6%)
Query: 118 ARRHGSVKPNEAAIPEGSEPEPAAGLNKSFGFSKHFANKYELGEEVGRGHFGYTCAAKFK 177
G A P P A +Y G +G+G F AK
Sbjct: 4 PADPGKAGVPGVAAPGAPAAAPPAKEIPEVLVDPRSRRRYVRGRFLGKGGF-----AKCF 58
Query: 178 KGELK--GQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVY 235
+ + A K++PK + E + E+ I R+L H ++V F +ED D V+
Sbjct: 59 EISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA-HQHVVGFHGFFEDNDFVF 117
Query: 236 VVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTT 295
VV+ELC LL+ R TE +A+ + QI+ + H V+HRDLK N
Sbjct: 118 VVLELCRRRSLLELHKRRK-ALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFL-- 174
Query: 296 KDENSVLKAIDFGLSDFV-RPDERLNDIVGSAYYVAPEVL-HRSYSTEADVWSIGVIAYI 353
+E+ +K DFGL+ V ER + G+ Y+APEVL + +S E DVWSIG I Y
Sbjct: 175 -NEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYT 233
Query: 354 LLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQ 412
LL G PF + + K + S P ++ A ++++L DP R T +
Sbjct: 234 LLVGKPPFETSCLKETYLRIKKNEYSI---P-KHINPVAASLIQKMLQTDPTARPTINE 288
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 256 bits (655), Expect = 2e-82
Identities = 68/278 (24%), Positives = 121/278 (43%), Gaps = 30/278 (10%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGE-LKGQQVAVKVIPKHKMTTAIAIEDVRREVKILR 213
Y + +++G G K + K Q A+K + + ++ R E+ L
Sbjct: 9 RIYSILKQIGSGGSS-----KVFQVLNEKKQIYAIKYVNLEEADNQ-TLDSYRNEIAYLN 62
Query: 214 ALTGHN-NLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNV 272
L H+ +++ +D +Y+VME C +L + + + K+ +L
Sbjct: 63 KLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKK-SIDPWERKSYWKNMLEA 120
Query: 273 VAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDER---LNDIVGSAYYV 329
V H G+VH DLKP NFL + +LK IDFG+++ ++PD + VG+ Y+
Sbjct: 121 VHTIHQHGIVHSDLKPANFLIV----DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYM 176
Query: 330 APEVLHRS------------YSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKAD 377
PE + S ++DVWS+G I Y + G PF I + D
Sbjct: 177 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-ISKLHAIID 235
Query: 378 PSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALS 415
P+ + + +D +K L +DP++R++ + L+
Sbjct: 236 PNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 273
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 252 bits (645), Expect = 2e-80
Identities = 73/328 (22%), Positives = 131/328 (39%), Gaps = 36/328 (10%)
Query: 105 PPPSPAKHIKAVLARRHGSVKPNEAAIPEGSEPEPAAGLNKSFGFSKHFANKYELGEEVG 164
P S K A + P+ + + + Y + +++G
Sbjct: 12 PRGSGMKETAA------AKFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSILKQIG 65
Query: 165 RGHFGYTCAAKFKKGE-LKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHN-NLV 222
G K + K Q A+K + + ++ R E+ L L H+ ++
Sbjct: 66 SGGSS-----KVFQVLNEKKQIYAIKYVNLEEADNQ-TLDSYRNEIAYLNKLQQHSDKII 119
Query: 223 KFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVV 282
+ +D +Y+VME C +L + + + K+ +L V H G+V
Sbjct: 120 RLYDYEITDQYIYMVME-CGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQHGIV 177
Query: 283 HRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDER---LNDIVGSAYYVAPEVLHRS-- 337
H DLKP NFL + +LK IDFG+++ ++PD + VG+ Y+ PE +
Sbjct: 178 HSDLKPANFLIV----DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSS 233
Query: 338 ----------YSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPS 387
S ++DVWS+G I Y + G PF I + DP+ +
Sbjct: 234 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-ISKLHAIIDPNHEIEFPDI 292
Query: 388 LSSEARDFVKRLLNKDPRKRLTAAQALS 415
+ +D +K L +DP++R++ + L+
Sbjct: 293 PEKDLQDVLKCCLKRDPKQRISIPELLA 320
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 248 bits (636), Expect = 9e-80
Identities = 87/261 (33%), Positives = 143/261 (54%), Gaps = 19/261 (7%)
Query: 156 KYELGEEVGRGHFGYTCAAKFKKGE--LKGQQVAVKVIPKHKMTTAIAIEDVRREVKILR 213
Y L + +G+G+F K K L G++VA+K+I K ++ +++ + REV+I++
Sbjct: 16 NYRLLKTIGKGNFA-----KVKLARHILTGREVAIKIIDKTQLNPT-SLQKLFREVRIMK 69
Query: 214 ALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVV 273
L H N+VK F+ E +Y++ME GGE+ D +++ G + E +A++ QI++ V
Sbjct: 70 ILN-HPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHG-RMKEKEARSKFRQIVSAV 127
Query: 274 AFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEV 333
+CH + +VHRDLK EN L D + +K DFG S+ +L+ G+ Y APE+
Sbjct: 128 QYCHQKRIVHRDLKAENLLL---DADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPEL 184
Query: 334 LH-RSYS-TEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSE 391
+ Y E DVWS+GVI Y L+ GS PF + + VL+ + + +S++
Sbjct: 185 FQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGK--YRIPFY--MSTD 240
Query: 392 ARDFVKRLLNKDPRKRLTAAQ 412
+ +KR L +P KR T Q
Sbjct: 241 CENLLKRFLVLNPIKRGTLEQ 261
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 242 bits (621), Expect = 3e-78
Identities = 97/277 (35%), Positives = 138/277 (49%), Gaps = 20/277 (7%)
Query: 156 KYELGEEVGRGHFGYTCAAKFKKGE--LKGQQVAVKVIPKHKMTTAIAIEDVRREVKILR 213
Y LG+ +G G FG K K GE L G +VAVK++ + K+ + + ++RE++ L+
Sbjct: 12 HYVLGDTLGVGTFG-----KVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLK 66
Query: 214 ALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVV 273
H +++K + + ++VME GGEL D I G + E +A+ + QIL+ V
Sbjct: 67 LFR-HPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHG-RVEEMEARRLFQQILSAV 124
Query: 274 AFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEV 333
+CH VVHRDLKPEN L D + K DFGLS+ + E L GS Y APEV
Sbjct: 125 DYCHRHMVVHRDLKPENVLL---DAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEV 181
Query: 334 L-HRSYS-TEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSE 391
+ R Y+ E D+WS GVI Y LLCG+ PF +F+ + F + L+
Sbjct: 182 ISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGV--FYIPEY--LNRS 237
Query: 392 ARDFVKRLLNKDPRKRLTAAQALSE--LLICYQSYLF 426
+ +L DP KR T SYLF
Sbjct: 238 VATLLMHMLQVDPLKRATIKDIREHEWFKQDLPSYLF 274
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 242 bits (621), Expect = 3e-78
Identities = 78/261 (29%), Positives = 133/261 (50%), Gaps = 14/261 (5%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRA 214
+E+G +G+G FG A+ K+ +A+KV+ K ++ A +RREV+I
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQ---SKFILALKVLFKAQLEKAGVEHQLRREVEIQSH 65
Query: 215 LTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVA 274
L H N+++ + + D VY+++E G + L + K+ E + ++ N ++
Sbjct: 66 LR-HPNILRLYGYFHDATRVYLILEYAPLGTVYRE-LQKLSKFDEQRTATYITELANALS 123
Query: 275 FCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVL 334
+CH + V+HRD+KPEN L LK DFG S P R D+ G+ Y+ PE++
Sbjct: 124 YCHSKRVIHRDIKPENLLL---GSAGELKIADFGWSVHA-PSSRRTDLCGTLDYLPPEMI 179
Query: 335 -HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEAR 393
R + + D+WS+GV+ Y L G PF A T ++ + + + +F P ++ AR
Sbjct: 180 EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTF---P-DFVTEGAR 235
Query: 394 DFVKRLLNKDPRKRLTAAQAL 414
D + RLL +P +R + L
Sbjct: 236 DLISRLLKHNPSQRPMLREVL 256
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 252 bits (644), Expect = 3e-77
Identities = 65/288 (22%), Positives = 118/288 (40%), Gaps = 39/288 (13%)
Query: 156 KYELGEEVGRGHFGYTCAAKFKKGELK--GQQVAVKVIPKHKMTTAIAIEDVRREVKILR 213
+E+ E +G G FG + + G+QVA+K + E E++I++
Sbjct: 15 PWEMKERLGTGGFG-----YVLRWIHQDTGEQVAIKQCRQELSPKNR--ERWCLEIQIMK 67
Query: 214 ALTGHNNLVKFFDAYED------TDNVYVVMELCEGGELLDRILSRG--GKYTEDDAKAV 265
L H N+V + + D + ME CEGG+L + E + +
Sbjct: 68 KLN-HPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTL 126
Query: 266 MIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGS 325
+ I + + + H ++HRDLKPEN + + + K ID G + + E + VG+
Sbjct: 127 LSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGT 186
Query: 326 AYYVAPEVL-HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAP 384
Y+APE+L + Y+ D WS G +A+ + G RPF + + ++ +
Sbjct: 187 LQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVV 246
Query: 385 W--------------------PSLSSEARDFVKRLLNKDPRKRLTAAQ 412
+ L+ + +++ +L R+R T Q
Sbjct: 247 YDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQ 294
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 243 bits (622), Expect = 3e-77
Identities = 55/354 (15%), Positives = 100/354 (28%), Gaps = 63/354 (17%)
Query: 100 FKRPFPPPSPAKHIKAVLARRHGSVKPNEAAIPEGSEPEPAAGLNKSFGFSKHFANKYEL 159
+ R PA ++AV P+ +E + L++ K +L
Sbjct: 24 YCREEALKEPAAMVEAV----------TATVWPQNAETTVDSLLSQG-------ERKLKL 66
Query: 160 GEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHN 219
E + G + + + A+KV + +E + L G +
Sbjct: 67 VEPLRVGDRSVVFLVRDVER---LEDFALKVFTMGAENSRSELERLHEATFAAARLLGES 123
Query: 220 -----------------------NLVKFFDAYEDTD--NVYVVMELCEG-----GELLDR 249
+ +D N ++M LD
Sbjct: 124 PEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDF 183
Query: 250 ILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGL 309
+ G + Q++ + A +G+VH P+N + L D
Sbjct: 184 VYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFI---MPDGRLMLGDVSA 240
Query: 310 SDFVRPDERLNDIVGSAYYVAPEVLHRS---YSTEADVWSIGVIAYILLCGSRPFWARTE 366
+ R Y E L+ S ++ + W +G+ Y + C PF T
Sbjct: 241 L--WKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTP 298
Query: 367 SGIFRAVLKAD-----PSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALS 415
+ S L + + R LN D R+RL +A+
Sbjct: 299 GIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 239 bits (611), Expect = 1e-76
Identities = 77/263 (29%), Positives = 127/263 (48%), Gaps = 18/263 (6%)
Query: 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRAL 215
++L + +G G +G + + + VAVK++ + E++++E+ I + L
Sbjct: 8 DWDLVQTLGEGAYG---EVQLAVNRVTEEAVAVKIVDMKRAVDCP--ENIKKEICINKML 62
Query: 216 TGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAF 275
H N+VKF+ + + Y+ +E C GGEL DRI E DA+ Q++ V +
Sbjct: 63 N-HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI-GMPEPDAQRFFHQLMAGVVY 120
Query: 276 CHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP---DERLNDIVGSAYYVAPE 332
H G+ HRD+KPEN L DE LK DFGL+ R + LN + G+ YVAPE
Sbjct: 121 LHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177
Query: 333 VL-HRSYS-TEADVWSIGVIAYILLCGSRPFWARTES-GIFRAVLKADPSFDEAPWPSLS 389
+L R + DVWS G++ +L G P+ ++S + + PW +
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK--TYLNPWKKID 235
Query: 390 SEARDFVKRLLNKDPRKRLTAAQ 412
S + ++L ++P R+T
Sbjct: 236 SAPLALLHKILVENPSARITIPD 258
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 238 bits (610), Expect = 2e-76
Identities = 77/288 (26%), Positives = 133/288 (46%), Gaps = 41/288 (14%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKM------------------ 196
N+Y L +E+G+G +G K E A+KV+ K K+
Sbjct: 13 NQYTLKDEIGKGSYG---VVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPA 69
Query: 197 -----TTAIAIEDVRREVKILRALTGHNNLVKFFDAYED--TDNVYVVMELCEGGELLDR 249
IE V +E+ IL+ L H N+VK + +D D++Y+V EL G +++
Sbjct: 70 PGGCIQPRGPIEQVYQEIAILKKLD-HPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEV 128
Query: 250 ILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGL 309
+ED A+ ++ + + H Q ++HRD+KP N L E+ +K DFG+
Sbjct: 129 P--TLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLV---GEDGHIKIADFGV 183
Query: 310 S-DFVRPDERLNDIVGSAYYVAPEVL---HRSYS-TEADVWSIGVIAYILLCGSRPFWAR 364
S +F D L++ VG+ ++APE L + +S DVW++GV Y + G PF
Sbjct: 184 SNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDE 243
Query: 365 TESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQ 412
+ + F + P ++ + +D + R+L+K+P R+ +
Sbjct: 244 RIMCLHSKIKSQALEFPD--QPDIAEDLKDLITRMLDKNPESRIVVPE 289
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 237 bits (607), Expect = 5e-76
Identities = 73/259 (28%), Positives = 132/259 (50%), Gaps = 14/259 (5%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRA 214
+ +++G +G+G FG A+ K+ +A+KV+ K ++ +RRE++I
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQ---NKFIMALKVLFKSQLEKEGVEHQLRREIEIQSH 70
Query: 215 LTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVA 274
L H N+++ ++ + D +Y+++E GEL L + G++ E + M ++ + +
Sbjct: 71 LR-HPNILRMYNYFHDRKRIYLMLEFAPRGELYKE-LQKHGRFDEQRSATFMEELADALH 128
Query: 275 FCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVL 334
+CH + V+HRD+KPEN L LK DFG S P R + G+ Y+ PE++
Sbjct: 129 YCHERKVIHRDIKPENLLM---GYKGELKIADFGWSVHA-PSLRRRTMCGTLDYLPPEMI 184
Query: 335 -HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEAR 393
+++ + D+W GV+ Y L G PF + + + R ++ D F P P LS ++
Sbjct: 185 EGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKF---P-PFLSDGSK 240
Query: 394 DFVKRLLNKDPRKRLTAAQ 412
D + +LL P +RL
Sbjct: 241 DLISKLLRYHPPQRLPLKG 259
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 237 bits (607), Expect = 1e-75
Identities = 76/287 (26%), Positives = 109/287 (37%), Gaps = 20/287 (6%)
Query: 132 PEGSEPEPAAGLNKSFGFSKHFANKYELGEEVGRGHFG--YTCAAKFKKGELKGQQVAVK 189
E SE + G + S S F ++ +G G +G + K + G+ AVK
Sbjct: 35 GEASETLQSPGYDPSRPES-FFQQSFQRLSRLGHGSYGEVFKV---RSKED--GRLYAVK 88
Query: 190 VIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDR 249
EV + H V+ A+E+ +Y+ ELC G L
Sbjct: 89 RSMSPFRGPK-DRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQH 146
Query: 250 ILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGL 309
+ G E + L +A H QG+VH D+KP N K DFGL
Sbjct: 147 CEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFL---GPRGRCKLGDFGL 203
Query: 310 SDFVRPDERLNDIVGSAYYVAPEVLHRSYSTEADVWSIGVIAYILLCG-SRPFWARTESG 368
+ G Y+APE+L SY T ADV+S+G+ + C P
Sbjct: 204 LVELGTAGAGEVQEGDPRYMAPELLQGSYGTAADVFSLGLTILEVACNMELPHGGEGWQQ 263
Query: 369 IFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALS 415
+ + L P F LSSE R + +L DP+ R TA L+
Sbjct: 264 LRQGYLP--PEF----TAGLSSELRSVLVMMLEPDPKLRATAEALLA 304
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 238 bits (609), Expect = 1e-75
Identities = 84/261 (32%), Positives = 133/261 (50%), Gaps = 19/261 (7%)
Query: 156 KYELGEEVGRGHFGYTCAAKFKKGE--LKGQQVAVKVIPKHKMTTAIAIEDVRREVKILR 213
Y + E +G G FG K K Q+VA+K I + + + V RE+ L+
Sbjct: 10 PYIIRETLGEGSFG-----KVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLK 64
Query: 214 ALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVV 273
L H +++K +D ++ +V+E GGEL D I+ + + TED+ + QI+ +
Sbjct: 65 LLR-HPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKK-RMTEDEGRRFFQQIICAI 121
Query: 274 AFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEV 333
+CH +VHRDLKPEN L D+N +K DFGLS+ + L GS Y APEV
Sbjct: 122 EYCHRHKIVHRDLKPENLLL---DDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEV 178
Query: 334 L-HRSYS-TEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSE 391
+ + Y+ E DVWS G++ Y++L G PF +F+ V + + LS
Sbjct: 179 INGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCV--YVMPDF--LSPG 234
Query: 392 ARDFVKRLLNKDPRKRLTAAQ 412
A+ ++R++ DP +R+T +
Sbjct: 235 AQSLIRRMIVADPMQRITIQE 255
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 237 bits (607), Expect = 1e-75
Identities = 77/263 (29%), Positives = 127/263 (48%), Gaps = 18/263 (6%)
Query: 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRAL 215
++L + +G G +G + + + VAVK++ + E++++E+ I + L
Sbjct: 8 DWDLVQTLGEGAYG---EVQLAVNRVTEEAVAVKIVDMKRAVDCP--ENIKKEICINKML 62
Query: 216 TGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAF 275
H N+VKF+ + + Y+ +E C GGEL DRI E DA+ Q++ V +
Sbjct: 63 N-HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI-GMPEPDAQRFFHQLMAGVVY 120
Query: 276 CHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP---DERLNDIVGSAYYVAPE 332
H G+ HRD+KPEN L DE LK DFGL+ R + LN + G+ YVAPE
Sbjct: 121 LHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177
Query: 333 VL-HRSYS-TEADVWSIGVIAYILLCGSRPFWARTES-GIFRAVLKADPSFDEAPWPSLS 389
+L R + DVWS G++ +L G P+ ++S + + PW +
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK--TYLNPWKKID 235
Query: 390 SEARDFVKRLLNKDPRKRLTAAQ 412
S + ++L ++P R+T
Sbjct: 236 SAPLALLHKILVENPSARITIPD 258
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 241 bits (616), Expect = 4e-75
Identities = 93/261 (35%), Positives = 136/261 (52%), Gaps = 18/261 (6%)
Query: 156 KYELGEEVGRGHFGYTCAAKFKKGE--LKGQQVAVKVIPKHKMTTAIAIEDVRREVKILR 213
Y LG+ +G G FG K K G+ L G +VAVK++ + K+ + + +RRE++ L+
Sbjct: 17 HYILGDTLGVGTFG-----KVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLK 71
Query: 214 ALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVV 273
H +++K + ++++VME GGEL D I G + E +++ + QIL+ V
Sbjct: 72 LFR-HPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNG-RLDEKESRRLFQQILSGV 129
Query: 274 AFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEV 333
+CH VVHRDLKPEN L D + K DFGLS+ + E L GS Y APEV
Sbjct: 130 DYCHRHMVVHRDLKPENVLL---DAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEV 186
Query: 334 L-HRSYS-TEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSE 391
+ R Y+ E D+WS GVI Y LLCG+ PF +F+ + F + L+
Sbjct: 187 ISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGI--FYTPQY--LNPS 242
Query: 392 ARDFVKRLLNKDPRKRLTAAQ 412
+K +L DP KR T
Sbjct: 243 VISLLKHMLQVDPMKRATIKD 263
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 233 bits (597), Expect = 3e-74
Identities = 80/298 (26%), Positives = 128/298 (42%), Gaps = 35/298 (11%)
Query: 126 PNEAAIPEGSEPEPAAGLNKSFGFSKHFANKYELGEEVGRGHFGYTCAAKFKKGE--LKG 183
P G+ P G ++ + F +Y LG +G+G FG G
Sbjct: 7 LQGPPAPPGTPTPPPGGKDR-----EAFEAEYRLGPLLGKGGFG-----TVFAGHRLTDR 56
Query: 184 QQVAVKVIPKHKMTTAIAIED---VRREVKILRAL---TGHNNLVKFFDAYEDTDNVYVV 237
QVA+KVIP++++ + D EV +L + GH +++ D +E + +V
Sbjct: 57 LQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLV 116
Query: 238 MEL-CEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTK 296
+E +L D I +G E ++ Q++ + CH +GVVHRD+K EN L +
Sbjct: 117 LERPLPAQDLFDYITEKG-PLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLR 175
Query: 297 DENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVL-HRSYS-TEADVWSIGVIAYIL 354
K IDFG + DE D G+ Y PE + Y A VWS+G++ Y +
Sbjct: 176 RGC--AKLIDFGSGALL-HDEPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDM 232
Query: 355 LCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQ 412
+CG PF + I A L P+ +S + ++R L P R + +
Sbjct: 233 VCGDIPF--ERDQEILEAELH-FPAH-------VSPDCCALIRRCLAPKPSSRPSLEE 280
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 234 bits (600), Expect = 4e-74
Identities = 85/265 (32%), Positives = 136/265 (51%), Gaps = 22/265 (8%)
Query: 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRAL 215
+Y+ +++G G+FG A+ + +L + VAVK I + E+V+RE+ R+L
Sbjct: 21 RYDFVKDIGSGNFG---VARLMRDKLTKELVAVKYIERGAAID----ENVQREIINHRSL 73
Query: 216 TGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAF 275
H N+V+F + ++ ++ME GGEL +RI + G +++ED+A+ Q+L+ V++
Sbjct: 74 R-HPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAG-RFSEDEARFFFQQLLSGVSY 131
Query: 276 CHLQGVVHRDLKPENFLFTTKDENSV--LKAIDFGLSDFVRPDERLNDIVGSAYYVAPEV 333
CH + HRDLK EN L D + LK DFG S + VG+ Y+APEV
Sbjct: 132 CHSMQICHRDLKLENTLL---DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 188
Query: 334 L-HRSYS-TEADVWSIGVIAYILLCGSRPFWARTESGIFR----AVLKADPSFDEAPWPS 387
L + Y ADVWS GV Y++L G+ PF E +R +L S +
Sbjct: 189 LLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIR-- 246
Query: 388 LSSEARDFVKRLLNKDPRKRLTAAQ 412
+S E + R+ DP R++ +
Sbjct: 247 ISPECCHLISRIFVADPATRISIPE 271
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 233 bits (596), Expect = 1e-73
Identities = 79/289 (27%), Positives = 118/289 (40%), Gaps = 34/289 (11%)
Query: 136 EPEPAAGLNKSFGFSKHFANKYELGEEVGRGHFGYTCAAKFKKGE--LKGQQVAVKVIPK 193
EP A L ++ KY +G G FG K ++V VK I K
Sbjct: 5 EPPKAVELEGLAACEGEYSQKYSTMSPLGSGAFG-----FVWTAVDKEKNKEVVVKFIKK 59
Query: 194 HKMTTAIAIED-----VRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMEL-CEGGELL 247
K+ IED V E+ IL + H N++K D +E+ +VME G +L
Sbjct: 60 EKVLEDCWIEDPKLGKVTLEIAILSRVE-HANIIKVLDIFENQGFFQLVMEKHGSGLDLF 118
Query: 248 DRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDF 307
I + E A + Q+++ V + L+ ++HRD+K EN + E+ +K IDF
Sbjct: 119 AFIDRHP-RLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVI---AEDFTIKLIDF 174
Query: 308 GLSDFVRPDERLNDIVGSAYYVAPEVLH-RSYS-TEADVWSIGVIAYILLCGSRPF--WA 363
G + ++ + G+ Y APEVL Y E ++WS+GV Y L+ PF
Sbjct: 175 GSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELE 234
Query: 364 RTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQ 412
T P +S E V LL P +R T +
Sbjct: 235 ETVEAAIH-----PPYL-------VSKELMSLVSGLLQPVPERRTTLEK 271
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 232 bits (594), Expect = 1e-73
Identities = 80/309 (25%), Positives = 133/309 (43%), Gaps = 32/309 (10%)
Query: 117 LARRHGSVKPNEAAIPEGSEPEPAAGLNKSFGFSKH----FANKYELGEEVGRGHFGYTC 172
+ H + +P GS P L+ + ++Y++G +G G FG
Sbjct: 1 MGSSHHHHHHSSGLVPRGSHMAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFG--- 57
Query: 173 AAKFKKGE--LKGQQVAVKVIPKHKMTTAIAIED---VRREVKILRALT-GHNNLVKFFD 226
G VA+K + K +++ + + V EV +L+ ++ G + +++ D
Sbjct: 58 --SVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLD 115
Query: 227 AYEDTDNVYVVMELCEG-GELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRD 285
+E D+ +++E E +L D I RG E+ A++ Q+L V CH GV+HRD
Sbjct: 116 WFERPDSFVLILERPEPVQDLFDFITERG-ALQEELARSFFWQVLEAVRHCHNCGVLHRD 174
Query: 286 LKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVL-HRSYS-TEAD 343
+K EN L LK IDFG + D D G+ Y PE + + Y A
Sbjct: 175 IKDENILIDLNRGE--LKLIDFGSGALL-KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAA 231
Query: 344 VWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKD 403
VWS+G++ Y ++CG PF + I R + +SSE + ++ L
Sbjct: 232 VWSLGILLYDMVCGDIPF--EHDEEIIRGQVF-FRQR-------VSSECQHLIRWCLALR 281
Query: 404 PRKRLTAAQ 412
P R T +
Sbjct: 282 PSDRPTFEE 290
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 233 bits (595), Expect = 2e-73
Identities = 67/331 (20%), Positives = 124/331 (37%), Gaps = 51/331 (15%)
Query: 126 PNEAAIPEGSEPEPAAGLNKSFGFSKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQ 185
P + S LNK + N Y + + +G F K E +
Sbjct: 2 PLGSMKDILSNYSNLIYLNKYVKEKDKYINDYRIIRTLNQGKFN-----KIILCEKDNKF 56
Query: 186 VAVKVIPKH--------------KMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231
A+K K K++ +D + E++I+ + + + +
Sbjct: 57 YALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIK-NEYCLTCEGIITNY 115
Query: 232 DNVYVVMELCEGGELLDRILSRG-------GKYTEDDAKAVMIQILNVVAFCHLQ-GVVH 283
D VY++ E E +L K ++ +LN ++ H + + H
Sbjct: 116 DEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICH 175
Query: 284 RDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRS---YST 340
RD+KP N L D+N +K DFG S+++ D+++ G+ ++ PE
Sbjct: 176 RDVKPSNILM---DKNGRVKLSDFGESEYM-VDKKIKGSRGTYEFMPPEFFSNESSYNGA 231
Query: 341 EADVWSIGVIAYILLCGSRPFWA-RTESGIFRAVLKADPSF---------------DEAP 384
+ D+WS+G+ Y++ PF + +F + + +
Sbjct: 232 KVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCS 291
Query: 385 WPSLSSEARDFVKRLLNKDPRKRLTAAQALS 415
LS+E DF+K L K+P +R+T+ AL
Sbjct: 292 NNFLSNEDIDFLKLFLRKNPAERITSEDALK 322
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 229 bits (587), Expect = 4e-73
Identities = 78/274 (28%), Positives = 125/274 (45%), Gaps = 25/274 (9%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRA 214
YE+ +G G +G + K G+ + K + MT A + + EV +LR
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSD---GKILVWKELDYGSMTEA-EKQMLVSEVNLLRE 61
Query: 215 LTGHNNLVKFFDAYEDTDN--VYVVMELCEGGELLDRI--LSRGGKY-TEDDAKAVMIQI 269
L H N+V+++D D N +Y+VME CEGG+L I ++ +Y E+ VM Q+
Sbjct: 62 LK-HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQL 120
Query: 270 LNVVAFCH-----LQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERL-NDIV 323
+ CH V+HRDLKP N +K DFGL+ + D V
Sbjct: 121 TLALKECHRRSDGGHTVLHRDLKPANVFLD---GKQNVKLGDFGLARILNHDTSFAKTFV 177
Query: 324 GSAYYVAPEVL-HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDE 382
G+ YY++PE + SY+ ++D+WS+G + Y L PF A ++ + + +
Sbjct: 178 GTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFR--- 234
Query: 383 APWPSL-SSEARDFVKRLLNKDPRKRLTAAQALS 415
P S E + + R+LN R + + L
Sbjct: 235 -RIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 267
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 227 bits (581), Expect = 2e-71
Identities = 73/265 (27%), Positives = 134/265 (50%), Gaps = 16/265 (6%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRA 214
KY +++G G FG K + G+Q +K I +M++ E+ RREV +L
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTED---GRQYVIKEINISRMSSK-EREESRREVAVLAN 79
Query: 215 LTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKY-TEDDAKAVMIQILNVV 273
+ H N+V++ +++E+ ++Y+VM+ CEGG+L RI ++ G ED +QI +
Sbjct: 80 MK-HPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLAL 138
Query: 274 AFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDERLNDIVGSAYYVAPE 332
H + ++HRD+K +N +F TKD ++ DFG++ E +G+ YY++PE
Sbjct: 139 KHVHDRKILHRDIKSQN-IFLTKDGT--VQLGDFGIARVLNSTVELARACIGTPYYLSPE 195
Query: 333 VL-HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPS-LSS 390
+ ++ Y+ ++D+W++G + Y L F A + + ++ P S
Sbjct: 196 ICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSF----PPVSLHYSY 251
Query: 391 EARDFVKRLLNKDPRKRLTAAQALS 415
+ R V +L ++PR R + L
Sbjct: 252 DLRSLVSQLFKRNPRDRPSVNSILE 276
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 224 bits (572), Expect = 1e-70
Identities = 71/270 (26%), Positives = 120/270 (44%), Gaps = 28/270 (10%)
Query: 156 KYELGEEVGRGHFGYTCAAKFKKGE--LKGQQVAVKVIPKHKMTTAIAIED-VRREVKIL 212
KY +G+ +G G +G K K+ + AVK++ K K+ E V++E+++L
Sbjct: 6 KYLMGDLLGEGSYG-----KVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLL 60
Query: 213 RALTGHNNLVKFFD--AYEDTDNVYVVMELCEGG--ELLDRILSRGGKYTEDDAKAVMIQ 268
R L H N+++ D E+ +Y+VME C G E+LD + ++ A Q
Sbjct: 61 RRLR-HKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPE--KRFPVCQAHGYFCQ 117
Query: 269 ILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS---DFVRPDERLNDIVGS 325
+++ + + H QG+VH+D+KP N L LK G++ D+ GS
Sbjct: 118 LIDGLEYLHSQGIVHKDIKPGNLLL---TTGGTLKISALGVAEALHPFAADDTCRTSQGS 174
Query: 326 AYYVAPEVL--HRSYS-TEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDE 382
+ PE+ ++S + D+WS GV Y + G PF +F + K +
Sbjct: 175 PAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGS--YAI 232
Query: 383 APWPSLSSEARDFVKRLLNKDPRKRLTAAQ 412
D +K +L +P KR + Q
Sbjct: 233 PGD--CGPPLSDLLKGMLEYEPAKRFSIRQ 260
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 226 bits (577), Expect = 2e-70
Identities = 46/303 (15%), Positives = 91/303 (30%), Gaps = 60/303 (19%)
Query: 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRAL 215
G +G+ A ++ G+ V V + + AI+ ++ EV LR L
Sbjct: 74 TLVRGTVLGQEDPYAYLEATDQET---GESFEVHVPYFTERPPSNAIKQMKEEVLRLRLL 130
Query: 216 ------------------------TGHNNLVKFFDAYEDTD--NVYVVMELCEG-----G 244
+++ D + + + + G
Sbjct: 131 RGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFG 190
Query: 245 ELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKA 304
E+L S + +Q++ ++A H G+VH L+P + + D+ +
Sbjct: 191 EVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVL---DQRGGVFL 247
Query: 305 IDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRS------------YSTEADVWSIGVIAY 352
F D S + PE+ R + D W++G++ Y
Sbjct: 248 TGFEHL---VRDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIY 304
Query: 353 ILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQ 412
+ C P G + + ++ R ++ L RL Q
Sbjct: 305 WIWCADLPITKDAALGGSEWIFR--------SCKNIPQPVRALLEGFLRYPKEDRLLPLQ 356
Query: 413 ALS 415
A+
Sbjct: 357 AME 359
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 220 bits (562), Expect = 3e-69
Identities = 67/287 (23%), Positives = 119/287 (41%), Gaps = 40/287 (13%)
Query: 151 KHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVK 210
K F ++ E +G G FG AK + G+ +K + + E REVK
Sbjct: 7 KRFGMDFKEIELIGSGGFGQVFKAKHRI---DGKTYVIKRVKYNN-------EKAEREVK 56
Query: 211 ILRALTGHNNLVKFFDAYEDTD----------------NVYVVMELCEGGELLDRILSRG 254
L L H N+V + ++ D +++ ME C+ G L I R
Sbjct: 57 ALAKLD-HVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR 115
Query: 255 GKY-TEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313
G+ + A + QI V + H + +++RDLKP N + +K DFGL +
Sbjct: 116 GEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLV---DTKQVKIGDFGLVTSL 172
Query: 314 RPDERLNDIVGSAYYVAPEVL-HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRA 372
+ D + G+ Y++PE + + Y E D++++G+I LL + ++ F
Sbjct: 173 KNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSK--FFTD 230
Query: 373 VLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLI 419
+ S + + +++LL+K P R ++ L L +
Sbjct: 231 LRDGIIS------DIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTV 271
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 212 bits (541), Expect = 8e-66
Identities = 71/298 (23%), Positives = 132/298 (44%), Gaps = 18/298 (6%)
Query: 125 KPNEAAIPEGSEPEPAAGLNKSFGFSKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQ 184
+ P + +P L G++ + + +++GRG F A G
Sbjct: 4 QSQGMQGPPVPQFQPQKALRPDMGYNT--LANFRIEKKIGRGQFSEVYRAACLLD---GV 58
Query: 185 QVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGG 244
VA+K + + A A D +E+ +L+ L H N++K++ ++ + + + +V+EL + G
Sbjct: 59 PVALKKVQIFDLMDAKARADCIKEIDLLKQLN-HPNVIKYYASFIEDNELNIVLELADAG 117
Query: 245 ELLDRI---LSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSV 301
+L I + E +Q+ + + H + V+HRD+KP N +F T V
Sbjct: 118 DLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPAN-VFITAT--GV 174
Query: 302 LKAIDFGLS-DFVRPDERLNDIVGSAYYVAPEVL-HRSYSTEADVWSIGVIAYILLCGSR 359
+K D GL F + +VG+ YY++PE + Y+ ++D+WS+G + Y +
Sbjct: 175 VKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQS 234
Query: 360 PFWARTES--GIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALS 415
PF+ + + + + + D + P S E R V +N DP KR
Sbjct: 235 PFYGDKMNLYSLCKKIEQCD--YPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYD 290
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 209 bits (534), Expect = 1e-64
Identities = 61/283 (21%), Positives = 102/283 (36%), Gaps = 32/283 (11%)
Query: 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRAL 215
Y +++G G F Y + G A+K I H+ E+ +RE + R
Sbjct: 30 HYLFIQKLGEGGFSYVDLVEGLHD---GHFYALKRILCHEQQ---DREEAQREADMHRLF 83
Query: 216 TGHNNLVKFFDAYEDTDN----VYVVMELCEGGELLDRI---LSRGGKYTEDDAKAVMIQ 268
H N+++ ++++ + G L + I +G TED +++
Sbjct: 84 -NHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLG 142
Query: 269 ILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPD----------ER 318
I + H +G HRDLKP N L + +D G + +
Sbjct: 143 ICRGLEAIHAKGYAHRDLKPTNILL---GDEGQPVLMDLGSMNQACIHVEGSRQALTLQD 199
Query: 319 LNDIVGSAYYVAPEVL----HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVL 374
+ Y APE+ H DVWS+G + Y ++ G P+ + G A L
Sbjct: 200 WAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVA-L 258
Query: 375 KADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSEL 417
P SS + ++ DP +R LS+L
Sbjct: 259 AVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQL 301
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 200 bits (510), Expect = 2e-61
Identities = 78/290 (26%), Positives = 121/290 (41%), Gaps = 42/290 (14%)
Query: 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKIL 212
+ +E + +GRG FG AK K A+K I A E V REVK L
Sbjct: 3 YLTDFEPIQCLGRGGFGVVFEAKNKVD---DCNYAIKRIRLPNRELAR--EKVMREVKAL 57
Query: 213 RALTGHNNLVKFFDAYEDTDN------------VYVVMELCEGGELLDRILSRGGKYT-- 258
L H +V++F+A+ + + +Y+ M+LC L D + R
Sbjct: 58 AKLE-HPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERE 116
Query: 259 EDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS-------- 310
+ +QI V F H +G++HRDLKP N FT + V+K DFGL
Sbjct: 117 RSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFT---MDDVVKVGDFGLVTAMDQDEE 173
Query: 311 -----DFVRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWAR 364
+ R VG+ Y++PE +H SYS + D++S+G+I + LL PF +
Sbjct: 174 EQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQ 230
Query: 365 TESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQAL 414
E ++ + F V+ +L+ P +R A +
Sbjct: 231 MERVRTLTDVR-NLKFPPLF-TQKYPCEYVMVQDMLSPSPMERPEAINII 278
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 196 bits (500), Expect = 2e-59
Identities = 59/291 (20%), Positives = 113/291 (38%), Gaps = 45/291 (15%)
Query: 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRAL 215
+ + + G F + A+ G++ A+K + ++ + +EV ++ L
Sbjct: 29 RLRVRRVLAEGGFAFVYEAQDVGS---GREYALKRLLSNEEE---KNRAIIQEVCFMKKL 82
Query: 216 TGHNNLVKFFDAY--------EDTDNVYVVMELCEGGELLDRILSR--GGKYTEDDAKAV 265
+GH N+V+F A ++ ELC+G L++ + G + D +
Sbjct: 83 SGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQ-LVEFLKKMESRGPLSCDTVLKI 141
Query: 266 MIQILNVVAFCHLQG--VVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPD------- 316
Q V H Q ++HRDLK EN L +K DFG + +
Sbjct: 142 FYQTCRAVQHMHRQKPPIIHRDLKVENLLL---SNQGTIKLCDFGSATTISHYPDYSWSA 198
Query: 317 ------ERLNDIVGSAYYVAPEVL----HRSYSTEADVWSIGVIAYILLCGSRPFWARTE 366
E + Y PE++ + + D+W++G I Y+L PF E
Sbjct: 199 QRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPF----E 254
Query: 367 SGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSEL 417
G ++ + P + + ++ +L +P +RL+ A+ + +L
Sbjct: 255 DGAKLRIVNG--KYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQL 303
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 196 bits (500), Expect = 3e-59
Identities = 47/282 (16%), Positives = 97/282 (34%), Gaps = 30/282 (10%)
Query: 155 NKYELGEEVGRGHFG--YTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKIL 212
+ +G G F Y Q+ +KV + ++ L
Sbjct: 65 KLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANP---WEFYIGTQLMERL 121
Query: 213 RALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRG----GKYTEDDAKAVMIQ 268
+ + +KF+ A+ + +V EL G LL+ I + + ++
Sbjct: 122 KPSM-QHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMR 180
Query: 269 ILNVVAFCHLQGVVHRDLKPENFLFTTK--------DENSVLKAIDFGLSDFVR---PDE 317
+L ++ H ++H D+KP+NF+ D ++ L ID G S ++
Sbjct: 181 MLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGT 240
Query: 318 RLNDIVGSAYYVAPEVL-HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKA 376
++ + E+L ++ ++ + D + + Y +L G+ + E G +
Sbjct: 241 IFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKV-KNEGGECKPEGLF 299
Query: 377 DPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELL 418
W +F +LN L + L + L
Sbjct: 300 RRLPHLDMWN-------EFFHVMLNIPDCHHLPSLDLLRQKL 334
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 193 bits (492), Expect = 7e-59
Identities = 60/291 (20%), Positives = 117/291 (40%), Gaps = 40/291 (13%)
Query: 148 GFSKHFANKYELGEEVGRGHFG--YTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDV 205
G + ++ E++G G FG + C + L G A+K K + ++
Sbjct: 4 GMKSRYTTEFHELEKIGSGEFGSVFKCVKR-----LDGCIYAIKRSKKPLAGSVD-EQNA 57
Query: 206 RREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSR---GGKYTEDDA 262
REV L H+++V++F A+ + D++ + E C GG L D I + E +
Sbjct: 58 LREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAEL 117
Query: 263 KAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTK----------------DENSVLKAID 306
K +++Q+ + + H +VH D+KP N + + K D
Sbjct: 118 KDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGD 177
Query: 307 FGLSDFVRPDERLNDIVGSAYYVAPEVLH--RSYSTEADVWSIGVIAYILLCGSRPFWAR 364
G V G + ++A EVL ++ +AD++++ + G+ P
Sbjct: 178 LGH---VTRISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVV-CAAGAEPLPRN 233
Query: 365 TESGIFRAVLKADPSFDEAPWPS-LSSEARDFVKRLLNKDPRKRLTAAQAL 414
+ + + + P LS E + +K +++ DP +R +A +
Sbjct: 234 GDQ--WHEIRQGRLP----RIPQVLSQEFTELLKVMIHPDPERRPSAMALV 278
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 193 bits (492), Expect = 2e-57
Identities = 51/352 (14%), Positives = 99/352 (28%), Gaps = 70/352 (19%)
Query: 107 PSPAKHIKAVLARRHGSVKPNEAAIPEGSEPEPAAGLNKSFGFSKHFANKYEL---GEEV 163
P + + + + G F + G +
Sbjct: 37 PQANVRTTSEYMQSAADSLVSTSLWNTGQ----------PFRVESELGERPRTLVRGTVL 86
Query: 164 GRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTG------ 217
G+ A ++ G+ V V + + AI+ ++ EV LR L G
Sbjct: 87 GQEDPYAYLEATDQET---GESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 143
Query: 218 ---------------HNNLVKFFDAYEDTD-----NVYVVMELCEG-----GELLDRILS 252
K D + + + + GE+L S
Sbjct: 144 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 203
Query: 253 RGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312
+ +Q++ ++A H G+VH L+P + + D+ + F
Sbjct: 204 THKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVL---DQRGGVFLTGFEHL-- 258
Query: 313 VRPDERLNDIVGSAY----YVAPEVLHRS------YSTEADVWSIGVIAYILLCGSRPFW 362
VR +G + A +L + D W++G+ Y + C P
Sbjct: 259 VRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNT 318
Query: 363 ARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQAL 414
G + ++ ++ R ++ L RL QA+
Sbjct: 319 DDAALGGSEWIFRSC--------KNIPQPVRALLEGFLRYPKEDRLLPLQAM 362
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 182 bits (465), Expect = 1e-54
Identities = 79/288 (27%), Positives = 135/288 (46%), Gaps = 22/288 (7%)
Query: 133 EGSEPEPAAGLNKSFGFSKHFANK------YELGEEVGRGHFGYTCAAKFKKGELKGQQV 186
+G+ EP G + ++ G+ +G G F A+ ++
Sbjct: 2 DGTAAEPRPGAGSLQHAQPPPQPRKKRPEDFKFGKILGEGSFSTVVLARELAT---SREY 58
Query: 187 AVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGEL 246
A+K++ K + + V RE ++ L H VK + ++D + +Y + + GEL
Sbjct: 59 AIKILEKRHIIKENKVPYVTRERDVMSRLD-HPFFVKLYFTFQDDEKLYFGLSYAKNGEL 117
Query: 247 LDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAID 306
L + + G + E + +I++ + + H +G++HRDLKPEN L +E+ ++ D
Sbjct: 118 LKY-IRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILL---NEDMHIQITD 173
Query: 307 FGLS---DFVRPDERLNDIVGSAYYVAPEVLHRS-YSTEADVWSIGVIAYILLCGSRPFW 362
FG + R N VG+A YV+PE+L +D+W++G I Y L+ G PF
Sbjct: 174 FGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFR 233
Query: 363 ARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTA 410
A E IF+ ++K + F P +ARD V++LL D KRL
Sbjct: 234 AGNEYLIFQKIIKLEYDF---P-EKFFPKARDLVEKLLVLDATKRLGC 277
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 3e-52
Identities = 65/268 (24%), Positives = 108/268 (40%), Gaps = 25/268 (9%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVR-REVKILR 213
+ VGRG FG K K+ G Q AVK + +E R E+
Sbjct: 58 HWMTHQPRVGRGSFGEVHRMKDKQ---TGFQCAVKKVR---------LEVFRVEELVACA 105
Query: 214 ALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVV 273
L+ +V + A + V + MEL EGG L ++ + G ED A + Q L +
Sbjct: 106 GLS-SPRIVPLYGAVREGPWVNIFMELLEGGSLGQ-LIKQMGCLPEDRALYYLGQALEGL 163
Query: 274 AFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS------DFVRPDERLNDIVGSAY 327
+ H + ++H D+K +N L + D + DFG + + + I G+
Sbjct: 164 EYLHTRRILHGDVKADNVL-LSSDGSRA-ALCDFGHALCLQPDGLGKSLLTGDYIPGTET 221
Query: 328 YVAPEVLHRS-YSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWP 386
++APEV+ + D+WS + +L G P+ + + P E P P
Sbjct: 222 HMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIP-P 280
Query: 387 SLSSEARDFVKRLLNKDPRKRLTAAQAL 414
S + ++ L K+P R +A +
Sbjct: 281 SCAPLTAQAIQEGLRKEPVHRASAMELR 308
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 4e-50
Identities = 74/287 (25%), Positives = 120/287 (41%), Gaps = 31/287 (10%)
Query: 144 NKSFGFSKHFANKYEL-----GEEVGRGHFG--YTCAAKFKKGELKGQQVAVKVIPKHKM 196
+ S YE +G+G +G Y +A+K IP+
Sbjct: 6 EEGDCESDLLEYDYEYDENGDRVVLGKGTYGIVY-AGRDLSNQVR----IAIKEIPERDS 60
Query: 197 TTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGK 256
+ + E+ + + L H N+V++ ++ + + + ME GG L + S+ G
Sbjct: 61 RY---SQPLHEEIALHKHLK-HKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGP 116
Query: 257 --YTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS-DFV 313
E QIL + + H +VHRD+K +N L T + VLK DFG S
Sbjct: 117 LKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTY--SGVLKISDFGTSKRLA 174
Query: 314 RPDERLNDIVGSAYYVAPEVLH---RSYSTEADVWSIGVIAYILLCGSRPFWARTE--SG 368
+ G+ Y+APE++ R Y AD+WS+G + G PF+ E +
Sbjct: 175 GINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAA 234
Query: 369 IFR-AVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQAL 414
+F+ + K P E S+S+EA+ F+ + DP KR A L
Sbjct: 235 MFKVGMFKVHPEIPE----SMSAEAKAFILKCFEPDPDKRACANDLL 277
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 4e-50
Identities = 66/257 (25%), Positives = 128/257 (49%), Gaps = 19/257 (7%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLV 222
+G+G FG C + + A+K + K K + +V +E++I++ L H LV
Sbjct: 23 IGKGSFGKVCIVQKND---TKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLE-HPFLV 78
Query: 223 KFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVV 282
+ +++D +++++V++L GG+L L + + E+ K + +++ + + Q ++
Sbjct: 79 NLWYSFQDEEDMFMVVDLLLGGDLRYH-LQQNVHFKEETVKLFICELVMALDYLQNQRII 137
Query: 283 HRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRS----Y 338
HRD+KP+N L DE+ + DF ++ + + ++ + G+ Y+APE+ Y
Sbjct: 138 HRDMKPDNILL---DEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGY 194
Query: 339 STEADVWSIGVIAYILLCGSRPFWARTESG---IFRAVLKADPSFDEAPWPSLSSEARDF 395
S D WS+GV AY LL G RP+ R+ + I ++ P + S E
Sbjct: 195 SFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTY---P-SAWSQEMVSL 250
Query: 396 VKRLLNKDPRKRLTAAQ 412
+K+LL +P +R +
Sbjct: 251 LKKLLEPNPDQRFSQLS 267
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 2e-49
Identities = 59/267 (22%), Positives = 109/267 (40%), Gaps = 22/267 (8%)
Query: 157 YELGEEVGRGHFG--YTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRA 214
+ E+GRG F Y +VA + K+T + + + E ++L+
Sbjct: 28 LKFDIEIGRGSFKTVYKG---LDTET--TVEVAWCELQDRKLTKS-ERQRFKEEAEMLKG 81
Query: 215 LTGHNNLVKFFDAYEDT----DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQIL 270
L H N+V+F+D++E T + +V EL G L L R ++ QIL
Sbjct: 82 LQ-HPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKT-YLKRFKVMKIKVLRSWCRQIL 139
Query: 271 NVVAFCHLQG--VVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYY 328
+ F H + ++HRDLK +N T +K D GL+ R ++G+ +
Sbjct: 140 KGLQFLHTRTPPIIHRDLKCDNIFITGP--TGSVKIGDLGLATLKRASFA-KAVIGTPEF 196
Query: 329 VAPEVLHRSYSTEADVWSIGVIAYILLCGSRPFWARTESG-IFRAVLKADPSFDEAPWPS 387
+APE+ Y DV++ G+ + P+ + I+R V +
Sbjct: 197 MAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKP--ASFDKV 254
Query: 388 LSSEARDFVKRLLNKDPRKRLTAAQAL 414
E ++ ++ + ++ +R + L
Sbjct: 255 AIPEVKEIIEGCIRQNKDERYSIKDLL 281
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 5e-48
Identities = 76/253 (30%), Positives = 125/253 (49%), Gaps = 15/253 (5%)
Query: 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALT 216
++ + +G G FG K K+ G A+K++ K K+ IE E +IL+A+
Sbjct: 43 FDRIKTLGTGSFGRVMLVKHKE---SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 217 GHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFC 276
LVK +++D N+Y+VME GGE+ L R G+++E A+ QI+ +
Sbjct: 100 -FPFLVKLEFSFKDNSNLYMVMEYVAGGEMF-SHLRRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 277 HLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHR 336
H +++RDLKPEN L D+ ++ DFG + V R + G+ +APE++
Sbjct: 158 HSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRV--KGRTWTLCGTPEALAPEIILS 212
Query: 337 S-YSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDF 395
Y+ D W++GV+ Y + G PF+A I+ ++ F P SS+ +D
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF---P-SHFSSDLKDL 268
Query: 396 VKRLLNKDPRKRL 408
++ LL D KR
Sbjct: 269 LRNLLQVDLTKRF 281
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 9e-48
Identities = 80/300 (26%), Positives = 126/300 (42%), Gaps = 59/300 (19%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVK---------VIPKHKMTTAIAIEDV 205
KYE ++G G +G + + GQ VA+K VI K A+
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRD---TGQIVAIKKFLESEDDPVIKK----IAL----- 50
Query: 206 RREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAV 265
RE+++L+ L H NLV + + +++V E C+ +L + E K++
Sbjct: 51 -REIRMLKQLK-HPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSI 107
Query: 266 MIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDERLNDIVG 324
Q L V FCH +HRD+KPEN L ++SV+K DFG + P + +D V
Sbjct: 108 TWQTLQAVNFCHKHNCIHRDVKPENILI---TKHSVIKLCDFGFARLLTGPSDYYDDEVA 164
Query: 325 SAYYVAPEVL--HRSYSTEADVWSIGVIAYILLCGSRPFW-ARTE----SGIFRAV---- 373
+ +Y +PE+L Y DVW+IG + LL G P W +++ I + +
Sbjct: 165 TRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSG-VPLWPGKSDVDQLYLIRKTLGDLI 223
Query: 374 ---------LKADPSFDEAPW----------PSLSSEARDFVKRLLNKDPRKRLTAAQAL 414
+ P++S A +K L+ DP +RLT Q L
Sbjct: 224 PRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLL 283
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 2e-47
Identities = 71/300 (23%), Positives = 120/300 (40%), Gaps = 55/300 (18%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRA 214
+ Y+L ++GRG + A ++V VK++ K RE+KIL
Sbjct: 36 DDYQLVRKLGRGKYSEVFEAINITN---NEKVVVKILKPVKKKKIK------REIKILEN 86
Query: 215 LTGHNNLVKFFDAYEDTDN---VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILN 271
L G N++ D +D + V + ++ T+ D + M +IL
Sbjct: 87 LRGGPNIITLADIVKDPVSRTPALVFEHVNN--TDFKQLYQ---TLTDYDIRFYMYEILK 141
Query: 272 VVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAP 331
+ +CH G++HRD+KP N + E+ L+ ID+GL++F P + N V S Y+ P
Sbjct: 142 ALDYCHSMGIMHRDVKPHNVMIDH--EHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGP 199
Query: 332 EVL--HRSYSTEADVWSIGVIAYILLCGSRPF-------------------------WAR 364
E+L ++ Y D+WS+G + ++ PF +
Sbjct: 200 ELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK 259
Query: 365 TESGIFRAVLKADPSFDEAPW---------PSLSSEARDFVKRLLNKDPRKRLTAAQALS 415
+ W +S EA DF+ +LL D + RLTA +A+
Sbjct: 260 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 3e-46
Identities = 67/253 (26%), Positives = 126/253 (49%), Gaps = 15/253 (5%)
Query: 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALT 216
+++ +G G FG + + G+ A+KV+ K + +E E +L +T
Sbjct: 8 FQILRTLGTGSFGRVHLIRSRHN---GRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT 64
Query: 217 GHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFC 276
H +++ + ++D ++++M+ EGGEL L + ++ AK ++ + +
Sbjct: 65 -HPFIIRMWGTFQDAQQIFMIMDYIEGGELFSL-LRKSQRFPNPVAKFYAAEVCLALEYL 122
Query: 277 HLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHR 336
H + +++RDLKPEN L D+N +K DFG + +V + + G+ Y+APEV+
Sbjct: 123 HSKDIIYRDLKPENILL---DKNGHIKITDFGFAKYV--PDVTYTLCGTPDYIAPEVVST 177
Query: 337 S-YSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDF 395
Y+ D WS G++ Y +L G PF+ + +L A+ F P P + + +D
Sbjct: 178 KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRF---P-PFFNEDVKDL 233
Query: 396 VKRLLNKDPRKRL 408
+ RL+ +D +RL
Sbjct: 234 LSRLITRDLSQRL 246
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 7e-46
Identities = 82/294 (27%), Positives = 123/294 (41%), Gaps = 47/294 (15%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVI---PKHKMTTAIAIEDVRREVKI 211
KYE VG G +G + K G+ VA+K KM IA+ RE+K+
Sbjct: 25 EKYENLGLVGEGSYGMVMKCRNKD---TGRIVAIKKFLESDDDKMVKKIAM----REIKL 77
Query: 212 LRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILN 271
L+ L H NLV + + Y+V E + +LD + + + QI+N
Sbjct: 78 LKQLR-HENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQIIN 135
Query: 272 VVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDERLNDIVGSAYYVA 330
+ FCH ++HRD+KPEN L ++ V+K DFG + P E +D V + +Y A
Sbjct: 136 GIGFCHSHNIIHRDIKPENILV---SQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRA 192
Query: 331 PEVL--HRSYSTEADVWSIGVIAYILLCGSRPFW-ARTE----SGIFRAV--LKAD--PS 379
PE+L Y DVW+IG + + G P + ++ I + L
Sbjct: 193 PELLVGDVKYGKAVDVWAIGCLVTEMFMG-EPLFPGDSDIDQLYHIMMCLGNLIPRHQEL 251
Query: 380 FDEAPW-------------------PSLSSEARDFVKRLLNKDPRKRLTAAQAL 414
F++ P P LS D K+ L+ DP KR A+ L
Sbjct: 252 FNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELL 305
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 1e-45
Identities = 77/283 (27%), Positives = 130/283 (45%), Gaps = 32/283 (11%)
Query: 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILR 213
+ YEL E +G G AA K ++VA+K I K T++ +++ +E++ +
Sbjct: 14 RDDYELQEVIGSGATAVVQAAYCAP---KKEKVAIKRINLEKCQTSM--DELLKEIQAMS 68
Query: 214 ALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLD-------RILSRGGKYTEDDAKAVM 266
H N+V ++ ++ D +++VM+L GG +LD + + G E ++
Sbjct: 69 QCH-HPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATIL 127
Query: 267 IQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS-------DFVRPDERL 319
++L + + H G +HRD+K N L E+ ++ DFG+S D R R
Sbjct: 128 REVLEGLEYLHKNGQIHRDVKAGNILLG---EDGSVQIADFGVSAFLATGGDITRNKVR- 183
Query: 320 NDIVGSAYYVAPEVLHRS--YSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKAD 377
VG+ ++APEV+ + Y +AD+WS G+ A L G+ P+ + L+ D
Sbjct: 184 KTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQND 243
Query: 378 P------SFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQAL 414
P D+ R + L KDP KR TAA+ L
Sbjct: 244 PPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELL 286
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 1e-45
Identities = 76/252 (30%), Positives = 124/252 (49%), Gaps = 13/252 (5%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLV 222
+G+G FG A+FKK Q A+K + K + +E E ++L H L
Sbjct: 25 LGKGSFGKVFLAEFKK---TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLT 81
Query: 223 KFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVV 282
F ++ +N++ VME GG+L+ I K+ A +I+ + F H +G+V
Sbjct: 82 HMFCTFQTKENLFFVMEYLNGGDLMYHI-QSCHKFDLSRATFYAAEIILGLQFLHSKGIV 140
Query: 283 HRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDERLNDIVGSAYYVAPEVLHR-SYST 340
+RDLK +N L D++ +K DFG+ + + D + N G+ Y+APE+L Y+
Sbjct: 141 YRDLKLDNILL---DKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNH 197
Query: 341 EADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLL 400
D WS GV+ Y +L G PF + E +F ++ +P + P L EA+D + +L
Sbjct: 198 SVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFY---P-RWLEKEAKDLLVKLF 253
Query: 401 NKDPRKRLTAAQ 412
++P KRL
Sbjct: 254 VREPEKRLGVRG 265
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 166 bits (421), Expect = 2e-45
Identities = 75/342 (21%), Positives = 135/342 (39%), Gaps = 14/342 (4%)
Query: 69 FPFYSPSPAHYFFSKKSSPARSSANSTPNRFFKRPFPPPSPAKHIKAVLARRHGSVKPNE 128
F + +F P PP + + +
Sbjct: 256 FMGSLSFGISELQKAGVDGWFKLLSQEEGEYFNVPVPPEGSEGNEELRQKFERAKIGQGT 315
Query: 129 AAIPEGSEPEPAAGLNKSFGFSKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAV 188
A PE + + + + + +G+G FG ++ K + AV
Sbjct: 316 KA-PEEKTANTISKFDNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKG---TDELYAV 371
Query: 189 KVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLD 248
K++ K + +E E ++L L + ++ D +Y VME GG+L+
Sbjct: 372 KILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMY 431
Query: 249 RILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFG 308
I + G++ E A +I + F +G+++RDLK +N + D +K DFG
Sbjct: 432 HI-QQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVML---DSEGHIKIADFG 487
Query: 309 LS-DFVRPDERLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTE 366
+ + + G+ Y+APE++ Y D W+ GV+ Y +L G PF E
Sbjct: 488 MCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE 547
Query: 367 SGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRL 408
+F+++++ + ++ P S+S EA K L+ K P KRL
Sbjct: 548 DELFQSIMEHNVAY---P-KSMSKEAVAICKGLMTKHPGKRL 585
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 158 bits (403), Expect = 2e-45
Identities = 77/250 (30%), Positives = 126/250 (50%), Gaps = 16/250 (6%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDV--RREVKILRALTGHNN 220
+G+G FG K G Q A+KV+ K + + V + E IL H
Sbjct: 32 LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATL---KVRDRVRTKMERDIL-VEVNHPF 87
Query: 221 LVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQG 280
+VK A++ +Y++++ GG+L R LS+ +TE+D K + ++ + H G
Sbjct: 88 IVKLHYAFQTEGKLYLILDFLRGGDLFTR-LSKEVMFTEEDVKFYLAELALALDHLHSLG 146
Query: 281 VVHRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDERLNDIVGSAYYVAPEVLHRS-Y 338
+++RDLKPEN L DE +K DFGLS + + +++ G+ Y+APEV++R +
Sbjct: 147 IIYRDLKPENILL---DEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGH 203
Query: 339 STEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKR 398
+ AD WS GV+ + +L G+ PF + +LKA P LS EA+ ++
Sbjct: 204 TQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGM---P-QFLSPEAQSLLRM 259
Query: 399 LLNKDPRKRL 408
L ++P RL
Sbjct: 260 LFKRNPANRL 269
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 161 bits (408), Expect = 2e-45
Identities = 72/253 (28%), Positives = 117/253 (46%), Gaps = 17/253 (6%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLV 222
+GRG FG + K + A+K++ K +M E I+ A +V
Sbjct: 77 IGRGAFGEVQLVRHKS---TRKVYAMKLLSKFEMIKRSDSAFFWEERDIM-AFANSPWVV 132
Query: 223 KFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVV 282
+ F A++D +Y+VME GG+L+ ++S E A+ +++ + H G +
Sbjct: 133 QLFYAFQDDRYLYMVMEYMPGGDLV-NLMSNY-DVPEKWARFYTAEVVLALDAIHSMGFI 190
Query: 283 HRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDE--RLNDIVGSAYYVAPEVL-----H 335
HRD+KP+N L D++ LK DFG + + R + VG+ Y++PEVL
Sbjct: 191 HRDVKPDNMLL---DKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGD 247
Query: 336 RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDF 395
Y E D WS+GV Y +L G PF+A + G + ++ S +S EA++
Sbjct: 248 GYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNL 307
Query: 396 VKRLLNKDPRKRL 408
+ L D RL
Sbjct: 308 ICAFL-TDREVRL 319
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 3e-45
Identities = 67/248 (27%), Positives = 117/248 (47%), Gaps = 13/248 (5%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLV 222
+G+G FG ++ K + AVK++ K + +E E ++L L
Sbjct: 28 LGKGSFGKVMLSERKG---TDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLT 84
Query: 223 KFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVV 282
+ ++ D +Y VME GG+L+ I + G++ E A +I + F +G++
Sbjct: 85 QLHSCFQTMDRLYFVMEYVNGGDLMYHI-QQVGRFKEPHAVFYAAEIAIGLFFLQSKGII 143
Query: 283 HRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDERLNDIVGSAYYVAPEVLHR-SYST 340
+RDLK +N + D +K DFG+ + + G+ Y+APE++ Y
Sbjct: 144 YRDLKLDNVML---DSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGK 200
Query: 341 EADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLL 400
D W+ GV+ Y +L G PF E +F+++++ + ++ P S+S EA K L+
Sbjct: 201 SVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAY---P-KSMSKEAVAICKGLM 256
Query: 401 NKDPRKRL 408
K P KRL
Sbjct: 257 TKHPGKRL 264
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 3e-45
Identities = 78/267 (29%), Positives = 126/267 (47%), Gaps = 15/267 (5%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLV 222
+G+G FG A+ K+ G AVKV+ K + +E E +IL H L
Sbjct: 31 LGKGSFGKVMLARVKE---TGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLT 87
Query: 223 KFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVV 282
+ F ++ D ++ VME GG+L+ I + ++ E A+ +I++ + F H +G++
Sbjct: 88 QLFCCFQTPDRLFFVMEFVNGGDLMFHI-QKSRRFDEARARFYAAEIISALMFLHDKGII 146
Query: 283 HRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDERLNDIVGSAYYVAPEVLHR-SYST 340
+RDLK +N L D K DFG+ + + G+ Y+APE+L Y
Sbjct: 147 YRDLKLDNVLL---DHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEMLYGP 203
Query: 341 EADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLL 400
D W++GV+ Y +LCG PF A E +F A+L + + P L +A +K +
Sbjct: 204 AVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVY---P-TWLHEDATGILKSFM 259
Query: 401 NKDPRKRLTAAQALSELLICYQSYLFF 427
K+P RL + E I + FF
Sbjct: 260 TKNPTMRLGSLTQGGEHAI--LRHPFF 284
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 161 bits (408), Expect = 3e-45
Identities = 75/257 (29%), Positives = 119/257 (46%), Gaps = 19/257 (7%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLV 222
+GRG F K K+ GQ A+K++ K M + R E +L +
Sbjct: 69 IGRGAFSEVAVVKMKQ---TGQVYAMKIMNKWDMLKRGEVSCFREERDVL-VNGDRRWIT 124
Query: 223 KFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVV 282
+ A++D + +Y+VME GG+LL + G + + A+ + +I+ + H G V
Sbjct: 125 QLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYV 184
Query: 283 HRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDE--RLNDIVGSAYYVAPEVLHR---- 336
HRD+KP+N L D ++ DFG +R D R VG+ Y++PE+L
Sbjct: 185 HRDIKPDNILL---DRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGG 241
Query: 337 ----SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPS-LSSE 391
SY E D W++GV AY + G PF+A + + + ++ + E
Sbjct: 242 PGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEGVPEE 301
Query: 392 ARDFVKRLLNKDPRKRL 408
ARDF++RLL P RL
Sbjct: 302 ARDFIQRLLC-PPETRL 317
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 4e-45
Identities = 79/265 (29%), Positives = 136/265 (51%), Gaps = 23/265 (8%)
Query: 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRAL 215
+ ++G G G C A+ K G+QVAVK++ + E + EV I+R
Sbjct: 46 LLDSYVKIGEGSTGIVCLAREKH---SGRQVAVKMMD---LRKQQRRELLFNEVVIMRDY 99
Query: 216 TGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAF 275
H N+V+ + +Y + ++V+ME +GG L D + + E+ V +L +A+
Sbjct: 100 Q-HFNVVEMYKSYLVGEELWVLMEFLQGGALTD--IVSQVRLNEEQIATVCEAVLQALAY 156
Query: 276 CHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPD-ERLNDIVGSAYYVAPEVL 334
H QGV+HRD+K ++ L T + +K DFG + D + +VG+ Y++APEV+
Sbjct: 157 LHAQGVIHRDIKSDSILLT---LDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVI 213
Query: 335 HRS-YSTEADVWSIGVIAYILLCGSRPFW----ARTESGIFRAVLKADPSFDEAPWPSLS 389
RS Y+TE D+WS+G++ ++ G P++ + + R P +S
Sbjct: 214 SRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQA---MKRLRDSPPPKLKN--SHKVS 268
Query: 390 SEARDFVKRLLNKDPRKRLTAAQAL 414
RDF++R+L +DP++R TA + L
Sbjct: 269 PVLRDFLERMLVRDPQERATAQELL 293
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 6e-45
Identities = 74/249 (29%), Positives = 121/249 (48%), Gaps = 12/249 (4%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPK-HKMTTAIAIEDVRREVKILRALTGHNNL 221
+G+G +G + G G+ A+KV+ K + A + E IL H +
Sbjct: 25 LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNIL-EEVKHPFI 83
Query: 222 VKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGV 281
V A++ +Y+++E GGEL + L R G + ED A + +I + H +G+
Sbjct: 84 VDLIYAFQTGGKLYLILEYLSGGELFMQ-LEREGIFMEDTACFYLAEISMALGHLHQKGI 142
Query: 282 VHRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDERLNDIVGSAYYVAPEVLHRS-YS 339
++RDLKPEN + + +K DFGL + + + G+ Y+APE+L RS ++
Sbjct: 143 IYRDLKPENIML---NHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSGHN 199
Query: 340 TEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRL 399
D WS+G + Y +L G+ PF +LK + P P L+ EARD +K+L
Sbjct: 200 RAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNL---P-PYLTQEARDLLKKL 255
Query: 400 LNKDPRKRL 408
L ++ RL
Sbjct: 256 LKRNAASRL 264
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 9e-45
Identities = 74/262 (28%), Positives = 124/262 (47%), Gaps = 17/262 (6%)
Query: 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRAL 215
KY E++G+G G A GQ+VA++ + + E + E+ ++R
Sbjct: 21 KYTRFEKIGQGASGTVYTAMDVA---TGQEVAIRQMN---LQQQPKKELIINEILVMREN 74
Query: 216 TGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAF 275
+ N+V + D+Y D ++VVME GG L D + E AV + L + F
Sbjct: 75 K-NPNIVNYLDSYLVGDELWVVMEYLAGGSLTD--VVTETCMDEGQIAAVCRECLQALEF 131
Query: 276 CHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDE-RLNDIVGSAYYVAPEVL 334
H V+HRD+K +N L + +K DFG + P++ + + +VG+ Y++APEV+
Sbjct: 132 LHSNQVIHRDIKSDNILLG---MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV 188
Query: 335 HRS-YSTEADVWSIGVIAYILLCGSRPFWARTE-SGIFRAVLKADPSFDEAPWPSLSSEA 392
R Y + D+WS+G++A ++ G P+ ++ P LS+
Sbjct: 189 TRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQN--PEKLSAIF 246
Query: 393 RDFVKRLLNKDPRKRLTAAQAL 414
RDF+ R L D KR +A + L
Sbjct: 247 RDFLNRCLEMDVEKRGSAKELL 268
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 2e-44
Identities = 77/282 (27%), Positives = 132/282 (46%), Gaps = 38/282 (13%)
Query: 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILR 213
A +EL E VG G +G + K GQ A+KV+ T E++++E+ +L+
Sbjct: 23 AGIFELVELVGNGTYGQVYKGRHVK---TGQLAAIKVMD----VTGDEEEEIKQEINMLK 75
Query: 214 ALTGHNNLVKFFDAY------EDTDNVYVVMELCEGGELLDRI-LSRGGKYTEDDAKAVM 266
+ H N+ ++ A+ D +++VME C G + D I ++G E+ +
Sbjct: 76 KYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYIC 135
Query: 267 IQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDERLNDIVGS 325
+IL ++ H V+HRD+K +N L T EN+ +K +DFG+S R R N +G+
Sbjct: 136 REILRGLSHLHQHKVIHRDIKGQNVLLT---ENAEVKLVDFGVSAQLDRTVGRRNTFIGT 192
Query: 326 AYYVAPEVLHR------SYSTEADVWSIGVIAYIL------LCGSRPFWARTESGIFRAV 373
Y++APEV+ +Y ++D+WS+G+ A + LC P A +F
Sbjct: 193 PYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA-----LFLIP 247
Query: 374 LKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALS 415
P W S + + F++ L K+ +R Q +
Sbjct: 248 RNPAPRLKSKKW---SKKFQSFIESCLVKNHSQRPATEQLMK 286
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 2e-44
Identities = 68/255 (26%), Positives = 116/255 (45%), Gaps = 17/255 (6%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLV 222
+GRG FG K K + A+K++ K +M R E +L +
Sbjct: 82 IGRGAFGEVAVVKLKN---ADKVFAMKILNKWEMLKRAETACFREERDVL-VNGDSKWIT 137
Query: 223 KFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVV 282
A++D +N+Y+VM+ GG+LL + + E+ A+ + +++ + H V
Sbjct: 138 TLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYV 197
Query: 283 HRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDE--RLNDIVGSAYYVAPEVL------ 334
HRD+KP+N L D N ++ DFG + D + + VG+ Y++PE+L
Sbjct: 198 HRDIKPDNILM---DMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGG 254
Query: 335 HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPS-LSSEAR 393
Y E D WS+GV Y +L G PF+A + + ++ F + +S A+
Sbjct: 255 KGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDVSENAK 314
Query: 394 DFVKRLLNKDPRKRL 408
D ++RL+ RL
Sbjct: 315 DLIRRLICSRE-HRL 328
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 2e-44
Identities = 74/285 (25%), Positives = 132/285 (46%), Gaps = 22/285 (7%)
Query: 135 SEPEPAAGLNKSFGFSKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKH 194
+ +GL + E++G+G FG + + VA+K+I
Sbjct: 2 AHSPVQSGLPGMQNLKADPEELFTKLEKIGKGSFGEVFKGIDNR---TQKVVAIKIIDLE 58
Query: 195 KMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRG 254
+ I ED+++E+ +L + K++ +Y ++++ME GG LD L
Sbjct: 59 EAEDEI--EDIQQEITVLSQCD-SPYVTKYYGSYLKDTKLWIIMEYLGGGSALD--LLEP 113
Query: 255 GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS-DFV 313
G E ++ +IL + + H + +HRD+K N L + E+ +K DFG++
Sbjct: 114 GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLS---EHGEVKLADFGVAGQLT 170
Query: 314 RPDERLNDIVGSAYYVAPEVLHRS-YSTEADVWSIGVIAYILLCGSRPFWARTESGIFRA 372
+ N VG+ +++APEV+ +S Y ++AD+WS+G+ A L G P E +
Sbjct: 171 DTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHS---ELHPMKV 227
Query: 373 VL---KADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQAL 414
+ K +P E + S ++FV+ LNK+P R TA + L
Sbjct: 228 LFLIPKNNPPTLEGNY---SKPLKEFVEACLNKEPSFRPTAKELL 269
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 4e-44
Identities = 68/255 (26%), Positives = 117/255 (45%), Gaps = 20/255 (7%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLV 222
+GRG FG A + K G+ A K + K ++ + E KIL A +V
Sbjct: 193 LGRGGFGEVFACQMKA---TGKLYACKKLNKKRLKKRKGYQGAMVEKKIL-AKVHSRFIV 248
Query: 223 KFFDAYEDTDNVYVVMELCEGGEL---LDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQ 279
A+E ++ +VM + GG++ + + + E A QI++ + H +
Sbjct: 249 SLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR 308
Query: 280 GVVHRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDERLNDIVGSAYYVAPEVLHR-S 337
+++RDLKPEN L D++ ++ D GL+ + + G+ ++APE+L
Sbjct: 309 NIIYRDLKPENVLL---DDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEE 365
Query: 338 YSTEADVWSIGVIAYILLCGSRPFWARTESG----IFRAVLKADPSFDEAPWPSLSSEAR 393
Y D +++GV Y ++ PF AR E + + VL+ ++ S ++
Sbjct: 366 YDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYP----DKFSPASK 421
Query: 394 DFVKRLLNKDPRKRL 408
DF + LL KDP KRL
Sbjct: 422 DFCEALLQKDPEKRL 436
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 4e-44
Identities = 76/248 (30%), Positives = 124/248 (50%), Gaps = 14/248 (5%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLV 222
+G+G FG + K G+ A+K++ K + + E ++L T H L
Sbjct: 13 LGKGTFGKVILVREKA---TGRYYAMKILRKEVIIAKDEVAHTVTESRVL-QNTRHPFLT 68
Query: 223 KFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVV 282
A++ D + VME GGEL LSR +TE+ A+ +I++ + + H + VV
Sbjct: 69 ALKYAFQTHDRLCFVMEYANGGELFFH-LSRERVFTEERARFYGAEIVSALEYLHSRDVV 127
Query: 283 HRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDERLNDIVGSAYYVAPEVLHR-SYST 340
+RD+K EN + D++ +K DFGL + + + G+ Y+APEVL Y
Sbjct: 128 YRDIKLENLML---DKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGR 184
Query: 341 EADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLL 400
D W +GV+ Y ++CG PF+ + +F +L + F P +LS EA+ + LL
Sbjct: 185 AVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRF---P-RTLSPEAKSLLAGLL 240
Query: 401 NKDPRKRL 408
KDP++RL
Sbjct: 241 KKDPKQRL 248
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 4e-44
Identities = 78/340 (22%), Positives = 135/340 (39%), Gaps = 34/340 (10%)
Query: 91 SANSTPNRFFKRPFPPPSPAKHIKAVLARRHGS---VKPNEAAIPEGSEPEPAAGLNKS- 146
S +H++ L ++ +P I + + +S
Sbjct: 110 DTYIMKELLACSHPFSKSAIEHVQGHLVKKQVPPDLFQPYIEEICQNLRGDVFQKFIESD 169
Query: 147 ----FGFSKHFANKYELGEE-------VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHK 195
F K+ L +GRG FG + G+ A+K + K +
Sbjct: 170 KFTRFCQWKNVELNIHLTMNDFSVHRIIGRGGFGEVYGCRKAD---TGKMYAMKCLDKKR 226
Query: 196 MTTAIAIEDVRREVKILRALTGHNN--LVKFFDAYEDTDNVYVVMELCEGGELLDRILSR 253
+ E +L ++ + +V A+ D + +++L GG+L LS+
Sbjct: 227 IKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYH-LSQ 285
Query: 254 GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313
G ++E D + +I+ + H + VV+RDLKP N L DE+ ++ D GL+
Sbjct: 286 HGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILL---DEHGHVRISDLGLACDF 342
Query: 314 RPDERLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESG--- 368
++ + VG+ Y+APEVL + +Y + AD +S+G + + LL G PF
Sbjct: 343 -SKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE 401
Query: 369 IFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRL 408
I R L S S E R ++ LL +D +RL
Sbjct: 402 IDRMTLTMAVELP----DSFSPELRSLLEGLLQRDVNRRL 437
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 6e-44
Identities = 83/276 (30%), Positives = 128/276 (46%), Gaps = 36/276 (13%)
Query: 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRAL 215
+E+ E+G G FG AK K+ G A KVI + +ED E++IL
Sbjct: 20 VWEIVGELGDGAFGKVYKAKNKE---TGALAAAKVIE---TKSEEELEDYIVEIEILATC 73
Query: 216 TGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAF 275
H +VK AY +++++E C GG + +L TE + V Q+L + F
Sbjct: 74 D-HPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNF 132
Query: 276 CHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPD-ERLNDIVGSAYYVAPEVL 334
H + ++HRDLK N L T ++ DFG+S ++ + +G+ Y++APEV+
Sbjct: 133 LHSKRIIHRDLKAGNVLMT---LEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVV 189
Query: 335 HR------SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVL---KADPSFDEAPW 385
Y +AD+WS+G+ + P E R +L K+DP
Sbjct: 190 MCETMKDTPYDYKADIWSLGITLIEMAQIEPPHH---ELNPMRVLLKIAKSDP------- 239
Query: 386 PSL------SSEARDFVKRLLNKDPRKRLTAAQALS 415
P+L S E RDF+K L+K+P R +AAQ L
Sbjct: 240 PTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 2e-43
Identities = 72/266 (27%), Positives = 128/266 (48%), Gaps = 23/266 (8%)
Query: 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRAL 215
+++ E++G G +G A K+ GQ VA+K +P ++++ +E+ I++
Sbjct: 30 VFDVLEKLGEGSYGSVYKAIHKE---TGQIVAIKQVPVES-----DLQEIIKEISIMQQC 81
Query: 216 TGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAF 275
++VK++ +Y ++++VME C G + D I R TED+ ++ L + +
Sbjct: 82 D-SPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEY 140
Query: 276 CHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDERLNDIVGSAYYVAPEVL 334
H +HRD+K N L K DFG++ + N ++G+ +++APEV+
Sbjct: 141 LHFMRKIHRDIKAGNILLN---TEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVI 197
Query: 335 HRS-YSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVL----KADPSFDEAPWPSLS 389
Y+ AD+WS+G+ A + G P+ + RA+ P+F + S
Sbjct: 198 QEIGYNCVADIWSLGITAIEMAEGKPPYA---DIHPMRAIFMIPTNPPPTFRKPEL--WS 252
Query: 390 SEARDFVKRLLNKDPRKRLTAAQALS 415
DFVK+ L K P +R TA Q L
Sbjct: 253 DNFTDFVKQCLVKSPEQRATATQLLQ 278
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 2e-43
Identities = 56/274 (20%), Positives = 102/274 (37%), Gaps = 28/274 (10%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLV 222
+ R + K E + +++ ++ +++ + + N V
Sbjct: 66 IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFS-TKNTV 124
Query: 223 KFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKA--VMIQILNVVAFCHLQG 280
+Y+ M+LC L D + R + + IQI V F H +G
Sbjct: 125 GQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKG 184
Query: 281 VVHRDLKPENFLFTTKDENSVLKAIDFGLS-------------DFVRPDERLNDIVGSAY 327
++HRDLKP N F + V+K DFGL + VG+
Sbjct: 185 LMHRDLKPSNIFF---TMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241
Query: 328 YVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTE-SGIFRAVLKADPSFDEAPW 385
Y++PE +H +YS + D++S+G+I + LL F + E I V +
Sbjct: 242 YMSPEQIHGNNYSHKVDIFSLGLILFELLY---SFSTQMERVRIITDVRNLKFPLL---F 295
Query: 386 PSLSSEARDFVKRLLNKDPRKRLTAAQAL-SELL 418
+ V+ +L+ P +R A + + +
Sbjct: 296 TQKYPQEHMMVQDMLSPSPTERPEATDIIENAIF 329
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 49.1 bits (117), Expect = 1e-06
Identities = 27/92 (29%), Positives = 41/92 (44%), Gaps = 6/92 (6%)
Query: 150 SKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREV 209
+ + +E + +GRG FG AK K + A+K I A E V REV
Sbjct: 1 ASRYLTDFEPIQCMGRGGFGVVFEAKNK---VDDCNYAIKRIRLPNREL--AREKVMREV 55
Query: 210 KILRALTGHNNLVKFFDAYEDTDNVYVVMELC 241
K L L H +V++F+A+ +T E+
Sbjct: 56 KALAKL-EHPGIVRYFNAWLETPPEKWQEEMD 86
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 2e-43
Identities = 89/299 (29%), Positives = 136/299 (45%), Gaps = 58/299 (19%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKM--------TTAIAIEDVR 206
KY E++G G +G A+ GE A+K I ++ +T I
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGET----FALKKI---RLEKEDEGIPSTTI------ 48
Query: 207 REVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEG--GELLDRILSRGGKYTEDDAKA 264
RE+ IL+ L H+N+VK +D + +V E + +LLD G AK+
Sbjct: 49 REISILKELK-HSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLD---VCEGGLESVTAKS 104
Query: 265 VMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDERLNDIV 323
++Q+LN +A+CH + V+HRDLKP+N L + LK DFGL+ F P + +
Sbjct: 105 FLLQLLNGIAYCHDRRVLHRDLKPQNLLI---NREGELKIADFGLARAFGIPVRKYTHEI 161
Query: 324 GSAYYVAPEVL--HRSYSTEADVWSIGVIAYILLCGSRPFWARTE----SGIFRA----- 372
+ +Y AP+VL + YST D+WS+G I ++ G+ F +E IFR
Sbjct: 162 VTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPN 221
Query: 373 ------VLK---ADPSFDEAP-------WPSLSSEARDFVKRLLNKDPRKRLTAAQALS 415
V + DP+F L D + ++L DP +R+TA QAL
Sbjct: 222 SKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 2e-43
Identities = 70/257 (27%), Positives = 123/257 (47%), Gaps = 22/257 (8%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLV 222
+GRG + + KK + A+KV+ K + I+ V+ E + + H LV
Sbjct: 17 IGRGSYAKVLLVRLKK---TDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLV 73
Query: 223 KFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVV 282
++ ++ V+E GG+L+ + R K E+ A+ +I + + H +G++
Sbjct: 74 GLHSCFQTESRLFFVIEYVNGGDLMFH-MQRQRKLPEEHARFYSAEISLALNYLHERGII 132
Query: 283 HRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDERLNDIVGSAYYVAPEVLHR-SYST 340
+RDLK +N L D +K D+G+ + +RP + + G+ Y+APE+L Y
Sbjct: 133 YRDLKLDNVLL---DSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGF 189
Query: 341 EADVWSIGVIAYILLCGSRPFW---------ARTESGIFRAVLKADPSFDEAPWPSLSSE 391
D W++GV+ + ++ G PF TE +F+ +L+ P SLS +
Sbjct: 190 SVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRI---P-RSLSVK 245
Query: 392 ARDFVKRLLNKDPRKRL 408
A +K LNKDP++RL
Sbjct: 246 AASVLKSFLNKDPKERL 262
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 5e-43
Identities = 87/382 (22%), Positives = 163/382 (42%), Gaps = 44/382 (11%)
Query: 35 PAPSPLNAESQSNNN--RTNVKGNDDAVIEGKKSPFFP---FYSPSPAHYFFSKKSSPAR 89
+PLN S + +T + +I + F+ +P ++
Sbjct: 47 QREAPLNNFSVAQCQLMKTERPRPNTFIIRCLQWTTVIERTFHVETP------EEREEWT 100
Query: 90 SSANSTPNRFFKRPFPPPSPAKHIKAVLARRHGSVKPNEAAIPEGSEPEPAAGLNKSFGF 149
++ + + L ++ + + P + ++ +
Sbjct: 101 TAIQTVADG------------------LKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPK 142
Query: 150 SKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREV 209
+ N++E + +G+G FG K K G+ A+K++ K + + E
Sbjct: 143 HRVTMNEFEYLKLLGKGTFGKVILVKEKA---TGRYYAMKILKKEVIVAKDEVAHTLTEN 199
Query: 210 KILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQI 269
++L + H L +++ D + VME GGEL LSR ++ED A+ +I
Sbjct: 200 RVL-QNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFH-LSRERVFSEDRARFYGAEI 257
Query: 270 LNVVAFCHLQ-GVVHRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDERLNDIVGSAY 327
++ + + H + VV+RDLK EN + D++ +K DFGL + ++ + G+
Sbjct: 258 VSALDYLHSEKNVVYRDLKLENLML---DKDGHIKITDFGLCKEGIKDGATMKTFCGTPE 314
Query: 328 YVAPEVLHRS-YSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWP 386
Y+APEVL + Y D W +GV+ Y ++CG PF+ + +F +L + F P
Sbjct: 315 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRF---P-R 370
Query: 387 SLSSEARDFVKRLLNKDPRKRL 408
+L EA+ + LL KDP++RL
Sbjct: 371 TLGPEAKSLLSGLLKKDPKQRL 392
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 6e-43
Identities = 83/300 (27%), Positives = 134/300 (44%), Gaps = 58/300 (19%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKM--------TTAIAIEDVR 206
KYE E++G G +G AK ++ + VA+K + ++ ++A+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRET---HEIVALKRV---RLDDDDEGVPSSAL------ 49
Query: 207 REVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEG--GELLDRILSRGGKYTEDDAKA 264
RE+ +L+ L H N+V+ D + +V E C+ + D S G + K+
Sbjct: 50 REICLLKELK-HKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFD---SCNGDLDPEIVKS 105
Query: 265 VMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDERLNDIV 323
+ Q+L + FCH + V+HRDLKP+N L + N LK +FGL+ F P + V
Sbjct: 106 FLFQLLKGLGFCHSRNVLHRDLKPQNLLI---NRNGELKLANFGLARAFGIPVRCYSAEV 162
Query: 324 GSAYYVAPEVL--HRSYSTEADVWSIGVIAYILLCGSRP-FWARTE----SGIFRAV--- 373
+ +Y P+VL + YST D+WS G I L RP F IFR +
Sbjct: 163 VTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTP 222
Query: 374 -------LKADPSFDEAP-----------WPSLSSEARDFVKRLLNKDPRKRLTAAQALS 415
+ P + P P L++ RD ++ LL +P +R++A +AL
Sbjct: 223 TEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 153 bits (390), Expect = 6e-43
Identities = 72/248 (29%), Positives = 118/248 (47%), Gaps = 13/248 (5%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLV 222
+G+G FG A+ K + AVKV+ K + + + E +L H LV
Sbjct: 46 IGKGSFGKVLLARHKA---EEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLV 102
Query: 223 KFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVV 282
+++ D +Y V++ GGEL L R + E A+ +I + + + H +V
Sbjct: 103 GLHFSFQTADKLYFVLDYINGGELFYH-LQRERCFLEPRARFYAAEIASALGYLHSLNIV 161
Query: 283 HRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDERLNDIVGSAYYVAPEVLHRS-YST 340
+RDLKPEN L D + DFGL + + + + G+ Y+APEVLH+ Y
Sbjct: 162 YRDLKPENILL---DSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQPYDR 218
Query: 341 EADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLL 400
D W +G + Y +L G PF++R + ++ +L P++++ AR ++ LL
Sbjct: 219 TVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQL---K-PNITNSARHLLEGLL 274
Query: 401 NKDPRKRL 408
KD KRL
Sbjct: 275 QKDRTKRL 282
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 8e-43
Identities = 69/268 (25%), Positives = 112/268 (41%), Gaps = 25/268 (9%)
Query: 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRAL 215
+ E+G G FG A+ + + VA+K + + +D+ +EV+ L+ L
Sbjct: 55 LFSDLREIGHGSFGAVYFARDVR---NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL 111
Query: 216 TGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAF 275
H N +++ Y ++VME C G D + E + AV L +A+
Sbjct: 112 R-HPNTIQYRGCYLREHTAWLVMEYCLGS-ASDLLEVHKKPLQEVEIAAVTHGALQGLAY 169
Query: 276 CHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLH 335
H ++HRD+K N L + E ++K DFG + + N VG+ Y++APEV+
Sbjct: 170 LHSHNMIHRDVKAGNILLS---EPGLVKLGDFGSASIM---APANSFVGTPYWMAPEVIL 223
Query: 336 RS----YSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVL----KADPSFDEAPWPS 387
Y + DVWS+G+ L P + A+ P+ W
Sbjct: 224 AMDEGQYDGKVDVWSLGITCIELAERKPPLF---NMNAMSALYHIAQNESPALQSGHW-- 278
Query: 388 LSSEARDFVKRLLNKDPRKRLTAAQALS 415
S R+FV L K P+ R T+ L
Sbjct: 279 -SEYFRNFVDSCLQKIPQDRPTSEVLLK 305
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 1e-42
Identities = 77/256 (30%), Positives = 131/256 (51%), Gaps = 18/256 (7%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHK-MTTAIAIEDVRREVKILRALTGHNNL 221
+G G +G + G G+ A+KV+ K + A E R E ++L + L
Sbjct: 62 LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 121
Query: 222 VKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGV 281
V A++ ++++++ GGEL LS+ ++TE + + + +I+ + H G+
Sbjct: 122 VTLHYAFQTETKLHLILDYINGGELFTH-LSQRERFTEHEVQIYVGEIVLALEHLHKLGI 180
Query: 282 VHRDLKPENFLFTTKDENSVLKAIDFGLS--DFVRPDERLNDIVGSAYYVAPEVLHRS-- 337
++RD+K EN L D N + DFGLS ER D G+ Y+AP+++
Sbjct: 181 IYRDIKLENILL---DSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDS 237
Query: 338 -YSTEADVWSIGVIAYILLCGSRPFWA----RTESGIFRAVLKADPSFDEAPWPSLSSEA 392
+ D WS+GV+ Y LL G+ PF +++ I R +LK++P + P +S+ A
Sbjct: 238 GHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPY---P-QEMSALA 293
Query: 393 RDFVKRLLNKDPRKRL 408
+D ++RLL KDP+KRL
Sbjct: 294 KDLIQRLLMKDPKKRL 309
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 1e-42
Identities = 69/257 (26%), Positives = 123/257 (47%), Gaps = 22/257 (8%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLV 222
+GRG + + KK + A++V+ K + I+ V+ E + + H LV
Sbjct: 60 IGRGSYAKVLLVRLKK---TDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLV 116
Query: 223 KFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVV 282
++ ++ V+E GG+L+ + R K E+ A+ +I + + H +G++
Sbjct: 117 GLHSCFQTESRLFFVIEYVNGGDLMFH-MQRQRKLPEEHARFYSAEISLALNYLHERGII 175
Query: 283 HRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDERLNDIVGSAYYVAPEVLHR-SYST 340
+RDLK +N L D +K D+G+ + +RP + + G+ Y+APE+L Y
Sbjct: 176 YRDLKLDNVLL---DSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGF 232
Query: 341 EADVWSIGVIAYILLCGSRPFW---------ARTESGIFRAVLKADPSFDEAPWPSLSSE 391
D W++GV+ + ++ G PF TE +F+ +L+ P SLS +
Sbjct: 233 SVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRI---P-RSLSVK 288
Query: 392 ARDFVKRLLNKDPRKRL 408
A +K LNKDP++RL
Sbjct: 289 AASVLKSFLNKDPKERL 305
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 2e-42
Identities = 71/252 (28%), Positives = 114/252 (45%), Gaps = 17/252 (6%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLV 222
+G+G FG CA + + G+ A K + K ++ E +IL +V
Sbjct: 192 LGKGGFGEVCACQVRA---TGKMYACKKLEKKRIKKRKGEAMALNEKQIL-EKVNSRFVV 247
Query: 223 KFFDAYEDTDNVYVVMELCEGGELLDRILSRG-GKYTEDDAKAVMIQILNVVAFCHLQGV 281
AYE D + +V+ L GG+L I G + E A +I + H + +
Sbjct: 248 SLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERI 307
Query: 282 VHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHR-SYST 340
V+RDLKPEN L D++ ++ D GL+ V + + VG+ Y+APEV+ Y+
Sbjct: 308 VYRDLKPENILL---DDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTF 364
Query: 341 EADVWSIGVIAYILLCGSRPFWARTESG----IFRAVLKADPSFDEAPWPSLSSEARDFV 396
D W++G + Y ++ G PF R + + R V + + S +AR
Sbjct: 365 SPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYS----ERFSPQARSLC 420
Query: 397 KRLLNKDPRKRL 408
+LL KDP +RL
Sbjct: 421 SQLLCKDPAERL 432
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 2e-42
Identities = 79/299 (26%), Positives = 125/299 (41%), Gaps = 57/299 (19%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKM-------TTAIAIEDVRR 207
Y +++G G + K K VA+K I ++ TAI R
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKL---TDNLVALKEI---RLEHEEGAPCTAI------R 49
Query: 208 EVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEG--GELLDRILSRGGKYTEDDAKAV 265
EV +L+ L H N+V D ++ +V E + + LD G + K
Sbjct: 50 EVSLLKDLK-HANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLD---DCGNIINMHNVKLF 105
Query: 266 MIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDERLNDIVG 324
+ Q+L +A+CH Q V+HRDLKP+N L +E LK DFGL+ P + ++ V
Sbjct: 106 LFQLLRGLAYCHRQKVLHRDLKPQNLLI---NERGELKLADFGLARAKSIPTKTYDNEVV 162
Query: 325 SAYYVAPEVL--HRSYSTEADVWSIGVIAYILLCGSRPFWARTE----SGIFRAV----- 373
+ +Y P++L YST+ D+W +G I Y + G F T IFR +
Sbjct: 163 TLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTE 222
Query: 374 -----LKADPSFDEAP------------WPSLSSEARDFVKRLLNKDPRKRLTAAQALS 415
+ ++ F P L S+ D + +LL + R R++A A+
Sbjct: 223 ETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 2e-42
Identities = 83/324 (25%), Positives = 134/324 (41%), Gaps = 62/324 (19%)
Query: 135 SEPEPAAGLNKSFGFSKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKH 194
++ + ++ S S ++Y ++G G +G A + VA+K I
Sbjct: 14 AQTQGPGSMSVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTV---TNETVAIKRI--- 67
Query: 195 KM--------TTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGEL 246
++ TAI REV +L+ L H N+++ ++++ E E
Sbjct: 68 RLEHEEEGVPGTAI------REVSLLKELQ-HRNIIELKSVIHHNHRLHLIFEYAEND-- 118
Query: 247 LDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENS--VLKA 304
L + + + + K+ + Q++N V FCH + +HRDLKP+N L + D + VLK
Sbjct: 119 LKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKI 178
Query: 305 IDFGLS-DFVRPDERLNDIVGSAYYVAPEVL--HRSYSTEADVWSIGVIAYILLCGSRPF 361
DFGL+ F P + + + +Y PE+L R YST D+WSI I +L + F
Sbjct: 179 GDFGLARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLF 238
Query: 362 WARTE----SGIFRAVLKADPSFDEAPWP--------------------------SLSSE 391
+E IF VL P + WP L E
Sbjct: 239 PGDSEIDQLFKIFE-VLGL-PD--DTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDE 294
Query: 392 ARDFVKRLLNKDPRKRLTAAQALS 415
D + +L DP KR++A AL
Sbjct: 295 GLDLLTAMLEMDPVKRISAKNALE 318
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 5e-42
Identities = 84/306 (27%), Positives = 131/306 (42%), Gaps = 59/306 (19%)
Query: 149 FSKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKM--------TTAI 200
+ + KY+ E+VG G +G AK +G + VA+K I ++ +TAI
Sbjct: 15 YFQGLMEKYQKLEKVGEGTYGVVYKAKDSQGRI----VALKRI---RLDAEDEGIPSTAI 67
Query: 201 AIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEG--GELLDRILSRGGKYT 258
RE+ +L+ L H N+V D + +V E E ++LD
Sbjct: 68 ------REISLLKELH-HPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLD---ENKTGLQ 117
Query: 259 EDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDE 317
+ K + Q+L VA CH ++HRDLKP+N L + + LK DFGL+ F P
Sbjct: 118 DSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLI---NSDGALKLADFGLARAFGIPVR 174
Query: 318 RLNDIVGSAYYVAPEVL--HRSYSTEADVWSIGVIAYILLCGSRPFWARTE----SGIFR 371
V + +Y AP+VL + YST D+WSIG I ++ G F T+ IF
Sbjct: 175 SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFS 234
Query: 372 AV----------LKADPSFDEAP------------WPSLSSEARDFVKRLLNKDPRKRLT 409
+ ++ P + + P E D + +L DP KR++
Sbjct: 235 ILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRIS 294
Query: 410 AAQALS 415
A A++
Sbjct: 295 ARDAMN 300
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 5e-42
Identities = 74/272 (27%), Positives = 120/272 (44%), Gaps = 30/272 (11%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRA 214
+ E+ E VGRG FG C K + + + VA+K I + E++ L
Sbjct: 8 KEIEVEEVVGRGAFGVVC-----KAKWRAKDVAIKQIESESE-----RKAFIVELRQLSR 57
Query: 215 LTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAV--MIQILNV 272
+ H N+VK + A + V +VME EGG L + + A A+ +Q
Sbjct: 58 VN-HPNIVKLYGAC--LNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQG 114
Query: 273 VAFCH---LQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYV 329
VA+ H + ++HRDLKP N L +VLK DFG + + + + GSA ++
Sbjct: 115 VAYLHSMQPKALIHRDLKPPNLLLV--AGGTVLKICDFGTACDI--QTHMTNNKGSAAWM 170
Query: 330 APEVL-HRSYSTEADVWSIGVIAYILLCGSRPFW--ARTESGIFRAVLKAD-PSFDEAPW 385
APEV +YS + DV+S G+I + ++ +PF I AV P +
Sbjct: 171 APEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLP 230
Query: 386 PSLSSEARDFVKRLLNKDPRKRLTAAQALSEL 417
+ + R +KDP +R + + + +
Sbjct: 231 KPI----ESLMTRCWSKDPSQRPSMEEIVKIM 258
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 2e-41
Identities = 73/338 (21%), Positives = 126/338 (37%), Gaps = 50/338 (14%)
Query: 103 PFPPPSPAKHIKAVLA-------RRHGSVKPNEAAIPEGSEPEPAAGLNKSFGFSKHF-- 153
P P + A++ +R + + G G F
Sbjct: 14 RAPDIDPLE---ALMTNPVVPESKRFCWNCGRPVGRSDSETKGASEGWCPYCGSPYSFLP 70
Query: 154 --------ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDV 205
A +YE+ + G G+ A + + G+ V +K + A A
Sbjct: 71 QLNPGDIVAGQYEVKGCIAHGGLGWIYLALDRN--VNGRPVVLKGL--VHSGDAEAQAMA 126
Query: 206 RREVKILRALTGHNNLVKFFDAYEDTDN-----VYVVMELCEGGELLDRILSRGGKYTED 260
E + L + H ++V+ F+ E TD Y+VME G L G K
Sbjct: 127 MAERQFLAEVV-HPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK---GQKLPVA 182
Query: 261 DAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLN 320
+A A +++IL +++ H G+V+ DLKPEN + T E + K ID G V
Sbjct: 183 EAIAYLLEILPALSYLHSIGLVYNDLKPENIMLT---EEQL-KLIDLGA---VSRINSFG 235
Query: 321 DIVGSAYYVAPEVLHRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSF 380
+ G+ + APE++ + D++++G L R + P
Sbjct: 236 YLYGTPGFQAPEIVRTGPTVATDIYTVGRTLAALTLDLPTRNGRY--------VDGLP-- 285
Query: 381 DEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELL 418
++ P ++R ++ DPR+R T A+ +S L
Sbjct: 286 EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQL 323
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 2e-41
Identities = 61/308 (19%), Positives = 107/308 (34%), Gaps = 54/308 (17%)
Query: 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIA-----IEDVR 206
+ Y + + G +G CA +G VA+K + +
Sbjct: 19 AMQSPYTVQRFISSGSYGAVCAGVDSEGI----PVAIKRVFNTVSDGRTVNILSDSFLCK 74
Query: 207 ---REVKILRALTGHNNLVKFFD-----AYEDTDNVYVVMELCEGGELLDRIL-SRGGKY 257
RE+++L H N++ D +Y+V EL L +++ +
Sbjct: 75 RVLREIRLLNHFH-HPNILGLRDIFVHFEEPAMHKLYLVTELMRTD--LAQVIHDQRIVI 131
Query: 258 TEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDE 317
+ + M IL + H GVVHRDL P N L +N+ + DF L+ D
Sbjct: 132 SPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILL---ADNNDITICDFNLAREDTADA 188
Query: 318 RLNDIVGSAYYVAPEVL--HRSYSTEADVWSIGVIAYILLCG------------------ 357
V +Y APE++ + ++ D+WS G + +
Sbjct: 189 NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVE 248
Query: 358 -----SRPFWARTESGIFRAVLKAD-PSFDEAPW----PSLSSEARDFVKRLLNKDPRKR 407
S R L+ + W P+ A D + ++L +P++R
Sbjct: 249 VVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRR 308
Query: 408 LTAAQALS 415
++ QAL
Sbjct: 309 ISTEQALR 316
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 3e-41
Identities = 83/299 (27%), Positives = 125/299 (41%), Gaps = 55/299 (18%)
Query: 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMT--------TAIAIEDV 205
A +YE + +G G F A+ K Q VA+K I + TA+
Sbjct: 9 AKRYEKLDFLGEGQFATVYKARDKN---TNQIVAIKKIKLGHRSEAKDGINRTAL----- 60
Query: 206 RREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEG--GELLDRILSRGGKYTEDDAK 263
RE+K+L+ L+ H N++ DA+ N+ +V + E ++ T K
Sbjct: 61 -REIKLLQELS-HPNIIGLLDAFGHKSNISLVFDFMETDLEVIIK---DNSLVLTPSHIK 115
Query: 264 AVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDERLNDI 322
A M+ L + + H ++HRDLKP N L DEN VLK DFGL+ F P+
Sbjct: 116 AYMLMTLQGLEYLHQHWILHRDLKPNNLLL---DENGVLKLADFGLAKSFGSPNRAYTHQ 172
Query: 323 VGSAYYVAPEVL--HRSYSTEADVWSIGVIAYILLCGSRPFWA-RTE----SGIFRAV-- 373
V + +Y APE+L R Y D+W++G I LL PF ++ + IF +
Sbjct: 173 VVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLR-VPFLPGDSDLDQLTRIFETLGT 231
Query: 374 --------------LKADPSFDEAPW----PSLSSEARDFVKRLLNKDPRKRLTAAQAL 414
SF P + + D ++ L +P R+TA QAL
Sbjct: 232 PTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQAL 290
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 3e-41
Identities = 60/277 (21%), Positives = 115/277 (41%), Gaps = 32/277 (11%)
Query: 158 ELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTG 217
E+GE +G+G FG + G G+ VA+++I + ++ +REV R
Sbjct: 36 EIGELIGKGRFG-----QVYHGRWHGE-VAIRLIDIERDNED-QLKAFKREVMAYRQTR- 87
Query: 218 HNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCH 277
H N+V F A ++ ++ LC+G L + + + + +I+ + + H
Sbjct: 88 HENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLH 147
Query: 278 LQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS------DFVRPDERLNDIVGSAYYVAP 331
+G++H+DLK +N + +N + DFGL R +++L G ++AP
Sbjct: 148 AKGILHKDLKSKNVFY----DNGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAP 203
Query: 332 EVL----------HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLK-ADPSF 380
E++ +S +DV+++G I Y L PF + I + P+
Sbjct: 204 EIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNL 263
Query: 381 DEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSEL 417
+ E D + + +R T + + L
Sbjct: 264 ---SQIGMGKEISDILLFCWAFEQEERPTFTKLMDML 297
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 3e-41
Identities = 67/268 (25%), Positives = 114/268 (42%), Gaps = 22/268 (8%)
Query: 158 ELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTG 217
+ E++G G FG + E G VAVK++ + + + REV I++ L
Sbjct: 40 NIKEKIGAGSFG-----TVHRAEWHGSDVAVKILMEQDFHAE-RVNEFLREVAIMKRLR- 92
Query: 218 HNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAV--MIQILNVVAF 275
H N+V F A N+ +V E G L + G + D+ + + + + +
Sbjct: 93 HPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNY 152
Query: 276 CHLQG--VVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDER-LNDIVGSAYYVAPE 332
H + +VHR+LK N L D+ +K DFGLS G+ ++APE
Sbjct: 153 LHNRNPPIVHRNLKSPNLLV---DKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPE 209
Query: 333 VL-HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKAD--PSFDEAPWPSLS 389
VL + ++DV+S GVI + L +P+ + + AV E P +L+
Sbjct: 210 VLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRL---EIP-RNLN 265
Query: 390 SEARDFVKRLLNKDPRKRLTAAQALSEL 417
+ ++ +P KR + A + L
Sbjct: 266 PQVAAIIEGCWTNEPWKRPSFATIMDLL 293
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 5e-41
Identities = 66/214 (30%), Positives = 98/214 (45%), Gaps = 19/214 (8%)
Query: 158 ELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMT-TAIAIEDVRREVKILRALT 216
L E +G G FG K + G +VAVK + IE+VR+E K+ L
Sbjct: 10 TLEEIIGIGGFG-----KVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLK 64
Query: 217 GHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFC 276
H N++ N+ +VME GG L + G + D +QI + +
Sbjct: 65 -HPNIIALRGVCLKEPNLCLVMEFARGGPLNRVL--SGKRIPPDILVNWAVQIARGMNYL 121
Query: 277 HLQG---VVHRDLKPENFLFTTKDE-----NSVLKAIDFGLSDFVRPDERLNDIVGSAYY 328
H + ++HRDLK N L K E N +LK DFGL+ +++ G+ +
Sbjct: 122 HDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSA-AGAYAW 180
Query: 329 VAPEVL-HRSYSTEADVWSIGVIAYILLCGSRPF 361
+APEV+ +S +DVWS GV+ + LL G PF
Sbjct: 181 MAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPF 214
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 5e-41
Identities = 70/275 (25%), Positives = 121/275 (44%), Gaps = 27/275 (9%)
Query: 158 ELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKH----KMTTAIAIEDVRREVKILR 213
E +++G+G FG + K VA+K + + ++ +REV I+
Sbjct: 22 EYEKQIGKGGFGLVHKGRLVK---DKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78
Query: 214 ALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVV 273
L H N+VK + + +VME G+L R+L + +M+ I +
Sbjct: 79 NLN-HPNIVKLYGLM--HNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGI 135
Query: 274 AFCHLQG--VVHRDLKPENFLFTTKDENS--VLKAIDFGLSDFVRPDERLNDIVGSAYYV 329
+ Q +VHRDL+ N + DEN+ K DFGLS ++ ++G+ ++
Sbjct: 136 EYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQS--VHSVSGLLGNFQWM 193
Query: 330 APEVL---HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKAD----PSFDE 382
APE + SY+ +AD +S +I Y +L G PF + I + + P+ E
Sbjct: 194 APETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIPE 253
Query: 383 APWPSLSSEARDFVKRLLNKDPRKRLTAAQALSEL 417
P L R+ ++ + DP+KR + + EL
Sbjct: 254 DCPPRL----RNVIELCWSGDPKKRPHFSYIVKEL 284
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 9e-41
Identities = 84/308 (27%), Positives = 127/308 (41%), Gaps = 58/308 (18%)
Query: 148 GFSKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRR 207
G + Y + +G G FG AK G+ VA+K + + K R
Sbjct: 47 GPDRPQEVSYTDTKVIGNGSFGVVYQAKLCD---SGELVAIKKVLQDKRFKN-------R 96
Query: 208 EVKILRALTGHNNLVK----FFDAYEDTDNVYV--VMELCEG--GELLDRILSRGGKYTE 259
E++I+R L H N+V+ F+ + E D VY+ V++ +
Sbjct: 97 ELQIMRKLD-HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPV 155
Query: 260 DDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENS-VLKAIDFGLSDFVRPDER 318
K M Q+ +A+ H G+ HRD+KP+N L D ++ VLK DFG + + E
Sbjct: 156 IYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLL---DPDTAVLKLCDFGSAKQLVRGEP 212
Query: 319 LNDIVGSAYYVAPEVLHRS--YSTEADVWSIG-VIAYILLCGSRPFWARTESG------I 369
+ S YY APE++ + Y++ DVWS G V+A +LL +P + +SG I
Sbjct: 213 NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG--QPIF-PGDSGVDQLVEI 269
Query: 370 FRAVL----KAD-------------PSFDEAPW-----PSLSSEARDFVKRLLNKDPRKR 407
+ VL + P PW P EA RLL P R
Sbjct: 270 IK-VLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTAR 328
Query: 408 LTAAQALS 415
LT +A +
Sbjct: 329 LTPLEACA 336
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 1e-40
Identities = 65/275 (23%), Positives = 118/275 (42%), Gaps = 27/275 (9%)
Query: 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIA-IEDVRREVKIL 212
A+ E E+GRG +G + GQ +AVK I T + + ++ I
Sbjct: 6 ADDLEPIMELGRGAYGVVEKMRHVPS---GQIMAVKRIR---ATVNSQEQKRLLMDLDIS 59
Query: 213 RALTGHNNLVKFFDAYEDTDNVYVVMELCEGG--ELLDRILSRGGKYTEDDAKAVMIQIL 270
V F+ A +V++ MEL + + +++ +G ED + + I+
Sbjct: 60 MRTVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIV 119
Query: 271 NVVAFCHLQG-VVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYV 329
+ H + V+HRD+KP N L + +K DFG+S ++ D + G Y+
Sbjct: 120 KALEHLHSKLSVIHRDVKPSNVLINALGQ---VKMCDFGISGYLVDDVAKDIDAGCKPYM 176
Query: 330 APEVLH-----RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRA----VLKADPSF 380
APE ++ + YS ++D+WS+G+ L P+ + F+ V + P
Sbjct: 177 APERINPELNQKGYSVKSDIWSLGITMIELAILRFPY--DSWGTPFQQLKQVVEEPSPQL 234
Query: 381 DEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALS 415
+ S+E DF + L K+ ++R T + +
Sbjct: 235 PADKF---SAEFVDFTSQCLKKNSKERPTYPELMQ 266
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 1e-40
Identities = 69/278 (24%), Positives = 113/278 (40%), Gaps = 36/278 (12%)
Query: 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIA-IEDVRREVKIL 212
N E E+G G G +F+K G +AVK + + + + ++ ++
Sbjct: 24 INDLENLGEMGSGTCGQVWKMRFRKT---GHVIAVKQMR---RSGNKEENKRILMDLDVV 77
Query: 213 RALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNV 272
+V+ F + +V++ MEL G E + + I+
Sbjct: 78 LKSHDCPYIVQCFGTFITNTDVFIAMELMGTC-AEKLKKRMQGPIPERILGKMTVAIVKA 136
Query: 273 VAFCHLQ-GVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAP 331
+ + + GV+HRD+KP N L + + +K DFG+S + D+ + G A Y+AP
Sbjct: 137 LYYLKEKHGVIHRDVKPSNILLDERGQ---IKLCDFGISGRLVDDKAKDRSAGCAAYMAP 193
Query: 332 EVL------HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFR---AVLKADPSFDE 382
E + Y ADVWS+G+ L G P+ + F VL+ +P
Sbjct: 194 ERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPY--KNCKTDFEVLTKVLQEEP---- 247
Query: 383 APWPSL------SSEARDFVKRLLNKDPRKRLTAAQAL 414
P L S + + FVK L KD RKR + L
Sbjct: 248 ---PLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLL 282
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 2e-40
Identities = 64/272 (23%), Positives = 115/272 (42%), Gaps = 27/272 (9%)
Query: 158 ELGEEVGRGHFG--YTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRAL 215
+G+ +G G FG Y KG+ G VAVK++ T ++ + EV +LR
Sbjct: 27 TVGQRIGSGSFGTVY-------KGKWHGD-VAVKMLNVTAPTPQ-QLQAFKNEVGVLRKT 77
Query: 216 TGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAF 275
H N++ F + +V + CEG L + + K+ + Q + +
Sbjct: 78 R-HVNILLFMGYSTA-PQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDY 135
Query: 276 CHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS---DFVRPDERLNDIVGSAYYVAPE 332
H + ++HRDLK N E++ +K DFGL+ + + GS ++APE
Sbjct: 136 LHAKSIIHRDLKSNNIFL---HEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPE 192
Query: 333 VL----HRSYSTEADVWSIGVIAYILLCGSRPFWART-ESGIFRAVLKAD--PSFDEAPW 385
V+ YS ++DV++ G++ Y L+ G P+ I V + P +
Sbjct: 193 VIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVR- 251
Query: 386 PSLSSEARDFVKRLLNKDPRKRLTAAQALSEL 417
+ + + L K +R + + L+E+
Sbjct: 252 SNCPKRMKRLMAECLKKKRDERPSFPRILAEI 283
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 2e-40
Identities = 77/306 (25%), Positives = 127/306 (41%), Gaps = 60/306 (19%)
Query: 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKM-------TTAIAIEDVR 206
+++++ E++G G + K G VA+K + K+ +TAI
Sbjct: 4 SSQFKQLEKLGNGTYATVYKGLNKT---TGVYVALKEV---KLDSEEGTPSTAI------ 51
Query: 207 REVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEG--GELLD--RILSRGGKYTEDDA 262
RE+ +++ L H N+V+ +D + + +V E + + +D + + +
Sbjct: 52 REISLMKELK-HENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLV 110
Query: 263 KAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDERLND 321
K Q+L +AFCH ++HRDLKP+N L ++ LK DFGL+ F P +
Sbjct: 111 KYFQWQLLQGLAFCHENKILHRDLKPQNLLI---NKRGQLKLGDFGLARAFGIPVNTFSS 167
Query: 322 IVGSAYYVAPEVL--HRSYSTEADVWSIGVIAYILLCGSRPFWARTE----SGIFR---- 371
V + +Y AP+VL R+YST D+WS G I ++ G F + IF
Sbjct: 168 EVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGT 227
Query: 372 ----------------AVLKADPS------FDEAPWPSLSSEARDFVKRLLNKDPRKRLT 409
++ P L DF+ LL +P RL+
Sbjct: 228 PNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLS 287
Query: 410 AAQALS 415
A QAL
Sbjct: 288 AKQALH 293
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 3e-40
Identities = 65/278 (23%), Positives = 107/278 (38%), Gaps = 31/278 (11%)
Query: 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIA-IEDVRREVKIL 212
A + E+GRG +G K GQ +AVK I T + + ++ ++
Sbjct: 21 AEDLKDLGEIGRGAYGSVNKMVHKPS---GQIMAVKRIR---STVDEKEQKQLLMDLDVV 74
Query: 213 RALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILS-----RGGKYTEDDAKAVMI 267
+ +V+F+ A + ++ MEL D+ E+ + +
Sbjct: 75 MRSSDCPYIVQFYGALFREGDCWICMELMSTS--FDKFYKYVYSVLDDVIPEEILGKITL 132
Query: 268 QILNVVAFCHLQG-VVHRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDERLNDIVGS 325
+ + ++HRD+KP N L +K DFG+S V + D G
Sbjct: 133 ATVKALNHLKENLKIIHRDIKPSNILLDRSGN---IKLCDFGISGQLVDSIAKTRD-AGC 188
Query: 326 AYYVAPEVLH-----RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRA---VLKAD 377
Y+APE + + Y +DVWS+G+ Y L G P+ + +F V+K D
Sbjct: 189 RPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPY--PKWNSVFDQLTQVVKGD 246
Query: 378 -PSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQAL 414
P + S +FV L KD KR + L
Sbjct: 247 PPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELL 284
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 3e-40
Identities = 81/300 (27%), Positives = 123/300 (41%), Gaps = 57/300 (19%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRA 214
Y + +G G FG AK ++ +VA+K + + K RE++I+R
Sbjct: 40 IAYTNCKVIGNGSFGVVFQAK----LVESDEVAIKKVLQDK-------RFKNRELQIMRI 88
Query: 215 LTGHNNLVKFFDAY------EDTDNVYVVMELCEG--GELLDRILSRGGKYTEDDAKAVM 266
+ H N+V + +D + +V+E K M
Sbjct: 89 VK-HPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYM 147
Query: 267 IQILNVVAFCHLQGVVHRDLKPENFLFTTKDENS-VLKAIDFGLSDFVRPDERLNDIVGS 325
Q+L +A+ H G+ HRD+KP+N L D S VLK IDFG + + E + S
Sbjct: 148 YQLLRSLAYIHSIGICHRDIKPQNLLL---DPPSGVLKLIDFGSAKILIAGEPNVSYICS 204
Query: 326 AYYVAPEVLHRS--YSTEADVWSIGVIAYILLCGSRPFWARTESG------IFRAVL--- 374
YY APE++ + Y+T D+WS G + L+ G +P + ESG I + VL
Sbjct: 205 RYYRAPELIFGATNYTTNIDIWSTGCVMAELMQG-QPLF-PGESGIDQLVEIIK-VLGTP 261
Query: 375 -----------KADPSF---DEAPW-----PSLSSEARDFVKRLLNKDPRKRLTAAQALS 415
+ F P+ P +A D + RLL P RLTA +AL
Sbjct: 262 SREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC 321
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 3e-40
Identities = 72/273 (26%), Positives = 119/273 (43%), Gaps = 14/273 (5%)
Query: 151 KHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVK 210
K +Y++ +++G G A+ + +VA+K I ++ REV
Sbjct: 7 KIINERYKIVDKLGGGGMSTVYLAE---DTILNIKVAIKAIFIPPREKEETLKRFEREVH 63
Query: 211 ILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQIL 270
L+ H N+V D E+ D Y+VME EG L + + G + D A QIL
Sbjct: 64 NSSQLS-HQNIVSMIDVDEEDDCYYLVMEYIEGPTLSE-YIESHGPLSVDTAINFTNQIL 121
Query: 271 NVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERL---NDIVGSAY 327
+ + H +VHRD+KP+N L N LK DFG++ + + L N ++G+
Sbjct: 122 DGIKHAHDMRIVHRDIKPQNILID---SNKTLKIFDFGIAKALS-ETSLTQTNHVLGTVQ 177
Query: 328 YVAPEVLHRSYSTEA-DVWSIGVIAYILLCGSRPFWARTESGI-FRAVLKADPSFDEAPW 385
Y +PE + E D++SIG++ Y +L G PF T I + + + P+
Sbjct: 178 YFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVR 237
Query: 386 PSLSSEARDFVKRLLNKDPRKRLTAAQALSELL 418
+ + + R KD R Q + + L
Sbjct: 238 KDIPQSLSNVILRATEKDKANRYKTIQEMKDDL 270
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 3e-40
Identities = 80/313 (25%), Positives = 128/313 (40%), Gaps = 64/313 (20%)
Query: 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVR--REV 209
++Y + +G G G +A ++VA+K I + RE+
Sbjct: 8 DLGSRYMDLKPLGCGGNGLVFSAVDND---CDKRVAIKKIVLTDPQSVK-----HALREI 59
Query: 210 KILRALTGHNNLVKFFD--------------AYEDTDNVYVVMELCEGGELLDRILSRGG 255
KI+R L H+N+VK F+ + + ++VY+V E E L +L G
Sbjct: 60 KIIRRL-DHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETD--LANVL-EQG 115
Query: 256 KYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP 315
E+ A+ M Q+L + + H V+HRDLKP N T E+ VLK DFGL+ + P
Sbjct: 116 PLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINT--EDLVLKIGDFGLARIMDP 173
Query: 316 DERLNDI----VGSAYYVAPEVL--HRSYSTEADVWSIGVIAYILLCG------------ 357
+ + +Y +P +L +Y+ D+W+ G I +L G
Sbjct: 174 HYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQ 233
Query: 358 -----------SRPFWARTESGIFRAVLKADPSFDEAPW----PSLSSEARDFVKRLLNK 402
S ++ D + P P +S EA DF++++L
Sbjct: 234 MQLILESIPVVHEEDRQELLSV-IPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTF 292
Query: 403 DPRKRLTAAQALS 415
P RLTA +ALS
Sbjct: 293 SPMDRLTAEEALS 305
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 2e-39
Identities = 78/302 (25%), Positives = 134/302 (44%), Gaps = 54/302 (17%)
Query: 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPK--HKMTTAIAIEDVRREV 209
+Y+ VG G +G CAA K G +VAVK + + + A RE+
Sbjct: 26 EVPERYQNLSPVGSGAYGSVCAAFDTK---TGLRVAVKKLSRPFQSIIHAKRT---YREL 79
Query: 210 KILRALTGHNNLVKFFD------AYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAK 263
++L+ + H N++ D + E+ ++VY+V L L+ I+ + K T+D +
Sbjct: 80 RLLKHMK-HENVIGLLDVFTPARSLEEFNDVYLVTHLMGAD--LNNIV-KCQKLTDDHVQ 135
Query: 264 AVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP-DERLNDI 322
++ QIL + + H ++HRDLKP N +E+ LK +DFGL+ R + +
Sbjct: 136 FLIYQILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLA---RHTADEMTGY 189
Query: 323 VGSAYYVAPEVL--HRSYSTEADVWSIGVIAYILLCG----------------------- 357
V + +Y APE++ Y+ D+WS+G I LL G
Sbjct: 190 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTP 249
Query: 358 SRPFWARTESGIFRAVLKADPSFDEAPW----PSLSSEARDFVKRLLNKDPRKRLTAAQA 413
+ S R +++ + + + A D ++++L D KR+TAAQA
Sbjct: 250 GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQA 309
Query: 414 LS 415
L+
Sbjct: 310 LA 311
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 7e-39
Identities = 79/299 (26%), Positives = 133/299 (44%), Gaps = 55/299 (18%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPK--HKMTTAIAIEDVRREVKIL 212
Y VG G +G C+A K+ G++VA+K + + A RE+ +L
Sbjct: 24 KTYVSPTHVGSGAYGSVCSAIDKR---SGEKVAIKKLSRPFQSEIFAKRA---YRELLLL 77
Query: 213 RALTGHNNLVKFFDA------YEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVM 266
+ + H N++ D + + Y+VM + L +I+ K++E+ + ++
Sbjct: 78 KHMQ-HENVIGLLDVFTPASSLRNFYDFYLVMPFMQTD--LQKIMGL--KFSEEKIQYLV 132
Query: 267 IQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP-DERLNDIVGS 325
Q+L + + H GVVHRDLKP N +E+ LK +DFGL+ R D + V +
Sbjct: 133 YQMLKGLKYIHSAGVVHRDLKPGNLAV---NEDCELKILDFGLA---RHADAEMTGYVVT 186
Query: 326 AYYVAPEVL--HRSYSTEADVWSIGVIAYILLCG-----------------------SRP 360
+Y APEV+ Y+ D+WS+G I +L G
Sbjct: 187 RWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTE 246
Query: 361 FWARTESGIFRAVLKADPSFDEAPW----PSLSSEARDFVKRLLNKDPRKRLTAAQALS 415
F + ++ +++ P + P S +A D ++++L D KRLTAAQAL+
Sbjct: 247 FVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 305
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 1e-38
Identities = 78/322 (24%), Positives = 138/322 (42%), Gaps = 57/322 (17%)
Query: 135 SEPEPAAGLNKSFGFSK---HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVI 191
S P PA +K Y + VG G +G C+A + G +VA+K +
Sbjct: 2 SSPPPARSGFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGR---TGAKVAIKKL 58
Query: 192 PK--HKMTTAIAIEDVRREVKILRALTGHNNLVKFFDA------YEDTDNVYVVMELCEG 243
+ A RE+++L+ + H N++ D +D + Y+VM
Sbjct: 59 YRPFQSELFAKRA---YRELRLLKHMR-HENVIGLLDVFTPDETLDDFTDFYLVMPFMGT 114
Query: 244 GELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLK 303
L +++ + K ED + ++ Q+L + + H G++HRDLKP N +E+ LK
Sbjct: 115 D--LGKLM-KHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAV---NEDCELK 168
Query: 304 AIDFGLSDFVRP-DERLNDIVGSAYYVAPEVL--HRSYSTEADVWSIGVIAYILLCG--- 357
+DFGL+ R D + V + +Y APEV+ Y+ D+WS+G I ++ G
Sbjct: 169 ILDFGLA---RQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTL 225
Query: 358 --------------------SRPFWARTESGIFRAVLKADPSFDEAPW----PSLSSEAR 393
F R +S + +K P ++ + + S A
Sbjct: 226 FKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAV 285
Query: 394 DFVKRLLNKDPRKRLTAAQALS 415
+ ++++L D +R+TA +AL+
Sbjct: 286 NLLEKMLVLDAEQRVTAGEALA 307
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 2e-38
Identities = 73/319 (22%), Positives = 121/319 (37%), Gaps = 65/319 (20%)
Query: 145 KSFGFSKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIED 204
+ S+ +++++ G+G FG K K G VA+K + +
Sbjct: 13 AADERSRKEMDRFQVERMAGQGTFGTVQLGKEKS---TGMSVAIKKVIQDPRFR------ 63
Query: 205 VRREVKILRALT--GHNNLVKFFDAY-----EDTDNVY--VVMELCEGGELLDRILSRGG 255
RE++I++ L H N+V+ + D ++Y VVME + L R
Sbjct: 64 -NRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVP--DTLHRCCRNYY 120
Query: 256 KY----TEDDAKAVMIQILNVVAFCHLQ--GVVHRDLKPENFLFTTKDENSVLKAIDFGL 309
+ K + Q++ + HL V HRD+KP N L + LK DFG
Sbjct: 121 RRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNE--ADGTLKLCDFGS 178
Query: 310 SDFVRPDERLNDIVGSAYYVAPEVL--HRSYSTEADVWSIG-VIAYILL-----CG---- 357
+ + P E + S YY APE++ ++ Y+T D+WS+G + A ++L G
Sbjct: 179 AKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSA 238
Query: 358 -------------SRPFWARTESGIFRAVLKADPSFDEAPW--------PSLSSEARDFV 396
SR + + PW + EA D +
Sbjct: 239 GQLHEIVRVLGCPSREVLRKLNPSHTD---VDLYNSKGIPWSNVFSDHSLKDAKEAYDLL 295
Query: 397 KRLLNKDPRKRLTAAQALS 415
LL P +R+ +AL
Sbjct: 296 SALLQYLPEERMKPYEALC 314
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 2e-38
Identities = 76/302 (25%), Positives = 115/302 (38%), Gaps = 55/302 (18%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMT--------TAIAIEDVR 206
++YE E+G G +G A+ G VA+K + + +
Sbjct: 9 SRYEPVAEIGVGAYGTVYKARDPH---SGHFVALKSVRVPNGGGGGGGLPISTV------ 59
Query: 207 REVKILRAL--TGHNNLVKFFD-----AYEDTDNVYVVMELCEG--GELLDRILSRGGKY 257
REV +LR L H N+V+ D + V +V E + LD+
Sbjct: 60 REVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKA--PPPGL 117
Query: 258 TEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDE 317
+ K +M Q L + F H +VHRDLKPEN L +K DFGL+
Sbjct: 118 PAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILV---TSGGTVKLADFGLARIYSYQM 174
Query: 318 RLNDIVGSAYYVAPEVL-HRSYSTEADVWSIGVIAYILLCGSRPFWARTE----SGIFRA 372
L +V + +Y APEVL +Y+T D+WS+G I + F +E IF
Sbjct: 175 ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDL 234
Query: 373 VLKAD----PSFDEAPW---------------PSLSSEARDFVKRLLNKDPRKRLTAAQA 413
+ P P P + + +L +P KR++A +A
Sbjct: 235 IGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRA 294
Query: 414 LS 415
L
Sbjct: 295 LQ 296
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 4e-38
Identities = 78/305 (25%), Positives = 125/305 (40%), Gaps = 63/305 (20%)
Query: 155 NKYELGEEVGRGHFG--YTCAAKFKKGELKGQQVAVKVIPKHKM--------TTAIAIED 204
+YE E+G G +G + K + + G+ VA+K + ++ + I
Sbjct: 11 QQYECVAEIGEGAYGKVF----KARDLKNGGRFVALKRV---RVQTGEEGMPLSTI---- 59
Query: 205 VRREVKILRAL--TGHNNLVKFFD-----AYEDTDNVYVVMELCEG--GELLDRILSRGG 255
REV +LR L H N+V+ FD + + +V E + LD++
Sbjct: 60 --REVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKV--PEP 115
Query: 256 KYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP 315
+ K +M Q+L + F H VVHRDLKP+N L + +K DFGL+
Sbjct: 116 GVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILV---TSSGQIKLADFGLARIYSF 172
Query: 316 DERLNDIVGSAYYVAPEVL-HRSYSTEADVWSIGVIAYILLCGSRP-FWARTE----SGI 369
L +V + +Y APEVL SY+T D+WS+G I + +P F ++ I
Sbjct: 173 QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRR-KPLFRGSSDVDQLGKI 231
Query: 370 FRAVLKAD----PSFDEAPW---------------PSLSSEARDFVKRLLNKDPRKRLTA 410
+ P P + +D + + L +P KR++A
Sbjct: 232 LDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISA 291
Query: 411 AQALS 415
ALS
Sbjct: 292 YSALS 296
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 5e-38
Identities = 75/277 (27%), Positives = 119/277 (42%), Gaps = 17/277 (6%)
Query: 151 KHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVK 210
H +++YELGE +G G A+ + VAVKV+ RRE +
Sbjct: 8 SHLSDRYELGEILGFGGMSEVHLAR---DLRDHRDVAVKVLRADLARDPSFYLRFRREAQ 64
Query: 211 ILRALTGHNNLVKFFDAYEDTDN----VYVVMELCEGGELLDRILSRGGKYTEDDAKAVM 266
AL H +V +D E Y+VME +G L D I+ G T A V+
Sbjct: 65 NAAALN-HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRD-IVHTEGPMTPKRAIEVI 122
Query: 267 IQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGL----SDFVRPDERLNDI 322
+ F H G++HRD+KP N + + + +K +DFG+ +D + +
Sbjct: 123 ADACQALNFSHQNGIIHRDVKPANIMIS---ATNAVKVMDFGIARAIADSGNSVTQTAAV 179
Query: 323 VGSAYYVAPEVLHRSYSTEA-DVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFD 381
+G+A Y++PE DV+S+G + Y +L G PF + + ++ DP
Sbjct: 180 IGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPP 239
Query: 382 EAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELL 418
A LS++ V + L K+P R A + L
Sbjct: 240 SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADL 276
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 2e-37
Identities = 80/302 (26%), Positives = 124/302 (41%), Gaps = 56/302 (18%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVI-PKHKMTTAIAIEDVR--REVKI 211
+Y +G G +G C+A +VA+K I P T R RE+KI
Sbjct: 27 PRYTNLSYIGEGAYGMVCSAYDNL---NKVRVAIKKISPFEHQTYCQ-----RTLREIKI 78
Query: 212 LRALTGHNNLVKFFD-----AYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVM 266
L H N++ D E +VY+V +L E L ++L + + D +
Sbjct: 79 LLRFR-HENIIGINDIIRAPTIEQMKDVYIVQDLMETD--LYKLL-KTQHLSNDHICYFL 134
Query: 267 IQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDI---- 322
QIL + + H V+HRDLKP N L + LK DFGL+ PD
Sbjct: 135 YQILRGLKYIHSANVLHRDLKPSNLLL---NTTCDLKICDFGLARVADPDHDHTGFLTEY 191
Query: 323 VGSAYYVAPEVL--HRSYSTEADVWSIGVIAYILLCG----------------------- 357
V + +Y APE++ + Y+ D+WS+G I +L
Sbjct: 192 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSP 251
Query: 358 SRPFWARTESGIFRAVLKADPSFDEAPW----PSLSSEARDFVKRLLNKDPRKRLTAAQA 413
S+ + R L + P ++ PW P+ S+A D + ++L +P KR+ QA
Sbjct: 252 SQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 311
Query: 414 LS 415
L+
Sbjct: 312 LA 313
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 2e-37
Identities = 88/314 (28%), Positives = 135/314 (42%), Gaps = 66/314 (21%)
Query: 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVI-PKHKMTTAIAIEDVR--RE 208
+ ++ ++L +G G +G C+A K G+ VA+K I P K A+ R RE
Sbjct: 8 NISSDFQLKSLLGEGAYGVVCSATHKP---TGEIVAIKKIEPFDKPLFAL-----RTLRE 59
Query: 209 VKILRALTGHNNLVKFFD-----AYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAK 263
+KIL+ H N++ F+ ++E+ + VY++ EL + L R++ ++D +
Sbjct: 60 IKILKHFK-HENIITIFNIQRPDSFENFNEVYIIQELMQTD--LHRVI-STQMLSDDHIQ 115
Query: 264 AVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIV 323
+ Q L V H V+HRDLKP N L + N LK DFGL+ + N
Sbjct: 116 YFIYQTLRAVKVLHGSNVIHRDLKPSNLLI---NSNCDLKVCDFGLARIIDESAADNSEP 172
Query: 324 GSA-----------YYVAPEVL--HRSYSTEADVWSIGVIAYILLCGSRPFW-------- 362
+Y APEV+ YS DVWS G I L RP +
Sbjct: 173 TGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLR-RPIFPGRDYRHQ 231
Query: 363 -----------------ARTESGIFRAVLKADPSFDEAPW----PSLSSEARDFVKRLLN 401
ES R +K+ P + AP P ++ + D ++R+L
Sbjct: 232 LLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLV 291
Query: 402 KDPRKRLTAAQALS 415
DP KR+TA +AL
Sbjct: 292 FDPAKRITAKEALE 305
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 5e-37
Identities = 55/272 (20%), Positives = 98/272 (36%), Gaps = 31/272 (11%)
Query: 158 ELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTG 217
++ H G KG +G + VKV+ +T D E LR +
Sbjct: 13 NFLTKLNENHSGELW-----KGRWQGNDIVVKVLKVRDWSTRK-SRDFNEECPRLRIFS- 65
Query: 218 HNNLVKFFDAYED--TDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAV--MIQILNVV 273
H N++ A + + ++ G L + +L G + D ++AV + + +
Sbjct: 66 HPNVLPVLGACQSPPAPHPTLITHWMPYGSLYN-VLHEGTNFVVDQSQAVKFALDMARGM 124
Query: 274 AFCHLQG--VVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAP 331
AF H + L + + DE+ + + + + + +VAP
Sbjct: 125 AFLHTLEPLIPRHALNSRSVMI---DEDMTARISMADVKFS----FQSPGRMYAPAWVAP 177
Query: 332 EVLHRS----YSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKAD--PSFDEAPW 385
E L + AD+WS V+ + L+ PF + I V P+ P
Sbjct: 178 EALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTI---P- 233
Query: 386 PSLSSEARDFVKRLLNKDPRKRLTAAQALSEL 417
P +S +K +N+DP KR + L
Sbjct: 234 PGISPHVSKLMKICMNEDPAKRPKFDMIVPIL 265
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 5e-37
Identities = 78/306 (25%), Positives = 125/306 (40%), Gaps = 26/306 (8%)
Query: 120 RHGSVKPNEAAIPEG---SEPEPAAGLNKSFGFSKHFANKYELGEEVGRGHFGYTCAAKF 176
H + E G FG Y L VGRG G A+
Sbjct: 5 HHHHHHSSGLVPRGSHMDGTAESREG--TQFG-------PYRLRRLVGRGGMGDVYEAE- 54
Query: 177 KKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYV 236
++ + VA+K++ + + + ++RE + L ++V D E +YV
Sbjct: 55 --DTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQ-EPHVVPIHDFGEIDGQLYV 111
Query: 237 VMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTK 296
M L G +L +L R G A A++ QI + + H G HRD+KPEN L +
Sbjct: 112 DMRLINGVDL-AAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSAD 170
Query: 297 DENSVLKAIDFGLSDFVRPDERL---NDIVGSAYYVAPEVLHRSYSTE-ADVWSIGVIAY 352
D +DFG++ DE+L + VG+ YY+APE S++T AD++++ + Y
Sbjct: 171 D---FAYLVDFGIASAT-TDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLY 226
Query: 353 ILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQ 412
L GS P+ S + + +A P P + + R + K+P R
Sbjct: 227 ECLTGSPPYQGDQLSVMGAHINQAIPRPSTVR-PGIPVAFDAVIARGMAKNPEDRYVTCG 285
Query: 413 ALSELL 418
LS
Sbjct: 286 DLSAAA 291
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 138 bits (348), Expect = 5e-37
Identities = 57/318 (17%), Positives = 113/318 (35%), Gaps = 64/318 (20%)
Query: 154 ANKYELGEEVGRGH--FGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKI 211
YEL +G+G A++K G+ V V+ I + + + ++ E+ +
Sbjct: 24 GGCYELLTVIGKGFEDLMTVNLARYKP---TGEYVTVRRINLEACSNEM-VTFLQGELHV 79
Query: 212 LRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRI-LSRGGKYTEDDAKAVMIQIL 270
+ H N+V + + + ++VV G D I E ++ +L
Sbjct: 80 SKLFN-HPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVL 138
Query: 271 NVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDERLN-------DI 322
+ + H G VHR +K + L + + + + + +R
Sbjct: 139 KALDYIHHMGYVHRSVKASHILIS---VDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYS 195
Query: 323 VGSAYYVAPEVLHRS---YSTEADVWSIGVIAYILLCGSRPF------------------ 361
V +++PEVL ++ Y ++D++S+G+ A L G PF
Sbjct: 196 VKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVP 255
Query: 362 ------------------WARTESGIFRAVLKADPSFDEAPWPS------LSSEARDFVK 397
+ SG+ ++ + P PS S FV+
Sbjct: 256 CLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVE 315
Query: 398 RLLNKDPRKRLTAAQALS 415
+ L ++P R +A+ L+
Sbjct: 316 QCLQRNPDARPSASTLLN 333
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 2e-36
Identities = 70/311 (22%), Positives = 126/311 (40%), Gaps = 67/311 (21%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPK--HKMTTAIAIEDVR--REVK 210
+Y+ + +G G G CAA + VA+K + + T A R RE+
Sbjct: 25 KRYQNLKPIGSGAQGIVCAAYDAI---LERNVAIKKLSRPFQNQTHAK-----RAYRELV 76
Query: 211 ILRALTGHNNLVKFFDA------YEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKA 264
+++ + H N++ + E+ +VY+VMEL + L +++ + +
Sbjct: 77 LMKCV-NHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQM--ELDHERMSY 131
Query: 265 VMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVG 324
++ Q+L + H G++HRDLKP N + + LK +DFGL+ + V
Sbjct: 132 LLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTPYVV 188
Query: 325 SAYYVAPEV-LHRSYSTEADVWSIGVIAYILLCG-----------------------SRP 360
+ YY APEV L Y D+WS+G I ++ G
Sbjct: 189 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPE 248
Query: 361 FWARTESGIFRAVLKADPSFDEAPW----------------PSLSSEARDFVKRLLNKDP 404
F + + + R ++ P + + +S+ARD + ++L D
Sbjct: 249 FMKKLQPTV-RTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDA 307
Query: 405 RKRLTAAQALS 415
KR++ +AL
Sbjct: 308 SKRISVDEALQ 318
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 136 bits (343), Expect = 2e-36
Identities = 68/308 (22%), Positives = 117/308 (37%), Gaps = 61/308 (19%)
Query: 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILR 213
+ +E E+G G+ G K G +A K+I + RE+++L
Sbjct: 32 DDDFEKISELGAGNGGVVFKVSHKPS---GLVMARKLIHLE--IKPAIRNQIIRELQVLH 86
Query: 214 ALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVV 273
+V F+ A+ + + ME +GG LD++L + G+ E V I ++ +
Sbjct: 87 ECN-SPYIVGFYGAFYSDGEISICMEHMDGG-SLDQVLKKAGRIPEQILGKVSIAVIKGL 144
Query: 274 AFCHLQG-VVHRDLKPENFLFTTKDENSVLKAIDFG----LSDFVRPDERLNDIVGSAYY 328
+ + ++HRD+KP N L ++ E +K DFG L D + N VG+ Y
Sbjct: 145 TYLREKHKIMHRDVKPSNILVNSRGE---IKLCDFGVSGQLIDSMA-----NSFVGTRSY 196
Query: 329 VAPEVLHRS-YSTEADVWSIGVIAYILLCGSRPF--------------------WARTES 367
++PE L + YS ++D+WS+G+ + G P
Sbjct: 197 MSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPR 256
Query: 368 GIFRAVLKADPSFDEAPWPSL--------------------SSEARDFVKRLLNKDPRKR 407
D P ++ S E +DFV + L K+P +R
Sbjct: 257 PRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAER 316
Query: 408 LTAAQALS 415
Q +
Sbjct: 317 ADLKQLMV 324
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 2e-36
Identities = 51/220 (23%), Positives = 90/220 (40%), Gaps = 26/220 (11%)
Query: 158 ELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTG 217
GE +G+G FG K + + + + +EVK++R L
Sbjct: 13 IHGEVLGKGCFGQAI-----KVTHRETGEVMVMKELIRFDEE-TQRTFLKEVKVMRCLE- 65
Query: 218 HNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCH 277
H N++KF + + E +GG L I S +Y + I + +A+ H
Sbjct: 66 HPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLH 125
Query: 278 LQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLND---------------I 322
++HRDL N L EN + DFGL+ + ++ + +
Sbjct: 126 SMNIIHRDLNSHNCLV---RENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTV 182
Query: 323 VGSAYYVAPEVL-HRSYSTEADVWSIGVIAYILLCGSRPF 361
VG+ Y++APE++ RSY + DV+S G++ ++
Sbjct: 183 VGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNAD 222
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 8e-36
Identities = 72/310 (23%), Positives = 127/310 (40%), Gaps = 67/310 (21%)
Query: 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPK--HKMTTAIAIEDVR--REVKI 211
+Y+ + +G G G CAA + VA+K + + T A R RE+ +
Sbjct: 63 RYQNLKPIGSGAQGIVCAAYDAV---LDRNVAIKKLSRPFQNQTHAK-----RAYRELVL 114
Query: 212 LRALTGHNNLVKFFDA------YEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAV 265
++ + H N++ + E+ +VY+VMEL + L +++ + + +
Sbjct: 115 MKCV-NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQM--ELDHERMSYL 169
Query: 266 MIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGS 325
+ Q+L + H G++HRDLKP N + + LK +DFGL+ + V +
Sbjct: 170 LYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTPYVVT 226
Query: 326 AYYVAPEV-LHRSYSTEADVWSIGVIAYILLCG-----------------------SRPF 361
YY APEV L Y D+WS+G I ++ F
Sbjct: 227 RYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEF 286
Query: 362 WARTESGIFRAVLKADPSFDEAPWPSL----------------SSEARDFVKRLLNKDPR 405
+ + + R ++ P + +P L +S+ARD + ++L DP
Sbjct: 287 MKKLQPTV-RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPA 345
Query: 406 KRLTAAQALS 415
KR++ AL
Sbjct: 346 KRISVDDALQ 355
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 4e-35
Identities = 68/334 (20%), Positives = 122/334 (36%), Gaps = 90/334 (26%)
Query: 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILR 213
+ KY LG+ +G G FG C + G++ A+K + + RE+ I++
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVFDIE---SGKRFALKKVLQDPRYK-------NRELDIMK 55
Query: 214 ALTGHNNLVKFFDAY--------------------------------------EDTDNVY 235
L H N++K D + +
Sbjct: 56 VLD-HVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLN 114
Query: 236 VVMELCEGGELLDRILSRGGKY----TEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENF 291
V+ME + L ++L + + + Q+ V F H G+ HRD+KP+N
Sbjct: 115 VIMEYVP--DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNL 172
Query: 292 LFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLH--RSYSTEADVWSIG- 348
L + +++ LK DFG + + P E + S +Y APE++ Y+ D+WSIG
Sbjct: 173 LVNS--KDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGC 230
Query: 349 VIAYILL-----CG-----------------SRPFWARTESGIFRAVLKADPSFDEAPWP 386
V ++L G ++ R P+ W
Sbjct: 231 VFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRF---PTLKAKDWR 287
Query: 387 SL-----SSEARDFVKRLLNKDPRKRLTAAQALS 415
+ S A D ++++L +P R+ +A++
Sbjct: 288 KILPEGTPSLAIDLLEQILRYEPDLRINPYEAMA 321
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 8e-35
Identities = 75/341 (21%), Positives = 126/341 (36%), Gaps = 95/341 (27%)
Query: 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVR----- 206
H KYEL +++G+G +G + ++ G+ VAVK I A ++
Sbjct: 6 HVLRKYELVKKLGKGAYGIVWKSIDRR---TGEVVAVKKIFD-------AFQNSTDAQRT 55
Query: 207 -REVKILRALTGHNNLVKFFDAY--EDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAK 263
RE+ IL L+GH N+V + ++ +VY+V + E L ++ R +
Sbjct: 56 FREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYMETD--LHAVI-RANILEPVHKQ 112
Query: 264 AVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIV 323
V+ Q++ V+ + H G++HRD+KP N L + +K DFGLS R+ + +
Sbjct: 113 YVVYQLIKVIKYLHSGGLLHRDMKPSNILL---NAECHVKVADFGLSRSFVNIRRVTNNI 169
Query: 324 GSA----------------------YYVAPEVL--HRSYSTEADVWSIGVI--------- 350
+ +Y APE+L Y+ D+WS+G I
Sbjct: 170 PLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKP 229
Query: 351 -----------------------------------AYILLCGSRPFWARTESGIFRAVLK 375
I + +S K
Sbjct: 230 IFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKV--EIRQSNKRDIFTK 287
Query: 376 ADPSFDEA-PWPSLSSEARDFVKRLLNKDPRKRLTAAQALS 415
+ P + EA D + +LL +P KR++A AL
Sbjct: 288 WKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISANDALK 328
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 8e-34
Identities = 81/322 (25%), Positives = 120/322 (37%), Gaps = 88/322 (27%)
Query: 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKM--------TTAIAIEDV 205
+KYE ++G+G FG A+ +K GQ+VA+K K M TA+
Sbjct: 16 VSKYEKLAKIGQGTFGEVFKARHRK---TGQKVALK---KVLMENEKEGFPITAL----- 64
Query: 206 RREVKILRALTGHNNLVKFFD--------AYEDTDNVYVVMELCEG--GELLDRILSRGG 255
RE+KIL+ L H N+V + ++Y+V + CE LL +
Sbjct: 65 -REIKILQLLK-HENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLS---NVLV 119
Query: 256 KYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP 315
K+T + K VM +LN + + H ++HRD+K N L + VLK DFGL+
Sbjct: 120 KFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLI---TRDGVLKLADFGLARAFSL 176
Query: 316 DERLNDIVGSAY--------YVAPEVL--HRSYSTEADVWSIGVIAYILLCGSRP-FWAR 364
+ + Y Y PE+L R Y D+W G I + P
Sbjct: 177 AKNSQP---NRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTR-SPIMQGN 232
Query: 365 TESG----IFRAVLKADPSFDEAPWP----------------------------SLSSEA 392
TE I + S WP A
Sbjct: 233 TEQHQLALISQLC----GSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYA 288
Query: 393 RDFVKRLLNKDPRKRLTAAQAL 414
D + +LL DP +R+ + AL
Sbjct: 289 LDLIDKLLVLDPAQRIDSDDAL 310
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 4e-33
Identities = 77/324 (23%), Positives = 128/324 (39%), Gaps = 71/324 (21%)
Query: 154 ANKYE-LGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKM-TTAIAIEDVRREVKI 211
+ +E G +VGRG +G+ AK K G+ + A+K I + +A RE+ +
Sbjct: 19 EDLFEYEGCKVGRGTYGHVYKAKRKDGK-DDKDYALKQIEGTGISMSAC------REIAL 71
Query: 212 LRALTGHNNLVKFFDA-YEDTDN-VYVVMELCEG--GELLD-----RILSRGGKYTEDDA 262
LR L H N++ D V+++ + E ++ + + +
Sbjct: 72 LRELK-HPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMV 130
Query: 263 KAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTK-DENSVLKAIDFGL----SDFVRPDE 317
K+++ QIL+ + + H V+HRDLKP N L + E +K D G + ++P
Sbjct: 131 KSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLA 190
Query: 318 RLNDIVGSAYYVAPEVL--HRSYSTEADVWSIGVIAYILLCGSRP-FWARTESGIFRAVL 374
L+ +V + +Y APE+L R Y+ D+W+IG I LL P F R E
Sbjct: 191 DLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS-EPIFHCRQEDIKTSNPY 249
Query: 375 KAD-----------------PSFDEAPW--------------------------PSLSSE 391
D + P S+
Sbjct: 250 HHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSK 309
Query: 392 ARDFVKRLLNKDPRKRLTAAQALS 415
A +++LL DP KR+T+ QA+
Sbjct: 310 AFHLLQKLLTMDPIKRITSEQAMQ 333
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 4e-33
Identities = 38/291 (13%), Positives = 69/291 (23%), Gaps = 47/291 (16%)
Query: 126 PNEAAIPEGSEPEPAAGLNKSFGFSKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQ 185
+A P+ + P A + +Y L G A +Q
Sbjct: 11 RESSAPPDDVQLVPGARI---------ANGRYRLLIFHGGVPPLQFWQAL---DTALDRQ 58
Query: 186 VAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGE 245
VA+ + + +++ L + + + D VV E GG
Sbjct: 59 VALTFVDPQGVLPDDVLQETLSRTLRLSRID-KPGVARVLDVVHTRAGGLVVAEWIRGGS 117
Query: 246 LLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAI 305
L + + + A M + H GV P
Sbjct: 118 LQEVADTSP---SPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVR------------- 161
Query: 306 DFGLSDFVRPDERLNDIVGSAYYVAPEVLHRSYSTEADVWSIGVIAYILLCGSRPFWART 365
V D + ++ + + + D+ IG Y LL P
Sbjct: 162 -------VSIDGDV--VLAYPATMPDA------NPQDDIRGIGASLYALLVNRWPLPEAG 206
Query: 366 ESGIFRAVLKADPSFDEAPW---PSLSSEARDFVKRLLNKDPRKRLTAAQA 413
+ P + + R + D R +
Sbjct: 207 VRSGLAPAERDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIRSASTLL 257
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 5e-33
Identities = 72/353 (20%), Positives = 126/353 (35%), Gaps = 103/353 (29%)
Query: 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPK--HKMTTAIAIEDVR--R 207
H + Y + +GRG +GY A K + VA+K + + + R R
Sbjct: 23 HVPDNYIIKHLIGRGSYGYVYLAYDKN---TEKNVAIKKVNRMFEDLIDCK-----RILR 74
Query: 208 EVKILRALTGHNNLVKFFD-----AYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDA 262
E+ IL L + +++ +D D +Y+V+E+ + L ++ TE+
Sbjct: 75 EITILNRL-KSDYIIRLYDLIIPDDLLKFDELYIVLEIADSD--LKKLFKTPIFLTEEHI 131
Query: 263 KAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDI 322
K ++ +L F H G++HRDLKP N L +++ +K DFGL+ + ++ N +
Sbjct: 132 KTILYNLLLGENFIHESGIIHRDLKPANCLL---NQDCSVKVCDFGLARTINSEKDTNIV 188
Query: 323 VGSA-----------------------YYVAPEVL--HRSYSTEADVWSIGVIAYILLCG 357
+Y APE++ +Y+ D+WS G I LL
Sbjct: 189 NDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNM 248
Query: 358 SRPFWARTESG--------------------------------IF--------------- 370
+ + IF
Sbjct: 249 LQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNIN 308
Query: 371 ----RAVLKADPSFDEAPW----PSLSSEARDFVKRLLNKDPRKRLTAAQALS 415
+K P PS+S + + ++ +L +P KR+T QAL
Sbjct: 309 KPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALD 361
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 8e-33
Identities = 75/327 (22%), Positives = 123/327 (37%), Gaps = 74/327 (22%)
Query: 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKI 211
+ +Y L ++G GHF AK VA+K++ K+ T A + E+K+
Sbjct: 16 YKDARYILVRKLGWGHFSTVWLAKDMV---NNTHVAMKIVRGDKVYTEAAED----EIKL 68
Query: 212 LRALT----------GHNNLVKFFDAYE----DTDNVYVVMELCEGGELLDRI-LSRGGK 256
L+ + G N+++K D + + +V +V E+ G LL I
Sbjct: 69 LQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRG 127
Query: 257 YTEDDAKAVMIQILNVVAFCHLQ-GVVHRDLKPENFLFTTKDEN---SVLKAIDFGLSDF 312
K + Q+L + + H + G++H D+KPEN L D +K D G + +
Sbjct: 128 IPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACW 187
Query: 313 VRPDERLNDIVGSAYYVAPEV-LHRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFR 371
DE + + + Y +PEV L + AD+WS + + L+ G F +
Sbjct: 188 Y--DEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTK 245
Query: 372 ---------AVLKADPS------------FDE----------APWP----------SLSS 390
+L PS F+ WP
Sbjct: 246 DDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKD 305
Query: 391 EAR---DFVKRLLNKDPRKRLTAAQAL 414
EA+ DF+ +L DPRKR A +
Sbjct: 306 EAKEISDFLSPMLQLDPRKRADAGGLV 332
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 5e-32
Identities = 66/302 (21%), Positives = 118/302 (39%), Gaps = 57/302 (18%)
Query: 158 ELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTG 217
L E +G+G FG +G+ +G++VAVK+ + + E+ L
Sbjct: 45 VLQESIGKGRFGEVW-----RGKWRGEEVAVKIFSSREERSWFR----EAEIYQTVMLR- 94
Query: 218 HNNLVKFFDAYEDTDNV----YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVV 273
H N++ F A + ++V + E G L D L+R T + + + + +
Sbjct: 95 HENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFD-YLNR-YTVTVEGMIKLALSTASGL 152
Query: 274 AFCHLQ--------GVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDI--- 322
A H++ + HRDLK +N L +N D GL+ DI
Sbjct: 153 AHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTCCIADLGLAVRHDSATDTIDIAPN 209
Query: 323 --VGSAYYVAPEVL-------HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGI-FRA 372
VG+ Y+APEVL H AD++++G++ + + + + +
Sbjct: 210 HRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD 269
Query: 373 VLKADPSFDEA-------------PWPSLSSEARDFVKRLL----NKDPRKRLTAAQALS 415
++ +DPS +E P S EA + +++ + RLTA +
Sbjct: 270 LVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 329
Query: 416 EL 417
L
Sbjct: 330 TL 331
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 2e-31
Identities = 79/396 (19%), Positives = 139/396 (35%), Gaps = 111/396 (28%)
Query: 118 ARRHGSVKPNEAAIPEGSEPEPAAGLNKSFGFSKHF--ANKYELGEEVGRGHFGYTCAAK 175
+ +V ++ + + + + ++YE+ +G G +G+ C A
Sbjct: 14 SGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHLIGTGSYGHVCEAY 73
Query: 176 FKKGELKGQQVAVKVIPK---HKMTTAIAIEDVRREVKILRALTGHNNLVKFFD-----A 227
K + + VA+K I + + + RE+ IL L H+++VK D
Sbjct: 74 DKL---EKRVVAIKKILRVFEDLIDCKRIL----REIAILNRL-NHDHVVKVLDIVIPKD 125
Query: 228 YEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLK 287
E D +YVV+E+ + ++ TE K ++ +L V + H G++HRDLK
Sbjct: 126 VEKFDELYVVLEIADSD--FKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLK 183
Query: 288 PENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSA--------------------- 326
P N L +++ +K DFGL+ V E N + +
Sbjct: 184 PANCLV---NQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQL 240
Query: 327 -------YYVAPEVL--HRSYSTEADVWSIGVI-AYILLC----------------GSRP 360
+Y APE++ +Y+ DVWSIG I A +L GS
Sbjct: 241 TGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSSC 300
Query: 361 FWARTESGIFRAVLKADPSF--------------DEAPWPSLSSE-ARDFVKR------- 398
F + E +L E A+ +++
Sbjct: 301 FPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGT 360
Query: 399 ---------------LLNK----DPRKRLTAAQALS 415
LL + +P KR+T + L+
Sbjct: 361 DLAERFPASSADAIHLLKRMLVFNPNKRITINECLA 396
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 4e-31
Identities = 62/303 (20%), Positives = 115/303 (37%), Gaps = 59/303 (19%)
Query: 158 ELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILR-ALT 216
L E VG+G +G + +G +G+ VAVK+ + RE ++ +
Sbjct: 11 TLLECVGKGRYG-----EVWRGSWQGENVAVKIFSSRDE------KSWFRETELYNTVML 59
Query: 217 GHNNLVKFFDAYEDTDN----VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNV 272
H N++ F + + + ++++ E G L D + + +++ I +
Sbjct: 60 RHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL--QLTTLDTVSCLRIVLSIASG 117
Query: 273 VAFCHLQ--------GVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDI-- 322
+A H++ + HRDLK +N L +N D GL+ D+
Sbjct: 118 LAHLHIEIFGTQGKPAIAHRDLKSKNILV---KKNGQCCIADLGLAVMHSQSTNQLDVGN 174
Query: 323 ---VGSAYYVAPEVL-------HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGI-FR 371
VG+ Y+APEVL D+W+ G++ + + + F
Sbjct: 175 NPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFY 234
Query: 372 AVLKADPSFDEA-----------PWPS--LSSEARDFVKRLL----NKDPRKRLTAAQAL 414
V+ DPSF++ P+ S + +L+ ++P RLTA +
Sbjct: 235 DVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIK 294
Query: 415 SEL 417
L
Sbjct: 295 KTL 297
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 2e-30
Identities = 76/328 (23%), Positives = 119/328 (36%), Gaps = 76/328 (23%)
Query: 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVI-PKHKMTTAIAIEDVRREVK 210
+ +YE+ + +G G FG K G+ VAVK++ + A E ++
Sbjct: 11 VLSARYEIVDTLGEGAFGKVVECIDHK--AGGRHVAVKIVKNVDRYCEAARSE-----IQ 63
Query: 211 ILRAL-----TGHNNLVKFFDAYEDTDNVYVVMELCEGG--ELLDRILSRGGKYTEDDAK 263
+L L V+ + +E ++ +V EL + + + D +
Sbjct: 64 VLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLP--FRLDHIR 121
Query: 264 AVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKD----------------ENSVLKAIDF 307
+ QI V F H + H DLKPEN LF D N +K +DF
Sbjct: 122 KMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDF 181
Query: 308 GLSDFVRPDERLNDIVGSAYYVAPEV-LHRSYSTEADVWSIGVIAYILLCGSRPFWARTE 366
G + + DE + +V + +Y APEV L +S DVWSIG I G F
Sbjct: 182 GSATYD--DEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDS 239
Query: 367 S----------GIF-RAVLKADPS-----FDEAPWPSLSSEAR----------------- 393
G + +++ D W SS R
Sbjct: 240 KEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQD 299
Query: 394 -------DFVKRLLNKDPRKRLTAAQAL 414
D ++++L DP KR+T +AL
Sbjct: 300 VEHERLFDLIQKMLEYDPAKRITLREAL 327
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 3e-30
Identities = 72/328 (21%), Positives = 113/328 (34%), Gaps = 76/328 (23%)
Query: 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVI-PKHKMTTAIAIEDVRREVK 210
+YE+ +G G FG QVA+K+I K A +E +
Sbjct: 16 WLQERYEIVGNLGEGTFGKVVECLDHARG--KSQVALKIIRNVGKYREAARLE-----IN 68
Query: 211 ILRAL-----TGHNNLVKFFDAYEDTDNVYVVMELCEGG--ELLDRILSRGGKYTEDDAK 263
+L+ + V D + ++ + EL E L + Y +
Sbjct: 69 VLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQP--YPLPHVR 126
Query: 264 AVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKD----------------ENSVLKAIDF 307
+ Q+ + + F H + H DLKPEN LF + +N+ ++ DF
Sbjct: 127 HMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADF 186
Query: 308 GLSDFVRPDERLNDIVGSAYYVAPEV-LHRSYSTEADVWSIGVIAYILLCGSRPFWARTE 366
G + F E IV + +Y PEV L ++ DVWSIG I + G F
Sbjct: 187 GSATFD--HEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHEN 244
Query: 367 ---------------SGIFRAVLKADPSFDE-APWPSLSSEAR----------------- 393
S + K + W SS+ R
Sbjct: 245 REHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDS 304
Query: 394 -------DFVKRLLNKDPRKRLTAAQAL 414
D ++R+L DP +R+T A+AL
Sbjct: 305 LEHVQLFDLMRRMLEFDPAQRITLAEAL 332
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 3e-30
Identities = 65/303 (21%), Positives = 117/303 (38%), Gaps = 59/303 (19%)
Query: 158 ELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILR-ALT 216
++ +++G+G +G + G+ +G++VAVKV + RE +I + L
Sbjct: 40 QMVKQIGKGRYG-----EVWMGKWRGEKVAVKVFFTTEE------ASWFRETEIYQTVLM 88
Query: 217 GHNNLVKFFDA----YEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNV 272
H N++ F A +Y++ + E G L D + + + ++
Sbjct: 89 RHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYL--KSTTLDAKSMLKLAYSSVSG 146
Query: 273 VAFCHLQ--------GVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDI-- 322
+ H + + HRDLK +N L +N D GL+ D DI
Sbjct: 147 LCHLHTEIFSTQGKPAIAHRDLKSKNILV---KKNGTCCIADLGLAVKFISDTNEVDIPP 203
Query: 323 ---VGSAYYVAPEVL-------HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGI-FR 371
VG+ Y+ PEVL H AD++S G+I + + E + +
Sbjct: 204 NTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYH 263
Query: 372 AVLKADPSFDEA-------------PWPSLSSEARDFVKRLL----NKDPRKRLTAAQAL 414
++ +DPS+++ P S E + +L+ +P RLTA +
Sbjct: 264 DLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVK 323
Query: 415 SEL 417
L
Sbjct: 324 KTL 326
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 4e-30
Identities = 58/231 (25%), Positives = 95/231 (41%), Gaps = 25/231 (10%)
Query: 158 ELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTG 217
L E++G G FG ++ K VAVK + ++ A++D REV + +L
Sbjct: 21 RLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD- 79
Query: 218 HNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCH 277
H NL++ + T + +V EL G LLDR+ G + +Q+ + +
Sbjct: 80 HRNLIRLY-GVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE 138
Query: 278 LQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYV-------- 329
+ +HRDL N L ++K DFGL + ++ Y +
Sbjct: 139 SKRFIHRDLAARNLLL---ATRDLVKIGDFGLMRALPQND-------DHYVMQEHRKVPF 188
Query: 330 ---APEVL-HRSYSTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAVLK 375
APE L R++S +D W GV + + G P+ S I + K
Sbjct: 189 AWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK 239
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 1e-29
Identities = 59/232 (25%), Positives = 96/232 (41%), Gaps = 32/232 (13%)
Query: 158 ELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTG 217
LGE++GRG+FG + + + VAVK + +E +IL+ +
Sbjct: 117 VLGEQIGRGNFGEVFSGRLRADN---TLVAVKSCRETLPPDLK--AKFLQEARILKQYS- 170
Query: 218 HNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCH 277
H N+V+ +Y+VMEL +GG+ L + + G + ++ + +
Sbjct: 171 HPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE 230
Query: 278 LQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYV-------- 329
+ +HRDL N L T E +VLK DFG+S Y
Sbjct: 231 SKCCIHRDLAARNCLVT---EKNVLKISDFGMSREEADGV---------YAASGGLRQVP 278
Query: 330 ----APEVL-HRSYSTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAVLK 375
APE L + YS+E+DVWS G++ + G+ P+ + V K
Sbjct: 279 VKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEK 330
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-29
Identities = 61/224 (27%), Positives = 99/224 (44%), Gaps = 22/224 (9%)
Query: 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVI-PKHKMTTAIAIEDVRREVK 210
H A +YE+ + +G+G FG A K Q VA+K++ + + A E ++
Sbjct: 94 HVAYRYEVLKVIGKGSFGQVVKAYDHK---VHQHVALKMVRNEKRFHRQAAEE-----IR 145
Query: 211 ILRAL-----TGHNNLVKFFDAYEDTDNVYVVMELCEGG--ELLDRILSRGGKYTEDDAK 263
IL L N++ + + +++ + EL EL+ + +G ++ +
Sbjct: 146 ILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQG--FSLPLVR 203
Query: 264 AVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIV 323
IL + H ++H DLKPEN L + S +K IDFG S + +R+ +
Sbjct: 204 KFAHSILQCLDALHKNRIIHCDLKPENILLKQQG-RSGIKVIDFGSSCYE--HQRVYTYI 260
Query: 324 GSAYYVAPEV-LHRSYSTEADVWSIGVIAYILLCGSRPFWARTE 366
S +Y APEV L Y D+WS+G I LL G E
Sbjct: 261 QSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDE 304
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 2e-29
Identities = 71/336 (21%), Positives = 118/336 (35%), Gaps = 86/336 (25%)
Query: 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVI-PKHKMTTAIAIEDVRREVK 210
N + + ++G G FG + + AVKV+ K T + IE
Sbjct: 32 LLNNAFLVIRKMGDGTFGRVLLCQHID---NKKYYAVKVVRNIKKYTRSAKIE-----AD 83
Query: 211 ILRAL----TGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKY---TEDDAK 263
IL+ + +NN+VK+ + D++ ++ E G L + + Y +D K
Sbjct: 84 ILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYE--IITRNNYNGFHIEDIK 140
Query: 264 AVMIQILNVVAFCHLQGVVHRDLKPENFLFT----------------------TKDENSV 301
I+IL + + + H DLKPEN L + +++
Sbjct: 141 LYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTG 200
Query: 302 LKAIDFGLSDFVRPDERLNDIVGSAYYVAPEV-LHRSYSTEADVWSIGVIAYILLCGSRP 360
+K IDFG + F + I+ + Y APEV L+ + +D+WS G + L GS
Sbjct: 201 IKLIDFGCATFK--SDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLL 258
Query: 361 FWARTE---------------SGIFRAVLKADPSF------DEAPWPSLSSEAR------ 393
F + K + S + WP +S
Sbjct: 259 FRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVK 318
Query: 394 ---------------DFVKRLLNKDPRKRLTAAQAL 414
DF+ +L DP R + A+ L
Sbjct: 319 KCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELL 354
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 9e-29
Identities = 55/225 (24%), Positives = 96/225 (42%), Gaps = 22/225 (9%)
Query: 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKI 211
+ ++YE+ +G+G FG A + + + VA+K+I K A + EV++
Sbjct: 51 KWMDRYEIDSLIGKGSFGQVVKAYDRV---EQEWVAIKIIKNKKAFLNQA----QIEVRL 103
Query: 212 LRAL-----TGHNNLVKFFDAYEDTDNVYVVMELCEGG--ELLDRILSRGGKYTEDDAKA 264
L + +V + +++ +V E+ +LL RG + + +
Sbjct: 104 LELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRG--VSLNLTRK 161
Query: 265 VMIQILNVVAFCHLQ--GVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDI 322
Q+ + F ++H DLKPEN L S +K +DFG S + +R+
Sbjct: 162 FAQQMCTALLFLATPELSIIHCDLKPENILLCNPK-RSAIKIVDFGSSCQL--GQRIYQY 218
Query: 323 VGSAYYVAPEV-LHRSYSTEADVWSIGVIAYILLCGSRPFWARTE 366
+ S +Y +PEV L Y D+WS+G I + G F E
Sbjct: 219 IQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANE 263
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 3e-28
Identities = 59/230 (25%), Positives = 101/230 (43%), Gaps = 36/230 (15%)
Query: 158 ELGEEVGRGHFGYTCAAKFKKGELKGQ-QVAVKVIPKHKMTTAIAIEDVRREVKILRALT 216
+E+G G FG G + +VA+K I + M+ ED E +++ L+
Sbjct: 11 TFVQEIGSGQFGLVH-----LGYWLNKDKVAIKTIREGAMSE----EDFIEEAEVMMKLS 61
Query: 217 GHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFC 276
H LV+ + + + +V E E G L D + ++ G + + + + + +A+
Sbjct: 62 -HPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL 120
Query: 277 HLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYV------- 329
V+HRDL N L EN V+K DFG++ FV D+ Y
Sbjct: 121 EEACVIHRDLAARNCLV---GENQVIKVSDFGMTRFVLDDQ---------YTSSTGTKFP 168
Query: 330 ----APEVL-HRSYSTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAV 373
+PEV YS+++DVWS GV+ + + G P+ R+ S + +
Sbjct: 169 VKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI 218
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 3e-28
Identities = 62/229 (27%), Positives = 100/229 (43%), Gaps = 36/229 (15%)
Query: 159 LGEEVGRGHFGYTCAAKFKKGELKGQ-QVAVKVIPKHKMTTAIAIEDVRREVKILRALTG 217
L +E+G G FG G+ KGQ VAVK+I + M+ ++ +E + + L+
Sbjct: 12 LLKELGSGQFGVVK-----LGKWKGQYDVAVKMIKEGSMSE----DEFFQEAQTMMKLS- 61
Query: 218 HNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCH 277
H LVKF+ +Y+V E G LL+ + S G + + +AF
Sbjct: 62 HPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLE 121
Query: 278 LQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYV-------- 329
+HRDL N L D + +K DFG++ +V D+ Y
Sbjct: 122 SHQFIHRDLAARNCLV---DRDLCVKVSDFGMTRYVLDDQ---------YVSSVGTKFPV 169
Query: 330 ---APEVL-HRSYSTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAV 373
APEV + YS+++DVW+ G++ + + G P+ T S + V
Sbjct: 170 KWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKV 218
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 7e-28
Identities = 51/230 (22%), Positives = 94/230 (40%), Gaps = 29/230 (12%)
Query: 158 ELGEEVGRGHFGYTCAAKFK-KGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALT 216
+ + +G G FG + +GE VA+K + + T+ A +++ E ++ ++
Sbjct: 18 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL--REATSPKANKEILDEAYVMASVD 75
Query: 217 GHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFC 276
+ ++ + T V ++ +L G LLD + +QI + +
Sbjct: 76 -NPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 133
Query: 277 HLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYV------- 329
+ +VHRDL N L +K DFGL+ + +E Y
Sbjct: 134 EDRRLVHRDLAARNVLVK---TPQHVKITDFGLAKLLGAEE--------KEYHAEGGKVP 182
Query: 330 ----APEVL-HRSYSTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAV 373
A E + HR Y+ ++DVWS GV + ++ GS+P+ S I +
Sbjct: 183 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 232
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-27
Identities = 54/232 (23%), Positives = 99/232 (42%), Gaps = 36/232 (15%)
Query: 158 ELGEEVGRGHFGYTCAAKFKKGELKGQ-QVAVKVIPKHKMTTAIAIEDVRREVKILRALT 216
+E+G G FG G+ +GQ VA+K+I + M+ ++ E K++ L+
Sbjct: 27 TFLKELGTGQFGVVK-----YGKWRGQYDVAIKMIKEGSMSE----DEFIEEAKVMMNLS 77
Query: 217 GHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFC 276
H LV+ + ++++ E G LL+ + ++ + + + +
Sbjct: 78 -HEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYL 136
Query: 277 HLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYV------- 329
+ +HRDL N L ++ V+K DFGLS +V DE Y
Sbjct: 137 ESKQFLHRDLAARNCLV---NDQGVVKVSDFGLSRYVLDDE---------YTSSVGSKFP 184
Query: 330 ----APEVL-HRSYSTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAVLK 375
PEVL + +S+++D+W+ GV+ + I G P+ T S + +
Sbjct: 185 VRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ 236
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 3e-27
Identities = 43/234 (18%), Positives = 78/234 (33%), Gaps = 31/234 (13%)
Query: 158 ELGEEVGRGHFGYTCAAKFK----KGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILR 213
E +G+G F + G+L +V +KV+ K + E ++
Sbjct: 11 IFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYS---ESFFEAASMMS 67
Query: 214 ALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVV 273
L+ H +LV + D +V E + G L + V Q+ +
Sbjct: 68 KLS-HKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAM 126
Query: 274 AFCHLQGVVHRDLKPENFLFTTKD-----ENSVLKAIDFGLSDFVRPDERLNDIVGSAYY 328
F ++H ++ +N L ++ +K D G+S V P +
Sbjct: 127 HFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD---------IL 177
Query: 329 ------VAPEVLH--RSYSTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAV 373
V PE + ++ + D WS G + I G +P A +
Sbjct: 178 QERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFY 231
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 5e-27
Identities = 58/229 (25%), Positives = 92/229 (40%), Gaps = 26/229 (11%)
Query: 158 ELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTG 217
+ + +G G G C + + + VA+K + T D E I+
Sbjct: 52 HIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKAL--KAGYTERQRRDFLSEASIMGQFD- 108
Query: 218 HNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCH 277
H N+++ +V E E G L + + G++T ++ + + +
Sbjct: 109 HPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLS 168
Query: 278 LQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYV-------- 329
G VHRDL N L D N V K DFGLS + D A Y
Sbjct: 169 DLGYVHRDLAARNVLV---DSNLVCKVSDFGLSRVLEDDP-------DAAYTTTGGKIPI 218
Query: 330 ---APEVL-HRSYSTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAV 373
APE + R++S+ +DVWS GV+ + +L G RP+W T + +V
Sbjct: 219 RWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSV 267
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 9e-27
Identities = 56/229 (24%), Positives = 85/229 (37%), Gaps = 29/229 (12%)
Query: 158 ELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTG 217
L +G G FG + + + VAVK K T E E I++ L
Sbjct: 15 VLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKD--CTLDNKEKFMSEAVIMKNLD- 71
Query: 218 HNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCH 277
H ++VK + + +++MEL GEL + +QI +A+
Sbjct: 72 HPHIVKLI-GIIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE 130
Query: 278 LQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYV-------- 329
VHRD+ N L +K DFGLS R I YY
Sbjct: 131 SINCVHRDIAVRNILV---ASPECVKLGDFGLS---R------YIEDEDYYKASVTRLPI 178
Query: 330 ---APEVL-HRSYSTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAV 373
+PE + R ++T +DVW V + IL G +PF+ + +
Sbjct: 179 KWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVL 227
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 1e-26
Identities = 57/242 (23%), Positives = 96/242 (39%), Gaps = 32/242 (13%)
Query: 158 ELGEEVGRGHFGYTCAAKFKK-GELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALT 216
+ ++G+G+FG ++ G+ G VAVK + + + D +RE++IL+AL
Sbjct: 26 KYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQL---QHSGPDQQRDFQREIQILKAL- 81
Query: 217 GHNNLVKFFDAYEDT--DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVA 274
+ +VK+ ++ +VME G L D + + QI +
Sbjct: 82 HSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGME 141
Query: 275 FCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYV----- 329
+ + VHRDL N L + +K DFGL+ + D+ YYV
Sbjct: 142 YLGSRRCVHRDLAARNILVE---SEAHVKIADFGLAKLLPLDK--------DYYVVREPG 190
Query: 330 -------APEVL-HRSYSTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAVLKADPSF 380
APE L +S ++DVWS GV+ Y + + E + P+
Sbjct: 191 QSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPAL 250
Query: 381 DE 382
Sbjct: 251 SR 252
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-26
Identities = 66/319 (20%), Positives = 112/319 (35%), Gaps = 74/319 (23%)
Query: 155 NKYELGEEVGRGHFG--YTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKIL 212
+ +L E +GRG +G Y KG L + VAVKV ++ E I
Sbjct: 13 DNLKLLELIGRGRYGAVY-------KGSLDERPVAVKVFSFANR------QNFINEKNIY 59
Query: 213 R-ALTGHNNLVKFFDA-----YEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVM 266
R L H+N+ +F + +VME G L + + +
Sbjct: 60 RVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH--TSDWVSSCRLA 117
Query: 267 IQILNVVAFCHLQ---------GVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDE 317
+ +A+ H + + HRDL N L + DFGLS + +
Sbjct: 118 HSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLV---KNDGTCVISDFGLSMRLTGNR 174
Query: 318 RL---------NDIVGSAYYVAPEVL--------HRSYSTEADVWSIGVIAYILL---CG 357
+ VG+ Y+APEVL S + D++++G+I + +
Sbjct: 175 LVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTD 234
Query: 358 SRPFWARTESGI-FRAVLKADPSFDE---------------APWPSLSSEARDFVKRLL- 400
P + E + F+ + P+F++ W S R + +
Sbjct: 235 LFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIED 294
Query: 401 --NKDPRKRLTAAQALSEL 417
++D RLTA A +
Sbjct: 295 CWDQDAEARLTAQXAEERM 313
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 2e-26
Identities = 57/228 (25%), Positives = 95/228 (41%), Gaps = 26/228 (11%)
Query: 159 LGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGH 218
+ + VG G FG C+ + K K VA+K + T D E I+ H
Sbjct: 49 IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL--KVGYTEKQRRDFLGEASIMGQFD-H 105
Query: 219 NNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHL 278
N+++ + V +V E E G L + ++T ++ I + + +
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD 165
Query: 279 QGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYV--------- 329
G VHRDL N L + N V K DFGL + D A Y
Sbjct: 166 MGYVHRDLAARNILI---NSNLVCKVSDFGLGRVLEDDP-------EAAYTTRGGKIPIR 215
Query: 330 --APEVL-HRSYSTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAV 373
+PE + +R +++ +DVWS G++ + ++ G RP+W + + +AV
Sbjct: 216 WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV 263
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 2e-26
Identities = 59/229 (25%), Positives = 91/229 (39%), Gaps = 29/229 (12%)
Query: 158 ELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTG 217
ELG +G G FG + E VA+K + E +E +R
Sbjct: 18 ELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVR--EKFLQEALTMRQFD- 74
Query: 218 HNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCH 277
H ++VK + V+++MELC GEL + R Q+ +A+
Sbjct: 75 HPHIVKLI-GVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE 133
Query: 278 LQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYV-------- 329
+ VHRD+ N L + N +K DFGLS R + S YY
Sbjct: 134 SKRFVHRDIAARNVLVS---SNDCVKLGDFGLS---R------YMEDSTYYKASKGKLPI 181
Query: 330 ---APEVL-HRSYSTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAV 373
APE + R +++ +DVW GV + IL+ G +PF + + +
Sbjct: 182 KWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 230
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 4e-26
Identities = 59/305 (19%), Positives = 103/305 (33%), Gaps = 57/305 (18%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRA 214
+L E RG FG K +L + VAVK+ P EV L
Sbjct: 24 MPLQLLEVKARGRFGCVW-----KAQLLNEYVAVKIFP----IQDKQSWQNEYEVYSLPG 74
Query: 215 LTGHNNLVKFFDAYEDTDNVYV----VMELCEGGELLDRILSRGGKYTEDDAKAVMIQIL 270
+ H N+++F A + +V V + E G L D + + + ++ + +
Sbjct: 75 MK-HENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL--KANVVSWNELCHIAETMA 131
Query: 271 NVVAFCHLQ----------GVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLN 320
+A+ H + HRD+K +N L N DFGL+ +
Sbjct: 132 RGLAYLHEDIPGLKDGHKPAISHRDIKSKNVL---LKNNLTACIADFGLALKFEAGKSAG 188
Query: 321 DI---VGSAYYVAPEVL------HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGI-- 369
D VG+ Y+APEVL R D++++G++ + L + +
Sbjct: 189 DTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLP 248
Query: 370 FRAVLKADPSFDEA-----------PWPS--LSSEARDFVKRLLNK----DPRKRLTAAQ 412
F + PS ++ + + + D RL+A
Sbjct: 249 FEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGC 308
Query: 413 ALSEL 417
+
Sbjct: 309 VGERI 313
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 4e-26
Identities = 59/229 (25%), Positives = 96/229 (41%), Gaps = 34/229 (14%)
Query: 158 ELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTG 217
+L + +G+G FG G+ +G +VAVK I + E ++ L
Sbjct: 196 KLLQTIGKGEFGDVM-----LGDYRGNKVAVKCIKNDATA-----QAFLAEASVMTQLR- 244
Query: 218 HNNLVKFFDA-YEDTDNVYVVMELCEGGELLDRILSRGGKY-TEDDAKAVMIQILNVVAF 275
H+NLV+ E+ +Y+V E G L+D + SRG D + + + +
Sbjct: 245 HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEY 304
Query: 276 CHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYV------ 329
VHRDL N L + E++V K DFGL+ + + +
Sbjct: 305 LEGNNFVHRDLAARNVLVS---EDNVAKVSDFGLT---K------EASSTQDTGKLPVKW 352
Query: 330 -APEVL-HRSYSTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAVLK 375
APE L + +ST++DVWS G++ + I G P+ + V K
Sbjct: 353 TAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK 401
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 7e-26
Identities = 51/232 (21%), Positives = 94/232 (40%), Gaps = 29/232 (12%)
Query: 158 ELGEEVGRGHFGYTCAAKFKKGELKGQ-QVAVKVIPKHKMTTAIAIEDVRREVKILRALT 216
+ + +G G FG + K + VA+K + + T+ A +++ E ++ ++
Sbjct: 18 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL--REATSPKANKEILDEAYVMASVD 75
Query: 217 GHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFC 276
+ ++ + T V ++ +L G LLD + +QI + +
Sbjct: 76 -NPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 133
Query: 277 HLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYV------- 329
+ +VHRDL N L +K DFGL+ + +E Y
Sbjct: 134 EDRRLVHRDLAARNVLVK---TPQHVKITDFGLAKLLGAEE--------KEYHAEGGKVP 182
Query: 330 ----APEVL-HRSYSTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAVLK 375
A E + HR Y+ ++DVWS GV + ++ GS+P+ S I + K
Sbjct: 183 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK 234
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 8e-26
Identities = 55/235 (23%), Positives = 96/235 (40%), Gaps = 32/235 (13%)
Query: 158 ELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTG 217
E +GRGHFG + K AVK + +++T + E I++ +
Sbjct: 28 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMKDFS- 84
Query: 218 HNNLVKFFDAYEDTDN-VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFC 276
H N++ ++ VV+ + G+L + I + T D +Q+ + +
Sbjct: 85 HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL 144
Query: 277 HLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYV------- 329
+ VHRDL N + DE +K DFGL+ R D+ YY
Sbjct: 145 ASKKFVHRDLAARNCML---DEKFTVKVADFGLA---R------DMYDKEYYSVHNKTGA 192
Query: 330 -------APEVLH-RSYSTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAVLK 375
A E L + ++T++DVWS GV+ + ++ G+ P+ I +L+
Sbjct: 193 KLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ 247
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 8e-26
Identities = 56/232 (24%), Positives = 95/232 (40%), Gaps = 34/232 (14%)
Query: 158 ELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTG 217
+ ++G G +G +KK L VAVK + + M E+ +E +++ +
Sbjct: 16 TMKHKLGGGQYGEVYEGVWKKYSLT---VAVKTLKEDTMEV----EEFLKEAAVMKEIK- 67
Query: 218 HNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKY-TEDDAKAVMIQILNVVAFC 276
H NLV+ Y++ E G LLD + + + + QI + + +
Sbjct: 68 HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL 127
Query: 277 HLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYV------- 329
+ +HRDL N L EN ++K DFGLS + D Y
Sbjct: 128 EKKNFIHRDLAARNCLV---GENHLVKVADFGLSRLMTGDT---------YTAHAGAKFP 175
Query: 330 ----APEVL-HRSYSTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAVLK 375
APE L + +S ++DVW+ GV+ + I G P+ S ++ + K
Sbjct: 176 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK 227
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-25
Identities = 58/227 (25%), Positives = 94/227 (41%), Gaps = 34/227 (14%)
Query: 158 ELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTG 217
+L + +G+G FG G+ +G +VAVK I + E ++ L
Sbjct: 24 KLLQTIGKGEFGDVM-----LGDYRGNKVAVKCIKNDATA-----QAFLAEASVMTQLR- 72
Query: 218 HNNLVKFFDA-YEDTDNVYVVMELCEGGELLDRILSRGGKY-TEDDAKAVMIQILNVVAF 275
H+NLV+ E+ +Y+V E G L+D + SRG D + + + +
Sbjct: 73 HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEY 132
Query: 276 CHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYV------ 329
VHRDL N L E++V K DFGL+ + + +
Sbjct: 133 LEGNNFVHRDLAARNVLV---SEDNVAKVSDFGLT---K------EASSTQDTGKLPVKW 180
Query: 330 -APEVL-HRSYSTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAV 373
APE L + +ST++DVWS G++ + I G P+ + V
Sbjct: 181 TAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV 227
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-25
Identities = 54/238 (22%), Positives = 94/238 (39%), Gaps = 34/238 (14%)
Query: 158 ELGEEVGRGHFG--YTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRAL 215
L +G G FG Y + QVAVK +P+ D E I+
Sbjct: 33 TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDE--LDFLMEALIISKF 90
Query: 216 TGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAV--MIQILNVV 273
H N+V+ + +++MEL GG+L + + ++ + A+ ++ + +
Sbjct: 91 N-HQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 149
Query: 274 AF--CHL--QGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYV 329
A +L +HRD+ N L T V K DFG++ R DI ++YY
Sbjct: 150 ACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA---R------DIYRASYYR 200
Query: 330 ------------APEVL-HRSYSTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAV 373
PE ++++ D WS GV+ + I G P+ +++ + V
Sbjct: 201 KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFV 258
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 3e-25
Identities = 53/229 (23%), Positives = 93/229 (40%), Gaps = 27/229 (11%)
Query: 159 LGEEVGRGHFGYTCAAKFK-KGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTG 217
+ +G G FG K K VA+K + T D E I+ +
Sbjct: 48 RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTL--KAGYTEKQRVDFLGEAGIMGQFS- 104
Query: 218 HNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCH 277
H+N+++ + ++ E E G L + + G+++ ++ I + +
Sbjct: 105 HHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA 164
Query: 278 LQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYV-------- 329
VHRDL N L + N V K DFGLS + D A Y
Sbjct: 165 NMNYVHRDLAARNILV---NSNLVCKVSDFGLSRVLEDDP-------EATYTTSGGKIPI 214
Query: 330 ---APEVL-HRSYSTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAV 373
APE + +R +++ +DVWS G++ + ++ G RP+W + + +A+
Sbjct: 215 RWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAI 263
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 3e-25
Identities = 53/223 (23%), Positives = 93/223 (41%), Gaps = 16/223 (7%)
Query: 158 ELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTG 217
+ ++G G +G +KK VAVK + + M E+ +E +++ +
Sbjct: 223 TMKHKLGGGQYGEVYEGVWKK---YSLTVAVKTLKEDTMEV----EEFLKEAAVMKEIK- 274
Query: 218 HNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKY-TEDDAKAVMIQILNVVAFC 276
H NLV+ Y++ E G LLD + + + + QI + + +
Sbjct: 275 HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL 334
Query: 277 HLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYY--VAPEVL 334
+ +HR+L N L EN ++K DFGLS + D APE L
Sbjct: 335 EKKNFIHRNLAARNCLVG---ENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL 391
Query: 335 -HRSYSTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAVLK 375
+ +S ++DVW+ GV+ + I G P+ S ++ + K
Sbjct: 392 AYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK 434
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 5e-25
Identities = 54/226 (23%), Positives = 96/226 (42%), Gaps = 30/226 (13%)
Query: 162 EVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNL 221
E+G G+FG ++ + K VA+KV+ + T E++ RE +I+ L + +
Sbjct: 17 ELGCGNFGSVRQGVYRMRK-KQIDVAIKVL--KQGTEKADTEEMMREAQIMHQLD-NPYI 72
Query: 222 VKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGV 281
V+ + + +VME+ GG L ++ + + + ++ Q+ + + +
Sbjct: 73 VRLI-GVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNF 131
Query: 282 VHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYV------------ 329
VHRDL N L K DFGLS + D+ +YY
Sbjct: 132 VHRDLAARNVLL---VNRHYAKISDFGLSKALGADD--------SYYTARSAGKWPLKWY 180
Query: 330 APEVL-HRSYSTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAV 373
APE + R +S+ +DVWS GV + L G +P+ + +
Sbjct: 181 APECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI 226
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 5e-25
Identities = 56/233 (24%), Positives = 100/233 (42%), Gaps = 38/233 (16%)
Query: 158 ELGEEVGRGHFGYTCAAKFKKGELKGQ-QVAVKVIPKHKMTTAIAIEDVRREVKILRALT 216
+L E +G G FG G G +VAVK + + M+ + E +++ L
Sbjct: 16 KLVERLGAGQFGEVW-----MGYYNGHTKVAVKSLKQGSMSP----DAFLAEANLMKQLQ 66
Query: 217 GHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKY-TEDDAKAVMIQILNVVAF 275
H LV+ + A + +Y++ E E G L+D + + G T + + QI +AF
Sbjct: 67 -HQRLVRLY-AVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAF 124
Query: 276 CHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYV------ 329
+ +HRDL+ N L + K DFGL+ + +E Y
Sbjct: 125 IEERNYIHRDLRAANILV---SDTLSCKIADFGLARLIEDNE---------YTAREGAKF 172
Query: 330 -----APEVL-HRSYSTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAVLK 375
APE + + +++ ++DVWS G++ I+ G P+ T + + + +
Sbjct: 173 PIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER 225
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 5e-25
Identities = 56/227 (24%), Positives = 93/227 (40%), Gaps = 31/227 (13%)
Query: 158 ELGEEVGRGHFGYTCAAKFK-KGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALT 216
+ ++G GHFG ++ +G+ G+QVAVK + + I D+++E++ILR L
Sbjct: 24 KRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSL--KPESGGNHIADLKKEIEILRNLY 81
Query: 217 GHNNLVKFFDA--YEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVA 274
H N+VK+ + + + ++ME G L + + K +QI +
Sbjct: 82 -HENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMD 140
Query: 275 FCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYV----- 329
+ + VHRDL N L + +K DFGL+ + D+ YY
Sbjct: 141 YLGSRQYVHRDLAARNVLV---ESEHQVKIGDFGLTKAIETDK--------EYYTVKDDR 189
Query: 330 -------APEVL-HRSYSTEADVWSIGVIAY-ILLCGSRPFWARTES 367
APE L + +DVWS GV + +L
Sbjct: 190 DSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALF 236
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 6e-25
Identities = 54/211 (25%), Positives = 93/211 (44%), Gaps = 31/211 (14%)
Query: 158 ELGEEVGRGHFGYTCAAKFK-KGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALT 216
+ +++G+G+FG ++ + G+ VAVK + + +T + D RE++IL++L
Sbjct: 44 KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL---QHSTEEHLRDFEREIEILKSLQ 100
Query: 217 GHNNLVKFFDA--YEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVA 274
H+N+VK+ N+ ++ME G L D + + QI +
Sbjct: 101 -HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGME 159
Query: 275 FCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYV----- 329
+ + +HRDL N L + + +K DFGL+ + D+ YY
Sbjct: 160 YLGTKRYIHRDLATRNILV---ENENRVKIGDFGLTKVLPQDK--------EYYKVKEPG 208
Query: 330 -------APEVL-HRSYSTEADVWSIGVIAY 352
APE L +S +DVWS GV+ Y
Sbjct: 209 ESPIFWYAPESLTESKFSVASDVWSFGVVLY 239
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 6e-25
Identities = 53/241 (21%), Positives = 94/241 (39%), Gaps = 34/241 (14%)
Query: 155 NKYELGEEVGRGHFG--YTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKIL 212
L +G G FG Y + QVAVK +P+ + D E I+
Sbjct: 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV--CSEQDELDFLMEALII 128
Query: 213 RALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAV--MIQIL 270
H N+V+ + ++++EL GG+L + + ++ + A+ ++ +
Sbjct: 129 SKFN-HQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA 187
Query: 271 NVVAF--CHL--QGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSA 326
+A +L +HRD+ N L T V K DFG++ R DI +
Sbjct: 188 RDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA---R------DIYRAG 238
Query: 327 YYV------------APEVL-HRSYSTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRA 372
YY PE ++++ D WS GV+ + I G P+ +++ +
Sbjct: 239 YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEF 298
Query: 373 V 373
V
Sbjct: 299 V 299
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 6e-25
Identities = 48/232 (20%), Positives = 91/232 (39%), Gaps = 29/232 (12%)
Query: 158 ELGEEVGRGHFGYTCAAKFK-KGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALT 216
+ +G G FG + +GE V +KVI + + + V + + +L
Sbjct: 16 RKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVI--EDKSGRQSFQAVTDHMLAIGSLD 73
Query: 217 GHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFC 276
H ++V+ ++ +V + G LLD + G +QI + +
Sbjct: 74 -HAHIVRLLGLCPG-SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYL 131
Query: 277 HLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYV------- 329
G+VHR+L N L S ++ DFG++D + PD+ +
Sbjct: 132 EEHGMVHRNLAARNVLL---KSPSQVQVADFGVADLLPPDD--------KQLLYSEAKTP 180
Query: 330 ----APEVL-HRSYSTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAVLK 375
A E + Y+ ++DVWS GV + ++ G+ P+ + + + K
Sbjct: 181 IKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEK 232
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 7e-25
Identities = 52/211 (24%), Positives = 93/211 (44%), Gaps = 31/211 (14%)
Query: 158 ELGEEVGRGHFGYTCAAKFK-KGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALT 216
+ +++G+G+FG ++ + G+ VAVK + + +T + D RE++IL++L
Sbjct: 13 KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL---QHSTEEHLRDFEREIEILKSLQ 69
Query: 217 GHNNLVKFFDA--YEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVA 274
H+N+VK+ N+ ++ME G L D + + QI +
Sbjct: 70 -HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGME 128
Query: 275 FCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYV----- 329
+ + +HRDL N L + + +K DFGL+ + D+ ++
Sbjct: 129 YLGTKRYIHRDLATRNILV---ENENRVKIGDFGLTKVLPQDK--------EFFKVKEPG 177
Query: 330 -------APEVL-HRSYSTEADVWSIGVIAY 352
APE L +S +DVWS GV+ Y
Sbjct: 178 ESPIFWYAPESLTESKFSVASDVWSFGVVLY 208
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 68/368 (18%), Positives = 122/368 (33%), Gaps = 118/368 (32%)
Query: 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIA--IEDVRREVK 210
F +Y + ++G GHF + + + VA+KV+ + E E++
Sbjct: 35 FNGRYHVIRKLGWGHFSTVWLSWDIQ---GKKFVAMKVV------KSAEHYTETALDEIR 85
Query: 211 ILRALT-------GHNNLVKFFDAYEDT----DNVYVVMELCEGGELLD-RILSRGGKYT 258
+L+++ +V+ D ++ + ++ +V E+ G LL I S
Sbjct: 86 LLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLP 144
Query: 259 EDDAKAVMIQILNVVAFCHLQ-GVVHRDLKPENFLFTTKD-------------------- 297
K ++ Q+L + + H + ++H D+KPEN L + +
Sbjct: 145 LPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPP 204
Query: 298 --------------------------ENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAP 331
E +K D G + + + + + Y +
Sbjct: 205 PSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNA--CWVHKHFTEDIQTRQYRSL 262
Query: 332 EV-LHRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFR---------AVLKADPS-- 379
EV + Y+T AD+WS +A+ L G F + R +L P
Sbjct: 263 EVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKL 322
Query: 380 ----------FDE----------APWPSLSS----------EAR---DFVKRLLNKDPRK 406
F + PW EA DF+ +L P K
Sbjct: 323 IVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEK 382
Query: 407 RLTAAQAL 414
R TAA+ L
Sbjct: 383 RATAAECL 390
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 2e-24
Identities = 55/243 (22%), Positives = 92/243 (37%), Gaps = 39/243 (16%)
Query: 158 ELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTG 217
LG +G+G FG A+ K+ + +VAVK++ K + + IE+ RE ++
Sbjct: 26 TLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKML-KADIIASSDIEEFLREAACMKEFD- 83
Query: 218 HNNLVKFF------DAYEDTDNVYVVMELCEGGELLD-----RILSRGGKYTEDDAKAVM 266
H ++ K A V++ + G+L RI M
Sbjct: 84 HPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFM 143
Query: 267 IQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSA 326
+ I + + + +HRDL N + E+ + DFGLS R I
Sbjct: 144 VDIACGMEYLSSRNFIHRDLAARNCML---AEDMTVCVADFGLS---R------KIYSGD 191
Query: 327 YYV------------APEVLH-RSYSTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRA 372
YY A E L Y+ +DVW+ GV + I+ G P+ + I+
Sbjct: 192 YYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNY 251
Query: 373 VLK 375
++
Sbjct: 252 LIG 254
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 2e-24
Identities = 63/248 (25%), Positives = 104/248 (41%), Gaps = 47/248 (18%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRA 214
N + + +G G+FG A+ KK L+ A+K + ++ + D E+++L
Sbjct: 25 NDIKFQDVIGEGNFGQVLKARIKKDGLR-MDAAIKRMKEY--ASKDDHRDFAGELEVLCK 81
Query: 215 LTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLD-----RILSRGGKYTEDDAKAVMIQI 269
L H N++ A E +Y+ +E G LLD R+L + ++ A +
Sbjct: 82 LGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSS 141
Query: 270 LNVVAFC--------HL--QGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERL 319
++ F +L + +HRDL N L EN V K DFGLS R
Sbjct: 142 QQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG---ENYVAKIADFGLS-------RG 191
Query: 320 NDIVGSAYYV------------APEVL-HRSYSTEADVWSIGVIAY-ILLCGSRPFWART 365
+ YV A E L + Y+T +DVWS GV+ + I+ G P+ T
Sbjct: 192 QE-----VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT 246
Query: 366 ESGIFRAV 373
+ ++ +
Sbjct: 247 CAELYEKL 254
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-24
Identities = 57/235 (24%), Positives = 97/235 (41%), Gaps = 32/235 (13%)
Query: 158 ELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTG 217
+G+GHFG ++ Q A+K + + T +E RE ++R L
Sbjct: 24 HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI--TEMQQVEAFLREGLLMRGLN- 80
Query: 218 HNNLVKFFDAYEDTDNV-YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFC 276
H N++ + + +V++ G+LL I S T D + +Q+ + +
Sbjct: 81 HPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYL 140
Query: 277 HLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYV------- 329
Q VHRDL N + DE+ +K DFGL+ R DI+ YY
Sbjct: 141 AEQKFVHRDLAARNCML---DESFTVKVADFGLA---R------DILDREYYSVQQHRHA 188
Query: 330 -------APEVLH-RSYSTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAVLK 375
A E L ++T++DVWS GV+ + +L G+ P+ + + +
Sbjct: 189 RLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQ 243
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 2e-24
Identities = 62/235 (26%), Positives = 94/235 (40%), Gaps = 43/235 (18%)
Query: 155 NKYELGEEVGRGHFG--YTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKIL 212
N + G+ +G G FG A E +VAVK++ A E + E+KI+
Sbjct: 46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKST--AHADEKEALMSELKIM 103
Query: 213 RALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNV 272
L H N+V A V V+ E C G+LL+ + + D A A+ +
Sbjct: 104 SHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTAST 163
Query: 273 ---VAFC--------HL--QGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERL 319
+ F L + +HRD+ N L T V K DFGL+ R
Sbjct: 164 RDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLT---NGHVAKIGDFGLA-------R- 212
Query: 320 NDIVGSAYYV------------APEVL-HRSYSTEADVWSIGVIAY-ILLCGSRP 360
DI+ + Y+ APE + Y+ ++DVWS G++ + I G P
Sbjct: 213 -DIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP 266
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 3e-24
Identities = 51/245 (20%), Positives = 94/245 (38%), Gaps = 38/245 (15%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRA 214
N LG+ +G G FG K+ + +VAVK + K ++ IE+ E ++
Sbjct: 34 NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTM-KLDNSSQREIEEFLSEAACMKD 92
Query: 215 LTGHNNLVKFF-----DAYEDTDNVYVVMELCEGGELLD-----RILSRGGKYTEDDAKA 264
+ H N+++ + + V++ + G+L R+ +
Sbjct: 93 FS-HPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLK 151
Query: 265 VMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVG 324
M+ I + + + +HRDL N + ++ + DFGLS + I
Sbjct: 152 FMVDIALGMEYLSNRNFLHRDLAARNCML---RDDMTVCVADFGLS---K------KIYS 199
Query: 325 SAYYV------------APEVL-HRSYSTEADVWSIGVIAY-ILLCGSRPFWARTESGIF 370
YY A E L R Y++++DVW+ GV + I G P+ ++
Sbjct: 200 GDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMY 259
Query: 371 RAVLK 375
+L
Sbjct: 260 DYLLH 264
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 3e-24
Identities = 54/235 (22%), Positives = 95/235 (40%), Gaps = 32/235 (13%)
Query: 158 ELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTG 217
E +GRGHFG + K AVK + +++T + E I++ +
Sbjct: 92 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMKDFS- 148
Query: 218 HNNLVKFFDAYEDTDN-VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFC 276
H N++ ++ VV+ + G+L + I + T D +Q+ + F
Sbjct: 149 HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL 208
Query: 277 HLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYV------- 329
+ VHRDL N + DE +K DFGL+ R D+ +
Sbjct: 209 ASKKFVHRDLAARNCML---DEKFTVKVADFGLA---R------DMYDKEFDSVHNKTGA 256
Query: 330 -------APEVLH-RSYSTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAVLK 375
A E L + ++T++DVWS GV+ + ++ G+ P+ I +L+
Sbjct: 257 KLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ 311
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 4e-24
Identities = 57/233 (24%), Positives = 94/233 (40%), Gaps = 38/233 (16%)
Query: 158 ELGEEVGRGHFGYTCAAKFKKGELKGQ-QVAVKVIPKHKMTTAIAIEDVRREVKILRALT 216
+L +++G G FG +VAVK + M+ E E +++ L
Sbjct: 191 KLEKKLGAGQFGEVW-----MATYNKHTKVAVKTMKPGSMSV----EAFLAEANVMKTLQ 241
Query: 217 GHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKY-TEDDAKAVMIQILNVVAF 275
H+ LVK + +Y++ E G LLD + S G QI +AF
Sbjct: 242 -HDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAF 299
Query: 276 CHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYV------ 329
+ +HRDL+ N L + V K DFGL+ + +E Y
Sbjct: 300 IEQRNYIHRDLRAANILV---SASLVCKIADFGLARVIEDNE---------YTAREGAKF 347
Query: 330 -----APEVL-HRSYSTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAVLK 375
APE + S++ ++DVWS G++ I+ G P+ + + RA+ +
Sbjct: 348 PIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALER 400
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 4e-24
Identities = 58/233 (24%), Positives = 96/233 (41%), Gaps = 38/233 (16%)
Query: 158 ELGEEVGRGHFGYTCAAKFKKGELKGQ-QVAVKVIPKHKMTTAIAIEDVRREVKILRALT 216
L ++G+G FG G G +VA+K + M+ E +E ++++ L
Sbjct: 187 RLEVKLGQGCFGEVW-----MGTWNGTTRVAIKTLKPGTMSP----EAFLQEAQVMKKLR 237
Query: 217 GHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKY-TEDDAKAVMIQILNVVAF 275
H LV+ + + + +Y+V E G LLD + GKY + QI + +A+
Sbjct: 238 -HEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAY 295
Query: 276 CHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYV------ 329
VHRDL+ N L EN V K DFGL+ + +E Y
Sbjct: 296 VERMNYVHRDLRAANILVG---ENLVCKVADFGLARLIEDNE---------YTARQGAKF 343
Query: 330 -----APEVL-HRSYSTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAVLK 375
APE + ++ ++DVWS G++ + G P+ + V +
Sbjct: 344 PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 396
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 103 bits (257), Expect = 7e-24
Identities = 70/363 (19%), Positives = 125/363 (34%), Gaps = 52/363 (14%)
Query: 29 ANGTPIPAPSPLNAESQSNNNRTNVKGNDDAVIEGKKSPFFPFYSPSPAHYFFSKKSSPA 88
GT L + + + + PAH P
Sbjct: 224 PEGTKFDTLWQLVEYLKLKADGLIYCLKEACPNSSASNASGAAAPTLPAHPSTLT--HPQ 281
Query: 89 RSSANSTPNRFFKRPFPPPSPAKHIKAVLARRHGSVKPNEAAIPEGSEPEPAAGLNKSFG 148
R + + P SP K P + ++ E +P +K
Sbjct: 282 RRIDTLNSDGYTPEPARITSPDKP----------RPMPMDTSVFESPFSDPEELKDKKLF 331
Query: 149 FSKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQ----QVAVKVIPKHKMTTAIAIED 204
+ N E+G G+FG +G + + VA+KV+ + T E+
Sbjct: 332 LKRD--NLLIADIELGCGNFGSVR-----QGVYRMRKKQIDVAIKVL--KQGTEKADTEE 382
Query: 205 VRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKA 264
+ RE +I+ L + +V+ + + +VME+ GG L ++ + + +
Sbjct: 383 MMREAQIMHQLD-NPYIVRLI-GVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAE 440
Query: 265 VMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVG 324
++ Q+ + + + VHR+L N L K DFGLS + D+
Sbjct: 441 LLHQVSMGMKYLEEKNFVHRNLAARNVLL---VNRHYAKISDFGLSKALGADD------- 490
Query: 325 SAYYV------------APEVL-HRSYSTEADVWSIGVIAY-ILLCGSRPFWARTESGIF 370
+YY APE + R +S+ +DVWS GV + L G +P+ +
Sbjct: 491 -SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVM 549
Query: 371 RAV 373
+
Sbjct: 550 AFI 552
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 7e-24
Identities = 59/229 (25%), Positives = 92/229 (40%), Gaps = 29/229 (12%)
Query: 158 ELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTG 217
ELG +G G FG + E VA+K T+ E +E +R
Sbjct: 393 ELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTC--KNCTSDSVREKFLQEALTMRQFD- 449
Query: 218 HNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCH 277
H ++VK + + V+++MELC GEL + R Q+ +A+
Sbjct: 450 HPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE 508
Query: 278 LQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYV-------- 329
+ VHRD+ N L + N +K DFGLS + S YY
Sbjct: 509 SKRFVHRDIAARNVLVS---SNDCVKLGDFGLSR---------YMEDSTYYKASKGKLPI 556
Query: 330 ---APEVL-HRSYSTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAV 373
APE + R +++ +DVW GV + IL+ G +PF + + +
Sbjct: 557 KWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 605
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 1e-23
Identities = 52/229 (22%), Positives = 98/229 (42%), Gaps = 30/229 (13%)
Query: 159 LGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGH 218
+E+G G+FG ++ + + VAVK++ K++ +++ E +++ L +
Sbjct: 21 EDKELGSGNFGTVKKGYYQ-MKKVVKTVAVKIL-KNEANDPALKDELLAEANVMQQLD-N 77
Query: 219 NNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHL 278
+V+ + ++ +VME+ E G L L + + + ++ Q+ + +
Sbjct: 78 PYIVRMI-GICEAESWMLVMEMAELGPLNKY-LQQNRHVKDKNIIELVHQVSMGMKYLEE 135
Query: 279 QGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYV--------- 329
VHRDL N L K DFGLS +R DE YY
Sbjct: 136 SNFVHRDLAARNVLL---VTQHYAKISDFGLSKALRADE--------NYYKAQTHGKWPV 184
Query: 330 ---APEVL-HRSYSTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAV 373
APE + + +S+++DVWS GV+ + G +P+ S + +
Sbjct: 185 KWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML 233
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 2e-23
Identities = 62/240 (25%), Positives = 100/240 (41%), Gaps = 46/240 (19%)
Query: 155 NKYELGEEVGRGHFG--YTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKIL 212
++ +LG+ +GRG FG A + VAVK++ + T + E+KIL
Sbjct: 27 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG--ATHSEHRALMSELKIL 84
Query: 213 RALTGHNNLVKFFDAYEDTDN-VYVVMELCEGGELLD-----RILSRGGKYTEDDAKAVM 266
+ H N+V A + V++E C+ G L R K +D
Sbjct: 85 IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF 144
Query: 267 IQILNVVAFC--------HL--QGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPD 316
+ + +++ + L + +HRDL N L + E +V+K DFGL+
Sbjct: 145 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS---EKNVVKICDFGLA------ 195
Query: 317 ERLNDIVGSAYYV------------APEVL-HRSYSTEADVWSIGVIAY-ILLCGSRPFW 362
R DI YV APE + R Y+ ++DVWS GV+ + I G+ P+
Sbjct: 196 -R--DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 252
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 2e-23
Identities = 58/239 (24%), Positives = 91/239 (38%), Gaps = 47/239 (19%)
Query: 155 NKYELGEEVGRGHFG--YTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKIL 212
N+ G+ +G G FG A VAVK++ E + E+K+L
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS--AHLTEREALMSELKVL 80
Query: 213 RALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLD-------RILSRGGKYTEDDAKAV 265
L H N+V A V+ E C G+LL+ + + +
Sbjct: 81 SYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDEL 140
Query: 266 MIQILNVVAFC--------HL--QGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP 315
+ + ++++F L + +HRDL N L T + K DFGL+ R
Sbjct: 141 ALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLT---HGRITKICDFGLA---R- 193
Query: 316 DERLNDIVGSAYYV------------APEVL-HRSYSTEADVWSIGVIAY-ILLCGSRP 360
DI + YV APE + + Y+ E+DVWS G+ + + GS P
Sbjct: 194 -----DIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP 247
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 6e-23
Identities = 54/246 (21%), Positives = 99/246 (40%), Gaps = 40/246 (16%)
Query: 155 NKYELGEEVGRGHFG--YTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKIL 212
K + E+G+G FG Y AK + +VA+K + + + + E ++
Sbjct: 25 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA--ASMRERIEFLNEASVM 82
Query: 213 RALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKA-------- 264
+ +++V+ V+MEL G+L + S + A
Sbjct: 83 KEF-NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMI 141
Query: 265 -VMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIV 323
+ +I + +A+ + VHRDL N + E+ +K DFG++ R DI
Sbjct: 142 QMAGEIADGMAYLNANKFVHRDLAARNCMVA---EDFTVKIGDFGMT---R------DIY 189
Query: 324 GSAYYV------------APEVL-HRSYSTEADVWSIGVIAY-ILLCGSRPFWARTESGI 369
+ YY +PE L ++T +DVWS GV+ + I +P+ + +
Sbjct: 190 ETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV 249
Query: 370 FRAVLK 375
R V++
Sbjct: 250 LRFVME 255
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 6e-23
Identities = 51/239 (21%), Positives = 84/239 (35%), Gaps = 46/239 (19%)
Query: 158 ELGEEVGRGHFG--YTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRAL 215
EE+G FG Y + Q VA+K + E+ R E + L
Sbjct: 12 RFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDK--AEGPLREEFRHEAMLRARL 69
Query: 216 TGHNNLVKFFDAYEDTDNVYVVMELCEGGELLD--RILSRGGKYTEDDAKAVMIQILNVV 273
H N+V + ++ C G+L + + S D + L
Sbjct: 70 Q-HPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPP 128
Query: 274 AFCHL-------------QGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLN 320
F HL VVH+DL N L + +K D GL R
Sbjct: 129 DFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVY---DKLNVKISDLGLF-------R-- 176
Query: 321 DIVGSAYYV------------APE-VLHRSYSTEADVWSIGVIAY-ILLCGSRPFWART 365
++ + YY APE +++ +S ++D+WS GV+ + + G +P+ +
Sbjct: 177 EVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS 235
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 7e-23
Identities = 55/234 (23%), Positives = 84/234 (35%), Gaps = 35/234 (14%)
Query: 158 ELGEEVGRGHFG--YTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRAL 215
+ ++G GHFG + G+ VAVK + ++E+ ILR L
Sbjct: 34 KKIRDLGEGHFGKVSLYCYD-PTNDGTGEMVAVKALKAD--AGPQHRSGWKQEIDILRTL 90
Query: 216 TGHNNLVKFFDA--YEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVV 273
H +++K+ ++ +VME G L D + QI +
Sbjct: 91 Y-HEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL--PRHSIGLAQLLLFAQQICEGM 147
Query: 274 AFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYV---- 329
A+ H Q +HRDL N L + ++K DFGL+ V YY
Sbjct: 148 AYLHAQHYIHRDLAARNVLLD---NDRLVKIGDFGLAKAVPEGHE--------YYRVRED 196
Query: 330 --------APEVL-HRSYSTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAV 373
APE L + +DVWS GV Y +L T+ +
Sbjct: 197 GDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGI 250
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 99 bits (249), Expect = 7e-23
Identities = 58/233 (24%), Positives = 96/233 (41%), Gaps = 38/233 (16%)
Query: 158 ELGEEVGRGHFGYTCAAKFKKGELKGQ-QVAVKVIPKHKMTTAIAIEDVRREVKILRALT 216
L ++G+G FG G G +VA+K + M+ E +E ++++ L
Sbjct: 270 RLEVKLGQGCFGEVW-----MGTWNGTTRVAIKTLKPGTMSP----EAFLQEAQVMKKLR 320
Query: 217 GHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKY-TEDDAKAVMIQILNVVAF 275
H LV+ + + + +Y+V E G LLD + GKY + QI + +A+
Sbjct: 321 -HEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAY 378
Query: 276 CHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYV------ 329
VHRDL+ N L EN V K DFGL+ + +E Y
Sbjct: 379 VERMNYVHRDLRAANILVG---ENLVCKVADFGLARLIEDNE---------YTARQGAKF 426
Query: 330 -----APEVL-HRSYSTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAVLK 375
APE + ++ ++DVWS G++ + G P+ + V +
Sbjct: 427 PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 479
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 8e-22
Identities = 60/232 (25%), Positives = 93/232 (40%), Gaps = 51/232 (21%)
Query: 155 NKYELGEEVGRGHFG--YTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKIL 212
E G+ +G G FG A QVAVK++ + + E + E+K++
Sbjct: 45 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEK--ADSSEREALMSELKMM 102
Query: 213 RALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLD------------RILSRGGKYTED 260
L H N+V A + +Y++ E C G+LL+ I K E+
Sbjct: 103 TQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEE 162
Query: 261 DAKAVMIQILNVVAFC--------HL--QGVVHRDLKPENFLFTTKDENSVLKAIDFGLS 310
+ ++ +++ F L + VHRDL N L T V+K DFGL+
Sbjct: 163 EEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVT---HGKVVKICDFGLA 219
Query: 311 DFVRPDERLNDIVGSAYYV------------APEVL-HRSYSTEADVWSIGV 349
R DI+ + YV APE L Y+ ++DVWS G+
Sbjct: 220 ---R------DIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGI 262
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 9e-22
Identities = 60/227 (26%), Positives = 94/227 (41%), Gaps = 46/227 (20%)
Query: 155 NKYELGEEVGRGHFG--YTCAAKFKKGELKGQ--QVAVKVIPKHKMTTAIAIEDVRREVK 210
+K LG+ +G G FG A + + VAVK++ T + D+ E++
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD--ATEKDLSDLVSEME 92
Query: 211 ILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLD-----RILSRGGKYTEDDAKAV 265
+++ + H N++ A +YV++E G L + R Y +
Sbjct: 93 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEE 152
Query: 266 MIQILNVVAFC--------HL--QGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP 315
+ ++V+ +L Q +HRDL N L T EN+V+K DFGL+ R
Sbjct: 153 QMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADFGLA---R- 205
Query: 316 DERLNDIVGSAYYV------------APEVL-HRSYSTEADVWSIGV 349
DI YY APE L R Y+ ++DVWS GV
Sbjct: 206 -----DINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGV 247
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 9e-22
Identities = 63/256 (24%), Positives = 101/256 (39%), Gaps = 48/256 (18%)
Query: 142 GLNKSFGFSKHFA-NKYELGEEVGRGHFG--YTCAAKFKKGELKGQQVAVKVIPKHKMTT 198
G S +H L E+G G FG + VAVK + +
Sbjct: 1 GAMHSGIHVQHIKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLA- 59
Query: 199 AIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLD-----RILSR 253
A +D +RE ++L L H ++VKF+ D D + +V E + G+L +
Sbjct: 60 --ARKDFQREAELLTNLQ-HEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAM 116
Query: 254 GGKYTEDDAKAVMIQILNVVAFC--------HL--QGVVHRDLKPENFLFTTKDENSVLK 303
+ + + ++ +L Q VHRDL N L N ++K
Sbjct: 117 ILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVG---ANLLVK 173
Query: 304 AIDFGLSDFVRPDERLNDIVGSAYYV------------APEVL-HRSYSTEADVWSIGVI 350
DFG+S R D+ + YY PE + +R ++TE+DVWS GVI
Sbjct: 174 IGDFGMS-------R--DVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVI 224
Query: 351 AY-ILLCGSRPFWART 365
+ I G +P++ +
Sbjct: 225 LWEIFTYGKQPWFQLS 240
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 1e-21
Identities = 62/252 (24%), Positives = 104/252 (41%), Gaps = 47/252 (18%)
Query: 155 NKYELGEEVGRGHFG--YTCAAK--FKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVK 210
++ LG+ +G G FG A K + +VAVK++ T + D+ E++
Sbjct: 69 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD--ATEKDLSDLISEME 126
Query: 211 ILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLD-----RILSRGGKYTEDDAKAV 265
+++ + H N++ A +YV++E G L + R Y
Sbjct: 127 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEE 186
Query: 266 MIQILNVVAFC--------HL--QGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP 315
+ ++V+ +L + +HRDL N L T E++V+K DFGL+ R
Sbjct: 187 QLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIADFGLA---R- 239
Query: 316 DERLNDIVGSAYYV------------APEVL-HRSYSTEADVWSIGVIAY-ILLCGSRPF 361
DI YY APE L R Y+ ++DVWS GV+ + I G P+
Sbjct: 240 -----DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY 294
Query: 362 WARTESGIFRAV 373
+F+ +
Sbjct: 295 PGVPVEELFKLL 306
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 1e-21
Identities = 64/252 (25%), Positives = 104/252 (41%), Gaps = 47/252 (18%)
Query: 155 NKYELGEEVGRGHFG--YTCAAKFKKGELKGQ--QVAVKVIPKHKMTTAIAIEDVRREVK 210
+K LG+ +G G FG A + + VAVK++ T + D+ E++
Sbjct: 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD--ATEKDLSDLVSEME 138
Query: 211 ILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLD-----RILSRGGKYTEDDAKAV 265
+++ + H N++ A +YV++E G L + R Y +
Sbjct: 139 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEE 198
Query: 266 MIQILNVVAFC--------HL--QGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP 315
+ ++V+ +L Q +HRDL N L T EN+V+K DFGL+ R
Sbjct: 199 QMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADFGLA---R- 251
Query: 316 DERLNDIVGSAYYV------------APEVL-HRSYSTEADVWSIGVIAY-ILLCGSRPF 361
DI YY APE L R Y+ ++DVWS GV+ + I G P+
Sbjct: 252 -----DINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 306
Query: 362 WARTESGIFRAV 373
+F+ +
Sbjct: 307 PGIPVEELFKLL 318
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 2e-21
Identities = 58/258 (22%), Positives = 99/258 (38%), Gaps = 54/258 (20%)
Query: 155 NKYELGEEVGRGHFG--YTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKIL 212
LG+ +G G FG A KG VAVK++ ++ + + D+ E +L
Sbjct: 23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKEN--ASPSELRDLLSEFNVL 80
Query: 213 RALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLD-------------RILSRGGKYTE 259
+ + H +++K + A + +++E + G L +
Sbjct: 81 KQV-NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSL 139
Query: 260 DDAKAVMIQILNVVAFC--------HL--QGVVHRDLKPENFLFTTKDENSVLKAIDFGL 309
D + + ++++F +L +VHRDL N L E +K DFGL
Sbjct: 140 DHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVA---EGRKMKISDFGL 196
Query: 310 SDFVRPDERLNDIVGSAYYV------------APEVL-HRSYSTEADVWSIGVIAY-ILL 355
S R D+ YV A E L Y+T++DVWS GV+ + I+
Sbjct: 197 S---R------DVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247
Query: 356 CGSRPFWARTESGIFRAV 373
G P+ +F +
Sbjct: 248 LGGNPYPGIPPERLFNLL 265
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 5e-21
Identities = 60/238 (25%), Positives = 97/238 (40%), Gaps = 46/238 (19%)
Query: 158 ELGEEVGRGHFG--YTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRAL 215
L E+G G FG + E VAVK + + + A +D +RE ++L L
Sbjct: 44 VLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASES---ARQDFQREAELLTML 100
Query: 216 TGHNNLVKFFDAYEDTDNVYVVMELCEGGELLD----RILSRGGKYTEDDAKAVMIQILN 271
H ++V+FF + + +V E G+L +D + +
Sbjct: 101 Q-HQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQ 159
Query: 272 VVAFC--------HL--QGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLND 321
++A +L VHRDL N L + V+K DFG+S R D
Sbjct: 160 LLAVASQVAAGMVYLAGLHFVHRDLATRNCLVG---QGLVVKIGDFGMS-------R--D 207
Query: 322 IVGSAYYV------------APEVL-HRSYSTEADVWSIGVIAY-ILLCGSRPFWART 365
I + YY PE + +R ++TE+DVWS GV+ + I G +P++ +
Sbjct: 208 IYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLS 265
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 2e-19
Identities = 54/247 (21%), Positives = 89/247 (36%), Gaps = 54/247 (21%)
Query: 158 ELGEEVGRGHFG--YTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRAL 215
E ++G G FG + A VAVK++ + +A D +RE ++
Sbjct: 50 EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE--ASADMQADFQREAALMAEF 107
Query: 216 TGHNNLVKFFDAYEDTDNVYVVMELCEGGELLD-------------RILSRGGKYTEDDA 262
+ N+VK + ++ E G+L + +
Sbjct: 108 -DNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 166
Query: 263 KAVMIQILNVVAFC--------HL--QGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312
+ + +L + VHRDL N L EN V+K DFGLS
Sbjct: 167 GPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVG---ENMVVKIADFGLS-- 221
Query: 313 VRPDERLNDIVGSAYYV------------APEVL-HRSYSTEADVWSIGVIAY-ILLCGS 358
R +I + YY PE + + Y+TE+DVW+ GV+ + I G
Sbjct: 222 -R------NIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 274
Query: 359 RPFWART 365
+P++
Sbjct: 275 QPYYGMA 281
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 6e-19
Identities = 49/224 (21%), Positives = 98/224 (43%), Gaps = 27/224 (12%)
Query: 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKV-IPKHKMTTAIAIEDVRREVKI 211
+ +G+++G G+FG K + VA+K+ K + + E +
Sbjct: 7 VGPNFRVGKKIGCGNFGELRLGKNLY---TNEYVAIKLEPMKSRAPQ------LHLEYRF 57
Query: 212 LRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILN 271
+ L + + + + +V+EL G L D ++ + IQ+++
Sbjct: 58 YKQLGSGDGIPQVYYFGPCGKYNAMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLIS 116
Query: 272 VVAFCHLQGVVHRDLKPENFLF---TTKDENSVLKAIDFGLS-DFVRPDERL-------N 320
+ + H + +++RD+KPENFL K + V+ IDF L+ +++ P+ +
Sbjct: 117 RMEYVHSKNLIYRDVKPENFLIGRPGNKTQQ-VIHIIDFALAKEYIDPETKKHIPYREHK 175
Query: 321 DIVGSAYYVAPEV-LHRSYSTEADVWSIG-VIAYILLCGSRPFW 362
+ G+A Y++ L + S D+ ++G + Y L GS P W
Sbjct: 176 SLTGTARYMSINTHLGKEQSRRDDLEALGHMFMY-FLRGSLP-W 217
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 2e-18
Identities = 58/221 (26%), Positives = 95/221 (42%), Gaps = 23/221 (10%)
Query: 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKV-IPKHKMTTAIAIEDVRREVKI 211
N+Y LG ++G G FG G++VA+K+ K K + E KI
Sbjct: 7 VGNRYRLGRKIGSGSFGDIYLGTDIAA---GEEVAIKLECVKTKHPQ------LHIESKI 57
Query: 212 LRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILN 271
+ + G + + D +VMEL G L D K++ + Q+++
Sbjct: 58 YKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMIS 116
Query: 272 VVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR--------PDERLNDIV 323
+ + H + +HRD+KP+NFL + +++ IDFGL+ R P ++
Sbjct: 117 RIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLT 176
Query: 324 GSAYYVAPEV-LHRSYSTEADVWSIG-VIAYILLCGSRPFW 362
G+A Y + L S D+ S+G V+ Y GS P W
Sbjct: 177 GTARYASINTHLGIEQSRRDDLESLGYVLMY-FNLGSLP-W 215
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 1e-17
Identities = 54/223 (24%), Positives = 95/223 (42%), Gaps = 25/223 (11%)
Query: 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIP-KHKMTTAIAIEDVRREVKI 211
Y++G +G G FG QQVA+K P + +R E +
Sbjct: 8 VGVHYKVGRRIGEGSFGVIFEGTNLLN---NQQVAIKFEPRRSDAPQ------LRDEYRT 58
Query: 212 LRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILN 271
+ L G + + ++ + +V++L G L D + G K++ Q+L
Sbjct: 59 YKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLA 117
Query: 272 VVAFCHLQGVVHRDLKPENFLF---TTKDENSVLKAIDFGLS-DFVRPDERL-------N 320
V H + +V+RD+KP+NFL +K+ N + +DFG+ + P +
Sbjct: 118 RVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIY-VVDFGMVKFYRDPVTKQHIPYREKK 176
Query: 321 DIVGSAYYVAPEV-LHRSYSTEADVWSIGVIAYILLCGSRPFW 362
++ G+A Y++ L R S D+ ++G + L GS P W
Sbjct: 177 NLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLP-W 218
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 82.5 bits (204), Expect = 2e-17
Identities = 42/244 (17%), Positives = 85/244 (34%), Gaps = 49/244 (20%)
Query: 153 FANKYELGEEVGRGHFG--YTCAAKFKKGELKGQQVAVKVIP-KHKMTTAIAIEDVRREV 209
A +++G +G+G FG Y + VKV P + + E+
Sbjct: 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNG--------PLFTEL 84
Query: 210 KILRALTGHNNL----------------VKFFDAYEDTDNVY--VVMELCEGGELLDRIL 251
K + + ++ Y ++M+ G +L
Sbjct: 85 KFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYE 143
Query: 252 SRGGKYTEDDAKAVM---IQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFG 308
+ +++ K V+ ++IL+++ + H VH D+K N L K+ + V +D+G
Sbjct: 144 ANAKRFSR---KTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVY-LVDYG 199
Query: 309 LSDFVRPDERLNDI--------VGSAYYVAPEV-LHRSYSTEADVWSIG-VIAYILLCGS 358
L+ P+ G+ + + + + S D+ +G + L G
Sbjct: 200 LAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQ-WLTGH 258
Query: 359 RPFW 362
P W
Sbjct: 259 LP-W 261
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 82.1 bits (203), Expect = 2e-17
Identities = 50/239 (20%), Positives = 90/239 (37%), Gaps = 42/239 (17%)
Query: 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKIL 212
N++ LG+++G G FG A K + VKV + + E+K
Sbjct: 35 EGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGP-------LFSELKFY 87
Query: 213 RALTGHNNLVKFFD------------------AYEDTDNVYVVMELCEGGELLDRILSRG 254
+ + + + K+ + ++ ++VME G L +I +
Sbjct: 88 QRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQKISGQN 145
Query: 255 GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314
G + + + I++L+V+ + H VH D+K N L K+ + V D+GLS
Sbjct: 146 GTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVY-LADYGLSYRYC 204
Query: 315 PDERLNDI--------VGSAYYVAPEVLHRSY--STEADVWSIG-VIAYILLCGSRPFW 362
P+ G+ + H+ S +DV +G + LCG P W
Sbjct: 205 PNGNHKQYQENPRKGHNGTIEF-TSLDAHKGVALSRRSDVEILGYCMLR-WLCGKLP-W 260
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 80.4 bits (198), Expect = 2e-16
Identities = 60/219 (27%), Positives = 91/219 (41%), Gaps = 21/219 (9%)
Query: 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIP-KHKMTTAIAIEDVRREVKIL 212
NK+ LG ++G G FG + ++VA+K+ K K + E KI
Sbjct: 6 GNKFRLGRKIGSGSFGEIYLGTNIQT---NEEVAIKLENVKTKHPQ------LLYESKIY 56
Query: 213 RALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNV 272
R L G + + D +VM+L G L D K + + Q++N
Sbjct: 57 RILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINR 115
Query: 273 VAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR--------PDERLNDIVG 324
V F H + +HRD+KP+NFL + + IDFGL+ R P ++ G
Sbjct: 116 VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTG 175
Query: 325 SAYYVAPEV-LHRSYSTEADVWSIGVIAYILLCGSRPFW 362
+A Y + L S D+ S+G + L GS P W
Sbjct: 176 TARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLP-W 213
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 76.4 bits (189), Expect = 1e-15
Identities = 71/342 (20%), Positives = 110/342 (32%), Gaps = 98/342 (28%)
Query: 133 EGSEPEPAAGLNKSFGFS------KHFANKYELGEE--VGRGHFG--YTCAAKFKKGELK 182
E E + SF F +F + +G G FG Y KG +
Sbjct: 1 ENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVY-------KGYVN 53
Query: 183 GQQVAVKVIPKHKMTTAIAIEDV------RREVKILRALTGHNNLVKFFDAYEDTDN--- 233
VAVK K+ + I +E+K++ H NLV+ + +
Sbjct: 54 NTTVAVK-----KLAAMVDITTEELKQQFDQEIKVMAKCQ-HENLVELL-GFSSDGDDLC 106
Query: 234 -VYVVMELCEGGELLDRILSRGGKYT----------EDDAKAVMIQILNVVAFCHLQGVV 282
VY G LLDR+ G + A + F H +
Sbjct: 107 LVY---VYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGI--------NFLHENHHI 155
Query: 283 HRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLND----------IVGSAYYVAPE 332
HRD+K N L DE K DFGL+ R ++ IVG+ Y+APE
Sbjct: 156 HRDIKSANILL---DEAFTAKISDFGLA-------RASEKFAQTVMTSRIVGTTAYMAPE 205
Query: 333 VLHRSYSTEADVWSIGVIAYILLCGSRPF-----------WAR---TESGIFRAVLKADP 378
L + ++D++S GV+ ++ G E D
Sbjct: 206 ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDY--IDK 263
Query: 379 SFDEAPWPSLSSEARDFVK---RLLNKDPRKRLTAAQALSEL 417
++A S+ + L++ KR + L
Sbjct: 264 KMNDAD----STSVEAMYSVASQCLHEKKNKRPDIKKVQQLL 301
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 74.8 bits (184), Expect = 5e-15
Identities = 42/234 (17%), Positives = 77/234 (32%), Gaps = 33/234 (14%)
Query: 155 NKYELGEEVGRGHFG-----YTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRR-- 207
+++L R + G + + Q+ ++K+ K R
Sbjct: 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAK 101
Query: 208 --EVKILRALTGHNNL----VKFFDAYEDTDNVYVVMELCEGGELLDRIL--SRGGKYTE 259
+V + L L F ++D ++V+ G L L S +E
Sbjct: 102 PLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYR-FLVLPSL--GRSLQSALDVSPKHVLSE 158
Query: 260 DDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPD--- 316
V ++L+ + F H VH ++ EN +D++ V +G + P
Sbjct: 159 RSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVT-LAGYGFAFRYCPSGKH 217
Query: 317 ----ERLND-IVGSAYYVAPEVLHRSY--STEADVWSIG-VIAYILLCGSRPFW 362
E G + LH+ S +D+ S+G + L G P W
Sbjct: 218 VAYVEGSRSPHEGDLEF-ISMDLHKGCGPSRRSDLQSLGYCMLK-WLYGFLP-W 268
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 69.5 bits (169), Expect = 3e-13
Identities = 49/318 (15%), Positives = 97/318 (30%), Gaps = 74/318 (23%)
Query: 149 FSKHFA-NKYELGEEVGRGHFG--YTCAAKFKKGELKGQQVAVKVIPKHKMTTA-----I 200
FS K + E++G G FG + + VA+K+I
Sbjct: 13 FSHCLPTEKLQRCEKIGEGVFGEVF-------QTIADHTPVAIKIIAIEGPDLVNGSHQK 65
Query: 201 AIEDVRREVKILRALTGHNN-------------------------LVKFFDAYEDT---- 231
E++ E+ I + L+ + L+K +D Y T
Sbjct: 66 TFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSA 125
Query: 232 ---------DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQ-GV 281
D +++V+E GG L+++ ++ + AK+++ Q+ +A
Sbjct: 126 NDRPDFFKDDQLFIVLEFEFGGIDLEQMRTK--LSSLATAKSILHQLTASLAVAEASLRF 183
Query: 282 VHRDLKPENFLFTT--------KDENSVLKAIDFGLS----DFVRP-DERLNDIVGSAYY 328
HRDL N L GL D+ ER +V
Sbjct: 184 EHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVS 243
Query: 329 VAPEVLHRSYSTEADVWSI-GVIAYILLCGSRP----FWARTESGIFRAVLKADPSFDEA 383
+ ++ + D++ + P W + + +
Sbjct: 244 MDEDLFTGDGDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTP 303
Query: 384 PWPSLSSEARDFVKRLLN 401
+ + ++F + +LN
Sbjct: 304 AMKQIKRKIQEFHRTMLN 321
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 64.1 bits (157), Expect = 1e-11
Identities = 64/298 (21%), Positives = 107/298 (35%), Gaps = 75/298 (25%)
Query: 125 KPNEAAIPEGSEPEPAAGLNKSFGFS------KHFANKYELGEEVGRGHFG--YTCAAKF 176
K + S + +F +K+ +G G FG Y
Sbjct: 7 KATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGH----GVFGKVY------ 56
Query: 177 KKGELK-GQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVY 235
KG L+ G +VA+K ++ IE+ E++ L H +LV ++ + +
Sbjct: 57 -KGVLRDGAKVALKRR---TPESSQGIEEFETEIETLSFCR-HPHLVSLIGFCDERNEMI 111
Query: 236 VVMELCEGGELLDRILSRGGKYTE------------DDAKAVMIQILNVVAFCHLQGVVH 283
++ + E G L L T A+ + + H + ++H
Sbjct: 112 LIYKYMENGNLKRH-LYGSDLPTMSMSWEQRLEICIGAARGL--------HYLHTRAIIH 162
Query: 284 RDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDE-----RLNDIVGSAYYVAPEVLHRS 337
RD+K N L DEN V K DFG+S D+ + G+ Y+ PE +
Sbjct: 163 RDVKSINILL---DENFVPKITDFGISKKGTELDQTHLSTV---VKGTLGYIDPEYFIKG 216
Query: 338 YSTE-ADVWSIGVIAYILLCGSRPF-------------WART--ESGIFRAVLKADPS 379
TE +DV+S GV+ + +LC WA +G + DP+
Sbjct: 217 RLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQI--VDPN 272
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 63.0 bits (154), Expect = 4e-11
Identities = 68/293 (23%), Positives = 108/293 (36%), Gaps = 58/293 (19%)
Query: 131 IPEGSEPEPAAGLNKSFGFS------KHFANKYELGEEVGRGHFG--YTCAAKFKKGELK 182
+P +PE G K F +F+NK LG G FG Y KG L
Sbjct: 4 VPAEEDPEVHLGQLKRFSLRELQVASDNFSNKNILGR----GGFGKVY-------KGRLA 52
Query: 183 -GQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELC 241
G VAVK + K + T ++ + EV+++ H NL++ +V
Sbjct: 53 DGTLVAVKRL-KEERTQGGELQ-FQTEVEMISMAV-HRNLLRLRGFCMTPTERLLVYPYM 109
Query: 242 EGGELLDRILSRGGKYTEDDAKAVMIQILNV---VAFCHLQG---VVHRDLKPENFLFTT 295
G + + R D L +A+ H ++HRD+K N L
Sbjct: 110 ANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILL-- 167
Query: 296 KDENSVLKAIDFGLSDFVRPDERLN---DIVGSAYYVAPEVLHRSYSTE-ADVWSIGVIA 351
DE DFGL+ + + + + G+ ++APE L S+E DV+ GV+
Sbjct: 168 -DEEFEAVVGDFGLAKLM-DYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVML 225
Query: 352 YILLCGSRPF---------------WART--ESGIFRAV----LKADPSFDEA 383
L+ G R F W + + A+ L+ + +E
Sbjct: 226 LELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEV 278
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 55.3 bits (133), Expect = 1e-08
Identities = 35/117 (29%), Positives = 51/117 (43%), Gaps = 26/117 (22%)
Query: 258 TEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDE 317
T + Q+ + F + +HRDL N L + E +V+K DFGL+
Sbjct: 191 TLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS---EKNVVKICDFGLA------- 240
Query: 318 RLNDIVGSAYYV------------APEVL-HRSYSTEADVWSIGVIAY-ILLCGSRP 360
R DI YV APE + R Y+ ++DVWS GV+ + I G+ P
Sbjct: 241 R--DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 295
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 54.9 bits (132), Expect = 2e-08
Identities = 37/186 (19%), Positives = 68/186 (36%), Gaps = 20/186 (10%)
Query: 158 ELGEEVGRGHFG--YTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRAL 215
+LG+ +GRG FG A + VAVK++ + T + E+KIL +
Sbjct: 25 KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG--ATHSEHRALMSELKILIHI 82
Query: 216 TGHNNLVKFFDAYEDTDN-VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVA 274
H N+V A + V++E C+ G L + S+ ++ +
Sbjct: 83 GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEF-----VPYKTKGARFRQ 137
Query: 275 FCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDER----------LNDIVG 324
G + DLK T+ ++ ++ V +E L ++
Sbjct: 138 GKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLIC 197
Query: 325 SAYYVA 330
++ VA
Sbjct: 198 YSFQVA 203
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 52.2 bits (124), Expect = 2e-07
Identities = 58/441 (13%), Positives = 115/441 (26%), Gaps = 153/441 (34%)
Query: 73 SPSPAHYFFSKKSSPARSSANSTPNRFFKRPFPPPSPAKHIKAVLARRHGSVKPNEAAIP 132
PS + ++ R + F K P ++ L ++P + +
Sbjct: 104 QPSMMTRMYIEQ----RDRLYNDNQVFAKYNVSRLQPYLKLRQALLE----LRPAKNVLI 155
Query: 133 EGSEPEPAAGLNKS---------FGFSKHFANK-YELGEEVGRGHFGYTCAAKFKKGELK 182
+G G K+ + K + L + + + L+
Sbjct: 156 DG-----VLGSGKTWVALDVCLSYKVQCKMDFKIFWL-------NLKNCNSPE---TVLE 200
Query: 183 GQQVAVKVI-------PKHKMTTAIAIEDVRREVKILRALTGHNN--LV-------KFFD 226
Q + I H + I ++ E++ L + N LV K ++
Sbjct: 201 MLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWN 260
Query: 227 AYED--------TDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHL 278
A+ + T V L + T D+ K+++++ L+
Sbjct: 261 AF-NLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQ--- 316
Query: 279 QGVVHRDLKPENFLFTTKDENSVLKAIDFG--LSDFV-RPD-------ERLNDIVGSAY- 327
DL E N +I + D + D ++L I+ S+
Sbjct: 317 ------DLPRE-----VLTTNPRRLSI-IAESIRDGLATWDNWKHVNCDKLTTIIESSLN 364
Query: 328 YVAPEVLHRSYST----EADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEA 383
+ P + + I ILL W
Sbjct: 365 VLEPAEYRKMFDRLSVFPPSAH----IPTILLS---LIW--------------------- 396
Query: 384 PWPSLSSEARDFV-----KRLLNKDP--------------RKRLTAAQALSELLI-CYQ- 422
+ + S+ V L+ K P + +L AL ++ Y
Sbjct: 397 -FDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYALHRSIVDHYNI 455
Query: 423 ---------------SYLFFY 428
Y + +
Sbjct: 456 PKTFDSDDLIPPYLDQYFYSH 476
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* Length = 258 | Back alignment and structure |
|---|
Score = 45.1 bits (106), Expect = 2e-05
Identities = 32/176 (18%), Positives = 58/176 (32%), Gaps = 34/176 (19%)
Query: 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDV----------- 205
+G + G A K +AVK+ +++ T+ +
Sbjct: 49 TAMGGVISTGKEANVFYADGVFDG-KPVAMAVKI---YRIETSEFDKMDEYLYGDERFDM 104
Query: 206 ----RREVKILRALTGHNNLVKFFDA-------YEDTDNVYVVMELCEGGEL-LDRILSR 253
+E + NL + +A Y NV ++ME EL ++
Sbjct: 105 RRISPKEKVFIWTEKEFRNLERAKEAGVSVPQPYTYMKNV-LLMEFIGEDELPAPTLVEL 163
Query: 254 GGKYTEDDAKAVMIQILN-VVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFG 308
G + E D + + ++ V +VH DL N ++ K + ID G
Sbjct: 164 GRELKELDVEGIFNDVVENVKRLYQEAELVHADLSEYNIMYIDK-----VYFIDMG 214
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* Length = 282 | Back alignment and structure |
|---|
Score = 43.8 bits (103), Expect = 5e-05
Identities = 37/147 (25%), Positives = 54/147 (36%), Gaps = 18/147 (12%)
Query: 163 VGRGHFGYTCAAKFKK-GELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNL 221
C KF K G ++V K + +AI R E + L+ L G
Sbjct: 108 NCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG---- 163
Query: 222 VKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGV 281
+ Y N V+MEL + EL ++ V+ IL VA + +G+
Sbjct: 164 LAVPKVYAWEGNA-VLMELIDAKELYR--------VRVENPDEVLDMILEEVAKFYHRGI 214
Query: 282 VHRDLKPENFLFTTKDENSVLKAIDFG 308
VH DL N L + + IDF
Sbjct: 215 VHGDLSQYNVLVS----EEGIWIIDFP 237
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 429 | |||
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 100.0 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.96 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.93 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.87 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.77 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.48 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.35 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.23 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.23 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.93 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.82 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.78 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.56 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.53 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.52 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.46 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.3 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 98.04 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.96 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.84 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.73 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.7 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.69 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.66 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.6 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.39 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.36 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.32 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 97.06 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.98 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 96.65 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.53 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.16 | |
| 1cja_A | 342 | Protein (actin-fragmin kinase); transferase; HET: | 83.45 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 80.56 |
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-64 Score=484.65 Aligned_cols=258 Identities=30% Similarity=0.559 Sum_probs=228.8
Q ss_pred CceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeE
Q 014210 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (429)
Q Consensus 155 ~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~ 234 (429)
++|+++++||+|+||.||+|+.+. +|+.||||++.+.........+.+.+|+++|++|+ |||||+++++|++++.+
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~---~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~ 107 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELA---TSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-HPFFVKLYFTFQDDEKL 107 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCC-CTTBCCEEEEEECSSEE
T ss_pred cccEEEEEEecccCeEEEEEEECC---CCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEEeCCEE
Confidence 579999999999999999999876 68999999997654444455678999999999998 99999999999999999
Q ss_pred EEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccccC
Q 014210 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (429)
Q Consensus 235 ~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~ 314 (429)
|||||||+||+|.+++.+. +.+++..++.++.||+.||+|||++|||||||||+|||| +.++.+||+|||+|+.+.
T Consensus 108 yivmEy~~gG~L~~~i~~~-~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl---~~~g~vKl~DFGla~~~~ 183 (311)
T 4aw0_A 108 YFGLSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILL---NEDMHIQITDFGTAKVLS 183 (311)
T ss_dssp EEEECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTSCEEECCCTTCEECC
T ss_pred EEEEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEE---cCCCCEEEEEcCCceecC
Confidence 9999999999999998654 679999999999999999999999999999999999999 788999999999998775
Q ss_pred CCc---cccccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCH
Q 014210 315 PDE---RLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSS 390 (429)
Q Consensus 315 ~~~---~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 390 (429)
... .....+||+.|||||++.+ .|+.++|||||||+||||++|+.||.+.+..+++..+++....++. .+++
T Consensus 184 ~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~p~----~~s~ 259 (311)
T 4aw0_A 184 PESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPE----KFFP 259 (311)
T ss_dssp TTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT----TCCH
T ss_pred CCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCc----ccCH
Confidence 332 3456799999999999874 6999999999999999999999999999999999999998876654 6899
Q ss_pred HHHHHHHHhcccCccCcCCHHHHHhhHhhhccce
Q 014210 391 EARDFVKRLLNKDPRKRLTAAQALSELLICYQSY 424 (429)
Q Consensus 391 ~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~~~ 424 (429)
++++||++||++||++|+|+.|++.|.|+..|.|
T Consensus 260 ~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~ 293 (311)
T 4aw0_A 260 KARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPF 293 (311)
T ss_dssp HHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGG
T ss_pred HHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCC
Confidence 9999999999999999999988644444444443
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-62 Score=469.82 Aligned_cols=255 Identities=34% Similarity=0.599 Sum_probs=212.8
Q ss_pred CceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeE
Q 014210 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (429)
Q Consensus 155 ~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~ 234 (429)
++|+++++||+|+||.||+|+.+. +|+.||||++.+.........+++.+|++++++|+ |||||++++++++++.+
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~---~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~~~~~~~~~~~~ 88 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTT---TGQKVALKIINKKVLAKSDMQGRIEREISYLRLLR-HPHIIKLYDVIKSKDEI 88 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTT---TCCEEEEEEEECC------CHHHHHHHHHHHHHCC-CTTBCCEEEEEECSSEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECC---CCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCC-CCCCCeEEEEEEECCEE
Confidence 579999999999999999998765 68999999998776666666778999999999998 99999999999999999
Q ss_pred EEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccccC
Q 014210 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (429)
Q Consensus 235 ~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~ 314 (429)
||||||| +|+|.+++.+ .+.+++..++.++.||+.||+|||++||+||||||+|||+ +.++++||+|||+|+...
T Consensus 89 ~ivmEy~-~g~L~~~l~~-~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl---~~~~~vkl~DFGla~~~~ 163 (275)
T 3hyh_A 89 IMVIEYA-GNELFDYIVQ-RDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLL---DEHLNVKIADFGLSNIMT 163 (275)
T ss_dssp EEEEECC-CEEHHHHHHH-SCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEE---CTTCCEEECCSSCC----
T ss_pred EEEEeCC-CCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEE---CCCCCEEEeecCCCeecC
Confidence 9999999 6799998865 4679999999999999999999999999999999999999 788899999999998877
Q ss_pred CCccccccccCCcccCcccccC-CC-CCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHH
Q 014210 315 PDERLNDIVGSAYYVAPEVLHR-SY-STEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEA 392 (429)
Q Consensus 315 ~~~~~~~~~gt~~y~aPE~~~~-~~-~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 392 (429)
........+||+.|||||++.+ .+ +.++|||||||++|||++|+.||.+.+....+..+.+....++ ..+++++
T Consensus 164 ~~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~~p----~~~s~~~ 239 (275)
T 3hyh_A 164 DGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLP----KFLSPGA 239 (275)
T ss_dssp -----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC----TTSCHHH
T ss_pred CCCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHH
Confidence 6666677899999999999975 34 6799999999999999999999999998888888888776654 3689999
Q ss_pred HHHHHHhcccCccCcCCHHHHHhhHhhhcc
Q 014210 393 RDFVKRLLNKDPRKRLTAAQALSELLICYQ 422 (429)
Q Consensus 393 ~~li~~~L~~dP~~Rps~~~iL~~~~~~~~ 422 (429)
++||++||++||++|||+.|+|+|+||+..
T Consensus 240 ~~li~~~L~~dP~~R~s~~eil~hpw~k~~ 269 (275)
T 3hyh_A 240 AGLIKRMLIVNPLNRISIHEIMQDDWFKVD 269 (275)
T ss_dssp HHHHHHHSCSSGGGSCCHHHHHHCHHHHTT
T ss_pred HHHHHHHccCChhHCcCHHHHHcCcccccC
Confidence 999999999999999999999999999854
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-63 Score=484.61 Aligned_cols=257 Identities=26% Similarity=0.516 Sum_probs=225.3
Q ss_pred CceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeE
Q 014210 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (429)
Q Consensus 155 ~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~ 234 (429)
++|+++++||+|+||.||+|+.+. +|+.||||++.+... .....+.+.+|+++|++|+ |||||++++++++++.+
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~---~~~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l~-HpnIV~~~~~~~~~~~~ 98 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTE---DGRQYVIKEINISRM-SSKEREESRREVAVLANMK-HPNIVQYRESFEENGSL 98 (350)
T ss_dssp CCEEEEEEC------CEEEEEETT---TCCEEEEEEEECTTS-CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEETTEE
T ss_pred cceEEeEEEecCCCeEEEEEEECC---CCCEEEEEEEehHHC-CHHHHHHHHHHHHHHHHCC-CCCCCcEEEEEEECCEE
Confidence 689999999999999999999776 689999999987653 4456788999999999998 99999999999999999
Q ss_pred EEEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCcccc
Q 014210 235 YVVMELCEGGELLDRILSRG-GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (429)
Q Consensus 235 ~lv~E~~~ggsL~~~i~~~~-~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~ 313 (429)
|||||||+||+|.++|..+. ..+++..++.|+.||+.||+|||++|||||||||+|||| +.++.+||+|||+|+..
T Consensus 99 yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl---~~~g~vKl~DFGla~~~ 175 (350)
T 4b9d_A 99 YIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFL---TKDGTVQLGDFGIARVL 175 (350)
T ss_dssp EEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEE---CTTCCEEECSTTEESCC
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEE---CCCCCEEEcccccceee
Confidence 99999999999999997654 468999999999999999999999999999999999999 78889999999999877
Q ss_pred CCCc-cccccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHH
Q 014210 314 RPDE-RLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSE 391 (429)
Q Consensus 314 ~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 391 (429)
.... .....+||+.|||||++.+ .|+.++|||||||+||||++|+.||.+.+..+.+..++...... .+..++++
T Consensus 176 ~~~~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~---~~~~~s~~ 252 (350)
T 4b9d_A 176 NSTVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPP---VSLHYSYD 252 (350)
T ss_dssp CHHHHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCC---CCTTSCHH
T ss_pred cCCcccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCC---CCccCCHH
Confidence 5432 2346789999999999875 69999999999999999999999999999999999988876432 23578999
Q ss_pred HHHHHHHhcccCccCcCCHHHHHhhHhhhcc
Q 014210 392 ARDFVKRLLNKDPRKRLTAAQALSELLICYQ 422 (429)
Q Consensus 392 ~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~ 422 (429)
+.+||.+||++||++|||+.|+|+|+||+..
T Consensus 253 ~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~ 283 (350)
T 4b9d_A 253 LRSLVSQLFKRNPRDRPSVNSILEKGFIAKR 283 (350)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHTSHHHHTT
T ss_pred HHHHHHHHccCChhHCcCHHHHhcCHHhhcC
Confidence 9999999999999999999999999999754
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-62 Score=479.30 Aligned_cols=255 Identities=30% Similarity=0.555 Sum_probs=226.8
Q ss_pred CceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeE
Q 014210 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (429)
Q Consensus 155 ~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~ 234 (429)
+.|+++++||+|+||.||+|+.+. +|+.||||++.+.... ..+.+.+|+++|++|+ |||||+++++|++++.+
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~---tg~~vAiK~i~~~~~~---~~~~~~~Ei~il~~l~-HpnIV~l~~~~~~~~~~ 146 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRS---SGKLVAVKKMDLRKQQ---RRELLFNEVVIMRDYQ-HENVVEMYNSYLVGDEL 146 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETT---TCCEEEEEEEEGGGCS---SGGGGHHHHHHHHHCC-CTTBCCEEEEEEETTEE
T ss_pred HhcEEeEEeecCcCeEEEEEEECC---CCCEEEEEEEecCchh---HHHHHHHHHHHHHhCC-CCCCCcEEEEEEECCEE
Confidence 579999999999999999999876 6999999999654322 2356789999999998 99999999999999999
Q ss_pred EEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccccC
Q 014210 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (429)
Q Consensus 235 ~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~ 314 (429)
|||||||+||+|.+++.. +.+++..++.|+.||+.||+|||++|||||||||+|||| +.++++||+|||+|+.+.
T Consensus 147 ~ivmEy~~gg~L~~~l~~--~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl---~~~g~vKl~DFGla~~~~ 221 (346)
T 4fih_A 147 WVVMEFLEGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILL---THDGRVKLSDFGFCAQVS 221 (346)
T ss_dssp EEEECCCTTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCCTTCEECC
T ss_pred EEEEeCCCCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEE---CCCCCEEEecCcCceecC
Confidence 999999999999998754 569999999999999999999999999999999999999 788899999999998775
Q ss_pred CC-ccccccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHH
Q 014210 315 PD-ERLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEA 392 (429)
Q Consensus 315 ~~-~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 392 (429)
.. ......+||+.|||||++.+ .|+.++|||||||+||||++|+.||.+.+..+.+..+....+. ....+..+++++
T Consensus 222 ~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~-~~~~~~~~s~~~ 300 (346)
T 4fih_A 222 KEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPP-RLKNLHKVSPSL 300 (346)
T ss_dssp SSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCC-CCSCGGGSCHHH
T ss_pred CCCCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCC-CCCccccCCHHH
Confidence 43 34567899999999999874 6999999999999999999999999999988888888765432 233446799999
Q ss_pred HHHHHHhcccCccCcCCHHHHHhhHhhhcc
Q 014210 393 RDFVKRLLNKDPRKRLTAAQALSELLICYQ 422 (429)
Q Consensus 393 ~~li~~~L~~dP~~Rps~~~iL~~~~~~~~ 422 (429)
++||++||++||++|||+.|+|+|+||+..
T Consensus 301 ~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~ 330 (346)
T 4fih_A 301 KGFLDRLLVRDPAQRATAAELLKHPFLAKA 330 (346)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred HHHHHHHcCCChhHCcCHHHHhcCHhhcCC
Confidence 999999999999999999999999999854
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-61 Score=463.55 Aligned_cols=258 Identities=21% Similarity=0.363 Sum_probs=217.2
Q ss_pred Cce-eEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEe---
Q 014210 155 NKY-ELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED--- 230 (429)
Q Consensus 155 ~~y-~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~--- 230 (429)
.+| ++.++||+|+||.||+|.... +|+.||||++.+.. ......+.+.+|++++++|+ |||||+++++|++
T Consensus 25 gr~~~~~~~iG~G~fg~Vy~a~~~~---~~~~vAiK~i~~~~-~~~~~~~~~~~E~~il~~l~-HpnIV~~~~~~~~~~~ 99 (290)
T 3fpq_A 25 GRFLKFDIEIGRGSFKTVYKGLDTE---TTVEVAWCELQDRK-LTKSERQRFKEEAEMLKGLQ-HPNIVRFYDSWESTVK 99 (290)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEGGG-SCHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEEEEET
T ss_pred CceEEeeeEEecCcCcEEEEEEECC---CCeEEEEEEEchhh-CCHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEeeccC
Confidence 344 788899999999999998776 68999999997644 34455678999999999998 9999999999975
Q ss_pred -CCeEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC--ceeccCCCCcEEEeecCCCceEEEeec
Q 014210 231 -TDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQG--VVHRDLKPENFLFTTKDENSVLKAIDF 307 (429)
Q Consensus 231 -~~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~--iiHrDIKp~NILl~~~~~~~~vkL~DF 307 (429)
++.+|||||||+||+|.+++.+ .+.+++..++.|+.||+.||+|||++| ||||||||+||||+ +.++.+||+||
T Consensus 100 ~~~~~~lvmEy~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~--~~~g~vKl~DF 176 (290)
T 3fpq_A 100 GKKCIVLVTELMTSGTLKTYLKR-FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFIT--GPTGSVKIGDL 176 (290)
T ss_dssp TEEEEEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEES--STTSCEEECCT
T ss_pred CCcEEEEEEeCCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEE--CCCCCEEEEeC
Confidence 3468999999999999998864 467999999999999999999999998 99999999999994 24788999999
Q ss_pred CCccccCCCccccccccCCcccCcccccCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHH-HHHHHHhcCCCCCCCCCC
Q 014210 308 GLSDFVRPDERLNDIVGSAYYVAPEVLHRSYSTEADVWSIGVIAYILLCGSRPFWARTESG-IFRAVLKADPSFDEAPWP 386 (429)
Q Consensus 308 Gla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~-~~~~i~~~~~~~~~~~~~ 386 (429)
|+|+... .......+||+.|||||++.+.|+.++|||||||+||||+||+.||....... ++..+..... +.....
T Consensus 177 Gla~~~~-~~~~~~~~GTp~YmAPE~~~~~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~--~~~~~~ 253 (290)
T 3fpq_A 177 GLATLKR-ASFAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK--PASFDK 253 (290)
T ss_dssp TGGGGCC-TTSBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCC--CGGGGG
T ss_pred cCCEeCC-CCccCCcccCccccCHHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCC--CCCCCc
Confidence 9998654 34456779999999999999899999999999999999999999997655444 4444433321 122234
Q ss_pred CCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhccc
Q 014210 387 SLSSEARDFVKRLLNKDPRKRLTAAQALSELLICYQS 423 (429)
Q Consensus 387 ~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~~ 423 (429)
.+++++.+||.+||++||++|||+.|+|+|+||+.++
T Consensus 254 ~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~~T 290 (290)
T 3fpq_A 254 VAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQEET 290 (290)
T ss_dssp CCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC---
T ss_pred cCCHHHHHHHHHHccCChhHCcCHHHHhcCccccCCC
Confidence 6789999999999999999999999999999998763
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-62 Score=471.75 Aligned_cols=259 Identities=29% Similarity=0.495 Sum_probs=224.0
Q ss_pred CceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeE
Q 014210 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (429)
Q Consensus 155 ~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~ 234 (429)
++|+++++||+|+||.||+|+...+..+++.||||++.+..... ....++.+|++++++|+ |||||++++++++++.+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~ 101 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKV-RDRVRTKMERDILVEVN-HPFIVKLHYAFQTEGKL 101 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEE-EECC------CCCCCCC-CTTEECEEEEEEETTEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcCh-HHHHHHHHHHHHHHHCC-CCCCCeEEEEEEECCEE
Confidence 67999999999999999999987665678999999997654322 22346789999999998 99999999999999999
Q ss_pred EEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccccC
Q 014210 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (429)
Q Consensus 235 ~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~ 314 (429)
|||||||+||+|.+++.+. +.+++..++.++.||+.||+|||++|||||||||+|||+ +.++.+||+|||+|+...
T Consensus 102 ~ivmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl---~~~g~vKl~DFGla~~~~ 177 (304)
T 3ubd_A 102 YLILDFLRGGDLFTRLSKE-VMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILL---DEEGHIKLTDFGLSKESI 177 (304)
T ss_dssp EEEECCCTTCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEE---CTTSCEEEESSEEEEC--
T ss_pred EEEEEcCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEE---cCCCCEEecccccceecc
Confidence 9999999999999988654 679999999999999999999999999999999999999 788899999999998654
Q ss_pred C-CccccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHH
Q 014210 315 P-DERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEA 392 (429)
Q Consensus 315 ~-~~~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 392 (429)
. .......+||+.|||||++. +.|+.++|||||||+||||+||+.||.+.+..+.+..+++....++ ..+++++
T Consensus 178 ~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p----~~~s~~~ 253 (304)
T 3ubd_A 178 DHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMP----QFLSPEA 253 (304)
T ss_dssp ---CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTSCHHH
T ss_pred CCCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCC----CcCCHHH
Confidence 3 33456789999999999987 4699999999999999999999999999999999999998776654 3689999
Q ss_pred HHHHHHhcccCccCcCC-----HHHHHhhHhhhccc
Q 014210 393 RDFVKRLLNKDPRKRLT-----AAQALSELLICYQS 423 (429)
Q Consensus 393 ~~li~~~L~~dP~~Rps-----~~~iL~~~~~~~~~ 423 (429)
.+||++||++||++||| ++|+++|+||+...
T Consensus 254 ~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~id 289 (304)
T 3ubd_A 254 QSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTID 289 (304)
T ss_dssp HHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTCC
T ss_pred HHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCCC
Confidence 99999999999999998 58999999998754
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-61 Score=482.83 Aligned_cols=256 Identities=30% Similarity=0.553 Sum_probs=227.8
Q ss_pred cCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~ 233 (429)
.+.|+++++||+|+||.||+|+.+. +|+.||||++....... .+.+.+|+.+|++|+ |||||+++++|++++.
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~---tg~~vAiK~i~~~~~~~---~~~~~~Ei~il~~l~-HpnIV~l~~~~~~~~~ 222 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRS---SGKLVAVKKMDLRKQQR---RELLFNEVVIMRDYQ-HENVVEMYNSYLVGDE 222 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETT---TCCEEEEEEEESTTCSS---GGGHHHHHHHHHHCC-CTTBCCEEEEEEETTE
T ss_pred hHhcEeeeEeccCcCcEEEEEEECC---CCCEEEEEEEeccchhH---HHHHHHHHHHHHhCC-CCCCCceEEEEEECCE
Confidence 4679999999999999999999876 69999999997653332 356889999999998 9999999999999999
Q ss_pred EEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCcccc
Q 014210 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (429)
Q Consensus 234 ~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~ 313 (429)
+|||||||+||+|.+++.. +.+++..++.|+.||+.||+|||++|||||||||+|||| +.++.+||+|||+|+.+
T Consensus 223 ~~iVmEy~~gG~L~~~i~~--~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl---~~~g~vKl~DFGla~~~ 297 (423)
T 4fie_A 223 LWVVMEFLEGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILL---THDGRVKLSDFGFCAQV 297 (423)
T ss_dssp EEEEEECCTTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEE---CTTCCEEECCCTTCEEC
T ss_pred EEEEEeCCCCCcHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEE---cCCCCEEEecCccceEC
Confidence 9999999999999998743 469999999999999999999999999999999999999 78889999999999876
Q ss_pred CCC-ccccccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHH
Q 014210 314 RPD-ERLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSE 391 (429)
Q Consensus 314 ~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 391 (429)
... ......+||+.|||||++.+ .|+.++|||||||++|||++|+.||.+.+....+..+....+. ....+..++++
T Consensus 298 ~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~-~~~~~~~~s~~ 376 (423)
T 4fie_A 298 SKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPP-RLKNLHKVSPS 376 (423)
T ss_dssp CSSCCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC-CCSCTTSSCHH
T ss_pred CCCCccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCC-CCcccccCCHH
Confidence 543 34567899999999999874 6999999999999999999999999999988888888765432 23345679999
Q ss_pred HHHHHHHhcccCccCcCCHHHHHhhHhhhcc
Q 014210 392 ARDFVKRLLNKDPRKRLTAAQALSELLICYQ 422 (429)
Q Consensus 392 ~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~ 422 (429)
+++||++||.+||++|||+.|+|+|+||+..
T Consensus 377 ~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~ 407 (423)
T 4fie_A 377 LKGFLDRLLVRDPAQRATAAELLKHPFLAKA 407 (423)
T ss_dssp HHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred HHHHHHHHcCCChhHCcCHHHHhcCHHhcCC
Confidence 9999999999999999999999999999853
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-58 Score=446.37 Aligned_cols=258 Identities=24% Similarity=0.401 Sum_probs=215.5
Q ss_pred cCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~ 233 (429)
.+++++.++||+|+||.||+|+.. ..||||+++... .+....++|.+|++++++|+ |||||++++++.+ +.
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~------~~vAvK~~~~~~-~~~~~~~~f~~E~~il~~l~-HpNIV~l~g~~~~-~~ 105 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWH------GDVAVKILKVVD-PTPEQFQAFRNEVAVLRKTR-HVNILLFMGYMTK-DN 105 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESS------SEEEEEECCCSS-CCHHHHHHHHHHHHHHTTCC-CTTBCCEEEEECS-SS
T ss_pred HHHeEEeeEEeeCCCcEEEEEEEC------CcEEEEEEEecC-CCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEC-Ce
Confidence 467889999999999999999743 359999986543 45566788999999999998 9999999998864 56
Q ss_pred EEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCcccc
Q 014210 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (429)
Q Consensus 234 ~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~ 313 (429)
++||||||+||+|.+++......+++..+..|+.||++||+|||+++||||||||+|||| ++++++||+|||+|+..
T Consensus 106 ~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl---~~~~~~Ki~DFGla~~~ 182 (307)
T 3omv_A 106 LAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFL---HEGLTVKIGDFGLATVK 182 (307)
T ss_dssp CEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEE---ETTEEEEECCCSSCBC-
T ss_pred EEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEE---CCCCcEEEeeccCceec
Confidence 899999999999999998777889999999999999999999999999999999999999 78899999999999876
Q ss_pred CCC---ccccccccCCcccCccccc----CCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCC--CCC
Q 014210 314 RPD---ERLNDIVGSAYYVAPEVLH----RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFD--EAP 384 (429)
Q Consensus 314 ~~~---~~~~~~~gt~~y~aPE~~~----~~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~--~~~ 384 (429)
... ......+||+.|||||++. +.|+.++|||||||+||||+||+.||.+.+....+..+.......+ ...
T Consensus 183 ~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~ 262 (307)
T 3omv_A 183 SRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKL 262 (307)
T ss_dssp -----------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTS
T ss_pred ccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcccc
Confidence 432 2345678999999999985 2489999999999999999999999988766555555544332222 234
Q ss_pred CCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhccc
Q 014210 385 WPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLICYQS 423 (429)
Q Consensus 385 ~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~~ 423 (429)
++.+++++.+||.+||+.||++|||+.++++++..-.++
T Consensus 263 ~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~ 301 (307)
T 3omv_A 263 YKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHS 301 (307)
T ss_dssp CTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTT
T ss_pred cccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcc
Confidence 467899999999999999999999999999988765544
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-59 Score=455.66 Aligned_cols=248 Identities=25% Similarity=0.335 Sum_probs=214.9
Q ss_pred cCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~ 233 (429)
.+.|++.++||+|+||.||+|+++. +|+.||||+++.... ..+|+.++++|+ |||||+++++|++++.
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~---~g~~vAiK~i~~~~~--------~~~E~~il~~l~-HpnIV~l~~~~~~~~~ 124 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQ---TGFQCAVKKVRLEVF--------RVEELVACAGLS-SPRIVPLYGAVREGPW 124 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEETTTC--------CTHHHHTTTTCC-CTTBCCEEEEEEETTE
T ss_pred hhheEeCcEeccCCCeEEEEEEECC---CCCEEEEEEECHHHh--------HHHHHHHHHhCC-CCCCCcEEEEEEECCE
Confidence 3679999999999999999999776 689999999976432 247999999998 9999999999999999
Q ss_pred EEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCc-eEEEeecCCccc
Q 014210 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENS-VLKAIDFGLSDF 312 (429)
Q Consensus 234 ~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~-~vkL~DFGla~~ 312 (429)
+|||||||+||+|.++|.+. +.+++..++.|+.||+.||+|||++|||||||||+|||| +.++ .+||+|||+|+.
T Consensus 125 ~~ivmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl---~~~g~~vKl~DFGla~~ 200 (336)
T 4g3f_A 125 VNIFMELLEGGSLGQLIKQM-GCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLL---SSDGSRAALCDFGHALC 200 (336)
T ss_dssp EEEEECCCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEE---CTTSCCEEECCCTTCEE
T ss_pred EEEEEeccCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEE---eCCCCEEEEeeCCCCeE
Confidence 99999999999999988654 679999999999999999999999999999999999999 5665 699999999987
Q ss_pred cCCCcc------ccccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCC
Q 014210 313 VRPDER------LNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPW 385 (429)
Q Consensus 313 ~~~~~~------~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 385 (429)
+..+.. ....+||+.|||||++.+ .|+.++|||||||+||||++|+.||.+......+..+....+... ..+
T Consensus 201 ~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~-~~~ 279 (336)
T 4g3f_A 201 LQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIR-EIP 279 (336)
T ss_dssp C------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGG-GSC
T ss_pred ccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCch-hcC
Confidence 754321 234689999999999875 699999999999999999999999998887777888877654432 234
Q ss_pred CCCCHHHHHHHHHhcccCccCcCCHHHHHhhHh
Q 014210 386 PSLSSEARDFVKRLLNKDPRKRLTAAQALSELL 418 (429)
Q Consensus 386 ~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~ 418 (429)
+.+++++.+||.+||++||++|||+.|+++|+.
T Consensus 280 ~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~ 312 (336)
T 4g3f_A 280 PSCAPLTAQAIQEGLRKEPVHRASAMELRRKVG 312 (336)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred ccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHH
Confidence 679999999999999999999999999976543
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-58 Score=444.75 Aligned_cols=252 Identities=25% Similarity=0.396 Sum_probs=217.4
Q ss_pred cCceeEeceeeccCceEEEEEEEecC--cccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeC
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKG--ELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~--~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~ 231 (429)
.++|.+.++||+|+||.||+|+.... ..+|+.||||++.. ......++|.+|+++|++|+ |||||+++|+|.++
T Consensus 12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~---~~~~~~~~f~~E~~il~~l~-HpnIV~l~g~~~~~ 87 (299)
T 4asz_A 12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKD---ASDNARKDFHREAELLTNLQ-HEHIVKFYGVCVEG 87 (299)
T ss_dssp GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECS---CCHHHHHHHHHHHHHHTTCC-CTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCC---CChHHHHHHHHHHHHHHhCC-CCCCccEEEEEeeC
Confidence 46899999999999999999987642 23588999999964 34566788999999999998 99999999999999
Q ss_pred CeEEEEEEecCCCcHHHHHHhcC------------CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCC
Q 014210 232 DNVYVVMELCEGGELLDRILSRG------------GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDEN 299 (429)
Q Consensus 232 ~~~~lv~E~~~ggsL~~~i~~~~------------~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~ 299 (429)
+.+|||||||++|+|.++|...+ ..+++.++..|+.||++||.|||+++||||||||+|||| +++
T Consensus 88 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl---~~~ 164 (299)
T 4asz_A 88 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLV---GEN 164 (299)
T ss_dssp SSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGG
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEE---CCC
Confidence 99999999999999999997542 469999999999999999999999999999999999999 788
Q ss_pred ceEEEeecCCccccCCCcc---ccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHH
Q 014210 300 SVLKAIDFGLSDFVRPDER---LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVL 374 (429)
Q Consensus 300 ~~vkL~DFGla~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~ellt-g~~Pf~~~~~~~~~~~i~ 374 (429)
+++||+|||+++....... .....||+.|||||++. +.|+.++|||||||+||||+| |+.||.+.+..+++..+.
T Consensus 165 ~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~ 244 (299)
T 4asz_A 165 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECIT 244 (299)
T ss_dssp GCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH
T ss_pred CcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 8999999999987644332 23456999999999886 679999999999999999998 899999999888888887
Q ss_pred hcCCCCCCCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHh
Q 014210 375 KADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALS 415 (429)
Q Consensus 375 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~ 415 (429)
...... ....+++++.+||.+||+.||++|||+.+++.
T Consensus 245 ~~~~~~---~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~ 282 (299)
T 4asz_A 245 QGRVLQ---RPRTCPQEVYELMLGCWQREPHMRKNIKGIHT 282 (299)
T ss_dssp HTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cCCCCC---CCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 765321 22468999999999999999999999999955
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-58 Score=444.18 Aligned_cols=255 Identities=20% Similarity=0.315 Sum_probs=218.8
Q ss_pred cCceeEeceeeccCceEEEEEEEec--CcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeC
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKK--GELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~--~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~ 231 (429)
.+++++.++||+|+||.||+|+... ...+++.||||++... ......++|.+|+.++++|+ |||||+++|+|.++
T Consensus 25 ~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~--~~~~~~~~f~~E~~il~~l~-HpNIV~l~g~~~~~ 101 (308)
T 4gt4_A 25 LSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDK--AEGPLREEFRHEAMLRARLQ-HPNVVCLLGVVTKD 101 (308)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC---CCC-CHHHHHHHHHHHHHCC-CTTBCCEEEEECSS
T ss_pred HHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcc--cChHHHHHHHHHHHHHHhCC-CCCCCCcceEEEEC
Confidence 4678999999999999999998753 2235789999999654 23445578999999999998 99999999999999
Q ss_pred CeEEEEEEecCCCcHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeec
Q 014210 232 DNVYVVMELCEGGELLDRILSRG---------------GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTK 296 (429)
Q Consensus 232 ~~~~lv~E~~~ggsL~~~i~~~~---------------~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~ 296 (429)
+.++||||||++|+|.++|..+. ..+++.++..|+.||++||+|||+++||||||||+||||
T Consensus 102 ~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl--- 178 (308)
T 4gt4_A 102 QPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLV--- 178 (308)
T ss_dssp SSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---
T ss_pred CEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEE---
Confidence 99999999999999999996532 358999999999999999999999999999999999999
Q ss_pred CCCceEEEeecCCccccCCCc---cccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHc-CCCCCCCCChHHHHH
Q 014210 297 DENSVLKAIDFGLSDFVRPDE---RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFR 371 (429)
Q Consensus 297 ~~~~~vkL~DFGla~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~ellt-g~~Pf~~~~~~~~~~ 371 (429)
++++++||+|||+++...... .....+||+.|||||++. +.|+.++|||||||+||||+| |+.||.+.+..+++.
T Consensus 179 ~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~ 258 (308)
T 4gt4_A 179 YDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVE 258 (308)
T ss_dssp CGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHH
T ss_pred CCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 788999999999998764332 234568999999999886 679999999999999999998 899999999888888
Q ss_pred HHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhH
Q 014210 372 AVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSEL 417 (429)
Q Consensus 372 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~ 417 (429)
.+...... ...+.++.++.+||.+||+.||++|||+.+|++++
T Consensus 259 ~i~~~~~~---~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L 301 (308)
T 4gt4_A 259 MIRNRQVL---PCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRL 301 (308)
T ss_dssp HHHTTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHcCCCC---CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 87765422 12347899999999999999999999999999876
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-57 Score=446.26 Aligned_cols=256 Identities=24% Similarity=0.386 Sum_probs=214.5
Q ss_pred cCceeEeceeeccCceEEEEEEEec--CcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeC
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKK--GELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~--~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~ 231 (429)
.++|.+.++||+|+||.||+|+.+. ...+++.||||+++. .+....++|.+|+++|++|+ |||||+++|+|.+.
T Consensus 40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~---~~~~~~~~f~~E~~il~~l~-HpnIV~l~g~~~~~ 115 (329)
T 4aoj_A 40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKE---ASESARQDFQREAELLTMLQ-HQHIVRFFGVCTEG 115 (329)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESC---CSHHHHHHHHHHHHHHTTCC-CTTBCCEEEEECSS
T ss_pred HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECc---CCHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEEEC
Confidence 3678999999999999999998763 223689999999964 34566788999999999998 99999999999999
Q ss_pred CeEEEEEEecCCCcHHHHHHhcC--------------CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecC
Q 014210 232 DNVYVVMELCEGGELLDRILSRG--------------GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKD 297 (429)
Q Consensus 232 ~~~~lv~E~~~ggsL~~~i~~~~--------------~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~ 297 (429)
+.+|||||||++|+|.+++.... +.+++.++..|+.||++||.|||+++||||||||+|||| +
T Consensus 116 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl---~ 192 (329)
T 4aoj_A 116 RPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLV---G 192 (329)
T ss_dssp SSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---E
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEE---C
Confidence 99999999999999999986532 459999999999999999999999999999999999999 7
Q ss_pred CCceEEEeecCCccccCCCc---cccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHc-CCCCCCCCChHHHHHH
Q 014210 298 ENSVLKAIDFGLSDFVRPDE---RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRA 372 (429)
Q Consensus 298 ~~~~vkL~DFGla~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~ellt-g~~Pf~~~~~~~~~~~ 372 (429)
+++++||+|||+++...... .....+||+.|||||++. +.|+.++|||||||+||||+| |+.||...+..+.+..
T Consensus 193 ~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~ 272 (329)
T 4aoj_A 193 QGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDC 272 (329)
T ss_dssp TTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHH
T ss_pred CCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 88999999999998764433 224567999999999887 469999999999999999999 8999999988888888
Q ss_pred HHhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhh
Q 014210 373 VLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLI 419 (429)
Q Consensus 373 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~ 419 (429)
+...... .....+++++.+||.+||+.||++|||+.||++++--
T Consensus 273 i~~g~~~---~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~ 316 (329)
T 4aoj_A 273 ITQGREL---ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQA 316 (329)
T ss_dssp HHHTCCC---CCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHH
T ss_pred HHcCCCC---CCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHH
Confidence 8765421 1224689999999999999999999999999987643
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-57 Score=456.16 Aligned_cols=259 Identities=29% Similarity=0.480 Sum_probs=222.2
Q ss_pred ccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEe--
Q 014210 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED-- 230 (429)
Q Consensus 153 ~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~-- 230 (429)
+.++|+++++||+|+||.||+|+.+. +|+.||||++.+.. ......+.+.+|+++|++|+ |||||++++++..
T Consensus 52 i~~~Y~~~~~lG~G~fG~V~~a~~~~---t~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~ 126 (398)
T 4b99_A 52 VGDEYEIIETIGNGAYGVVSSARRRL---TGQQVAIKKIPNAF-DVVTNAKRTLRELKILKHFK-HDNIIAIKDILRPTV 126 (398)
T ss_dssp CCSSEEEEEEEEECSSCEEEEEEETT---TCCEEEEEEETTTT-SSHHHHHHHHHHHHHHHHCC-CTTBCCEEEECCCSS
T ss_pred CCCCeEEEEEEecccCeEEEEEEECC---CCCEEEEEEECccc-cchHHHHHHHHHHHHHHhcC-CCCcceEeeeeeccc
Confidence 45789999999999999999999776 69999999997643 34455678899999999998 9999999999764
Q ss_pred ----CCeEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEee
Q 014210 231 ----TDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAID 306 (429)
Q Consensus 231 ----~~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~D 306 (429)
.+.+|||||||+ |+|.+++. ..+.+++..++.|+.||+.||.|||++|||||||||+|||+ +.++.+||+|
T Consensus 127 ~~~~~~~~~ivmE~~~-g~L~~~i~-~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~---~~~~~~Ki~D 201 (398)
T 4b99_A 127 PYGEFKSVYVVLDLME-SDLHQIIH-SSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLV---NENCELKIGD 201 (398)
T ss_dssp CTTTCCCEEEEEECCS-EEHHHHHT-SSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTCCEEECC
T ss_pred ccccCCEEEEEEeCCC-CCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCcccccc---CCCCCEEEee
Confidence 367999999996 68888774 45789999999999999999999999999999999999999 7888999999
Q ss_pred cCCccccCCC-----ccccccccCCcccCcccccC--CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCC
Q 014210 307 FGLSDFVRPD-----ERLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPS 379 (429)
Q Consensus 307 FGla~~~~~~-----~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~ 379 (429)
||+++.+... ......+||+.|||||++.+ .++.++|||||||++|||++|+.||.+.+..+.+..|+.....
T Consensus 202 FGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~ 281 (398)
T 4b99_A 202 FGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGT 281 (398)
T ss_dssp CTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCC
T ss_pred cceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCC
Confidence 9999876432 23456799999999998764 4799999999999999999999999999998888887654332
Q ss_pred CCCC---------------------------CCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhc
Q 014210 380 FDEA---------------------------PWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLICY 421 (429)
Q Consensus 380 ~~~~---------------------------~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~ 421 (429)
.... .++.+++++.+||++||.+||++|||+.|+|+|+||+.
T Consensus 282 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~ 350 (398)
T 4b99_A 282 PSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAK 350 (398)
T ss_dssp CCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTT
T ss_pred CChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCc
Confidence 2211 12457899999999999999999999999999999975
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-57 Score=446.99 Aligned_cols=260 Identities=25% Similarity=0.444 Sum_probs=213.2
Q ss_pred cccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeC
Q 014210 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (429)
Q Consensus 152 ~~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~ 231 (429)
.+.++|+++++||+|+||.||+|+.+....+++.||||++.+.. ...++.+|+++|+.+.+|||||+++++|++.
T Consensus 18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~-----~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~ 92 (361)
T 4f9c_A 18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS-----HPIRIAAELQCLTVAGGQDNVMGVKYCFRKN 92 (361)
T ss_dssp GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS-----CHHHHHHHHHHHHHTCSBTTBCCCSEEEEET
T ss_pred CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc-----CHHHHHHHHHHHHHhcCCCCCceEEEEEEEC
Confidence 45688999999999999999999877544468999999986532 2346789999999997799999999999999
Q ss_pred CeEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCcc
Q 014210 232 DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (429)
Q Consensus 232 ~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~ 311 (429)
+++|||||||+||+|.+++ +.+++.+++.++.||+.||+|||++|||||||||+|||++ .+.+.+||+|||+|+
T Consensus 93 ~~~~lvmE~~~g~~L~~~~----~~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~--~~~~~~kl~DFGla~ 166 (361)
T 4f9c_A 93 DHVVIAMPYLEHESFLDIL----NSLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYN--RRLKKYALVDFGLAQ 166 (361)
T ss_dssp TEEEEEEECCCCCCHHHHH----TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE--TTTTEEEECCCTTCE
T ss_pred CEEEEEEeCCCcccHHHHH----cCCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEe--CCCCeEEECcCCCCc
Confidence 9999999999999999987 4699999999999999999999999999999999999994 334789999999997
Q ss_pred ccCCCc-----------------------------cccccccCCcccCcccccC--CCCCcccHHHHHHHHHHHHcCCCC
Q 014210 312 FVRPDE-----------------------------RLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRP 360 (429)
Q Consensus 312 ~~~~~~-----------------------------~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlGvll~elltg~~P 360 (429)
...... .....+||+.|||||++.+ .|+.++||||+||++|||++|+.|
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~P 246 (361)
T 4f9c_A 167 GTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYP 246 (361)
T ss_dssp ECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSS
T ss_pred ccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCC
Confidence 543221 1234589999999998864 489999999999999999999999
Q ss_pred CCCC-ChHHHHHHHHhc--------------------------------------C------------CCCCCCCCCCCC
Q 014210 361 FWAR-TESGIFRAVLKA--------------------------------------D------------PSFDEAPWPSLS 389 (429)
Q Consensus 361 f~~~-~~~~~~~~i~~~--------------------------------------~------------~~~~~~~~~~~s 389 (429)
|... ++.+.+..+... . .......|..++
T Consensus 247 f~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is 326 (361)
T 4f9c_A 247 FYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVP 326 (361)
T ss_dssp SSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCC
T ss_pred CCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCC
Confidence 9654 333444333220 0 001112356789
Q ss_pred HHHHHHHHHhcccCccCcCCHHHHHhhHhhhcc
Q 014210 390 SEARDFVKRLLNKDPRKRLTAAQALSELLICYQ 422 (429)
Q Consensus 390 ~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~ 422 (429)
++++|||++||+.||++|+|++|+|+|+||++-
T Consensus 327 ~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~i 359 (361)
T 4f9c_A 327 DEAYDLLDKLLDLNPASRITAEEALLHPFFKDM 359 (361)
T ss_dssp HHHHHHHHHHTCSCTTTSCCHHHHHTSGGGTTC
T ss_pred HHHHHHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence 999999999999999999999999999999864
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-57 Score=439.31 Aligned_cols=255 Identities=31% Similarity=0.495 Sum_probs=200.2
Q ss_pred cCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCC-
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD- 232 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~- 232 (429)
.++|++++.||+|+||.||+|+.+. +|+.||||++... ......+.+.+|+++|++|+ |||||+++++|.+.+
T Consensus 4 l~dy~~~~~lG~G~fg~V~~a~~~~---~~~~vAiK~i~~~--~~~~~~~~~~~E~~il~~l~-HpnIV~~~~~~~~~~~ 77 (299)
T 4g31_A 4 LTDFEPIQCLGRGGFGVVFEAKNKV---DDCNYAIKRIRLP--NRELAREKVMREVKALAKLE-HPGIVRYFNAWLEKNT 77 (299)
T ss_dssp HHHEEEEEEEEECC--EEEEEEETT---TCCEEEEEEEEEC--SSHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEEEC-
T ss_pred chhCEEeeEEecCCCeEEEEEEECC---CCCEEEEEEEecc--CCHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEEecCc
Confidence 3569999999999999999999776 6899999999654 34555678999999999998 999999999997654
Q ss_pred -----------eEEEEEEecCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCC
Q 014210 233 -----------NVYVVMELCEGGELLDRILSRGG--KYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDEN 299 (429)
Q Consensus 233 -----------~~~lv~E~~~ggsL~~~i~~~~~--~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~ 299 (429)
.+|||||||+||+|.+++..+.. ...+..++.|+.||+.||+|||++|||||||||+|||| +.+
T Consensus 78 ~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl---~~~ 154 (299)
T 4g31_A 78 TEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFF---TMD 154 (299)
T ss_dssp ---------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTT
T ss_pred cccccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEE---CCC
Confidence 37999999999999999865432 35677899999999999999999999999999999999 778
Q ss_pred ceEEEeecCCccccCCCcc-------------ccccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHcCCCCCCCCC
Q 014210 300 SVLKAIDFGLSDFVRPDER-------------LNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWART 365 (429)
Q Consensus 300 ~~vkL~DFGla~~~~~~~~-------------~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~elltg~~Pf~~~~ 365 (429)
+++||+|||+|+....+.. ....+||+.|||||++.+ .|+.++|||||||+||||++ ||....
T Consensus 155 ~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~ 231 (299)
T 4g31_A 155 DVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM 231 (299)
T ss_dssp CCEEECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH
T ss_pred CcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc
Confidence 8999999999987654322 234589999999999875 69999999999999999996 886433
Q ss_pred hH-HHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhccc
Q 014210 366 ES-GIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLICYQS 423 (429)
Q Consensus 366 ~~-~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~~ 423 (429)
+. ..+..+.... ++ ..++..++++.+||++||++||++|||+.|+|+|+||+...
T Consensus 232 ~~~~~~~~~~~~~--~p-~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~~ 287 (299)
T 4g31_A 232 ERVRTLTDVRNLK--FP-PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLD 287 (299)
T ss_dssp HHHHHHHHHHTTC--CC-HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC-
T ss_pred HHHHHHHHHhcCC--CC-CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCCC
Confidence 22 2222232221 11 11234567789999999999999999999999999998654
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-57 Score=472.75 Aligned_cols=262 Identities=33% Similarity=0.593 Sum_probs=240.2
Q ss_pred ccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCC
Q 014210 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (429)
Q Consensus 153 ~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~ 232 (429)
..++|+++++||+|+||.||+|+.+. +|+.||||++.+. .....+.+.+|+++|+.|+ |||||+++++|++++
T Consensus 155 il~~Y~i~~~lG~G~fg~V~~~~~~~---tg~~~AiK~i~~~---~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~ 227 (573)
T 3uto_A 155 VLDHYDIHEELGTGAFGVVHRVTERA---TGNNFAAKFVMTP---HESDKETVRKEIQTMSVLR-HPTLVNLHDAFEDDN 227 (573)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEECC---SHHHHHHHHHHHHHHHHTC-CTTBCCEEEEEECSS
T ss_pred CccccEEEEEEeeccCeEEEEEEECC---CCCEEEEEEEecc---chhhHHHHHHHHHHHHhCC-CCCCCeEEEEEEECC
Confidence 45789999999999999999999876 6999999999653 3445577899999999998 999999999999999
Q ss_pred eEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccc
Q 014210 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (429)
Q Consensus 233 ~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~ 312 (429)
.+|||||||+||+|.++|..+.+.+++..++.++.||+.||+|||++||+||||||+|||++. +..+.+||+|||+++.
T Consensus 228 ~~~iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~-~~~~~vKl~DFG~a~~ 306 (573)
T 3uto_A 228 EMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTT-KRSNELKLIDFGLTAH 306 (573)
T ss_dssp EEEEEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS-SSCCCEEECCCSSCEE
T ss_pred EEEEEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccC-CCCCCEEEeeccceeE
Confidence 999999999999999999777778999999999999999999999999999999999999953 2347899999999999
Q ss_pred cCCCccccccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHH
Q 014210 313 VRPDERLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSE 391 (429)
Q Consensus 313 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 391 (429)
+.........+||+.|||||++.+ .|+.++|||||||+||||++|+.||.+....+.+..+......+....++.++++
T Consensus 307 ~~~~~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 386 (573)
T 3uto_A 307 LDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISED 386 (573)
T ss_dssp CCTTSEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHH
T ss_pred ccCCCceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHH
Confidence 887777778899999999999875 6899999999999999999999999999999999999998888888888899999
Q ss_pred HHHHHHHhcccCccCcCCHHHHHhhHhhhcc
Q 014210 392 ARDFVKRLLNKDPRKRLTAAQALSELLICYQ 422 (429)
Q Consensus 392 ~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~ 422 (429)
+++||++||+.||++||++.|+|+|+||+..
T Consensus 387 ~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~ 417 (573)
T 3uto_A 387 GKDFIRKLLLADPNTRMTIHQALEHPWLTPG 417 (573)
T ss_dssp HHHHHHTTSCSSGGGSCCHHHHHHSTTTSCC
T ss_pred HHHHHHHHccCChhHCcCHHHHhcCcCcCCC
Confidence 9999999999999999999999999999753
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-56 Score=439.21 Aligned_cols=257 Identities=26% Similarity=0.392 Sum_probs=216.9
Q ss_pred cCceeEeceeeccCceEEEEEEEecCc--ccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeC
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGE--LKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~--~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~ 231 (429)
.++|+++++||+|+||.||+|+..... ..++.||||++... ......+.+.+|+++|.++.+|||||+++|+|.+.
T Consensus 63 ~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~--~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~ 140 (353)
T 4ase_A 63 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG--ATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 140 (353)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTT--CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred HHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccc--cChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEec
Confidence 478999999999999999999877532 35688999999754 34455678999999999998679999999999764
Q ss_pred -CeEEEEEEecCCCcHHHHHHhc---------------CCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEee
Q 014210 232 -DNVYVVMELCEGGELLDRILSR---------------GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTT 295 (429)
Q Consensus 232 -~~~~lv~E~~~ggsL~~~i~~~---------------~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~ 295 (429)
+.++||||||++|+|.++|... ...+++..+..++.||++||+|||+++||||||||+|||+
T Consensus 141 ~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl-- 218 (353)
T 4ase_A 141 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL-- 218 (353)
T ss_dssp TSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE--
T ss_pred CCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceee--
Confidence 5689999999999999999753 2358999999999999999999999999999999999999
Q ss_pred cCCCceEEEeecCCccccCCCc---cccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHc-CCCCCCCCChHHHH
Q 014210 296 KDENSVLKAIDFGLSDFVRPDE---RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIF 370 (429)
Q Consensus 296 ~~~~~~vkL~DFGla~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~ellt-g~~Pf~~~~~~~~~ 370 (429)
++++++||+|||+|+....+. .....+||+.|||||++. +.|+.++|||||||+||||+| |+.||.+......+
T Consensus 219 -~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~ 297 (353)
T 4ase_A 219 -SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF 297 (353)
T ss_dssp -CGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHH
T ss_pred -CCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 788899999999998765443 234567999999999886 579999999999999999998 99999886655544
Q ss_pred HHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhH
Q 014210 371 RAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSEL 417 (429)
Q Consensus 371 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~ 417 (429)
..++....... ....+++++.+||.+||+.||++|||+.+|++|+
T Consensus 298 ~~~i~~g~~~~--~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L 342 (353)
T 4ase_A 298 CRRLKEGTRMR--APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 342 (353)
T ss_dssp HHHHHHTCCCC--CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHcCCCCC--CCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHH
Confidence 44444332222 1246899999999999999999999999999985
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-56 Score=464.51 Aligned_cols=258 Identities=26% Similarity=0.417 Sum_probs=219.8
Q ss_pred cCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHH---HHHHHHhcCCCCcceEEEEEEe
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRRE---VKILRALTGHNNLVKFFDAYED 230 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E---i~il~~l~~h~nIv~l~~~~~~ 230 (429)
.++|+++++||+|+||.||+|+.+. +|+.||||++.+...........+.+| +.+++.+. |||||+++++|++
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~---tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~-HP~IV~l~~~f~~ 263 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKAD---TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD-CPFIVCMSYAFHT 263 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSC-CTTBCCEEEEEEC
T ss_pred hHHeEEEEEEecccCeEEEEEEECC---CCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCC-CCCEeEEEEEEEE
Confidence 4789999999999999999999876 699999999976443333333344445 45555555 9999999999999
Q ss_pred CCeEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCc
Q 014210 231 TDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS 310 (429)
Q Consensus 231 ~~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla 310 (429)
.+.+|||||||+||+|.++|.+. +.+++..++.++.||+.||+|||++|||||||||+|||| +.++++||+|||+|
T Consensus 264 ~~~lylVmEy~~GGdL~~~l~~~-~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILl---d~~G~vKL~DFGlA 339 (689)
T 3v5w_A 264 PDKLSFILDLMNGGDLHYHLSQH-GVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILL---DEHGHVRISDLGLA 339 (689)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEE---CTTSCEEECCCTTC
T ss_pred CCEEEEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEE---eCCCCEEeccccee
Confidence 99999999999999999988654 679999999999999999999999999999999999999 88999999999999
Q ss_pred cccCCCccccccccCCcccCccccc-C-CCCCcccHHHHHHHHHHHHcCCCCCCCC---ChHHHHHHHHhcCCCCCCCCC
Q 014210 311 DFVRPDERLNDIVGSAYYVAPEVLH-R-SYSTEADVWSIGVIAYILLCGSRPFWAR---TESGIFRAVLKADPSFDEAPW 385 (429)
Q Consensus 311 ~~~~~~~~~~~~~gt~~y~aPE~~~-~-~~~~~sDiwSlGvll~elltg~~Pf~~~---~~~~~~~~i~~~~~~~~~~~~ 385 (429)
+..... .....+||+.|||||++. + .|+.++|||||||+||||++|+.||.+. ....+...++.....++
T Consensus 340 ~~~~~~-~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~~~p---- 414 (689)
T 3v5w_A 340 CDFSKK-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELP---- 414 (689)
T ss_dssp EECSSC-CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCCCCC----
T ss_pred eecCCC-CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCCCC----
Confidence 877543 445679999999999986 3 5999999999999999999999999753 33345566666665544
Q ss_pred CCCCHHHHHHHHHhcccCccCcCC-----HHHHHhhHhhhccce
Q 014210 386 PSLSSEARDFVKRLLNKDPRKRLT-----AAQALSELLICYQSY 424 (429)
Q Consensus 386 ~~~s~~~~~li~~~L~~dP~~Rps-----~~~iL~~~~~~~~~~ 424 (429)
..+++++++||++||++||++|++ +.+|++|+||+...|
T Consensus 415 ~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~idW 458 (689)
T 3v5w_A 415 DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDW 458 (689)
T ss_dssp TTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCCH
T ss_pred ccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCCH
Confidence 468999999999999999999998 799999999987654
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-52 Score=409.72 Aligned_cols=262 Identities=29% Similarity=0.545 Sum_probs=236.0
Q ss_pred cccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeC
Q 014210 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (429)
Q Consensus 152 ~~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~ 231 (429)
.+.++|++.+.||+|+||.||+|.... +|+.||+|++... ....+.+.+|+.+++.++ ||||+++++++.+.
T Consensus 2 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~---~~~~~a~K~~~~~----~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~ 73 (321)
T 1tki_A 2 ELYEKYMIAEDLGRGEFGIVHRCVETS---SKKTYMAKFVKVK----GTDQVLVKKEISILNIAR-HRNILHLHESFESM 73 (321)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEECCC----THHHHHHHHHHHHHHHSC-CTTBCCEEEEEEET
T ss_pred chhhceEeeeEEecCCCeEEEEEEECC---CCcEEEEEEEecC----cccHHHHHHHHHHHHhCC-CCCCCeEeEEEecC
Confidence 356899999999999999999998766 6899999998643 234567889999999998 99999999999999
Q ss_pred CeEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCcc
Q 014210 232 DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (429)
Q Consensus 232 ~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~ 311 (429)
+..++|||||+|++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.. .++.+||+|||++.
T Consensus 74 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~-~~~~~kl~Dfg~a~ 152 (321)
T 1tki_A 74 EELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTR-RSSTIKIIEFGQAR 152 (321)
T ss_dssp TEEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSS-SCCCEEECCCTTCE
T ss_pred CEEEEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccC-CCCCEEEEECCCCe
Confidence 99999999999999999986666689999999999999999999999999999999999999421 26789999999998
Q ss_pred ccCCCccccccccCCcccCcccccCC-CCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCH
Q 014210 312 FVRPDERLNDIVGSAYYVAPEVLHRS-YSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSS 390 (429)
Q Consensus 312 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 390 (429)
............||+.|+|||++.+. ++.++|||||||++|+|++|+.||........+..+......+....++.++.
T Consensus 153 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 232 (321)
T 1tki_A 153 QLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISI 232 (321)
T ss_dssp ECCTTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCH
T ss_pred ECCCCCccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCH
Confidence 88766666677899999999998754 78999999999999999999999999999999999998887777666778999
Q ss_pred HHHHHHHHhcccCccCcCCHHHHHhhHhhhcc
Q 014210 391 EARDFVKRLLNKDPRKRLTAAQALSELLICYQ 422 (429)
Q Consensus 391 ~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~ 422 (429)
++.+||++||..||++|||+.|+|+|+||+..
T Consensus 233 ~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~ 264 (321)
T 1tki_A 233 EAMDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred HHHHHHHHHcCCChhHCcCHHHHhcChhhccC
Confidence 99999999999999999999999999999864
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-52 Score=413.98 Aligned_cols=265 Identities=35% Similarity=0.701 Sum_probs=238.8
Q ss_pred ccccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEe
Q 014210 151 KHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED 230 (429)
Q Consensus 151 ~~~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~ 230 (429)
..+.++|++.+.||+|+||.||+|..+. +|+.||||++..... .....+.+.+|+.++++|+ ||||+++++++.+
T Consensus 25 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~~avK~~~~~~~-~~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~~ 99 (362)
T 2bdw_A 25 TKFSDNYDVKEELGKGAFSVVRRCVHKT---TGLEFAAKIINTKKL-SARDFQKLEREARICRKLQ-HPNIVRLHDSIQE 99 (362)
T ss_dssp CHHHHHEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEETTTC-CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEC
T ss_pred CCcccCeEEeeEEecCCCeEEEEEEECC---CCCEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEEe
Confidence 3456889999999999999999998765 589999999976543 4455678999999999998 9999999999999
Q ss_pred CCeEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCc
Q 014210 231 TDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS 310 (429)
Q Consensus 231 ~~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla 310 (429)
.+..|+|||||+||+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++..+.++.+||+|||++
T Consensus 100 ~~~~~lv~e~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a 178 (362)
T 2bdw_A 100 ESFHYLVFDLVTGGELFEDIVA-REFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLA 178 (362)
T ss_dssp SSEEEEEECCCCSCBHHHHHTT-CSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred CCEEEEEEecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcc
Confidence 9999999999999999998754 467999999999999999999999999999999999999976555678999999999
Q ss_pred cccCCCccccccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCC
Q 014210 311 DFVRPDERLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLS 389 (429)
Q Consensus 311 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 389 (429)
............+||+.|+|||++.+ .++.++|||||||++|+|++|+.||+.......+..+......++...|..++
T Consensus 179 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 258 (362)
T 2bdw_A 179 IEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVT 258 (362)
T ss_dssp BCCTTCCSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSC
T ss_pred eEecCCcccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCC
Confidence 88776666667789999999999875 69999999999999999999999999999888888888888777777778899
Q ss_pred HHHHHHHHHhcccCccCcCCHHHHHhhHhhhc
Q 014210 390 SEARDFVKRLLNKDPRKRLTAAQALSELLICY 421 (429)
Q Consensus 390 ~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~ 421 (429)
+++.+||.+||+.||++||++.++|+|+|++.
T Consensus 259 ~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~ 290 (362)
T 2bdw_A 259 PEAKSLIDSMLTVNPKKRITADQALKVPWICN 290 (362)
T ss_dssp HHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHT
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHhcCcccCC
Confidence 99999999999999999999999999999975
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-52 Score=414.59 Aligned_cols=266 Identities=36% Similarity=0.618 Sum_probs=234.9
Q ss_pred cccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCc---HHHHHHHHHHHHHHHHhcCCCCcceEEEEE
Q 014210 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTT---AIAIEDVRREVKILRALTGHNNLVKFFDAY 228 (429)
Q Consensus 152 ~~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~---~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~ 228 (429)
.+.++|++++.||+|+||.||+|+.+. +|+.||||++.+..... ....+.+.+|+.+++++. ||||+++++++
T Consensus 9 ~~~~~y~~~~~LG~G~fg~V~~~~~~~---~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~ 84 (361)
T 2yab_A 9 KVEDFYDIGEELGSGQFAIVKKCREKS---TGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVL-HPNIITLHDVY 84 (361)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCC-CTTBCCEEEEE
T ss_pred ChhhceEEeeEEeeCcCEEEEEEEECC---CCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCC-CcCCCcEEEEE
Confidence 456889999999999999999999776 68999999997654322 123567899999999998 99999999999
Q ss_pred EeCCeEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCC-CceEEEeec
Q 014210 229 EDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDE-NSVLKAIDF 307 (429)
Q Consensus 229 ~~~~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~-~~~vkL~DF 307 (429)
.+.+..+||||||+||+|.+++. ..+.+++..++.++.||+.||.|||++||+||||||+|||+...+. ...+||+||
T Consensus 85 ~~~~~~~lv~e~~~gg~L~~~l~-~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DF 163 (361)
T 2yab_A 85 ENRTDVVLILELVSGGELFDFLA-QKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (361)
T ss_dssp ECSSEEEEEEECCCSCBHHHHHT-TCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EeCCEEEEEEEcCCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEec
Confidence 99999999999999999999874 4567999999999999999999999999999999999999942211 127999999
Q ss_pred CCccccCCCccccccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCC
Q 014210 308 GLSDFVRPDERLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWP 386 (429)
Q Consensus 308 Gla~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 386 (429)
|++............+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+.+..+......+....|.
T Consensus 164 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 243 (361)
T 2yab_A 164 GLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFS 243 (361)
T ss_dssp SSCEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHT
T ss_pred CCceEcCCCCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhcc
Confidence 99988776666667889999999999874 68999999999999999999999999999999999998887777766667
Q ss_pred CCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhcc
Q 014210 387 SLSSEARDFVKRLLNKDPRKRLTAAQALSELLICYQ 422 (429)
Q Consensus 387 ~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~ 422 (429)
.++.++++||++||..||++|||+.++|+|+||+..
T Consensus 244 ~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~ 279 (361)
T 2yab_A 244 QTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPV 279 (361)
T ss_dssp TSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCS
T ss_pred CCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCC
Confidence 899999999999999999999999999999999854
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-53 Score=407.92 Aligned_cols=250 Identities=23% Similarity=0.306 Sum_probs=191.9
Q ss_pred cCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCC-
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD- 232 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~- 232 (429)
.++|.+.++||+|+||.||+|+. +|+.||||++... ......+..|+..+.+|+ |||||+++++|.+++
T Consensus 2 ar~i~L~~~iG~G~fG~Vy~~~~-----~g~~VAvK~l~~~----~~~~~~~e~Ei~~~~~l~-HpNIv~l~g~~~~~~~ 71 (303)
T 3hmm_A 2 ARTIVLQESIGKGRFGEVWRGKW-----RGEEVAVKIFSSR----EERSWFREAEIYQTVMLR-HENILGFIAADNKDNG 71 (303)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEE-----TTEEEEEEEECGG----GHHHHHHHHHHHTSTTCC-CTTBCCEEEEEEEECS
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE-----CCEEEEEEEECcc----chhhHHHHHHHHHHhcCC-CCCCCcEEEEEEecCC
Confidence 46799999999999999999974 3789999998542 122223345666667787 999999999998764
Q ss_pred ---eEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHc--------CceeccCCCCcEEEeecCCCce
Q 014210 233 ---NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQ--------GVVHRDLKPENFLFTTKDENSV 301 (429)
Q Consensus 233 ---~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~--------~iiHrDIKp~NILl~~~~~~~~ 301 (429)
.+|||||||++|+|.+++.. ..++++.+.+++.|+++||+|||++ +||||||||+|||| +.+++
T Consensus 72 ~~~~~~lV~Ey~~~gsL~~~l~~--~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl---~~~~~ 146 (303)
T 3hmm_A 72 TWTQLWLVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGT 146 (303)
T ss_dssp SSEEEEEEEECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEE---CTTSC
T ss_pred CceEEEEEecCCCCCcHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEE---CCCCC
Confidence 58999999999999999854 4689999999999999999999987 89999999999999 78899
Q ss_pred EEEeecCCccccCCCcc-----ccccccCCcccCcccccCC-------CCCcccHHHHHHHHHHHHcCCCCCCC------
Q 014210 302 LKAIDFGLSDFVRPDER-----LNDIVGSAYYVAPEVLHRS-------YSTEADVWSIGVIAYILLCGSRPFWA------ 363 (429)
Q Consensus 302 vkL~DFGla~~~~~~~~-----~~~~~gt~~y~aPE~~~~~-------~~~~sDiwSlGvll~elltg~~Pf~~------ 363 (429)
+||+|||+++....... ....+||+.|||||++.+. ++.++|||||||+||||+||+.||..
T Consensus 147 ~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~ 226 (303)
T 3hmm_A 147 CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQL 226 (303)
T ss_dssp EEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCC
T ss_pred EEEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccc
Confidence 99999999987654322 2346899999999998643 56789999999999999999766522
Q ss_pred ----C-----ChHHHHHHHHhcC--CCCCCCC-CCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHh
Q 014210 364 ----R-----TESGIFRAVLKAD--PSFDEAP-WPSLSSEARDFVKRLLNKDPRKRLTAAQALSELL 418 (429)
Q Consensus 364 ----~-----~~~~~~~~i~~~~--~~~~~~~-~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~ 418 (429)
. ........+.... +..+... ......++.+||.+||+.||++|||+.++++.+-
T Consensus 227 p~~~~~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 293 (303)
T 3hmm_A 227 PYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 293 (303)
T ss_dssp TTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHH
T ss_pred cchhcccccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHH
Confidence 1 1122222222222 1111110 0123357889999999999999999999998753
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-52 Score=414.36 Aligned_cols=259 Identities=29% Similarity=0.516 Sum_probs=226.4
Q ss_pred cCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~ 233 (429)
.++|+++++||+|+||.||+|+.+. +|+.||||++.+.........+.+.+|+.+++.+.+||||+++++++.+.+.
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~---~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~ 98 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKE---TGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDR 98 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcC---CCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCE
Confidence 4789999999999999999999776 5899999999765434445567788999999998679999999999999999
Q ss_pred EEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCcccc
Q 014210 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (429)
Q Consensus 234 ~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~ 313 (429)
+|||||||+||+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++..
T Consensus 99 ~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl---~~~g~ikL~DFG~a~~~ 174 (353)
T 3txo_A 99 LFFVMEFVNGGDLMFHIQKS-RRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLL---DHEGHCKLADFGMCKEG 174 (353)
T ss_dssp EEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCS
T ss_pred EEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEE---CCCCCEEEccccceeec
Confidence 99999999999999988554 679999999999999999999999999999999999999 78889999999999864
Q ss_pred CC-CccccccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHH
Q 014210 314 RP-DERLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSE 391 (429)
Q Consensus 314 ~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 391 (429)
.. .......+||+.|+|||++.+ .++.++|||||||++|||++|+.||...+..+.+..++.....++. .++.+
T Consensus 175 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~----~~~~~ 250 (353)
T 3txo_A 175 ICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPT----WLHED 250 (353)
T ss_dssp CC---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TSCHH
T ss_pred ccCCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCC----CCCHH
Confidence 32 334556789999999998874 6999999999999999999999999999999999999988766653 58999
Q ss_pred HHHHHHHhcccCccCcCCH------HHHHhhHhhhccc
Q 014210 392 ARDFVKRLLNKDPRKRLTA------AQALSELLICYQS 423 (429)
Q Consensus 392 ~~~li~~~L~~dP~~Rps~------~~iL~~~~~~~~~ 423 (429)
+.+||++||++||++||++ .++++|+||+...
T Consensus 251 ~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~~ 288 (353)
T 3txo_A 251 ATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEID 288 (353)
T ss_dssp HHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTCC
T ss_pred HHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCCC
Confidence 9999999999999999999 9999999998754
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-52 Score=405.41 Aligned_cols=257 Identities=33% Similarity=0.611 Sum_probs=231.0
Q ss_pred ccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCC
Q 014210 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (429)
Q Consensus 153 ~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~ 232 (429)
..++|++++.||+|+||.||+|++.. +|+.||||++.+.. ......+.+.+|+++++.++ ||||+++++++.+.+
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~---~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~ 87 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHIL---TGREVAIKIIDKTQ-LNPTSLQKLFREVRIMKILN-HPNIVKLFEVIETEK 87 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEGGG-SCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEECSS
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECC---CCCEEEEEEEEhhc-CCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEECC
Confidence 45789999999999999999998765 68999999997643 34556678899999999998 999999999999999
Q ss_pred eEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccc
Q 014210 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (429)
Q Consensus 233 ~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~ 312 (429)
..|+||||+++|+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++..
T Consensus 88 ~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll---~~~~~~kl~DFG~a~~ 163 (328)
T 3fe3_A 88 TLYLIMEYASGGEVFDYLVAH-GRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLL---DADMNIKIADFGFSNE 163 (328)
T ss_dssp EEEEEECCCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECSTTCCGG
T ss_pred EEEEEEECCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEE---cCCCCEEEeeccCcee
Confidence 999999999999999988654 579999999999999999999999999999999999999 7888999999999988
Q ss_pred cCCCccccccccCCcccCcccccC-CC-CCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCH
Q 014210 313 VRPDERLNDIVGSAYYVAPEVLHR-SY-STEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSS 390 (429)
Q Consensus 313 ~~~~~~~~~~~gt~~y~aPE~~~~-~~-~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 390 (429)
..........+||+.|+|||++.+ .+ +.++|||||||++|+|++|+.||...........+.......+. .++.
T Consensus 164 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~----~~s~ 239 (328)
T 3fe3_A 164 FTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPF----YMST 239 (328)
T ss_dssp GSSSCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TSCH
T ss_pred cCCCCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC----CCCH
Confidence 776666777899999999999875 44 46899999999999999999999999988888888887665543 5899
Q ss_pred HHHHHHHHhcccCccCcCCHHHHHhhHhhhcc
Q 014210 391 EARDFVKRLLNKDPRKRLTAAQALSELLICYQ 422 (429)
Q Consensus 391 ~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~ 422 (429)
++.+||++||..||.+|||+.|+|+|+|++..
T Consensus 240 ~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~ 271 (328)
T 3fe3_A 240 DCENLLKRFLVLNPIKRGTLEQIMKDRWINAG 271 (328)
T ss_dssp HHHHHHHHHCCSSTTTSCCHHHHTTCTTTTTT
T ss_pred HHHHHHHHHCCCChhHCcCHHHHhcCHhhcCC
Confidence 99999999999999999999999999999753
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-51 Score=419.37 Aligned_cols=265 Identities=35% Similarity=0.658 Sum_probs=237.0
Q ss_pred cccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeC
Q 014210 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (429)
Q Consensus 152 ~~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~ 231 (429)
.+.++|+++++||+|+||.||+|.... +|+.||+|++.... ......+.+.+|+.++++++ ||||+++++++.++
T Consensus 8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~---~~~~~a~K~i~~~~-~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~ 82 (444)
T 3soa_A 8 RFTEEYQLFEELGKGAFSVVRRCVKVL---AGQEYAAMIINTKK-LSARDHQKLEREARICRLLK-HPNIVRLHDSISEE 82 (444)
T ss_dssp HHHHHEEEEEEEEEC--CEEEEEEETT---TTEEEEEEEEESCS-CHHHHHHHHHHHHHHHHHCC-BTTBCCEEEEEECS
T ss_pred cccCCeEEEEEeccCCCeEEEEEEECC---CCcEEEEEEEEccc-CCHHHHHHHHHHHHHHHhCC-CcCCCeEEEEEEEC
Confidence 457899999999999999999998766 68999999997654 33455677999999999998 99999999999999
Q ss_pred CeEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCcc
Q 014210 232 DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (429)
Q Consensus 232 ~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~ 311 (429)
+..|||||||+||+|.+++..+ +.+++..++.++.||+.||.|||++||+||||||+|||++.+..++.+||+|||++.
T Consensus 83 ~~~~lv~E~~~gg~L~~~i~~~-~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~ 161 (444)
T 3soa_A 83 GHHYLIFDLVTGGELFEDIVAR-EYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAI 161 (444)
T ss_dssp SEEEEEECCCBCCBHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCB
T ss_pred CEEEEEEEeCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeE
Confidence 9999999999999999988654 679999999999999999999999999999999999999765567899999999998
Q ss_pred ccCCCc-cccccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCC
Q 014210 312 FVRPDE-RLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLS 389 (429)
Q Consensus 312 ~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 389 (429)
...... .....+||+.|+|||++.+ .++.++|||||||++|+|++|+.||+.......+..+......++...|+.++
T Consensus 162 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 241 (444)
T 3soa_A 162 EVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVT 241 (444)
T ss_dssp CCCTTCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSC
T ss_pred EecCCCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccCC
Confidence 765443 3356789999999999875 69999999999999999999999999999999999999988888888888999
Q ss_pred HHHHHHHHHhcccCccCcCCHHHHHhhHhhhcc
Q 014210 390 SEARDFVKRLLNKDPRKRLTAAQALSELLICYQ 422 (429)
Q Consensus 390 ~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~ 422 (429)
+++.+||.+||+.||++||++.|+|+|+|++..
T Consensus 242 ~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~~ 274 (444)
T 3soa_A 242 PEAKDLINKMLTINPSKRITAAEALKHPWISHR 274 (444)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHHH
T ss_pred HHHHHHHHHHcCCChhHCCCHHHHhcCccccCC
Confidence 999999999999999999999999999999753
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-51 Score=405.91 Aligned_cols=258 Identities=28% Similarity=0.524 Sum_probs=228.3
Q ss_pred cCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~ 233 (429)
.++|++++.||+|+||.||+|+.+. +|+.||||++.+.........+.+.+|+.+++.++ ||||+++++++.+.+.
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~l~~~~~~~~~ 79 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKA---TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR-HPFLTALKYAFQTHDR 79 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCC-CTTBCCEEEEEECSSE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECC---CCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCC-CCcCcceEEEEEeCCE
Confidence 4689999999999999999998765 68999999996543223344567889999999998 9999999999999999
Q ss_pred EEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCcccc
Q 014210 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (429)
Q Consensus 234 ~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~ 313 (429)
+||||||++||+|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++..
T Consensus 80 ~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~g~vkL~DFG~a~~~ 155 (337)
T 1o6l_A 80 LCFVMEYANGGELFFHLSR-ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLML---DKDGHIKITDFGLCKEG 155 (337)
T ss_dssp EEEEEECCTTCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCS
T ss_pred EEEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEE---CCCCCEEEeeccchhhc
Confidence 9999999999999988754 4679999999999999999999999999999999999999 78889999999999864
Q ss_pred C-CCccccccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHH
Q 014210 314 R-PDERLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSE 391 (429)
Q Consensus 314 ~-~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 391 (429)
. ........+||+.|+|||++.+ .++.++|||||||++|||++|+.||........+..+......++. .++++
T Consensus 156 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~ 231 (337)
T 1o6l_A 156 ISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR----TLSPE 231 (337)
T ss_dssp CCTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TSCHH
T ss_pred ccCCCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCC----CCCHH
Confidence 3 3344567789999999999874 6899999999999999999999999998888888888877665543 68999
Q ss_pred HHHHHHHhcccCccCcC-----CHHHHHhhHhhhccc
Q 014210 392 ARDFVKRLLNKDPRKRL-----TAAQALSELLICYQS 423 (429)
Q Consensus 392 ~~~li~~~L~~dP~~Rp-----s~~~iL~~~~~~~~~ 423 (429)
+.+||++||+.||++|| ++.++++|+||....
T Consensus 232 ~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~~ 268 (337)
T 1o6l_A 232 AKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSIN 268 (337)
T ss_dssp HHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCC
T ss_pred HHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCCC
Confidence 99999999999999999 999999999997654
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-51 Score=412.91 Aligned_cols=259 Identities=32% Similarity=0.598 Sum_probs=214.2
Q ss_pred ccCceeEe-ceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEe-
Q 014210 153 FANKYELG-EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED- 230 (429)
Q Consensus 153 ~~~~y~~~-~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~- 230 (429)
+.++|.+. ++||+|+||.||++..+. +|+.||||++... ..+.+|+.++.++.+|+||+++++++..
T Consensus 59 ~~~~y~~~~~~LG~G~~g~V~~~~~~~---~~~~vAiK~~~~~--------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~ 127 (400)
T 1nxk_A 59 IIDDYKVTSQVLGLGINGKVLQIFNKR---TQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENL 127 (400)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEE
T ss_pred ccccceeccceeeeccCeEEEEEEECC---CCCEEEEEEeCcc--------hhHHHHHHHHHHhcCCCCcceEeEEEeec
Confidence 34667776 789999999999998766 6899999998532 3567899998777679999999999876
Q ss_pred ---CCeEEEEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEee
Q 014210 231 ---TDNVYVVMELCEGGELLDRILSRG-GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAID 306 (429)
Q Consensus 231 ---~~~~~lv~E~~~ggsL~~~i~~~~-~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~D 306 (429)
.+.+|||||||+||+|.+++.... ..+++..++.|+.||+.||.|||++||+||||||+|||++..+.++.+||+|
T Consensus 128 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~D 207 (400)
T 1nxk_A 128 YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTD 207 (400)
T ss_dssp ETTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECC
T ss_pred ccCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEe
Confidence 567999999999999999987653 3699999999999999999999999999999999999996444478999999
Q ss_pred cCCccccCCCccccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHcCCCCCCCCChH----HHHHHHHhcCCCCC
Q 014210 307 FGLSDFVRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTES----GIFRAVLKADPSFD 381 (429)
Q Consensus 307 FGla~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~elltg~~Pf~~~~~~----~~~~~i~~~~~~~~ 381 (429)
||+++...........+||+.|+|||++. +.++.++|||||||++|||++|+.||...... .....+......++
T Consensus 208 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~ 287 (400)
T 1nxk_A 208 FGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFP 287 (400)
T ss_dssp CTTCEECC-----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCC
T ss_pred cccccccCCCCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCC
Confidence 99998776555566788999999999986 46899999999999999999999999765432 24556666666667
Q ss_pred CCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhcc
Q 014210 382 EAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLICYQ 422 (429)
Q Consensus 382 ~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~ 422 (429)
...|..++.++.+||++||+.||++|||+.++|+|+||...
T Consensus 288 ~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 328 (400)
T 1nxk_A 288 NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 328 (400)
T ss_dssp TTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred CcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCC
Confidence 66777899999999999999999999999999999999753
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-51 Score=411.84 Aligned_cols=259 Identities=27% Similarity=0.497 Sum_probs=224.2
Q ss_pred cCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~ 233 (429)
.++|+++++||+|+||.||+|+.+. +|+.||||++.+.........+.+.+|..++.++.+|||||++++++.+.+.
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~---~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~ 127 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKK---TDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESR 127 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECC---CCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCE
Confidence 4789999999999999999999876 5899999999876555556667788999999998669999999999999999
Q ss_pred EEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCcccc
Q 014210 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (429)
Q Consensus 234 ~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~ 313 (429)
+|||||||+||+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||| +.++.+||+|||+++..
T Consensus 128 ~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl---~~~g~ikL~DFGla~~~ 203 (396)
T 4dc2_A 128 LFFVIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLL---DSEGHIKLTDYGMCKEG 203 (396)
T ss_dssp EEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCC
T ss_pred EEEEEEcCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEE---CCCCCEEEeecceeeec
Confidence 99999999999999887644 679999999999999999999999999999999999999 78899999999999863
Q ss_pred -CCCccccccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHcCCCCCCCC---------ChHHHHHHHHhcCCCCCC
Q 014210 314 -RPDERLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWAR---------TESGIFRAVLKADPSFDE 382 (429)
Q Consensus 314 -~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~elltg~~Pf~~~---------~~~~~~~~i~~~~~~~~~ 382 (429)
.........+||+.|+|||++.+ .++.++|||||||++|||++|+.||... ........++.....++.
T Consensus 204 ~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~ 283 (396)
T 4dc2_A 204 LRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR 283 (396)
T ss_dssp CCTTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCCCT
T ss_pred ccCCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCCCC
Confidence 34455667899999999998874 6899999999999999999999999532 334456667766655543
Q ss_pred CCCCCCCHHHHHHHHHhcccCccCcCCH------HHHHhhHhhhccc
Q 014210 383 APWPSLSSEARDFVKRLLNKDPRKRLTA------AQALSELLICYQS 423 (429)
Q Consensus 383 ~~~~~~s~~~~~li~~~L~~dP~~Rps~------~~iL~~~~~~~~~ 423 (429)
.++.++.+||++||+.||++||++ .++++|+||+...
T Consensus 284 ----~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~ 326 (396)
T 4dc2_A 284 ----SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVD 326 (396)
T ss_dssp ----TSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCC
T ss_pred ----cCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCC
Confidence 589999999999999999999985 8999999998654
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-51 Score=400.65 Aligned_cols=267 Identities=36% Similarity=0.631 Sum_probs=232.7
Q ss_pred cccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCc---HHHHHHHHHHHHHHHHhcCCCCcceEEEEE
Q 014210 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTT---AIAIEDVRREVKILRALTGHNNLVKFFDAY 228 (429)
Q Consensus 152 ~~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~---~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~ 228 (429)
.+.++|++.+.||+|+||.||+|+... +|+.||||++.+..... ....+.+.+|+.++++++ ||||+++++++
T Consensus 8 ~~~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~ 83 (326)
T 2y0a_A 8 NVDDYYDTGEELGSGQFAVVKKCREKS---TGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ-HPNVITLHEVY 83 (326)
T ss_dssp CHHHHEEEEEEEECCSSEEEEEEEETT---TCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCC-CTTBCCEEEEE
T ss_pred CcccceEeceEEeeCCCeEEEEEEECC---CCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCC-CCCCCcEEEEE
Confidence 456789999999999999999998776 58999999986543221 123577899999999998 99999999999
Q ss_pred EeCCeEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecC-CCceEEEeec
Q 014210 229 EDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKD-ENSVLKAIDF 307 (429)
Q Consensus 229 ~~~~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~-~~~~vkL~DF 307 (429)
.+.+..++|||||++++|.+++. ..+.+++..++.++.||+.||.|||++||+||||||+|||+...+ ....+||+||
T Consensus 84 ~~~~~~~lv~e~~~~~~L~~~l~-~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Df 162 (326)
T 2y0a_A 84 ENKTDVILILELVAGGELFDFLA-EKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDF 162 (326)
T ss_dssp ECSSEEEEEEECCCSCBHHHHHT-TSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCC
T ss_pred EeCCEEEEEEEcCCCCCHHHHHH-hcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEEC
Confidence 99999999999999999999874 456799999999999999999999999999999999999994222 1227999999
Q ss_pred CCccccCCCccccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCC
Q 014210 308 GLSDFVRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWP 386 (429)
Q Consensus 308 Gla~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 386 (429)
|++.............||+.|+|||++. ..++.++|||||||++|+|++|+.||........+..+......+....+.
T Consensus 163 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (326)
T 2y0a_A 163 GLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFS 242 (326)
T ss_dssp TTCEECCTTSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHT
T ss_pred CCCeECCCCCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCccccc
Confidence 9998876555566778999999999887 468999999999999999999999999998888888888777666655556
Q ss_pred CCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhccc
Q 014210 387 SLSSEARDFVKRLLNKDPRKRLTAAQALSELLICYQS 423 (429)
Q Consensus 387 ~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~~ 423 (429)
.++.++.+||++||+.||++|||+.++|+|+||+...
T Consensus 243 ~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 279 (326)
T 2y0a_A 243 NTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKD 279 (326)
T ss_dssp TSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCCS
T ss_pred cCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccCCc
Confidence 7899999999999999999999999999999997643
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-50 Score=385.83 Aligned_cols=266 Identities=36% Similarity=0.702 Sum_probs=238.6
Q ss_pred cccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeC
Q 014210 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (429)
Q Consensus 152 ~~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~ 231 (429)
.+.++|++.+.||+|+||.||+|.... +|+.||+|++.... ......+.+.+|+.++++++ |+||+++++++.+.
T Consensus 3 ~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~ 77 (284)
T 3kk8_A 3 KFSDNYDVKEELGKGAFSVVRRCVHKT---TGLEFAAKIINTKK-LSARDFQKLEREARICRKLQ-HPNIVRLHDSIQEE 77 (284)
T ss_dssp TTTTTEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEEGGG-CCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEECS
T ss_pred hhhhhhhhhhhhcCcCCeEEEEEEEcC---CCceEEEEEeeccc-CCHHHHHHHHHHHHHHHHcC-CCCcCeEEEEEEcC
Confidence 457899999999999999999998776 58999999986543 34555678899999999998 99999999999999
Q ss_pred CeEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCcc
Q 014210 232 DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (429)
Q Consensus 232 ~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~ 311 (429)
+..++||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.++.+||+|||++.
T Consensus 78 ~~~~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~ 156 (284)
T 3kk8_A 78 SFHYLVFDLVTGGELFEDIVAR-EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAI 156 (284)
T ss_dssp SEEEEEECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCE
T ss_pred CEEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeE
Confidence 9999999999999999888654 579999999999999999999999999999999999999655556679999999998
Q ss_pred ccCCCccccccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCH
Q 014210 312 FVRPDERLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSS 390 (429)
Q Consensus 312 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 390 (429)
............||+.|+|||++.+ .++.++||||||+++|+|++|+.||...........+.......+...+..+++
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T 3kk8_A 157 EVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTP 236 (284)
T ss_dssp ECCSSCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCH
T ss_pred EcccCccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCH
Confidence 8776666667789999999998874 589999999999999999999999999998888888888877777777778999
Q ss_pred HHHHHHHHhcccCccCcCCHHHHHhhHhhhccc
Q 014210 391 EARDFVKRLLNKDPRKRLTAAQALSELLICYQS 423 (429)
Q Consensus 391 ~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~~ 423 (429)
++.+||.+||+.||++||++.++|+|+||+...
T Consensus 237 ~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 269 (284)
T 3kk8_A 237 EAKSLIDSMLTVNPKKRITADQALKVPWICNRE 269 (284)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCC
T ss_pred HHHHHHHHHcccChhhCCCHHHHhcCccccCCh
Confidence 999999999999999999999999999998654
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-50 Score=400.19 Aligned_cols=259 Identities=27% Similarity=0.490 Sum_probs=226.6
Q ss_pred cCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~ 233 (429)
.++|++++.||+|+||.||+|+.+. +|+.||||++.+.........+.+.+|+.+++++.+||||+++++++.+.+.
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~ 84 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKK---TDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESR 84 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred hhheEEEEEEEecCCeEEEEEEECC---CCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCE
Confidence 4689999999999999999999876 5899999999877666677778899999999998569999999999999999
Q ss_pred EEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCcccc
Q 014210 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (429)
Q Consensus 234 ~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~ 313 (429)
+|||||||+||+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++..
T Consensus 85 ~~lv~e~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~g~~kL~DFG~a~~~ 160 (345)
T 3a8x_A 85 LFFVIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLL---DSEGHIKLTDYGMCKEG 160 (345)
T ss_dssp EEEEECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCGGGCBCS
T ss_pred EEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEE---CCCCCEEEEeccccccc
Confidence 99999999999999988544 579999999999999999999999999999999999999 78889999999999864
Q ss_pred C-CCccccccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHcCCCCCCC---------CChHHHHHHHHhcCCCCCC
Q 014210 314 R-PDERLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWA---------RTESGIFRAVLKADPSFDE 382 (429)
Q Consensus 314 ~-~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~elltg~~Pf~~---------~~~~~~~~~i~~~~~~~~~ 382 (429)
. ........+||+.|+|||++.+ .++.++|||||||++|||++|+.||.. .........+......++
T Consensus 161 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p- 239 (345)
T 3a8x_A 161 LRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP- 239 (345)
T ss_dssp CCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCCC-
T ss_pred cCCCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCCC-
Confidence 3 3344567789999999998874 689999999999999999999999965 233445566666655544
Q ss_pred CCCCCCCHHHHHHHHHhcccCccCcCCH------HHHHhhHhhhccc
Q 014210 383 APWPSLSSEARDFVKRLLNKDPRKRLTA------AQALSELLICYQS 423 (429)
Q Consensus 383 ~~~~~~s~~~~~li~~~L~~dP~~Rps~------~~iL~~~~~~~~~ 423 (429)
..++.++.+||++||+.||++||++ .++++|+||....
T Consensus 240 ---~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~ 283 (345)
T 3a8x_A 240 ---RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVD 283 (345)
T ss_dssp ---TTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCC
T ss_pred ---CCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCC
Confidence 3689999999999999999999995 8999999998644
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-51 Score=407.09 Aligned_cols=266 Identities=33% Similarity=0.610 Sum_probs=227.0
Q ss_pred cccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcC--cHHHHHHHHHHHHHHHHhcCCCCcceEEEEEE
Q 014210 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMT--TAIAIEDVRREVKILRALTGHNNLVKFFDAYE 229 (429)
Q Consensus 152 ~~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~--~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~ 229 (429)
.+.++|++.+.||+|+||.||+|..+. +|+.||||++...... .....+.+.+|+.+++.++ ||||+++++++.
T Consensus 21 ~~~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~ 96 (351)
T 3c0i_A 21 LFEDVYELCEVIGKGPFSVVRRCINRE---TGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLK-HPHIVELLETYS 96 (351)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCC-CTTBCCEEEEEE
T ss_pred ccccceEEeeEEeeCCCEEEEEEEECC---CCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCC-CCCCCcEEEEEE
Confidence 346789999999999999999998776 6899999998532211 1123467899999999998 999999999999
Q ss_pred eCCeEEEEEEecCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEee
Q 014210 230 DTDNVYVVMELCEGGELLDRILSR---GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAID 306 (429)
Q Consensus 230 ~~~~~~lv~E~~~ggsL~~~i~~~---~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~D 306 (429)
+++..|||||||+|++|.+++..+ +..+++..++.++.||+.||.|||++||+||||||+|||++.++....+||+|
T Consensus 97 ~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~D 176 (351)
T 3c0i_A 97 SDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGG 176 (351)
T ss_dssp ETTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECC
T ss_pred eCCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEec
Confidence 999999999999999998887653 34589999999999999999999999999999999999996555566799999
Q ss_pred cCCccccCCCcc-ccccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCC
Q 014210 307 FGLSDFVRPDER-LNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAP 384 (429)
Q Consensus 307 FGla~~~~~~~~-~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 384 (429)
||++........ ....+||+.|+|||++.+ .++.++|||||||++|+|++|+.||... ....+..+...........
T Consensus 177 fg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~-~~~~~~~i~~~~~~~~~~~ 255 (351)
T 3c0i_A 177 FGVAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT-KERLFEGIIKGKYKMNPRQ 255 (351)
T ss_dssp CTTCEECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSS-HHHHHHHHHHTCCCCCHHH
T ss_pred CcceeEecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCc-HHHHHHHHHcCCCCCCccc
Confidence 999987654432 345689999999999874 6899999999999999999999999875 4556667777665555545
Q ss_pred CCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhcc
Q 014210 385 WPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLICYQ 422 (429)
Q Consensus 385 ~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~ 422 (429)
|..++.++.+||++||+.||++||++.++|+|+||+..
T Consensus 256 ~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~ 293 (351)
T 3c0i_A 256 WSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKER 293 (351)
T ss_dssp HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTH
T ss_pred cccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCC
Confidence 56789999999999999999999999999999999863
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-51 Score=404.78 Aligned_cols=259 Identities=30% Similarity=0.506 Sum_probs=228.7
Q ss_pred cCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~ 233 (429)
.++|++.+.||+|+||.||+|+.+. +|+.||||++.+.........+.+.+|..++..+.+||||+++++++.+.+.
T Consensus 16 ~~~y~~~~~lG~G~fg~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 16 IEDFILHKMLGKGSFGKVFLAEFKK---TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETT---TTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECC---CCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 5789999999999999999999876 6899999999654322233456788999999988559999999999999999
Q ss_pred EEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCcccc
Q 014210 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (429)
Q Consensus 234 ~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~ 313 (429)
+|||||||+||+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++..
T Consensus 93 ~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~g~vkL~DFG~a~~~ 168 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQSC-HKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILL---DKDGHIKIADFGMCKEN 168 (345)
T ss_dssp EEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCC
T ss_pred EEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEE---CCCCCEEEeEChhhhhc
Confidence 99999999999999988654 579999999999999999999999999999999999999 78889999999999864
Q ss_pred CC-CccccccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHH
Q 014210 314 RP-DERLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSE 391 (429)
Q Consensus 314 ~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 391 (429)
.. .......+||+.|+|||++.+ .++.++|||||||++|||++|+.||...+....+..+....+.++. .++++
T Consensus 169 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~ 244 (345)
T 1xjd_A 169 MLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPR----WLEKE 244 (345)
T ss_dssp CCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TSCHH
T ss_pred ccCCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCCCCCc----ccCHH
Confidence 32 334567789999999998874 6899999999999999999999999999998888888887765543 58999
Q ss_pred HHHHHHHhcccCccCcCCHH-HHHhhHhhhccc
Q 014210 392 ARDFVKRLLNKDPRKRLTAA-QALSELLICYQS 423 (429)
Q Consensus 392 ~~~li~~~L~~dP~~Rps~~-~iL~~~~~~~~~ 423 (429)
+.+||++||+.||++||++. ++++|+||....
T Consensus 245 ~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~~~ 277 (345)
T 1xjd_A 245 AKDLLVKLFVREPEKRLGVRGDIRQHPLFREIN 277 (345)
T ss_dssp HHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCC
T ss_pred HHHHHHHHhcCCHhHcCCChHHHHcCccccCCC
Confidence 99999999999999999998 999999998654
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-51 Score=423.66 Aligned_cols=266 Identities=38% Similarity=0.693 Sum_probs=242.6
Q ss_pred cccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeC
Q 014210 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (429)
Q Consensus 152 ~~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~ 231 (429)
.+.++|++.++||+|+||.||+|+... +|+.||||++.+.........+.+.+|+.+++++. ||||+++++++.+.
T Consensus 23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~ 98 (484)
T 3nyv_A 23 IFSDRYKGQRVLGKGSFGEVILCKDKI---TGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD-HPNIMKLYEFFEDK 98 (484)
T ss_dssp CHHHHEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCC-CTTBCCEEEEEECS
T ss_pred cccCceEEeeEEecCCCEEEEEEEECC---CCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCC-CCCCCcEEEEEEeC
Confidence 456899999999999999999998765 68999999997765554555678999999999998 99999999999999
Q ss_pred CeEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCcc
Q 014210 232 DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (429)
Q Consensus 232 ~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~ 311 (429)
+..++|||||.+|+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||+...+.++.+||+|||++.
T Consensus 99 ~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 177 (484)
T 3nyv_A 99 GYFYLVGEVYTGGELFDEIIS-RKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLST 177 (484)
T ss_dssp SEEEEEECCCCSCBHHHHHHT-CSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHH
T ss_pred CEEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeE
Confidence 999999999999999998854 4679999999999999999999999999999999999999766677899999999998
Q ss_pred ccCCCccccccccCCcccCcccccCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHH
Q 014210 312 FVRPDERLNDIVGSAYYVAPEVLHRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSE 391 (429)
Q Consensus 312 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 391 (429)
...........+||+.|+|||++.+.++.++|||||||++|+|++|+.||......+.+..+......+....|..++++
T Consensus 178 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 257 (484)
T 3nyv_A 178 HFEASKKMKDKIGTAYYIAPEVLHGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSES 257 (484)
T ss_dssp HBCCCCSHHHHTTGGGTCCHHHHHTCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCHH
T ss_pred EcccccccccCCCCccccCceeecCCCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCCHH
Confidence 87766666677899999999999989999999999999999999999999999999999999988887777777889999
Q ss_pred HHHHHHHhcccCccCcCCHHHHHhhHhhhcc
Q 014210 392 ARDFVKRLLNKDPRKRLTAAQALSELLICYQ 422 (429)
Q Consensus 392 ~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~ 422 (429)
+.+||++||+.||++|||+.++|+|+||+..
T Consensus 258 ~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~ 288 (484)
T 3nyv_A 258 AKDLIRKMLTYVPSMRISARDALDHEWIQTY 288 (484)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHTSHHHHHH
T ss_pred HHHHHHHHCCCChhHCcCHHHHhhChhhccc
Confidence 9999999999999999999999999999754
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-51 Score=403.98 Aligned_cols=260 Identities=26% Similarity=0.454 Sum_probs=229.1
Q ss_pred ccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCC
Q 014210 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (429)
Q Consensus 153 ~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~ 232 (429)
..++|++++.||+|+||.||+|+.+. +|+.||||++.+.........+.+.+|..++..+.+|+||+++++++.+.+
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~---~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~ 94 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKG---TDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD 94 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETT---EEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSS
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECC---CCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCC
Confidence 35789999999999999999999775 689999999965433333445678899999998866999999999999999
Q ss_pred eEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccc
Q 014210 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (429)
Q Consensus 233 ~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~ 312 (429)
.+|||||||+||+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.
T Consensus 95 ~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll---~~~g~vkL~DFG~a~~ 170 (353)
T 2i0e_A 95 RLYFVMEYVNGGDLMYHIQQV-GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVML---DSEGHIKIADFGMCKE 170 (353)
T ss_dssp EEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBC
T ss_pred EEEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEE---cCCCcEEEEeCCcccc
Confidence 999999999999999988654 579999999999999999999999999999999999999 7888999999999986
Q ss_pred cC-CCccccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCH
Q 014210 313 VR-PDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSS 390 (429)
Q Consensus 313 ~~-~~~~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 390 (429)
.. ........+||+.|+|||++. +.++.++|||||||++|||++|+.||........+..++.....++. .++.
T Consensus 171 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~ 246 (353)
T 2i0e_A 171 NIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPK----SMSK 246 (353)
T ss_dssp CCCTTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TSCH
T ss_pred cccCCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCC----CCCH
Confidence 43 233456678999999999887 46899999999999999999999999999999999999887766553 6899
Q ss_pred HHHHHHHHhcccCccCcC-----CHHHHHhhHhhhccc
Q 014210 391 EARDFVKRLLNKDPRKRL-----TAAQALSELLICYQS 423 (429)
Q Consensus 391 ~~~~li~~~L~~dP~~Rp-----s~~~iL~~~~~~~~~ 423 (429)
++.+||++||+.||++|| ++.++++|+||....
T Consensus 247 ~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~~ 284 (353)
T 2i0e_A 247 EAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYID 284 (353)
T ss_dssp HHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTCC
T ss_pred HHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCCC
Confidence 999999999999999999 469999999998644
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-51 Score=390.00 Aligned_cols=263 Identities=36% Similarity=0.668 Sum_probs=224.0
Q ss_pred cccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeC
Q 014210 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (429)
Q Consensus 152 ~~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~ 231 (429)
.+.++|++.++||+|+||.||+++... +|+.||+|++.... .....+.+.+|++++++++ ||||+++++++.+.
T Consensus 19 ~i~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~ 92 (285)
T 3is5_A 19 TIDDLFIFKRKLGSGAFGDVHLVEERS---SGLERVIKTINKDR--SQVPMEQIEAEIEVLKSLD-HPNIIKIFEVFEDY 92 (285)
T ss_dssp CHHHHEEEEEEEEECSSCEEEEEEETT---TCCEEEEEEEEGGG--CCSCHHHHHHHHHHHHTCC-CTTBCCEEEEEECS
T ss_pred ChhhheeecceeccCCCeEEEEEEEcc---CCceEEEEEeeccc--cchhHHHHHHHHHHHHhCC-CchHHhHHHheecC
Confidence 456899999999999999999998765 58999999986543 2233577899999999998 99999999999999
Q ss_pred CeEEEEEEecCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecC
Q 014210 232 DNVYVVMELCEGGELLDRILSR---GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFG 308 (429)
Q Consensus 232 ~~~~lv~E~~~ggsL~~~i~~~---~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFG 308 (429)
+..++||||+++++|.+++... +..+++..++.++.||+.||.|||++||+||||||+|||+...+.++.+||+|||
T Consensus 93 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg 172 (285)
T 3is5_A 93 HNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFG 172 (285)
T ss_dssp SEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCC
T ss_pred CeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeee
Confidence 9999999999999999988643 4679999999999999999999999999999999999999765667889999999
Q ss_pred CccccCCCccccccccCCcccCcccccCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCC
Q 014210 309 LSDFVRPDERLNDIVGSAYYVAPEVLHRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSL 388 (429)
Q Consensus 309 la~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 388 (429)
++.............||..|+|||++.+.++.++||||||+++|||++|+.||...........+.......... ...+
T Consensus 173 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~ 251 (285)
T 3is5_A 173 LAELFKSDEHSTNAAGTALYMAPEVFKRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVE-CRPL 251 (285)
T ss_dssp CCCC----------CTTGGGCCHHHHTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC---CCC
T ss_pred cceecCCcccCcCcccccCcCChHHhccCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccccc-cCcC
Confidence 998876666666778999999999998889999999999999999999999999888877777766655544432 2347
Q ss_pred CHHHHHHHHHhcccCccCcCCHHHHHhhHhhhc
Q 014210 389 SSEARDFVKRLLNKDPRKRLTAAQALSELLICY 421 (429)
Q Consensus 389 s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~ 421 (429)
++++.+||++||+.||++||++.|+|+|+||+.
T Consensus 252 ~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 284 (285)
T 3is5_A 252 TPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284 (285)
T ss_dssp CHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence 899999999999999999999999999999975
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-51 Score=397.87 Aligned_cols=256 Identities=25% Similarity=0.531 Sum_probs=227.3
Q ss_pred cCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~ 233 (429)
.++|++++.||+|+||.||+|+.+. +|+.||||++.+.........+.+.+|+.+++.+. ||||+++++++.+.+.
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~Iv~~~~~~~~~~~ 80 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRH---NGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT-HPFIIRMWGTFQDAQQ 80 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETT---TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCC-BTTBCCEEEEEECSSE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECC---CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCC-CCCCceEeEEEEeCCE
Confidence 4689999999999999999998765 68999999986543323344567889999999997 9999999999999999
Q ss_pred EEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCcccc
Q 014210 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (429)
Q Consensus 234 ~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~ 313 (429)
+|+||||++||+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++..
T Consensus 81 ~~lv~e~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~g~~kL~Dfg~a~~~ 156 (318)
T 1fot_A 81 IFMIMDYIEGGELFSLLRK-SQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILL---DKNGHIKITDFGFAKYV 156 (318)
T ss_dssp EEEEECCCCSCBHHHHHHH-TSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEE---CTTSCEEECCCSSCEEC
T ss_pred EEEEEeCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEE---cCCCCEEEeecCcceec
Confidence 9999999999999998754 4679999999999999999999999999999999999999 78889999999999876
Q ss_pred CCCccccccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHH
Q 014210 314 RPDERLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEA 392 (429)
Q Consensus 314 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 392 (429)
.. .....+||+.|+|||++.+ .++.++|||||||++|||++|+.||........+..++.....++ +.++.++
T Consensus 157 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p----~~~~~~~ 230 (318)
T 1fot_A 157 PD--VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFP----PFFNEDV 230 (318)
T ss_dssp SS--CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCC----TTSCHHH
T ss_pred CC--ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----CCCCHHH
Confidence 43 3346789999999998874 689999999999999999999999999988888888888766554 3689999
Q ss_pred HHHHHHhcccCccCcC-----CHHHHHhhHhhhccc
Q 014210 393 RDFVKRLLNKDPRKRL-----TAAQALSELLICYQS 423 (429)
Q Consensus 393 ~~li~~~L~~dP~~Rp-----s~~~iL~~~~~~~~~ 423 (429)
.+||++||+.||++|+ +++++++|+||....
T Consensus 231 ~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~~ 266 (318)
T 1fot_A 231 KDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVV 266 (318)
T ss_dssp HHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCC
T ss_pred HHHHHHHhccCHHHcCCCcCCCHHHHhcCccccCCC
Confidence 9999999999999999 999999999998644
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-51 Score=407.07 Aligned_cols=262 Identities=35% Similarity=0.572 Sum_probs=234.6
Q ss_pred ccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCC
Q 014210 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (429)
Q Consensus 153 ~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~ 232 (429)
+.++|+++++||+|+||.||+|..+. +|+.||+|++... .......+.+|+.++++|+ |+||+++++++.+.+
T Consensus 49 ~~~~y~i~~~LG~G~~g~Vy~~~~~~---~~~~~a~K~~~~~---~~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~~~~ 121 (387)
T 1kob_A 49 VYDYYDILEELGSGAFGVVHRCVEKA---TGRVFVAKFINTP---YPLDKYTVKNEISIMNQLH-HPKLINLHDAFEDKY 121 (387)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEECC---SHHHHHHHHHHHHHHTTCC-STTBCCEEEEEECSS
T ss_pred cccceEEEEEEecCCCEEEEEEEECC---CCCEEEEEEeccc---chhhHHHHHHHHHHHHhCC-CcCCCeEEEEEEeCC
Confidence 45789999999999999999998776 5899999998653 2344567899999999998 999999999999999
Q ss_pred eEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccc
Q 014210 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (429)
Q Consensus 233 ~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~ 312 (429)
..+||||||+||+|.+++......+++..++.++.||+.||+|||++||+||||||+|||++. +.++.+||+|||++..
T Consensus 122 ~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~-~~~~~vkL~DFG~a~~ 200 (387)
T 1kob_A 122 EMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCET-KKASSVKIIDFGLATK 200 (387)
T ss_dssp EEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS-TTCCCEEECCCTTCEE
T ss_pred EEEEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEec-CCCCceEEEeccccee
Confidence 999999999999999988666668999999999999999999999999999999999999942 1346799999999988
Q ss_pred cCCCccccccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHH
Q 014210 313 VRPDERLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSE 391 (429)
Q Consensus 313 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 391 (429)
...........||+.|+|||++.+ .++.++|||||||++|||++|+.||........+..+......+....+..++++
T Consensus 201 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 280 (387)
T 1kob_A 201 LNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPE 280 (387)
T ss_dssp CCTTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHH
T ss_pred cCCCcceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCHH
Confidence 776655566789999999998874 5889999999999999999999999999888888888888777777777889999
Q ss_pred HHHHHHHhcccCccCcCCHHHHHhhHhhhcc
Q 014210 392 ARDFVKRLLNKDPRKRLTAAQALSELLICYQ 422 (429)
Q Consensus 392 ~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~ 422 (429)
+.+||++||+.||++||++.++|+|+||...
T Consensus 281 ~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 311 (387)
T 1kob_A 281 AKDFIKNLLQKEPRKRLTVHDALEHPWLKGD 311 (387)
T ss_dssp HHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred HHHHHHHHcCCChhHCcCHHHHhhCccccCC
Confidence 9999999999999999999999999999754
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-51 Score=415.87 Aligned_cols=264 Identities=27% Similarity=0.461 Sum_probs=227.6
Q ss_pred cccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeC
Q 014210 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (429)
Q Consensus 152 ~~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~ 231 (429)
...++|+++++||+|+||.||+|+.+. +|+.||||++.+.........+.+.+|+.+++.++ |||||+++++|.+.
T Consensus 66 ~~~~~y~~~~~LG~G~fG~V~~~~~~~---~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~~~ 141 (410)
T 3v8s_A 66 MKAEDYEVVKVIGRGAFGEVQLVRHKS---TRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN-SPWVVQLFYAFQDD 141 (410)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCC-CTTBCCEEEEEECS
T ss_pred cCccccEEEEEEEcCCCEEEEEEEECC---CCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCC-CCCCCeEEEEEEEC
Confidence 345789999999999999999999776 58999999986532222222345789999999998 99999999999999
Q ss_pred CeEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCcc
Q 014210 232 DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (429)
Q Consensus 232 ~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~ 311 (429)
+.+|||||||+||+|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++
T Consensus 142 ~~~~lV~E~~~gg~L~~~l~~--~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl---~~~g~ikL~DFG~a~ 216 (410)
T 3v8s_A 142 RYLYMVMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLL---DKSGHLKLADFGTCM 216 (410)
T ss_dssp SEEEEEECCCTTEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCE
T ss_pred CEEEEEEeCCCCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeE---CCCCCEEEeccceeE
Confidence 999999999999999998754 469999999999999999999999999999999999999 788999999999998
Q ss_pred ccCCCc--cccccccCCcccCcccccC-C----CCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCC
Q 014210 312 FVRPDE--RLNDIVGSAYYVAPEVLHR-S----YSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAP 384 (429)
Q Consensus 312 ~~~~~~--~~~~~~gt~~y~aPE~~~~-~----~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 384 (429)
...... .....+||+.|+|||++.+ . ++.++|||||||++|||++|+.||...+..+.+..++..........
T Consensus 217 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~ 296 (410)
T 3v8s_A 217 KMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPD 296 (410)
T ss_dssp ECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCT
T ss_pred eeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCC
Confidence 765443 2346789999999998863 2 78899999999999999999999999999988888887543333333
Q ss_pred CCCCCHHHHHHHHHhcccCccC--cCCHHHHHhhHhhhccce
Q 014210 385 WPSLSSEARDFVKRLLNKDPRK--RLTAAQALSELLICYQSY 424 (429)
Q Consensus 385 ~~~~s~~~~~li~~~L~~dP~~--Rps~~~iL~~~~~~~~~~ 424 (429)
+..++.++++||++||+.+|.+ |+++.+|++|+||+...|
T Consensus 297 ~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~w 338 (410)
T 3v8s_A 297 DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQW 338 (410)
T ss_dssp TCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSSC
T ss_pred cccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCCCH
Confidence 4579999999999999999999 999999999999987654
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-50 Score=393.13 Aligned_cols=265 Identities=28% Similarity=0.435 Sum_probs=220.6
Q ss_pred ccccccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEE
Q 014210 149 FSKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAY 228 (429)
Q Consensus 149 ~~~~~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~ 228 (429)
..+.+.++|+++++||+|+||.||+|+... |+.||||++.... ......+.+.+|++++++++ ||||+++++++
T Consensus 15 ~~q~l~~~y~~~~~lG~G~~g~V~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~ 88 (311)
T 3niz_A 15 YFQGLMEKYQKLEKVGEGTYGVVYKAKDSQ----GRIVALKRIRLDA-EDEGIPSTAIREISLLKELH-HPNIVSLIDVI 88 (311)
T ss_dssp CEECSSCEEEEEEEEEECSSCEEEEEEETT----SCEEEEEEEC-------CHHHHHHHHHHHHHHCC-CTTBCCEEEEE
T ss_pred eecchHhhhHhhhhccCCCCeEEEEEEECC----CCEEEEEEEeccc-ccchhhHHHHHHHHHHHHcC-CCCEeeeeeEE
Confidence 345678999999999999999999998643 8899999986543 23334567889999999998 99999999999
Q ss_pred EeCCeEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecC
Q 014210 229 EDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFG 308 (429)
Q Consensus 229 ~~~~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFG 308 (429)
.+++..+||||||++ +|.+.+......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||
T Consensus 89 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~---~~~~~~kl~Dfg 164 (311)
T 3niz_A 89 HSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLI---NSDGALKLADFG 164 (311)
T ss_dssp CCSSCEEEEEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCT
T ss_pred ccCCEEEEEEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEE---CCCCCEEEccCc
Confidence 999999999999975 8888887777789999999999999999999999999999999999999 778899999999
Q ss_pred CccccCCC-ccccccccCCcccCcccccC--CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCC--
Q 014210 309 LSDFVRPD-ERLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEA-- 383 (429)
Q Consensus 309 la~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~-- 383 (429)
++...... .......||+.|+|||++.+ .++.++|||||||++|+|++|+.||......+.+..+..........
T Consensus 165 ~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 244 (311)
T 3niz_A 165 LARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREW 244 (311)
T ss_dssp TCEETTSCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTS
T ss_pred CceecCCCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHh
Confidence 99876433 33445679999999998864 58999999999999999999999998877776666654421111110
Q ss_pred ------------------------CCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhccc
Q 014210 384 ------------------------PWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLICYQS 423 (429)
Q Consensus 384 ------------------------~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~~ 423 (429)
..+.+++++.+||++||+.||++|||+.|+|+|+||+...
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 308 (311)
T 3niz_A 245 PQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLD 308 (311)
T ss_dssp GGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSC
T ss_pred hhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCC
Confidence 1235788999999999999999999999999999998754
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-51 Score=420.23 Aligned_cols=264 Identities=38% Similarity=0.698 Sum_probs=234.7
Q ss_pred cccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeC
Q 014210 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (429)
Q Consensus 152 ~~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~ 231 (429)
.+.++|+++++||+|+||.||+|+.+. +|+.||||++.+.... ......+.+|+.+++.+. ||||++++++|.+.
T Consensus 34 ~~~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~ 108 (494)
T 3lij_A 34 HLSEMYQRVKKLGSGAYGEVLLCRDKV---THVERAIKIIRKTSVS-TSSNSKLLEEVAVLKLLD-HPNIMKLYDFFEDK 108 (494)
T ss_dssp CHHHHEEEEEEEECC---EEEEEEETT---TCCEEEEEEEEC------CTTHHHHHHHHHHTTCC-CTTBCCEEEEEECS
T ss_pred chhcCeEEeeEEecCCCEEEEEEEECC---CCcEEEEEEEeccccC-chHHHHHHHHHHHHHhCC-CCCCCeEEEEEEeC
Confidence 456789999999999999999999766 5899999999764322 223467889999999998 99999999999999
Q ss_pred CeEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCcc
Q 014210 232 DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (429)
Q Consensus 232 ~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~ 311 (429)
+..|||||||++|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+...+.++.+||+|||++.
T Consensus 109 ~~~~lv~e~~~~g~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~ 187 (494)
T 3lij_A 109 RNYYLVMECYKGGELFDEIIHR-MKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSA 187 (494)
T ss_dssp SEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred CEEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCe
Confidence 9999999999999999988654 579999999999999999999999999999999999999765667789999999998
Q ss_pred ccCCCccccccccCCcccCcccccCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHH
Q 014210 312 FVRPDERLNDIVGSAYYVAPEVLHRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSE 391 (429)
Q Consensus 312 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 391 (429)
...........+||+.|+|||++.+.++.++|||||||++|+|++|+.||......+.+..+......+....|..++++
T Consensus 188 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 267 (494)
T 3lij_A 188 VFENQKKMKERLGTAYYIAPEVLRKKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEG 267 (494)
T ss_dssp ECBTTBCBCCCCSCTTTCCHHHHTTCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCHH
T ss_pred ECCCCccccccCCCcCeeCHHHHcccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCHH
Confidence 88766666778899999999999988999999999999999999999999999999999999998888887778899999
Q ss_pred HHHHHHHhcccCccCcCCHHHHHhhHhhhc
Q 014210 392 ARDFVKRLLNKDPRKRLTAAQALSELLICY 421 (429)
Q Consensus 392 ~~~li~~~L~~dP~~Rps~~~iL~~~~~~~ 421 (429)
+.+||++||+.||.+|||+.++|+|+||+.
T Consensus 268 ~~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 297 (494)
T 3lij_A 268 AKDLIKQMLQFDSQRRISAQQALEHPWIKE 297 (494)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHHTCHHHHH
T ss_pred HHHHHHHHCCCChhhCccHHHHhcCccccc
Confidence 999999999999999999999999999975
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-51 Score=417.98 Aligned_cols=264 Identities=25% Similarity=0.444 Sum_probs=227.8
Q ss_pred cccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeC
Q 014210 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (429)
Q Consensus 152 ~~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~ 231 (429)
...++|+++++||+|+||.||+|+.+. +|+.||||++.+.........+.+.+|+.++..++ |+||++++++|.+.
T Consensus 71 ~~~~~y~~~~~LG~G~fG~V~~~~~~~---~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~-hp~Iv~l~~~~~~~ 146 (437)
T 4aw2_A 71 LHREDFEILKVIGRGAFGEVAVVKLKN---ADKVFAMKILNKWEMLKRAETACFREERDVLVNGD-SKWITTLHYAFQDD 146 (437)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSC-TTTBCCEEEEEECS
T ss_pred CChhheEEEEEEEeCCCEEEEEEEEcC---CCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCC-CCCEEEEEEEEeeC
Confidence 346899999999999999999999876 58999999986532222222344889999999997 99999999999999
Q ss_pred CeEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCcc
Q 014210 232 DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (429)
Q Consensus 232 ~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~ 311 (429)
+.+|||||||+||+|.+++....+.+++..++.++.||+.||.|||++|||||||||+|||| +.++.+||+|||+++
T Consensus 147 ~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl---~~~g~vkL~DFGla~ 223 (437)
T 4aw2_A 147 NNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILM---DMNGHIRLADFGSCL 223 (437)
T ss_dssp SEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCE
T ss_pred CEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeE---cCCCCEEEcchhhhh
Confidence 99999999999999999987767789999999999999999999999999999999999999 788999999999997
Q ss_pred ccCCCcc--ccccccCCcccCccccc------CCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcC--CCCC
Q 014210 312 FVRPDER--LNDIVGSAYYVAPEVLH------RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKAD--PSFD 381 (429)
Q Consensus 312 ~~~~~~~--~~~~~gt~~y~aPE~~~------~~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~--~~~~ 381 (429)
....... ....+||+.|+|||++. +.++.++|||||||++|||++|+.||...+..+.+..++... ..++
T Consensus 224 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p 303 (437)
T 4aw2_A 224 KLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFP 303 (437)
T ss_dssp ECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC
T ss_pred hcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCC
Confidence 7654433 23468999999999875 358999999999999999999999999999888888887543 2222
Q ss_pred CCCCCCCCHHHHHHHHHhcccCccC--cCCHHHHHhhHhhhccc
Q 014210 382 EAPWPSLSSEARDFVKRLLNKDPRK--RLTAAQALSELLICYQS 423 (429)
Q Consensus 382 ~~~~~~~s~~~~~li~~~L~~dP~~--Rps~~~iL~~~~~~~~~ 423 (429)
. .+..+++++++||++||+.+|++ |++++++++|+||....
T Consensus 304 ~-~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~ 346 (437)
T 4aw2_A 304 T-QVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGID 346 (437)
T ss_dssp S-SCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCC
T ss_pred c-ccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCC
Confidence 2 22468999999999999999998 99999999999998654
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-51 Score=387.18 Aligned_cols=263 Identities=39% Similarity=0.736 Sum_probs=236.4
Q ss_pred cccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeC
Q 014210 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (429)
Q Consensus 152 ~~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~ 231 (429)
.+.++|++.+.||+|+||.||+|+... +++.||+|++..... ...+.+.+|++++++++ |+||+++++++.+.
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~~a~k~~~~~~~---~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~ 78 (277)
T 3f3z_A 6 DINQYYTLENTIGRGSWGEVKIAVQKG---TRIRRAAKKIPKYFV---EDVDRFKQEIEIMKSLD-HPNIIRLYETFEDN 78 (277)
T ss_dssp CHHHHEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEEGGGC---SCHHHHHHHHHHHHTCC-CTTBCCEEEEEECS
T ss_pred hhhhhEEeeeEEeecCCEEEEEEEeCC---CCcEEEEEeehhhcc---chHHHHHHHHHHHHhCC-CCCEeeEEEEEecC
Confidence 356789999999999999999998766 588999999865432 23467899999999997 99999999999999
Q ss_pred CeEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCcc
Q 014210 232 DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (429)
Q Consensus 232 ~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~ 311 (429)
+..++||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+..++.++.+||+|||++.
T Consensus 79 ~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~ 157 (277)
T 3f3z_A 79 TDIYLVMELCTGGELFERVVHK-RVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAA 157 (277)
T ss_dssp SEEEEEEECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCE
T ss_pred CeEEEEEeccCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccce
Confidence 9999999999999999987654 569999999999999999999999999999999999999766678899999999998
Q ss_pred ccCCCccccccccCCcccCcccccCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHH
Q 014210 312 FVRPDERLNDIVGSAYYVAPEVLHRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSE 391 (429)
Q Consensus 312 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 391 (429)
............||+.|+|||++.+.++.++||||||+++|+|++|+.||......+....+......++...+..++++
T Consensus 158 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (277)
T 3f3z_A 158 RFKPGKMMRTKVGTPYYVSPQVLEGLYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQ 237 (277)
T ss_dssp ECCTTSCBCCCCSCTTTCCHHHHTTCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHH
T ss_pred eccCccchhccCCCCCccChHHhcccCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCCHH
Confidence 87766666777899999999999888999999999999999999999999999988888888888777766556678999
Q ss_pred HHHHHHHhcccCccCcCCHHHHHhhHhhhcc
Q 014210 392 ARDFVKRLLNKDPRKRLTAAQALSELLICYQ 422 (429)
Q Consensus 392 ~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~ 422 (429)
+.+||++||+.||++||++.++|+|+||+.+
T Consensus 238 ~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~ 268 (277)
T 3f3z_A 238 AESLIRRLLTKSPKQRITSLQALEHEWFEKQ 268 (277)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHTTSHHHHHH
T ss_pred HHHHHHHHccCChhhCcCHHHHhcCHHHhcc
Confidence 9999999999999999999999999999864
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-51 Score=419.87 Aligned_cols=265 Identities=38% Similarity=0.709 Sum_probs=236.8
Q ss_pred cccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeC
Q 014210 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (429)
Q Consensus 152 ~~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~ 231 (429)
.+.++|+++++||+|+||.||+|+... +|+.||||++.+... .....+.+.+|+++++++. ||||+++++++.+.
T Consensus 19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~ 93 (486)
T 3mwu_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRI---TQQEYAVKVINKASA-KNKDTSTILREVELLKKLD-HPNIMKLFEILEDS 93 (486)
T ss_dssp HHHHHEEEEEEEECCSSSEEEEEEETT---TCCEEEEEEEEHHHH-BCSCHHHHHHHHHHHHHCC-CTTBCCEEEEEECS
T ss_pred ChhcceEEeEEEeecCCEEEEEEEECC---CCCEEEEEEEecccc-cchHHHHHHHHHHHHHhCC-CCCcCeEEEEEEcC
Confidence 457899999999999999999998765 589999999854321 1223467889999999998 99999999999999
Q ss_pred CeEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCcc
Q 014210 232 DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (429)
Q Consensus 232 ~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~ 311 (429)
+..|+|||||.+|+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||+...+.++.+||+|||++.
T Consensus 94 ~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 172 (486)
T 3mwu_A 94 SSFYIVGELYTGGELFDEIIKR-KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLST 172 (486)
T ss_dssp SEEEEEECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTT
T ss_pred CEEEEEEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCe
Confidence 9999999999999999988655 579999999999999999999999999999999999999766677789999999998
Q ss_pred ccCCCccccccccCCcccCcccccCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHH
Q 014210 312 FVRPDERLNDIVGSAYYVAPEVLHRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSE 391 (429)
Q Consensus 312 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 391 (429)
...........+||+.|+|||++.+.++.++|||||||++|+|++|+.||......+.+..+......+....|..++++
T Consensus 173 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 252 (486)
T 3mwu_A 173 CFQQNTKMKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDD 252 (486)
T ss_dssp TBCCC----CCTTGGGGCCGGGGGSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSCHH
T ss_pred ECCCCCccCCCcCCCCCCCHHHhCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCCHH
Confidence 87766666677899999999999999999999999999999999999999999999999999888877777777889999
Q ss_pred HHHHHHHhcccCccCcCCHHHHHhhHhhhcc
Q 014210 392 ARDFVKRLLNKDPRKRLTAAQALSELLICYQ 422 (429)
Q Consensus 392 ~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~ 422 (429)
+.+||++||+.||++|||+.++|+|+|++..
T Consensus 253 ~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~ 283 (486)
T 3mwu_A 253 AKDLIRKMLTFHPSLRITATQCLEHPWIQKY 283 (486)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHHHCHHHHHT
T ss_pred HHHHHHHHcCCChhhCcCHHHHhcCHhhccC
Confidence 9999999999999999999999999999864
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-50 Score=419.43 Aligned_cols=267 Identities=39% Similarity=0.678 Sum_probs=235.4
Q ss_pred cccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcH----------HHHHHHHHHHHHHHHhcCCCCc
Q 014210 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTA----------IAIEDVRREVKILRALTGHNNL 221 (429)
Q Consensus 152 ~~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~----------~~~~~~~~Ei~il~~l~~h~nI 221 (429)
.+.++|+++++||+|+||.||+|+.+. +++.||||++.+...... ...+.+.+|+.++++|+ ||||
T Consensus 33 ~i~~~Y~~~~~lG~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpni 108 (504)
T 3q5i_A 33 KIGESYFKVRKLGSGAYGEVLLCKEKN---GHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLD-HPNI 108 (504)
T ss_dssp CGGGTEEEEEEEEC--CEEEEEEEETT---TCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCC-CTTB
T ss_pred CcccceEEEeEecccCCeEEEEEEECC---CCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCC-CCCC
Confidence 467899999999999999999999776 589999999976543221 33567899999999998 9999
Q ss_pred ceEEEEEEeCCeEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCce
Q 014210 222 VKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSV 301 (429)
Q Consensus 222 v~l~~~~~~~~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~ 301 (429)
+++++++.+.+..+||||||+||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||+...+....
T Consensus 109 v~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~ 187 (504)
T 3q5i_A 109 IKLFDVFEDKKYFYLVTEFYEGGELFEQIINR-HKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLN 187 (504)
T ss_dssp CCEEEEEECSSEEEEEEECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSS
T ss_pred CeEEEEEEcCCEEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCcc
Confidence 99999999999999999999999999988654 57999999999999999999999999999999999999965444457
Q ss_pred EEEeecCCccccCCCccccccccCCcccCcccccCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCC
Q 014210 302 LKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFD 381 (429)
Q Consensus 302 vkL~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~ 381 (429)
+||+|||++............+||+.|+|||++.+.++.++|||||||++|+|++|..||......+.+..+......+.
T Consensus 188 ~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~ 267 (504)
T 3q5i_A 188 IKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKKKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFD 267 (504)
T ss_dssp EEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTTCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC
T ss_pred EEEEECCCCEEcCCCCccccccCCcCCCCHHHhccCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence 99999999988876666677889999999999998899999999999999999999999999999999999988887777
Q ss_pred CCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhccc
Q 014210 382 EAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLICYQS 423 (429)
Q Consensus 382 ~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~~ 423 (429)
...|..+++++.+||++||+.||.+|||+.++|+|+||+...
T Consensus 268 ~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 309 (504)
T 3q5i_A 268 FNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYA 309 (504)
T ss_dssp HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTC
T ss_pred ccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhch
Confidence 666778999999999999999999999999999999997643
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-50 Score=399.48 Aligned_cols=263 Identities=38% Similarity=0.670 Sum_probs=213.1
Q ss_pred cccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeC
Q 014210 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (429)
Q Consensus 152 ~~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~ 231 (429)
.+.++|++.++||+|+||.||+|+... +++.||||++.... ..+.+.+|+++++++. |+||+++++++.+.
T Consensus 50 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~---~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~ 120 (349)
T 2w4o_A 50 ALSDFFEVESELGRGATSIVYRCKQKG---TQKPYALKVLKKTV-----DKKIVRTEIGVLLRLS-HPNIIKLKEIFETP 120 (349)
T ss_dssp CGGGTEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEC---------------CHHHHHCC-CTTBCCEEEEEECS
T ss_pred cccCcEEEeeEEeeCCCEEEEEEEECC---CCcEEEEEEeccch-----hHHHHHHHHHHHHhCC-CCCCcceeeeEecC
Confidence 456889999999999999999998776 58899999986532 3356889999999998 99999999999999
Q ss_pred CeEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCcc
Q 014210 232 DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (429)
Q Consensus 232 ~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~ 311 (429)
+..+|||||+++++|.+++. ..+.+++..++.++.||+.||.|||++||+||||||+|||++..+.++.+||+|||+++
T Consensus 121 ~~~~lv~e~~~~~~L~~~l~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~ 199 (349)
T 2w4o_A 121 TEISLVLELVTGGELFDRIV-EKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSK 199 (349)
T ss_dssp SEEEEEECCCCSCBHHHHHT-TCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC---
T ss_pred CeEEEEEEeCCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCcccc
Confidence 99999999999999999874 44679999999999999999999999999999999999999654558899999999998
Q ss_pred ccCCCccccccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHcCCCCCCCCChHH-HHHHHHhcCCCCCCCCCCCCC
Q 014210 312 FVRPDERLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESG-IFRAVLKADPSFDEAPWPSLS 389 (429)
Q Consensus 312 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~s 389 (429)
............||+.|+|||++.+ .++.++|||||||++|||++|+.||....... .+..+......+....+..++
T Consensus 200 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 279 (349)
T 2w4o_A 200 IVEHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVS 279 (349)
T ss_dssp -------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSC
T ss_pred ccCcccccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCC
Confidence 7765555566789999999998875 68999999999999999999999997765544 666777776666666677899
Q ss_pred HHHHHHHHHhcccCccCcCCHHHHHhhHhhhccce
Q 014210 390 SEARDFVKRLLNKDPRKRLTAAQALSELLICYQSY 424 (429)
Q Consensus 390 ~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~~~ 424 (429)
.++.+||++||+.||++||++.++|+|+||.....
T Consensus 280 ~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~ 314 (349)
T 2w4o_A 280 LNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKAA 314 (349)
T ss_dssp HHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTSTTC
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhcCcccCCCcc
Confidence 99999999999999999999999999999986543
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-50 Score=390.89 Aligned_cols=259 Identities=25% Similarity=0.326 Sum_probs=216.1
Q ss_pred cccccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEE
Q 014210 150 SKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYE 229 (429)
Q Consensus 150 ~~~~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~ 229 (429)
...+.++|+++++||+|+||.||+|+... +|+.||||++.... .......+...|+..+.++.+|+||++++++|.
T Consensus 52 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~ 127 (311)
T 3p1a_A 52 ESFFQQSFQRLSRLGHGSYGEVFKVRSKE---DGRLYAVKRSMSPF-RGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWE 127 (311)
T ss_dssp SCHHHHHEEEEEEEEEETTEEEEEEEETT---TSCEEEEEEESSSC-CSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred cchhhhheeeeheeccCCCeEEEEEEECC---CCeEEEEEEecccc-cChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEE
Confidence 44567899999999999999999999776 58999999986543 334445566677777777756999999999999
Q ss_pred eCCeEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCC
Q 014210 230 DTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGL 309 (429)
Q Consensus 230 ~~~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGl 309 (429)
+++..+|||||+ +++|.+++...+..+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+
T Consensus 128 ~~~~~~lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll---~~~~~~kl~DFG~ 203 (311)
T 3p1a_A 128 EGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFL---GPRGRCKLGDFGL 203 (311)
T ss_dssp ETTEEEEEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CGGGCEEECCCTT
T ss_pred eCCEEEEEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEE---CCCCCEEEcccee
Confidence 999999999999 679999988887889999999999999999999999999999999999999 7788999999999
Q ss_pred ccccCCCccccccccCCcccCcccccCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCC
Q 014210 310 SDFVRPDERLNDIVGSAYYVAPEVLHRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLS 389 (429)
Q Consensus 310 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 389 (429)
+.............||+.|+|||++.+.++.++|||||||++|||++|..++..... ...+.... ........++
T Consensus 204 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~---~~~~~~~~--~~~~~~~~~~ 278 (311)
T 3p1a_A 204 LVELGTAGAGEVQEGDPRYMAPELLQGSYGTAADVFSLGLTILEVACNMELPHGGEG---WQQLRQGY--LPPEFTAGLS 278 (311)
T ss_dssp CEECC------CCCCCGGGCCGGGGGTCCSTHHHHHHHHHHHHHHHHTCCCCSSHHH---HHHHTTTC--CCHHHHTTSC
T ss_pred eeecccCCCCcccCCCccccCHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCccH---HHHHhccC--CCcccccCCC
Confidence 987766555566789999999999998999999999999999999999877754322 22222211 1112234689
Q ss_pred HHHHHHHHHhcccCccCcCCHHHHHhhHhhhc
Q 014210 390 SEARDFVKRLLNKDPRKRLTAAQALSELLICY 421 (429)
Q Consensus 390 ~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~ 421 (429)
+++.+||.+||+.||++||++.++|+|+||+.
T Consensus 279 ~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 310 (311)
T 3p1a_A 279 SELRSVLVMMLEPDPKLRATAEALLALPVLRQ 310 (311)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence 99999999999999999999999999999975
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-50 Score=384.85 Aligned_cols=258 Identities=29% Similarity=0.483 Sum_probs=218.6
Q ss_pred CceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeE
Q 014210 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (429)
Q Consensus 155 ~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~ 234 (429)
++|+++++||+|+||.||+|+... +|+.||||++.... ......+.+.+|+.++++++ |+||+++++++.+++..
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~ 76 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRE---THEIVALKRVRLDD-DDEGVPSSALREICLLKELK-HKNIVRLHDVLHSDKKL 76 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETT---TCCEEEEEEEESSC-SSTTHHHHHHHHHHHHTTCC-CTTBCCEEEEEEETTEE
T ss_pred CCceeeeEecCCCCeEEEEEEECC---CCceEEEEeeeccC-CcCCcchHHHHHHHHHhcCC-CCCEeeEEeEEEeCCEE
Confidence 579999999999999999999776 58999999997654 33445577889999999998 99999999999999999
Q ss_pred EEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccccC
Q 014210 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (429)
Q Consensus 235 ~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~ 314 (429)
+|||||+++ +|.+++....+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++....
T Consensus 77 ~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~---~~~~~~kl~Dfg~~~~~~ 152 (292)
T 3o0g_A 77 TLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLI---NRNGELKLANFGLARAFG 152 (292)
T ss_dssp EEEEECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECC
T ss_pred EEEEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCCCEEEeecccceecC
Confidence 999999975 7788787777889999999999999999999999999999999999999 778899999999998764
Q ss_pred CC-ccccccccCCcccCcccccC-C-CCCcccHHHHHHHHHHHHcCCCCC-CCCChHHHHHHHHhcCCCCCC--------
Q 014210 315 PD-ERLNDIVGSAYYVAPEVLHR-S-YSTEADVWSIGVIAYILLCGSRPF-WARTESGIFRAVLKADPSFDE-------- 382 (429)
Q Consensus 315 ~~-~~~~~~~gt~~y~aPE~~~~-~-~~~~sDiwSlGvll~elltg~~Pf-~~~~~~~~~~~i~~~~~~~~~-------- 382 (429)
.. .......||..|+|||++.+ . ++.++|||||||++|||++|..|| ......+.+..+.+.......
T Consensus 153 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 232 (292)
T 3o0g_A 153 IPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTK 232 (292)
T ss_dssp SCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGG
T ss_pred CccccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcc
Confidence 33 33455689999999998864 3 799999999999999999988885 455555666665542211111
Q ss_pred -----------------CCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhc
Q 014210 383 -----------------APWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLICY 421 (429)
Q Consensus 383 -----------------~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~ 421 (429)
...+.++.++.+||++||+.||++|||+.|+|+|+||+.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~ 288 (292)
T 3o0g_A 233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288 (292)
T ss_dssp STTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred cccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCccccc
Confidence 112357899999999999999999999999999999985
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-50 Score=401.28 Aligned_cols=257 Identities=28% Similarity=0.534 Sum_probs=228.7
Q ss_pred cCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~ 233 (429)
.++|++++.||+|+||.||+|+.+. +|+.||||++.+.........+.+.+|+.+++++. ||||+++++++.+.+.
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~ 115 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKE---SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN-FPFLVKLEFSFKDNSN 115 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETT---TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCC-CTTBCCEEEEEECSSE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECC---CCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEEcCCE
Confidence 4789999999999999999999776 58999999986543333344577889999999997 9999999999999999
Q ss_pred EEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCcccc
Q 014210 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (429)
Q Consensus 234 ~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~ 313 (429)
+||||||++||+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++..
T Consensus 116 ~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~g~~kL~DFg~a~~~ 191 (350)
T 1rdq_E 116 LYMVMEYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRV 191 (350)
T ss_dssp EEEEEECCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEEC
T ss_pred EEEEEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEE---CCCCCEEEcccccceec
Confidence 99999999999999988654 579999999999999999999999999999999999999 78889999999999876
Q ss_pred CCCccccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHH
Q 014210 314 RPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEA 392 (429)
Q Consensus 314 ~~~~~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 392 (429)
.. .....+||+.|+|||++. ..++.++|||||||++|||++|+.||........+..+......++ ..++.++
T Consensus 192 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p----~~~~~~~ 265 (350)
T 1rdq_E 192 KG--RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFSSDL 265 (350)
T ss_dssp SS--CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTCCHHH
T ss_pred cC--CcccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHH
Confidence 43 234678999999999886 4689999999999999999999999999998888888888766554 3689999
Q ss_pred HHHHHHhcccCccCcCC-----HHHHHhhHhhhccce
Q 014210 393 RDFVKRLLNKDPRKRLT-----AAQALSELLICYQSY 424 (429)
Q Consensus 393 ~~li~~~L~~dP~~Rps-----~~~iL~~~~~~~~~~ 424 (429)
.+||++||+.||++||+ +.++++|+||....|
T Consensus 266 ~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~~w 302 (350)
T 1rdq_E 266 KDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 302 (350)
T ss_dssp HHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCH
T ss_pred HHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCCCCH
Confidence 99999999999999998 999999999986543
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-50 Score=402.26 Aligned_cols=260 Identities=33% Similarity=0.576 Sum_probs=227.3
Q ss_pred CceeE--eceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCC
Q 014210 155 NKYEL--GEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (429)
Q Consensus 155 ~~y~~--~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~ 232 (429)
+.|.+ .+.||+|+||.||+|+... +|+.||||++... .....+.+.+|++++++|+ |+||+++++++.+.+
T Consensus 87 ~~~~~~~~~~lG~G~~g~Vy~a~~~~---~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~ 159 (373)
T 2x4f_A 87 SFYTVSKTEILGGGRFGQVHKCEETA---TGLKLAAKIIKTR---GMKDKEEVKNEISVMNQLD-HANLIQLYDAFESKN 159 (373)
T ss_dssp GTEEEEEEEECC-----CEEEEEETT---TCCEEEEEEEECC---SHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEECSS
T ss_pred cceeeecceEEecCcCEEEEEEEEcC---CCcEEEEEEEccc---ccccHHHHHHHHHHHHhCC-CCCCCeEEEEEEECC
Confidence 44555 6789999999999998766 5899999999653 3345678999999999998 999999999999999
Q ss_pred eEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccc
Q 014210 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (429)
Q Consensus 233 ~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~ 312 (429)
..+||||||++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+.. +.++.+||+|||+++.
T Consensus 160 ~~~lv~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~~~~kl~DFG~a~~ 238 (373)
T 2x4f_A 160 DIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVN-RDAKQIKIIDFGLARR 238 (373)
T ss_dssp EEEEEEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEE-TTTTEEEECCCSSCEE
T ss_pred EEEEEEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEec-CCCCcEEEEeCCCcee
Confidence 999999999999999998777678999999999999999999999999999999999999953 3467899999999988
Q ss_pred cCCCccccccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHH
Q 014210 313 VRPDERLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSE 391 (429)
Q Consensus 313 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 391 (429)
...........||+.|+|||++.+ .++.++|||||||++|||++|+.||......+.+..++.....+....+..++++
T Consensus 239 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 318 (373)
T 2x4f_A 239 YKPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEE 318 (373)
T ss_dssp CCTTCBCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHH
T ss_pred cCCccccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHH
Confidence 776666666789999999998874 5888999999999999999999999999998888899887776666666789999
Q ss_pred HHHHHHHhcccCccCcCCHHHHHhhHhhhcc
Q 014210 392 ARDFVKRLLNKDPRKRLTAAQALSELLICYQ 422 (429)
Q Consensus 392 ~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~ 422 (429)
+.+||.+||+.||++||++.++|+|+||...
T Consensus 319 ~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~ 349 (373)
T 2x4f_A 319 AKEFISKLLIKEKSWRISASEALKHPWLSDH 349 (373)
T ss_dssp HHHHHHTTSCSSGGGSCCHHHHHHSHHHHCH
T ss_pred HHHHHHHHcCCChhhCCCHHHHhcCcCcCCC
Confidence 9999999999999999999999999999865
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-51 Score=411.66 Aligned_cols=264 Identities=29% Similarity=0.476 Sum_probs=226.5
Q ss_pred cccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeC
Q 014210 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (429)
Q Consensus 152 ~~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~ 231 (429)
...++|+++++||+|+||.||+|+.+. +|+.||||++.+.........+.+.+|+.++..++ |+||+++++++.+.
T Consensus 58 ~~~~~f~~~~~lG~G~fG~V~~~~~~~---~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~-hp~Iv~l~~~~~~~ 133 (412)
T 2vd5_A 58 LQRDDFEILKVIGRGAFSEVAVVKMKQ---TGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGD-RRWITQLHFAFQDE 133 (412)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETT---TCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSC-TTTBCCEEEEEECS
T ss_pred CChhhEEEEEEEeeCCCeEEEEEEECC---CCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcC-CCCeeeEEEEEeeC
Confidence 346889999999999999999999776 68999999996543333334455889999999997 99999999999999
Q ss_pred CeEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCcc
Q 014210 232 DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (429)
Q Consensus 232 ~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~ 311 (429)
+.+|||||||+||+|.+++...+..+++..++.++.||+.||+|||++|||||||||+|||+ +.++++||+|||+++
T Consensus 134 ~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl---d~~g~vkL~DFGla~ 210 (412)
T 2vd5_A 134 NYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILL---DRCGHIRLADFGSCL 210 (412)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCE
T ss_pred CEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeee---cCCCCEEEeechhhe
Confidence 99999999999999999997776789999999999999999999999999999999999999 788999999999998
Q ss_pred ccCCCcc--ccccccCCcccCccccc--------CCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcC--CC
Q 014210 312 FVRPDER--LNDIVGSAYYVAPEVLH--------RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKAD--PS 379 (429)
Q Consensus 312 ~~~~~~~--~~~~~gt~~y~aPE~~~--------~~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~--~~ 379 (429)
....... ....+||+.|+|||++. +.++.++|||||||++|||++|+.||...+..+.+..++... ..
T Consensus 211 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~ 290 (412)
T 2vd5_A 211 KLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLS 290 (412)
T ss_dssp ECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCC
T ss_pred eccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcC
Confidence 7754443 23568999999999885 358999999999999999999999999999888888887532 22
Q ss_pred CCCCCCCCCCHHHHHHHHHhcccCccCc---CCHHHHHhhHhhhccce
Q 014210 380 FDEAPWPSLSSEARDFVKRLLNKDPRKR---LTAAQALSELLICYQSY 424 (429)
Q Consensus 380 ~~~~~~~~~s~~~~~li~~~L~~dP~~R---ps~~~iL~~~~~~~~~~ 424 (429)
++. ....+++++++||++||+ +|.+| ++++++++|+||....|
T Consensus 291 ~p~-~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~w 336 (412)
T 2vd5_A 291 LPL-VDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLDW 336 (412)
T ss_dssp CC-----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTCCS
T ss_pred CCc-cccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCCCH
Confidence 221 124689999999999999 99998 59999999999986543
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-50 Score=387.57 Aligned_cols=258 Identities=28% Similarity=0.471 Sum_probs=222.4
Q ss_pred ccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCC
Q 014210 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (429)
Q Consensus 153 ~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~ 232 (429)
..++|++.++||+|+||.||+|.... +|+.||||++...... ..+.+.+|+.++++++ ||||+++++++.+.+
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~---~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~ 90 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVA---TGQEVAIRQMNLQQQP---KKELIINEILVMRENK-NPNIVNYLDSYLVGD 90 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTT---TCCEEEEEEEEGGGCS---CHHHHHHHHHHHHHCC-CTTBCCEEEEEEETT
T ss_pred hhhceeeeeeeccCCCeEEEEEEECC---CCcEEEEEEeeccccc---HHHHHHHHHHHHhcCC-CCCCCeEeEEEEECC
Confidence 45789999999999999999998655 6899999998654322 2456889999999998 999999999999999
Q ss_pred eEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccc
Q 014210 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (429)
Q Consensus 233 ~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~ 312 (429)
..++|||||+||+|.+++... .+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..
T Consensus 91 ~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~---~~~~~~kl~Dfg~~~~ 165 (297)
T 3fxz_A 91 ELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL---GMDGSVKLTDFGFCAQ 165 (297)
T ss_dssp EEEEEEECCTTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCCTTCEE
T ss_pred EEEEEEECCCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEE---CCCCCEEEeeCCCcee
Confidence 999999999999999988553 68999999999999999999999999999999999999 7788999999999877
Q ss_pred cCCCc-cccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCH
Q 014210 313 VRPDE-RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSS 390 (429)
Q Consensus 313 ~~~~~-~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 390 (429)
..... ......||+.|+|||++. ..++.++||||||+++|||++|+.||...........+........ .....++.
T Consensus 166 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 244 (297)
T 3fxz_A 166 ITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPEL-QNPEKLSA 244 (297)
T ss_dssp CCSTTCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCC-SCGGGSCH
T ss_pred cCCcccccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC-CCccccCH
Confidence 65433 344568999999999886 4689999999999999999999999988887776666554432221 22346899
Q ss_pred HHHHHHHHhcccCccCcCCHHHHHhhHhhhccc
Q 014210 391 EARDFVKRLLNKDPRKRLTAAQALSELLICYQS 423 (429)
Q Consensus 391 ~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~~ 423 (429)
++.+||.+||+.||++||++.++|+|+||+...
T Consensus 245 ~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~ 277 (297)
T 3fxz_A 245 IFRDFLNRCLEMDVEKRGSAKELLQHQFLKIAK 277 (297)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred HHHHHHHHHccCChhHCcCHHHHhhChhhcccC
Confidence 999999999999999999999999999998654
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-50 Score=397.02 Aligned_cols=259 Identities=38% Similarity=0.631 Sum_probs=226.0
Q ss_pred cccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeC
Q 014210 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (429)
Q Consensus 152 ~~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~ 231 (429)
.+.++|++.+.||+|+||.||+|+.+. +|+.||||++.+... ...+|++++.++.+||||+++++++.++
T Consensus 19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~~avK~~~~~~~-------~~~~E~~~l~~~~~hp~iv~~~~~~~~~ 88 (342)
T 2qr7_A 19 QFTDGYEVKEDIGVGSYSVCKRCIHKA---TNMEFAVKIIDKSKR-------DPTEEIEILLRYGQHPNIITLKDVYDDG 88 (342)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEEETTTC-------CCHHHHHHHHHHTTSTTBCCEEEEEECS
T ss_pred CccccEEEEEEEeeCCCEEEEEEEECC---CCCEEEEEEEEcccC-------ChHHHHHHHHHhcCCCCcCeEEEEEEcC
Confidence 356889999999999999999999776 689999999976532 2347889999986699999999999999
Q ss_pred CeEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecC-CCceEEEeecCCc
Q 014210 232 DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKD-ENSVLKAIDFGLS 310 (429)
Q Consensus 232 ~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~-~~~~vkL~DFGla 310 (429)
+..|||||||+||+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||+...+ ..+.+||+|||++
T Consensus 89 ~~~~lv~E~~~gg~L~~~i~~-~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a 167 (342)
T 2qr7_A 89 KYVYVVTELMKGGELLDKILR-QKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFA 167 (342)
T ss_dssp SEEEEEECCCCSCBHHHHHHT-CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTC
T ss_pred CEEEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCc
Confidence 999999999999999998854 46799999999999999999999999999999999999985332 2346999999999
Q ss_pred cccCCC-ccccccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHcCCCCCCC---CChHHHHHHHHhcCCCCCCCCC
Q 014210 311 DFVRPD-ERLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWA---RTESGIFRAVLKADPSFDEAPW 385 (429)
Q Consensus 311 ~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~elltg~~Pf~~---~~~~~~~~~i~~~~~~~~~~~~ 385 (429)
+..... ......+||+.|+|||++.+ .++.++|||||||++|||++|+.||.. ....+++..+......+....|
T Consensus 168 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~ 247 (342)
T 2qr7_A 168 KQLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYW 247 (342)
T ss_dssp EECBCTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTT
T ss_pred ccCcCCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCcccc
Confidence 876543 33456789999999999875 588899999999999999999999975 4566778888888877777778
Q ss_pred CCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhc
Q 014210 386 PSLSSEARDFVKRLLNKDPRKRLTAAQALSELLICY 421 (429)
Q Consensus 386 ~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~ 421 (429)
+.+++++.+||++||..||++||++.++|+|+||..
T Consensus 248 ~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~ 283 (342)
T 2qr7_A 248 NSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVH 283 (342)
T ss_dssp TTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHT
T ss_pred ccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecC
Confidence 889999999999999999999999999999999964
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-50 Score=402.15 Aligned_cols=259 Identities=25% Similarity=0.528 Sum_probs=225.6
Q ss_pred cCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~ 233 (429)
.++|++++.||+|+||.||+|+... +|+.||||++.+.........+.+.+|+.+++.++ |||||+++++|.+.+.
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~---~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~~~~~ 89 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKND---TKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLE-HPFLVNLWYSFQDEED 89 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETT---TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCC-CTTBCCEEEEEECSSE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECC---CCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEEeCCE
Confidence 5789999999999999999998776 58999999986544333445577899999999998 9999999999999999
Q ss_pred EEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCcccc
Q 014210 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (429)
Q Consensus 234 ~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~ 313 (429)
+|+|||||.||+|.+++. ....+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++...
T Consensus 90 ~~lv~e~~~gg~L~~~l~-~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll---~~~g~vkL~DFG~a~~~ 165 (384)
T 4fr4_A 90 MFMVVDLLLGGDLRYHLQ-QNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILL---DEHGHVHITDFNIAAML 165 (384)
T ss_dssp EEEEECCCTTEEHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEEC
T ss_pred EEEEEecCCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEE---CCCCCEEEeccceeeec
Confidence 999999999999998875 45679999999999999999999999999999999999999 78889999999999887
Q ss_pred CCCccccccccCCcccCcccccC----CCCCcccHHHHHHHHHHHHcCCCCCCCC---ChHHHHHHHHhcCCCCCCCCCC
Q 014210 314 RPDERLNDIVGSAYYVAPEVLHR----SYSTEADVWSIGVIAYILLCGSRPFWAR---TESGIFRAVLKADPSFDEAPWP 386 (429)
Q Consensus 314 ~~~~~~~~~~gt~~y~aPE~~~~----~~~~~sDiwSlGvll~elltg~~Pf~~~---~~~~~~~~i~~~~~~~~~~~~~ 386 (429)
.........+||+.|+|||++.+ .++.++|||||||++|||++|+.||... .....+..+......++ .
T Consensus 166 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~p----~ 241 (384)
T 4fr4_A 166 PRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYP----S 241 (384)
T ss_dssp CTTCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCCCC----T
T ss_pred cCCCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccCCC----C
Confidence 76667778899999999999852 4889999999999999999999999743 33444555555544443 3
Q ss_pred CCCHHHHHHHHHhcccCccCcCC-HHHHHhhHhhhccce
Q 014210 387 SLSSEARDFVKRLLNKDPRKRLT-AAQALSELLICYQSY 424 (429)
Q Consensus 387 ~~s~~~~~li~~~L~~dP~~Rps-~~~iL~~~~~~~~~~ 424 (429)
.++.++.+||++||+.||++||+ +.+++.|+||....|
T Consensus 242 ~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~~w 280 (384)
T 4fr4_A 242 AWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDINW 280 (384)
T ss_dssp TSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTCCH
T ss_pred cCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhcCCH
Confidence 68999999999999999999998 899999999986543
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-49 Score=390.53 Aligned_cols=262 Identities=28% Similarity=0.483 Sum_probs=218.1
Q ss_pred ccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcC-cHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeC
Q 014210 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMT-TAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (429)
Q Consensus 153 ~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~-~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~ 231 (429)
..++|++.+.||+|+||.||+++...+..+|+.||||++.+.... .......+.+|+.++++++ |+||+++++++.+.
T Consensus 15 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~ 93 (327)
T 3a62_A 15 RPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVK-HPFIVDLIYAFQTG 93 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCC-CTTBCCEEEEEECS
T ss_pred CHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCC-CCCccceeEEEEcC
Confidence 357899999999999999999998755557999999999765322 2334566889999999998 99999999999999
Q ss_pred CeEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCcc
Q 014210 232 DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (429)
Q Consensus 232 ~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~ 311 (429)
+..|||||||+|++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill---~~~~~~kl~Dfg~~~ 169 (327)
T 3a62_A 94 GKLYLILEYLSGGELFMQLER-EGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIML---NHQGHVKLTDFGLCK 169 (327)
T ss_dssp SCEEEEEECCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEE---CTTSCEEECCCSCC-
T ss_pred CEEEEEEeCCCCCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEE---CCCCcEEEEeCCccc
Confidence 999999999999999998854 4579999999999999999999999999999999999999 778899999999997
Q ss_pred ccCCC-ccccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCC
Q 014210 312 FVRPD-ERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLS 389 (429)
Q Consensus 312 ~~~~~-~~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 389 (429)
..... ......+||+.|+|||++. ..++.++||||||+++|||++|+.||........+..+......++ +.++
T Consensus 170 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p----~~~~ 245 (327)
T 3a62_A 170 ESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLP----PYLT 245 (327)
T ss_dssp ---------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCC----TTSC
T ss_pred ccccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCC----CCCC
Confidence 64332 3345678999999999886 4689999999999999999999999999988888888887765544 3689
Q ss_pred HHHHHHHHHhcccCccCcC-----CHHHHHhhHhhhccc
Q 014210 390 SEARDFVKRLLNKDPRKRL-----TAAQALSELLICYQS 423 (429)
Q Consensus 390 ~~~~~li~~~L~~dP~~Rp-----s~~~iL~~~~~~~~~ 423 (429)
.++.+||++||..||++|| ++.++++|+||+...
T Consensus 246 ~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~~ 284 (327)
T 3a62_A 246 QEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHIN 284 (327)
T ss_dssp HHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSCC
T ss_pred HHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCCC
Confidence 9999999999999999999 899999999997643
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-51 Score=402.54 Aligned_cols=258 Identities=33% Similarity=0.573 Sum_probs=219.9
Q ss_pred cccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeC
Q 014210 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (429)
Q Consensus 152 ~~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~ 231 (429)
...++|++.+.||+|+||.||+|+... +|+.||||++.+.........+.+.+|+.+++.++ ||||+++++++.+.
T Consensus 6 ~~i~~Y~i~~~lG~G~~g~V~~a~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~ 81 (336)
T 3h4j_B 6 RHIGPYIIRETLGEGSFGKVKLATHYK---TQQKVALKFISRQLLKKSDMHMRVEREISYLKLLR-HPHIIKLYDVITTP 81 (336)
T ss_dssp SEETTEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCC-CTTBCCEEEEEECS
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECC---CCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCC-CCCCCeEEEEEEeC
Confidence 345789999999999999999999766 58999999986432222233457889999999998 99999999999999
Q ss_pred CeEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCcc
Q 014210 232 DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (429)
Q Consensus 232 ~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~ 311 (429)
+..++||||+ +|+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.
T Consensus 82 ~~~~lv~E~~-~g~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll---~~~~~~kl~DFG~s~ 156 (336)
T 3h4j_B 82 TDIVMVIEYA-GGELFDYIVEK-KRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLL---DDNLNVKIADFGLSN 156 (336)
T ss_dssp SEEEEEECCC-CEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEE---CTTCCEEECCSSCTB
T ss_pred CEEEEEEECC-CCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEE---cCCCCEEEEEeccce
Confidence 9999999999 67999988655 579999999999999999999999999999999999999 788899999999998
Q ss_pred ccCCCccccccccCCcccCcccccCC-C-CCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCC
Q 014210 312 FVRPDERLNDIVGSAYYVAPEVLHRS-Y-STEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLS 389 (429)
Q Consensus 312 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~-~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 389 (429)
...........+||+.|+|||++.+. + +.++|||||||++|+|++|+.||........+..+..... .....++
T Consensus 157 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~----~~p~~~s 232 (336)
T 3h4j_B 157 IMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVY----VMPDFLS 232 (336)
T ss_dssp TTTTSBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCSSCC----CCCTTSC
T ss_pred eccCCcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCC----CCcccCC
Confidence 88777667778999999999998754 3 6799999999999999999999977654433322222221 2224589
Q ss_pred HHHHHHHHHhcccCccCcCCHHHHHhhHhhhcc
Q 014210 390 SEARDFVKRLLNKDPRKRLTAAQALSELLICYQ 422 (429)
Q Consensus 390 ~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~ 422 (429)
+++.+||++||+.||.+|||+.|+++|+||+..
T Consensus 233 ~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 265 (336)
T 3h4j_B 233 PGAQSLIRRMIVADPMQRITIQEIRRDPWFNVN 265 (336)
T ss_dssp HHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHTT
T ss_pred HHHHHHHHHHcCCChhHCcCHHHHHhChhhccC
Confidence 999999999999999999999999999999754
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-50 Score=395.56 Aligned_cols=275 Identities=30% Similarity=0.523 Sum_probs=235.6
Q ss_pred CcCccccccCceeEe-ceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceE
Q 014210 146 SFGFSKHFANKYELG-EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKF 224 (429)
Q Consensus 146 ~~~~~~~~~~~y~~~-~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l 224 (429)
.+...+.+.++|.+. ++||+|+||.||+|+... +|+.||||++.... ........+.+|+.+++++.+|+||+++
T Consensus 19 ~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~~iv~~ 94 (327)
T 3lm5_A 19 YFQSMENFNNFYILTSKELGRGKFAVVRQCISKS---TGQEYAAKFLKKRR-RGQDCRAEILHEIAVLELAKSCPRVINL 94 (327)
T ss_dssp CSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEESEE-TTEECHHHHHHHHHHHHHTTTCTTBCCE
T ss_pred HHHHHHhhhhEEeeccceeCCCCCeEEEEEEECC---CCCEEEEEEEehhh-cchHHHHHHHHHHHHHHhccCCCCEEEE
Confidence 444556788899998 899999999999998776 58999999987643 2233456789999999999878999999
Q ss_pred EEEEEeCCeEEEEEEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEE
Q 014210 225 FDAYEDTDNVYVVMELCEGGELLDRILSR-GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLK 303 (429)
Q Consensus 225 ~~~~~~~~~~~lv~E~~~ggsL~~~i~~~-~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vk 303 (429)
++++.+.+..++|||||++|+|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++....++.+|
T Consensus 95 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~k 174 (327)
T 3lm5_A 95 HEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIK 174 (327)
T ss_dssp EEEEECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEE
T ss_pred EEEEEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEE
Confidence 99999999999999999999999877533 35799999999999999999999999999999999999995434478899
Q ss_pred EeecCCccccCCCccccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCC
Q 014210 304 AIDFGLSDFVRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDE 382 (429)
Q Consensus 304 L~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~ 382 (429)
|+|||++.............||+.|+|||++. ..++.++||||||+++|+|++|+.||........+..+.........
T Consensus 175 L~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~ 254 (327)
T 3lm5_A 175 IVDFGMSRKIGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSE 254 (327)
T ss_dssp ECCGGGCEEC---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT
T ss_pred EeeCccccccCCccccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCc
Confidence 99999998876665566778999999999887 46899999999999999999999999999988888888888777777
Q ss_pred CCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhccce
Q 014210 383 APWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLICYQSY 424 (429)
Q Consensus 383 ~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~~~ 424 (429)
..+..+++++.+||++||+.||++||++.++|+|+||+...+
T Consensus 255 ~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~~ 296 (327)
T 3lm5_A 255 ETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDF 296 (327)
T ss_dssp TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCCT
T ss_pred hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhccccc
Confidence 777889999999999999999999999999999999986544
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-50 Score=399.81 Aligned_cols=258 Identities=28% Similarity=0.515 Sum_probs=218.0
Q ss_pred cCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHH-HHhcCCCCcceEEEEEEeCC
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKIL-RALTGHNNLVKFFDAYEDTD 232 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il-~~l~~h~nIv~l~~~~~~~~ 232 (429)
.++|++++.||+|+||.||+|+.+. +++.||||++.+.........+.+.+|..++ +.+. ||||+++++++.+.+
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~---~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~-hp~Iv~l~~~~~~~~ 112 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKA---EEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVK-HPFLVGLHFSFQTAD 112 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETT---TCCEEEEEEEEGGGBC-------------CCBCCCC-CTTBCCEEEEEECSS
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcC---CCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCC-CCCCCCEEEEEEeCC
Confidence 5789999999999999999999776 5899999999876655555566778888874 5565 999999999999999
Q ss_pred eEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccc
Q 014210 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (429)
Q Consensus 233 ~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~ 312 (429)
.+|||||||+||+|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.
T Consensus 113 ~~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll---~~~g~ikL~DFG~a~~ 188 (373)
T 2r5t_A 113 KLYFVLDYINGGELFYHLQR-ERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILL---DSQGHIVLTDFGLCKE 188 (373)
T ss_dssp EEEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEECCCCBCGG
T ss_pred EEEEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEE---CCCCCEEEeeCccccc
Confidence 99999999999999998754 4679999999999999999999999999999999999999 7888999999999986
Q ss_pred cC-CCccccccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCH
Q 014210 313 VR-PDERLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSS 390 (429)
Q Consensus 313 ~~-~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 390 (429)
.. ........+||+.|+|||++.+ .++.++|||||||++|||++|+.||......+.+..++.....++ +.++.
T Consensus 189 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~----~~~~~ 264 (373)
T 2r5t_A 189 NIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLK----PNITN 264 (373)
T ss_dssp GBCCCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCCCC----SSSCH
T ss_pred cccCCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccCCC----CCCCH
Confidence 43 3344567789999999998874 689999999999999999999999999998889988888765544 36899
Q ss_pred HHHHHHHHhcccCccCcCCH----HHHHhhHhhhccc
Q 014210 391 EARDFVKRLLNKDPRKRLTA----AQALSELLICYQS 423 (429)
Q Consensus 391 ~~~~li~~~L~~dP~~Rps~----~~iL~~~~~~~~~ 423 (429)
++.+||++||+.||++||++ .++++|+||....
T Consensus 265 ~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~~ 301 (373)
T 2r5t_A 265 SARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLIN 301 (373)
T ss_dssp HHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTCC
T ss_pred HHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccCCC
Confidence 99999999999999999987 6999999998654
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-50 Score=383.98 Aligned_cols=258 Identities=29% Similarity=0.467 Sum_probs=215.0
Q ss_pred CceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeE
Q 014210 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (429)
Q Consensus 155 ~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~ 234 (429)
++|+++++||+|+||.||+|+.. +|+.||||++..... .....+.+.+|++++++++ ||||+++++++.+.+..
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~----~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~ 75 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNN----YGETFALKKIRLEKE-DEGIPSTTIREISILKELK-HSNIVKLYDVIHTKKRL 75 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET----TSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGCC-CTTBCCEEEEEECSSCE
T ss_pred ccchhhhhcccCCCEEEEEEEcC----CCCEEEEEEEecccc-ccccchhHHHHHHHHHhcC-CCCEeeeeeEEccCCeE
Confidence 57999999999999999999863 488999999865432 2223466889999999998 99999999999999999
Q ss_pred EEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccccC
Q 014210 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (429)
Q Consensus 235 ~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~ 314 (429)
++||||+++ +|.+++....+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++....
T Consensus 76 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~ 151 (288)
T 1ob3_A 76 VLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLI---NREGELKIADFGLARAFG 151 (288)
T ss_dssp EEEEECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECCTTHHHHHC
T ss_pred EEEEEecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---cCCCCEEEeECccccccC
Confidence 999999975 9999887767789999999999999999999999999999999999999 778899999999997654
Q ss_pred CC-ccccccccCCcccCcccccC--CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCC---------
Q 014210 315 PD-ERLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDE--------- 382 (429)
Q Consensus 315 ~~-~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~--------- 382 (429)
.. .......||+.|+|||++.+ .++.++|||||||++|||++|+.||......+.+..+.+.......
T Consensus 152 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (288)
T 1ob3_A 152 IPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTEL 231 (288)
T ss_dssp C---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGS
T ss_pred ccccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcc
Confidence 32 23345678999999998864 5899999999999999999999999988877777666542111100
Q ss_pred ----------------CCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhcc
Q 014210 383 ----------------APWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLICYQ 422 (429)
Q Consensus 383 ----------------~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~ 422 (429)
.....+++++.+||++||+.||++|||+.++|+|+||+..
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 287 (288)
T 1ob3_A 232 PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN 287 (288)
T ss_dssp TTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC-
T ss_pred cccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence 1123578999999999999999999999999999999863
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=385.76 Aligned_cols=267 Identities=27% Similarity=0.410 Sum_probs=216.8
Q ss_pred ccccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcC--cHHHHHHHHHHHHHHHHhc--CCCCcceEEE
Q 014210 151 KHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMT--TAIAIEDVRREVKILRALT--GHNNLVKFFD 226 (429)
Q Consensus 151 ~~~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~--~~~~~~~~~~Ei~il~~l~--~h~nIv~l~~ 226 (429)
..+.++|++.++||+|+||.||+|+... +|+.||||++...... .......+.+|+.+++++. .|+||+++++
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~ 81 (308)
T 3g33_A 5 SMATSRYEPVAEIGVGAYGTVYKARDPH---SGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMD 81 (308)
T ss_dssp -----CCEEEEEECCSSSCCEEEEECTT---TCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEE
T ss_pred cccccceEEEEEEecCCCeEEEEEEECC---CCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeee
Confidence 4567899999999999999999998655 6899999998633211 1111235667888777765 4999999999
Q ss_pred EEEeCC-----eEEEEEEecCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCc
Q 014210 227 AYEDTD-----NVYVVMELCEGGELLDRILSRGG-KYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENS 300 (429)
Q Consensus 227 ~~~~~~-----~~~lv~E~~~ggsL~~~i~~~~~-~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~ 300 (429)
++.+.. ..++||||+. ++|.+++..... .+++..++.++.||+.||+|||++||+||||||+|||+ +.++
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~---~~~~ 157 (308)
T 3g33_A 82 VCATSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILV---TSGG 157 (308)
T ss_dssp EEEECCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEE---CTTS
T ss_pred eeeccCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---cCCC
Confidence 998765 5899999996 599998865543 49999999999999999999999999999999999999 7788
Q ss_pred eEEEeecCCccccCCCccccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCC
Q 014210 301 VLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPS 379 (429)
Q Consensus 301 ~vkL~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~ 379 (429)
.+||+|||++.............||+.|+|||++. +.++.++|||||||++|||++|+.||......+.+..+......
T Consensus 158 ~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~ 237 (308)
T 3g33_A 158 TVKLADFGLARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGL 237 (308)
T ss_dssp CEEECSCSCTTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred CEEEeeCccccccCCCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 99999999998876666667788999999999885 56899999999999999999999999999888888777654322
Q ss_pred CCCCCC-----------------------CCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhccce
Q 014210 380 FDEAPW-----------------------PSLSSEARDFVKRLLNKDPRKRLTAAQALSELLICYQSY 424 (429)
Q Consensus 380 ~~~~~~-----------------------~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~~~ 424 (429)
.....| +.+++++.+||.+||+.||++|||+.++|+|+||+....
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~~~ 305 (308)
T 3g33_A 238 PPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDEG 305 (308)
T ss_dssp CCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC-----
T ss_pred CChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCCCC
Confidence 222211 357899999999999999999999999999999987543
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-49 Score=383.65 Aligned_cols=256 Identities=29% Similarity=0.550 Sum_probs=215.0
Q ss_pred cCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCc-----------------------HHHHHHHHHHHH
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTT-----------------------AIAIEDVRREVK 210 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~-----------------------~~~~~~~~~Ei~ 210 (429)
.++|++.+.||+|+||.||+|+... +|+.||||++....... ....+.+.+|++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 88 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNEN---DNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIA 88 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETT---TTEEEEEEEEECC-------------------------------CHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECC---CCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHH
Confidence 5789999999999999999998765 58999999997643221 122456889999
Q ss_pred HHHHhcCCCCcceEEEEEEe--CCeEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCC
Q 014210 211 ILRALTGHNNLVKFFDAYED--TDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKP 288 (429)
Q Consensus 211 il~~l~~h~nIv~l~~~~~~--~~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp 288 (429)
++++++ |+||+++++++.+ .+..+|||||+++++|.+++ ....+++..++.++.||+.||.|||++||+||||||
T Consensus 89 ~l~~l~-h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp 165 (298)
T 2zv2_A 89 ILKKLD-HPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP--TLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKP 165 (298)
T ss_dssp HHHTCC-CTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS--CSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCG
T ss_pred HHHhCC-CCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCH
Confidence 999998 9999999999987 56899999999999988743 446799999999999999999999999999999999
Q ss_pred CcEEEeecCCCceEEEeecCCccccCCCc-cccccccCCcccCcccccCC----CCCcccHHHHHHHHHHHHcCCCCCCC
Q 014210 289 ENFLFTTKDENSVLKAIDFGLSDFVRPDE-RLNDIVGSAYYVAPEVLHRS----YSTEADVWSIGVIAYILLCGSRPFWA 363 (429)
Q Consensus 289 ~NILl~~~~~~~~vkL~DFGla~~~~~~~-~~~~~~gt~~y~aPE~~~~~----~~~~sDiwSlGvll~elltg~~Pf~~ 363 (429)
+|||+ +.++.+||+|||++....... ......||+.|+|||++.+. ++.++||||||+++|+|++|+.||..
T Consensus 166 ~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 242 (298)
T 2zv2_A 166 SNLLV---GEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD 242 (298)
T ss_dssp GGEEE---CTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred HHEEE---CCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence 99999 778899999999998765433 33456899999999998753 36789999999999999999999988
Q ss_pred CChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhh
Q 014210 364 RTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLIC 420 (429)
Q Consensus 364 ~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~ 420 (429)
.........+......++. .+.+++++.+||.+||+.||++||++.++|+|+||+
T Consensus 243 ~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~ 297 (298)
T 2zv2_A 243 ERIMCLHSKIKSQALEFPD--QPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT 297 (298)
T ss_dssp SSHHHHHHHHHHCCCCCCS--SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHH
T ss_pred ccHHHHHHHHhcccCCCCC--ccccCHHHHHHHHHHhhcChhhCCCHHHHhcCcccc
Confidence 8777776666665544432 347899999999999999999999999999999996
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-50 Score=409.63 Aligned_cols=260 Identities=28% Similarity=0.520 Sum_probs=218.8
Q ss_pred ccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCC
Q 014210 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (429)
Q Consensus 153 ~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~ 232 (429)
..++|+++++||+|+||.||+|+... +|+.||||++.+...........+.+|+.+++.++ |+||+++++++.+.+
T Consensus 146 ~~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~l~~~~~~~~ 221 (446)
T 4ejn_A 146 TMNEFEYLKLLGKGTFGKVILVKEKA---TGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR-HPFLTALKYSFQTHD 221 (446)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEEHHHHC-------------CCCCCS-CTTSCCEEEEEEETT
T ss_pred ChHHcEEeEEEeeCcCEEEEEEEEcC---CCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCC-CCeEeeEEEEEeeCC
Confidence 45789999999999999999998766 68999999997544344455567889999999998 999999999999999
Q ss_pred eEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-cCceeccCCCCcEEEeecCCCceEEEeecCCcc
Q 014210 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHL-QGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (429)
Q Consensus 233 ~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~-~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~ 311 (429)
.++||||||++|+|.+++.. .+.+++..++.++.||+.||+|||+ .||+||||||+|||| +.++.+||+|||+++
T Consensus 222 ~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll---~~~~~~kl~DFG~a~ 297 (446)
T 4ejn_A 222 RLCFVMEYANGGELFFHLSR-ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLML---DKDGHIKITDFGLCK 297 (446)
T ss_dssp EEEEEECCCSSCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEE---CSSSCEEECCCCCCC
T ss_pred EEEEEEeeCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEE---CCCCCEEEccCCCce
Confidence 99999999999999988754 4579999999999999999999998 899999999999999 778899999999998
Q ss_pred ccCC-CccccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCC
Q 014210 312 FVRP-DERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLS 389 (429)
Q Consensus 312 ~~~~-~~~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 389 (429)
.... .......+||+.|+|||++. +.++.++|||||||++|||++|+.||........+..+......++. .++
T Consensus 298 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~----~~~ 373 (446)
T 4ejn_A 298 EGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR----TLG 373 (446)
T ss_dssp TTCC-----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TSC
T ss_pred eccCCCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCc----cCC
Confidence 6433 33455678999999999886 56999999999999999999999999999988888888887765553 589
Q ss_pred HHHHHHHHHhcccCccCcC-----CHHHHHhhHhhhccce
Q 014210 390 SEARDFVKRLLNKDPRKRL-----TAAQALSELLICYQSY 424 (429)
Q Consensus 390 ~~~~~li~~~L~~dP~~Rp-----s~~~iL~~~~~~~~~~ 424 (429)
+++.+||.+||+.||++|| ++.++|+|+||....+
T Consensus 374 ~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~~~ 413 (446)
T 4ejn_A 374 PEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVW 413 (446)
T ss_dssp HHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCH
T ss_pred HHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCCCH
Confidence 9999999999999999999 9999999999987543
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=388.45 Aligned_cols=263 Identities=36% Similarity=0.632 Sum_probs=230.7
Q ss_pred cccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCc---HHHHHHHHHHHHHHHHhcCCCCcceEEEEE
Q 014210 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTT---AIAIEDVRREVKILRALTGHNNLVKFFDAY 228 (429)
Q Consensus 152 ~~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~---~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~ 228 (429)
.+.++|++.+.||+|+||.||+|+... +|+.||||++....... ....+.+.+|+.+++++. |+||+++++++
T Consensus 9 ~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~ 84 (321)
T 2a2a_A 9 KVEDFYDIGEELGSGQFAIVKKCREKS---TGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL-HHNVITLHDVY 84 (321)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCC-CTTBCCEEEEE
T ss_pred hhhccEEEeeEeeecCCEEEEEEEECC---CCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCC-CCCcceEEEEE
Confidence 456889999999999999999999776 58999999986543222 123577899999999998 99999999999
Q ss_pred EeCCeEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCc----eEEE
Q 014210 229 EDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENS----VLKA 304 (429)
Q Consensus 229 ~~~~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~----~vkL 304 (429)
.+.+..++||||+++++|.+++. ....+++..++.++.||+.||.|||++||+||||||+|||+ +.++ .+||
T Consensus 85 ~~~~~~~lv~e~~~~~~L~~~l~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~---~~~~~~~~~~kl 160 (321)
T 2a2a_A 85 ENRTDVVLILELVSGGELFDFLA-QKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIML---LDKNIPIPHIKL 160 (321)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHH-TCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---SCTTSSSCCEEE
T ss_pred ecCCEEEEEEEcCCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEE---ecCCCCcCCEEE
Confidence 99999999999999999999875 45679999999999999999999999999999999999999 4444 7999
Q ss_pred eecCCccccCCCccccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCC
Q 014210 305 IDFGLSDFVRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEA 383 (429)
Q Consensus 305 ~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~ 383 (429)
+|||++.............||+.|+|||++. +.++.++||||||+++|+|++|+.||......+.+..+......+...
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 240 (321)
T 2a2a_A 161 IDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEE 240 (321)
T ss_dssp CCCTTCEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHH
T ss_pred ccCccceecCccccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChh
Confidence 9999998876665566778999999999887 468999999999999999999999999988888888887766555544
Q ss_pred CCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhcc
Q 014210 384 PWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLICYQ 422 (429)
Q Consensus 384 ~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~ 422 (429)
.+..++.++.+||++||+.||++||++.++|+|+||...
T Consensus 241 ~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~ 279 (321)
T 2a2a_A 241 FFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPV 279 (321)
T ss_dssp HHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCS
T ss_pred hhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccCC
Confidence 445789999999999999999999999999999999754
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=388.42 Aligned_cols=258 Identities=27% Similarity=0.436 Sum_probs=205.0
Q ss_pred cCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~ 233 (429)
.++|+++++||+|+||.||+|..+. +|+.||||++.... .....+.+.+|++++++++ ||||+++++++.+++.
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~ 77 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKT---TGVYVALKEVKLDS--EEGTPSTAIREISLMKELK-HENIVRLYDVIHTENK 77 (317)
T ss_dssp ---------------CEEEEEECSS---SCCEEEEEEEECCS--TTCSCHHHHHHHHHHTTCC-BTTBCCEEEEECCTTE
T ss_pred ccceeEeeEECCCCCEEEEEEEECC---CCcEEEEEEeeccc--ccccHHHHHHHHHHHHhcC-CCCcceEEEEEEECCe
Confidence 4689999999999999999998665 68999999986543 2223356789999999998 9999999999999999
Q ss_pred EEEEEEecCCCcHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecC
Q 014210 234 VYVVMELCEGGELLDRILSRG-----GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFG 308 (429)
Q Consensus 234 ~~lv~E~~~ggsL~~~i~~~~-----~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFG 308 (429)
.+|||||++ ++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||
T Consensus 78 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~---~~~~~~kl~Dfg 153 (317)
T 2pmi_A 78 LTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLI---NKRGQLKLGDFG 153 (317)
T ss_dssp EEEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCS
T ss_pred EEEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEE---cCCCCEEECcCc
Confidence 999999997 59999886542 459999999999999999999999999999999999999 778899999999
Q ss_pred CccccCCC-ccccccccCCcccCcccccC--CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCC--
Q 014210 309 LSDFVRPD-ERLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEA-- 383 (429)
Q Consensus 309 la~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~-- 383 (429)
++...... .......||+.|+|||++.+ .++.++|||||||++|||++|+.||......+.+..+..........
T Consensus 154 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 233 (317)
T 2pmi_A 154 LARAFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLW 233 (317)
T ss_dssp SCEETTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTC
T ss_pred cceecCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHh
Confidence 99876433 23445689999999998864 58999999999999999999999999988887777665421111100
Q ss_pred ----------------------------CCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhc
Q 014210 384 ----------------------------PWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLICY 421 (429)
Q Consensus 384 ----------------------------~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~ 421 (429)
....++.++.+||++||+.||++|||+.|+|+|+||..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 299 (317)
T 2pmi_A 234 PSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAE 299 (317)
T ss_dssp GGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGG
T ss_pred hhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhc
Confidence 11257889999999999999999999999999999985
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=386.62 Aligned_cols=265 Identities=33% Similarity=0.567 Sum_probs=216.8
Q ss_pred ccccCceeEe-ceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEE
Q 014210 151 KHFANKYELG-EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYE 229 (429)
Q Consensus 151 ~~~~~~y~~~-~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~ 229 (429)
..+.++|++. +.||+|+||.||+|+... +|+.||||++.... ....+.+.+|++++.++.+|+||+++++++.
T Consensus 8 ~~~~~~y~i~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~ 81 (316)
T 2ac3_A 8 GRFEDVYQLQEDVLGEGAHARVQTCINLI---TSQEYAVKIIEKQP---GHIRSRVFREVEMLYQCQGHRNVLELIEFFE 81 (316)
T ss_dssp CCTTTSCEECCCCCCCCSSEEEEEEECSS---SCCEEEEEEEECCS---SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred cccceeEEecCceecCCceEEEEEEEEcC---CCcEEEEEEEeeCc---chhHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence 4467889995 789999999999998665 58999999996543 2334678899999999766999999999999
Q ss_pred eCCeEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCC
Q 014210 230 DTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGL 309 (429)
Q Consensus 230 ~~~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGl 309 (429)
+++..+|||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++....+||+|||+
T Consensus 82 ~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~ 160 (316)
T 2ac3_A 82 EEDRFYLVFEKMRGGSILSHIHKR-RHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDL 160 (316)
T ss_dssp ETTEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTC
T ss_pred eCCEEEEEEEcCCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccC
Confidence 999999999999999999988654 5799999999999999999999999999999999999995444344599999999
Q ss_pred ccccCCCc--------cccccccCCcccCccccc------CCCCCcccHHHHHHHHHHHHcCCCCCCCCCh---------
Q 014210 310 SDFVRPDE--------RLNDIVGSAYYVAPEVLH------RSYSTEADVWSIGVIAYILLCGSRPFWARTE--------- 366 (429)
Q Consensus 310 a~~~~~~~--------~~~~~~gt~~y~aPE~~~------~~~~~~sDiwSlGvll~elltg~~Pf~~~~~--------- 366 (429)
+....... .....+||..|+|||++. ..++.++|||||||++|||++|+.||.....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~ 240 (316)
T 2ac3_A 161 GSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGE 240 (316)
T ss_dssp CC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----
T ss_pred ccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccc
Confidence 87654221 123456999999999885 3488999999999999999999999976542
Q ss_pred ------HHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhcc
Q 014210 367 ------SGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLICYQ 422 (429)
Q Consensus 367 ------~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~ 422 (429)
...+..+......++...+..++.++.+||++||+.||++||++.++|+|+||+..
T Consensus 241 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 302 (316)
T 2ac3_A 241 ACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGC 302 (316)
T ss_dssp CCHHHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC--
T ss_pred cchhHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCC
Confidence 33556666666555544445789999999999999999999999999999999864
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-49 Score=388.57 Aligned_cols=257 Identities=26% Similarity=0.416 Sum_probs=225.0
Q ss_pred ccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCC
Q 014210 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (429)
Q Consensus 153 ~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~ 232 (429)
..++|++++.||+|+||.||+|+... +|+.||||++...........+++.+|++++++++ ||||+++++++.+++
T Consensus 52 ~~~~y~~~~~lG~G~~g~Vy~a~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~ 127 (348)
T 1u5q_A 52 PEKLFSDLREIGHGSFGAVYFARDVR---NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR-HPNTIQYRGCYLREH 127 (348)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEETT
T ss_pred hhhheeeeeEEccCCCEEEEEEEEcc---CCeEEEEEEEccccccchHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEECC
Confidence 35679999999999999999998765 58999999997665555666778999999999998 999999999999999
Q ss_pred eEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccc
Q 014210 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (429)
Q Consensus 233 ~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~ 312 (429)
..+|||||+. |+|.+.+......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..
T Consensus 128 ~~~lv~e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kL~DfG~a~~ 203 (348)
T 1u5q_A 128 TAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILL---SEPGLVKLGDFGSASI 203 (348)
T ss_dssp EEEEEEECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEE---ETTTEEEECCCTTCBS
T ss_pred eEEEEEecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEE---CCCCCEEEeeccCcee
Confidence 9999999997 58888887777889999999999999999999999999999999999999 6788999999999987
Q ss_pred cCCCccccccccCCcccCccccc----CCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCC
Q 014210 313 VRPDERLNDIVGSAYYVAPEVLH----RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSL 388 (429)
Q Consensus 313 ~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 388 (429)
.... ....||+.|+|||++. +.++.++|||||||++|||++|+.||........+..+........ ....+
T Consensus 204 ~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~ 278 (348)
T 1u5q_A 204 MAPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPAL--QSGHW 278 (348)
T ss_dssp SSSB---CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC--CCTTS
T ss_pred cCCC---CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC--CCCCC
Confidence 6432 3567999999999873 4689999999999999999999999988887777666665543222 22468
Q ss_pred CHHHHHHHHHhcccCccCcCCHHHHHhhHhhhcc
Q 014210 389 SSEARDFVKRLLNKDPRKRLTAAQALSELLICYQ 422 (429)
Q Consensus 389 s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~ 422 (429)
++++.+||.+||+.||++||++.++|+|+|+...
T Consensus 279 ~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~ 312 (348)
T 1u5q_A 279 SEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 312 (348)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred CHHHHHHHHHHcccChhhCcCHHHHhhChhhhcc
Confidence 9999999999999999999999999999999754
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-49 Score=377.37 Aligned_cols=265 Identities=34% Similarity=0.605 Sum_probs=233.9
Q ss_pred cccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcC------cHHHHHHHHHHHHHHHHhcCCCCcceEE
Q 014210 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMT------TAIAIEDVRREVKILRALTGHNNLVKFF 225 (429)
Q Consensus 152 ~~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~------~~~~~~~~~~Ei~il~~l~~h~nIv~l~ 225 (429)
.+.++|++.+.||+|+||.||+|+.+. +|+.||||++...... .....+.+.+|+++++++.+|+||++++
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~ 90 (298)
T 1phk_A 14 GFYENYEPKEILGRGVSSVVRRCIHKP---TCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLK 90 (298)
T ss_dssp -CTTTEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred chhhccceeeeecCCCceEEEEEEEcC---cCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeee
Confidence 356899999999999999999998766 5899999998654311 1234567889999999997799999999
Q ss_pred EEEEeCCeEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEe
Q 014210 226 DAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAI 305 (429)
Q Consensus 226 ~~~~~~~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~ 305 (429)
+++.+.+..++||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+
T Consensus 91 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~ 166 (298)
T 1phk_A 91 DTYETNTFFFLVFDLMKKGELFDYLTEK-VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILL---DDDMNIKLT 166 (298)
T ss_dssp EEEECSSEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEEC
T ss_pred eeeccCCeEEEEEeccCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEE---cCCCcEEEe
Confidence 9999999999999999999999988654 579999999999999999999999999999999999999 778889999
Q ss_pred ecCCccccCCCccccccccCCcccCccccc-------CCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCC
Q 014210 306 DFGLSDFVRPDERLNDIVGSAYYVAPEVLH-------RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADP 378 (429)
Q Consensus 306 DFGla~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~ 378 (429)
|||++.............|+..|+|||++. ..++.++||||||+++|+|++|+.||...........+.....
T Consensus 167 dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~ 246 (298)
T 1phk_A 167 DFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNY 246 (298)
T ss_dssp CCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC
T ss_pred cccchhhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCc
Confidence 999998876666666778999999999874 3578899999999999999999999999888888888888777
Q ss_pred CCCCCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhccc
Q 014210 379 SFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLICYQS 423 (429)
Q Consensus 379 ~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~~ 423 (429)
.+....+..++.++.+||.+||+.||++||++.++|+|+||+...
T Consensus 247 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 291 (298)
T 1phk_A 247 QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYV 291 (298)
T ss_dssp CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC
T ss_pred ccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhcc
Confidence 666666678999999999999999999999999999999998653
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-49 Score=394.65 Aligned_cols=263 Identities=35% Similarity=0.669 Sum_probs=231.5
Q ss_pred ccccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcC-----cHHHHHHHHHHHHHHHHhcCCCCcceEE
Q 014210 151 KHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMT-----TAIAIEDVRREVKILRALTGHNNLVKFF 225 (429)
Q Consensus 151 ~~~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~-----~~~~~~~~~~Ei~il~~l~~h~nIv~l~ 225 (429)
..+.++|++.+.||+|+||.||+|+... +|+.||||++...... .....+.+.+|+.+++++.+|+||++++
T Consensus 90 ~~~~~~y~~~~~lg~G~~g~Vy~a~~~~---~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 166 (365)
T 2y7j_A 90 KEFYQKYDPKDVIGRGVSSVVRRCVHRA---TGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLI 166 (365)
T ss_dssp HHHHHHEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred hhhhhhcccceEEecCCCEEEEEEEECC---CCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEE
Confidence 4456789999999999999999998765 5899999998654311 1233566889999999995699999999
Q ss_pred EEEEeCCeEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEe
Q 014210 226 DAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAI 305 (429)
Q Consensus 226 ~~~~~~~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~ 305 (429)
+++...+..+|||||++|++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+
T Consensus 167 ~~~~~~~~~~lv~e~~~g~~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~---~~~~~ikl~ 242 (365)
T 2y7j_A 167 DSYESSSFMFLVFDLMRKGELFDYLTEK-VALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILL---DDNMQIRLS 242 (365)
T ss_dssp EEEEBSSEEEEEECCCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEEC
T ss_pred EEEeeCCEEEEEEEeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---CCCCCEEEE
Confidence 9999999999999999999999988644 579999999999999999999999999999999999999 788899999
Q ss_pred ecCCccccCCCccccccccCCcccCcccccC-------CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCC
Q 014210 306 DFGLSDFVRPDERLNDIVGSAYYVAPEVLHR-------SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADP 378 (429)
Q Consensus 306 DFGla~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~ 378 (429)
|||++.............||+.|+|||++.+ .++.++|||||||++|+|++|+.||........+..+.....
T Consensus 243 DfG~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~ 322 (365)
T 2y7j_A 243 DFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQY 322 (365)
T ss_dssp CCTTCEECCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC
T ss_pred ecCcccccCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCC
Confidence 9999988776666677889999999998742 478899999999999999999999999888888888877766
Q ss_pred CCCCCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhh
Q 014210 379 SFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLIC 420 (429)
Q Consensus 379 ~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~ 420 (429)
.+....|..++.++.+||++||+.||++||++.++|+|+||+
T Consensus 323 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~ 364 (365)
T 2y7j_A 323 QFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFE 364 (365)
T ss_dssp CCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGC
T ss_pred CCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccC
Confidence 665555567899999999999999999999999999999996
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-49 Score=388.15 Aligned_cols=266 Identities=27% Similarity=0.424 Sum_probs=214.0
Q ss_pred ccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCC
Q 014210 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (429)
Q Consensus 153 ~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~ 232 (429)
..++|+++++||+|+||.||+|+... +|+.||||++.... ......+.+.+|+.++++++ |+||+++++++.+++
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~ 106 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTV---TNETVAIKRIRLEH-EEEGVPGTAIREVSLLKELQ-HRNIIELKSVIHHNH 106 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETT---TTEEEEEEECCCCC---------CHHHHHHGGGCC-CTTBCCEEEEEEETT
T ss_pred chhhEEEEEEEEecCCeEEEEEEECC---CCceEEEEEEcccc-cccccchhHHHHHHHHHHcC-CCCcceEEEEEecCC
Confidence 45789999999999999999998765 68999999997543 23344566789999999998 999999999999999
Q ss_pred eEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeec--CCCceEEEeecCCc
Q 014210 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTK--DENSVLKAIDFGLS 310 (429)
Q Consensus 233 ~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~--~~~~~vkL~DFGla 310 (429)
..+|||||+++ +|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+... ++++.+||+|||++
T Consensus 107 ~~~lv~e~~~~-~L~~~~~~-~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a 184 (329)
T 3gbz_A 107 RLHLIFEYAEN-DLKKYMDK-NPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLA 184 (329)
T ss_dssp EEEEEEECCSE-EHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHH
T ss_pred EEEEEEecCCC-CHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCc
Confidence 99999999975 99988754 4569999999999999999999999999999999999999643 34567999999999
Q ss_pred cccCCC-ccccccccCCcccCcccccC--CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCC-
Q 014210 311 DFVRPD-ERLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWP- 386 (429)
Q Consensus 311 ~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~- 386 (429)
...... .......||..|+|||++.+ .++.++|||||||++|||++|+.||......+.+..+...........|+
T Consensus 185 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (329)
T 3gbz_A 185 RAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPG 264 (329)
T ss_dssp HHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTT
T ss_pred cccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhh
Confidence 766432 23345678999999998864 48999999999999999999999999988888777776542222221111
Q ss_pred -------------------------CCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhcccee
Q 014210 387 -------------------------SLSSEARDFVKRLLNKDPRKRLTAAQALSELLICYQSYL 425 (429)
Q Consensus 387 -------------------------~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~~~~ 425 (429)
.++.++.+||++||+.||++|||+.|+|+|+||+...|-
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~ 328 (329)
T 3gbz_A 265 VTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHNDFD 328 (329)
T ss_dssp GGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSCSC
T ss_pred hhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCCCC
Confidence 167999999999999999999999999999999987653
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-49 Score=408.50 Aligned_cols=259 Identities=34% Similarity=0.580 Sum_probs=229.0
Q ss_pred cccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeC
Q 014210 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (429)
Q Consensus 152 ~~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~ 231 (429)
...++|.+++.||+|+||.||+|+... +|+.||||++.+.........+.+.+|+.+++.++ ||||+++++++.+.
T Consensus 13 ~~~~~Y~l~~~LG~G~fg~V~~a~~~~---~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~~~~~~~ 88 (476)
T 2y94_A 13 VKIGHYILGDTLGVGTFGKVKVGKHEL---TGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFR-HPHIIKLYQVISTP 88 (476)
T ss_dssp CEETTEEEEEEEECCSSSCEEEEEETT---TCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCC-CTTBCCEEEEEECS
T ss_pred ceecCEEEEEEEeeCCCeEEEEEEECC---CCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEEEC
Confidence 346789999999999999999998775 68999999986543323334567899999999998 99999999999999
Q ss_pred CeEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCcc
Q 014210 232 DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (429)
Q Consensus 232 ~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~ 311 (429)
+.+|||||||+||+|.+++. ..+.+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++.
T Consensus 89 ~~~~lv~E~~~gg~L~~~l~-~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll---~~~~~vkL~DFG~a~ 164 (476)
T 2y94_A 89 SDIFMVMEYVSGGELFDYIC-KNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLL---DAHMNAKIADFGLSN 164 (476)
T ss_dssp SEEEEEEECCSSEEHHHHTT-SSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEE---CTTCCEEECCCSSCE
T ss_pred CEEEEEEeCCCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEE---ecCCCeEEEeccchh
Confidence 99999999999999999874 45679999999999999999999999999999999999999 788899999999998
Q ss_pred ccCCCccccccccCCcccCcccccCC--CCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCC
Q 014210 312 FVRPDERLNDIVGSAYYVAPEVLHRS--YSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLS 389 (429)
Q Consensus 312 ~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 389 (429)
...........+||+.|+|||++.+. .+.++|||||||++|+|++|+.||........+..+.......+ ..++
T Consensus 165 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s 240 (476)
T 2y94_A 165 MMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTP----QYLN 240 (476)
T ss_dssp ECCTTCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCCCC----TTCC
T ss_pred hccccccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcCCC----ccCC
Confidence 87766666778899999999998754 36799999999999999999999998888888888877654433 3589
Q ss_pred HHHHHHHHHhcccCccCcCCHHHHHhhHhhhcc
Q 014210 390 SEARDFVKRLLNKDPRKRLTAAQALSELLICYQ 422 (429)
Q Consensus 390 ~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~ 422 (429)
+++.+||++||+.||++|||+.++++|+||...
T Consensus 241 ~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~ 273 (476)
T 2y94_A 241 PSVISLLKHMLQVDPMKRATIKDIREHEWFKQD 273 (476)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred HHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence 999999999999999999999999999999754
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-50 Score=391.90 Aligned_cols=260 Identities=36% Similarity=0.635 Sum_probs=204.5
Q ss_pred cCceeEe---ceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEe
Q 014210 154 ANKYELG---EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED 230 (429)
Q Consensus 154 ~~~y~~~---~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~ 230 (429)
.++|++. ++||+|+||.||+|+... +|+.||||++.+. ....+.+|+.+++.+.+||||+++++++.+
T Consensus 7 ~~~y~~~~~~~~lG~G~~g~V~~~~~~~---~~~~vavK~~~~~------~~~~~~~e~~~l~~l~~h~niv~~~~~~~~ 77 (325)
T 3kn6_A 7 YQHYDLDLKDKPLGEGSFSICRKCVHKK---SNQAFAVKIISKR------MEANTQKEITALKLCEGHPNIVKLHEVFHD 77 (325)
T ss_dssp HHHEEECTTSCCSEEETTEEEEEEEETT---TCCEEEEEEEEGG------GHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred hhccccccCCCccccCCCeEEEEEEECC---CCCEEEEEEEChh------hhhhHHHHHHHHHHhcCCCCeeEEEEEEEc
Confidence 4567775 789999999999999776 5899999998532 345678999999999889999999999999
Q ss_pred CCeEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCc
Q 014210 231 TDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS 310 (429)
Q Consensus 231 ~~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla 310 (429)
.+..|||||||++|+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++..+.+..+||+|||++
T Consensus 78 ~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a 156 (325)
T 3kn6_A 78 QLHTFLVMELLNGGELFERIKK-KKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFA 156 (325)
T ss_dssp SSEEEEEECCCCSCBHHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTC
T ss_pred CCEEEEEEEccCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccc
Confidence 9999999999999999998865 467999999999999999999999999999999999999975555558999999999
Q ss_pred cccCCCc-cccccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHcCCCCCCCCC-------hHHHHHHHHhcCCCCC
Q 014210 311 DFVRPDE-RLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWART-------ESGIFRAVLKADPSFD 381 (429)
Q Consensus 311 ~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~elltg~~Pf~~~~-------~~~~~~~i~~~~~~~~ 381 (429)
+...... .....+||..|+|||++.+ .++.++||||||+++|+|++|+.||.... ..+.+..+......+.
T Consensus 157 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~ 236 (325)
T 3kn6_A 157 RLKPPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFE 236 (325)
T ss_dssp EECCC----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCC
T ss_pred eecCCCCCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCC
Confidence 8665433 3456678999999999874 68999999999999999999999997543 2456666666666666
Q ss_pred CCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhccc
Q 014210 382 EAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLICYQS 423 (429)
Q Consensus 382 ~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~~ 423 (429)
...|..+++++.+||++||+.||++||++.++++|+||+...
T Consensus 237 ~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~ 278 (325)
T 3kn6_A 237 GEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGS 278 (325)
T ss_dssp SHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTC
T ss_pred cccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccCc
Confidence 555567899999999999999999999999999999998653
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=386.95 Aligned_cols=264 Identities=28% Similarity=0.467 Sum_probs=223.2
Q ss_pred ccccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEe
Q 014210 151 KHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED 230 (429)
Q Consensus 151 ~~~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~ 230 (429)
..+.++|++.++||+|+||.||+|+... +|+.||||++...........+.+.+|+.++++++ ||||+++++++..
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~ 83 (311)
T 3ork_A 8 SHLSDRYELGEILGFGGMSEVHLARDLR---DHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN-HPAIVAVYDTGEA 83 (311)
T ss_dssp SEETTTEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCC-CTTBCCEEEEEEE
T ss_pred ceecCcEEEEEEEccCCCEEEEEEEECC---CCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCC-CCCcceEEEeeec
Confidence 4567899999999999999999999766 58999999998766666777788999999999998 9999999999886
Q ss_pred CCe----EEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEee
Q 014210 231 TDN----VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAID 306 (429)
Q Consensus 231 ~~~----~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~D 306 (429)
.+. .||||||++|++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|
T Consensus 84 ~~~~~~~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~kl~D 159 (311)
T 3ork_A 84 ETPAGPLPYIVMEYVDGVTLRDIVHTE-GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMI---SATNAVKVMD 159 (311)
T ss_dssp EETTEEEEEEEEECCCEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---ETTSCEEECC
T ss_pred cCCCCcccEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEE---cCCCCEEEee
Confidence 553 49999999999999988654 579999999999999999999999999999999999999 6778899999
Q ss_pred cCCccccCCCc----cccccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCC
Q 014210 307 FGLSDFVRPDE----RLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFD 381 (429)
Q Consensus 307 FGla~~~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~ 381 (429)
||++....... ......||+.|+|||++.+ .++.++||||||+++|||++|+.||...........+........
T Consensus 160 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~ 239 (311)
T 3ork_A 160 FGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPP 239 (311)
T ss_dssp CSCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCH
T ss_pred ccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCc
Confidence 99998764332 2234579999999998874 688999999999999999999999999888887777777665554
Q ss_pred CCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhcc
Q 014210 382 EAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLICYQ 422 (429)
Q Consensus 382 ~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~ 422 (429)
......++.++.+||.+||+.||++||++.++|.+.|++..
T Consensus 240 ~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 280 (311)
T 3ork_A 240 SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 280 (311)
T ss_dssp HHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred ccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHh
Confidence 44456799999999999999999999999999999998753
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-49 Score=379.01 Aligned_cols=267 Identities=39% Similarity=0.705 Sum_probs=235.4
Q ss_pred ccccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEe
Q 014210 151 KHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED 230 (429)
Q Consensus 151 ~~~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~ 230 (429)
..+.++|++++.||+|+||.||+|+... +|+.||||++..... .....+.+.+|++++++++ |+||+++++++.+
T Consensus 18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~---~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~ 92 (287)
T 2wei_A 18 GTFAERYNIVCMLGKGSFGEVLKCKDRI---TQQEYAVKVINKASA-KNKDTSTILREVELLKKLD-HPNIMKLFEILED 92 (287)
T ss_dssp HHHHHHEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEEGGGB-SSSCHHHHHHHHHHHHTCC-CTTBCCEEEEEEC
T ss_pred HHHhhcceeeEEEcCCCCEEEEEEEEcC---CCcEEEEEEeccccc-chHHHHHHHHHHHHHHhcc-CCCccEEEEEEeC
Confidence 3456899999999999999999998765 589999999865432 2334567899999999997 9999999999999
Q ss_pred CCeEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCc
Q 014210 231 TDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS 310 (429)
Q Consensus 231 ~~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla 310 (429)
.+..++||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++..+.+..+||+|||++
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~ 171 (287)
T 2wei_A 93 SSSFYIVGELYTGGELFDEIIKR-KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLS 171 (287)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGG
T ss_pred CCeEEEEEEccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcc
Confidence 99999999999999999988654 57999999999999999999999999999999999999965555668999999999
Q ss_pred cccCCCccccccccCCcccCcccccCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCH
Q 014210 311 DFVRPDERLNDIVGSAYYVAPEVLHRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSS 390 (429)
Q Consensus 311 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 390 (429)
.............||..|+|||++.+.++.++||||||+++|+|++|+.||...........+......+....+..++.
T Consensus 172 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (287)
T 2wei_A 172 TCFQQNTKMKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISD 251 (287)
T ss_dssp GTBCCCSSCSCHHHHHTTCCHHHHTTCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSCH
T ss_pred eeecCCCccccccCcccccChHHhcCCCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcCH
Confidence 87765555556679999999999988899999999999999999999999999888888888887776666555678999
Q ss_pred HHHHHHHHhcccCccCcCCHHHHHhhHhhhccc
Q 014210 391 EARDFVKRLLNKDPRKRLTAAQALSELLICYQS 423 (429)
Q Consensus 391 ~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~~ 423 (429)
++.+||++||+.||++||++.++|+|+||+...
T Consensus 252 ~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~~ 284 (287)
T 2wei_A 252 DAKDLIRKMLTFHPSLRITATQCLEHPWIQKYS 284 (287)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHHC
T ss_pred HHHHHHHHHcccChhhCcCHHHHhcCHHHhccc
Confidence 999999999999999999999999999998643
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-49 Score=389.87 Aligned_cols=258 Identities=31% Similarity=0.542 Sum_probs=214.9
Q ss_pred ccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCC
Q 014210 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (429)
Q Consensus 153 ~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~ 232 (429)
+.++|+++++||+|+||.||+|+... +|+.||||++..... ....+.+.+|+.+++.++ |+||+++++++.+++
T Consensus 5 ~~~~y~i~~~lG~G~~g~V~~~~~~~---~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~ 78 (323)
T 3tki_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRV---TEEAVAVKIVDMKRA--VDCPENIKKEICINKMLN-HENVVKFYGHRREGN 78 (323)
T ss_dssp TTTCEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEECC---------CHHHHHHHHHHCC-CTTBCCEEEEEECSS
T ss_pred HhhhceeeeEEecCCCEEEEEEEECC---CCcEEEEEEEEcccc--cchHHHHHHHHHHHHhCC-CCCCCeEEEEEecCC
Confidence 46799999999999999999998775 589999999865432 223466889999999998 999999999999999
Q ss_pred eEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccc
Q 014210 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (429)
Q Consensus 233 ~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~ 312 (429)
..|||||||++++|.+++ .....+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++..
T Consensus 79 ~~~lv~e~~~~~~L~~~l-~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll---~~~~~~kl~Dfg~a~~ 154 (323)
T 3tki_A 79 IQYLFLEYCSGGELFDRI-EPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL---DERDNLKISDFGLATV 154 (323)
T ss_dssp EEEEEEECCTTEEGGGGS-BTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCTTCEE
T ss_pred eEEEEEEcCCCCcHHHHH-hhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEE---eCCCCEEEEEeeccce
Confidence 999999999999999877 344579999999999999999999999999999999999999 7788999999999976
Q ss_pred cCCCc---cccccccCCcccCcccccC-C-CCCcccHHHHHHHHHHHHcCCCCCCCCChHHH-HHHHHhcCCCCCCCCCC
Q 014210 313 VRPDE---RLNDIVGSAYYVAPEVLHR-S-YSTEADVWSIGVIAYILLCGSRPFWARTESGI-FRAVLKADPSFDEAPWP 386 (429)
Q Consensus 313 ~~~~~---~~~~~~gt~~y~aPE~~~~-~-~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~-~~~i~~~~~~~~~~~~~ 386 (429)
..... .....+||+.|+|||++.+ . ++.++|||||||++|+|++|+.||........ +....... .....+.
T Consensus 155 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~--~~~~~~~ 232 (323)
T 3tki_A 155 FRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK--TYLNPWK 232 (323)
T ss_dssp CEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTC--TTSTTGG
T ss_pred eccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhccc--ccCCccc
Confidence 54222 2345789999999998864 3 47789999999999999999999987655432 33333222 2223345
Q ss_pred CCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhcc
Q 014210 387 SLSSEARDFVKRLLNKDPRKRLTAAQALSELLICYQ 422 (429)
Q Consensus 387 ~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~ 422 (429)
.++.++.+||++||+.||++|||+.|+++|+||+..
T Consensus 233 ~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~ 268 (323)
T 3tki_A 233 KIDSAPLALLHKILVENPSARITIPDIKKDRWYNKP 268 (323)
T ss_dssp GSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred cCCHHHHHHHHHHccCChhhCcCHHHHhhChhhccc
Confidence 789999999999999999999999999999999753
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-49 Score=376.18 Aligned_cols=259 Identities=29% Similarity=0.558 Sum_probs=223.3
Q ss_pred ccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCC
Q 014210 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (429)
Q Consensus 153 ~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~ 232 (429)
..++|++.+.||+|+||.||+|+... +++.||||++...........+.+.+|+.+++++. |+||+++++++.+.+
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~ 82 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQ---SKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HPNILRLYGYFHDAT 82 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCC-CTTBCCEEEEEECSS
T ss_pred ecccEEEeeEEecCCCeEEEEEEEcc---CCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCC-CCCCcchhheEecCC
Confidence 45789999999999999999998776 58899999986543333334567899999999998 999999999999999
Q ss_pred eEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccc
Q 014210 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (429)
Q Consensus 233 ~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~ 312 (429)
..++||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..
T Consensus 83 ~~~lv~e~~~~~~l~~~l~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili---~~~~~~~l~Dfg~~~~ 158 (279)
T 3fdn_A 83 RVYLILEYAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLL---GSAGELKIADFGWSVH 158 (279)
T ss_dssp EEEEEECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEE---CTTSCEEECSCCEESC
T ss_pred EEEEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEE---cCCCCEEEEecccccc
Confidence 999999999999999988654 569999999999999999999999999999999999999 7888999999999865
Q ss_pred cCCCccccccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHH
Q 014210 313 VRPDERLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSE 391 (429)
Q Consensus 313 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 391 (429)
.... ......||..|+|||++.+ .++.++||||||+++|+|++|+.||...........+......++. .++.+
T Consensus 159 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~ 233 (279)
T 3fdn_A 159 APSS-RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEG 233 (279)
T ss_dssp C---------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCT----TSCHH
T ss_pred CCcc-cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCCCCC----cCCHH
Confidence 5432 3345689999999998875 5788999999999999999999999998888888877776655443 58899
Q ss_pred HHHHHHHhcccCccCcCCHHHHHhhHhhhccce
Q 014210 392 ARDFVKRLLNKDPRKRLTAAQALSELLICYQSY 424 (429)
Q Consensus 392 ~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~~~ 424 (429)
+.+||.+||+.||++||++.++|+|+||.....
T Consensus 234 ~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~~~ 266 (279)
T 3fdn_A 234 ARDLISRLLKHNPSQRPMLREVLEHPWITANSS 266 (279)
T ss_dssp HHHHHHHHCCSSGGGSCCHHHHHHCHHHHHHCS
T ss_pred HHHHHHHHhccChhhCCCHHHHhhCccccCCcc
Confidence 999999999999999999999999999987553
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-50 Score=392.02 Aligned_cols=267 Identities=34% Similarity=0.594 Sum_probs=225.9
Q ss_pred ccccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCc--CcHHHHHHHHHHHHHHHHhcCCCCcceEEEEE
Q 014210 151 KHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKM--TTAIAIEDVRREVKILRALTGHNNLVKFFDAY 228 (429)
Q Consensus 151 ~~~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~--~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~ 228 (429)
..+.++|++.+.||+|+||.||+|+... +++.||||++.+... ......+.+.+|++++++++ ||||+++++++
T Consensus 22 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~ 97 (345)
T 3hko_A 22 LELQKKYHLKGAIGQGSYGVVRVAIENQ---TRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLH-HPNIARLYEVY 97 (345)
T ss_dssp HHHHHHEEEEEEEEECSSCEEEEEEETT---TCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCC-CTTBCCEEEEE
T ss_pred hhhhhheeecceeeecCCeEEEEEEECC---CCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCC-CCCcceeehhh
Confidence 3567899999999999999999998765 589999999864321 12345678999999999998 99999999999
Q ss_pred EeCCeEEEEEEecCCCcHHHHHHhc---------------------------------------CCCCCHHHHHHHHHHH
Q 014210 229 EDTDNVYVVMELCEGGELLDRILSR---------------------------------------GGKYTEDDAKAVMIQI 269 (429)
Q Consensus 229 ~~~~~~~lv~E~~~ggsL~~~i~~~---------------------------------------~~~l~~~~~~~i~~qi 269 (429)
.+.+..+||||||+||+|.+++... ...+++..++.++.||
T Consensus 98 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi 177 (345)
T 3hko_A 98 EDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQI 177 (345)
T ss_dssp ECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHH
T ss_pred ccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHH
Confidence 9999999999999999999877310 1124678899999999
Q ss_pred HHHHHHHHHcCceeccCCCCcEEEeecCCCc--eEEEeecCCccccCCCc-----cccccccCCcccCccccc---CCCC
Q 014210 270 LNVVAFCHLQGVVHRDLKPENFLFTTKDENS--VLKAIDFGLSDFVRPDE-----RLNDIVGSAYYVAPEVLH---RSYS 339 (429)
Q Consensus 270 ~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~--~vkL~DFGla~~~~~~~-----~~~~~~gt~~y~aPE~~~---~~~~ 339 (429)
+.||.|||++||+||||||+|||+ +.++ .+||+|||++....... ......||+.|+|||++. +.++
T Consensus 178 ~~~l~~LH~~~ivH~Dlkp~NIll---~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 254 (345)
T 3hko_A 178 FSALHYLHNQGICHRDIKPENFLF---STNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYG 254 (345)
T ss_dssp HHHHHHHHHTTEECCCCCGGGEEE---SCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCC
T ss_pred HHHHHHHHHCCccccCCChhhEEE---ecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCC
Confidence 999999999999999999999999 4444 89999999997653211 234567999999999885 4688
Q ss_pred CcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhh
Q 014210 340 TEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLI 419 (429)
Q Consensus 340 ~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~ 419 (429)
.++||||||+++|||++|+.||......+....++.....+....+..+++++.+||++||+.||++||++.++|+|+||
T Consensus 255 ~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~ 334 (345)
T 3hko_A 255 PKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWI 334 (345)
T ss_dssp THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHH
T ss_pred cHHHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhh
Confidence 99999999999999999999999999988888888887777766666789999999999999999999999999999999
Q ss_pred hccce
Q 014210 420 CYQSY 424 (429)
Q Consensus 420 ~~~~~ 424 (429)
+....
T Consensus 335 ~~~~~ 339 (345)
T 3hko_A 335 SQFSD 339 (345)
T ss_dssp HTTSS
T ss_pred ccChH
Confidence 87654
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-49 Score=425.05 Aligned_cols=260 Identities=26% Similarity=0.455 Sum_probs=231.3
Q ss_pred ccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCC
Q 014210 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (429)
Q Consensus 153 ~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~ 232 (429)
..++|+++++||+|+||.||+|+.+. +|+.||||++.+.........+.+.+|..++..+.+|++|+++++++++.+
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~---~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~ 415 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKG---TDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD 415 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESS---SCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSS
T ss_pred cccceEEEEEEccCCCEEEEEEEECC---CCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCC
Confidence 35789999999999999999999876 589999999875433333445678899999998877999999999999999
Q ss_pred eEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccc
Q 014210 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (429)
Q Consensus 233 ~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~ 312 (429)
.+||||||++||+|.+++... +.+++..++.++.||+.||+|||++|||||||||+|||| +.++.+||+|||+++.
T Consensus 416 ~~~lV~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl---~~~g~ikL~DFGla~~ 491 (674)
T 3pfq_A 416 RLYFVMEYVNGGDLMYHIQQV-GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVML---DSEGHIKIADFGMCKE 491 (674)
T ss_dssp EEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEE---CSSSCEEECCCTTCEE
T ss_pred EEEEEEeCcCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEE---cCCCcEEEeecceeec
Confidence 999999999999999988654 579999999999999999999999999999999999999 7888999999999986
Q ss_pred cC-CCccccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCH
Q 014210 313 VR-PDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSS 390 (429)
Q Consensus 313 ~~-~~~~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 390 (429)
.. ........+||+.|+|||++. ..++.++|||||||+||||++|+.||...+..+++..++.....++. .+++
T Consensus 492 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~ 567 (674)
T 3pfq_A 492 NIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPK----SMSK 567 (674)
T ss_dssp CCCTTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCCCCT----TSCH
T ss_pred cccCCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCc----cCCH
Confidence 43 334456788999999999887 56999999999999999999999999999999999999988766654 6899
Q ss_pred HHHHHHHHhcccCccCcCCH-----HHHHhhHhhhccc
Q 014210 391 EARDFVKRLLNKDPRKRLTA-----AQALSELLICYQS 423 (429)
Q Consensus 391 ~~~~li~~~L~~dP~~Rps~-----~~iL~~~~~~~~~ 423 (429)
++.+||++||++||++|+++ ++|++|+||+...
T Consensus 568 ~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~ 605 (674)
T 3pfq_A 568 EAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYID 605 (674)
T ss_dssp HHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSCC
T ss_pred HHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCCC
Confidence 99999999999999999997 9999999998654
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-49 Score=389.36 Aligned_cols=267 Identities=24% Similarity=0.395 Sum_probs=223.5
Q ss_pred CCCcCccccccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhc----CCC
Q 014210 144 NKSFGFSKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALT----GHN 219 (429)
Q Consensus 144 ~~~~~~~~~~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~----~h~ 219 (429)
..++..+..+.++|+++++||+|+||.||+|+... +|+.||||++.. .....+.+.+|+.+++.+. +|+
T Consensus 24 ~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vavK~~~~----~~~~~~~~~~e~~~l~~l~~~~~~h~ 96 (360)
T 3llt_A 24 HFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHID---NKKYYAVKVVRN----IKKYTRSAKIEADILKKIQNDDINNN 96 (360)
T ss_dssp SCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEECS----CHHHHHHHHHHHHHHHHTCCCSTTGG
T ss_pred eeeeecceEecCEEEEEEEEcccCCeEEEEEEECC---CCeEEEEEEecc----chhhhhhhHHHHHHHHHhcccCCCCC
Confidence 34566677788999999999999999999998766 589999999853 2445567788999999997 599
Q ss_pred CcceEEEEEEeCCeEEEEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeec--
Q 014210 220 NLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRG-GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTK-- 296 (429)
Q Consensus 220 nIv~l~~~~~~~~~~~lv~E~~~ggsL~~~i~~~~-~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~-- 296 (429)
||+++++++...+..+|||||+ +++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||+...
T Consensus 97 ~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~ 175 (360)
T 3llt_A 97 NIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYF 175 (360)
T ss_dssp GBCCEEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTC
T ss_pred CeecccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccc
Confidence 9999999999999999999999 889999887654 369999999999999999999999999999999999999421
Q ss_pred --------------------CCCceEEEeecCCccccCCCccccccccCCcccCcccccC-CCCCcccHHHHHHHHHHHH
Q 014210 297 --------------------DENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILL 355 (429)
Q Consensus 297 --------------------~~~~~vkL~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~ell 355 (429)
..++.+||+|||++..... ......||+.|+|||++.+ .++.++|||||||++|+|+
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell 253 (360)
T 3llt_A 176 EKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD--YHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELY 253 (360)
T ss_dssp CEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTS--CCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHH
T ss_pred cccccchhcccccccccccccCCCCEEEEeccCceecCC--CCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHH
Confidence 1267899999999976543 3345689999999998864 6999999999999999999
Q ss_pred cCCCCCCCCChHHHHHHHHhcCCCCCCC---------------------CCC---------------------CCCHHHH
Q 014210 356 CGSRPFWARTESGIFRAVLKADPSFDEA---------------------PWP---------------------SLSSEAR 393 (429)
Q Consensus 356 tg~~Pf~~~~~~~~~~~i~~~~~~~~~~---------------------~~~---------------------~~s~~~~ 393 (429)
+|+.||......+.+..+.......+.. .|+ ..++++.
T Consensus 254 ~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 333 (360)
T 3llt_A 254 TGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFC 333 (360)
T ss_dssp HSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHH
T ss_pred HCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHH
Confidence 9999999888777766665543222210 011 1247788
Q ss_pred HHHHHhcccCccCcCCHHHHHhhHhhh
Q 014210 394 DFVKRLLNKDPRKRLTAAQALSELLIC 420 (429)
Q Consensus 394 ~li~~~L~~dP~~Rps~~~iL~~~~~~ 420 (429)
+||++||+.||++|||+.++|+|+||+
T Consensus 334 ~li~~~L~~dP~~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 334 DFLYSILQIDPTLRPSPAELLKHKFLE 360 (360)
T ss_dssp HHHHHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred HHHHHHhcCChhhCCCHHHHhcCcccC
Confidence 999999999999999999999999985
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-49 Score=385.21 Aligned_cols=258 Identities=32% Similarity=0.488 Sum_probs=228.5
Q ss_pred ccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCC
Q 014210 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (429)
Q Consensus 153 ~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~ 232 (429)
..++|.+.+.||+|+||.||+++... +++.||+|++.+.........+.+.+|+.+++++. |+||+++++++.+.+
T Consensus 39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~ 114 (335)
T 2owb_A 39 SRRRYVRGRFLGKGGFAKCFEISDAD---TKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA-HQHVVGFHGFFEDND 114 (335)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEECSS
T ss_pred cCCceEEEEEEeeCCCeEEEEEEECC---CCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEecCC
Confidence 45789999999999999999998766 58899999997665556677788999999999998 999999999999999
Q ss_pred eEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccc
Q 014210 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (429)
Q Consensus 233 ~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~ 312 (429)
..++||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..
T Consensus 115 ~~~lv~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~---~~~~~~kl~Dfg~~~~ 190 (335)
T 2owb_A 115 FVFVVLELCRRRSLLELHKR-RKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFL---NEDLEVKIGDFGLATK 190 (335)
T ss_dssp EEEEEECCCTTCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---CTTCCEEECCCTTCEE
T ss_pred eEEEEEecCCCCCHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEE---cCCCCEEEeeccCcee
Confidence 99999999999999987754 4679999999999999999999999999999999999999 7788999999999987
Q ss_pred cCCC-ccccccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCH
Q 014210 313 VRPD-ERLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSS 390 (429)
Q Consensus 313 ~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 390 (429)
.... .......||..|+|||++.+ .++.++||||||+++|+|++|+.||......+.+..+.......+ ..++.
T Consensus 191 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~----~~~~~ 266 (335)
T 2owb_A 191 VEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIP----KHINP 266 (335)
T ss_dssp CCSTTCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCC----TTSCH
T ss_pred cccCcccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCCCC----ccCCH
Confidence 6432 33455679999999998864 588999999999999999999999998888777777776655443 36889
Q ss_pred HHHHHHHHhcccCccCcCCHHHHHhhHhhhcc
Q 014210 391 EARDFVKRLLNKDPRKRLTAAQALSELLICYQ 422 (429)
Q Consensus 391 ~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~ 422 (429)
++.+||++||+.||++||++.++|+|+||...
T Consensus 267 ~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~ 298 (335)
T 2owb_A 267 VAASLIQKMLQTDPTARPTINELLNDEFFTSG 298 (335)
T ss_dssp HHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTS
T ss_pred HHHHHHHHHccCChhHCcCHHHHhcCccccCC
Confidence 99999999999999999999999999999754
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=378.30 Aligned_cols=263 Identities=42% Similarity=0.702 Sum_probs=230.1
Q ss_pred cccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeC
Q 014210 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (429)
Q Consensus 152 ~~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~ 231 (429)
.+.++|++.+.||+|+||.||+++... +|+.||||++.... ....+.+.+|+.++++++ |+||+++++++.+.
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~ 78 (304)
T 2jam_A 6 NIRKTFIFMEVLGSGAFSEVFLVKQRL---TGKLFALKCIKKSP---AFRDSSLENEIAVLKKIK-HENIVTLEDIYEST 78 (304)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEECC---------HHHHHHHHHHHCC-CTTBCCEEEEEECS
T ss_pred chhccceeeeeccCCCCceEEEEEECC---CCCEEEEEEEeccc---ccchHHHHHHHHHHHhCC-CCCeeehhhhcccC
Confidence 456789999999999999999998765 58999999997542 223356889999999998 99999999999999
Q ss_pred CeEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCcc
Q 014210 232 DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (429)
Q Consensus 232 ~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~ 311 (429)
+..++||||+++++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||+...+.++.+||+|||++.
T Consensus 79 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~ 157 (304)
T 2jam_A 79 THYYLVMQLVSGGELFDRILER-GVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSK 157 (304)
T ss_dssp SEEEEEECCCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTC
T ss_pred CEEEEEEEcCCCccHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcce
Confidence 9999999999999999988654 579999999999999999999999999999999999999665678899999999997
Q ss_pred ccCCCccccccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCH
Q 014210 312 FVRPDERLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSS 390 (429)
Q Consensus 312 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 390 (429)
.... .......||..|+|||++.+ .++.++||||||+++|+|++|+.||........+..+......+....+..++.
T Consensus 158 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 236 (304)
T 2jam_A 158 MEQN-GIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISE 236 (304)
T ss_dssp CCCC-BTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCH
T ss_pred ecCC-CccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCH
Confidence 6543 23345579999999998874 588999999999999999999999999888888888888777666666778999
Q ss_pred HHHHHHHHhcccCccCcCCHHHHHhhHhhhccc
Q 014210 391 EARDFVKRLLNKDPRKRLTAAQALSELLICYQS 423 (429)
Q Consensus 391 ~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~~ 423 (429)
++.+||.+||..||++||++.++|+|+||....
T Consensus 237 ~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 269 (304)
T 2jam_A 237 SAKDFICHLLEKDPNERYTCEKALSHPWIDGNT 269 (304)
T ss_dssp HHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSSC
T ss_pred HHHHHHHHHcCCChhHCcCHHHHhcCccccCCC
Confidence 999999999999999999999999999998654
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-49 Score=394.09 Aligned_cols=261 Identities=20% Similarity=0.312 Sum_probs=216.3
Q ss_pred cCceeEeceeecc--CceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeC
Q 014210 154 ANKYELGEEVGRG--HFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (429)
Q Consensus 154 ~~~y~~~~~IG~G--~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~ 231 (429)
.++|+++++||+| +||.||+|+.+. +|+.||||++.... ......+.+.+|+.++++++ |+|||++++++.+.
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~ 98 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKP---TGEYVTVRRINLEA-CSNEMVTFLQGELHVSKLFN-HPNIVPYRATFIAD 98 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETT---TCCEEEEEEEEGGG-SCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEET
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcC---CCCEEEEEEecccc-cChHHHHHHHHHHHHHHhCC-CCCCCcEeEEEEEC
Confidence 5789999999999 999999999876 58999999997643 34556778899999999998 99999999999999
Q ss_pred CeEEEEEEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCc
Q 014210 232 DNVYVVMELCEGGELLDRILSR-GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS 310 (429)
Q Consensus 232 ~~~~lv~E~~~ggsL~~~i~~~-~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla 310 (429)
+..+||||||++|+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll---~~~~~~kl~dfg~~ 175 (389)
T 3gni_B 99 NELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILI---SVDGKVYLSGLRSN 175 (389)
T ss_dssp TEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCGGGC
T ss_pred CEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCCCEEEcccccc
Confidence 9999999999999999988764 3569999999999999999999999999999999999999 77889999999987
Q ss_pred cccCCC--------ccccccccCCcccCcccccC---CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCC
Q 014210 311 DFVRPD--------ERLNDIVGSAYYVAPEVLHR---SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPS 379 (429)
Q Consensus 311 ~~~~~~--------~~~~~~~gt~~y~aPE~~~~---~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~ 379 (429)
...... ......+||..|+|||++.+ .++.++|||||||++|||++|+.||........+..++.....
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 255 (389)
T 3gni_B 176 LSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVP 255 (389)
T ss_dssp EECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC------
T ss_pred eeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCC
Confidence 644221 11233478999999998865 5899999999999999999999999876655444433322110
Q ss_pred C------------------------------------------CCCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhH
Q 014210 380 F------------------------------------------DEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSEL 417 (429)
Q Consensus 380 ~------------------------------------------~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~ 417 (429)
. ....+..+++++.+||++||+.||++|||+.++|+|+
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp 335 (389)
T 3gni_B 256 CLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHS 335 (389)
T ss_dssp --------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSG
T ss_pred ccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCH
Confidence 0 0112345789999999999999999999999999999
Q ss_pred hhhcc
Q 014210 418 LICYQ 422 (429)
Q Consensus 418 ~~~~~ 422 (429)
||+..
T Consensus 336 ~f~~~ 340 (389)
T 3gni_B 336 FFKQI 340 (389)
T ss_dssp GGGGC
T ss_pred HHHHH
Confidence 99864
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-49 Score=412.67 Aligned_cols=260 Identities=28% Similarity=0.469 Sum_probs=226.0
Q ss_pred ccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCC
Q 014210 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (429)
Q Consensus 153 ~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~ 232 (429)
..++|++.++||+|+||.||+|+.+. +|+.||||++.+.........+.+.+|+.++++++ |+|||++++++.+.+
T Consensus 182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~---tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~~~~~~ 257 (576)
T 2acx_A 182 TKNTFRQYRVLGKGGFGEVCACQVRA---TGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVN-SRFVVSLAYAYETKD 257 (576)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCC-CTTBCCEEEEEECSS
T ss_pred cccceEEEEEEeeCCCEEEEEEEECC---CCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcC-CCCEeeEEEEEeeCC
Confidence 45789999999999999999999776 68999999986543333344567889999999998 999999999999999
Q ss_pred eEEEEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCcc
Q 014210 233 NVYVVMELCEGGELLDRILSRG-GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (429)
Q Consensus 233 ~~~lv~E~~~ggsL~~~i~~~~-~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~ 311 (429)
.+|||||||+||+|.+++...+ ..+++..++.++.||+.||+|||++|||||||||+|||+ +.++.+||+|||+++
T Consensus 258 ~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILl---d~~g~vKL~DFGla~ 334 (576)
T 2acx_A 258 ALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILL---DDHGHIRISDLGLAV 334 (576)
T ss_dssp EEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTSCEEECCCTTCE
T ss_pred EEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEE---eCCCCeEEEecccce
Confidence 9999999999999999886543 359999999999999999999999999999999999999 788899999999998
Q ss_pred ccCCCccccccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHcCCCCCCCCC----hHHHHHHHHhcCCCCCCCCCC
Q 014210 312 FVRPDERLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWART----ESGIFRAVLKADPSFDEAPWP 386 (429)
Q Consensus 312 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~elltg~~Pf~~~~----~~~~~~~i~~~~~~~~~~~~~ 386 (429)
...........+||+.|+|||++.+ .++.++|||||||++|||++|+.||.... ...+...+......++ .
T Consensus 335 ~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~~p----~ 410 (576)
T 2acx_A 335 HVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYS----E 410 (576)
T ss_dssp ECCTTCCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCCCC----T
T ss_pred ecccCccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccccCC----c
Confidence 8776666667799999999998875 68999999999999999999999997753 3445555555444433 4
Q ss_pred CCCHHHHHHHHHhcccCccCcC-----CHHHHHhhHhhhccc
Q 014210 387 SLSSEARDFVKRLLNKDPRKRL-----TAAQALSELLICYQS 423 (429)
Q Consensus 387 ~~s~~~~~li~~~L~~dP~~Rp-----s~~~iL~~~~~~~~~ 423 (429)
.+++++.+||++||+.||++|| ++.++++|+||+...
T Consensus 411 ~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i~ 452 (576)
T 2acx_A 411 RFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLN 452 (576)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTCC
T ss_pred cCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccCC
Confidence 6899999999999999999999 899999999998644
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-49 Score=388.16 Aligned_cols=259 Identities=28% Similarity=0.458 Sum_probs=213.5
Q ss_pred CceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeE
Q 014210 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (429)
Q Consensus 155 ~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~ 234 (429)
++|+++++||+|+||.||+|+... +|+.||||++.... .......+.+|+.++++++ |+||+++++++.+.+..
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~ 75 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKL---TDNLVALKEIRLEH--EEGAPCTAIREVSLLKDLK-HANIVTLHDIIHTEKSL 75 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEECC--------CCCCCCCHHHHSCCC-CTTBCCEEEEEECSSCE
T ss_pred CceEEEEEEcCCCCEEEEEEEECC---CCcEEEEEEEeccc--ccccchhHHHHHHHHHhcC-CCCCCeeeeEEeeCCEE
Confidence 579999999999999999998775 58999999986432 1112224568999999998 99999999999999999
Q ss_pred EEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccccC
Q 014210 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (429)
Q Consensus 235 ~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~ 314 (429)
+|||||++ |+|.+++...+..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++....
T Consensus 76 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~---~~~~~~kl~Dfg~a~~~~ 151 (324)
T 3mtl_A 76 TLVFEYLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLI---NERGELKLADFGLARAKS 151 (324)
T ss_dssp EEEEECCS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEE---CTTCCEEECSSSEEECC-
T ss_pred EEEecccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEE---CCCCCEEEccCccccccc
Confidence 99999997 59999988877789999999999999999999999999999999999999 778899999999997654
Q ss_pred CC-ccccccccCCcccCcccccC--CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCC------
Q 014210 315 PD-ERLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPW------ 385 (429)
Q Consensus 315 ~~-~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~------ 385 (429)
.. .......||..|+|||++.+ .++.++|||||||++|+|++|+.||......+.+..+.+.........|
T Consensus 152 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 231 (324)
T 3mtl_A 152 IPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSN 231 (324)
T ss_dssp -----------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGC
T ss_pred CCccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcc
Confidence 33 23345678999999998864 5899999999999999999999999998888877776653222222222
Q ss_pred --------------------CCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhccc
Q 014210 386 --------------------PSLSSEARDFVKRLLNKDPRKRLTAAQALSELLICYQS 423 (429)
Q Consensus 386 --------------------~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~~ 423 (429)
+.++.++.+||++||+.||++|||+.|+|+|+||....
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 289 (324)
T 3mtl_A 232 EEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLG 289 (324)
T ss_dssp HHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGC
T ss_pred hhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcc
Confidence 34789999999999999999999999999999998654
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-49 Score=393.69 Aligned_cols=261 Identities=30% Similarity=0.510 Sum_probs=210.8
Q ss_pred ccccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEe
Q 014210 151 KHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED 230 (429)
Q Consensus 151 ~~~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~ 230 (429)
+.+.++|+++++||+|+||.||+|.... +|+.||||++.+. .......+++.+|+.+++++.+|+||+++++++..
T Consensus 5 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vaiK~i~~~-~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~ 80 (388)
T 3oz6_A 5 RHVLRKYELVKKLGKGAYGIVWKSIDRR---TGEVVAVKKIFDA-FQNSTDAQRTFREIMILTELSGHENIVNLLNVLRA 80 (388)
T ss_dssp HHHHTTEEEEEC-------CEEEEEETT---TCCEEEEEEECC---CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred CcccCceEEEEEeeeCCCeEEEEEEECC---CCCEEEEEEeccc-ccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEec
Confidence 4567899999999999999999998776 6899999998654 34456667888999999999889999999999986
Q ss_pred CC--eEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecC
Q 014210 231 TD--NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFG 308 (429)
Q Consensus 231 ~~--~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFG 308 (429)
.+ .+|||||||+ ++|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||
T Consensus 81 ~~~~~~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll---~~~~~~kl~DFG 154 (388)
T 3oz6_A 81 DNDRDVYLVFDYME-TDLHAVIRA--NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILL---NAECHVKVADFG 154 (388)
T ss_dssp TTSSCEEEEEECCS-EEHHHHHHH--TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCT
T ss_pred CCCCEEEEEecccC-cCHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEE---cCCCCEEecCCc
Confidence 54 6899999997 588887754 579999999999999999999999999999999999999 788899999999
Q ss_pred CccccCCC----------------------ccccccccCCcccCcccccC--CCCCcccHHHHHHHHHHHHcCCCCCCCC
Q 014210 309 LSDFVRPD----------------------ERLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWAR 364 (429)
Q Consensus 309 la~~~~~~----------------------~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlGvll~elltg~~Pf~~~ 364 (429)
+++..... ......+||+.|+|||++.+ .++.++|||||||++|||++|+.||.+.
T Consensus 155 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 234 (388)
T 3oz6_A 155 LSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGS 234 (388)
T ss_dssp TCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Confidence 99765321 12234689999999998864 5899999999999999999999999998
Q ss_pred ChHHHHHHHHhcCCCCC------------------------------C-------------CCCCCCCHHHHHHHHHhcc
Q 014210 365 TESGIFRAVLKADPSFD------------------------------E-------------APWPSLSSEARDFVKRLLN 401 (429)
Q Consensus 365 ~~~~~~~~i~~~~~~~~------------------------------~-------------~~~~~~s~~~~~li~~~L~ 401 (429)
.....+..++....... . .....+++++.+||++||+
T Consensus 235 ~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~ 314 (388)
T 3oz6_A 235 STMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQ 314 (388)
T ss_dssp SHHHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCC
T ss_pred CHHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhc
Confidence 88777776654211100 0 0122678999999999999
Q ss_pred cCccCcCCHHHHHhhHhhhc
Q 014210 402 KDPRKRLTAAQALSELLICY 421 (429)
Q Consensus 402 ~dP~~Rps~~~iL~~~~~~~ 421 (429)
.||++|||+.|+|+|+||..
T Consensus 315 ~dP~~R~t~~e~l~Hp~~~~ 334 (388)
T 3oz6_A 315 FNPNKRISANDALKHPFVSI 334 (388)
T ss_dssp SSGGGSCCHHHHTTSTTTTT
T ss_pred cCcccCCCHHHHhCCHHHHH
Confidence 99999999999999999864
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=388.62 Aligned_cols=254 Identities=33% Similarity=0.561 Sum_probs=203.8
Q ss_pred cCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~ 233 (429)
.++|+++++||+|+||.||+++... +|+.||||++....... +.+.+|+.++++++ ||||+++++++.+.+.
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~----~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~ 90 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKL---TKELVAVKYIERGAAID----ENVQREIINHRSLR-HPNIVRFKEVILTPTH 90 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETT---TCCEEEEEEEESSTTSC----HHHHHHHHHHHHCC-CTTBCCEEEEEECSSE
T ss_pred CCcEEEEEEeccCCCEEEEEEEECC---CCcEEEEEEEecCcccc----HHHHHHHHHHHhCC-CCCCCcEEEEEeeCCE
Confidence 5789999999999999999999775 58999999997543322 55789999999998 9999999999999999
Q ss_pred EEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCc--eEEEeecCCcc
Q 014210 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENS--VLKAIDFGLSD 311 (429)
Q Consensus 234 ~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~--~vkL~DFGla~ 311 (429)
.+||||||++|+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||+ +.++ .+||+|||+++
T Consensus 91 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill---~~~~~~~~kl~Dfg~a~ 166 (361)
T 3uc3_A 91 LAIIMEYASGGELYERICNA-GRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLL---DGSPAPRLKICDFGYSK 166 (361)
T ss_dssp EEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEE---CSSSSCCEEECCCCCC-
T ss_pred EEEEEEeCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---cCCCCceEEEeecCccc
Confidence 99999999999999988554 579999999999999999999999999999999999999 4444 49999999998
Q ss_pred ccCCCccccccccCCcccCcccccC-CCCCc-ccHHHHHHHHHHHHcCCCCCCCCCh----HHHHHHHHhcCCCCCCCCC
Q 014210 312 FVRPDERLNDIVGSAYYVAPEVLHR-SYSTE-ADVWSIGVIAYILLCGSRPFWARTE----SGIFRAVLKADPSFDEAPW 385 (429)
Q Consensus 312 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~-sDiwSlGvll~elltg~~Pf~~~~~----~~~~~~i~~~~~~~~~~~~ 385 (429)
...........+||+.|+|||++.+ .+..+ +|||||||++|+|++|+.||..... ...+..+......++. .
T Consensus 167 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~--~ 244 (361)
T 3uc3_A 167 SSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPD--D 244 (361)
T ss_dssp --------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCT--T
T ss_pred cccccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCC--c
Confidence 6554555566789999999998864 45554 8999999999999999999976543 3444445444433332 2
Q ss_pred CCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhc
Q 014210 386 PSLSSEARDFVKRLLNKDPRKRLTAAQALSELLICY 421 (429)
Q Consensus 386 ~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~ 421 (429)
..+++++.+||++||+.||++|||+.++++|+||..
T Consensus 245 ~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~ 280 (361)
T 3uc3_A 245 IRISPECCHLISRIFVADPATRISIPEIKTHSWFLK 280 (361)
T ss_dssp SCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHT
T ss_pred CCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhc
Confidence 368999999999999999999999999999999954
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-49 Score=375.82 Aligned_cols=265 Identities=37% Similarity=0.673 Sum_probs=224.2
Q ss_pred ccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCc---HHHHHHHHHHHHHHHHhcCCCCcceEEEEEE
Q 014210 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTT---AIAIEDVRREVKILRALTGHNNLVKFFDAYE 229 (429)
Q Consensus 153 ~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~---~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~ 229 (429)
+.++|++.+.||+|+||.||+++... +|+.||||++....... ....+.+.+|+.++++++ |+||+++++++.
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~ 78 (283)
T 3bhy_A 3 VEDHYEMGEELGSGQFAIVRKCRQKG---TGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIR-HPNIITLHDIFE 78 (283)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCC-CTTBCCEEEEEE
T ss_pred hhhhhhhHHhhcccCceEEEEEEEcC---CCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCC-CCCeeehhheec
Confidence 35789999999999999999998775 58999999986543222 123577899999999998 999999999999
Q ss_pred eCCeEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecC-CCceEEEeecC
Q 014210 230 DTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKD-ENSVLKAIDFG 308 (429)
Q Consensus 230 ~~~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~-~~~~vkL~DFG 308 (429)
+.+..++||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+...+ .+..+||+|||
T Consensus 79 ~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg 157 (283)
T 3bhy_A 79 NKTDVVLILELVSGGELFDFLAE-KESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFG 157 (283)
T ss_dssp CSSEEEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred CCCeEEEEEeecCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecc
Confidence 99999999999999999998854 45799999999999999999999999999999999999994322 12379999999
Q ss_pred CccccCCCccccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCC
Q 014210 309 LSDFVRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPS 387 (429)
Q Consensus 309 la~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 387 (429)
++.............|++.|+|||++. +.++.++||||||+++|+|++|+.||........+..+...........+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (283)
T 3bhy_A 158 IAHKIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSN 237 (283)
T ss_dssp TCEECC--------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTT
T ss_pred cceeccCCCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhccc
Confidence 998776555556678999999999887 4689999999999999999999999999888888877776665555444467
Q ss_pred CCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhcc
Q 014210 388 LSSEARDFVKRLLNKDPRKRLTAAQALSELLICYQ 422 (429)
Q Consensus 388 ~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~ 422 (429)
++.++.+||++||+.||++||++.++|+|+||+..
T Consensus 238 ~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 272 (283)
T 3bhy_A 238 TSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAI 272 (283)
T ss_dssp CCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHH
T ss_pred CCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHH
Confidence 89999999999999999999999999999999754
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-49 Score=386.73 Aligned_cols=260 Identities=29% Similarity=0.464 Sum_probs=221.1
Q ss_pred cCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEe---
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED--- 230 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~--- 230 (429)
.++|+++++||+|+||.||+|+... +|+.||||++...... ......+.+|++++++++ |+||+++++++.+
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~ 90 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRK---TGQKVALKKVLMENEK-EGFPITALREIKILQLLK-HENVVNLIEICRTKAS 90 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETT---TCCEEEEEECCCSSCS-SSSCHHHHHHHHHHHHCC-CTTBCCEEEEEEEC--
T ss_pred ccceeEEEEEecCCCcEEEEEEECC---CCCEEEEEEEeccccc-ccchHHHHHHHHHHHhcc-CCCcccHhheeecccc
Confidence 4789999999999999999999766 5899999998665422 223356779999999998 9999999999987
Q ss_pred -----CCeEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEe
Q 014210 231 -----TDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAI 305 (429)
Q Consensus 231 -----~~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~ 305 (429)
.+.++|||||+++ +|.+.+......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+
T Consensus 91 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~---~~~~~~kl~ 166 (351)
T 3mi9_A 91 PYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLI---TRDGVLKLA 166 (351)
T ss_dssp ------CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEEC
T ss_pred ccccCCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEE---cCCCCEEEc
Confidence 4568999999975 8888887777789999999999999999999999999999999999999 778899999
Q ss_pred ecCCccccCCC-----ccccccccCCcccCcccccC--CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCC
Q 014210 306 DFGLSDFVRPD-----ERLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADP 378 (429)
Q Consensus 306 DFGla~~~~~~-----~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~ 378 (429)
|||++...... .......||+.|+|||++.+ .++.++|||||||++|||++|+.||........+..+.....
T Consensus 167 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~ 246 (351)
T 3mi9_A 167 DFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCG 246 (351)
T ss_dssp CCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred cchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Confidence 99999765422 22345678999999998864 489999999999999999999999999988888777766544
Q ss_pred CCCCCCCCCC----------------------------CHHHHHHHHHhcccCccCcCCHHHHHhhHhhhcc
Q 014210 379 SFDEAPWPSL----------------------------SSEARDFVKRLLNKDPRKRLTAAQALSELLICYQ 422 (429)
Q Consensus 379 ~~~~~~~~~~----------------------------s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~ 422 (429)
......++.+ ++++.+||++||+.||++|||+.|+|+|+||...
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 318 (351)
T 3mi9_A 247 SITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSD 318 (351)
T ss_dssp CCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSS
T ss_pred CCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCC
Confidence 4444433332 7889999999999999999999999999999754
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-49 Score=402.99 Aligned_cols=267 Identities=32% Similarity=0.589 Sum_probs=214.5
Q ss_pred ccccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcC-----cHHHHHHHHHHHHHHHHhcCCCCcceEE
Q 014210 151 KHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMT-----TAIAIEDVRREVKILRALTGHNNLVKFF 225 (429)
Q Consensus 151 ~~~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~-----~~~~~~~~~~Ei~il~~l~~h~nIv~l~ 225 (429)
+.+.++|++.++||+|+||.||+|.... +|+.||||++.+.... .......+.+|+.++++++ ||||++++
T Consensus 131 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~ 206 (419)
T 3i6u_A 131 KALRDEYIMSKTLGSGACGEVKLAFERK---TCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLN-HPCIIKIK 206 (419)
T ss_dssp HHHHTTEEEEEEEEECSSSEEEEEEETT---TCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCC-CTTBCCCC
T ss_pred hhhhccEEEEeEEeeCCCeEEEEEEECC---CCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCC-CCCEeeEE
Confidence 4457899999999999999999998776 6899999998654322 1222345789999999998 99999999
Q ss_pred EEEEeCCeEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEe
Q 014210 226 DAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAI 305 (429)
Q Consensus 226 ~~~~~~~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~ 305 (429)
+++. .+..+||||||++|+|.+++. ..+.+++..++.++.||+.||.|||++||+||||||+|||++..+++..+||+
T Consensus 207 ~~~~-~~~~~lv~e~~~~g~L~~~l~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~ 284 (419)
T 3i6u_A 207 NFFD-AEDYYIVLELMEGGELFDKVV-GNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKIT 284 (419)
T ss_dssp EEEE-SSEEEEEEECCTTCBGGGGTS-SSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEEC
T ss_pred EEEe-cCceEEEEEcCCCCcHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEe
Confidence 9985 456899999999999988764 45679999999999999999999999999999999999999765666789999
Q ss_pred ecCCccccCCCccccccccCCcccCccccc----CCCCCcccHHHHHHHHHHHHcCCCCCCCCChH-HHHHHHHhcCCCC
Q 014210 306 DFGLSDFVRPDERLNDIVGSAYYVAPEVLH----RSYSTEADVWSIGVIAYILLCGSRPFWARTES-GIFRAVLKADPSF 380 (429)
Q Consensus 306 DFGla~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~sDiwSlGvll~elltg~~Pf~~~~~~-~~~~~i~~~~~~~ 380 (429)
|||+++...........+||+.|+|||++. ..++.++|||||||++|+|++|+.||...... .....+......+
T Consensus 285 DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~ 364 (419)
T 3i6u_A 285 DFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNF 364 (419)
T ss_dssp CSSTTTSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCC
T ss_pred ecccceecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCC
Confidence 999999877666666788999999999874 35788999999999999999999999765433 3344444444444
Q ss_pred CCCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhccc
Q 014210 381 DEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLICYQS 423 (429)
Q Consensus 381 ~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~~ 423 (429)
....+..++.++.+||++||+.||++||++.++|+|+||+...
T Consensus 365 ~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 407 (419)
T 3i6u_A 365 IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDED 407 (419)
T ss_dssp CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCCHH
T ss_pred CchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCChh
Confidence 4444567899999999999999999999999999999998643
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-48 Score=377.53 Aligned_cols=261 Identities=28% Similarity=0.475 Sum_probs=214.5
Q ss_pred cCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~ 233 (429)
.++|+++++||+|+||.||+|+... +|+.||||++.... ......+.+.+|+.++++++ |+||+++++++.+.+.
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~ 76 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRD---TGQIVAIKKFLESE-DDPVIKKIALREIRMLKQLK-HPNLVNLLEVFRRKRR 76 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEECCCC-C-HHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEETTE
T ss_pred cccceEeeEEeecCCeEEEEEEeCC---CCcEEEEEEeeccc-cchHHHHHHHHHHHHHHhCC-CCCccchhheeecCCe
Confidence 4689999999999999999998766 58999999986643 34455677889999999998 9999999999999999
Q ss_pred EEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCcccc
Q 014210 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (429)
Q Consensus 234 ~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~ 313 (429)
.++||||+++++|.+++ ...+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++...
T Consensus 77 ~~lv~e~~~~~~l~~~~-~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~ 152 (311)
T 4agu_A 77 LHLVFEYCDHTVLHELD-RYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILI---TKHSVIKLCDFGFARLL 152 (311)
T ss_dssp EEEEEECCSEEHHHHHH-HTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEEC
T ss_pred EEEEEEeCCCchHHHHH-hhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEE---cCCCCEEEeeCCCchhc
Confidence 99999999998877755 455679999999999999999999999999999999999999 77889999999999876
Q ss_pred CCC-ccccccccCCcccCcccccC--CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCC-----------
Q 014210 314 RPD-ERLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPS----------- 379 (429)
Q Consensus 314 ~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~----------- 379 (429)
... .......||..|+|||++.+ .++.++||||||+++|+|++|+.||......+.+..+.+....
T Consensus 153 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (311)
T 4agu_A 153 TGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFST 232 (311)
T ss_dssp C------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHT
T ss_pred cCcccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccc
Confidence 533 23345689999999998863 5899999999999999999999999888877666554432110
Q ss_pred --------CCC--------CCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhccc
Q 014210 380 --------FDE--------APWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLICYQS 423 (429)
Q Consensus 380 --------~~~--------~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~~ 423 (429)
.+. ..++.++.++.+||++||+.||++|||+.++|+|+||+...
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 292 (311)
T 4agu_A 233 NQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIR 292 (311)
T ss_dssp CGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred ccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhcc
Confidence 000 01246889999999999999999999999999999998654
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-48 Score=374.75 Aligned_cols=263 Identities=27% Similarity=0.419 Sum_probs=219.5
Q ss_pred cccccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEE
Q 014210 150 SKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYE 229 (429)
Q Consensus 150 ~~~~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~ 229 (429)
++.+.++|++++.||+|+||.||+++... +|+.||||++...........+.+.+|+.++++++ ||||+++++++.
T Consensus 6 g~~~~~~y~i~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-hp~iv~~~~~~~ 81 (294)
T 4eqm_A 6 GKIINERYKIVDKLGGGGMSTVYLAEDTI---LNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLS-HQNIVSMIDVDE 81 (294)
T ss_dssp SSCEETTEEEEEEEEEETTEEEEEEEETT---TCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCC-BTTBCCEEEEEE
T ss_pred hhHhhccEEEEEEEccCCCEEEEEEEECC---CCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCC-CCCCceEEEeee
Confidence 45677899999999999999999998765 58999999997766666777889999999999998 999999999999
Q ss_pred eCCeEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCC
Q 014210 230 DTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGL 309 (429)
Q Consensus 230 ~~~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGl 309 (429)
+++..++||||++|++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+
T Consensus 82 ~~~~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~---~~~~~~kl~Dfg~ 157 (294)
T 4eqm_A 82 EDDCYYLVMEYIEGPTLSEYIESH-GPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILI---DSNKTLKIFDFGI 157 (294)
T ss_dssp CSSEEEEEEECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEECCCSS
T ss_pred eCCeEEEEEeCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEEeCCC
Confidence 999999999999999999988654 579999999999999999999999999999999999999 7788999999999
Q ss_pred ccccCCCc--cccccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCC-CCCCCC
Q 014210 310 SDFVRPDE--RLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPS-FDEAPW 385 (429)
Q Consensus 310 a~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~-~~~~~~ 385 (429)
+....... ......||+.|+|||++.+ .++.++||||||+++|+|++|+.||.................. ......
T Consensus 158 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (294)
T 4eqm_A 158 AKALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVR 237 (294)
T ss_dssp STTC-------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSC
T ss_pred ccccccccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcc
Confidence 98765432 2344679999999998874 5888999999999999999999999988877665555544322 222334
Q ss_pred CCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhh
Q 014210 386 PSLSSEARDFVKRLLNKDPRKRLTAAQALSELLIC 420 (429)
Q Consensus 386 ~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~ 420 (429)
+.++.++.++|.+||..||++||+..+.+.+.|..
T Consensus 238 ~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~ 272 (294)
T 4eqm_A 238 KDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSS 272 (294)
T ss_dssp TTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHT
T ss_pred cCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHH
Confidence 57899999999999999999999666666665543
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-48 Score=371.32 Aligned_cols=260 Identities=33% Similarity=0.579 Sum_probs=216.9
Q ss_pred ccccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEe
Q 014210 151 KHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED 230 (429)
Q Consensus 151 ~~~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~ 230 (429)
+...++|++.+.||+|+||.||+|+... +|+.||||++...........+.+.+|+.+++.++ |+||+++++++.+
T Consensus 7 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~ 82 (276)
T 2h6d_A 7 RVKIGHYVLGDTLGVGTFGKVKIGEHQL---TGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFR-HPHIIKLYQVIST 82 (276)
T ss_dssp CCEETTEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCC-CTTBCCEEEEEEC
T ss_pred cceeccEEEEeeecCCCCeEEEEEEECC---CCceEEEEEeccccccchhHHHHHHHHHHHHhcCC-CCCEeEEEEEEec
Confidence 3446899999999999999999998765 58999999986433223334567899999999998 9999999999999
Q ss_pred CCeEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCc
Q 014210 231 TDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS 310 (429)
Q Consensus 231 ~~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla 310 (429)
.+..++||||+++++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 83 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~~l~dfg~~ 158 (276)
T 2h6d_A 83 PTDFFMVMEYVSGGELFDYICKH-GRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLL---DAHMNAKIADFGLS 158 (276)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEE---CTTSCEEECCCCGG
T ss_pred CCeEEEEEeccCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEE---CCCCCEEEeecccc
Confidence 99999999999999999988654 569999999999999999999999999999999999999 77889999999999
Q ss_pred cccCCCccccccccCCcccCcccccCC-C-CCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCC
Q 014210 311 DFVRPDERLNDIVGSAYYVAPEVLHRS-Y-STEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSL 388 (429)
Q Consensus 311 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~-~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 388 (429)
.............|++.|+|||++.+. + +.++||||||+++|+|++|+.||........+..+.......+ ..+
T Consensus 159 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~ 234 (276)
T 2h6d_A 159 NMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIP----EYL 234 (276)
T ss_dssp GCCCC-------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTS
T ss_pred cccCCCcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccCc----hhc
Confidence 887665555567899999999998754 3 5789999999999999999999998887777777766554433 357
Q ss_pred CHHHHHHHHHhcccCccCcCCHHHHHhhHhhhcc
Q 014210 389 SSEARDFVKRLLNKDPRKRLTAAQALSELLICYQ 422 (429)
Q Consensus 389 s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~ 422 (429)
+.++.+||.+||+.||++||++.++++|+||+..
T Consensus 235 ~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~ 268 (276)
T 2h6d_A 235 NRSVATLLMHMLQVDPLKRATIKDIREHEWFKQD 268 (276)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHTT
T ss_pred CHHHHHHHHHHccCChhhCCCHHHHHhChhhccC
Confidence 8999999999999999999999999999999764
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-48 Score=379.85 Aligned_cols=258 Identities=24% Similarity=0.353 Sum_probs=220.9
Q ss_pred cccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeC
Q 014210 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (429)
Q Consensus 152 ~~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~ 231 (429)
...++|++.+.||+|+||.||+|+.......+..||||++... ......+.+.+|+.++++++ |+||+++++++.+.
T Consensus 46 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~ 122 (325)
T 3kul_A 46 IEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAG--YTERQRRDFLSEASIMGQFD-HPNIIRLEGVVTRG 122 (325)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTT--CCHHHHHHHHHHHHHHTTCC-CTTBCCEEEEECGG
T ss_pred cChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCC--CCHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEEeC
Confidence 3467899999999999999999998765445678999999654 34556678999999999998 99999999999999
Q ss_pred CeEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCcc
Q 014210 232 DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (429)
Q Consensus 232 ~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~ 311 (429)
+..+|||||+++++|.+++....+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++
T Consensus 123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~a~ 199 (325)
T 3kul_A 123 RLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLV---DSNLVCKVSDFGLSR 199 (325)
T ss_dssp GCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCSSCE
T ss_pred CccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEE---CCCCCEEECCCCccc
Confidence 99999999999999999987777789999999999999999999999999999999999999 788899999999998
Q ss_pred ccCCCcc----ccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCCCC
Q 014210 312 FVRPDER----LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPW 385 (429)
Q Consensus 312 ~~~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 385 (429)
....... .....+|..|+|||++. +.++.++||||||+++|||++ |+.||...........+....... ..
T Consensus 200 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~---~~ 276 (325)
T 3kul_A 200 VLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLP---AP 276 (325)
T ss_dssp ECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCC---CC
T ss_pred ccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCC---CC
Confidence 7654321 22334677899999887 568999999999999999999 999999998888877776653221 22
Q ss_pred CCCCHHHHHHHHHhcccCccCcCCHHHHHhhHh
Q 014210 386 PSLSSEARDFVKRLLNKDPRKRLTAAQALSELL 418 (429)
Q Consensus 386 ~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~ 418 (429)
..++.++.+||..||+.||++||++.++++.+-
T Consensus 277 ~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~ 309 (325)
T 3kul_A 277 MGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLD 309 (325)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCcCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 468999999999999999999999999998664
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-49 Score=376.40 Aligned_cols=258 Identities=32% Similarity=0.570 Sum_probs=198.3
Q ss_pred cCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~ 233 (429)
.++|++.+.||+|+||.||+|+... +|+.||||++...........+.+.+|+.++++++ |+||+++++++.+.+.
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~ 85 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIH---TGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLK-HPSILELYNYFEDSNY 85 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBC-CTTBCCEEEEEECSSE
T ss_pred cccceeeeeecCCCceEEEEEEEcc---CCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCC-CCCeEeEEEEEccCCe
Confidence 3679999999999999999998765 58999999986433222333577899999999998 9999999999999999
Q ss_pred EEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCcccc
Q 014210 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (429)
Q Consensus 234 ~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~ 313 (429)
.++||||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++...
T Consensus 86 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili---~~~~~~kl~dfg~~~~~ 162 (278)
T 3cok_A 86 VYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLL---TRNMNIKIADFGLATQL 162 (278)
T ss_dssp EEEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEE---CTTCCEEECCCTTCEEC
T ss_pred EEEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---cCCCCEEEEeecceeec
Confidence 999999999999999987776789999999999999999999999999999999999999 77889999999999876
Q ss_pred CCC-ccccccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHH
Q 014210 314 RPD-ERLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSE 391 (429)
Q Consensus 314 ~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 391 (429)
... .......||+.|+|||++.+ .++.++||||||+++|+|++|+.||........+..+...... ....++.+
T Consensus 163 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~----~~~~~~~~ 238 (278)
T 3cok_A 163 KMPHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYE----MPSFLSIE 238 (278)
T ss_dssp C----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSSCCC----CCTTSCHH
T ss_pred cCCCCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhcccC----CccccCHH
Confidence 432 23345679999999998874 5888999999999999999999999876655544443332222 22358999
Q ss_pred HHHHHHHhcccCccCcCCHHHHHhhHhhhcc
Q 014210 392 ARDFVKRLLNKDPRKRLTAAQALSELLICYQ 422 (429)
Q Consensus 392 ~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~ 422 (429)
+.+||.+||+.||++||++.++|+|+||...
T Consensus 239 ~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 269 (278)
T 3cok_A 239 AKDLIHQLLRRNPADRLSLSSVLDHPFMSRN 269 (278)
T ss_dssp HHHHHHHHSCSSGGGSCCHHHHTTSTTTC--
T ss_pred HHHHHHHHcccCHhhCCCHHHHhcCccccCC
Confidence 9999999999999999999999999999764
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-48 Score=378.80 Aligned_cols=255 Identities=30% Similarity=0.545 Sum_probs=220.1
Q ss_pred ceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEE
Q 014210 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVY 235 (429)
Q Consensus 156 ~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~~ 235 (429)
.|+..+.||+|+||.||+|+... +|+.||||++.... ....+.+.+|+.++++++ |+||+++++++...+..+
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~---~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~ 118 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKH---SGRQVAVKMMDLRK---QQRRELLFNEVVIMRDYQ-HFNVVEMYKSYLVGEELW 118 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEETTT---CCSHHHHHHHHHHHTTCC-CTTBCCEEEEEEETTEEE
T ss_pred hhhccEEeccCCCeEEEEEEECC---CCcEEEEEEEeccc---hhHHHHHHHHHHHHHhCC-CCCcceEEEEEEECCEEE
Confidence 47888899999999999998765 58999999986543 233467889999999998 999999999999999999
Q ss_pred EEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccccCC
Q 014210 236 VVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP 315 (429)
Q Consensus 236 lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~ 315 (429)
+||||+++++|.+++. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.....
T Consensus 119 lv~e~~~~~~L~~~l~--~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~~~~~~~ 193 (321)
T 2c30_A 119 VLMEFLQGGALTDIVS--QVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILL---TLDGRVKLSDFGFCAQISK 193 (321)
T ss_dssp EEECCCCSCBHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCCTTCEECCS
T ss_pred EEEecCCCCCHHHHHH--hcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCcEEEeeeeeeeeccc
Confidence 9999999999998763 3579999999999999999999999999999999999999 7788999999999987654
Q ss_pred Cc-cccccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHH
Q 014210 316 DE-RLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEAR 393 (429)
Q Consensus 316 ~~-~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 393 (429)
.. ......||+.|+|||++.+ .++.++||||||+++|||++|+.||........+..+........ .....+++++.
T Consensus 194 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~ 272 (321)
T 2c30_A 194 DVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKL-KNSHKVSPVLR 272 (321)
T ss_dssp SSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCC-TTGGGSCHHHH
T ss_pred CccccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCc-CccccCCHHHH
Confidence 32 3356689999999998864 689999999999999999999999998887777766665443221 22345889999
Q ss_pred HHHHHhcccCccCcCCHHHHHhhHhhhccc
Q 014210 394 DFVKRLLNKDPRKRLTAAQALSELLICYQS 423 (429)
Q Consensus 394 ~li~~~L~~dP~~Rps~~~iL~~~~~~~~~ 423 (429)
+||.+||+.||++||++.++|+|+||....
T Consensus 273 ~li~~~l~~dp~~Rps~~ell~hp~~~~~~ 302 (321)
T 2c30_A 273 DFLERMLVRDPQERATAQELLDHPFLLQTG 302 (321)
T ss_dssp HHHHHHSCSSTTTSCCHHHHHTSGGGGGCC
T ss_pred HHHHHHccCChhhCcCHHHHhcChhhccCC
Confidence 999999999999999999999999997643
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-49 Score=403.61 Aligned_cols=258 Identities=26% Similarity=0.471 Sum_probs=210.5
Q ss_pred cccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeC
Q 014210 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (429)
Q Consensus 152 ~~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~ 231 (429)
...++|+++++||+|+||.||+|+... +|+.||||++.+. .......+++.+|+.+++.++ |+||+++++++...
T Consensus 59 ~~~~~y~~~~~lG~G~~g~V~~a~~~~---~~~~vAiK~~~~~-~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~ 133 (464)
T 3ttj_A 59 TVLKRYQNLKPIGSGAQGIVCAAYDAV---LDRNVAIKKLSRP-FQNQTHAKRAYRELVLMKCVN-HKNIISLLNVFTPQ 133 (464)
T ss_dssp EEETTEEEEEEEEECSSCEEEEEEETT---TTEEEEEEEEESG-GGSHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSC
T ss_pred eecCCeEEEEEeecCCCeEEEEEEECC---CCCEEEEEEECcc-ccChHHHHHHHHHHHHHHhCC-CCCCCcEEEEEccC
Confidence 346899999999999999999998766 6899999999754 234556678899999999998 99999999999654
Q ss_pred ------CeEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEe
Q 014210 232 ------DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAI 305 (429)
Q Consensus 232 ------~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~ 305 (429)
+.+|||||||++ +|.+.+. ..+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+
T Consensus 134 ~~~~~~~~~~lv~E~~~~-~l~~~~~---~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll---~~~~~~kl~ 206 (464)
T 3ttj_A 134 KTLEEFQDVYLVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKIL 206 (464)
T ss_dssp CSTTTCCEEEEEEECCSE-EHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEEC
T ss_pred CccccCCeEEEEEeCCCC-CHHHHHh---hcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEE---eCCCCEEEE
Confidence 467999999976 5666552 359999999999999999999999999999999999999 788899999
Q ss_pred ecCCccccCCCccccccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCC-----
Q 014210 306 DFGLSDFVRPDERLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPS----- 379 (429)
Q Consensus 306 DFGla~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~----- 379 (429)
|||+++...........+||+.|+|||++.+ .|+.++|||||||++|||++|+.||.+....+.+..+.+....
T Consensus 207 DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~ 286 (464)
T 3ttj_A 207 DFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEF 286 (464)
T ss_dssp CCCCC-----CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred EEEeeeecCCCcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence 9999988766656667899999999998874 6999999999999999999999999998877777666542111
Q ss_pred -----------------CCCCCCC----C------------CCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhc
Q 014210 380 -----------------FDEAPWP----S------------LSSEARDFVKRLLNKDPRKRLTAAQALSELLICY 421 (429)
Q Consensus 380 -----------------~~~~~~~----~------------~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~ 421 (429)
.....++ . .++++.+||++||..||++|||+.|+|+|+||..
T Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~ 361 (464)
T 3ttj_A 287 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINV 361 (464)
T ss_dssp HTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGG
T ss_pred HHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhh
Confidence 1110000 0 1567999999999999999999999999999974
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-48 Score=372.44 Aligned_cols=259 Identities=32% Similarity=0.487 Sum_probs=228.4
Q ss_pred cccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeC
Q 014210 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (429)
Q Consensus 152 ~~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~ 231 (429)
...++|++.+.||+|+||.||+++... +++.||+|++.+.........+.+.+|+.+++.+. |+||+++++++.+.
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~ 87 (294)
T 2rku_A 12 RSRRRYVRGRFLGKGGFAKCFEISDAD---TKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA-HQHVVGFHGFFEDN 87 (294)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEECS
T ss_pred CcccceEEEEEEeecCCEEEEEEEECC---CCceEEEEEechhhccCHHHHHHHHHHHHHHHhCC-CCCEeeeeeeeccC
Confidence 346789999999999999999998776 58899999997765556677788999999999997 99999999999999
Q ss_pred CeEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCcc
Q 014210 232 DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (429)
Q Consensus 232 ~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~ 311 (429)
+..++||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.
T Consensus 88 ~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~dfg~~~ 163 (294)
T 2rku_A 88 DFVFVVLELCRRRSLLELHKR-RKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFL---NEDLEVKIGDFGLAT 163 (294)
T ss_dssp SEEEEEEECCTTCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCE
T ss_pred CEEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEE---cCCCCEEEEeccCce
Confidence 999999999999999987754 4579999999999999999999999999999999999999 778899999999998
Q ss_pred ccCCC-ccccccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCC
Q 014210 312 FVRPD-ERLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLS 389 (429)
Q Consensus 312 ~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 389 (429)
..... .......||..|+|||++.+ .++.++||||||+++|+|++|+.||......+.+..+.......+ ..++
T Consensus 164 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~ 239 (294)
T 2rku_A 164 KVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIP----KHIN 239 (294)
T ss_dssp ECCSTTCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCC----TTSC
T ss_pred ecccCccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccCCCc----cccC
Confidence 76432 33445679999999998874 588899999999999999999999998888777777766554433 3688
Q ss_pred HHHHHHHHHhcccCccCcCCHHHHHhhHhhhcc
Q 014210 390 SEARDFVKRLLNKDPRKRLTAAQALSELLICYQ 422 (429)
Q Consensus 390 ~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~ 422 (429)
.++.+||++||+.||++||++.++++|+||...
T Consensus 240 ~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~ 272 (294)
T 2rku_A 240 PVAASLIQKMLQTDPTARPTINELLNDEFFTSG 272 (294)
T ss_dssp HHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTS
T ss_pred HHHHHHHHHHcccChhhCcCHHHHhhChheecC
Confidence 999999999999999999999999999999754
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-48 Score=386.76 Aligned_cols=267 Identities=19% Similarity=0.288 Sum_probs=225.8
Q ss_pred ccccCceeEeceeeccCceEEEEEEEec--CcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEE
Q 014210 151 KHFANKYELGEEVGRGHFGYTCAAKFKK--GELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAY 228 (429)
Q Consensus 151 ~~~~~~y~~~~~IG~G~fg~V~~~~~~~--~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~ 228 (429)
+...++|+++++||+|+||.||+|+... ...+++.||||++... .......++.+|+.++++++ |+||+++++++
T Consensus 67 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~ 143 (367)
T 3l9p_A 67 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV--CSEQDELDFLMEALIISKFN-HQNIVRCIGVS 143 (367)
T ss_dssp BCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSS--CCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEE
T ss_pred hcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccc--cChhhHHHHHHHHHHHHhCC-CCCCCeEEEEE
Confidence 3446889999999999999999998654 2236889999998643 34556678899999999998 99999999999
Q ss_pred EeCCeEEEEEEecCCCcHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceE
Q 014210 229 EDTDNVYVVMELCEGGELLDRILSRG------GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVL 302 (429)
Q Consensus 229 ~~~~~~~lv~E~~~ggsL~~~i~~~~------~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~v 302 (429)
.+.+..+||||||++|+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++..+.+..+
T Consensus 144 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~ 223 (367)
T 3l9p_A 144 LQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVA 223 (367)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCE
T ss_pred ecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceE
Confidence 99999999999999999999987654 459999999999999999999999999999999999999654566679
Q ss_pred EEeecCCccccCCC---ccccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcC
Q 014210 303 KAIDFGLSDFVRPD---ERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKAD 377 (429)
Q Consensus 303 kL~DFGla~~~~~~---~~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~ellt-g~~Pf~~~~~~~~~~~i~~~~ 377 (429)
||+|||+++..... .......||+.|+|||++. +.++.++|||||||++|||++ |..||........+..+....
T Consensus 224 kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~ 303 (367)
T 3l9p_A 224 KIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGG 303 (367)
T ss_dssp EECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC
T ss_pred EECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence 99999999754221 2233456899999999885 578999999999999999998 999999988888877776654
Q ss_pred CCCCCCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhccc
Q 014210 378 PSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLICYQS 423 (429)
Q Consensus 378 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~~ 423 (429)
.... ...++.++.+||++||+.||++||++.+++++++...+.
T Consensus 304 ~~~~---~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~ 346 (367)
T 3l9p_A 304 RMDP---PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 346 (367)
T ss_dssp CCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CCCC---CccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhC
Confidence 3222 246899999999999999999999999999999987553
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-49 Score=383.82 Aligned_cols=266 Identities=33% Similarity=0.589 Sum_probs=217.8
Q ss_pred ccccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcC-----cHHHHHHHHHHHHHHHHhcCCCCcceEE
Q 014210 151 KHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMT-----TAIAIEDVRREVKILRALTGHNNLVKFF 225 (429)
Q Consensus 151 ~~~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~-----~~~~~~~~~~Ei~il~~l~~h~nIv~l~ 225 (429)
+.+.++|++.+.||+|+||.||+|+... +|+.||||++...... .......+.+|+++++++. |+||++++
T Consensus 6 ~~l~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~ 81 (322)
T 2ycf_A 6 KALRDEYIMSKTLGSGACGEVKLAFERK---TCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLN-HPCIIKIK 81 (322)
T ss_dssp HHHHHHEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEECC---------------CHHHHHHHHHHCC-CTTBCCEE
T ss_pred hhhhhceeEeeEEecCCCEEEEEEEEcC---CCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCC-CCCCceEe
Confidence 3456899999999999999999998766 5899999998754321 2223345889999999997 99999999
Q ss_pred EEEEeCCeEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEe
Q 014210 226 DAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAI 305 (429)
Q Consensus 226 ~~~~~~~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~ 305 (429)
+++..++ .++||||+++++|.+++. ....+++..++.++.||+.||.|||++||+||||||+|||++..+.+..+||+
T Consensus 82 ~~~~~~~-~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~ 159 (322)
T 2ycf_A 82 NFFDAED-YYIVLELMEGGELFDKVV-GNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKIT 159 (322)
T ss_dssp EEEESSS-EEEEEECCTTEETHHHHS-TTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEEC
T ss_pred eEEcCCc-eEEEEecCCCCcHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEc
Confidence 9987665 899999999999998774 45679999999999999999999999999999999999999655555679999
Q ss_pred ecCCccccCCCccccccccCCcccCccccc----CCCCCcccHHHHHHHHHHHHcCCCCCCCCChH-HHHHHHHhcCCCC
Q 014210 306 DFGLSDFVRPDERLNDIVGSAYYVAPEVLH----RSYSTEADVWSIGVIAYILLCGSRPFWARTES-GIFRAVLKADPSF 380 (429)
Q Consensus 306 DFGla~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~sDiwSlGvll~elltg~~Pf~~~~~~-~~~~~i~~~~~~~ 380 (429)
|||++.............||..|+|||++. ..++.++||||||+++|+|++|+.||...... .....+......+
T Consensus 160 Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 239 (322)
T 2ycf_A 160 DFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNF 239 (322)
T ss_dssp CCTTCEECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCC
T ss_pred cCccceecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCcccc
Confidence 999998776555455667999999999873 46889999999999999999999999765433 3334444444333
Q ss_pred CCCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhcc
Q 014210 381 DEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLICYQ 422 (429)
Q Consensus 381 ~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~ 422 (429)
....+..++.++.+||++||+.||++||++.++|+|+||+..
T Consensus 240 ~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~~ 281 (322)
T 2ycf_A 240 IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE 281 (322)
T ss_dssp CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCCH
T ss_pred CchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCCH
Confidence 333345789999999999999999999999999999999754
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-48 Score=371.86 Aligned_cols=258 Identities=28% Similarity=0.563 Sum_probs=224.9
Q ss_pred ccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCC
Q 014210 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (429)
Q Consensus 153 ~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~ 232 (429)
..++|++.+.||+|+||.||+|+... +++.||||++...........+.+.+|++++++++ |+||+++++++.+.+
T Consensus 12 ~~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~ 87 (284)
T 2vgo_A 12 TIDDFDIGRPLGKGKFGNVYLAREKQ---NKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLR-HPNILRMYNYFHDRK 87 (284)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCC-CTTBCCEEEEEECSS
T ss_pred hhhhceeeheecCCCCeEEEEEEEcC---CCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCC-CCCEeeEEEEEEcCC
Confidence 35789999999999999999998765 58899999986433222333467899999999998 999999999999999
Q ss_pred eEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccc
Q 014210 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (429)
Q Consensus 233 ~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~ 312 (429)
..++||||+++++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..
T Consensus 88 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~Dfg~~~~ 163 (284)
T 2vgo_A 88 RIYLMLEFAPRGELYKELQKH-GRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLM---GYKGELKIADFGWSVH 163 (284)
T ss_dssp EEEEEECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEE---CTTCCEEECCCTTCEE
T ss_pred EEEEEEEeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEE---cCCCCEEEeccccccc
Confidence 999999999999999988654 579999999999999999999999999999999999999 7788899999999876
Q ss_pred cCCCccccccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHH
Q 014210 313 VRPDERLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSE 391 (429)
Q Consensus 313 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 391 (429)
... .......|+..|+|||++.+ .++.++||||||+++|+|++|+.||...........+......++ +.++.+
T Consensus 164 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~----~~~~~~ 238 (284)
T 2vgo_A 164 APS-LRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFP----PFLSDG 238 (284)
T ss_dssp CSS-SCBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCC----TTSCHH
T ss_pred Ccc-cccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccccCCC----CcCCHH
Confidence 543 23345679999999998874 589999999999999999999999998888887777777655443 368999
Q ss_pred HHHHHHHhcccCccCcCCHHHHHhhHhhhccc
Q 014210 392 ARDFVKRLLNKDPRKRLTAAQALSELLICYQS 423 (429)
Q Consensus 392 ~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~~ 423 (429)
+.+||++||+.||.+||++.++++|+||+...
T Consensus 239 ~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~ 270 (284)
T 2vgo_A 239 SKDLISKLLRYHPPQRLPLKGVMEHPWVKANS 270 (284)
T ss_dssp HHHHHHHHSCSSGGGSCCHHHHHTCHHHHHHC
T ss_pred HHHHHHHHhhcCHhhCCCHHHHhhCHHHHhhc
Confidence 99999999999999999999999999998643
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-48 Score=387.91 Aligned_cols=257 Identities=25% Similarity=0.452 Sum_probs=213.5
Q ss_pred ccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcC-CCCcceEEEEEEeC
Q 014210 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTG-HNNLVKFFDAYEDT 231 (429)
Q Consensus 153 ~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~-h~nIv~l~~~~~~~ 231 (429)
..++|+++++||+|+||.||++.... |+.||||++.... ......+.+.+|+.++++|.+ |+||+++++++..+
T Consensus 54 ~~~~y~~~~~LG~G~fg~Vy~~~~~~----~~~vaiK~~~~~~-~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~ 128 (390)
T 2zmd_A 54 KGRIYSILKQIGSGGSSKVFQVLNEK----KQIYAIKYVNLEE-ADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD 128 (390)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEECTT----CCEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred cCCceEEEEEEccCCCeEEEEEEcCC----CCEEEEEEEeccc-ccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecC
Confidence 35679999999999999999997543 7899999997654 345667889999999999974 69999999999999
Q ss_pred CeEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCcc
Q 014210 232 DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (429)
Q Consensus 232 ~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~ 311 (429)
+.+||||| +.+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+ + ++.+||+|||+++
T Consensus 129 ~~~~lv~E-~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll---~-~~~~kl~DFG~a~ 202 (390)
T 2zmd_A 129 QYIYMVME-CGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI---V-DGMLKLIDFGIAN 202 (390)
T ss_dssp SEEEEEEE-CCSEEHHHHHHHC-SSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEE---S-SSCEEECCCSSSC
T ss_pred CEEEEEEe-cCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEE---E-CCeEEEEecCccc
Confidence 99999999 5578999988654 579999999999999999999999999999999999999 3 4679999999998
Q ss_pred ccCCCc---cccccccCCcccCcccccC------------CCCCcccHHHHHHHHHHHHcCCCCCCCCCh-HHHHHHHHh
Q 014210 312 FVRPDE---RLNDIVGSAYYVAPEVLHR------------SYSTEADVWSIGVIAYILLCGSRPFWARTE-SGIFRAVLK 375 (429)
Q Consensus 312 ~~~~~~---~~~~~~gt~~y~aPE~~~~------------~~~~~sDiwSlGvll~elltg~~Pf~~~~~-~~~~~~i~~ 375 (429)
...... .....+||+.|+|||++.+ .++.++|||||||++|||++|+.||..... ...+..++.
T Consensus 203 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~ 282 (390)
T 2zmd_A 203 QMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID 282 (390)
T ss_dssp CC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHC
T ss_pred cccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhC
Confidence 765433 2345689999999998853 588899999999999999999999987543 345555554
Q ss_pred cCCCCCCCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhcc
Q 014210 376 ADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLICYQ 422 (429)
Q Consensus 376 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~ 422 (429)
....... ....+.++.+||++||+.||++||++.++|+|+||+.+
T Consensus 283 ~~~~~~~--~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 327 (390)
T 2zmd_A 283 PNHEIEF--PDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 327 (390)
T ss_dssp TTSCCCC--CCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred ccccCCC--CccchHHHHHHHHHHcccChhhCCCHHHHhhCcCcccc
Confidence 4333222 23457899999999999999999999999999999864
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-48 Score=379.85 Aligned_cols=266 Identities=25% Similarity=0.402 Sum_probs=219.5
Q ss_pred ccccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEe
Q 014210 151 KHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED 230 (429)
Q Consensus 151 ~~~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~ 230 (429)
....++|++.++||+|+||.||+|+... +|+.||||++..... ....+.+.+|++++++++ |+||+++++++.+
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~ 78 (319)
T 4euu_A 5 STSNHLWLLSDILGQGATANVFRGRHKK---TGDLFAIKVFNNISF--LRPVDVQMREFEVLKKLN-HKNIVKLFAIEEE 78 (319)
T ss_dssp ECSSEEEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEECGGGG--GSCHHHHHHHHHHHHHCC-CTTBCCEEEEEEC
T ss_pred cCCCCCEEEEEEecCCCCeEEEEEEECC---CCcEEEEEEeccccc--cchHHHHHHHHHHHHhcC-CCCcceEEEEeec
Confidence 3456899999999999999999998776 589999999865432 233567789999999998 9999999999987
Q ss_pred CC--eEEEEEEecCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEee-cCCCceEEEe
Q 014210 231 TD--NVYVVMELCEGGELLDRILSRGG--KYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTT-KDENSVLKAI 305 (429)
Q Consensus 231 ~~--~~~lv~E~~~ggsL~~~i~~~~~--~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~-~~~~~~vkL~ 305 (429)
.+ ..+|||||+++++|.+++..... .+++..++.++.||+.||.|||++||+||||||+|||+.. .+.++.+||+
T Consensus 79 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~ 158 (319)
T 4euu_A 79 TTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLT 158 (319)
T ss_dssp TTTCCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEEC
T ss_pred CCCceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEc
Confidence 65 78999999999999998875433 3999999999999999999999999999999999999843 3456789999
Q ss_pred ecCCccccCCCccccccccCCcccCccccc---------CCCCCcccHHHHHHHHHHHHcCCCCCCCC----ChHHHHHH
Q 014210 306 DFGLSDFVRPDERLNDIVGSAYYVAPEVLH---------RSYSTEADVWSIGVIAYILLCGSRPFWAR----TESGIFRA 372 (429)
Q Consensus 306 DFGla~~~~~~~~~~~~~gt~~y~aPE~~~---------~~~~~~sDiwSlGvll~elltg~~Pf~~~----~~~~~~~~ 372 (429)
|||+++............||..|+|||++. ..++.++|||||||++|||++|+.||... .....+..
T Consensus 159 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~ 238 (319)
T 4euu_A 159 DFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYK 238 (319)
T ss_dssp CCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHH
T ss_pred cCCCceecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHH
Confidence 999998877666666778999999999874 56889999999999999999999999643 23455666
Q ss_pred HHhcCCCCC---------------------CCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhcc
Q 014210 373 VLKADPSFD---------------------EAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLICYQ 422 (429)
Q Consensus 373 i~~~~~~~~---------------------~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~ 422 (429)
++...+... ......++..+.+||++||+.||++||++.|+|+|+--..+
T Consensus 239 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~~ 309 (319)
T 4euu_A 239 IITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH 309 (319)
T ss_dssp HHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHTC
T ss_pred HhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHhh
Confidence 665544211 01112345688999999999999999999999999865443
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-48 Score=405.32 Aligned_cols=259 Identities=27% Similarity=0.428 Sum_probs=225.0
Q ss_pred cCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~ 233 (429)
.++|++.++||+|+||.||+|+.+. +|+.||||++.+.........+.+.+|++++++++ ||||+++++++.+.+.
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~---tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~~~~~~~ 259 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKA---TGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVH-SRFIVSLAYAFETKTD 259 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETT---TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCC-CTTBCCEEEEEECSSE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECC---CCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcC-CCCEeeEEEEEeeCCE
Confidence 4789999999999999999999766 68999999996543333344567889999999998 9999999999999999
Q ss_pred EEEEEEecCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCc
Q 014210 234 VYVVMELCEGGELLDRILSR---GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS 310 (429)
Q Consensus 234 ~~lv~E~~~ggsL~~~i~~~---~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla 310 (429)
+|||||||+||+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 260 l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl---~~~g~vkL~DFGla 336 (543)
T 3c4z_A 260 LCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLL---DDDGNVRISDLGLA 336 (543)
T ss_dssp EEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTSCEEECCCTTC
T ss_pred EEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEE---eCCCCEEEeeccee
Confidence 99999999999999988654 3469999999999999999999999999999999999999 78899999999999
Q ss_pred cccCCCcc-ccccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHcCCCCCCCC----ChHHHHHHHHhcCCCCCCCC
Q 014210 311 DFVRPDER-LNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWAR----TESGIFRAVLKADPSFDEAP 384 (429)
Q Consensus 311 ~~~~~~~~-~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~elltg~~Pf~~~----~~~~~~~~i~~~~~~~~~~~ 384 (429)
+....... ....+||+.|+|||++.+ .++.++|||||||++|||++|+.||... ....+...++.....++
T Consensus 337 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~~p--- 413 (543)
T 3c4z_A 337 VELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYP--- 413 (543)
T ss_dssp EECCTTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCCCC---
T ss_pred eeccCCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccCCC---
Confidence 87654443 345689999999998875 6899999999999999999999999765 33556667776655444
Q ss_pred CCCCCHHHHHHHHHhcccCccCcCC-----HHHHHhhHhhhccc
Q 014210 385 WPSLSSEARDFVKRLLNKDPRKRLT-----AAQALSELLICYQS 423 (429)
Q Consensus 385 ~~~~s~~~~~li~~~L~~dP~~Rps-----~~~iL~~~~~~~~~ 423 (429)
..++.++.+||++||+.||++||+ +.+++.|+||+...
T Consensus 414 -~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i~ 456 (543)
T 3c4z_A 414 -DKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDIS 456 (543)
T ss_dssp -TTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTCC
T ss_pred -cccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCCC
Confidence 368999999999999999999996 58999999998754
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=384.86 Aligned_cols=262 Identities=28% Similarity=0.409 Sum_probs=215.4
Q ss_pred ccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCc--HHHHHHHHHHHHHHHHhcCCCCcceEEEEEEe
Q 014210 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTT--AIAIEDVRREVKILRALTGHNNLVKFFDAYED 230 (429)
Q Consensus 153 ~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~--~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~ 230 (429)
..++|++++.||+|+||.||+|+... +|+.||||++....... ....+.+.+|++++++++ |+||+++++++.+
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~ 83 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKN---TNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELS-HPNIIGLLDAFGH 83 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSS---CCSEEEEEEC------------CTHHHHHHHHHHHCC-CTTBCCEEEEECC
T ss_pred HhcccEEEeEEeecCCEEEEEEEECC---CCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCC-CCCCCeEEEEEee
Confidence 35789999999999999999998765 58999999986533221 112346789999999998 9999999999999
Q ss_pred CCeEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCc
Q 014210 231 TDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS 310 (429)
Q Consensus 231 ~~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla 310 (429)
.+..++||||+++ +|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 84 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~---~~~~~~kl~Dfg~a 159 (346)
T 1ua2_A 84 KSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLL---DENGVLKLADFGLA 159 (346)
T ss_dssp TTCCEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEECCCGGG
T ss_pred CCceEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEE---cCCCCEEEEecccc
Confidence 9999999999976 8888887666789999999999999999999999999999999999999 77889999999999
Q ss_pred cccCCC-ccccccccCCcccCcccccC--CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCC---
Q 014210 311 DFVRPD-ERLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAP--- 384 (429)
Q Consensus 311 ~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~--- 384 (429)
...... .......||+.|+|||++.+ .++.++|||||||++|||++|..||......+.+..+...........
T Consensus 160 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 239 (346)
T 1ua2_A 160 KSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPD 239 (346)
T ss_dssp STTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSS
T ss_pred eeccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhh
Confidence 876433 33455689999999998864 478899999999999999999999999888888777765322211111
Q ss_pred ---------------------CCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhcc
Q 014210 385 ---------------------WPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLICYQ 422 (429)
Q Consensus 385 ---------------------~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~ 422 (429)
+..++.++.+||++||+.||++|||+.|+|+|+||...
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~ 298 (346)
T 1ua2_A 240 MCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR 298 (346)
T ss_dssp TTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSS
T ss_pred hccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcC
Confidence 13567999999999999999999999999999999764
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-48 Score=396.74 Aligned_cols=260 Identities=30% Similarity=0.473 Sum_probs=198.5
Q ss_pred ccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEe--
Q 014210 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED-- 230 (429)
Q Consensus 153 ~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~-- 230 (429)
+.++|+++++||+|+||.||+|+.+. +|+.||||++.+. .......+++.+|+++|++|+ |+|||++++++..
T Consensus 51 ~~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vaiK~i~~~-~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~ 125 (458)
T 3rp9_A 51 IPDRYEIRHLIGTGSYGHVCEAYDKL---EKRVVAIKKILRV-FEDLIDCKRILREIAILNRLN-HDHVVKVLDIVIPKD 125 (458)
T ss_dssp SCTTEEECCC-------CEEEEEECC-----CEEEEEEECST-TSSHHHHHHHHHHHHHHHHCC-CTTBCCEEEECCCSC
T ss_pred cCCCeEEeeEeeecCCeEEEEEEECC---CCcEEEEEEechh-hcCHHHHHHHHHHHHHHHhCC-CCCCCceEEEEecCC
Confidence 45789999999999999999998776 5899999998653 345566788999999999998 9999999999954
Q ss_pred ---CCeEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeec
Q 014210 231 ---TDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDF 307 (429)
Q Consensus 231 ---~~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DF 307 (429)
.+.+||||||+ +++|.+++. ....+++..++.++.||+.||+|||++|||||||||+|||| +.++.+||+||
T Consensus 126 ~~~~~~~~lv~e~~-~~~L~~~~~-~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl---~~~~~~kl~DF 200 (458)
T 3rp9_A 126 VEKFDELYVVLEIA-DSDFKKLFR-TPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLV---NQDCSVKVCDF 200 (458)
T ss_dssp TTTCCCEEEEECCC-SEEHHHHHH-SSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTCCEEECCC
T ss_pred cccCceEEEEEecc-ccchhhhcc-cCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEE---CCCCCEeeccc
Confidence 35799999999 468888774 45679999999999999999999999999999999999999 78889999999
Q ss_pred CCccccCCCc----------------------------cccccccCCcccCccccc--CCCCCcccHHHHHHHHHHHHc-
Q 014210 308 GLSDFVRPDE----------------------------RLNDIVGSAYYVAPEVLH--RSYSTEADVWSIGVIAYILLC- 356 (429)
Q Consensus 308 Gla~~~~~~~----------------------------~~~~~~gt~~y~aPE~~~--~~~~~~sDiwSlGvll~ellt- 356 (429)
|+++...... .....+||+.|+|||++. ..++.++|||||||+||||++
T Consensus 201 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 201 GLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp TTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred ccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 9998764221 234567899999999763 469999999999999999999
Q ss_pred ----------CCCCCCCCCh--------------------HHHHHHHHhc-----------------------CC----C
Q 014210 357 ----------GSRPFWARTE--------------------SGIFRAVLKA-----------------------DP----S 379 (429)
Q Consensus 357 ----------g~~Pf~~~~~--------------------~~~~~~i~~~-----------------------~~----~ 379 (429)
|+.+|.+... .+.+..+.+. .+ .
T Consensus 281 ~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 360 (458)
T 3rp9_A 281 IKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGT 360 (458)
T ss_dssp STTTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCC
T ss_pred ccccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCC
Confidence 6666654331 1222222211 00 0
Q ss_pred CCCCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhcc
Q 014210 380 FDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLICYQ 422 (429)
Q Consensus 380 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~ 422 (429)
.....++.+++++.+||++||..||++|||+.|+|+|+||+..
T Consensus 361 ~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~ 403 (458)
T 3rp9_A 361 DLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEV 403 (458)
T ss_dssp CGGGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred CHHHHCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhc
Confidence 1112245679999999999999999999999999999999864
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=382.23 Aligned_cols=257 Identities=25% Similarity=0.411 Sum_probs=219.3
Q ss_pred cCceeEeceeeccCceEEEEEEEec----CcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEE
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKK----GELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYE 229 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~----~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~ 229 (429)
.++|++++.||+|+||.||+|+... ....+..||||++... ......+++.+|+.+++++.+||||++++++|.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 157 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD--ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 157 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTT--CBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEEC
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCC--cCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEc
Confidence 5789999999999999999998753 1225678999999754 345667889999999999955999999999999
Q ss_pred eCCeEEEEEEecCCCcHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEe
Q 014210 230 DTDNVYVVMELCEGGELLDRILSRG---------------GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFT 294 (429)
Q Consensus 230 ~~~~~~lv~E~~~ggsL~~~i~~~~---------------~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~ 294 (429)
+.+.+||||||+++|+|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 158 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll- 236 (370)
T 2psq_A 158 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV- 236 (370)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE-
T ss_pred cCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEE-
Confidence 9999999999999999999987643 358999999999999999999999999999999999999
Q ss_pred ecCCCceEEEeecCCccccCCCc---cccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHc-CCCCCCCCChHHH
Q 014210 295 TKDENSVLKAIDFGLSDFVRPDE---RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGI 369 (429)
Q Consensus 295 ~~~~~~~vkL~DFGla~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~ellt-g~~Pf~~~~~~~~ 369 (429)
+.++.+||+|||+++...... ......+|+.|+|||++. +.++.++|||||||++|||++ |+.||........
T Consensus 237 --~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~ 314 (370)
T 2psq_A 237 --TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL 314 (370)
T ss_dssp --CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH
T ss_pred --CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 788899999999998664432 223456788999999886 468999999999999999999 9999998887777
Q ss_pred HHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHh
Q 014210 370 FRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELL 418 (429)
Q Consensus 370 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~ 418 (429)
+..+...... .....++.++.+||.+||+.||++||++.++++++-
T Consensus 315 ~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~ 360 (370)
T 2psq_A 315 FKLLKEGHRM---DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 360 (370)
T ss_dssp HHHHHTTCCC---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHhcCCCC---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 7666554322 122468999999999999999999999999998764
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-49 Score=389.41 Aligned_cols=261 Identities=31% Similarity=0.533 Sum_probs=219.7
Q ss_pred cCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcC-cHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCC
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMT-TAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~-~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~ 232 (429)
.++|+++++||+|+||.||+++...+..+|+.||||++.+.... .....+.+.+|+++++++.+|+||+++++++.+.+
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 47899999999999999999998655557999999998653221 12233457789999999977999999999999999
Q ss_pred eEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccc
Q 014210 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (429)
Q Consensus 233 ~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~ 312 (429)
..+||||||++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kl~DfG~a~~ 208 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQR-ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILL---DSNGHVVLTDFGLSKE 208 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEESCSSEEEE
T ss_pred eEEEEeecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCcEEEeeCCCCee
Confidence 999999999999999988654 579999999999999999999999999999999999999 7888999999999986
Q ss_pred cCCCc--cccccccCCcccCcccccC---CCCCcccHHHHHHHHHHHHcCCCCCCCC----ChHHHHHHHHhcCCCCCCC
Q 014210 313 VRPDE--RLNDIVGSAYYVAPEVLHR---SYSTEADVWSIGVIAYILLCGSRPFWAR----TESGIFRAVLKADPSFDEA 383 (429)
Q Consensus 313 ~~~~~--~~~~~~gt~~y~aPE~~~~---~~~~~sDiwSlGvll~elltg~~Pf~~~----~~~~~~~~i~~~~~~~~~~ 383 (429)
..... .....+||+.|+|||++.+ .++.++|||||||++|||++|+.||... ....+...+....+.++
T Consensus 209 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-- 286 (355)
T 1vzo_A 209 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYP-- 286 (355)
T ss_dssp CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCC--
T ss_pred cccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCCCCC--
Confidence 54332 2345689999999999874 3788999999999999999999999643 23444555555554443
Q ss_pred CCCCCCHHHHHHHHHhcccCccCcC-----CHHHHHhhHhhhcc
Q 014210 384 PWPSLSSEARDFVKRLLNKDPRKRL-----TAAQALSELLICYQ 422 (429)
Q Consensus 384 ~~~~~s~~~~~li~~~L~~dP~~Rp-----s~~~iL~~~~~~~~ 422 (429)
..++.++.+||.+||..||++|| ++.++++|+||+..
T Consensus 287 --~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~ 328 (355)
T 1vzo_A 287 --QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKI 328 (355)
T ss_dssp --TTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTC
T ss_pred --cccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcC
Confidence 36899999999999999999999 99999999999864
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-48 Score=383.59 Aligned_cols=258 Identities=26% Similarity=0.485 Sum_probs=214.0
Q ss_pred cccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeC
Q 014210 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (429)
Q Consensus 152 ~~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~ 231 (429)
.+.++|++++.||+|+||.||+|.... +|+.||||++.... ......+++.+|++++++++ |+||+++++++...
T Consensus 22 ~~~~~y~~~~~lG~G~~g~V~~a~~~~---~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~ 96 (367)
T 1cm8_A 22 EVRAVYRDLQPVGSGAYGAVCSAVDGR---TGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMR-HENVIGLLDVFTPD 96 (367)
T ss_dssp CCBSSEEEEEEC------CEEEEEETT---TCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCC-BTTBCCCSEEECSC
T ss_pred eecceEEEeEEeeecCCeEEEEEEECC---CCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCC-CcCCCCceeeEecC
Confidence 346889999999999999999998765 68999999986542 44556678999999999998 99999999999866
Q ss_pred C------eEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEe
Q 014210 232 D------NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAI 305 (429)
Q Consensus 232 ~------~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~ 305 (429)
+ .+|+||||+ +++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll---~~~~~~kl~ 170 (367)
T 1cm8_A 97 ETLDDFTDFYLVMPFM-GTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAV---NEDCELKIL 170 (367)
T ss_dssp SSTTTCCCCEEEEECC-SEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEEC
T ss_pred CccccCceEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEE---cCCCCEEEE
Confidence 3 469999999 7899888754 579999999999999999999999999999999999999 778899999
Q ss_pred ecCCccccCCCccccccccCCcccCcccccC--CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCC----
Q 014210 306 DFGLSDFVRPDERLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPS---- 379 (429)
Q Consensus 306 DFGla~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~---- 379 (429)
|||+++.... .....+||..|+|||++.+ .++.++|||||||++|||++|+.||.+....+.+..+.+....
T Consensus 171 Dfg~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~ 248 (367)
T 1cm8_A 171 DFGLARQADS--EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAE 248 (367)
T ss_dssp CCTTCEECCS--SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHH
T ss_pred eeeccccccc--ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHH
Confidence 9999987643 3455789999999998764 6899999999999999999999999988877776666542111
Q ss_pred -------------------CC----CCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhcc
Q 014210 380 -------------------FD----EAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLICYQ 422 (429)
Q Consensus 380 -------------------~~----~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~ 422 (429)
.. ...++.+++++.+||.+||+.||++|||+.++|+|+||...
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~ 314 (367)
T 1cm8_A 249 FVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 314 (367)
T ss_dssp HHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred HHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhh
Confidence 11 11235679999999999999999999999999999999753
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=379.47 Aligned_cols=261 Identities=26% Similarity=0.375 Sum_probs=217.4
Q ss_pred cccCceeEeceeeccCceEEEEEEEec--CcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEE
Q 014210 152 HFANKYELGEEVGRGHFGYTCAAKFKK--GELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYE 229 (429)
Q Consensus 152 ~~~~~y~~~~~IG~G~fg~V~~~~~~~--~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~ 229 (429)
...++|+++++||+|+||.||+|+... ...+++.||||++... ......+.+.+|++++.++.+||||+++++++.
T Consensus 19 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~ 96 (359)
T 3vhe_A 19 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG--ATHSEHRALMSELKILIHIGHHLNVVNLLGACT 96 (359)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT--CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCc--CCHHHHHHHHHHHHHHHhhcCCcceeeeeeeee
Confidence 346899999999999999999998654 3346899999999754 344556789999999999966999999999998
Q ss_pred eCCe-EEEEEEecCCCcHHHHHHhcCC-----------------------------------------------------
Q 014210 230 DTDN-VYVVMELCEGGELLDRILSRGG----------------------------------------------------- 255 (429)
Q Consensus 230 ~~~~-~~lv~E~~~ggsL~~~i~~~~~----------------------------------------------------- 255 (429)
+.+. .++|||||++|+|.+++.....
T Consensus 97 ~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (359)
T 3vhe_A 97 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDV 176 (359)
T ss_dssp STTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------------
T ss_pred cCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchh
Confidence 8654 8999999999999999875432
Q ss_pred ------------CCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccccCCCc---ccc
Q 014210 256 ------------KYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDE---RLN 320 (429)
Q Consensus 256 ------------~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~---~~~ 320 (429)
.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++....... ...
T Consensus 177 ~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll---~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 253 (359)
T 3vhe_A 177 EEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL---SEKNVVKICDFGLARDIYKDPDYVRKG 253 (359)
T ss_dssp -------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCCGGGSCTTSCTTCEEC-
T ss_pred hhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEE---cCCCcEEEEeccceeeecccccchhcc
Confidence 18999999999999999999999999999999999999 678889999999998664332 233
Q ss_pred ccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHH
Q 014210 321 DIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKR 398 (429)
Q Consensus 321 ~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ 398 (429)
...||..|+|||++. ..++.++||||||+++|||++ |+.||........+...+........ ...+++++.+||.+
T Consensus 254 ~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~ 331 (359)
T 3vhe_A 254 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRA--PDYTTPEMYQTMLD 331 (359)
T ss_dssp -CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCC--CTTCCHHHHHHHHH
T ss_pred ccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCC--CCCCCHHHHHHHHH
Confidence 467889999999886 568999999999999999998 99999877655555444443322221 24688999999999
Q ss_pred hcccCccCcCCHHHHHhhHhh
Q 014210 399 LLNKDPRKRLTAAQALSELLI 419 (429)
Q Consensus 399 ~L~~dP~~Rps~~~iL~~~~~ 419 (429)
||+.||++||++.++++|+--
T Consensus 332 ~l~~dP~~Rps~~ell~~L~~ 352 (359)
T 3vhe_A 332 CWHGEPSQRPTFSELVEHLGN 352 (359)
T ss_dssp HTCSSGGGSCCHHHHHHHHHH
T ss_pred HccCChhhCCCHHHHHHHHHH
Confidence 999999999999999998753
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-47 Score=366.58 Aligned_cols=259 Identities=20% Similarity=0.328 Sum_probs=216.5
Q ss_pred cCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEe---
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED--- 230 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~--- 230 (429)
...|++.++||+|+||.||+|.... ++..||+|++.... ......+.+.+|+.++++++ |+||+++++++..
T Consensus 25 ~~~~~~~~~lg~G~~g~Vy~~~~~~---~~~~va~k~~~~~~-~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~ 99 (290)
T 1t4h_A 25 GRFLKFDIEIGRGSFKTVYKGLDTE---TTVEVAWCELQDRK-LTKSERQRFKEEAEMLKGLQ-HPNIVRFYDSWESTVK 99 (290)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEGGG-SCHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEEESS
T ss_pred ceeEEeeeeccCCCCeEEEEeEecC---CceEEEEEEecchh-hCHHHHHHHHHHHHHHHhCC-CCCeeeeeeeeccccC
Confidence 5679999999999999999998765 58899999986543 34556778999999999998 9999999999876
Q ss_pred -CCeEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC--ceeccCCCCcEEEeecCCCceEEEeec
Q 014210 231 -TDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQG--VVHRDLKPENFLFTTKDENSVLKAIDF 307 (429)
Q Consensus 231 -~~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~--iiHrDIKp~NILl~~~~~~~~vkL~DF 307 (429)
...+++||||+++++|.+++... ..+++..++.++.||+.||.|||++| |+||||||+|||++ +.++.+||+||
T Consensus 100 ~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~--~~~~~~kl~Df 176 (290)
T 1t4h_A 100 GKKCIVLVTELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFIT--GPTGSVKIGDL 176 (290)
T ss_dssp SCEEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEES--STTSCEEECCT
T ss_pred CCceEEEEEEecCCCCHHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEE--CCCCCEEEeeC
Confidence 35689999999999999988543 67999999999999999999999999 99999999999993 26788999999
Q ss_pred CCccccCCCccccccccCCcccCcccccCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCC
Q 014210 308 GLSDFVRPDERLNDIVGSAYYVAPEVLHRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPS 387 (429)
Q Consensus 308 Gla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 387 (429)
|++..... .......||+.|+|||++.+.++.++||||||+++|+|++|+.||.................. .......
T Consensus 177 g~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~ 254 (290)
T 1t4h_A 177 GLATLKRA-SFAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK-PASFDKV 254 (290)
T ss_dssp TGGGGCCT-TSBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCC-CGGGGGC
T ss_pred CCcccccc-cccccccCCcCcCCHHHHhccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCC-ccccCCC
Confidence 99976543 333456799999999999888999999999999999999999999875554444333332211 1112235
Q ss_pred CCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhcc
Q 014210 388 LSSEARDFVKRLLNKDPRKRLTAAQALSELLICYQ 422 (429)
Q Consensus 388 ~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~ 422 (429)
.++++.+||.+||+.||++||++.++|+|+||+.+
T Consensus 255 ~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~~ 289 (290)
T 1t4h_A 255 AIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQEE 289 (290)
T ss_dssp CCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC--
T ss_pred CCHHHHHHHHHHccCChhhCCCHHHHhhCcccccC
Confidence 77999999999999999999999999999999865
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-48 Score=378.93 Aligned_cols=262 Identities=28% Similarity=0.472 Sum_probs=216.4
Q ss_pred cCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~ 233 (429)
.++|++++.||+|+||.||+|+... +|+.||||++.... ......+.+.+|+.++++++ |+||+++++++.+.+.
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~ 98 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKD---TGRIVAIKKFLESD-DDKMVKKIAMREIKLLKQLR-HENLVNLLEVCKKKKR 98 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETT---TCCEEEEEEEESCS-SCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEETTE
T ss_pred hhhheeeeEEeecCCEEEEEEEECC---CCceEEEEEEecCC-CchHHHHHHHHHHHHHhhCC-CCCEeeEEEEeecCCE
Confidence 5789999999999999999998766 58999999986543 34555677889999999998 9999999999999999
Q ss_pred EEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCcccc
Q 014210 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (429)
Q Consensus 234 ~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~ 313 (429)
.++||||+++++|.+++ .....+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++...
T Consensus 99 ~~lv~e~~~~~~l~~~~-~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~ 174 (331)
T 4aaa_A 99 WYLVFEFVDHTILDDLE-LFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILV---SQSGVVKLCDFGFARTL 174 (331)
T ss_dssp EEEEEECCSEEHHHHHH-HSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEECCCTTC---
T ss_pred EEEEEecCCcchHHHHH-hhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEE---cCCCcEEEEeCCCceee
Confidence 99999999987776654 455679999999999999999999999999999999999999 77889999999999765
Q ss_pred CCC-ccccccccCCcccCcccccC--CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCC-----------
Q 014210 314 RPD-ERLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPS----------- 379 (429)
Q Consensus 314 ~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~----------- 379 (429)
... .......||..|+|||++.+ .++.++||||||+++|+|++|+.||......+.+..+......
T Consensus 175 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (331)
T 4aaa_A 175 AAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNK 254 (331)
T ss_dssp ---------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHH
T ss_pred cCCccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhh
Confidence 433 23345679999999998875 5889999999999999999999999988877666555432110
Q ss_pred ---CCC-------------CCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhccce
Q 014210 380 ---FDE-------------APWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLICYQSY 424 (429)
Q Consensus 380 ---~~~-------------~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~~~ 424 (429)
+.. ..++.+++++.+||++||+.||++||++.|+|+|+||+...+
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~ 315 (331)
T 4aaa_A 255 NPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMDGF 315 (331)
T ss_dssp CGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGGGH
T ss_pred ccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccCCh
Confidence 000 012357899999999999999999999999999999987653
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-49 Score=386.10 Aligned_cols=254 Identities=30% Similarity=0.488 Sum_probs=216.1
Q ss_pred cccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcH-----HHHHHHHHHHHHHHHhcCCCCcceEEE
Q 014210 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTA-----IAIEDVRREVKILRALTGHNNLVKFFD 226 (429)
Q Consensus 152 ~~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~-----~~~~~~~~Ei~il~~l~~h~nIv~l~~ 226 (429)
.+.++|++.+.||+|+||.||+|+... +|+.||||++........ ...+.+.+|+.++++++ |+||+++++
T Consensus 21 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~Iv~~~~ 96 (335)
T 3dls_A 21 EYSQKYSTMSPLGSGAFGFVWTAVDKE---KNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVE-HANIIKVLD 96 (335)
T ss_dssp HHHHHEEEEEECSSSSSCSEEEEEETT---TTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCC-CTTBCCEEE
T ss_pred ccccceEEEeEEEecCCEEEEEEEECC---CCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCC-CCCEeeEEE
Confidence 456899999999999999999998766 589999999976543221 13345778999999997 999999999
Q ss_pred EEEeCCeEEEEEEecCCC-cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEe
Q 014210 227 AYEDTDNVYVVMELCEGG-ELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAI 305 (429)
Q Consensus 227 ~~~~~~~~~lv~E~~~gg-sL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~ 305 (429)
++.+.+..++||||+.+| +|.+++. ....+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+
T Consensus 97 ~~~~~~~~~lv~e~~~~g~~l~~~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll---~~~~~~kL~ 172 (335)
T 3dls_A 97 IFENQGFFQLVMEKHGSGLDLFAFID-RHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVI---AEDFTIKLI 172 (335)
T ss_dssp EEECSSEEEEEEECCTTSCBHHHHHH-TCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTSCEEEC
T ss_pred EEeeCCEEEEEEEeCCCCccHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEE---cCCCcEEEe
Confidence 999999999999999776 8888774 45679999999999999999999999999999999999999 778899999
Q ss_pred ecCCccccCCCccccccccCCcccCcccccC-CC-CCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCC
Q 014210 306 DFGLSDFVRPDERLNDIVGSAYYVAPEVLHR-SY-STEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEA 383 (429)
Q Consensus 306 DFGla~~~~~~~~~~~~~gt~~y~aPE~~~~-~~-~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~ 383 (429)
|||++.............||+.|+|||++.+ .+ +.++||||||+++|+|++|+.||..... ... ....
T Consensus 173 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~~----~~~~ 242 (335)
T 3dls_A 173 DFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE------TVE----AAIH 242 (335)
T ss_dssp CCTTCEECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG------GTT----TCCC
T ss_pred ecccceECCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH------HHh----hccC
Confidence 9999988776666667789999999998875 34 7789999999999999999999975322 111 1112
Q ss_pred CCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhccc
Q 014210 384 PWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLICYQS 423 (429)
Q Consensus 384 ~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~~ 423 (429)
....+++++.+||++||+.||++||++.++|+|+||+...
T Consensus 243 ~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~~ 282 (335)
T 3dls_A 243 PPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQPV 282 (335)
T ss_dssp CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTCCC
T ss_pred CCcccCHHHHHHHHHHccCChhhCcCHHHHhcCccccCCc
Confidence 2235899999999999999999999999999999997644
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-48 Score=379.37 Aligned_cols=255 Identities=31% Similarity=0.491 Sum_probs=206.1
Q ss_pred ccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCC
Q 014210 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (429)
Q Consensus 153 ~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~ 232 (429)
+.++|++++.||+|+||.||+|+.+. +|+.||||++.... .....+.+.+|++++++|+ ||||++++++|.+.+
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~---~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~ 77 (332)
T 3qd2_B 4 YLTDFEPIQCMGRGGFGVVFEAKNKV---DDCNYAIKRIRLPN--RELAREKVMREVKALAKLE-HPGIVRYFNAWLETP 77 (332)
T ss_dssp HHHHEEEEEEEECC-CSEEEEEEETT---TCCEEEEEEEECCS--TTTHHHHHHHHHHHHTSCC-CTTBCCEEEEEEECC
T ss_pred hhhcCceeeEecCCCCeEEEEEEEcC---CCcEEEEEEeecCC--chhHHHHHHHHHHHHHhCC-CCCEeeEEEEEEEec
Confidence 45789999999999999999999775 58999999997543 3345578999999999998 999999999987654
Q ss_pred ---------------------------------------------------------eEEEEEEecCCCcHHHHHHhcCC
Q 014210 233 ---------------------------------------------------------NVYVVMELCEGGELLDRILSRGG 255 (429)
Q Consensus 233 ---------------------------------------------------------~~~lv~E~~~ggsL~~~i~~~~~ 255 (429)
..++|||||++++|.+++.....
T Consensus 78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~ 157 (332)
T 3qd2_B 78 PEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS 157 (332)
T ss_dssp SCHHHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCS
T ss_pred cchhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccC
Confidence 38999999999999998865432
Q ss_pred --CCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccccCCCc-------------ccc
Q 014210 256 --KYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDE-------------RLN 320 (429)
Q Consensus 256 --~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~-------------~~~ 320 (429)
...+..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++....... ...
T Consensus 158 ~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~ 234 (332)
T 3qd2_B 158 LEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFF---TMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHT 234 (332)
T ss_dssp GGGSCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCEECSCC--------------CCC
T ss_pred ccchhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEE---eCCCCEEEeecCcccccccchhhcccccccccccccc
Confidence 35777899999999999999999999999999999999 778899999999998765442 223
Q ss_pred ccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHh
Q 014210 321 DIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRL 399 (429)
Q Consensus 321 ~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~ 399 (429)
...||+.|+|||++.+ .++.++||||||+++|||++|..|+.. .......+.... .+ ..+...++++.+||++|
T Consensus 235 ~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~--~~~~~~~~~~~~--~~-~~~~~~~~~~~~li~~~ 309 (332)
T 3qd2_B 235 GQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME--RVRIITDVRNLK--FP-LLFTQKYPQEHMMVQDM 309 (332)
T ss_dssp SCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH--HHHHHHHHHTTC--CC-HHHHHHCHHHHHHHHHH
T ss_pred ccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH--HHHHHHHhhccC--CC-cccccCChhHHHHHHHH
Confidence 4579999999998864 689999999999999999998766421 111222222221 11 11224568899999999
Q ss_pred cccCccCcCCHHHHHhhHhhhc
Q 014210 400 LNKDPRKRLTAAQALSELLICY 421 (429)
Q Consensus 400 L~~dP~~Rps~~~iL~~~~~~~ 421 (429)
|+.||++||++.++|+|+||+.
T Consensus 310 l~~~p~~Rps~~~~l~~~~f~~ 331 (332)
T 3qd2_B 310 LSPSPTERPEATDIIENAIFEN 331 (332)
T ss_dssp HCSSGGGSCCHHHHHHSTTCCC
T ss_pred ccCCCCcCCCHHHHhhchhhhc
Confidence 9999999999999999999974
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-47 Score=376.24 Aligned_cols=258 Identities=25% Similarity=0.445 Sum_probs=210.4
Q ss_pred ccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCC-CCcceEEEEEEeC
Q 014210 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGH-NNLVKFFDAYEDT 231 (429)
Q Consensus 153 ~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h-~nIv~l~~~~~~~ 231 (429)
..++|+++++||+|+||.||++... +++.||||++.... ......+.+.+|+.+++++.+| +||+++++++.++
T Consensus 7 ~~~~y~i~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~ 81 (343)
T 3dbq_A 7 KGRIYSILKQIGSGGSSKVFQVLNE----KKQIYAIKYVNLEE-ADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD 81 (343)
T ss_dssp SSCEEEEEEEESCCSSEEEEEEECT----TSCEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred ecCEEEEEEEEecCCCeEEEEEEeC----CCCEEEEEEeeccc-cchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeC
Confidence 4678999999999999999999763 38899999987643 4456668899999999999832 9999999999999
Q ss_pred CeEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCcc
Q 014210 232 DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (429)
Q Consensus 232 ~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~ 311 (429)
+..+||||+ .+++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+. ++.+||+|||++.
T Consensus 82 ~~~~lv~e~-~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~----~~~~kl~DFG~a~ 155 (343)
T 3dbq_A 82 QYIYMVMEC-GNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV----DGMLKLIDFGIAN 155 (343)
T ss_dssp SEEEEEECC-CSEEHHHHHHH-SCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE----TTEEEECCCSSSC
T ss_pred CEEEEEEeC-CCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE----CCcEEEeeccccc
Confidence 999999995 57899998865 46799999999999999999999999999999999999993 5679999999998
Q ss_pred ccCCCcc---ccccccCCcccCccccc------------CCCCCcccHHHHHHHHHHHHcCCCCCCCCChH-HHHHHHHh
Q 014210 312 FVRPDER---LNDIVGSAYYVAPEVLH------------RSYSTEADVWSIGVIAYILLCGSRPFWARTES-GIFRAVLK 375 (429)
Q Consensus 312 ~~~~~~~---~~~~~gt~~y~aPE~~~------------~~~~~~sDiwSlGvll~elltg~~Pf~~~~~~-~~~~~i~~ 375 (429)
....... ....+||+.|+|||++. +.++.++|||||||++|||++|+.||...... ..+..+..
T Consensus 156 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~ 235 (343)
T 3dbq_A 156 QMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID 235 (343)
T ss_dssp CC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHC
T ss_pred ccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhc
Confidence 7654332 23567999999999874 45788999999999999999999999765433 33444443
Q ss_pred cCCCCCCCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhccc
Q 014210 376 ADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLICYQS 423 (429)
Q Consensus 376 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~~ 423 (429)
..... ......+.++.+||.+||+.||.+|||+.++|+|+|++.+.
T Consensus 236 ~~~~~--~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~ 281 (343)
T 3dbq_A 236 PNHEI--EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 281 (343)
T ss_dssp TTSCC--CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred CCccc--CCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccccC
Confidence 32222 22235678999999999999999999999999999998643
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-47 Score=370.01 Aligned_cols=254 Identities=26% Similarity=0.394 Sum_probs=208.9
Q ss_pred cccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeC
Q 014210 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (429)
Q Consensus 152 ~~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~ 231 (429)
...++|++.++||+|+||.||+|+. .|+.||||++.... ......+++.+|++++++++ |+||+++++++.+.
T Consensus 34 i~~~~y~i~~~lG~G~~g~V~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~ 106 (309)
T 3p86_A 34 IPWCDLNIKEKIGAGSFGTVHRAEW-----HGSDVAVKILMEQD-FHAERVNEFLREVAIMKRLR-HPNIVLFMGAVTQP 106 (309)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEE-----TTEEEEEEEECCCC-CSHHHHHHHHHHHHHHHHCC-CTTBCCEEEEECST
T ss_pred CChhHceeeeEeecCCCeEEEEEEE-----CCCcEEEEEecCCC-CCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEEC
Confidence 3467899999999999999999964 37889999987654 34556678999999999998 99999999999999
Q ss_pred CeEEEEEEecCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHcC--ceeccCCCCcEEEeecCCCceEEEeec
Q 014210 232 DNVYVVMELCEGGELLDRILSRGG--KYTEDDAKAVMIQILNVVAFCHLQG--VVHRDLKPENFLFTTKDENSVLKAIDF 307 (429)
Q Consensus 232 ~~~~lv~E~~~ggsL~~~i~~~~~--~l~~~~~~~i~~qi~~gL~~LH~~~--iiHrDIKp~NILl~~~~~~~~vkL~DF 307 (429)
+..++||||+++|+|.+++..... .+++..++.++.||+.||+|||++| |+||||||+|||+ +.++.+||+||
T Consensus 107 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll---~~~~~~kL~Df 183 (309)
T 3p86_A 107 PNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLV---DKKYTVKVCDF 183 (309)
T ss_dssp TCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEE---CTTCCEEECCC
T ss_pred CceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEE---eCCCcEEECCC
Confidence 999999999999999998865432 3999999999999999999999999 9999999999999 78889999999
Q ss_pred CCccccCCCc-cccccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCC
Q 014210 308 GLSDFVRPDE-RLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPW 385 (429)
Q Consensus 308 Gla~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 385 (429)
|+++...... ......||+.|+|||++.+ .++.++||||||+++|||++|+.||...........+........ ..
T Consensus 184 g~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~--~~ 261 (309)
T 3p86_A 184 GLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLE--IP 261 (309)
T ss_dssp C-----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCC--CC
T ss_pred CCCccccccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC--CC
Confidence 9997654332 2345679999999999874 589999999999999999999999998888777766654433222 22
Q ss_pred CCCCHHHHHHHHHhcccCccCcCCHHHHHhhH
Q 014210 386 PSLSSEARDFVKRLLNKDPRKRLTAAQALSEL 417 (429)
Q Consensus 386 ~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~ 417 (429)
..+++++.+||++||+.||++||++.++++.+
T Consensus 262 ~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L 293 (309)
T 3p86_A 262 RNLNPQVAAIIEGCWTNEPWKRPSFATIMDLL 293 (309)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred ccCCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 46899999999999999999999999999854
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-47 Score=362.01 Aligned_cols=251 Identities=25% Similarity=0.437 Sum_probs=218.9
Q ss_pred cCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~ 233 (429)
.++|++.+.||+|+||.||+++... ++.||||++...... .+++.+|++++++++ |+||+++++++.+.+.
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~ 79 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLN----KDKVAIKTIREGAMS----EEDFIEEAEVMMKLS-HPKLVQLYGVCLEQAP 79 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETT----TEEEEEEEECTTSBC----HHHHHHHHHHHHTCC-CTTBCCEEEEECSSSS
T ss_pred hhhceeeheecCCCccEEEEEEecC----CCeEEEEEecccccC----HHHHHHHHHHHHhCC-CCCEeeEEEEEecCCc
Confidence 4789999999999999999998654 678999999764322 256889999999998 9999999999999999
Q ss_pred EEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCcccc
Q 014210 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (429)
Q Consensus 234 ~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~ 313 (429)
.++||||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++...
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~---~~~~~~kl~Dfg~~~~~ 156 (269)
T 4hcu_A 80 ICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLV---GENQVIKVSDFGMTRFV 156 (269)
T ss_dssp EEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CGGGCEEECCTTGGGGB
T ss_pred eEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEE---cCCCCEEeccccccccc
Confidence 999999999999999997777789999999999999999999999999999999999999 67788999999999876
Q ss_pred CCCc--cccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCC
Q 014210 314 RPDE--RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLS 389 (429)
Q Consensus 314 ~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 389 (429)
.... ......+|..|+|||++. ..++.++||||||+++|+|++ |+.||...........+........ ...++
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~ 233 (269)
T 4hcu_A 157 LDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK---PRLAS 233 (269)
T ss_dssp CCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCC---CTTSC
T ss_pred cccccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCCC---CCcCC
Confidence 5432 223455778899999887 578999999999999999999 9999999888888777766533222 23578
Q ss_pred HHHHHHHHHhcccCccCcCCHHHHHhhHhh
Q 014210 390 SEARDFVKRLLNKDPRKRLTAAQALSELLI 419 (429)
Q Consensus 390 ~~~~~li~~~L~~dP~~Rps~~~iL~~~~~ 419 (429)
.++.+||.+||+.||++||++.++++++.-
T Consensus 234 ~~~~~li~~~l~~~p~~Rps~~~ll~~l~~ 263 (269)
T 4hcu_A 234 THVYQIMNHCWRERPEDRPAFSRLLRQLAE 263 (269)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHHHHHHHccCCcccCcCHHHHHHHHHH
Confidence 999999999999999999999999998754
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=382.04 Aligned_cols=257 Identities=26% Similarity=0.451 Sum_probs=205.8
Q ss_pred ccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCC
Q 014210 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (429)
Q Consensus 153 ~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~ 232 (429)
..++|++++.||+|+||.||+|+... +|+.||||++.... ......+.+.+|+.+++.++ ||||+++++++...+
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~ 97 (371)
T 2xrw_A 23 VLKRYQNLKPIGSGAQGIVCAAYDAI---LERNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVN-HKNIIGLLNVFTPQK 97 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEEECTT-SSHHHHHHHHHHHHHHHHCC-CTTBCCEEEEECSCC
T ss_pred hhhheeEeeeeEecCCEEEEEEEECC---CCceEEEEEecccc-CChHHHHHHHHHHHHHHhcC-CCCccceEEeecccc
Confidence 45899999999999999999998765 58999999987543 34556678899999999998 999999999998665
Q ss_pred ------eEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEee
Q 014210 233 ------NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAID 306 (429)
Q Consensus 233 ------~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~D 306 (429)
..|||||||++ +|.+.+. ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|
T Consensus 98 ~~~~~~~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~---~~~~~~kl~D 170 (371)
T 2xrw_A 98 SLEEFQDVYIVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILD 170 (371)
T ss_dssp STTTCCEEEEEEECCSE-EHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECC
T ss_pred ccccccceEEEEEcCCC-CHHHHHh---hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEE---cCCCCEEEEE
Confidence 78999999975 7888774 458999999999999999999999999999999999999 7788999999
Q ss_pred cCCccccCCCccccccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCC-----
Q 014210 307 FGLSDFVRPDERLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSF----- 380 (429)
Q Consensus 307 FGla~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~----- 380 (429)
||++.............||..|+|||++.+ .++.++|||||||++|+|++|+.||.+....+.+..+++.....
T Consensus 171 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 250 (371)
T 2xrw_A 171 FGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFM 250 (371)
T ss_dssp CCC----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHH
T ss_pred eecccccccccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 999987765555566789999999998874 68999999999999999999999999888877777665432111
Q ss_pred -----------------CCC---------CCCC-------CCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhc
Q 014210 381 -----------------DEA---------PWPS-------LSSEARDFVKRLLNKDPRKRLTAAQALSELLICY 421 (429)
Q Consensus 381 -----------------~~~---------~~~~-------~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~ 421 (429)
... .++. .+.++.+||++||..||++|||+.++|+|+||..
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~ 324 (371)
T 2xrw_A 251 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINV 324 (371)
T ss_dssp TTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHT
T ss_pred HHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhh
Confidence 000 0000 1568999999999999999999999999999974
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-47 Score=363.52 Aligned_cols=261 Identities=21% Similarity=0.341 Sum_probs=213.2
Q ss_pred cccccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEE
Q 014210 150 SKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYE 229 (429)
Q Consensus 150 ~~~~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~ 229 (429)
...+.++|++.++||+|+||.||+|+... +|+.||||++..... ......++.+|+.++.++.+||||+++++++.
T Consensus 6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~ 81 (289)
T 1x8b_A 6 KSRYTTEFHELEKIGSGEFGSVFKCVKRL---DGCIYAIKRSKKPLA-GSVDEQNALREVYAHAVLGQHSHVVRYFSAWA 81 (289)
T ss_dssp CCHHHHHEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEECCCT-TSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEE
T ss_pred cccccchhhhhhhhcCCCceEEEEEEEcC---CCceEEEEEeccccc-ccHHHHHHHHHHHHHHHhCCCCCeeeeeeeee
Confidence 34567899999999999999999998765 589999999876433 33445678899999999955999999999999
Q ss_pred eCCeEEEEEEecCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecC---------
Q 014210 230 DTDNVYVVMELCEGGELLDRILSR---GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKD--------- 297 (429)
Q Consensus 230 ~~~~~~lv~E~~~ggsL~~~i~~~---~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~--------- 297 (429)
+.+..++||||+++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++..+
T Consensus 82 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~ 161 (289)
T 1x8b_A 82 EDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEG 161 (289)
T ss_dssp ETTEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC------------
T ss_pred cCCeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCccccccc
Confidence 999999999999999999988654 36799999999999999999999999999999999999995332
Q ss_pred -------CCceEEEeecCCccccCCCccccccccCCcccCcccccCC--CCCcccHHHHHHHHHHHHcCCCCCCCCChHH
Q 014210 298 -------ENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRS--YSTEADVWSIGVIAYILLCGSRPFWARTESG 368 (429)
Q Consensus 298 -------~~~~vkL~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~sDiwSlGvll~elltg~~Pf~~~~~~~ 368 (429)
....+||+|||++....... ...||..|+|||++.+. ++.++||||||+++|+|++|..++....
T Consensus 162 ~~~~~~~~~~~~kl~Dfg~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~--- 235 (289)
T 1x8b_A 162 DEDDWASNKVMFKIGDLGHVTRISSPQ---VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD--- 235 (289)
T ss_dssp --------CCCEEECCCTTCEETTCSC---CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH---
T ss_pred ccccccCCceEEEEcccccccccCCcc---ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh---
Confidence 45579999999998765432 34699999999998754 5579999999999999999988775432
Q ss_pred HHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhccc
Q 014210 369 IFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLICYQS 423 (429)
Q Consensus 369 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~~ 423 (429)
....+...... .....++.++.+||++||+.||++||++.++|+|+||....
T Consensus 236 ~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 287 (289)
T 1x8b_A 236 QWHEIRQGRLP---RIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSAS 287 (289)
T ss_dssp HHHHHHTTCCC---CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC----
T ss_pred HHHHHHcCCCC---CCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhhc
Confidence 23344333221 12246899999999999999999999999999999998653
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-47 Score=364.85 Aligned_cols=259 Identities=25% Similarity=0.368 Sum_probs=199.0
Q ss_pred ccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCC
Q 014210 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (429)
Q Consensus 153 ~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~ 232 (429)
..++|++.++||+|+||.||+|+... +|+.||||++.... ......+.+.++...++.+. |+||+++++++.+++
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~~~~~~~~~~~~-h~~iv~~~~~~~~~~ 79 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHVP---SGQIMAVKRIRATV-NSQEQKRLLMDLDISMRTVD-CPFTVTFYGALFREG 79 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEEC----CHHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEECSS
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEecC---CCeEEEEEEeeccc-CcHHHHHHHHHHHHHHHhCC-CCeEEEEeeeeeccC
Confidence 45789999999999999999999765 58999999986542 22222333444444455565 999999999999999
Q ss_pred eEEEEEEecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHc-CceeccCCCCcEEEeecCCCceEEEeecC
Q 014210 233 NVYVVMELCEGGELLDRILS---RGGKYTEDDAKAVMIQILNVVAFCHLQ-GVVHRDLKPENFLFTTKDENSVLKAIDFG 308 (429)
Q Consensus 233 ~~~lv~E~~~ggsL~~~i~~---~~~~l~~~~~~~i~~qi~~gL~~LH~~-~iiHrDIKp~NILl~~~~~~~~vkL~DFG 308 (429)
..++||||+++ +|.+++.. .+..+++..++.++.||+.||.|||++ ||+||||||+|||+ +.++.+||+|||
T Consensus 80 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg 155 (290)
T 3fme_A 80 DVWICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLI---NALGQVKMCDFG 155 (290)
T ss_dssp SEEEEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEE---CTTCCEEBCCC-
T ss_pred CEEEEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEE---CCCCCEEEeecC
Confidence 99999999975 88776643 467899999999999999999999998 99999999999999 778899999999
Q ss_pred CccccCCCccccccccCCcccCccccc-----CCCCCcccHHHHHHHHHHHHcCCCCCCCC-ChHHHHHHHHhcCCCCCC
Q 014210 309 LSDFVRPDERLNDIVGSAYYVAPEVLH-----RSYSTEADVWSIGVIAYILLCGSRPFWAR-TESGIFRAVLKADPSFDE 382 (429)
Q Consensus 309 la~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~sDiwSlGvll~elltg~~Pf~~~-~~~~~~~~i~~~~~~~~~ 382 (429)
++.............||+.|+|||++. ..++.++||||||+++|+|++|+.||... .....+........ ..
T Consensus 156 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~ 233 (290)
T 3fme_A 156 ISGYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPS--PQ 233 (290)
T ss_dssp --------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCC--CC
T ss_pred CcccccccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCC--CC
Confidence 998776655555668999999999862 35788999999999999999999999763 33344444443332 12
Q ss_pred CCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhcc
Q 014210 383 APWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLICYQ 422 (429)
Q Consensus 383 ~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~ 422 (429)
.....++.++.+||.+||+.||++|||+.++++|+||+..
T Consensus 234 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~ 273 (290)
T 3fme_A 234 LPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLH 273 (290)
T ss_dssp CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred cccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccC
Confidence 2234689999999999999999999999999999999754
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-47 Score=371.36 Aligned_cols=256 Identities=28% Similarity=0.495 Sum_probs=212.0
Q ss_pred ccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEe--
Q 014210 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED-- 230 (429)
Q Consensus 153 ~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~-- 230 (429)
..++|+++++||+|+||.||+|+... +|+.||||++.... .+.+.+|+.+++++.+|+||+++++++.+
T Consensus 34 ~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~ 104 (330)
T 3nsz_A 34 NQDDYQLVRKLGRGKYSEVFEAINIT---NNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPV 104 (330)
T ss_dssp EGGGEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEECSCC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTT
T ss_pred CCCceEEEEEecccCCeEEEEEEECC---CCcEEEEEEecccc------hHHHHHHHHHHHHcCCCCCEEEeeeeeccCC
Confidence 35789999999999999999998766 58999999986431 35688999999999889999999999998
Q ss_pred CCeEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCc
Q 014210 231 TDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS 310 (429)
Q Consensus 231 ~~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla 310 (429)
....++||||+++++|.+++ ..+++..++.++.||+.||.|||++||+||||||+|||++ .++..+||+|||++
T Consensus 105 ~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~--~~~~~~kl~Dfg~a 178 (330)
T 3nsz_A 105 SRTPALVFEHVNNTDFKQLY----QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMID--HEHRKLRLIDWGLA 178 (330)
T ss_dssp TCCEEEEEECCCCCCHHHHG----GGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE--TTTTEEEECCCTTC
T ss_pred CCceEEEEeccCchhHHHHH----HhCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEc--CCCCEEEEEeCCCc
Confidence 66799999999999998876 3489999999999999999999999999999999999994 23348999999999
Q ss_pred cccCCCccccccccCCcccCcccccC--CCCCcccHHHHHHHHHHHHcCCCCCCCCC-hHHHHHHHHh------------
Q 014210 311 DFVRPDERLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWART-ESGIFRAVLK------------ 375 (429)
Q Consensus 311 ~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlGvll~elltg~~Pf~~~~-~~~~~~~i~~------------ 375 (429)
+............||..|+|||++.+ .++.++|||||||++|+|++|+.||.... ..+.+..+..
T Consensus 179 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 258 (330)
T 3nsz_A 179 EFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYID 258 (330)
T ss_dssp EECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHH
T ss_pred eEcCCCCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHH
Confidence 88776666677789999999998764 58999999999999999999999995433 2222222111
Q ss_pred -cCCCC--------------------CCCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhccc
Q 014210 376 -ADPSF--------------------DEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLICYQS 423 (429)
Q Consensus 376 -~~~~~--------------------~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~~ 423 (429)
..... .......+++++.+||++||+.||++|||+.++|+|+||+...
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~ 327 (330)
T 3nsz_A 259 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV 327 (330)
T ss_dssp HTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred HhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhc
Confidence 11100 0011123799999999999999999999999999999998653
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-47 Score=363.98 Aligned_cols=258 Identities=23% Similarity=0.372 Sum_probs=209.5
Q ss_pred cccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeC
Q 014210 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (429)
Q Consensus 152 ~~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~ 231 (429)
...++|++.+.||+|+||.||+|....+...+..||||++... ......+.+.+|+.++++++ ||||+++++++. +
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~-~ 87 (281)
T 1mp8_A 12 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC--TSDSVREKFLQEALTMRQFD-HPHIVKLIGVIT-E 87 (281)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT--TSHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEC-S
T ss_pred EehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEecccc--CCHHHHHHHHHHHHHHHhCC-CCccceEEEEEc-c
Confidence 3468999999999999999999998765445788999998653 34556678999999999998 999999999984 5
Q ss_pred CeEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCcc
Q 014210 232 DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (429)
Q Consensus 232 ~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~ 311 (429)
+..++||||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~ 164 (281)
T 1mp8_A 88 NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLV---SSNDCVKLGDFGLSR 164 (281)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---EETTEEEECC-----
T ss_pred CccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEE---CCCCCEEECcccccc
Confidence 67899999999999999998777789999999999999999999999999999999999999 567789999999998
Q ss_pred ccCCCcc--ccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCC
Q 014210 312 FVRPDER--LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPS 387 (429)
Q Consensus 312 ~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 387 (429)
....... .....+++.|+|||++. ..++.++||||||+++|||++ |..||......+.+..+...... ...+.
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~---~~~~~ 241 (281)
T 1mp8_A 165 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL---PMPPN 241 (281)
T ss_dssp --------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC---CCCTT
T ss_pred ccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCC---CCCCC
Confidence 7654332 23345678999999886 568999999999999999996 99999988887777777654422 12347
Q ss_pred CCHHHHHHHHHhcccCccCcCCHHHHHhhHhh
Q 014210 388 LSSEARDFVKRLLNKDPRKRLTAAQALSELLI 419 (429)
Q Consensus 388 ~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~ 419 (429)
+++++.+||.+||+.||++||++.++++++.-
T Consensus 242 ~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~ 273 (281)
T 1mp8_A 242 CPPTLYSLMTKCWAYDPSRRPRFTELKAQLST 273 (281)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 89999999999999999999999999987653
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-47 Score=386.47 Aligned_cols=260 Identities=27% Similarity=0.484 Sum_probs=208.4
Q ss_pred ccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeC-
Q 014210 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT- 231 (429)
Q Consensus 153 ~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~- 231 (429)
+.++|++++.||+|+||.||+|+... +|+.||||++... .......+++.+|++++++++ |+||+++++++...
T Consensus 24 i~~~y~~~~~lG~G~~g~V~~a~~~~---~~~~vAiK~~~~~-~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~ 98 (432)
T 3n9x_A 24 VPDNYIIKHLIGRGSYGYVYLAYDKN---TEKNVAIKKVNRM-FEDLIDCKRILREITILNRLK-SDYIIRLYDLIIPDD 98 (432)
T ss_dssp CCTTEEEEEEEEEETTEEEEEEEETT---TTEEEEEEEECST-TTSHHHHHHHHHHHHHHHHCC-CTTBCCEEEECCCSC
T ss_pred ecCCEEEEEEEeecCCEEEEEEEECC---CCcEEEEEEeCch-hcChHHHHHHHHHHHHHHHcC-CCCcceEEEEEecCC
Confidence 56899999999999999999999776 6899999999653 345566778999999999998 99999999999876
Q ss_pred ----CeEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeec
Q 014210 232 ----DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDF 307 (429)
Q Consensus 232 ----~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DF 307 (429)
+.+||||||++ ++|.+++. ....+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+||
T Consensus 99 ~~~~~~~~lv~e~~~-~~L~~~~~-~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl---~~~~~~kL~DF 173 (432)
T 3n9x_A 99 LLKFDELYIVLEIAD-SDLKKLFK-TPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLL---NQDCSVKVCDF 173 (432)
T ss_dssp TTTCCCEEEEEECCS-EEHHHHHH-SSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCC
T ss_pred CCcCCeEEEEEecCC-cCHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEE---CCCCCEEEccC
Confidence 57999999996 59988774 45679999999999999999999999999999999999999 78889999999
Q ss_pred CCccccCCCc-----------------------cccccccCCcccCccccc--CCCCCcccHHHHHHHHHHHHcCCCCC-
Q 014210 308 GLSDFVRPDE-----------------------RLNDIVGSAYYVAPEVLH--RSYSTEADVWSIGVIAYILLCGSRPF- 361 (429)
Q Consensus 308 Gla~~~~~~~-----------------------~~~~~~gt~~y~aPE~~~--~~~~~~sDiwSlGvll~elltg~~Pf- 361 (429)
|+++...... .....+||+.|+|||++. ..++.++|||||||++|||++|..||
T Consensus 174 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 174 GLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp TTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred CCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 9998764332 235678999999999863 46999999999999999999854443
Q ss_pred ----------CCCC-----------------hHHHHHHHHh-----------------------cCCCCCC----CCCCC
Q 014210 362 ----------WART-----------------ESGIFRAVLK-----------------------ADPSFDE----APWPS 387 (429)
Q Consensus 362 ----------~~~~-----------------~~~~~~~i~~-----------------------~~~~~~~----~~~~~ 387 (429)
.+.. ..+.+..+.. ..+.... ..++.
T Consensus 254 ~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 333 (432)
T 3n9x_A 254 NDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPS 333 (432)
T ss_dssp SSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTT
T ss_pred cccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCC
Confidence 2221 1122222211 1111111 11256
Q ss_pred CCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhcc
Q 014210 388 LSSEARDFVKRLLNKDPRKRLTAAQALSELLICYQ 422 (429)
Q Consensus 388 ~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~ 422 (429)
+++++.+||++||+.||++|||+.|+|+|+||...
T Consensus 334 ~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 368 (432)
T 3n9x_A 334 ISDDGINLLESMLKFNPNKRITIDQALDHPYLKDV 368 (432)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHHTCGGGTTT
T ss_pred CCHHHHHHHHHHhcCCcccCCCHHHHhcChhhhhc
Confidence 89999999999999999999999999999999864
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-47 Score=368.19 Aligned_cols=261 Identities=27% Similarity=0.482 Sum_probs=215.1
Q ss_pred ccccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEe
Q 014210 151 KHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED 230 (429)
Q Consensus 151 ~~~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~ 230 (429)
....++|++.+.||+|+||.||+|+... +|+.||||++..... ..+.+.+|+.+++++.+|+||+++++++..
T Consensus 20 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 92 (326)
T 2x7f_A 20 RDPAGIFELVELVGNGTYGQVYKGRHVK---TGQLAAIKVMDVTGD----EEEEIKQEINMLKKYSHHRNIATYYGAFIK 92 (326)
T ss_dssp CCCTTTEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEECCSS----TTHHHHHHHHHHHHHCCSTTBCCEEEEEEE
T ss_pred cCCCCcEEEEEEeccCCCEEEEEEEECC---CCCeEEEEEEecCcc----cHHHHHHHHHHHHhccCCCCeeeeeeEEee
Confidence 3457899999999999999999998765 589999999865432 235788999999999669999999999987
Q ss_pred ------CCeEEEEEEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEE
Q 014210 231 ------TDNVYVVMELCEGGELLDRILSR-GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLK 303 (429)
Q Consensus 231 ------~~~~~lv~E~~~ggsL~~~i~~~-~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vk 303 (429)
.+..+|||||+++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+|
T Consensus 93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~---~~~~~~k 169 (326)
T 2x7f_A 93 KNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLL---TENAEVK 169 (326)
T ss_dssp CC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEE---CTTCCEE
T ss_pred ccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEE---cCCCCEE
Confidence 56899999999999999988764 3579999999999999999999999999999999999999 7788999
Q ss_pred EeecCCccccCCCc-cccccccCCcccCccccc------CCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhc
Q 014210 304 AIDFGLSDFVRPDE-RLNDIVGSAYYVAPEVLH------RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKA 376 (429)
Q Consensus 304 L~DFGla~~~~~~~-~~~~~~gt~~y~aPE~~~------~~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~ 376 (429)
|+|||++....... ......||..|+|||++. ..++.++||||||+++|+|++|+.||...........+...
T Consensus 170 l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~ 249 (326)
T 2x7f_A 170 LVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN 249 (326)
T ss_dssp ECCCTTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS
T ss_pred EeeCcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcC
Confidence 99999997764322 234567999999999885 35889999999999999999999999887776666555544
Q ss_pred CCCCCCCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhccc
Q 014210 377 DPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLICYQS 423 (429)
Q Consensus 377 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~~ 423 (429)
... ......++.++.+||++||..||.+||++.++++|+||+...
T Consensus 250 ~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~ 294 (326)
T 2x7f_A 250 PAP--RLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQP 294 (326)
T ss_dssp CCC--CCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCCT
T ss_pred ccc--cCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhCc
Confidence 322 222346899999999999999999999999999999998653
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-47 Score=377.14 Aligned_cols=258 Identities=22% Similarity=0.384 Sum_probs=221.0
Q ss_pred ccCceeEeceeeccCceEEEEEEEecC----cccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEE
Q 014210 153 FANKYELGEEVGRGHFGYTCAAKFKKG----ELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAY 228 (429)
Q Consensus 153 ~~~~y~~~~~IG~G~fg~V~~~~~~~~----~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~ 228 (429)
..++|+++++||+|+||.||+|+.... ...+..||||++... ......+++.+|+++++++.+|+||+++++++
T Consensus 67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~ 144 (382)
T 3tt0_A 67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD--ATEKDLSDLISEMEMMKMIGKHKNIINLLGAC 144 (382)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTT--CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccc--cCHHHHHHHHHHHHHHHHhcCCchhhhheeee
Confidence 357999999999999999999987532 124578999999754 44566688999999999995599999999999
Q ss_pred EeCCeEEEEEEecCCCcHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEE
Q 014210 229 EDTDNVYVVMELCEGGELLDRILSRG---------------GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLF 293 (429)
Q Consensus 229 ~~~~~~~lv~E~~~ggsL~~~i~~~~---------------~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl 293 (429)
.+.+..+|||||+++|+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 145 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll 224 (382)
T 3tt0_A 145 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV 224 (382)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred ccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEEE
Confidence 99999999999999999999987654 359999999999999999999999999999999999999
Q ss_pred eecCCCceEEEeecCCccccCCCc---cccccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHc-CCCCCCCCChHH
Q 014210 294 TTKDENSVLKAIDFGLSDFVRPDE---RLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLC-GSRPFWARTESG 368 (429)
Q Consensus 294 ~~~~~~~~vkL~DFGla~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~ellt-g~~Pf~~~~~~~ 368 (429)
+.++.+||+|||+++...... ......+|..|+|||++.+ .++.++|||||||++|||++ |+.||.......
T Consensus 225 ---~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~ 301 (382)
T 3tt0_A 225 ---TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE 301 (382)
T ss_dssp ---CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred ---cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 778899999999998765432 2334567889999998864 68999999999999999999 999999888877
Q ss_pred HHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHh
Q 014210 369 IFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELL 418 (429)
Q Consensus 369 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~ 418 (429)
....+....... ....++.++.+||++||+.||++||++.++++++.
T Consensus 302 ~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 348 (382)
T 3tt0_A 302 LFKLLKEGHRMD---KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 348 (382)
T ss_dssp HHHHHHTTCCCC---CCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHHcCCCCC---CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 777666543222 22468999999999999999999999999999864
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-47 Score=359.28 Aligned_cols=253 Identities=27% Similarity=0.408 Sum_probs=218.7
Q ss_pred ccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCC
Q 014210 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (429)
Q Consensus 153 ~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~ 232 (429)
..++|++.+.||+|+||.||+++... +..||||++...... .+++.+|++++++++ |+||+++++++.+.+
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~ 76 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWKG----QYDVAVKMIKEGSMS----EDEFFQEAQTMMKLS-HPKLVKFYGVCSKEY 76 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETT----TEEEEEEEECBTTBC----HHHHHHHHHHHHHCC-CTTBCCEEEEECSSS
T ss_pred chhheeeeeeeccCCCceEEEEEecC----ceeEEEEEeccCCCc----HHHHHHHHHHHHhCC-CCCEeeEEEEEccCC
Confidence 35789999999999999999997654 678999999654322 356889999999998 999999999999999
Q ss_pred eEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccc
Q 014210 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (429)
Q Consensus 233 ~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~ 312 (429)
..++||||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..
T Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~---~~~~~~~l~Dfg~~~~ 153 (268)
T 3sxs_A 77 PIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLV---DRDLCVKVSDFGMTRY 153 (268)
T ss_dssp SEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEE---CTTCCEEECCTTCEEE
T ss_pred ceEEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEE---CCCCCEEEccCcccee
Confidence 9999999999999999998777779999999999999999999999999999999999999 7888999999999987
Q ss_pred cCCCcc--ccccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCC
Q 014210 313 VRPDER--LNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSL 388 (429)
Q Consensus 313 ~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 388 (429)
...... .....+|..|+|||++.+ .++.++||||||+++|+|++ |+.||...........+......... ..+
T Consensus 154 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~ 230 (268)
T 3sxs_A 154 VLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRP---HLA 230 (268)
T ss_dssp CCTTCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCC---TTS
T ss_pred cchhhhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCCC---CcC
Confidence 654432 223456778999998874 68999999999999999999 99999988888777777665433322 357
Q ss_pred CHHHHHHHHHhcccCccCcCCHHHHHhhHhhh
Q 014210 389 SSEARDFVKRLLNKDPRKRLTAAQALSELLIC 420 (429)
Q Consensus 389 s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~ 420 (429)
++++.+||.+||+.||++|||+.++++++.--
T Consensus 231 ~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l 262 (268)
T 3sxs_A 231 SDTIYQIMYSCWHELPEKRPTFQQLLSSIEPL 262 (268)
T ss_dssp CHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGG
T ss_pred hHHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence 89999999999999999999999999987543
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-47 Score=365.22 Aligned_cols=257 Identities=27% Similarity=0.482 Sum_probs=222.7
Q ss_pred ccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCC
Q 014210 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (429)
Q Consensus 153 ~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~ 232 (429)
..+.|++++.||+|+||.||+|+... +|+.||||++..... ....+.+.+|+.+++++. |+||+++++++.+.+
T Consensus 20 ~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~ 93 (303)
T 3a7i_A 20 PEELFTKLEKIGKGSFGEVFKGIDNR---TQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCD-SPYVTKYYGSYLKDT 93 (303)
T ss_dssp GGGTEEEEEEEEECSSSEEEEEEETT---TCCEEEEEEEETTTC--STTHHHHHHHHHHHHHCC-CTTBCCEEEEEEETT
T ss_pred hHHHHHHhhhhcccCCeEEEEEEECC---CCcEEEEEEeccccc--HHHHHHHHHHHHHHHhCC-CCCEeEEEEEEecCC
Confidence 45789999999999999999998765 589999999975532 234577999999999997 999999999999999
Q ss_pred eEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccc
Q 014210 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (429)
Q Consensus 233 ~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~ 312 (429)
..++||||+++++|.+++. .+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..
T Consensus 94 ~~~lv~e~~~~~~L~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~Dfg~~~~ 168 (303)
T 3a7i_A 94 KLWIIMEYLGGGSALDLLE--PGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLL---SEHGEVKLADFGVAGQ 168 (303)
T ss_dssp EEEEEEECCTTEEHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEE
T ss_pred eEEEEEEeCCCCcHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEE---CCCCCEEEeeccccee
Confidence 9999999999999999873 4679999999999999999999999999999999999999 7788999999999977
Q ss_pred cCCCc-cccccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCH
Q 014210 313 VRPDE-RLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSS 390 (429)
Q Consensus 313 ~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 390 (429)
..... ......||..|+|||++.+ .++.++||||||+++|+|++|+.||...........+....... ....++.
T Consensus 169 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~ 245 (303)
T 3a7i_A 169 LTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPT---LEGNYSK 245 (303)
T ss_dssp CBTTBCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC---CCSSCCH
T ss_pred cCccccccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCCCC---CccccCH
Confidence 65433 3345679999999998874 68899999999999999999999998887777666665544322 2246899
Q ss_pred HHHHHHHHhcccCccCcCCHHHHHhhHhhhccc
Q 014210 391 EARDFVKRLLNKDPRKRLTAAQALSELLICYQS 423 (429)
Q Consensus 391 ~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~~ 423 (429)
++.+||.+||+.||++||++.++++|+||....
T Consensus 246 ~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 278 (303)
T 3a7i_A 246 PLKEFVEACLNKEPSFRPTAKELLKHKFILRNA 278 (303)
T ss_dssp HHHHHHHHHCCSSGGGSCCHHHHTTCHHHHHHC
T ss_pred HHHHHHHHHcCCChhhCcCHHHHhhChhhhcCC
Confidence 999999999999999999999999999997543
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-47 Score=382.54 Aligned_cols=256 Identities=27% Similarity=0.457 Sum_probs=212.9
Q ss_pred cccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEe-
Q 014210 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED- 230 (429)
Q Consensus 152 ~~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~- 230 (429)
...++|++++.||+|+||.||+|+... +|+.||||++...... ..+|+++++.++ |+||++++++|..
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~---~~~~vAiK~~~~~~~~-------~~~E~~il~~l~-hpnIv~l~~~~~~~ 72 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIE---SGKRFALKKVLQDPRY-------KNRELDIMKVLD-HVNIIKLVDYFYTT 72 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETT---TCCEEEEEEEECCTTS-------CCHHHHHHTTCC-CTTBCCEEEEEEEC
T ss_pred cccceEEEEEEEEeccCEEEEEEEECC---CCCEEEEEEEecCcch-------HHHHHHHHHHcC-CCCccchhheeeec
Confidence 346789999999999999999998766 6899999998654221 237999999998 9999999999844
Q ss_pred -------------------------------------CCeEEEEEEecCCCcHHHHHH---hcCCCCCHHHHHHHHHHHH
Q 014210 231 -------------------------------------TDNVYVVMELCEGGELLDRIL---SRGGKYTEDDAKAVMIQIL 270 (429)
Q Consensus 231 -------------------------------------~~~~~lv~E~~~ggsL~~~i~---~~~~~l~~~~~~~i~~qi~ 270 (429)
...++||||||++ +|.+.+. ..+..+++..++.++.||+
T Consensus 73 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~ 151 (383)
T 3eb0_A 73 GDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLF 151 (383)
T ss_dssp -------------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHH
T ss_pred CcccccccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHH
Confidence 3348899999975 7776664 3467899999999999999
Q ss_pred HHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccccCCCccccccccCCcccCcccccC--CCCCcccHHHHH
Q 014210 271 NVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHR--SYSTEADVWSIG 348 (429)
Q Consensus 271 ~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG 348 (429)
+||.|||++||+||||||+|||++ ..++.+||+|||+++............||..|+|||++.+ .++.++||||||
T Consensus 152 ~aL~~LH~~gi~H~Dikp~Nil~~--~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG 229 (383)
T 3eb0_A 152 RAVGFIHSLGICHRDIKPQNLLVN--SKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIG 229 (383)
T ss_dssp HHHHHHHTTTEECSCCCGGGEEEE--TTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHH
T ss_pred HHHHHHHHCcCccCccCHHHEEEc--CCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHH
Confidence 999999999999999999999994 2578999999999988776666667789999999998764 489999999999
Q ss_pred HHHHHHHcCCCCCCCCChHHHHHHHHhcC------------CCCCCC-------------CCCCCCHHHHHHHHHhcccC
Q 014210 349 VIAYILLCGSRPFWARTESGIFRAVLKAD------------PSFDEA-------------PWPSLSSEARDFVKRLLNKD 403 (429)
Q Consensus 349 vll~elltg~~Pf~~~~~~~~~~~i~~~~------------~~~~~~-------------~~~~~s~~~~~li~~~L~~d 403 (429)
|++|||++|+.||......+.+..+.+.. +.+... ....++.++.+||.+||+.|
T Consensus 230 ~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 309 (383)
T 3eb0_A 230 CVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYE 309 (383)
T ss_dssp HHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSS
T ss_pred HHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCC
Confidence 99999999999999988877776665421 111110 11247899999999999999
Q ss_pred ccCcCCHHHHHhhHhhhc
Q 014210 404 PRKRLTAAQALSELLICY 421 (429)
Q Consensus 404 P~~Rps~~~iL~~~~~~~ 421 (429)
|++|||+.|+|+|+||..
T Consensus 310 P~~R~t~~e~l~hp~f~~ 327 (383)
T 3eb0_A 310 PDLRINPYEAMAHPFFDH 327 (383)
T ss_dssp GGGSCCHHHHHTSGGGHH
T ss_pred hhhCCCHHHHhcCHHHHH
Confidence 999999999999999975
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-47 Score=387.94 Aligned_cols=260 Identities=26% Similarity=0.383 Sum_probs=216.4
Q ss_pred ccccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhc-----CCCCcceEE
Q 014210 151 KHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALT-----GHNNLVKFF 225 (429)
Q Consensus 151 ~~~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~-----~h~nIv~l~ 225 (429)
+.+..+|+++++||+|+||.||+|.... +|+.||||++.. .....+++.+|+.+++.++ +|+||++++
T Consensus 93 ~~~~~ry~~~~~LG~G~fg~V~~a~~~~---~~~~vAvK~~~~----~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~ 165 (429)
T 3kvw_A 93 DHVAYRYEVLKVIGKGSFGQVVKAYDHK---VHQHVALKMVRN----EKRFHRQAAEEIRILEHLRKQDKDNTMNVIHML 165 (429)
T ss_dssp CEETTTEEEEEEEEESSSEEEEEEEETT---TTEEEEEEEECS----CHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEE
T ss_pred CcccCcEEEEEEcccCccEEEEEEEECC---CCcEEEEEEECC----ccchHHHHHHHHHHHHHHhhccccCCcCEEEEE
Confidence 4567899999999999999999998766 589999999864 2344567889999999885 377999999
Q ss_pred EEEEeCCeEEEEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCce--E
Q 014210 226 DAYEDTDNVYVVMELCEGGELLDRILSRG-GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSV--L 302 (429)
Q Consensus 226 ~~~~~~~~~~lv~E~~~ggsL~~~i~~~~-~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~--v 302 (429)
+++...+.++|||||+. ++|.+++.... ..+++..++.++.||+.||.|||++|||||||||+|||+ +.++. +
T Consensus 166 ~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl---~~~~~~~v 241 (429)
T 3kvw_A 166 ENFTFRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILL---KQQGRSGI 241 (429)
T ss_dssp EEEEETTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEE---SSTTSCCE
T ss_pred eecccCCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---ccCCCcce
Confidence 99999999999999996 58999887654 459999999999999999999999999999999999999 55555 9
Q ss_pred EEeecCCccccCCCccccccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCC
Q 014210 303 KAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFD 381 (429)
Q Consensus 303 kL~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~ 381 (429)
||+|||++.... ......+||+.|+|||++.+ .++.++|||||||++|||++|+.||......+.+..+.+......
T Consensus 242 kL~DFG~a~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~ 319 (429)
T 3kvw_A 242 KVIDFGSSCYEH--QRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPS 319 (429)
T ss_dssp EECCCTTCEETT--CCCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred EEeecccceecC--CcccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCC
Confidence 999999997653 33445789999999998864 699999999999999999999999999888777766554211000
Q ss_pred C--------------------------------------------------C-----CCCCCCHHHHHHHHHhcccCccC
Q 014210 382 E--------------------------------------------------A-----PWPSLSSEARDFVKRLLNKDPRK 406 (429)
Q Consensus 382 ~--------------------------------------------------~-----~~~~~s~~~~~li~~~L~~dP~~ 406 (429)
. . .....++++.+||++||++||++
T Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~ 399 (429)
T 3kvw_A 320 QKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAV 399 (429)
T ss_dssp HHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTT
T ss_pred HHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhh
Confidence 0 0 00124788999999999999999
Q ss_pred cCCHHHHHhhHhhhccc
Q 014210 407 RLTAAQALSELLICYQS 423 (429)
Q Consensus 407 Rps~~~iL~~~~~~~~~ 423 (429)
|||+.|+|+|+||+...
T Consensus 400 Rpta~e~L~Hpw~~~~~ 416 (429)
T 3kvw_A 400 RMTPGQALRHPWLRRRL 416 (429)
T ss_dssp SCCHHHHHTSTTTC---
T ss_pred CCCHHHHhCChhhccCC
Confidence 99999999999998653
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-47 Score=384.77 Aligned_cols=254 Identities=28% Similarity=0.425 Sum_probs=210.8
Q ss_pred cCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeC--
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT-- 231 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~-- 231 (429)
..+|++.++||+|+||.||+|+... +|+.||||++..... ...+|++++++|+ |+|||+++++|...
T Consensus 53 ~~~y~~~~~lG~G~fg~Vy~~~~~~---~~~~vaiK~~~~~~~-------~~~~E~~il~~l~-hpniv~l~~~~~~~~~ 121 (420)
T 1j1b_A 53 EVSYTDTKVIGNGSFGVVYQAKLCD---SGELVAIKKVLQDKR-------FKNRELQIMRKLD-HCNIVRLRYFFYSSGE 121 (420)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEECCTT-------SCCHHHHHHHTCC-CTTBCCEEEEEEEEET
T ss_pred cceEEeeeEEeeCCCEEEEEEEECC---CCcEEEEEEecccch-------hHHHHHHHHHHcC-CCCccceeeEEeccCC
Confidence 4679999999999999999999876 589999999865421 2347999999998 99999999998542
Q ss_pred ----CeEEEEEEecCCCcHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEE
Q 014210 232 ----DNVYVVMELCEGGELLDRIL---SRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKA 304 (429)
Q Consensus 232 ----~~~~lv~E~~~ggsL~~~i~---~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL 304 (429)
..+++||||+++ +|.+.+. .....+++..++.++.||++||.|||++||+||||||+||||+ .+++.+||
T Consensus 122 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~--~~~~~~kl 198 (420)
T 1j1b_A 122 KKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLD--PDTAVLKL 198 (420)
T ss_dssp TTTEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEE--TTTTEEEE
T ss_pred CCcceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEe--CCCCeEEe
Confidence 236799999976 6665554 3456899999999999999999999999999999999999994 24567999
Q ss_pred eecCCccccCCCccccccccCCcccCcccccC--CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhc------
Q 014210 305 IDFGLSDFVRPDERLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKA------ 376 (429)
Q Consensus 305 ~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~------ 376 (429)
+|||+++...........+||+.|+|||++.+ .++.++|||||||++|||++|+.||.+....+.+..+++.
T Consensus 199 ~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~ 278 (420)
T 1j1b_A 199 CDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTR 278 (420)
T ss_dssp CCCTTCEECCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCH
T ss_pred ccchhhhhcccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence 99999988766655667789999999998864 5899999999999999999999999988877766665542
Q ss_pred ------CCCCCCCC-------------CCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhc
Q 014210 377 ------DPSFDEAP-------------WPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLICY 421 (429)
Q Consensus 377 ------~~~~~~~~-------------~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~ 421 (429)
.+.+.... .+.+++++.+||++||..||++||++.|+|+|+||..
T Consensus 279 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~ 342 (420)
T 1j1b_A 279 EQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDE 342 (420)
T ss_dssp HHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGG
T ss_pred HHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcc
Confidence 11111111 1356899999999999999999999999999999965
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-47 Score=361.47 Aligned_cols=252 Identities=22% Similarity=0.375 Sum_probs=215.6
Q ss_pred ccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCC
Q 014210 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (429)
Q Consensus 153 ~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~ 232 (429)
..++|+++++||+|+||.||+++... +..||||++...... .+++.+|++++++++ |+||+++++++.+.+
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~ 92 (283)
T 3gen_A 22 DPKDLTFLKELGTGQFGVVKYGKWRG----QYDVAIKMIKEGSMS----EDEFIEEAKVMMNLS-HEKLVQLYGVCTKQR 92 (283)
T ss_dssp CGGGEEEEEECC---CEEEEEEEETT----TEEEEEEEECTTSBC----HHHHHHHHHHHHTCC-CTTBCCEEEEECSSS
T ss_pred CHHHHHhHhhcCCCCCceEEEEEEcC----CCeEEEEEecCCCCC----HHHHHHHHHHHhcCC-CCCEeeEEEEEecCC
Confidence 35789999999999999999997653 678999999764332 256889999999998 999999999999999
Q ss_pred eEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccc
Q 014210 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (429)
Q Consensus 233 ~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~ 312 (429)
..++||||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..
T Consensus 93 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili---~~~~~~kl~Dfg~~~~ 169 (283)
T 3gen_A 93 PIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLV---NDQGVVKVSDFGLSRY 169 (283)
T ss_dssp SEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEE---CTTSCEEECSTTGGGG
T ss_pred CeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEE---cCCCCEEEcccccccc
Confidence 9999999999999999987766789999999999999999999999999999999999999 7888999999999987
Q ss_pred cCCCcc--ccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCC
Q 014210 313 VRPDER--LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSL 388 (429)
Q Consensus 313 ~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 388 (429)
...... .....+|..|+|||++. ..++.++||||||+++|+|++ |+.||...........+........ ...+
T Consensus 170 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~ 246 (283)
T 3gen_A 170 VLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYR---PHLA 246 (283)
T ss_dssp BCCHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCC---CTTC
T ss_pred ccccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCC---CCcC
Confidence 654322 23345678899999887 568999999999999999998 9999998888877777766533222 2357
Q ss_pred CHHHHHHHHHhcccCccCcCCHHHHHhhHhh
Q 014210 389 SSEARDFVKRLLNKDPRKRLTAAQALSELLI 419 (429)
Q Consensus 389 s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~ 419 (429)
++++.+||.+||+.||++||++.++++++.-
T Consensus 247 ~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~ 277 (283)
T 3gen_A 247 SEKVYTIMYSCWHEKADERPTFKILLSNILD 277 (283)
T ss_dssp CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHHHHHHH
Confidence 8999999999999999999999999998864
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-47 Score=371.61 Aligned_cols=260 Identities=22% Similarity=0.296 Sum_probs=221.2
Q ss_pred cccCceeEeceeeccCceEEEEEEEecCc--ccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEE
Q 014210 152 HFANKYELGEEVGRGHFGYTCAAKFKKGE--LKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYE 229 (429)
Q Consensus 152 ~~~~~y~~~~~IG~G~fg~V~~~~~~~~~--~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~ 229 (429)
...++|++.+.||+|+||.||+|+..... .+++.||||++... ......+.+.+|+.++++++ |+||+++++++.
T Consensus 44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~ 120 (343)
T 1luf_A 44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE--ASADMQADFQREAALMAEFD-NPNIVKLLGVCA 120 (343)
T ss_dssp CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTT--CCHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEC
T ss_pred ecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccc--cCHHHHHHHHHHHHHHHhCC-CCCEEEEEEEEc
Confidence 34688999999999999999999987421 24689999999754 34556678999999999997 999999999999
Q ss_pred eCCeEEEEEEecCCCcHHHHHHhcC-----------------------CCCCHHHHHHHHHHHHHHHHHHHHcCceeccC
Q 014210 230 DTDNVYVVMELCEGGELLDRILSRG-----------------------GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDL 286 (429)
Q Consensus 230 ~~~~~~lv~E~~~ggsL~~~i~~~~-----------------------~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDI 286 (429)
+.+..+|||||+++++|.+++.... ..+++..++.++.||+.||.|||++||+||||
T Consensus 121 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dl 200 (343)
T 1luf_A 121 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDL 200 (343)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred cCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCC
Confidence 9999999999999999999987642 57999999999999999999999999999999
Q ss_pred CCCcEEEeecCCCceEEEeecCCccccCCCc---cccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHc-CCCCC
Q 014210 287 KPENFLFTTKDENSVLKAIDFGLSDFVRPDE---RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPF 361 (429)
Q Consensus 287 Kp~NILl~~~~~~~~vkL~DFGla~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~ellt-g~~Pf 361 (429)
||+|||+ +.++.+||+|||++....... ......+|..|+|||++. +.++.++||||||+++|||++ |+.||
T Consensus 201 kp~NIl~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~ 277 (343)
T 1luf_A 201 ATRNCLV---GENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 277 (343)
T ss_dssp SGGGEEE---CGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred CcceEEE---CCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcC
Confidence 9999999 778899999999997654332 223456889999999876 568999999999999999999 99999
Q ss_pred CCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhh
Q 014210 362 WARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLIC 420 (429)
Q Consensus 362 ~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~ 420 (429)
......+....+....... ....++.++.+||++||+.||++||++.++++++--.
T Consensus 278 ~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~ 333 (343)
T 1luf_A 278 YGMAHEEVIYYVRDGNILA---CPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRM 333 (343)
T ss_dssp TTSCHHHHHHHHHTTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred CCCChHHHHHHHhCCCcCC---CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHH
Confidence 9988888777776654322 2246899999999999999999999999999876543
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-47 Score=376.89 Aligned_cols=259 Identities=25% Similarity=0.394 Sum_probs=216.8
Q ss_pred ccccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEe
Q 014210 151 KHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED 230 (429)
Q Consensus 151 ~~~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~ 230 (429)
+...++|++.++||+|+||.||+++... +|+.||+|++... ......+.+.+|+.++++++ |+||+++++++.+
T Consensus 29 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~va~K~~~~~--~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~ 102 (360)
T 3eqc_A 29 ELKDDDFEKISELGAGNGGVVFKVSHKP---SGLVMARKLIHLE--IKPAIRNQIIRELQVLHECN-SPYIVGFYGAFYS 102 (360)
T ss_dssp CCCGGGEEEEEEEEECSSCEEEEEEETT---TCCEEEEEEEECC--CCHHHHHHHHHHHGGGGGCC-CTTBCCEEEEEEE
T ss_pred ccccccceeeeeecCCCCeEEEEEEECC---CCcEEEEEEeccc--cCHHHHHHHHHHHHHHHHCC-CCCEEEEeEEEEE
Confidence 4456899999999999999999999775 5899999999764 34556678999999999997 9999999999999
Q ss_pred CCeEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHc-CceeccCCCCcEEEeecCCCceEEEeecCC
Q 014210 231 TDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQ-GVVHRDLKPENFLFTTKDENSVLKAIDFGL 309 (429)
Q Consensus 231 ~~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~-~iiHrDIKp~NILl~~~~~~~~vkL~DFGl 309 (429)
++..+|||||+++++|.+++... +.+++..++.++.||+.||.|||+. ||+||||||+|||+ +.++.+||+|||+
T Consensus 103 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~ 178 (360)
T 3eqc_A 103 DGEISICMEHMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILV---NSRGEIKLCDFGV 178 (360)
T ss_dssp TTEEEEEECCCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEE---CTTCCEEECCCCC
T ss_pred CCEEEEEEECCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEE---CCCCCEEEEECCC
Confidence 99999999999999999988554 5799999999999999999999996 99999999999999 7788899999999
Q ss_pred ccccCCCccccccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHH-----------------
Q 014210 310 SDFVRPDERLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFR----------------- 371 (429)
Q Consensus 310 a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~----------------- 371 (429)
+..... .......||+.|+|||++.+ .++.++||||||+++|+|++|+.||..........
T Consensus 179 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (360)
T 3eqc_A 179 SGQLID-SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRP 257 (360)
T ss_dssp CHHHHH-HC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC--------------
T ss_pred Cccccc-ccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCc
Confidence 865532 22345689999999998874 58999999999999999999999997765543321
Q ss_pred -------------------------HHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhcc
Q 014210 372 -------------------------AVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLICYQ 422 (429)
Q Consensus 372 -------------------------~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~ 422 (429)
.+.... ........++.++.+||++||+.||++|||+.++|+|+||+..
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 331 (360)
T 3eqc_A 258 RTPGRPLNKFGMDSRPPMAIFELLDYIVNEP--PPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 331 (360)
T ss_dssp ----------------CCCHHHHHHHHHHSC--CCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHH
T ss_pred ccCCCcccccccCCCCcccchhhhhHHhccC--CCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcc
Confidence 111111 1112223578999999999999999999999999999999753
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=363.76 Aligned_cols=259 Identities=26% Similarity=0.370 Sum_probs=218.8
Q ss_pred ccCceeEeceeeccCceEEEEEEEec--CcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEe
Q 014210 153 FANKYELGEEVGRGHFGYTCAAKFKK--GELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED 230 (429)
Q Consensus 153 ~~~~y~~~~~IG~G~fg~V~~~~~~~--~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~ 230 (429)
..++|++.+.||+|+||.||+|+... ...+++.||||++... ......+.+.+|+.+++++.+||||+++++++.+
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 98 (313)
T 1t46_A 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS--AHLTEREALMSELKVLSYLGNHMNIVNLLGACTI 98 (313)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT--CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcc--hhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEec
Confidence 35789999999999999999998653 2336789999999754 3344567899999999999559999999999999
Q ss_pred CCeEEEEEEecCCCcHHHHHHhcCC-----------------CCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEE
Q 014210 231 TDNVYVVMELCEGGELLDRILSRGG-----------------KYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLF 293 (429)
Q Consensus 231 ~~~~~lv~E~~~ggsL~~~i~~~~~-----------------~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl 293 (429)
.+..++||||+++|+|.+++..... .+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~ 178 (313)
T 1t46_A 99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL 178 (313)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred CCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEE
Confidence 9999999999999999999876543 48999999999999999999999999999999999999
Q ss_pred eecCCCceEEEeecCCccccCCCcc---ccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHc-CCCCCCCCChHH
Q 014210 294 TTKDENSVLKAIDFGLSDFVRPDER---LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESG 368 (429)
Q Consensus 294 ~~~~~~~~vkL~DFGla~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~ellt-g~~Pf~~~~~~~ 368 (429)
+.++.+||+|||++........ .....+|..|+|||++. ..++.++||||||+++|+|++ |+.||.......
T Consensus 179 ---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~ 255 (313)
T 1t46_A 179 ---THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS 255 (313)
T ss_dssp ---ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH
T ss_pred ---cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchh
Confidence 6788999999999987654432 23455788999999876 568999999999999999999 999998876655
Q ss_pred HHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHh
Q 014210 369 IFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELL 418 (429)
Q Consensus 369 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~ 418 (429)
.+........... ....++.++.+||.+||+.||.+||++.++++++-
T Consensus 256 ~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~ 303 (313)
T 1t46_A 256 KFYKMIKEGFRML--SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE 303 (313)
T ss_dssp HHHHHHHHTCCCC--CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHhccCCCCC--CcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHH
Confidence 5555554432222 22468999999999999999999999999998764
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-47 Score=374.83 Aligned_cols=260 Identities=35% Similarity=0.629 Sum_probs=189.6
Q ss_pred cccCceeEec-eeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEe
Q 014210 152 HFANKYELGE-EVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED 230 (429)
Q Consensus 152 ~~~~~y~~~~-~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~ 230 (429)
.+.++|++.+ .||+|+||.||+|+.+. +|+.||||++... . ...+|+..+.++.+|+||+++++++..
T Consensus 25 ~~~~~y~i~~~~lG~G~~g~V~~~~~~~---~~~~vavK~~~~~----~----~~~~e~~~~~~~~~h~~i~~~~~~~~~ 93 (336)
T 3fhr_A 25 AVTDDYQLSKQVLGLGVNGKVLECFHRR---TGQKCALKLLYDS----P----KARQEVDHHWQASGGPHIVCILDVYEN 93 (336)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEESS----H----HHHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred cccceeEecceeeeeCCCeEEEEEEECC---CCCEEEEEEecCc----H----HHHHHHHHHHHhcCCCChHHHHHHHhh
Confidence 3568899965 69999999999999776 5899999998542 2 233444444444459999999999986
Q ss_pred ----CCeEEEEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEe
Q 014210 231 ----TDNVYVVMELCEGGELLDRILSRG-GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAI 305 (429)
Q Consensus 231 ----~~~~~lv~E~~~ggsL~~~i~~~~-~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~ 305 (429)
....+||||||+||+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++..+.++.+||+
T Consensus 94 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~ 173 (336)
T 3fhr_A 94 MHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLT 173 (336)
T ss_dssp EETTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEEC
T ss_pred ccCCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEe
Confidence 455899999999999999987654 369999999999999999999999999999999999999765567789999
Q ss_pred ecCCccccCCCccccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHH----HHHHHhcCCCC
Q 014210 306 DFGLSDFVRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGI----FRAVLKADPSF 380 (429)
Q Consensus 306 DFGla~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~----~~~i~~~~~~~ 380 (429)
|||++..... .......||+.|+|||++. ..++.++||||||+++|+|++|+.||........ ...+......+
T Consensus 174 Dfg~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 252 (336)
T 3fhr_A 174 DFGFAKETTQ-NALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGF 252 (336)
T ss_dssp CCTTCEEC-----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CC
T ss_pred ccccceeccc-cccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhcccccc
Confidence 9999976653 3334567899999999886 4588899999999999999999999976654433 22333334444
Q ss_pred CCCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhccc
Q 014210 381 DEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLICYQS 423 (429)
Q Consensus 381 ~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~~ 423 (429)
....+..++.++.+||++||+.||++|||+.++|+|+||+...
T Consensus 253 ~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 295 (336)
T 3fhr_A 253 PNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSM 295 (336)
T ss_dssp CTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGG
T ss_pred CchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccccc
Confidence 5555668999999999999999999999999999999998643
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-48 Score=385.97 Aligned_cols=261 Identities=17% Similarity=0.174 Sum_probs=201.8
Q ss_pred cCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhc-CCCCcceEE-------
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALT-GHNNLVKFF------- 225 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~-~h~nIv~l~------- 225 (429)
..+|++.++||+|+||.||+|+... +|+.||||++...........+.+.+|+.+++.|. .||||++++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~ 137 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVE---RLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPS 137 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCC
T ss_pred ceeeeeeeeccCCCCEEEEEEEECC---CCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeee
Confidence 3569999999999999999999766 58999999998876556677788899977666665 499988765
Q ss_pred EEEEeC-----------------CeEEEEEEecCCCcHHHHHHhcCCCCCHHHH------HHHHHHHHHHHHHHHHcCce
Q 014210 226 DAYEDT-----------------DNVYVVMELCEGGELLDRILSRGGKYTEDDA------KAVMIQILNVVAFCHLQGVV 282 (429)
Q Consensus 226 ~~~~~~-----------------~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~------~~i~~qi~~gL~~LH~~~ii 282 (429)
+++... ..+|||||||+ |+|.+++...+..+.+..+ ..++.||+.||+|||++||+
T Consensus 138 d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~iv 216 (371)
T 3q60_A 138 DAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLV 216 (371)
T ss_dssp EEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred hheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCc
Confidence 555443 33899999998 7999999776555666666 78889999999999999999
Q ss_pred eccCCCCcEEEeecCCCceEEEeecCCccccCCCccccccccCCcccCcccccC---CCCCcccHHHHHHHHHHHHcCCC
Q 014210 283 HRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHR---SYSTEADVWSIGVIAYILLCGSR 359 (429)
Q Consensus 283 HrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~sDiwSlGvll~elltg~~ 359 (429)
||||||+|||+ +.++.+||+|||+++..... .....+|+.|+|||++.+ .++.++|||||||++|||++|+.
T Consensus 217 HrDikp~NIll---~~~~~~kL~DFG~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~ 291 (371)
T 3q60_A 217 HGHFTPDNLFI---MPDGRLMLGDVSALWKVGTR--GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFL 291 (371)
T ss_dssp ETTCSGGGEEE---CTTSCEEECCGGGEEETTCE--EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSC
T ss_pred cCcCCHHHEEE---CCCCCEEEEecceeeecCCC--ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCC
Confidence 99999999999 77889999999999876432 224567799999999864 58999999999999999999999
Q ss_pred CCCCCChHHH--HHH---HHhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhccc
Q 014210 360 PFWARTESGI--FRA---VLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLICYQS 423 (429)
Q Consensus 360 Pf~~~~~~~~--~~~---i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~~ 423 (429)
||........ +.. ............++.+++++.+||.+||+.||++||++.++|+|+||+...
T Consensus 292 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 360 (371)
T 3q60_A 292 PFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQLQ 360 (371)
T ss_dssp STTBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHHH
T ss_pred CCCCcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHHH
Confidence 9976633210 000 011111222233357899999999999999999999999999999998654
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-47 Score=377.89 Aligned_cols=258 Identities=28% Similarity=0.474 Sum_probs=216.8
Q ss_pred ccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeC-
Q 014210 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT- 231 (429)
Q Consensus 153 ~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~- 231 (429)
+.++|++++.||+|+||.||+|+... +|+.||||++... ......+.+.+|++++++++ |+||+++++++...
T Consensus 25 ~~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~ 98 (364)
T 3qyz_A 25 VGPRYTNLSYIGEGAYGMVCSAYDNL---NKVRVAIKKISPF--EHQTYCQRTLREIKILLRFR-HENIIGINDIIRAPT 98 (364)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEECCT--TCHHHHHHHHHHHHHHHHCC-CTTBCCCCEEECCSS
T ss_pred ccccEEEEEEeecCCCeEEEEEEECC---CCeEEEEEEeccc--cCcHHHHHHHHHHHHHHhcC-CCCCccceeEEecCC
Confidence 35799999999999999999998765 5899999998653 34555678899999999998 99999999999765
Q ss_pred ----CeEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeec
Q 014210 232 ----DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDF 307 (429)
Q Consensus 232 ----~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DF 307 (429)
...|+||||++ ++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+||
T Consensus 99 ~~~~~~~~iv~e~~~-~~L~~~l~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~---~~~~~~kl~Df 172 (364)
T 3qyz_A 99 IEQMKDVYIVQDLME-TDLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLL---NTTCDLKICDF 172 (364)
T ss_dssp TTTCCCEEEEEECCS-EEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCC
T ss_pred ccccceEEEEEcccC-cCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEE---CCCCCEEEEeC
Confidence 36899999997 599988754 469999999999999999999999999999999999999 77888999999
Q ss_pred CCccccCCCcc----ccccccCCcccCccccc--CCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCC-
Q 014210 308 GLSDFVRPDER----LNDIVGSAYYVAPEVLH--RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSF- 380 (429)
Q Consensus 308 Gla~~~~~~~~----~~~~~gt~~y~aPE~~~--~~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~- 380 (429)
|++........ ....+||+.|+|||++. ..++.++|||||||++|+|++|+.||......+.+..+.......
T Consensus 173 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~ 252 (364)
T 3qyz_A 173 GLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPS 252 (364)
T ss_dssp TTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCC
T ss_pred cceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 99987653322 24568999999999864 348999999999999999999999998887776666654321110
Q ss_pred ----------------------CC----CCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhcc
Q 014210 381 ----------------------DE----APWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLICYQ 422 (429)
Q Consensus 381 ----------------------~~----~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~ 422 (429)
.. ...+.++.++.+||++||+.||++|||+.++|+|+||+..
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~ 320 (364)
T 3qyz_A 253 QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 320 (364)
T ss_dssp HHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTT
T ss_pred HHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhc
Confidence 00 0124678999999999999999999999999999999864
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-48 Score=389.04 Aligned_cols=264 Identities=28% Similarity=0.461 Sum_probs=198.9
Q ss_pred cccCceeE-eceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEe
Q 014210 152 HFANKYEL-GEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED 230 (429)
Q Consensus 152 ~~~~~y~~-~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~ 230 (429)
.+.+.|++ +++||+|+||.||+|+.+.+. +++.||||++..... .+.+.+|+.++++|+ |+||+++++++..
T Consensus 17 ~~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~-~~~~vaiK~~~~~~~-----~~~~~~E~~~l~~l~-hpniv~~~~~~~~ 89 (405)
T 3rgf_A 17 RVEDLFEYEGCKVGRGTYGHVYKAKRKDGK-DDKDYALKQIEGTGI-----SMSACREIALLRELK-HPNVISLQKVFLS 89 (405)
T ss_dssp CHHHHEECSSCCCC-----EEEEEEESSSS-CCCCEEEEECSSSSC-----CHHHHHHHHHHHHCC-CTTBCCCCEEEEE
T ss_pred hhhhhhhhcCcEeeecCCeEEEEEEEccCC-CCeEEEEEEECCCCC-----CHHHHHHHHHHHhcC-CCCeeeEeeEEec
Confidence 34567887 558999999999999876432 578999999965432 135779999999998 9999999999964
Q ss_pred --CCeEEEEEEecCCCcHHHHHHhc--------CCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeec-CCC
Q 014210 231 --TDNVYVVMELCEGGELLDRILSR--------GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTK-DEN 299 (429)
Q Consensus 231 --~~~~~lv~E~~~ggsL~~~i~~~--------~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~-~~~ 299 (429)
...++|||||+++ +|.+++... ...+++..++.|+.||+.||.|||++||+||||||+||||... +.+
T Consensus 90 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~ 168 (405)
T 3rgf_A 90 HADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPER 168 (405)
T ss_dssp TTTTEEEEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTT
T ss_pred CCCCeEEEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCC
Confidence 6789999999964 888877532 1249999999999999999999999999999999999999644 456
Q ss_pred ceEEEeecCCccccCCC----ccccccccCCcccCcccccC--CCCCcccHHHHHHHHHHHHcCCCCCCCCCh-------
Q 014210 300 SVLKAIDFGLSDFVRPD----ERLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTE------- 366 (429)
Q Consensus 300 ~~vkL~DFGla~~~~~~----~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlGvll~elltg~~Pf~~~~~------- 366 (429)
+.+||+|||+++..... ......+||+.|+|||++.+ .++.++|||||||++|||++|+.||.....
T Consensus 169 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~ 248 (405)
T 3rgf_A 169 GRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNP 248 (405)
T ss_dssp TCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CC
T ss_pred CcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCcccccccccc
Confidence 89999999999876532 23345689999999998864 489999999999999999999999976544
Q ss_pred --HHHHHHHHhcCCCCCCCCCC----------------------------------CCCHHHHHHHHHhcccCccCcCCH
Q 014210 367 --SGIFRAVLKADPSFDEAPWP----------------------------------SLSSEARDFVKRLLNKDPRKRLTA 410 (429)
Q Consensus 367 --~~~~~~i~~~~~~~~~~~~~----------------------------------~~s~~~~~li~~~L~~dP~~Rps~ 410 (429)
.+.+..+...........|. ..+.++.+||++||+.||++|||+
T Consensus 249 ~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta 328 (405)
T 3rgf_A 249 YHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITS 328 (405)
T ss_dssp CCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCH
T ss_pred chHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCH
Confidence 24444444322222222221 126789999999999999999999
Q ss_pred HHHHhhHhhhccc
Q 014210 411 AQALSELLICYQS 423 (429)
Q Consensus 411 ~~iL~~~~~~~~~ 423 (429)
.|+|+|+||....
T Consensus 329 ~e~L~hp~f~~~~ 341 (405)
T 3rgf_A 329 EQAMQDPYFLEDP 341 (405)
T ss_dssp HHHHTSGGGTSSS
T ss_pred HHHhcChhhccCC
Confidence 9999999998643
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-47 Score=381.54 Aligned_cols=258 Identities=28% Similarity=0.422 Sum_probs=211.8
Q ss_pred cccccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEE
Q 014210 150 SKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYE 229 (429)
Q Consensus 150 ~~~~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~ 229 (429)
++....+|++.++||+|+||.||+|+... +..||+|++...... ..+|+++++.++ |+||+++++++.
T Consensus 35 ~~~~~~~Y~~~~~lG~G~~g~V~~a~~~~----~~~~aikk~~~~~~~-------~~~E~~il~~l~-h~niv~l~~~~~ 102 (394)
T 4e7w_A 35 GEQREIAYTNCKVIGNGSFGVVFQAKLVE----SDEVAIKKVLQDKRF-------KNRELQIMRIVK-HPNVVDLKAFFY 102 (394)
T ss_dssp CCEEEEEEEEEEEEEEETTEEEEEEEETT----TEEEEEEEEECCTTS-------CCHHHHHHHTCC-CTTBCCEEEEEE
T ss_pred CCcccceEEEeEEEeeCCCeEEEEEEECC----CCeEEEEEEecCcch-------HHHHHHHHHhCC-CCCcceEEEEEE
Confidence 34456789999999999999999998765 345888887543221 237999999998 999999999996
Q ss_pred eCCe------EEEEEEecCCCcHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCc
Q 014210 230 DTDN------VYVVMELCEGGELLDRIL---SRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENS 300 (429)
Q Consensus 230 ~~~~------~~lv~E~~~ggsL~~~i~---~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~ 300 (429)
..+. +++|||||+++ +...+. .....+++..++.++.||++||+|||++||+||||||+|||++ ..++
T Consensus 103 ~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~--~~~~ 179 (394)
T 4e7w_A 103 SNGDKKDEVFLNLVLEYVPET-VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLD--PPSG 179 (394)
T ss_dssp EESSSSSCEEEEEEEECCSEE-HHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE--TTTT
T ss_pred ecCCCCCceEEEEEeeccCcc-HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEc--CCCC
Confidence 5443 88999999874 444333 3356899999999999999999999999999999999999993 2688
Q ss_pred eEEEeecCCccccCCCccccccccCCcccCcccccC--CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCC
Q 014210 301 VLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADP 378 (429)
Q Consensus 301 ~vkL~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~ 378 (429)
.+||+|||+++............||+.|+|||++.+ .++.++|||||||++|||++|+.||.+....+.+..+.+...
T Consensus 180 ~~kL~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g 259 (394)
T 4e7w_A 180 VLKLIDFGSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLG 259 (394)
T ss_dssp EEEECCCTTCEECCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred cEEEeeCCCcccccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 999999999988766666667789999999998864 589999999999999999999999999888777766654210
Q ss_pred -----------------CCCC--------CCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhcc
Q 014210 379 -----------------SFDE--------APWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLICYQ 422 (429)
Q Consensus 379 -----------------~~~~--------~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~ 422 (429)
.++. ...+.+++++.+||.+||+.||++|||+.++|+|+||...
T Consensus 260 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 328 (394)
T 4e7w_A 260 TPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDEL 328 (394)
T ss_dssp CCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTT
T ss_pred CCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhh
Confidence 1111 0123488999999999999999999999999999999753
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-47 Score=367.63 Aligned_cols=262 Identities=32% Similarity=0.516 Sum_probs=214.0
Q ss_pred ccccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEE-
Q 014210 151 KHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYE- 229 (429)
Q Consensus 151 ~~~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~- 229 (429)
..+.++|++++.||+|+||.||+|.... +|+.||||++.. ......+++.+|++++++++ |+||+++++++.
T Consensus 7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~---~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~ 79 (320)
T 2i6l_A 7 FDLGSRYMDLKPLGCGGNGLVFSAVDND---CDKRVAIKKIVL---TDPQSVKHALREIKIIRRLD-HDNIVKVFEILGP 79 (320)
T ss_dssp EEETTTEEEEEECC-----CEEEEEETT---TTEEEEEEEEEC---CSHHHHHHHHHHHHHHHTCC-CTTBCCEEEEECT
T ss_pred CccCCceeEEEEeccCCCeEEEEEEECC---CCeEEEEEEEec---CChHHHHHHHHHHHHHHhcC-CCCeeEEEEeccc
Confidence 3467899999999999999999998765 589999999864 34566788999999999998 999999999874
Q ss_pred -------------eCCeEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeec
Q 014210 230 -------------DTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTK 296 (429)
Q Consensus 230 -------------~~~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~ 296 (429)
+.+..++||||++ |+|.+++ ..+.+++..++.++.||+.||+|||++||+||||||+|||++
T Consensus 80 ~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~-- 154 (320)
T 2i6l_A 80 SGSQLTDDVGSLTELNSVYIVQEYME-TDLANVL--EQGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFIN-- 154 (320)
T ss_dssp TSCBCCC----CCSCSEEEEEEECCS-EEHHHHH--TTCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEE--
T ss_pred cccccccccccccccCceeEEeeccC-CCHHHHh--hcCCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEc--
Confidence 4467899999997 5999877 346799999999999999999999999999999999999994
Q ss_pred CCCceEEEeecCCccccCCC----ccccccccCCcccCccccc--CCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHH
Q 014210 297 DENSVLKAIDFGLSDFVRPD----ERLNDIVGSAYYVAPEVLH--RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIF 370 (429)
Q Consensus 297 ~~~~~vkL~DFGla~~~~~~----~~~~~~~gt~~y~aPE~~~--~~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~ 370 (429)
.+++.+||+|||++...... .......+|..|+|||++. +.++.++||||||+++|||++|+.||........+
T Consensus 155 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~ 234 (320)
T 2i6l_A 155 TEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQM 234 (320)
T ss_dssp TTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred CCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 35678999999999876432 2233456799999999875 46889999999999999999999999988887777
Q ss_pred HHHHhcCCCCCC--------------------------CCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhccce
Q 014210 371 RAVLKADPSFDE--------------------------APWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLICYQSY 424 (429)
Q Consensus 371 ~~i~~~~~~~~~--------------------------~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~~~ 424 (429)
..+....+.... ..++.++.++.+||++||+.||++||++.++|+|+||....+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 314 (320)
T 2i6l_A 235 QLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSF 314 (320)
T ss_dssp HHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTCC
T ss_pred HHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccccC
Confidence 766654322110 112468999999999999999999999999999999986554
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-47 Score=363.42 Aligned_cols=258 Identities=31% Similarity=0.545 Sum_probs=216.9
Q ss_pred ccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCC
Q 014210 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (429)
Q Consensus 153 ~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~ 232 (429)
+.++|++.+.||+|+||.||+|+... +|+.||||++..... ....+.+.+|+.+++.++ |+||+++++++.+.+
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~ 78 (276)
T 2yex_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRV---TEEAVAVKIVDMKRA--VDCPENIKKEICINKMLN-HENVVKFYGHRREGN 78 (276)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETT---TCCEEEEEEEEGGGC--TTHHHHHHHHHHHHHTCC-CTTBCCEEEEEEETT
T ss_pred eecceEEEEEeecCCCcEEEEEEECC---CCcEEEEEEeeeccc--hhhhHHHHHHHHHHHhcC-CCCceeeeeEEEcCC
Confidence 45789999999999999999998765 589999999864432 234577899999999998 999999999999999
Q ss_pred eEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccc
Q 014210 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (429)
Q Consensus 233 ~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~ 312 (429)
..++||||+++++|.+++ .....+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..
T Consensus 79 ~~~lv~e~~~~~~L~~~l-~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~dfg~~~~ 154 (276)
T 2yex_A 79 IQYLFLEYCSGGELFDRI-EPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL---DERDNLKISDFGLATV 154 (276)
T ss_dssp EEEEEEECCTTEEGGGGS-BTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCTTCEE
T ss_pred EEEEEEEecCCCcHHHHH-hhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEE---ccCCCEEEeeCCCccc
Confidence 999999999999999876 344579999999999999999999999999999999999999 6788899999999976
Q ss_pred cCCCc---cccccccCCcccCcccccC-C-CCCcccHHHHHHHHHHHHcCCCCCCCCChH-HHHHHHHhcCCCCCCCCCC
Q 014210 313 VRPDE---RLNDIVGSAYYVAPEVLHR-S-YSTEADVWSIGVIAYILLCGSRPFWARTES-GIFRAVLKADPSFDEAPWP 386 (429)
Q Consensus 313 ~~~~~---~~~~~~gt~~y~aPE~~~~-~-~~~~sDiwSlGvll~elltg~~Pf~~~~~~-~~~~~i~~~~~~~~~~~~~ 386 (429)
..... ......||..|+|||++.+ . ++.++||||||+++|+|++|+.||...... ..+..+..... ....+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~ 232 (276)
T 2yex_A 155 FRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT--YLNPWK 232 (276)
T ss_dssp CEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCT--TSTTGG
T ss_pred cCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhccc--ccCchh
Confidence 54222 2345679999999999874 3 367899999999999999999999876543 23333333222 122345
Q ss_pred CCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhcc
Q 014210 387 SLSSEARDFVKRLLNKDPRKRLTAAQALSELLICYQ 422 (429)
Q Consensus 387 ~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~ 422 (429)
.++.++.+||++||+.||++||++.++++|+||+..
T Consensus 233 ~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (276)
T 2yex_A 233 KIDSAPLALLHKILVENPSARITIPDIKKDRWYNKP 268 (276)
T ss_dssp GSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred hcCHHHHHHHHHHCCCCchhCCCHHHHhcCccccCh
Confidence 689999999999999999999999999999999864
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-47 Score=367.29 Aligned_cols=261 Identities=30% Similarity=0.476 Sum_probs=218.9
Q ss_pred cccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeC
Q 014210 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (429)
Q Consensus 152 ~~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~ 231 (429)
...++|++++.||+|+||.||+|+... +|+.||+|++... .....+.+.+|+.+++++. ||||+++++++.+.
T Consensus 16 ~~~~~y~i~~~lg~G~~g~V~~~~~~~---~~~~~aiK~~~~~---~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~ 88 (302)
T 2j7t_A 16 DPNEVWEIVGELGDGAFGKVYKAKNKE---TGALAAAKVIETK---SEEELEDYIVEIEILATCD-HPYIVKLLGAYYHD 88 (302)
T ss_dssp CGGGTEEEEEEEECSTTCCEEEEEETT---TCCEEEEEEEC-------CCHHHHHHHHHHHHHCC-CTTBCCEEEEEECC
T ss_pred CCccceeecceeccCCCeEEEEEEEcC---CCcEEEEEEecCC---CHHHHHHHHHHHHHHhcCC-CCCEeeeeeeeeeC
Confidence 356889999999999999999998765 5899999998653 2334567889999999998 99999999999999
Q ss_pred CeEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCcc
Q 014210 232 DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (429)
Q Consensus 232 ~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~ 311 (429)
+..++||||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.
T Consensus 89 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~ 165 (302)
T 2j7t_A 89 GKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLM---TLEGDIRLADFGVSA 165 (302)
T ss_dssp -CEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEE---CTTSCEEECCCHHHH
T ss_pred CeEEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEE---CCCCCEEEEECCCCc
Confidence 99999999999999999887777889999999999999999999999999999999999999 778889999999875
Q ss_pred ccCCC-ccccccccCCcccCcccc------cCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCC
Q 014210 312 FVRPD-ERLNDIVGSAYYVAPEVL------HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAP 384 (429)
Q Consensus 312 ~~~~~-~~~~~~~gt~~y~aPE~~------~~~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 384 (429)
..... .......||..|+|||++ ...++.++||||||+++|+|++|+.||........+..+........ ..
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~ 244 (302)
T 2j7t_A 166 KNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTL-LT 244 (302)
T ss_dssp HHHHHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC-SS
T ss_pred cccccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCccc-CC
Confidence 43211 122345799999999987 24588999999999999999999999998887777776666543322 12
Q ss_pred CCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhccc
Q 014210 385 WPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLICYQS 423 (429)
Q Consensus 385 ~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~~ 423 (429)
...++.++.+||++||+.||++||++.++++|+||+...
T Consensus 245 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 283 (302)
T 2j7t_A 245 PSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSIT 283 (302)
T ss_dssp GGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCC
T ss_pred ccccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhhc
Confidence 246889999999999999999999999999999998643
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-47 Score=366.07 Aligned_cols=260 Identities=27% Similarity=0.493 Sum_probs=216.2
Q ss_pred ccccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEe
Q 014210 151 KHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED 230 (429)
Q Consensus 151 ~~~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~ 230 (429)
+...++|++.+.||+|+||.||+|.... +|+.||||++.... ..+.+.+|+.+++++. |+||+++++++.+
T Consensus 25 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~ 95 (314)
T 3com_A 25 KQPEEVFDVLEKLGEGSYGSVYKAIHKE---TGQIVAIKQVPVES-----DLQEIIKEISIMQQCD-SPHVVKYYGSYFK 95 (314)
T ss_dssp -----CEEEEEECC----CEEEEEEETT---TCCEEEEEEEETTS-----CCHHHHHHHHHHHTCC-CTTBCCEEEEEEE
T ss_pred hcchhhhhhheeeccCCCeEEEEEEECC---CCCEEEEEecCchH-----HHHHHHHHHHHHHhCC-CCCCccEEEEEEe
Confidence 3456789999999999999999998765 58999999986532 2356889999999997 9999999999999
Q ss_pred CCeEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCc
Q 014210 231 TDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS 310 (429)
Q Consensus 231 ~~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla 310 (429)
.+..++||||+++++|.+++......+++..++.++.||+.||.|||+.||+|+||||+|||+ +.++.+||+|||++
T Consensus 96 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~dfg~~ 172 (314)
T 3com_A 96 NTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILL---NTEGHAKLADFGVA 172 (314)
T ss_dssp TTEEEEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCCTTC
T ss_pred CCEEEEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEE---CCCCCEEEeecccc
Confidence 999999999999999999987777889999999999999999999999999999999999999 67889999999999
Q ss_pred cccCCCc-cccccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCC
Q 014210 311 DFVRPDE-RLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSL 388 (429)
Q Consensus 311 ~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 388 (429)
....... ......||..|+|||++.+ .++.++||||||+++|+|++|+.||...........+...... .......+
T Consensus 173 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 251 (314)
T 3com_A 173 GQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPP-TFRKPELW 251 (314)
T ss_dssp EECBTTBSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC-CCSSGGGS
T ss_pred hhhhhhccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCc-ccCCcccC
Confidence 7665432 2345679999999998874 6899999999999999999999999887766555544443321 11222357
Q ss_pred CHHHHHHHHHhcccCccCcCCHHHHHhhHhhhccc
Q 014210 389 SSEARDFVKRLLNKDPRKRLTAAQALSELLICYQS 423 (429)
Q Consensus 389 s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~~ 423 (429)
+.++.+||.+||..||.+||++.++|+|+||+...
T Consensus 252 ~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~~ 286 (314)
T 3com_A 252 SDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAK 286 (314)
T ss_dssp CHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTCC
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHhCHHHhcCC
Confidence 89999999999999999999999999999998653
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-47 Score=379.95 Aligned_cols=257 Identities=30% Similarity=0.526 Sum_probs=201.4
Q ss_pred cccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeC
Q 014210 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (429)
Q Consensus 152 ~~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~ 231 (429)
.+.++|++++.||+|+||.||+|.... +|+.||||++.... ......+++.+|+.+++.++ |+||+++++++...
T Consensus 26 ~~~~~y~~~~~lG~G~~g~V~~a~~~~---~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~ 100 (367)
T 2fst_X 26 EVPERYQNLSPVGSGAYGSVCAAFDTK---TGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMK-HENVIGLLDVFTPA 100 (367)
T ss_dssp EEETTEEEEEECC----CCEEEEEETT---TTEEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSC
T ss_pred CCCCceEEeeEEeecCCeEEEEEEECC---CCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEecC
Confidence 456899999999999999999998765 68999999986532 44556678899999999998 99999999999754
Q ss_pred ------CeEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEe
Q 014210 232 ------DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAI 305 (429)
Q Consensus 232 ------~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~ 305 (429)
...|+|||++ +++|.+++.. ..+++..++.++.||++||.|||++||+||||||+|||+ +.++.+||+
T Consensus 101 ~~~~~~~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll---~~~~~~kL~ 174 (367)
T 2fst_X 101 RSLEEFNDVYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKIL 174 (367)
T ss_dssp SSGGGCCCCEEEEECC-CEECC-------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEEC
T ss_pred CccccCCeEEEEeccc-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEE---CCCCCEEEe
Confidence 5689999999 6799887743 579999999999999999999999999999999999999 778899999
Q ss_pred ecCCccccCCCccccccccCCcccCcccccC--CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCC----
Q 014210 306 DFGLSDFVRPDERLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPS---- 379 (429)
Q Consensus 306 DFGla~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~---- 379 (429)
|||+++.... .....+||..|+|||++.+ .++.++|||||||++|||++|+.||.+....+.+..+.+....
T Consensus 175 DFG~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~ 252 (367)
T 2fst_X 175 DFGLARHTAD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 252 (367)
T ss_dssp C-----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHH
T ss_pred eccccccccc--cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 9999987543 2345689999999998864 6899999999999999999999999988877776666542111
Q ss_pred -------------------CCCC----CCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhc
Q 014210 380 -------------------FDEA----PWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLICY 421 (429)
Q Consensus 380 -------------------~~~~----~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~ 421 (429)
.... .++.+++++.+||++||+.||++|||+.++|+|+||+.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~ 317 (367)
T 2fst_X 253 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 317 (367)
T ss_dssp HHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred HHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhh
Confidence 1111 12457899999999999999999999999999999975
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=390.58 Aligned_cols=251 Identities=18% Similarity=0.212 Sum_probs=202.8
Q ss_pred cCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhc--CCCCcceEE------
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALT--GHNNLVKFF------ 225 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~--~h~nIv~l~------ 225 (429)
.++|++.+.||+|+||.||+|+... +|+.||||++...........+.+.+|+.+++.+. .|||||+++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~ 148 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQE---TGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFP 148 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-C---CCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCC
T ss_pred CceEEEcceeecCCCEEEEEEEECC---CCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhh
Confidence 5789999999999999999999765 58999999997654555566788999996555554 499999998
Q ss_pred -EEEEeCCe-----------------EEEEEEecCCCcHHHHHHhcCC------CCCHHHHHHHHHHHHHHHHHHHHcCc
Q 014210 226 -DAYEDTDN-----------------VYVVMELCEGGELLDRILSRGG------KYTEDDAKAVMIQILNVVAFCHLQGV 281 (429)
Q Consensus 226 -~~~~~~~~-----------------~~lv~E~~~ggsL~~~i~~~~~------~l~~~~~~~i~~qi~~gL~~LH~~~i 281 (429)
+++++.+. .||||||+ +|+|.+++..... .+++..++.|+.||+.||+|||++||
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i 227 (377)
T 3byv_A 149 FDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGL 227 (377)
T ss_dssp SEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred hhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCe
Confidence 77776543 89999999 6799998875421 23358888999999999999999999
Q ss_pred eeccCCCCcEEEeecCCCceEEEeecCCccccCCCccccccccCCcccCcccccC------------CCCCcccHHHHHH
Q 014210 282 VHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHR------------SYSTEADVWSIGV 349 (429)
Q Consensus 282 iHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~~------------~~~~~sDiwSlGv 349 (429)
+||||||+|||+ +.++.+||+|||+++... ......+| ..|+|||++.+ .++.++|||||||
T Consensus 228 vHrDikp~NIll---~~~~~~kL~DFG~a~~~~--~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~ 301 (377)
T 3byv_A 228 VHTYLRPVDIVL---DQRGGVFLTGFEHLVRDG--ARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL 301 (377)
T ss_dssp ECSCCCGGGEEE---CTTCCEEECCGGGCEETT--CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred ecCCCCHHHEEE---cCCCCEEEEechhheecC--CcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence 999999999999 678899999999998643 33455678 99999998864 5899999999999
Q ss_pred HHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhcc
Q 014210 350 IAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLICYQ 422 (429)
Q Consensus 350 ll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~ 422 (429)
++|||++|+.||...........+. ..++.+++++.+||.+||+.||++||++.++|+|+||+..
T Consensus 302 il~elltg~~Pf~~~~~~~~~~~~~--------~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~ 366 (377)
T 3byv_A 302 VIYWIWCADLPITKDAALGGSEWIF--------RSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQL 366 (377)
T ss_dssp HHHHHHHSSCCC------CCSGGGG--------SSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHHH
T ss_pred HHHHHHHCCCCCcccccccchhhhh--------hhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHHH
Confidence 9999999999997654433222221 1225789999999999999999999999999999999753
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=364.20 Aligned_cols=248 Identities=24% Similarity=0.372 Sum_probs=209.9
Q ss_pred cCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~ 233 (429)
.++|++.++||+|+||.||+|.... +|+.||+|++.. ......+.+.+|++++++++ ||||+++++++.+++.
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~---~~~~va~K~~~~---~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~ 81 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRE---TGEVMVMKELIR---FDEETQRTFLKEVKVMRCLE-HPNVLKFIGVLYKDKR 81 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETT---TCCEEEEEEESC---CCHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEETTE
T ss_pred hhHeeccceecCCCCEEEEEEEECC---CCcEEEEEEecc---CCHHHHHHHHHHHHHHHhCC-CcCcccEEEEEecCCe
Confidence 5789999999999999999998776 589999998854 35666788999999999998 9999999999999999
Q ss_pred EEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCcccc
Q 014210 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (429)
Q Consensus 234 ~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~ 313 (429)
.++||||+++++|.+++......+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++...
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~ 158 (310)
T 3s95_A 82 LNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLV---RENKNVVVADFGLARLM 158 (310)
T ss_dssp EEEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEE---CTTSCEEECCCTTCEEC
T ss_pred eEEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEE---CCCCCEEEeecccceec
Confidence 999999999999999998877889999999999999999999999999999999999999 78889999999999776
Q ss_pred CCCccc---------------cccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHcCCCCCCCCChHH-----HHHH
Q 014210 314 RPDERL---------------NDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESG-----IFRA 372 (429)
Q Consensus 314 ~~~~~~---------------~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~-----~~~~ 372 (429)
...... ....||+.|+|||++.+ .++.++||||||+++|||++|..||....... ....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~ 238 (310)
T 3s95_A 159 VDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRG 238 (310)
T ss_dssp C--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHH
T ss_pred ccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhc
Confidence 433221 14679999999998874 68999999999999999999999985432111 1111
Q ss_pred HHhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhH
Q 014210 373 VLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSEL 417 (429)
Q Consensus 373 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~ 417 (429)
..... ..+.+++++.+||.+||+.||++||++.++++.+
T Consensus 239 ~~~~~------~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L 277 (310)
T 3s95_A 239 FLDRY------CPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWL 277 (310)
T ss_dssp HHHHT------CCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred ccccc------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 11111 1235788999999999999999999999998754
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=360.57 Aligned_cols=255 Identities=26% Similarity=0.423 Sum_probs=210.3
Q ss_pred ccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHH----HHHHHHHHHHHHhcCCCCcceEEEEE
Q 014210 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAI----EDVRREVKILRALTGHNNLVKFFDAY 228 (429)
Q Consensus 153 ~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~----~~~~~Ei~il~~l~~h~nIv~l~~~~ 228 (429)
..++|++.+.||+|+||.||+|+... +++.||||++........... +.+.+|+.++++++ |+||+++++++
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~ 92 (287)
T 4f0f_A 17 ADNEIEYEKQIGKGGFGLVHKGRLVK---DKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN-HPNIVKLYGLM 92 (287)
T ss_dssp CSTTEEEEEECCCCSSSCEEEEEETT---TCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCC-CTTBCCEEEEE
T ss_pred hhccceehhccccCCceeEEEEEEcC---CceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCC-CCCchhhheee
Confidence 46889999999999999999999776 589999999866543332222 67899999999998 99999999999
Q ss_pred EeCCeEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC--ceeccCCCCcEEEeecCC--CceEEE
Q 014210 229 EDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQG--VVHRDLKPENFLFTTKDE--NSVLKA 304 (429)
Q Consensus 229 ~~~~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~--iiHrDIKp~NILl~~~~~--~~~vkL 304 (429)
.+.. ++||||+++++|.+++......+++..++.++.||+.||.|||++| |+||||||+|||++..+. ...+||
T Consensus 93 ~~~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl 170 (287)
T 4f0f_A 93 HNPP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKV 170 (287)
T ss_dssp TTTT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEE
T ss_pred cCCC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEe
Confidence 7665 7999999999999999888788999999999999999999999999 999999999999943221 223999
Q ss_pred eecCCccccCCCccccccccCCcccCccccc---CCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHH--HHHHHhcCCC
Q 014210 305 IDFGLSDFVRPDERLNDIVGSAYYVAPEVLH---RSYSTEADVWSIGVIAYILLCGSRPFWARTESGI--FRAVLKADPS 379 (429)
Q Consensus 305 ~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~--~~~i~~~~~~ 379 (429)
+|||+++.... ......||..|+|||++. ..++.++||||||+++|||++|+.||........ ...+.....
T Consensus 171 ~Dfg~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~- 247 (287)
T 4f0f_A 171 ADFGLSQQSVH--SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGL- 247 (287)
T ss_dssp CCCTTCBCCSS--CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCC-
T ss_pred CCCCccccccc--cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCC-
Confidence 99999975533 345578999999999984 3478899999999999999999999976654433 333333222
Q ss_pred CCCCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhH
Q 014210 380 FDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSEL 417 (429)
Q Consensus 380 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~ 417 (429)
.......+++++.+||++||+.||++||++.++++.+
T Consensus 248 -~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L 284 (287)
T 4f0f_A 248 -RPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKEL 284 (287)
T ss_dssp -CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred -CCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHH
Confidence 2223357899999999999999999999999999865
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-47 Score=378.76 Aligned_cols=256 Identities=25% Similarity=0.390 Sum_probs=208.3
Q ss_pred cCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~ 233 (429)
.++|++.+.||+|+||.||+|+.......+..||||++... ......+++.+|+.++++++ |+||+++++++.+.+.
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~ 120 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG--YTEKQRRDFLGEASIMGQFD-HPNIIRLEGVVTKSKP 120 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTT--CCHHHHHHHHHHHHHHTTCC-CTTBCCEEEEECSSSS
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCc--cCHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEeeCCc
Confidence 56899999999999999999987744345788999998654 34556678999999999998 9999999999999999
Q ss_pred EEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCcccc
Q 014210 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (429)
Q Consensus 234 ~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~ 313 (429)
.+||||||++|+|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++..
T Consensus 121 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~a~~~ 197 (373)
T 2qol_A 121 VMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILI---NSNLVCKVSDFGLGRVL 197 (373)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECCC------
T ss_pred eEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEE---cCCCCEEECcCcccccc
Confidence 999999999999999997777789999999999999999999999999999999999999 78889999999999876
Q ss_pred CCCcc----ccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCC
Q 014210 314 RPDER----LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPS 387 (429)
Q Consensus 314 ~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 387 (429)
..... .....++..|+|||++. +.++.++||||||+++|||++ |+.||+..........+...... .....
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~---~~~~~ 274 (373)
T 2qol_A 198 EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRL---PPPMD 274 (373)
T ss_dssp ----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEEC---CCCTT
T ss_pred ccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC---CCCcc
Confidence 54321 12234577899999886 568999999999999999998 99999998887777766554211 12236
Q ss_pred CCHHHHHHHHHhcccCccCcCCHHHHHhhHh
Q 014210 388 LSSEARDFVKRLLNKDPRKRLTAAQALSELL 418 (429)
Q Consensus 388 ~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~ 418 (429)
++.++.+||.+||+.||++||++.++++.+-
T Consensus 275 ~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~ 305 (373)
T 2qol_A 275 CPAALYQLMLDCWQKDRNNRPKFEQIVSILD 305 (373)
T ss_dssp CBHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred ccHHHHHHHHHHhCcChhhCcCHHHHHHHHH
Confidence 8899999999999999999999999988653
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-47 Score=380.13 Aligned_cols=253 Identities=24% Similarity=0.376 Sum_probs=216.6
Q ss_pred cCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~ 233 (429)
.++|++.++||+|+||.||+|+... +|+.||||++... ......+++.+|++++++++ ||||+++++++.+.+.
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~---~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~ 186 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRA---DNTLVAVKSCRET--LPPDLKAKFLQEARILKQYS-HPNIVRLIGVCTQKQP 186 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETT---TCCEEEEEECCTT--SCHHHHTTTTHHHHHHTTCC-CTTBCCEEEEECSSSS
T ss_pred hHHeEEeeEeccCCCCeEEEEEEec---CCeEEEEEEcccc--CCHHHHHHHHHHHHHHHhCC-CCCEEEEEEEEecCCC
Confidence 5789999999999999999999775 5889999998653 34455567899999999998 9999999999999999
Q ss_pred EEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCcccc
Q 014210 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (429)
Q Consensus 234 ~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~ 313 (429)
.+||||||++|+|.+++...+..+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++..
T Consensus 187 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~---~~~~~~kl~DfG~s~~~ 263 (377)
T 3cbl_A 187 IYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLV---TEKNVLKISDFGMSREE 263 (377)
T ss_dssp CEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCGGGCEEC
T ss_pred cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEE---cCCCcEEECcCCCceec
Confidence 999999999999999998777789999999999999999999999999999999999999 77889999999999765
Q ss_pred CCCccc---cccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCC
Q 014210 314 RPDERL---NDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSL 388 (429)
Q Consensus 314 ~~~~~~---~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 388 (429)
...... ....++..|+|||++. +.++.++|||||||++|||++ |+.||...........+...... + ....+
T Consensus 264 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~-~--~~~~~ 340 (377)
T 3cbl_A 264 ADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRL-P--CPELC 340 (377)
T ss_dssp TTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCC-C--CCTTC
T ss_pred CCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC-C--CCCCC
Confidence 433211 1223567899999886 568999999999999999998 99999888877766665543321 1 12358
Q ss_pred CHHHHHHHHHhcccCccCcCCHHHHHhhHh
Q 014210 389 SSEARDFVKRLLNKDPRKRLTAAQALSELL 418 (429)
Q Consensus 389 s~~~~~li~~~L~~dP~~Rps~~~iL~~~~ 418 (429)
+.++.+||.+||+.||++|||+.++++.+-
T Consensus 341 ~~~l~~li~~cl~~dP~~Rps~~~i~~~L~ 370 (377)
T 3cbl_A 341 PDAVFRLMEQCWAYEPGQRPSFSTIYQELQ 370 (377)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CHHHHHHHHHHcCCCchhCcCHHHHHHHHH
Confidence 899999999999999999999999998653
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-47 Score=376.17 Aligned_cols=263 Identities=23% Similarity=0.377 Sum_probs=210.9
Q ss_pred ccccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCc--------CcHHHHHHHHHHHHHHHHhcCCCCcc
Q 014210 151 KHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKM--------TTAIAIEDVRREVKILRALTGHNNLV 222 (429)
Q Consensus 151 ~~~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~--------~~~~~~~~~~~Ei~il~~l~~h~nIv 222 (429)
..+.++|++++.||+|+||.||+|.... |+.||||++..... ......+.+.+|++++++++ |+||+
T Consensus 18 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv 92 (362)
T 3pg1_A 18 HAMQSPYTVQRFISSGSYGAVCAGVDSE----GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFH-HPNIL 92 (362)
T ss_dssp HHTTCSCEEEEEEEEETTEEEEEEECTT----SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCC-CTTBC
T ss_pred HHhccceEEeEEeccCCCEEEEEEECCC----CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCC-CcCcc
Confidence 4567899999999999999999998643 88999999854321 23344578999999999998 99999
Q ss_pred eEEEEEEe-----CCeEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecC
Q 014210 223 KFFDAYED-----TDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKD 297 (429)
Q Consensus 223 ~l~~~~~~-----~~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~ 297 (429)
++++++.. ....|+||||++ |+|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +
T Consensus 93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~---~ 168 (362)
T 3pg1_A 93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILL---A 168 (362)
T ss_dssp CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---C
T ss_pred ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEE---c
Confidence 99999854 336899999997 58999888777789999999999999999999999999999999999999 7
Q ss_pred CCceEEEeecCCccccCCCccccccccCCcccCccccc--CCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHh
Q 014210 298 ENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLH--RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLK 375 (429)
Q Consensus 298 ~~~~vkL~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~ 375 (429)
.++.+||+|||++.............||..|+|||++. ..++.++|||||||++|+|++|+.||......+.+..+..
T Consensus 169 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~ 248 (362)
T 3pg1_A 169 DNNDITICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVE 248 (362)
T ss_dssp TTCCEEECCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred CCCCEEEEecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 78889999999998766555566678999999999876 4589999999999999999999999998887777666643
Q ss_pred cCCCC------------------------CCC----CCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhcc
Q 014210 376 ADPSF------------------------DEA----PWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLICYQ 422 (429)
Q Consensus 376 ~~~~~------------------------~~~----~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~ 422 (429)
..... ... ..+.+++++.+||.+||+.||++|||+.++|+|+||+..
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 323 (362)
T 3pg1_A 249 VVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESL 323 (362)
T ss_dssp HHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTT
T ss_pred HcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhc
Confidence 21110 000 123568999999999999999999999999999999753
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-47 Score=368.25 Aligned_cols=264 Identities=28% Similarity=0.388 Sum_probs=218.6
Q ss_pred ccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhc--CCCCcceEEEEEE-
Q 014210 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALT--GHNNLVKFFDAYE- 229 (429)
Q Consensus 153 ~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~--~h~nIv~l~~~~~- 229 (429)
..++|++.+.||+|+||.||+|+.... +|+.||||++...... ......+.+|+.+++.+. +|+||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~--~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~ 85 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKN--GGRFVALKRVRVQTGE-EGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTV 85 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTT--TTEEEEEEEEEEEBCT-TSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEE
T ss_pred chhceeeeeeecccccEEEEEEEecCC--CCEEEEEEEeccCccc-ccCCchhhHHHHHHHhhhccCCCCeEeeeeeeee
Confidence 457899999999999999999987532 4889999998643221 111234667888888774 4999999999987
Q ss_pred ----eCCeEEEEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEE
Q 014210 230 ----DTDNVYVVMELCEGGELLDRILSRG-GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKA 304 (429)
Q Consensus 230 ----~~~~~~lv~E~~~ggsL~~~i~~~~-~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL 304 (429)
.....++||||++ |+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili---~~~~~~kl 161 (326)
T 1blx_A 86 SRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILV---TSSGQIKL 161 (326)
T ss_dssp EECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEE
T ss_pred cccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEE---cCCCCEEE
Confidence 5567899999997 59999887654 359999999999999999999999999999999999999 77889999
Q ss_pred eecCCccccCCCccccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCC---
Q 014210 305 IDFGLSDFVRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSF--- 380 (429)
Q Consensus 305 ~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~--- 380 (429)
+|||++.............||..|+|||++. +.++.++||||||+++|+|++|+.||........+..++......
T Consensus 162 ~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 241 (326)
T 1blx_A 162 ADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE 241 (326)
T ss_dssp CSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGG
T ss_pred ecCcccccccCCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcc
Confidence 9999998776555556678999999999886 468999999999999999999999999988877777766421100
Q ss_pred --------------------CCCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhccc
Q 014210 381 --------------------DEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLICYQS 423 (429)
Q Consensus 381 --------------------~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~~ 423 (429)
....++.++.++.+||.+||..||++||++.++|+|+||+...
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 304 (326)
T 1blx_A 242 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE 304 (326)
T ss_dssp GSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred cCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccc
Confidence 0112346899999999999999999999999999999998654
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=376.94 Aligned_cols=264 Identities=23% Similarity=0.409 Sum_probs=218.0
Q ss_pred CccccccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCC-----cc
Q 014210 148 GFSKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNN-----LV 222 (429)
Q Consensus 148 ~~~~~~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~n-----Iv 222 (429)
..++.+.++|++.++||+|+||.||+|+... +|+.||||++.. .....+++.+|+.+++.+..|++ |+
T Consensus 47 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vaiK~~~~----~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv 119 (382)
T 2vx3_A 47 KNGEKWMDRYEIDSLIGKGSFGQVVKAYDRV---EQEWVAIKIIKN----KKAFLNQAQIEVRLLELMNKHDTEMKYYIV 119 (382)
T ss_dssp CTTCEETTTEEEEEEEEEETTEEEEEEEETT---TTEEEEEEEECS----SHHHHHHHHHHHHHHHHHHHCSSGGGGGBC
T ss_pred ecCCEeeeeEEEEEEEeecCCEEEEEEEEcC---CCcEEEEEEEec----cHHHHHHHHHHHHHHHHHHhcccccceeEE
Confidence 4456678999999999999999999998765 589999999864 23455778899999999875664 99
Q ss_pred eEEEEEEeCCeEEEEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH--HcCceeccCCCCcEEEeecCCC
Q 014210 223 KFFDAYEDTDNVYVVMELCEGGELLDRILSRG-GKYTEDDAKAVMIQILNVVAFCH--LQGVVHRDLKPENFLFTTKDEN 299 (429)
Q Consensus 223 ~l~~~~~~~~~~~lv~E~~~ggsL~~~i~~~~-~~l~~~~~~~i~~qi~~gL~~LH--~~~iiHrDIKp~NILl~~~~~~ 299 (429)
++++++...+..+|||||++ ++|.+++.... ..+++..++.++.||+.||.||| +.||+||||||+|||++. +.+
T Consensus 120 ~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~-~~~ 197 (382)
T 2vx3_A 120 HLKRHFMFRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCN-PKR 197 (382)
T ss_dssp CEEEEEEETTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESS-TTS
T ss_pred EeeeeeccCCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEec-CCC
Confidence 99999999999999999996 49999887654 56999999999999999999999 579999999999999942 236
Q ss_pred ceEEEeecCCccccCCCccccccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCC
Q 014210 300 SVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADP 378 (429)
Q Consensus 300 ~~vkL~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~ 378 (429)
+.+||+|||+++.... ......||+.|+|||++.+ .++.++|||||||++|||++|+.||......+.+..+.....
T Consensus 198 ~~~kL~DFG~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~ 275 (382)
T 2vx3_A 198 SAIKIVDFGSSCQLGQ--RIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLG 275 (382)
T ss_dssp CCEEECCCTTCEETTC--CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred CcEEEEeccCceeccc--ccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 7899999999987643 3446789999999998875 689999999999999999999999999888877776654211
Q ss_pred CCC------------------CCCC--------------CC----------------------------CCHHHHHHHHH
Q 014210 379 SFD------------------EAPW--------------PS----------------------------LSSEARDFVKR 398 (429)
Q Consensus 379 ~~~------------------~~~~--------------~~----------------------------~s~~~~~li~~ 398 (429)
..+ ...| +. ..+++.+||++
T Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~ 355 (382)
T 2vx3_A 276 IPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILR 355 (382)
T ss_dssp SCCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHH
T ss_pred CCCHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHH
Confidence 110 0000 00 01478999999
Q ss_pred hcccCccCcCCHHHHHhhHhhhcc
Q 014210 399 LLNKDPRKRLTAAQALSELLICYQ 422 (429)
Q Consensus 399 ~L~~dP~~Rps~~~iL~~~~~~~~ 422 (429)
||+.||++|||+.|+|+|+||+..
T Consensus 356 mL~~dP~~Rpta~e~L~hp~f~~~ 379 (382)
T 2vx3_A 356 MLDYDPKTRIQPYYALQHSFFKKT 379 (382)
T ss_dssp HTCSCTTTSCCHHHHTTSGGGCC-
T ss_pred hcCCChhhCCCHHHHhcCcccccC
Confidence 999999999999999999999864
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-47 Score=379.27 Aligned_cols=267 Identities=23% Similarity=0.371 Sum_probs=212.1
Q ss_pred CCcCccccccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcC-------
Q 014210 145 KSFGFSKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTG------- 217 (429)
Q Consensus 145 ~~~~~~~~~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~------- 217 (429)
..+..++.+.++|++.++||+|+||.||+|+... +|+.||||++... ....+.+.+|+.+++++..
T Consensus 27 ~~~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~ 99 (397)
T 1wak_A 27 HLVKIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQ---GKKFVAMKVVKSA----EHYTETALDEIRLLKSVRNSDPNDPN 99 (397)
T ss_dssp CSSCTTCEETTTEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHSCTTCGG
T ss_pred eEEehhhhcCCeEEEEEEeeecCCeeEEEEEecC---CCeEEEEEEEecC----CcchHHHHHHHHHHHHHhhcCCCCCC
Confidence 3455567778999999999999999999998766 5899999998642 4456778999999999962
Q ss_pred CCCcceEEEEEE----eCCeEEEEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHc-CceeccCCCCcE
Q 014210 218 HNNLVKFFDAYE----DTDNVYVVMELCEGGELLDRILSRG-GKYTEDDAKAVMIQILNVVAFCHLQ-GVVHRDLKPENF 291 (429)
Q Consensus 218 h~nIv~l~~~~~----~~~~~~lv~E~~~ggsL~~~i~~~~-~~l~~~~~~~i~~qi~~gL~~LH~~-~iiHrDIKp~NI 291 (429)
|+||+++++++. +....+|||||+ +++|++++.... ..+++..++.++.||+.||.|||++ ||+||||||+||
T Consensus 100 ~~~iv~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NI 178 (397)
T 1wak_A 100 REMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENI 178 (397)
T ss_dssp GGGBCCEEEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGE
T ss_pred cceeeeeecceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHe
Confidence 788999999998 556799999999 567777776554 5799999999999999999999999 999999999999
Q ss_pred EEeecC----------------------------------------------CCceEEEeecCCccccCCCccccccccC
Q 014210 292 LFTTKD----------------------------------------------ENSVLKAIDFGLSDFVRPDERLNDIVGS 325 (429)
Q Consensus 292 Ll~~~~----------------------------------------------~~~~vkL~DFGla~~~~~~~~~~~~~gt 325 (429)
|++.++ ....+||+|||++..... .....+||
T Consensus 179 ll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~--~~~~~~gt 256 (397)
T 1wak_A 179 LLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK--HFTEDIQT 256 (397)
T ss_dssp EECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB--CSCSCCSC
T ss_pred eEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccc--cCccCCCC
Confidence 994221 113799999999987643 34456899
Q ss_pred CcccCcccccC-CCCCcccHHHHHHHHHHHHcCCCCCCCCC------hHHHHHHHHhcCCCCCC----------------
Q 014210 326 AYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWART------ESGIFRAVLKADPSFDE---------------- 382 (429)
Q Consensus 326 ~~y~aPE~~~~-~~~~~sDiwSlGvll~elltg~~Pf~~~~------~~~~~~~i~~~~~~~~~---------------- 382 (429)
..|+|||++.+ .++.++|||||||++|||++|+.||.... ....+..+.......+.
T Consensus 257 ~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~ 336 (397)
T 1wak_A 257 RQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKK 336 (397)
T ss_dssp GGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTT
T ss_pred CcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCc
Confidence 99999998864 58999999999999999999999997544 22233322221110000
Q ss_pred ----------------------CCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhc
Q 014210 383 ----------------------APWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLICY 421 (429)
Q Consensus 383 ----------------------~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~ 421 (429)
......+.++.+||.+||+.||++|||+.|+|+|+||+.
T Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 397 (397)
T 1wak_A 337 GDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS 397 (397)
T ss_dssp SSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred cccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence 000123467889999999999999999999999999973
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-47 Score=367.87 Aligned_cols=266 Identities=21% Similarity=0.340 Sum_probs=199.2
Q ss_pred cccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeC
Q 014210 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (429)
Q Consensus 152 ~~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~ 231 (429)
...++|++++.||+|+||.||+|+...+......||||++..... .....+++.+|++++++++ |+||+++++++.+.
T Consensus 20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~ 97 (323)
T 3qup_A 20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADII-ASSDIEEFLREAACMKEFD-HPHVAKLVGVSLRS 97 (323)
T ss_dssp CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC-------CHHHHHHHHHHHHHTTCC-CTTBCCCCEEEECC
T ss_pred cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEeccccc-CHHHHHHHHHHHHHHHHCC-CCceehhhceeecc
Confidence 346789999999999999999998776432234899999865432 3345678999999999997 99999999999887
Q ss_pred CeE------EEEEEecCCCcHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCc
Q 014210 232 DNV------YVVMELCEGGELLDRILSRG-----GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENS 300 (429)
Q Consensus 232 ~~~------~lv~E~~~ggsL~~~i~~~~-----~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~ 300 (429)
+.. ++||||+++|+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++
T Consensus 98 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli---~~~~ 174 (323)
T 3qup_A 98 RAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCML---AEDM 174 (323)
T ss_dssp -------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CTTS
T ss_pred ccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEE---cCCC
Confidence 655 99999999999999886432 259999999999999999999999999999999999999 7788
Q ss_pred eEEEeecCCccccCCCccc---cccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHh
Q 014210 301 VLKAIDFGLSDFVRPDERL---NDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLK 375 (429)
Q Consensus 301 ~vkL~DFGla~~~~~~~~~---~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~ellt-g~~Pf~~~~~~~~~~~i~~ 375 (429)
.+||+|||+++........ ....++..|+|||++. ..++.++||||||+++|||++ |+.||...........+..
T Consensus 175 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~ 254 (323)
T 3qup_A 175 TVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIG 254 (323)
T ss_dssp CEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHT
T ss_pred CEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhc
Confidence 9999999999876543322 2345678899999886 468999999999999999999 9999998888887777766
Q ss_pred cCCCCCCCCCCCCCHHHHHHHHHhcccCccCcCC-------HHHHHhhHhhhcccee
Q 014210 376 ADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLT-------AAQALSELLICYQSYL 425 (429)
Q Consensus 376 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps-------~~~iL~~~~~~~~~~~ 425 (429)
..... ..+.++.++.+||.+||+.||++||+ .++++.|+|+...+..
T Consensus 255 ~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~~~ 308 (323)
T 3qup_A 255 GNRLK---QPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQD 308 (323)
T ss_dssp TCCCC---CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC---------
T ss_pred CCCCC---CCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCCCC
Confidence 54322 22468999999999999999999999 7777888888765543
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=369.32 Aligned_cols=262 Identities=25% Similarity=0.355 Sum_probs=217.0
Q ss_pred ccCceeEeceeeccCceEEEEEEEecC--cccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEe
Q 014210 153 FANKYELGEEVGRGHFGYTCAAKFKKG--ELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED 230 (429)
Q Consensus 153 ~~~~y~~~~~IG~G~fg~V~~~~~~~~--~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~ 230 (429)
..++|++.+.||+|+||.||+|+.... ...++.||||++... ......+.+.+|+.+++++.+||||+++++++.+
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 120 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEK--ADSSEREALMSELKMMTQLGSHENIVNLLGACTL 120 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccc--cCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEee
Confidence 357899999999999999999997532 125788999999754 2334457789999999999559999999999999
Q ss_pred CCeEEEEEEecCCCcHHHHHHhcCC----------------------CCCHHHHHHHHHHHHHHHHHHHHcCceeccCCC
Q 014210 231 TDNVYVVMELCEGGELLDRILSRGG----------------------KYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKP 288 (429)
Q Consensus 231 ~~~~~lv~E~~~ggsL~~~i~~~~~----------------------~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp 288 (429)
.+..+|||||+++|+|.+++..... .+++..++.++.||+.||.|||++||+||||||
T Consensus 121 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp 200 (344)
T 1rjb_A 121 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAA 200 (344)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSG
T ss_pred CCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCh
Confidence 9999999999999999999876543 379999999999999999999999999999999
Q ss_pred CcEEEeecCCCceEEEeecCCccccCCCcc---ccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHc-CCCCCCC
Q 014210 289 ENFLFTTKDENSVLKAIDFGLSDFVRPDER---LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWA 363 (429)
Q Consensus 289 ~NILl~~~~~~~~vkL~DFGla~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~ellt-g~~Pf~~ 363 (429)
+|||+ +.++.+||+|||++........ .....||+.|+|||++. +.++.++||||||+++|+|++ |+.||..
T Consensus 201 ~NIll---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~ 277 (344)
T 1rjb_A 201 RNVLV---THGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG 277 (344)
T ss_dssp GGEEE---ETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred hhEEE---cCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCccc
Confidence 99999 6788999999999986643322 23456788999999876 568999999999999999998 9999988
Q ss_pred CChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhc
Q 014210 364 RTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLICY 421 (429)
Q Consensus 364 ~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~ 421 (429)
......+..++....... ....+++++.+||.+||+.||++||++.++++++.-..
T Consensus 278 ~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~ 333 (344)
T 1rjb_A 278 IPVDANFYKLIQNGFKMD--QPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQL 333 (344)
T ss_dssp CCCSHHHHHHHHTTCCCC--CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred CCcHHHHHHHHhcCCCCC--CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence 776666655555443222 22468999999999999999999999999999887543
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-47 Score=368.24 Aligned_cols=262 Identities=29% Similarity=0.507 Sum_probs=200.4
Q ss_pred ccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCC
Q 014210 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (429)
Q Consensus 153 ~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~ 232 (429)
..++|++.+.||+|+||.||+|+... +|+.||||++.... .....+++.+|+.++++++ |+||+++++++.+.+
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~ 86 (303)
T 2vwi_A 13 NRDDYELQEVIGSGATAVVQAAYCAP---KKEKVAIKRINLEK--CQTSMDELLKEIQAMSQCH-HPNIVSYYTSFVVKD 86 (303)
T ss_dssp CCCCCEEEEECC---CCCEEEEEC-------CEEEEECCC------------------CCCCCC-CTTBCCEEEEEESSS
T ss_pred chhhhhhhheeccccceEEEEEEECC---CCcEEEEEEEEhhh--cchhHHHHHHHHHHHhhcC-CCCEeeEEEEEeecC
Confidence 35789999999999999999998665 58899999986542 2334567889999999998 999999999999999
Q ss_pred eEEEEEEecCCCcHHHHHHh-------cCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEe
Q 014210 233 NVYVVMELCEGGELLDRILS-------RGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAI 305 (429)
Q Consensus 233 ~~~lv~E~~~ggsL~~~i~~-------~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~ 305 (429)
..++||||+++++|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+
T Consensus 87 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~ 163 (303)
T 2vwi_A 87 ELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILL---GEDGSVQIA 163 (303)
T ss_dssp CEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEE---CTTCCEEEC
T ss_pred CcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEE---cCCCCEEEE
Confidence 99999999999999998864 24569999999999999999999999999999999999999 778899999
Q ss_pred ecCCccccCCCc------cccccccCCcccCccccc--CCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcC
Q 014210 306 DFGLSDFVRPDE------RLNDIVGSAYYVAPEVLH--RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKAD 377 (429)
Q Consensus 306 DFGla~~~~~~~------~~~~~~gt~~y~aPE~~~--~~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~ 377 (429)
|||++....... ......||+.|+|||++. ..++.++||||||+++|+|++|+.||................
T Consensus 164 dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 243 (303)
T 2vwi_A 164 DFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQND 243 (303)
T ss_dssp CCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSS
T ss_pred eccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccC
Confidence 999987654322 123457999999999886 368999999999999999999999998877766665555443
Q ss_pred CCCCC------CCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhccc
Q 014210 378 PSFDE------APWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLICYQS 423 (429)
Q Consensus 378 ~~~~~------~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~~ 423 (429)
..... .....++.++.+||.+||+.||++||++.++++|+||+...
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 295 (303)
T 2vwi_A 244 PPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAK 295 (303)
T ss_dssp CCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC----
T ss_pred CCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCC
Confidence 32221 22346889999999999999999999999999999998543
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-47 Score=360.71 Aligned_cols=258 Identities=30% Similarity=0.491 Sum_probs=219.2
Q ss_pred cCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEe--C
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED--T 231 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~--~ 231 (429)
.++|++++.||+|+||.||+++... +|+.||+|++.... ......+.+.+|+.++++++ |+||+++++++.+ .
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~ 79 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKS---DGKILVWKELDYGS-MTEAEKQMLVSEVNLLRELK-HPNIVRYYDRIIDRTN 79 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETT---TCCEEEEEEEECTT-CCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEEGGG
T ss_pred hhheeeehhccCCCCcEEEEEEECC---CCcEEEEEEEEccc-CCHHHHHHHHHHHHHHHhcC-CCCCCeEEEEEecCCC
Confidence 4789999999999999999998775 58999999997654 24455678999999999998 9999999998854 5
Q ss_pred CeEEEEEEecCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHcC-----ceeccCCCCcEEEeecCCCceEE
Q 014210 232 DNVYVVMELCEGGELLDRILSR---GGKYTEDDAKAVMIQILNVVAFCHLQG-----VVHRDLKPENFLFTTKDENSVLK 303 (429)
Q Consensus 232 ~~~~lv~E~~~ggsL~~~i~~~---~~~l~~~~~~~i~~qi~~gL~~LH~~~-----iiHrDIKp~NILl~~~~~~~~vk 303 (429)
+..++||||+++++|.+++... ...+++..++.++.||+.||.|||+.| |+||||||+|||+ +.++.+|
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~---~~~~~~k 156 (279)
T 2w5a_A 80 TTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFL---DGKQNVK 156 (279)
T ss_dssp TEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEE---CSSSCEE
T ss_pred ceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEE---cCCCCEE
Confidence 6899999999999999988653 345999999999999999999999999 9999999999999 7788999
Q ss_pred EeecCCccccCCCcc-ccccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCC
Q 014210 304 AIDFGLSDFVRPDER-LNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFD 381 (429)
Q Consensus 304 L~DFGla~~~~~~~~-~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~ 381 (429)
|+|||++........ .....||..|+|||++.+ .++.++||||||+++|+|++|+.||...........+.......
T Consensus 157 l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~- 235 (279)
T 2w5a_A 157 LGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRR- 235 (279)
T ss_dssp ECCCCHHHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC-
T ss_pred EecCchheeeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhccccc-
Confidence 999999977654322 234578999999998864 68899999999999999999999999888777777776654321
Q ss_pred CCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhcc
Q 014210 382 EAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLICYQ 422 (429)
Q Consensus 382 ~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~ 422 (429)
....++.++.+||.+||+.||++||++.++|+|+|+...
T Consensus 236 --~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~ 274 (279)
T 2w5a_A 236 --IPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEH 274 (279)
T ss_dssp --CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGG
T ss_pred --CCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhh
Confidence 123689999999999999999999999999999998754
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-47 Score=375.83 Aligned_cols=256 Identities=30% Similarity=0.537 Sum_probs=213.9
Q ss_pred cccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeC
Q 014210 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (429)
Q Consensus 152 ~~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~ 231 (429)
.+.++|.+.+.||+|+||.||+|.... +|+.||||++.... ......+.+.+|+.+++.++ |+||+++++++...
T Consensus 39 ~l~~~y~~~~~lG~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~ 113 (371)
T 4exu_A 39 ELPKTYVSPTHVGSGAYGSVCSAIDKR---SGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQ-HENVIGLLDVFTPA 113 (371)
T ss_dssp EEETTEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEECSTT-SSHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSC
T ss_pred cccccEEEEeEEecCCCeEEEEEEECC---CCCEEEEEEecccc-cchhHHHHHHHHHHHHHhcC-CCCchhhhhheecc
Confidence 456899999999999999999998776 68999999997543 44556678899999999998 99999999999887
Q ss_pred CeE------EEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEe
Q 014210 232 DNV------YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAI 305 (429)
Q Consensus 232 ~~~------~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~ 305 (429)
+.. ++||||+. ++|.+.+ ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+
T Consensus 114 ~~~~~~~~~~lv~e~~~-~~l~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll---~~~~~~kL~ 186 (371)
T 4exu_A 114 SSLRNFYDFYLVMPFMQ-TDLQKIM---GMEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAV---NEDCELKIL 186 (371)
T ss_dssp SSSTTCCCCEEEEECCC-EEHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEEC
T ss_pred CCcccceeEEEEEcccc-ccHHHHh---hcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEE---CCCCCEEEE
Confidence 755 99999997 5887765 3459999999999999999999999999999999999999 788899999
Q ss_pred ecCCccccCCCccccccccCCcccCcccccC--CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCC---
Q 014210 306 DFGLSDFVRPDERLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSF--- 380 (429)
Q Consensus 306 DFGla~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~--- 380 (429)
|||+++.... ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||......+.+..+.......
T Consensus 187 Dfg~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 264 (371)
T 4exu_A 187 DFGLARHADA--EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTE 264 (371)
T ss_dssp STTCC----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHH
T ss_pred ecCccccccc--CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHH
Confidence 9999986543 3345688999999998864 68999999999999999999999999888777766665421111
Q ss_pred --------------------CC----CCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhc
Q 014210 381 --------------------DE----APWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLICY 421 (429)
Q Consensus 381 --------------------~~----~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~ 421 (429)
.. ..++.+++++.+||++||+.||++|||+.++|+|+||+.
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 329 (371)
T 4exu_A 265 FVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEP 329 (371)
T ss_dssp HHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTT
T ss_pred HHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCccccc
Confidence 10 012457899999999999999999999999999999974
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-46 Score=356.05 Aligned_cols=257 Identities=23% Similarity=0.326 Sum_probs=216.1
Q ss_pred ccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCC
Q 014210 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (429)
Q Consensus 153 ~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~ 232 (429)
..++|++.+.||+|+||.||+|+.......+..||||++... ......+.+.+|+.++++++ ||||+++++++.+ +
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~-~ 85 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKD--CTLDNKEKFMSEAVIMKNLD-HPHIVKLIGIIEE-E 85 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTT--SCHHHHHHHHHHHHHHHHHC-CTTBCCEEEEECS-S
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccc--cCchHHHHHHHHHHHHHhCC-CCCcceEEEEEcC-C
Confidence 357899999999999999999988765545678999998754 34456678999999999998 9999999999865 4
Q ss_pred eEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccc
Q 014210 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (429)
Q Consensus 233 ~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~ 312 (429)
..++||||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..
T Consensus 86 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~ 162 (281)
T 3cc6_A 86 PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILV---ASPECVKLGDFGLSRY 162 (281)
T ss_dssp SCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEE---EETTEEEECCCCGGGC
T ss_pred CCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEE---CCCCcEEeCccCCCcc
Confidence 5689999999999999998777789999999999999999999999999999999999999 5677899999999987
Q ss_pred cCCCcc--ccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCC
Q 014210 313 VRPDER--LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSL 388 (429)
Q Consensus 313 ~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 388 (429)
...... .....++..|+|||++. +.++.++||||||+++|+|++ |+.||...........+....... ....+
T Consensus 163 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~ 239 (281)
T 3cc6_A 163 IEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLP---KPDLC 239 (281)
T ss_dssp C---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCC---CCTTC
T ss_pred cccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCC---CCCCC
Confidence 654332 23445788999999886 568999999999999999998 999998777776666665543222 12368
Q ss_pred CHHHHHHHHHhcccCccCcCCHHHHHhhHhh
Q 014210 389 SSEARDFVKRLLNKDPRKRLTAAQALSELLI 419 (429)
Q Consensus 389 s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~ 419 (429)
++++.+||.+||+.||++||++.++++++.-
T Consensus 240 ~~~l~~li~~~l~~~p~~Rps~~ell~~L~~ 270 (281)
T 3cc6_A 240 PPVLYTLMTRCWDYDPSDRPRFTELVCSLSD 270 (281)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CHHHHHHHHHHccCCchhCcCHHHHHHHHHH
Confidence 8999999999999999999999999988653
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=367.18 Aligned_cols=266 Identities=20% Similarity=0.300 Sum_probs=219.9
Q ss_pred ccccCceeEeceeeccCceEEEEEEEec--CcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEE
Q 014210 151 KHFANKYELGEEVGRGHFGYTCAAKFKK--GELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAY 228 (429)
Q Consensus 151 ~~~~~~y~~~~~IG~G~fg~V~~~~~~~--~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~ 228 (429)
+...++|++++.||+|+||.||+|+... ...+++.||||++... .......++.+|+.+++++. |+||+++++++
T Consensus 26 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~ 102 (327)
T 2yfx_A 26 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV--CSEQDELDFLMEALIISKFN-HQNIVRCIGVS 102 (327)
T ss_dssp BCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSS--CCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEE
T ss_pred cCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccc--cchhhHHHHHHHHHHHhhCC-CCCCCeEEEEE
Confidence 3456899999999999999999998543 2236889999998643 34556678999999999997 99999999999
Q ss_pred EeCCeEEEEEEecCCCcHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceE
Q 014210 229 EDTDNVYVVMELCEGGELLDRILSRG------GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVL 302 (429)
Q Consensus 229 ~~~~~~~lv~E~~~ggsL~~~i~~~~------~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~v 302 (429)
.+.+..+|||||+++++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++..+.+..+
T Consensus 103 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~ 182 (327)
T 2yfx_A 103 LQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVA 182 (327)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCE
T ss_pred cCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceE
Confidence 99999999999999999999987654 358999999999999999999999999999999999999655566789
Q ss_pred EEeecCCccccCCCc---cccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcC
Q 014210 303 KAIDFGLSDFVRPDE---RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKAD 377 (429)
Q Consensus 303 kL~DFGla~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~ellt-g~~Pf~~~~~~~~~~~i~~~~ 377 (429)
||+|||++....... ......||..|+|||++. +.++.++||||||+++|+|++ |+.||...........+....
T Consensus 183 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~ 262 (327)
T 2yfx_A 183 KIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGG 262 (327)
T ss_dssp EECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC
T ss_pred EECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCC
Confidence 999999987543222 223456889999999886 568999999999999999998 999998888777777666554
Q ss_pred CCCCCCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhcc
Q 014210 378 PSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLICYQ 422 (429)
Q Consensus 378 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~ 422 (429)
... ....++.++.+||.+||+.||++||++.++++++|...+
T Consensus 263 ~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 304 (327)
T 2yfx_A 263 RMD---PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 304 (327)
T ss_dssp CCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCC---CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhc
Confidence 322 224689999999999999999999999999999998654
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-47 Score=364.81 Aligned_cols=258 Identities=25% Similarity=0.446 Sum_probs=216.2
Q ss_pred ccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcC-cHHHHHHHHHHHHHHHHhcCCCCcceEEEEEE--
Q 014210 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMT-TAIAIEDVRREVKILRALTGHNNLVKFFDAYE-- 229 (429)
Q Consensus 153 ~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~-~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~-- 229 (429)
+.++|++.+.||+|+||.||++.... +|+.||||++...... .....+.+.+|++++++++ |+||+++++++.
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~---~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~ 78 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSE---TLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLR-HKNVIQLVDVLYNE 78 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTT---TCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCC-CTTBCCEEEEEECC
T ss_pred cccceeEeeEEecCCCeEEEEEEECC---CCcEEEEEEeccccccccchhHHHHHHHHHHHHhcC-CCCeeEEEEEEEcC
Confidence 45789999999999999999998665 6899999998643211 1234577999999999998 999999999984
Q ss_pred eCCeEEEEEEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecC
Q 014210 230 DTDNVYVVMELCEGGELLDRILSR-GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFG 308 (429)
Q Consensus 230 ~~~~~~lv~E~~~ggsL~~~i~~~-~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFG 308 (429)
+.+..+|||||++++ |.+++... ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||
T Consensus 79 ~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~---~~~~~~kl~dfg 154 (305)
T 2wtk_C 79 EKQKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLL---TTGGTLKISALG 154 (305)
T ss_dssp ---CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCT
T ss_pred CCCeEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEE---cCCCcEEeeccc
Confidence 456799999999876 67766543 4579999999999999999999999999999999999999 778899999999
Q ss_pred CccccCCC---ccccccccCCcccCcccccCC---CCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCC
Q 014210 309 LSDFVRPD---ERLNDIVGSAYYVAPEVLHRS---YSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDE 382 (429)
Q Consensus 309 la~~~~~~---~~~~~~~gt~~y~aPE~~~~~---~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~ 382 (429)
++...... .......||..|+|||++.+. ++.++||||||+++|||++|+.||........+..+.......+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~- 233 (305)
T 2wtk_C 155 VAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIP- 233 (305)
T ss_dssp TCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCC-
T ss_pred cccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCCCCC-
Confidence 99776432 233456799999999988642 46789999999999999999999999888888877777654443
Q ss_pred CCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhcc
Q 014210 383 APWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLICYQ 422 (429)
Q Consensus 383 ~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~ 422 (429)
..+++++.+||++||+.||++||++.++++|+||+..
T Consensus 234 ---~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 270 (305)
T 2wtk_C 234 ---GDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKK 270 (305)
T ss_dssp ---SSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSC
T ss_pred ---CccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccC
Confidence 3689999999999999999999999999999999754
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=362.77 Aligned_cols=257 Identities=23% Similarity=0.337 Sum_probs=218.7
Q ss_pred ccCceeEeceeeccCceEEEEEEEecC--cccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEe
Q 014210 153 FANKYELGEEVGRGHFGYTCAAKFKKG--ELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED 230 (429)
Q Consensus 153 ~~~~y~~~~~IG~G~fg~V~~~~~~~~--~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~ 230 (429)
..++|++.+.||+|+||.||+|..... ...++.||||++... ......+.+.+|++++++++ ||||+++++++.+
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~ 97 (314)
T 2ivs_A 21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKEN--ASPSELRDLLSEFNVLKQVN-HPHVIKLYGACSQ 97 (314)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTT--CCHHHHHHHHHHHHHHTTCC-CTTBCCEEEEECS
T ss_pred chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCC--CCHHHHHHHHHHHHHHhhCC-CCceeeEEEEEec
Confidence 367899999999999999999987532 235689999999754 34566688999999999997 9999999999999
Q ss_pred CCeEEEEEEecCCCcHHHHHHhcC-----------------------CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCC
Q 014210 231 TDNVYVVMELCEGGELLDRILSRG-----------------------GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLK 287 (429)
Q Consensus 231 ~~~~~lv~E~~~ggsL~~~i~~~~-----------------------~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIK 287 (429)
.+..++||||+++++|.+++.... ..+++..++.++.||+.||.|||++||+|||||
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dik 177 (314)
T 2ivs_A 98 DGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLA 177 (314)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCS
T ss_pred CCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccc
Confidence 999999999999999999987643 238999999999999999999999999999999
Q ss_pred CCcEEEeecCCCceEEEeecCCccccCCCcc---ccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHc-CCCCCC
Q 014210 288 PENFLFTTKDENSVLKAIDFGLSDFVRPDER---LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFW 362 (429)
Q Consensus 288 p~NILl~~~~~~~~vkL~DFGla~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~ellt-g~~Pf~ 362 (429)
|+|||+ +.++.+||+|||++........ .....+|..|+|||++. ..++.++||||||+++|||++ |+.||.
T Consensus 178 p~NIli---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 254 (314)
T 2ivs_A 178 ARNILV---AEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYP 254 (314)
T ss_dssp GGGEEE---ETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred hheEEE---cCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 999999 6788999999999986644332 23446788899999886 458899999999999999999 999998
Q ss_pred CCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHh
Q 014210 363 ARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELL 418 (429)
Q Consensus 363 ~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~ 418 (429)
..........+...... .....+++++.+||.+||+.||++||++.++++++-
T Consensus 255 ~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~ 307 (314)
T 2ivs_A 255 GIPPERLFNLLKTGHRM---ERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLE 307 (314)
T ss_dssp TCCGGGHHHHHHTTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCHHHHHHHhhcCCcC---CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 88877776666554321 222468999999999999999999999999998754
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=362.28 Aligned_cols=256 Identities=29% Similarity=0.495 Sum_probs=211.0
Q ss_pred ccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEe--
Q 014210 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED-- 230 (429)
Q Consensus 153 ~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~-- 230 (429)
+.++|++++.||+|+||.||+|+... +|+.||||++.. .....+.+.+|+.++++++ |+||+++++++.+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~----~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~ 75 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNAL---DSRYYAIKKIRH----TEEKLSTILSEVMLLASLN-HQYVVRYYAAWLERR 75 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEE----EHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEECC
T ss_pred ccccchhhheeccCCcEEEEEEEEcC---CCeEEEEEEEec----cHHHHHHHHHHHHHHHhcC-chHHHHHHHHHHhhc
Confidence 45789999999999999999998765 589999999853 3455678999999999998 9999999999865
Q ss_pred -----------CCeEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCC
Q 014210 231 -----------TDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDEN 299 (429)
Q Consensus 231 -----------~~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~ 299 (429)
.+..++||||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.+
T Consensus 76 ~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~---~~~ 152 (303)
T 1zy4_A 76 NFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFI---DES 152 (303)
T ss_dssp CCCC------CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTT
T ss_pred chhhhhcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEE---cCC
Confidence 356899999999999999998777778999999999999999999999999999999999999 778
Q ss_pred ceEEEeecCCccccCCC---------------ccccccccCCcccCcccccC--CCCCcccHHHHHHHHHHHHcCCCCCC
Q 014210 300 SVLKAIDFGLSDFVRPD---------------ERLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFW 362 (429)
Q Consensus 300 ~~vkL~DFGla~~~~~~---------------~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlGvll~elltg~~Pf~ 362 (429)
+.+||+|||++...... .......||..|+|||++.+ .++.++||||||+++|+|++ ||.
T Consensus 153 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~ 229 (303)
T 1zy4_A 153 RNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFS 229 (303)
T ss_dssp SCEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCS
T ss_pred CCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccC
Confidence 89999999999766422 12234579999999999864 58999999999999999998 664
Q ss_pred CC-ChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhcc
Q 014210 363 AR-TESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLICYQ 422 (429)
Q Consensus 363 ~~-~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~ 422 (429)
.. .....+..+......++.......+.++.+||++||+.||.+||++.++++|+||...
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 290 (303)
T 1zy4_A 230 TGMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVK 290 (303)
T ss_dssp SHHHHHHHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCC
T ss_pred CchhHHHHHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCC
Confidence 33 2234444555545555555555778899999999999999999999999999999754
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-47 Score=370.55 Aligned_cols=252 Identities=18% Similarity=0.259 Sum_probs=207.9
Q ss_pred ccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCC
Q 014210 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (429)
Q Consensus 153 ~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~ 232 (429)
+.++|++.+.||+|+||.||+|+... +|+.||||++...... +.+.+|+.++++|.+|+||+++++++.+++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~-----~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 78 (330)
T 2izr_A 7 VGPNFRVGKKIGCGNFGELRLGKNLY---TNEYVAIKLEPMKSRA-----PQLHLEYRFYKQLGSGDGIPQVYYFGPCGK 78 (330)
T ss_dssp ETTTEEEEEECCC-CTTSEEEEEETT---TTEEEEEEEEETTCSS-----CCHHHHHHHHHHHCSCTTSCCEEEEEEETT
T ss_pred EcCCeEEEEEeeccCCceEEEEEECC---CCcEEEEEEeccccch-----HHHHHHHHHHHHhhCCCCCCEEEEEEecCC
Confidence 46889999999999999999998765 6899999998654321 357899999999955999999999999999
Q ss_pred eEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCce-----EEEeec
Q 014210 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSV-----LKAIDF 307 (429)
Q Consensus 233 ~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~-----vkL~DF 307 (429)
..+|||||+ +++|.+++....+.+++..++.++.||+.||+|||++||+||||||+|||+ +.++. +||+||
T Consensus 79 ~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill---~~~~~~~~~~~kl~DF 154 (330)
T 2izr_A 79 YNAMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLI---GRPGNKTQQVIHIIDF 154 (330)
T ss_dssp EEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CCGGGTCTTSEEECCC
T ss_pred ccEEEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeee---ccCCCCCCceEEEEEc
Confidence 999999999 899999987767789999999999999999999999999999999999999 55555 999999
Q ss_pred CCccccCCCcc--------ccccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHcCCCCCCCCC---hHHHHHHHHh
Q 014210 308 GLSDFVRPDER--------LNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWART---ESGIFRAVLK 375 (429)
Q Consensus 308 Gla~~~~~~~~--------~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~elltg~~Pf~~~~---~~~~~~~i~~ 375 (429)
|+++....... .....||+.|+|||++.+ .++.++|||||||++|||++|+.||.... ....+..+..
T Consensus 155 g~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~ 234 (330)
T 2izr_A 155 ALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGD 234 (330)
T ss_dssp TTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHH
T ss_pred ccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHh
Confidence 99987644322 245689999999998875 58999999999999999999999998743 3334444433
Q ss_pred cCCCCCCC-CCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhH
Q 014210 376 ADPSFDEA-PWPSLSSEARDFVKRLLNKDPRKRLTAAQALSEL 417 (429)
Q Consensus 376 ~~~~~~~~-~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~ 417 (429)
........ ....++ ++.+||..||+.||.+||++.++++.+
T Consensus 235 ~~~~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l 276 (330)
T 2izr_A 235 TKRATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLF 276 (330)
T ss_dssp HHHHSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHH
T ss_pred hhccCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHH
Confidence 22211111 112344 999999999999999999999987744
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-46 Score=364.99 Aligned_cols=266 Identities=27% Similarity=0.418 Sum_probs=217.6
Q ss_pred CccccccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCC------Cc
Q 014210 148 GFSKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHN------NL 221 (429)
Q Consensus 148 ~~~~~~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~------nI 221 (429)
..++.+.++|++.++||+|+||.||+|..... +|+.||||++... ....+.+.+|+++++.+. |+ +|
T Consensus 7 ~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~--~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~-~~~~~~~~~i 79 (339)
T 1z57_A 7 QSGDVLSARYEIVDTLGEGAFGKVVECIDHKA--GGRHVAVKIVKNV----DRYCEAARSEIQVLEHLN-TTDPNSTFRC 79 (339)
T ss_dssp STTCEETTTEEEEEEEEEETTEEEEEEEETTT--TTEEEEEEEECSS----HHHHHHHHHHHHHHHHHH-HHCTTCTTCB
T ss_pred ecCCCccCceEEEEEEecCCCeEEEEEEecCC--CCcEEEEEEEecC----CchhHHHHHHHHHHHHhh-hcCCCCceee
Confidence 34566788999999999999999999986332 5899999998532 345677899999999987 54 59
Q ss_pred ceEEEEEEeCCeEEEEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCC--
Q 014210 222 VKFFDAYEDTDNVYVVMELCEGGELLDRILSRG-GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDE-- 298 (429)
Q Consensus 222 v~l~~~~~~~~~~~lv~E~~~ggsL~~~i~~~~-~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~-- 298 (429)
+++++++.+.+..+|||||+ +++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++..+.
T Consensus 80 ~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~ 158 (339)
T 1z57_A 80 VQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTE 158 (339)
T ss_dssp CCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEE
T ss_pred EeeecccccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEecccccc
Confidence 99999999999999999999 789999887654 36899999999999999999999999999999999999953221
Q ss_pred --------------CceEEEeecCCccccCCCccccccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHcCCCCCCC
Q 014210 299 --------------NSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWA 363 (429)
Q Consensus 299 --------------~~~vkL~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~elltg~~Pf~~ 363 (429)
++.+||+|||++..... ......||..|+|||++.+ .++.++||||||+++|||++|+.||..
T Consensus 159 ~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 236 (339)
T 1z57_A 159 AYNPKIKRDERTLINPDIKVVDFGSATYDDE--HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPT 236 (339)
T ss_dssp EEC----CEEEEESCCCEEECCCSSCEETTS--CCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred ccCCccccccccccCCCceEeeCcccccCcc--ccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCC
Confidence 56799999999976532 3345689999999998874 689999999999999999999999988
Q ss_pred CChHHHHHHHHhcCCCCCC----------------------------------------CCCCCCCHHHHHHHHHhcccC
Q 014210 364 RTESGIFRAVLKADPSFDE----------------------------------------APWPSLSSEARDFVKRLLNKD 403 (429)
Q Consensus 364 ~~~~~~~~~i~~~~~~~~~----------------------------------------~~~~~~s~~~~~li~~~L~~d 403 (429)
....+....+.......+. ......++++.+||++||+.|
T Consensus 237 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~d 316 (339)
T 1z57_A 237 HDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYD 316 (339)
T ss_dssp SCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSS
T ss_pred CChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcC
Confidence 7776655444332111110 001123567899999999999
Q ss_pred ccCcCCHHHHHhhHhhhccc
Q 014210 404 PRKRLTAAQALSELLICYQS 423 (429)
Q Consensus 404 P~~Rps~~~iL~~~~~~~~~ 423 (429)
|++|||+.|+|+|+||+...
T Consensus 317 P~~Rpt~~ell~hp~f~~~~ 336 (339)
T 1z57_A 317 PAKRITLREALKHPFFDLLK 336 (339)
T ss_dssp TTTSCCHHHHTTSGGGGGGG
T ss_pred cccccCHHHHhcCHHHHHHh
Confidence 99999999999999998643
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-46 Score=367.95 Aligned_cols=260 Identities=29% Similarity=0.490 Sum_probs=215.7
Q ss_pred ccccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEe
Q 014210 151 KHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED 230 (429)
Q Consensus 151 ~~~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~ 230 (429)
..+.++|++.+.||+|+||.||+|+... +|+.||||++... ........+.+|++++++++ |+||+++++++..
T Consensus 7 ~~i~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~ 80 (353)
T 2b9h_A 7 YNISSDFQLKSLLGEGAYGVVCSATHKP---TGEIVAIKKIEPF--DKPLFALRTLREIKILKHFK-HENIITIFNIQRP 80 (353)
T ss_dssp CCSCTTEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEECCC--SSHHHHHHHHHHHHHHHHCC-CTTBCCEEEECCC
T ss_pred cccccceEEeeEEcCCCCeEEEEEEECC---CCcEEEEEeeccc--ccchHHHHHHHHHHHHHhCc-CCCcCCeeeeecc
Confidence 3457899999999999999999998765 5899999999643 34556677889999999998 9999999998876
Q ss_pred C-----CeEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEe
Q 014210 231 T-----DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAI 305 (429)
Q Consensus 231 ~-----~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~ 305 (429)
. ...++||||+. ++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+
T Consensus 81 ~~~~~~~~~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~---~~~~~~kl~ 154 (353)
T 2b9h_A 81 DSFENFNEVYIIQELMQ-TDLHRVIST--QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLI---NSNCDLKVC 154 (353)
T ss_dssp SCSTTCCCEEEEECCCS-EEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---CTTCCEEEC
T ss_pred cccCccceEEEEEeccC-ccHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---cCCCcEEEE
Confidence 4 67899999997 589888754 579999999999999999999999999999999999999 778899999
Q ss_pred ecCCccccCCCcc-----------ccccccCCcccCccccc--CCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHH
Q 014210 306 DFGLSDFVRPDER-----------LNDIVGSAYYVAPEVLH--RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRA 372 (429)
Q Consensus 306 DFGla~~~~~~~~-----------~~~~~gt~~y~aPE~~~--~~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~ 372 (429)
|||++........ .....||..|+|||++. ..++.++|||||||++|+|++|+.||........+..
T Consensus 155 Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~ 234 (353)
T 2b9h_A 155 DFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLL 234 (353)
T ss_dssp CCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred ecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHH
Confidence 9999987643221 22357899999999874 4688999999999999999999999998877665554
Q ss_pred HHhcCC------------------------CCCC----CCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhcc
Q 014210 373 VLKADP------------------------SFDE----APWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLICYQ 422 (429)
Q Consensus 373 i~~~~~------------------------~~~~----~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~ 422 (429)
+..... .... ..++.++.++.+||++||+.||++||++.++|+|+||+..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 312 (353)
T 2b9h_A 235 IFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTY 312 (353)
T ss_dssp HHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred HHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCcccccc
Confidence 433111 0110 0124689999999999999999999999999999999753
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-46 Score=358.65 Aligned_cols=258 Identities=23% Similarity=0.394 Sum_probs=204.3
Q ss_pred ccccccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEE
Q 014210 149 FSKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAY 228 (429)
Q Consensus 149 ~~~~~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~ 228 (429)
..+...++|++.++||+|+||.||+++.. ..||||++.... ......+.+.+|+.++++++ |+||+++++++
T Consensus 18 ~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~------~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~ 89 (289)
T 3og7_A 18 DWEIPDGQITVGQRIGSGSFGTVYKGKWH------GDVAVKMLNVTA-PTPQQLQAFKNEVGVLRKTR-HVNILLFMGYS 89 (289)
T ss_dssp CCBCCTTSCEEEEEEEECSSEEEEEEESS------SEEEEEEESCSS-CCHHHHHHHHHHHHHHTTCC-CTTBCCEEEEE
T ss_pred CCccCccceeeeeEecCCCCeEEEEEEEc------CceEEEEEeccC-CCHHHHHHHHHHHHHHHhCC-CCcEEEEEeec
Confidence 34555789999999999999999999743 359999987643 45566788999999999998 99999999955
Q ss_pred EeCCeEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecC
Q 014210 229 EDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFG 308 (429)
Q Consensus 229 ~~~~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFG 308 (429)
..+..++||||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||
T Consensus 90 -~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~---~~~~~~kl~Dfg 165 (289)
T 3og7_A 90 -TAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFL---HEDNTVKIGDFG 165 (289)
T ss_dssp -CSSSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---ETTTEEEECCCC
T ss_pred -cCCccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEE---CCCCCEEEccce
Confidence 5667899999999999999887777789999999999999999999999999999999999999 677899999999
Q ss_pred CccccCCC---ccccccccCCcccCccccc----CCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcC-CCC
Q 014210 309 LSDFVRPD---ERLNDIVGSAYYVAPEVLH----RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKAD-PSF 380 (429)
Q Consensus 309 la~~~~~~---~~~~~~~gt~~y~aPE~~~----~~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~-~~~ 380 (429)
++...... .......||..|+|||++. ..++.++||||||+++|+|++|+.||........+....... ...
T Consensus 166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 245 (289)
T 3og7_A 166 LATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSP 245 (289)
T ss_dssp ------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCC
T ss_pred eccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCc
Confidence 99765432 2234567999999999875 357889999999999999999999998766555544444332 221
Q ss_pred -CCCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHh
Q 014210 381 -DEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELL 418 (429)
Q Consensus 381 -~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~ 418 (429)
.......+++++.+||.+||+.||++||++.++++.+-
T Consensus 246 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~ 284 (289)
T 3og7_A 246 DLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIE 284 (289)
T ss_dssp CTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred chhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHH
Confidence 22234578999999999999999999999999998764
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=367.37 Aligned_cols=256 Identities=20% Similarity=0.278 Sum_probs=209.5
Q ss_pred cCceeEeceeeccCceEEEEEEEecCc-ccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCC
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGE-LKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~-~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~ 232 (429)
.++|++.++||+|+||.||+|+...+. .-...||+|.+... ......+++.+|+.++++++ |+||++++++|.+.+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~ 90 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASVD-NPHVCRLLGICLTST 90 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC---------CHHHHHHHHHHHHHCC-BTTBCCEEEEEESSS
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccc--cCHHHHHHHHHHHHHHHhCC-CCCEeEEEEEEecCC
Confidence 578999999999999999999876521 12345788887543 23345578999999999998 999999999998765
Q ss_pred eEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccc
Q 014210 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (429)
Q Consensus 233 ~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~ 312 (429)
.++||||+.+|+|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.
T Consensus 91 -~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll---~~~~~~kl~Dfg~a~~ 166 (327)
T 3poz_A 91 -VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLV---KTPQHVKITDFGLAKL 166 (327)
T ss_dssp -EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---EETTEEEECCTTHHHH
T ss_pred -eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEE---CCCCCEEEccCcceeE
Confidence 789999999999999998878889999999999999999999999999999999999999 5678899999999987
Q ss_pred cCCCcc---ccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCC
Q 014210 313 VRPDER---LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPS 387 (429)
Q Consensus 313 ~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 387 (429)
...... .....+|..|+|||++. +.++.++|||||||++|||++ |+.||...........+....... ..+.
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~ 243 (327)
T 3poz_A 167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP---QPPI 243 (327)
T ss_dssp HTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCC---CCTT
T ss_pred ccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCCC---CCcc
Confidence 654332 22345688999999876 568999999999999999999 999998887776665555443211 2246
Q ss_pred CCHHHHHHHHHhcccCccCcCCHHHHHhhHhh
Q 014210 388 LSSEARDFVKRLLNKDPRKRLTAAQALSELLI 419 (429)
Q Consensus 388 ~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~ 419 (429)
++.++.+||.+||+.||++||++.+++.++..
T Consensus 244 ~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~ 275 (327)
T 3poz_A 244 CTIDVYMIMVKCWMIDADSRPKFRELIIEFSK 275 (327)
T ss_dssp BCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHH
T ss_pred CCHHHHHHHHHHcCCChhhCCCHHHHHHHHHH
Confidence 88999999999999999999999999988643
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-46 Score=356.15 Aligned_cols=257 Identities=22% Similarity=0.370 Sum_probs=217.4
Q ss_pred cCceeEec-eeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCC
Q 014210 154 ANKYELGE-EVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (429)
Q Consensus 154 ~~~y~~~~-~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~ 232 (429)
.++|.+.+ .||+|+||.||+|...... +++.||||++... ......+++.+|++++++++ |+||+++++++ +.+
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~-~~~ 82 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRK-KQIDVAIKVLKQG--TEKADTEEMMREAQIMHQLD-NPYIVRLIGVC-QAE 82 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC----CCEEEEEEEECSS--CCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEE-ESS
T ss_pred HHHhhhhhccccccCceeEEEeEeccCC-CcceEEEEecCCc--cchhHHHHHHHHHHHHHhCC-CCCEeEEEEEe-cCC
Confidence 46787777 9999999999999865322 4789999999754 34566788999999999997 99999999999 556
Q ss_pred eEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccc
Q 014210 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (429)
Q Consensus 233 ~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~ 312 (429)
..++||||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..
T Consensus 83 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili---~~~~~~kl~Dfg~~~~ 159 (287)
T 1u59_A 83 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLL---VNRHYAKISDFGLSKA 159 (287)
T ss_dssp SEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---EETTEEEECCCTTCEE
T ss_pred CcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEE---cCCCCEEECcccceee
Confidence 7899999999999999887667789999999999999999999999999999999999999 5677899999999987
Q ss_pred cCCCcc----ccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCCCCC
Q 014210 313 VRPDER----LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWP 386 (429)
Q Consensus 313 ~~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 386 (429)
...... .....+|..|+|||++. ..++.++||||||+++|||++ |+.||...........+...... ...+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~---~~~~ 236 (287)
T 1u59_A 160 LGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRM---ECPP 236 (287)
T ss_dssp CTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCC---CCCT
T ss_pred eccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcC---CCCC
Confidence 654332 22345688999999886 568899999999999999998 99999888877777766654322 1224
Q ss_pred CCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhc
Q 014210 387 SLSSEARDFVKRLLNKDPRKRLTAAQALSELLICY 421 (429)
Q Consensus 387 ~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~ 421 (429)
.+++++.+||.+||+.||++||++.+++++++-..
T Consensus 237 ~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 271 (287)
T 1u59_A 237 ECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY 271 (287)
T ss_dssp TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 78999999999999999999999999999887643
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-46 Score=361.67 Aligned_cols=261 Identities=25% Similarity=0.373 Sum_probs=216.6
Q ss_pred cccCceeEeceeeccCceEEEEEEEec--CcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEE
Q 014210 152 HFANKYELGEEVGRGHFGYTCAAKFKK--GELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYE 229 (429)
Q Consensus 152 ~~~~~y~~~~~IG~G~fg~V~~~~~~~--~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~ 229 (429)
...++|++.+.||+|+||.||+|+... ...+++.||||++... ......+.+.+|+.+++++.+|+||+++++++.
T Consensus 24 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 101 (316)
T 2xir_A 24 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG--ATHSEHRALMSELKILIHIGHHLNVVNLLGACT 101 (316)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT--CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccC--CCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEe
Confidence 346899999999999999999998654 2346899999999754 344556789999999999966999999999998
Q ss_pred eCC-eEEEEEEecCCCcHHHHHHhcCCC---------------CCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEE
Q 014210 230 DTD-NVYVVMELCEGGELLDRILSRGGK---------------YTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLF 293 (429)
Q Consensus 230 ~~~-~~~lv~E~~~ggsL~~~i~~~~~~---------------l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl 293 (429)
+.+ ..++||||+++++|.+++...... +++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 102 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~ 181 (316)
T 2xir_A 102 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL 181 (316)
T ss_dssp CTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred cCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEE
Confidence 765 489999999999999998765432 8999999999999999999999999999999999999
Q ss_pred eecCCCceEEEeecCCccccCCCcc---ccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHc-CCCCCCCCChHH
Q 014210 294 TTKDENSVLKAIDFGLSDFVRPDER---LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESG 368 (429)
Q Consensus 294 ~~~~~~~~vkL~DFGla~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~ellt-g~~Pf~~~~~~~ 368 (429)
+.++.+||+|||++........ .....||..|+|||++. +.++.++||||||+++|+|++ |+.||.......
T Consensus 182 ---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~ 258 (316)
T 2xir_A 182 ---SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE 258 (316)
T ss_dssp ---CGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH
T ss_pred ---CCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhH
Confidence 6788899999999987644322 23456888999999886 568999999999999999998 999998766544
Q ss_pred HHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhh
Q 014210 369 IFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLI 419 (429)
Q Consensus 369 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~ 419 (429)
.+...+....... ....+++++.+||.+||+.||.+||++.++++++.-
T Consensus 259 ~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~ 307 (316)
T 2xir_A 259 EFCRRLKEGTRMR--APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 307 (316)
T ss_dssp HHHHHHHHTCCCC--CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHHhccCccCC--CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 4444433332222 123588999999999999999999999999998754
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=361.08 Aligned_cols=258 Identities=22% Similarity=0.331 Sum_probs=207.2
Q ss_pred cccCceeEeceeeccCceEEEEEEEec-CcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEe
Q 014210 152 HFANKYELGEEVGRGHFGYTCAAKFKK-GELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED 230 (429)
Q Consensus 152 ~~~~~y~~~~~IG~G~fg~V~~~~~~~-~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~ 230 (429)
...++|+++++||+|+||.||+|+... ...+|+.||||++.. ......+.+.+|++++++++ |+||+++++++..
T Consensus 7 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~ 82 (295)
T 3ugc_A 7 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQH---STEEHLRDFEREIEILKSLQ-HDNIVKYKGVCYS 82 (295)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESC---CCHHHHHHHHHHHHHHHTCC-CTTBCCEEEEECH
T ss_pred CCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEccc---CCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEec
Confidence 346899999999999999999998542 223689999999864 34556678999999999998 9999999999865
Q ss_pred C--CeEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecC
Q 014210 231 T--DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFG 308 (429)
Q Consensus 231 ~--~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFG 308 (429)
. ...++||||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||
T Consensus 83 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~---~~~~~~kl~Dfg 159 (295)
T 3ugc_A 83 AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILV---ENENRVKIGDFG 159 (295)
T ss_dssp HHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---EETTEEEECCCC
T ss_pred CCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEE---cCCCeEEEccCc
Confidence 3 56899999999999999998776779999999999999999999999999999999999999 567889999999
Q ss_pred CccccCCCcc----ccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHcCCCCCCCCChHH---------------
Q 014210 309 LSDFVRPDER----LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESG--------------- 368 (429)
Q Consensus 309 la~~~~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~--------------- 368 (429)
++........ .....++..|+|||++. ..++.++||||||+++|||++|..||.......
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (295)
T 3ugc_A 160 LTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVF 239 (295)
T ss_dssp SCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHH
T ss_pred ccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHH
Confidence 9987654322 22345778899999886 568999999999999999999999985432110
Q ss_pred HHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHh
Q 014210 369 IFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELL 418 (429)
Q Consensus 369 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~ 418 (429)
.....+...... .....+++++.+||++||+.||++|||+.++++.+-
T Consensus 240 ~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~ 287 (295)
T 3ugc_A 240 HLIELLKNNGRL--PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVD 287 (295)
T ss_dssp HHHHHHHTTCCC--CCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHHhccCcC--CCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHH
Confidence 111112222122 223478999999999999999999999999998764
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=360.23 Aligned_cols=257 Identities=17% Similarity=0.224 Sum_probs=210.4
Q ss_pred cccCceeEeceeeccCceEEEEEEEecCc----ccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEE
Q 014210 152 HFANKYELGEEVGRGHFGYTCAAKFKKGE----LKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDA 227 (429)
Q Consensus 152 ~~~~~y~~~~~IG~G~fg~V~~~~~~~~~----~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~ 227 (429)
...++|++.+.||+|+||.||+|+..... ..+..||+|++... .....+.+.+|+.++++++ |+||++++++
T Consensus 5 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~---~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~ 80 (289)
T 4fvq_A 5 IRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKA---HRNYSESFFEAASMMSKLS-HKHLVLNYGV 80 (289)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGG---GGGGHHHHHHHHHHHHTSC-CTTBCCEEEE
T ss_pred echhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccc---cHHHHHHHHHHHHHHHhCC-CCCEeEEEEE
Confidence 34679999999999999999999877632 12368999998543 3445577999999999998 9999999999
Q ss_pred EEeCCeEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCC-----ceE
Q 014210 228 YEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDEN-----SVL 302 (429)
Q Consensus 228 ~~~~~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~-----~~v 302 (429)
+.+.+..++||||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.. +.+
T Consensus 81 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~ 160 (289)
T 4fvq_A 81 CVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFI 160 (289)
T ss_dssp ECCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEE
T ss_pred EEeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCccccccccee
Confidence 999999999999999999999997766669999999999999999999999999999999999999533221 129
Q ss_pred EEeecCCccccCCCccccccccCCcccCcccccC--CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCC
Q 014210 303 KAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSF 380 (429)
Q Consensus 303 kL~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~ 380 (429)
||+|||++...... ....||..|+|||++.+ .++.++||||||+++|||++|..|++..................
T Consensus 161 kl~Dfg~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~ 237 (289)
T 4fvq_A 161 KLSDPGISITVLPK---DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQL 237 (289)
T ss_dssp EECCCCSCTTTSCH---HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCC
T ss_pred eeccCcccccccCc---cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhhccCCC
Confidence 99999998765432 23468899999998864 58999999999999999999665555544444444444443333
Q ss_pred CCCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhh
Q 014210 381 DEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLI 419 (429)
Q Consensus 381 ~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~ 419 (429)
+. .++.++.+||++||+.||++|||+.++++++--
T Consensus 238 ~~----~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~ 272 (289)
T 4fvq_A 238 PA----PKAAELANLINNCMDYEPDHRPSFRAIIRDLNS 272 (289)
T ss_dssp CC----CSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHT
T ss_pred CC----CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 32 467889999999999999999999999998753
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=358.17 Aligned_cols=257 Identities=26% Similarity=0.500 Sum_probs=204.9
Q ss_pred ccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCC
Q 014210 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (429)
Q Consensus 153 ~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~ 232 (429)
..++|++.+.||+|+||.||+|.... +|+.||||++...........+.+.+|+.++++++ |+||+++++++.+.+
T Consensus 30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~ 105 (310)
T 2wqm_A 30 TLANFRIEKKIGRGQFSEVYRAACLL---DGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN-HPNVIKYYASFIEDN 105 (310)
T ss_dssp SGGGEEEEEEEECC--CEEEEEEETT---TCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEEETT
T ss_pred cccceEEEEeecCCCCceEEEEEEcC---CCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEcCC
Confidence 45789999999999999999998765 58999999998765566777788999999999998 999999999999999
Q ss_pred eEEEEEEecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCC
Q 014210 233 NVYVVMELCEGGELLDRILS---RGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGL 309 (429)
Q Consensus 233 ~~~lv~E~~~ggsL~~~i~~---~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGl 309 (429)
..++||||+++++|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+
T Consensus 106 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~---~~~~~~kl~Dfg~ 182 (310)
T 2wqm_A 106 ELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFI---TATGVVKLGDLGL 182 (310)
T ss_dssp EEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEECCC--
T ss_pred cEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEE---cCCCCEEEEeccc
Confidence 99999999999999998864 35679999999999999999999999999999999999999 7788999999999
Q ss_pred ccccCCCc-cccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHcCCCCCCCCCh--HHHHHHHHhcCCCCCCCCC
Q 014210 310 SDFVRPDE-RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTE--SGIFRAVLKADPSFDEAPW 385 (429)
Q Consensus 310 a~~~~~~~-~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~elltg~~Pf~~~~~--~~~~~~i~~~~~~~~~~~~ 385 (429)
+....... ......|+..|+|||++. +.++.++||||||+++|+|++|+.||..... ......+.... +.....
T Consensus 183 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~ 260 (310)
T 2wqm_A 183 GRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCD--YPPLPS 260 (310)
T ss_dssp ----------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTC--SCCCCT
T ss_pred eeeecCCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhccc--CCCCcc
Confidence 87664332 234567999999999886 4688999999999999999999999976432 23333333322 222333
Q ss_pred CCCCHHHHHHHHHhcccCccCcCCHHHHHhhHh
Q 014210 386 PSLSSEARDFVKRLLNKDPRKRLTAAQALSELL 418 (429)
Q Consensus 386 ~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~ 418 (429)
..++.++.+||.+||..||++||++.++++++.
T Consensus 261 ~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~ 293 (310)
T 2wqm_A 261 DHYSEELRQLVNMCINPDPEKRPDVTYVYDVAK 293 (310)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred cccCHHHHHHHHHHcCCChhhCCCHHHHHHHHH
Confidence 568999999999999999999999999998653
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-46 Score=352.69 Aligned_cols=253 Identities=28% Similarity=0.418 Sum_probs=202.7
Q ss_pred cCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCc-HHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCC
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTT-AIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~-~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~ 232 (429)
.++|++.++||+|+||.||+|.. .|+.||||++....... ....+.+.+|+++++.++ |+||+++++++.+.+
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~ 79 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFW-----IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLK-HPNIIALRGVCLKEP 79 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEE-----TTEEEEEEEC----------CHHHHHHHHHHHHHCC-CTTBCCEEEEECCC-
T ss_pred hhheeeeeeeccCCCeEEEEEEE-----cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcC-CCCEeeEEEEEecCC
Confidence 57899999999999999999984 37889999986543222 334577899999999998 999999999999999
Q ss_pred eEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecC-----CCceEEE
Q 014210 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQG---VVHRDLKPENFLFTTKD-----ENSVLKA 304 (429)
Q Consensus 233 ~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~---iiHrDIKp~NILl~~~~-----~~~~vkL 304 (429)
..++||||+++++|.+++ ....+++..++.++.||+.||.|||++| |+||||||+|||++... .++.+||
T Consensus 80 ~~~lv~e~~~~~~L~~~~--~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl 157 (271)
T 3dtc_A 80 NLCLVMEFARGGPLNRVL--SGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKI 157 (271)
T ss_dssp -CEEEEECCTTEEHHHHH--TSSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEE
T ss_pred ceEEEEEcCCCCCHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEE
Confidence 999999999999998877 3567999999999999999999999999 99999999999995322 2678999
Q ss_pred eecCCccccCCCccccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCC
Q 014210 305 IDFGLSDFVRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEA 383 (429)
Q Consensus 305 ~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~ 383 (429)
+|||++....... .....||..|+|||++. ..++.++||||||+++|+|++|+.||...........+........
T Consensus 158 ~Dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-- 234 (271)
T 3dtc_A 158 TDFGLAREWHRTT-KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALP-- 234 (271)
T ss_dssp CCCCC--------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCC--
T ss_pred ccCCccccccccc-ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCC--
Confidence 9999998665333 23567999999999886 4689999999999999999999999998887777666655543332
Q ss_pred CCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhH
Q 014210 384 PWPSLSSEARDFVKRLLNKDPRKRLTAAQALSEL 417 (429)
Q Consensus 384 ~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~ 417 (429)
....+++++.+||.+||+.||++||++.++++++
T Consensus 235 ~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L 268 (271)
T 3dtc_A 235 IPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQL 268 (271)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHH
Confidence 2346899999999999999999999999999986
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=361.77 Aligned_cols=259 Identities=20% Similarity=0.287 Sum_probs=212.6
Q ss_pred ccccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEe
Q 014210 151 KHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED 230 (429)
Q Consensus 151 ~~~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~ 230 (429)
..+.++|++.+.||+|+||.||+|+... +|+.||||++..... .+.+.+|+.+++++.+|+|++++++++.+
T Consensus 6 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~-----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~ 77 (298)
T 1csn_A 6 NVVGVHYKVGRRIGEGSFGVIFEGTNLL---NNQQVAIKFEPRRSD-----APQLRDEYRTYKLLAGCTGIPNVYYFGQE 77 (298)
T ss_dssp CEETTTEEEEEEEEECSSCEEEEEEETT---TTEEEEEEEEECCTT-----SCCHHHHHHHHHHTTTCTTCCCEEEEEEE
T ss_pred cccccceEEEEEEeecCCEEEEEEEECC---CCcEEEEEEeccCCc-----cHHHHHHHHHHHHHhcCCCCCeEEeecCC
Confidence 4567899999999999999999998765 589999999864322 23578899999999779999999999999
Q ss_pred CCeEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeec--CCCceEEEeecC
Q 014210 231 TDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTK--DENSVLKAIDFG 308 (429)
Q Consensus 231 ~~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~--~~~~~vkL~DFG 308 (429)
....++||||+ +++|.+++...+..+++..++.++.||+.||.|||++||+||||||+|||++.. +....+||+|||
T Consensus 78 ~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg 156 (298)
T 1csn_A 78 GLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFG 156 (298)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCT
T ss_pred CceeEEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECc
Confidence 99999999999 899999998777789999999999999999999999999999999999999432 123349999999
Q ss_pred CccccCCCcc--------ccccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHcCCCCCCCCC---hHHHHHHHHhc
Q 014210 309 LSDFVRPDER--------LNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWART---ESGIFRAVLKA 376 (429)
Q Consensus 309 la~~~~~~~~--------~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~elltg~~Pf~~~~---~~~~~~~i~~~ 376 (429)
++........ .....||..|+|||++.+ .++.++||||||+++|||++|+.||.... ....+..+...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 236 (298)
T 1csn_A 157 MVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEK 236 (298)
T ss_dssp TCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHH
T ss_pred cccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhh
Confidence 9987654322 345679999999998874 68999999999999999999999997743 33333333322
Q ss_pred CC-CCCCCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHh
Q 014210 377 DP-SFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELL 418 (429)
Q Consensus 377 ~~-~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~ 418 (429)
.. .......+.+++++.+||.+||+.||++||++.++++.+.
T Consensus 237 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~ 279 (298)
T 1csn_A 237 KQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFS 279 (298)
T ss_dssp HHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHH
T ss_pred ccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHH
Confidence 11 1111112368899999999999999999999999987654
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-46 Score=360.77 Aligned_cols=256 Identities=25% Similarity=0.392 Sum_probs=209.3
Q ss_pred cCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~ 233 (429)
.++|++.+.||+|+||.||+++... +|+.||||++...........+.+.+|+.++++++ |+||+++++++.+++.
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-hp~iv~~~~~~~~~~~ 108 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTV---RERIVALKLMSETLSSDPVFRTRMQREARTAGRLQ-EPHVVPIHDFGEIDGQ 108 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETT---TTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEETTE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcC---CCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcC-CCCeeEEEEEEeeCCe
Confidence 4789999999999999999998765 58999999997665555666788999999999998 9999999999999999
Q ss_pred EEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCcccc
Q 014210 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (429)
Q Consensus 234 ~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~ 313 (429)
.++||||+++++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++...
T Consensus 109 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~---~~~~~~kl~Dfg~~~~~ 184 (309)
T 2h34_A 109 LYVDMRLINGVDLAAMLRRQ-GPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILV---SADDFAYLVDFGIASAT 184 (309)
T ss_dssp EEEEEECCCCEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECSCCC----
T ss_pred EEEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEE---cCCCCEEEecCccCccc
Confidence 99999999999999988654 579999999999999999999999999999999999999 67889999999999776
Q ss_pred CCCc--cccccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCH
Q 014210 314 RPDE--RLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSS 390 (429)
Q Consensus 314 ~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 390 (429)
.... ......|+..|+|||++.+ .++.++||||||+++|+|++|+.||...... .+...+...........+.++.
T Consensus 185 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 263 (309)
T 2h34_A 185 TDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS-VMGAHINQAIPRPSTVRPGIPV 263 (309)
T ss_dssp ------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH-HHHHHHHSCCCCGGGTSTTCCT
T ss_pred cccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH-HHHHHhccCCCCccccCCCCCH
Confidence 5432 2335679999999998864 6889999999999999999999999876654 3444444444434344567899
Q ss_pred HHHHHHHHhcccCccCcC-CHHHHHhhHh
Q 014210 391 EARDFVKRLLNKDPRKRL-TAAQALSELL 418 (429)
Q Consensus 391 ~~~~li~~~L~~dP~~Rp-s~~~iL~~~~ 418 (429)
++.+||.+||+.||++|| +++++++.+.
T Consensus 264 ~l~~li~~~l~~dP~~Rp~s~~~l~~~l~ 292 (309)
T 2h34_A 264 AFDAVIARGMAKNPEDRYVTCGDLSAAAH 292 (309)
T ss_dssp HHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred HHHHHHHHhccCCHHHHHHhHHHHHHHHH
Confidence 999999999999999999 8888877654
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-46 Score=351.00 Aligned_cols=251 Identities=25% Similarity=0.435 Sum_probs=217.7
Q ss_pred cCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~ 233 (429)
.++|++.+.||+|+||.||+++... ++.||||++...... .+.+.+|++++++++ |+||+++++++.+.+.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~----~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~ 77 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWLN----KDKVAIKTIREGAMS----EEDFIEEAEVMMKLS-HPKLVQLYGVCLEQAP 77 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETT----TEEEEEEEECTTTBC----HHHHHHHHHHHHTCC-CTTBCCEEEEECSSSS
T ss_pred hhheeeeeEecCCCceeEEEEEecC----CCeEEEEEccccCCC----HHHHHHHHHHHHhCC-CCCEeeEEEEEccCCC
Confidence 4689999999999999999998753 678999999764322 257889999999998 9999999999999999
Q ss_pred EEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCcccc
Q 014210 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (429)
Q Consensus 234 ~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~ 313 (429)
.++||||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++...
T Consensus 78 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili---~~~~~~kl~dfg~~~~~ 154 (267)
T 3t9t_A 78 ICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLV---GENQVIKVSDFGMTRFV 154 (267)
T ss_dssp CEEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEE---CGGGCEEECCTTGGGGB
T ss_pred eEEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEE---CCCCCEEEccccccccc
Confidence 999999999999999998777789999999999999999999999999999999999999 67888999999999876
Q ss_pred CCCc--cccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCC
Q 014210 314 RPDE--RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLS 389 (429)
Q Consensus 314 ~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 389 (429)
.... ......++..|+|||++. ..++.++||||||+++|+|++ |+.||...........+........ ...++
T Consensus 155 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~~---~~~~~ 231 (267)
T 3t9t_A 155 LDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK---PRLAS 231 (267)
T ss_dssp CCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCC---CTTSC
T ss_pred ccccccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCCC---CccCc
Confidence 4332 223456778899999887 568899999999999999999 8999998888877777766533222 23578
Q ss_pred HHHHHHHHHhcccCccCcCCHHHHHhhHhh
Q 014210 390 SEARDFVKRLLNKDPRKRLTAAQALSELLI 419 (429)
Q Consensus 390 ~~~~~li~~~L~~dP~~Rps~~~iL~~~~~ 419 (429)
.++.+||.+||+.||++||++.++++++.-
T Consensus 232 ~~l~~li~~~l~~~p~~Rps~~~ll~~L~~ 261 (267)
T 3t9t_A 232 THVYQIMNHCWRERPEDRPAFSRLLRQLAE 261 (267)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 999999999999999999999999998754
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-46 Score=359.87 Aligned_cols=267 Identities=19% Similarity=0.289 Sum_probs=212.8
Q ss_pred CCCcCccccccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcce
Q 014210 144 NKSFGFSKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVK 223 (429)
Q Consensus 144 ~~~~~~~~~~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~ 223 (429)
...+.......++|.+.+.||+|+||.||+|.......+++.||||++.... ......+.+.+|+.++++++ |+||++
T Consensus 23 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~-h~~iv~ 100 (313)
T 3brb_A 23 QNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDN-SSQREIEEFLSEAACMKDFS-HPNVIR 100 (313)
T ss_dssp -CCTTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---C-CCHHHHHHHHHHHHHHHTCC-CTTBCC
T ss_pred hhhHHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccc-cchhHHHHHHHHHHHHhcCC-CCCeee
Confidence 3333444445689999999999999999999887765567899999986543 34556678999999999998 999999
Q ss_pred EEEEEEeCCe-----EEEEEEecCCCcHHHHHHh-----cCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEE
Q 014210 224 FFDAYEDTDN-----VYVVMELCEGGELLDRILS-----RGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLF 293 (429)
Q Consensus 224 l~~~~~~~~~-----~~lv~E~~~ggsL~~~i~~-----~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl 293 (429)
+++++.+.+. .++||||+++++|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 101 ~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli 180 (313)
T 3brb_A 101 LLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCML 180 (313)
T ss_dssp CCEEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEE
T ss_pred eeEEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEE
Confidence 9999987653 5999999999999998853 23569999999999999999999999999999999999999
Q ss_pred eecCCCceEEEeecCCccccCCCcc---ccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHc-CCCCCCCCChHH
Q 014210 294 TTKDENSVLKAIDFGLSDFVRPDER---LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESG 368 (429)
Q Consensus 294 ~~~~~~~~vkL~DFGla~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~ellt-g~~Pf~~~~~~~ 368 (429)
+.++.+||+|||++........ .....++..|+|||++. ..++.++||||||+++|+|++ |..||.......
T Consensus 181 ---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~ 257 (313)
T 3brb_A 181 ---RDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE 257 (313)
T ss_dssp ---CTTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG
T ss_pred ---cCCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHH
Confidence 7788999999999987644321 22345788999999886 468999999999999999999 999998888777
Q ss_pred HHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHh
Q 014210 369 IFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELL 418 (429)
Q Consensus 369 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~ 418 (429)
....+...... .....++.++.+||.+||..||++||++.++++++-
T Consensus 258 ~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~ 304 (313)
T 3brb_A 258 MYDYLLHGHRL---KQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLE 304 (313)
T ss_dssp HHHHHHTTCCC---CCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHHcCCCC---CCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 77776655322 122468899999999999999999999999998764
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-47 Score=373.81 Aligned_cols=264 Identities=22% Similarity=0.423 Sum_probs=221.8
Q ss_pred cccccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcH--------------HHHHHHHHHHHHHHHh
Q 014210 150 SKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTA--------------IAIEDVRREVKILRAL 215 (429)
Q Consensus 150 ~~~~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~--------------~~~~~~~~Ei~il~~l 215 (429)
.+...++|++.+.||+|+||.||+|+. +|+.||||++........ ...+.+.+|+.+++++
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 100 (348)
T 2pml_X 26 KDKYINDYRIIRTLNQGKFNKIILCEK-----DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDI 100 (348)
T ss_dssp SCEEETTEEEEEEEECCSSCCEEEEEE-----TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTC
T ss_pred cccccCceEEEEEEcCCCCeEEEEEEc-----CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhC
Confidence 344568999999999999999999986 489999999854322211 1127789999999999
Q ss_pred cCCCCcceEEEEEEeCCeEEEEEEecCCCcHHHH------HHhc-CCCCCHHHHHHHHHHHHHHHHHHHH-cCceeccCC
Q 014210 216 TGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDR------ILSR-GGKYTEDDAKAVMIQILNVVAFCHL-QGVVHRDLK 287 (429)
Q Consensus 216 ~~h~nIv~l~~~~~~~~~~~lv~E~~~ggsL~~~------i~~~-~~~l~~~~~~~i~~qi~~gL~~LH~-~~iiHrDIK 287 (429)
+ |+||+++++++.+.+..++||||+++++|.++ +... ...+++..++.++.||+.||.|||+ .||+|||||
T Consensus 101 ~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~ 179 (348)
T 2pml_X 101 K-NEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVK 179 (348)
T ss_dssp C-CTTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCC
T ss_pred C-CCCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCC
Confidence 8 99999999999999999999999999999887 4332 5679999999999999999999999 999999999
Q ss_pred CCcEEEeecCCCceEEEeecCCccccCCCccccccccCCcccCcccccCC--CCC-cccHHHHHHHHHHHHcCCCCCCCC
Q 014210 288 PENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRS--YST-EADVWSIGVIAYILLCGSRPFWAR 364 (429)
Q Consensus 288 p~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~-~sDiwSlGvll~elltg~~Pf~~~ 364 (429)
|+|||+ +.++.+||+|||++...... ......||..|+|||++.+. ++. ++||||||+++|||++|+.||...
T Consensus 180 p~Nil~---~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 255 (348)
T 2pml_X 180 PSNILM---DKNGRVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLK 255 (348)
T ss_dssp GGGEEE---CTTSCEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred hHhEEE---cCCCcEEEeccccccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 999999 78889999999999876543 44567899999999998754 555 899999999999999999999887
Q ss_pred Ch-HHHHHHHHhcCCCCCCCC---------------CCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhccc
Q 014210 365 TE-SGIFRAVLKADPSFDEAP---------------WPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLICYQS 423 (429)
Q Consensus 365 ~~-~~~~~~i~~~~~~~~~~~---------------~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~~ 423 (429)
.. ...+..+......++... ...++.++.+||++||+.||.+||++.++|+|+||....
T Consensus 256 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~~ 330 (348)
T 2pml_X 256 ISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTN 330 (348)
T ss_dssp SCSHHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred CcHHHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCCC
Confidence 76 666666665544443211 146899999999999999999999999999999998654
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=361.93 Aligned_cols=258 Identities=24% Similarity=0.389 Sum_probs=217.8
Q ss_pred ccCceeEeceeeccCceEEEEEEEecC----cccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEE
Q 014210 153 FANKYELGEEVGRGHFGYTCAAKFKKG----ELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAY 228 (429)
Q Consensus 153 ~~~~y~~~~~IG~G~fg~V~~~~~~~~----~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~ 228 (429)
..++|++.+.||+|+||.||+|+.... ..+++.||||++... ......+.+.+|+++++++.+||||+++++++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 110 (334)
T 2pvf_A 33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD--ATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 110 (334)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTT--CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccC--CcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEE
Confidence 358999999999999999999987531 135789999999754 34556778999999999995599999999999
Q ss_pred EeCCeEEEEEEecCCCcHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEE
Q 014210 229 EDTDNVYVVMELCEGGELLDRILSRG---------------GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLF 293 (429)
Q Consensus 229 ~~~~~~~lv~E~~~ggsL~~~i~~~~---------------~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl 293 (429)
.+.+..++||||+++|+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 111 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll 190 (334)
T 2pvf_A 111 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV 190 (334)
T ss_dssp CSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred ccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEE
Confidence 99999999999999999999987543 248999999999999999999999999999999999999
Q ss_pred eecCCCceEEEeecCCccccCCCcc---ccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHc-CCCCCCCCChHH
Q 014210 294 TTKDENSVLKAIDFGLSDFVRPDER---LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESG 368 (429)
Q Consensus 294 ~~~~~~~~vkL~DFGla~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~ellt-g~~Pf~~~~~~~ 368 (429)
+.++.+||+|||++........ .....+|..|+|||++. +.++.++||||||+++|||++ |+.||......+
T Consensus 191 ---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~ 267 (334)
T 2pvf_A 191 ---TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE 267 (334)
T ss_dssp ---CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred ---cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHH
Confidence 7788999999999987654332 23345788999999886 468899999999999999999 999999888877
Q ss_pred HHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHh
Q 014210 369 IFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELL 418 (429)
Q Consensus 369 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~ 418 (429)
....+....... ....++.++.+||++||+.||++||++.++++++-
T Consensus 268 ~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~ 314 (334)
T 2pvf_A 268 LFKLLKEGHRMD---KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 314 (334)
T ss_dssp HHHHHHHTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHhcCCCCC---CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 777666554222 22468999999999999999999999999998754
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-46 Score=365.54 Aligned_cols=267 Identities=24% Similarity=0.395 Sum_probs=217.5
Q ss_pred cCccccccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCC------
Q 014210 147 FGFSKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNN------ 220 (429)
Q Consensus 147 ~~~~~~~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~n------ 220 (429)
...++.+.++|++.+.||+|+||.||+|..... .++.||||++.. .....+.+.+|+.+++++. |++
T Consensus 11 ~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~--~~~~vavK~~~~----~~~~~~~~~~E~~~l~~l~-~~~~~~~~~ 83 (355)
T 2eu9_A 11 CRIGDWLQERYEIVGNLGEGTFGKVVECLDHAR--GKSQVALKIIRN----VGKYREAARLEINVLKKIK-EKDKENKFL 83 (355)
T ss_dssp CCTTCEETTTEEEEEEEEEETTEEEEEEEETTT--TTEEEEEEEECS----CHHHHHHHHHHHHHHHHHH-HHCTTSCSC
T ss_pred cccCceecccEEEEEEeeccCCeEEEEEEecCC--CceEEEEEEEcc----cccchhHHHHHHHHHHHHh-hcCCCCcee
Confidence 344567789999999999999999999987652 247999999864 2345577889999999998 555
Q ss_pred cceEEEEEEeCCeEEEEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeec---
Q 014210 221 LVKFFDAYEDTDNVYVVMELCEGGELLDRILSRG-GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTK--- 296 (429)
Q Consensus 221 Iv~l~~~~~~~~~~~lv~E~~~ggsL~~~i~~~~-~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~--- 296 (429)
++.+++++...+..+|||||+ +++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||+...
T Consensus 84 ~~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~ 162 (355)
T 2eu9_A 84 CVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFE 162 (355)
T ss_dssp BCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEE
T ss_pred EEEeeeeeeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccc
Confidence 999999999999999999999 667788776654 579999999999999999999999999999999999999532
Q ss_pred -------------CCCceEEEeecCCccccCCCccccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHcCCCCCC
Q 014210 297 -------------DENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFW 362 (429)
Q Consensus 297 -------------~~~~~vkL~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~elltg~~Pf~ 362 (429)
+.++.+||+|||++..... ......||..|+|||++. ..++.++||||||+++|||++|+.||.
T Consensus 163 ~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~ 240 (355)
T 2eu9_A 163 TLYNEHKSCEEKSVKNTSIRVADFGSATFDHE--HHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQ 240 (355)
T ss_dssp EEECCC-CCCEEEESCCCEEECCCTTCEETTS--CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred ccccccccccccccCCCcEEEeecCccccccc--cccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCC
Confidence 3567899999999976532 334568999999999886 468999999999999999999999998
Q ss_pred CCChHHHHHHHHhcCCCCCC----------------CCC------------------------CCCCHHHHHHHHHhccc
Q 014210 363 ARTESGIFRAVLKADPSFDE----------------APW------------------------PSLSSEARDFVKRLLNK 402 (429)
Q Consensus 363 ~~~~~~~~~~i~~~~~~~~~----------------~~~------------------------~~~s~~~~~li~~~L~~ 402 (429)
.......+..+.+.....+. ..| ...+.++.+||++||+.
T Consensus 241 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 320 (355)
T 2eu9_A 241 THENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEF 320 (355)
T ss_dssp CSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCS
T ss_pred CCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcC
Confidence 88776655544332211110 000 11245789999999999
Q ss_pred CccCcCCHHHHHhhHhhhccc
Q 014210 403 DPRKRLTAAQALSELLICYQS 423 (429)
Q Consensus 403 dP~~Rps~~~iL~~~~~~~~~ 423 (429)
||++|||+.++|+|+||....
T Consensus 321 dP~~Rpt~~e~l~hp~f~~~~ 341 (355)
T 2eu9_A 321 DPAQRITLAEALLHPFFAGLT 341 (355)
T ss_dssp STTTSCCHHHHTTSGGGGGCC
T ss_pred ChhhCcCHHHHhcChhhcCCC
Confidence 999999999999999998643
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-46 Score=368.26 Aligned_cols=259 Identities=25% Similarity=0.350 Sum_probs=203.4
Q ss_pred ccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCC
Q 014210 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (429)
Q Consensus 153 ~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~ 232 (429)
..++|++.++||+|+||.||+|+... +|+.||||++....... ....+|++.+..++ |+||+++++++...+
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~----~~~~~~~~~l~~l~-h~niv~~~~~~~~~~ 92 (360)
T 3e3p_A 21 EMDRFQVERMAGQGTFGTVQLGKEKS---TGMSVAIKKVIQDPRFR----NRELQIMQDLAVLH-HPNIVQLQSYFYTLG 92 (360)
T ss_dssp HHTTEEEC----------CEEEEETT---TCCEEEEEEEECCTTCC----CHHHHHHHHHHHHC-CTTBCCEEEEEEEEC
T ss_pred hccceEEEEEEecCCCeEEEEEEECC---CCCEEEEEEEecCcccc----HHHHHHHHHHHhcC-CCCcccHHHhhhccc
Confidence 35789999999999999999998766 58999999986543222 34567888888887 999999999997644
Q ss_pred e-------EEEEEEecCCCcHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHH--HcCceeccCCCCcEEEeecCCCc
Q 014210 233 N-------VYVVMELCEGGELLDRIL---SRGGKYTEDDAKAVMIQILNVVAFCH--LQGVVHRDLKPENFLFTTKDENS 300 (429)
Q Consensus 233 ~-------~~lv~E~~~ggsL~~~i~---~~~~~l~~~~~~~i~~qi~~gL~~LH--~~~iiHrDIKp~NILl~~~~~~~ 300 (429)
. .++||||+++ +|.+.+. .....+++..++.++.||+.||.||| ++||+||||||+|||++ ..++
T Consensus 93 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~--~~~~ 169 (360)
T 3e3p_A 93 ERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVN--EADG 169 (360)
T ss_dssp SSCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEE--TTTT
T ss_pred cccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEe--CCCC
Confidence 3 8899999976 5555443 35567999999999999999999999 99999999999999994 2378
Q ss_pred eEEEeecCCccccCCCccccccccCCcccCcccccC--CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCC
Q 014210 301 VLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADP 378 (429)
Q Consensus 301 ~vkL~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~ 378 (429)
.+||+|||++.............||..|+|||++.+ .++.++|||||||++|||++|+.||........+..+.+...
T Consensus 170 ~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~ 249 (360)
T 3e3p_A 170 TLKLCDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLG 249 (360)
T ss_dssp EEEECCCTTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred cEEEeeCCCceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcC
Confidence 999999999988776666667789999999998853 489999999999999999999999999888777766654211
Q ss_pred CCC----------------------------CCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhcc
Q 014210 379 SFD----------------------------EAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLICYQ 422 (429)
Q Consensus 379 ~~~----------------------------~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~ 422 (429)
... ......++.++.+||.+||+.||++|||+.++|+|+||+..
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 321 (360)
T 3e3p_A 250 CPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDEL 321 (360)
T ss_dssp CCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGG
T ss_pred CCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCcccccc
Confidence 100 00112357899999999999999999999999999999864
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-46 Score=359.59 Aligned_cols=258 Identities=28% Similarity=0.419 Sum_probs=196.4
Q ss_pred cCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~ 233 (429)
.++|++++.||+|+||.||+|+... +|+.||||++.... ......+.+.++..+++.+. |+||+++++++.+.+.
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~~~~~~~~~~~~-h~~i~~~~~~~~~~~~ 98 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRK---TGHVIAVKQMRRSG-NKEENKRILMDLDVVLKSHD-CPYIVQCFGTFITNTD 98 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETT---TCCEEEEEEEETTS-CHHHHHHHHHHHHHHHHTTT-CTTBCCEEEEEECSSE
T ss_pred hccccccceeeecCCeeEEEEEEec---CCeEEEEEEecccc-cchHHHHHHHHHHHHHHhcC-CCceeeEEEEEecCCc
Confidence 5789999999999999999999776 58999999997643 22222333444444566665 9999999999999999
Q ss_pred EEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHc-CceeccCCCCcEEEeecCCCceEEEeecCCccc
Q 014210 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQ-GVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (429)
Q Consensus 234 ~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~-~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~ 312 (429)
.+|||||+ ++.+..........+++..++.++.||+.||.|||++ ||+||||||+|||+ +.++.+||+|||++..
T Consensus 99 ~~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~---~~~~~~kl~dfg~~~~ 174 (318)
T 2dyl_A 99 VFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILL---DERGQIKLCDFGISGR 174 (318)
T ss_dssp EEEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEE---CTTSCEEECCCTTC--
T ss_pred EEEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEE---CCCCCEEEEECCCchh
Confidence 99999999 5566555555567899999999999999999999995 99999999999999 7788999999999987
Q ss_pred cCCCccccccccCCcccCccccc------CCCCCcccHHHHHHHHHHHHcCCCCCCCC-ChHHHHHHHHhcCCCCCCCCC
Q 014210 313 VRPDERLNDIVGSAYYVAPEVLH------RSYSTEADVWSIGVIAYILLCGSRPFWAR-TESGIFRAVLKADPSFDEAPW 385 (429)
Q Consensus 313 ~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~sDiwSlGvll~elltg~~Pf~~~-~~~~~~~~i~~~~~~~~~~~~ 385 (429)
...........||..|+|||++. ..++.++||||||+++|||++|+.||... .....+..+........ ...
T Consensus 175 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~ 253 (318)
T 2dyl_A 175 LVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLL-PGH 253 (318)
T ss_dssp ------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCC-CSS
T ss_pred ccCCccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCC-Ccc
Confidence 76555555678999999999884 35888999999999999999999999873 44555666655543322 222
Q ss_pred CCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhc
Q 014210 386 PSLSSEARDFVKRLLNKDPRKRLTAAQALSELLICY 421 (429)
Q Consensus 386 ~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~ 421 (429)
..++.++.+||.+||+.||.+||++.++++|+||+.
T Consensus 254 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 289 (318)
T 2dyl_A 254 MGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKR 289 (318)
T ss_dssp SCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHH
T ss_pred CCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHh
Confidence 468999999999999999999999999999999975
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=361.95 Aligned_cols=257 Identities=22% Similarity=0.346 Sum_probs=213.3
Q ss_pred ccCceeEeceeeccCceEEEEEEEecCc-ccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeC
Q 014210 153 FANKYELGEEVGRGHFGYTCAAKFKKGE-LKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (429)
Q Consensus 153 ~~~~y~~~~~IG~G~fg~V~~~~~~~~~-~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~ 231 (429)
..++|++.+.||+|+||.||+|...... ..+..||||++... ........+.+|+.+++++. |+||+++++++.+.
T Consensus 42 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~ 118 (333)
T 1mqb_A 42 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG--YTEKQRVDFLGEAGIMGQFS-HHNIIRLEGVISKY 118 (333)
T ss_dssp CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTT--CCHHHHHHHHHHHHHHHTCC-CTTBCCEEEEECSS
T ss_pred ChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCC--CCHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEecC
Confidence 3578999999999999999999877532 23567999998654 34455677999999999998 99999999999999
Q ss_pred CeEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCcc
Q 014210 232 DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (429)
Q Consensus 232 ~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~ 311 (429)
+..+|||||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.
T Consensus 119 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~---~~~~~~kl~Dfg~~~ 195 (333)
T 1mqb_A 119 KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILV---NSNLVCKVSDFGLSR 195 (333)
T ss_dssp SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECCCCC--
T ss_pred CCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEE---CCCCcEEECCCCcch
Confidence 99999999999999999998777889999999999999999999999999999999999999 778899999999998
Q ss_pred ccCCCcc----ccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCCCC
Q 014210 312 FVRPDER----LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPW 385 (429)
Q Consensus 312 ~~~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 385 (429)
....... .....+|..|+|||++. +.++.++||||||+++|||++ |+.||......+.+..+...... ...
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~---~~~ 272 (333)
T 1mqb_A 196 VLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRL---PTP 272 (333)
T ss_dssp ---------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC---CCC
T ss_pred hhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcC---CCc
Confidence 7654321 12334678899999886 568899999999999999999 99999988887777776654321 122
Q ss_pred CCCCHHHHHHHHHhcccCccCcCCHHHHHhhHh
Q 014210 386 PSLSSEARDFVKRLLNKDPRKRLTAAQALSELL 418 (429)
Q Consensus 386 ~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~ 418 (429)
..++.++.+||.+||+.||++||++.++++++.
T Consensus 273 ~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~ 305 (333)
T 1mqb_A 273 MDCPSAIYQLMMQCWQQERARRPKFADIVSILD 305 (333)
T ss_dssp TTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHH
T ss_pred ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 468999999999999999999999999998764
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-46 Score=364.88 Aligned_cols=255 Identities=24% Similarity=0.360 Sum_probs=212.0
Q ss_pred cCceeEeceeeccCceEEEEEEEecCcccCeE--EEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeC
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQ--VAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~--vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~ 231 (429)
.++|++.+.||+|+||.||+|+... +|.. +|||++... ......+.+.+|+++++++.+||||+++++++.+.
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~~~v~iK~~~~~--~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 98 (327)
T 1fvr_A 24 WNDIKFQDVIGEGNFGQVLKARIKK---DGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR 98 (327)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEE---TTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEET
T ss_pred HHHccceeeeecCCCceEEEEEEcc---CCcccceeeeeeccc--cchHHHHHHHHHHHHHHhccCCCchhhhceeeeeC
Confidence 4789999999999999999999876 4664 499998643 33445567899999999995599999999999999
Q ss_pred CeEEEEEEecCCCcHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeec
Q 014210 232 DNVYVVMELCEGGELLDRILSRG---------------GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTK 296 (429)
Q Consensus 232 ~~~~lv~E~~~ggsL~~~i~~~~---------------~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~ 296 (429)
+..+|||||+++++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~--- 175 (327)
T 1fvr_A 99 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV--- 175 (327)
T ss_dssp TEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---
T ss_pred CceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEE---
Confidence 99999999999999999886543 479999999999999999999999999999999999999
Q ss_pred CCCceEEEeecCCccccCCCccccccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHH
Q 014210 297 DENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVL 374 (429)
Q Consensus 297 ~~~~~vkL~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~ellt-g~~Pf~~~~~~~~~~~i~ 374 (429)
+.++.+||+|||+++............++..|+|||++.+ .++.++||||||+++|||++ |+.||...........+.
T Consensus 176 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~ 255 (327)
T 1fvr_A 176 GENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP 255 (327)
T ss_dssp CGGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGG
T ss_pred cCCCeEEEcccCcCccccccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhh
Confidence 6788999999999975443333344567889999998874 58899999999999999998 999999888777766665
Q ss_pred hcCCCCCCCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhh
Q 014210 375 KADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLI 419 (429)
Q Consensus 375 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~ 419 (429)
.... ......++.++.+||.+||+.||++||++.++++++.-
T Consensus 256 ~~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~ 297 (327)
T 1fvr_A 256 QGYR---LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNR 297 (327)
T ss_dssp GTCC---CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred cCCC---CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 4321 12224689999999999999999999999999998754
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-46 Score=360.50 Aligned_cols=260 Identities=18% Similarity=0.294 Sum_probs=220.2
Q ss_pred ccccCceeEeceeeccCceEEEEEEEec--CcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEE
Q 014210 151 KHFANKYELGEEVGRGHFGYTCAAKFKK--GELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAY 228 (429)
Q Consensus 151 ~~~~~~y~~~~~IG~G~fg~V~~~~~~~--~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~ 228 (429)
+...++|++.+.||+|+||.||+|+... ....++.||||++... ........+.+|+.+++++. |+||+++++++
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~ 97 (322)
T 1p4o_A 21 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA--ASMRERIEFLNEASVMKEFN-CHHVVRLLGVV 97 (322)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT--SCHHHHHHHHHHHHHGGGCC-CTTBCCEEEEE
T ss_pred cchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccc--cCHHHHHHHHHHHHHHHhcC-CCCEeeeEEEE
Confidence 3456899999999999999999998763 1225789999998754 34455677899999999998 99999999999
Q ss_pred EeCCeEEEEEEecCCCcHHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCC
Q 014210 229 EDTDNVYVVMELCEGGELLDRILSRG---------GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDEN 299 (429)
Q Consensus 229 ~~~~~~~lv~E~~~ggsL~~~i~~~~---------~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~ 299 (429)
.+.+..++||||+++|+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.+
T Consensus 98 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli---~~~ 174 (322)
T 1p4o_A 98 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMV---AED 174 (322)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEE---CTT
T ss_pred ccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEE---cCC
Confidence 99999999999999999999886532 457999999999999999999999999999999999999 778
Q ss_pred ceEEEeecCCccccCCCcc---ccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHH
Q 014210 300 SVLKAIDFGLSDFVRPDER---LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVL 374 (429)
Q Consensus 300 ~~vkL~DFGla~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~ellt-g~~Pf~~~~~~~~~~~i~ 374 (429)
+.+||+|||++........ .....+|..|+|||++. +.++.++||||||+++|+|++ |+.||...........+.
T Consensus 175 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~ 254 (322)
T 1p4o_A 175 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM 254 (322)
T ss_dssp CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHH
T ss_pred CeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHH
Confidence 8999999999976543321 23346788999999886 568999999999999999999 899998888877777776
Q ss_pred hcCCCCCCCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhh
Q 014210 375 KADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLI 419 (429)
Q Consensus 375 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~ 419 (429)
...... ....++.++.+||.+||+.||++||++.++++++.-
T Consensus 255 ~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~ 296 (322)
T 1p4o_A 255 EGGLLD---KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 296 (322)
T ss_dssp TTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGG
T ss_pred cCCcCC---CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHH
Confidence 544322 224689999999999999999999999999998643
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-46 Score=358.21 Aligned_cols=259 Identities=24% Similarity=0.377 Sum_probs=210.6
Q ss_pred cCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~ 233 (429)
.++|++.+.||+|+||.||+|+.......+..||||++...........+.+.+|++++++++ |+||+++++++.+.+
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~- 94 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD-HRNLIRLYGVVLTPP- 94 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCC-CTTBCCEEEEECSSS-
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCC-CCCcccEEEEEccCC-
Confidence 578999999999999999999876543344579999997655455566788999999999998 999999999998765
Q ss_pred EEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCcccc
Q 014210 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (429)
Q Consensus 234 ~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~ 313 (429)
.++||||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++...
T Consensus 95 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili---~~~~~~kl~Dfg~~~~~ 171 (291)
T 1u46_A 95 MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLL---ATRDLVKIGDFGLMRAL 171 (291)
T ss_dssp CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---EETTEEEECCCTTCEEC
T ss_pred ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEE---cCCCCEEEccccccccc
Confidence 899999999999999998777789999999999999999999999999999999999999 56778999999999876
Q ss_pred CCCcc----ccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCC
Q 014210 314 RPDER----LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPS 387 (429)
Q Consensus 314 ~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 387 (429)
..... .....+|..|+|||++. ..++.++||||||+++|+|++ |+.||........+..+......... ...
T Consensus 172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~ 249 (291)
T 1u46_A 172 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPR--PED 249 (291)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCC--CTT
T ss_pred cccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCCC--CcC
Confidence 54332 23346788999999886 458889999999999999999 99999998888887777665443332 346
Q ss_pred CCHHHHHHHHHhcccCccCcCCHHHHHhhHhh
Q 014210 388 LSSEARDFVKRLLNKDPRKRLTAAQALSELLI 419 (429)
Q Consensus 388 ~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~ 419 (429)
++.++.+||.+||..||++||++.++++++.-
T Consensus 250 ~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~ 281 (291)
T 1u46_A 250 CPQDIYNVMVQCWAHKPEDRPTFVALRDFLLE 281 (291)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred cCHHHHHHHHHHccCCcccCcCHHHHHHHHHH
Confidence 89999999999999999999999999987653
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-46 Score=365.86 Aligned_cols=256 Identities=31% Similarity=0.544 Sum_probs=212.7
Q ss_pred cccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeC
Q 014210 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (429)
Q Consensus 152 ~~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~ 231 (429)
.+.++|.+.+.||+|+||.||+|+... +|+.||||++.... ......+.+.+|+.++++++ |+||+++++++...
T Consensus 21 ~l~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~ 95 (353)
T 3coi_A 21 ELPKTYVSPTHVGSGAYGSVCSAIDKR---SGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQ-HENVIGLLDVFTPA 95 (353)
T ss_dssp EEETTEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEESSTT-SSHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSC
T ss_pred ccCceEEEeeeEecCCCeEEEEEEECC---CCCEEEEEEecccc-cchHHHHHHHHHHHHHHhcC-CCCcccHhheEecc
Confidence 346889999999999999999998765 68999999987543 44556678899999999998 99999999999876
Q ss_pred Ce------EEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEe
Q 014210 232 DN------VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAI 305 (429)
Q Consensus 232 ~~------~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~ 305 (429)
+. .++||||++ ++|.+++ ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+
T Consensus 96 ~~~~~~~~~~lv~e~~~-~~l~~~~---~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~---~~~~~~kl~ 168 (353)
T 3coi_A 96 SSLRNFYDFYLVMPFMQ-TDLQKIM---GLKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAV---NEDCELKIL 168 (353)
T ss_dssp SSGGGCCCCEEEEECCS-EEGGGTT---TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEE---CTTCCEEEC
T ss_pred cccccceeEEEEecccc-CCHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeE---CCCCcEEEe
Confidence 54 499999997 5887755 2459999999999999999999999999999999999999 778899999
Q ss_pred ecCCccccCCCccccccccCCcccCcccccC--CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcC------
Q 014210 306 DFGLSDFVRPDERLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKAD------ 377 (429)
Q Consensus 306 DFGla~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~------ 377 (429)
|||++..... ......||..|+|||++.+ .++.++||||||+++|+|++|+.||......+.+..+.+..
T Consensus 169 Dfg~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 246 (353)
T 3coi_A 169 DFGLARHADA--EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTE 246 (353)
T ss_dssp STTCTTC----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHH
T ss_pred ecccccCCCC--CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 9999986543 2345678999999998764 68999999999999999999999999888766665554321
Q ss_pred -----------------CC----CCCCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhc
Q 014210 378 -----------------PS----FDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLICY 421 (429)
Q Consensus 378 -----------------~~----~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~ 421 (429)
+. .....++.++.++.+||++||+.||++||++.++|+|+||..
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~ 311 (353)
T 3coi_A 247 FVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEP 311 (353)
T ss_dssp HHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTT
T ss_pred HHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhh
Confidence 00 011223568999999999999999999999999999999975
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=353.53 Aligned_cols=254 Identities=22% Similarity=0.360 Sum_probs=217.7
Q ss_pred ccccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEe
Q 014210 151 KHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED 230 (429)
Q Consensus 151 ~~~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~ 230 (429)
+...++|++.+.||+|+||.||+|.... +++.||||++... ....+.+.+|++++++++ |+||+++++++.+
T Consensus 9 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~----~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~ 80 (288)
T 3kfa_A 9 EMERTDITMKHKLGGGQYGEVYEGVWKK---YSLTVAVKTLKED----TMEVEEFLKEAAVMKEIK-HPNLVQLLGVCTR 80 (288)
T ss_dssp BCCGGGEEEEEESGGGTTCSEEEEEEGG---GTEEEEEEEECSC----STHHHHHHHHHHHHHHCC-CTTBCCEEEEECS
T ss_pred cccccceeEEeecCCCCceeEEEeEecC---CCEEEEEEecCcC----HHHHHHHHHHHHHHHhCC-CCCEeeEEEEEcc
Confidence 3456889999999999999999999776 5899999998643 234567899999999998 9999999999999
Q ss_pred CCeEEEEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCC
Q 014210 231 TDNVYVVMELCEGGELLDRILSRG-GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGL 309 (429)
Q Consensus 231 ~~~~~lv~E~~~ggsL~~~i~~~~-~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGl 309 (429)
.+..++||||+++++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+
T Consensus 81 ~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~---~~~~~~~l~Dfg~ 157 (288)
T 3kfa_A 81 EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV---GENHLVKVADFGL 157 (288)
T ss_dssp SSSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEE---CGGGCEEECCCCG
T ss_pred CCCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEE---cCCCCEEEccCcc
Confidence 999999999999999999987643 459999999999999999999999999999999999999 6778899999999
Q ss_pred ccccCCCcc--ccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCCCC
Q 014210 310 SDFVRPDER--LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPW 385 (429)
Q Consensus 310 a~~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 385 (429)
+........ .....+|..|+|||++. +.++.++||||||+++|+|++ |..||...........+...... ...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~---~~~ 234 (288)
T 3kfa_A 158 SRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM---ERP 234 (288)
T ss_dssp GGTSCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCC---CCC
T ss_pred ceeccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCC---CCC
Confidence 987654332 23445788999999886 568999999999999999999 99999887777666655544221 223
Q ss_pred CCCCHHHHHHHHHhcccCccCcCCHHHHHhhHh
Q 014210 386 PSLSSEARDFVKRLLNKDPRKRLTAAQALSELL 418 (429)
Q Consensus 386 ~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~ 418 (429)
..+++++.+||++||+.||.+||++.++++.+.
T Consensus 235 ~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~ 267 (288)
T 3kfa_A 235 EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 267 (288)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHH
Confidence 468999999999999999999999999988643
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=368.30 Aligned_cols=255 Identities=20% Similarity=0.309 Sum_probs=210.2
Q ss_pred cCceeEeceeeccCceEEEEEEEecCc-ccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCC
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGE-LKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~-~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~ 232 (429)
.++|+++++||+|+||.||+|+..... .....||+|++.... .....+.+.+|+.++++++ |+||+++++++. ++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~-~~ 87 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS--GRQSFQAVTDHMLAIGSLD-HAHIVRLLGLCP-GS 87 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTT--SCSCBCSCCHHHHHHHTCC-CTTBCCEEEEEC-BS
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccc--cHHHHHHHHHHHHHHhcCC-CCCcCeEEEEEc-CC
Confidence 578999999999999999999876531 123348888875432 2222345778999999998 999999999886 56
Q ss_pred eEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccc
Q 014210 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (429)
Q Consensus 233 ~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~ 312 (429)
..++||||+.+|+|.+++....+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.
T Consensus 88 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~---~~~~~~kl~Dfg~a~~ 164 (325)
T 3kex_A 88 SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLL---KSPSQVQVADFGVADL 164 (325)
T ss_dssp SEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEE---SSSSCEEECSCSGGGG
T ss_pred ccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEE---CCCCeEEECCCCcccc
Confidence 6899999999999999987766789999999999999999999999999999999999999 7788899999999987
Q ss_pred cCCCcc---ccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCC
Q 014210 313 VRPDER---LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPS 387 (429)
Q Consensus 313 ~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 387 (429)
...... .....||..|+|||++. +.++.++||||||+++|+|++ |+.||...........+........ ...
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~ 241 (325)
T 3kex_A 165 LPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQ---PQI 241 (325)
T ss_dssp SCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCCC---CTT
T ss_pred cCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCC---CCc
Confidence 654332 24456888999999887 578999999999999999999 9999988877777666665432222 124
Q ss_pred CCHHHHHHHHHhcccCccCcCCHHHHHhhHh
Q 014210 388 LSSEARDFVKRLLNKDPRKRLTAAQALSELL 418 (429)
Q Consensus 388 ~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~ 418 (429)
++.++.+||.+||+.||++||++.++++++.
T Consensus 242 ~~~~~~~li~~~l~~dp~~Rps~~el~~~l~ 272 (325)
T 3kex_A 242 CTIDVYMVMVKCWMIDENIRPTFKELANEFT 272 (325)
T ss_dssp BCTTTTHHHHHHTCSCTTTSCCHHHHHHHHH
T ss_pred CcHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 7788999999999999999999999999864
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=355.18 Aligned_cols=257 Identities=21% Similarity=0.308 Sum_probs=212.5
Q ss_pred cCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEE-eCC
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYE-DTD 232 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~-~~~ 232 (429)
..+|++.++||+|+||.||+|+...+...+..||||++... ......+.+.+|+.++++++ |+||+++++++. .++
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~--~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~ 100 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFS-HPNVLSLLGICLRSEG 100 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTC--CSHHHHHHHHHHHHHHHTCC-CTTBCCCCEEECCSSS
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccC--CCHHHHHHHHHHHHHHHhCC-CCCEeeeeeEEEcCCC
Confidence 46799999999999999999987765445667999998653 45566678999999999998 999999999865 456
Q ss_pred eEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccc
Q 014210 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (429)
Q Consensus 233 ~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~ 312 (429)
..++||||+++|+|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..
T Consensus 101 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~---~~~~~~kl~Dfg~a~~ 177 (298)
T 3f66_A 101 SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCML---DEKFTVKVADFGLARD 177 (298)
T ss_dssp CCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CTTCCEEECSCGGGCC
T ss_pred ceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEE---CCCCCEEECccccccc
Confidence 7899999999999999997777789999999999999999999999999999999999999 7888999999999987
Q ss_pred cCCCcc-----ccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCCCC
Q 014210 313 VRPDER-----LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPW 385 (429)
Q Consensus 313 ~~~~~~-----~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 385 (429)
...... .....+|..|+|||++. ..++.++||||||+++|+|++ |..||......+....+.........
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 254 (298)
T 3f66_A 178 MYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQP--- 254 (298)
T ss_dssp CSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCCCCC---
T ss_pred ccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCCCCC---
Confidence 654332 23446788999999886 468999999999999999999 56667666666666666554433322
Q ss_pred CCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhh
Q 014210 386 PSLSSEARDFVKRLLNKDPRKRLTAAQALSELLI 419 (429)
Q Consensus 386 ~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~ 419 (429)
..++.++.+||.+||+.||++||++.++++.+--
T Consensus 255 ~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~ 288 (298)
T 3f66_A 255 EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISA 288 (298)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 3578999999999999999999999999987643
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=354.74 Aligned_cols=257 Identities=24% Similarity=0.377 Sum_probs=208.7
Q ss_pred ccCceeEeceeeccCceEEEEEEEec-CcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeC
Q 014210 153 FANKYELGEEVGRGHFGYTCAAKFKK-GELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (429)
Q Consensus 153 ~~~~y~~~~~IG~G~fg~V~~~~~~~-~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~ 231 (429)
..++|+++++||+|+||.||+|+... +..+|+.||||++.... .....+.+.+|++++++++ |+||+++++++.+.
T Consensus 19 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~ 95 (302)
T 4e5w_A 19 EKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLY-HENIVKYKGICTED 95 (302)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-------CCHHHHHHHHHHHHTCC-CTTBCCEEEEEEC-
T ss_pred hhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc--cchhHHHHHHHHHHHHhCC-CCCeeeeeeEEecC
Confidence 35779999999999999999998542 22368999999987542 3334577899999999998 99999999999877
Q ss_pred --CeEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCC
Q 014210 232 --DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGL 309 (429)
Q Consensus 232 --~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGl 309 (429)
+.+++||||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+
T Consensus 96 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~---~~~~~~kl~Dfg~ 172 (302)
T 4e5w_A 96 GGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLV---ESEHQVKIGDFGL 172 (302)
T ss_dssp --CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---EETTEEEECCCTT
T ss_pred CCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEE---cCCCCEEECcccc
Confidence 66899999999999999997777889999999999999999999999999999999999999 5677899999999
Q ss_pred ccccCCCcc----ccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHcCCCCCCCC--------------ChHHHH
Q 014210 310 SDFVRPDER----LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWAR--------------TESGIF 370 (429)
Q Consensus 310 a~~~~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~elltg~~Pf~~~--------------~~~~~~ 370 (429)
+........ .....||..|+|||++. ..++.++||||||+++|+|++|+.|+... .....+
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 252 (302)
T 4e5w_A 173 TKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRL 252 (302)
T ss_dssp CEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHH
T ss_pred cccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHH
Confidence 987654432 23456888899999886 46888999999999999999999886321 111222
Q ss_pred HHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhH
Q 014210 371 RAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSEL 417 (429)
Q Consensus 371 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~ 417 (429)
.......... ...+.+++++.+||++||+.||++|||+.++++.+
T Consensus 253 ~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L 297 (302)
T 4e5w_A 253 VNTLKEGKRL--PCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGF 297 (302)
T ss_dssp HHHHHTTCCC--CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred HHHHhccCCC--CCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHH
Confidence 2222222222 22347899999999999999999999999999865
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=356.63 Aligned_cols=261 Identities=25% Similarity=0.427 Sum_probs=211.2
Q ss_pred cccccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcC-CCCcceEEEEE
Q 014210 150 SKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTG-HNNLVKFFDAY 228 (429)
Q Consensus 150 ~~~~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~-h~nIv~l~~~~ 228 (429)
.....++|++++.||+|+||.||++... +|+.||||++.... ......+.+.+|+.+++++.+ |+||+++++++
T Consensus 23 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~ 97 (313)
T 3cek_A 23 MSVKGRIYSILKQIGSGGSSKVFQVLNE----KKQIYAIKYVNLEE-ADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE 97 (313)
T ss_dssp EEETTEEEEEEEEEECCSSEEEEEEECT----TCCEEEEEEEECSS-CCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEE
T ss_pred eeeccceEEEEEEecCCCCEEEEEEEcC----CCcEEEEEEecccc-ccccchHHHHHHHHHHHhccccCCceEEEEEEe
Confidence 3445678999999999999999999864 38899999997643 345567889999999999984 69999999999
Q ss_pred EeCCeEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecC
Q 014210 229 EDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFG 308 (429)
Q Consensus 229 ~~~~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFG 308 (429)
.+.+..++|||+ .+++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+. ++.+||+|||
T Consensus 98 ~~~~~~~lv~e~-~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~----~~~~kL~Dfg 171 (313)
T 3cek_A 98 ITDQYIYMVMEC-GNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV----DGMLKLIDFG 171 (313)
T ss_dssp ECSSEEEEEECC-CSEEHHHHHHH-CSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE----TTEEEECCCS
T ss_pred ecCCEEEEEEec-CCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE----CCeEEEeecc
Confidence 999999999994 57899998865 46799999999999999999999999999999999999993 3789999999
Q ss_pred CccccCCCcc---ccccccCCcccCcccccC------------CCCCcccHHHHHHHHHHHHcCCCCCCCCChH-HHHHH
Q 014210 309 LSDFVRPDER---LNDIVGSAYYVAPEVLHR------------SYSTEADVWSIGVIAYILLCGSRPFWARTES-GIFRA 372 (429)
Q Consensus 309 la~~~~~~~~---~~~~~gt~~y~aPE~~~~------------~~~~~sDiwSlGvll~elltg~~Pf~~~~~~-~~~~~ 372 (429)
++........ .....||..|+|||++.+ .++.++||||||+++|||++|+.||...... ..+..
T Consensus 172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~ 251 (313)
T 3cek_A 172 IANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHA 251 (313)
T ss_dssp SSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHH
T ss_pred ccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHH
Confidence 9987654332 234579999999998864 5788999999999999999999999765433 33444
Q ss_pred HHhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhccc
Q 014210 373 VLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLICYQS 423 (429)
Q Consensus 373 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~~ 423 (429)
+....... ......+.++.+||++||+.||++||++.++|+|+||+.+.
T Consensus 252 ~~~~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~ 300 (313)
T 3cek_A 252 IIDPNHEI--EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 300 (313)
T ss_dssp HHCTTSCC--CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC-
T ss_pred HHhccccc--CCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCCC
Confidence 44332222 12235689999999999999999999999999999998754
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-46 Score=356.03 Aligned_cols=257 Identities=26% Similarity=0.424 Sum_probs=207.3
Q ss_pred ceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEE
Q 014210 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVY 235 (429)
Q Consensus 156 ~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~~ 235 (429)
+|.....||+|+||.||+|+... +++.||||++... .....+.+.+|+.+++.++ |+||+++++++.+.+..+
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~---~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~ 95 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLS---NQVRIAIKEIPER---DSRYSQPLHEEIALHKHLK-HKNIVQYLGSFSENGFIK 95 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETT---TCCEEEEEEEECC---CC---HHHHHHHHHHHTCC-CTTBCCEEEEEEETTEEE
T ss_pred CCCCcEEEeecCcEEEEEEEECC---CCeEEEEEEccCC---chHHHHHHHHHHHHHHhCC-CCCEeeEeeEEEeCCcEE
Confidence 34455699999999999998765 5899999998654 2344577899999999998 999999999999999999
Q ss_pred EEEEecCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCcccc
Q 014210 236 VVMELCEGGELLDRILSRGG--KYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (429)
Q Consensus 236 lv~E~~~ggsL~~~i~~~~~--~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~ 313 (429)
+||||+++++|.+++..... .+++..++.++.||+.||.|||++||+||||||+|||++ ..++.+||+|||++...
T Consensus 96 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~--~~~~~~kl~Dfg~~~~~ 173 (295)
T 2clq_A 96 IFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLIN--TYSGVLKISDFGTSKRL 173 (295)
T ss_dssp EEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE--TTTCCEEECCTTTCEES
T ss_pred EEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEE--CCCCCEEEeeccccccc
Confidence 99999999999998876543 467999999999999999999999999999999999994 23778999999999876
Q ss_pred CCCc-cccccccCCcccCcccccC---CCCCcccHHHHHHHHHHHHcCCCCCCCCChHH-HHHHHHhcCCCCCCCCCCCC
Q 014210 314 RPDE-RLNDIVGSAYYVAPEVLHR---SYSTEADVWSIGVIAYILLCGSRPFWARTESG-IFRAVLKADPSFDEAPWPSL 388 (429)
Q Consensus 314 ~~~~-~~~~~~gt~~y~aPE~~~~---~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~ 388 (429)
.... ......||..|+|||++.+ .++.++||||||+++|+|++|+.||....... ......... ........+
T Consensus 174 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~--~~~~~~~~~ 251 (295)
T 2clq_A 174 AGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFK--VHPEIPESM 251 (295)
T ss_dssp CC-----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHC--CCCCCCTTS
T ss_pred CCCCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhcccc--ccccccccC
Confidence 5332 2345679999999998863 37889999999999999999999997543322 222221111 111223468
Q ss_pred CHHHHHHHHHhcccCccCcCCHHHHHhhHhhhccc
Q 014210 389 SSEARDFVKRLLNKDPRKRLTAAQALSELLICYQS 423 (429)
Q Consensus 389 s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~~ 423 (429)
+.++.+||.+||+.||++||++.++|.|+||+...
T Consensus 252 ~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 286 (295)
T 2clq_A 252 SAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSS 286 (295)
T ss_dssp CHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC--
T ss_pred CHHHHHHHHHHccCChhhCCCHHHHhcChhhhhcc
Confidence 99999999999999999999999999999997543
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=360.90 Aligned_cols=261 Identities=24% Similarity=0.329 Sum_probs=217.5
Q ss_pred cccCceeEeceeeccCceEEEEEEEecCc--ccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEE
Q 014210 152 HFANKYELGEEVGRGHFGYTCAAKFKKGE--LKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYE 229 (429)
Q Consensus 152 ~~~~~y~~~~~IG~G~fg~V~~~~~~~~~--~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~ 229 (429)
...++|++.+.||+|+||.||+|...... ..++.||||++... ......+.+.+|+.+++++.+||||+++++++.
T Consensus 43 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 120 (333)
T 2i1m_A 43 FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKST--AHADEKEALMSELKIMSHLGQHENIVNLLGACT 120 (333)
T ss_dssp CCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTT--CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred CCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccc--cChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence 34688999999999999999999876521 13468999998654 344556789999999999945999999999999
Q ss_pred eCCeEEEEEEecCCCcHHHHHHhc-------------CCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeec
Q 014210 230 DTDNVYVVMELCEGGELLDRILSR-------------GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTK 296 (429)
Q Consensus 230 ~~~~~~lv~E~~~ggsL~~~i~~~-------------~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~ 296 (429)
+.+..++||||+++|+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 121 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~--- 197 (333)
T 2i1m_A 121 HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLL--- 197 (333)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEE---
T ss_pred cCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEE---
Confidence 999999999999999999988653 3468999999999999999999999999999999999999
Q ss_pred CCCceEEEeecCCccccCCCcc---ccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHc-CCCCCCCCChHHHHH
Q 014210 297 DENSVLKAIDFGLSDFVRPDER---LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFR 371 (429)
Q Consensus 297 ~~~~~vkL~DFGla~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~ellt-g~~Pf~~~~~~~~~~ 371 (429)
+.++.+||+|||++........ .....+|..|+|||++. ..++.++||||||+++|||++ |..||........+.
T Consensus 198 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~ 277 (333)
T 2i1m_A 198 TNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFY 277 (333)
T ss_dssp EGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHH
T ss_pred CCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHH
Confidence 6778999999999986543322 23455788999999876 568999999999999999998 999998876666665
Q ss_pred HHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhh
Q 014210 372 AVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLI 419 (429)
Q Consensus 372 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~ 419 (429)
.+......... ...++.++.+||.+||+.||.+||++.++++++.-
T Consensus 278 ~~~~~~~~~~~--~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~ 323 (333)
T 2i1m_A 278 KLVKDGYQMAQ--PAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQE 323 (333)
T ss_dssp HHHHHTCCCCC--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHhcCCCCCC--CCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHH
Confidence 55554433222 23578999999999999999999999999987643
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-45 Score=352.06 Aligned_cols=255 Identities=23% Similarity=0.291 Sum_probs=212.6
Q ss_pred CceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeE
Q 014210 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (429)
Q Consensus 155 ~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~ 234 (429)
-.|++.++||+|+||.||+|+...+...+..||+|++... ......+.+.+|+.++++++ |+||+++++++.+.+..
T Consensus 21 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~ 97 (298)
T 3pls_A 21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI--TEMQQVEAFLREGLLMRGLN-HPNVLALIGIMLPPEGL 97 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTC--CSHHHHHHHHHHHHHHHTCC-CTTBCCCCEEECCSSSC
T ss_pred eEEccCceeccCCCceEEEEEEecCCCceeeeeeeecccc--ccHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEecCCCC
Confidence 4678889999999999999998765545668999998653 45566788999999999998 99999999999877665
Q ss_pred -EEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCcccc
Q 014210 235 -YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (429)
Q Consensus 235 -~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~ 313 (429)
++||||+.+++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++...
T Consensus 98 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili---~~~~~~kl~Dfg~~~~~ 174 (298)
T 3pls_A 98 PHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCML---DESFTVKVADFGLARDI 174 (298)
T ss_dssp CEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CTTCCEEECCTTSSCTT
T ss_pred cEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEE---cCCCcEEeCcCCCcccc
Confidence 99999999999999997777789999999999999999999999999999999999999 77889999999999765
Q ss_pred CCCc-----cccccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHcCCCCC-CCCChHHHHHHHHhcCCCCCCCCCC
Q 014210 314 RPDE-----RLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPF-WARTESGIFRAVLKADPSFDEAPWP 386 (429)
Q Consensus 314 ~~~~-----~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~elltg~~Pf-~~~~~~~~~~~i~~~~~~~~~~~~~ 386 (429)
.... ......++..|+|||++.+ .++.++||||||+++|+|++|..|| ...........+....... ...
T Consensus 175 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~---~~~ 251 (298)
T 3pls_A 175 LDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLP---QPE 251 (298)
T ss_dssp TTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCCC---CCT
T ss_pred cCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCCC---CCc
Confidence 4332 2234568889999998875 6899999999999999999965555 4445445544444433221 224
Q ss_pred CCCHHHHHHHHHhcccCccCcCCHHHHHhhHh
Q 014210 387 SLSSEARDFVKRLLNKDPRKRLTAAQALSELL 418 (429)
Q Consensus 387 ~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~ 418 (429)
.++.++.+||++||+.||.+|||+.++++.+-
T Consensus 252 ~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~ 283 (298)
T 3pls_A 252 YCPDSLYQVMQQCWEADPAVRPTFRVLVGEVE 283 (298)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred cchHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 68899999999999999999999999988654
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-46 Score=371.46 Aligned_cols=264 Identities=17% Similarity=0.231 Sum_probs=200.6
Q ss_pred cccCceeEeceeeccCceEEEEEEEecCc--ccCeEEEEEEccCCCcCcHHHH--------HHHHHHHHHHHHhcCCCCc
Q 014210 152 HFANKYELGEEVGRGHFGYTCAAKFKKGE--LKGQQVAVKVIPKHKMTTAIAI--------EDVRREVKILRALTGHNNL 221 (429)
Q Consensus 152 ~~~~~y~~~~~IG~G~fg~V~~~~~~~~~--~~g~~vAvK~~~~~~~~~~~~~--------~~~~~Ei~il~~l~~h~nI 221 (429)
...++|++.++||+|+||.||+|.+..+. ..++.||||++........... ..+..|+..+..+. |+||
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~-h~~i 110 (364)
T 3op5_A 32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLK-YLGV 110 (364)
T ss_dssp TTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCS-CCCS
T ss_pred cCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhcc-CCCC
Confidence 34679999999999999999999887643 2468999999865421100000 11223444455555 9999
Q ss_pred ceEEEEEEeC----CeEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecC
Q 014210 222 VKFFDAYEDT----DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKD 297 (429)
Q Consensus 222 v~l~~~~~~~----~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~ 297 (429)
+++++++.+. ...+|||||| |++|.+++....+.+++..++.|+.||+.||.|||++||+||||||+|||++. +
T Consensus 111 v~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~-~ 188 (364)
T 3op5_A 111 PKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNY-K 188 (364)
T ss_dssp CCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEES-S
T ss_pred CeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEec-C
Confidence 9999999875 4589999999 99999998877788999999999999999999999999999999999999942 2
Q ss_pred CCceEEEeecCCccccCCCccc--------cccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHcCCCCCCCCChHH
Q 014210 298 ENSVLKAIDFGLSDFVRPDERL--------NDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESG 368 (429)
Q Consensus 298 ~~~~vkL~DFGla~~~~~~~~~--------~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~ 368 (429)
.++.+||+|||+++.+...... ....||+.|+|||++.+ .++.++|||||||++|||++|+.||.......
T Consensus 189 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~ 268 (364)
T 3op5_A 189 NPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDP 268 (364)
T ss_dssp CTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCH
T ss_pred CCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCH
Confidence 6788999999999776433221 33459999999998875 58999999999999999999999997543322
Q ss_pred HHHHHHhcC--CCCC-----CCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHh
Q 014210 369 IFRAVLKAD--PSFD-----EAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELL 418 (429)
Q Consensus 369 ~~~~i~~~~--~~~~-----~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~ 418 (429)
......... .... ......++.++.+||..||+.||++||++.++++.+-
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~ 325 (364)
T 3op5_A 269 KYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDILL 325 (364)
T ss_dssp HHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHH
T ss_pred HHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHH
Confidence 221111100 0000 0011367899999999999999999999999987543
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=376.72 Aligned_cols=264 Identities=25% Similarity=0.409 Sum_probs=217.0
Q ss_pred ccccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEe
Q 014210 151 KHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED 230 (429)
Q Consensus 151 ~~~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~ 230 (429)
....++|++.++||+|+||.||+|+... +|+.||||++..... ....+.+.+|++++++++ |+||+++++++.+
T Consensus 5 ~~~~~~y~i~~~LG~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~ 78 (396)
T 4eut_A 5 STSNHLWLLSDILGQGATANVFRGRHKK---TGDLFAIKVFNNISF--LRPVDVQMREFEVLKKLN-HKNIVKLFAIEEE 78 (396)
T ss_dssp ECSSEEEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEECGGGG--GSCHHHHHHHHHHHHHCC-CTTBCCEEEEEEC
T ss_pred CCCCCceEEEEEEEcCCCeEEEEEEECC---CCcEEEEEEeccccc--cchHHHHHHHHHHHHhcC-CCCCCeEEEeecc
Confidence 3457899999999999999999999776 589999999865422 233567789999999998 9999999999987
Q ss_pred CC--eEEEEEEecCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEee-cCCCceEEEe
Q 014210 231 TD--NVYVVMELCEGGELLDRILSRG--GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTT-KDENSVLKAI 305 (429)
Q Consensus 231 ~~--~~~lv~E~~~ggsL~~~i~~~~--~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~-~~~~~~vkL~ 305 (429)
.+ ..+||||||++|+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||+.. .+.++.+||+
T Consensus 79 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~ 158 (396)
T 4eut_A 79 TTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLT 158 (396)
T ss_dssp TTTCCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEEC
T ss_pred CCCCeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEe
Confidence 65 7899999999999999886432 23999999999999999999999999999999999999843 3456789999
Q ss_pred ecCCccccCCCccccccccCCcccCccccc---------CCCCCcccHHHHHHHHHHHHcCCCCCCC----CChHHHHHH
Q 014210 306 DFGLSDFVRPDERLNDIVGSAYYVAPEVLH---------RSYSTEADVWSIGVIAYILLCGSRPFWA----RTESGIFRA 372 (429)
Q Consensus 306 DFGla~~~~~~~~~~~~~gt~~y~aPE~~~---------~~~~~~sDiwSlGvll~elltg~~Pf~~----~~~~~~~~~ 372 (429)
|||+++............||..|+|||++. +.++.++|||||||++|||++|+.||.. ....+.+..
T Consensus 159 DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~ 238 (396)
T 4eut_A 159 DFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYK 238 (396)
T ss_dssp CGGGCEECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHH
T ss_pred cCCCceEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHH
Confidence 999998877666666778999999999875 3467899999999999999999999964 334456666
Q ss_pred HHhcCCCCCC---------------------CCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhh
Q 014210 373 VLKADPSFDE---------------------APWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLIC 420 (429)
Q Consensus 373 i~~~~~~~~~---------------------~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~ 420 (429)
++...+.... .....++..+.+||++||..||++||++.++++++.-.
T Consensus 239 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~i 307 (396)
T 4eut_A 239 IITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (396)
T ss_dssp HHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred HhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHH
Confidence 6665442110 00122456788999999999999999999998877554
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-46 Score=361.58 Aligned_cols=260 Identities=24% Similarity=0.360 Sum_probs=191.1
Q ss_pred cCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~ 233 (429)
.++|++++.||+|+||.||+|.... +|+.||||++... .......++.+|+..+.+..+|+||+++++++.+.+.
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~vaiK~~~~~--~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~ 95 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKP---SGQIMAVKRIRST--VDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGD 95 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETT---TTEEEEEEEEECC--CCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSE
T ss_pred HHHhhehheeccCCCEEEEEEEEcC---CCCEEEEEEeecc--cCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCc
Confidence 5789999999999999999998765 5899999999754 2344455667777744443349999999999999999
Q ss_pred EEEEEEecCCCcHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHc-CceeccCCCCcEEEeecCCCceEEEeecC
Q 014210 234 VYVVMELCEGGELLDRILS----RGGKYTEDDAKAVMIQILNVVAFCHLQ-GVVHRDLKPENFLFTTKDENSVLKAIDFG 308 (429)
Q Consensus 234 ~~lv~E~~~ggsL~~~i~~----~~~~l~~~~~~~i~~qi~~gL~~LH~~-~iiHrDIKp~NILl~~~~~~~~vkL~DFG 308 (429)
.+|||||+++ +|.+++.. ....+++..++.++.|++.||.|||+. ||+||||||+|||+ +.++.+||+|||
T Consensus 96 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll---~~~~~~kl~Dfg 171 (327)
T 3aln_A 96 CWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILL---DRSGNIKLCDFG 171 (327)
T ss_dssp EEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEE---ETTTEEEECCCS
T ss_pred eEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEE---cCCCCEEEccCC
Confidence 9999999975 77776653 256799999999999999999999999 99999999999999 678899999999
Q ss_pred CccccCCCccccccccCCcccCccccc-----CCCCCcccHHHHHHHHHHHHcCCCCCCCCChH-HHHHHHHhcC-CCCC
Q 014210 309 LSDFVRPDERLNDIVGSAYYVAPEVLH-----RSYSTEADVWSIGVIAYILLCGSRPFWARTES-GIFRAVLKAD-PSFD 381 (429)
Q Consensus 309 la~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~sDiwSlGvll~elltg~~Pf~~~~~~-~~~~~i~~~~-~~~~ 381 (429)
++.............||..|+|||++. ..++.++||||||+++|+|++|+.||...... +.+..+.... +.+.
T Consensus 172 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 251 (327)
T 3aln_A 172 ISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLS 251 (327)
T ss_dssp SSCC------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCCCCC
T ss_pred CceecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCCCCC
Confidence 998776555455568999999999983 35889999999999999999999999764321 2222222211 1222
Q ss_pred CCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhcc
Q 014210 382 EAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLICYQ 422 (429)
Q Consensus 382 ~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~ 422 (429)
......++.++.+||++||+.||++||++.++++|+||...
T Consensus 252 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 292 (327)
T 3aln_A 252 NSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMY 292 (327)
T ss_dssp CCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred CcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHh
Confidence 22334689999999999999999999999999999999753
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=379.42 Aligned_cols=253 Identities=22% Similarity=0.357 Sum_probs=216.5
Q ss_pred cccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeC
Q 014210 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (429)
Q Consensus 152 ~~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~ 231 (429)
...++|++.++||+|+||.||+|..+. +++.||||++..... ..+++.+|+.++++++ |+||++++++|.+.
T Consensus 217 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~---~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~ 288 (495)
T 1opk_A 217 MERTDITMKHKLGGGQYGEVYEGVWKK---YSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-HPNLVQLLGVCTRE 288 (495)
T ss_dssp CCGGGEEEEEESGGGTTSSEEEEEEGG---GTEEEEEEECCSSSS----CHHHHHHHHHHHHHCC-CTTBCCEEEEECSS
T ss_pred cCHHHceeeeEecCCCCeEEEEEEEcC---CCeEEEEEEecCccc----chHHHHHHHHHHHhcC-CCCEeeEEEEEecC
Confidence 345789999999999999999999776 589999999975432 2467899999999998 99999999999999
Q ss_pred CeEEEEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCc
Q 014210 232 DNVYVVMELCEGGELLDRILSRG-GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS 310 (429)
Q Consensus 232 ~~~~lv~E~~~ggsL~~~i~~~~-~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla 310 (429)
+.++||||||++|+|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 289 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll---~~~~~~kl~DFG~a 365 (495)
T 1opk_A 289 PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLV---GENHLVKVADFGLS 365 (495)
T ss_dssp SSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CGGGCEEECCTTCE
T ss_pred CcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEE---CCCCcEEEeecccc
Confidence 99999999999999999997643 469999999999999999999999999999999999999 77889999999999
Q ss_pred cccCCCcc--ccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCCCCC
Q 014210 311 DFVRPDER--LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWP 386 (429)
Q Consensus 311 ~~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 386 (429)
+....... .....++..|+|||++. +.++.++|||||||+||||++ |+.||...........+..... .....
T Consensus 366 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~---~~~~~ 442 (495)
T 1opk_A 366 RLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR---MERPE 442 (495)
T ss_dssp ECCTTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC---CCCCT
T ss_pred eeccCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC---CCCCC
Confidence 87654332 22345678899999886 568999999999999999999 9999988877766665544321 12234
Q ss_pred CCCHHHHHHHHHhcccCccCcCCHHHHHhhHh
Q 014210 387 SLSSEARDFVKRLLNKDPRKRLTAAQALSELL 418 (429)
Q Consensus 387 ~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~ 418 (429)
.+++++.+||.+||+.||++||++.++++.+-
T Consensus 443 ~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~ 474 (495)
T 1opk_A 443 GCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 474 (495)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCHHHHHHHHHHcCcChhHCcCHHHHHHHHH
Confidence 68999999999999999999999999988653
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-46 Score=370.29 Aligned_cols=256 Identities=22% Similarity=0.302 Sum_probs=206.3
Q ss_pred CceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEe-CCe
Q 014210 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED-TDN 233 (429)
Q Consensus 155 ~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~-~~~ 233 (429)
..|++.++||+|+||.||+|+.......+..||||.+... ......+++.+|+.++++++ ||||+++++++.+ ++.
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~~~~~~ 165 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFS-HPNVLSLLGICLRSEGS 165 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC--SCSHHHHHHHHHHTTSTTCC-CTTBCCCCEEECCCSSC
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC--CCHHHHHHHHHHHHHHHhCC-CCCcceEEEEEEcCCCC
Confidence 4689999999999999999998764434567999998643 34456688999999999998 9999999998754 567
Q ss_pred EEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCcccc
Q 014210 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (429)
Q Consensus 234 ~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~ 313 (429)
.++||||+++|+|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++..
T Consensus 166 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~~~~kL~DFG~a~~~ 242 (373)
T 3c1x_A 166 PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCML---DEKFTVKVADFGLARDM 242 (373)
T ss_dssp CEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECCC------
T ss_pred eEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEE---CCCCCEEEeeccccccc
Confidence 899999999999999997777789999999999999999999999999999999999999 78889999999999865
Q ss_pred CCCcc-----ccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCCCCC
Q 014210 314 RPDER-----LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWP 386 (429)
Q Consensus 314 ~~~~~-----~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 386 (429)
..... .....+|..|+|||++. +.++.++||||||+++|||++ |..||......+....+........ ..
T Consensus 243 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~---p~ 319 (373)
T 3c1x_A 243 YDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQ---PE 319 (373)
T ss_dssp ---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCCCC---CT
T ss_pred cccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCCCC---CC
Confidence 43321 23345778999999886 568999999999999999999 6778877666666555555432221 24
Q ss_pred CCCHHHHHHHHHhcccCccCcCCHHHHHhhHhh
Q 014210 387 SLSSEARDFVKRLLNKDPRKRLTAAQALSELLI 419 (429)
Q Consensus 387 ~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~ 419 (429)
.++.++.+||.+||+.||++||++.++++++.-
T Consensus 320 ~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~ 352 (373)
T 3c1x_A 320 YCPDPLYEVMLKCWHPKAEMRPSFSELVSRISA 352 (373)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 688999999999999999999999999987754
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=376.37 Aligned_cols=251 Identities=25% Similarity=0.398 Sum_probs=214.2
Q ss_pred cccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeC
Q 014210 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (429)
Q Consensus 152 ~~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~ 231 (429)
...++|++.++||+|+||.||+|.... +..||||++..... ..+.+.+|+.++++|+ |+||+++++++. .
T Consensus 185 i~~~~~~~~~~lG~G~fg~V~~~~~~~----~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~-h~~iv~l~~~~~-~ 254 (454)
T 1qcf_A 185 IPRESLKLEKKLGAGQFGEVWMATYNK----HTKVAVKTMKPGSM----SVEAFLAEANVMKTLQ-HDKLVKLHAVVT-K 254 (454)
T ss_dssp CCGGGEEEEEEEECCSSEEEEEEEETT----TEEEEEEEECTTSB----CHHHHHHHHHHHTTCC-CTTBCCEEEEEC-S
T ss_pred echHHeEEEEEcccCCceEEEEEEECC----ccEEEEEEecCCCc----cHHHHHHHHHHHhhCC-CCCEeeEEEEEe-C
Confidence 346789999999999999999998754 67899999975432 3567899999999998 999999999986 6
Q ss_pred CeEEEEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCc
Q 014210 232 DNVYVVMELCEGGELLDRILSRG-GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS 310 (429)
Q Consensus 232 ~~~~lv~E~~~ggsL~~~i~~~~-~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla 310 (429)
+..+||||||++|+|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 255 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill---~~~~~~kl~DFG~a 331 (454)
T 1qcf_A 255 EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILV---SASLVCKIADFGLA 331 (454)
T ss_dssp SSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEE---CTTCCEEECSTTGG
T ss_pred CccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEE---CCCCcEEEeeCCCc
Confidence 67899999999999999986543 368999999999999999999999999999999999999 77889999999999
Q ss_pred cccCCCcc--ccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCCCCC
Q 014210 311 DFVRPDER--LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWP 386 (429)
Q Consensus 311 ~~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 386 (429)
+....... .....++..|+|||++. +.++.++|||||||+||||++ |+.||......+.+..+...... ....
T Consensus 332 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~---~~~~ 408 (454)
T 1qcf_A 332 RVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRM---PRPE 408 (454)
T ss_dssp GGBCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCC---CCCT
T ss_pred eEcCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC---CCCC
Confidence 87654321 22345678899999887 679999999999999999999 99999988888877777654321 1224
Q ss_pred CCCHHHHHHHHHhcccCccCcCCHHHHHhhHh
Q 014210 387 SLSSEARDFVKRLLNKDPRKRLTAAQALSELL 418 (429)
Q Consensus 387 ~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~ 418 (429)
.+++++.+||.+||+.||++||++.+++..+-
T Consensus 409 ~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~ 440 (454)
T 1qcf_A 409 NCPEELYNIMMRCWKNRPEERPTFEYIQSVLD 440 (454)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCHHHHHHHHHHccCChhHCcCHHHHHHHHH
Confidence 68999999999999999999999999987654
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=366.43 Aligned_cols=258 Identities=21% Similarity=0.329 Sum_probs=208.9
Q ss_pred cccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeC
Q 014210 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (429)
Q Consensus 152 ~~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~ 231 (429)
...++|++.+.||+|+||.||+|+.. +|+.||||++... .....+.+.+|+.++++++ ||||+++++++.+.
T Consensus 36 ~~~~~y~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~ 107 (321)
T 2qkw_B 36 EATNNFDHKFLIGHGVFGKVYKGVLR----DGAKVALKRRTPE---SSQGIEEFETEIETLSFCR-HPHLVSLIGFCDER 107 (321)
T ss_dssp CCCCCCSCCCCSCBCSSSEEEEEECT----TCCEEEEEECCSC---CSSHHHHHHHHHHGGGSCC-CTTBCCEEEECCCT
T ss_pred HHHhccCccceeecCCCeeEEEEEEC----CCCEEEEEEeccc---ChHHHHHHHHHHHHHHhCC-CCCEeeEEEEEcCC
Confidence 45689999999999999999999854 3889999998653 3345678999999999998 99999999999999
Q ss_pred CeEEEEEEecCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecC
Q 014210 232 DNVYVVMELCEGGELLDRILSRG---GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFG 308 (429)
Q Consensus 232 ~~~~lv~E~~~ggsL~~~i~~~~---~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFG 308 (429)
+..++||||+++|+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||
T Consensus 108 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg 184 (321)
T 2qkw_B 108 NEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILL---DENFVPKITDFG 184 (321)
T ss_dssp TCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEE---CTTCCEEECCCT
T ss_pred CeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEE---CCCCCEEEeecc
Confidence 99999999999999998875432 358999999999999999999999999999999999999 788899999999
Q ss_pred CccccCCCc---cccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHH-----HHhcCCC
Q 014210 309 LSDFVRPDE---RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRA-----VLKADPS 379 (429)
Q Consensus 309 la~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~-----i~~~~~~ 379 (429)
++....... ......||..|+|||++. +.++.++||||||+++|||++|+.||........... .......
T Consensus 185 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 264 (321)
T 2qkw_B 185 ISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQ 264 (321)
T ss_dssp TCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTC
T ss_pred cccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhcccccc
Confidence 997654222 223456899999999875 5799999999999999999999999975433211100 0111111
Q ss_pred C--------CCCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhh
Q 014210 380 F--------DEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLIC 420 (429)
Q Consensus 380 ~--------~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~ 420 (429)
. .....+.++.++.+||.+||+.||++||++.++++++...
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 313 (321)
T 2qkw_B 265 LEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYA 313 (321)
T ss_dssp CCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 1 1111123457789999999999999999999999988643
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-45 Score=374.15 Aligned_cols=246 Identities=26% Similarity=0.404 Sum_probs=209.4
Q ss_pred cCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCC-
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD- 232 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~- 232 (429)
.++|++.++||+|+||.||+|... |+.||||++.... ..+.+.+|+.++++++ |+||+++++++.+.+
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~~-----~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~ 260 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDYR-----GNKVAVKCIKNDA-----TAQAFLAEASVMTQLR-HSNLVQLLGVIVEEKG 260 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET-----TEEEEEEEESSCT-----TSHHHHHHHHHHHTCC-CTTBCCEEEEEECTTS
T ss_pred hHHeEEEeeecCcCCeeEEEEEec-----CCeEEEEEeCCch-----HHHHHHHHHHHHHhcc-CCCEEEEEEEEEcCCC
Confidence 578999999999999999999753 6799999996542 3467899999999998 999999999987765
Q ss_pred eEEEEEEecCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCcc
Q 014210 233 NVYVVMELCEGGELLDRILSRGG-KYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (429)
Q Consensus 233 ~~~lv~E~~~ggsL~~~i~~~~~-~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~ 311 (429)
..+||||||++|+|.+++...+. .+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++
T Consensus 261 ~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill---~~~~~~kl~DfG~a~ 337 (450)
T 1k9a_A 261 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLV---SEDNVAKVSDFGLTK 337 (450)
T ss_dssp CEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---CTTSCEEECCCTTCE
T ss_pred ceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEE---CCCCCEEEeeCCCcc
Confidence 79999999999999999987654 37999999999999999999999999999999999999 778899999999998
Q ss_pred ccCCCccccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCC
Q 014210 312 FVRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLS 389 (429)
Q Consensus 312 ~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 389 (429)
...... ....++..|+|||++. +.++.++||||||+++|||++ |+.||......+....+..... ......++
T Consensus 338 ~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~---~~~p~~~~ 412 (450)
T 1k9a_A 338 EASSTQ--DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK---MDAPDGCP 412 (450)
T ss_dssp ECC--------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCC---CCCCTTCC
T ss_pred cccccc--cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC---CCCCCcCC
Confidence 653322 2346788999999886 568999999999999999998 9999988877777776665432 12234689
Q ss_pred HHHHHHHHHhcccCccCcCCHHHHHhhHh
Q 014210 390 SEARDFVKRLLNKDPRKRLTAAQALSELL 418 (429)
Q Consensus 390 ~~~~~li~~~L~~dP~~Rps~~~iL~~~~ 418 (429)
+++.+||++||+.||++||++.+++..+-
T Consensus 413 ~~l~~li~~cl~~dp~~Rpt~~~l~~~L~ 441 (450)
T 1k9a_A 413 PAVYDVMKNCWHLDAATRPTFLQLREQLE 441 (450)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 99999999999999999999999987653
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=360.86 Aligned_cols=256 Identities=20% Similarity=0.284 Sum_probs=207.6
Q ss_pred cCceeEeceeeccCceEEEEEEEecCc-ccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCC
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGE-LKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~-~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~ 232 (429)
.++|+++++||+|+||.||+|+..... .-...||+|.+... ......+.+.+|+.++++++ ||||+++++++.+.+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~--~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~ 90 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASVD-NPHVCRLLGICLTST 90 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCC--SSCCCHHHHHHHHHHHTTCC-BTTBCCCCEEEESSS
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccc--cCHHHHHHHHHHHHHHHhCC-CCCeeEEEEEEecCC
Confidence 578999999999999999999976531 11234688877543 23344577899999999998 999999999998765
Q ss_pred eEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccc
Q 014210 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (429)
Q Consensus 233 ~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~ 312 (429)
.++||||+.+|+|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.
T Consensus 91 -~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~---~~~~~~kL~DfG~a~~ 166 (327)
T 3lzb_A 91 -VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLV---KTPQHVKITDFGLAKL 166 (327)
T ss_dssp -EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---EETTEEEECCTTC---
T ss_pred -ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEE---cCCCCEEEccCcceeE
Confidence 789999999999999998888889999999999999999999999999999999999999 5677899999999987
Q ss_pred cCCCcc---ccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCC
Q 014210 313 VRPDER---LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPS 387 (429)
Q Consensus 313 ~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 387 (429)
...... .....+|..|+|||++. ..++.++||||||+++|||++ |+.||...........+....... ..+.
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~ 243 (327)
T 3lzb_A 167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP---QPPI 243 (327)
T ss_dssp -------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCC---CCTT
T ss_pred ccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCC---CCcc
Confidence 644332 22345678899999886 568999999999999999999 999998888777666665543222 2246
Q ss_pred CCHHHHHHHHHhcccCccCcCCHHHHHhhHhh
Q 014210 388 LSSEARDFVKRLLNKDPRKRLTAAQALSELLI 419 (429)
Q Consensus 388 ~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~ 419 (429)
++.++.+||++||..||.+||++.++++.+--
T Consensus 244 ~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~ 275 (327)
T 3lzb_A 244 CTIDVYMIMRKCWMIDADSRPKFRELIIEFSK 275 (327)
T ss_dssp BCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 89999999999999999999999999986543
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=351.82 Aligned_cols=252 Identities=27% Similarity=0.456 Sum_probs=212.6
Q ss_pred cccccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEE
Q 014210 150 SKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYE 229 (429)
Q Consensus 150 ~~~~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~ 229 (429)
.+.+.++|++.+.||+|+||.||+|+... +|+.||||++.... +.+.+|++++++++ |+||+++++++.
T Consensus 6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~-------~~~~~e~~~l~~l~-h~~i~~~~~~~~ 74 (284)
T 2a19_B 6 DKRFGMDFKEIELIGSGGFGQVFKAKHRI---DGKTYVIKRVKYNN-------EKAEREVKALAKLD-HVNIVHYNGCWD 74 (284)
T ss_dssp CHHHHHHEEEEEEEECSSSCCEEEEEETT---TCCEEEEEEEECCS-------GGGHHHHHHHHHCC-CTTBCCEEEEEE
T ss_pred cchhccccceeeeeccCCceEEEEEEEcC---CCeEEEEEEecccc-------HHHHHHHHHHHhCC-CCCEEEEeeeEe
Confidence 34567899999999999999999998765 58999999986542 24678999999998 999999999986
Q ss_pred e----------------CCeEEEEEEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEE
Q 014210 230 D----------------TDNVYVVMELCEGGELLDRILSR-GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFL 292 (429)
Q Consensus 230 ~----------------~~~~~lv~E~~~ggsL~~~i~~~-~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NIL 292 (429)
. ....++||||+++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 75 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil 154 (284)
T 2a19_B 75 GFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIF 154 (284)
T ss_dssp EEEEC---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred ccccCcccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEE
Confidence 5 44589999999999999998754 357999999999999999999999999999999999999
Q ss_pred EeecCCCceEEEeecCCccccCCCccccccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHH
Q 014210 293 FTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFR 371 (429)
Q Consensus 293 l~~~~~~~~vkL~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~ 371 (429)
+ +.++.+||+|||++.............||..|+|||++.+ .++.++||||||+++|+|++|..||... .....
T Consensus 155 ~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~--~~~~~ 229 (284)
T 2a19_B 155 L---VDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET--SKFFT 229 (284)
T ss_dssp E---EETTEEEECCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH--HHHHH
T ss_pred E---cCCCCEEECcchhheeccccccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH--HHHHH
Confidence 9 5677899999999988766655566789999999998864 6899999999999999999999987422 22222
Q ss_pred HHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhccc
Q 014210 372 AVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLICYQS 423 (429)
Q Consensus 372 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~~ 423 (429)
.+.... ....++.++.+||++||+.||++||++.+++++++....+
T Consensus 230 ~~~~~~------~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~ 275 (284)
T 2a19_B 230 DLRDGI------ISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKS 275 (284)
T ss_dssp HHHTTC------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-
T ss_pred Hhhccc------ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhC
Confidence 332221 1235889999999999999999999999999999876543
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-45 Score=347.15 Aligned_cols=249 Identities=18% Similarity=0.250 Sum_probs=213.0
Q ss_pred cCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeC--
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT-- 231 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~-- 231 (429)
.++|++.+.||+|+||.||+|+.. |+.||||++.... ......+.+.+|+.++++++ |+||+++++++.+.
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~avK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~ 81 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQ-----GNDIVVKVLKVRD-WSTRKSRDFNEECPRLRIFS-HPNVLPVLGACQSPPA 81 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEET-----TEEEEEEEECCTT-CCHHHHHHHHHHGGGGCCCS-CTTEECEEEEECTTTS
T ss_pred HHHhHHHHHhcCCCcceEEEEEEC-----CeeEEEEEecccc-cCHHHHHHHHHHHHHHHhcC-CCchhheEEEEccCCC
Confidence 478999999999999999999853 7889999997643 34555678999999999998 99999999999887
Q ss_pred CeEEEEEEecCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHcC--ceeccCCCCcEEEeecCCCceEEEeecC
Q 014210 232 DNVYVVMELCEGGELLDRILSRGG-KYTEDDAKAVMIQILNVVAFCHLQG--VVHRDLKPENFLFTTKDENSVLKAIDFG 308 (429)
Q Consensus 232 ~~~~lv~E~~~ggsL~~~i~~~~~-~l~~~~~~~i~~qi~~gL~~LH~~~--iiHrDIKp~NILl~~~~~~~~vkL~DFG 308 (429)
+..++||||+++|+|.+++..... .+++..++.++.||+.||.|||++| |+||||||+|||+ +.++.++|+|||
T Consensus 82 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~---~~~~~~~l~~~~ 158 (271)
T 3kmu_A 82 PHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMI---DEDMTARISMAD 158 (271)
T ss_dssp SSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEE---CTTSCEEEEGGG
T ss_pred CCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEE---cCCcceeEEecc
Confidence 788999999999999999876543 5999999999999999999999999 9999999999999 778889999999
Q ss_pred CccccCCCccccccccCCcccCcccccCC-C---CCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCC
Q 014210 309 LSDFVRPDERLNDIVGSAYYVAPEVLHRS-Y---STEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAP 384 (429)
Q Consensus 309 la~~~~~~~~~~~~~gt~~y~aPE~~~~~-~---~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 384 (429)
++..... ....||+.|+|||++.+. + +.++||||||+++|||++|+.||...........+........ .
T Consensus 159 ~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~--~ 232 (271)
T 3kmu_A 159 VKFSFQS----PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPT--I 232 (271)
T ss_dssp SCCTTSC----TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCC--C
T ss_pred ceeeecc----cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCC--C
Confidence 8765332 345789999999988643 3 3379999999999999999999998888777776665543322 2
Q ss_pred CCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHh
Q 014210 385 WPSLSSEARDFVKRLLNKDPRKRLTAAQALSELL 418 (429)
Q Consensus 385 ~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~ 418 (429)
...++.++.+||.+||+.||++|||+.++++.+-
T Consensus 233 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~ 266 (271)
T 3kmu_A 233 PPGISPHVSKLMKICMNEDPAKRPKFDMIVPILE 266 (271)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 3468999999999999999999999999998754
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-45 Score=351.16 Aligned_cols=258 Identities=21% Similarity=0.283 Sum_probs=207.5
Q ss_pred cccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeC
Q 014210 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (429)
Q Consensus 152 ~~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~ 231 (429)
.+.++|++.+.||+|+||.||+|+... +|+.||||++...... +++.+|+.+++.+.+|+++..+..++.+.
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~-----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~ 77 (296)
T 3uzp_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIA---AGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEG 77 (296)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETT---TTEEEEEEEEESCSSC-----CHHHHHHHHHHHHTTSTTCCCEEEEEEET
T ss_pred eeccEEEEEEEEccCCCeEEEEEEEcC---CCcEEEEEEecCCcch-----hHHHHHHHHHHHhhcCCCCCccccccCCC
Confidence 356899999999999999999998765 5899999998654322 35789999999999444455555555777
Q ss_pred CeEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCcc
Q 014210 232 DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (429)
Q Consensus 232 ~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~ 311 (429)
+..++||||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++..+.++.+||+|||++.
T Consensus 78 ~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~ 156 (296)
T 3uzp_A 78 DYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156 (296)
T ss_dssp TEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCE
T ss_pred CceEEEEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcc
Confidence 8899999999 889999997777789999999999999999999999999999999999999655577889999999998
Q ss_pred ccCCCcc--------ccccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHcCCCCCCCCCh---HHHHHHHHhcCCC
Q 014210 312 FVRPDER--------LNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTE---SGIFRAVLKADPS 379 (429)
Q Consensus 312 ~~~~~~~--------~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~elltg~~Pf~~~~~---~~~~~~i~~~~~~ 379 (429)
....... .....||..|+|||++.+ .++.++||||||+++|||++|+.||..... ...+..+......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 236 (296)
T 3uzp_A 157 KYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS 236 (296)
T ss_dssp ECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccC
Confidence 7654332 245679999999998875 688999999999999999999999976322 2233333222111
Q ss_pred CC-CCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHh
Q 014210 380 FD-EAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELL 418 (429)
Q Consensus 380 ~~-~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~ 418 (429)
.+ ......+++++.+||++||+.||++||++.++++.+-
T Consensus 237 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~ 276 (296)
T 3uzp_A 237 TPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFR 276 (296)
T ss_dssp SCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHH
T ss_pred CchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHH
Confidence 11 1112368899999999999999999999999987543
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-45 Score=349.15 Aligned_cols=253 Identities=22% Similarity=0.333 Sum_probs=209.8
Q ss_pred cCceeEec-eeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCC
Q 014210 154 ANKYELGE-EVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (429)
Q Consensus 154 ~~~y~~~~-~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~ 232 (429)
.++|++.+ .||+|+||.||+|...... .++.||||++.... ......+++.+|+++++.++ |+||+++++++ +.+
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~-~~~ 90 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKK-VVKTVAVKILKNEA-NDPALKDELLAEANVMQQLD-NPYIVRMIGIC-EAE 90 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSS-SEEEEEEEEEC------CHHHHHHHHHHHHHHTCC-CTTBCCEEEEE-ESS
T ss_pred chhhhhccCccccccCeeeEeeeecCCC-ceeeEEEEeecccc-cCHHHHHHHHHHHHHHHhCC-CCCEEEEEEEE-CCC
Confidence 46899988 9999999999999654322 57899999997543 33445678999999999998 99999999999 667
Q ss_pred eEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccc
Q 014210 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (429)
Q Consensus 233 ~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~ 312 (429)
..++||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..
T Consensus 91 ~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~---~~~~~~kl~Dfg~~~~ 166 (291)
T 1xbb_A 91 SWMLVMEMAELGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLL---VTQHYAKISDFGLSKA 166 (291)
T ss_dssp SEEEEEECCTTEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---EETTEEEECCCTTCEE
T ss_pred CcEEEEEeCCCCCHHHHHHh-CcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEE---eCCCcEEEccCCccee
Confidence 78999999999999998865 4679999999999999999999999999999999999999 5677899999999987
Q ss_pred cCCCccc----cccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCCCCC
Q 014210 313 VRPDERL----NDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWP 386 (429)
Q Consensus 313 ~~~~~~~----~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 386 (429)
....... ....++..|+|||++. ..++.++||||||+++|+|++ |+.||...........+....... ...
T Consensus 167 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~ 243 (291)
T 1xbb_A 167 LRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMG---CPA 243 (291)
T ss_dssp CCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC---CCT
T ss_pred eccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCC---CCC
Confidence 6544321 2234678899999886 458889999999999999999 999999888877776666543221 224
Q ss_pred CCCHHHHHHHHHhcccCccCcCCHHHHHhhH
Q 014210 387 SLSSEARDFVKRLLNKDPRKRLTAAQALSEL 417 (429)
Q Consensus 387 ~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~ 417 (429)
.++.++.+||++||+.||++||++.++++.+
T Consensus 244 ~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L 274 (291)
T 1xbb_A 244 GCPREMYDLMNLCWTYDVENRPGFAAVELRL 274 (291)
T ss_dssp TCCHHHHHHHHHHTCSSTTTSCCHHHHHHHH
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 6899999999999999999999999998754
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-46 Score=361.44 Aligned_cols=255 Identities=27% Similarity=0.473 Sum_probs=212.4
Q ss_pred ccccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcH---HHHHHHHHHHHHHHHhc-CCCCcceEEE
Q 014210 151 KHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTA---IAIEDVRREVKILRALT-GHNNLVKFFD 226 (429)
Q Consensus 151 ~~~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~---~~~~~~~~Ei~il~~l~-~h~nIv~l~~ 226 (429)
+.+.++|++.+.||+|+||.||+|+... +|+.||||++........ ...+.+.+|+.+++++. +|+||+++++
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~ 115 (320)
T 3a99_A 39 EPLESQYQVGPLLGSGGFGSVYSGIRVS---DNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLD 115 (320)
T ss_dssp -CCTTTEEEEEECSSSSSCEEEEEEETT---TTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEE
T ss_pred CCccCceEEEEEEeeCCCeEEEEEEECC---CCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEE
Confidence 4467899999999999999999998765 589999999865432221 12245678999999997 3799999999
Q ss_pred EEEeCCeEEEEEEecCC-CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEe
Q 014210 227 AYEDTDNVYVVMELCEG-GELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAI 305 (429)
Q Consensus 227 ~~~~~~~~~lv~E~~~g-gsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~ 305 (429)
++.+.+..++|||++.+ ++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++ .+++.+||+
T Consensus 116 ~~~~~~~~~lv~e~~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~--~~~~~~kL~ 192 (320)
T 3a99_A 116 WFERPDSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILID--LNRGELKLI 192 (320)
T ss_dssp EEECSSEEEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE--TTTTEEEEC
T ss_pred EEecCCcEEEEEEcCCCCccHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEe--CCCCCEEEe
Confidence 99999999999999976 899998865 46799999999999999999999999999999999999994 267889999
Q ss_pred ecCCccccCCCccccccccCCcccCcccccC-C-CCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCC
Q 014210 306 DFGLSDFVRPDERLNDIVGSAYYVAPEVLHR-S-YSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEA 383 (429)
Q Consensus 306 DFGla~~~~~~~~~~~~~gt~~y~aPE~~~~-~-~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~ 383 (429)
|||++...... ......||..|+|||++.+ . ++.++||||||+++|||++|+.||.... .+......+.
T Consensus 193 Dfg~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------~~~~~~~~~~-- 263 (320)
T 3a99_A 193 DFGSGALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFR-- 263 (320)
T ss_dssp CCTTCEECCSS-CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCCCCCS--
T ss_pred eCccccccccc-cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh------hhhccccccc--
Confidence 99999876533 3445679999999998863 3 4678999999999999999999996532 2233332222
Q ss_pred CCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhcc
Q 014210 384 PWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLICYQ 422 (429)
Q Consensus 384 ~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~ 422 (429)
..+++++.+||++||+.||++||++.++++|+||+..
T Consensus 264 --~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~ 300 (320)
T 3a99_A 264 --QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 300 (320)
T ss_dssp --SCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred --ccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCc
Confidence 4689999999999999999999999999999999764
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-45 Score=357.63 Aligned_cols=256 Identities=23% Similarity=0.356 Sum_probs=210.9
Q ss_pred cCceeEeceeeccCceEEEEEEEec-CcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEE--e
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKK-GELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYE--D 230 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~-~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~--~ 230 (429)
.++|++.++||+|+||.||++++.. +..+|+.||||++... .....+.+.+|++++++++ |+||+++++++. +
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~ 97 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS---GPDQQRDFQREIQILKALH-SDFIVKYRGVSYGPG 97 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC---CHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEECSS
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC---CHHHHHHHHHHHHHHHhcC-CCceeEEEEEEecCC
Confidence 4789999999999999999998543 2236899999998653 4555678999999999997 999999999987 4
Q ss_pred CCeEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCc
Q 014210 231 TDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS 310 (429)
Q Consensus 231 ~~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla 310 (429)
.+..+|||||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~---~~~~~~kl~Dfg~~ 174 (327)
T 3lxl_A 98 RQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILV---ESEAHVKIADFGLA 174 (327)
T ss_dssp SCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---EETTEEEECCGGGC
T ss_pred CceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEE---CCCCCEEEcccccc
Confidence 566999999999999999997766779999999999999999999999999999999999999 56788999999999
Q ss_pred cccCCCcc----ccccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHcCCCCCCCCChH--------------HHHH
Q 014210 311 DFVRPDER----LNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTES--------------GIFR 371 (429)
Q Consensus 311 ~~~~~~~~----~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~elltg~~Pf~~~~~~--------------~~~~ 371 (429)
........ .....||..|+|||++.+ .++.++||||||+++|+|++|+.||...... ..+.
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (327)
T 3lxl_A 175 KLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLL 254 (327)
T ss_dssp EECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHH
T ss_pred eecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHH
Confidence 87654332 234568888999998864 5788999999999999999999998543321 1122
Q ss_pred HHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHh
Q 014210 372 AVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELL 418 (429)
Q Consensus 372 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~ 418 (429)
........ ......+++++.+||++||+.||++||++.++++++-
T Consensus 255 ~~~~~~~~--~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 299 (327)
T 3lxl_A 255 ELLEEGQR--LPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLD 299 (327)
T ss_dssp HHHHTTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHhhcccC--CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 22222221 2223578999999999999999999999999987664
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=353.34 Aligned_cols=257 Identities=21% Similarity=0.286 Sum_probs=202.2
Q ss_pred cccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeC
Q 014210 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (429)
Q Consensus 152 ~~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~ 231 (429)
.+.++|++.+.||+|+||.||+|+... +|+.||||++..... .+++.+|+.+++.+.+|++|..+..++.+.
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~-----~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~ 77 (296)
T 4hgt_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIA---AGEEVAIKLECVKTK-----HPQLHIESKIYKMMQGGVGIPTIRWCGAEG 77 (296)
T ss_dssp -----CEEEEEEEECSSSEEEEEEETT---TTEEEEEEEEEC--------CCCHHHHHHHHHHHTTSTTCCCEEEEEEET
T ss_pred ccCCceEEeeeecCCCCeEEEEEEEcC---CCceEEEEeeccccc-----chHHHHHHHHHHHhcCCCCCCeeeeecCCC
Confidence 356899999999999999999998765 589999998754322 234788999999999444455555556778
Q ss_pred CeEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCcc
Q 014210 232 DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (429)
Q Consensus 232 ~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~ 311 (429)
+..++||||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+...+.++.+||+|||++.
T Consensus 78 ~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~ 156 (296)
T 4hgt_A 78 DYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156 (296)
T ss_dssp TEEEEEEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCE
T ss_pred CceEEEEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccce
Confidence 8899999999 889999987777789999999999999999999999999999999999999655677889999999998
Q ss_pred ccCCCcc--------ccccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHcCCCCCCCCChH---HHHHHHHhcCCC
Q 014210 312 FVRPDER--------LNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTES---GIFRAVLKADPS 379 (429)
Q Consensus 312 ~~~~~~~--------~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~elltg~~Pf~~~~~~---~~~~~i~~~~~~ 379 (429)
....... .....||..|+|||++.+ .++.++|||||||++|+|++|+.||...... ..+..+......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 236 (296)
T 4hgt_A 157 KYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS 236 (296)
T ss_dssp ECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHH
T ss_pred eccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhccccc
Confidence 7654322 235679999999998874 6889999999999999999999999764321 222222221111
Q ss_pred CC-CCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhH
Q 014210 380 FD-EAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSEL 417 (429)
Q Consensus 380 ~~-~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~ 417 (429)
.+ ......+++++.+||.+||+.||++||++.++++.+
T Consensus 237 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l 275 (296)
T 4hgt_A 237 TPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLF 275 (296)
T ss_dssp SCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHH
T ss_pred chhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHH
Confidence 11 111235789999999999999999999999998754
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-45 Score=354.04 Aligned_cols=257 Identities=25% Similarity=0.356 Sum_probs=208.3
Q ss_pred cccCce-eEeceeeccCceEEEEEEEec-CcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEE
Q 014210 152 HFANKY-ELGEEVGRGHFGYTCAAKFKK-GELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYE 229 (429)
Q Consensus 152 ~~~~~y-~~~~~IG~G~fg~V~~~~~~~-~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~ 229 (429)
.+.++| +++++||+|+||.||++.... ...+|+.||||++... ......+.+.+|++++++++ |+||+++++++.
T Consensus 27 ~~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~ 103 (318)
T 3lxp_A 27 VFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD--AGPQHRSGWKQEIDILRTLY-HEHIIKYKGCCE 103 (318)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTT--CCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEE
T ss_pred eecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccc--cChHHHHHHHHHHHHHHhCC-CcchhhEEEEEe
Confidence 345555 999999999999999986543 2336899999999754 34566778999999999998 999999999998
Q ss_pred eC--CeEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeec
Q 014210 230 DT--DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDF 307 (429)
Q Consensus 230 ~~--~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DF 307 (429)
+. ..+++||||+++++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+||
T Consensus 104 ~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~---~~~~~~kl~Df 178 (318)
T 3lxp_A 104 DAGAASLQLVMEYVPLGSLRDYLPR--HSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLL---DNDRLVKIGDF 178 (318)
T ss_dssp ETTTTEEEEEECCCTTCBHHHHGGG--SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCG
T ss_pred cCCCceEEEEEecccCCcHHHHHhh--CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEE---cCCCCEEECCc
Confidence 84 678999999999999998743 359999999999999999999999999999999999999 77889999999
Q ss_pred CCccccCCCcc----ccccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHcCCCCCCCCChH--------------H
Q 014210 308 GLSDFVRPDER----LNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTES--------------G 368 (429)
Q Consensus 308 Gla~~~~~~~~----~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~elltg~~Pf~~~~~~--------------~ 368 (429)
|++........ .....+|..|+|||++.+ .++.++||||||+++|+|++|+.||...... .
T Consensus 179 g~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~ 258 (318)
T 3lxp_A 179 GLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVL 258 (318)
T ss_dssp GGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHH
T ss_pred cccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHH
Confidence 99987754432 234568889999998874 6888999999999999999999999643221 0
Q ss_pred HHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHh
Q 014210 369 IFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELL 418 (429)
Q Consensus 369 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~ 418 (429)
.+...+..... ......++.++.+||++||+.||++||++.++++.+-
T Consensus 259 ~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 306 (318)
T 3lxp_A 259 RLTELLERGER--LPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILK 306 (318)
T ss_dssp HHHHHHHTTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHHhcccC--CCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence 11222222221 2223468999999999999999999999999997653
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=360.71 Aligned_cols=251 Identities=21% Similarity=0.295 Sum_probs=199.7
Q ss_pred cCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCC-
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD- 232 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~- 232 (429)
.++|+++++||+|+||.||+|+.. |+.||||++... ........+|+.++++++ ||||+++++++.+..
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~ 92 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL-----NEYVAVKIFPIQ----DKQSWQNEYEVYSLPGMK-HENILQFIGAEKRGTS 92 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET-----TEEEEEEEECGG----GHHHHHHHHHHHTSTTCC-CTTBCCEEEEEEEECS
T ss_pred hhhchhhheecccCceEEEEEEEC-----CCEEEEEEeecC----chHHHHHHHHHHHHhcCC-CCCchhhcceeccCCC
Confidence 578999999999999999999743 689999998542 233455667999999998 999999999998754
Q ss_pred ---eEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHc----------CceeccCCCCcEEEeecCCC
Q 014210 233 ---NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQ----------GVVHRDLKPENFLFTTKDEN 299 (429)
Q Consensus 233 ---~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~----------~iiHrDIKp~NILl~~~~~~ 299 (429)
.+++|||||++|+|.+++.. ..+++..++.++.||+.||.|||+. ||+||||||+|||+ +.+
T Consensus 93 ~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill---~~~ 167 (322)
T 3soc_A 93 VDVDLWLITAFHEKGSLSDFLKA--NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLL---KNN 167 (322)
T ss_dssp SSEEEEEEEECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEE---CTT
T ss_pred CCceEEEEEecCCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEE---CCC
Confidence 47999999999999998854 4599999999999999999999999 99999999999999 778
Q ss_pred ceEEEeecCCccccCCCcc---ccccccCCcccCcccccC------CCCCcccHHHHHHHHHHHHcCCCCCCCCCh----
Q 014210 300 SVLKAIDFGLSDFVRPDER---LNDIVGSAYYVAPEVLHR------SYSTEADVWSIGVIAYILLCGSRPFWARTE---- 366 (429)
Q Consensus 300 ~~vkL~DFGla~~~~~~~~---~~~~~gt~~y~aPE~~~~------~~~~~sDiwSlGvll~elltg~~Pf~~~~~---- 366 (429)
+.+||+|||+++....... .....||+.|+|||++.+ .++.++|||||||++|||++|+.||.....
T Consensus 168 ~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~ 247 (322)
T 3soc_A 168 LTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYML 247 (322)
T ss_dssp CCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCC
T ss_pred CeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhcc
Confidence 8999999999977654332 334679999999999875 355678999999999999999999965321
Q ss_pred -----------HHHHHHHHhcCCCCCCC--CC--CCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhh
Q 014210 367 -----------SGIFRAVLKADPSFDEA--PW--PSLSSEARDFVKRLLNKDPRKRLTAAQALSELLI 419 (429)
Q Consensus 367 -----------~~~~~~i~~~~~~~~~~--~~--~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~ 419 (429)
...+..........+.. .+ ...+.++.+||++||+.||++|||+.++++.+.-
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 315 (322)
T 3soc_A 248 PFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQ 315 (322)
T ss_dssp TTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred chhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 11122222111111110 00 1124569999999999999999999999987653
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=364.53 Aligned_cols=260 Identities=24% Similarity=0.372 Sum_probs=208.0
Q ss_pred ccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcC----------CCCcc
Q 014210 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTG----------HNNLV 222 (429)
Q Consensus 153 ~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~----------h~nIv 222 (429)
..++|++.++||+|+||.||+|+... +|+.||||++.. .....+.+.+|+.+++++.. |+||+
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~----~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~ 89 (373)
T 1q8y_A 17 KDARYILVRKLGWGHFSTVWLAKDMV---NNTHVAMKIVRG----DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHIL 89 (373)
T ss_dssp TTTTEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEECS----CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBC
T ss_pred cCCeEEEEEeeeecCCeEEEEEEecC---CCcEEEEEEecC----CccchhhhhHHHHHHHHhhcccccchhccccchHH
Confidence 35789999999999999999998765 589999999864 23445678899999998862 78999
Q ss_pred eEEEEEEeCC----eEEEEEEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHc-CceeccCCCCcEEEeec
Q 014210 223 KFFDAYEDTD----NVYVVMELCEGGELLDRILSR-GGKYTEDDAKAVMIQILNVVAFCHLQ-GVVHRDLKPENFLFTTK 296 (429)
Q Consensus 223 ~l~~~~~~~~----~~~lv~E~~~ggsL~~~i~~~-~~~l~~~~~~~i~~qi~~gL~~LH~~-~iiHrDIKp~NILl~~~ 296 (429)
++++++...+ ..++||||+ +++|.+++... ...+++..++.++.||+.||.|||++ ||+||||||+|||++..
T Consensus 90 ~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~ 168 (373)
T 1q8y_A 90 KLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIV 168 (373)
T ss_dssp CCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEE
T ss_pred HHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEecc
Confidence 9999998654 789999999 88999988764 34699999999999999999999998 99999999999999643
Q ss_pred ---CCCceEEEeecCCccccCCCccccccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHcCCCCCCCCC------h
Q 014210 297 ---DENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWART------E 366 (429)
Q Consensus 297 ---~~~~~vkL~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~elltg~~Pf~~~~------~ 366 (429)
+..+.+||+|||++..... ......||+.|+|||++.+ .++.++|||||||++|||++|+.||.... .
T Consensus 169 ~~~~~~~~~kl~Dfg~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~ 246 (373)
T 1q8y_A 169 DSPENLIQIKIADLGNACWYDE--HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD 246 (373)
T ss_dssp ETTTTEEEEEECCCTTCEETTB--CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CH
T ss_pred CCCcCcceEEEcccccccccCC--CCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCCh
Confidence 3445899999999977643 3345689999999998864 58999999999999999999999997543 2
Q ss_pred HHHHHHHHhcCCCCCC--------------------------------------CCCCCCCHHHHHHHHHhcccCccCcC
Q 014210 367 SGIFRAVLKADPSFDE--------------------------------------APWPSLSSEARDFVKRLLNKDPRKRL 408 (429)
Q Consensus 367 ~~~~~~i~~~~~~~~~--------------------------------------~~~~~~s~~~~~li~~~L~~dP~~Rp 408 (429)
...+..+.......+. .....++.++.+||++||+.||++||
T Consensus 247 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp 326 (373)
T 1q8y_A 247 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA 326 (373)
T ss_dssp HHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCB
T ss_pred HHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccC
Confidence 2233333221110000 00113457889999999999999999
Q ss_pred CHHHHHhhHhhhcc
Q 014210 409 TAAQALSELLICYQ 422 (429)
Q Consensus 409 s~~~iL~~~~~~~~ 422 (429)
|+.++|+|+||+..
T Consensus 327 t~~ell~hp~f~~~ 340 (373)
T 1q8y_A 327 DAGGLVNHPWLKDT 340 (373)
T ss_dssp CHHHHHTCGGGTTC
T ss_pred CHHHHhhChhhhcc
Confidence 99999999999864
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-45 Score=346.55 Aligned_cols=249 Identities=23% Similarity=0.380 Sum_probs=210.6
Q ss_pred ccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCC
Q 014210 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (429)
Q Consensus 153 ~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~ 232 (429)
..++|++++.||+|+||.||+|+... ++.||||++..... ..+.+.+|++++++++ |+||+++++++. .+
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~-h~~i~~~~~~~~-~~ 80 (279)
T 1qpc_A 11 PRETLKLVERLGAGQFGEVWMGYYNG----HTKVAVKSLKQGSM----SPDAFLAEANLMKQLQ-HQRLVRLYAVVT-QE 80 (279)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETT----TEEEEEEEECTTSS----CHHHHHHHHHHHHHCC-CTTBCCEEEEEC-SS
T ss_pred CHHhhhheeeecCCCCeEEEEEEEcC----CcEEEEEEecCCcc----cHHHHHHHHHHHHhCC-CcCcceEEEEEc-CC
Confidence 35789999999999999999998653 67899999865432 2467889999999998 999999999886 45
Q ss_pred eEEEEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCcc
Q 014210 233 NVYVVMELCEGGELLDRILSRG-GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (429)
Q Consensus 233 ~~~lv~E~~~ggsL~~~i~~~~-~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~ 311 (429)
..++||||+++++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.
T Consensus 81 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~---~~~~~~kl~Dfg~~~ 157 (279)
T 1qpc_A 81 PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILV---SDTLSCKIADFGLAR 157 (279)
T ss_dssp SCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTSCEEECCCTTCE
T ss_pred CcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEE---cCCCCEEECCCcccc
Confidence 6899999999999999875432 269999999999999999999999999999999999999 778899999999998
Q ss_pred ccCCCcc--ccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCC
Q 014210 312 FVRPDER--LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPS 387 (429)
Q Consensus 312 ~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 387 (429)
....... .....++..|+|||++. +.++.++||||||+++|||++ |+.||........+..+...... .....
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~ 234 (279)
T 1qpc_A 158 LIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRM---VRPDN 234 (279)
T ss_dssp ECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC---CCCTT
T ss_pred cccCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCC---CCccc
Confidence 7654332 23345778999999887 568899999999999999999 99999988887777776654322 12246
Q ss_pred CCHHHHHHHHHhcccCccCcCCHHHHHhhH
Q 014210 388 LSSEARDFVKRLLNKDPRKRLTAAQALSEL 417 (429)
Q Consensus 388 ~s~~~~~li~~~L~~dP~~Rps~~~iL~~~ 417 (429)
++.++.+||.+||..||++||++.++++.+
T Consensus 235 ~~~~l~~li~~~l~~~p~~Rps~~~l~~~l 264 (279)
T 1qpc_A 235 CPEELYQLMRLCWKERPEDRPTFDYLRSVL 264 (279)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred ccHHHHHHHHHHhccChhhCCCHHHHHHHH
Confidence 899999999999999999999999998754
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-45 Score=355.86 Aligned_cols=252 Identities=23% Similarity=0.398 Sum_probs=190.8
Q ss_pred ccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEE---
Q 014210 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYE--- 229 (429)
Q Consensus 153 ~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~--- 229 (429)
...+|++.++||+|+||.||+|+... +|+.||||++.. ......+.+.+|+.+++++.+|+||+++++++.
T Consensus 26 ~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~---~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~ 99 (337)
T 3ll6_A 26 GELRLRVRRVLAEGGFAFVYEAQDVG---SGREYALKRLLS---NEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGK 99 (337)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEEETT---TCCEEEEEEEEE---SSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECT
T ss_pred cCceEEEEEEEccCCceEEEEEEECC---CCcEEEEEEecC---CchHHHHHHHHHHHHHHHhccCCChhhccccccccc
Confidence 35689999999999999999999765 589999999844 345556788999999999977999999999994
Q ss_pred -----eCCeEEEEEEecCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHcC--ceeccCCCCcEEEeecCCCc
Q 014210 230 -----DTDNVYVVMELCEGGELLDRILS--RGGKYTEDDAKAVMIQILNVVAFCHLQG--VVHRDLKPENFLFTTKDENS 300 (429)
Q Consensus 230 -----~~~~~~lv~E~~~ggsL~~~i~~--~~~~l~~~~~~~i~~qi~~gL~~LH~~~--iiHrDIKp~NILl~~~~~~~ 300 (429)
.....++||||+. |+|.+++.. ..+.+++..++.++.||+.||.|||++| |+||||||+|||+ +.++
T Consensus 100 ~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~---~~~~ 175 (337)
T 3ll6_A 100 EESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLL---SNQG 175 (337)
T ss_dssp TTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEE---CTTS
T ss_pred cccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEE---CCCC
Confidence 3345899999996 699988864 3567999999999999999999999999 9999999999999 7788
Q ss_pred eEEEeecCCccccCCCccc-------------cccccCCcccCccccc----CCCCCcccHHHHHHHHHHHHcCCCCCCC
Q 014210 301 VLKAIDFGLSDFVRPDERL-------------NDIVGSAYYVAPEVLH----RSYSTEADVWSIGVIAYILLCGSRPFWA 363 (429)
Q Consensus 301 ~vkL~DFGla~~~~~~~~~-------------~~~~gt~~y~aPE~~~----~~~~~~sDiwSlGvll~elltg~~Pf~~ 363 (429)
.+||+|||++......... ....||+.|+|||++. ..++.++||||||+++|+|++|+.||..
T Consensus 176 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~ 255 (337)
T 3ll6_A 176 TIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFED 255 (337)
T ss_dssp CEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC--
T ss_pred CEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcc
Confidence 9999999999876543221 1456899999999873 3578899999999999999999999976
Q ss_pred CChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhh
Q 014210 364 RTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLIC 420 (429)
Q Consensus 364 ~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~ 420 (429)
........ ... .......++.++.+||++||+.||++||++.+++++++..
T Consensus 256 ~~~~~~~~----~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~ 306 (337)
T 3ll6_A 256 GAKLRIVN----GKY--SIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEI 306 (337)
T ss_dssp --------------C--CCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred hhHHHhhc----Ccc--cCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 54433222 111 1122345778899999999999999999999999998754
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=357.83 Aligned_cols=257 Identities=29% Similarity=0.529 Sum_probs=202.8
Q ss_pred ccccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcH---HHHHHHHHHHHHHHHhc---CCCCcceE
Q 014210 151 KHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTA---IAIEDVRREVKILRALT---GHNNLVKF 224 (429)
Q Consensus 151 ~~~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~---~~~~~~~~Ei~il~~l~---~h~nIv~l 224 (429)
+.+.++|++.+.||+|+||.||+|+... +|+.||||++........ .....+.+|+.+++++. +|+||+++
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~ 103 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLT---DRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRL 103 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTT---TCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCE
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEcc---CCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeE
Confidence 3457889999999999999999998665 589999999976543221 22334668999999993 39999999
Q ss_pred EEEEEeCCeEEEEEEe-cCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEE
Q 014210 225 FDAYEDTDNVYVVMEL-CEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLK 303 (429)
Q Consensus 225 ~~~~~~~~~~~lv~E~-~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vk 303 (429)
++++.+.+..++|||| +.+++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++ ..++.+|
T Consensus 104 ~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~--~~~~~~k 180 (312)
T 2iwi_A 104 LDWFETQEGFMLVLERPLPAQDLFDYITEK-GPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILID--LRRGCAK 180 (312)
T ss_dssp EEEC-----CEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEE--TTTTEEE
T ss_pred EEEEecCCeEEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEe--CCCCeEE
Confidence 9999999999999999 7899999988654 5699999999999999999999999999999999999994 2678899
Q ss_pred EeecCCccccCCCccccccccCCcccCcccccC-CC-CCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCC
Q 014210 304 AIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHR-SY-STEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFD 381 (429)
Q Consensus 304 L~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~~-~~-~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~ 381 (429)
|+|||++...... ......||..|+|||++.+ .+ +.++||||||+++|+|++|+.||.... .+......+.
T Consensus 181 l~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~~~~~~~~~ 253 (312)
T 2iwi_A 181 LIDFGSGALLHDE-PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------EILEAELHFP 253 (312)
T ss_dssp ECCCSSCEECCSS-CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHTCCCCC
T ss_pred EEEcchhhhcccC-cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH------HHhhhccCCc
Confidence 9999999876543 3456679999999998864 34 458999999999999999999996432 2333333322
Q ss_pred CCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhccce
Q 014210 382 EAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLICYQSY 424 (429)
Q Consensus 382 ~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~~~ 424 (429)
..++.++.+||.+||+.||++||++.++++|+||+....
T Consensus 254 ----~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~~ 292 (312)
T 2iwi_A 254 ----AHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAE 292 (312)
T ss_dssp ----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC---
T ss_pred ----ccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCchh
Confidence 468999999999999999999999999999999986543
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-45 Score=356.03 Aligned_cols=256 Identities=22% Similarity=0.347 Sum_probs=206.1
Q ss_pred ccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEe--
Q 014210 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED-- 230 (429)
Q Consensus 153 ~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~-- 230 (429)
..++|++.+.||+|+||.||+++... +|+.||||++.. ......+.+.+|++++++++ |+||+++++++..
T Consensus 27 ~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~ 99 (317)
T 2buj_A 27 DNKHYLFIQKLGEGGFSYVDLVEGLH---DGHFYALKRILC---HEQQDREEAQREADMHRLFN-HPNILRLVAYCLRER 99 (317)
T ss_dssp TTEEEEEEEEEEC--CEEEEEEEETT---TCCEEEEEEEEE---SSHHHHHHHHHHHHHHHTCC-CTTBCCCCEEEEEEE
T ss_pred CCeEEEEEEEecCCCCeEEEEEEecC---CCcEEEEEEEec---CCHHHHHHHHHHHHHHhhcC-CCCeeeEEEEEEecc
Confidence 35789999999999999999998765 589999999854 34556678999999999997 9999999999873
Q ss_pred --CCeEEEEEEecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEe
Q 014210 231 --TDNVYVVMELCEGGELLDRILS---RGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAI 305 (429)
Q Consensus 231 --~~~~~lv~E~~~ggsL~~~i~~---~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~ 305 (429)
.+..++||||+++++|.+++.. .+..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+
T Consensus 100 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~---~~~~~~kl~ 176 (317)
T 2buj_A 100 GAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILL---GDEGQPVLM 176 (317)
T ss_dssp TTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTSCEEEC
T ss_pred CCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE---cCCCCEEEE
Confidence 3478999999999999998865 35679999999999999999999999999999999999999 778899999
Q ss_pred ecCCccccCCCcc----------ccccccCCcccCcccccCC----CCCcccHHHHHHHHHHHHcCCCCCCCCChH-HHH
Q 014210 306 DFGLSDFVRPDER----------LNDIVGSAYYVAPEVLHRS----YSTEADVWSIGVIAYILLCGSRPFWARTES-GIF 370 (429)
Q Consensus 306 DFGla~~~~~~~~----------~~~~~gt~~y~aPE~~~~~----~~~~sDiwSlGvll~elltg~~Pf~~~~~~-~~~ 370 (429)
|||++........ .....||..|+|||++.+. ++.++||||||+++|+|++|+.||...... ...
T Consensus 177 dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~ 256 (317)
T 2buj_A 177 DLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSV 256 (317)
T ss_dssp CCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCH
T ss_pred ecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchh
Confidence 9999876532111 1234579999999998642 688999999999999999999999531110 011
Q ss_pred HHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhh
Q 014210 371 RAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLIC 420 (429)
Q Consensus 371 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~ 420 (429)
.......... ...+.++.++.+||.+||+.||.+||++.++++++.-.
T Consensus 257 ~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~ 304 (317)
T 2buj_A 257 ALAVQNQLSI--PQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEAL 304 (317)
T ss_dssp HHHHHCC--C--CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred hHHhhccCCC--CccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhc
Confidence 1222222222 22346899999999999999999999999999987643
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-46 Score=361.05 Aligned_cols=264 Identities=19% Similarity=0.238 Sum_probs=208.7
Q ss_pred ccccccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEE
Q 014210 149 FSKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAY 228 (429)
Q Consensus 149 ~~~~~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~ 228 (429)
..+...++|++.+.||+|+||.||+|+.. +|+.||||++...... .....+.+|+++++++. |+||+++++++
T Consensus 24 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~-h~~iv~~~~~~ 96 (326)
T 3uim_A 24 ELQVASDNFSNKNILGRGGFGKVYKGRLA----DGTLVAVKRLKEERTQ--GGELQFQTEVEMISMAV-HRNLLRLRGFC 96 (326)
T ss_dssp HHHTTTTSSCSTTEEECCSSSEEEEECCS----SSCCEEEEECCC-------CCCHHHHHHHGGGTCC-CTTBCCCCEEE
T ss_pred HHHHHhhccccceeEecCCCcEEEEEEec----CCCEEEEEEeccccCc--hHHHHHHHHHHHHHhcc-CCCccceEEEE
Confidence 34556789999999999999999999743 3889999998754322 22236889999999998 99999999999
Q ss_pred EeCCeEEEEEEecCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceE
Q 014210 229 EDTDNVYVVMELCEGGELLDRILSRG---GKYTEDDAKAVMIQILNVVAFCHLQ---GVVHRDLKPENFLFTTKDENSVL 302 (429)
Q Consensus 229 ~~~~~~~lv~E~~~ggsL~~~i~~~~---~~l~~~~~~~i~~qi~~gL~~LH~~---~iiHrDIKp~NILl~~~~~~~~v 302 (429)
.+.+..++||||+++|+|.+++.... ..+++..++.++.||+.||.|||++ ||+||||||+|||+ +.++.+
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~---~~~~~~ 173 (326)
T 3uim_A 97 MTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILL---DEEFEA 173 (326)
T ss_dssp CCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEE---CTTCCE
T ss_pred ecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEE---CCCCCE
Confidence 99999999999999999999887543 2499999999999999999999999 99999999999999 778899
Q ss_pred EEeecCCccccCCCc--cccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHcCCCCCCC----CChHHHHHHHHh
Q 014210 303 KAIDFGLSDFVRPDE--RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWA----RTESGIFRAVLK 375 (429)
Q Consensus 303 kL~DFGla~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~elltg~~Pf~~----~~~~~~~~~i~~ 375 (429)
||+|||++....... ......||+.|+|||++. +.++.++||||||+++|+|++|+.||.. ............
T Consensus 174 kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 253 (326)
T 3uim_A 174 VVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK 253 (326)
T ss_dssp EECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHT
T ss_pred EeccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHH
Confidence 999999998764332 234456999999999886 5689999999999999999999999941 111111111111
Q ss_pred cCC---CCCC--------CCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhcc
Q 014210 376 ADP---SFDE--------APWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLICYQ 422 (429)
Q Consensus 376 ~~~---~~~~--------~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~ 422 (429)
... .... ......+.++.+||.+||+.||++|||+.++++++.-...
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~ 311 (326)
T 3uim_A 254 GLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGL 311 (326)
T ss_dssp TTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSC
T ss_pred HHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcch
Confidence 110 0000 0011234689999999999999999999999999975543
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=383.72 Aligned_cols=253 Identities=21% Similarity=0.354 Sum_probs=209.7
Q ss_pred cCceeEec-eeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCC
Q 014210 154 ANKYELGE-EVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (429)
Q Consensus 154 ~~~y~~~~-~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~ 232 (429)
.+++.+.+ +||+|+||.||+|..+... .+..||||++... ......+++.+|++++++++ |+|||++++++.+ +
T Consensus 334 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~-~~~~vAvK~~~~~--~~~~~~~~~~~E~~il~~l~-hpniv~l~~~~~~-~ 408 (613)
T 2ozo_A 334 RDNLLIADIELGCGNFGSVRQGVYRMRK-KQIDVAIKVLKQG--TEKADTEEMMREAQIMHQLD-NPYIVRLIGVCQA-E 408 (613)
T ss_dssp TTSEEEEEEEEEECSSSEEEEEEEECSS-CEEEEEEEECCCC--CSSTTHHHHHHHHHHHTTCC-CTTBCCEEEEEES-S
T ss_pred ccceeEcCcEEecCCCcEEEEEEEecCC-CcEEEEEEEcCCC--CChHHHHHHHHHHHHHHhCC-CCCEeeEEEEecc-C
Confidence 35566666 8999999999999876432 4678999999764 23345578999999999998 9999999999976 5
Q ss_pred eEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccc
Q 014210 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (429)
Q Consensus 233 ~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~ 312 (429)
.++||||||++|+|.+++......+++..++.++.||+.||+|||++|||||||||+|||| +.++.+||+|||+++.
T Consensus 409 ~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl---~~~~~vkL~DFGla~~ 485 (613)
T 2ozo_A 409 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLL---VNRHYAKISDFGLSKA 485 (613)
T ss_dssp SEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---EETTEEEECCCSTTTT
T ss_pred CeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEE---cCCCcEEEeeccCccc
Confidence 6899999999999999987777789999999999999999999999999999999999999 5678999999999987
Q ss_pred cCCCccc----cccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCCCCC
Q 014210 313 VRPDERL----NDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWP 386 (429)
Q Consensus 313 ~~~~~~~----~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 386 (429)
....... ....++..|+|||++. +.++.++|||||||+||||++ |+.||......+.+..+...... ....
T Consensus 486 ~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~---~~p~ 562 (613)
T 2ozo_A 486 LGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRM---ECPP 562 (613)
T ss_dssp CC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCC---CCCT
T ss_pred ccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC---CCCC
Confidence 6543321 2234568899999886 679999999999999999998 99999988888887777665422 1224
Q ss_pred CCCHHHHHHHHHhcccCccCcCCHHHHHhhH
Q 014210 387 SLSSEARDFVKRLLNKDPRKRLTAAQALSEL 417 (429)
Q Consensus 387 ~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~ 417 (429)
.+++++.+||.+||+.||++||++.++++.+
T Consensus 563 ~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L 593 (613)
T 2ozo_A 563 ECPPELYALMSDCWIYKWEDRPDFLTVEQRM 593 (613)
T ss_dssp TCCHHHHHHHHHTTCSSTTTSCCHHHHHHHH
T ss_pred cCCHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 6899999999999999999999999986543
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=370.22 Aligned_cols=250 Identities=24% Similarity=0.379 Sum_probs=208.0
Q ss_pred ccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCC
Q 014210 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (429)
Q Consensus 153 ~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~ 232 (429)
..++|++.++||+|+||.||+|.... +..||||++..... ..+.+.+|++++++|+ ||||+++++++.+ +
T Consensus 182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~-~ 251 (452)
T 1fmk_A 182 PRESLRLEVKLGQGCFGEVWMGTWNG----TTRVAIKTLKPGTM----SPEAFLQEAQVMKKLR-HEKLVQLYAVVSE-E 251 (452)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETT----TEEEEEEECCTTSS----CHHHHHHHHHHHHHCC-CTTBCCEEEEECS-S
T ss_pred ChhHceeeeeecCCCCeEEEEEEECC----CceEEEEEeccCCC----CHHHHHHHHHHHHhCC-CCCEeeEEEEEcC-C
Confidence 35789999999999999999998764 56799999975432 2357899999999998 9999999999876 6
Q ss_pred eEEEEEEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCcc
Q 014210 233 NVYVVMELCEGGELLDRILSR-GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (429)
Q Consensus 233 ~~~lv~E~~~ggsL~~~i~~~-~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~ 311 (429)
..+||||||++|+|.+++... +..+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++
T Consensus 252 ~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill---~~~~~~kl~DfG~a~ 328 (452)
T 1fmk_A 252 PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV---GENLVCKVADFGLAR 328 (452)
T ss_dssp SCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCCCTTC
T ss_pred ceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEE---CCCCCEEECCCccce
Confidence 789999999999999998643 3569999999999999999999999999999999999999 678899999999998
Q ss_pred ccCCCcc--ccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCC
Q 014210 312 FVRPDER--LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPS 387 (429)
Q Consensus 312 ~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 387 (429)
....... .....++..|+|||++. +.++.++||||||+++|||++ |+.||......+.+..+...... ...+.
T Consensus 329 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~---~~~~~ 405 (452)
T 1fmk_A 329 LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM---PCPPE 405 (452)
T ss_dssp --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC---CCCTT
T ss_pred ecCCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC---CCCCC
Confidence 7653322 22345678899999876 578999999999999999999 99999988888877777654321 12246
Q ss_pred CCHHHHHHHHHhcccCccCcCCHHHHHhhHh
Q 014210 388 LSSEARDFVKRLLNKDPRKRLTAAQALSELL 418 (429)
Q Consensus 388 ~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~ 418 (429)
+++++.+||.+||+.||++|||+.++++.+-
T Consensus 406 ~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~ 436 (452)
T 1fmk_A 406 CPESLHDLMCQCWRKEPEERPTFEYLQAFLE 436 (452)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 8999999999999999999999999988643
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-45 Score=350.69 Aligned_cols=250 Identities=24% Similarity=0.394 Sum_probs=199.5
Q ss_pred ccccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHH--hcCCCCcceEEEEE
Q 014210 151 KHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRA--LTGHNNLVKFFDAY 228 (429)
Q Consensus 151 ~~~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~--l~~h~nIv~l~~~~ 228 (429)
+.+.++|++.++||+|+||.||+|+. +|+.||||++... ..+.+.+|.+++.. ++ |+||+++++++
T Consensus 4 ~~~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~vavK~~~~~------~~~~~~~e~~~~~~~~l~-h~niv~~~~~~ 71 (301)
T 3q4u_A 4 RTVARDITLLECVGKGRYGEVWRGSW-----QGENVAVKIFSSR------DEKSWFRETELYNTVMLR-HENILGFIASD 71 (301)
T ss_dssp CCCGGGCEEEEEEEECSSEEEEEEEE-----TTEEEEEEEECGG------GHHHHHHHHHHHHHTCCC-CTTBCCEEEEE
T ss_pred ccccCcEEEEEeeccCCCcEEEEEEE-----CCEEEEEEEeccc------cchhhHHHHHHHHHhhcc-CcCeeeEEEee
Confidence 45678999999999999999999975 3789999998532 23456677787777 55 99999999987
Q ss_pred EeC----CeEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--------HcCceeccCCCCcEEEeec
Q 014210 229 EDT----DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCH--------LQGVVHRDLKPENFLFTTK 296 (429)
Q Consensus 229 ~~~----~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH--------~~~iiHrDIKp~NILl~~~ 296 (429)
.+. +..++||||+++|+|.+++ +...+++..++.++.||+.||.||| +.||+||||||+|||+
T Consensus 72 ~~~~~~~~~~~lv~e~~~~g~L~~~l--~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill--- 146 (301)
T 3q4u_A 72 MTSRHSSTQLWLITHYHEMGSLYDYL--QLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILV--- 146 (301)
T ss_dssp EEEETTEEEEEEEECCCTTCBHHHHH--TTCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEE---
T ss_pred ccccCCCceeEEehhhccCCCHHHHH--hhcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEE---
Confidence 653 4589999999999999988 4457999999999999999999999 9999999999999999
Q ss_pred CCCceEEEeecCCccccCCCcc-----ccccccCCcccCcccccCC-------CCCcccHHHHHHHHHHHHcC-------
Q 014210 297 DENSVLKAIDFGLSDFVRPDER-----LNDIVGSAYYVAPEVLHRS-------YSTEADVWSIGVIAYILLCG------- 357 (429)
Q Consensus 297 ~~~~~vkL~DFGla~~~~~~~~-----~~~~~gt~~y~aPE~~~~~-------~~~~sDiwSlGvll~elltg------- 357 (429)
+.++.+||+|||+++....... .....||+.|+|||++.+. ++.++||||||+++|||++|
T Consensus 147 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~ 226 (301)
T 3q4u_A 147 KKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIV 226 (301)
T ss_dssp CTTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBC
T ss_pred cCCCCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccc
Confidence 7788999999999976543322 2335799999999998753 34689999999999999999
Q ss_pred ---CCCCCCCC----hHHHHHHHHhcCCCCCCCCC----CCCCHHHHHHHHHhcccCccCcCCHHHHHhhH
Q 014210 358 ---SRPFWART----ESGIFRAVLKADPSFDEAPW----PSLSSEARDFVKRLLNKDPRKRLTAAQALSEL 417 (429)
Q Consensus 358 ---~~Pf~~~~----~~~~~~~i~~~~~~~~~~~~----~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~ 417 (429)
+.||.... ....+.............+. ..++.++.+||++||+.||++|||+.++++.+
T Consensus 227 ~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L 297 (301)
T 3q4u_A 227 EDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTL 297 (301)
T ss_dssp CCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHH
T ss_pred ccccccccccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHH
Confidence 88985432 22333333333222222111 12457899999999999999999999999875
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=364.54 Aligned_cols=264 Identities=20% Similarity=0.219 Sum_probs=200.2
Q ss_pred cccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHH--------HHHHHHHHHHHHHHhcCCCCcce
Q 014210 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAI--------AIEDVRREVKILRALTGHNNLVK 223 (429)
Q Consensus 152 ~~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~--------~~~~~~~Ei~il~~l~~h~nIv~ 223 (429)
...++|++.++||+|+||.||+|+...+...+..||||++......... ..+.+.+|+.+++.+. |+||++
T Consensus 34 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~-h~ni~~ 112 (345)
T 2v62_A 34 MEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLD-YLGIPL 112 (345)
T ss_dssp TTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCS-CCCCCC
T ss_pred ccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhcccc-ccCcce
Confidence 3467899999999999999999998765556889999998754321111 1123567888888887 999999
Q ss_pred EEEEEEe----CCeEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCC
Q 014210 224 FFDAYED----TDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDEN 299 (429)
Q Consensus 224 l~~~~~~----~~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~ 299 (429)
+++++.+ .+..||||||+ +++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++ .
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~-~ 189 (345)
T 2v62_A 113 FYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQN-GTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKN-P 189 (345)
T ss_dssp EEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGG-GBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSS-T
T ss_pred eecccccccCCCcEEEEEEecc-CCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCC-C
Confidence 9999988 67899999999 89999987544 4899999999999999999999999999999999999995321 2
Q ss_pred ceEEEeecCCccccCCCcc--------ccccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHcCCCCCCCC--ChHH
Q 014210 300 SVLKAIDFGLSDFVRPDER--------LNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWAR--TESG 368 (429)
Q Consensus 300 ~~vkL~DFGla~~~~~~~~--------~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~elltg~~Pf~~~--~~~~ 368 (429)
+.+||+|||+++....... .....||..|+|||++.+ .++.++|||||||++|||++|+.||... ....
T Consensus 190 ~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~ 269 (345)
T 2v62_A 190 DQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVA 269 (345)
T ss_dssp TSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHH
T ss_pred CcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHH
Confidence 3899999999976643221 244579999999998875 5899999999999999999999999653 2222
Q ss_pred HHHHHHhcCCCCCC-----CCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhh
Q 014210 369 IFRAVLKADPSFDE-----APWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLI 419 (429)
Q Consensus 369 ~~~~i~~~~~~~~~-----~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~ 419 (429)
............+. .....++.++.+||.+||..||++||++.++++.+.-
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~ 325 (345)
T 2v62_A 270 VQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNP 325 (345)
T ss_dssp HHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCT
T ss_pred HHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 22111111111111 0112688999999999999999999999999987653
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-45 Score=373.23 Aligned_cols=257 Identities=23% Similarity=0.282 Sum_probs=211.9
Q ss_pred cccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeC
Q 014210 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (429)
Q Consensus 152 ~~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~ 231 (429)
.+.++|+++++||+|+||.||+|+... +|+.||||++...... .++.+|+++++.|.+|++|..+..++.+.
T Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~---~~~~vAvK~~~~~~~~-----~~~~~E~~il~~L~~~~~i~~i~~~~~~~ 75 (483)
T 3sv0_A 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQ---TNEEVAIKLENVKTKH-----PQLLYESKIYRILQGGTGIPNVRWFGVEG 75 (483)
T ss_dssp EETTTEECCCCCEECSSCEEEEEEETT---TCCEEEEEEEETTCSS-----CCHHHHHHHHHHTTTSTTCCCEEEEEEET
T ss_pred CcCCcEEEEEEEeeCCCEEEEEEEECC---CCcEEEEEEecccccc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeeC
Confidence 456899999999999999999998765 5899999998654322 34779999999999678888888888899
Q ss_pred CeEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCcc
Q 014210 232 DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (429)
Q Consensus 232 ~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~ 311 (429)
+..+|||||+ +++|.+++......+++..++.|+.||+.||.|||++|||||||||+||||...+.++.+||+|||+++
T Consensus 76 ~~~~lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~ 154 (483)
T 3sv0_A 76 DYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154 (483)
T ss_dssp TEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCE
T ss_pred CEEEEEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcce
Confidence 9999999999 889999997777889999999999999999999999999999999999999655578899999999998
Q ss_pred ccCCCcc--------ccccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHcCCCCCCCCCh---HHHHHHHHhcCC-
Q 014210 312 FVRPDER--------LNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTE---SGIFRAVLKADP- 378 (429)
Q Consensus 312 ~~~~~~~--------~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~elltg~~Pf~~~~~---~~~~~~i~~~~~- 378 (429)
....... .....||..|+|||++.+ .++.++|||||||+||||++|+.||..... ...+..+.....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (483)
T 3sv0_A 155 KYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVA 234 (483)
T ss_dssp ECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHH
T ss_pred eccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcccc
Confidence 7654432 125689999999998874 689999999999999999999999976443 233333322211
Q ss_pred CCCCCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhH
Q 014210 379 SFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSEL 417 (429)
Q Consensus 379 ~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~ 417 (429)
.........++.++.+||..||+.||++||++.+|++.+
T Consensus 235 ~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L 273 (483)
T 3sv0_A 235 TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLF 273 (483)
T ss_dssp SCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHH
T ss_pred ccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHH
Confidence 111111136789999999999999999999999887643
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-45 Score=371.38 Aligned_cols=256 Identities=25% Similarity=0.361 Sum_probs=200.0
Q ss_pred cCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~ 233 (429)
..+|++.++||+|+||.|+..... +|+.||||++...... .+.+|+++++++.+|||||++++++.+.+.
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~~~~~----~~~~vAvK~~~~~~~~------~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~ 92 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVYRGMF----DNRDVAVKRILPECFS------FADREVQLLRESDEHPNVIRYFCTEKDRQF 92 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEEEEES----SSSEEEEEEECTTTEE------ECHHHHHHHHHSCCCTTBCCEEEEEEETTE
T ss_pred cEEEecCCeeecCcCEEEEEEEEe----CCeEEEEEEECHHHHH------HHHHHHHHHHhccCCCCcCeEEEEEecCCE
Confidence 457999999999999987643322 5899999998654322 256899999999569999999999999999
Q ss_pred EEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecC--CCceEEEeecCCcc
Q 014210 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKD--ENSVLKAIDFGLSD 311 (429)
Q Consensus 234 ~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~--~~~~vkL~DFGla~ 311 (429)
.|||||||. |+|.+++......+.+..++.++.||+.||.|||++||+||||||+|||++..+ ....+||+|||+++
T Consensus 93 ~~lv~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~ 171 (432)
T 3p23_A 93 QYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCK 171 (432)
T ss_dssp EEEEEECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEE
T ss_pred EEEEEECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEeccccee
Confidence 999999996 599999977766677778889999999999999999999999999999996433 23468899999998
Q ss_pred ccCCCc----cccccccCCcccCccccc----CCCCCcccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCC
Q 014210 312 FVRPDE----RLNDIVGSAYYVAPEVLH----RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDE 382 (429)
Q Consensus 312 ~~~~~~----~~~~~~gt~~y~aPE~~~----~~~~~~sDiwSlGvll~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~ 382 (429)
...... .....+||+.|+|||++. ..++.++|||||||++|||++ |..||........ ..+.........
T Consensus 172 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~-~~~~~~~~~~~~ 250 (432)
T 3p23_A 172 KLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQA-NILLGACSLDCL 250 (432)
T ss_dssp CC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHH-HHHTTCCCCTTS
T ss_pred eccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHH-HHHhccCCcccc
Confidence 765432 234567999999999986 346779999999999999999 9999965544332 222222111111
Q ss_pred CCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhc
Q 014210 383 APWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLICY 421 (429)
Q Consensus 383 ~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~ 421 (429)
......+..+.+||.+||+.||++||++.++|+|+||..
T Consensus 251 ~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~ 289 (432)
T 3p23_A 251 HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWS 289 (432)
T ss_dssp CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCC
T ss_pred CccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccC
Confidence 112234567899999999999999999999999999965
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=377.51 Aligned_cols=250 Identities=24% Similarity=0.379 Sum_probs=212.9
Q ss_pred ccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCC
Q 014210 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (429)
Q Consensus 153 ~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~ 232 (429)
..++|++.++||+|+||.||+|.... +..||||++..... ..+++.+|+++|++|+ |+||+++++++.+ +
T Consensus 265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~-hpniv~~~~~~~~-~ 334 (535)
T 2h8h_A 265 PRESLRLEVKLGQGCFGEVWMGTWNG----TTRVAIKTLKPGTM----SPEAFLQEAQVMKKLR-HEKLVQLYAVVSE-E 334 (535)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETT----TEEEEEEEECTTSS----CHHHHHHHHHHHHHCC-CTTBCCEEEEECS-S
T ss_pred chhhhhhheecccCCCeEEEEEEECC----CceEEEEEeCCCCC----CHHHHHHHHHHHHhCC-CCCEeeEEEEEee-c
Confidence 35789999999999999999998764 56799999975432 2357899999999998 9999999999876 6
Q ss_pred eEEEEEEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCcc
Q 014210 233 NVYVVMELCEGGELLDRILSR-GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (429)
Q Consensus 233 ~~~lv~E~~~ggsL~~~i~~~-~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~ 311 (429)
..+||||||++|+|.+++... +..+++..++.++.||+.||.|||++|||||||||+|||| ++++.+||+|||+++
T Consensus 335 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll---~~~~~~kl~DFG~a~ 411 (535)
T 2h8h_A 335 PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV---GENLVCKVADFGLAR 411 (535)
T ss_dssp SCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCTTSTT
T ss_pred cceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEE---cCCCcEEEcccccce
Confidence 789999999999999998643 3569999999999999999999999999999999999999 678899999999998
Q ss_pred ccCCCcc--ccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCC
Q 014210 312 FVRPDER--LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPS 387 (429)
Q Consensus 312 ~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 387 (429)
....... .....++..|+|||++. +.++.++|||||||+||||++ |+.||......+.+..+...... .....
T Consensus 412 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~---~~~~~ 488 (535)
T 2h8h_A 412 LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM---PCPPE 488 (535)
T ss_dssp TCCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCC---CCCTT
T ss_pred ecCCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC---CCCCC
Confidence 7653321 22345678899999876 578999999999999999999 99999988888877777654321 12246
Q ss_pred CCHHHHHHHHHhcccCccCcCCHHHHHhhHh
Q 014210 388 LSSEARDFVKRLLNKDPRKRLTAAQALSELL 418 (429)
Q Consensus 388 ~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~ 418 (429)
++.++.+||.+||+.||++||++.++++.+-
T Consensus 489 ~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~ 519 (535)
T 2h8h_A 489 CPESLHDLMCQCWRKEPEERPTFEYLQAFLE 519 (535)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 8999999999999999999999999988654
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-44 Score=379.53 Aligned_cols=251 Identities=23% Similarity=0.334 Sum_probs=207.3
Q ss_pred eeE-eceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEE
Q 014210 157 YEL-GEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVY 235 (429)
Q Consensus 157 y~~-~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~~ 235 (429)
+.+ .++||+|+||.||+|.+.... .++.||||++.... ......+++.+|++++++|+ |+|||++++++.+ +..+
T Consensus 370 ~~l~~~~LG~G~fG~Vy~~~~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~-~~~~ 445 (635)
T 4fl3_A 370 LTLEDKELGSGNFGTVKKGYYQMKK-VVKTVAVKILKNEA-NDPALKDELLAEANVMQQLD-NPYIVRMIGICEA-ESWM 445 (635)
T ss_dssp EEEEEEEEEECSSEEEEEEEEECSS-CEEEEEEEEECGGG-GCGGGHHHHHHHHHHHHHCC-CTTBCCEEEEEES-SSEE
T ss_pred ccccCCEeccCCCEEEEEEEEcCCC-cceEEEEEEecccc-CCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEec-CCEE
Confidence 444 358999999999999765322 47899999986542 33445678999999999998 9999999999964 5689
Q ss_pred EEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccccCC
Q 014210 236 VVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP 315 (429)
Q Consensus 236 lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~ 315 (429)
||||||++|+|.+++. ....+++..++.|+.||+.||+|||++|||||||||+|||| +.++.+||+|||+++....
T Consensus 446 lv~E~~~~g~L~~~l~-~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl---~~~~~~kL~DFGla~~~~~ 521 (635)
T 4fl3_A 446 LVMEMAELGPLNKYLQ-QNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLL---VTQHYAKISDFGLSKALRA 521 (635)
T ss_dssp EEEECCTTEEHHHHHH-HCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---EETTEEEECCTTHHHHTTC
T ss_pred EEEEccCCCCHHHHHh-hCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEE---eCCCCEEEEEcCCcccccc
Confidence 9999999999999885 45679999999999999999999999999999999999999 5677899999999987654
Q ss_pred Ccc----ccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCC
Q 014210 316 DER----LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLS 389 (429)
Q Consensus 316 ~~~----~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 389 (429)
+.. .....+|..|+|||++. ..++.++|||||||++|||++ |+.||......+....+....... ....++
T Consensus 522 ~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~---~p~~~~ 598 (635)
T 4fl3_A 522 DENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMG---CPAGCP 598 (635)
T ss_dssp -------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC---CCTTCC
T ss_pred CccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC---CCCCCC
Confidence 332 22345678899999887 479999999999999999998 999999998888877776654222 224689
Q ss_pred HHHHHHHHHhcccCccCcCCHHHHHhhHh
Q 014210 390 SEARDFVKRLLNKDPRKRLTAAQALSELL 418 (429)
Q Consensus 390 ~~~~~li~~~L~~dP~~Rps~~~iL~~~~ 418 (429)
.++.+||+.||+.||++||++.++++.+-
T Consensus 599 ~~l~~li~~cl~~dP~~RPs~~~l~~~L~ 627 (635)
T 4fl3_A 599 REMYDLMNLCWTYDVENRPGFAAVELRLR 627 (635)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHHHHH
T ss_pred HHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence 99999999999999999999999987653
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=366.84 Aligned_cols=258 Identities=29% Similarity=0.423 Sum_probs=198.7
Q ss_pred ccccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEe
Q 014210 151 KHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED 230 (429)
Q Consensus 151 ~~~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~ 230 (429)
+.+.+.|.+.++||+|+||+||.+... +|+.||||++... ..+.+.+|+.+++++.+|||||++++++.+
T Consensus 11 ~~l~~~~~~~~~LG~G~~g~V~~~~~~----~g~~vAvK~~~~~------~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~ 80 (434)
T 2rio_A 11 QSLKNLVVSEKILGYGSSGTVVFQGSF----QGRPVAVKRMLID------FCDIALMEIKLLTESDDHPNVIRYYCSETT 80 (434)
T ss_dssp CSCSSCEEEEEEEEECSTTCEEEEEES----SSSEEEEEEEEGG------GHHHHHHHHHHHHHHTTSTTBCCEEEEEEC
T ss_pred hhhhheeeccCeEeeCCCeEEEEEEEE----CCeEEEEEEEcHH------HHHHHHHHHHHHHhccCCCCcCeEEEEEec
Confidence 445677888999999999999865432 5899999998532 234578999999988569999999999999
Q ss_pred CCeEEEEEEecCCCcHHHHHHhcCCC------CCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeec--------
Q 014210 231 TDNVYVVMELCEGGELLDRILSRGGK------YTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTK-------- 296 (429)
Q Consensus 231 ~~~~~lv~E~~~ggsL~~~i~~~~~~------l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~-------- 296 (429)
++..|||||||. |+|.+++...... ..+..++.++.||+.||+|||++||+||||||+|||++..
T Consensus 81 ~~~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~ 159 (434)
T 2rio_A 81 DRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQ 159 (434)
T ss_dssp SSEEEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCT
T ss_pred CCeEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccc
Confidence 999999999996 5999988654321 1334567899999999999999999999999999999643
Q ss_pred --CCCceEEEeecCCccccCCCcc-----ccccccCCcccCccccc--------CCCCCcccHHHHHHHHHHHHc-CCCC
Q 014210 297 --DENSVLKAIDFGLSDFVRPDER-----LNDIVGSAYYVAPEVLH--------RSYSTEADVWSIGVIAYILLC-GSRP 360 (429)
Q Consensus 297 --~~~~~vkL~DFGla~~~~~~~~-----~~~~~gt~~y~aPE~~~--------~~~~~~sDiwSlGvll~ellt-g~~P 360 (429)
+.+..+||+|||+++....... .....||+.|+|||++. +.++.++|||||||++|||++ |+.|
T Consensus 160 ~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~P 239 (434)
T 2rio_A 160 TGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHP 239 (434)
T ss_dssp TCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCT
T ss_pred cCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCC
Confidence 2456899999999987754332 23467999999999885 357889999999999999999 9999
Q ss_pred CCCCChHHHHHHHHhcCCCCCCCC---CCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhc
Q 014210 361 FWARTESGIFRAVLKADPSFDEAP---WPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLICY 421 (429)
Q Consensus 361 f~~~~~~~~~~~i~~~~~~~~~~~---~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~ 421 (429)
|....... ..++.......... ...++.++.+||.+||+.||++||++.++++|+||..
T Consensus 240 f~~~~~~~--~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~ 301 (434)
T 2rio_A 240 FGDKYSRE--SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP 301 (434)
T ss_dssp TCSTTTHH--HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred CCCchhhH--HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence 97654433 33444433322211 1234688999999999999999999999999999964
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-44 Score=347.80 Aligned_cols=245 Identities=31% Similarity=0.484 Sum_probs=195.9
Q ss_pred cCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~ 233 (429)
.++|++.+.||+|+||.||+++.. ++.||||++.. ....+.+.+|++++++++ ||||+++++++. +.
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~~-----~~~vavK~~~~-----~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~--~~ 73 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKWR-----AKDVAIKQIES-----ESERKAFIVELRQLSRVN-HPNIVKLYGACL--NP 73 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEET-----TEEEEEEECSS-----TTHHHHHHHHHHHHHHCC-CTTBCCEEEBCT--TT
T ss_pred HhHeeeeeEeecCCCceEEEEEEC-----CeeEEEEEecC-----hhHHHHHHHHHHHHhcCC-CCCcCeEEEEEc--CC
Confidence 468999999999999999999743 68899999853 234567899999999998 999999999886 44
Q ss_pred EEEEEEecCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHH---cCceeccCCCCcEEEeecCCCc-eEEEeec
Q 014210 234 VYVVMELCEGGELLDRILSRGG--KYTEDDAKAVMIQILNVVAFCHL---QGVVHRDLKPENFLFTTKDENS-VLKAIDF 307 (429)
Q Consensus 234 ~~lv~E~~~ggsL~~~i~~~~~--~l~~~~~~~i~~qi~~gL~~LH~---~~iiHrDIKp~NILl~~~~~~~-~vkL~DF 307 (429)
.++||||+++++|.+++..... .+++..++.++.||++||.|||+ +||+||||||+|||++ .++ .+||+||
T Consensus 74 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~---~~~~~~kl~Df 150 (307)
T 2eva_A 74 VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLV---AGGTVLKICDF 150 (307)
T ss_dssp TEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEE---TTTTEEEECCC
T ss_pred cEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEe---CCCCEEEEccc
Confidence 7999999999999998865433 47899999999999999999999 8999999999999994 444 5899999
Q ss_pred CCccccCCCccccccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHcCCCCCCCCChH--HHHHHHHhcCCCCCCCC
Q 014210 308 GLSDFVRPDERLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTES--GIFRAVLKADPSFDEAP 384 (429)
Q Consensus 308 Gla~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~elltg~~Pf~~~~~~--~~~~~i~~~~~~~~~~~ 384 (429)
|++...... .....||..|+|||++.+ .++.++||||||+++|||++|+.||...... .....+..... ...
T Consensus 151 g~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~ 225 (307)
T 2eva_A 151 GTACDIQTH--MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTR---PPL 225 (307)
T ss_dssp CC--------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCC---CCC
T ss_pred ccccccccc--cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCC---CCc
Confidence 999765422 234579999999998875 6899999999999999999999999754332 23333333221 122
Q ss_pred CCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhh
Q 014210 385 WPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLI 419 (429)
Q Consensus 385 ~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~ 419 (429)
...++.++.+||.+||+.||++||++.++++++--
T Consensus 226 ~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~ 260 (307)
T 2eva_A 226 IKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTH 260 (307)
T ss_dssp BTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHH
Confidence 34689999999999999999999999999987643
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=345.37 Aligned_cols=246 Identities=25% Similarity=0.393 Sum_probs=201.8
Q ss_pred cCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeC-C
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT-D 232 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~-~ 232 (429)
.++|++.+.||+|+||.||+++. .|+.||||++.... ..+.+.+|+.++++++ |+||+++++++.+. +
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~-----~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~ 88 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDY-----RGNKVAVKCIKNDA-----TAQAFLAEASVMTQLR-HSNLVQLLGVIVEEKG 88 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE-----TTEEEEEEECCCCC-------HHHHHTHHHHTTCC-CTTBCCEEEEECCC--
T ss_pred hhhceEEeEEecCCCceEEEEEE-----cCCEEEEEEecchh-----HHHHHHHHHHHHHhCC-CCCEeeEEEEEEcCCC
Confidence 57899999999999999999974 37899999986432 3467889999999998 99999999997654 4
Q ss_pred eEEEEEEecCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCcc
Q 014210 233 NVYVVMELCEGGELLDRILSRGG-KYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (429)
Q Consensus 233 ~~~lv~E~~~ggsL~~~i~~~~~-~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~ 311 (429)
..++||||+++++|.+++..... .+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~~l~Dfg~~~ 165 (278)
T 1byg_A 89 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLV---SEDNVAKVSDFGLTK 165 (278)
T ss_dssp CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CTTSCEEECCCCC--
T ss_pred ceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEE---eCCCcEEEeeccccc
Confidence 78999999999999998865533 38999999999999999999999999999999999999 778899999999987
Q ss_pred ccCCCccccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCC
Q 014210 312 FVRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLS 389 (429)
Q Consensus 312 ~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 389 (429)
..... .....++..|+|||++. +.++.++||||||+++|+|++ |+.||...........+..... ......++
T Consensus 166 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~ 240 (278)
T 1byg_A 166 EASST--QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK---MDAPDGCP 240 (278)
T ss_dssp ------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCC---CCCCTTCC
T ss_pred ccccc--ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC---CCCcccCC
Confidence 65432 23346788999999886 568999999999999999998 9999988877766666544322 22234789
Q ss_pred HHHHHHHHHhcccCccCcCCHHHHHhhHh
Q 014210 390 SEARDFVKRLLNKDPRKRLTAAQALSELL 418 (429)
Q Consensus 390 ~~~~~li~~~L~~dP~~Rps~~~iL~~~~ 418 (429)
+++.+||++||+.||++||++.++++.+-
T Consensus 241 ~~l~~li~~~l~~~p~~Rps~~~l~~~L~ 269 (278)
T 1byg_A 241 PAVYEVMKNCWHLDAAMRPSFLQLREQLE 269 (278)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHHHHHHhcCChhhCCCHHHHHHHHH
Confidence 99999999999999999999999988654
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=350.24 Aligned_cols=253 Identities=24% Similarity=0.312 Sum_probs=205.8
Q ss_pred eeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCc-CcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEE
Q 014210 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKM-TTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVY 235 (429)
Q Consensus 157 y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~-~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~~ 235 (429)
|...+.||+|+||.||+|.. .++.||||++..... ......+.+.+|+.++++++ ||||+++++++.+.+..+
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~ 106 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYV-----NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQ-HENLVELLGFSSDGDDLC 106 (307)
T ss_dssp TTTCCEEEECSSEEEEEEES-----SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCC-CTTBCCEEEEECSSSSCE
T ss_pred cccCCccccCCCeEEEEEEE-----CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcC-CCCeEEEEEEEecCCceE
Confidence 33458999999999999974 378999999865432 33455678999999999998 999999999999999999
Q ss_pred EEEEecCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCcccc
Q 014210 236 VVMELCEGGELLDRILSR--GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (429)
Q Consensus 236 lv~E~~~ggsL~~~i~~~--~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~ 313 (429)
+||||+++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++...
T Consensus 107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili---~~~~~~kl~Dfg~~~~~ 183 (307)
T 2nru_A 107 LVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILL---DEAFTAKISDFGLARAS 183 (307)
T ss_dssp EEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---CTTCCEEECCCTTCEEC
T ss_pred EEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEE---cCCCcEEEeeccccccc
Confidence 999999999999988643 3469999999999999999999999999999999999999 78889999999998765
Q ss_pred CCCc---cccccccCCcccCcccccCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHH----HHHHHHhcCCCC------
Q 014210 314 RPDE---RLNDIVGSAYYVAPEVLHRSYSTEADVWSIGVIAYILLCGSRPFWARTESG----IFRAVLKADPSF------ 380 (429)
Q Consensus 314 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~----~~~~i~~~~~~~------ 380 (429)
.... ......||..|+|||++.+.++.++||||||+++|+|++|+.||....... +...+.......
T Consensus 184 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (307)
T 2nru_A 184 EKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDK 263 (307)
T ss_dssp CSCSSCEECSSCCSCGGGCCHHHHTTEECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCS
T ss_pred ccccccccccccCCCcCcCChHHhcCCCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhccc
Confidence 4322 233467999999999998889999999999999999999999997654322 222222111110
Q ss_pred -CCCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHh
Q 014210 381 -DEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELL 418 (429)
Q Consensus 381 -~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~ 418 (429)
.......++.++.+||.+||+.||.+||++.++++++-
T Consensus 264 ~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~ 302 (307)
T 2nru_A 264 KMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQ 302 (307)
T ss_dssp SCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHH
T ss_pred cccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence 01111234577899999999999999999999998864
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=359.69 Aligned_cols=253 Identities=18% Similarity=0.223 Sum_probs=199.7
Q ss_pred cccCceeEeceeeccCceEEEEEEEec--CcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcC--CCCcceEEEE
Q 014210 152 HFANKYELGEEVGRGHFGYTCAAKFKK--GELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTG--HNNLVKFFDA 227 (429)
Q Consensus 152 ~~~~~y~~~~~IG~G~fg~V~~~~~~~--~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~--h~nIv~l~~~ 227 (429)
...++|++.++||+|+||.||+|.... ....++.||||++.... ..++.+|++++++++. |+||++++++
T Consensus 62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~------~~~~~~e~~~~~~l~~~~~~~iv~~~~~ 135 (365)
T 3e7e_A 62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN------PWEFYIGTQLMERLKPSMQHMFMKFYSA 135 (365)
T ss_dssp CSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC------HHHHHHHHHHHHHSCGGGGGGBCCEEEE
T ss_pred ECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC------hhHHHHHHHHHHHhhhhhhhhhhhhhee
Confidence 446889999999999999999995432 12368999999986431 2457788888888763 8999999999
Q ss_pred EEeCCeEEEEEEecCCCcHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEee--------
Q 014210 228 YEDTDNVYVVMELCEGGELLDRILS----RGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTT-------- 295 (429)
Q Consensus 228 ~~~~~~~~lv~E~~~ggsL~~~i~~----~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~-------- 295 (429)
+...+..+||||||++|+|.+++.. ....+++..++.|+.||+.||+|||++|||||||||+|||++.
T Consensus 136 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~ 215 (365)
T 3e7e_A 136 HLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDE 215 (365)
T ss_dssp EECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC---
T ss_pred eecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCcccc
Confidence 9999999999999999999999875 3457999999999999999999999999999999999999943
Q ss_pred cCCCceEEEeecCCccccC---CCccccccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHH
Q 014210 296 KDENSVLKAIDFGLSDFVR---PDERLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFR 371 (429)
Q Consensus 296 ~~~~~~vkL~DFGla~~~~---~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~ 371 (429)
.+.++.+||+|||+++... ........+||..|+|||++.+ .++.++|||||||++|||++|+.||.......
T Consensus 216 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~--- 292 (365)
T 3e7e_A 216 DDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE--- 292 (365)
T ss_dssp ---CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE---
T ss_pred ccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc---
Confidence 1227899999999996542 3344566789999999998875 58999999999999999999999996433210
Q ss_pred HHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHh
Q 014210 372 AVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELL 418 (429)
Q Consensus 372 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~ 418 (429)
......+... ..++.+.+++..||+.+|.+|++..+.|.+.+
T Consensus 293 --~~~~~~~~~~---~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l 334 (365)
T 3e7e_A 293 --CKPEGLFRRL---PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKL 334 (365)
T ss_dssp --EEECSCCTTC---SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHH
T ss_pred --eeechhcccc---CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHH
Confidence 0011111111 24678999999999999999976655555443
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-45 Score=359.11 Aligned_cols=252 Identities=15% Similarity=0.183 Sum_probs=203.2
Q ss_pred cCceeEeceeeccCceEEEEEEEecCcc-----cCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcce-----
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGEL-----KGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVK----- 223 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~~-----~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~----- 223 (429)
.++|++.+.||+|+||.||+|+...+.. .++.||||++... +.+.+|++++++++ |+||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--------~~~~~E~~~l~~l~-h~niv~~~~~~ 111 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--------GRLFNEQNFFQRAA-KPLQVNKWKKL 111 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--------STHHHHHHHHHHHC-CHHHHHHHHHH
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--------chHHHHHHHHHHhc-ccchhhhhhhh
Confidence 5799999999999999999999775311 3789999998643 35789999999998 999887
Q ss_pred ----------EEEEEEe-CCeEEEEEEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcE
Q 014210 224 ----------FFDAYED-TDNVYVVMELCEGGELLDRILSR-GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENF 291 (429)
Q Consensus 224 ----------l~~~~~~-~~~~~lv~E~~~ggsL~~~i~~~-~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NI 291 (429)
+++++.. ++..+|||||+ +++|.+++... ...+++..++.++.||+.||.|||++||+||||||+||
T Consensus 112 ~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NI 190 (352)
T 2jii_A 112 YSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENI 190 (352)
T ss_dssp TTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGE
T ss_pred ccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHE
Confidence 6788876 77899999999 99999998754 46799999999999999999999999999999999999
Q ss_pred EEeecCCCc--eEEEeecCCccccCCCcc--------ccccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHcCCCC
Q 014210 292 LFTTKDENS--VLKAIDFGLSDFVRPDER--------LNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRP 360 (429)
Q Consensus 292 Ll~~~~~~~--~vkL~DFGla~~~~~~~~--------~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~elltg~~P 360 (429)
|+ +.++ .+||+|||+++....... .....||+.|+|||++.+ .++.++||||||+++|||++|+.|
T Consensus 191 l~---~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p 267 (352)
T 2jii_A 191 FV---DPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLP 267 (352)
T ss_dssp EE---ETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCT
T ss_pred EE---cCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 99 5566 899999999977653321 234579999999998875 689999999999999999999999
Q ss_pred CCCCC--hHHHHHHHH---hcCCCCC--CCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHh
Q 014210 361 FWART--ESGIFRAVL---KADPSFD--EAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELL 418 (429)
Q Consensus 361 f~~~~--~~~~~~~i~---~~~~~~~--~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~ 418 (429)
|.... ......... .....+. ...+..++.++.+||++||..||++||++.++++.+.
T Consensus 268 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~ 332 (352)
T 2jii_A 268 WTNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLE 332 (352)
T ss_dssp TGGGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHH
T ss_pred cccCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHH
Confidence 97653 222322222 2222111 1122357999999999999999999999999988654
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=378.37 Aligned_cols=257 Identities=23% Similarity=0.368 Sum_probs=217.5
Q ss_pred cccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeC
Q 014210 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (429)
Q Consensus 152 ~~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~ 231 (429)
...++|++.+.||+|+||.||+|........+..||||++... ......+.+.+|+.++++++ ||||+++++++. +
T Consensus 387 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~-~ 462 (656)
T 2j0j_A 387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC--TSDSVREKFLQEALTMRQFD-HPHIVKLIGVIT-E 462 (656)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSST--TCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEC-S
T ss_pred cccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEeccc--CCHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEe-c
Confidence 3457899999999999999999998765545788999998643 34556678999999999998 999999999985 4
Q ss_pred CeEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCcc
Q 014210 232 DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (429)
Q Consensus 232 ~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~ 311 (429)
+..+|||||+++|+|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++
T Consensus 463 ~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl---~~~~~vkL~DFG~a~ 539 (656)
T 2j0j_A 463 NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLV---SSNDCVKLGDFGLSR 539 (656)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---EETTEEEECCCCCCC
T ss_pred CceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEE---eCCCCEEEEecCCCe
Confidence 66899999999999999998777789999999999999999999999999999999999999 567889999999998
Q ss_pred ccCCCcc--ccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCC
Q 014210 312 FVRPDER--LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPS 387 (429)
Q Consensus 312 ~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 387 (429)
....... .....+|..|+|||++. +.++.++||||||+++|||++ |..||......+.+..+....... ..+.
T Consensus 540 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~---~~~~ 616 (656)
T 2j0j_A 540 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLP---MPPN 616 (656)
T ss_dssp SCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCCC---CCTT
T ss_pred ecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCC---CCcc
Confidence 7654332 22345778999999886 568999999999999999997 999999888888877776654322 2246
Q ss_pred CCHHHHHHHHHhcccCccCcCCHHHHHhhHh
Q 014210 388 LSSEARDFVKRLLNKDPRKRLTAAQALSELL 418 (429)
Q Consensus 388 ~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~ 418 (429)
+++++.+||.+||..||++||++.++++.+-
T Consensus 617 ~~~~l~~li~~~l~~dP~~RPs~~el~~~L~ 647 (656)
T 2j0j_A 617 CPPTLYSLMTKCWAYDPSRRPRFTELKAQLS 647 (656)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred ccHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 8999999999999999999999999988754
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-44 Score=344.42 Aligned_cols=240 Identities=31% Similarity=0.585 Sum_probs=192.8
Q ss_pred ccCceeEe-ceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEe-
Q 014210 153 FANKYELG-EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED- 230 (429)
Q Consensus 153 ~~~~y~~~-~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~- 230 (429)
+.++|.+. +.||+|+||.||++.... +|+.||||++... ..+.+|+.++.++.+|+||+++++++.+
T Consensus 15 ~~~~y~~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~ 83 (299)
T 3m2w_A 15 IIDDYKVTSQVLGLGINGKVLQIFNKR---TQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENL 83 (299)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEE
T ss_pred cccchhhcCcccccCCCeEEEEEEEcC---CCcEEEEEEeccc--------HHHHHHHHHHHHhccCCCchhHHhhhhhh
Confidence 45677777 789999999999998765 5899999998532 3567899998666669999999999987
Q ss_pred ---CCeEEEEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEee
Q 014210 231 ---TDNVYVVMELCEGGELLDRILSRG-GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAID 306 (429)
Q Consensus 231 ---~~~~~lv~E~~~ggsL~~~i~~~~-~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~D 306 (429)
.+..+|||||+++|+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++..+.++.+||+|
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~D 163 (299)
T 3m2w_A 84 YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTD 163 (299)
T ss_dssp ETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECC
T ss_pred cCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEec
Confidence 677999999999999999987654 3699999999999999999999999999999999999996444478999999
Q ss_pred cCCccccCCCccccccccCCcccCcccccCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHh----cCCCCCC
Q 014210 307 FGLSDFVRPDERLNDIVGSAYYVAPEVLHRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLK----ADPSFDE 382 (429)
Q Consensus 307 FGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~----~~~~~~~ 382 (429)
||++..... ..++.++|||||||++|||++|+.||...........+.. ....++.
T Consensus 164 fg~a~~~~~--------------------~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (299)
T 3m2w_A 164 FGFAKETTG--------------------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPN 223 (299)
T ss_dssp CTTCEECTT--------------------CGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSCH
T ss_pred ccccccccc--------------------ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCCc
Confidence 999865431 3467789999999999999999999976554332211111 1111111
Q ss_pred CCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhccc
Q 014210 383 APWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLICYQS 423 (429)
Q Consensus 383 ~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~~ 423 (429)
..+..++.++.+||.+||+.||++||++.++|+|+||....
T Consensus 224 ~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~ 264 (299)
T 3m2w_A 224 PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 264 (299)
T ss_dssp HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGG
T ss_pred hhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccc
Confidence 11246899999999999999999999999999999997654
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=346.86 Aligned_cols=257 Identities=23% Similarity=0.333 Sum_probs=208.8
Q ss_pred ccCceeEeceeeccCceEEEEEEEec-CcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeC
Q 014210 153 FANKYELGEEVGRGHFGYTCAAKFKK-GELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (429)
Q Consensus 153 ~~~~y~~~~~IG~G~fg~V~~~~~~~-~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~ 231 (429)
..++|+++++||+|+||.||+++... ...+|+.||||++... .....+.+.+|++++++++ |+||+++++++...
T Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~ 114 (326)
T 2w1i_A 39 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQ-HDNIVKYKGVCYSA 114 (326)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC---CSHHHHHHHHHHHHHHTCC-CTTBCCEEEEECC-
T ss_pred CHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC---CHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEEec
Confidence 35789999999999999999998532 2236899999998653 3455678999999999998 99999999998765
Q ss_pred C--eEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCC
Q 014210 232 D--NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGL 309 (429)
Q Consensus 232 ~--~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGl 309 (429)
+ ..++||||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+
T Consensus 115 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli---~~~~~~kL~Dfg~ 191 (326)
T 2w1i_A 115 GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILV---ENENRVKIGDFGL 191 (326)
T ss_dssp ---CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---EETTEEEECCCTT
T ss_pred CCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEE---cCCCcEEEecCcc
Confidence 4 7899999999999999998777789999999999999999999999999999999999999 5677899999999
Q ss_pred ccccCCCcc----ccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHcCCCCCCCCChH------------H---H
Q 014210 310 SDFVRPDER----LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTES------------G---I 369 (429)
Q Consensus 310 a~~~~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~elltg~~Pf~~~~~~------------~---~ 369 (429)
+........ .....++..|+|||++. ..++.++||||||+++|||++|..||...... . .
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (326)
T 2w1i_A 192 TKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 271 (326)
T ss_dssp CEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHH
T ss_pred hhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHH
Confidence 987654432 22345778899999886 45888999999999999999999998532110 0 1
Q ss_pred HHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHh
Q 014210 370 FRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELL 418 (429)
Q Consensus 370 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~ 418 (429)
+...+...... .....++.++.+||++||+.||++||++.++++.+-
T Consensus 272 ~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~ 318 (326)
T 2w1i_A 272 LIELLKNNGRL--PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVD 318 (326)
T ss_dssp HHHHHHTTCCC--CCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred HHHHhhcCCCC--CCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 11222222222 123468999999999999999999999999998653
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-45 Score=353.20 Aligned_cols=252 Identities=23% Similarity=0.391 Sum_probs=208.3
Q ss_pred ccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCC
Q 014210 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (429)
Q Consensus 153 ~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~ 232 (429)
..++|++.+.||+|+||.||+|+... .||||++..... .....+.+.+|+.++++++ |+||+++++++.+.+
T Consensus 31 ~~~~~~~~~~lg~G~~g~V~~~~~~~------~~avk~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~ 102 (319)
T 2y4i_B 31 PFEQLEIGELIGKGRFGQVYHGRWHG------EVAIRLIDIERD-NEDQLKAFKREVMAYRQTR-HENVVLFMGACMSPP 102 (319)
T ss_dssp CCSCEECCCBCCCSSSSEEEEEEESS------SEEEEECCCCSC-CCCCCCCCCTTGGGGTTCC-CTTBCCCCEEEECSS
T ss_pred CHHHeEEeeEeccCCceEEEEEEEcC------eEEEEEeecCCC-CHHHHHHHHHHHHHHhcCC-CCCEeEEEEEEecCC
Confidence 35789999999999999999997543 499999875432 2223355778999999998 999999999999999
Q ss_pred eEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccc
Q 014210 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (429)
Q Consensus 233 ~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~ 312 (429)
..++||||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ + ++.+||+|||++..
T Consensus 103 ~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~---~-~~~~~l~Dfg~~~~ 178 (319)
T 2y4i_B 103 HLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFY---D-NGKVVITDFGLFSI 178 (319)
T ss_dssp CEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEE---C---CCEECCCSCCC-
T ss_pred ceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEE---e-CCCEEEeecCCccc
Confidence 9999999999999999886666679999999999999999999999999999999999999 4 56899999999875
Q ss_pred cCC------CccccccccCCcccCcccccC----------CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhc
Q 014210 313 VRP------DERLNDIVGSAYYVAPEVLHR----------SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKA 376 (429)
Q Consensus 313 ~~~------~~~~~~~~gt~~y~aPE~~~~----------~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~ 376 (429)
... ........||..|+|||++.+ .++.++||||||+++|||++|+.||...........+...
T Consensus 179 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~ 258 (319)
T 2y4i_B 179 SGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTG 258 (319)
T ss_dssp ---------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTT
T ss_pred cccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccC
Confidence 432 122334568999999998753 3688999999999999999999999988887777666554
Q ss_pred CCCCCCCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHh
Q 014210 377 DPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELL 418 (429)
Q Consensus 377 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~ 418 (429)
.... .....++.++.+||.+||..||++||++.++++.+-
T Consensus 259 ~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~ 298 (319)
T 2y4i_B 259 MKPN--LSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLE 298 (319)
T ss_dssp CCCC--CCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHT
T ss_pred CCCC--CCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHH
Confidence 3222 222357889999999999999999999999998654
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=346.28 Aligned_cols=254 Identities=24% Similarity=0.365 Sum_probs=197.1
Q ss_pred cccccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhc-CCCCcceEEEEE
Q 014210 150 SKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALT-GHNNLVKFFDAY 228 (429)
Q Consensus 150 ~~~~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~-~h~nIv~l~~~~ 228 (429)
.+.+.++|++.++||+|+||.||+|+.. |+.||||++... ....+.+|.+++..+. .|+||+++++++
T Consensus 32 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~vavK~~~~~------~~~~~~~e~~~~~~~~~~h~~i~~~~~~~ 100 (337)
T 3mdy_A 32 QRTIAKQIQMVKQIGKGRYGEVWMGKWR-----GEKVAVKVFFTT------EEASWFRETEIYQTVLMRHENILGFIAAD 100 (337)
T ss_dssp HTTHHHHCEEEEEEEEETTEEEEEEEET-----TEEEEEEEEEGG------GHHHHHHHHHHHTSTTCCCTTBCCEEEEE
T ss_pred ccccccceEEEeEeecCCCeEEEEEEEC-----CceEEEEEEecc------ccchhhhHHHHHHHHhhcCCCeeeEEEEE
Confidence 3456789999999999999999999753 789999998432 1234455666665541 499999999999
Q ss_pred EeC----CeEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHc--------CceeccCCCCcEEEeec
Q 014210 229 EDT----DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQ--------GVVHRDLKPENFLFTTK 296 (429)
Q Consensus 229 ~~~----~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~--------~iiHrDIKp~NILl~~~ 296 (429)
.+. +..++||||+++|+|.+++.. ..+++..++.++.||+.||.|||++ ||+||||||+|||+
T Consensus 101 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill--- 175 (337)
T 3mdy_A 101 IKGTGSWTQLYLITDYHENGSLYDYLKS--TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILV--- 175 (337)
T ss_dssp EESCGGGCEEEEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEE---
T ss_pred ccCCCCCCceEEEEeccCCCcHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEE---
Confidence 887 789999999999999998854 3699999999999999999999999 99999999999999
Q ss_pred CCCceEEEeecCCccccCCCccc-----cccccCCcccCcccccCC-CCCc------ccHHHHHHHHHHHHcC-------
Q 014210 297 DENSVLKAIDFGLSDFVRPDERL-----NDIVGSAYYVAPEVLHRS-YSTE------ADVWSIGVIAYILLCG------- 357 (429)
Q Consensus 297 ~~~~~vkL~DFGla~~~~~~~~~-----~~~~gt~~y~aPE~~~~~-~~~~------sDiwSlGvll~elltg------- 357 (429)
+.++.+||+|||++......... ....||..|+|||++.+. .... +|||||||++|||++|
T Consensus 176 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~ 255 (337)
T 3mdy_A 176 KKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIV 255 (337)
T ss_dssp CTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBC
T ss_pred CCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccc
Confidence 77889999999999766433321 345799999999998753 3343 8999999999999999
Q ss_pred ---CCCCCCCC----hHHHHHHHHhcCCCCCCCC----CCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhh
Q 014210 358 ---SRPFWART----ESGIFRAVLKADPSFDEAP----WPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLI 419 (429)
Q Consensus 358 ---~~Pf~~~~----~~~~~~~i~~~~~~~~~~~----~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~ 419 (429)
+.||.... ....+.............+ ...+++++.+||++||+.||++||++.++++++--
T Consensus 256 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~ 328 (337)
T 3mdy_A 256 EEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAK 328 (337)
T ss_dssp CCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred ccccccHhhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHH
Confidence 77775432 1222333332221111111 11456789999999999999999999999998754
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-43 Score=343.18 Aligned_cols=253 Identities=24% Similarity=0.349 Sum_probs=203.2
Q ss_pred cccccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHH--hcCCCCcceEEEE
Q 014210 150 SKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRA--LTGHNNLVKFFDA 227 (429)
Q Consensus 150 ~~~~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~--l~~h~nIv~l~~~ 227 (429)
.+.+.++|++.+.||+|+||.||+++. +|+.||||++... ..+.+.+|++++.. ++ |+||++++++
T Consensus 37 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~-----~~~~vavK~~~~~------~~~~~~~e~~~~~~~~l~-h~ni~~~~~~ 104 (342)
T 1b6c_B 37 QRTIARTIVLQESIGKGRFGEVWRGKW-----RGEEVAVKIFSSR------EERSWFREAEIYQTVMLR-HENILGFIAA 104 (342)
T ss_dssp HHHHHHHCEEEEEEEEETTEEEEEEEE-----TTEEEEEEEECGG------GHHHHHHHHHHHHHSCCC-CTTBCCEEEE
T ss_pred cccccccEEEEeeecCCCCcEEEEEEE-----cCccEEEEEeCch------hHHHHHHHHHHHHHhhcC-CCcEEEEEee
Confidence 455678999999999999999999975 3789999998532 23567889999988 55 9999999999
Q ss_pred EEeCC----eEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--------HcCceeccCCCCcEEEee
Q 014210 228 YEDTD----NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCH--------LQGVVHRDLKPENFLFTT 295 (429)
Q Consensus 228 ~~~~~----~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH--------~~~iiHrDIKp~NILl~~ 295 (429)
+.+.+ ..++||||+++|+|.+++.. ..+++..++.++.||+.||.||| +.||+||||||+|||+
T Consensus 105 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll-- 180 (342)
T 1b6c_B 105 DNKDNGTWTQLWLVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV-- 180 (342)
T ss_dssp EECCCSSCCCEEEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEE--
T ss_pred ecccCCccceeEEEEeecCCCcHHHHHhc--cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEE--
Confidence 98876 79999999999999998854 46999999999999999999999 8999999999999999
Q ss_pred cCCCceEEEeecCCccccCCCc-----cccccccCCcccCcccccCCC-------CCcccHHHHHHHHHHHHcC------
Q 014210 296 KDENSVLKAIDFGLSDFVRPDE-----RLNDIVGSAYYVAPEVLHRSY-------STEADVWSIGVIAYILLCG------ 357 (429)
Q Consensus 296 ~~~~~~vkL~DFGla~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~-------~~~sDiwSlGvll~elltg------ 357 (429)
+.++.+||+|||++....... ......||..|+|||++.+.. +.++||||||+++|||++|
T Consensus 181 -~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~ 259 (342)
T 1b6c_B 181 -KKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI 259 (342)
T ss_dssp -CTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTB
T ss_pred -CCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCc
Confidence 778899999999997765433 234567999999999987542 2579999999999999999
Q ss_pred ----CCCCCCCC-----hHHHHHHHHhcCCCCCCC-C--CCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhh
Q 014210 358 ----SRPFWART-----ESGIFRAVLKADPSFDEA-P--WPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLI 419 (429)
Q Consensus 358 ----~~Pf~~~~-----~~~~~~~i~~~~~~~~~~-~--~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~ 419 (429)
+.||.... .......+.......... . ...++..+.+||.+||+.||++||++.++++++.-
T Consensus 260 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~ 333 (342)
T 1b6c_B 260 HEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 333 (342)
T ss_dssp CCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHH
T ss_pred ccccccCccccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHH
Confidence 88986542 222333332221111100 0 01234678999999999999999999999998754
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-43 Score=342.42 Aligned_cols=248 Identities=23% Similarity=0.343 Sum_probs=188.1
Q ss_pred cCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHH--HHHhcCCCCcceEEEEEEe-
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKI--LRALTGHNNLVKFFDAYED- 230 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~i--l~~l~~h~nIv~l~~~~~~- 230 (429)
.++|+++++||+|+||.||+|+. +|+.||||++.... ...+..|.++ +..+. |+||+++++.+..
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-----~~~~vavK~~~~~~------~~~~~~e~~~~~~~~~~-h~~i~~~~~~~~~~ 79 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-----DERPVAVKVFSFAN------RQNFINEKNIYRVPLME-HDNIARFIVGDERV 79 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-----TTEEEEEEEEEGGG------HHHHHHHHHHHTSTTCC-CTTBCCEEEEEEEE
T ss_pred hHHhheeeecccCCCeEEEEEEE-----CCeEEEEEEeeccc------hhhHHHHHHHHHHHhcc-Ccchhhheeccccc
Confidence 47899999999999999999964 47899999985321 2334444444 44466 9999999986653
Q ss_pred ----CCeEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHc---------CceeccCCCCcEEEeecC
Q 014210 231 ----TDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQ---------GVVHRDLKPENFLFTTKD 297 (429)
Q Consensus 231 ----~~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~---------~iiHrDIKp~NILl~~~~ 297 (429)
....+||||||++|+|.+++... ..++..++.++.||+.||.|||+. ||+||||||+|||+ +
T Consensus 80 ~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill---~ 154 (336)
T 3g2f_A 80 TADGRMEYLLVMEYYPNGSLXKYLSLH--TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLV---K 154 (336)
T ss_dssp CTTSCEEEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEE---C
T ss_pred ccCCCceEEEEEecCCCCcHHHHHhhc--ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEE---c
Confidence 23578999999999999988543 458999999999999999999999 99999999999999 7
Q ss_pred CCceEEEeecCCccccCCCc---------cccccccCCcccCcccccC--------CCCCcccHHHHHHHHHHHHcCCCC
Q 014210 298 ENSVLKAIDFGLSDFVRPDE---------RLNDIVGSAYYVAPEVLHR--------SYSTEADVWSIGVIAYILLCGSRP 360 (429)
Q Consensus 298 ~~~~vkL~DFGla~~~~~~~---------~~~~~~gt~~y~aPE~~~~--------~~~~~sDiwSlGvll~elltg~~P 360 (429)
.++.+||+|||+++...... ......||..|+|||++.+ .++.++|||||||++|||++|..|
T Consensus 155 ~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p 234 (336)
T 3g2f_A 155 NDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTD 234 (336)
T ss_dssp TTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGG
T ss_pred CCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCc
Confidence 78899999999997764322 2234579999999999875 355689999999999999999887
Q ss_pred CCCCCh-----------------HHHHHHHHhcC---CCCCCCC--CCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHh
Q 014210 361 FWARTE-----------------SGIFRAVLKAD---PSFDEAP--WPSLSSEARDFVKRLLNKDPRKRLTAAQALSELL 418 (429)
Q Consensus 361 f~~~~~-----------------~~~~~~i~~~~---~~~~~~~--~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~ 418 (429)
|..... ...+....... +.++... ...+++++.+||.+||+.||++|||+.++++.+-
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~ 314 (336)
T 3g2f_A 235 LFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMA 314 (336)
T ss_dssp GSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred CCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHH
Confidence 633211 11122222211 1111110 1124558999999999999999999999977654
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-43 Score=337.43 Aligned_cols=232 Identities=15% Similarity=0.076 Sum_probs=192.0
Q ss_pred cccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeC
Q 014210 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (429)
Q Consensus 152 ~~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~ 231 (429)
.+.++|++.+.||+|+||.||+|+... +|+.||||++...........+.+.+|+.++.++. |+||+++++++.++
T Consensus 28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-hp~iv~~~~~~~~~ 103 (286)
T 3uqc_A 28 IANGRYRLLIFHGGVPPLQFWQALDTA---LDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRID-KPGVARVLDVVHTR 103 (286)
T ss_dssp ETTTTEEEEEEEEBSTTCEEEEEEETT---TTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEEET
T ss_pred EecCcEEEEEEEcccCCeEEEEEEecC---CCceEEEEEECcccccCHHHHHHHHHHHHHHhcCC-CCCcceeeEEEEEC
Confidence 456889999999999999999998765 58999999998766666677788999999999998 99999999999999
Q ss_pred CeEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCcc
Q 014210 232 DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (429)
Q Consensus 232 ~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~ 311 (429)
+..||||||++|++|.+++. . + .....+..|+.||+.||.|||++||+||||||+|||+ +.++.+||+++|.
T Consensus 104 ~~~~lv~e~~~g~~L~~~l~-~-~-~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll---~~~g~~kl~~~~~-- 175 (286)
T 3uqc_A 104 AGGLVVAEWIRGGSLQEVAD-T-S-PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRV---SIDGDVVLAYPAT-- 175 (286)
T ss_dssp TEEEEEEECCCEEEHHHHHT-T-C-CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEE---ETTSCEEECSCCC--
T ss_pred CcEEEEEEecCCCCHHHHHh-c-C-CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEE---cCCCCEEEEeccc--
Confidence 99999999999999999873 2 2 4666789999999999999999999999999999999 6778899985543
Q ss_pred ccCCCccccccccCCcccCcccccCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHH---HHHhcCCCCCCCCCCCC
Q 014210 312 FVRPDERLNDIVGSAYYVAPEVLHRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFR---AVLKADPSFDEAPWPSL 388 (429)
Q Consensus 312 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~---~i~~~~~~~~~~~~~~~ 388 (429)
++ .++.++|||||||++|||++|+.||........+. ..............+.+
T Consensus 176 -----------------~~------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T 3uqc_A 176 -----------------MP------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDI 232 (286)
T ss_dssp -----------------CT------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTS
T ss_pred -----------------cC------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCC
Confidence 33 36789999999999999999999998765432110 11111111111223568
Q ss_pred CHHHHHHHHHhcccCccCcCCHHHHHhhHhh
Q 014210 389 SSEARDFVKRLLNKDPRKRLTAAQALSELLI 419 (429)
Q Consensus 389 s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~ 419 (429)
++++.+||.+||+.||++| |+.++++.+.-
T Consensus 233 ~~~l~~li~~~l~~dP~~R-s~~el~~~L~~ 262 (286)
T 3uqc_A 233 PFQISAVAARSVQGDGGIR-SASTLLNLMQQ 262 (286)
T ss_dssp CHHHHHHHHHHHCTTSSCC-CHHHHHHHHHH
T ss_pred CHHHHHHHHHHcccCCccC-CHHHHHHHHHH
Confidence 9999999999999999999 99999987654
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-44 Score=379.04 Aligned_cols=262 Identities=26% Similarity=0.429 Sum_probs=210.6
Q ss_pred cCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEe---
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED--- 230 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~--- 230 (429)
.++|++.++||+|+||.||+|.... +|+.||||++... ......+.+.+|++++++++ ||||+++++++..
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~---tg~~VAVKvi~~~--~~~~~~~~~~~Ei~iL~~L~-HpnIV~l~~v~~~~~~ 86 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQD---TGEQVAIKQCRQE--LSPKNRERWCLEIQIMKKLN-HPNVVSAREVPDGLQK 86 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTT---TTCCEEECCCCSC--CCHHHHHHHHHHHHHHHHCC-BTTBCCEEECCTTTCC
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECC---CCcEEEEEEeccc--CCHHHHHHHHHHHHHHHhCC-CCCCCceeeeeccccc
Confidence 4789999999999999999998665 5899999998654 35566788999999999998 9999999999765
Q ss_pred ---CCeEEEEEEecCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEe
Q 014210 231 ---TDNVYVVMELCEGGELLDRILSRGG--KYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAI 305 (429)
Q Consensus 231 ---~~~~~lv~E~~~ggsL~~~i~~~~~--~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~ 305 (429)
++..+||||||+||+|.+++..... .+++..++.++.||+.||.|||+.||+||||||+|||++.++....+||+
T Consensus 87 ~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~ 166 (676)
T 3qa8_A 87 LAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKII 166 (676)
T ss_dssp CCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEEC
T ss_pred ccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEc
Confidence 6778999999999999998865432 69999999999999999999999999999999999999765556679999
Q ss_pred ecCCccccCCCccccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHH---------HH--
Q 014210 306 DFGLSDFVRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFR---------AV-- 373 (429)
Q Consensus 306 DFGla~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~---------~i-- 373 (429)
|||++.............||..|+|||++. +.++.++||||||+++|+|++|+.||.......... .+
T Consensus 167 DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~ 246 (676)
T 3qa8_A 167 DLGYAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVV 246 (676)
T ss_dssp SCCCCCBTTSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCS
T ss_pred ccccccccccccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhh
Confidence 999998877666666778999999999887 568999999999999999999999997643321110 00
Q ss_pred ---HhcCCCC------CCCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhc
Q 014210 374 ---LKADPSF------DEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLICY 421 (429)
Q Consensus 374 ---~~~~~~~------~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~ 421 (429)
......+ +......+++++.+||++||..||++||++.+++.|+||..
T Consensus 247 ~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~ 303 (676)
T 3qa8_A 247 YDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQA 303 (676)
T ss_dssp CCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHH
T ss_pred hhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHH
Confidence 0001111 11112236789999999999999999999999999999864
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-44 Score=360.11 Aligned_cols=250 Identities=18% Similarity=0.200 Sum_probs=194.8
Q ss_pred cCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcc---------e-
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLV---------K- 223 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv---------~- 223 (429)
..+|.+.++||+|+||.||+|++.. +|+.||||++...........+.+.+|+.+++.+.++.|.. .
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~---~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~ 153 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQE---TGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFP 153 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCC
T ss_pred ceeEEEecccccCCCEEEEEEEecC---CCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccc
Confidence 3568899999999999999999776 58999999997554455555678999999999987223211 1
Q ss_pred -----------EEEEEEe-----CCeEEEEEEecCCCcHHHHHHh------cCCCCCHHHHHHHHHHHHHHHHHHHHcCc
Q 014210 224 -----------FFDAYED-----TDNVYVVMELCEGGELLDRILS------RGGKYTEDDAKAVMIQILNVVAFCHLQGV 281 (429)
Q Consensus 224 -----------l~~~~~~-----~~~~~lv~E~~~ggsL~~~i~~------~~~~l~~~~~~~i~~qi~~gL~~LH~~~i 281 (429)
++.++.. ....+++|+++ +++|.+++.. .+..+++..++.++.||++||+|||++||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i 232 (413)
T 3dzo_A 154 FDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGL 232 (413)
T ss_dssp CEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred hhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence 1111222 22467888877 6799888742 24458888999999999999999999999
Q ss_pred eeccCCCCcEEEeecCCCceEEEeecCCccccCCCccccccccCCcccCcccc----------cC-CCCCcccHHHHHHH
Q 014210 282 VHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVL----------HR-SYSTEADVWSIGVI 350 (429)
Q Consensus 282 iHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~gt~~y~aPE~~----------~~-~~~~~sDiwSlGvl 350 (429)
|||||||+|||| +.++.+||+|||+++..... ....+| +.|+|||++ .+ .++.++|||||||+
T Consensus 233 iHrDiKp~NILl---~~~~~~kL~DFG~a~~~~~~--~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvi 306 (413)
T 3dzo_A 233 VHTYLRPVDIVL---DQRGGVFLTGFEHLVRDGAS--AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLA 306 (413)
T ss_dssp ECSCCCGGGEEE---CTTCCEEECCGGGCEETTEE--ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHH
T ss_pred ccCCcccceEEE---ecCCeEEEEeccceeecCCc--cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHH
Confidence 999999999999 77888999999998765432 455678 999999988 32 37789999999999
Q ss_pred HHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhc
Q 014210 351 AYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLICY 421 (429)
Q Consensus 351 l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~ 421 (429)
+|||++|+.||...........++. .+..+++++.+||.+||+.||++||++.++++|+||+.
T Consensus 307 l~elltg~~Pf~~~~~~~~~~~~~~--------~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~ 369 (413)
T 3dzo_A 307 IYWIWCADLPNTDDAALGGSEWIFR--------SCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ 369 (413)
T ss_dssp HHHHHHSSCCCCTTGGGSCSGGGGS--------SCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred HHHHHHCCCCCCCcchhhhHHHHHh--------hcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHH
Confidence 9999999999987655433332222 22368899999999999999999999999999999975
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=345.75 Aligned_cols=251 Identities=18% Similarity=0.220 Sum_probs=197.3
Q ss_pred cCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcC-----cHHHHHHHHHHHHHHHHhc--------CCCC
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMT-----TAIAIEDVRREVKILRALT--------GHNN 220 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~-----~~~~~~~~~~Ei~il~~l~--------~h~n 220 (429)
.++|+++++||+|+||.||+|+. +|+.||||++...... .....+.+.+|+.++++|+ .|+|
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-----~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~n 93 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-----DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEG 93 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-----TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCC
T ss_pred cccchheeeecccCceEEEEEEe-----CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCc
Confidence 47899999999999999999985 3799999999765321 2334467889999999986 5888
Q ss_pred cceEEEEEE------------------------------eCCeEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHH
Q 014210 221 LVKFFDAYE------------------------------DTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQIL 270 (429)
Q Consensus 221 Iv~l~~~~~------------------------------~~~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~ 270 (429)
||++++.+. +.+..|||||||++|++++.+. .+.+++..++.++.||+
T Consensus 94 iv~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~--~~~~~~~~~~~i~~qi~ 171 (336)
T 2vuw_A 94 FIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMR--TKLSSLATAKSILHQLT 171 (336)
T ss_dssp BCCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGT--TTCCCHHHHHHHHHHHH
T ss_pred hhhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHH--hcCCCHHHHHHHHHHHH
Confidence 888888753 2678999999999998777763 36789999999999999
Q ss_pred HHHHHHH-HcCceeccCCCCcEEEeecC-----------------CCceEEEeecCCccccCCCccccccccCCcccCcc
Q 014210 271 NVVAFCH-LQGVVHRDLKPENFLFTTKD-----------------ENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPE 332 (429)
Q Consensus 271 ~gL~~LH-~~~iiHrDIKp~NILl~~~~-----------------~~~~vkL~DFGla~~~~~~~~~~~~~gt~~y~aPE 332 (429)
.||.||| ++||+||||||+|||++..+ ....+||+|||+++..... ..+||+.|+|||
T Consensus 172 ~aL~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~----~~~gt~~y~aPE 247 (336)
T 2vuw_A 172 ASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG----IVVFCDVSMDED 247 (336)
T ss_dssp HHHHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT----EEECCCCTTCSG
T ss_pred HHHHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC----cEEEeecccChh
Confidence 9999999 99999999999999996433 1238999999999876532 348999999999
Q ss_pred cccCCCCCcccHHHHHHH-HHHHHcCCCCCCCCCh-HHHHHHHHhcCCC---CCCCCCCCCCHHHHHHHHHhcccCccCc
Q 014210 333 VLHRSYSTEADVWSIGVI-AYILLCGSRPFWARTE-SGIFRAVLKADPS---FDEAPWPSLSSEARDFVKRLLNKDPRKR 407 (429)
Q Consensus 333 ~~~~~~~~~sDiwSlGvl-l~elltg~~Pf~~~~~-~~~~~~i~~~~~~---~~~~~~~~~s~~~~~li~~~L~~dP~~R 407 (429)
++.+..+.++||||||++ .+++++|..||..... ......+...... .....++.+++++.+||++||+.|
T Consensus 248 ~~~g~~~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d---- 323 (336)
T 2vuw_A 248 LFTGDGDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS---- 323 (336)
T ss_dssp GGCCCSSHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS----
T ss_pred hhcCCCccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC----
Confidence 998777889999998777 7788899999843211 1122333322111 111112347889999999999987
Q ss_pred CCHHHHH-hhHhhh
Q 014210 408 LTAAQAL-SELLIC 420 (429)
Q Consensus 408 ps~~~iL-~~~~~~ 420 (429)
|+.|+| +|+||+
T Consensus 324 -sa~e~l~~Hp~f~ 336 (336)
T 2vuw_A 324 -SATDLLCQHSLFK 336 (336)
T ss_dssp -SHHHHHHHCGGGC
T ss_pred -CHHHHHhcCCCcC
Confidence 999999 999985
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-43 Score=373.42 Aligned_cols=249 Identities=27% Similarity=0.397 Sum_probs=204.9
Q ss_pred cCccccccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEE
Q 014210 147 FGFSKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFD 226 (429)
Q Consensus 147 ~~~~~~~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~ 226 (429)
+..++.+.++|++.++||+|+||.||++.+... +|+.||||++... ......+.+.+|+.++++++ ||||+++++
T Consensus 72 ~~~g~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~--~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~ 146 (681)
T 2pzi_A 72 LNPGDIVAGQYEVKGCIAHGGLGWIYLALDRNV--NGRPVVLKGLVHS--GDAEAQAMAMAERQFLAEVV-HPSIVQIFN 146 (681)
T ss_dssp SCTTCEETTTEEEEEEEEEETTEEEEEEEEGGG--TTEEEEEEESCSS--CCHHHHHHHHHHHGGGGGCC-CTTBCCEEE
T ss_pred CCCCCEeCCceEEEEEEeeCCCeEEEEEEEcCC--CCcEEEEEEeCcc--CCHHHHHHHHHHHHHHHhcC-CCCcCeEee
Confidence 334566779999999999999999999987642 4789999998653 34556678899999999998 999999999
Q ss_pred EEEeCCe-----EEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCce
Q 014210 227 AYEDTDN-----VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSV 301 (429)
Q Consensus 227 ~~~~~~~-----~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~ 301 (429)
++.+.+. .|||||||+|++|.+++.. .+++..++.|+.||+.||.|||++|||||||||+|||++ .+ .
T Consensus 147 ~~~~~~~~~~~~~~lv~E~~~g~~L~~~~~~---~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~---~~-~ 219 (681)
T 2pzi_A 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ---KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLT---EE-Q 219 (681)
T ss_dssp EEEEECTTSCEEEEEEEECCCCEECC----C---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---SS-C
T ss_pred eEeecCCCCCceeEEEEEeCCCCcHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEe---CC-c
Confidence 9988765 7999999999999886532 799999999999999999999999999999999999994 33 7
Q ss_pred EEEeecCCccccCCCccccccccCCcccCcccccCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCC
Q 014210 302 LKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFD 381 (429)
Q Consensus 302 vkL~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~ 381 (429)
+||+|||+++..... ....||+.|+|||++.+.++.++|||||||++|+|++|..||........ + .
T Consensus 220 ~kl~DFG~a~~~~~~---~~~~gt~~y~aPE~~~~~~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~--------~--~ 286 (681)
T 2pzi_A 220 LKLIDLGAVSRINSF---GYLYGTPGFQAPEIVRTGPTVATDIYTVGRTLAALTLDLPTRNGRYVDGL--------P--E 286 (681)
T ss_dssp EEECCCTTCEETTCC---SCCCCCTTTSCTTHHHHCSCHHHHHHHHHHHHHHHHSCCCEETTEECSSC--------C--T
T ss_pred EEEEecccchhcccC---CccCCCccccCHHHHcCCCCCceehhhhHHHHHHHHhCCCCCcccccccc--------c--c
Confidence 999999999876543 45679999999999987778899999999999999999988864221100 0 0
Q ss_pred CCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhh
Q 014210 382 EAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLIC 420 (429)
Q Consensus 382 ~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~ 420 (429)
.......++++.+||.+||+.||++||+..+++.+.|+.
T Consensus 287 ~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 287 DDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp TCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred cccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence 001112467899999999999999999999999988875
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=318.11 Aligned_cols=190 Identities=18% Similarity=0.145 Sum_probs=135.5
Q ss_pred ceeeccCceEEEEEEEecCcccCeEEEEEEccCCCc-------CcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe
Q 014210 161 EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKM-------TTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (429)
Q Consensus 161 ~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~-------~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~ 233 (429)
..++.|++|.+..++.+- .|+.||||++.+... ......+++.+|+++|+++..|+||+++++++++++.
T Consensus 240 ~~~~~~~~~~h~~~rr~~---fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~ 316 (569)
T 4azs_A 240 NQPYAGAGLAHKRSRRYF---FGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQS 316 (569)
T ss_dssp CC-C--------CCEEEE---ECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSE
T ss_pred hccccCCccccccccccc---ccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCE
Confidence 345677777666555443 689999999976432 1244567799999999999779999999999999999
Q ss_pred EEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCcccc
Q 014210 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (429)
Q Consensus 234 ~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~ 313 (429)
.|||||||+|++|.++|. +++.+++. +|+.||+.||+|||++|||||||||+|||| +.++++||+|||+|+..
T Consensus 317 ~yLVMEyv~G~~L~d~i~-~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL---~~dg~vKL~DFGlAr~~ 389 (569)
T 4azs_A 317 GWLVMEKLPGRLLSDMLA-AGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMV---DARQHARLIDFGSIVTT 389 (569)
T ss_dssp EEEEEECCCSEEHHHHHH-TTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEE---CTTSCEEECCCTTEESC
T ss_pred EEEEEecCCCCcHHHHHH-hCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEE---CCCCCEEEeecccCeeC
Confidence 999999999999999885 44667764 589999999999999999999999999999 78889999999999876
Q ss_pred CCC-ccccccccCCcccCcccccCCCCCcccHHHHHHHHHHHHcCCCC
Q 014210 314 RPD-ERLNDIVGSAYYVAPEVLHRSYSTEADVWSIGVIAYILLCGSRP 360 (429)
Q Consensus 314 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~sDiwSlGvll~elltg~~P 360 (429)
..+ ......+||+.|||||++.+.+..++|+||+|+++++|.++..+
T Consensus 390 ~~~~~~~~t~vGTp~YmAPE~l~g~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 390 PQDCSWPTNLVQSFFVFVNELFAENKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp C---CCSHHHHHHHHHHHHHHC-----------------CCCCTTHHH
T ss_pred CCCCccccCceechhhccHHHhCCCCCCcccccccccchhhhccccch
Confidence 543 33456789999999999999888999999999998877665433
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=6.6e-30 Score=266.22 Aligned_cols=185 Identities=22% Similarity=0.249 Sum_probs=145.6
Q ss_pred eEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcH-----HHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCC
Q 014210 158 ELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTA-----IAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (429)
Q Consensus 158 ~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~-----~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~ 232 (429)
...++||+|+||.||++.. .++.+++|++........ ...+++.+|++++++++ |+||+++..++.+.+
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-----~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-h~nIv~~~~~~~~~~ 412 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-----LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVK-DFGIPAPYIFDVDLD 412 (540)
T ss_dssp ---------CCEEEEEEEC-----SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGG-GGTCCCCCEEEEETT
T ss_pred CCCCEEeeCCCEEEEEEEE-----CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcC-CCCcCceEEEEEeCC
Confidence 4567999999999999932 478899998755333222 22456899999999998 999996666666788
Q ss_pred eEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccc
Q 014210 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (429)
Q Consensus 233 ~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~ 312 (429)
..|||||||+|++|.+++.. +..++.||++||.|||++||+||||||+|||+ +. .+||+|||+++.
T Consensus 413 ~~~lVmE~~~ggsL~~~l~~---------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl---~~--~~kL~DFGla~~ 478 (540)
T 3en9_A 413 NKRIMMSYINGKLAKDVIED---------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIF---DK--DLYIIDFGLGKI 478 (540)
T ss_dssp TTEEEEECCCSEEHHHHSTT---------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEE---SS--SEEECCCTTCEE
T ss_pred ccEEEEECCCCCCHHHHHHH---------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEE---CC--eEEEEECccCEE
Confidence 88999999999999998743 67899999999999999999999999999999 44 899999999988
Q ss_pred cCCCcc--------ccccccCCcccCcccccC---CCCCcccHHHHHHHHHHHHcCCCCCC
Q 014210 313 VRPDER--------LNDIVGSAYYVAPEVLHR---SYSTEADVWSIGVIAYILLCGSRPFW 362 (429)
Q Consensus 313 ~~~~~~--------~~~~~gt~~y~aPE~~~~---~~~~~sDiwSlGvll~elltg~~Pf~ 362 (429)
...... ....+||+.|||||++.. .|+...|+|+..+-.++.+.++.+|.
T Consensus 479 ~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 479 SNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred CCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 765432 135689999999999874 57888899999999998888877763
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=5.2e-26 Score=217.80 Aligned_cols=160 Identities=27% Similarity=0.283 Sum_probs=122.4
Q ss_pred CceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcH---------------HHHHHHHHHHHHHHHhcCCC
Q 014210 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTA---------------IAIEDVRREVKILRALTGHN 219 (429)
Q Consensus 155 ~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~---------------~~~~~~~~Ei~il~~l~~h~ 219 (429)
..|++++.||+|+||.||+|+. . +|+.||||++........ .....+.+|+.+++++. |
T Consensus 90 ~~~~~~~~iG~G~~g~Vy~~~~-~---~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~-~- 163 (282)
T 1zar_A 90 KVDAIGKLMGEGKESAVFNCYS-E---KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ-G- 163 (282)
T ss_dssp SCSEEEEEEEECSSEEEEEEEE-T---TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT-T-
T ss_pred eEEEecCEeccCCCceEEEEEe-C---CCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc-C-
Confidence 4566779999999999999987 3 589999999864321110 24567899999999998 4
Q ss_pred CcceEEEEEEeCCeEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCC
Q 014210 220 NLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDEN 299 (429)
Q Consensus 220 nIv~l~~~~~~~~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~ 299 (429)
+++++++.. +..|+|||||+|++|.+ + .......++.||+.||.|||++||+||||||+|||+ + +
T Consensus 164 --~~v~~~~~~-~~~~lvmE~~~g~~L~~-l-------~~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl---~-~ 228 (282)
T 1zar_A 164 --LAVPKVYAW-EGNAVLMELIDAKELYR-V-------RVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLV---S-E 228 (282)
T ss_dssp --SSSCCEEEE-ETTEEEEECCCCEEGGG-C-------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEE---E-T
T ss_pred --CCcCeEEec-cceEEEEEecCCCcHHH-c-------chhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEE---E-C
Confidence 455554433 55699999999999987 3 123456799999999999999999999999999999 5 7
Q ss_pred ceEEEeecCCccccCCCccccccccCCcccCcccccC-----------CCCCcccHHHH
Q 014210 300 SVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHR-----------SYSTEADVWSI 347 (429)
Q Consensus 300 ~~vkL~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~sDiwSl 347 (429)
+.+||+|||++.. +..++|||++.+ .|+..+|+|.+
T Consensus 229 ~~vkl~DFG~a~~------------~~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~~ 275 (282)
T 1zar_A 229 EGIWIIDFPQSVE------------VGEEGWREILERDVRNIITYFSRTYRTEKDINSA 275 (282)
T ss_dssp TEEEECCCTTCEE------------TTSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHHH
T ss_pred CcEEEEECCCCeE------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCChHHH
Confidence 8899999999853 345788998742 34556666653
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=1.9e-22 Score=190.45 Aligned_cols=141 Identities=16% Similarity=0.151 Sum_probs=107.7
Q ss_pred ceeEeceeeccCceEEEEEEEecCcccCeE--EEEEEccCCCcC---------------------cHHHHHHHHHHHHHH
Q 014210 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQ--VAVKVIPKHKMT---------------------TAIAIEDVRREVKIL 212 (429)
Q Consensus 156 ~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~--vAvK~~~~~~~~---------------------~~~~~~~~~~Ei~il 212 (429)
.|++.+.||+|+||.||+|.... +|+. ||||++...... .......+.+|+.++
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~---~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 124 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVF---DGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNL 124 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEE---TTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcC---CCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHH
Confidence 47899999999999999998744 4888 999997543111 012224688999999
Q ss_pred HHhcCCCCc--ceEEEEEEeCCeEEEEEEecCC-C----cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH-HcCceec
Q 014210 213 RALTGHNNL--VKFFDAYEDTDNVYVVMELCEG-G----ELLDRILSRGGKYTEDDAKAVMIQILNVVAFCH-LQGVVHR 284 (429)
Q Consensus 213 ~~l~~h~nI--v~l~~~~~~~~~~~lv~E~~~g-g----sL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH-~~~iiHr 284 (429)
.+|. |+++ ..+++. +..+|||||+.+ | +|.+.... .++..+..++.||+.+|.||| +.|||||
T Consensus 125 ~~l~-~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~----~~~~~~~~i~~qi~~~l~~lH~~~givHr 195 (258)
T 1zth_A 125 ERAK-EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE----LKELDVEGIFNDVVENVKRLYQEAELVHA 195 (258)
T ss_dssp HHHH-HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG----GGGSCHHHHHHHHHHHHHHHHHTSCEECS
T ss_pred HHHH-hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc----cChHHHHHHHHHHHHHHHHHHHHCCEEeC
Confidence 9998 7653 444442 356899999942 3 56554321 345678899999999999999 9999999
Q ss_pred cCCCCcEEEeecCCCceEEEeecCCcccc
Q 014210 285 DLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (429)
Q Consensus 285 DIKp~NILl~~~~~~~~vkL~DFGla~~~ 313 (429)
||||+|||+ +. .++|+|||++...
T Consensus 196 Dlkp~NILl---~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 196 DLSEYNIMY---ID--KVYFIDMGQAVTL 219 (258)
T ss_dssp SCSTTSEEE---SS--SEEECCCTTCEET
T ss_pred CCCHHHEEE---cC--cEEEEECcccccC
Confidence 999999999 44 7999999999654
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.77 E-value=6.4e-19 Score=174.35 Aligned_cols=143 Identities=16% Similarity=0.188 Sum_probs=100.0
Q ss_pred ceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcC---------------cHHH----HHHHHHHHHHHHHhc
Q 014210 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMT---------------TAIA----IEDVRREVKILRALT 216 (429)
Q Consensus 156 ~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~---------------~~~~----~~~~~~Ei~il~~l~ 216 (429)
-|++++.||+|+||.||+|... +|+.||||+++..... .... .-...+|...|.+|.
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~----~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~ 171 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADE----KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALY 171 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECT----TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEecCEeeeCCceEEEEEECC----CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHH
Confidence 3999999999999999999864 4899999997532110 0000 111246777788876
Q ss_pred CCCCcceEEEEEEeCCeEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeec
Q 014210 217 GHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTK 296 (429)
Q Consensus 217 ~h~nIv~l~~~~~~~~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~ 296 (429)
+.++....-+... ..+|||||++|+.|.... .......++.||+.+|.+||+.|||||||||.|||++.+
T Consensus 172 -~~gv~vp~p~~~~--~~~LVME~i~G~~L~~l~-------~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~d 241 (397)
T 4gyi_A 172 -EEGFPVPEPIAQS--RHTIVMSLVDALPMRQVS-------SVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREE 241 (397)
T ss_dssp -HTTCSCCCEEEEE--TTEEEEECCSCEEGGGCC-------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEE
T ss_pred -hcCCCCCeeeecc--CceEEEEecCCccHhhhc-------ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCC
Confidence 4444322211112 237999999988875421 223456789999999999999999999999999999643
Q ss_pred CCC-------ceEEEeecCCccc
Q 014210 297 DEN-------SVLKAIDFGLSDF 312 (429)
Q Consensus 297 ~~~-------~~vkL~DFGla~~ 312 (429)
++. ..+.|+||+-+..
T Consensus 242 gd~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 242 KDAEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp ECSSCTTSEEEEEEECCCTTCEE
T ss_pred CCcccccccccceEEEEeCCccc
Confidence 321 1489999997744
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.48 E-value=1.9e-13 Score=128.29 Aligned_cols=141 Identities=16% Similarity=0.143 Sum_probs=111.7
Q ss_pred CceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeE
Q 014210 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (429)
Q Consensus 155 ~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~ 234 (429)
..|++...++.|+++.||++.. .|+.+++|+....... ....+.+|+.+++.|..+..+.++++++.+.+..
T Consensus 14 ~~~~~~~~~~g~s~~~v~~~~~-----~~~~~vlK~~~~~~~~---~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~ 85 (263)
T 3tm0_A 14 EKYRCVKDTEGMSPAKVYKLVG-----ENENLYLKMTDSRYKG---TTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS 85 (263)
T ss_dssp TTSEEEECCSCCSSSEEEEEEC-----SSCEEEEEEECGGGTT---STTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred ccceeEeeccCCCCCeEEEEEC-----CCCcEEEEeCCcccCC---CHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCce
Confidence 4688889999999999998862 2678999998542111 1235889999999997677888999999999999
Q ss_pred EEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH------------------------------------
Q 014210 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHL------------------------------------ 278 (429)
Q Consensus 235 ~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~------------------------------------ 278 (429)
|+||||++|.+|.+.+ .+......++.+++++|..||+
T Consensus 86 ~lv~e~i~G~~l~~~~------~~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (263)
T 3tm0_A 86 NLLMSEADGVLCSEEY------EDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE 159 (263)
T ss_dssp EEEEECCSSEEHHHHC------CTTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGS
T ss_pred EEEEEecCCeehhhcc------CCcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccc
Confidence 9999999998887642 1223345788999999999998
Q ss_pred -----------------------cCceeccCCCCcEEEeecCCCceEEEeecCCccc
Q 014210 279 -----------------------QGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (429)
Q Consensus 279 -----------------------~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~ 312 (429)
..++|+|+++.|||+ +++..+.|+||+.+..
T Consensus 160 ~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~---~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFV---KDGKVSGFIDLGRSGR 213 (263)
T ss_dssp TTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEE---ETTEEEEECCCTTCEE
T ss_pred ccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEE---ECCcEEEEEEchhccc
Confidence 458999999999999 4456678999997743
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.35 E-value=3.2e-12 Score=119.10 Aligned_cols=136 Identities=14% Similarity=0.126 Sum_probs=98.6
Q ss_pred CceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCC-cceEEEEEEeCCe
Q 014210 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNN-LVKFFDAYEDTDN 233 (429)
Q Consensus 155 ~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~n-Iv~l~~~~~~~~~ 233 (429)
..|.+....+.|..+.||++... +|+.++||+.... ....+.+|+.+++.|..+.- +.++++++.+.+.
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~~~----~g~~~vlK~~~~~------~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~ 89 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLSAQ----GRPVLFVKTDLSG------ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGR 89 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEECT----TSCCEEEEEECSC------TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSC
T ss_pred CCCceEecccCCCCceEEEEecC----CCCeEEEEeCCcc------cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCC
Confidence 44565544455666899988642 3678999997543 12457899999999985522 5678998888888
Q ss_pred EEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC---------------------------------
Q 014210 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQG--------------------------------- 280 (429)
Q Consensus 234 ~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~--------------------------------- 280 (429)
.++||||++|.+|. + .... ...++.++++.|..||+..
T Consensus 90 ~~~v~e~i~G~~l~--~----~~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (264)
T 1nd4_A 90 DWLLLGEVPGQDLL--S----SHLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDE 160 (264)
T ss_dssp EEEEEECCSSEETT--T----SCCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCG
T ss_pred CEEEEEecCCcccC--c----CcCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhh
Confidence 99999999998873 2 1112 2356677777777777643
Q ss_pred -------------------------ceeccCCCCcEEEeecCCCceEEEeecCCccc
Q 014210 281 -------------------------VVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (429)
Q Consensus 281 -------------------------iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~ 312 (429)
++|+|++|.|||+ ++++.++|+|||.+..
T Consensus 161 ~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~---~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 161 EHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMV---ENGRFSGFIDCGRLGV 214 (264)
T ss_dssp GGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEE---ETTEEEEECCCTTCEE
T ss_pred hccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEE---ECCcEEEEEcchhccc
Confidence 9999999999999 4556677999998753
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.23 E-value=3e-11 Score=118.73 Aligned_cols=144 Identities=24% Similarity=0.386 Sum_probs=105.2
Q ss_pred EeceeeccCceEEEEEEEecCcccCeEEEEEEcc--CCCcCcHHHHHHHHHHHHHHHHhcC-CCCcceEEEEEEeC---C
Q 014210 159 LGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIP--KHKMTTAIAIEDVRREVKILRALTG-HNNLVKFFDAYEDT---D 232 (429)
Q Consensus 159 ~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~--~~~~~~~~~~~~~~~Ei~il~~l~~-h~nIv~l~~~~~~~---~ 232 (429)
..+.|+.|.++.||++... +..+++|+.. .... ......+.+|+.+++.|.. +..+.+++.++.+. +
T Consensus 42 ~~~~l~~G~sn~~y~v~~~-----~~~~vlr~~~~p~~~~--~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g 114 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTP-----GQTYVMRAKPGPKSKL--LPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIG 114 (359)
T ss_dssp EEEECCC-CCSCEEEEECS-----SCEEEEECCCC------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTS
T ss_pred eEEEcCCcccceEEEEEEC-----CceEEEEeCCCCCCCC--CCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccC
Confidence 3567889999999987643 4678999875 3211 1223568899999999984 24588899988776 4
Q ss_pred eEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH----------------------------------
Q 014210 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHL---------------------------------- 278 (429)
Q Consensus 233 ~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~---------------------------------- 278 (429)
..|+||||++|..+.+. ....++......++.++++.|..||.
T Consensus 115 ~~~~vme~v~G~~l~~~---~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (359)
T 3dxp_A 115 RAFYIMEFVSGRVLWDQ---SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSET 191 (359)
T ss_dssp SCEEEEECCCCBCCCCT---TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCC
T ss_pred CeEEEEEecCCeecCCC---ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCC
Confidence 58999999998776431 12347888899999999999999997
Q ss_pred ------------------------cCceeccCCCCcEEEeecCCCceEEEeecCCcccc
Q 014210 279 ------------------------QGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (429)
Q Consensus 279 ------------------------~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~ 313 (429)
..++|+|+++.|||+..++ ...+.|+||+++...
T Consensus 192 ~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~-~~v~~viDwe~a~~g 249 (359)
T 3dxp_A 192 ESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTE-PRVLAVLDWELSTLG 249 (359)
T ss_dssp SCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSS-SCEEEECCCTTCEEE
T ss_pred cCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCC-CcEEEEECccccccC
Confidence 3589999999999994211 135799999988653
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.23 E-value=1.9e-11 Score=117.33 Aligned_cols=185 Identities=17% Similarity=0.243 Sum_probs=123.3
Q ss_pred eceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCC--cceEEEEEEeCC---eE
Q 014210 160 GEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNN--LVKFFDAYEDTD---NV 234 (429)
Q Consensus 160 ~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~n--Iv~l~~~~~~~~---~~ 234 (429)
.+.++.|....||++. ..+++|+.. .......+.+|+++++.|..+.. +.+++......+ ..
T Consensus 25 i~~~~~G~~n~v~~v~--------~~~vlR~~~-----~~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~ 91 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN--------RDFIFKFPK-----HSRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMS 91 (304)
T ss_dssp CCEEEECSSEEEEEST--------TSEEEEEES-----SHHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCS
T ss_pred eEecCCCCcceEEEEC--------CEEEEEecC-----CcchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcc
Confidence 3458999999998753 358999853 22445778999999999863433 445555544333 34
Q ss_pred EEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH------------------------------------
Q 014210 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHL------------------------------------ 278 (429)
Q Consensus 235 ~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~------------------------------------ 278 (429)
|+|||+++|..|.+... ..++..+...++.++++.|..||+
T Consensus 92 ~~vm~~i~G~~l~~~~~---~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (304)
T 3sg8_A 92 FAGFTKIKGVPLTPLLL---NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGP 168 (304)
T ss_dssp CEEEECCCCEECCHHHH---HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHH
T ss_pred eEEEcccCCeECCcccc---ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcc
Confidence 88999999988765332 347788888899999999999886
Q ss_pred ----------------------cCceeccCCCCcEEEeecCCCceEEEeecCCccccCCCccccccccCCcccCccccc-
Q 014210 279 ----------------------QGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLH- 335 (429)
Q Consensus 279 ----------------------~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~- 335 (429)
..++|+|+++.|||++.+ ....+.|+||+.+.................-..++...
T Consensus 169 ~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~-~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~ 247 (304)
T 3sg8_A 169 QMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTE-KNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSK 247 (304)
T ss_dssp HHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETT-TTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHH
T ss_pred cHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCC-CCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHH
Confidence 136999999999999421 15678999999886543221111111000002222211
Q ss_pred --CCC------------CCcccHHHHHHHHHHHHcCCCCC
Q 014210 336 --RSY------------STEADVWSIGVIAYILLCGSRPF 361 (429)
Q Consensus 336 --~~~------------~~~sDiwSlGvll~elltg~~Pf 361 (429)
..| ....++|+++.++|.+.+|..+|
T Consensus 248 ~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 248 ILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 111 11258999999999999998776
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.82 E-value=9.7e-08 Score=91.64 Aligned_cols=138 Identities=18% Similarity=0.308 Sum_probs=94.7
Q ss_pred eceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCC--CcceEEEEEE-eCCeEEE
Q 014210 160 GEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHN--NLVKFFDAYE-DTDNVYV 236 (429)
Q Consensus 160 ~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~--nIv~l~~~~~-~~~~~~l 236 (429)
.+.++.|....||+. |..++||+- ........+.+|+++|+.|..+- .+.+.+.++. ..+..++
T Consensus 24 v~~l~~G~~n~v~~v--------g~~~VlR~~-----~~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~ 90 (306)
T 3tdw_A 24 VESLGEGFRNYAILV--------NGDWVFRFP-----KSQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFV 90 (306)
T ss_dssp EEEEEECSSEEEEEE--------TTTEEEEEE-----SSHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEE
T ss_pred eeecCCCcceeEEEE--------CCEEEEEec-----CCchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEE
Confidence 445788888889876 356889984 22344578899999999998432 3567777764 4556789
Q ss_pred EEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHc-------------------------------------
Q 014210 237 VMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQ------------------------------------- 279 (429)
Q Consensus 237 v~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~------------------------------------- 279 (429)
||||++|..|.+... ..++......++.++.+.|..||+.
T Consensus 91 v~e~i~G~~l~~~~~---~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~ 167 (306)
T 3tdw_A 91 GYRKVQGQILGEDGM---AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDES 167 (306)
T ss_dssp EEECCCSEECHHHHH---TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHH
T ss_pred EEeccCCeECchhhh---hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchh
Confidence 999999987765321 2345555555555555555555542
Q ss_pred -----------------------CceeccCCCCcEEEeecCC-CceEEEeecCCcccc
Q 014210 280 -----------------------GVVHRDLKPENFLFTTKDE-NSVLKAIDFGLSDFV 313 (429)
Q Consensus 280 -----------------------~iiHrDIKp~NILl~~~~~-~~~vkL~DFGla~~~ 313 (429)
.++|+|+++.|||+...+. ...+.|+||+.+...
T Consensus 168 ~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 168 LRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp HHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred hHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 3599999999999942111 345689999987654
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.78 E-value=9.9e-08 Score=89.35 Aligned_cols=134 Identities=19% Similarity=0.201 Sum_probs=94.3
Q ss_pred eeeccCce-EEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEe
Q 014210 162 EVGRGHFG-YTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMEL 240 (429)
Q Consensus 162 ~IG~G~fg-~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~~lv~E~ 240 (429)
.+..|..| .||+..... .+..++||+-.. ....++.+|..+|+.|..+--+.++++++.+.+..++|||+
T Consensus 31 ~~~~G~S~~~v~rl~~~~---~~~~~~lk~~~~------~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~ 101 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKP---NAPELFLKHGKG------SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTA 101 (272)
T ss_dssp EEECSSSSCEEEEEECCT---TCCCEEEEEEET------HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEEC
T ss_pred EccCCCcCCeEEEEEecC---CCeEEEEEECCC------CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEe
Confidence 34445444 688776444 367899998532 23456889999999998655577899999999999999999
Q ss_pred cCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHc-----------------------------------------
Q 014210 241 CEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQ----------------------------------------- 279 (429)
Q Consensus 241 ~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~----------------------------------------- 279 (429)
++|.++.+..... ......+..++...|..||..
T Consensus 102 l~G~~~~~~~~~~-----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (272)
T 4gkh_A 102 IPGKTAFQVLEEY-----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPV 176 (272)
T ss_dssp CCSEEHHHHHHHC-----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCH
T ss_pred eCCccccccccCC-----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHH
Confidence 9998776644221 122234445555555555521
Q ss_pred -----------------CceeccCCCCcEEEeecCCCceEEEeecCCccc
Q 014210 280 -----------------GVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (429)
Q Consensus 280 -----------------~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~ 312 (429)
.++|+|+.+.|||+ +.++.+-|+||+.+..
T Consensus 177 ~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~---~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 177 EQVWKEMHKLLPFSPDSVVTHGDFSLDNLIF---DEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHHHHHTTCCCCCCEEEECSCCCTTSEEE---ETTEEEEECCCTTCEE
T ss_pred HHHHHHHHhcccccCCcEEEcCCCCCCeEEE---ECCeEEEEEECccccc
Confidence 16899999999999 5566778999998754
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.53 E-value=9.4e-08 Score=93.41 Aligned_cols=89 Identities=12% Similarity=0.133 Sum_probs=57.7
Q ss_pred eEecee-eccCceEEEEEEEe---cCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCC--CCcceEEEEEEeC
Q 014210 158 ELGEEV-GRGHFGYTCAAKFK---KGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGH--NNLVKFFDAYEDT 231 (429)
Q Consensus 158 ~~~~~I-G~G~fg~V~~~~~~---~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h--~nIv~l~~~~~~~ 231 (429)
...+.| +.|....+|++... .+...|..+++|+..............+.+|+.+++.|..+ -.+.+++.++.+.
T Consensus 23 ~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~ 102 (357)
T 3ats_A 23 TVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTG 102 (357)
T ss_dssp EEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSS
T ss_pred EEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCC
Confidence 345677 77888899987654 11112578999986542200000013577899999998754 2577788887665
Q ss_pred ---CeEEEEEEecCCCcH
Q 014210 232 ---DNVYVVMELCEGGEL 246 (429)
Q Consensus 232 ---~~~~lv~E~~~ggsL 246 (429)
+..++||||++|..+
T Consensus 103 ~~~g~~~~v~e~l~G~~l 120 (357)
T 3ats_A 103 DVLGTPFFLMDYVEGVVP 120 (357)
T ss_dssp TTTSSCEEEEECCCCBCC
T ss_pred CccCCceEEEEecCCCCh
Confidence 356899999988654
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.46 E-value=5.9e-07 Score=89.15 Aligned_cols=81 Identities=20% Similarity=0.242 Sum_probs=51.4
Q ss_pred eceeeccCceEEEEEEEecCcccCeEEEEEEccCCCc-Cc---HHHHHHHHHHHHHHHHhcCC-CC-cceEEEEEEeCCe
Q 014210 160 GEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKM-TT---AIAIEDVRREVKILRALTGH-NN-LVKFFDAYEDTDN 233 (429)
Q Consensus 160 ~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~-~~---~~~~~~~~~Ei~il~~l~~h-~n-Iv~l~~~~~~~~~ 233 (429)
.+.||.|.++.||++.... .++.++||....... .. ....+++..|.++++.+..+ +. +.+++.+ +.+.
T Consensus 35 ~~~lg~G~~n~vyrv~~~~---~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~ 109 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQE---HDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEM 109 (397)
T ss_dssp EEECCSSSSEEEEEEEC-------CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTT
T ss_pred EEECCCCceEEEEEEEECC---CCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCc
Confidence 5678999999999997543 367899998643211 00 01234567899999988643 33 4456543 3455
Q ss_pred EEEEEEecCCCc
Q 014210 234 VYVVMELCEGGE 245 (429)
Q Consensus 234 ~~lv~E~~~ggs 245 (429)
.++||||++|..
T Consensus 110 ~~lvmE~l~g~~ 121 (397)
T 2olc_A 110 AVTVMEDLSHLK 121 (397)
T ss_dssp TEEEECCCTTSE
T ss_pred cEEEEEeCCCcc
Confidence 689999998743
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.30 E-value=8.8e-06 Score=78.36 Aligned_cols=138 Identities=14% Similarity=0.117 Sum_probs=78.5
Q ss_pred eceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCC-CCcceEEE------EEEeCC
Q 014210 160 GEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGH-NNLVKFFD------AYEDTD 232 (429)
Q Consensus 160 ~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h-~nIv~l~~------~~~~~~ 232 (429)
.+.|+.|..+.||++... +..+++|+.... . .++..|+.+++.|..+ -.+.+++. +....+
T Consensus 37 ~~~l~gG~~n~~~~v~~~-----~~~~vlk~~~~~----~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~ 104 (346)
T 2q83_A 37 IDVIQGNQMALVWKVHTD-----SGAVCLKRIHRP----E---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGS 104 (346)
T ss_dssp EEECC----CEEEEEEET-----TEEEEEEEECSC----H---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETT
T ss_pred eeeccccccCcEEEEEeC-----CCCEEEEecCCC----H---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECC
Confidence 345666677899988643 335999998541 1 3344566666666521 12334432 123467
Q ss_pred eEEEEEEecCCCcHH--------------HHHHhcCCC-------------CCHHH------------------------
Q 014210 233 NVYVVMELCEGGELL--------------DRILSRGGK-------------YTEDD------------------------ 261 (429)
Q Consensus 233 ~~~lv~E~~~ggsL~--------------~~i~~~~~~-------------l~~~~------------------------ 261 (429)
..+++|||++|..+. ..++..... -.|..
T Consensus 105 ~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 184 (346)
T 2q83_A 105 FLFVVYDWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPF 184 (346)
T ss_dssp EEEEEEECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHH
T ss_pred EEEEEEEeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcH
Confidence 789999999986431 122211110 11211
Q ss_pred -------HHHHHHHHHHHHHHHHH-------------cCceeccCCCCcEEEeecCCCceEEEeecCCccc
Q 014210 262 -------AKAVMIQILNVVAFCHL-------------QGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (429)
Q Consensus 262 -------~~~i~~qi~~gL~~LH~-------------~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~ 312 (429)
+..+..++..++.+|+. ..++|+|+++.|||+ +.++.+.|+||+.+..
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~---~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 185 SQLYLQEIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLL---GENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEE---CGGGCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEE---eCCCcEEEEehhhccc
Confidence 11112233445666653 469999999999999 5566799999998743
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=98.04 E-value=2.5e-05 Score=78.08 Aligned_cols=78 Identities=8% Similarity=0.005 Sum_probs=45.8
Q ss_pred EeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCc--Cc----HHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCC
Q 014210 159 LGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKM--TT----AIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (429)
Q Consensus 159 ~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~--~~----~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~ 232 (429)
..+.||.|..+.||++.. .++.++||....... .. ......+..|+..+..-.....+.+++.+. .+
T Consensus 38 ~i~~l~~G~~n~vyrv~~-----~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~ 110 (420)
T 2pyw_A 38 VIKEVGDGNLNFVFIVVG-----SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RT 110 (420)
T ss_dssp EEEECCCSSSCEEEEEEC-----SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TT
T ss_pred EEEEccCCCcEEEEEEEc-----CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CC
Confidence 356788899999998852 367899994321100 00 011223444444333222234567777665 56
Q ss_pred eEEEEEEec-CC
Q 014210 233 NVYVVMELC-EG 243 (429)
Q Consensus 233 ~~~lv~E~~-~g 243 (429)
..++||||+ +|
T Consensus 111 ~~~lv~e~l~~g 122 (420)
T 2pyw_A 111 MALIGMRYLEPP 122 (420)
T ss_dssp TTEEEECCCCTT
T ss_pred ccEEEEeecCCc
Confidence 679999999 77
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.96 E-value=5.2e-05 Score=72.77 Aligned_cols=77 Identities=16% Similarity=0.112 Sum_probs=60.4
Q ss_pred EeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCC--CCcceEEEEEEeCCeEEE
Q 014210 159 LGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGH--NNLVKFFDAYEDTDNVYV 236 (429)
Q Consensus 159 ~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h--~nIv~l~~~~~~~~~~~l 236 (429)
-.+.|+.|....+|+... .+..++||+.... ....+.+|...|+.|..+ -.+.+.+.++...+..++
T Consensus 40 ~~~~l~gG~~n~~y~v~~-----~~~~~vlK~~~~~------~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~l 108 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLIND-----EVQTVFVKINERS------YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFL 108 (312)
T ss_dssp EEEEECCSSSSEEEEEES-----SSCEEEEEEEEGG------GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEE
T ss_pred eeEEeCCccceeeeEEEE-----CCCeEEEEeCCcc------cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEE
Confidence 356789999999998763 2578899986421 246688999999998743 468889998888889999
Q ss_pred EEEecCCCcH
Q 014210 237 VMELCEGGEL 246 (429)
Q Consensus 237 v~E~~~ggsL 246 (429)
||||++|..+
T Consensus 109 vme~l~G~~~ 118 (312)
T 3jr1_A 109 LLEALNKSKN 118 (312)
T ss_dssp EEECCCCCCC
T ss_pred EEEeccCCCC
Confidence 9999998753
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.84 E-value=0.00016 Score=64.96 Aligned_cols=136 Identities=15% Similarity=0.066 Sum_probs=91.4
Q ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-cCceeccCCCCcEEEeecCCCceEEEeecCCccccCCCcccccc
Q 014210 244 GELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHL-QGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDI 322 (429)
Q Consensus 244 gsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~-~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~ 322 (429)
-+|.+.+...+..++++++|.++.|.+..|.-+-. +.-..+=+-|..|++ ..+|.|-+.+ +.+.
T Consensus 33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l---~~dG~V~f~~-~~s~----------- 97 (229)
T 2yle_A 33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRV---WRDGAVTLAP-AADD----------- 97 (229)
T ss_dssp EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEE---ETTSCEEECC-C--------------
T ss_pred ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEE---ecCCceeccc-cccc-----------
Confidence 48999998899999999999999999999877622 222233445688888 5677775553 1110
Q ss_pred ccCCcccCcccccCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhccc
Q 014210 323 VGSAYYVAPEVLHRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNK 402 (429)
Q Consensus 323 ~gt~~y~aPE~~~~~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~ 402 (429)
.....+.+||......+.+.=|||||+++|.-+--..| ...-..+++++..||..|...
T Consensus 98 ~~~~~~~~pe~~~~~~te~~~IysLG~tLY~ALDygL~---------------------e~eE~eLS~~LE~LL~~Mt~~ 156 (229)
T 2yle_A 98 AGEPPPVAGKLGYSQCMETEVIESLGIIIYKALDYGLK---------------------ENEERELSPPLEQLIDHMANT 156 (229)
T ss_dssp ---------CCSSSSSCHHHHHHHHHHHHHHHHTTTCC---------------------TTEEECCCHHHHHHHHHHTTC
T ss_pred ccccCCCChhhccccchHHHHHHHHHHHHHHHhhcCCC---------------------cccchhhCHHHHHHHHHHHhc
Confidence 12334668887755566788899999999987743222 111236899999999999755
Q ss_pred -------------------------CccCcCCHHHHHh
Q 014210 403 -------------------------DPRKRLTAAQALS 415 (429)
Q Consensus 403 -------------------------dP~~Rps~~~iL~ 415 (429)
.+..|.+.++||+
T Consensus 157 ~~d~~~~DeG~~~~~eg~~d~~~~~~~~~~~sl~~Vi~ 194 (229)
T 2yle_A 157 VEADGSNDEGYEAAEEGLGDEDEKRKISAIRSYRDVMK 194 (229)
T ss_dssp CC--------------------CCSCCCCCCSHHHHHH
T ss_pred ccccccccccccccccccccccccccccCcCCHHHHHH
Confidence 2468899999986
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.73 E-value=4.1e-05 Score=72.77 Aligned_cols=72 Identities=10% Similarity=-0.018 Sum_probs=46.2
Q ss_pred eceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEE
Q 014210 160 GEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVME 239 (429)
Q Consensus 160 ~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~~lv~E 239 (429)
.+.|+.|....+|++ ..+++|+..... ...-...+|+.+++.+..+.-..++++++ .+.-++++|
T Consensus 23 i~~l~gG~tN~~~~~---------~~~vlR~~~~~~----~~~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e 87 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA---------GDLCLRIPGKGT----EEYINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTR 87 (301)
T ss_dssp CEEEESCSSEEEEEE---------TTEEEEEECC--------CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEE
T ss_pred eeEcCCcccccccee---------eeEEEECCCCCc----cceeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEe
Confidence 677888998999987 248899875421 11112357888888887443335666543 334478999
Q ss_pred ec-CCCcH
Q 014210 240 LC-EGGEL 246 (429)
Q Consensus 240 ~~-~ggsL 246 (429)
|+ +|.+|
T Consensus 88 ~i~~g~~l 95 (301)
T 3dxq_A 88 YIAGAQTM 95 (301)
T ss_dssp CCTTCEEC
T ss_pred ecCCCccC
Confidence 99 66443
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.70 E-value=6.5e-05 Score=71.88 Aligned_cols=141 Identities=14% Similarity=0.105 Sum_probs=79.5
Q ss_pred EeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCC-CcceEEEE------EEeC
Q 014210 159 LGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHN-NLVKFFDA------YEDT 231 (429)
Q Consensus 159 ~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~-nIv~l~~~------~~~~ 231 (429)
..+.|+.|....+|++.... ..+++|+.... ...+++..|+.+++.|..+. .+.+++.. ....
T Consensus 26 ~~~~i~~G~~n~~~~v~~~~-----g~~vlk~~~~~-----~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~ 95 (322)
T 2ppq_A 26 SYKGIAEGVENSNFLLHTTK-----DPLILTLYEKR-----VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELS 95 (322)
T ss_dssp EEEEECC---EEEEEEEESS-----CCEEEEEECC--------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEET
T ss_pred EeeccCCCcccceEEEEeCC-----ccEEEEEeCCC-----CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEEC
Confidence 45667778888999886432 36889988542 11234667888888886331 12333321 1234
Q ss_pred CeEEEEEEecCCCcHH--------------HHHHhcCCC--------CC---HHHHHH------------HHHHHHHHHH
Q 014210 232 DNVYVVMELCEGGELL--------------DRILSRGGK--------YT---EDDAKA------------VMIQILNVVA 274 (429)
Q Consensus 232 ~~~~lv~E~~~ggsL~--------------~~i~~~~~~--------l~---~~~~~~------------i~~qi~~gL~ 274 (429)
+..+++|+|++|..+. ..++..... .. |..... +...+...++
T Consensus 96 g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~ 175 (322)
T 2ppq_A 96 GRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEID 175 (322)
T ss_dssp TEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHH
T ss_pred CEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHH
Confidence 6679999999885421 112221111 11 111000 0112344555
Q ss_pred HHHH-------cCceeccCCCCcEEEeecCCCceEEEeecCCccc
Q 014210 275 FCHL-------QGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (429)
Q Consensus 275 ~LH~-------~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~ 312 (429)
.|+. .+++|+|+++.|||+ +.+..+.|+||+.+..
T Consensus 176 ~l~~~~~~~~~~~liHgDl~~~Nil~---~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 176 YLAAHWPKDLPAGVIHADLFQDNVFF---LGDELSGLIDFYFACN 217 (322)
T ss_dssp HHHHHCCCSSCEEEECSCCCGGGEEE---ETTEEEEECCCTTCEE
T ss_pred HHHhhCcccCCcccCCCCCCccCEEE---eCCceEEEecchhccC
Confidence 6653 368999999999999 4455568999998754
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.69 E-value=0.00019 Score=67.62 Aligned_cols=81 Identities=16% Similarity=0.055 Sum_probs=57.6
Q ss_pred cCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCC--CcceEEEEEEeC
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHN--NLVKFFDAYEDT 231 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~--nIv~l~~~~~~~ 231 (429)
+.+..-.+.+|.|..+.||+++..+ |+.|.||+....... ....+.+|...|+.|.... -+.+.+++. .
T Consensus 14 G~~v~~v~~~g~G~~~~vyrv~l~D----G~~~~vK~~~~~~~~---~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~--~ 84 (288)
T 3f7w_A 14 GREVAAVAERGHSHRWHLYRVELAD----GTPLFVKALPDDAPA---LDGLFRAEALGLDWLGRSFGSPVPQVAGWD--D 84 (288)
T ss_dssp CCCEEEEEEEEEETTEEEEEEEETT----SCEEEEEECCTTCCC---CTTHHHHHHHHHHHHTCSTTCCSCCEEEEE--T
T ss_pred CCCeEEEEecCCCCCeEEEEEEECC----CCEEEEEEeCCCCcc---hhhHHHHHHHHHHHHHhhCCCCcceEEecc--C
Confidence 4566778899999999999998654 789999986543211 1235789999999996432 345555542 2
Q ss_pred CeEEEEEEecCCCc
Q 014210 232 DNVYVVMELCEGGE 245 (429)
Q Consensus 232 ~~~~lv~E~~~ggs 245 (429)
-++||||++++.
T Consensus 85 --~~lv~e~l~~~~ 96 (288)
T 3f7w_A 85 --RTLAMEWVDERP 96 (288)
T ss_dssp --TEEEEECCCCCC
T ss_pred --ceEEEEeecccC
Confidence 378999998764
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.66 E-value=9.7e-05 Score=71.16 Aligned_cols=124 Identities=14% Similarity=0.143 Sum_probs=68.2
Q ss_pred CeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCC-CcceEEEEEEeCCeEEEEEEecCCCcHHHHHHhc--------
Q 014210 183 GQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHN-NLVKFFDAYEDTDNVYVVMELCEGGELLDRILSR-------- 253 (429)
Q Consensus 183 g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~-nIv~l~~~~~~~~~~~lv~E~~~ggsL~~~i~~~-------- 253 (429)
|..+++|....... +++..|+.+++.|..+. .+.+++.+..+.+ +++||++.+..+.+.+...
T Consensus 43 ~~~~vlk~~~~~~~------~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~~l~~~l~~~~~~~~~~~ 114 (333)
T 3csv_A 43 GAKAVLMDWSPEEG------GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDALFTEVINNDPAQEMPLY 114 (333)
T ss_dssp CCEEEEEECCTTTT------CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSCBHHHHHHHCGGGHHHHH
T ss_pred CCeEEEEECCCCCC------ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCcchHHHhcCCCccHHHHH
Confidence 56677886543210 23557888888887442 2556776643333 7899999776654433210
Q ss_pred -------------C----CCCCHHHHHH--------H------------HHHHHHHHHHHH------HcCceeccCCCCc
Q 014210 254 -------------G----GKYTEDDAKA--------V------------MIQILNVVAFCH------LQGVVHRDLKPEN 290 (429)
Q Consensus 254 -------------~----~~l~~~~~~~--------i------------~~qi~~gL~~LH------~~~iiHrDIKp~N 290 (429)
. ..++...... + ...+...+..|. ...++|+|+.+.|
T Consensus 115 ~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~~~~~~~lvHgD~~~~N 194 (333)
T 3csv_A 115 RAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQLEGDMVFVHRDFHAQN 194 (333)
T ss_dssp HHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHHCCSCCEEECSCCSGGG
T ss_pred HHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhcccCCCeeEeCCcCccc
Confidence 0 1122211100 0 011122233331 2359999999999
Q ss_pred EEEeecCC-CceEEEeecCCccccC
Q 014210 291 FLFTTKDE-NSVLKAIDFGLSDFVR 314 (429)
Q Consensus 291 ILl~~~~~-~~~vkL~DFGla~~~~ 314 (429)
||+..+.. .+.+.|+||+.+....
T Consensus 195 il~~~~~~~~~~~~lIDf~~a~~G~ 219 (333)
T 3csv_A 195 LLWLPEREGLARVGVIDFQDAKLGH 219 (333)
T ss_dssp EEECTTSCGGGGEEECCCTTCEEEC
T ss_pred EEeccCcCCCCCeEEEeCCCcCcCC
Confidence 99942100 2678999999886543
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.60 E-value=0.00016 Score=69.28 Aligned_cols=75 Identities=8% Similarity=0.072 Sum_probs=47.4
Q ss_pred eeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCC-CcceEEEE-----EEeCCeEE
Q 014210 162 EVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHN-NLVKFFDA-----YEDTDNVY 235 (429)
Q Consensus 162 ~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~-nIv~l~~~-----~~~~~~~~ 235 (429)
.|+ |....||++... +|+.+++|+...... ..+.+..|+.+++.|..+. .+.+++.. ...++..+
T Consensus 33 ~l~-g~~n~~y~v~~~----~g~~~vlK~~~~~~~----~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~ 103 (328)
T 1zyl_A 33 PLN-SYENRVYQFQDE----DRRRFVVKFYRPERW----TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYF 103 (328)
T ss_dssp EEC-CSSSEEEEECCT----TCCCEEEEEECTTTS----CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEE
T ss_pred eec-CcccceEEEEcC----CCCEEEEEEcCCCCC----CHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEE
Confidence 455 777788876533 366799999853321 2245677899888887332 13444432 22355678
Q ss_pred EEEEecCCCc
Q 014210 236 VVMELCEGGE 245 (429)
Q Consensus 236 lv~E~~~ggs 245 (429)
++|||++|..
T Consensus 104 ~l~~~i~G~~ 113 (328)
T 1zyl_A 104 AVFPSVGGRQ 113 (328)
T ss_dssp EEEECCCCEE
T ss_pred EEEEecCCCC
Confidence 9999998754
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.39 E-value=0.0005 Score=67.68 Aligned_cols=144 Identities=11% Similarity=0.125 Sum_probs=83.0
Q ss_pred ceeeccCceEEEEEEEecC----cccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEE
Q 014210 161 EEVGRGHFGYTCAAKFKKG----ELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYV 236 (429)
Q Consensus 161 ~~IG~G~fg~V~~~~~~~~----~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~~l 236 (429)
+.|.-|-...+|++....+ ...++.+++|+.... ......+.+|..+++.|..+.-..++++.+.+ .+
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~----~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~ 127 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI----LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GR 127 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc----cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----cc
Confidence 4455566667888765321 113578999986321 11234567999999999865555677776643 38
Q ss_pred EEEecCCCcHHH----------H-------HHhc----CCCC--CHHHHHHHHHHHHH-------------------HHH
Q 014210 237 VMELCEGGELLD----------R-------ILSR----GGKY--TEDDAKAVMIQILN-------------------VVA 274 (429)
Q Consensus 237 v~E~~~ggsL~~----------~-------i~~~----~~~l--~~~~~~~i~~qi~~-------------------gL~ 274 (429)
||||++|..|.. . ++.. .... -+.++.++..++-. .+.
T Consensus 128 v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 207 (379)
T 3feg_A 128 LEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMG 207 (379)
T ss_dssp EEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHH
T ss_pred EEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHH
Confidence 999998754321 1 1111 1112 24556666554422 233
Q ss_pred HHHH----c----CceeccCCCCcEEEeec-CCCceEEEeecCCccc
Q 014210 275 FCHL----Q----GVVHRDLKPENFLFTTK-DENSVLKAIDFGLSDF 312 (429)
Q Consensus 275 ~LH~----~----~iiHrDIKp~NILl~~~-~~~~~vkL~DFGla~~ 312 (429)
.|.+ . .++|+|+.+.|||+..+ +..+.+.|+||..+..
T Consensus 208 ~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 208 NLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 3332 2 48999999999999532 1236799999998754
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.36 E-value=0.0007 Score=67.83 Aligned_cols=77 Identities=12% Similarity=0.059 Sum_probs=51.2
Q ss_pred eceeeccCceEEEEEEEecCc----ccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEE
Q 014210 160 GEEVGRGHFGYTCAAKFKKGE----LKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVY 235 (429)
Q Consensus 160 ~~~IG~G~fg~V~~~~~~~~~----~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~~ 235 (429)
.+.|+.|....||++....+. ..++.+++|+.... .. .+.+.+|+.+++.|..+.-..++++.+.+ .
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~---~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g 148 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ET---ESHLVAESVIFTLLSERHLGPKLYGIFSG----G 148 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CC---HHHHHHHHHHHHHHHHTTSSSCEEEEETT----E
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--Cc---HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----C
Confidence 456777888899998764311 12578999987321 11 13455899999999855444677776542 3
Q ss_pred EEEEecCCCc
Q 014210 236 VVMELCEGGE 245 (429)
Q Consensus 236 lv~E~~~ggs 245 (429)
+||||++|..
T Consensus 149 ~v~e~l~G~~ 158 (429)
T 1nw1_A 149 RLEEYIPSRP 158 (429)
T ss_dssp EEECCCCEEE
T ss_pred EEEEEeCCcc
Confidence 8999998643
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.32 E-value=0.00038 Score=68.04 Aligned_cols=78 Identities=10% Similarity=0.124 Sum_probs=46.2
Q ss_pred eceeeccCceEEEEEEEecCc-----ccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeE
Q 014210 160 GEEVGRGHFGYTCAAKFKKGE-----LKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (429)
Q Consensus 160 ~~~IG~G~fg~V~~~~~~~~~-----~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~ 234 (429)
.+.|+.|....+|++....+. ..+..+++|+..... ....+...|..+++.|..+.-+.++++.. .+
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~----~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~~-- 109 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV----DELYNTISEFEVYKTMSKYKIAPQLLNTF--NG-- 109 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG----GGTSCHHHHHHHHHHHHHTTSSCCEEEEE--TT--
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc----cceecHHHHHHHHHHHHhcCCCCceEEec--CC--
Confidence 456777777799988754311 013679999874321 11113468999999887443345777554 23
Q ss_pred EEEEEecCCCc
Q 014210 235 YVVMELCEGGE 245 (429)
Q Consensus 235 ~lv~E~~~ggs 245 (429)
++||||++|..
T Consensus 110 ~~v~e~i~G~~ 120 (369)
T 3c5i_A 110 GRIEEWLYGDP 120 (369)
T ss_dssp EEEEECCCSEE
T ss_pred cEEEEEecCCc
Confidence 78999998753
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=97.06 E-value=0.0018 Score=62.60 Aligned_cols=65 Identities=8% Similarity=0.013 Sum_probs=41.7
Q ss_pred ceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcC--CCCcceEEEE------EEeCCeEEEEEE
Q 014210 168 FGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTG--HNNLVKFFDA------YEDTDNVYVVME 239 (429)
Q Consensus 168 fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~--h~nIv~l~~~------~~~~~~~~lv~E 239 (429)
...||++.... | .+++|+...... .+|+.+++.|.. -+++.+.+.. ....+..+++|+
T Consensus 36 ~N~vy~v~~~~----g-~~vLK~~~~~~~---------~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~ 101 (339)
T 3i1a_A 36 NAFAYQADSES----K-SYFIKLKYGYHD---------EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYP 101 (339)
T ss_dssp SCEEEEEECSS----C-EEEEEEEECSSC---------CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEE
T ss_pred ccceEEEEeCC----C-CEEEEEecCccc---------hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEe
Confidence 56899876332 4 899998765431 357777776652 2334554432 234577899999
Q ss_pred ecCCCcH
Q 014210 240 LCEGGEL 246 (429)
Q Consensus 240 ~~~ggsL 246 (429)
|++|..+
T Consensus 102 ~i~G~~~ 108 (339)
T 3i1a_A 102 FIHAPNG 108 (339)
T ss_dssp CCCCCBT
T ss_pred ccCCCcC
Confidence 9998754
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.98 E-value=0.0047 Score=62.27 Aligned_cols=76 Identities=17% Similarity=0.120 Sum_probs=48.4
Q ss_pred eceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEE
Q 014210 160 GEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVME 239 (429)
Q Consensus 160 ~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~~lv~E 239 (429)
.+.|+.|-...+|++.... .+..+++|+..... .. . -+..+|..+++.|..+.-..++++.+. + .+|||
T Consensus 113 i~~lsgG~tN~~y~v~~~~---~~~~~vLRi~g~~~-~~--~-idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e 181 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMS---KQAKYLIRLYGPKT-DE--I-INREREKKISCILYNKNIAKKIYVFFT--N--GRIEE 181 (458)
T ss_dssp EEEECC--CEEEEEEEETT---TTEEEEEEEECC-C-CS--C-SCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEE
T ss_pred EEEcCCCeEeEEEEEEECC---CCceEEEEECCCCh-hh--h-cCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEE
Confidence 4567778778999887532 24789999874321 11 1 112589999999985544467887762 2 35999
Q ss_pred ecCCCcH
Q 014210 240 LCEGGEL 246 (429)
Q Consensus 240 ~~~ggsL 246 (429)
|++|..|
T Consensus 182 ~I~G~~l 188 (458)
T 2qg7_A 182 FMDGYAL 188 (458)
T ss_dssp CCCSEEC
T ss_pred eeCCccC
Confidence 9987543
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=96.65 E-value=0.0024 Score=63.69 Aligned_cols=78 Identities=13% Similarity=0.198 Sum_probs=49.0
Q ss_pred eceeeccCceEEEEEEEecCccc----CeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEE
Q 014210 160 GEEVGRGHFGYTCAAKFKKGELK----GQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVY 235 (429)
Q Consensus 160 ~~~IG~G~fg~V~~~~~~~~~~~----g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~~ 235 (429)
++.|..|--..+|++....+..+ ++.+++++..... .. .-+..+|..+++.|..+.-..++++.+ .+ +
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t---~~-~idR~~E~~~l~~L~~~gi~P~l~~~~--~~--~ 146 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV---GK-FYDSKVELDVFRYLSNINIAPNIIADF--PE--G 146 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC----C-CCCHHHHHHHHHHHHHTTSSCCEEEEE--TT--E
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc---ch-hcCHHHHHHHHHHHHhcCCCCCEEEEc--CC--C
Confidence 45566566678898876532212 5789999864321 11 112458999999987554456677543 23 7
Q ss_pred EEEEecCCCc
Q 014210 236 VVMELCEGGE 245 (429)
Q Consensus 236 lv~E~~~ggs 245 (429)
+||||++|..
T Consensus 147 ~I~efI~G~~ 156 (424)
T 3mes_A 147 RIEEFIDGEP 156 (424)
T ss_dssp EEEECCCSEE
T ss_pred EEEEEeCCcc
Confidence 8999999865
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=95.16 E-value=0.062 Score=52.92 Aligned_cols=32 Identities=31% Similarity=0.496 Sum_probs=26.1
Q ss_pred ceeccCCCCcEEEee---cCCCceEEEeecCCccc
Q 014210 281 VVHRDLKPENFLFTT---KDENSVLKAIDFGLSDF 312 (429)
Q Consensus 281 iiHrDIKp~NILl~~---~~~~~~vkL~DFGla~~ 312 (429)
++|+|+.+.|||+.. ++++..++|+||.+|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 689999999999953 24567899999998754
|
| >1cja_A Protein (actin-fragmin kinase); transferase; HET: AMP; 2.90A {Physarum polycephalum} SCOP: d.144.1.3 | Back alignment and structure |
|---|
Probab=83.45 E-value=5.6 Score=37.77 Aligned_cols=139 Identities=16% Similarity=0.130 Sum_probs=74.5
Q ss_pred ceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEE--------
Q 014210 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDA-------- 227 (429)
Q Consensus 156 ~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~-------- 227 (429)
+++.++..-.|..| ||.+.. ++..|+||-. .....+.+-.++...-.+. .|+..-+...
T Consensus 70 ~v~~I~~s~~Gstg-vff~~t-----d~~~~VVK~s------~~l~~E~l~s~LA~~LGlp-iP~~Riv~~~~~E~~e~~ 136 (342)
T 1cja_A 70 QFKGIERSEKGTEG-LFFVET-----ESGVFIVKRS------TNIESETFCSLLCMRLGLH-APKVRVVSSNSEEGTNML 136 (342)
T ss_dssp GEEEEEECCSTTSC-EEEEEE-----SSCEEEEECC------TTHHHHHHHHHHHHHHTCC-CCCEEEEESSSHHHHHHH
T ss_pred CeeEEEeccCCCCC-eEEEEe-----CCCEEEEeCc------HHHHHHHHHHHHHHHhCCC-CCCeeEEeeCcHHHHHHH
Confidence 46777777777655 444443 3678999943 1223344555555544454 5553332211
Q ss_pred ---------E-----EeCCeEEEEEEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHH--HHHHHHHHHcC----cee-cc
Q 014210 228 ---------Y-----EDTDNVYVVMELCEGGELLDRILSR-GGKYTEDDAKAVMIQI--LNVVAFCHLQG----VVH-RD 285 (429)
Q Consensus 228 ---------~-----~~~~~~~lv~E~~~ggsL~~~i~~~-~~~l~~~~~~~i~~qi--~~gL~~LH~~~----iiH-rD 285 (429)
+ ...+..+++|||++|..|.+.-... ...+. .+.+.++ +-++..+..++ .++ .-
T Consensus 137 ~~L~~~~~~~~~l~~l~~~~~~l~meyv~G~~L~e~~~~~~~~~f~----~~~~k~LG~Ii~FDi~InN~DR~Pl~W~n~ 212 (342)
T 1cja_A 137 ECLAAIDKSFRVITTLANQANILLMELVRGITLNKLTTTSAPEVLT----KSTMQQLGSLMALDVIVNNSDRLPIAWTNE 212 (342)
T ss_dssp HHHHHHCSSSCHHHHHTTCSEEEEEECCCEEESTTCCSSSHHHHSC----HHHHHHHHHHHHHHHHHTCCSSSCSSSCSC
T ss_pred HHHHHhhhhhHHHHHhhcccceehhhhcCCCccccchhhhhhhhcC----HHHHHhhchhheehhhhcCCccCcccccCC
Confidence 0 0122467999999876654310000 00122 2233333 34555566553 111 23
Q ss_pred CCCCcEEEeecCCCceEEEeecCCcccc
Q 014210 286 LKPENFLFTTKDENSVLKAIDFGLSDFV 313 (429)
Q Consensus 286 IKp~NILl~~~~~~~~vkL~DFGla~~~ 313 (429)
-.++|||+.. ++..+.++|-+++..-
T Consensus 213 GN~~NIL~~~--~n~~~~~IDhn~af~~ 238 (342)
T 1cja_A 213 GNLDNIMLSE--RGATVVPIDSKIIPLD 238 (342)
T ss_dssp CCGGGEEEES--BTTCEEECSCCCCCCC
T ss_pred CChhheEEeC--CCCeEEEEcCCccccC
Confidence 5889999973 3457999999998653
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=80.56 E-value=3.7 Score=36.59 Aligned_cols=93 Identities=18% Similarity=0.153 Sum_probs=65.9
Q ss_pred HHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHH-HHHHcCceeccC
Q 014210 208 EVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVA-FCHLQGVVHRDL 286 (429)
Q Consensus 208 Ei~il~~l~~h~nIv~l~~~~~~~~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~-~LH~~~iiHrDI 286 (429)
|+.+|.. .||++ -...-++++.+.|.++.-+++.-+..+ ..++....++++.+|+.... ++ ..-+|--|
T Consensus 41 e~~lL~~--~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i----~~~~~~eKlrll~nl~~L~~~~~--~~r~tf~l 110 (219)
T 4ano_A 41 ELEVLKE--VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI----RKTTLLSRIRAAIHLVSKVKHHS--ARRLIFIV 110 (219)
T ss_dssp GGGGGGG--SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH----HTSCHHHHHHHHHHHHHHHSSCC--SSSEECCC
T ss_pred HHHHHhc--cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH----HhcCHHHHHHHHHHHHHHHHHhh--hCceeEEE
Confidence 4444433 37888 334447778888888876554334445 45789999999998887765 44 34577789
Q ss_pred CCCcEEEeecCCCceEEEeecCCcccc
Q 014210 287 KPENFLFTTKDENSVLKAIDFGLSDFV 313 (429)
Q Consensus 287 Kp~NILl~~~~~~~~vkL~DFGla~~~ 313 (429)
.|+||++ +.++.++|.-.|+-..+
T Consensus 111 ~P~NL~f---~~~~~p~i~hRGi~~~l 134 (219)
T 4ano_A 111 CPENLMF---NRALEPFFLHVGVKESL 134 (219)
T ss_dssp CGGGEEE---CTTCCEEESCCEETTTB
T ss_pred eCceEEE---eCCCcEEEEEcCCcccC
Confidence 9999999 88999999988865433
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 429 | ||||
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-83 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-82 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 5e-82 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 6e-81 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-79 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 4e-79 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 3e-77 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-76 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 9e-75 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-74 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-74 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-72 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-72 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-72 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-71 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 5e-70 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-69 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-69 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 7e-69 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 3e-68 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-66 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 4e-65 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-64 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 3e-63 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 5e-63 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 5e-62 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 5e-62 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 7e-62 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-61 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-61 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-61 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 3e-61 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 9e-61 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-59 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-59 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-59 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 6e-59 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 6e-59 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 3e-58 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 4e-58 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 5e-58 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-57 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-57 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-57 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 3e-57 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 6e-57 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 4e-56 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 8e-56 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 8e-56 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 9e-56 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-55 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-55 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 5e-55 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 3e-54 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-53 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 5e-51 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 6e-51 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-50 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-49 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 3e-49 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-48 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 3e-38 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 8e-21 | |
| d1j7la_ | 263 | d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phos | 3e-05 | |
| d2pula1 | 392 | d.144.1.6 (A:5-396) Methylthioribose kinase MtnK { | 0.003 |
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 258 bits (659), Expect = 1e-83
Identities = 88/266 (33%), Positives = 137/266 (51%), Gaps = 9/266 (3%)
Query: 151 KHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVK 210
H + Y++ EE+G G FG + G A K + + E VR+E++
Sbjct: 22 DHVLDHYDIHEELGTGAFGVVHRVTERA---TGNNFAAKFVMTPHES---DKETVRKEIQ 75
Query: 211 ILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQIL 270
+ L H LV DA+ED + + ++ E GGEL +++ K +ED+A M Q+
Sbjct: 76 TMSVLR-HPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVC 134
Query: 271 NVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVA 330
+ H VH DLKPEN +FTT ++ LK IDFGL+ + P + + G+A + A
Sbjct: 135 KGLCHMHENNYVHLDLKPENIMFTT-KRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAA 193
Query: 331 PEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLS 389
PEV + D+WS+GV++YILL G PF + R V D + D++ + +S
Sbjct: 194 PEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGIS 253
Query: 390 SEARDFVKRLLNKDPRKRLTAAQALS 415
+ +DF+++LL DP R+T QAL
Sbjct: 254 EDGKDFIRKLLLADPNTRMTIHQALE 279
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 255 bits (652), Expect = 2e-82
Identities = 93/262 (35%), Positives = 135/262 (51%), Gaps = 9/262 (3%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRA 214
+ Y++ EE+G G FG K G+ K I + V+ E+ I+
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKA---TGRVFVAKFINTPYP---LDKYTVKNEISIMNQ 82
Query: 215 LTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVA 274
L H L+ DA+ED + +++E GGEL DRI + K +E + M Q +
Sbjct: 83 LH-HPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLK 141
Query: 275 FCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVL 334
H +VH D+KPEN + TK +SV K IDFGL+ + PDE + +A + APE++
Sbjct: 142 HMHEHSIVHLDIKPENIMCETKKASSV-KIIDFGLATKLNPDEIVKVTTATAEFAAPEIV 200
Query: 335 HRS-YSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEAR 393
R D+W+IGV+ Y+LL G PF + + V + D FDE + S+S EA+
Sbjct: 201 DREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAK 260
Query: 394 DFVKRLLNKDPRKRLTAAQALS 415
DF+K LL K+PRKRLT AL
Sbjct: 261 DFIKNLLQKEPRKRLTVHDALE 282
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 251 bits (642), Expect = 5e-82
Identities = 93/276 (33%), Positives = 138/276 (50%), Gaps = 20/276 (7%)
Query: 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIA------IEDVR 206
F YE E +GRG K ++ AVK+I + A E
Sbjct: 1 FYENYEPKEILGRGVSSVVRRCIHKPT---CKEYAVKIIDVTGGGSFSAEEVQELREATL 57
Query: 207 REVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVM 266
+EV ILR ++GH N+++ D YE ++V +L + GEL D + + +E + + +M
Sbjct: 58 KEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL-TEKVTLSEKETRKIM 116
Query: 267 IQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSA 326
+L V+ H +VHRDLKPEN L D++ +K DFG S + P E+L ++ G+
Sbjct: 117 RALLEVICALHKLNIVHRDLKPENILL---DDDMNIKLTDFGFSCQLDPGEKLREVCGTP 173
Query: 327 YYVAPEVL-------HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPS 379
Y+APE++ H Y E D+WS GVI Y LL GS PFW R + + R ++ +
Sbjct: 174 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQ 233
Query: 380 FDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALS 415
F W S +D V R L P+KR TA +AL+
Sbjct: 234 FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 249 bits (638), Expect = 6e-81
Identities = 107/267 (40%), Positives = 154/267 (57%), Gaps = 8/267 (2%)
Query: 150 SKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREV 209
++ + Y+ + +G G F A+ K+ + VA+K I K + + E+
Sbjct: 4 AEDIRDIYDFRDVLGTGAFSEVILAEDKRT---QKLVAIKCIAKKALEGKE--GSMENEI 58
Query: 210 KILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQI 269
+L + H N+V D YE ++Y++M+L GGEL DRI+ +G YTE DA ++ Q+
Sbjct: 59 AVLHKIK-HPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG-FYTERDASRLIFQV 116
Query: 270 LNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYV 329
L+ V + H G+VHRDLKPEN L+ + DE+S + DFGLS P L+ G+ YV
Sbjct: 117 LDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYV 176
Query: 330 APEVL-HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSL 388
APEVL + YS D WSIGVIAYILLCG PF+ ++ +F +LKA+ FD W +
Sbjct: 177 APEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDI 236
Query: 389 SSEARDFVKRLLNKDPRKRLTAAQALS 415
S A+DF++ L+ KDP KR T QAL
Sbjct: 237 SDSAKDFIRHLMEKDPEKRFTCEQALQ 263
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 246 bits (628), Expect = 2e-79
Identities = 77/265 (29%), Positives = 133/265 (50%), Gaps = 10/265 (3%)
Query: 151 KHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVK 210
K KY + E++GRG FG + K + V++E+
Sbjct: 1 KELYEKYMIAEDLGRGEFGIVHRCVETSS---KKTYMAKFVKVKGTDQ----VLVKKEIS 53
Query: 211 ILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQIL 270
IL H N++ +++E + + ++ E G ++ +RI + + E + + + Q+
Sbjct: 54 ILNIA-RHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVC 112
Query: 271 NVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVA 330
+ F H + H D++PEN ++ T +S +K I+FG + ++P + + + Y A
Sbjct: 113 EALQFLHSHNIGHFDIRPENIIYQT-RRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYA 171
Query: 331 PEVL-HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLS 389
PEV H ST D+WS+G + Y+LL G PF A T I ++ A+ +FDE + +S
Sbjct: 172 PEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEIS 231
Query: 390 SEARDFVKRLLNKDPRKRLTAAQAL 414
EA DFV RLL K+ + R+TA++AL
Sbjct: 232 IEAMDFVDRLLVKERKSRMTASEAL 256
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 243 bits (622), Expect = 4e-79
Identities = 77/262 (29%), Positives = 132/262 (50%), Gaps = 14/262 (5%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRA 214
+E+G +G+G FG A+ K+ +A+KV+ K ++ A +RREV+I
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQS---KFILALKVLFKAQLEKAGVEHQLRREVEIQSH 62
Query: 215 LTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVA 274
L H N+++ + + D VY+++E G + R L + K+ E + ++ N ++
Sbjct: 63 L-RHPNILRLYGYFHDATRVYLILEYAPLGTV-YRELQKLSKFDEQRTATYITELANALS 120
Query: 275 FCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVL 334
+CH + V+HRD+KPEN L LK DFG S P R + G+ Y+ PE++
Sbjct: 121 YCHSKRVIHRDIKPENLLL---GSAGELKIADFGWSVHA-PSSRRTTLCGTLDYLPPEMI 176
Query: 335 -HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEAR 393
R + + D+WS+GV+ Y L G PF A T ++ + + + +F ++ AR
Sbjct: 177 EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTF----PDFVTEGAR 232
Query: 394 DFVKRLLNKDPRKRLTAAQALS 415
D + RLL +P +R + L
Sbjct: 233 DLISRLLKHNPSQRPMLREVLE 254
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 239 bits (612), Expect = 3e-77
Identities = 79/266 (29%), Positives = 126/266 (47%), Gaps = 18/266 (6%)
Query: 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALT 216
+E+ E+G G FG A+ K+ A KVI +ED E+ IL +
Sbjct: 14 WEIIGELGDGAFGKVYKAQNKET---SVLAAAKVIDTKSEE---ELEDYMVEIDILASCD 67
Query: 217 GHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFC 276
H N+VK DA+ +N+++++E C GG + +L TE + V Q L+ + +
Sbjct: 68 -HPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYL 126
Query: 277 HLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDERLNDIVGSAYYVAPEVLH 335
H ++HRDLK N LF + +K DFG+S R +R + +G+ Y++APEV+
Sbjct: 127 HDNKIIHRDLKAGNILF---TLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVM 183
Query: 336 ------RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLS 389
R Y +ADVWS+G+ + P + + K++P P S
Sbjct: 184 CETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQP-SRWS 242
Query: 390 SEARDFVKRLLNKDPRKRLTAAQALS 415
S +DF+K+ L K+ R T +Q L
Sbjct: 243 SNFKDFLKKCLEKNVDARWTTSQLLQ 268
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 237 bits (606), Expect = 2e-76
Identities = 79/273 (28%), Positives = 136/273 (49%), Gaps = 16/273 (5%)
Query: 151 KHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVK 210
K ++ G+ +G G F A+ ++ A+K++ K + + V RE
Sbjct: 4 KKRPEDFKFGKILGEGSFSTVVLARELAT---SREYAIKILEKRHIIKENKVPYVTRERD 60
Query: 211 ILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQIL 270
++ L H VK + ++D + +Y + + GELL I + G + E + +I+
Sbjct: 61 VMSRLD-HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTAEIV 118
Query: 271 NVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDE---RLNDIVGSAY 327
+ + + H +G++HRDLKPEN L +E+ ++ DFG + + P+ R N VG+A
Sbjct: 119 SALEYLHGKGIIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANSFVGTAQ 175
Query: 328 YVAPEVL-HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWP 386
YV+PE+L +S +D+W++G I Y L+ G PF A E IF+ ++K + F E
Sbjct: 176 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPE---- 231
Query: 387 SLSSEARDFVKRLLNKDPRKRLTAAQALSELLI 419
+ARD V++LL D KRL + +
Sbjct: 232 KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPL 264
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 233 bits (594), Expect = 9e-75
Identities = 73/275 (26%), Positives = 119/275 (43%), Gaps = 11/275 (4%)
Query: 151 KHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVK 210
H +++YELGE +G G A+ + + VAVKV+ RRE +
Sbjct: 3 SHLSDRYELGEILGFGGMSEVHLARDLR---LHRDVAVKVLRADLARDPSFYLRFRREAQ 59
Query: 211 ILRALTGHNNLVKFFDAYEDTDN----VYVVMELCEGGELLDRILSRGGKYTEDDAKAVM 266
AL H +V +D E Y+VME +G L D I+ G T A V+
Sbjct: 60 NAAAL-NHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRD-IVHTEGPMTPKRAIEVI 117
Query: 267 IQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFG-LSDFVRPDERLNDIVGS 325
+ F H G++HRD+KP N + + + V+ ++D + ++G+
Sbjct: 118 ADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGT 177
Query: 326 AYYVAPEVL-HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAP 384
A Y++PE S +DV+S+G + Y +L G PF + + ++ DP A
Sbjct: 178 AQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSAR 237
Query: 385 WPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLI 419
LS++ V + L K+P R A + L+
Sbjct: 238 HEGLSADLDAVVLKALAKNPENRYQTAAEMRADLV 272
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 232 bits (593), Expect = 2e-74
Identities = 95/273 (34%), Positives = 151/273 (55%), Gaps = 11/273 (4%)
Query: 149 FSK-HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTA---IAIED 204
F + + + Y+ GEE+G G F + K G Q A K I K + ++ ++ ED
Sbjct: 3 FRQENVDDYYDTGEELGSGQFAVVKKCREKS---TGLQYAAKFIKKRRTKSSRRGVSRED 59
Query: 205 VRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKA 264
+ REV IL+ + H N++ + YE+ +V +++EL GGEL D + + TE++A
Sbjct: 60 IEREVSILKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEATE 117
Query: 265 VMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDE-NSVLKAIDFGLSDFVRPDERLNDIV 323
+ QILN V + H + H DLKPEN + ++ +K IDFGL+ + +I
Sbjct: 118 FLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF 177
Query: 324 GSAYYVAPEVL-HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDE 382
G+ +VAPE++ + EAD+WSIGVI YILL G+ PF T+ V + F++
Sbjct: 178 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFED 237
Query: 383 APWPSLSSEARDFVKRLLNKDPRKRLTAAQALS 415
+ + S+ A+DF++RLL KDP+KR+T +L
Sbjct: 238 EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 231 bits (591), Expect = 2e-74
Identities = 82/268 (30%), Positives = 133/268 (49%), Gaps = 16/268 (5%)
Query: 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKIL 212
F ++L + +G G +G A + + VAVK++ + E++++E+ I
Sbjct: 3 FVEDWDLVQTLGEGAYGEVQLAVNRVT---EEAVAVKIVDMKRAVDCP--ENIKKEICIN 57
Query: 213 RALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNV 272
+ L H N+VKF+ + + Y+ +E C GGEL DRI G E DA+ Q++
Sbjct: 58 KMLN-HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG-MPEPDAQRFFHQLMAG 115
Query: 273 VAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDER---LNDIVGSAYYV 329
V + H G+ HRD+KPEN L DE LK DFGL+ R + R LN + G+ YV
Sbjct: 116 VVYLHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 172
Query: 330 APEVLHRS--YSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPS 387
APE+L R ++ DVWS G++ +L G P+ ++S + K ++ PW
Sbjct: 173 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLN-PWKK 231
Query: 388 LSSEARDFVKRLLNKDPRKRLTAAQALS 415
+ S + ++L ++P R+T
Sbjct: 232 IDSAPLALLHKILVENPSARITIPDIKK 259
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 227 bits (581), Expect = 1e-72
Identities = 72/263 (27%), Positives = 127/263 (48%), Gaps = 15/263 (5%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRA 214
KY E++G+G G A GQ+VA++ + + E + E+ ++R
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVA---TGQEVAIRQMNLQQQP---KKELIINEILVMRE 73
Query: 215 LTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVA 274
+ N+V + D+Y D ++VVME GG L D + E AV + L +
Sbjct: 74 N-KNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALE 130
Query: 275 FCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDE-RLNDIVGSAYYVAPEV 333
F H V+HRD+K +N L + +K DFG + P++ + + +VG+ Y++APEV
Sbjct: 131 FLHSNQVIHRDIKSDNILL---GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEV 187
Query: 334 L-HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEA 392
+ ++Y + D+WS+G++A ++ G P+ + + + + LS+
Sbjct: 188 VTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT-NGTPELQNPEKLSAIF 246
Query: 393 RDFVKRLLNKDPRKRLTAAQALS 415
RDF+ R L+ D KR +A + L
Sbjct: 247 RDFLNRCLDMDVEKRGSAKELLQ 269
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 228 bits (582), Expect = 2e-72
Identities = 69/272 (25%), Positives = 112/272 (41%), Gaps = 18/272 (6%)
Query: 149 FSKH-FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRR 207
F K + E+G G FG A+ + + VA+K + + +D+ +
Sbjct: 8 FFKDDPEKLFSDLREIGHGSFGAVYFARDVRN---SEVVAIKKMSYSGKQSNEKWQDIIK 64
Query: 208 EVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMI 267
EV+ L+ L H N +++ Y ++VME C G D + E + AV
Sbjct: 65 EVRFLQKLR-HPNTIQYRGCYLREHTAWLVMEYCLGS-ASDLLEVHKKPLQEVEIAAVTH 122
Query: 268 QILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAY 327
L +A+ H ++HRD+K N L E ++K DFG + + P N VG+ Y
Sbjct: 123 GALQGLAYLHSHNMIHRDVKAGNILL---SEPGLVKLGDFGSASIMAPA---NSFVGTPY 176
Query: 328 YVAPEVL----HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEA 383
++APEV+ Y + DVWS+G+ L P + + + +
Sbjct: 177 WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES--PAL 234
Query: 384 PWPSLSSEARDFVKRLLNKDPRKRLTAAQALS 415
S R+FV L K P+ R T+ L
Sbjct: 235 QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 228 bits (583), Expect = 2e-72
Identities = 83/276 (30%), Positives = 133/276 (48%), Gaps = 22/276 (7%)
Query: 151 KHFANKYELGEEV-GRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREV 209
+ Y++ +V G G G K+ ++ A+K++ RREV
Sbjct: 7 NAIIDDYKVTSQVLGLGINGKVLQIFNKR---TQEKFALKMLQDCPK--------ARREV 55
Query: 210 KILRALTGHNNLVKFFDAYEDT----DNVYVVMELCEGGELLDRILSRGGK-YTEDDAKA 264
++ + ++V+ D YE+ + +VME +GGEL RI RG + +TE +A
Sbjct: 56 ELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASE 115
Query: 265 VMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVG 324
+M I + + H + HRD+KPEN L+T+K N++LK DFG + L
Sbjct: 116 IMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY 175
Query: 325 SAYYVAPEVL-HRSYSTEADVWSIGVIAYILLCGSRPFWARTE----SGIFRAVLKADPS 379
+ YYVAPEVL Y D+WS+GVI YILLCG PF++ G+ +
Sbjct: 176 TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYE 235
Query: 380 FDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALS 415
F W +S E + ++ LL +P +R+T + ++
Sbjct: 236 FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 225 bits (574), Expect = 1e-71
Identities = 61/272 (22%), Positives = 110/272 (40%), Gaps = 21/272 (7%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRA 214
+ +G+ +G G FG KG+ G VAVK++ T ++ + EV +LR
Sbjct: 8 GQITVGQRIGSGSFG-----TVYKGKWHGD-VAVKMLNVTAPTPQ-QLQAFKNEVGVLRK 60
Query: 215 LTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVA 274
H N++ F Y + +V + CEG L + K+ + Q +
Sbjct: 61 TR-HVNILLFMG-YSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMD 118
Query: 275 FCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDE---RLNDIVGSAYYVAP 331
+ H + ++HRDLK N E+ +K DFGL+ + + GS ++AP
Sbjct: 119 YLHAKSIIHRDLKSNNIFL---HEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAP 175
Query: 332 EVL----HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAP--W 385
EV+ YS ++DV++ G++ Y L+ G P+ ++ +
Sbjct: 176 EVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVR 235
Query: 386 PSLSSEARDFVKRLLNKDPRKRLTAAQALSEL 417
+ + + L K +R Q L+ +
Sbjct: 236 SNCPKAMKRLMAECLKKKRDERPLFPQILASI 267
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 222 bits (566), Expect = 5e-70
Identities = 76/262 (29%), Positives = 128/262 (48%), Gaps = 13/262 (4%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRA 214
+ L + +G+G FG A+FKK Q A+K + K + +E E ++L
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKT---NQFFAIKALKKDVVLMDDDVECTMVEKRVLSL 58
Query: 215 LTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVA 274
H L F ++ +N++ VME GG+L+ I K+ A +I+ +
Sbjct: 59 AWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHI-QSCHKFDLSRATFYAAEIILGLQ 117
Query: 275 FCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDERLNDIVGSAYYVAPEV 333
F H +G+V+RDLK +N L D++ +K DFG+ + + D + N G+ Y+APE+
Sbjct: 118 FLHSKGIVYRDLKLDNILL---DKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEI 174
Query: 334 L-HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEA 392
L + Y+ D WS GV+ Y +L G PF + E +F ++ +P + L EA
Sbjct: 175 LLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFY----PRWLEKEA 230
Query: 393 RDFVKRLLNKDPRKRLTAAQAL 414
+D + +L ++P KRL +
Sbjct: 231 KDLLVKLFVREPEKRLGVRGDI 252
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 219 bits (559), Expect = 1e-69
Identities = 58/266 (21%), Positives = 110/266 (41%), Gaps = 18/266 (6%)
Query: 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALT 216
+ E+GRG F + +VA + K+T + + + E ++L+ L
Sbjct: 11 LKFDIEIGRGSFKTVYKGLDTET---TVEVAWCELQDRKLTKS-ERQRFKEEAEMLKGLQ 66
Query: 217 GHNNLVKFFDAYEDT----DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNV 272
H N+V+F+D++E T + +V EL G L L R ++ QIL
Sbjct: 67 -HPNIVRFYDSWESTVKGKKCIVLVTELMTSG-TLKTYLKRFKVMKIKVLRSWCRQILKG 124
Query: 273 VAFCHLQG--VVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVA 330
+ F H + ++HRDLK +N T +K D GL+ R ++G+ ++A
Sbjct: 125 LQFLHTRTPPIIHRDLKCDNIFIT--GPTGSVKIGDLGLATLKRAS-FAKAVIGTPEFMA 181
Query: 331 PEVLHRSYSTEADVWSIGVIAYILLCGSRPFW-ARTESGIFRAVLKADPSFDEAPWPSLS 389
PE+ Y DV++ G+ + P+ + + I+R V
Sbjct: 182 PEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPAS--FDKVAI 239
Query: 390 SEARDFVKRLLNKDPRKRLTAAQALS 415
E ++ ++ + ++ +R + L+
Sbjct: 240 PEVKEIIEGCIRQNKDERYSIKDLLN 265
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 218 bits (557), Expect = 2e-69
Identities = 79/273 (28%), Positives = 125/273 (45%), Gaps = 23/273 (8%)
Query: 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILR 213
A YE+ +G G +G + K G+ + K + MT A + + EV +LR
Sbjct: 3 AEDYEVLYTIGTGSYGRCQKIRRKSD---GKILVWKELDYGSMTEA-EKQMLVSEVNLLR 58
Query: 214 ALTGHNNLVKFFDAYEDTDN--VYVVMELCEGGELLDRI---LSRGGKYTEDDAKAVMIQ 268
L H N+V+++D D N +Y+VME CEGG+L I E+ VM Q
Sbjct: 59 ELK-HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQ 117
Query: 269 ILNVVAFCHLQG-----VVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDE-RLNDI 322
+ + CH + V+HRDLKP N D +K DFGL+ + D
Sbjct: 118 LTLALKECHRRSDGGHTVLHRDLKPANVFL---DGKQNVKLGDFGLARILNHDTSFAKAF 174
Query: 323 VGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFD 381
VG+ YY++PE ++R SY+ ++D+WS+G + Y L PF A ++ + + +
Sbjct: 175 VGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRR- 233
Query: 382 EAPWPSLSSEARDFVKRLLNKDPRKRLTAAQAL 414
S E + + R+LN R + + L
Sbjct: 234 --IPYRYSDELNEIITRMLNLKDYHRPSVEEIL 264
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 217 bits (554), Expect = 7e-69
Identities = 71/269 (26%), Positives = 124/269 (46%), Gaps = 22/269 (8%)
Query: 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIED---VRREV 209
++Y++G +G G FG + VA+K + K +++ + + V EV
Sbjct: 2 LESQYQVGPLLGSGGFGSVYSGIRVSD---NLPVAIKHVEKDRISDWGELPNGTRVPMEV 58
Query: 210 KILRAL-TGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQ 268
+L+ + +G + +++ D +E D+ +++E E + L ++ G E+ A++ Q
Sbjct: 59 VLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQ 118
Query: 269 ILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYY 328
+L V CH GV+HRD+K EN L LK IDFG + D D G+ Y
Sbjct: 119 VLEAVRHCHNCGVLHRDIKDENILIDLNRGE--LKLIDFGSGALL-KDTVYTDFDGTRVY 175
Query: 329 VAPEVL--HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWP 386
PE + HR + A VWS+G++ Y ++CG PF E +++ F
Sbjct: 176 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFR----Q 225
Query: 387 SLSSEARDFVKRLLNKDPRKRLTAAQALS 415
+SSE + ++ L P R T + +
Sbjct: 226 RVSSECQHLIRWCLALRPSDRPTFEEIQN 254
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 217 bits (554), Expect = 3e-68
Identities = 68/303 (22%), Positives = 118/303 (38%), Gaps = 53/303 (17%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRA 214
+ +E E+G G+ G K G +A K+I + RE+++L
Sbjct: 6 DDFEKISELGAGNGGVVFKVSHKPS---GLVMARKLIHLEIKPAIR--NQIIRELQVLHE 60
Query: 215 LTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVA 274
+V F+ A+ + + ME +GG L D++L + G+ E V I ++ +
Sbjct: 61 CN-SPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILGKVSIAVIKGLT 118
Query: 275 FCH-LQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEV 333
+ ++HRD+KP N L + +K DFG+S + D N VG+ Y++PE
Sbjct: 119 YLREKHKIMHRDVKPSNILV---NSRGEIKLCDFGVSGQL-IDSMANSFVGTRSYMSPER 174
Query: 334 LH-RSYSTEADVWSIGVIAYILLCGSRPFWARTES---GIFRAVLKADPSF--------- 380
L YS ++D+WS+G+ + G P +F ++ D +
Sbjct: 175 LQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 234
Query: 381 ----------------------------DEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQ 412
+ P S E +DFV + L K+P +R Q
Sbjct: 235 RPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQ 294
Query: 413 ALS 415
+
Sbjct: 295 LMV 297
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (539), Expect = 1e-66
Identities = 61/268 (22%), Positives = 102/268 (38%), Gaps = 13/268 (4%)
Query: 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALT 216
L E++G G FG ++ K VAVK + ++ A++D REV + +L
Sbjct: 10 LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD 69
Query: 217 GHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFC 276
H NL++ + + +V EL G LLDR+ G + +Q+ + +
Sbjct: 70 -HRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYL 127
Query: 277 HLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDE----RLNDIVGSAYYVAPE 332
+ +HRDL N L ++K DFGL + ++ + APE
Sbjct: 128 ESKRFIHRDLAARNLLL---ATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE 184
Query: 333 VL-HRSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLSS 390
L R++S +D W GV + + G P+ S I + K
Sbjct: 185 SLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPR--PEDCPQ 242
Query: 391 EARDFVKRLLNKDPRKRLTAAQALSELL 418
+ + + + P R T LL
Sbjct: 243 DIYNVMVQCWAHKPEDRPTFVALRDFLL 270
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 210 bits (536), Expect = 4e-65
Identities = 67/266 (25%), Positives = 120/266 (45%), Gaps = 13/266 (4%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRA 214
N + + +GRG FG + G+ A+K + K ++ E +L
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKAD---TGKMYAMKCLDKKRIKMKQGETLALNERIMLSL 60
Query: 215 LT--GHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNV 272
++ +V A+ D + +++L GG+L LS+ G ++E D + +I+
Sbjct: 61 VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDL-HYHLSQHGVFSEADMRFYAAEIILG 119
Query: 273 VAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPE 332
+ H + VV+RDLKP N L DE+ ++ D GL+ ++ + VG+ Y+APE
Sbjct: 120 LEHMHNRFVVYRDLKPANILL---DEHGHVRISDLGLACDF-SKKKPHASVGTHGYMAPE 175
Query: 333 VLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSS 390
VL + +Y + AD +S+G + + LL G PF + + + S S
Sbjct: 176 VLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EIDRMTLTMAVELPDSFSP 234
Query: 391 EARDFVKRLLNKDPRKRLTAAQALSE 416
E R ++ LL +D +RL ++
Sbjct: 235 ELRSLLEGLLQRDVNRRLGCLGRGAQ 260
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (525), Expect = 1e-64
Identities = 63/267 (23%), Positives = 106/267 (39%), Gaps = 23/267 (8%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRA 214
+ +L + +G+G FG G+ +G +VAVK I + E ++
Sbjct: 7 KELKLLQTIGKGEFG-----DVMLGDYRGNKVAVKCIKNDAT-----AQAFLAEASVMTQ 56
Query: 215 LTGHNNLVKFFDA-YEDTDNVYVVMELCEGGELLDRILSRGGKY-TEDDAKAVMIQILNV 272
L H+NLV+ E+ +Y+V E G L+D + SRG D + +
Sbjct: 57 LR-HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEA 115
Query: 273 VAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPE 332
+ + VHRDL N L E++V K DFGL+ + + APE
Sbjct: 116 MEYLEGNNFVHRDLAARNVLV---SEDNVAKVSDFGLTKEA--SSTQDTGKLPVKWTAPE 170
Query: 333 VL-HRSYSTEADVWSIGVIAYILL-CGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSS 390
L + +ST++DVWS G++ + + G P+ + V K +
Sbjct: 171 ALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK---GYKMDAPDGCPP 227
Query: 391 EARDFVKRLLNKDPRKRLTAAQALSEL 417
+ +K + D R + Q +L
Sbjct: 228 AVYEVMKNCWHLDAAMRPSFLQLREQL 254
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (515), Expect = 3e-63
Identities = 58/269 (21%), Positives = 111/269 (41%), Gaps = 21/269 (7%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELK-GQQVAVKVIPKHKMTTAIAIEDVRREVKILR 213
+E+G G FG K G+ + VA+K+I + M+ ++ E K++
Sbjct: 4 KDLTFLKELGTGQFG-----VVKYGKWRGQYDVAIKMIKEGSMSE----DEFIEEAKVMM 54
Query: 214 ALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVV 273
L+ H LV+ + ++++ E G LL+ + ++ + + +
Sbjct: 55 NLS-HEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAM 113
Query: 274 AFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDE--RLNDIVGSAYYVAP 331
+ + +HRDL N L ++ V+K DFGLS +V DE + P
Sbjct: 114 EYLESKQFLHRDLAARNCLV---NDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPP 170
Query: 332 EVL-HRSYSTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLS 389
EVL + +S+++D+W+ GV+ + I G P+ T S + + + S
Sbjct: 171 EVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRP---HLAS 227
Query: 390 SEARDFVKRLLNKDPRKRLTAAQALSELL 418
+ + ++ +R T LS +L
Sbjct: 228 EKVYTIMYSCWHEKADERPTFKILLSNIL 256
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 203 bits (518), Expect = 5e-63
Identities = 67/266 (25%), Positives = 130/266 (48%), Gaps = 16/266 (6%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRA 214
+++ +G G FG + + G+ A+KV+ K + +E E +L
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRH---NGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSI 60
Query: 215 LTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVA 274
+T H +++ + ++D ++++M+ EGGEL +L + ++ AK ++ +
Sbjct: 61 VT-HPFIIRMWGTFQDAQQIFMIMDYIEGGELFS-LLRKSQRFPNPVAKFYAAEVCLALE 118
Query: 275 FCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVL 334
+ H + +++RDLKPEN L D+N +K DFG + +V + + G+ Y+APEV+
Sbjct: 119 YLHSKDIIYRDLKPENILL---DKNGHIKITDFGFAKYV--PDVTYTLCGTPDYIAPEVV 173
Query: 335 -HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEAR 393
+ Y+ D WS G++ Y +L G PF+ + +L A+ F P + + +
Sbjct: 174 STKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRF----PPFFNEDVK 229
Query: 394 DFVKRLLNKDPRKRLTAAQA-LSELL 418
D + RL+ +D +RL Q ++
Sbjct: 230 DLLSRLITRDLSQRLGNLQNGTEDVK 255
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (512), Expect = 5e-62
Identities = 74/268 (27%), Positives = 128/268 (47%), Gaps = 10/268 (3%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMT-TAIAIEDVRREVKILR 213
+EL + +G G +G + G G+ A+KV+ K + A E R E ++L
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 214 ALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVV 273
+ LV A++ ++++++ GGEL LS+ ++TE + + + +I+ +
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGEL-FTHLSQRERFTEHEVQIYVGEIVLAL 142
Query: 274 AFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP--DERLNDIVGSAYYVAP 331
H G+++RD+K EN L D N + DFGLS ER D G+ Y+AP
Sbjct: 143 EHLHKLGIIYRDIKLENILL---DSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAP 199
Query: 332 EVL---HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSL 388
+++ + D WS+GV+ Y LL G+ PF E + + + +
Sbjct: 200 DIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEM 259
Query: 389 SSEARDFVKRLLNKDPRKRLTAAQALSE 416
S+ A+D ++RLL KDP+KRL ++
Sbjct: 260 SALAKDLIQRLLMKDPKKRLGCGPRDAD 287
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (512), Expect = 5e-62
Identities = 69/292 (23%), Positives = 114/292 (39%), Gaps = 36/292 (12%)
Query: 155 NKYELGEEVGRGHFG--YTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKIL 212
E G+ +G G FG A QVAVK++ + ++ E + E+K++
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSER--EALMSELKMM 94
Query: 213 RALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTED------------ 260
L H N+V A + +Y++ E C G+LL+ + S+ K++ED
Sbjct: 95 TQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEE 154
Query: 261 ----------DAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS 310
D Q+ + F + VHRDL N L V+K DFGL+
Sbjct: 155 EEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLV---THGKVVKICDFGLA 211
Query: 311 DFVRPDERL---NDIVGSAYYVAPEVLHRS-YSTEADVWSIGVIAY-ILLCGSRPFWART 365
+ D + ++APE L Y+ ++DVWS G++ + I G P+
Sbjct: 212 RDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 271
Query: 366 ESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSEL 417
F +++ D + E ++ D RKR + S L
Sbjct: 272 VDANFYKLIQNGFKMD--QPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL 321
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (509), Expect = 7e-62
Identities = 76/292 (26%), Positives = 117/292 (40%), Gaps = 37/292 (12%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRA 214
+YE E+G G +G A+ K G+ VA+K + + REV +LR
Sbjct: 7 QQYECVAEIGEGAYGKVFKARDLK--NGGRFVALKRVRVQTGEEGMP-LSTIREVAVLRH 63
Query: 215 LTG--HNNLVKFFDAYEDTDN-----VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMI 267
L H N+V+ FD + + +V E + + K +M
Sbjct: 64 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMF 123
Query: 268 QILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAY 327
Q+L + F H VVHRDLKP+N L + +K DFGL+ L +V + +
Sbjct: 124 QLLRGLDFLHSHRVVHRDLKPQNILV---TSSGQIKLADFGLARIYSFQMALTSVVVTLW 180
Query: 328 YVAPEVLHRS-YSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWP 386
Y APEVL +S Y+T D+WS+G I + F ++ +L E WP
Sbjct: 181 YRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 240
Query: 387 -----------------------SLSSEARDFVKRLLNKDPRKRLTAAQALS 415
+ +D + + L +P KR++A ALS
Sbjct: 241 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (504), Expect = 2e-61
Identities = 60/267 (22%), Positives = 114/267 (42%), Gaps = 19/267 (7%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRA 214
++ +E+G G FG + +VA+K I + M+ ED E +++
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNK----DKVAIKTIREGAMSE----EDFIEEAEVMMK 56
Query: 215 LTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVA 274
L+ H LV+ + + + +V E E G L D + ++ G + + + + + +A
Sbjct: 57 LS-HPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMA 115
Query: 275 FCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLND--IVGSAYYVAPE 332
+ V+HRDL N L EN V+K DFG++ FV D+ + + +PE
Sbjct: 116 YLEEACVIHRDLAARNCLV---GENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPE 172
Query: 333 VL-HRSYSTEADVWSIGVIAYILLCGSRPFW-ARTESGIFRAVLKADPSFDEAPWPSLSS 390
V YS+++DVWS GV+ + + + + R+ S + + + S+
Sbjct: 173 VFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK---PRLAST 229
Query: 391 EARDFVKRLLNKDPRKRLTAAQALSEL 417
+ + P R ++ L +L
Sbjct: 230 HVYQIMNHCWKERPEDRPAFSRLLRQL 256
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (510), Expect = 2e-61
Identities = 75/267 (28%), Positives = 130/267 (48%), Gaps = 15/267 (5%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRA 214
N ++ + +G+G FG + K G+ A+K++ K + + E ++L+
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKA---TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61
Query: 215 LTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVA 274
H L A++ D + VME GGEL + SR +TE+ A+ +I++ +
Sbjct: 62 TR-HPFLTALKYAFQTHDRLCFVMEYANGGELFFHL-SRERVFTEERARFYGAEIVSALE 119
Query: 275 FCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR-PDERLNDIVGSAYYVAPEV 333
+ H + VV+RD+K EN + D++ +K DFGL + G+ Y+APEV
Sbjct: 120 YLHSRDVVYRDIKLENLML---DKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEV 176
Query: 334 LHRS-YSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEA 392
L + Y D W +GV+ Y ++CG PF+ + +F +L + F +LS EA
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRF----PRTLSPEA 232
Query: 393 RDFVKRLLNKDPRKRLTAAQA-LSELL 418
+ + LL KDP++RL + E++
Sbjct: 233 KSLLAGLLKKDPKQRLGGGPSDAKEVM 259
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 198 bits (505), Expect = 2e-61
Identities = 81/289 (28%), Positives = 129/289 (44%), Gaps = 38/289 (13%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRA 214
KY E++G G +G A+ G + A+K I K I RE+ IL+
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYG----ETFALKKIRLEKEDEGI-PSTTIREISILKE 56
Query: 215 LTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVA 274
L H+N+VK +D + +V E + +L + G AK+ ++Q+LN +A
Sbjct: 57 LK-HSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIA 114
Query: 275 FCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR-PDERLNDIVGSAYYVAPEV 333
+CH + V+HRDLKP+N L + LK DFGL+ P + + + +Y AP+V
Sbjct: 115 YCHDRRVLHRDLKPQNLLI---NREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDV 171
Query: 334 LHRS--YSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWP----- 386
L S YST D+WS+G I ++ G+ F +E+ + + + + WP
Sbjct: 172 LMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTEL 231
Query: 387 --------------------SLSSEARDFVKRLLNKDPRKRLTAAQALS 415
L D + ++L DP +R+TA QAL
Sbjct: 232 PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (503), Expect = 3e-61
Identities = 61/267 (22%), Positives = 107/267 (40%), Gaps = 14/267 (5%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRA 214
+ ELG +G G FG + E VA+K T+ E +E +R
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTC--KNCTSDSVREKFLQEALTMRQ 64
Query: 215 LTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVA 274
H ++VK + + V+++MELC GEL + R Q+ +A
Sbjct: 65 F-DHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALA 122
Query: 275 FCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDE--RLNDIVGSAYYVAPE 332
+ + VHRD+ N L N +K DFGLS ++ + + ++APE
Sbjct: 123 YLESKRFVHRDIAARNVLV---SSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPE 179
Query: 333 VL-HRSYSTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSS 390
+ R +++ +DVW GV + IL+ G +PF + + + + P+
Sbjct: 180 SINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER---LPMPPNCPP 236
Query: 391 EARDFVKRLLNKDPRKRLTAAQALSEL 417
+ + DP +R + ++L
Sbjct: 237 TLYSLMTKCWAYDPSRRPRFTELKAQL 263
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 197 bits (502), Expect = 9e-61
Identities = 53/277 (19%), Positives = 99/277 (35%), Gaps = 22/277 (7%)
Query: 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILR 213
N+Y LG ++G G FG G++VA+K+ + E KI +
Sbjct: 6 GNRYRLGRKIGSGSFGDIYLGTDIA---AGEEVAIKLECVKTK-----HPQLHIESKIYK 57
Query: 214 ALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVV 273
+ G + + D +VMEL L D K++ + Q+++ +
Sbjct: 58 MMQGGVGIPTIRWCGAEGDYNVMVMELLGPS-LEDLFNFCSRKFSLKTVLLLADQMISRI 116
Query: 274 AFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDE--------RLNDIVGS 325
+ H + +HRD+KP+NFL + +++ IDFGL+ R ++ G+
Sbjct: 117 EYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGT 176
Query: 326 AYYVAPEVL-HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAP 384
A Y + S D+ S+G + GS P+ + + + P
Sbjct: 177 ARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 236
Query: 385 ----WPSLSSEARDFVKRLLNKDPRKRLTAAQALSEL 417
SE ++ + + +
Sbjct: 237 IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLF 273
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 194 bits (494), Expect = 1e-59
Identities = 64/279 (22%), Positives = 109/279 (39%), Gaps = 18/279 (6%)
Query: 148 GFSKHF-ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVR 206
F+K + ++ + +G G FG C+ K + VA+K + T D
Sbjct: 18 EFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTL--KSGYTEKQRRDFL 75
Query: 207 REVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVM 266
E I+ H N++ + V ++ E E G L + G++T ++
Sbjct: 76 SEASIMGQFD-HPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGML 134
Query: 267 IQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLND----- 321
I + + VHRDL N L + N V K DFGLS F+ D
Sbjct: 135 RGIAAGMKYLADMNYVHRDLAARNILV---NSNLVCKVSDFGLSRFLEDDTSDPTYTSAL 191
Query: 322 -IVGSAYYVAPEVL-HRSYSTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAVLKADP 378
+ APE + +R +++ +DVWS G++ + ++ G RP+W T + A+ +
Sbjct: 192 GGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQ--- 248
Query: 379 SFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSEL 417
+ P S + KD R Q ++ L
Sbjct: 249 DYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTL 287
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (493), Expect = 1e-59
Identities = 58/278 (20%), Positives = 107/278 (38%), Gaps = 18/278 (6%)
Query: 155 NKYELGE-EVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILR 213
+ + + E+G G+FG ++ + K VA+KV+ + T E++ RE +I+
Sbjct: 8 DNLLIADIELGCGNFGSVRQGVYRMRK-KQIDVAIKVL--KQGTEKADTEEMMREAQIMH 64
Query: 214 ALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVV 273
L + +V+ + + + +VME+ GG L ++ + + + ++ Q+ +
Sbjct: 65 QLD-NPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGM 122
Query: 274 AFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLND----IVGSAYYV 329
+ + VHRDL N L K DFGLS + D+ +
Sbjct: 123 KYLEEKNFVHRDLAARNVLL---VNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY 179
Query: 330 APEVL-HRSYSTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPS 387
APE + R +S+ +DVWS GV + L G +P+ + + + P
Sbjct: 180 APECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKR---MECPPE 236
Query: 388 LSSEARDFVKRLLNKDPRKRLTAAQALSELLICYQSYL 425
E + R + CY S
Sbjct: 237 CPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA 274
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 195 bits (495), Expect = 2e-59
Identities = 75/299 (25%), Positives = 130/299 (43%), Gaps = 53/299 (17%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRA 214
+ Y+L ++GRG + A ++V VK++ K + ++RE+KIL
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITN---NEKVVVKILKPVKK------KKIKREIKILEN 85
Query: 215 LTGHNNLVKFFDAYEDTDN--VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNV 272
L G N++ D +D + +V E + T+ D + M +IL
Sbjct: 86 LRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY----QTLTDYDIRFYMYEILKA 141
Query: 273 VAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPE 332
+ +CH G++HRD+KP N + E+ L+ ID+GL++F P + N V S Y+ PE
Sbjct: 142 LDYCHSMGIMHRDVKPHNVMID--HEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPE 199
Query: 333 VL--HRSYSTEADVWSIGVIAYILLCGSRPFWA------------------RTESGIFRA 372
+L ++ Y D+WS+G + ++ PF+ I +
Sbjct: 200 LLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY 259
Query: 373 VLKADPSFDE----------------APWPSLSSEARDFVKRLLNKDPRKRLTAAQALS 415
++ DP F++ +S EA DF+ +LL D + RLTA +A+
Sbjct: 260 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (489), Expect = 6e-59
Identities = 77/286 (26%), Positives = 117/286 (40%), Gaps = 37/286 (12%)
Query: 158 ELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTA--IAIEDVRREVKILRAL 215
E + +G G F A+ K Q VA+K I + A RE+K+L+ L
Sbjct: 1 EKLDFLGEGQFATVYKARDKNT---NQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL 57
Query: 216 TGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAF 275
+ H N++ DA+ N+ +V + E + I T KA M+ L + +
Sbjct: 58 S-HPNIIGLLDAFGHKSNISLVFDFMETDLEVI-IKDNSLVLTPSHIKAYMLMTLQGLEY 115
Query: 276 CHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDERLNDIVGSAYYVAPEVL 334
H ++HRDLKP N L DEN VLK DFGL+ F P+ V + +Y APE+L
Sbjct: 116 LHQHWILHRDLKPNNLLL---DENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELL 172
Query: 335 --HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWP------ 386
R Y D+W++G I LL ++ + + + E WP
Sbjct: 173 FGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLP 232
Query: 387 ------------------SLSSEARDFVKRLLNKDPRKRLTAAQAL 414
+ + D ++ L +P R+TA QAL
Sbjct: 233 DYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQAL 278
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (488), Expect = 6e-59
Identities = 62/268 (23%), Positives = 107/268 (39%), Gaps = 21/268 (7%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRA 214
L ++G+G FG + +VA+K + M + E +E ++++
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGT----TRVAIKTLKPGTM----SPEAFLQEAQVMKK 68
Query: 215 LTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYT-EDDAKAVMIQILNVV 273
L H LV+ + + + +Y+V E G LLD + GKY + QI + +
Sbjct: 69 L-RHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGM 126
Query: 274 AFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDE--RLNDIVGSAYYVAP 331
A+ VHRDL+ N L EN V K DFGL+ + +E + AP
Sbjct: 127 AYVERMNYVHRDLRAANILV---GENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAP 183
Query: 332 EVL-HRSYSTEADVWSIGVIAYILLCGSRPFW-ARTESGIFRAVLKADPSFDEAPWPSLS 389
E + ++ ++DVWS G++ L R + + V + + P
Sbjct: 184 EAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG---YRMPCPPECP 240
Query: 390 SEARDFVKRLLNKDPRKRLTAAQALSEL 417
D + + K+P +R T + L
Sbjct: 241 ESLHDLMCQCWRKEPEERPTFEYLQAFL 268
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (485), Expect = 3e-58
Identities = 77/304 (25%), Positives = 123/304 (40%), Gaps = 52/304 (17%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRA 214
+KYE ++G+G FG A+ +K GQ+VA+K + I RE+KIL+
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRK---TGQKVALKKVLMENEKEGFPIT-ALREIKILQL 65
Query: 215 LTGHNNLVKFFDAYEDTD--------NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVM 266
L H N+V + ++Y+V + CE L + + K+T + K VM
Sbjct: 66 L-KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHD-LAGLLSNVLVKFTLSEIKRVM 123
Query: 267 IQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDE-----RLND 321
+LN + + H ++HRD+K N L + VLK DFGL+ + R +
Sbjct: 124 QMLLNGLYYIHRNKILHRDMKAANVLI---TRDGVLKLADFGLARAFSLAKNSQPNRYTN 180
Query: 322 IVGSAYYVAPEVL--HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPS 379
V + +Y PE+L R Y D+W G I + S TE + + S
Sbjct: 181 RVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGS 240
Query: 380 FDEAPWPSL----------------------------SSEARDFVKRLLNKDPRKRLTAA 411
WP++ A D + +LL DP +R+ +
Sbjct: 241 ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSD 300
Query: 412 QALS 415
AL+
Sbjct: 301 DALN 304
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (487), Expect = 4e-58
Identities = 75/300 (25%), Positives = 118/300 (39%), Gaps = 50/300 (16%)
Query: 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILR 213
+Y +G G +G C+A +VA+K I + T + RE+KIL
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVN---KVRVAIKKISPFEHQTYC--QRTLREIKILL 61
Query: 214 ALTGHNNLVKFFDAYEDTD-----NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQ 268
H N++ D +VY+V L G +L + + + D + Q
Sbjct: 62 RFR-HENIIGINDIIRAPTIEQMKDVYLVTHLM-GADLYKLL--KTQHLSNDHICYFLYQ 117
Query: 269 ILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDE----RLNDIVG 324
IL + + H V+HRDLKP N L + LK DFGL+ PD L + V
Sbjct: 118 ILRGLKYIHSANVLHRDLKPSNLLL---NTTCDLKICDFGLARVADPDHDHTGFLTEYVA 174
Query: 325 SAYYVAPEVLHRS--YSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDE 382
+ +Y APE++ S Y+ D+WS+G I +L F + +L S +
Sbjct: 175 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ 234
Query: 383 APW---------------------------PSLSSEARDFVKRLLNKDPRKRLTAAQALS 415
P+ S+A D + ++L +P KR+ QAL+
Sbjct: 235 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (484), Expect = 5e-58
Identities = 64/287 (22%), Positives = 105/287 (36%), Gaps = 31/287 (10%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELK--GQQVAVKVIPKHKMTTAIAIEDVRREVKIL 212
N+ G+ +G G FG A VAVK++ T E + E+K+L
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTER--EALMSELKVL 80
Query: 213 RALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKY--------------- 257
L H N+V A V+ E C G+LL+ + + +
Sbjct: 81 SYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDEL 140
Query: 258 --TEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP 315
+D + Q+ +AF + +HRDL N L + K DFGL+ ++
Sbjct: 141 ALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNIL---LTHGRITKICDFGLARDIKN 197
Query: 316 DERL---NDIVGSAYYVAPEVLHRSY-STEADVWSIGVIAYILLCGSRP-FWARTESGIF 370
D + ++APE + + E+DVWS G+ + L + F
Sbjct: 198 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF 257
Query: 371 RAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSEL 417
++K +E D +K + DP KR T Q + +
Sbjct: 258 YKMIKEGFRML--SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLI 302
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (482), Expect = 1e-57
Identities = 62/280 (22%), Positives = 111/280 (39%), Gaps = 26/280 (9%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRA 214
N + + +G G+FG A+ KK G ++ + + + D E+++L
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKD---GLRMDAAIKRMKEYASKDDHRDFAGELEVLCK 66
Query: 215 LTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRIL---------------SRGGKYTE 259
L H N++ A E +Y+ +E G LLD + S +
Sbjct: 67 LGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSS 126
Query: 260 DDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERL 319
+ + + + +HRDL N L EN V K DFGLS +
Sbjct: 127 QQLLHFAADVARGMDYLSQKQFIHRDLAARNILV---GENYVAKIADFGLSRGQEVYVKK 183
Query: 320 NDIVGSAYYVAPEVLHRS-YSTEADVWSIGVIAYILL-CGSRPFWARTESGIFRAVLKAD 377
++A E L+ S Y+T +DVWS GV+ + ++ G P+ T + ++ + +
Sbjct: 184 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG- 242
Query: 378 PSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSEL 417
+ + E D +++ + P +R + AQ L L
Sbjct: 243 --YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSL 280
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (478), Expect = 2e-57
Identities = 58/268 (21%), Positives = 109/268 (40%), Gaps = 21/268 (7%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRA 214
+L E +G G FG + +VAVK + + M+ + E +++
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGH----TKVAVKSLKQGSMSP----DAFLAEANLMKQ 64
Query: 215 LTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGG-KYTEDDAKAVMIQILNVV 273
L H LV+ + + +Y++ E E G L+D + + G K T + + QI +
Sbjct: 65 LQ-HQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGM 122
Query: 274 AFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDE--RLNDIVGSAYYVAP 331
AF + +HRDL+ N L + K DFGL+ + +E + AP
Sbjct: 123 AFIEERNYIHRDLRAANILV---SDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAP 179
Query: 332 EVL-HRSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLS 389
E + + +++ ++DVWS G++ ++ G P+ T + + + + +
Sbjct: 180 EAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR---PDNCP 236
Query: 390 SEARDFVKRLLNKDPRKRLTAAQALSEL 417
E ++ + P R T S L
Sbjct: 237 EELYQLMRLCWKERPEDRPTFDYLRSVL 264
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (479), Expect = 2e-57
Identities = 55/284 (19%), Positives = 115/284 (40%), Gaps = 26/284 (9%)
Query: 155 NKYELGEEVGRGHFGYTCAAKF----KKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVK 210
++ LG+ +G G FG A+ K + +VAVK++ T + D+ E++
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEME 70
Query: 211 ILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRG---------------G 255
+++ + H N++ A +YV++E G L + + +R
Sbjct: 71 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEE 130
Query: 256 KYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP 315
+ + D + Q+ + + + +HRDL N L T + + +
Sbjct: 131 QLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY 190
Query: 316 DERLNDIVGSAYYVAPEVL-HRSYSTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAV 373
++ + ++APE L R Y+ ++DVWS GV+ + I G P+ +F+ +
Sbjct: 191 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL 250
Query: 374 LKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSEL 417
+ + ++E ++ + P +R T Q + +L
Sbjct: 251 KEGHR---MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 291
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (478), Expect = 3e-57
Identities = 77/288 (26%), Positives = 121/288 (42%), Gaps = 36/288 (12%)
Query: 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRAL 215
++ E++G G +G A+ K G+ VA+K I T + RE+ +L+ L
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKL---TGEVVALKKIRLDTETEGV-PSTAIREISLLKEL 58
Query: 216 TGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAF 275
H N+VK D + +Y+V E S K+ + Q+L +AF
Sbjct: 59 -NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 117
Query: 276 CHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV-RPDERLNDIVGSAYYVAPEVL 334
CH V+HRDLKP+N L + +K DFGL+ P V + +Y APE+L
Sbjct: 118 CHSHRVLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEIL 174
Query: 335 HRS--YSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPS----- 387
YST D+WS+G I ++ F +E + + + DE WP
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMP 234
Query: 388 --------------------LSSEARDFVKRLLNKDPRKRLTAAQALS 415
L + R + ++L+ DP KR++A AL+
Sbjct: 235 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (474), Expect = 6e-57
Identities = 58/262 (22%), Positives = 107/262 (40%), Gaps = 17/262 (6%)
Query: 162 EVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNL 221
E+G G+FG ++ ++ + VAVK++ A+ +++ E +++ L + +
Sbjct: 14 ELGSGNFGTVKKGYYQMKKV-VKTVAVKILKNEANDPAL-KDELLAEANVMQQLD-NPYI 70
Query: 222 VKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGV 281
V+ E ++ +VME+ E G L ++ L + + + ++ Q+ + +
Sbjct: 71 VRMIGICEA-ESWMLVMEMAELGPL-NKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNF 128
Query: 282 VHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLND----IVGSAYYVAPEVL-HR 336
VHRDL N L K DFGLS +R DE + APE + +
Sbjct: 129 VHRDLAARNVLL---VTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 185
Query: 337 SYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDF 395
+S+++DVWS GV+ + G +P+ S + + K + E D
Sbjct: 186 KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGER---MGCPAGCPREMYDL 242
Query: 396 VKRLLNKDPRKRLTAAQALSEL 417
+ D R A L
Sbjct: 243 MNLCWTYDVENRPGFAAVELRL 264
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 184 bits (469), Expect = 4e-56
Identities = 54/267 (20%), Positives = 104/267 (38%), Gaps = 17/267 (6%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRA 214
+ ++G G +G +KK VAVK + + M +E+ +E +++
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKY---SLTVAVKTLKEDTM----EVEEFLKEAAVMKE 69
Query: 215 LTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRG-GKYTEDDAKAVMIQILNVV 273
+ H NLV+ Y++ E G LLD + + + + QI + +
Sbjct: 70 IK-HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAM 128
Query: 274 AFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDE--RLNDIVGSAYYVAP 331
+ + +HRDL N L EN ++K DFGLS + D + AP
Sbjct: 129 EYLEKKNFIHRDLAARNCLV---GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAP 185
Query: 332 EVL-HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSS 390
E L + +S ++DVW+ GV+ + + + + +L+ D +
Sbjct: 186 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRME--RPEGCPE 243
Query: 391 EARDFVKRLLNKDPRKRLTAAQALSEL 417
+ + ++ +P R + A+
Sbjct: 244 KVYELMRACWQWNPSDRPSFAEIHQAF 270
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 186 bits (472), Expect = 8e-56
Identities = 75/266 (28%), Positives = 132/266 (49%), Gaps = 16/266 (6%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRA 214
++++ + +G G FG K K+ G A+K++ K K+ IE E +IL+A
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKE---SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 215 LTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVA 274
+ LVK +++D N+Y+VME GGE+ L R G+++E A+ QI+
Sbjct: 98 V-NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFS-HLRRIGRFSEPHARFYAAQIVLTFE 155
Query: 275 FCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVL 334
+ H +++RDLKPEN L D+ ++ DFG + R R + G+ +APE++
Sbjct: 156 YLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAK--RVKGRTWTLCGTPEALAPEII 210
Query: 335 -HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEAR 393
+ Y+ D W++GV+ Y + G PF+A I+ ++ F SS+ +
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF----PSHFSSDLK 266
Query: 394 DFVKRLLNKDPRKRLTAAQA-LSELL 418
D ++ LL D KR + ++++
Sbjct: 267 DLLRNLLQVDLTKRFGNLKNGVNDIK 292
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (472), Expect = 8e-56
Identities = 70/294 (23%), Positives = 112/294 (38%), Gaps = 48/294 (16%)
Query: 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALT 216
Y + +G G FG AK G+ VA+K + + K RE++I+R L
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCD---SGELVAIKKVLQDK-------RFKNRELQIMRKL- 70
Query: 217 GHNNLVKFFDAY------EDTDNVYVVMELCEGG--ELLDRILSRGGKYTEDDAKAVMIQ 268
H N+V+ + +D + +V++ + K M Q
Sbjct: 71 DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ 130
Query: 269 ILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYY 328
+ +A+ H G+ HRD+KP+N L + +VLK DFG + + E + S YY
Sbjct: 131 LFRSLAYIHSFGICHRDIKPQNLLLD--PDTAVLKLCDFGSAKQLVRGEPNVSYICSRYY 188
Query: 329 VAPEVLHRS--YSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKA---------- 376
APE++ + Y++ DVWS G + LL G F + ++K
Sbjct: 189 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR 248
Query: 377 ---------------DPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALS 415
+ + P EA RLL P RLT +A +
Sbjct: 249 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 184 bits (467), Expect = 9e-56
Identities = 55/286 (19%), Positives = 101/286 (35%), Gaps = 24/286 (8%)
Query: 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILR 213
Y++G +G G FG QQVA+K P+ +R E + +
Sbjct: 4 GVHYKVGRRIGEGSFGVIFEGTNLL---NNQQVAIKFEPRRSD-----APQLRDEYRTYK 55
Query: 214 ALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVV 273
L G + + ++ + +V++L G L D + G K++ Q+L V
Sbjct: 56 LLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARV 114
Query: 274 AFCHLQGVVHRDLKPENFLFTTKD--ENSVLKAIDFGLSDFVRPDE--------RLNDIV 323
H + +V+RD+KP+NFL + +++ +DFG+ F R ++
Sbjct: 115 QSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLS 174
Query: 324 GSAYYVAPEVL-HRSYSTEADVWSIGVIAYILLCGSRPFWARTESG----IFRAVLKADP 378
G+A Y++ R S D+ ++G + L GS P+ + R K
Sbjct: 175 GTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS 234
Query: 379 SFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLICYQSY 424
+ E ++ N +
Sbjct: 235 TPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL 280
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 184 bits (467), Expect = 1e-55
Identities = 57/293 (19%), Positives = 105/293 (35%), Gaps = 39/293 (13%)
Query: 155 NKYELGEEVGRGHFG--YTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKIL 212
N E ++G G FG + A VAVK++ + D +RE ++
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASAD--MQADFQREAALM 70
Query: 213 RALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKY--------------- 257
+ N+VK + ++ E G+L + + S
Sbjct: 71 AEF-DNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARV 129
Query: 258 --------TEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGL 309
+ + + Q+ +A+ + VHRDL N L EN V+K DFGL
Sbjct: 130 SSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLV---GENMVVKIADFGL 186
Query: 310 SDFVRPDERL---NDIVGSAYYVAPEVL-HRSYSTEADVWSIGVIAYILLCGSR-PFWAR 364
S + + + ++ PE + + Y+TE+DVW+ GV+ + + P++
Sbjct: 187 SRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM 246
Query: 365 TESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSEL 417
+ V + A + E + ++ +K P R + L
Sbjct: 247 AHEEVIYYVRDGNI---LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRIL 296
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (465), Expect = 2e-55
Identities = 78/290 (26%), Positives = 125/290 (43%), Gaps = 38/290 (13%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRA 214
KYE E++G G +G AK ++ + VA+K + + RE+ +L+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRET---HEIVALKRVRLDDDDEGV-PSSALREICLLKE 57
Query: 215 LTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVA 274
L H N+V+ D + +V E C+ G + K+ + Q+L +
Sbjct: 58 LK-HKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNG-DLDPEIVKSFLFQLLKGLG 115
Query: 275 FCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDERLNDIVGSAYYVAPEV 333
FCH + V+HRDLKP+N L + N LK +FGL+ F P + V + +Y P+V
Sbjct: 116 FCHSRNVLHRDLKPQNLLI---NRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDV 172
Query: 334 LHRS--YSTEADVWSIGVIAYILLCGSRP-FWARTESGIFRAVLKADPSFDEAPWPS--- 387
L + YST D+WS G I L RP F + + + + E WPS
Sbjct: 173 LFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTK 232
Query: 388 ----------------------LSSEARDFVKRLLNKDPRKRLTAAQALS 415
L++ RD ++ LL +P +R++A +AL
Sbjct: 233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (467), Expect = 5e-55
Identities = 65/295 (22%), Positives = 123/295 (41%), Gaps = 42/295 (14%)
Query: 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKIL 212
Y + VG G +G C+A + G +VA+K + + + A + RE+++L
Sbjct: 16 VRAVYRDLQPVGSGAYGAVCSAVDGR---TGAKVAIKKLYRPFQSELFA-KRAYRELRLL 71
Query: 213 RALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRI---LSRGGKYTEDDAKAVMIQI 269
+ + H N++ D + + + + + L + K ED + ++ Q+
Sbjct: 72 KHMR-HENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQM 130
Query: 270 LNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYV 329
L + + H G++HRDLKP N +E+ LK +DFGL+ D + V + +Y
Sbjct: 131 LKGLRYIHAAGIIHRDLKPGNLAV---NEDCELKILDFGLARQ--ADSEMTGYVVTRWYR 185
Query: 330 APEVL--HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPW-- 385
APEV+ Y+ D+WS+G I ++ G F + ++K +
Sbjct: 186 APEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQR 245
Query: 386 -------------------------PSLSSEARDFVKRLLNKDPRKRLTAAQALS 415
+ S A + ++++L D +R+TA +AL+
Sbjct: 246 LQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 300
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (459), Expect = 3e-54
Identities = 55/267 (20%), Positives = 107/267 (40%), Gaps = 16/267 (5%)
Query: 157 YELGEEVGRGHFGYTCAAKFKK-GELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRAL 215
++ + +G G FG + GE VA+K + + T+ A +++ E ++ ++
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL--REATSPKANKEILDEAYVMASV 68
Query: 216 TGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAF 275
+ ++ + V ++ +L G LLD + +QI + +
Sbjct: 69 D-NPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 126
Query: 276 CHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDER---LNDIVGSAYYVAPE 332
+ +VHRDL N L +K DFGL+ + +E+ ++A E
Sbjct: 127 LEDRRLVHRDLAARNVLV---KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 183
Query: 333 VL-HRSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLSS 390
+ HR Y+ ++DVWS GV + L+ GS+P+ S I + K + P +
Sbjct: 184 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER---LPQPPICTI 240
Query: 391 EARDFVKRLLNKDPRKRLTAAQALSEL 417
+ + + D R + + E
Sbjct: 241 DVYMIMVKCWMIDADSRPKFRELIIEF 267
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (455), Expect = 1e-53
Identities = 55/278 (19%), Positives = 108/278 (38%), Gaps = 17/278 (6%)
Query: 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRAL 215
E +GRGHFG + K AVK + +++T + E I++
Sbjct: 28 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMKDF 85
Query: 216 TGHNNLVKFFDAYEDTDN-VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVA 274
+ H N++ ++ VV+ + G+L + I + T D +Q+ +
Sbjct: 86 S-HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMK 144
Query: 275 FCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDE-----RLNDIVGSAYYV 329
F + VHRDL N + DE +K DFGL+ + E ++
Sbjct: 145 FLASKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM 201
Query: 330 APEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWA-RTESGIFRAVLKADPSFDEAPWPS 387
A E L + ++T++DVWS GV+ + L+ P + I +L+
Sbjct: 202 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQP---EY 258
Query: 388 LSSEARDFVKRLLNKDPRKRLTAAQALSELLICYQSYL 425
+ + + + R + ++ +S + + +++
Sbjct: 259 CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 296
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (434), Expect = 5e-51
Identities = 57/270 (21%), Positives = 106/270 (39%), Gaps = 16/270 (5%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKK-GELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILR 213
+ + +G G FG K K VA+K + T D E I+
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTL--KAGYTEKQRVDFLGEAGIMG 64
Query: 214 ALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVV 273
H+N+++ + ++ E E G L + + G+++ ++ I +
Sbjct: 65 QF-SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGM 123
Query: 274 AFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDER----LNDIVGSAYYV 329
+ VHRDL N L + N V K DFGLS + D + +
Sbjct: 124 KYLANMNYVHRDLAARNILV---NSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT 180
Query: 330 APEVL-HRSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPS 387
APE + +R +++ +DVWS G++ + ++ G RP+W + + +A+ + F
Sbjct: 181 APEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAI---NDGFRLPTPMD 237
Query: 388 LSSEARDFVKRLLNKDPRKRLTAAQALSEL 417
S + + ++ +R A +S L
Sbjct: 238 CPSAIYQLMMQCWQQERARRPKFADIVSIL 267
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (439), Expect = 6e-51
Identities = 68/306 (22%), Positives = 121/306 (39%), Gaps = 57/306 (18%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRA 214
+Y+ + +G G G CAA + VA+K + + + RE+ +++
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAV---LDRNVAIKKLSRPFQNQT-HAKRAYRELVLMKC 72
Query: 215 LTGHNNLVKFFDAY------EDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQ 268
+ H N++ + + E+ +VY+VMEL + + + ++ Q
Sbjct: 73 V-NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ----MELDHERMSYLLYQ 127
Query: 269 ILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYY 328
+L + H G++HRDLKP N + + LK +DFGL+ + V + YY
Sbjct: 128 MLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTPYVVTRYY 184
Query: 329 VAPE-VLHRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKA----------- 376
APE +L Y D+WS+G I ++ F R + V++
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 244
Query: 377 -----------DPSFDEAPWPSL----------------SSEARDFVKRLLNKDPRKRLT 409
P + +P L +S+ARD + ++L DP KR++
Sbjct: 245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRIS 304
Query: 410 AAQALS 415
AL
Sbjct: 305 VDDALQ 310
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (432), Expect = 2e-50
Identities = 61/307 (19%), Positives = 114/307 (37%), Gaps = 59/307 (19%)
Query: 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILR 213
A L E +G+G FG + +G+ +G++VAVK+ + RE +I +
Sbjct: 2 ARTIVLQESIGKGRFG-----EVWRGKWRGEEVAVKIFSSREE------RSWFREAEIYQ 50
Query: 214 -ALTGHNNLVKFFDAYEDTDN----VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQ 268
+ H N++ F A + +++V + E G L D + T + + +
Sbjct: 51 TVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALS 108
Query: 269 ILNVVAFCHLQ--------GVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDE--- 317
+ +A H++ + HRDLK +N L +N D GL+
Sbjct: 109 TASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTCCIADLGLAVRHDSATDTI 165
Query: 318 --RLNDIVGSAYYVAPEVL-------HRSYSTEADVWSIGVIAYILLCGSRPFWARTESG 368
N VG+ Y+APEVL H AD++++G++ + + +
Sbjct: 166 DIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQ 225
Query: 369 I-FRAVLKADPSFDE-----------------APWPSLSSEARDFVKRLLNKDPRKRLTA 410
+ + ++ +DPS +E ++ + RLTA
Sbjct: 226 LPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTA 285
Query: 411 AQALSEL 417
+ L
Sbjct: 286 LRIKKTL 292
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (429), Expect = 1e-49
Identities = 74/297 (24%), Positives = 128/297 (43%), Gaps = 46/297 (15%)
Query: 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKIL 212
+Y+ VG G +G CAA K G +VAVK + + + I + RE+++L
Sbjct: 16 VPERYQNLSPVGSGAYGSVCAAFDTK---TGLRVAVKKLSRPFQSI-IHAKRTYRELRLL 71
Query: 213 RALTGHNNLVKFFDAYED-----TDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMI 267
+ + H N++ D + N ++ G +L + + + K T+D + ++
Sbjct: 72 KHMK-HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNN--IVKCQKLTDDHVQFLIY 128
Query: 268 QILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAY 327
QIL + + H ++HRDLKP N +E+ LK +DFGL+ D+ + V + +
Sbjct: 129 QILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLARH--TDDEMTGYVATRW 183
Query: 328 YVAPEVLHRS--YSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPW 385
Y APE++ Y+ D+WS+G I LL G F + +L+ +
Sbjct: 184 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 243
Query: 386 ---------------------------PSLSSEARDFVKRLLNKDPRKRLTAAQALS 415
+ A D ++++L D KR+TAAQAL+
Sbjct: 244 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (424), Expect = 3e-49
Identities = 53/295 (17%), Positives = 114/295 (38%), Gaps = 29/295 (9%)
Query: 155 NKYELGEEVGRGHFG--YTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKIL 212
K + E+G+G FG Y AK + +VA+K + + + E ++
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMR--ERIEFLNEASVM 77
Query: 213 RALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGG---------KYTEDDAK 263
+ +++V+ V+MEL G+L + S +
Sbjct: 78 KEF-NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMI 136
Query: 264 AVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERL---N 320
+ +I + +A+ + VHRDL N + E+ +K DFG++ + +
Sbjct: 137 QMAGEIADGMAYLNANKFVHRDLAARNCMV---AEDFTVKIGDFGMTRDIYETDYYRKGG 193
Query: 321 DIVGSAYYVAPEVL-HRSYSTEADVWSIGVIAYILLCGSR-PFWARTESGIFRAVLKADP 378
+ +++PE L ++T +DVWS GV+ + + + P+ + + R V++
Sbjct: 194 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGL 253
Query: 379 SFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLICYQSYL----FFYS 429
+ + ++ +P+ R + + +S + + F+YS
Sbjct: 254 ---LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVSFYYS 305
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (419), Expect = 1e-48
Identities = 65/286 (22%), Positives = 115/286 (40%), Gaps = 30/286 (10%)
Query: 155 NKYELGEEVGRGHFG--YTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKIL 212
++ +LG+ +GRG FG A + VAVK++ + + + E+KIL
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS--EHRALMSELKIL 70
Query: 213 RALTGHNNLVKFFDA-YEDTDNVYVVMELCEGGELLDRILSRGGKY-------------- 257
+ H N+V A + + V++E C+ G L + S+ ++
Sbjct: 71 IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF 130
Query: 258 -TEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPD 316
T + Q+ + F + +HRDL N L E +V+K DFGL+ + D
Sbjct: 131 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL---SEKNVVKICDFGLARDIYKD 187
Query: 317 E---RLNDIVGSAYYVAPEVL-HRSYSTEADVWSIGVIAYILLCGSR-PFWARTESGIFR 371
R D ++APE + R Y+ ++DVWS GV+ + + P+ F
Sbjct: 188 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 247
Query: 372 AVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSEL 417
LK + E + + +P +R T ++ + L
Sbjct: 248 RRLKEGTRMR--APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 291
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 139 bits (351), Expect = 3e-38
Identities = 68/321 (21%), Positives = 110/321 (34%), Gaps = 68/321 (21%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRA 214
+Y L ++G GHF AK VA+K++ K+ T E E+K+L+
Sbjct: 13 ARYILVRKLGWGHFSTVWLAKDMVN---NTHVAMKIVRGDKVYT----EAAEDEIKLLQR 65
Query: 215 L----------TGHNNLVK----FFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTED 260
+ G N+++K F + +V +V E+ L
Sbjct: 66 VNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLI 125
Query: 261 DAKAVMIQILNVVAFCHLQ-GVVHRDLKPENFLFTTKDENSVLKAI-DFGLSDFVRPDER 318
K + Q+L + + H + G++H D+KPEN L D L I L + DE
Sbjct: 126 YVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH 185
Query: 319 LNDIVGSAYYVAPEVL-HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIF------- 370
+ + + Y +PEVL + AD+WS + + L+ G F
Sbjct: 186 YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIA 245
Query: 371 --------------------------RAVLKADPSFDEAPW-----------PSLSSEAR 393
R +L+ P + E
Sbjct: 246 QIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEIS 305
Query: 394 DFVKRLLNKDPRKRLTAAQAL 414
DF+ +L DPRKR A +
Sbjct: 306 DFLSPMLQLDPRKRADAGGLV 326
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 87.5 bits (216), Expect = 8e-21
Identities = 45/214 (21%), Positives = 74/214 (34%), Gaps = 41/214 (19%)
Query: 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMT---------------TAIA 201
+G+ +G G +K + VK + + +A
Sbjct: 2 DAIGKLMGEGKESAVFNCYSEKF----GECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLA 57
Query: 202 IEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDD 261
I R E + L+ L + K + + V+MEL + + ++
Sbjct: 58 IRSARNEFRALQKL-QGLAVPKVYAWEGN----AVLMELIDAK--------ELYRVRVEN 104
Query: 262 AKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPD-ERLN 320
V+ IL VA + +G+VH DL N L + + + IDF S V E
Sbjct: 105 PDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEG----IWIIDFPQS--VEVGEEGWR 158
Query: 321 DIVGSAYYVAPEVLHRSYSTEADVWSIGVIAYIL 354
+I+ R+Y TE D+ S I IL
Sbjct: 159 EILERDVRNIITYFSRTYRTEKDINS--AIDRIL 190
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Score = 43.1 bits (100), Expect = 3e-05
Identities = 22/184 (11%), Positives = 53/184 (28%), Gaps = 4/184 (2%)
Query: 172 CAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231
AK K + + + +K+ T DV RE ++ L G + K
Sbjct: 26 SPAKVYKLVGENENLYLKMTDSRYKGTT---YDVEREKDMMLWLEGKLPVPKVLHFERHD 82
Query: 232 DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENF 291
++M +G + + A I++ + + D +
Sbjct: 83 GWSNLLMSEADGVLCSEEYEDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAEL 142
Query: 292 LFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVL-HRSYSTEADVWSIGVI 350
+ ++ + + ++ + L D + + V H G +
Sbjct: 143 DYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKV 202
Query: 351 AYIL 354
+ +
Sbjct: 203 SGFI 206
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} Length = 392 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Score = 37.1 bits (85), Expect = 0.003
Identities = 23/165 (13%), Positives = 53/165 (32%), Gaps = 8/165 (4%)
Query: 161 EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIP----KHKMTTAIAIEDVRREVKILRALT 216
+E+G G+ Y ++ + + +K + + I+ R E L
Sbjct: 32 QEIGDGNLNYVFHIYDQEH---DRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQG 88
Query: 217 GHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFC 276
H + Y DT+ VME ++ + L G+ ++ + + + +
Sbjct: 89 EHVPHLVPRVFYSDTEMAVTVMEDLSHLKIARKGL-IEGENYPHLSQHIGEFLGKTLFYS 147
Query: 277 HLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLND 321
+ + K FT + + + + F F +
Sbjct: 148 SDYALEPKVKKQLVKQFTNPELCDITERLVFTDPFFDHDTNDFEE 192
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 429 | |||
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.93 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.69 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.17 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.14 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.53 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.35 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.74 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-61 Score=457.50 Aligned_cols=257 Identities=29% Similarity=0.559 Sum_probs=230.4
Q ss_pred cCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~ 233 (429)
.++|++++.||+|+||.||+|+.+. +|+.||||++.+.........+.+.+|++++++++ |||||++++++.+++.
T Consensus 5 l~dy~i~~~iG~G~fg~Vy~~~~~~---~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~~~~~ 80 (263)
T d2j4za1 5 LEDFEIGRPLGKGKFGNVYLAREKQ---SKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HPNILRLYGYFHDATR 80 (263)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCC-CTTBCCEEEEEECSSE
T ss_pred hhHeEEEEEEecCCCcEEEEEEECC---CCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcC-CCCCCeEEEEEEECCE
Confidence 3689999999999999999999876 58999999987554444445677899999999998 9999999999999999
Q ss_pred EEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCcccc
Q 014210 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (429)
Q Consensus 234 ~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~ 313 (429)
+|||||||++|+|.+++.. .+.+++..++.++.||++||+|||++|||||||||+|||+ +.++.+||+|||+++..
T Consensus 81 ~~ivmEy~~~g~L~~~l~~-~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill---~~~~~~kl~DFG~a~~~ 156 (263)
T d2j4za1 81 VYLILEYAPLGTVYRELQK-LSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLL---GSAGELKIADFGWSVHA 156 (263)
T ss_dssp EEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEECCCCSCSCC
T ss_pred EEEEEeecCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeecccccee---cCCCCEeecccceeeec
Confidence 9999999999999998864 4579999999999999999999999999999999999999 77889999999999876
Q ss_pred CCCccccccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHH
Q 014210 314 RPDERLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEA 392 (429)
Q Consensus 314 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 392 (429)
... ......||+.|||||++.+ .++.++|||||||+||||++|+.||.+.+....+..+.+....++. .+++++
T Consensus 157 ~~~-~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~ 231 (263)
T d2j4za1 157 PSS-RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGA 231 (263)
T ss_dssp CCC-CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCT----TSCHHH
T ss_pred CCC-cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCc----cCCHHH
Confidence 533 3456789999999999985 5899999999999999999999999999998998888887765543 589999
Q ss_pred HHHHHHhcccCccCcCCHHHHHhhHhhhccc
Q 014210 393 RDFVKRLLNKDPRKRLTAAQALSELLICYQS 423 (429)
Q Consensus 393 ~~li~~~L~~dP~~Rps~~~iL~~~~~~~~~ 423 (429)
.+||.+||+.||++|||+.|+|+|+||+..+
T Consensus 232 ~~li~~~L~~dp~~R~t~~eil~hp~~~~~s 262 (263)
T d2j4za1 232 RDLISRLLKHNPSQRPMLREVLEHPWITANS 262 (263)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHTCHHHHHHC
T ss_pred HHHHHHHccCCHhHCcCHHHHHcCcCcCCcC
Confidence 9999999999999999999999999998654
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5e-61 Score=464.53 Aligned_cols=265 Identities=41% Similarity=0.728 Sum_probs=220.9
Q ss_pred ccccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEe
Q 014210 151 KHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED 230 (429)
Q Consensus 151 ~~~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~ 230 (429)
+.+.+.|+++++||+|+||.||+|+.+. +|+.||||++.+..... ..+.+.+|++++++|+ |||||++++++.+
T Consensus 5 edi~d~Y~~~~~lG~G~fg~Vy~~~~~~---~~~~vAvK~i~~~~~~~--~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~ 78 (307)
T d1a06a_ 5 EDIRDIYDFRDVLGTGAFSEVILAEDKR---TQKLVAIKCIAKKALEG--KEGSMENEIAVLHKIK-HPNIVALDDIYES 78 (307)
T ss_dssp SCGGGTEEEEEESBSGGGGGEEEEEETT---TCCEEEEEEEEC------------CHHHHHHHTCC-CTTBCCEEEEEEC
T ss_pred CCCccceEEEEEEeeccCeEEEEEEECC---CCCEEEEEEEchHHhhh--HHHHHHHHHHHHHhCC-CCCCCcEEEEEEE
Confidence 3456789999999999999999998776 58999999997654332 3356889999999998 9999999999999
Q ss_pred CCeEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCc
Q 014210 231 TDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS 310 (429)
Q Consensus 231 ~~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla 310 (429)
++.+|||||||+||+|.+++.. .+.+++..++.++.||+.||+|||++|||||||||+|||+...++++.+||+|||++
T Consensus 79 ~~~~~lvmE~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a 157 (307)
T d1a06a_ 79 GGHLYLIMQLVSGGELFDRIVE-KGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLS 157 (307)
T ss_dssp SSEEEEEECCCCSCBHHHHHHT-CSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC---
T ss_pred CCEEEEEEeccCCCcHHHhhhc-ccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEecccee
Confidence 9999999999999999998854 567999999999999999999999999999999999999977677889999999999
Q ss_pred cccCCCccccccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCC
Q 014210 311 DFVRPDERLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLS 389 (429)
Q Consensus 311 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 389 (429)
+...........+||+.|||||++.+ .|+.++|||||||++|||++|+.||.+.........+++....+....++.++
T Consensus 158 ~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 237 (307)
T d1a06a_ 158 KMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDIS 237 (307)
T ss_dssp ---------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSC
T ss_pred EEccCCCeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCC
Confidence 98776666677899999999999875 68999999999999999999999999999999999999988888777778899
Q ss_pred HHHHHHHHHhcccCccCcCCHHHHHhhHhhhcc
Q 014210 390 SEARDFVKRLLNKDPRKRLTAAQALSELLICYQ 422 (429)
Q Consensus 390 ~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~ 422 (429)
+++.+||++||++||++|||+.|+|+|+||+..
T Consensus 238 ~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 270 (307)
T d1a06a_ 238 DSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGD 270 (307)
T ss_dssp HHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTSS
T ss_pred HHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 999999999999999999999999999999754
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-60 Score=452.98 Aligned_cols=258 Identities=31% Similarity=0.539 Sum_probs=217.8
Q ss_pred cCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~ 233 (429)
.++|+++++||+|+||.||+|+.+. +|+.||||++.+... ....+++.+|++++++++ |||||++++++.+++.
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~---~~~~vAiK~i~~~~~--~~~~~~~~~Ei~~l~~l~-HpnIv~~~~~~~~~~~ 77 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRV---TEEAVAVKIVDMKRA--VDCPENIKKEICINKMLN-HENVVKFYGHRREGNI 77 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEECC---------CHHHHHHHHHTCC-CTTBCCEEEEEEETTE
T ss_pred CcceEEEEEEecCcCeEEEEEEECC---CCCEEEEEEEehhhc--chHHHHHHHHHHHHHhCC-CCCEeeEeeeeccCce
Confidence 5689999999999999999999876 589999999976532 234467899999999998 9999999999999999
Q ss_pred EEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCcccc
Q 014210 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (429)
Q Consensus 234 ~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~ 313 (429)
+|||||||+||+|.+++ ...+.+++..++.++.||++||+|||++||+||||||+|||+ ++++.+||+|||+|+..
T Consensus 78 ~~ivmEy~~gg~L~~~l-~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl---~~~~~~KL~DFG~a~~~ 153 (271)
T d1nvra_ 78 QYLFLEYCSGGELFDRI-EPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL---DERDNLKISDFGLATVF 153 (271)
T ss_dssp EEEEEECCTTEEGGGGS-BTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---CTTCCEEECCCTTCEEC
T ss_pred eEEEEeccCCCcHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEE---CCCCCEEEccchhheee
Confidence 99999999999999987 445679999999999999999999999999999999999999 77889999999999876
Q ss_pred CCCc---cccccccCCcccCcccccC-CC-CCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCC
Q 014210 314 RPDE---RLNDIVGSAYYVAPEVLHR-SY-STEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSL 388 (429)
Q Consensus 314 ~~~~---~~~~~~gt~~y~aPE~~~~-~~-~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 388 (429)
.... .....+||+.|||||++.+ .+ +.++|||||||++|||++|+.||.................. ....+..+
T Consensus 154 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~ 232 (271)
T d1nvra_ 154 RYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT-YLNPWKKI 232 (271)
T ss_dssp EETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCT-TSTTGGGS
T ss_pred ccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC-CCCccccC
Confidence 4332 2456789999999999864 44 57899999999999999999999776554443333333322 23345678
Q ss_pred CHHHHHHHHHhcccCccCcCCHHHHHhhHhhhcc
Q 014210 389 SSEARDFVKRLLNKDPRKRLTAAQALSELLICYQ 422 (429)
Q Consensus 389 s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~ 422 (429)
++++.+||++||+.||++|||+.|+|+|+||+..
T Consensus 233 s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~ 266 (271)
T d1nvra_ 233 DSAPLALLHKILVENPSARITIPDIKKDRWYNKP 266 (271)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred CHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCcC
Confidence 9999999999999999999999999999999753
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=9.7e-60 Score=463.29 Aligned_cols=262 Identities=33% Similarity=0.593 Sum_probs=238.3
Q ss_pred ccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCC
Q 014210 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (429)
Q Consensus 153 ~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~ 232 (429)
+.++|+++++||+|+||.||+|+.+. +|+.||||++.+. .....+.+.+|+++|++|+ |||||++++++.+++
T Consensus 24 il~~Y~i~~~lG~G~fg~Vy~~~~~~---~g~~vAvK~i~~~---~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~ 96 (350)
T d1koaa2 24 VLDHYDIHEELGTGAFGVVHRVTERA---TGNNFAAKFVMTP---HESDKETVRKEIQTMSVLR-HPTLVNLHDAFEDDN 96 (350)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETT---TTEEEEEEEECCC---SHHHHHHHHHHHHHHHHTC-CTTBCCEEEEEEETT
T ss_pred CccCeEEEEEEecCcCeEEEEEEECC---CCCEEEEEEEccc---chhhHHHHHHHHHHHHhCC-CCCCCcEEEEEEECC
Confidence 35789999999999999999999776 6899999999654 3445678899999999998 999999999999999
Q ss_pred eEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccc
Q 014210 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (429)
Q Consensus 233 ~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~ 312 (429)
.+|||||||+||+|.+++....+.+++..++.|+.||+.||+|||++|||||||||+|||+.. +.++.+||+|||+++.
T Consensus 97 ~~~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~-~~~~~vkL~DFG~a~~ 175 (350)
T d1koaa2 97 EMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTT-KRSNELKLIDFGLTAH 175 (350)
T ss_dssp EEEEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS-TTSCCEEECCCTTCEE
T ss_pred EEEEEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeecc-CCCCeEEEeecchhee
Confidence 999999999999999998777778999999999999999999999999999999999999953 2357899999999998
Q ss_pred cCCCccccccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHH
Q 014210 313 VRPDERLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSE 391 (429)
Q Consensus 313 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 391 (429)
...........||+.|||||++.+ .++.++|||||||++|||++|+.||.+.+..+.+..+......+....++.++++
T Consensus 176 ~~~~~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 255 (350)
T d1koaa2 176 LDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISED 255 (350)
T ss_dssp CCTTSCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHH
T ss_pred cccccccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHH
Confidence 877776677899999999999875 5899999999999999999999999999999999999988887777777789999
Q ss_pred HHHHHHHhcccCccCcCCHHHHHhhHhhhcc
Q 014210 392 ARDFVKRLLNKDPRKRLTAAQALSELLICYQ 422 (429)
Q Consensus 392 ~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~ 422 (429)
+++||++||+.||++|||+.|+|+|+||+..
T Consensus 256 ~~~li~~~L~~dP~~R~t~~eil~hp~~~~~ 286 (350)
T d1koaa2 256 GKDFIRKLLLADPNTRMTIHQALEHPWLTPG 286 (350)
T ss_dssp HHHHHHHHCCSSGGGSCCHHHHHHSTTTSCT
T ss_pred HHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence 9999999999999999999999999999864
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-60 Score=454.95 Aligned_cols=259 Identities=30% Similarity=0.554 Sum_probs=224.5
Q ss_pred CceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeE
Q 014210 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (429)
Q Consensus 155 ~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~ 234 (429)
++|+++++||+|+||.||+|+.+. +|+.||||++.+.........+.+.+|++++++++ |||||++++++.+++.+
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~---~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~ 83 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELA---TSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-HPFFVKLYFTFQDDEKL 83 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETT---TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCC-STTBCCEEEEEECSSEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECC---CCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcC-CCCeeEEEEEEEECCEE
Confidence 679999999999999999999776 58999999997544334445677999999999998 99999999999999999
Q ss_pred EEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccccC
Q 014210 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (429)
Q Consensus 235 ~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~ 314 (429)
|||||||+||+|.+++... +.+++..++.++.||+.||+|||++|||||||||+|||+ ++++.+||+|||+++.+.
T Consensus 84 ~ivmEy~~gg~L~~~~~~~-~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll---~~~~~vkl~DFG~a~~~~ 159 (288)
T d1uu3a_ 84 YFGLSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILL---NEDMHIQITDFGTAKVLS 159 (288)
T ss_dssp EEEECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTSCEEECCCTTCEECC
T ss_pred EEEEEccCCCCHHHhhhcc-CCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCcccccc---CCCceEEecccccceecc
Confidence 9999999999999987544 679999999999999999999999999999999999999 788899999999998765
Q ss_pred CCc---cccccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCH
Q 014210 315 PDE---RLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSS 390 (429)
Q Consensus 315 ~~~---~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 390 (429)
... .....+||+.|||||++.+ .++.++|||||||++|||++|+.||.+.+....+..+++....++ ..+++
T Consensus 160 ~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~ 235 (288)
T d1uu3a_ 160 PESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFP----EKFFP 235 (288)
T ss_dssp ----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCC----TTCCH
T ss_pred cCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCCCC----ccCCH
Confidence 332 3345789999999999874 689999999999999999999999999999999999988776554 36899
Q ss_pred HHHHHHHHhcccCccCcCCHHHHHhhHhhhcccee
Q 014210 391 EARDFVKRLLNKDPRKRLTAAQALSELLICYQSYL 425 (429)
Q Consensus 391 ~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~~~~ 425 (429)
++++||++||+.||++|||++|++++.|+..|.||
T Consensus 236 ~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff 270 (288)
T d1uu3a_ 236 KARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFF 270 (288)
T ss_dssp HHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGG
T ss_pred HHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCcc
Confidence 99999999999999999999986555555554443
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.7e-59 Score=461.99 Aligned_cols=260 Identities=35% Similarity=0.576 Sum_probs=237.8
Q ss_pred cCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~ 233 (429)
.++|+++++||+|+||.||+|+.+. +|+.||||++.+. .....+.+.+|+.+|++|+ |||||+++++|++++.
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~---~~~~vAiK~i~~~---~~~~~~~~~~Ei~il~~l~-HpnIv~~~~~~~~~~~ 100 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKA---TGRVFVAKFINTP---YPLDKYTVKNEISIMNQLH-HPKLINLHDAFEDKYE 100 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEECC---SHHHHHHHHHHHHHHTTCC-STTBCCEEEEEECSSE
T ss_pred ccceEEEEEEecCCCeEEEEEEECC---CCCEEEEEEECCc---chhHHHHHHHHHHHHHhCC-CCCCCcEEEEEEECCE
Confidence 4679999999999999999998766 6899999999754 2344567889999999998 9999999999999999
Q ss_pred EEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCcccc
Q 014210 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (429)
Q Consensus 234 ~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~ 313 (429)
+|||||||+||+|.+++...+..+++.+++.|+.||+.||.|||++|||||||||+||||.. ..++.+||+|||++...
T Consensus 101 ~~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~-~~~~~vkL~DFGla~~~ 179 (352)
T d1koba_ 101 MVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCET-KKASSVKIIDFGLATKL 179 (352)
T ss_dssp EEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS-TTCCCEEECCCTTCEEC
T ss_pred EEEEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccc-cCCCeEEEeecccceec
Confidence 99999999999999988767778999999999999999999999999999999999999942 24678999999999988
Q ss_pred CCCccccccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHH
Q 014210 314 RPDERLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEA 392 (429)
Q Consensus 314 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 392 (429)
..+.......||+.|||||++.+ .++.++|||||||++|||++|+.||.+.+....+..+......++...++.+++++
T Consensus 180 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 259 (352)
T d1koba_ 180 NPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEA 259 (352)
T ss_dssp CTTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHH
T ss_pred CCCCceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHH
Confidence 87777777899999999999875 58999999999999999999999999999999999999988888888888999999
Q ss_pred HHHHHHhcccCccCcCCHHHHHhhHhhhc
Q 014210 393 RDFVKRLLNKDPRKRLTAAQALSELLICY 421 (429)
Q Consensus 393 ~~li~~~L~~dP~~Rps~~~iL~~~~~~~ 421 (429)
.+||++||++||++|||+.|+|+|+||+.
T Consensus 260 ~~li~~~L~~dp~~R~s~~eil~Hp~~~~ 288 (352)
T d1koba_ 260 KDFIKNLLQKEPRKRLTVHDALEHPWLKG 288 (352)
T ss_dssp HHHHHTTSCSSGGGSCCHHHHHTSTTTSS
T ss_pred HHHHHHHccCChhHCcCHHHHhcCHhhCC
Confidence 99999999999999999999999999975
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.7e-60 Score=451.45 Aligned_cols=257 Identities=30% Similarity=0.488 Sum_probs=227.2
Q ss_pred CceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeE
Q 014210 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (429)
Q Consensus 155 ~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~ 234 (429)
+.|+++++||+|+||.||+|+.+. +|+.||||++.+. .....+.+.+|++++++|+ |||||++++++.+++.+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~---~~~~vAvK~i~~~---~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~ 84 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKE---TSVLAAAKVIDTK---SEEELEDYMVEIDILASCD-HPNIVKLLDAFYYENNL 84 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEECS---SSGGGGGTHHHHHHHHHCC-CTTBCCEEEEEEETTEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECC---CCeEEEEEEECcC---CHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEeeCCeE
Confidence 579999999999999999999776 6899999999654 2334567889999999998 99999999999999999
Q ss_pred EEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccccC
Q 014210 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (429)
Q Consensus 235 ~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~ 314 (429)
|||||||+||+|.+++.+..+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++...
T Consensus 85 ~lvmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll---~~~~~~Kl~DFG~a~~~~ 161 (288)
T d2jfla1 85 WILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILF---TLDGDIKLADFGVSAKNT 161 (288)
T ss_dssp EEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECH
T ss_pred EEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeE---CCCCCEEEEechhhhccC
Confidence 99999999999999887777889999999999999999999999999999999999999 778899999999997654
Q ss_pred CC-ccccccccCCcccCccccc------CCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCC
Q 014210 315 PD-ERLNDIVGSAYYVAPEVLH------RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPS 387 (429)
Q Consensus 315 ~~-~~~~~~~gt~~y~aPE~~~------~~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 387 (429)
.. ......+||+.|||||++. +.|+.++|||||||++|||++|+.||...+..+.+..+....+.... ....
T Consensus 162 ~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~-~~~~ 240 (288)
T d2jfla1 162 RTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLA-QPSR 240 (288)
T ss_dssp HHHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCS-SGGG
T ss_pred CCcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCC-cccc
Confidence 32 2334678999999999873 34889999999999999999999999998888888888877643322 2346
Q ss_pred CCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhcc
Q 014210 388 LSSEARDFVKRLLNKDPRKRLTAAQALSELLICYQ 422 (429)
Q Consensus 388 ~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~ 422 (429)
+++++.+||++||+.||++|||+.|+|+|+||+..
T Consensus 241 ~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~~ 275 (288)
T d2jfla1 241 WSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVD 275 (288)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCCC
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence 89999999999999999999999999999999754
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-59 Score=449.88 Aligned_cols=267 Identities=36% Similarity=0.633 Sum_probs=236.2
Q ss_pred cccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCc---HHHHHHHHHHHHHHHHhcCCCCcceEEEEE
Q 014210 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTT---AIAIEDVRREVKILRALTGHNNLVKFFDAY 228 (429)
Q Consensus 152 ~~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~---~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~ 228 (429)
.+.++|+++++||+|+||.||+|+.+. +|+.||||++.+..... ....+.+.+|+++|++|+ |||||+++++|
T Consensus 7 ~i~d~Y~~~~~lG~G~fg~Vy~~~~~~---~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~ 82 (293)
T d1jksa_ 7 NVDDYYDTGEELGSGQFAVVKKCREKS---TGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ-HPNVITLHEVY 82 (293)
T ss_dssp CGGGTEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCC-CTTBCCEEEEE
T ss_pred CcccCEEEeEEEecCCCeEEEEEEECC---CCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCC-CCCCCcEEEEE
Confidence 356789999999999999999999776 68999999997543322 234578999999999998 99999999999
Q ss_pred EeCCeEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecC-CCceEEEeec
Q 014210 229 EDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKD-ENSVLKAIDF 307 (429)
Q Consensus 229 ~~~~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~-~~~~vkL~DF 307 (429)
++.+.+|||||||+||+|.+++... +.+++..++.++.||+.||+|||++|||||||||+|||++..+ ....+||+||
T Consensus 83 ~~~~~~~iv~E~~~gg~L~~~i~~~-~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~Df 161 (293)
T d1jksa_ 83 ENKTDVILILELVAGGELFDFLAEK-ESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDF 161 (293)
T ss_dssp ECSSEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCC
T ss_pred EECCEEEEEEEcCCCccccchhccc-cccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecch
Confidence 9999999999999999999988654 5799999999999999999999999999999999999995332 2236999999
Q ss_pred CCccccCCCccccccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCC
Q 014210 308 GLSDFVRPDERLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWP 386 (429)
Q Consensus 308 Gla~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 386 (429)
|++.............||+.|+|||++.+ .++.++|||||||++|||++|+.||.+.+..+.+..+......+....++
T Consensus 162 G~a~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 241 (293)
T d1jksa_ 162 GLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFS 241 (293)
T ss_dssp TTCEECTTSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHT
T ss_pred hhhhhcCCCccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcC
Confidence 99998877777777899999999999875 68999999999999999999999999999999999998887777666667
Q ss_pred CCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhccc
Q 014210 387 SLSSEARDFVKRLLNKDPRKRLTAAQALSELLICYQS 423 (429)
Q Consensus 387 ~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~~ 423 (429)
.++.++.+||++||+.||++|||+.|+|+|+||+...
T Consensus 242 ~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~ 278 (293)
T d1jksa_ 242 NTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKD 278 (293)
T ss_dssp TSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC--
T ss_pred CCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence 8999999999999999999999999999999998643
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-59 Score=448.25 Aligned_cols=256 Identities=29% Similarity=0.480 Sum_probs=223.9
Q ss_pred cCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~ 233 (429)
.++|+++++||+|+||.||+|+.+. +|+.||||++...... ..+.+.+|++++++++ |||||+++++|.+++.
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~---~~~~vAvK~~~~~~~~---~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~ 91 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVA---TGQEVAIRQMNLQQQP---KKELIINEILVMRENK-NPNIVNYLDSYLVGDE 91 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTT---TCCEEEEEEEEGGGCS---CHHHHHHHHHHHHHCC-CTTBCCEEEEEEETTE
T ss_pred ccccEEEEEEecCcCcEEEEEEECC---CCCEEEEEEEecccCh---HHHHHHHHHHHHHhCC-CCCEeeEeEEEEECCE
Confidence 4589999999999999999998765 6899999998654322 3467899999999998 9999999999999999
Q ss_pred EEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCcccc
Q 014210 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (429)
Q Consensus 234 ~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~ 313 (429)
+|||||||+||+|.+++.. +.+++..++.++.||+.||+|||++|||||||||+|||+ +.++.+||+|||+++..
T Consensus 92 ~~ivmEy~~gg~L~~~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl---~~~~~vkl~DFG~a~~~ 166 (293)
T d1yhwa1 92 LWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL---GMDGSVKLTDFGFCAQI 166 (293)
T ss_dssp EEEEEECCTTCBHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCCTTCEEC
T ss_pred EEEEEEecCCCcHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEE---CCCCcEeeccchhheee
Confidence 9999999999999987644 469999999999999999999999999999999999999 67889999999999876
Q ss_pred CCC-ccccccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHH
Q 014210 314 RPD-ERLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSE 391 (429)
Q Consensus 314 ~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 391 (429)
..+ ......+||+.|||||++.+ .++.++|||||||++|||++|+.||.+......+..+........ ..++.++++
T Consensus 167 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~ 245 (293)
T d1yhwa1 167 TPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPEL-QNPEKLSAI 245 (293)
T ss_dssp CSTTCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCC-SSGGGSCHH
T ss_pred ccccccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCC-CCcccCCHH
Confidence 543 34556789999999998875 589999999999999999999999998888777777665543222 233578999
Q ss_pred HHHHHHHhcccCccCcCCHHHHHhhHhhhcc
Q 014210 392 ARDFVKRLLNKDPRKRLTAAQALSELLICYQ 422 (429)
Q Consensus 392 ~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~ 422 (429)
+++||++||+.||++|||+.|+|+|+||+..
T Consensus 246 ~~~li~~~L~~dP~~R~s~~eil~Hp~~~~~ 276 (293)
T d1yhwa1 246 FRDFLNRCLDMDVEKRGSAKELLQHQFLKIA 276 (293)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHTTCGGGGGC
T ss_pred HHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence 9999999999999999999999999999753
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=2e-58 Score=439.87 Aligned_cols=263 Identities=35% Similarity=0.615 Sum_probs=236.8
Q ss_pred ccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCc------HHHHHHHHHHHHHHHHhcCCCCcceEEE
Q 014210 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTT------AIAIEDVRREVKILRALTGHNNLVKFFD 226 (429)
Q Consensus 153 ~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~------~~~~~~~~~Ei~il~~l~~h~nIv~l~~ 226 (429)
|.++|+++++||+|+||+||+|+.+. +|+.||||++.+..... ....+.+.+|+.++++|..|||||++++
T Consensus 1 f~~~y~~~~~iG~G~~g~V~~~~~~~---~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~ 77 (277)
T d1phka_ 1 FYENYEPKEILGRGVSSVVRRCIHKP---TCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKD 77 (277)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEE
T ss_pred CcccCEEceEEecCcCeEEEEEEECC---CCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEe
Confidence 35789999999999999999998766 58999999997654332 2234568899999999988999999999
Q ss_pred EEEeCCeEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEee
Q 014210 227 AYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAID 306 (429)
Q Consensus 227 ~~~~~~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~D 306 (429)
++.+++.+|||||||+||+|.+++..+ +.+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|
T Consensus 78 ~~~~~~~~~ivmE~~~~g~L~~~l~~~-~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill---~~~~~~kl~D 153 (277)
T d1phka_ 78 TYETNTFFFLVFDLMKKGELFDYLTEK-VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILL---DDDMNIKLTD 153 (277)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECC
T ss_pred ecccCcceEEEEEcCCCchHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEE---cCCCCeEEcc
Confidence 999999999999999999999998654 579999999999999999999999999999999999999 7888999999
Q ss_pred cCCccccCCCccccccccCCcccCccccc-------CCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCC
Q 014210 307 FGLSDFVRPDERLNDIVGSAYYVAPEVLH-------RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPS 379 (429)
Q Consensus 307 FGla~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~ 379 (429)
||+++...........+||..|+|||++. ..++.++|||||||++|||++|+.||.+.+....+..++.....
T Consensus 154 FG~a~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~ 233 (277)
T d1phka_ 154 FGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQ 233 (277)
T ss_dssp CTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC
T ss_pred chheeEccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCC
Confidence 99999887766667789999999999874 23688999999999999999999999999999999999988877
Q ss_pred CCCCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhcc
Q 014210 380 FDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLICYQ 422 (429)
Q Consensus 380 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~ 422 (429)
.....++.+++++++||++||+.||++|||+.|+|+|+||+..
T Consensus 234 ~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~~ 276 (277)
T d1phka_ 234 FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY 276 (277)
T ss_dssp CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHHh
Confidence 7766677899999999999999999999999999999999753
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-58 Score=440.20 Aligned_cols=253 Identities=22% Similarity=0.367 Sum_probs=215.0
Q ss_pred eeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEe----CC
Q 014210 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED----TD 232 (429)
Q Consensus 157 y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~----~~ 232 (429)
|++.++||+|+||.||+|+... +|+.||||++..... .....+.+.+|+++|++|+ |||||+++++|++ ++
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~---~~~~va~K~i~~~~~-~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~~~~ 85 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTE---TTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQ-HPNIVRFYDSWESTVKGKK 85 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEEESSSCE
T ss_pred EEeeeEEecCcCcEEEEEEECC---CCeEEEEEEEchhhC-CHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEeeccccCC
Confidence 4788899999999999998776 589999999876443 4455678999999999998 9999999999975 34
Q ss_pred eEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC--ceeccCCCCcEEEeecCCCceEEEeecCCc
Q 014210 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQG--VVHRDLKPENFLFTTKDENSVLKAIDFGLS 310 (429)
Q Consensus 233 ~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~--iiHrDIKp~NILl~~~~~~~~vkL~DFGla 310 (429)
.+|||||||++|+|.+++.+. ..+++..++.++.||++||+|||+++ ||||||||+|||++ ++++.+||+|||++
T Consensus 86 ~~~ivmE~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~--~~~~~~Kl~DFGla 162 (270)
T d1t4ha_ 86 CIVLVTELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFIT--GPTGSVKIGDLGLA 162 (270)
T ss_dssp EEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEES--STTSCEEECCTTGG
T ss_pred EEEEEEeCCCCCcHHHHHhcc-ccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceee--CCCCCEEEeecCcc
Confidence 689999999999999988544 67999999999999999999999998 99999999999994 35778999999999
Q ss_pred cccCCCccccccccCCcccCcccccCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHH-HHHHHHhcCCCCCCCCCCCCC
Q 014210 311 DFVRPDERLNDIVGSAYYVAPEVLHRSYSTEADVWSIGVIAYILLCGSRPFWARTESG-IFRAVLKADPSFDEAPWPSLS 389 (429)
Q Consensus 311 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~s 389 (429)
+.... ......+||+.|||||++.+.++.++|||||||++|||++|+.||....... ++..+..... +......++
T Consensus 163 ~~~~~-~~~~~~~GT~~Y~aPE~~~~~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~--~~~~~~~~~ 239 (270)
T d1t4ha_ 163 TLKRA-SFAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK--PASFDKVAI 239 (270)
T ss_dssp GGCCT-TSBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCC--CGGGGGCCC
T ss_pred eeccC-CccCCcccCccccCHHHhCCCCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCC--CcccCccCC
Confidence 86543 3345678999999999999899999999999999999999999997655444 4444443322 112234678
Q ss_pred HHHHHHHHHhcccCccCcCCHHHHHhhHhhh
Q 014210 390 SEARDFVKRLLNKDPRKRLTAAQALSELLIC 420 (429)
Q Consensus 390 ~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~ 420 (429)
+++.+||.+||+.||++|||+.|+|+|+||+
T Consensus 240 ~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 240 PEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp HHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred HHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence 9999999999999999999999999999985
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=8.6e-59 Score=449.08 Aligned_cols=256 Identities=26% Similarity=0.407 Sum_probs=226.9
Q ss_pred cCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~ 233 (429)
.+.|+++++||+|+||.||+|+... +|+.||||++.+.........+++.+|++++++|+ |||||++++++.+++.
T Consensus 14 ~~~y~~l~~lG~G~fg~Vy~a~~~~---~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~~~~~~~~~~~ 89 (309)
T d1u5ra_ 14 EKLFSDLREIGHGSFGAVYFARDVR---NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR-HPNTIQYRGCYLREHT 89 (309)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETT---TTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEETTE
T ss_pred HHhcEeeEEEecCCCeEEEEEEECC---CCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCC-CCCEeeEEEEEEECCE
Confidence 3569999999999999999999776 58999999998776666777788999999999998 9999999999999999
Q ss_pred EEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCcccc
Q 014210 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (429)
Q Consensus 234 ~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~ 313 (429)
+|||||||++|+|..++ ...+.+++..++.++.||+.||.|||++|||||||||+|||| +.++++||+|||+++..
T Consensus 90 ~~iv~E~~~~g~l~~~~-~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl---~~~~~~Kl~DFG~a~~~ 165 (309)
T d1u5ra_ 90 AWLVMEYCLGSASDLLE-VHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILL---SEPGLVKLGDFGSASIM 165 (309)
T ss_dssp EEEEEECCSEEHHHHHH-HHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEE---ETTTEEEECCCTTCBSS
T ss_pred EEEEEEecCCCchHHHH-HhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEE---CCCCCEEEeeccccccc
Confidence 99999999998876544 455789999999999999999999999999999999999999 67889999999999876
Q ss_pred CCCccccccccCCcccCccccc----CCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCC
Q 014210 314 RPDERLNDIVGSAYYVAPEVLH----RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLS 389 (429)
Q Consensus 314 ~~~~~~~~~~gt~~y~aPE~~~----~~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 389 (429)
... ...+||+.|||||++. +.|+.++|||||||++|||++|+.||.+......+..+......... ...++
T Consensus 166 ~~~---~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~--~~~~s 240 (309)
T d1u5ra_ 166 APA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQ--SGHWS 240 (309)
T ss_dssp SSB---CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCS--CTTSC
T ss_pred CCC---CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCC--CCCCC
Confidence 432 4568999999999875 35899999999999999999999999988888888777776543322 24689
Q ss_pred HHHHHHHHHhcccCccCcCCHHHHHhhHhhhcc
Q 014210 390 SEARDFVKRLLNKDPRKRLTAAQALSELLICYQ 422 (429)
Q Consensus 390 ~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~ 422 (429)
+++.+||.+||+.||++|||+.|+|+|+||...
T Consensus 241 ~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~~ 273 (309)
T d1u5ra_ 241 EYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 273 (309)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred HHHHHHHHHHCcCChhHCcCHHHHHhCHHhcCC
Confidence 999999999999999999999999999999754
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-59 Score=441.87 Aligned_cols=255 Identities=31% Similarity=0.504 Sum_probs=213.4
Q ss_pred cCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEe--C
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED--T 231 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~--~ 231 (429)
.++|+++++||+|+||.||+|+.+. +|+.||||++..... .....+.+.+|++++++++ |||||++++++.+ +
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~---~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~ 77 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKS---DGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELK-HPNIVRYYDRIIDRTN 77 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEECCTTS-CHHHHHHHHHHHHHTTSCC-CTTBCCEEEEEEC---
T ss_pred chhCEEeEEEecCCCeEEEEEEECC---CCCEEEEEEEChhhC-CHHHHHHHHHHHHHHHHCC-CCCEeeEEEEEEeCCC
Confidence 3689999999999999999999776 689999999977653 4455678999999999998 9999999999965 4
Q ss_pred CeEEEEEEecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHcC-----ceeccCCCCcEEEeecCCCceEE
Q 014210 232 DNVYVVMELCEGGELLDRILS---RGGKYTEDDAKAVMIQILNVVAFCHLQG-----VVHRDLKPENFLFTTKDENSVLK 303 (429)
Q Consensus 232 ~~~~lv~E~~~ggsL~~~i~~---~~~~l~~~~~~~i~~qi~~gL~~LH~~~-----iiHrDIKp~NILl~~~~~~~~vk 303 (429)
+.+|||||||+||+|.+++.. .+..+++..++.++.||+.||.|||++| ||||||||+|||| +.++.+|
T Consensus 78 ~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll---~~~~~vk 154 (269)
T d2java1 78 TTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFL---DGKQNVK 154 (269)
T ss_dssp -CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEE---CTTSCEE
T ss_pred CEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCc---CCCCcEE
Confidence 568999999999999998864 3567999999999999999999999987 9999999999999 7788999
Q ss_pred EeecCCccccCCCc-cccccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCC
Q 014210 304 AIDFGLSDFVRPDE-RLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFD 381 (429)
Q Consensus 304 L~DFGla~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~ 381 (429)
|+|||+++....+. .....+||+.|||||++.+ .|+.++|||||||++|||++|+.||.+.+..+.+..+.......
T Consensus 155 l~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~- 233 (269)
T d2java1 155 LGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRR- 233 (269)
T ss_dssp ECCHHHHHHC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCC-
T ss_pred EeeccceeecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCC-
Confidence 99999998875443 3456789999999999874 68999999999999999999999999998888888887765432
Q ss_pred CCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhh
Q 014210 382 EAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLI 419 (429)
Q Consensus 382 ~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~ 419 (429)
....+++++.+||++||+.||++|||+.|+|+|+|+
T Consensus 234 --~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 234 --IPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp --CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred --CCcccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 224689999999999999999999999999999995
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-58 Score=451.37 Aligned_cols=257 Identities=28% Similarity=0.526 Sum_probs=231.2
Q ss_pred cCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~ 233 (429)
.++|++++.||+|+||.||+|+.+. +|+.||||++.+.........+.+.+|+.+|++++ |||||+++++|++.+.
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~---~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~~~~~ 79 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKA---TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR-HPFLTALKYAFQTHDR 79 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCC-CTTBCCEEEEEECSSE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECC---CCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCC-CCCEEEEEeeeccccc
Confidence 4689999999999999999999776 68999999997654444445678899999999998 9999999999999999
Q ss_pred EEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCcccc
Q 014210 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (429)
Q Consensus 234 ~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~ 313 (429)
+|||||||+||+|.+++.. .+.+++..++.++.||+.||+|||++|||||||||+|||+ +.++.+||+|||+++..
T Consensus 80 ~~iv~ey~~gg~L~~~~~~-~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl---~~~g~vkl~DFG~a~~~ 155 (337)
T d1o6la_ 80 LCFVMEYANGGELFFHLSR-ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLML---DKDGHIKITDFGLCKEG 155 (337)
T ss_dssp EEEEEECCTTCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCS
T ss_pred cccceeccCCCchhhhhhc-ccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEe---cCCCCEEEeeccccccc
Confidence 9999999999999998754 4679999999999999999999999999999999999999 78899999999999876
Q ss_pred CC-CccccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHH
Q 014210 314 RP-DERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSE 391 (429)
Q Consensus 314 ~~-~~~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 391 (429)
.. .......+||+.|||||++. +.|+.++|||||||++|||++|+.||.+.+...++..+......++. .++++
T Consensus 156 ~~~~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~~p~----~~s~~ 231 (337)
T d1o6la_ 156 ISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR----TLSPE 231 (337)
T ss_dssp CCTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TSCHH
T ss_pred ccCCcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCCCCc----cCCHH
Confidence 43 34556789999999999987 46999999999999999999999999999999999999888766653 68999
Q ss_pred HHHHHHHhcccCccCcCC-----HHHHHhhHhhhcc
Q 014210 392 ARDFVKRLLNKDPRKRLT-----AAQALSELLICYQ 422 (429)
Q Consensus 392 ~~~li~~~L~~dP~~Rps-----~~~iL~~~~~~~~ 422 (429)
+++||++||++||++|++ ++++++|+||...
T Consensus 232 ~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i 267 (337)
T d1o6la_ 232 AKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI 267 (337)
T ss_dssp HHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred HHHHHHhhccCCchhhcccccccHHHHHcCcccccC
Confidence 999999999999999994 9999999999764
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-58 Score=449.13 Aligned_cols=262 Identities=29% Similarity=0.537 Sum_probs=236.7
Q ss_pred cccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeC
Q 014210 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (429)
Q Consensus 152 ~~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~ 231 (429)
.+-++|+++++||+|+||.||+|..+. +|+.||||++.+.. .....+.+|+++|++++ |||||+++++|+++
T Consensus 2 ~~~~rY~i~~~lG~G~fg~Vy~~~~~~---~~~~~AiK~i~~~~----~~~~~~~~Ei~il~~l~-HpnIv~~~~~~~~~ 73 (321)
T d1tkia_ 2 ELYEKYMIAEDLGRGEFGIVHRCVETS---SKKTYMAKFVKVKG----TDQVLVKKEISILNIAR-HRNILHLHESFESM 73 (321)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEECCCT----HHHHHHHHHHHHHHHSC-CTTBCCEEEEEEET
T ss_pred CCccceEEEEEEecCCCeEEEEEEECC---CCcEEEEEEEcCCc----ccHHHHHHHHHHHHhCC-CCCCCeEEEEEEEC
Confidence 356789999999999999999999776 58999999997542 23456889999999998 99999999999999
Q ss_pred CeEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCcc
Q 014210 232 DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (429)
Q Consensus 232 ~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~ 311 (429)
+.+|||||||+||+|.+++...+..+++.+++.|+.||+.||+|||++||+||||||+|||++. +....+||+|||+++
T Consensus 74 ~~~~lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~-~~~~~ikl~DFG~~~ 152 (321)
T d1tkia_ 74 EELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQT-RRSSTIKIIEFGQAR 152 (321)
T ss_dssp TEEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS-SSCCCEEECCCTTCE
T ss_pred CEEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecC-CCceEEEEcccchhh
Confidence 9999999999999999998766668999999999999999999999999999999999999943 234589999999998
Q ss_pred ccCCCccccccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCH
Q 014210 312 FVRPDERLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSS 390 (429)
Q Consensus 312 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 390 (429)
............||+.|+|||++.+ .++.++|||||||++|+|++|+.||...+..+.+..+++....++...++.+++
T Consensus 153 ~~~~~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 232 (321)
T d1tkia_ 153 QLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISI 232 (321)
T ss_dssp ECCTTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCH
T ss_pred ccccCCcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCH
Confidence 8776666667789999999998874 589999999999999999999999999999999999999888887777778999
Q ss_pred HHHHHHHHhcccCccCcCCHHHHHhhHhhhcc
Q 014210 391 EARDFVKRLLNKDPRKRLTAAQALSELLICYQ 422 (429)
Q Consensus 391 ~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~ 422 (429)
++++||++||..||++|||+.|+|+|+||+..
T Consensus 233 ~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 264 (321)
T d1tkia_ 233 EAMDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred HHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence 99999999999999999999999999999754
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-58 Score=448.39 Aligned_cols=256 Identities=25% Similarity=0.398 Sum_probs=214.1
Q ss_pred ccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCC
Q 014210 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (429)
Q Consensus 153 ~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~ 232 (429)
..++|+++++||+|+||.||+|+.+. +|+.||||++.+.. .....+++.+|+.+|++++ |||||+++++|.+++
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~---~~~~vAiK~i~~~~--~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~ 77 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKP---SGLVMARKLIHLEI--KPAIRNQIIRELQVLHECN-SPYIVGFYGAFYSDG 77 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETT---TTEEEEEEEEECCC--CTTHHHHHHHHGGGGGGCC-CTTBCCEEEEEECSS
T ss_pred CccCCEEEEEEecCCCeEEEEEEECC---CCcEEEEEEEChhh--CHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEEECC
Confidence 36789999999999999999999776 68999999997642 3344578999999999998 999999999999999
Q ss_pred eEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHc-CceeccCCCCcEEEeecCCCceEEEeecCCcc
Q 014210 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQ-GVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (429)
Q Consensus 233 ~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~-~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~ 311 (429)
++|||||||+||+|.+++.+. +.+++..++.++.||+.||.|||++ ||+||||||+|||| +.++++||+|||+|+
T Consensus 78 ~~~iVmEy~~gg~L~~~l~~~-~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl---~~~~~vkl~DFGla~ 153 (322)
T d1s9ja_ 78 EISICMEHMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILV---NSRGEIKLCDFGVSG 153 (322)
T ss_dssp EEEEEEECCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEE---CTTCCEEECCCCCCH
T ss_pred EEEEEEEcCCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeE---CCCCCEEEeeCCCcc
Confidence 999999999999999988654 5799999999999999999999974 99999999999999 778899999999998
Q ss_pred ccCCCccccccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHH-------------------
Q 014210 312 FVRPDERLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFR------------------- 371 (429)
Q Consensus 312 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~------------------- 371 (429)
.... ......+||+.|||||++.+ .|+.++|||||||++|||++|+.||..........
T Consensus 154 ~~~~-~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (322)
T d1s9ja_ 154 QLID-SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRT 232 (322)
T ss_dssp HHHH-HTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-----------------
T ss_pred ccCC-CccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccc
Confidence 6643 33456799999999999875 69999999999999999999999997654322100
Q ss_pred -----------------------HHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhc
Q 014210 372 -----------------------AVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLICY 421 (429)
Q Consensus 372 -----------------------~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~ 421 (429)
.+.... .+..+...++.++.+||++||+.||++|||++|+|+|+||+.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~ 303 (322)
T d1s9ja_ 233 PGRPLSSYGMDSRPPMAIFELLDYIVNEP--PPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 303 (322)
T ss_dssp -------------CCCCHHHHHHHHHTSC--CCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHH
T ss_pred ccccccccccccccchhHHHHHhhhhccC--CccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCc
Confidence 000000 011111246899999999999999999999999999999975
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=5.6e-58 Score=444.80 Aligned_cols=255 Identities=25% Similarity=0.541 Sum_probs=228.6
Q ss_pred CceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeE
Q 014210 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (429)
Q Consensus 155 ~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~ 234 (429)
++|+++++||+|+||.||+|+.+. +|+.||||++.+.........+.+.+|+.++++++ |||||++++++.+++.+
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~---~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~~ 79 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRH---NGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT-HPFIIRMWGTFQDAQQI 79 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETT---TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCC-BTTBCCEEEEEECSSEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECC---CCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhcc-CcChhheeeeEeeCCee
Confidence 679999999999999999999776 68999999997544344445678999999999998 99999999999999999
Q ss_pred EEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccccC
Q 014210 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (429)
Q Consensus 235 ~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~ 314 (429)
|+|||||+||+|..++ .....+++..++.++.||+.||+|||++|||||||||+|||| +.++.+||+|||+++...
T Consensus 80 ~ivmE~~~gg~l~~~~-~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl---~~~g~vkL~DFG~a~~~~ 155 (316)
T d1fota_ 80 FMIMDYIEGGELFSLL-RKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILL---DKNGHIKITDFGFAKYVP 155 (316)
T ss_dssp EEEECCCCSCBHHHHH-HHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEE---CTTSCEEECCCSSCEECS
T ss_pred eeEeeecCCccccccc-cccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeE---cCCCCEEEecCccceEec
Confidence 9999999999988766 455678999999999999999999999999999999999999 788899999999998765
Q ss_pred CCccccccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHH
Q 014210 315 PDERLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEAR 393 (429)
Q Consensus 315 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 393 (429)
. .....+||+.|||||++.+ .|+.++|||||||++|||++|+.||.+.+..+.+..++.....++ +.+++++.
T Consensus 156 ~--~~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~ 229 (316)
T d1fota_ 156 D--VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFP----PFFNEDVK 229 (316)
T ss_dssp S--CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCC----TTSCHHHH
T ss_pred c--ccccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCC----CCCCHHHH
Confidence 3 3346789999999999875 589999999999999999999999999999999999988776554 36899999
Q ss_pred HHHHHhcccCccCcC-----CHHHHHhhHhhhccc
Q 014210 394 DFVKRLLNKDPRKRL-----TAAQALSELLICYQS 423 (429)
Q Consensus 394 ~li~~~L~~dP~~Rp-----s~~~iL~~~~~~~~~ 423 (429)
+||++||.+||.+|+ +++++|+|+||+...
T Consensus 230 ~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i~ 264 (316)
T d1fota_ 230 DLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVV 264 (316)
T ss_dssp HHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCC
T ss_pred HHHHHHhhhCHHhccccchhhHHHHHcCcccccCC
Confidence 999999999999996 999999999998654
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.4e-57 Score=446.26 Aligned_cols=256 Identities=29% Similarity=0.534 Sum_probs=229.4
Q ss_pred CceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeE
Q 014210 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (429)
Q Consensus 155 ~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~ 234 (429)
++|+++++||+|+||.||+|+.+. +|+.||||++.+.........+.+.+|+++|+.++ |||||++++++.+.+..
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~---~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~~~~~~ 116 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKE---SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN-FPFLVKLEFSFKDNSNL 116 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETT---TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCC-CTTBCCEEEEEECSSEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECC---CCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcC-CCcEeeccccccccccc
Confidence 689999999999999999999776 68999999986544344455677899999999998 99999999999999999
Q ss_pred EEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccccC
Q 014210 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (429)
Q Consensus 235 ~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~ 314 (429)
++||||+.||+|.+++... +.+++..++.++.||+.||.|||++|||||||||+|||| +.++++||+|||+++...
T Consensus 117 ~~v~e~~~~g~l~~~l~~~-~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl---~~~g~ikL~DFG~a~~~~ 192 (350)
T d1rdqe_ 117 YMVMEYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVK 192 (350)
T ss_dssp EEEEECCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECS
T ss_pred ccccccccccchhhhHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHccc---CCCCCEEeeeceeeeecc
Confidence 9999999999999988654 579999999999999999999999999999999999999 778899999999998775
Q ss_pred CCccccccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHH
Q 014210 315 PDERLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEAR 393 (429)
Q Consensus 315 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 393 (429)
. ......||+.|||||++.+ .++.++|||||||++|||++|+.||.+.+....+..+......++ ..+++++.
T Consensus 193 ~--~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~ 266 (350)
T d1rdqe_ 193 G--RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFSSDLK 266 (350)
T ss_dssp S--CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTCCHHHH
T ss_pred c--ccccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCCC----ccCCHHHH
Confidence 3 3346789999999999875 589999999999999999999999999998888999988776554 36899999
Q ss_pred HHHHHhcccCccCcC-----CHHHHHhhHhhhccce
Q 014210 394 DFVKRLLNKDPRKRL-----TAAQALSELLICYQSY 424 (429)
Q Consensus 394 ~li~~~L~~dP~~Rp-----s~~~iL~~~~~~~~~~ 424 (429)
+||++||++||++|+ +++++++|+||+...|
T Consensus 267 ~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~~~ 302 (350)
T d1rdqe_ 267 DLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 302 (350)
T ss_dssp HHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCH
T ss_pred HHHHHHhhhCHHhccccccccHHHHHcCccccCCCH
Confidence 999999999999995 9999999999986543
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-57 Score=444.99 Aligned_cols=259 Identities=32% Similarity=0.590 Sum_probs=218.7
Q ss_pred ccCceeEec-eeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEe-
Q 014210 153 FANKYELGE-EVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED- 230 (429)
Q Consensus 153 ~~~~y~~~~-~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~- 230 (429)
+.++|++.+ .||+|+||.||+|+... +|+.||||++.+. ..+.+|+.++.++.+|||||+++++|++
T Consensus 9 i~~~y~i~~~~lG~G~fg~Vy~a~~~~---~~~~vAiK~i~~~--------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~ 77 (335)
T d2ozaa1 9 IIDDYKVTSQVLGLGINGKVLQIFNKR---TQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENL 77 (335)
T ss_dssp GGGTEEEEEEEEEECSSCEEEEEEETT---TCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEE
T ss_pred cccCEEEeeEEeeeccCeEEEEEEECC---CCCEEEEEEECCc--------HHHHHHHHHHHHhcCCCCCCeEEEEEeec
Confidence 457899875 59999999999999776 6899999998542 4577899998877669999999999976
Q ss_pred ---CCeEEEEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEee
Q 014210 231 ---TDNVYVVMELCEGGELLDRILSRG-GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAID 306 (429)
Q Consensus 231 ---~~~~~lv~E~~~ggsL~~~i~~~~-~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~D 306 (429)
++.+|||||||+||+|.+++.+++ ..+++.+++.|+.||+.||+|||++||+||||||+|||++..++.+.+||+|
T Consensus 78 ~~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~D 157 (335)
T d2ozaa1 78 YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTD 157 (335)
T ss_dssp ETTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECC
T ss_pred ccCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccc
Confidence 466899999999999999997654 4699999999999999999999999999999999999997666678899999
Q ss_pred cCCccccCCCccccccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHh----cCCCCC
Q 014210 307 FGLSDFVRPDERLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLK----ADPSFD 381 (429)
Q Consensus 307 FGla~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~----~~~~~~ 381 (429)
||+++...........+||+.|||||++.+ .|+.++|||||||+||+|+||+.||.+.........+.. ....++
T Consensus 158 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~ 237 (335)
T d2ozaa1 158 FGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFP 237 (335)
T ss_dssp CTTCEECCCCCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCC
T ss_pred cceeeeccCCCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCC
Confidence 999998877777778899999999999875 599999999999999999999999977665444433332 333344
Q ss_pred CCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhcc
Q 014210 382 EAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLICYQ 422 (429)
Q Consensus 382 ~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~ 422 (429)
...+..+++++.+||++||+.||++|||+.|+|+|+||...
T Consensus 238 ~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 278 (335)
T d2ozaa1 238 NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 278 (335)
T ss_dssp TTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTT
T ss_pred CcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCC
Confidence 44445689999999999999999999999999999999754
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-57 Score=437.20 Aligned_cols=257 Identities=30% Similarity=0.504 Sum_probs=225.8
Q ss_pred CceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeE
Q 014210 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (429)
Q Consensus 155 ~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~ 234 (429)
++|+++++||+|+||+||+|+.+. +|+.||||++.+.........+.+.+|+.++.+..+|||||++++++.+++.+
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~---t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~ 78 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKK---TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL 78 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETT---TTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECC---CCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCce
Confidence 579999999999999999999776 68999999997544333444566778888776433499999999999999999
Q ss_pred EEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccccC
Q 014210 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (429)
Q Consensus 235 ~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~ 314 (429)
|||||||+||+|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||+ ++++.+||+|||+++...
T Consensus 79 yivmEy~~~g~L~~~i~~-~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~---~~~~~~kl~DFG~a~~~~ 154 (320)
T d1xjda_ 79 FFVMEYLNGGDLMYHIQS-CHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILL---DKDGHIKIADFGMCKENM 154 (320)
T ss_dssp EEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCCC
T ss_pred eEEEeecCCCcHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceee---cCCCceeccccchhhhcc
Confidence 999999999999998854 4679999999999999999999999999999999999999 788899999999998665
Q ss_pred CC-ccccccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHH
Q 014210 315 PD-ERLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEA 392 (429)
Q Consensus 315 ~~-~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 392 (429)
.. .......||+.|+|||++.+ .++.++|||||||++|||++|+.||.+.+....+..+....+.++. .+++++
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~----~~s~~~ 230 (320)
T d1xjda_ 155 LGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPR----WLEKEA 230 (320)
T ss_dssp CTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TSCHHH
T ss_pred cccccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCc----cCCHHH
Confidence 33 33455789999999998874 6999999999999999999999999999999999999887765553 689999
Q ss_pred HHHHHHhcccCccCcCCHH-HHHhhHhhhcc
Q 014210 393 RDFVKRLLNKDPRKRLTAA-QALSELLICYQ 422 (429)
Q Consensus 393 ~~li~~~L~~dP~~Rps~~-~iL~~~~~~~~ 422 (429)
.+||++||++||++||++. ++++|+||+..
T Consensus 231 ~dli~~~L~~dP~~R~s~~~~l~~hpff~~~ 261 (320)
T d1xjda_ 231 KDLLVKLFVREPEKRLGVRGDIRQHPLFREI 261 (320)
T ss_dssp HHHHHHHSCSSGGGSBTTBSCGGGSGGGTTC
T ss_pred HHHHHHhcccCCCCCcCHHHHHHhCchhccC
Confidence 9999999999999999995 89999999763
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-56 Score=424.69 Aligned_cols=254 Identities=23% Similarity=0.396 Sum_probs=211.9
Q ss_pred cCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~ 233 (429)
.++|+++++||+|+||.||+|+.+ ..||||++.... ......+.+.+|++++++++ |||||++++++. ++.
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~------~~vAvK~~~~~~-~~~~~~~~~~~E~~~l~~l~-HpnIv~~~~~~~-~~~ 77 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH------GDVAVKMLNVTA-PTPQQLQAFKNEVGVLRKTR-HVNILLFMGYST-APQ 77 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS------SEEEEEECCCSS-CCTTHHHHHHHHHHHHTTCC-CTTBCCEEEEEC-SSS
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC------CEEEEEEEEccc-CCHHHHHHHHHHHHHHHhCC-CCCEeeeeEEEe-ccE
Confidence 467999999999999999999732 359999997654 33456788999999999998 999999999875 456
Q ss_pred EEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCcccc
Q 014210 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (429)
Q Consensus 234 ~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~ 313 (429)
++||||||++|+|.+++......+++..+..++.||++||+|||++|||||||||+|||| +.++.+||+|||+++..
T Consensus 78 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl---~~~~~~Kl~DFGla~~~ 154 (276)
T d1uwha_ 78 LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFL---HEDLTVKIGDFGLATVK 154 (276)
T ss_dssp CEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---ETTSSEEECCCCCSCC-
T ss_pred EEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEE---cCCCCEEEccccceeec
Confidence 899999999999999998777889999999999999999999999999999999999999 67889999999999876
Q ss_pred CCCc---cccccccCCcccCcccccC----CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCC--CCC
Q 014210 314 RPDE---RLNDIVGSAYYVAPEVLHR----SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFD--EAP 384 (429)
Q Consensus 314 ~~~~---~~~~~~gt~~y~aPE~~~~----~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~--~~~ 384 (429)
.... ......||+.|||||++.+ .|+.++|||||||+||||+||+.||.+......+..+.......+ ...
T Consensus 155 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~ 234 (276)
T d1uwha_ 155 SRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKV 234 (276)
T ss_dssp -----------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGS
T ss_pred cccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhc
Confidence 5332 3345689999999999852 478899999999999999999999988776655555544332222 233
Q ss_pred CCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhh
Q 014210 385 WPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLI 419 (429)
Q Consensus 385 ~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~ 419 (429)
...+++++.+||.+||+.||++|||+.++++++..
T Consensus 235 ~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~ 269 (276)
T d1uwha_ 235 RSNCPKAMKRLMAECLKKKRDERPLFPQILASIEL 269 (276)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred cccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 45789999999999999999999999999999754
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.5e-56 Score=442.97 Aligned_cols=260 Identities=25% Similarity=0.388 Sum_probs=216.0
Q ss_pred cCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHH---HHHHHHhcCCCCcceEEEEEEe
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRRE---VKILRALTGHNNLVKFFDAYED 230 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E---i~il~~l~~h~nIv~l~~~~~~ 230 (429)
.++|+++++||+|+||.||+|+.+. +|+.||||++.+...........+.+| +.+++.+. |||||+++++|.+
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~---t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~-hpnIv~l~~~~~~ 78 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKAD---TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD-CPFIVCMSYAFHT 78 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETT---TCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSC-CTTBCCEEEEEEC
T ss_pred HHhCeeeeEEecCCCeEEEEEEECC---CCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCC-CCcEEEEEEEEEE
Confidence 3689999999999999999999776 689999999865433333333444555 55555555 9999999999999
Q ss_pred CCeEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCc
Q 014210 231 TDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS 310 (429)
Q Consensus 231 ~~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla 310 (429)
.+.+|||||||+||+|.+++... ..+++..++.++.||+.||.|||++|||||||||+|||+ +.++.+||+|||+|
T Consensus 79 ~~~~~ivmE~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl---~~~g~iKl~DFGla 154 (364)
T d1omwa3 79 PDKLSFILDLMNGGDLHYHLSQH-GVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILL---DEHGHVRISDLGLA 154 (364)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CSSSCEEECCCTTC
T ss_pred CCEEEEEEEecCCCcHHHHHHhc-ccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEE---cCCCcEEEeeecee
Confidence 99999999999999999988554 678999999999999999999999999999999999999 78889999999999
Q ss_pred cccCCCccccccccCCcccCccccc-C-CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCC
Q 014210 311 DFVRPDERLNDIVGSAYYVAPEVLH-R-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSL 388 (429)
Q Consensus 311 ~~~~~~~~~~~~~gt~~y~aPE~~~-~-~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 388 (429)
+.+... .....+||+.|||||++. + .|+.++|||||||+||||++|+.||.......... +...........+..+
T Consensus 155 ~~~~~~-~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~-~~~~~~~~~~~~~~~~ 232 (364)
T d1omwa3 155 CDFSKK-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-IDRMTLTMAVELPDSF 232 (364)
T ss_dssp EECSSS-CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHH-HHHHSSSCCCCCCSSS
T ss_pred eecCCC-cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHhcccCCCCCCCCC
Confidence 877543 345678999999999886 3 48999999999999999999999998765433322 2222223333344579
Q ss_pred CHHHHHHHHHhcccCccCcCC-----HHHHHhhHhhhccc
Q 014210 389 SSEARDFVKRLLNKDPRKRLT-----AAQALSELLICYQS 423 (429)
Q Consensus 389 s~~~~~li~~~L~~dP~~Rps-----~~~iL~~~~~~~~~ 423 (429)
++++.+||.+||+.||++||+ ++++++|+||+...
T Consensus 233 s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~ 272 (364)
T d1omwa3 233 SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLD 272 (364)
T ss_dssp CHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTCC
T ss_pred CHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccCCC
Confidence 999999999999999999999 79999999998654
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6.5e-56 Score=427.14 Aligned_cols=255 Identities=24% Similarity=0.390 Sum_probs=210.6
Q ss_pred cCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~ 233 (429)
.++|++.++||+|+||.||+|+.+........||||.+... ......+++.+|+++|++|+ |||||+++|+|.+++.
T Consensus 25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~-HpnIv~l~g~~~~~~~ 101 (299)
T d1jpaa_ 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG--YTEKQRRDFLSEASIMGQFD-HPNVIHLEGVVTKSTP 101 (299)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSS--CCHHHHHHHHHHHHHHTTCC-CTTBCCEEEEECSSSS
T ss_pred hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcc--cCHHHHHHHHHHHHHHHhCC-CCCCccEEEEEeeCCE
Confidence 46799999999999999999998764333457999998654 34556678999999999998 9999999999999999
Q ss_pred EEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCcccc
Q 014210 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (429)
Q Consensus 234 ~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~ 313 (429)
++||||||++|+|.+++....+.+++..+..++.||++||.|||++|||||||||+|||| +.++++||+|||+++..
T Consensus 102 ~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl---~~~~~~Kl~DFGla~~~ 178 (299)
T d1jpaa_ 102 VMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILV---NSNLVCKVSDFGLSRFL 178 (299)
T ss_dssp CEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECCC------
T ss_pred EEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEE---CCCCcEEECCcccceEc
Confidence 999999999999999887777789999999999999999999999999999999999999 78899999999999876
Q ss_pred CCCccc------cccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCCCC
Q 014210 314 RPDERL------NDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPW 385 (429)
Q Consensus 314 ~~~~~~------~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 385 (429)
...... ....||+.|||||++. +.++.++|||||||+||||+| |+.||......+++..+...... ...
T Consensus 179 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~---~~~ 255 (299)
T d1jpaa_ 179 EDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRL---PPP 255 (299)
T ss_dssp -----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC---CCC
T ss_pred cCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC---CCC
Confidence 544322 1245789999999886 579999999999999999998 89999999888888777654321 123
Q ss_pred CCCCHHHHHHHHHhcccCccCcCCHHHHHhhH
Q 014210 386 PSLSSEARDFVKRLLNKDPRKRLTAAQALSEL 417 (429)
Q Consensus 386 ~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~ 417 (429)
..+++++.+||.+||+.||++|||+.|+++++
T Consensus 256 ~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L 287 (299)
T d1jpaa_ 256 MDCPSALHQLMLDCWQKDRNHRPKFGQIVNTL 287 (299)
T ss_dssp TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHH
T ss_pred ccchHHHHHHHHHHcCCCHhHCcCHHHHHHHH
Confidence 46899999999999999999999999999875
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=9.9e-56 Score=421.32 Aligned_cols=262 Identities=28% Similarity=0.462 Sum_probs=223.1
Q ss_pred cccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeC
Q 014210 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (429)
Q Consensus 152 ~~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~ 231 (429)
.+.++|++.+.||+|+||.||+|+... +|+.||||++.+....+....+.+.+|++++++++ |||||++++++.+.
T Consensus 4 ~l~drY~i~~~lG~G~fg~Vy~a~~~~---~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~-hpniv~~~~~~~~~ 79 (277)
T d1o6ya_ 4 HLSDRYELGEILGFGGMSEVHLARDLR---LHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN-HPAIVAVYDTGEAE 79 (277)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEEEE
T ss_pred CccceeEEeEEEeeCCCeEEEEEEECC---CCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcC-CCCCCcccceeeec
Confidence 456889999999999999999999776 68999999998876667777888999999999998 99999999999875
Q ss_pred C----eEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeec
Q 014210 232 D----NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDF 307 (429)
Q Consensus 232 ~----~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DF 307 (429)
+ ..|||||||+|++|.+++.. .+.+++.+++.++.||+.||+|||++|||||||||+|||+ +.++.++|+||
T Consensus 80 ~~~~~~~~lvmE~~~g~~L~~~~~~-~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll---~~~~~~~l~d~ 155 (277)
T d1o6ya_ 80 TPAGPLPYIVMEYVDGVTLRDIVHT-EGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMI---SATNAVKVMDF 155 (277)
T ss_dssp CSSSEEEEEEEECCCEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---ETTSCEEECCC
T ss_pred cCCCceEEEEEECCCCCEehhhhcc-cCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCccccc---Cccccceeehh
Confidence 4 38999999999999987754 4679999999999999999999999999999999999999 67788999999
Q ss_pred CCccccCCCc----cccccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCC
Q 014210 308 GLSDFVRPDE----RLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDE 382 (429)
Q Consensus 308 Gla~~~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~ 382 (429)
|.+....... .....+||+.|||||++.+ .++.++|||||||++|||+||+.||...+..+.+..++...+..+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~ 235 (277)
T d1o6ya_ 156 GIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPS 235 (277)
T ss_dssp TTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGG
T ss_pred hhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCc
Confidence 9987553322 3345689999999999875 5899999999999999999999999999988888888888877777
Q ss_pred CCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhc
Q 014210 383 APWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLICY 421 (429)
Q Consensus 383 ~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~ 421 (429)
..++.+++++.+||++||++||++||+..+.|.+.|++.
T Consensus 236 ~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~ 274 (277)
T d1o6ya_ 236 ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 274 (277)
T ss_dssp GTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred hhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHH
Confidence 777889999999999999999999995555556777654
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-55 Score=416.94 Aligned_cols=249 Identities=25% Similarity=0.442 Sum_probs=206.6
Q ss_pred CceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeE
Q 014210 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (429)
Q Consensus 155 ~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~ 234 (429)
++|+++++||+|+||.||+|+... ++.||||++..... ..+++.+|++++++++ |||||+++|+|.+++..
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~----~~~vAvK~i~~~~~----~~~~~~~E~~~l~~l~-HpnIv~~~g~~~~~~~~ 75 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLN----KDKVAIKTIREGAM----SEEDFIEEAEVMMKLS-HPKLVQLYGVCLEQAPI 75 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETT----TEEEEEEECCSSSS----CHHHHHHHHHHHHHCC-CTTBCCEEEEECSSSSC
T ss_pred HHcEEEEEEeeCCCeEEEEEEECC----CCEEEEEEECCCcC----cHHHHHHHHHHHHhcC-CCCcccccceeccCCce
Confidence 579999999999999999998654 67899999975432 2357899999999998 99999999999999999
Q ss_pred EEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccccC
Q 014210 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (429)
Q Consensus 235 ~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~ 314 (429)
+||||||++|+|.+++......+++..+..++.||+.||+|||+++|+||||||+|||+ ++++++||+|||+++...
T Consensus 76 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill---~~~~~~Kl~DFGla~~~~ 152 (263)
T d1sm2a_ 76 CLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLV---GENQVIKVSDFGMTRFVL 152 (263)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEE---CGGGCEEECSCC------
T ss_pred EEEEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheee---cCCCCeEecccchheecc
Confidence 99999999999999988777889999999999999999999999999999999999999 788899999999998765
Q ss_pred CCcc--ccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCH
Q 014210 315 PDER--LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLSS 390 (429)
Q Consensus 315 ~~~~--~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 390 (429)
.... .....||..|||||++. +.++.++|||||||++|||+| |+.||........+..+........ ...+++
T Consensus 153 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~---p~~~~~ 229 (263)
T d1sm2a_ 153 DDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK---PRLAST 229 (263)
T ss_dssp ------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCC---CTTSCH
T ss_pred CCCceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCC---ccccCH
Confidence 4432 23467899999999987 469999999999999999999 5666666777777777766533222 236789
Q ss_pred HHHHHHHHhcccCccCcCCHHHHHhhHh
Q 014210 391 EARDFVKRLLNKDPRKRLTAAQALSELL 418 (429)
Q Consensus 391 ~~~~li~~~L~~dP~~Rps~~~iL~~~~ 418 (429)
++.+||.+||+.||++|||++++++++-
T Consensus 230 ~l~~li~~cl~~~p~~Rps~~~il~~L~ 257 (263)
T d1sm2a_ 230 HVYQIMNHCWKERPEDRPAFSRLLRQLA 257 (263)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHHHHHccCCHhHCcCHHHHHHHHH
Confidence 9999999999999999999999999853
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-55 Score=424.96 Aligned_cols=258 Identities=29% Similarity=0.464 Sum_probs=216.3
Q ss_pred CceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeE
Q 014210 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (429)
Q Consensus 155 ~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~ 234 (429)
++|+++++||+|+||.||+|+... +|+.||||++.... ......+++.+|++++++++ |||||+++++|.+++++
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~---~~~~vAvK~i~~~~-~~~~~~~~~~~Ei~il~~l~-Hp~Iv~~~~~~~~~~~~ 76 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKL---TGEVVALKKIRLDT-ETEGVPSTAIREISLLKELN-HPNIVKLLDVIHTENKL 76 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETT---TCCEEEEEEEC--------CCHHHHHHHHHHTTCC-CTTBCCEEEEEEETTEE
T ss_pred CCCEeccEEecCcCeEEEEEEECC---CCCEEEEEEEehhh-cChHHHHHHHHHHHHHHhCC-CCcEEEeccccccccce
Confidence 589999999999999999999876 68999999996543 22334567899999999998 99999999999999999
Q ss_pred EEEEEecCCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCcccc
Q 014210 235 YVVMELCEGGELLDRILS-RGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (429)
Q Consensus 235 ~lv~E~~~ggsL~~~i~~-~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~ 313 (429)
|||||||.+ .+.+++.. ....+++..++.++.||+.||.|||++|||||||||+|||+ +.++.+||+|||+++..
T Consensus 77 ~iv~e~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~---~~~~~~kl~DFG~a~~~ 152 (298)
T d1gz8a_ 77 YLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLI---NTEGAIKLADFGLARAF 152 (298)
T ss_dssp EEEEECCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECSTTHHHHH
T ss_pred eEEEeecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheee---cccCcceeccCCcceec
Confidence 999999976 44555543 45679999999999999999999999999999999999999 77889999999999876
Q ss_pred CCC-ccccccccCCcccCcccccC--CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCC------
Q 014210 314 RPD-ERLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAP------ 384 (429)
Q Consensus 314 ~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~------ 384 (429)
... .......||+.|+|||++.. .++.++|||||||++|+|++|+.||.+.+..+.+..+.+......+..
T Consensus 153 ~~~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 232 (298)
T d1gz8a_ 153 GVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 232 (298)
T ss_dssp CCCSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred cCCcccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccc
Confidence 543 34456789999999998653 468899999999999999999999998888877777655322222211
Q ss_pred -------------------CCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhc
Q 014210 385 -------------------WPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLICY 421 (429)
Q Consensus 385 -------------------~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~ 421 (429)
.+.+++++++||++||..||++|||+.|+|+|+||+.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~ 288 (298)
T d1gz8a_ 233 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 288 (298)
T ss_dssp STTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTT
T ss_pred ccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhcc
Confidence 1356899999999999999999999999999999975
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-56 Score=426.02 Aligned_cols=257 Identities=28% Similarity=0.409 Sum_probs=213.6
Q ss_pred eEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcH--HHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEE
Q 014210 158 ELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTA--IAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVY 235 (429)
Q Consensus 158 ~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~--~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~~ 235 (429)
+.+++||+|+||+||+|+++. +|+.||||++........ ...+.+.+|+.++++++ |||||++++++.+++++|
T Consensus 1 E~l~~lG~G~fg~Vy~~~~~~---~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~~~~~~~~~~~~~ 76 (299)
T d1ua2a_ 1 EKLDFLGEGQFATVYKARDKN---TNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELS-HPNIIGLLDAFGHKSNIS 76 (299)
T ss_dssp CEEEEEEEETTEEEEEEECSS---CCSEEEEEEC------------CTHHHHHHHHHHHCC-CTTBCCEEEEECCTTCCE
T ss_pred CcceEeccCcCeEEEEEEECC---CCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCC-CCCEeEEEeeeccCCcee
Confidence 357899999999999999766 689999999976533221 22356889999999998 999999999999999999
Q ss_pred EEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccccCC
Q 014210 236 VVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP 315 (429)
Q Consensus 236 lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~ 315 (429)
||||||.++++. .+......+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++....
T Consensus 77 ivmE~~~~~~~~-~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli---~~~~~~KL~DFG~a~~~~~ 152 (299)
T d1ua2a_ 77 LVFDFMETDLEV-IIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLL---DENGVLKLADFGLAKSFGS 152 (299)
T ss_dssp EEEECCSEEHHH-HHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEECCCGGGSTTTS
T ss_pred ehhhhhcchHHh-hhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEe---cCCCccccccCccccccCC
Confidence 999999886654 445566789999999999999999999999999999999999999 7888999999999987654
Q ss_pred Cc-cccccccCCcccCccccc--CCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCC--------
Q 014210 316 DE-RLNDIVGSAYYVAPEVLH--RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAP-------- 384 (429)
Q Consensus 316 ~~-~~~~~~gt~~y~aPE~~~--~~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~-------- 384 (429)
.. .....+||+.|+|||++. ..|+.++|||||||++|||++|+.||.+.++.+.+..+.+.........
T Consensus 153 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~ 232 (299)
T d1ua2a_ 153 PNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLP 232 (299)
T ss_dssp CCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSST
T ss_pred CcccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccc
Confidence 43 345678999999999875 3579999999999999999999999999998888887765321111110
Q ss_pred ----------------CCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhcc
Q 014210 385 ----------------WPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLICYQ 422 (429)
Q Consensus 385 ----------------~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~ 422 (429)
++.+++++.+||++||+.||++|||+.|+|+|+||+..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~ 286 (299)
T d1ua2a_ 233 DYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR 286 (299)
T ss_dssp TCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSS
T ss_pred hhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCC
Confidence 13568999999999999999999999999999999854
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-55 Score=417.02 Aligned_cols=254 Identities=22% Similarity=0.346 Sum_probs=215.7
Q ss_pred CceeEec-eeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe
Q 014210 155 NKYELGE-EVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (429)
Q Consensus 155 ~~y~~~~-~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~ 233 (429)
++|.+.+ +||+|+||.||+|..+... ++..||||++... ......+++.+|+++|++++ |||||++++++.+ +.
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~-~~~~vAvK~l~~~--~~~~~~~~~~~E~~il~~l~-HpnIv~l~g~~~~-~~ 82 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRK-KQIDVAIKVLKQG--TEKADTEEMMREAQIMHQLD-NPYIVRLIGVCQA-EA 82 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC----CCEEEEEEEECSS--CCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEES-SS
T ss_pred cCeEECCcEEecccCeEEEEEEEecCC-CcEEEEEEEEChh--cCHHHHHHHHHHHHHHHhCC-CCCEeeEeeeecc-Ce
Confidence 5788888 4999999999999765422 4678999999754 44566788999999999998 9999999999865 56
Q ss_pred EEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCcccc
Q 014210 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (429)
Q Consensus 234 ~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~ 313 (429)
+|||||||++|+|.+++......+++..+..++.||++||+|||++|||||||||+|||+ +.++.+||+|||+++..
T Consensus 83 ~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill---~~~~~~Kl~DFGla~~~ 159 (285)
T d1u59a_ 83 LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLL---VNRHYAKISDFGLSKAL 159 (285)
T ss_dssp EEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---EETTEEEECCCTTCEEC
T ss_pred EEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheee---ccCCceeeccchhhhcc
Confidence 899999999999999887777789999999999999999999999999999999999999 56789999999999876
Q ss_pred CCCcc----ccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCC
Q 014210 314 RPDER----LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPS 387 (429)
Q Consensus 314 ~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 387 (429)
..... .....||+.|||||++. +.++.++|||||||++|||+| |+.||......+++..+.+.... ...+.
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~---~~p~~ 236 (285)
T d1u59a_ 160 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRM---ECPPE 236 (285)
T ss_dssp TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCC---CCCTT
T ss_pred cccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC---CCCCc
Confidence 54332 23456899999999887 568999999999999999998 99999988887777777664422 22357
Q ss_pred CCHHHHHHHHHhcccCccCcCCHHHHH---hhHhh
Q 014210 388 LSSEARDFVKRLLNKDPRKRLTAAQAL---SELLI 419 (429)
Q Consensus 388 ~s~~~~~li~~~L~~dP~~Rps~~~iL---~~~~~ 419 (429)
+++++.+||.+||+.||++||++.+|+ ++.|+
T Consensus 237 ~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~ 271 (285)
T d1u59a_ 237 CPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 271 (285)
T ss_dssp CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 899999999999999999999999884 55555
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-55 Score=427.17 Aligned_cols=258 Identities=26% Similarity=0.374 Sum_probs=216.5
Q ss_pred cCceeEeceeeccCceEEEEEEEecCcc--cCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeC
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGEL--KGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~ 231 (429)
.++|+++++||+|+||.||+|+.+.... ....||||++.... .......+.+|+.++.++.+|||||+++++|.+.
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~ 113 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGACTLS 113 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc--CHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeC
Confidence 3689999999999999999999875321 34579999986542 3344567899999999995599999999999999
Q ss_pred CeEEEEEEecCCCcHHHHHHhcC----------------------CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCC
Q 014210 232 DNVYVVMELCEGGELLDRILSRG----------------------GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPE 289 (429)
Q Consensus 232 ~~~~lv~E~~~ggsL~~~i~~~~----------------------~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~ 289 (429)
+.+|||||||++|+|.++|..+. ..+++..++.++.||++||+|||++|||||||||+
T Consensus 114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~ 193 (325)
T d1rjba_ 114 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAAR 193 (325)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGG
T ss_pred CeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchh
Confidence 99999999999999999987543 24899999999999999999999999999999999
Q ss_pred cEEEeecCCCceEEEeecCCccccCCCcc---ccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHc-CCCCCCCC
Q 014210 290 NFLFTTKDENSVLKAIDFGLSDFVRPDER---LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWAR 364 (429)
Q Consensus 290 NILl~~~~~~~~vkL~DFGla~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~ellt-g~~Pf~~~ 364 (429)
|||+ +.++++||+|||+|+....... .....||+.|||||++. +.++.++|||||||++|||+| |+.||.+.
T Consensus 194 Nill---~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~ 270 (325)
T d1rjba_ 194 NVLV---THGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI 270 (325)
T ss_dssp GEEE---ETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred cccc---ccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCC
Confidence 9999 6788999999999987654332 23567899999999886 679999999999999999997 89999887
Q ss_pred ChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHh
Q 014210 365 TESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELL 418 (429)
Q Consensus 365 ~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~ 418 (429)
.....+..++......+ ....+++++.+||.+||+.||++|||+.||++|+-
T Consensus 271 ~~~~~~~~~~~~~~~~~--~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 271 PVDANFYKLIQNGFKMD--QPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp CCSHHHHHHHHTTCCCC--CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CHHHHHHHHHhcCCCCC--CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 77666777766554332 23468999999999999999999999999999873
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-55 Score=411.59 Aligned_cols=248 Identities=22% Similarity=0.386 Sum_probs=219.5
Q ss_pred CceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeE
Q 014210 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (429)
Q Consensus 155 ~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~ 234 (429)
++|+++++||+|+||.||+|+.+ +++.||||++++.... .+++.+|++++++++ |||||+++++|.+++.+
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~----~~~~vAvK~l~~~~~~----~~~~~~Ev~~~~~l~-HpnIv~~~g~~~~~~~~ 74 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWR----GQYDVAIKMIKEGSMS----EDEFIEEAKVMMNLS-HEKLVQLYGVCTKQRPI 74 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEET----TTEEEEEEEEESSSSC----HHHHHHHHHHHHTCC-CTTBCCEEEEECCSSSE
T ss_pred HHCEEeEEEecCCCeEEEEEEEC----CCCEEEEEEECcCcCC----HHHHHHHHHHHHhcC-CCceeeEEEEEeeCCce
Confidence 67899999999999999999975 3789999999765432 357899999999998 99999999999999999
Q ss_pred EEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccccC
Q 014210 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (429)
Q Consensus 235 ~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~ 314 (429)
++||||+++|+|.+++......+++..+++++.||++||+|||++||+||||||+|||+ ++++.+||+|||+++...
T Consensus 75 ~iv~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill---~~~~~~kl~DfG~a~~~~ 151 (258)
T d1k2pa_ 75 FIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLV---NDQGVVKVSDFGLSRYVL 151 (258)
T ss_dssp EEEEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEE---CTTCCEEECCCSSCCBCS
T ss_pred EEEEEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEE---cCCCcEEECcchhheecc
Confidence 99999999999999988878889999999999999999999999999999999999999 788899999999998765
Q ss_pred CCcc--ccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCH
Q 014210 315 PDER--LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLSS 390 (429)
Q Consensus 315 ~~~~--~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 390 (429)
.... .....||..|+|||++. +.++.++|||||||++|||+| |+.||...+..++...+....... ....+++
T Consensus 152 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~---~p~~~~~ 228 (258)
T d1k2pa_ 152 DDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLY---RPHLASE 228 (258)
T ss_dssp SSSCCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCC---CCTTCCH
T ss_pred CCCceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCC---CcccccH
Confidence 4432 23467899999999887 578999999999999999998 899999999888888887654322 2246889
Q ss_pred HHHHHHHHhcccCccCcCCHHHHHhhH
Q 014210 391 EARDFVKRLLNKDPRKRLTAAQALSEL 417 (429)
Q Consensus 391 ~~~~li~~~L~~dP~~Rps~~~iL~~~ 417 (429)
++.+||++||+.||++|||+.++|+|+
T Consensus 229 ~l~~li~~cl~~dP~~RPt~~eil~~L 255 (258)
T d1k2pa_ 229 KVYTIMYSCWHEKADERPTFKILLSNI 255 (258)
T ss_dssp HHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHHHccCCHhHCcCHHHHHHHh
Confidence 999999999999999999999999996
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=7.6e-55 Score=417.24 Aligned_cols=251 Identities=22% Similarity=0.357 Sum_probs=212.7
Q ss_pred cCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~ 233 (429)
.++|++.++||+|+||.||+|+.+. +|+.||||++..+.. ..+++.+|+++|++|+ |||||+++++|.+++.
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~---~~~~vAvK~i~~~~~----~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~ 87 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKK---YSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-HPNLVQLLGVCTREPP 87 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGG---GTEEEEEEECCTTCS----CHHHHHHHHHHHHHCC-CTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECC---CCeEEEEEEECCccc----hHHHHHHHHHHHHhCC-CCCEecCCccEeeCCe
Confidence 4689999999999999999999876 589999999875432 2467899999999998 9999999999999999
Q ss_pred EEEEEEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccc
Q 014210 234 VYVVMELCEGGELLDRILSR-GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (429)
Q Consensus 234 ~~lv~E~~~ggsL~~~i~~~-~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~ 312 (429)
.+||||||++|+|.+++... ...+++..++.|+.||++||+|||++|||||||||+|||| ++++++||+|||+++.
T Consensus 88 ~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl---~~~~~~Kl~DFG~a~~ 164 (287)
T d1opja_ 88 FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV---GENHLVKVADFGLSRL 164 (287)
T ss_dssp CEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCCCCTTT
T ss_pred eEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEE---CCCCcEEEccccceee
Confidence 99999999999999988754 4579999999999999999999999999999999999999 7888999999999987
Q ss_pred cCCCcc--ccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCC
Q 014210 313 VRPDER--LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLS 389 (429)
Q Consensus 313 ~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 389 (429)
...+.. .....|+..|||||++. +.++.++|||||||++|||++|..||........+..++...... .....++
T Consensus 165 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~--~~~~~~~ 242 (287)
T d1opja_ 165 MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM--ERPEGCP 242 (287)
T ss_dssp CCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCC--CCCTTCC
T ss_pred cCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCC--CCCccch
Confidence 754432 23346889999999876 679999999999999999999777765544444444444333222 2234789
Q ss_pred HHHHHHHHHhcccCccCcCCHHHHHhhH
Q 014210 390 SEARDFVKRLLNKDPRKRLTAAQALSEL 417 (429)
Q Consensus 390 ~~~~~li~~~L~~dP~~Rps~~~iL~~~ 417 (429)
+++.+||.+||+.||++|||+.++++.+
T Consensus 243 ~~l~~li~~cl~~dP~~Rps~~ei~~~L 270 (287)
T d1opja_ 243 EKVYELMRACWQWNPSDRPSFAEIHQAF 270 (287)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHHHHcCCCHhHCcCHHHHHHHH
Confidence 9999999999999999999999998753
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-55 Score=421.38 Aligned_cols=263 Identities=28% Similarity=0.371 Sum_probs=219.2
Q ss_pred cCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhc--CCCCcceEEEEEEe-
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALT--GHNNLVKFFDAYED- 230 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~--~h~nIv~l~~~~~~- 230 (429)
.++|+++++||+|+||.||+|++... .++.||||++....... .....+.+|+.+++.|. +||||++++++|..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~--~~~~vAiK~i~~~~~~~-~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~ 82 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKN--GGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVS 82 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTT--TTEEEEEEEEEEEBCTT-SCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEE
T ss_pred cCCEEEEEEEecccCeEEEEEEEECC--CCEEEEEEEEehhhccc-hHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccc
Confidence 57899999999999999999987652 36789999986532221 12234567888887774 49999999999863
Q ss_pred ----CCeEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEee
Q 014210 231 ----TDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAID 306 (429)
Q Consensus 231 ----~~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~D 306 (429)
...++++||||+++.+..........+++..++.++.||+.||+|||++|||||||||+|||+ +.++.+||+|
T Consensus 83 ~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi---~~~~~~kl~d 159 (305)
T d1blxa_ 83 RTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILV---TSSGQIKLAD 159 (305)
T ss_dssp ECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEECS
T ss_pred ccccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEE---cCCCCeeecc
Confidence 346899999999877665555566789999999999999999999999999999999999999 7888999999
Q ss_pred cCCccccCCCccccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCC----
Q 014210 307 FGLSDFVRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFD---- 381 (429)
Q Consensus 307 FGla~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~---- 381 (429)
||+++............||+.|||||++. ..|+.++|||||||++|||++|+.||.+.+..+.+..++.......
T Consensus 160 fg~~~~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 239 (305)
T d1blxa_ 160 FGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 239 (305)
T ss_dssp CCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGS
T ss_pred hhhhhhhcccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcc
Confidence 99998877666777889999999999886 5699999999999999999999999999988888777765311110
Q ss_pred -------------------CCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhcc
Q 014210 382 -------------------EAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLICYQ 422 (429)
Q Consensus 382 -------------------~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~ 422 (429)
...+..+++++.+||++||++||++|||+.|+|+|+||+.-
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i 299 (305)
T d1blxa_ 240 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL 299 (305)
T ss_dssp CTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred cccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCc
Confidence 11234578999999999999999999999999999999864
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-55 Score=417.71 Aligned_cols=252 Identities=27% Similarity=0.481 Sum_probs=211.6
Q ss_pred ccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcH---HHHHHHHHHHHHHHHhc-CCCCcceEEEEE
Q 014210 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTA---IAIEDVRREVKILRALT-GHNNLVKFFDAY 228 (429)
Q Consensus 153 ~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~---~~~~~~~~Ei~il~~l~-~h~nIv~l~~~~ 228 (429)
+.++|+++++||+|+||.||+|+... +|+.||||++.+...... ....++.+|+.++++++ +|||||++++++
T Consensus 2 l~~~Y~i~~~lG~G~fg~Vy~a~~~~---~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~ 78 (273)
T d1xwsa_ 2 LESQYQVGPLLGSGGFGSVYSGIRVS---DNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF 78 (273)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE
T ss_pred CCCeEEEeEEEeeCCCeEEEEEEECC---CCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEE
Confidence 45789999999999999999999776 589999999875433221 12234678999999997 489999999999
Q ss_pred EeCCeEEEEEEecCC-CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeec
Q 014210 229 EDTDNVYVVMELCEG-GELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDF 307 (429)
Q Consensus 229 ~~~~~~~lv~E~~~g-gsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DF 307 (429)
.+.+..++||||+.+ +++.+++. ..+.+++..++.++.||+.||+|||++||+||||||+|||++ .+++.+||+||
T Consensus 79 ~~~~~~~lv~e~~~~~~~l~~~~~-~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~--~~~~~vkl~DF 155 (273)
T d1xwsa_ 79 ERPDSFVLILERPEPVQDLFDFIT-ERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILID--LNRGELKLIDF 155 (273)
T ss_dssp ECSSEEEEEEECCSSEEEHHHHHH-HHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE--TTTTEEEECCC
T ss_pred eeCCeEEEEEEeccCcchHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEe--cCCCeEEECcc
Confidence 999999999999976 56666664 446799999999999999999999999999999999999994 24578999999
Q ss_pred CCccccCCCccccccccCCcccCcccccC-C-CCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCC
Q 014210 308 GLSDFVRPDERLNDIVGSAYYVAPEVLHR-S-YSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPW 385 (429)
Q Consensus 308 Gla~~~~~~~~~~~~~gt~~y~aPE~~~~-~-~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 385 (429)
|+++.... ......+||+.|||||++.+ . ++.++|||||||++|||++|+.||... ..+.+....+.
T Consensus 156 G~a~~~~~-~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~------~~i~~~~~~~~---- 224 (273)
T d1xwsa_ 156 GSGALLKD-TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EEIIRGQVFFR---- 224 (273)
T ss_dssp TTCEECCS-SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH------HHHHHCCCCCS----
T ss_pred ccceeccc-ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCc------hHHhhcccCCC----
Confidence 99986543 34456789999999999864 3 466789999999999999999999653 23445444333
Q ss_pred CCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhc
Q 014210 386 PSLSSEARDFVKRLLNKDPRKRLTAAQALSELLICY 421 (429)
Q Consensus 386 ~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~ 421 (429)
+.+++++.+||++||+.||++|||++|+|+|+||+.
T Consensus 225 ~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~ 260 (273)
T d1xwsa_ 225 QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 260 (273)
T ss_dssp SCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSS
T ss_pred CCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCC
Confidence 368999999999999999999999999999999975
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-54 Score=411.30 Aligned_cols=251 Identities=22% Similarity=0.375 Sum_probs=211.1
Q ss_pred cCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~ 233 (429)
.++|++.++||+|+||.||+|+.+. ++.||||++..... ..+++.+|++++++++ |||||++++++.+ +.
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~----~~~vAvK~~~~~~~----~~~~~~~E~~~l~~l~-HpnIv~~~g~~~~-~~ 81 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNG----HTKVAVKSLKQGSM----SPDAFLAEANLMKQLQ-HQRLVRLYAVVTQ-EP 81 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETT----TEEEEEEEECTTSS----CHHHHHHHHHHHHHCC-CTTBCCEEEEECS-SS
T ss_pred HHHeEEeEEEecCCCcEEEEEEECC----CCEEEEEEEccCcC----CHHHHHHHHHHHHhCC-CCCEeEEEeeecc-CC
Confidence 4689999999999999999998653 68899999975432 2357899999999998 9999999998754 56
Q ss_pred EEEEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccc
Q 014210 234 VYVVMELCEGGELLDRILSRG-GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (429)
Q Consensus 234 ~~lv~E~~~ggsL~~~i~~~~-~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~ 312 (429)
.+||||||++|+|.+++.... ..+++..+..|+.||++||.|||+++|+||||||+|||| ++++.+||+|||+++.
T Consensus 82 ~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll---~~~~~~Kl~DFGla~~ 158 (272)
T d1qpca_ 82 IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILV---SDTLSCKIADFGLARL 158 (272)
T ss_dssp CEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTSCEEECCCTTCEE
T ss_pred eEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheee---ecccceeeccccceEE
Confidence 799999999999998775433 369999999999999999999999999999999999999 7889999999999988
Q ss_pred cCCCc--cccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHcCC-CCCCCCChHHHHHHHHhcCCCCCCCCCCCC
Q 014210 313 VRPDE--RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGS-RPFWARTESGIFRAVLKADPSFDEAPWPSL 388 (429)
Q Consensus 313 ~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~elltg~-~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 388 (429)
..... ......||+.|||||++. +.++.++|||||||++|||+||. .||......+.+..+....... ....+
T Consensus 159 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~---~p~~~ 235 (272)
T d1qpca_ 159 IEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMV---RPDNC 235 (272)
T ss_dssp CSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC---CCTTC
T ss_pred ccCCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCC---CcccC
Confidence 75443 234567899999999887 56999999999999999999965 4556666666777666543222 22468
Q ss_pred CHHHHHHHHHhcccCccCcCCHHHHHh--hHhhh
Q 014210 389 SSEARDFVKRLLNKDPRKRLTAAQALS--ELLIC 420 (429)
Q Consensus 389 s~~~~~li~~~L~~dP~~Rps~~~iL~--~~~~~ 420 (429)
++++.+||++||+.||++|||+.++++ +.||.
T Consensus 236 ~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 236 PEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence 999999999999999999999999998 56664
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-54 Score=411.49 Aligned_cols=249 Identities=22% Similarity=0.334 Sum_probs=206.4
Q ss_pred ceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEe
Q 014210 161 EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMEL 240 (429)
Q Consensus 161 ~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~~lv~E~ 240 (429)
++||+|+||.||+|.+.... .++.||||++.... .+....+++.+|++++++|+ |||||+++++|++ +..+|||||
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~~~E~~il~~l~-HpnIv~~~g~~~~-~~~~lvmE~ 88 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKK-VVKTVAVKILKNEA-NDPALKDELLAEANVMQQLD-NPYIVRMIGICEA-ESWMLVMEM 88 (277)
T ss_dssp EEEEECSSEEEEEEEEECSS-SEEEEEEEEEC------CHHHHHHHHHHHHHHTCC-CTTBCCEEEEEES-SSEEEEEEC
T ss_pred CCcccCCCeEEEEEEEccCC-cCeEEEEEEEChhh-CCHHHHHHHHHHHHHHHhCC-CCCCceEEEEecc-CCEEEEEEc
Confidence 57999999999999876432 47899999996543 34455678999999999998 9999999999965 457899999
Q ss_pred cCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccccCCCcc--
Q 014210 241 CEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDER-- 318 (429)
Q Consensus 241 ~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~-- 318 (429)
|++|+|.+++. ....+++..+..|+.||+.||+|||++|||||||||+|||+ +.++.+||+|||+++.......
T Consensus 89 ~~~g~L~~~l~-~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill---~~~~~~kl~DFGla~~~~~~~~~~ 164 (277)
T d1xbba_ 89 AELGPLNKYLQ-QNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLL---VTQHYAKISDFGLSKALRADENYY 164 (277)
T ss_dssp CTTEEHHHHHH-HCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---EETTEEEECCCTTCEECCTTCSEE
T ss_pred CCCCcHHHHHh-hccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcc---cccCcccccchhhhhhcccccccc
Confidence 99999999875 45679999999999999999999999999999999999999 6788999999999987654332
Q ss_pred --ccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHH
Q 014210 319 --LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARD 394 (429)
Q Consensus 319 --~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 394 (429)
.....||+.|||||++. +.++.++|||||||++|||+| |+.||.+.+..++...+.+.... .....+++++.+
T Consensus 165 ~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~---~~p~~~~~~~~~ 241 (277)
T d1xbba_ 165 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM---GCPAGCPREMYD 241 (277)
T ss_dssp EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC---CCCTTCCHHHHH
T ss_pred ccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCC---CCCcccCHHHHH
Confidence 23457899999999886 568999999999999999998 89999998888777777664322 122468999999
Q ss_pred HHHHhcccCccCcCCHHHHH---hhHhhh
Q 014210 395 FVKRLLNKDPRKRLTAAQAL---SELLIC 420 (429)
Q Consensus 395 li~~~L~~dP~~Rps~~~iL---~~~~~~ 420 (429)
||.+||+.||++|||+.+|+ ++.|+.
T Consensus 242 li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 270 (277)
T d1xbba_ 242 LMNLCWTYDVENRPGFAAVELRLRNYYYD 270 (277)
T ss_dssp HHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred HHHHHcCCCHhHCcCHHHHHHHhhCHHhh
Confidence 99999999999999999984 555543
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-54 Score=409.54 Aligned_cols=255 Identities=24% Similarity=0.390 Sum_probs=210.8
Q ss_pred cCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~ 233 (429)
.++|+++++||+|+||.||+|++......+..||||.+... ......+.+.+|+.++++++ |||||++++++. ++.
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~--~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~-~~~ 81 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC--TSDSVREKFLQEALTMRQFD-HPHIVKLIGVIT-ENP 81 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT--TSHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEC-SSS
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccc--cCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEe-cCe
Confidence 46899999999999999999988765445678999998643 45566678999999999998 999999999986 467
Q ss_pred EEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCcccc
Q 014210 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (429)
Q Consensus 234 ~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~ 313 (429)
+|||||||++|+|.+++......+++..++.++.||++||.|||++|||||||||+|||+ +.++.+||+|||+++..
T Consensus 82 ~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll---~~~~~~Kl~DfG~a~~~ 158 (273)
T d1mp8a_ 82 VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLV---SSNDCVKLGDFGLSRYM 158 (273)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---EETTEEEECC-------
T ss_pred EEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheee---cCCCcEEEccchhheec
Confidence 899999999999999888888889999999999999999999999999999999999999 66788999999999876
Q ss_pred CCCc--cccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCC
Q 014210 314 RPDE--RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLS 389 (429)
Q Consensus 314 ~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 389 (429)
.... ......||+.|+|||++. +.++.++|||||||++|||++ |..||......+.+..+...... ..++.++
T Consensus 159 ~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~---~~~~~~~ 235 (273)
T d1mp8a_ 159 EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL---PMPPNCP 235 (273)
T ss_dssp ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC---CCCTTCC
T ss_pred cCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC---CCCCCCC
Confidence 5433 234567899999999987 578999999999999999998 89999998888888887765432 2345799
Q ss_pred HHHHHHHHHhcccCccCcCCHHHHHhhHh
Q 014210 390 SEARDFVKRLLNKDPRKRLTAAQALSELL 418 (429)
Q Consensus 390 ~~~~~li~~~L~~dP~~Rps~~~iL~~~~ 418 (429)
+++.+||.+||+.||++|||+.+|++++-
T Consensus 236 ~~~~~li~~cl~~dp~~Rps~~ei~~~L~ 264 (273)
T d1mp8a_ 236 PTLYSLMTKCWAYDPSRRPRFTELKAQLS 264 (273)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence 99999999999999999999999999864
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=3.5e-54 Score=412.28 Aligned_cols=257 Identities=30% Similarity=0.461 Sum_probs=215.2
Q ss_pred CceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeE
Q 014210 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (429)
Q Consensus 155 ~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~ 234 (429)
++|+++++||+|+||.||+|+.+ +|+.||||++..... .....+++.+|+.+|++++ |||||+++++|.+++..
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~----~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~~~~~~ 75 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN----YGETFALKKIRLEKE-DEGIPSTTIREISILKELK-HSNIVKLYDVIHTKKRL 75 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET----TSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGCC-CTTBCCEEEEEECSSCE
T ss_pred CCceeccEEecCCCcEEEEEEeC----CCCEEEEEEEehhhc-ChHHHHHHHHHHHHHHhCC-CCcEEeeeeecccCCce
Confidence 68999999999999999999865 478999999976542 3334577899999999998 99999999999999999
Q ss_pred EEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccccC
Q 014210 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (429)
Q Consensus 235 ~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~ 314 (429)
+++|||+.++ ++..+....+.+++..++.++.||+.||+|||+.|||||||||+|||+ +.++.+||+|||++....
T Consensus 76 ~i~~e~~~~~-~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll---~~~~~~kl~DfG~a~~~~ 151 (286)
T d1ob3a_ 76 VLVFEHLDQD-LKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLI---NREGELKIADFGLARAFG 151 (286)
T ss_dssp EEEEECCSEE-HHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECCTTHHHHHC
T ss_pred eEEEEeehhh-hHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeE---cCCCCEEecccccceecc
Confidence 9999999765 455566777889999999999999999999999999999999999999 788899999999998765
Q ss_pred CCc-cccccccCCcccCcccccC--CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCC---------
Q 014210 315 PDE-RLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDE--------- 382 (429)
Q Consensus 315 ~~~-~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~--------- 382 (429)
... ......|++.|+|||.+.+ .++.++|||||||++|||++|+.||.+....+.+..+.+.......
T Consensus 152 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 231 (286)
T d1ob3a_ 152 IPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTEL 231 (286)
T ss_dssp C---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGS
T ss_pred cCccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhh
Confidence 432 3445679999999998863 5799999999999999999999999988887777766542211111
Q ss_pred ----------------CCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhc
Q 014210 383 ----------------APWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLICY 421 (429)
Q Consensus 383 ----------------~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~ 421 (429)
...+.+++++.|||++||+.||++|||+.|+|+|+||++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 232 PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp TTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred hhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence 112457899999999999999999999999999999974
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-53 Score=406.33 Aligned_cols=255 Identities=21% Similarity=0.326 Sum_probs=208.1
Q ss_pred cCceeEeceeeccCceEEEEEEEecCcc-cCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCC
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGEL-KGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~ 232 (429)
.+.|++.++||+|+||.||+|.++.+.. ....||||++... .......++.+|++++++|+ |||||+++|++.+.+
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~~E~~il~~l~-H~nIv~~~g~~~~~~ 82 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG--YTEKQRVDFLGEAGIMGQFS-HHNIIRLEGVISKYK 82 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTT--CCHHHHHHHHHHHHHHHTCC-CTTBCCEEEEECSSS
T ss_pred HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcc--cChHHHHHHHHHHHHHHhcC-CCCEeeeeEEEecCC
Confidence 4679999999999999999998876321 2357999998654 34455677999999999998 999999999999999
Q ss_pred eEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccc
Q 014210 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (429)
Q Consensus 233 ~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~ 312 (429)
..++|||||.++++.+++......+++..+..++.||+.||+|||+++|+||||||+|||| +.++.+||+|||+++.
T Consensus 83 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl---~~~~~~Kl~DFGla~~ 159 (283)
T d1mqba_ 83 PMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILV---NSNLVCKVSDFGLSRV 159 (283)
T ss_dssp SEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECCCCC---
T ss_pred ceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEE---CCCCeEEEcccchhhc
Confidence 9999999999999999888888889999999999999999999999999999999999999 7889999999999987
Q ss_pred cCCCcc----ccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHcCCCC-CCCCChHHHHHHHHhcCCCCCCCCCC
Q 014210 313 VRPDER----LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRP-FWARTESGIFRAVLKADPSFDEAPWP 386 (429)
Q Consensus 313 ~~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~elltg~~P-f~~~~~~~~~~~i~~~~~~~~~~~~~ 386 (429)
...... .....||..|||||++. +.++.++|||||||++|||++|..| |.......++..+..... . ....
T Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~-~--~~~~ 236 (283)
T d1mqba_ 160 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFR-L--PTPM 236 (283)
T ss_dssp --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC-C--CCCT
T ss_pred ccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCC-C--CCch
Confidence 654322 23356899999999886 5799999999999999999996555 555566666666554322 1 1224
Q ss_pred CCCHHHHHHHHHhcccCccCcCCHHHHHhhH
Q 014210 387 SLSSEARDFVKRLLNKDPRKRLTAAQALSEL 417 (429)
Q Consensus 387 ~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~ 417 (429)
.++.++.+||.+||+.||++||++.++++.+
T Consensus 237 ~~~~~l~~li~~cl~~~p~~RPt~~eil~~L 267 (283)
T d1mqba_ 237 DCPSAIYQLMMQCWQQERARRPKFADIVSIL 267 (283)
T ss_dssp TCBHHHHHHHHHHTCSSTTTSCCHHHHHHHH
T ss_pred hhHHHHHHHHHHHCcCCHhHCcCHHHHHHHH
Confidence 6889999999999999999999999998855
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-54 Score=407.98 Aligned_cols=256 Identities=23% Similarity=0.372 Sum_probs=210.8
Q ss_pred cCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~ 233 (429)
.++|++.+.||+|+||.||+|+.......+..||||++.+.........+++.+|+.++++++ |||||+++|++.+ +.
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~-H~nIv~~~g~~~~-~~ 84 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD-HRNLIRLYGVVLT-PP 84 (273)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCC-CTTBCCEEEEECS-SS
T ss_pred hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCC-CCCEEEEEEEEee-cc
Confidence 367999999999999999999877654345689999998776666677788999999999998 9999999999965 46
Q ss_pred EEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCcccc
Q 014210 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (429)
Q Consensus 234 ~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~ 313 (429)
.++|||||++|+|.+++..+.+.+++..+..++.||+.||.|||++||+||||||+|||| +.++.+||+|||+++..
T Consensus 85 ~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll---~~~~~vkl~DfGl~~~~ 161 (273)
T d1u46a_ 85 MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLL---ATRDLVKIGDFGLMRAL 161 (273)
T ss_dssp CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---EETTEEEECCCTTCEEC
T ss_pred hheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhcc---ccccceeeccchhhhhc
Confidence 789999999999999988887889999999999999999999999999999999999999 56778999999999877
Q ss_pred CCCcc----ccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCC
Q 014210 314 RPDER----LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPS 387 (429)
Q Consensus 314 ~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 387 (429)
..... .....|+..|+|||++. +.++.++|||||||++|||+| |+.||.+.+..+.+..+.+.....+ ..+.
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~--~~~~ 239 (273)
T d1u46a_ 162 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP--RPED 239 (273)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCC--CCTT
T ss_pred ccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCC--Cccc
Confidence 54432 23456888999999887 468889999999999999998 8999999999998888877654433 2357
Q ss_pred CCHHHHHHHHHhcccCccCcCCHHHHHhh
Q 014210 388 LSSEARDFVKRLLNKDPRKRLTAAQALSE 416 (429)
Q Consensus 388 ~s~~~~~li~~~L~~dP~~Rps~~~iL~~ 416 (429)
++.++.+||++||+.||++|||+.+|++.
T Consensus 240 ~~~~l~~li~~cl~~dp~~RPt~~ei~~~ 268 (273)
T d1u46a_ 240 CPQDIYNVMVQCWAHKPEDRPTFVALRDF 268 (273)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ccHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 89999999999999999999999999753
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-53 Score=405.31 Aligned_cols=258 Identities=26% Similarity=0.367 Sum_probs=207.2
Q ss_pred cCceeEeceeeccCceEEEEEEEecC--cccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeC
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKG--ELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~--~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~ 231 (429)
.++|+++++||+|+||.||+|+.... ..+++.||||++... ......+.+.+|+.++.++.+|+|||.+++++.+.
T Consensus 12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~ 89 (299)
T d1ywna1 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG--ATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 89 (299)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC------CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccc--cCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccC
Confidence 36899999999999999999987653 235789999998654 34455677889999999998799999999998765
Q ss_pred -CeEEEEEEecCCCcHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEee
Q 014210 232 -DNVYVVMELCEGGELLDRILSRG---------------GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTT 295 (429)
Q Consensus 232 -~~~~lv~E~~~ggsL~~~i~~~~---------------~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~ 295 (429)
+.+++|||||++|+|.+++..+. ..+++..++.++.||++||.|||++|||||||||+||||
T Consensus 90 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl-- 167 (299)
T d1ywna1 90 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL-- 167 (299)
T ss_dssp TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE--
T ss_pred CCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeE--
Confidence 46899999999999999987542 358999999999999999999999999999999999999
Q ss_pred cCCCceEEEeecCCccccCCCc---cccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHcC-CCCCCCCChHHHH
Q 014210 296 KDENSVLKAIDFGLSDFVRPDE---RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCG-SRPFWARTESGIF 370 (429)
Q Consensus 296 ~~~~~~vkL~DFGla~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~elltg-~~Pf~~~~~~~~~ 370 (429)
+.++++||+|||+++...... ......||+.|||||++. +.++.++|||||||++|||++| ..||........+
T Consensus 168 -~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~ 246 (299)
T d1ywna1 168 -SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF 246 (299)
T ss_dssp -CGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHH
T ss_pred -CCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 778899999999998654332 234567999999999886 5689999999999999999987 5678776655555
Q ss_pred HHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHh
Q 014210 371 RAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELL 418 (429)
Q Consensus 371 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~ 418 (429)
..++....... ....+++++.+||.+||+.||++|||+.|+++|+-
T Consensus 247 ~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~ 292 (299)
T d1ywna1 247 CRRLKEGTRMR--APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLG 292 (299)
T ss_dssp HHHHHHTCCCC--CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHhcCCCCC--CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 55554433222 22468999999999999999999999999999874
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-53 Score=409.08 Aligned_cols=255 Identities=21% Similarity=0.291 Sum_probs=212.1
Q ss_pred CceeEeceeeccCceEEEEEEEecC-cccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe
Q 014210 155 NKYELGEEVGRGHFGYTCAAKFKKG-ELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (429)
Q Consensus 155 ~~y~~~~~IG~G~fg~V~~~~~~~~-~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~ 233 (429)
++|+++++||+|+||.||+|+.... ......||||.+... ......+++.+|++++++++ |||||+++++|.++ .
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~-HpnIv~l~g~~~~~-~ 84 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASVD-NPHVCRLLGICLTS-T 84 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC------CTHHHHHHHHHHHHHCC-CTTBCCEEEEEESS-S
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccc--cCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEecC-C
Confidence 4699999999999999999987652 122347899988643 33445678999999999998 99999999999865 5
Q ss_pred EEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCcccc
Q 014210 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (429)
Q Consensus 234 ~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~ 313 (429)
.+++|||+.+|+|.+++......+++..+++++.||+.||+|||++|||||||||+|||| +.++.+||+|||+++..
T Consensus 85 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll---~~~~~~kl~DFGla~~~ 161 (317)
T d1xkka_ 85 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLV---KTPQHVKITDFGLAKLL 161 (317)
T ss_dssp EEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---EETTEEEECCCSHHHHT
T ss_pred eeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhccee---CCCCCeEeeccccceec
Confidence 678899999999999998888899999999999999999999999999999999999999 67789999999999876
Q ss_pred CCCcc---ccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCC
Q 014210 314 RPDER---LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSL 388 (429)
Q Consensus 314 ~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 388 (429)
..... .....||..|||||++. +.++.++|||||||++|||+| |+.||...+...+...+.+.... ...+.+
T Consensus 162 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~---~~p~~~ 238 (317)
T d1xkka_ 162 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL---PQPPIC 238 (317)
T ss_dssp TTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCC---CCCTTB
T ss_pred ccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC---CCCccc
Confidence 54332 23456899999999876 579999999999999999998 89999888877777666654422 122468
Q ss_pred CHHHHHHHHHhcccCccCcCCHHHHHhhHhh
Q 014210 389 SSEARDFVKRLLNKDPRKRLTAAQALSELLI 419 (429)
Q Consensus 389 s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~ 419 (429)
++++.+||.+||+.||++|||+.+++.++..
T Consensus 239 ~~~~~~li~~cl~~dP~~RPs~~eil~~l~~ 269 (317)
T d1xkka_ 239 TIDVYMIMVKCWMIDADSRPKFRELIIEFSK 269 (317)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CHHHHHHHHHhCCCChhhCcCHHHHHHHHHH
Confidence 9999999999999999999999999998654
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.1e-52 Score=409.56 Aligned_cols=255 Identities=28% Similarity=0.498 Sum_probs=212.2
Q ss_pred cCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeC--
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT-- 231 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~-- 231 (429)
.++|+++++||+|+||+||+|+.+. +|+.||||+++... .+++.+|+++|+++.+||||++++++|...
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~---~~~~vAiK~i~~~~------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~ 104 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINIT---NNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVS 104 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEECSSC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTT
T ss_pred CcCeEEEEEEecCcCeEEEEEEECC---CCCEEEEEEECHHH------HHHHHHHHHHHHhccCCCCCcEEEEEEEecCC
Confidence 4689999999999999999999776 68999999986432 356889999999998899999999999854
Q ss_pred CeEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCcc
Q 014210 232 DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (429)
Q Consensus 232 ~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~ 311 (429)
..+++|||||.+++|... .+.+++..++.++.||+.||+|||++|||||||||+|||++ .++..+||+|||++.
T Consensus 105 ~~~~~v~e~~~~~~L~~~----~~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~--~~~~~vkl~DFG~a~ 178 (328)
T d3bqca1 105 RTPALVFEHVNNTDFKQL----YQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMID--HEHRKLRLIDWGLAE 178 (328)
T ss_dssp CSEEEEEECCCSCBGGGT----TTSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE--TTTTEEEECCGGGCE
T ss_pred CceeEEEeecCCCcHHHH----hcCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEc--CCCCeeeecccccce
Confidence 569999999999998654 35799999999999999999999999999999999999995 345579999999999
Q ss_pred ccCCCccccccccCCcccCcccccC--CCCCcccHHHHHHHHHHHHcCCCCCCCCChH-HHHHHHHh-------------
Q 014210 312 FVRPDERLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTES-GIFRAVLK------------- 375 (429)
Q Consensus 312 ~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlGvll~elltg~~Pf~~~~~~-~~~~~i~~------------- 375 (429)
...........+||..|+|||++.+ .++.++|||||||++|||++|+.||...... .....+.+
T Consensus 179 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~ 258 (328)
T d3bqca1 179 FYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK 258 (328)
T ss_dssp ECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHH
T ss_pred eccCCCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhh
Confidence 8877777778899999999998764 4899999999999999999999999765432 22222111
Q ss_pred cCCC--------------------CCCCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhccc
Q 014210 376 ADPS--------------------FDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLICYQS 423 (429)
Q Consensus 376 ~~~~--------------------~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~~ 423 (429)
.... ........+++++.|||++||+.||++|||++|+|+|+||+...
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~ 326 (328)
T d3bqca1 259 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV 326 (328)
T ss_dssp TTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSC
T ss_pred cccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence 0000 01111234789999999999999999999999999999998754
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-52 Score=412.28 Aligned_cols=252 Identities=28% Similarity=0.405 Sum_probs=211.3
Q ss_pred CceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeC---
Q 014210 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT--- 231 (429)
Q Consensus 155 ~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~--- 231 (429)
.+|+.+++||+|+||+||+|+++. +|+.||||++.+... .+.+|+++|++|+ |+|||+++++|...
T Consensus 20 ~~Y~~~k~LG~G~fg~Vy~a~~~~---~~~~vAiK~i~~~~~-------~~~~Ei~il~~l~-h~niv~~~~~~~~~~~~ 88 (350)
T d1q5ka_ 20 VSYTDTKVIGNGSFGVVYQAKLCD---SGELVAIKKVLQDKR-------FKNRELQIMRKLD-HCNIVRLRYFFYSSGEK 88 (350)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEECCSS-------SCCHHHHHHHHCC-CTTBCCEEEEEEEC--C
T ss_pred CCcEeeeEEeeCcCeEEEEEEECC---CCCEEEEEEECccch-------HHHHHHHHHHhcC-CCCCCcEEEEEEecCcc
Confidence 479999999999999999999876 689999999976432 2347999999998 99999999998643
Q ss_pred ---CeEEEEEEecCCCcHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCC-ceEEE
Q 014210 232 ---DNVYVVMELCEGGELLDRIL---SRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDEN-SVLKA 304 (429)
Q Consensus 232 ---~~~~lv~E~~~ggsL~~~i~---~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~-~~vkL 304 (429)
.++|||||||+++. .+.+. .....+++..++.++.||+.||+|||++||+||||||+|||+ +.+ ..+||
T Consensus 89 ~~~~~~~lv~Ey~~~~~-~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl---~~~~~~~kl 164 (350)
T d1q5ka_ 89 KDEVYLNLVLDYVPETV-YRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLL---DPDTAVLKL 164 (350)
T ss_dssp CSCCEEEEEEECCSEEH-HHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEE---CTTTCCEEE
T ss_pred CCceEEEEEEeccCCcc-HHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEE---ecCCCceeE
Confidence 35899999997654 33332 345679999999999999999999999999999999999999 544 48999
Q ss_pred eecCCccccCCCccccccccCCcccCccccc--CCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCC----
Q 014210 305 IDFGLSDFVRPDERLNDIVGSAYYVAPEVLH--RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADP---- 378 (429)
Q Consensus 305 ~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~---- 378 (429)
+|||+++...........+||..|+|||++. ..++.++|||||||++|||++|+.||......+.+..+.+...
T Consensus 165 ~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~ 244 (350)
T d1q5ka_ 165 CDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTR 244 (350)
T ss_dssp CCCTTCEECCTTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCH
T ss_pred ecccchhhccCCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChH
Confidence 9999998887777677789999999999765 3589999999999999999999999998888777766653210
Q ss_pred -------------CCC--------CCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhc
Q 014210 379 -------------SFD--------EAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLICY 421 (429)
Q Consensus 379 -------------~~~--------~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~ 421 (429)
.+. ....+.+++++.+||++||..||++|||+.|+|+|+||+.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~ 308 (350)
T d1q5ka_ 245 EQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDE 308 (350)
T ss_dssp HHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGG
T ss_pred HhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcc
Confidence 011 1112457899999999999999999999999999999975
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-52 Score=400.83 Aligned_cols=253 Identities=24% Similarity=0.362 Sum_probs=206.0
Q ss_pred cCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~ 233 (429)
.++|++++.||+|+||.||+|+.+. ++.||||++..... ..+.+.+|+.++++++ |+|||+++++|.+ +.
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~----~~~vAiK~l~~~~~----~~~~~~~E~~~l~~l~-h~nIv~~~g~~~~-~~ 85 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNG----TTRVAIKTLKPGTM----SPEAFLQEAQVMKKLR-HEKLVQLYAVVSE-EP 85 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETT----TEEEEEEECCTTSS----CHHHHHHHHHHHHHCC-CTTBCCEEEEECS-SS
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECC----CCEEEEEEECcccC----CHHHHHHHHHHHHhcc-cCCEeEEEEEEec-CC
Confidence 3689999999999999999998764 56799999975432 2367899999999998 9999999999854 56
Q ss_pred EEEEEEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccc
Q 014210 234 VYVVMELCEGGELLDRILSR-GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (429)
Q Consensus 234 ~~lv~E~~~ggsL~~~i~~~-~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~ 312 (429)
.++|||||++|+|..++... ...+++..++.++.||+.||+|||++||+||||||+|||| +.++.+||+|||+++.
T Consensus 86 ~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll---~~~~~~kl~DfGla~~ 162 (285)
T d1fmka3 86 IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV---GENLVCKVADFGLARL 162 (285)
T ss_dssp CEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCCCTTC-
T ss_pred eEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEE---CCCCcEEEcccchhhh
Confidence 79999999999999887643 3569999999999999999999999999999999999999 7788999999999987
Q ss_pred cCCCc--cccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHcCCCCC-CCCChHHHHHHHHhcCCCCCCCCCCCC
Q 014210 313 VRPDE--RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPF-WARTESGIFRAVLKADPSFDEAPWPSL 388 (429)
Q Consensus 313 ~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~elltg~~Pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~ 388 (429)
..... ......||+.|+|||++. +.++.++|||||||++|||++|..|| ......+.+..+.+... . ...+.+
T Consensus 163 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~-~--~~~~~~ 239 (285)
T d1fmka3 163 IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR-M--PCPPEC 239 (285)
T ss_dssp -------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC-C--CCCTTS
T ss_pred ccCCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCC-C--CCCccc
Confidence 65433 223467999999999886 57999999999999999999965555 55566666666655432 1 233578
Q ss_pred CHHHHHHHHHhcccCccCcCCHHHHHh--hHhhhcc
Q 014210 389 SSEARDFVKRLLNKDPRKRLTAAQALS--ELLICYQ 422 (429)
Q Consensus 389 s~~~~~li~~~L~~dP~~Rps~~~iL~--~~~~~~~ 422 (429)
++++.+||.+||+.||++||++++|+. +.|+...
T Consensus 240 ~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 240 PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 275 (285)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred CHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence 999999999999999999999999987 6666543
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-52 Score=405.90 Aligned_cols=260 Identities=28% Similarity=0.447 Sum_probs=213.5
Q ss_pred cCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEe---
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED--- 230 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~--- 230 (429)
.++|+++++||+|+||+||+|+... +|+.||||++.+... .....+++.+|+++|++++ |+||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~---~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~-h~nii~~~~~~~~~~~ 83 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRK---TGQKVALKKVLMENE-KEGFPITALREIKILQLLK-HENVVNLIEICRTKAS 83 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETT---TCCEEEEEEC----C-TTSSCHHHHHHHHHHHHCC-CTTBCCEEEEEEC---
T ss_pred cCCEEEEEEEecCcCeEEEEEEECC---CCCEEEEEEEehhhc-chHHHHHHHHHHHHHHHhc-CCCccceEeeeecccc
Confidence 4789999999999999999999775 689999999876543 3334567889999999998 9999999999865
Q ss_pred -----CCeEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEe
Q 014210 231 -----TDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAI 305 (429)
Q Consensus 231 -----~~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~ 305 (429)
++.+|+|||||.++. ...+......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+
T Consensus 84 ~~~~~~~~~~iv~e~~~~~~-~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl---~~~~~~kl~ 159 (318)
T d3blha1 84 PYNRCKGSIYLVFDFCEHDL-AGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLI---TRDGVLKLA 159 (318)
T ss_dssp -------CEEEEEECCCEEH-HHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTSCEEEC
T ss_pred cccccCceEEEEEeccCCCc-cchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheee---cCCCcEEee
Confidence 456899999997755 44455566789999999999999999999999999999999999999 788899999
Q ss_pred ecCCccccCCCc-----cccccccCCcccCcccccC--CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCC
Q 014210 306 DFGLSDFVRPDE-----RLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADP 378 (429)
Q Consensus 306 DFGla~~~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~ 378 (429)
|||+++...... .....+||+.|+|||++.+ .++.++|||||||++|||++|+.||........+..+.+...
T Consensus 160 dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~ 239 (318)
T d3blha1 160 DFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCG 239 (318)
T ss_dssp CCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred ecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcC
Confidence 999997654322 2334679999999998763 589999999999999999999999998888877776655433
Q ss_pred CCCCCCCCC----------------------------CCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhcc
Q 014210 379 SFDEAPWPS----------------------------LSSEARDFVKRLLNKDPRKRLTAAQALSELLICYQ 422 (429)
Q Consensus 379 ~~~~~~~~~----------------------------~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~ 422 (429)
.+....+.. .++++.|||++||+.||++|||+.|+|.|+||+..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~ 311 (318)
T d3blha1 240 SITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSD 311 (318)
T ss_dssp CCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSS
T ss_pred CCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccC
Confidence 333222211 36788999999999999999999999999999853
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-53 Score=414.20 Aligned_cols=266 Identities=29% Similarity=0.463 Sum_probs=220.3
Q ss_pred cCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcC-cHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCC
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMT-TAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~-~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~ 232 (429)
.++|+++++||+|+||+||+|+...+..+|+.||||++.+.... .....+.+.+|+++++++++||||+++++++++.+
T Consensus 23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~ 102 (322)
T d1vzoa_ 23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 102 (322)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCC
Confidence 37899999999999999999998776667999999998754322 22334568899999999985689999999999999
Q ss_pred eEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccc
Q 014210 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (429)
Q Consensus 233 ~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~ 312 (429)
..+++||||.+|+|.+++... +.+.+..++.++.||+.||+|||++|||||||||+|||+ +.++.+||+|||+++.
T Consensus 103 ~~~~v~e~~~~~~L~~~i~~~-~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill---~~~~~vkL~DFG~a~~ 178 (322)
T d1vzoa_ 103 KLHLILDYINGGELFTHLSQR-ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILL---DSNGHVVLTDFGLSKE 178 (322)
T ss_dssp EEEEEECCCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEESCSSEEEE
T ss_pred ceeeeeecccccHHHHHHHhc-ccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceee---cCCCCEEEeeccchhh
Confidence 999999999999999987544 568899999999999999999999999999999999999 7788999999999987
Q ss_pred cCCC--ccccccccCCcccCcccccC---CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCCCCCCCC
Q 014210 313 VRPD--ERLNDIVGSAYYVAPEVLHR---SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPS 387 (429)
Q Consensus 313 ~~~~--~~~~~~~gt~~y~aPE~~~~---~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 387 (429)
+... .......|++.|+|||.+.+ .++.++|||||||+||||++|+.||...........+.+............
T Consensus 179 ~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~ 258 (322)
T d1vzoa_ 179 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQE 258 (322)
T ss_dssp CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTT
T ss_pred hcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCccc
Confidence 6433 23455789999999998863 478899999999999999999999977655444433433222222222346
Q ss_pred CCHHHHHHHHHhcccCccCcC-----CHHHHHhhHhhhccc
Q 014210 388 LSSEARDFVKRLLNKDPRKRL-----TAAQALSELLICYQS 423 (429)
Q Consensus 388 ~s~~~~~li~~~L~~dP~~Rp-----s~~~iL~~~~~~~~~ 423 (429)
+++++.+||++||++||++|| +++|+|+|+||+...
T Consensus 259 ~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~ 299 (322)
T d1vzoa_ 259 MSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKIN 299 (322)
T ss_dssp SCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCC
T ss_pred CCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCC
Confidence 899999999999999999999 589999999998643
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-52 Score=410.52 Aligned_cols=256 Identities=26% Similarity=0.488 Sum_probs=211.2
Q ss_pred ccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCC
Q 014210 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (429)
Q Consensus 153 ~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~ 232 (429)
+.++|+++++||+|+||.||+|+.+. +|+.||||++.+.. ......+.+.+|+++|++++ |||||+++++|...+
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~---~~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l~-hpniv~l~~~~~~~~ 90 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCSAVDGR---TGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMR-HENVIGLLDVFTPDE 90 (346)
T ss_dssp CBSSEEEEEEC------CEEEEEETT---TCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCC-BTTBCCCSEEECSCS
T ss_pred cCCcEEEEEEEecCCCeEEEEEEECC---CCCEEEEEEEchhh-cChHHHHHHHHHHHHHHhcC-CCCeeEEEEEeccCc
Confidence 56899999999999999999999766 68999999997643 45566778999999999998 999999999998665
Q ss_pred ------eEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEee
Q 014210 233 ------NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAID 306 (429)
Q Consensus 233 ------~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~D 306 (429)
.+||||||| +.+|...+. .+.+++..++.++.||+.||+|||++|||||||||+|||+ +.++.+||+|
T Consensus 91 ~~~~~~~~~lv~e~~-~~~l~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~---~~~~~~kl~D 164 (346)
T d1cm8a_ 91 TLDDFTDFYLVMPFM-GTDLGKLMK--HEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAV---NEDCELKILD 164 (346)
T ss_dssp STTTCCCCEEEEECC-SEEHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECC
T ss_pred cccccceEEEEEecc-cccHHHHHH--hccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhc---cccccccccc
Confidence 579999999 557766553 3579999999999999999999999999999999999999 7889999999
Q ss_pred cCCccccCCCccccccccCCcccCcccccC--CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCC------
Q 014210 307 FGLSDFVRPDERLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADP------ 378 (429)
Q Consensus 307 FGla~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~------ 378 (429)
||+++.... ......||+.|+|||++.+ .++.++|||||||++|||++|+.||.+.+....+..+.....
T Consensus 165 fg~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 242 (346)
T d1cm8a_ 165 FGLARQADS--EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEF 242 (346)
T ss_dssp CTTCEECCS--SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred ccceeccCC--ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHH
Confidence 999987643 3456789999999998754 478999999999999999999999988877666554433211
Q ss_pred -----------------CCCC----CCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhc
Q 014210 379 -----------------SFDE----APWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLICY 421 (429)
Q Consensus 379 -----------------~~~~----~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~ 421 (429)
.... ...+.+++++.+||++||..||++|||+.|+|+|+||+.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~ 306 (346)
T d1cm8a_ 243 VQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFES 306 (346)
T ss_dssp HHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTT
T ss_pred HhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCc
Confidence 1111 122467899999999999999999999999999999975
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.4e-52 Score=400.75 Aligned_cols=255 Identities=23% Similarity=0.312 Sum_probs=218.1
Q ss_pred cCceeEeceeeccCceEEEEEEEecC--cccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeC
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKG--ELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~--~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~ 231 (429)
.++|++.++||+|+||.||+|+.+.. ..+++.||||++... ......+++.+|++++++++ |+||++++++|.+.
T Consensus 12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~--~~~~~~~~~~~E~~il~~l~-h~niv~~~~~~~~~ 88 (301)
T d1lufa_ 12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE--ASADMQADFQREAALMAEFD-NPNIVKLLGVCAVG 88 (301)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTT--CCHHHHHHHHHHHHHHHTCC-CTTBCCEEEEECSS
T ss_pred HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChh--cChHHHHHHHHHHHHHHhcC-CCCcccceeeeccC
Confidence 57899999999999999999987642 235789999998754 34556678999999999998 99999999999999
Q ss_pred CeEEEEEEecCCCcHHHHHHhcC-----------------------CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCC
Q 014210 232 DNVYVVMELCEGGELLDRILSRG-----------------------GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKP 288 (429)
Q Consensus 232 ~~~~lv~E~~~ggsL~~~i~~~~-----------------------~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp 288 (429)
+..++||||+++|+|.+++.... ..+++..+..|+.||+.||+|||+++||||||||
T Consensus 89 ~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp 168 (301)
T d1lufa_ 89 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLAT 168 (301)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred CceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEcc
Confidence 99999999999999999886432 2489999999999999999999999999999999
Q ss_pred CcEEEeecCCCceEEEeecCCccccCCCc---cccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHcCC-CCCCC
Q 014210 289 ENFLFTTKDENSVLKAIDFGLSDFVRPDE---RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGS-RPFWA 363 (429)
Q Consensus 289 ~NILl~~~~~~~~vkL~DFGla~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~elltg~-~Pf~~ 363 (429)
+|||| +.++++||+|||+++...... ......||+.|+|||++. ..++.++|||||||++|||++|. .||..
T Consensus 169 ~NILl---d~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~ 245 (301)
T d1lufa_ 169 RNCLV---GENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG 245 (301)
T ss_dssp GGEEE---CGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred cceEE---CCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCC
Confidence 99999 778899999999998664332 223567899999999887 47999999999999999999985 67888
Q ss_pred CChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhH
Q 014210 364 RTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSEL 417 (429)
Q Consensus 364 ~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~ 417 (429)
....+.+..+.+.... .....+++++.+||.+||+.||++|||+.||++.+
T Consensus 246 ~~~~e~~~~v~~~~~~---~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L 296 (301)
T d1lufa_ 246 MAHEEVIYYVRDGNIL---ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRIL 296 (301)
T ss_dssp SCHHHHHHHHHTTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCHHHHHHHHHcCCCC---CCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 8888888887765532 12347899999999999999999999999998754
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-52 Score=399.77 Aligned_cols=256 Identities=23% Similarity=0.424 Sum_probs=214.5
Q ss_pred cCceeEeceeeccCceEEEEEEEecCc----ccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEE
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGE----LKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYE 229 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~----~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~ 229 (429)
.++|+++++||+|+||.||+|+..... .++..||||++.+. .......++.+|+..+.++.+|||||+++++|.
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~ 89 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD--ATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 89 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTT--CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcc--cChHHHHHHHHHHHHHHHhcCCCeEEecccccc
Confidence 478999999999999999999876432 23568999999764 345566789999999999966999999999999
Q ss_pred eCCeEEEEEEecCCCcHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEe
Q 014210 230 DTDNVYVVMELCEGGELLDRILSRG---------------GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFT 294 (429)
Q Consensus 230 ~~~~~~lv~E~~~ggsL~~~i~~~~---------------~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~ 294 (429)
+++.+++|||||++|+|.++|..+. ..+++..++.++.||+.||+|||+++||||||||+|||+
T Consensus 90 ~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl- 168 (299)
T d1fgka_ 90 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV- 168 (299)
T ss_dssp SSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE-
T ss_pred cCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceee-
Confidence 9999999999999999999997553 358999999999999999999999999999999999999
Q ss_pred ecCCCceEEEeecCCccccCCCc---cccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHc-CCCCCCCCChHHH
Q 014210 295 TKDENSVLKAIDFGLSDFVRPDE---RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGI 369 (429)
Q Consensus 295 ~~~~~~~vkL~DFGla~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~ellt-g~~Pf~~~~~~~~ 369 (429)
+.++.+||+|||+++...... ......||+.|+|||++. +.|+.++|||||||++|||++ |..||...+....
T Consensus 169 --~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~ 246 (299)
T d1fgka_ 169 --TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 246 (299)
T ss_dssp --CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH
T ss_pred --cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHH
Confidence 788899999999998765433 234467899999999886 679999999999999999998 7899988888777
Q ss_pred HHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhH
Q 014210 370 FRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSEL 417 (429)
Q Consensus 370 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~ 417 (429)
+..+..... .. ....+++++.+||.+||+.||++|||+.|+++.+
T Consensus 247 ~~~i~~~~~-~~--~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L 291 (299)
T d1fgka_ 247 FKLLKEGHR-MD--KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 291 (299)
T ss_dssp HHHHHTTCC-CC--CCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHcCCC-CC--CCccchHHHHHHHHHHccCCHhHCcCHHHHHHHH
Confidence 766655432 22 2246899999999999999999999999999865
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-52 Score=404.59 Aligned_cols=252 Identities=24% Similarity=0.365 Sum_probs=211.5
Q ss_pred CceeEeceeeccCceEEEEEEEecCcccCe--EEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCC
Q 014210 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQ--QVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (429)
Q Consensus 155 ~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~--~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~ 232 (429)
++|++.++||+|+||.||+|+.+. +|. .||||++... ......+++.+|+++|.++.+|||||+++++|.+++
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~---~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~ 84 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKK---DGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG 84 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEE---TTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT
T ss_pred HHcEEEEEEeeCCCcEEEEEEECC---CCeEEEEEEEEECcc--cChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCC
Confidence 689999999999999999999876 344 5788887543 333455779999999999955999999999999999
Q ss_pred eEEEEEEecCCCcHHHHHHhc---------------CCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecC
Q 014210 233 NVYVVMELCEGGELLDRILSR---------------GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKD 297 (429)
Q Consensus 233 ~~~lv~E~~~ggsL~~~i~~~---------------~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~ 297 (429)
.++||||||++|+|.++|... ...+++..+..++.||+.||.|||+++||||||||+|||+ +
T Consensus 85 ~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~---~ 161 (309)
T d1fvra_ 85 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV---G 161 (309)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---C
T ss_pred eeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEE---c
Confidence 999999999999999988643 3579999999999999999999999999999999999999 7
Q ss_pred CCceEEEeecCCccccCCCccccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHcCC-CCCCCCChHHHHHHHHh
Q 014210 298 ENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGS-RPFWARTESGIFRAVLK 375 (429)
Q Consensus 298 ~~~~vkL~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~elltg~-~Pf~~~~~~~~~~~i~~ 375 (429)
.++.+||+|||+++............||..|+|||.+. +.++.++|||||||++|||++|. .||...+..+++..+.+
T Consensus 162 ~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~ 241 (309)
T d1fvra_ 162 ENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ 241 (309)
T ss_dssp GGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGG
T ss_pred CCCceEEccccccccccccccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHh
Confidence 78899999999998766555555667999999999886 56899999999999999999975 57888888777777665
Q ss_pred cCCCCCCCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhH
Q 014210 376 ADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSEL 417 (429)
Q Consensus 376 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~ 417 (429)
... ...+..+++++.+||.+||+.||++|||+.++++++
T Consensus 242 ~~~---~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L 280 (309)
T d1fvra_ 242 GYR---LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSL 280 (309)
T ss_dssp TCC---CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred cCC---CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 422 122346899999999999999999999999999974
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-52 Score=407.84 Aligned_cols=259 Identities=27% Similarity=0.440 Sum_probs=211.3
Q ss_pred ccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCC
Q 014210 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (429)
Q Consensus 153 ~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~ 232 (429)
++++|+++++||+|+||+||+|+... +|+.||||++.+. ......+++.+|+.+|++|+ ||||+++++++....
T Consensus 6 i~~rY~~~~~LG~G~fg~Vy~~~~~~---~~~~vAvK~i~~~--~~~~~~~~~~~Ei~il~~l~-hp~iv~~~~~~~~~~ 79 (345)
T d1pmea_ 6 VGPRYTNLSYIGEGAYGMVCSAYDNV---NKVRVAIKKISPF--EHQTYCQRTLREIKILLRFR-HENIIGINDIIRAPT 79 (345)
T ss_dssp CCTTEEEEEECC---CCCEEEEEETT---TCSEEEEEEECCT--TCHHHHHHHHHHHHHHHHCC-CTTBCCCCEEECCSS
T ss_pred cCCCeEEEEEEeeccCeEEEEEEECC---CCcEEEEEEEehh--cChHHHHHHHHHHHHHHHcC-CCCCCcEEEEEeecc
Confidence 45789999999999999999998765 6899999999754 34556678999999999998 999999999997653
Q ss_pred ----eEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecC
Q 014210 233 ----NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFG 308 (429)
Q Consensus 233 ----~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFG 308 (429)
..+++|+|+.+|+|.+++.. +.+++..++.++.||+.||+|||++|||||||||+|||+ +.++.+||+|||
T Consensus 80 ~~~~~~~~l~~~~~~g~L~~~l~~--~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl---~~~~~~kl~DfG 154 (345)
T d1pmea_ 80 IEQMKDVYLVTHLMGADLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLL---NTTCDLKICDFG 154 (345)
T ss_dssp TTTCCCEEEEEECCCEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCT
T ss_pred ccccceEEEEEeecCCchhhhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEE---CCCCCEEEcccC
Confidence 23445566668999998854 469999999999999999999999999999999999999 788899999999
Q ss_pred CccccCCCc----cccccccCCcccCcccccC--CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcC-----
Q 014210 309 LSDFVRPDE----RLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKAD----- 377 (429)
Q Consensus 309 la~~~~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~----- 377 (429)
+++...... .....+||+.|+|||++.. .++.++||||+||++|||++|+.||......+.........
T Consensus 155 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~ 234 (345)
T d1pmea_ 155 LARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ 234 (345)
T ss_dssp TCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCH
T ss_pred ceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCCh
Confidence 997764332 2345679999999998853 57889999999999999999999998877665554433211
Q ss_pred ------------------CCCCC----CCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhcc
Q 014210 378 ------------------PSFDE----APWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLICYQ 422 (429)
Q Consensus 378 ------------------~~~~~----~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~~ 422 (429)
+.... ..++.++.++++||.+||+.||++|||+.|+|+|+||+..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~ 301 (345)
T d1pmea_ 235 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 301 (345)
T ss_dssp HHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTT
T ss_pred hhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence 00111 1134678999999999999999999999999999999854
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-51 Score=395.46 Aligned_cols=258 Identities=28% Similarity=0.459 Sum_probs=217.3
Q ss_pred CceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeE
Q 014210 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (429)
Q Consensus 155 ~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~ 234 (429)
++|+++++||+|+||+||+|++.. +|+.||||+++... ......+++.+|+.++++++ |+||++++++|.+.+..
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~---~~~~vAvK~i~~~~-~~~~~~~~~~~E~~il~~l~-h~niv~~~~~~~~~~~~ 76 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRE---THEIVALKRVRLDD-DDEGVPSSALREICLLKELK-HKNIVRLHDVLHSDKKL 76 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETT---TCCEEEEEEEESSC-SSTTHHHHHHHHHHHHTTCC-CTTBCCEEEEEECSSEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECC---CCcEEEEEEEehhh-CChHHHHHHHHHHHHHHhcC-cCCEEeeccccccccce
Confidence 589999999999999999999776 58999999997654 34456788999999999998 99999999999999999
Q ss_pred EEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccccC
Q 014210 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (429)
Q Consensus 235 ~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~ 314 (429)
++|||++.+++|..+ ....+.+++..++.++.|++.||+|||++|||||||||+|||+ +.++.+||+|||.++...
T Consensus 77 ~iv~~~~~~~~l~~~-~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli---~~~~~~kl~DFG~a~~~~ 152 (292)
T d1unla_ 77 TLVFEFCDQDLKKYF-DSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLI---NRNGELKLANFGLARAFG 152 (292)
T ss_dssp EEEEECCSEEHHHHH-HHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCCTTCEECC
T ss_pred eEEeeeccccccccc-cccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCccccc---ccCCceeeeecchhhccc
Confidence 999999988776654 4566789999999999999999999999999999999999999 677889999999998775
Q ss_pred CCc-cccccccCCcccCcccccC--CCCCcccHHHHHHHHHHHHcCCCCCC-CCChHHHHHHHHhcCCCCC---------
Q 014210 315 PDE-RLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFW-ARTESGIFRAVLKADPSFD--------- 381 (429)
Q Consensus 315 ~~~-~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlGvll~elltg~~Pf~-~~~~~~~~~~i~~~~~~~~--------- 381 (429)
... ......++..|+|||++.+ .++.++|||||||++|||++|+.||. +....+.+..+........
T Consensus 153 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (292)
T d1unla_ 153 IPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTK 232 (292)
T ss_dssp SCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGG
T ss_pred CCCccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhh
Confidence 443 3345567889999998764 37899999999999999999999964 4455555555543221111
Q ss_pred ----------------CCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhc
Q 014210 382 ----------------EAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLICY 421 (429)
Q Consensus 382 ----------------~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~ 421 (429)
....+.+++++.+||++||+.||++|||++|+|+|+||++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~ 288 (292)
T d1unla_ 233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288 (292)
T ss_dssp STTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSS
T ss_pred cccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcC
Confidence 1122357899999999999999999999999999999975
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-52 Score=393.04 Aligned_cols=245 Identities=25% Similarity=0.401 Sum_probs=202.6
Q ss_pred cCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEe-CC
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED-TD 232 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~-~~ 232 (429)
.++|+++++||+|+||.||+|+.+ |+.||||+++++. ..+++.+|++++++++ |||||+++|+|.+ .+
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~-----~~~vAvK~i~~~~-----~~~~~~~E~~~l~~l~-HpnIv~~~g~~~~~~~ 74 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDYR-----GNKVAVKCIKNDA-----TAQAFLAEASVMTQLR-HSNLVQLLGVIVEEKG 74 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-----TEEEEEEECCCCC-------HHHHHTHHHHTTCC-CTTBCCEEEEECCC--
T ss_pred HHHeEEeEEEecCCCeEEEEEEEC-----CeEEEEEEECcHH-----HHHHHHHHHHHHHhCC-CCCEeeEEEEEEecCC
Confidence 467999999999999999999853 6789999996532 3367899999999998 9999999999865 46
Q ss_pred eEEEEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCcc
Q 014210 233 NVYVVMELCEGGELLDRILSRG-GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (429)
Q Consensus 233 ~~~lv~E~~~ggsL~~~i~~~~-~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~ 311 (429)
.++|||||+++|+|.+++..+. ..+++..+++|+.||+.||.|||+.+|+||||||+|||+ +.++.+||+|||+++
T Consensus 75 ~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~---~~~~~~kl~dfg~s~ 151 (262)
T d1byga_ 75 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLV---SEDNVAKVSDFGLTK 151 (262)
T ss_dssp CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CTTSCEEECCCCC--
T ss_pred cEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhhee---cCCCCEeecccccce
Confidence 6899999999999999987553 358999999999999999999999999999999999999 788999999999998
Q ss_pred ccCCCccccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCC
Q 014210 312 FVRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLS 389 (429)
Q Consensus 312 ~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 389 (429)
..... .....+|..|+|||++. +.++.++|||||||++|||+| |+.||...+..++...+.+.... ...+.++
T Consensus 152 ~~~~~--~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~---~~~~~~~ 226 (262)
T d1byga_ 152 EASST--QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKM---DAPDGCP 226 (262)
T ss_dssp ------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCC---CCCTTCC
T ss_pred ecCCC--CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC---CCCccCC
Confidence 76433 34457899999999886 679999999999999999998 78888888887777777653221 1224688
Q ss_pred HHHHHHHHHhcccCccCcCCHHHHHhhH
Q 014210 390 SEARDFVKRLLNKDPRKRLTAAQALSEL 417 (429)
Q Consensus 390 ~~~~~li~~~L~~dP~~Rps~~~iL~~~ 417 (429)
+++.+||++||+.||++|||+.++++++
T Consensus 227 ~~~~~li~~cl~~dP~~Rps~~~l~~~L 254 (262)
T d1byga_ 227 PAVYEVMKNCWHLDAAMRPSFLQLREQL 254 (262)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHHHHcccCHhHCcCHHHHHHHH
Confidence 9999999999999999999999999976
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-51 Score=395.58 Aligned_cols=257 Identities=26% Similarity=0.371 Sum_probs=217.5
Q ss_pred cCceeEeceeeccCceEEEEEEEecC--cccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeC
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKG--ELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~--~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~ 231 (429)
.++|+++++||+|+||.||+|+.+.. ...++.||||++... .......++.+|+.+++++.+|||||+++++|.+.
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~--~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~ 99 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS--AHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG 99 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT--CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcc--cCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeC
Confidence 47899999999999999999987642 236789999999764 34555678999999999997799999999999999
Q ss_pred CeEEEEEEecCCCcHHHHHHhcC-----------------CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEe
Q 014210 232 DNVYVVMELCEGGELLDRILSRG-----------------GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFT 294 (429)
Q Consensus 232 ~~~~lv~E~~~ggsL~~~i~~~~-----------------~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~ 294 (429)
+..+||||||++|+|.+++.... ..+++..+..++.||++||+|||++|||||||||+|||+
T Consensus 100 ~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~- 178 (311)
T d1t46a_ 100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL- 178 (311)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE-
T ss_pred CEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccccccc-
Confidence 99999999999999999987543 258999999999999999999999999999999999999
Q ss_pred ecCCCceEEEeecCCccccCCCcc---ccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHc-CCCCCCCCChHHH
Q 014210 295 TKDENSVLKAIDFGLSDFVRPDER---LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGI 369 (429)
Q Consensus 295 ~~~~~~~vkL~DFGla~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~ellt-g~~Pf~~~~~~~~ 369 (429)
+.++.+||+|||+++....... .....||+.|+|||++. +.++.++|||||||++|||+| |..||......+.
T Consensus 179 --~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~ 256 (311)
T d1t46a_ 179 --THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK 256 (311)
T ss_dssp --ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH
T ss_pred --cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHH
Confidence 6788999999999987654332 23467899999999887 568999999999999999999 5566666666666
Q ss_pred HHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhH
Q 014210 370 FRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSEL 417 (429)
Q Consensus 370 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~ 417 (429)
+..+......... ...+++++.+||.+||+.||++|||+.+|++.+
T Consensus 257 ~~~~i~~~~~~~~--~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L 302 (311)
T d1t46a_ 257 FYKMIKEGFRMLS--PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLI 302 (311)
T ss_dssp HHHHHHHTCCCCC--CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHhcCCCCCC--cccccHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 6666554432222 246889999999999999999999999999855
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-51 Score=395.90 Aligned_cols=255 Identities=19% Similarity=0.304 Sum_probs=218.3
Q ss_pred cCceeEeceeeccCceEEEEEEEec--CcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeC
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKK--GELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~--~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~ 231 (429)
.++|+++++||+|+||.||+|.+.. ....++.||||++.+. ........+.+|++++++++ |||||+++++|..+
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~--~~~~~~~~~~~E~~il~~l~-h~nIv~~~~~~~~~ 95 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA--ASMRERIEFLNEASVMKEFN-CHHVVRLLGVVSQG 95 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT--SCHHHHHHHHHHHHHGGGCC-CTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcc--cChHHHHHHHHHHHHHHHcC-CCCEeeeeeEEecC
Confidence 4789999999999999999998753 1224689999999754 34556678999999999998 99999999999999
Q ss_pred CeEEEEEEecCCCcHHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceE
Q 014210 232 DNVYVVMELCEGGELLDRILSRG---------GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVL 302 (429)
Q Consensus 232 ~~~~lv~E~~~ggsL~~~i~~~~---------~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~v 302 (429)
+..++|||||++|+|.+++.... ..+++..+.+++.||++||.|||+++|+||||||+|||+ ++++++
T Consensus 96 ~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLl---d~~~~~ 172 (308)
T d1p4oa_ 96 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMV---AEDFTV 172 (308)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEE---CTTCCE
T ss_pred CceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceee---cCCceE
Confidence 99999999999999999886431 347999999999999999999999999999999999999 788999
Q ss_pred EEeecCCccccCCCcc---ccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHcC-CCCCCCCChHHHHHHHHhcC
Q 014210 303 KAIDFGLSDFVRPDER---LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCG-SRPFWARTESGIFRAVLKAD 377 (429)
Q Consensus 303 kL~DFGla~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~elltg-~~Pf~~~~~~~~~~~i~~~~ 377 (429)
||+|||+++....... .....||+.|+|||.+. +.++.++||||||+++|||+|| +.||...+....+..+.+..
T Consensus 173 Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~ 252 (308)
T d1p4oa_ 173 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGG 252 (308)
T ss_dssp EECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTC
T ss_pred EEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCC
Confidence 9999999987654332 33457899999999887 5688899999999999999998 57888888888888777654
Q ss_pred CCCCCCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhH
Q 014210 378 PSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSEL 417 (429)
Q Consensus 378 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~ 417 (429)
... ..+.+++++.+||.+||+.||++|||+.++++++
T Consensus 253 ~~~---~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L 289 (308)
T d1p4oa_ 253 LLD---KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSI 289 (308)
T ss_dssp CCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCC---CcccchHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 322 2246899999999999999999999999999843
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-51 Score=405.15 Aligned_cols=257 Identities=28% Similarity=0.487 Sum_probs=214.0
Q ss_pred ccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeC-
Q 014210 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT- 231 (429)
Q Consensus 153 ~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~- 231 (429)
+.++|+++++||+|+||+||+|+... +|+.||||++.+.. .+....+++.+|+++|++|+ |+|||++++++...
T Consensus 16 ~~~rY~i~~~LG~G~fg~Vy~a~~~~---~~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l~-h~~iv~~~~~~~~~~ 90 (348)
T d2gfsa1 16 VPERYQNLSPVGSGAYGSVCAAFDTK---TGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMK-HENVIGLLDVFTPAR 90 (348)
T ss_dssp EETTEEEEEECGGGTTSSEEEEEETT---TTEEEEEEECSCTT-SSHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSCS
T ss_pred CCCCeEEEEEEecCCCeEEEEEEECC---CCCEEEEEEECchh-cChHHHHHHHHHHHHHHhcC-CCCeeeEEEEEeecc
Confidence 46789999999999999999998776 69999999997653 44555678899999999998 99999999999643
Q ss_pred ----CeEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeec
Q 014210 232 ----DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDF 307 (429)
Q Consensus 232 ----~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DF 307 (429)
...+++|||+.||+|.+++ ..+.+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+||
T Consensus 91 ~~~~~~~~~i~~~~~gg~L~~~~--~~~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi---~~~~~~kl~df 165 (348)
T d2gfsa1 91 SLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDF 165 (348)
T ss_dssp STTTCCCCEEEEECCSEEHHHHH--TTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEECCC
T ss_pred ccccCceEEEEEeecCCchhhhc--ccccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccc---ccccccccccc
Confidence 3456677788899999877 34579999999999999999999999999999999999999 78889999999
Q ss_pred CCccccCCCccccccccCCcccCcccccC--CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCCCCC----
Q 014210 308 GLSDFVRPDERLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFD---- 381 (429)
Q Consensus 308 Gla~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~~~~---- 381 (429)
|++.... .......||..|+|||++.+ .++.++|||||||++|+|++|+.||.+.+.......+++......
T Consensus 166 g~a~~~~--~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~ 243 (348)
T d2gfsa1 166 GLARHTD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 243 (348)
T ss_dssp ----CCT--GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred chhcccC--cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHh
Confidence 9997653 34456789999999998654 468899999999999999999999998887777666654322211
Q ss_pred -------------------CC----CCCCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhc
Q 014210 382 -------------------EA----PWPSLSSEARDFVKRLLNKDPRKRLTAAQALSELLICY 421 (429)
Q Consensus 382 -------------------~~----~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~ 421 (429)
.. .+..+++++++||++||+.||++|||+.|+|+|+||+.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~ 306 (348)
T d2gfsa1 244 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 306 (348)
T ss_dssp TTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred hhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCC
Confidence 00 12457899999999999999999999999999999974
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-50 Score=392.82 Aligned_cols=254 Identities=22% Similarity=0.302 Sum_probs=208.7
Q ss_pred eEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEe-CCeEEE
Q 014210 158 ELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED-TDNVYV 236 (429)
Q Consensus 158 ~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~-~~~~~l 236 (429)
...++||+|+||+||+|++..+..+...||||++++. ......+++.+|++++++|+ |||||+++|++.+ ++..++
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~~E~~~l~~l~-HpnIv~~~g~~~~~~~~~~l 106 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFS-HPNVLSLLGICLRSEGSPLV 106 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCC--CCHHHHHHHHHHHHHHHTCC-CTTBCCCCEEEEETTTEEEE
T ss_pred ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc--cCHHHHHHHHHHHHHHHhCC-CCCEeEEeEEEEecCCceEE
Confidence 3367899999999999998765434567999998643 45666788999999999998 9999999999876 468999
Q ss_pred EEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccccCCC
Q 014210 237 VMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPD 316 (429)
Q Consensus 237 v~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~ 316 (429)
|||||++|+|.+++......+++..+..++.||+.||.|||+.+|+||||||+|||| ++++.+||+|||+++.....
T Consensus 107 v~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl---~~~~~~kL~DFG~~~~~~~~ 183 (311)
T d1r0pa_ 107 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYDK 183 (311)
T ss_dssp EEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CTTCCEEECSSGGGCCTTTT
T ss_pred EEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeE---CCCCCEEEecccchhhcccc
Confidence 999999999999888777789999999999999999999999999999999999999 78899999999999876544
Q ss_pred cc-----ccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHcCCCCCCCCC-hHHHHHHHHhcCCCCCCCCCCCCC
Q 014210 317 ER-----LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWART-ESGIFRAVLKADPSFDEAPWPSLS 389 (429)
Q Consensus 317 ~~-----~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~elltg~~Pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~s 389 (429)
.. .....||..|+|||++. +.++.++||||||+++|||+||..||.... ..+....+....... ..+.++
T Consensus 184 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~---~p~~~~ 260 (311)
T d1r0pa_ 184 EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLL---QPEYCP 260 (311)
T ss_dssp TCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCC---CCTTCC
T ss_pred ccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCC---CcccCc
Confidence 32 22356899999999876 679999999999999999999888886543 333444454443221 124688
Q ss_pred HHHHHHHHHhcccCccCcCCHHHHHhhHhhh
Q 014210 390 SEARDFVKRLLNKDPRKRLTAAQALSELLIC 420 (429)
Q Consensus 390 ~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~ 420 (429)
+++.+||.+||+.||++||++.||++++---
T Consensus 261 ~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i 291 (311)
T d1r0pa_ 261 DPLYEVMLKCWHPKAEMRPSFSELVSRISAI 291 (311)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 9999999999999999999999999985433
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-51 Score=401.77 Aligned_cols=257 Identities=26% Similarity=0.449 Sum_probs=202.8
Q ss_pred ccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEe--
Q 014210 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED-- 230 (429)
Q Consensus 153 ~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~-- 230 (429)
+.++|+++++||+|+||+||+|+++. +|+.||||++.+.. ......+++.+|+.++++++ |||||+++++|..
T Consensus 15 i~~~Y~i~~~LG~G~fg~V~~~~d~~---t~~~vAvK~i~~~~-~~~~~~~~~~~Ei~il~~l~-hpnIv~~~~~f~~~~ 89 (355)
T d2b1pa1 15 VLKRYQNLKPIGSGAQGIVCAAYDAV---LDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVN-HKNIISLLNVFTPQK 89 (355)
T ss_dssp EETTEEEEEECSCC--CEEEEEEETT---TTEEEEEEEEESTT-SSHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSCC
T ss_pred ecCCeEEEEEeecCcCeEEEEEEECC---CCCEEEEEEEChhh-cCHHHHHHHHHHHHHHHhcC-CCCeeEEEEEEeccc
Confidence 34789999999999999999999776 68999999997654 34556678999999999998 9999999999964
Q ss_pred ----CCeEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEee
Q 014210 231 ----TDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAID 306 (429)
Q Consensus 231 ----~~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~D 306 (429)
..++|+|||||.+ ++++.+ ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|
T Consensus 90 ~~~~~~~~~iv~Ey~~~-~l~~~~---~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~---~~~~~~kl~d 162 (355)
T d2b1pa1 90 TLEEFQDVYLVMELMDA-NLCQVI---QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILD 162 (355)
T ss_dssp STTTCCEEEEEEECCSE-EHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECC
T ss_pred ccccCceeEEEEeccch-HHHHhh---hcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCcccccc---ccccceeeec
Confidence 3689999999976 455544 3568999999999999999999999999999999999999 7788899999
Q ss_pred cCCccccCCCccccccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhcCC-------
Q 014210 307 FGLSDFVRPDERLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADP------- 378 (429)
Q Consensus 307 FGla~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~~~~~------- 378 (429)
||+++...........+||+.|+|||++.+ .++.++||||+||++|||++|+.||.+.+.......++....
T Consensus 163 f~~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~ 242 (355)
T d2b1pa1 163 FGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM 242 (355)
T ss_dssp CCC---------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred hhhhhccccccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHH
Confidence 999988877777777889999999999874 689999999999999999999999988877666555443211
Q ss_pred ---------------CCCCCCC----------------CCCCHHHHHHHHHhcccCccCcCCHHHHHhhHhhhc
Q 014210 379 ---------------SFDEAPW----------------PSLSSEARDFVKRLLNKDPRKRLTAAQALSELLICY 421 (429)
Q Consensus 379 ---------------~~~~~~~----------------~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~~~~~ 421 (429)
......+ ...++++.+||++||..||++|||++|+|+|+||+.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~ 316 (355)
T d2b1pa1 243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINV 316 (355)
T ss_dssp TTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGG
T ss_pred HHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCC
Confidence 1111000 013568899999999999999999999999999975
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.8e-50 Score=387.50 Aligned_cols=259 Identities=21% Similarity=0.277 Sum_probs=207.9
Q ss_pred ccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCC
Q 014210 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (429)
Q Consensus 153 ~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~ 232 (429)
.+++|+++++||+|+||.||+|+... +|+.||||++...... +++.+|+++++.+.+|++|+.+.+++.+++
T Consensus 5 vg~rY~l~~~iG~G~fG~Vy~a~~~~---~~~~vAvK~~~~~~~~-----~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~ 76 (299)
T d1ckia_ 5 VGNRYRLGRKIGSGSFGDIYLGTDIA---AGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGD 76 (299)
T ss_dssp ETTTEEEEEEEEECSSSEEEEEEETT---TTEEEEEEEEESCTTS-----CCHHHHHHHHHHSTTSTTCCCEEEEEEETT
T ss_pred ECCEEEEeEEEeeCCCcEEEEEEECC---CCCEEEEEEEchhccC-----HHHHHHHHHHHHccCCCcccEEEEEEecCC
Confidence 45789999999999999999998765 5899999998654322 347789999999985666777778888889
Q ss_pred eEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEEeecCCccc
Q 014210 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (429)
Q Consensus 233 ~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~ 312 (429)
..++||||| +++|.+.+....+.+++..+..++.||+.||+|||++|||||||||+|||++..+.+..+||+|||+++.
T Consensus 77 ~~~ivme~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~ 155 (299)
T d1ckia_ 77 YNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 155 (299)
T ss_dssp EEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEE
T ss_pred EEEEEEEEc-CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCccee
Confidence 999999999 5678887877788999999999999999999999999999999999999997666778899999999987
Q ss_pred cCCCc--------cccccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHH---hcC-CC
Q 014210 313 VRPDE--------RLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVL---KAD-PS 379 (429)
Q Consensus 313 ~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~elltg~~Pf~~~~~~~~~~~i~---~~~-~~ 379 (429)
..... ......||+.|||||++.+ .++.++|||||||++|||++|+.||...........+. ... ..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~ 235 (299)
T d1ckia_ 156 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST 235 (299)
T ss_dssp CBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHS
T ss_pred ccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCC
Confidence 65432 2235679999999998875 58999999999999999999999997655443322221 111 01
Q ss_pred CCCCCCCCCCHHHHHHHHHhcccCccCcCCHHH---HHhhHhhh
Q 014210 380 FDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQ---ALSELLIC 420 (429)
Q Consensus 380 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~---iL~~~~~~ 420 (429)
......+.+++++.+||+.||+.||++||++.+ +|+++|..
T Consensus 236 ~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~ 279 (299)
T d1ckia_ 236 PIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 279 (299)
T ss_dssp CHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHH
T ss_pred ChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHH
Confidence 111123468999999999999999999999875 46777654
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=3.4e-49 Score=378.99 Aligned_cols=254 Identities=20% Similarity=0.303 Sum_probs=208.5
Q ss_pred ccCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCC
Q 014210 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (429)
Q Consensus 153 ~~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~ 232 (429)
++++|+++++||+|+||.||+|+... +|+.||||++...... ..+.+|+++++.|.+|+|++.+++++.+++
T Consensus 3 ig~~Y~i~~~iG~G~fG~Vy~a~~~~---~~~~vAvK~~~~~~~~-----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~ 74 (293)
T d1csna_ 3 VGVHYKVGRRIGEGSFGVIFEGTNLL---NNQQVAIKFEPRRSDA-----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGL 74 (293)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETT---TTEEEEEEEEECCTTS-----CCHHHHHHHHHHTTTCTTCCCEEEEEEETT
T ss_pred CCCceEEEEEEecCCCeEEEEEEECC---CCCEEEEEEEccccCc-----HHHHHHHHHHHHhcCCCCCCEEEEEeecCC
Confidence 46899999999999999999999776 5899999998654321 346789999999997799999999999999
Q ss_pred eEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecC--CCceEEEeecCCc
Q 014210 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKD--ENSVLKAIDFGLS 310 (429)
Q Consensus 233 ~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~--~~~~vkL~DFGla 310 (429)
..++||||+ +++|.+++...+..+++..+..++.|++.||+|||++|||||||||+|||++... .++.+||+|||++
T Consensus 75 ~~~~vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a 153 (293)
T d1csna_ 75 HNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV 153 (293)
T ss_dssp EEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred ccEEEEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEccccee
Confidence 999999999 6799998887778899999999999999999999999999999999999996432 3568999999999
Q ss_pred cccCCCc--------cccccccCCcccCcccccC-CCCCcccHHHHHHHHHHHHcCCCCCCCCCh---HHHHHHHHhcC-
Q 014210 311 DFVRPDE--------RLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTE---SGIFRAVLKAD- 377 (429)
Q Consensus 311 ~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlGvll~elltg~~Pf~~~~~---~~~~~~i~~~~- 377 (429)
+.+.... .....+||+.|||||++.+ .++.++|||||||++|||++|+.||.+... ......+....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~ 233 (293)
T d1csna_ 154 KFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ 233 (293)
T ss_dssp EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHH
T ss_pred EEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccC
Confidence 8764321 2345689999999998875 599999999999999999999999975432 23333332211
Q ss_pred CCCCCCCCCCCCHHHHHHHHHhcccCccCcCCHHHHHh
Q 014210 378 PSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALS 415 (429)
Q Consensus 378 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~ 415 (429)
........+.+++++.+|+..|+..+|++||+++.+.+
T Consensus 234 ~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~ 271 (293)
T d1csna_ 234 STPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271 (293)
T ss_dssp HSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred CCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 11111122468899999999999999999999877644
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-48 Score=375.98 Aligned_cols=249 Identities=23% Similarity=0.297 Sum_probs=190.9
Q ss_pred cCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCC-
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD- 232 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~- 232 (429)
..+|.+.++||+|+||.||+|+. +|+.||||++... .......+.|+..+.+++ |||||++++++.+.+
T Consensus 2 ~~~~~l~~~iG~G~fg~Vy~~~~-----~g~~vAvK~~~~~----~~~~~~~e~ei~~~~~~~-HpnIv~~~~~~~~~~~ 71 (303)
T d1vjya_ 2 ARTIVLQESIGKGRFGEVWRGKW-----RGEEVAVKIFSSR----EERSWFREAEIYQTVMLR-HENILGFIAADNKDNG 71 (303)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE-----TTEEEEEEEECGG----GHHHHHHHHHHHTSTTCC-CTTBCCEEEEEEEECS
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE-----CCEEEEEEEECcc----chhHHHHHHHHHHHhhCC-CCcCcceEEEEEeCCC
Confidence 46789999999999999999974 4789999998532 111222334555556777 999999999998754
Q ss_pred ---eEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH--------cCceeccCCCCcEEEeecCCCce
Q 014210 233 ---NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHL--------QGVVHRDLKPENFLFTTKDENSV 301 (429)
Q Consensus 233 ---~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~--------~~iiHrDIKp~NILl~~~~~~~~ 301 (429)
.+|||||||++|+|.+++.+ ..+++..+..++.|++.||.|||+ +|||||||||+|||| +.++.
T Consensus 72 ~~~~~~lv~Ey~~~g~L~~~l~~--~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl---~~~~~ 146 (303)
T d1vjya_ 72 TWTQLWLVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGT 146 (303)
T ss_dssp SSEEEEEEEECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEE---CTTSC
T ss_pred cceEEEEEEecccCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEE---cCCCC
Confidence 58999999999999999865 368999999999999999999996 589999999999999 78899
Q ss_pred EEEeecCCccccCCCc-----cccccccCCcccCcccccCC-------CCCcccHHHHHHHHHHHHcCCCCCCCCC----
Q 014210 302 LKAIDFGLSDFVRPDE-----RLNDIVGSAYYVAPEVLHRS-------YSTEADVWSIGVIAYILLCGSRPFWART---- 365 (429)
Q Consensus 302 vkL~DFGla~~~~~~~-----~~~~~~gt~~y~aPE~~~~~-------~~~~sDiwSlGvll~elltg~~Pf~~~~---- 365 (429)
+||+|||+++...... .....+||+.|||||++.+. ++.++|||||||+||||+||..||....
T Consensus 147 ~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~ 226 (303)
T d1vjya_ 147 CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQL 226 (303)
T ss_dssp EEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCC
T ss_pred eEEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCccccccc
Confidence 9999999998764432 23456899999999998643 4668999999999999999988763211
Q ss_pred ----------hHHHHHHHHhcCCC---CCCCC-CCCCCHHHHHHHHHhcccCccCcCCHHHHHhhH
Q 014210 366 ----------ESGIFRAVLKADPS---FDEAP-WPSLSSEARDFVKRLLNKDPRKRLTAAQALSEL 417 (429)
Q Consensus 366 ----------~~~~~~~i~~~~~~---~~~~~-~~~~s~~~~~li~~~L~~dP~~Rps~~~iL~~~ 417 (429)
....+......... ++... ......++.+|+.+||+.||++|||+.|+++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L 292 (303)
T d1vjya_ 227 PYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTL 292 (303)
T ss_dssp TTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHH
T ss_pred chhhcccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHH
Confidence 11222333222211 11100 011235689999999999999999999998865
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.3e-44 Score=356.51 Aligned_cols=263 Identities=25% Similarity=0.359 Sum_probs=198.1
Q ss_pred ccccc-CceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhc----------CC
Q 014210 150 SKHFA-NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALT----------GH 218 (429)
Q Consensus 150 ~~~~~-~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~----------~h 218 (429)
++.+. ++|+++++||+|+||+||+|+.+. +|+.||||++.+. ....+.+.+|+++++++. +|
T Consensus 7 g~~~~~~rY~i~~~LG~G~fg~Vy~~~~~~---~g~~vAvKvi~~~----~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~ 79 (362)
T d1q8ya_ 7 GEPYKDARYILVRKLGWGHFSTVWLAKDMV---NNTHVAMKIVRGD----KVYTEAAEDEIKLLQRVNDADNTKEDSMGA 79 (362)
T ss_dssp TCEETTTTEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHTCCSHHHHHHH
T ss_pred CCCccCCcEEEEEEEeeCCCeEEEEEEECC---CCCEEEEEEEecc----ccchHHHHHHHHHHHHhcchhhhhhhhcCc
Confidence 45444 469999999999999999999776 6899999999653 233467789999998886 26
Q ss_pred CCcceEEEEEEe--CCeEEEEEEecCCCcHHHH--HHhcCCCCCHHHHHHHHHHHHHHHHHHHH-cCceeccCCCCcEEE
Q 014210 219 NNLVKFFDAYED--TDNVYVVMELCEGGELLDR--ILSRGGKYTEDDAKAVMIQILNVVAFCHL-QGVVHRDLKPENFLF 293 (429)
Q Consensus 219 ~nIv~l~~~~~~--~~~~~lv~E~~~ggsL~~~--i~~~~~~l~~~~~~~i~~qi~~gL~~LH~-~~iiHrDIKp~NILl 293 (429)
+||+++++++.. ....+++|+++..+..... .......+++..++.++.||+.||.|||+ .||+||||||+||||
T Consensus 80 ~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll 159 (362)
T d1q8ya_ 80 NHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLM 159 (362)
T ss_dssp TTBCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEE
T ss_pred CceEEEEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeee
Confidence 889999998864 3566777777655543322 22345679999999999999999999998 899999999999999
Q ss_pred eecCCC---ceEEEeecCCccccCCCccccccccCCcccCccccc-CCCCCcccHHHHHHHHHHHHcCCCCCCCCChH--
Q 014210 294 TTKDEN---SVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTES-- 367 (429)
Q Consensus 294 ~~~~~~---~~vkL~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlGvll~elltg~~Pf~~~~~~-- 367 (429)
+..+.. ..+||+|||.+.... ......+||+.|+|||++. ..++.++|||||||++++|++|+.||......
T Consensus 160 ~~~~~~~~~~~~kl~dfg~s~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~ 237 (362)
T d1q8ya_ 160 EIVDSPENLIQIKIADLGNACWYD--EHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSY 237 (362)
T ss_dssp EEEETTTTEEEEEECCCTTCEETT--BCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC--------
T ss_pred eccCcccccceeeEeecccccccc--cccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccc
Confidence 643322 259999999987653 3345678999999999876 56899999999999999999999999644321
Q ss_pred ----HHHHHHHhcCC------------------------CCC--------------CCCCCCCCHHHHHHHHHhcccCcc
Q 014210 368 ----GIFRAVLKADP------------------------SFD--------------EAPWPSLSSEARDFVKRLLNKDPR 405 (429)
Q Consensus 368 ----~~~~~i~~~~~------------------------~~~--------------~~~~~~~s~~~~~li~~~L~~dP~ 405 (429)
..+........ ... .......++++.|||.+||..||.
T Consensus 238 ~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~ 317 (362)
T d1q8ya_ 238 TKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPR 317 (362)
T ss_dssp -CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTT
T ss_pred cchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChh
Confidence 11111111000 000 000112467899999999999999
Q ss_pred CcCCHHHHHhhHhhhc
Q 014210 406 KRLTAAQALSELLICY 421 (429)
Q Consensus 406 ~Rps~~~iL~~~~~~~ 421 (429)
+|||++|+|+|+||+.
T Consensus 318 ~Rpta~e~L~Hp~f~~ 333 (362)
T d1q8ya_ 318 KRADAGGLVNHPWLKD 333 (362)
T ss_dssp TCBCHHHHHTCGGGTT
T ss_pred HCcCHHHHhcCcccCC
Confidence 9999999999999974
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.93 E-value=4.1e-27 Score=210.22 Aligned_cols=168 Identities=26% Similarity=0.249 Sum_probs=122.8
Q ss_pred eeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcC---------------cHHHHHHHHHHHHHHHHhcCCCCc
Q 014210 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMT---------------TAIAIEDVRREVKILRALTGHNNL 221 (429)
Q Consensus 157 y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~---------------~~~~~~~~~~Ei~il~~l~~h~nI 221 (429)
+.++++||+|+||.||+|+.. +|+.||||++...... .........+|...+.++. |.++
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~----~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~v 76 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE----KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ-GLAV 76 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET----TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT-TSSS
T ss_pred chhCCEeeeCcceEEEEEECC----CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHcc-CCCc
Confidence 467899999999999999864 3889999987532110 0112234567899999998 8999
Q ss_pred ceEEEEEEeCCeEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCce
Q 014210 222 VKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSV 301 (429)
Q Consensus 222 v~l~~~~~~~~~~~lv~E~~~ggsL~~~i~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iiHrDIKp~NILl~~~~~~~~ 301 (429)
+..+++. . .+|+|||+++..+. .+++..+..++.||+.+|.|||++||+||||||+|||++ + ..
T Consensus 77 ~~~~~~~--~--~~lvme~~~~~~~~--------~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~---~-~~ 140 (191)
T d1zara2 77 PKVYAWE--G--NAVLMELIDAKELY--------RVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS---E-EG 140 (191)
T ss_dssp CCEEEEE--T--TEEEEECCCCEEGG--------GCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE---T-TE
T ss_pred ceEEEec--C--CEEEEEeecccccc--------chhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeee---C-CC
Confidence 9988653 2 27999999886543 245566788999999999999999999999999999994 3 34
Q ss_pred EEEeecCCccccCCCccccccccCCcccC------cccccCCCCCcccHHHHHHHHH
Q 014210 302 LKAIDFGLSDFVRPDERLNDIVGSAYYVA------PEVLHRSYSTEADVWSIGVIAY 352 (429)
Q Consensus 302 vkL~DFGla~~~~~~~~~~~~~gt~~y~a------PE~~~~~~~~~sDiwSlGvll~ 352 (429)
++|+|||+|......... .|.. .+.+.+.|+.++|+||+.--++
T Consensus 141 ~~liDFG~a~~~~~~~~~-------~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~~~ 190 (191)
T d1zara2 141 IWIIDFPQSVEVGEEGWR-------EILERDVRNIITYFSRTYRTEKDINSAIDRIL 190 (191)
T ss_dssp EEECCCTTCEETTSTTHH-------HHHHHHHHHHHHHHHHHHCCCCCHHHHHHHHH
T ss_pred EEEEECCCcccCCCCCcH-------HHHHHHHHHHHHHHcCCCCCcccHHHHHHHHh
Confidence 899999998765422211 1111 1223467899999999865443
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.69 E-value=5.2e-08 Score=88.55 Aligned_cols=87 Identities=14% Similarity=0.075 Sum_probs=61.1
Q ss_pred cCceeEeceeeccCceEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe
Q 014210 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (429)
Q Consensus 154 ~~~y~~~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~ 233 (429)
...|+..+..+-++.+.||+... .++.++||+....... ....+.+|..++..|..+--+.+++.++.+++.
T Consensus 13 ~~~~~~~~~~~G~s~~~v~rv~~-----~~~~~vlk~~~~~~~~---~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~ 84 (263)
T d1j7la_ 13 IEKYRCVKDTEGMSPAKVYKLVG-----ENENLYLKMTDSRYKG---TTYDVEREKDMMLWLEGKLPVPKVLHFERHDGW 84 (263)
T ss_dssp HTTSEEEECSCCCSSSEEEEEEC-----SSCEEEEEEECGGGTT---STTCHHHHHHHHHHHTTTSCCCCEEEEEEETTE
T ss_pred hhceEEEEcCCCCCCCcEEEEEe-----CCCeEEEEEcCCCccc---chhhHHHHHHHHHHHhccCCCCcEEEEEecCCc
Confidence 34666666544344468997652 3667889987543211 123467899999988765557788988888999
Q ss_pred EEEEEEecCCCcHHH
Q 014210 234 VYVVMELCEGGELLD 248 (429)
Q Consensus 234 ~~lv~E~~~ggsL~~ 248 (429)
.++||++++|..+.+
T Consensus 85 ~~lv~~~l~G~~~~~ 99 (263)
T d1j7la_ 85 SNLLMSEADGVLCSE 99 (263)
T ss_dssp EEEEEECCSSEEHHH
T ss_pred eEEEEEecccccccc
Confidence 999999999877654
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.17 E-value=4.2e-06 Score=75.10 Aligned_cols=74 Identities=12% Similarity=0.108 Sum_probs=51.6
Q ss_pred eeccCc-eEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCC-CcceEEEEEEeCCeEEEEEEe
Q 014210 163 VGRGHF-GYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHN-NLVKFFDAYEDTDNVYVVMEL 240 (429)
Q Consensus 163 IG~G~f-g~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~-nIv~l~~~~~~~~~~~lv~E~ 240 (429)
+..|.. +.||+..... |..+++|.-..... ..+..|...++.|..+. .+.+++.+..+.+..++|||+
T Consensus 18 ~~~G~s~~~v~r~~~~~----~~~~vlK~~~~~~~------~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~ 87 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQG----RPVLFVKTDLSGAL------NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGE 87 (255)
T ss_dssp CSCTTSSCEEEEEECTT----SCCEEEEEECSCTT------SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEEC
T ss_pred cCCcccCCeEEEEEeCC----CCEEEEEeCCccCH------hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEe
Confidence 344443 5788876433 66789998654321 24678888888887432 256788888888899999999
Q ss_pred cCCCcH
Q 014210 241 CEGGEL 246 (429)
Q Consensus 241 ~~ggsL 246 (429)
++|.++
T Consensus 88 i~G~~~ 93 (255)
T d1nd4a_ 88 VPGQDL 93 (255)
T ss_dssp CSSEET
T ss_pred eecccc
Confidence 988654
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.14 E-value=3.6e-06 Score=81.21 Aligned_cols=82 Identities=20% Similarity=0.236 Sum_probs=50.9
Q ss_pred eceeeccCceEEEEEEEecCcccCeEEEEEEccCCC----cCcHHHHHHHHHHHHHHHHhcCC--CCcceEEEEEEeCCe
Q 014210 160 GEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHK----MTTAIAIEDVRREVKILRALTGH--NNLVKFFDAYEDTDN 233 (429)
Q Consensus 160 ~~~IG~G~fg~V~~~~~~~~~~~g~~vAvK~~~~~~----~~~~~~~~~~~~Ei~il~~l~~h--~nIv~l~~~~~~~~~ 233 (429)
.+.||.|....||++.... .|+.|+||.-.... .......++...|.+.|+.+..+ ..+.+++.+ +.+.
T Consensus 31 ~~eig~G~~N~vfrV~~~~---~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~ 105 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQE---HDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEM 105 (392)
T ss_dssp EEECCSSSSEEEEEEEC-------CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTT
T ss_pred EEEeCCCceEeEEEEEeCC---CCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCC
Confidence 4578999999999987544 46789999643210 00111234466788888887644 245566654 4455
Q ss_pred EEEEEEecCCCcH
Q 014210 234 VYVVMELCEGGEL 246 (429)
Q Consensus 234 ~~lv~E~~~ggsL 246 (429)
.++|||++++..+
T Consensus 106 ~~lvmE~L~~~~~ 118 (392)
T d2pula1 106 AVTVMEDLSHLKI 118 (392)
T ss_dssp TEEEECCCTTSEE
T ss_pred CEEEEeccCCccc
Confidence 6889999987543
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.53 E-value=8.1e-05 Score=71.38 Aligned_cols=77 Identities=12% Similarity=0.059 Sum_probs=52.2
Q ss_pred eceeeccCceEEEEEEEecCc----ccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEE
Q 014210 160 GEEVGRGHFGYTCAAKFKKGE----LKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVY 235 (429)
Q Consensus 160 ~~~IG~G~fg~V~~~~~~~~~----~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv~l~~~~~~~~~~~ 235 (429)
++.|+-|---.+|++....+. ...+.|.+++.... .. .-...+|..+++.+..+.-..++++++.+ +
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~--~~---~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g 117 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ET---ESHLVAESVIFTLLSERHLGPKLYGIFSG----G 117 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CC---HHHHHHHHHHHHHHHHTTSSSCEEEEETT----E
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc--ch---hhHHHHHHHHHHHHHhCCCCCeEEEEcCC----c
Confidence 356776777799999876542 13466778776421 12 23456899999999866555678887643 6
Q ss_pred EEEEecCCCc
Q 014210 236 VVMELCEGGE 245 (429)
Q Consensus 236 lv~E~~~ggs 245 (429)
+||||++|..
T Consensus 118 ~I~efi~g~~ 127 (395)
T d1nw1a_ 118 RLEEYIPSRP 127 (395)
T ss_dssp EEECCCCEEE
T ss_pred eEEEEecccc
Confidence 8999998754
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.35 E-value=0.00026 Score=65.82 Aligned_cols=67 Identities=9% Similarity=0.093 Sum_probs=43.6
Q ss_pred eEEEEEEEecCcccCeEEEEEEccCCCcCcHHHHHHHHHHHHHHHHhcCCCCcc--eEE-----EEEEeCCeEEEEEEec
Q 014210 169 GYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLV--KFF-----DAYEDTDNVYVVMELC 241 (429)
Q Consensus 169 g~V~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~Ei~il~~l~~h~nIv--~l~-----~~~~~~~~~~lv~E~~ 241 (429)
-.||+++..+ |+.|++|+...... ..+++..|+..+..|..+ .|. ..+ ..++.++..+.+++++
T Consensus 36 N~vy~v~~~d----g~~~VlK~~rp~~~----s~~~i~~E~~~l~~L~~~-gipv~~p~~~~g~~~~~~~~~~~~l~~~~ 106 (325)
T d1zyla1 36 NRVYQFQDED----RRRFVVKFYRPERW----TADQILEEHQFALQLVND-EVPVAAPVAFNGQTLLNHQGFYFAVFPSV 106 (325)
T ss_dssp SEEEEECCTT----CCCEEEEEECTTTS----CHHHHHHHHHHHHHHHHT-TCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred ceeEEEEcCC----CCEEEEEEeCCCCC----CHHHHHHHHHHHHHHHhc-CCCCCCceecCCCeeeeeeeEEEEEEeec
Confidence 5899887544 78899999864322 235677899998888732 221 111 1224466788999999
Q ss_pred CCC
Q 014210 242 EGG 244 (429)
Q Consensus 242 ~gg 244 (429)
+|.
T Consensus 107 ~G~ 109 (325)
T d1zyla1 107 GGR 109 (325)
T ss_dssp CCE
T ss_pred CCc
Confidence 764
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.74 E-value=0.0015 Score=59.83 Aligned_cols=30 Identities=33% Similarity=0.476 Sum_probs=25.7
Q ss_pred CceeccCCCCcEEEeecCCCceEEEeecCCccc
Q 014210 280 GVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (429)
Q Consensus 280 ~iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~ 312 (429)
|+||+|+.++||++ +.+...-|+||+.+..
T Consensus 184 giIHgDl~~dNvl~---~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 184 GVIHADLFQDNVFF---LGDELSGLIDFYFACN 213 (316)
T ss_dssp EEECSCCCGGGEEE---ETTEEEEECCCTTCEE
T ss_pred ccccCCcchhhhhc---ccccceeEeccccccc
Confidence 69999999999999 5666778999998753
|